"pdb","title","DOI","resolution","Mean_B_Factor","oligo","oligo_sequence","residue_links","oligo_mean_B_Factor","comments","warnings","errors"
"146D","SOLUTION STRUCTURE OF THE MITHRAMYCIN DIMER-DNA COMPLEX","10.1021/BI00077A012 ","2.95026e-39",0,"146d_oligo15","DAltp[6H,2H,3<R1>]b1-3DTalp[6H,2H]b1-3DOlipb1-","MDA(3_D_)-DDL(2_D_)-DDA(1_D_)",0.239333,"","",""
"146D","SOLUTION STRUCTURE OF THE MITHRAMYCIN DIMER-DNA COMPLEX","10.1021/BI00077A012 ","2.95026e-39",0,"146d_oligo14","DAltp[6H,2H,3<R1>]b1-3DTalp[6H,2H]b1-3DOlipb1-","MDA(3_F_)-DDL(2_F_)-DDA(1_F_)",0.248333,"","",""
"1A14","COMPLEX BETWEEN NC10 ANTI-INFLUENZA VIRUS NEURAMINIDASE SINGLE CHAIN ANTIBODY WITH A 5 RESIDUE LINKER AND INFLUENZA VIRUS NEURAMINIDASE","10.1006/JMBI.1998.1794 ",2.5,0,"1a14_oligo1","DManpa1-2DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_A_)-MAN(5_A_)-MAN(4_A_)-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(200_N_)",10.0011,"","",""
"1ABR","CRYSTAL STRUCTURE OF ABRIN-A","10.1006/JMBI.1995.0382 ",2.14,30.1,"1abr_oligo2","DManpb1-3[DManpa1-6]DGlcpa1-4LGlcpNAca1-4DGlcpNAcx1-","MAN(5_C_)-[BMA(4_C_)]-MAN(3_C_)-NGZ(2_C_)-NDG(1_C_)",51.1106,"","",""
"1ABR","CRYSTAL STRUCTURE OF ABRIN-A","10.1006/JMBI.1995.0382 ",2.14,30.1,"1abr_oligo1","DManpb1-3[DManpa1-6]DGlcpb1-4LManpNAca1-4DGlcpNAcx1-","MAN(5_D_)-[BMA(4_D_)]-BGC(3_D_)-NDG(2_D_)-NDG(1_D_)",60.705,"","",""
"1AGM","REFINED STRUCTURE FOR THE COMPLEX OF ACARBOSE WITH GLUCOAMYLASE FROM ASPERGILLUS AWAMORI VAR. X100 TO 2.4 ANGSTROMS RESOLUTION","",2.3,0,"1agm_oligo1","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(171_A_)",30.536,"","",""
"1AGM","REFINED STRUCTURE FOR THE COMPLEX OF ACARBOSE WITH GLUCOAMYLASE FROM ASPERGILLUS AWAMORI VAR. X100 TO 2.4 ANGSTROMS RESOLUTION","",2.3,0,"1agm_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_C_)-MAN(7_C_)-[MAN(6_C_)-MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(395_A_)",25.2255,"","",""
"1AX0","ERYTHRINA CORALLODENDRON LECTIN IN COMPLEX WITH N-ACTYLGALACTOSAMINE","10.1006/JMBI.1998.1664 ",1.9,25.1,"1ax0_oligo2","DXylpb1-2[DManpa1-3][DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(6_B_)-[MAN(5_B_)]-[XYP(4_B_)]-BMA(3_B_)-NAG(2_B_)-[FUC(7_B_)]-NAG(1_B_)-ASN(17_A_)",33.6915,"","",""
"1AX1","ERYTHRINA CORALLODENDRON LECTIN IN COMPLEX WITH LACTOSE","10.1006/JMBI.1998.1664 ",1.95,32.4,"1ax1_oligo1","DXylpb1-2[DManpa1-3][DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(6_B_)-[MAN(5_B_)]-[XYP(4_B_)]-BMA(3_B_)-NAG(2_B_)-[FUC(7_B_)]-NAG(1_B_)-ASN(17_A_)",39.5702,"","",""
"1AX2","ERYTHRINA CORALLODENDRON LECTIN IN COMPLEX WITH N-ACETYLLACTOSAMINE","10.1006/JMBI.1998.1664 ",1.95,27.5,"1ax2_oligo1","DXylpb1-2[DManpa1-3][DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(6_B_)-[MAN(5_B_)]-[XYP(4_B_)]-BMA(3_B_)-NAG(2_B_)-[FUC(7_B_)]-NAG(1_B_)-ASN(17_A_)",36.984,"","",""
"1AXY","ERYTHRINA CORALLODENDRON LECTIN","10.1006/JMBI.1998.1664 ",1.95,27.4,"1axy_oligo1","DXylpb1-2[DManpa1-3][DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(6_B_)-[MAN(5_B_)]-[XYP(4_B_)]-BMA(3_B_)-NAG(2_B_)-[FUC(7_B_)]-NAG(1_B_)-ASN(17_A_)",33.4228,"","",""
"1AXZ","ERYTHRINA CORALLODENDRON LECTIN IN COMPLEX WITH D-GALACTOSE","10.1006/JMBI.1998.1664 ",1.95,23.2,"1axz_oligo1","DXylpb1-2[DManpa1-3][DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(6_B_)-[MAN(5_B_)]-[XYP(4_B_)]-BMA(3_B_)-NAG(2_B_)-[FUC(7_B_)]-NAG(1_B_)-ASN(17_A_)",29.3988,"","",""
"1AY2","STRUCTURE OF THE FIBER-FORMING PROTEIN PILIN AT 2.6 ANGSTROMS RESOLUTION","10.1038/378032A0 ",2.6,30,"1ay2_oligo1","DGalpa1-3DGlcpNAcb1-SER","GLA(2_B_)-NAG(1_B_)-SER(63_A_)",34.19,"","",""
"1B37","A 30 ANGSTROM U-SHAPED CATALYTIC TUNNEL IN THE CRYSTAL STRUCTURE OF POLYAMINE OXIDASE","10.1016/S0969-2126(99)80037-9 ",1.9,0,"1b37_oligo6","DFucpa1-3DGlcpNAcb1-ASN","FCA(5_F_)-NAG(1_F_)-ASN(77_C_)",31.6955,"","",""
"1B5F","NATIVE CARDOSIN A FROM CYNARA CARDUNCULUS L.","10.1074/JBC.274.39.27694 ",1.72,0,"1b5f_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-[FUC(6_G_)]-NAG(1_G_)-ASN(67_C_)",55.8461,"","",""
"1B5F","NATIVE CARDOSIN A FROM CYNARA CARDUNCULUS L.","10.1074/JBC.274.39.27694 ",1.72,0,"1b5f_oligo4","DManpa1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","BMA(3_H_)-NAG(2_H_)-[FUC(4_H_)]-NAG(1_H_)-ASN(257_D_)",91.357,"","",""
"1B5F","NATIVE CARDOSIN A FROM CYNARA CARDUNCULUS L.","10.1074/JBC.274.39.27694 ",1.72,0,"1b5f_oligo3","DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","BMA(3_F_)-NAG(2_F_)-[FUC(4_F_)]-NAG(1_F_)-ASN(257_B_)",69.8023,"","",""
"1B5F","NATIVE CARDOSIN A FROM CYNARA CARDUNCULUS L.","10.1074/JBC.274.39.27694 ",1.72,0,"1b5f_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-[FUC(5_E_)]-NAG(1_E_)-ASN(67_A_)",44.0482,"","",""
"1B5Q","A 30 ANGSTROM U-SHAPED CATALYTIC TUNNEL IN THE CRYSTAL STRUCTURE OF POLYAMINE OXIDASE","10.1016/S0969-2126(99)80037-9 ",1.9,0,"1b5q_oligo8","DFucpa1-3DGlcpNAcb1-ASN","FCA(5_F_)-NAG(1_F_)-ASN(77_C_)",22.0027,"","",""
"1BCS","COMPLEX OF THE WHEAT SERINE CARBOXYPEPTIDASE, CPDW-II, WITH THE MICROBIAL PEPTIDE ALDEHYDE INHIBITOR, CHYMOSTATIN, AND ARGININE AT 100 DEGREES KELVIN","10.1006/JMBI.1996.0058 ",2.08,0,"1bcs_oligo1","LFucpa1-3[DManpNAca1-4]DGlcpNAcx1-","NDG(3_D_)-[FUC(2_D_)]-NAG(1_D_)",67.7379,"","",""
"1BHG","HUMAN BETA-GLUCURONIDASE AT 2.6 A RESOLUTION","10.1038/NSB0496-375 ",2.53,0,"1bhg_oligo1","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-MAN(5_D_)-[MAN(7_D_)]-MAN(4_D_)-[MAN(9_D_)-MAN(8_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(173_B_)",19.3783,"","",""
"1BHG","HUMAN BETA-GLUCURONIDASE AT 2.6 A RESOLUTION","10.1038/NSB0496-375 ",2.53,0,"1bhg_oligo2","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-MAN(5_C_)-[MAN(7_C_)]-MAN(4_C_)-[MAN(9_C_)-MAN(8_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(173_A_)",15.4829,"","",""
"1BJI","THE X-RAY STRUCTURE OF A COMPLEX OF TERN N9 INFLUENZA VIRUS NEURAMINIDASE COMPLEXED WITH THE GLAXO 6-CARBOXAMIDE SIALIC ACID ANALOGUE GR217029","10.1021/JM9703754 ",2,0,"1bji_oligo1","DManpa1-2DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-MAN(5_B_)-MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",26.9342,"","",""
"1BLF","STRUCTURE OF DIFERRIC BOVINE LACTOFERRIN AT 2.8 ANGSTROMS RESOLUTION","10.1006/JMBI.1997.1386 ",2.8,0,"1blf_oligo1","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)]-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(545_A_)",68.3311,"","",""
"1BP8","4:2:1 MITHRAMYCIN:MG++:D(ACCCGGGT)2 COMPLEX","10.1002/1097-0282(200008)54:2<104::AID-BIP3>3.0.CO;2-2 ","2.95026e-39",0,"1bp8_oligo25","DAltp[6H,2H,3<R1>]b1-3DTalp[6H,2H]b1-3DOlipb1-","MDA(3_F_)-DDL(2_F_)-DDA(1_F_)",0,"","",""
"1BP8","4:2:1 MITHRAMYCIN:MG++:D(ACCCGGGT)2 COMPLEX","10.1002/1097-0282(200008)54:2<104::AID-BIP3>3.0.CO;2-2 ","2.95026e-39",0,"1bp8_oligo21","DAltp[6H,2H,3<R1>]b1-3DTalp[6H,2H]b1-3DOlipb1-","MDA(3_D_)-DDL(2_D_)-DDA(1_D_)",0,"","",""
"1BP8","4:2:1 MITHRAMYCIN:MG++:D(ACCCGGGT)2 COMPLEX","10.1002/1097-0282(200008)54:2<104::AID-BIP3>3.0.CO;2-2 ","2.95026e-39",0,"1bp8_oligo26","DAltp[6H,2H,3<R1>]b1-3DTalp[6H,2H]b1-3DOlipb1-C21O9","MDA(3_G_)-DDL(2_G_)-DDA(1_G_)",0,"","",""
"1BP8","4:2:1 MITHRAMYCIN:MG++:D(ACCCGGGT)2 COMPLEX","10.1002/1097-0282(200008)54:2<104::AID-BIP3>3.0.CO;2-2 ","2.95026e-39",0,"1bp8_oligo20","DAltp[6H,2H,3<R1>]b1-3DTalp[6H,2H]b1-3DOlipb1-","MDA(3_J_)-DDL(2_J_)-DDA(1_J_)",0,"","",""
"1BZB","GLYCOSYLATED EEL CALCITONIN","10.1021/BI983018J ","2.95026e-39",0,"1bzb_oligo1","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_B_)-[MAN(7_B_)]-MAN(6_B_)-[MAN(5_B_)-MAN(4_B_)]-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(3_A_)",0,"","",""
"1C1Z","CRYSTAL STRUCTURE OF HUMAN BETA-2-GLYCOPROTEIN-I (APOLIPOPROTEIN-H)","10.1093/EMBOJ/18.22.6228 ",2.87,55.3,"1c1z_oligo2","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAca1-4DGlcpNAcb1-ASN","MAN(5_C_)-[BMA(4_C_)]-BMA(3_C_)-NDG(2_C_)-NAG(1_C_)-ASN(174_A_)",118.151,"","",""
"1C39","STRUCTURE OF CATION-DEPENDENT MANNOSE 6-PHOSPHATE RECEPTOR BOUND TO PENTAMANNOSYL PHOSPHATE","10.1074/JBC.274.42.29889 ",1.85,29.8,"1c39_oligo1","DManp[6P]a1-3DManpa1-3DManpa1-ROH","M6P(3_E_)-MAN(2_E_)-MAN(1_E_)",43.3721,"","",""
"1C39","STRUCTURE OF CATION-DEPENDENT MANNOSE 6-PHOSPHATE RECEPTOR BOUND TO PENTAMANNOSYL PHOSPHATE","10.1074/JBC.274.42.29889 ",1.85,29.8,"1c39_oligo4","DManp[6P]a1-3DManpa1-3DManpa1-ROH","M6P(3_F_)-MAN(2_F_)-MAN(1_F_)",35.9673,"","",""
"1C3M","CRYSTAL STRUCTURE OF HELTUBA COMPLEXED TO MAN(1-3)MAN","10.1016/S0969-2126(00)88338-0 ",2,0,"1c3m_oligo1","DManpa1-3DManpx1-","MAN(2_B_)-MAN(1_B_)",51.3128,"","",""
"1CAP","CONFORMATION AND MOLECULAR ORGANIZATION IN FIBERS OF THE CAPSULAR POLYSACCHARIDE FROM ESCHERICHIA COLI M41 MUTANT","10.1016/S0022-2836(77)80018-1 ",3,0,"1cap_oligo1","DManpa1-3DGlcpb1-3[DManp[2<R1>]a1-4]DGlcpAb1-3DGalpa1-2DManpa1-3DGlcpb1-3[DManp[2<R2>]a1-4]DGlcpAb1-3DGalpx1-","MAN(11_A_)-MAN(9_A_)-[MAN(8_A_)-BGC(7_A_)]-BDP(6_A_)-GAL(5_A_)-MAN(4_A_)-BGC(3_A_)]-BDP(2_A_)-GAL(1_A_)",0,"","",""
"1CF3","GLUCOSE OXIDASE FROM APERGILLUS NIGER","10.1107/S0907444999003431 ",1.9,24.22,"1cf3_oligo5","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(89_A_)",40.0258,"","",""
"1CKL","N-TERMINAL TWO DOMAINS OF HUMAN CD46 (MEMBRANE COFACTOR PROTEIN, MCP)","10.1093/EMBOJ/18.11.2911 ",3.1,0,"1ckl_oligo4","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_P_)-MAN(5_P_)-[MAN(7_P_)]-MAN(4_P_)-[MAN(8_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(80_E_)",132.307,"","",""
"1CKL","N-TERMINAL TWO DOMAINS OF HUMAN CD46 (MEMBRANE COFACTOR PROTEIN, MCP)","10.1093/EMBOJ/18.11.2911 ",3.1,0,"1ckl_oligo6","DManpa1-3DManpb1-","MAN(4_H_)-BMA(3_H_)-NAG(2_H_)",163.795,"","",""
"1CKL","N-TERMINAL TWO DOMAINS OF HUMAN CD46 (MEMBRANE COFACTOR PROTEIN, MCP)","10.1093/EMBOJ/18.11.2911 ",3.1,0,"1ckl_oligo12","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(80_D_)",126.692,"","",""
"1CKL","N-TERMINAL TWO DOMAINS OF HUMAN CD46 (MEMBRANE COFACTOR PROTEIN, MCP)","10.1093/EMBOJ/18.11.2911 ",3.1,0,"1ckl_oligo2","DManpa1-2DManpa1-3DManpa1-","MAN(6_G_)-MAN(5_G_)-MAN(4_G_)-BMA(3_G_)",153.911,"","",""
"1CKL","N-TERMINAL TWO DOMAINS OF HUMAN CD46 (MEMBRANE COFACTOR PROTEIN, MCP)","10.1093/EMBOJ/18.11.2911 ",3.1,0,"1ckl_oligo14","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Q_)-[MAN(5_Q_)]-MAN(4_Q_)-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(49_F_)",126.858,"","",""
"1CKL","N-TERMINAL TWO DOMAINS OF HUMAN CD46 (MEMBRANE COFACTOR PROTEIN, MCP)","10.1093/EMBOJ/18.11.2911 ",3.1,0,"1ckl_oligo15","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_R_)-[MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(80_F_)",126.788,"","",""
"1CLY","IGG FAB (HUMAN IGG1, KAPPA) CHIMERIC FRAGMENT (CBR96) COMPLEXED WITH LEWIS Y NONOATE METHYL ESTER","10.1038/NSB0695-466 ",2.5,47.7,"1cly_oligo1","LFucpa1-2DGalpb1-4[LFucpa1-3]DGlcpNAcb1-C10O3","FUC(3_A_)-GAL(2_A_)-[FUC(4_A_)]-NAG(1_A_)",30.7455,"","",""
"1CLZ","IGG FAB (IGG3, KAPPA) FRAGMENT (MBR96) COMPLEXED WITH LEWIS Y NONOATE METHYL ESTER","10.1038/NSB0695-466 ",2.8,14.9,"1clz_oligo1","LFucpa1-2DGalpb1-4[LFucpa1-3]DGlcpNAcb1-C10O3","FUC(3_A_)-GAL(2_A_)-[FUC(4_A_)]-NAG(1_A_)",11.6152,"","",""
"1CP8","NMR STRUCTURE OF DNA (5'-D(TTGGCCAA)2-3') COMPLEXED WITH NOVEL ANTITUMOR DRUG UCH9","10.1093/NAR/26.3.744 ","2.95026e-39","1.15243e-41","1cp8_oligo23","DOlipb1-3DOlip[4Me]b1-3DTalp[6H,2H]b1-3DOlipb1-C24O9","DDA(4_D_)-DRI(3_D_)-DDL(2_D_)-DDA(1_D_)",0.00875,"","",""
"1CP8","NMR STRUCTURE OF DNA (5'-D(TTGGCCAA)2-3') COMPLEXED WITH NOVEL ANTITUMOR DRUG UCH9","10.1093/NAR/26.3.744 ","2.95026e-39","1.15243e-41","1cp8_oligo25","DOlipb1-3DOlip[4Me]b1-3DTalp[6H,2H]b1-3DOlipb1-C24O9","DDA(4_C_)-DRI(3_C_)-DDL(2_C_)-DDA(1_C_)",0.00875,"","",""
"1CPO","CHLOROPEROXIDASE","10.1016/S0969-2126(01)00274-X ",1.9,0,"1cpo_oligo1","DManpa1-3DLyxpa1-6[DLyxpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-XYS(4_B_)-[XYS(6_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(93_A_)",37.9158,"","",""
"1CT1","CHOLERA TOXIN B-PENTAMER MUTANT G33R BOUND TO RECEPTOR PENTASACCHARIDE","",2.3,27,"1ct1_oligo1","DGalpb1-3DGalpNAcb1-4[DNeup5Aca2-3]DGalpb1-4DGlcpb1-ROH","GAL(4_A_)-NGA(3_A_)-[SIA(5_A_)]-GAL(2_A_)-BGC(1_A_)",38.1714,"","",""
"1CT1","CHOLERA TOXIN B-PENTAMER MUTANT G33R BOUND TO RECEPTOR PENTASACCHARIDE","",2.3,27,"1ct1_oligo2","DGalpb1-3DGalpNAcb1-4[DNeup5Aca2-3]DGalpb1-4DGlcpb1-ROH","GAL(4_B_)-NGA(3_B_)-[SIA(5_B_)]-GAL(2_B_)-BGC(1_B_)",42.5491,"","",""
"1CVI","CRYSTAL STRUCTURE OF HUMAN PROSTATIC ACID PHOSPHATASE","10.1002/(SICI)1097-0045(20000215)42:3<211::AID-PROS7>3.0.CO 2-U ",3.2,45.4,"1cvi_oligo5","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_E_)-[NAG(7_E_)-MAN(6_E_)-[NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(1188_A_)",95.1556,"","",""
"1CVI","CRYSTAL STRUCTURE OF HUMAN PROSTATIC ACID PHOSPHATASE","10.1002/(SICI)1097-0045(20000215)42:3<211::AID-PROS7>3.0.CO 2-U ",3.2,45.4,"1cvi_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(1301_A_)",79.6025,"","",""
"1CVI","CRYSTAL STRUCTURE OF HUMAN PROSTATIC ACID PHOSPHATASE","10.1002/(SICI)1097-0045(20000215)42:3<211::AID-PROS7>3.0.CO 2-U ",3.2,45.4,"1cvi_oligo4","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-MAN(4_I_)-[MAN(6_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(2301_B_)",90.0091,"","",""
"1CVN","CONCANAVALIN A COMPLEXED TO TRIMANNOSIDE","10.1074/JBC.271.2.972 ",2.3,17.96,"1cvn_oligo2","DManpa1-3[DManpa1-6]DManpa1-ROH","MAN(3_F_)-[MAN(2_F_)]-MAN(1_F_)",26.2806,"","",""
"1CVN","CONCANAVALIN A COMPLEXED TO TRIMANNOSIDE","10.1074/JBC.271.2.972 ",2.3,17.96,"1cvn_oligo4","DManpa1-3[DManpa1-6]DManpa1-ROH","MAN(3_H_)-[MAN(2_H_)]-MAN(1_H_)",16.8776,"","",""
"1CVN","CONCANAVALIN A COMPLEXED TO TRIMANNOSIDE","10.1074/JBC.271.2.972 ",2.3,17.96,"1cvn_oligo3","DManpa1-3[DManpa1-6]DManpa1-ROH","MAN(3_E_)-[MAN(2_E_)]-MAN(1_E_)",15.0533,"","",""
"1CVN","CONCANAVALIN A COMPLEXED TO TRIMANNOSIDE","10.1074/JBC.271.2.972 ",2.3,17.96,"1cvn_oligo1","DManpa1-3[DManpa1-6]DManpa1-ROH","MAN(3_G_)-[MAN(2_G_)]-MAN(1_G_)",22.8291,"","",""
"1CXP","CRYOGENIC CRYSTAL STRUCTURE OF HUMAN MYELOPEROXIDASE ISOFORM C","10.1074/JBC.275.16.11964 ",1.8,0,"1cxp_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_E_)-[MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(317_C_)",14.6659,"","",""
"1CXP","CRYOGENIC CRYSTAL STRUCTURE OF HUMAN MYELOPEROXIDASE ISOFORM C","10.1074/JBC.275.16.11964 ",1.8,0,"1cxp_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_F_)-[MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(317_D_)",13.8448,"","",""
"1D2V","CRYSTAL STRUCTURE OF BROMIDE-BOUND HUMAN MYELOPEROXIDASE ISOFORM C AT PH 5.5","10.1074/JBC.275.16.11964 ",1.75,0,"1d2v_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_E_)-[MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(317_C_)",14.0189,"","",""
"1D2V","CRYSTAL STRUCTURE OF BROMIDE-BOUND HUMAN MYELOPEROXIDASE ISOFORM C AT PH 5.5","10.1074/JBC.275.16.11964 ",1.75,0,"1d2v_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_F_)-[MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(317_D_)",13.4588,"","",""
"1D5L","CRYSTAL STRUCTURE OF CYANIDE-BOUND HUMAN MYELOPEROXIDASE ISOFORM C AT PH 5.5","10.1021/BI0111808 ",1.9,0,"1d5l_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_E_)-[MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(317_C_)",13.0735,"","",""
"1D5L","CRYSTAL STRUCTURE OF CYANIDE-BOUND HUMAN MYELOPEROXIDASE ISOFORM C AT PH 5.5","10.1021/BI0111808 ",1.9,0,"1d5l_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_F_)-[MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(317_D_)",12.6232,"","",""
"1D7W","CRYSTAL STRUCTURE OF HUMAN MYELOPEROXIDASE ISOFORM C COMPLEXED WITH CYANIDE AND BROMIDE AT PH 4.0","10.1021/BI0111808 ",1.9,0,"1d7w_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_F_)-[MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(317_D_)",15.8158,"","",""
"1D7W","CRYSTAL STRUCTURE OF HUMAN MYELOPEROXIDASE ISOFORM C COMPLEXED WITH CYANIDE AND BROMIDE AT PH 4.0","10.1021/BI0111808 ",1.9,0,"1d7w_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_E_)-[MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(317_C_)",15.8056,"","",""
"1D83","STRUCTURE REFINEMENT OF THE CHROMOMYCIN DIMER/DNA OLIGOMER COMPLEX IN SOLUTION","10.1016/0022-2836(92)90730-8 ","2.95026e-39",0,"1d83_oligo18","LOlip[3<R1>,4Ac]a1-3DOlipb1-3DOlipb1-","ERI(3_F_)-CDR(2_F_)-CDR(1_F_)",0.0113333,"","",""
"1D83","STRUCTURE REFINEMENT OF THE CHROMOMYCIN DIMER/DNA OLIGOMER COMPLEX IN SOLUTION","10.1016/0022-2836(92)90730-8 ","2.95026e-39",0,"1d83_oligo21","LOlip[3<R1>,4Ac]a1-3DOlipb1-3DOlipb1-C21O9","ERI(3_C_)-CDR(2_C_)-CDR(1_C_)",0.0116667,"","",""
"1DBG","CRYSTAL STRUCTURE OF CHONDROITINASE B","10.1006/JMBI.1999.3292 ",1.7,0,"1dbg_oligo1","DGalp[4H]a1-3[DGlcpb1-4]DArap[2Me]b1-4DXylpb1-4DGlcpAa1-2[LRhapa1-4]DManpa1-SER","RAM(7_B_)-[BGC(6_B_)-G4D(5_B_)--XYP(3_B_)-GCU(2_B_)]-MAN(1_B_)-SER(234_A_)",15.3994,"","",""
"1DBO","CRYSTAL STRUCTURE OF CHONDROITINASE B","10.1006/JMBI.1999.3292 ",1.7,0,"1dbo_oligo1","DGalp[4H]a1-3[DGlcpb1-4]DArap[2Me]b1-4DXylpb1-4DGlcpAa1-2[LRhapa1-4]DManpa1-SER","RAM(7_B_)-[BGC(6_B_)-G4D(5_B_)--XYP(3_B_)-GCU(2_B_)]-MAN(1_B_)-SER(234_A_)",17.5812,"","",""
"1DEO","RHAMNOGALACTURONAN ACETYLESTERASE FROM ASPERGILLUS ACULEATUS AT 1.55 A RESOLUTION WITH SO4 IN THE ACTIVE SITE","10.1016/S0969-2126(00)00118-0 ",1.55,0,"1deo_oligo1","DManpa1-3[DManpa1-6]DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[MAN(5_B_)]-BMA(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(182_A_)",33.3305,"","",""
"1DEX","RHAMNOGALACTURONAN ACETYLESTERASE FROM ASPERGILLUS ACULEATUS AT 1.9 A RESOLUTION","10.1016/S0969-2126(00)00118-0 ",1.9,0,"1dex_oligo1","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[MAN(5_B_)]-MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(182_A_)",34.9688,"","",""
"1DGL","LECTIN FROM DIOCLEA GRANDIFLORA COMPLEXED TO TRIMANNOSIDE","10.1074/JBC.273.49.32818 ",2.4,0,"1dgl_oligo1","DManpa1-3[DManpa1-6]DManpa1-OME","MAN(3_D_)-[MAN(2_D_)]-MMA(1_D_)",34.3364,"","",""
"1DGL","LECTIN FROM DIOCLEA GRANDIFLORA COMPLEXED TO TRIMANNOSIDE","10.1074/JBC.273.49.32818 ",2.4,0,"1dgl_oligo2","DManpa1-3[DManpa1-6]DManpa1-OME","MAN(3_C_)-[MAN(2_C_)]-MMA(1_C_)",36.9403,"","",""
"1DIY","CRYSTAL STRUCTURE OF ARACHIDONIC ACID BOUND IN THE CYCLOOXYGENASE ACTIVE SITE OF PGHS-1","10.1126/SCIENCE.289.5486.1933 ",3,0,"1diy_oligo6","DManpa1-3DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-BMA(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(144_A_)",64.1649,"","",""
"1DL2","CRYSTAL STRUCTURE OF CLASS I ALPHA-1,2-MANNOSIDASE FROM SACCHAROMYCES CEREVISIAE AT 1.54 ANGSTROM RESOLUTION","10.1093/EMBOJ/19.4.581 ",1.54,26.1,"1dl2_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAca1-4DGlcpNAcx1-","MAN(6_B_)-[MAN(5_B_)]-MAN(4_B_)-[MAN(7_B_)]-BMA(3_B_)-NDG(2_B_)-NAG(1_B_)",27.4757,"","",""
"1DN2","FC FRAGMENT OF HUMAN IGG1 IN COMPLEX WITH AN ENGINEERED 13 RESIDUE PEPTIDE DCAWHLGELVWCT-NH2","10.1126/SCIENCE.287.5456.1279 ",2.7,0,"1dn2_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",40.4411,"","",""
"1DN2","FC FRAGMENT OF HUMAN IGG1 IN COMPLEX WITH AN ENGINEERED 13 RESIDUE PEPTIDE DCAWHLGELVWCT-NH2","10.1126/SCIENCE.287.5456.1279 ",2.7,0,"1dn2_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(8_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",42.0837,"","",""
"1DNU","STRUCTURAL ANALYSES OF HUMAN MYELOPEROXIDASE-THIOCYANATE COMPLEX","10.1021/BI0111808 ",1.85,0,"1dnu_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_E_)-[MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(317_C_)",15.8106,"","",""
"1DNU","STRUCTURAL ANALYSES OF HUMAN MYELOPEROXIDASE-THIOCYANATE COMPLEX","10.1021/BI0111808 ",1.85,0,"1dnu_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_F_)-[MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(317_D_)",15.5174,"","",""
"1DNW","HUMAN MYELOPEROXIDASE-CYANIDE-THIOCYANATE COMPLEX","10.1021/BI0111808 ",1.9,0,"1dnw_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_E_)-[MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(317_C_)",14.932,"","",""
"1DNW","HUMAN MYELOPEROXIDASE-CYANIDE-THIOCYANATE COMPLEX","10.1021/BI0111808 ",1.9,0,"1dnw_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_F_)-[MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(317_D_)",15.428,"","",""
"1DOG","REFINED STRUCTURE FOR THE COMPLEX OF 1-DEOXYNOJIRIMYCIN WITH GLUCOAMYLASE FROM (ASPERGILLUS AWAMORI) VAR. X100 TO 2.4 ANGSTROMS RESOLUTION","10.1021/BI00057A028 ",2.3,0,"1dog_oligo4","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_C_)-MAN(7_C_)-[MAN(6_C_)-MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(395_A_)",26.1206,"","",""
"1DOG","REFINED STRUCTURE FOR THE COMPLEX OF 1-DEOXYNOJIRIMYCIN WITH GLUCOAMYLASE FROM (ASPERGILLUS AWAMORI) VAR. X100 TO 2.4 ANGSTROMS RESOLUTION","10.1021/BI00057A028 ",2.3,0,"1dog_oligo1","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(171_A_)",30.2258,"","",""
"1DP5","THE STRUCTURE OF PROTEINASE A COMPLEXED WITH A IA3 MUTANT INHIBITOR","10.1038/72378 ",2.2,0,"1dp5_oligo1","DManpb1-2DManpa1-2[DManpa1-6]DManpa1-3[DManpb1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(9_C_)-MAN(8_C_)-[MAN(7_C_)-[BMA(6_C_)-MAN(5_C_)]-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(67_A_)",41.1271,"","",""
"1DPJ","THE STRUCTURE OF PROTEINASE A COMPLEXED WITH IA3 PEPTIDE INHIBITOR","10.1038/72378 ",1.8,0,"1dpj_oligo1","DManpb1-2DManpa1-2[DManpa1-2DManpa1-6]DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_C_)-[MAN(8_C_)-MAN(7_C_)-[BMA(6_C_)-MAN(5_C_)]-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(67_A_)",30.7005,"","",""
"1DWA","STUDY ON RADIATION DAMAGE ON A CRYOCOOLED CRYSTAL. PART 1: STRUCTURE PRIOR TO IRRADIATION","10.1107/S0907444999016261 ",2,18,"1dwa_oligo1","DXylpb1-2DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","XYP(4_B_)-BMA(3_B_)-NAG(2_B_)-[FUC(5_B_)]-NAG(1_B_)",31.0677,"","",""
"1DWA","STUDY ON RADIATION DAMAGE ON A CRYOCOOLED CRYSTAL. PART 1: STRUCTURE PRIOR TO IRRADIATION","10.1107/S0907444999016261 ",2,18,"1dwa_oligo3","DXylpb1-2[DManpa1-3][DManpAa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","MAN(6_C_)-[MAN(5_C_)]-[XYP(4_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(7_C_)]-NAG(1_C_)",28.6489,"","",""
"1DWF","STUDY ON RADIATION DAMAGE ON A CRYOCOOLED CRYSTAL. PART 2: STRUCTURE AFTER IRRADIATION WITH 9.1*10E15 PHOTONS/MM2","10.1107/S0907444999016261 ",2,19.4,"1dwf_oligo2","DXylpb1-2DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","XYP(4_B_)-BMA(3_B_)-NAG(2_B_)-[FUC(5_B_)]-NAG(1_B_)",33.1077,"","",""
"1DWF","STUDY ON RADIATION DAMAGE ON A CRYOCOOLED CRYSTAL. PART 2: STRUCTURE AFTER IRRADIATION WITH 9.1*10E15 PHOTONS/MM2","10.1107/S0907444999016261 ",2,19.4,"1dwf_oligo3","DXylpb1-2[DManpa1-3][DManpAa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","MAN(6_C_)-[MAN(5_C_)]-[XYP(4_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(7_C_)]-NAG(1_C_)",30.6889,"","",""
"1DWG","STUDY ON RADIATION DAMAGE ON A CRYOCOOLED CRYSTAL: PART 3 STRUCTURE AFTER IRRADIATION WITH 18.2*10E15 PHOTONS/MM2.","10.1107/S0907444999016261 ",2,22.3,"1dwg_oligo3","DXylpb1-2[DManpa1-3][DManpAa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","MAN(6_C_)-[MAN(5_C_)]-[XYP(4_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(7_C_)]-NAG(1_C_)",33.6089,"","",""
"1DWG","STUDY ON RADIATION DAMAGE ON A CRYOCOOLED CRYSTAL: PART 3 STRUCTURE AFTER IRRADIATION WITH 18.2*10E15 PHOTONS/MM2.","10.1107/S0907444999016261 ",2,22.3,"1dwg_oligo1","DXylpb1-2DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","XYP(4_B_)-BMA(3_B_)-NAG(2_B_)-[FUC(5_B_)]-NAG(1_B_)",36.0277,"","",""
"1DWH","STUDY ON RADIATION DAMAGE ON A CRYOCOOLED CRYSTAL. PART 4: STRUCTURE AFTER IRRADIATION WITH 27.2*10E15 PHOTONS/MM2","10.1107/S0907444999016261 ",2,25.7,"1dwh_oligo1","DXylpb1-2DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","XYP(4_B_)-BMA(3_B_)-NAG(2_B_)-[FUC(5_B_)]-NAG(1_B_)",39.4177,"","",""
"1DWH","STUDY ON RADIATION DAMAGE ON A CRYOCOOLED CRYSTAL. PART 4: STRUCTURE AFTER IRRADIATION WITH 27.2*10E15 PHOTONS/MM2","10.1107/S0907444999016261 ",2,25.7,"1dwh_oligo3","DXylpb1-2[DManpa1-3][DManpAa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","MAN(6_C_)-[MAN(5_C_)]-[XYP(4_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(7_C_)]-NAG(1_C_)",36.9989,"","",""
"1DWI","STUDY ON RADIATION DAMAGE ON A CRYOCOOLED CRYSTAL. PART 5: STRUCTURE AFTER IRRADIATION WITH 54.0*10E15 PHOTONS/MM2","10.1107/S0907444999016261 ",2,40.1,"1dwi_oligo3","DXylpb1-2[DManpa1-3][DManpAa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","MAN(6_C_)-[MAN(5_C_)]-[XYP(4_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(7_C_)]-NAG(1_C_)",51.4189,"","",""
"1DWI","STUDY ON RADIATION DAMAGE ON A CRYOCOOLED CRYSTAL. PART 5: STRUCTURE AFTER IRRADIATION WITH 54.0*10E15 PHOTONS/MM2","10.1107/S0907444999016261 ",2,40.1,"1dwi_oligo1","DXylpb1-2DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","XYP(4_B_)-BMA(3_B_)-NAG(2_B_)-[FUC(5_B_)]-NAG(1_B_)",53.8377,"","",""
"1DWJ","STUDY ON RADIATION DAMAGE ON A CRYOCOOLED CRYSTAL. REFINED PART 6: STRUCTURE AFTER A RADIATION DOSE OF 54*10E15 PHOTONS/MM2","10.1107/S0907444999016261 ",2.4,42.6,"1dwj_oligo1","DXylpb1-2DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","XYP(4_B_)-BMA(3_B_)-NAG(2_B_)-[FUC(5_B_)]-NAG(1_B_)-ASN(265_M_)",56.2611,"","",""
"1DWJ","STUDY ON RADIATION DAMAGE ON A CRYOCOOLED CRYSTAL. REFINED PART 6: STRUCTURE AFTER A RADIATION DOSE OF 54*10E15 PHOTONS/MM2","10.1107/S0907444999016261 ",2.4,42.6,"1dwj_oligo3","DXylpb1-2[DManpa1-3][DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)]-[XYP(4_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(7_C_)]-NAG(1_C_)-ASN(292_M_)",53.8593,"","",""
"1DZH","P14-FLUORESCEIN-N135Q-S380C-ANTITHROMBIN-III","10.1074/JBC.275.20.15377 ",2.85,66,"1dzh_oligo1","DManpb1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(192_L_)",128.1,"","",""
"1E04","PLASMA BETA ANTITHROMBIN-III","10.1016/S0022-2836(02)01382-7 ",2.6,53,"1e04_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(192_L_)",129.508,"","",""
"1E05","PLASMA ALPHA ANTITHROMBIN-III","10.1016/S0022-2836(02)01382-7 ",2.62,53,"1e05_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[BMA(8_D_)-MAN(7_D_)]-GUP(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(192_L_)",119.17,"","",""
"1E4K","CRYSTAL STRUCTURE OF SOLUBLE HUMAN IGG1 FC FRAGMENT-FC-GAMMA RECEPTOR III COMPLEX","10.1038/35018508 ",3.2,95.1,"1e4k_oligo1","DGalpa1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_D_)-[GLA(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_A_)",99.2311,"","",""
"1E4K","CRYSTAL STRUCTURE OF SOLUBLE HUMAN IGG1 FC FRAGMENT-FC-GAMMA RECEPTOR III COMPLEX","10.1038/35018508 ",3.2,95.1,"1e4k_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[NAG(8_E_)-MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_B_)",73.1865,"","",""
"1E4M","MYROSINASE FROM SINAPIS ALBA","10.1074/JBC.M006796200 ",1.2,14.5,"1e4m_oligo3","DXylpb1-2[DManpa1-3][LGulpb1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","MAN(6_C_)-[MAN(5_C_)]-[XYP(4_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(7_C_)]-NAG(1_C_)",22.7357,"","",""
"1E4M","MYROSINASE FROM SINAPIS ALBA","10.1074/JBC.M006796200 ",1.2,14.5,"1e4m_oligo1","DXylpb1-2DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","XYP(4_B_)-BMA(3_B_)-NAG(2_B_)-[FUC(5_B_)]-NAG(1_B_)",26.2439,"","",""
"1E6Q","MYROSINASE FROM SINAPIS ALBA WITH THE BOUND TRANSITION STATE ANALOGUE GLUCO-TETRAZOLE","10.1074/JBC.M006796200 ",1.35,16.2,"1e6q_oligo2","DXylpb1-2DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","XYP(4_B_)-BMA(3_B_)-NAG(2_B_)-[FUC(5_B_)]-NAG(1_B_)",28.1375,"","",""
"1E6Q","MYROSINASE FROM SINAPIS ALBA WITH THE BOUND TRANSITION STATE ANALOGUE GLUCO-TETRAZOLE","10.1074/JBC.M006796200 ",1.35,16.2,"1e6q_oligo3","DXylpb1-2[DManpa1-3][DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","MAN(6_C_)-[MAN(5_C_)]-[XYP(4_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(7_C_)]-NAG(1_C_)",28.8593,"","",""
"1E6S","MYROSINASE FROM SINAPIS ALBA WITH BOUND GLUCO-HYDROXIMOLACTAM AND SULFATE","10.1074/JBC.M006796200 ",1.35,17.2,"1e6s_oligo2","DXylpb1-2DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","XYP(4_B_)-BMA(3_B_)-NAG(2_B_)-[FUC(5_B_)]-NAG(1_B_)",29.5754,"","",""
"1E6S","MYROSINASE FROM SINAPIS ALBA WITH BOUND GLUCO-HYDROXIMOLACTAM AND SULFATE","10.1074/JBC.M006796200 ",1.35,17.2,"1e6s_oligo4","DXylpb1-2[DManpa1-3][DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","MAN(6_C_)-[MAN(5_C_)]-[XYP(4_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(7_C_)]-NAG(1_C_)",27.5871,"","",""
"1E6X","MYROSINASE FROM SINAPIS ALBA WITH A BOUND TRANSITION STATE ANALOGUE,D- GLUCONO-1,5-LACTONE","10.1074/JBC.M006796200 ",1.6,21.4,"1e6x_oligo3","DXylpb1-2[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","MAN(5_C_)-[XYP(4_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(6_C_)]-NAG(1_C_)",34.215,"","",""
"1E6X","MYROSINASE FROM SINAPIS ALBA WITH A BOUND TRANSITION STATE ANALOGUE,D- GLUCONO-1,5-LACTONE","10.1074/JBC.M006796200 ",1.6,21.4,"1e6x_oligo1","DXylpb1-2DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","XYP(4_B_)-BMA(3_B_)-NAG(2_B_)-[FUC(5_B_)]-NAG(1_B_)",34.6181,"","",""
"1E70","2-F-GLUCOSYLATED MYROSINASE FROM SINAPIS ALBA","10.1074/JBC.M006796200 ",1.65,31.8,"1e70_oligo3","DXylpb1-2[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","MAN(5_C_)-[XYP(4_C_)]-MAN(3_C_)-NAG(2_C_)-[FUC(6_C_)]-NAG(1_C_)",45.2864,"","",""
"1E70","2-F-GLUCOSYLATED MYROSINASE FROM SINAPIS ALBA","10.1074/JBC.M006796200 ",1.65,31.8,"1e70_oligo1","DXylpb1-2DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","XYP(4_B_)-BMA(3_B_)-NAG(2_B_)-[FUC(5_B_)]-NAG(1_B_)",47.5184,"","",""
"1E71","MYROSINASE FROM SINAPIS ALBA WITH BOUND ASCORBATE","10.1074/JBC.M006796200 ",1.5,19.8,"1e71_oligo4","DXylpb1-2[DManpa1-3][LGulpb1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","MAN(6_C_)-[MAN(5_C_)]-[XYP(4_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(7_C_)]-NAG(1_C_)",31.513,"","",""
"1E71","MYROSINASE FROM SINAPIS ALBA WITH BOUND ASCORBATE","10.1074/JBC.M006796200 ",1.5,19.8,"1e71_oligo1","DXylpb1-2DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","XYP(4_B_)-BMA(3_B_)-NAG(2_B_)-[FUC(5_B_)]-NAG(1_B_)",32.7296,"","",""
"1E72","MYROSINASE FROM SINAPIS ALBA WITH BOUND GLUCO-HYDROXIMOLACTAM AND SULFATE OR ASCORBATE","10.1074/JBC.M006796200 ",1.6,20.5,"1e72_oligo5","DXylpb1-2[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","MAN(5_C_)-[XYP(4_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(6_C_)]-NAG(1_C_)",29.2069,"","",""
"1E72","MYROSINASE FROM SINAPIS ALBA WITH BOUND GLUCO-HYDROXIMOLACTAM AND SULFATE OR ASCORBATE","10.1074/JBC.M006796200 ",1.6,20.5,"1e72_oligo2","DXylpb1-2DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","XYP(4_B_)-BMA(3_B_)-NAG(2_B_)-[FUC(5_B_)]-NAG(1_B_)",33.6342,"","",""
"1E73","2-F-GLUCOSYLATED MYROSINASE FROM SINAPIS ALBA WITH BOUND L-ASCORBATE","10.1074/JBC.M006796200 ",1.5,20.2,"1e73_oligo4","DXylpb1-2[DManpa1-3][LGulpb1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","MAN(6_C_)-[MAN(5_C_)]-[XYP(4_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(7_C_)]-NAG(1_C_)",33.0363,"","",""
"1E73","2-F-GLUCOSYLATED MYROSINASE FROM SINAPIS ALBA WITH BOUND L-ASCORBATE","10.1074/JBC.M006796200 ",1.5,20.2,"1e73_oligo1","DXylpb1-2DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","XYP(4_B_)-BMA(3_B_)-NAG(2_B_)-[FUC(5_B_)]-NAG(1_B_)",32.9706,"","",""
"1EKH","NMR STRUCTURE OF D(TTGGCCAA)2 BOUND TO CHROMOMYCIN-A3 AND COBALT","10.1016/S0969-2126(00)00124-6 ","2.95026e-39",0,"1ekh_oligo27","LOlip[3<R1>,4Ac]a1-3DOlipb1-3DOlipb1-","ERI(3_E_)-DDA(2_E_)-DDA(1_E_)",0.067,"","",""
"1EKH","NMR STRUCTURE OF D(TTGGCCAA)2 BOUND TO CHROMOMYCIN-A3 AND COBALT","10.1016/S0969-2126(00)00124-6 ","2.95026e-39",0,"1ekh_oligo26","LOlip[3<R1>,4Ac]a1-3DOlipb1-3DOlipb1-","ERI(3_F_)-DDA(2_F_)-DDA(1_F_)",0.462667,"","",""
"1EKI","AVERAGE SOLUTION STRUCTURE OF D(TTGGCCAA)2 BOUND TO CHROMOMYCIN-A3 AND COBALT","10.1016/S0969-2126(00)00124-6 ","2.95026e-39","1.15243e-41","1eki_oligo25","LOlip[3<R1>,4Ac]a1-3DOlipb1-3DOlipb1-","ERI(3_F_)-DDA(2_F_)-DDA(1_F_)",0.436333,"","",""
"1EKI","AVERAGE SOLUTION STRUCTURE OF D(TTGGCCAA)2 BOUND TO CHROMOMYCIN-A3 AND COBALT","10.1016/S0969-2126(00)00124-6 ","2.95026e-39","1.15243e-41","1eki_oligo27","LOlip[3<R1>,4Ac]a1-3DOlipb1-3DOlipb1-","ERI(3_E_)-DDA(2_E_)-DDA(1_E_)",0.460667,"","",""
"1EOM","CRYSTAL STRUCTURE OF THE COMPLEX OF ENDO-BETA-N-ACETYLGLUCOSAMINIDASE F3 WITH A BIANTENNARY COMPLEX OCTASACCHARIDE","10.1021/BI0001731 ",2.1,20.6,"1eom_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-ROH","GAL(8_B_)-NAG(7_B_)-MAN(6_B_)-[GAL(5_B_)-NAG(4_B_)-MAN(3_B_)]-MAN(2_B_)-NAG(1_B_)",38.3739,"","",""
"1ETH","TRIACYLGLYCEROL LIPASE/COLIPASE COMPLEX","10.1074/JBC.271.30.18007 ",2.8,19.73,"1eth_oligo2","DManpa1-3[DManpa1-6]DManpb1-","BMA(5_E_)-[BMA(4_E_)]-BMA(3_E_)-NAG(2_E_)",48.5009,"","",""
"1ETH","TRIACYLGLYCEROL LIPASE/COLIPASE COMPLEX","10.1074/JBC.271.30.18007 ",2.8,19.73,"1eth_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","BMA(5_F_)-[BMA(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)",45.3998,"","",""
"1EX1","BETA-D-GLUCAN EXOHYDROLASE FROM BARLEY","10.1016/S0969-2126(99)80024-0 ",2.2,0,"1ex1_oligo1","DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","NAG(5_B_)-MAN(4_B_)-MAN(3_B_)-NAG(2_B_)-[FCA(6_B_)]-NAG(1_B_)-ASN(498_A_)",62.2608,"","",""
"1F6A","STRUCTURE OF THE HUMAN IGE-FC BOUND TO ITS HIGH AFFINITY RECEPTOR FC(EPSILON)RI(ALPHA)","10.1038/35018500 ",3.5,89.2,"1f6a_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-MAN(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(42_A_)",88.8044,"","",""
"1F6A","STRUCTURE OF THE HUMAN IGE-FC BOUND TO ITS HIGH AFFINITY RECEPTOR FC(EPSILON)RI(ALPHA)","10.1038/35018500 ",3.5,89.2,"1f6a_oligo1","DManpa1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-MAN(4_G_)-[MAN(6_G_)]-MAN(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(394_B_)",123.404,"","",""
"1F8B","NATIVE INFLUENZA VIRUS NEURAMINIDASE IN COMPLEX WITH NEU5AC2EN","10.1110/PS.41801 ",1.8,0,"1f8b_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",26.7296,"","",""
"1F8C","NATIVE INFLUENZA NEURAMINIDASE IN COMPLEX WITH 4-AMINO-2-DEOXY-2,3- DEHYDRO-N-NEURAMINIC ACID","10.1110/PS.41801 ",1.7,0,"1f8c_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",19.9523,"","",""
"1F8D","NATIVE INFLUENZA NEURAMINIDASE IN COMPLEX WITH 9-AMINO-2-DEOXY-2,3- DEHYDRO-N-NEURAMINIC ACID","10.1110/PS.41801 ",1.4,0,"1f8d_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",18.1599,"","",""
"1F8E","NATIVE INFLUENZA NEURAMINIDASE IN COMPLEX WITH 4,9-DIAMINO-2-DEOXY-2, 3-DEHYDRO-N-ACETYL-NEURAMINIC ACID","10.1110/PS.41801 ",1.4,0,"1f8e_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",18.2405,"","",""
"1FC1","CRYSTALLOGRAPHIC REFINEMENT AND ATOMIC MODELS OF A HUMAN FC FRAGMENT AND ITS COMPLEX WITH FRAGMENT B OF PROTEIN A FROM STAPHYLOCOCCUS AUREUS AT 2.9-AND 2.8-ANGSTROMS RESOLUTION","10.1021/BI00512A001 ",2.9,0,"1fc1_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[DAltp[6H]a1-6]DGlcpNAcb1-ASN","FUC(9_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-MAN(7_C_)]-MAN(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",30.6905,"","",""
"1FC1","CRYSTALLOGRAPHIC REFINEMENT AND ATOMIC MODELS OF A HUMAN FC FRAGMENT AND ITS COMPLEX WITH FRAGMENT B OF PROTEIN A FROM STAPHYLOCOCCUS AUREUS AT 2.9-AND 2.8-ANGSTROMS RESOLUTION","10.1021/BI00512A001 ",2.9,0,"1fc1_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[DAltp[6H]a1-6]DGlcpNAcb1-ASN","FUC(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-MAN(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",23.2549,"","",""
"1FC2","CRYSTALLOGRAPHIC REFINEMENT AND ATOMIC MODELS OF A HUMAN FC FRAGMENT AND ITS COMPLEX WITH FRAGMENT B OF PROTEIN A FROM STAPHYLOCOCCUS AUREUS AT 2.9-AND 2.8-ANGSTROMS RESOLUTION","10.1021/BI00512A001 ",2.8,0,"1fc2_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[DAltp[6H]a1-6]DGlcpNAcb1-ASN","FUC(9_A_)-[GAL(6_A_)-NAG(5_A_)-MAN(4_A_)-[NAG(8_A_)-MAN(7_A_)]-MAN(3_A_)-NAG(2_A_)]-NAG(1_A_)-ASN(297_D_)",22.9883,"","",""
"1FE2","CRYSTAL STRUCTURE OF DIHOMO-GAMMA-LINOLEIC ACID BOUND IN THE CYCLOOXYGENASE CHANNEL OF PROSTAGLANDIN ENDOPEROXIDE H SYNTHASE-1.","10.1074/JBC.M009378200 ",3,0,"1fe2_oligo5","DManpa1-3DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_C_)-BMA(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(144_A_)",62.8149,"","",""
"1FGG","CRYSTAL STRUCTURE OF 1,3-GLUCURONYLTRANSFERASE I (GLCAT-I) COMPLEXED WITH GAL-GAL-XYL, UDP, AND MN2+","10.1074/JBC.M007399200 ",2.3,29.8,"1fgg_oligo3","DGalpb1-3DGalpb1-ROH","GAL(2_C_)-GAL(1_C_)",47.6282,"","",""
"1FI1","FHUA IN COMPLEX WITH LIPOPOLYSACCHARIDE AND RIFAMYCIN CGP4832","10.1016/S0969-2126(01)00631-1 ",2.9,68.4,"1fi1_oligo1","DGlcpa1-2DGlcpa1-3[DGalpa1-6]DGlcpa1-3[GMH1-7]GMH1-3GMH1-5[DKdopa2-4]DKdopa2-6DGlcp[2<R1>,3<R2>,4P]b1-6DGlcp[2<R3>,3<R4>]a1-O7P2","GMH(10_B_)-[GLA(9_B_)-[GLC(8_B_)-GLC(7_B_)]-GLC(6_B_)]-GMH(5_B_)-GMH(4_B_)-[KDO(11_B_)]-KDO(3_B_)-GCN(2_B_)-PA1(1_B_)",87.83,"","",""
"1FQ4","CRYSTAL STRUCTURE OF A COMPLEX BETWEEN HYDROXYETHYLENE INHIBITOR CP- 108,420 AND YEAST ASPARTIC PROTEINASE A","10.1006/JMBI.2000.4181 ",2.7,0,"1fq4_oligo1","DGlcpb1-2DManpb1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BGC(5_B_)-BMA(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(67_A_)",48.2635,"","",""
"1FQ5","X-RAY STRUCTURE OF A CYCLIC STATINE INHIBITOR PD-129,541 BOUND TO YEAST PROTEINASE A","10.1006/JMBI.2000.4181 ",2.4,0,"1fq5_oligo3","DManp[2H]b1-3DAltp[2H]b1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_B_)-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(67_A_)",56.6772,"","",""
"1FQ6","X-RAY STRUCTURE OF GLYCOL INHIBITOR PD-133,450 BOUND TO SACCHAROPEPSIN","10.1006/JMBI.2000.4181 ",2.7,0,"1fq6_oligo1","LGulpa1-2DManpb1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GUP(5_B_)-BMA(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(67_A_)",45.0336,"","",""
"1FQ7","X-RAY STRUCTURE OF INHIBITOR CP-72,647 BOUND TO SACCHAROPEPSIN","10.1006/JMBI.2000.4181 ",2.8,0,"1fq7_oligo3","DGlcpb1-2DManpb1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","KBG(5_B_)-BMA(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(67_A_)",43.5969,"","",""
"1FQ8","X-RAY STRUCTURE OF DIFLUOROSTATINE INHIBITOR CP81,198 BOUND TO SACCHAROPEPSIN","10.1006/JMBI.2000.4181 ",2.8,0,"1fq8_oligo2","DManp[2H]b1-3DAltp[2H]b1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_B_)-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(67_A_)",41.6808,"","",""
"1FRT","CRYSTAL STRUCTURE OF THE COMPLEX OF RAT NEONATAL FC RECEPTOR WITH FC","10.1038/372379A0 ",4.5,199,"1frt_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[DAltp[6H]a1-6]DGlcpNAcb1-ASN","FUC(9_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[NAG(8_E_)-MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_C_)",515.103,"","",""
"1FV2","THE HC FRAGMENT OF TETANUS TOXIN COMPLEXED WITH AN ANALOGUE OF ITS GANGLIOSIDE RECEPTOR GT1B","10.1074/JBC.M103285200 ",2.5,35.71,"1fv2_oligo1","DNeup5Aca2-3DGalpb1-3DGalpNAcb1-4[DNeup5Aca2-8DNeup5Acb2-3]DGalpb1-4DGlcpb1-C2O1","SIA(5_B_)-GAL(4_B_)-NGA(3_B_)-[SIA(7_B_)-SLB(6_B_)]-GAL(2_B_)-BGC(1_B_)",46.4876,"","",""
"1FV3","THE HC FRAGMENT OF TETANUS TOXIN COMPLEXED WITH AN ANALOGUE OF ITS GANGLIOSIDE RECEPTOR GT1B","10.1074/JBC.M103285200 ",2.3,32.84,"1fv3_oligo1","DNeup5Aca2-3DGalpb1-3DGalpNAcb1-4[DNeup5Aca2-8DNeup5Acb2-3]DGalpb1-4DGlcpb1-C2O1","SIA(5_C_)-GAL(4_C_)-NGA(3_C_)-[SIA(7_C_)-SLB(6_C_)]-GAL(2_C_)-BGC(1_C_)",54.4177,"","",""
"1FV3","THE HC FRAGMENT OF TETANUS TOXIN COMPLEXED WITH AN ANALOGUE OF ITS GANGLIOSIDE RECEPTOR GT1B","10.1074/JBC.M103285200 ",2.3,32.84,"1fv3_oligo2","DNeup5Aca2-3DGalpb1-3DGalpNAcb1-4[DNeup5Aca2-8DNeup5Acb2-3]DGalpb1-4DGlcpb1-C2O1","SIA(5_D_)-GAL(4_D_)-NGA(3_D_)-[SIA(7_D_)-SLB(6_D_)]-GAL(2_D_)-BGC(1_D_)",47.8451,"","",""
"1FWU","CRYSTAL STRUCTURE OF THE CYSTEINE-RICH DOMAIN OF MANNOSE RECEPTOR COMPLEXED WITH 3-SO4-LEWIS(X)","10.1006/JMBI.2000.4326 ",1.9,0,"1fwu_oligo1","LFucpa1-3[DGalp[3S]b1-4]DGlcpNAcb1-ROH","SGA(3_B_)-[FUC(2_B_)]-MAG(1_B_)",57.8009,"","",""
"1FWV","CRYSTAL STRUCTURE OF THE CYSTEINE-RICH DOMAIN OF MANNOSE RECEPTOR COMPLEXED WITH 3-SO4-LEWIS(A)","10.1006/JMBI.2000.4326 ",2.2,0,"1fwv_oligo1","DGalp[3S]b1-3[LFucpa1-4]DGlcpNAcb1-ROH","FUC(3_B_)-SGA(2_B_)]-MAG(1_B_)",80.4297,"","",""
"1FX5","CRYSTAL STRUCTURE ANALYSIS OF ULEX EUROPAEUS LECTIN I","10.1006/JMBI.2000.4214 ",2.2,0,"1fx5_oligo3","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_E_)-[FUC(2_E_)]-NAG(1_E_)-ASN(111_B_)",76.6245,"","",""
"1FX5","CRYSTAL STRUCTURE ANALYSIS OF ULEX EUROPAEUS LECTIN I","10.1006/JMBI.2000.4214 ",2.2,0,"1fx5_oligo1","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_D_)-[FUC(2_D_)]-NAG(1_D_)-ASN(111_A_)",64.8421,"","",""
"1FX5","CRYSTAL STRUCTURE ANALYSIS OF ULEX EUROPAEUS LECTIN I","10.1006/JMBI.2000.4214 ",2.2,0,"1fx5_oligo2","DXylpb1-2[DManpa1-3][DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)]-[XYL(4_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(7_C_)]-NAG(1_C_)-ASN(23_A_)",57.5082,"","",""
"1FZD","STRUCTURE OF RECOMBINANT ALPHAEC DOMAIN FROM HUMAN FIBRINOGEN-420","10.1073/PNAS.95.16.9099 ",2.1,0,"1fzd_oligo2","DGlcpNAcb1-2DManpa1-6[DRhapa1-3]DManpb1-4DGlcpNAca1-C6N1O4","NAG(5_J_)-MAN(4_J_)-[MAN(6_J_)]-MAN(3_J_)-NDG(2_J_)-NAG(1_J_)",55.3113,"","",""
"1FZD","STRUCTURE OF RECOMBINANT ALPHAEC DOMAIN FROM HUMAN FIBRINOGEN-420","10.1073/PNAS.95.16.9099 ",2.1,0,"1fzd_oligo4","DGlcpNAcb1-2DManpa1-6[DManpb1-3]DManpa1-4DGlcpNAcb1-4NAG1-ASN","NAG(5_L_)-MAN(4_L_)-[MAN(6_L_)]-MAN(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(667_D_)",48.1047,"","",""
"1FZD","STRUCTURE OF RECOMBINANT ALPHAEC DOMAIN FROM HUMAN FIBRINOGEN-420","10.1073/PNAS.95.16.9099 ",2.1,0,"1fzd_oligo1","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_I_)-MAN(4_I_)-[MAN(6_I_)]-MAN(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(667_A_)",48.8518,"","",""
"1FZD","STRUCTURE OF RECOMBINANT ALPHAEC DOMAIN FROM HUMAN FIBRINOGEN-420","10.1073/PNAS.95.16.9099 ",2.1,0,"1fzd_oligo3","DGlcpNAcb1-2DManpa1-6[DManpb1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_K_)-MAN(4_K_)-[MAN(6_K_)]-MAN(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(667_C_)",48.0854,"","",""
"1G0V","THE STRUCTURE OF PROTEINASE A COMPLEXED WITH A IA3 MUTANT, MVV","10.1074/JBC.M008520200 ",2,20.6,"1g0v_oligo1","DManpb1-2DManpa1-2[DManpa1-2DManpa1-6]DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_C_)-MAN(7_C_)-[BMA(6_C_)-MAN(5_C_)]-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(67_A_)",31.4385,"","",""
"1G1R","CRYSTAL STRUCTURE OF P-SELECTIN LECTIN/EGF DOMAINS COMPLEXED WITH SLEX","10.1016/S0092-8674(00)00138-0 ",3.4,0,"1g1r_oligo1","DNeup5Aca2-3DGalpb1-4[LFucpa1-3]DGlcpNAcb1-OME","SIA(3_G_)-GAL(2_G_)-[FUC(4_G_)]-MAG(1_G_)",71.64,"","",""
"1G1R","CRYSTAL STRUCTURE OF P-SELECTIN LECTIN/EGF DOMAINS COMPLEXED WITH SLEX","10.1016/S0092-8674(00)00138-0 ",3.4,0,"1g1r_oligo3","DNeup5Aca2-3DGalpb1-4[LFucpa1-3]DGlcpNAcb1-OME","SIA(3_E_)-GAL(2_E_)-[FUC(4_E_)]-MAG(1_E_)",71.64,"","",""
"1G1R","CRYSTAL STRUCTURE OF P-SELECTIN LECTIN/EGF DOMAINS COMPLEXED WITH SLEX","10.1016/S0092-8674(00)00138-0 ",3.4,0,"1g1r_oligo2","DNeup5Aca2-3DGalpb1-4[LFucpa1-3]DGlcpNAcb1-OME","SIA(3_F_)-GAL(2_F_)-[FUC(4_F_)]-MAG(1_F_)",71.64,"","",""
"1G1S","P-SELECTIN LECTIN/EGF DOMAINS COMPLEXED WITH PSGL-1 PEPTIDE","10.1016/S0092-8674(00)00138-0 ",1.9,0,"1g1s_oligo2","DNeup5Aca2-3DGalpb1-4[LFucpa1-3]DGlcpNAcb1-6[DGalpb1-3]DGalpNAca1-THR","SIA(4_F_)-GAL(3_F_)-[FUC(5_F_)]-NAG(2_F_)-[GAL(6_F_)]-NGA(1_F_)-THR(616_D_)",44.7282,"","",""
"1G1S","P-SELECTIN LECTIN/EGF DOMAINS COMPLEXED WITH PSGL-1 PEPTIDE","10.1016/S0092-8674(00)00138-0 ",1.9,0,"1g1s_oligo1","DNeup5Aca2-3DGalpb1-4[LFucpa1-3]DGlcpNAcb1-6[DGalpb1-3]DGalpNAca1-THR","SIA(4_E_)-GAL(3_E_)-[FUC(5_E_)]-NAG(2_E_)-[GAL(6_E_)]-NGA(1_E_)-THR(616_C_)",50.8761,"","",""
"1G1T","CRYSTAL STRUCTURE OF E-SELECTIN LECTIN/EGF DOMAINS COMPLEXED WITH SLEX","10.1016/S0092-8674(00)00138-0 ",1.5,0,"1g1t_oligo1","DNeup5Aca2-3DGalpb1-4[LFucpa1-3]DGlcpNAcb1-OME","SIA(3_B_)-GAL(2_B_)-[FUC(4_B_)]-MAG(1_B_)",34.7435,"","",""
"1G6I","CRYSTAL STRUCTURE OF THE YEAST ALPHA-1,2-MANNOSIDASE WITH BOUND 1- DEOXYMANNOJIRIMYCIN AT 1.59 A RESOLUTION","",1.59,27.8,"1g6i_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(224_A_)",48.1344,"","",""
"1G6I","CRYSTAL STRUCTURE OF THE YEAST ALPHA-1,2-MANNOSIDASE WITH BOUND 1- DEOXYMANNOJIRIMYCIN AT 1.59 A RESOLUTION","",1.59,27.8,"1g6i_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAca1-4DGlcpNAcb1-ASN","MAN(6_B_)-[MAN(5_B_)]-MAN(4_B_)-[MAN(7_B_)]-BMA(3_B_)-NDG(2_B_)-NAG(1_B_)-ASN(96_A_)",33.063,"","",""
"1G7Y","THE CRYSTAL STRUCTURE OF THE 58KD VEGETATIVE LECTIN FROM THE TROPICAL LEGUME DOLICHOS BIFLORUS","10.1006/JMBI.2001.4639 ",2.5,38.8,"1g7y_oligo1","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_G_)-[FUC(2_G_)]-NAG(1_G_)-ASN(79_B_)",82.6042,"","",""
"1G7Y","THE CRYSTAL STRUCTURE OF THE 58KD VEGETATIVE LECTIN FROM THE TROPICAL LEGUME DOLICHOS BIFLORUS","10.1006/JMBI.2001.4639 ",2.5,38.8,"1g7y_oligo3","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_I_)-[FUC(2_I_)]-NAG(1_I_)-ASN(79_E_)",48.8309,"","",""
"1GAH","GLUCOAMYLASE-471 COMPLEXED WITH ACARBOSE","10.1021/BI960321G ",2,14.3,"1gah_oligo1","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(171_A_)",32.5949,"","",""
"1GAH","GLUCOAMYLASE-471 COMPLEXED WITH ACARBOSE","10.1021/BI960321G ",2,14.3,"1gah_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_C_)-[MAN(8_C_)]-MAN(7_C_)-[MAN(6_C_)-MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(395_A_)",33.145,"","",""
"1GAI","GLUCOAMYLASE-471 COMPLEXED WITH D-GLUCO-DIHYDROACARBOSE","10.1021/BI960321G ",1.7,14.7,"1gai_oligo1","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(171_A_)",31.3453,"","",""
"1GAI","GLUCOAMYLASE-471 COMPLEXED WITH D-GLUCO-DIHYDROACARBOSE","10.1021/BI960321G ",1.7,14.7,"1gai_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_C_)-[MAN(8_C_)]-MAN(7_C_)-[MAN(6_C_)-MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(395_A_)",29.4852,"","",""
"1GAL","CRYSTAL STRUCTURE OF GLUCOSE OXIDASE FROM ASPERGILLUS NIGER: REFINED AT 2.3 ANGSTROMS RESOLUTION","10.1006/JMBI.1993.1015 ",2.3,0,"1gal_oligo2","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(89_A_)",45.7433,"","",""
"1GLM","REFINED CRYSTAL STRUCTURES OF GLUCOAMYLASE FROM ASPERGILLUS AWAMORI VAR. X100","10.1006/JMBI.1994.1316 ",2.4,0,"1glm_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_C_)-MAN(7_C_)-[MAN(6_C_)-MAN(5_C_)-MAN(4_C_)]-MAN(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(395_A_)",29.2817,"","",""
"1GLM","REFINED CRYSTAL STRUCTURES OF GLUCOAMYLASE FROM ASPERGILLUS AWAMORI VAR. X100","10.1006/JMBI.1994.1316 ",2.4,0,"1glm_oligo1","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-MAN(4_B_)-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(171_A_)",31.4351,"","",""
"1GPE","GLUCOSE OXIDASE FROM PENICILLIUM AMAGASAKIENSE","10.1107/S0907444999003431 ",1.8,14.9,"1gpe_oligo2","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(93_B_)",35.1376,"","",""
"1GPE","GLUCOSE OXIDASE FROM PENICILLIUM AMAGASAKIENSE","10.1107/S0907444999003431 ",1.8,14.9,"1gpe_oligo4","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(93_A_)",36.01,"","",""
"1GQH","QUERCETIN 2,3-DIOXYGENASE IN COMPLEX WITH THE INHIBITOR KOJIC ACID","10.1021/BI0159736 ",2.15,0,"1gqh_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-MAN(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(191_B_)",39.262,"","",""
"1GSL","LECTIN (FOURTH ISOLATED FROM (GRIFFONIA SIMPLICIFOLIA)) COMPLEX WITH Y HUMAN BLOOD GROUP DETERMINANT","10.1006/JMBI.1993.1212 ",2,31.29,"1gsl_oligo2","LFucpa1-2DGalpb1-4[LFucpa1-3]DGlcpNAcb1-OME","FUC(3_B_)-GAL(2_B_)-[FUC(4_B_)]-MAG(1_B_)",51.8343,"","",""
"1GSL","LECTIN (FOURTH ISOLATED FROM (GRIFFONIA SIMPLICIFOLIA)) COMPLEX WITH Y HUMAN BLOOD GROUP DETERMINANT","10.1006/JMBI.1993.1212 ",2,31.29,"1gsl_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","BMA(3_C_)-NAG(2_C_)-[FUC(4_C_)]-NAG(1_C_)-ASN(18_A_)",49.712,"","",""
"1GW0","CRYSTAL STRUCTURE OF LACCASE FROM MELANOCARPUS ALBOMYCES IN FOUR COPPER FORM","10.1038/NSB823 ",2.4,24.6,"1gw0_oligo2","DManpa1-3[DManpb1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(6_C_)-[MAN(5_C_)]-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(88_A_)",60.3469,"","",""
"1GW0","CRYSTAL STRUCTURE OF LACCASE FROM MELANOCARPUS ALBOMYCES IN FOUR COPPER FORM","10.1038/NSB823 ",2.4,24.6,"1gw0_oligo8","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(289_B_)",53.6429,"","",""
"1GW0","CRYSTAL STRUCTURE OF LACCASE FROM MELANOCARPUS ALBOMYCES IN FOUR COPPER FORM","10.1038/NSB823 ",2.4,24.6,"1gw0_oligo3","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(289_A_)",56.4098,"","",""
"1GW0","CRYSTAL STRUCTURE OF LACCASE FROM MELANOCARPUS ALBOMYCES IN FOUR COPPER FORM","10.1038/NSB823 ",2.4,24.6,"1gw0_oligo6","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-MAN(4_H_)-[MAN(6_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(88_B_)",65.432,"","",""
"1GYA","N-GLYCAN AND POLYPEPTIDE NMR SOLUTION STRUCTURES OF THE ADHESION DOMAIN OF HUMAN CD2","","2.95026e-39",0,"1gya_oligo1","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-MAN(5_B_)-[MAN(7_B_)]-MAN(4_B_)-[MAN(9_B_)-MAN(8_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(65_A_)",0,"","",""
"1H1M","CRYSTAL STRUCTURE OF QUERCETIN 2,3-DIOXYGENASE ANAEROBICALLY COMPLEXED WITH THE SUBSTRATE KAEMPFEROL","10.1073/PNAS.262506299 ",1.9,12.83,"1h1m_oligo1","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(191_A_)",46.5247,"","",""
"1H3U","CRYSTAL STRUCTURE OF THE HUMAN IGG1 FC-FRAGMENT,GLYCOFORM (M3N2F)2","10.1016/S0022-2836(02)01250-0 ",2.4,0,"1h3u_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(6_C_)-[MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",63.5065,"","",""
"1H3U","CRYSTAL STRUCTURE OF THE HUMAN IGG1 FC-FRAGMENT,GLYCOFORM (M3N2F)2","10.1016/S0022-2836(02)01250-0 ",2.4,0,"1h3u_oligo1","DManpb1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(6_D_)-[MAN(5_D_)-[BMA(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",91.4576,"","",""
"1H3V","CRYSTAL STRUCTURE OF THE HUMAN IGG1 FC-FRAGMENT,GLYCOFORM (G2F)2,SG P212121","10.1016/S0022-2836(02)01250-0 ",3.1,0,"1h3v_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(8_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",48.3753,"","",""
"1H3V","CRYSTAL STRUCTURE OF THE HUMAN IGG1 FC-FRAGMENT,GLYCOFORM (G2F)2,SG P212121","10.1016/S0022-2836(02)01250-0 ",3.1,0,"1h3v_oligo1","DGalpb1-4DGlcpNAcb1-2DManpb1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAca1-ASN","FUL(8_D_)-[GAL(6_D_)-NAG(5_D_)-BMA(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",79.6368,"","",""
"1H3X","CRYSTAL STRUCTURE OF THE HUMAN IGG1 FC-FRAGMENT,GLYCOFORM (G0F)2","10.1016/S0022-2836(02)01250-0 ",2.44,0,"1h3x_oligo1","DGlcpNAca1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",90.2742,"","",""
"1H3X","CRYSTAL STRUCTURE OF THE HUMAN IGG1 FC-FRAGMENT,GLYCOFORM (G0F)2","10.1016/S0022-2836(02)01250-0 ",2.44,0,"1h3x_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",58.5281,"","",""
"1H3Y","CRYSTAL STRUCTURE OF A HUMAN IGG1 FC-FRAGMENT,HIGH SALT CONDITION","10.1016/S0022-2836(02)01250-0 ",4.1,0,"1h3y_oligo1","DGalpa1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_D_)-[GLA(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",36.1271,"","",""
"1H3Y","CRYSTAL STRUCTURE OF A HUMAN IGG1 FC-FRAGMENT,HIGH SALT CONDITION","10.1016/S0022-2836(02)01250-0 ",4.1,0,"1h3y_oligo2","DGalpa1-4DGlcpNAca1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpa1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_C_)-[GLA(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-MAN(7_C_)]-MAN(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",73.9137,"","",""
"1H4P","CRYSTAL STRUCTURE OF EXO-1,3-BETA GLUCANSE FROM SACCHAROMYCES CEREVISIAE","10.1038/NSMB715 ",1.75,28,"1h4p_oligo1","DManpb1-2DManpa1-3[DManpa1-2DManpb1-6]DManpa1-6[DManpb1-2DManpb1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_C_)-BMA(7_C_)-[BMA(6_C_)-MAN(5_C_)]-MAN(4_C_)-[BMA(10_C_)-BMA(9_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(165_A_)",83.5686,"","",""
"1H4P","CRYSTAL STRUCTURE OF EXO-1,3-BETA GLUCANSE FROM SACCHAROMYCES CEREVISIAE","10.1038/NSMB715 ",1.75,28,"1h4p_oligo2","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_D_)-[BMA(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(325_A_)",89.9071,"","",""
"1H4P","CRYSTAL STRUCTURE OF EXO-1,3-BETA GLUCANSE FROM SACCHAROMYCES CEREVISIAE","10.1038/NSMB715 ",1.75,28,"1h4p_oligo3","DManpb1-2DManpb1-3[DManpb1-3[DManpb1-6]DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(8_E_)-[BMA(7_E_)]-BMA(6_E_)-[BMA(5_E_)-BMA(4_E_)]-MAN(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(165_B_)",80.0983,"","",""
"1H81","STRUCTURE OF POLYAMINE OXIDASE IN THE REDUCED STATE","10.1021/BI002751J ",2.1,0,"1h81_oligo8","DFucpa1-3DGlcpNAcb1-ASN","FCA(5_F_)-NAG(1_F_)-ASN(77_C_)",28.05,"","",""
"1H82","STRUCTURE OF POLYAMINE OXIDASE IN COMPLEX WITH GUAZATINE","10.1021/BI002751J ",1.9,0,"1h82_oligo8","DFucpa1-3DGlcpNAcb1-ASN","FCA(5_F_)-NAG(1_F_)-ASN(77_C_)",22.4564,"","",""
"1H83","STRUCTURE OF POLYAMINE OXIDASE IN COMPLEX WITH 1,8-DIAMINOOCTANE","10.1021/BI002751J ",1.9,0,"1h83_oligo8","DFucpa1-3DGlcpNAcb1-ASN","FCA(5_F_)-NAG(1_F_)-ASN(77_C_)",18.4327,"","",""
"1H84","COVALENT ADDUCT BETWEEN POLYAMINE OXIDASE AND N1ETHYLN11((CYCLOHEPTYL)METHYL)4,8DIAZAUNDECANE AT PH 4.6","10.1021/BI002751J ",2,0,"1h84_oligo8","DFucpa1-3DGlcpNAcb1-ASN","FCA(5_F_)-NAG(1_F_)-ASN(77_C_)",23.3523,"","",""
"1H86","COVALENT ADDUCT BETWEEN POLYAMINE OXIDASE AND N1ETHYLN11((CYCLOHEPTYL)METHYL)4,8DIAZAUNDECANE AT PH 7.0","10.1021/BI002751J ",2,0,"1h86_oligo6","DFucpa1-3DGlcpNAcb1-ASN","FCA(5_E_)-NAG(1_E_)-ASN(77_C_)",23.5127,"","",""
"1HD4","SOLUTION STRUCTURE OF THE A-SUBUNIT OF HUMAN CHORIONIC GONADOTROPIN [MODELED WITH DIANTENNARY GLYCAN AT ASN78]","10.1021/BI992786N ","2.95026e-39",0,"1hd4_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(9_B_)-NAG(8_B_)-MAN(7_B_)-[GAL(6_B_)-NAG(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(78_A_)",0,"","",""
"1HM2","ACTIVE SITE OF CHONDROITINASE AC LYASE REVEALED BY THE STRUCTURE OF ENZYME-OLIGOSACCHARIDE COMPLEXES AND MUTAGENESIS","10.1021/BI0024254 ",2,0,"1hm2_oligo3","LIdopAa1-3DGalpNAcb1-4LIdopAa1-3DGalpNAc[4S]b1-ROH","IDR(4_D_)-ASG(3_D_)-IDR(2_D_)-ASG(1_D_)",46.7445,"","",""
"1HQL","THE XENOGRAFT ANTIGEN IN COMPLEX WITH THE B4 ISOLECTIN OF GRIFFONIA SIMPLICIFOLIA LECTIN-1","10.1074/JBC.M109919200 ",2.2,38.9,"1hql_oligo2","DGalpa1-3DGalpb1-OME","GLA(2_C_)-MBG(1_C_)",51.1323,"","",""
"1HQL","THE XENOGRAFT ANTIGEN IN COMPLEX WITH THE B4 ISOLECTIN OF GRIFFONIA SIMPLICIFOLIA LECTIN-1","10.1074/JBC.M109919200 ",2.2,38.9,"1hql_oligo3","DGalpa1-3DGalpb1-OME","GLA(2_E_)-MBG(1_E_)",49.65,"","",""
"1HWM","EBULIN,ORTHORHOMBIC CRYSTAL FORM MODEL","10.1002/PROT.1043 ",2.8,0,"1hwm_oligo1","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(186_B_)",19.4704,"","",""
"1HZH","CRYSTAL STRUCTURE OF THE INTACT HUMAN IGG B12 WITH BROAD AND POTENT ACTIVITY AGAINST PRIMARY HIV-1 ISOLATES: A TEMPLATE FOR HIV VACCINE DESIGN","10.1126/SCIENCE.1061692 ",2.7,90.1,"1hzh_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","GAL(9_A_)-NAG(8_A_)-MAN(7_A_)-[GAL(6_A_)-NAG(5_A_)-MAN(4_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)",160.95,"","",""
"1HZH","CRYSTAL STRUCTURE OF THE INTACT HUMAN IGG B12 WITH BROAD AND POTENT ACTIVITY AGAINST PRIMARY HIV-1 ISOLATES: A TEMPLATE FOR HIV VACCINE DESIGN","10.1126/SCIENCE.1061692 ",2.7,90.1,"1hzh_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(9_B_)-[GAL(6_B_)-NAG(5_B_)-MAN(4_B_)-[NAG(8_B_)-MAN(7_B_)]-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)",117.935,"","",""
"1HZX","CRYSTAL STRUCTURE OF BOVINE RHODOPSIN","10.1021/BI0155091 ",2.8,45.3,"1hzx_oligo11","DManpb1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(15_B_)",74.4609,"","",""
"1I1A","CRYSTAL STRUCTURE OF THE NEONATAL FC RECEPTOR COMPLEXED WITH A HETERODIMERIC FC","10.1016/S1097-2765(01)00230-1 ",2.8,78.2,"1i1a_oligo4","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(8_H_)-[NAG(7_H_)-MAN(6_H_)-[NAG(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)]-NAG(1_H_)-ASN(297_D_)",199.986,"","",""
"1I1A","CRYSTAL STRUCTURE OF THE NEONATAL FC RECEPTOR COMPLEXED WITH A HETERODIMERIC FC","10.1016/S1097-2765(01)00230-1 ",2.8,78.2,"1i1a_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(8_G_)-[NAG(7_G_)-MAN(6_G_)-[NAG(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(297_C_)",121.533,"","",""
"1I1A","CRYSTAL STRUCTURE OF THE NEONATAL FC RECEPTOR COMPLEXED WITH A HETERODIMERIC FC","10.1016/S1097-2765(01)00230-1 ",2.8,78.2,"1i1a_oligo3","DGlcpNAca1-2DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAca1-ASN","FUC(6_F_)-[NDG(5_F_)-MAN(4_F_)-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(128_A_)",131.845,"","",""
"1I1C","NON-FCRN BINDING FC FRAGMENT OF RAT IGG2A","10.1016/S1097-2765(01)00230-1 ",2.7,41.2,"1i1c_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",100.324,"","",""
"1I1C","NON-FCRN BINDING FC FRAGMENT OF RAT IGG2A","10.1016/S1097-2765(01)00230-1 ",2.7,41.2,"1i1c_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",91.0807,"","",""
"1IEQ","CRYSTAL STRUCTURE OF BARLEY BETA-D-GLUCAN GLUCOHYDROLASE ISOENZYME EXO1","10.1016/S0969-2126(01)00673-6 ",2.7,0,"1ieq_oligo2","DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","NAG(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-[FUC(6_C_)]-NAG(1_C_)-ASN(498_A_)",72.3941,"","",""
"1IEV","CRYSTAL STRUCTURE OF BARLEY BETA-D-GLUCAN GLUCOHYDROLASE ISOENZYME EXO1 IN COMPLEX WITH CYCLOHEXITOL","10.1016/S0969-2126(01)00673-6 ",2.8,0,"1iev_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","BMA(3_B_)-NAG(2_B_)-[FUC(6_B_)]-NAG(1_B_)-ASN(498_A_)",76.7766,"","",""
"1IEX","CRYSTAL STRUCTURE OF BARLEY BETA-D-GLUCAN GLUCOHYDROLASE ISOENZYME EXO1 IN COMPLEX WITH 4I,4III,4V-S-TRITHIOCELLOHEXAOSE","10.1016/S0969-2126(01)00673-6 ",2.2,0,"1iex_oligo2","DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","NAG(5_B_)-MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-[FUC(6_B_)]-NAG(1_B_)-ASN(498_A_)",87.07,"","",""
"1IGR","TYPE 1 INSULIN-LIKE GROWTH FACTOR RECEPTOR (DOMAINS 1-3)","10.1038/28668 ",2.6,52.3,"1igr_oligo2","DManpa1-3DManpb1-4DGlcpNb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_C_)-[MAN(4_C_)-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(284_A_)",55.4538,"","",""
"1IGT","STRUCTURE OF IMMUNOGLOBULIN","10.1021/BI962514+ ",2.8,52,"1igt_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAca1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[NAG(8_E_)-MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(314_B_)",67.7962,"","",""
"1IGT","STRUCTURE OF IMMUNOGLOBULIN","10.1021/BI962514+ ",2.8,52,"1igt_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAca1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(9_F_)-[GAL(6_F_)-NAG(5_F_)-MAN(4_F_)-[NAG(8_F_)-MAN(7_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(314_D_)",142.475,"","",""
"1IGX","CRYSTAL STRUCTURE OF EICOSAPENTANOIC ACID BOUND IN THE CYCLOOXYGENASE CHANNEL OF PROSTAGLANDIN ENDOPEROXIDE H SYNTHASE-1.","10.1074/JBC.M105982200 ",3.1,0,"1igx_oligo5","DManpa1-3DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-BMA(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(144_A_)",64.8125,"","",""
"1IGY","STRUCTURE OF IMMUNOGLOBULIN","10.1006/JMBI.1997.1508 ",3.2,57.1,"1igy_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAca1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[NAG(8_E_)-MAN(7_E_)]-BMA(3_E_)-NDG(2_E_)]-NAG(1_E_)-ASN(314_B_)",79.4591,"","",""
"1IGY","STRUCTURE OF IMMUNOGLOBULIN","10.1006/JMBI.1997.1508 ",3.2,57.1,"1igy_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAca1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(9_F_)-[GAL(6_F_)-NAG(5_F_)-MAN(4_F_)-[NAG(8_F_)-MAN(7_F_)]-BMA(3_F_)-NDG(2_F_)]-NAG(1_F_)-ASN(314_D_)",77.3494,"","",""
"1IGZ","CRYSTAL STRUCTURE OF LINOLEIC ACID BOUND IN THE CYCLOOXYGENASE CHANNEL OF PROSTAGLANDIN ENDOPEROXIDE H SYNTHASE-1.","10.1074/JBC.M105982200 ",2.9,0,"1igz_oligo5","DManpa1-3DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-BMA(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(144_A_)",69.8235,"","",""
"1ING","INFLUENZA A SUBTYPE N2 NEURAMINIDASE COMPLEXED WITH AROMATIC BANA109 INHIBITOR","10.1021/JM00017A005 ",2.4,0,"1ing_oligo8","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4[DManpa1-6]DGlcpNAcb1-ASN","MAN(6_I_)-[MAN(5_I_)-MAN(4_I_)-BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(200_B_)",37.2152,"","",""
"1ING","INFLUENZA A SUBTYPE N2 NEURAMINIDASE COMPLEXED WITH AROMATIC BANA109 INHIBITOR","10.1021/JM00017A005 ",2.4,0,"1ing_oligo1","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(200_A_)",35.9689,"","",""
"1INW","A SIALIC ACID DERIVED PHOSPHONATE ANALOG INHIBITS DIFFERENT STRAINS OF INFLUENZA VIRUS NEURAMINIDASE WITH DIFFERENT EFFICIENCIES","10.1006/JMBI.1994.0051 ",2.4,12.79,"1inw_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",34.2862,"","",""
"1INX","A SIALIC ACID DERIVED PHOSPHONATE ANALOG INHIBITS DIFFERENT STRAINS OF INFLUENZA VIRUS NEURAMINIDASE WITH DIFFERENT EFFICIENCIES","10.1006/JMBI.1994.0051 ",2.4,9.28,"1inx_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",28.9496,"","",""
"1INY","A SIALIC ACID DERIVED PHOSPHONATE ANALOG INHIBITS DIFFERENT STRAINS OF INFLUENZA VIRUS NEURAMINIDASE WITH DIFFERENT EFFICIENCIES","10.1006/JMBI.1994.0051 ",2.4,12.79,"1iny_oligo4","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-C8N1O5","MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)",33.9415,"","",""
"1IOA","ARCELIN-5, A LECTIN-LIKE DEFENSE PROTEIN FROM PHASEOLUS VULGARIS","10.1074/JBC.271.51.32796 ",2.7,16.1,"1ioa_oligo1","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_C_)-[FUC(2_C_)]-NAG(1_C_)-ASN(22_A_)",32.917,"","",""
"1IOA","ARCELIN-5, A LECTIN-LIKE DEFENSE PROTEIN FROM PHASEOLUS VULGARIS","10.1074/JBC.271.51.32796 ",2.7,16.1,"1ioa_oligo2","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_D_)-[FUC(2_D_)]-NAG(1_D_)-ASN(22_B_)",34.0264,"","",""
"1IQQ","CRYSTAL STRUCTURE OF JAPANESE PEAR S3-RNASE","10.1074/JBC.M107617200 ",1.5,14.2,"1iqq_oligo1","DXylpb1-2[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[XYP(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(116_A_)",26.8881,"","",""
"1IVC","STRUCTURES OF AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE","10.1021/BI00010A003 ",2.4,0,"1ivc_oligo5","DManp[2<R1>]a1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(200_A_)",33.1414,"","",""
"1IVC","STRUCTURES OF AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE","10.1021/BI00010A003 ",2.4,0,"1ivc_oligo7","DManp[2<R1>]a1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(200_B_)",33.1414,"","",""
"1IVF","STRUCTURES OF AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE","10.1021/BI00010A003 ",2.4,0,"1ivf_oligo1","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4[DManpa1-6]DGlcp[2<R1>]b1-ASN","MAN(6_F_)-[MAN(5_F_)-MAN(4_F_)-BMA(3_F_)-NAG(2_F_)--ASN(200_A_)",36.5564,"","",""
"1IVF","STRUCTURES OF AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE","10.1021/BI00010A003 ",2.4,0,"1ivf_oligo7","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4[DManpa1-6]DGlcpNAcb1-ASN","MAN(6_I_)-[MAN(5_I_)-MAN(4_I_)-BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(200_B_)",36.5564,"","",""
"1J86","HUMAN HIGH AFFINITY FC RECEPTOR FC(EPSILON)RI(ALPHA), MONOCLINIC CRYSTAL FORM 2","10.1006/JMBI.2001.4929 ",3.2,67.5,"1j86_oligo4","DFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_E_)-[FCA(2_E_)]-NAG(1_E_)-ASN(74_A_)",133.042,"","",""
"1J86","HUMAN HIGH AFFINITY FC RECEPTOR FC(EPSILON)RI(ALPHA), MONOCLINIC CRYSTAL FORM 2","10.1006/JMBI.2001.4929 ",3.2,67.5,"1j86_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(42_B_)",104.019,"","",""
"1J87","HUMAN HIGH AFFINITY FC RECEPTOR FC(EPSILON)RI(ALPHA), HEXAGONAL CRYSTAL FORM 1","10.1006/JMBI.2001.4929 ",3.2,96,"1j87_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(42_A_)",112.179,"","",""
"1J88","HUMAN HIGH AFFINITY FC RECEPTOR FC(EPSILON)RI(ALPHA), TETRAGONAL CRYSTAL FORM 1","10.1006/JMBI.2001.4929 ",3.2,126.8,"1j88_oligo1","DManpa1-3DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_G_)-MAN(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(42_A_)",129.252,"","",""
"1J8R","BINARY COMPLEX OF THE PAPG RECEPTOR-BINDING DOMAIN BOUND TO GBO4 RECEPTOR","10.1016/S0092-8674(01)00388-9 ",1.8,30.1,"1j8r_oligo1","DGalpNAcb1-3DGalpa1-4DGalpb1-4DGlcpb1-ROH","NGA(4_B_)-GLA(3_B_)-GAL(2_B_)-BGC(1_B_)",40.2332,"","",""
"1J8V","CRYSTAL STRUCTURE OF BARLEY BETA-D-GLUCAN GLUCOHYDROLASE ISOENZYME EXO1 IN COMPLEX WITH 4'-NITROPHENYL 3I-THIOLAMINARITRIOSIDE","10.1105/TPC.010442 ",2.4,0,"1j8v_oligo2","DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","NAG(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-[FUC(6_C_)]-NAG(1_C_)-ASN(498_A_)",61.3233,"","",""
"1JLX","AGGLUTININ IN COMPLEX WITH T-DISACCHARIDE","10.1038/NSB1097-779 ",2.2,23.06,"1jlx_oligo2","DGalpb1-3DGalpNAca1-C7O1","GAL(2_D_)-A2G(1_D_)",15.3973,"","",""
"1JLX","AGGLUTININ IN COMPLEX WITH T-DISACCHARIDE","10.1038/NSB1097-779 ",2.2,23.06,"1jlx_oligo1","DGalpb1-3DGalpNAca1-C7O1","GAL(2_C_)-A2G(1_C_)",18.6109,"","",""
"1JND","CRYSTAL STRUCTURE OF IMAGINAL DISC GROWTH FACTOR-2","10.1074/JBC.M110502200 ",1.3,0,"1jnd_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",28.6184,"","",""
"1JNE","CRYSTAL STRUCTURE OF IMAGINAL DISC GROWTH FACTOR-2","10.1074/JBC.M110502200 ",1.7,0,"1jne_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",29.4293,"","",""
"1JOT","STRUCTURE OF THE LECTIN MPA COMPLEXED WITH T-ANTIGEN DISACCHARIDE","10.1074/JBC.273.11.6312 ",2.2,0,"1jot_oligo1","DGalpb1-3DGalpNAca1-ROH","GAL(2_C_)-A2G(1_C_)",27.3027,"","",""
"1JPC","MANNOSE-SPECIFIC AGGLUTININ (LECTIN) FROM SNOWDROP (GALANTHUS NIVALIS) BULBS IN COMPLEX WITH MANNOSE-ALPHA1,6-(MANNOSE-ALPHA1,3)-MANNOSE- ALPHA1,6-(MANNOSE-ALPHA1,3)-MANNOSE","10.1016/S0969-2126(96)00141-4 ",2,33.5,"1jpc_oligo3","DManpa1-3[DManpa1-6]DManpa1-ROH","MAN(3_B_)-[MAN(2_B_)]-MAN(1_B_)",27.9779,"","",""
"1JPC","MANNOSE-SPECIFIC AGGLUTININ (LECTIN) FROM SNOWDROP (GALANTHUS NIVALIS) BULBS IN COMPLEX WITH MANNOSE-ALPHA1,6-(MANNOSE-ALPHA1,3)-MANNOSE- ALPHA1,6-(MANNOSE-ALPHA1,3)-MANNOSE","10.1016/S0969-2126(96)00141-4 ",2,33.5,"1jpc_oligo1","DManpa1-3[DManpa1-6]DManpa1-ROH","MAN(3_D_)-[MAN(2_D_)]-MAN(1_D_)",39.1379,"","",""
"1JS8","STRUCTURE OF A FUNCTIONAL UNIT FROM OCTOPUS HEMOCYANIN","10.1006/JMBI.1998.1647 ",2.3,0,"1js8_oligo3","DManpa1-3[DManpb1-6]DManpx1-","BMA(3_E_)-[MAN(2_E_)]-MAN(1_E_)",49.2162,"","",""
"1JS8","STRUCTURE OF A FUNCTIONAL UNIT FROM OCTOPUS HEMOCYANIN","10.1006/JMBI.1998.1647 ",2.3,0,"1js8_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpb1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAca1-ASN","MAN(6_C_)-[MAN(5_C_)]-MAN(4_C_)-[BMA(7_C_)]-BMA(3_C_)-NAG(2_C_)-NDG(1_C_)-ASN(2553_A_)",31.9926,"","",""
"1JSN","STRUCTURE OF AVIAN H5 HAEMAGGLUTININ COMPLEXED WITH LSTA RECEPTRO ANALOG","10.1073/PNAS.201401198 ",2.4,0,"1jsn_oligo1","DNeup5Aca2-3DGalpb1-3DGlcpNAcb1-ROH","SIA(3_D_)-GAL(2_D_)-NAG(1_D_)",62.241,"","",""
"1JU2","CRYSTAL STRUCTURE OF THE HYDROXYNITRILE LYASE FROM ALMOND","10.1016/S0969-2126(01)00639-6 ",1.47,16.7,"1ju2_oligo5","DManpb1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","BMA(4_E_)-BMA(3_E_)-NAG(2_E_)-[FUC(5_E_)]-NAG(1_E_)-ASN(392_A_)",33.4707,"","",""
"1JU2","CRYSTAL STRUCTURE OF THE HYDROXYNITRILE LYASE FROM ALMOND","10.1016/S0969-2126(01)00639-6 ",1.47,16.7,"1ju2_oligo7","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-[FUC(5_G_)]-NAG(1_G_)-ASN(135_B_)",34.9513,"","",""
"1JU2","CRYSTAL STRUCTURE OF THE HYDROXYNITRILE LYASE FROM ALMOND","10.1016/S0969-2126(01)00639-6 ",1.47,16.7,"1ju2_oligo4","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-[FUC(5_D_)]-NAG(1_D_)-ASN(135_A_)",33.6445,"","",""
"1JU2","CRYSTAL STRUCTURE OF THE HYDROXYNITRILE LYASE FROM ALMOND","10.1016/S0969-2126(01)00639-6 ",1.47,16.7,"1ju2_oligo8","DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","BMA(3_H_)-NAG(2_H_)-[FUC(4_H_)]-NAG(1_H_)-ASN(392_B_)",42.2784,"","",""
"1JUH","CRYSTAL STRUCTURE OF QUERCETIN 2,3-DIOXYGENASE","10.1016/S0969-2126(02)00704-9 ",1.6,20.88,"1juh_oligo1","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_E_)-MAN(6_E_)-[MAN(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(191_A_)",37.8903,"","",""
"1JUH","CRYSTAL STRUCTURE OF QUERCETIN 2,3-DIOXYGENASE","10.1016/S0969-2126(02)00704-9 ",1.6,20.88,"1juh_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(191_B_)",37.3725,"","",""
"1K4Y","CRYSTAL STRUCTURE OF RABBIT LIVER CARBOXYLESTERASE IN COMPLEX WITH 4- PIPERIDINO-PIPERIDINE","10.1038/NSB790 ",2.5,61.6,"1k4y_oligo4","DManpa1-3DManpb1-3DManpb1-4DGlcpNAca1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-MAN(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(389_A_)",93.4104,"","",""
"1K7C","RHAMNOGALACTURONAN ACETYLESTERASE WITH SEVEN N-LINKED CARBOHYDRATE RESIDUES DISTRIBUTED AT TWO N-GLYCOSYLATION SITES REFINED AT 1.12 A RESOLUTION","10.1107/S0907444901018479 ",1.12,0,"1k7c_oligo1","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DManp[2H]b1-ASN","MAN(6_B_)-[MAN(5_B_)]-MAN(4_B_)-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(182_A_)",22.691,"","",""
"1K9I","COMPLEX OF DC-SIGN AND GLCNAC2MAN3","10.1126/SCIENCE.1066371 ",2.5,49.1,"1k9i_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpa1-ROH","NAG(5_K_)-MAN(4_K_)-[NAG(3_K_)-MAN(2_K_)]-MAN(1_K_)",57.0844,"","",""
"1K9I","COMPLEX OF DC-SIGN AND GLCNAC2MAN3","10.1126/SCIENCE.1066371 ",2.5,49.1,"1k9i_oligo3","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpa1-ROH","NAG(5_M_)-MAN(4_M_)-[NAG(3_M_)-MAN(2_M_)]-MAN(1_M_)",34.8735,"","",""
"1K9I","COMPLEX OF DC-SIGN AND GLCNAC2MAN3","10.1126/SCIENCE.1066371 ",2.5,49.1,"1k9i_oligo4","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpa1-ROH","NAG(5_N_)-MAN(4_N_)-[NAG(3_N_)-MAN(2_N_)]-MAN(1_N_)",41.1196,"","",""
"1K9I","COMPLEX OF DC-SIGN AND GLCNAC2MAN3","10.1126/SCIENCE.1066371 ",2.5,49.1,"1k9i_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpa1-ROH","NAG(5_L_)-MAN(4_L_)-[NAG(3_L_)-MAN(2_L_)]-MAN(1_L_)",45.066,"","",""
"1K9I","COMPLEX OF DC-SIGN AND GLCNAC2MAN3","10.1126/SCIENCE.1066371 ",2.5,49.1,"1k9i_oligo5","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpa1-ROH","NAG(5_O_)-MAN(4_O_)-[NAG(3_O_)-MAN(2_O_)]-MAN(1_O_)",41.8747,"","",""
"1K9J","COMPLEX OF DC-SIGNR AND GLCNAC2MAN3","10.1126/SCIENCE.1066371 ",1.9,26.1,"1k9j_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpa1-ROH","NAG(5_C_)-MAN(4_C_)-[NAG(3_C_)-MAN(2_C_)]-MAN(1_C_)",34.5642,"","",""
"1KJ2","MURINE ALLOREACTIVE SCFV TCR-PEPTIDE-MHC CLASS I MOLECULE COMPLEX","10.1016/S1074-7613(02)00288-1 ",2.71,45.65,"1kj2_oligo1","DNeup5Aca2-3DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpb1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","SIA(7_C_)-GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[MAN(8_C_)]-MAN(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(21_A_)",94.329,"","",""
"1KKT","STRUCTURE OF P. CITRINUM ALPHA 1,2-MANNOSIDASE REVEALS THE BASIS FOR DIFFERENCES IN SPECIFICITY OF THE ER AND GOLGI CLASS I ENZYMES","10.1074/JBC.M110243200 ",2.2,0,"1kkt_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAca1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(366_A_)",39.4729,"","",""
"1KKT","STRUCTURE OF P. CITRINUM ALPHA 1,2-MANNOSIDASE REVEALS THE BASIS FOR DIFFERENCES IN SPECIFICITY OF THE ER AND GOLGI CLASS I ENZYMES","10.1074/JBC.M110243200 ",2.2,0,"1kkt_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAca1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-MAN(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(366_B_)",59.0089,"","",""
"1KRE","STRUCTURE OF P. CITRINUM ALPHA 1,2-MANNOSIDASE REVEALS THE BASIS FOR DIFFERENCES IN SPECIFICITY OF THE ER AND GOLGI CLASS I ENZYMES","10.1074/JBC.M110243200 ",2.2,0,"1kre_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAca1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(366_A_)",36.67,"","",""
"1KRE","STRUCTURE OF P. CITRINUM ALPHA 1,2-MANNOSIDASE REVEALS THE BASIS FOR DIFFERENCES IN SPECIFICITY OF THE ER AND GOLGI CLASS I ENZYMES","10.1074/JBC.M110243200 ",2.2,0,"1kre_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAca1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-MAN(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(366_B_)",55.8665,"","",""
"1KRF","STRUCTURE OF P. CITRINUM ALPHA 1,2-MANNOSIDASE REVEALS THE BASIS FOR DIFFERENCES IN SPECIFICITY OF THE ER AND GOLGI CLASS I ENZYMES","10.1074/JBC.M110243200 ",2.2,0,"1krf_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAca1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-MAN(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(366_B_)",56.2936,"","",""
"1KRF","STRUCTURE OF P. CITRINUM ALPHA 1,2-MANNOSIDASE REVEALS THE BASIS FOR DIFFERENCES IN SPECIFICITY OF THE ER AND GOLGI CLASS I ENZYMES","10.1074/JBC.M110243200 ",2.2,0,"1krf_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAca1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(366_A_)",41.0025,"","",""
"1KWY","RAT MANNOSE PROTEIN A COMPLEXED WITH MAN-A13-MAN.","10.1074/JBC.M200493200 ",2,0,"1kwy_oligo1","DManpa1-3DManpa1-ROH","MAN(2_D_)-MAN(1_D_)",41.9705,"","",""
"1KWY","RAT MANNOSE PROTEIN A COMPLEXED WITH MAN-A13-MAN.","10.1074/JBC.M200493200 ",2,0,"1kwy_oligo3","DManpa1-3DManpa1-ROH","MAN(2_F_)-MAN(1_F_)",47.3227,"","",""
"1KWY","RAT MANNOSE PROTEIN A COMPLEXED WITH MAN-A13-MAN.","10.1074/JBC.M200493200 ",2,0,"1kwy_oligo2","DManpa1-3DManpa1-ROH","MAN(2_E_)-MAN(1_E_)",45.1932,"","",""
"1KWZ","RAT MANNOSE PROTEIN A (H189V) COMPLEXED WITH MAN-A13-MAN","10.1074/JBC.M200493200 ",1.9,0,"1kwz_oligo1","DManpa1-3DManpa1-ROH","MAN(2_D_)-MAN(1_D_)",44.5064,"","",""
"1KWZ","RAT MANNOSE PROTEIN A (H189V) COMPLEXED WITH MAN-A13-MAN","10.1074/JBC.M200493200 ",1.9,0,"1kwz_oligo2","DManpa1-3DManpa1-ROH","MAN(2_E_)-MAN(1_E_)",52.3836,"","",""
"1KWZ","RAT MANNOSE PROTEIN A (H189V) COMPLEXED WITH MAN-A13-MAN","10.1074/JBC.M200493200 ",1.9,0,"1kwz_oligo3","DManpa1-3DManpa1-ROH","MAN(2_F_)-MAN(1_F_)",51.9918,"","",""
"1KX0","RAT MANNOSE PROTEIN A (H189V I207V) COMPLEXED WITH MAN-A13-MAN","10.1074/JBC.M200493200 ",2,0,"1kx0_oligo2","DManpa1-3DManpa1-ROH","MAN(2_E_)-MAN(1_E_)",50.1818,"","",""
"1KX0","RAT MANNOSE PROTEIN A (H189V I207V) COMPLEXED WITH MAN-A13-MAN","10.1074/JBC.M200493200 ",2,0,"1kx0_oligo3","DManpa1-3DManpa1-ROH","MAN(2_F_)-MAN(1_F_)",89.665,"","",""
"1KX0","RAT MANNOSE PROTEIN A (H189V I207V) COMPLEXED WITH MAN-A13-MAN","10.1074/JBC.M200493200 ",2,0,"1kx0_oligo1","DManpa1-3DManpa1-ROH","MAN(2_D_)-MAN(1_D_)",28.0986,"","",""
"1KX1","RAT MANNOSE PROTEIN A COMPLEXED WITH MAN6-GLCNAC2-ASN","10.1074/JBC.M200493200 ",2.8,38.4,"1kx1_oligo1","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-ROH","MAN(6_G_)-[MAN(5_G_)]-MAN(4_G_)-[MAN(3_G_)-MAN(2_G_)]-MAN(1_G_)",59.5029,"","",""
"1KX1","RAT MANNOSE PROTEIN A COMPLEXED WITH MAN6-GLCNAC2-ASN","10.1074/JBC.M200493200 ",2.8,38.4,"1kx1_oligo2","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-ROH","MAN(6_H_)-[MAN(5_H_)]-MAN(4_H_)-[MAN(3_H_)-MAN(2_H_)]-MAN(1_H_)",59.547,"","",""
"1L6X","FC FRAGMENT OF RITUXIMAB BOUND TO A MINIMIZED VERSION OF THE B-DOMAIN FROM PROTEIN A CALLED Z34C","",1.65,24.8,"1l6x_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(10_C_)-[GAL(9_C_)-NAG(8_C_)-MAN(7_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",34.0833,"","",""
"1L7F","CRYSTAL STRUCTURE OF INFLUENZA VIRUS NEURAMINIDASE IN COMPLEX WITH BCX-1812","10.1021/JM010528U ",1.8,0,"1l7f_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",23.1586,"","",""
"1L7G","CRYSTAL STRUCTURE OF E119G MUTANT INFLUENZA VIRUS NEURAMINIDASE IN COMPLEX WITH BCX-1812","10.1021/JM010528U ",1.85,0,"1l7g_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",28.4565,"","",""
"1L7H","CRYSTAL STRUCTURE OF R292K MUTANT INFLUENZA VIRUS NEURAMINIDASE IN COMPLEX WITH BCX-1812","10.1021/JM010528U ",1.85,0,"1l7h_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",23.8791,"","",""
"1LEC","STRUCTURES OF THE LECTIN IV OF GRIFFONIA SIMPLICIFOLIA AND ITS COMPLEX WITH THE LEWIS B HUMAN BLOOD GROUP DETERMINANT AT 2.0 ANGSTROMS RESOLUTION","10.1006/JMBI.1993.1212 ",2,0,"1lec_oligo1","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_B_)-[FUC(2_B_)]-NAG(1_B_)-ASN(18_A_)",38.8339,"","",""
"1LED","STRUCTURES OF THE LECTIN IV OF GRIFFONIA SIMPLICIFOLIA AND ITS COMPLEX WITH THE LEWIS B HUMAN BLOOD GROUP DETERMINANT AT 2.0 ANGSTROMS RESOLUTION","10.1006/JMBI.1993.1212 ",2,0,"1led_oligo3","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_C_)-[FUC(2_C_)]-NAG(1_C_)-ASN(18_A_)",37.9727,"","",""
"1LED","STRUCTURES OF THE LECTIN IV OF GRIFFONIA SIMPLICIFOLIA AND ITS COMPLEX WITH THE LEWIS B HUMAN BLOOD GROUP DETERMINANT AT 2.0 ANGSTROMS RESOLUTION","10.1006/JMBI.1993.1212 ",2,0,"1led_oligo1","LFucpa1-2DGalpb1-3[LFucpa1-4]DGlcpNAcb1-OME","FUC(4_B_)-[FUC(3_B_)-GAL(2_B_)]-MAG(1_B_)",33.9282,"","",""
"1LGB","INTERACTION OF A LEGUME LECTIN WITH THE N2 FRAGMENT OF HUMAN LACTOTRANSFERRIN OR WITH THE ISOLATED BIANTENNARY GLYCOPEPTIDE: ROLE OF THE FUCOSE MOIETY","10.1016/S0969-2126(00)00022-8 ",3.3,0,"1lgb_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_D_)-[NAG(8_D_)-MAN(7_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(137_C_)",54.3261,"","",""
"1LGC","INTERACTION OF A LEGUME LECTIN WITH THE N2 FRAGMENT OF HUMAN LACTOTRANSFERRIN OR WITH THE ISOLATED BIANTENNARY GLYCOPEPTIDE: ROLE OF THE FUCOSE MOIETY","10.1016/S0969-2126(00)00022-8 ",2.8,0,"1lgc_oligo1","DNeup5Aca2-6DGalpb1-4DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_K_)-[MAN(8_K_)-[SIA(7_K_)-GAL(6_K_)-NAG(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(512_I_)",57.2812,"","",""
"1LGC","INTERACTION OF A LEGUME LECTIN WITH THE N2 FRAGMENT OF HUMAN LACTOTRANSFERRIN OR WITH THE ISOLATED BIANTENNARY GLYCOPEPTIDE: ROLE OF THE FUCOSE MOIETY","10.1016/S0969-2126(00)00022-8 ",2.8,0,"1lgc_oligo2","LFucpa1-3[DGalpb1-4]DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(10_G_)-[NAG(9_G_)-MAN(8_G_)-[GAL(7_G_)-[FUC(6_G_)]-NAG(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(512_H_)",52.396,"","",""
"1LGC","INTERACTION OF A LEGUME LECTIN WITH THE N2 FRAGMENT OF HUMAN LACTOTRANSFERRIN OR WITH THE ISOLATED BIANTENNARY GLYCOPEPTIDE: ROLE OF THE FUCOSE MOIETY","10.1016/S0969-2126(00)00022-8 ",2.8,0,"1lgc_oligo3","DNeup5Aca2-6DGalpb1-4DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_L_)-[MAN(8_L_)-[SIA(7_L_)-GAL(6_L_)-NAG(5_L_)-MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)]-NAG(1_L_)-ASN(512_J_)",59.1371,"","",""
"1LK9","THE THREE-DIMENSIONAL STRUCTURE OF ALLIINASE FROM GARLIC","10.1074/JBC.M208669200 ",1.53,25.8,"1lk9_oligo5","LFucpa1-3DGlcpNAcb1-ASN","FUC(2_E_)-NAG(1_E_)-ASN(146_B_)",51.2073,"","",""
"1LK9","THE THREE-DIMENSIONAL STRUCTURE OF ALLIINASE FROM GARLIC","10.1074/JBC.M208669200 ",1.53,25.8,"1lk9_oligo3","DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","BMA(3_C_)-NAG(2_C_)-[FUC(4_C_)]-NAG(1_C_)-ASN(146_A_)",43.2852,"","",""
"1LOF","X-RAY STRUCTURE OF A BIANTENNARY OCTASACCHARIDE-LECTIN COMPLEX AT 2.3 ANGSTROMS RESOLUTION","",2.3,0,"1lof_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-ROH","GAL(8_E_)-NAG(7_E_)-MAN(6_E_)-[GAL(5_E_)-NAG(4_E_)-MAN(3_E_)]-BMA(2_E_)-NAG(1_E_)",77.3305,"","",""
"1LOF","X-RAY STRUCTURE OF A BIANTENNARY OCTASACCHARIDE-LECTIN COMPLEX AT 2.3 ANGSTROMS RESOLUTION","",2.3,0,"1lof_oligo2","DGlcpNAcb1-2DManpa1-3DManpx1-","NAG(3_F_)-MAN(2_F_)-MAN(1_F_)",66.324,"","",""
"1LOG","X-RAY STRUCTURE OF A (ALPHA-MAN(1-3)BETA-MAN(1-4)GLCNAC)-LECTIN COMPLEX AT 2.1 ANGSTROMS RESOLUTION","",2.1,0,"1log_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-ROH","MAN(3_E_)-BMA(2_E_)-NAG(1_E_)",35.6658,"","",""
"1LOG","X-RAY STRUCTURE OF A (ALPHA-MAN(1-3)BETA-MAN(1-4)GLCNAC)-LECTIN COMPLEX AT 2.1 ANGSTROMS RESOLUTION","",2.1,0,"1log_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-ROH","MAN(3_F_)-BMA(2_F_)-NAG(1_F_)",31.5582,"","",""
"1LQ2","CRYSTAL STRUCTURE OF BARLEY BETA-D-GLUCAN GLUCOHYDROLASE ISOENZYME EXO1 IN COMPLEX WITH GLUCO-PHENYLIMIDAZOLE","10.1074/JBC.M307188200 ",2.7,0,"1lq2_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","BMA(3_C_)-NAG(2_C_)-[FUC(4_C_)]-NAG(1_C_)-ASN(600_A_)",55.7293,"","",""
"1LQ2","CRYSTAL STRUCTURE OF BARLEY BETA-D-GLUCAN GLUCOHYDROLASE ISOENZYME EXO1 IN COMPLEX WITH GLUCO-PHENYLIMIDAZOLE","10.1074/JBC.M307188200 ",2.7,0,"1lq2_oligo2","DGlcpNAcb1-2DManpa1-6DManpa1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","NAG(5_B_)-MAN(4_B_)-MAN(3_B_)-NAG(2_B_)-[FUC(6_B_)]-NAG(1_B_)-ASN(498_A_)",75.7435,"","",""
"1LQ8","CRYSTAL STRUCTURE OF CLEAVED PROTEIN C INHIBITOR","10.1016/S0969-2126(02)00944-9 ",2.4,0,"1lq8_oligo3","DManpa1-3[DManpa1-6]DManpa1-ROH","MAN(3_L_)-[MAN(2_L_)]-MAN(1_L_)",151.655,"","",""
"1LR5","CRYSTAL STRUCTURE OF AUXIN BINDING PROTEIN","10.1093/EMBOJ/CDF291 ",1.9,0,"1lr5_oligo4","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-[MAN(5_H_)]-MAN(4_H_)-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(95_D_)",26.8577,"","",""
"1LR5","CRYSTAL STRUCTURE OF AUXIN BINDING PROTEIN","10.1093/EMBOJ/CDF291 ",1.9,0,"1lr5_oligo2","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)]-MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(95_B_)",11.1053,"","",""
"1LR5","CRYSTAL STRUCTURE OF AUXIN BINDING PROTEIN","10.1093/EMBOJ/CDF291 ",1.9,0,"1lr5_oligo1","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-[MAN(5_E_)]-MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(95_A_)",11.0156,"","",""
"1LR5","CRYSTAL STRUCTURE OF AUXIN BINDING PROTEIN","10.1093/EMBOJ/CDF291 ",1.9,0,"1lr5_oligo3","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_G_)-[MAN(5_G_)]-MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(95_C_)",26.3032,"","",""
"1LRH","CRYSTAL STRUCTURE OF AUXIN-BINDING PROTEIN 1 IN COMPLEX WITH 1- NAPHTHALENE ACETIC ACID","10.1093/EMBOJ/CDF291 ",1.9,0,"1lrh_oligo4","DManpb1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-[MAN(5_H_)]-MAN(4_H_)-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(95_D_)",28.0773,"","",""
"1LRH","CRYSTAL STRUCTURE OF AUXIN-BINDING PROTEIN 1 IN COMPLEX WITH 1- NAPHTHALENE ACETIC ACID","10.1093/EMBOJ/CDF291 ",1.9,0,"1lrh_oligo3","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)]-MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(95_B_)",12.8217,"","",""
"1LRH","CRYSTAL STRUCTURE OF AUXIN-BINDING PROTEIN 1 IN COMPLEX WITH 1- NAPHTHALENE ACETIC ACID","10.1093/EMBOJ/CDF291 ",1.9,0,"1lrh_oligo2","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_G_)-[MAN(5_G_)]-MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(95_C_)",24.4688,"","",""
"1LRH","CRYSTAL STRUCTURE OF AUXIN-BINDING PROTEIN 1 IN COMPLEX WITH 1- NAPHTHALENE ACETIC ACID","10.1093/EMBOJ/CDF291 ",1.9,0,"1lrh_oligo1","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-[MAN(5_E_)]-MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(95_A_)",14.0645,"","",""
"1LTE","STRUCTURE OF A LEGUME LECTIN WITH AN ORDERED N-LINKED CARBOHYDRATE IN COMPLEX WITH LACTOSE","",2,0,"1lte_oligo1","DXylpb1-2[DManpa1-3][DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(6_B_)-[MAN(5_B_)]-[XYL(4_B_)]-BMA(3_B_)-NAG(2_B_)-[FUC(7_B_)]-NAG(1_B_)-ASN(17_A_)",31.3476,"","",""
"1LTI","HEAT-LABILE ENTEROTOXIN (LT-I) COMPLEX WITH T-ANTIGEN","",2.13,33.9,"1lti_oligo1","DGalpb1-3DGalpNAca1-ROH","GAL(2_B_)-A2G(1_B_)",65.7068,"","",""
"1LU1","THE STRUCTURE OF THE DOLICHOS BIFLORUS SEED LECTIN IN COMPLEX WITH THE FORSSMAN DISACCHARIDE","10.1006/JMBI.1998.2534 ",2.6,46,"1lu1_oligo1","DGalpNAca1-3DFucpNAcb1-ROH","A2G(2_B_)-NGA(1_B_)",64.1745,"","",""
"1LX5","CRYSTAL STRUCTURE OF THE BMP7/ACTRII EXTRACELLULAR DOMAIN COMPLEX","10.1016/S1097-2765(03)00094-7 ",3.3,69.6,"1lx5_oligo1","DManpa1-3[DManpb1-4][DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-[BMA(5_C_)]-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(80_A_)",127.69,"","",""
"1M26","CRYSTAL STRUCTURE OF JACALIN-T-ANTIGEN COMPLEX","10.1016/S0022-2836(02)00674-5 ",1.62,24,"1m26_oligo2","DGalpb1-3DGalpNAca1-ROH","GAL(2_J_)-A2G(1_J_)",22.9432,"","",""
"1M26","CRYSTAL STRUCTURE OF JACALIN-T-ANTIGEN COMPLEX","10.1016/S0022-2836(02)00674-5 ",1.62,24,"1m26_oligo3","DGalpb1-3DGalpNAca1-ROH","GAL(2_K_)-A2G(1_K_)",26.3718,"","",""
"1M26","CRYSTAL STRUCTURE OF JACALIN-T-ANTIGEN COMPLEX","10.1016/S0022-2836(02)00674-5 ",1.62,24,"1m26_oligo1","DGalpb1-3DGalpNAca1-ROH","GAL(2_I_)-A2G(1_I_)",27.1064,"","",""
"1M26","CRYSTAL STRUCTURE OF JACALIN-T-ANTIGEN COMPLEX","10.1016/S0022-2836(02)00674-5 ",1.62,24,"1m26_oligo4","DGalpb1-3DGalpNAca1-ROH","GAL(2_L_)-A2G(1_L_)",31.7432,"","",""
"1M7D","CRYSTAL STRUCTURE OF A MONOCLONAL FAB SPECIFIC FOR SHIGELLA FLEXNERI Y LIPOPOLYSACCHARIDE COMPLEXED WITH A TRISACCHARIDE","10.1021/BI0261387 ",2.3,40.2,"1m7d_oligo1","LRhapa1-3LOlipa1-3DGlcpNAcb1-OME","RAM(3_C_)-RAE(2_C_)-MAG(1_C_)",41.0598,"","",""
"1M7I","CRYSTAL STRUCTURE OF A MONOCLONAL FAB SPECIFIC FOR SHIGELLA FLEXNERI Y LIPOPOLYSACCHARIDE COMPLEXED WITH A PENTASACCHARIDE","10.1021/BI0261387 ",2.5,35.6,"1m7i_oligo1","LRhapa1-2LRhapa1-3LRhapa1-3DGlcpNAcb1-2LRhapa1-OME","RAM(5_C_)-RAM(4_C_)-RAM(3_C_)-NAG(2_C_)-RAO(1_C_)",43.9771,"","",""
"1MFA","STRUCTURE OF A SINGLE-CHAIN FV FRAGMENT COMPLEXED WITH A CARBOHYDRATE ANTIGEN AT 1.7 ANGSTROMS RESOLUTION","10.1073/PNAS.91.14.6423 ",1.7,0,"1mfa_oligo1","DGalpa1-2[DAbepa1-3]DManpa1-OME","ABE(3_A_)-[GLA(2_A_)]-MMA(1_A_)",28.426,"","",""
"1MFB","HIGH RESOLUTION STRUCTURES OF ANTIBODY FAB FRAGMENT COMPLEXED WITH CELL-SURFACE OLIGOSACCHARIDE OF PATHOGENIC SALMONELLA","",2.1,0,"1mfb_oligo1","DGalpa1-2DManpa1-4LRhapa1-3DGalpa1-2[DAbepa1-3]DManpa1-4LRhapa1-ROH","ABE(7_A_)-[GLA(6_A_)-MAN(5_A_)-RAM(4_A_)-GLA(3_A_)]-MAN(2_A_)-RAM(1_A_)",42.5652,"","",""
"1MFC","HIGH RESOLUTION STRUCTURES OF ANTIBODY FAB FRAGMENT COMPLEXED WITH CELL-SURFACE OLIGOSACCHARIDE OF PATHOGENIC SALMONELLA","",2.1,0,"1mfc_oligo1","DGalpa1-2[DAbepa1-3]DManpa1-4LRhapa1-ROH","ABE(4_A_)-[GLA(3_A_)]-MAN(2_A_)-RAM(1_A_)",40.3633,"","",""
"1MFD","THE SOLUTION STRUCTURE OF A TRISACCHARIDE-ANTIBODY COMPLEX: COMPARISON OF NMR MEASUREMENTS WITH A CRYSTAL STRUCTURE","10.1021/BI00183A023 ",2.1,0,"1mfd_oligo1","DGalpa1-2[DAbepa1-3]DManpa1-OME","ABE(3_A_)-[GLA(2_A_)]-MMA(1_A_)",41.0118,"","",""
"1MFE","RECOGNITION OF A CELL-SURFACE OLIGO-SACCHARIDE OF PATHOGENIC SALMONELLA BY AN ANTIBODY FAB FRAGMENT","",2,0,"1mfe_oligo1","DGalpa1-2[DAbepa1-3]DManpa1-ROH","ABE(3_A_)-[GLA(2_A_)]-MAN(1_A_)",30.0014,"","",""
"1MHL","CRYSTAL STRUCTURE OF HUMAN MYELOPEROXIDASE ISOFORM C CRYSTALLIZED IN SPACE GROUP P2(1) AT PH 5.5 AND 20 DEG C","10.1006/ABBI.1995.1086 ",2.25,20.3,"1mhl_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_E_)-[MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(317_C_)",26.4176,"","",""
"1MHL","CRYSTAL STRUCTURE OF HUMAN MYELOPEROXIDASE ISOFORM C CRYSTALLIZED IN SPACE GROUP P2(1) AT PH 5.5 AND 20 DEG C","10.1006/ABBI.1995.1086 ",2.25,20.3,"1mhl_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_F_)-[MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(317_D_)",27.063,"","",""
"1MOX","CRYSTAL STRUCTURE OF HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR (RESIDUES 1-501) IN COMPLEX WITH TGF-ALPHA","10.1016/S0092-8674(02)00940-6 ",2.5,0,"1mox_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(328_A_)",79.5445,"","",""
"1MQM","BHA/LSTA","10.1016/S0042-6822(03)00068-0 ",2.6,0,"1mqm_oligo7","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_M_)-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(165_G_)",58.9543,"","",""
"1MQM","BHA/LSTA","10.1016/S0042-6822(03)00068-0 ",2.6,0,"1mqm_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_K_)-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(165_D_)",71.8827,"","",""
"1MQM","BHA/LSTA","10.1016/S0042-6822(03)00068-0 ",2.6,0,"1mqm_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(165_A_)",76.745,"","",""
"1MQM","BHA/LSTA","10.1016/S0042-6822(03)00068-0 ",2.6,0,"1mqm_oligo2","DNeup5Aca2-3DGalpb1-3DGlcpNAcb1-ROH","SIA(3_J_)-GAL(2_J_)-NAG(1_J_)",75.2747,"","",""
"1MQM","BHA/LSTA","10.1016/S0042-6822(03)00068-0 ",2.6,0,"1mqm_oligo6","DNeup5Aca2-3DGalpb1-3DGlcpNAcb1-ROH","SIA(3_L_)-GAL(2_L_)-NAG(1_L_)",72.6063,"","",""
"1MQN","BHA/LSTC","10.1016/S0042-6822(03)00068-0 ",3.2,0,"1mqn_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(165_A_)",74.0318,"","",""
"1MQN","BHA/LSTC","10.1016/S0042-6822(03)00068-0 ",3.2,0,"1mqn_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_K_)-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(165_D_)",73.08,"","",""
"1MQN","BHA/LSTC","10.1016/S0042-6822(03)00068-0 ",3.2,0,"1mqn_oligo7","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_M_)-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(165_G_)",56.6734,"","",""
"1MWE","THE X-RAY STRUCTURE OF A COMPLEX OF TERN N9 INFLUENZA VIRUS NEURAMINIDASE COMPLEXED WITH SIALIC ACID AT 4 DEGREES C REVEALING A SECOND SIALIC ACID BINDING SITE","10.1073/PNAS.94.22.11808 ",1.7,0,"1mwe_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6DManp[3<R1>]a1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_B_)-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",20.8249,"","",""
"1MYR","MYROSINASE FROM SINAPIS ALBA","10.1016/S0969-2126(97)00221-9 ",1.64,16.7,"1myr_oligo1","DXylpb1-2[DManpa1-3][DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(6_D_)-[MAN(5_D_)]-[XYP(4_D_)]-BMA(3_D_)-NAG(2_D_)-[FUC(7_D_)]-NAG(1_D_)-ASN(292_A_)",30.7501,"","",""
"1MYR","MYROSINASE FROM SINAPIS ALBA","10.1016/S0969-2126(97)00221-9 ",1.64,16.7,"1myr_oligo8","DXylpb1-2DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","XYP(4_C_)-BMA(3_C_)-NAG(2_C_)-[FUC(5_C_)]-NAG(1_C_)-ASN(265_A_)",34.581,"","",""
"1N3Q","PTEROCARPUS ANGOLENSIS LECTIN COMPLEXED WITH TURANOSE","10.1074/JBC.M211148200 ",2.2,0,"1n3q_oligo2","DGlcpa1-3DFrupb2-ROH","GLC(2_D_)-BDF(1_D_)",33.2109,"","",""
"1N3Q","PTEROCARPUS ANGOLENSIS LECTIN COMPLEXED WITH TURANOSE","10.1074/JBC.M211148200 ",2.2,0,"1n3q_oligo1","DGlcpa1-3DFrufb2-ROH","GLC(2_C_)-FRU(1_C_)",33.0097,"","",""
"1N47","ISOLECTIN B4 FROM VICIA VILLOSA IN COMPLEX WITH THE TN ANTIGEN","10.1016/S0014-5793(03)00037-1 ",2.7,33.57,"1n47_oligo8","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_H_)-[FUC(2_H_)]-NAG(1_H_)-ASN(61_D_)",61.683,"","",""
"1N47","ISOLECTIN B4 FROM VICIA VILLOSA IN COMPLEX WITH THE TN ANTIGEN","10.1016/S0014-5793(03)00037-1 ",2.7,33.57,"1n47_oligo7","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_G_)-[FUC(2_G_)]-NAG(1_G_)-ASN(61_C_)",50.7724,"","",""
"1N47","ISOLECTIN B4 FROM VICIA VILLOSA IN COMPLEX WITH THE TN ANTIGEN","10.1016/S0014-5793(03)00037-1 ",2.7,33.57,"1n47_oligo3","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_F_)-[FUC(2_F_)]-NAG(1_F_)-ASN(61_B_)",52.2649,"","",""
"1N47","ISOLECTIN B4 FROM VICIA VILLOSA IN COMPLEX WITH THE TN ANTIGEN","10.1016/S0014-5793(03)00037-1 ",2.7,33.57,"1n47_oligo2","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_E_)-[FUC(2_E_)]-NAG(1_E_)-ASN(61_A_)",62.8476,"","",""
"1N7D","EXTRACELLULAR DOMAIN OF THE LDL RECEPTOR","10.1126/SCIENCE.1078124 ",3.7,124.7,"1n7d_oligo2","DRhapa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)",124.7,"","",""
"1NCA","REFINED CRYSTAL STRUCTURE OF THE INFLUENZA VIRUS N9 NEURAMINIDASE-NC41 FAB COMPLEX","10.1016/0022-2836(92)90687-F ",2.5,0,"1nca_oligo1","DManpa1-2DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_A_)-MAN(5_A_)-MAN(4_A_)-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(200_N_)",13.5127,"","",""
"1NCB","CRYSTAL STRUCTURES OF TWO MUTANT NEURAMINIDASE-ANTIBODY COMPLEXES WITH AMINO ACID SUBSTITUTIONS IN THE INTERFACE","10.1016/0022-2836(92)90688-G ",2.5,0,"1ncb_oligo1","DManpa1-2DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_A_)-MAN(5_A_)-MAN(4_A_)-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(200_N_)",13.5139,"","",""
"1NCC","CRYSTAL STRUCTURES OF TWO MUTANT NEURAMINIDASE-ANTIBODY COMPLEXES WITH AMINO ACID SUBSTITUTIONS IN THE INTERFACE","10.1016/0022-2836(92)90688-G ",2.5,0,"1ncc_oligo1","DManpa1-2DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_A_)-MAN(5_A_)-MAN(4_A_)-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(200_N_)",11.2364,"","",""
"1NCD","REFINED CRYSTAL STRUCTURE OF THE INFLUENZA VIRUS N9 NEURAMINIDASE-NC41 FAB COMPLEX","10.1016/0022-2836(92)90687-F ",2.9,0,"1ncd_oligo1","DManpa1-2DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_A_)-MAN(5_A_)-MAN(4_A_)-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(200_N_)",13.1409,"","",""
"1NHC","STRUCTURAL INSIGHTS INTO THE PROCESSIVITY OF ENDOPOLYGALACTURONASE I FROM ASPERGILLUS NIGER","10.1016/S0014-5793(03)01221-3 ",1.7,25,"1nhc_oligo2","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-[MAN(5_H_)]-MAN(4_H_)-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(246_B_)",53.813,"","",""
"1NIV","MANNOSE-SPECIFIC AGGLUTININ (LECTIN) FROM SNOWDROP (GALANTHUS NIVALIS) BULBS IN COMPLEX WITH MANNOSE-ALPHA 1,3-METHYL-D-MANNOSE","10.1006/JMBI.1996.0532 ",3,32.3,"1niv_oligo1","DManpa1-3DManpa1-OME","MAN(2_B_)-MMA(1_B_)",15.84,"","",""
"1NIV","MANNOSE-SPECIFIC AGGLUTININ (LECTIN) FROM SNOWDROP (GALANTHUS NIVALIS) BULBS IN COMPLEX WITH MANNOSE-ALPHA 1,3-METHYL-D-MANNOSE","10.1006/JMBI.1996.0532 ",3,32.3,"1niv_oligo2","DManpa1-3DManpa1-OME","MAN(2_D_)-MMA(1_D_)",21.49,"","",""
"1NIV","MANNOSE-SPECIFIC AGGLUTININ (LECTIN) FROM SNOWDROP (GALANTHUS NIVALIS) BULBS IN COMPLEX WITH MANNOSE-ALPHA 1,3-METHYL-D-MANNOSE","10.1006/JMBI.1996.0532 ",3,32.3,"1niv_oligo3","DManpa1-3DManpa1-OME","MAN(2_E_)-MMA(1_E_)",50,"","",""
"1NMA","N9 NEURAMINIDASE COMPLEXES WITH ANTIBODIES NC41 AND NC10: EMPIRICAL FREE-ENERGY CALCULATIONS CAPTURE SPECIFICITY TRENDS OBSERVED WITH MUTANT BINDING DATA","10.1021/BI00192A002 ",3,0,"1nma_oligo1","DManpa1-2DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(6_A_)-MAN(5_A_)-MAN(4_A_)-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)",22.5,"","",""
"1NMB","THE STRUCTURE OF A COMPLEX BETWEEN THE NC10 ANTIBODY AND INFLUENZA VIRUS NEURAMINIDASE AND COMPARISON WITH THE OVERLAPPING BINDING SITE OF THE NC41 ANTIBODY","10.1016/S0969-2126(00)00074-5 ",2.2,0,"1nmb_oligo1","DManpa1-2DManpa1-2DManpa1-3[DGlcpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(7_A_)-[MAN(6_A_)-MAN(5_A_)-MAN(4_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)",9.05912,"","",""
"1NMC","COMPLEX BETWEEN NC10 ANTI-INFLUENZA VIRUS NEURAMINIDASE SINGLE CHAIN ANTIBODY WITH A 15 RESIDUE LINKER AND INFLUENZA VIRUS NEURAMINIDASE","10.1006/JMBI.1998.1794 ",2.5,23,"1nmc_oligo1","DManpa1-2DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-MAN(5_D_)-MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(200_N_)",13.8361,"","",""
"1NMC","COMPLEX BETWEEN NC10 ANTI-INFLUENZA VIRUS NEURAMINIDASE SINGLE CHAIN ANTIBODY WITH A 15 RESIDUE LINKER AND INFLUENZA VIRUS NEURAMINIDASE","10.1006/JMBI.1998.1794 ",2.5,23,"1nmc_oligo2","DManpa1-2DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-MAN(5_E_)-MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(200_A_)",13.8361,"","",""
"1NN2","THREE-DIMENSIONAL STRUCTURE OF THE NEURAMINIDASE OF INFLUENZA VIRUS A(SLASH)TOKYO(SLASH)3(SLASH)67 AT 2.2 ANGSTROMS RESOLUTION","10.1016/0022-2836(91)80068-6 ",2.2,0,"1nn2_oligo1","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-[MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(200_A_)",47.1244,"","",""
"1NN2","THREE-DIMENSIONAL STRUCTURE OF THE NEURAMINIDASE OF INFLUENZA VIRUS A(SLASH)TOKYO(SLASH)3(SLASH)67 AT 2.2 ANGSTROMS RESOLUTION","10.1016/0022-2836(91)80068-6 ",2.2,0,"1nn2_oligo3","DGalpNAca1-4DGlcpNAcb1-4DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NGK(6_C_)-NAG(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(146_A_)",83.2973,"","",""
"1NNC","INFLUENZA VIRUS NEURAMINIDASE SUBTYPE N9 (TERN) COMPLEXED WITH 4- GUANIDINO-NEU5AC2EN INHIBITOR","",1.8,0,"1nnc_oligo1","DManpa1-2DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-MAN(5_B_)-MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",23.5261,"","",""
"1NPL","MANNOSE-SPECIFIC AGGLUTININ (LECTIN) FROM DAFFODIL (NARCISSUS PSEUDONARCISSUS) BULBS IN COMPLEX WITH MANNOSE-ALPHA1,3-MANNOSE","10.1006/JMBI.1999.2862 ",2,27.6,"1npl_oligo1","DManpa1-3DManpa1-ROH","MAN(2_C_)-MAN(1_C_)",31.4377,"","",""
"1NPL","MANNOSE-SPECIFIC AGGLUTININ (LECTIN) FROM DAFFODIL (NARCISSUS PSEUDONARCISSUS) BULBS IN COMPLEX WITH MANNOSE-ALPHA1,3-MANNOSE","10.1006/JMBI.1999.2862 ",2,27.6,"1npl_oligo4","DManpa1-3DManpa1-ROH","MAN(2_E_)-MAN(1_E_)",54.7277,"","",""
"1NPL","MANNOSE-SPECIFIC AGGLUTININ (LECTIN) FROM DAFFODIL (NARCISSUS PSEUDONARCISSUS) BULBS IN COMPLEX WITH MANNOSE-ALPHA1,3-MANNOSE","10.1006/JMBI.1999.2862 ",2,27.6,"1npl_oligo3","DManpa1-3DManpa1-ROH","MAN(2_B_)-MAN(1_B_)",34.2295,"","",""
"1NPL","MANNOSE-SPECIFIC AGGLUTININ (LECTIN) FROM DAFFODIL (NARCISSUS PSEUDONARCISSUS) BULBS IN COMPLEX WITH MANNOSE-ALPHA1,3-MANNOSE","10.1006/JMBI.1999.2862 ",2,27.6,"1npl_oligo2","DManpa1-3DManpa1-ROH","MAN(2_D_)-MAN(1_D_)",37.3518,"","",""
"1O0V","THE CRYSTAL STRUCTURE OF IGE FC REVEALS AN ASYMMETRICALLY BENT CONFORMATION","10.1038/NI811 ",2.6,46,"1o0v_oligo1","DManpa1-3[DManpb1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(6_D_)-[MAN(5_D_)]-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(394_B_)",76.5565,"","",""
"1O0V","THE CRYSTAL STRUCTURE OF IGE FC REVEALS AN ASYMMETRICALLY BENT CONFORMATION","10.1038/NI811 ",2.6,46,"1o0v_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)]-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(394_A_)",95.6934,"","",""
"1O7D","THE STRUCTURE OF THE BOVINE LYSOSOMAL A-MANNOSIDASE SUGGESTS A NOVEL MECHANISM FOR LOW PH ACTIVATION","10.1016/S0022-2836(03)00172-4 ",2.7,38.8,"1o7d_oligo1","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAca1-ASN","MAN(6_F_)-MAN(5_F_)-[MAN(7_F_)]-MAN(4_F_)-[MAN(9_F_)-MAN(8_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(497_C_)",39.3178,"","",""
"1O7V","HIGH RESOLUTION STRUCTURE OF SIGLEC-7","10.1074/JBC.M210602200 ",1.9,34.09,"1o7v_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAca1-4DGlcpNAcb1-ASN","MAN(6_B_)-[MAN(5_B_)]-MAN(4_B_)-[MAN(7_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(105_A_)",52.8605,"","",""
"1ONA","CO-CRYSTALS OF CONCANAVALIN A WITH METHYL-3,6-DI-O-(ALPHA-D- MANNOPYRANOSYL)-ALPHA-D-MANNOPYRANOSIDE","10.1074/JBC.271.48.30614 ",2.35,15.9,"1ona_oligo1","DManpa1-3[DManpa1-6]DManpa1-OME","MAN(3_G_)-[MAN(2_G_)]-MMA(1_G_)",16.4364,"","",""
"1ONA","CO-CRYSTALS OF CONCANAVALIN A WITH METHYL-3,6-DI-O-(ALPHA-D- MANNOPYRANOSYL)-ALPHA-D-MANNOPYRANOSIDE","10.1074/JBC.271.48.30614 ",2.35,15.9,"1ona_oligo2","DManpa1-3[DManpa1-6]DManpa1-OME","MAN(3_F_)-[MAN(2_F_)]-MMA(1_F_)",23.5794,"","",""
"1ONA","CO-CRYSTALS OF CONCANAVALIN A WITH METHYL-3,6-DI-O-(ALPHA-D- MANNOPYRANOSYL)-ALPHA-D-MANNOPYRANOSIDE","10.1074/JBC.271.48.30614 ",2.35,15.9,"1ona_oligo3","DManpa1-3[DManpa1-6]DManpa1-OME","MAN(3_E_)-[MAN(2_E_)]-MMA(1_E_)",30.12,"","",""
"1ONA","CO-CRYSTALS OF CONCANAVALIN A WITH METHYL-3,6-DI-O-(ALPHA-D- MANNOPYRANOSYL)-ALPHA-D-MANNOPYRANOSIDE","10.1074/JBC.271.48.30614 ",2.35,15.9,"1ona_oligo4","DManpa1-3[DManpa1-6]DManpa1-OME","MAN(3_H_)-[MAN(2_H_)]-MMA(1_H_)",38.4997,"","",""
"1OOK","CRYSTAL STRUCTURE OF THE COMPLEX OF PLATELET RECEPTOR GPIB-ALPHA AND HUMAN ALPHA-THROMBIN","10.1126/SCIENCE.1084183 ",2.3,0,"1ook_oligo1","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-MAN(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(60_B_)",83.9736,"","",""
"1OQO","COMPLEX BETWEEN G0 VERSION OF AN FC BOUND TO A MINIMIZED VERSION OF PROTEIN A CALLED MINI-Z","",2.3,42.9,"1oqo_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(8_E_)-[NAG(7_E_)-MAN(6_E_)-[NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_A_)",68.4325,"","",""
"1OQO","COMPLEX BETWEEN G0 VERSION OF AN FC BOUND TO A MINIMIZED VERSION OF PROTEIN A CALLED MINI-Z","",2.3,42.9,"1oqo_oligo1","DGlcpNAca1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(8_F_)-[NAG(7_F_)-MAN(6_F_)-[NDG(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(297_B_)",55.5502,"","",""
"1OQX","G-2 GLYCOVARIANT OF HUMAN IGG FC BOUND TO MINIMIZED VERSION OF PROTEIN A CALLED Z34C","",2.6,55.8,"1oqx_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(6_E_)-[MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_A_)",81.8391,"","",""
"1OQX","G-2 GLYCOVARIANT OF HUMAN IGG FC BOUND TO MINIMIZED VERSION OF PROTEIN A CALLED Z34C","",2.6,55.8,"1oqx_oligo1","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(6_F_)-[BMA(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(297_B_)",83.1185,"","",""
"1OW0","CRYSTAL STRUCTURE OF HUMAN FCARI BOUND TO IGA1-FC","10.1038/NATURE01685 ",3.1,98.2,"1ow0_oligo1","DManpa1-3[DManpb1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_G_)-[MAN(4_G_)]-MAN(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(58_C_)",184.379,"","",""
"1OW0","CRYSTAL STRUCTURE OF HUMAN FCARI BOUND TO IGA1-FC","10.1038/NATURE01685 ",3.1,98.2,"1ow0_oligo4","DManpa1-3[DManpb1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_J_)-[MAN(4_J_)]-MAN(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(58_D_)",184.379,"","",""
"1OYH","CRYSTAL STRUCTURE OF P13 ALANINE VARIANT OF ANTITHROMBIN","10.1074/JBC.M311644200 ",2.62,0,"1oyh_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAca1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(192_L_)",129.564,"","",""
"1P8J","CRYSTAL STRUCTURE OF THE PROPROTEIN CONVERTASE FURIN","10.1038/NSB941 ",2.6,21.3,"1p8j_oligo1","DGalpb1-4DGlcpNAcb1-2[DGalpb1-4DGlcpNAcb1-4]DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(11_I_)-[NAG(10_I_)-MAN(9_I_)-[GAL(8_I_)-NAG(7_I_)-[GAL(6_I_)-NAG(5_I_)]-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(440_A_)",52.6426,"","",""
"1P9A","CRYSTAL STRUCTURE OF N-TERMINAL DOMAIN OF HUMAN PLATELET RECEPTOR GLYCOPROTEIN IB-ALPHA AT 1.7 ANGSTROM RESOLUTION","10.1126/SCIENCE.1084183 ",1.7,0,"1p9a_oligo1","DManpb1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_A_)-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(159_G_)",37.9573,"","",""
"1PPF","X-RAY CRYSTAL STRUCTURE OF THE COMPLEX OF HUMAN LEUKOCYTE ELASTASE (PMN ELASTASE) AND THE THIRD DOMAIN OF THE TURKEY OVOMUCOID INHIBITOR","",1.8,0,"1ppf_oligo2","DAllpa1-4LTalpNAca1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_B_)-[GLC(6_B_)-NAG(5_B_)-MAN(4_B_)-[MAN(7_B_)]-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(109_E_)",14.9883,"","",""
"1PPF","X-RAY CRYSTAL STRUCTURE OF THE COMPLEX OF HUMAN LEUKOCYTE ELASTASE (PMN ELASTASE) AND THE THIRD DOMAIN OF THE TURKEY OVOMUCOID INHIBITOR","",1.8,0,"1ppf_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_A_)-[GAL(6_A_)-NAG(5_A_)-MAN(4_A_)-[MAN(7_A_)]-BMA(3_A_)-NAG(2_A_)]-NAG(1_A_)-ASN(159_E_)",12.708,"","",""
"1PPG","THE REFINED 2.3 ANGSTROMS CRYSTAL STRUCTURE OF HUMAN LEUKOCYTE ELASTASE IN A COMPLEX WITH A VALINE CHLOROMETHYL KETONE INHIBITOR","10.1016/0014-5793(88)80118-2 ",2.3,0,"1ppg_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_A_)-[GAL(6_A_)-NAG(5_A_)-MAN(4_A_)-[MAN(7_A_)]-BMA(3_A_)-NAG(2_A_)]-NAG(1_A_)-ASN(159_E_)",8.11784,"","",""
"1PPG","THE REFINED 2.3 ANGSTROMS CRYSTAL STRUCTURE OF HUMAN LEUKOCYTE ELASTASE IN A COMPLEX WITH A VALINE CHLOROMETHYL KETONE INHIBITOR","10.1016/0014-5793(88)80118-2 ",2.3,0,"1ppg_oligo2","DAllpa1-4DAllpNAca1-2DManpb1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_B_)-[GLC(6_B_)-NDG(5_B_)-BMA(4_B_)-[MAN(7_B_)]-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(109_E_)",9.54705,"","",""
"1Q25","CRYSTAL STRUCTURE OF N-TERMINAL 3 DOMAINS OF CI-MPR","10.1038/SJ.EMBOJ.7600215 ",1.8,34.19,"1q25_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(76_A_)",31.1918,"","",""
"1Q8P","PTEROCARPUS ANGOLENSIS LECTIN PAL IN COMPLEX WITH THE DIMANNOSIDE MAN(ALPHA1-3)MAN","10.1016/J.JMB.2003.11.043 ",1.75,0,"1q8p_oligo4","DManpa1-3DManpa1-OME","MAN(2_D_)-MMA(1_D_)",34.8914,"","",""
"1Q8P","PTEROCARPUS ANGOLENSIS LECTIN PAL IN COMPLEX WITH THE DIMANNOSIDE MAN(ALPHA1-3)MAN","10.1016/J.JMB.2003.11.043 ",1.75,0,"1q8p_oligo3","DManpa1-3DManpa1-OME","MAN(2_C_)-MMA(1_C_)",23.4391,"","",""
"1Q8V","PTEROCARPUS ANGOLENSIS LECTIN (PAL) IN COMPLEX WITH THE TRIMANNOSIDE [MAN(ALPHA1-3)]MAN(ALPHA1-6)MAN","10.1016/J.JMB.2003.11.043 ",1.85,0,"1q8v_oligo4","DManpa1-3[DManpa1-6]DManpa1-ROH","MAN(3_D_)-[MAN(2_D_)]-MAN(1_D_)",36.2103,"","",""
"1QDD","CRYSTAL STRUCTURE OF HUMAN LITHOSTATHINE TO 1.3 A RESOLUTION","10.1074/JBC.275.2.1057 ",1.3,0,"1qdd_oligo1","DGalpb1-3[DNeup5Aca2-6]DGlcpNAca1-THR","SIA(3_B_)-[GAL(2_B_)]-NDG(1_B_)-THR(5_A_)",23.499,"","",""
"1QDO","MAN(APLHA1-3)MAN(ALPHA1-O)METHYL CONCANAVALIN A COMPLEX","10.1074/JBC.274.41.29188 ",2.8,33,"1qdo_oligo2","DManpa1-3DManpa1-OME","MAN(2_F_)-MMA(1_F_)",55.085,"","",""
"1QDO","MAN(APLHA1-3)MAN(ALPHA1-O)METHYL CONCANAVALIN A COMPLEX","10.1074/JBC.274.41.29188 ",2.8,33,"1qdo_oligo1","DManpa1-3DManpa1-OME","MAN(2_H_)-MMA(1_H_)",51.8055,"","",""
"1QDO","MAN(APLHA1-3)MAN(ALPHA1-O)METHYL CONCANAVALIN A COMPLEX","10.1074/JBC.274.41.29188 ",2.8,33,"1qdo_oligo3","DManpa1-3DManpa1-OME","MAN(2_G_)-MMA(1_G_)",52.7077,"","",""
"1QDO","MAN(APLHA1-3)MAN(ALPHA1-O)METHYL CONCANAVALIN A COMPLEX","10.1074/JBC.274.41.29188 ",2.8,33,"1qdo_oligo4","DManpa1-3DManpa1-OME","MAN(2_E_)-MMA(1_E_)",51.0936,"","",""
"1QFG","E. COLI FERRIC HYDROXAMATE RECEPTOR (FHUA)","10.1016/S0969-2126(00)00143-X ",2.5,65.4,"1qfg_oligo1","DGlcpa1-3[DGalpa1-6]DGlcpa1-3GMH1-3GMH1-5[DKdopa2-4]DKdopa2-6DGlcp[2<R1>,3<R2>,4P]a1-6DGlcp[2<R3>,3<R4>]a1-O7P2","GLA(8_B_)-[GLC(7_B_)]-GLC(6_B_)-GMH(5_B_)-GMH(4_B_)-[KDO(9_B_)]-KDO(3_B_)-GCN(2_B_)-PA1(1_B_)",72.7149,"","",""
"1QFX","PH 2.5 ACID PHOSPHATASE FROM ASPERGILLUS NIGER","10.1006/JMBI.1999.2736 ",2.4,25.6,"1qfx_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_C_)-[MAN(6_C_)-MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(172_A_)",48.3257,"","",""
"1QFX","PH 2.5 ACID PHOSPHATASE FROM ASPERGILLUS NIGER","10.1006/JMBI.1999.2736 ",2.4,25.6,"1qfx_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(172_B_)",44.4504,"","",""
"1QKC","ESCHERICHIA COLI FERRIC HYDROXAMATE UPTAKE RECEPTOR (FHUA) IN COMPLEX DELTA TWO-ALBOMYCIN","10.1110/PS.9.5.956 ",3.1,82.4,"1qkc_oligo2","DGlcpa1-2DGlcpa1-3[DGalpa1-6]DGlcpa1-3[GMH1-7]GMH1-3GMH1-5[DKdopa2-4]DKdopa2-6DAltp[2<R1>,3<R2>,4P]b1-6DGlcp[2<R3>,3<R4>]a1-O7P2","GMH(10_B_)-[GLA(9_B_)-[GLC(8_B_)-GLC(7_B_)]-GLC(6_B_)]-GMH(5_B_)-GMH(4_B_)-[KDO(11_B_)]-KDO(3_B_)-GCN(2_B_)-PA1(1_B_)",93.3385,"","",""
"1QW8","CRYSTAL STRUCTURE OF A FAMILY 51 ALPHA-L-ARABINOFURANOSIDASE IN COMPLEX WITH ARA-ALPHA(1,3)-XYL","10.1093/EMBOJ/CDG494 ",1.8,0,"1qw8_oligo1","LArafa1-3DXylpb1-ROH","AHR(2_C_)-XYP(1_C_)",42.8602,"","",""
"1QW8","CRYSTAL STRUCTURE OF A FAMILY 51 ALPHA-L-ARABINOFURANOSIDASE IN COMPLEX WITH ARA-ALPHA(1,3)-XYL","10.1093/EMBOJ/CDG494 ",1.8,0,"1qw8_oligo2","LArafa1-3DXylpb1-ROH","AHR(2_D_)-XYP(1_D_)",44.2986,"","",""
"1QYY","CRYSTAL STRUCTURE OF N-TERMINAL DOMAIN OF HUMAN PLATELET RECEPTOR GLYCOPROTEIN IB-ALPHA AT 2.8 ANGSTROM RESOLUTION","10.1107/S0907444903026805 ",2.8,0,"1qyy_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_B_)-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(159_A_)",88.8366,"","",""
"1R46","STRUCTURE OF HUMAN ALPHA-GALACTOSIDASE","10.1016/J.JMB.2004.01.035 ",3.25,64.4,"1r46_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_E_)-[MAN(5_E_)-[MAN(4_E_)]-MAN(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(139_B_)",137.761,"","",""
"1R46","STRUCTURE OF HUMAN ALPHA-GALACTOSIDASE","10.1016/J.JMB.2004.01.035 ",3.25,64.4,"1r46_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-MAN(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(192_B_)",100.812,"","",""
"1R46","STRUCTURE OF HUMAN ALPHA-GALACTOSIDASE","10.1016/J.JMB.2004.01.035 ",3.25,64.4,"1r46_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-MAN(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(192_A_)",105.814,"","",""
"1R47","STRUCTURE OF HUMAN ALPHA-GALACTOSIDASE","10.1016/J.JMB.2004.01.035 ",3.45,56.7,"1r47_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-MAN(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(192_B_)",119.562,"","",""
"1R47","STRUCTURE OF HUMAN ALPHA-GALACTOSIDASE","10.1016/J.JMB.2004.01.035 ",3.45,56.7,"1r47_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_F_)-[MAN(5_F_)-[MAN(4_F_)]-MAN(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(139_B_)",172.644,"","",""
"1R47","STRUCTURE OF HUMAN ALPHA-GALACTOSIDASE","10.1016/J.JMB.2004.01.035 ",3.45,56.7,"1r47_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(192_A_)",127.796,"","",""
"1R55","CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN ADAM 33","10.1016/J.JMB.2003.10.037 ",1.58,0,"1r55_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(276_A_)",32.1833,"","",""
"1RD8","CRYSTAL STRUCTURE OF THE 1918 HUMAN H1 HEMAGGLUTININ PRECURSOR (HA0)","10.1126/SCIENCE.1093373 ",3,40.31,"1rd8_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_H_)-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(95_C_)",77.5745,"","",""
"1RER","CRYSTAL STRUCTURE OF THE HOMOTRIMER OF FUSION GLYCOPROTEIN E1 FROM SEMLIKI FOREST VIRUS.","10.1038/NATURE02239 ",3.2,0,"1rer_oligo1","DGlcpNAcb1-2DManpb1-3DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(6_D_)-[NAG(5_D_)-BMA(4_D_)-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(141_A_)",134.071,"","",""
"1RER","CRYSTAL STRUCTURE OF THE HOMOTRIMER OF FUSION GLYCOPROTEIN E1 FROM SEMLIKI FOREST VIRUS.","10.1038/NATURE02239 ",3.2,0,"1rer_oligo2","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAca1-ASN","FUC(7_E_)-[MAN(6_E_)-[NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(141_B_)",134.96,"","",""
"1RMG","RHAMNOGALACTURONASE A FROM ASPERGILLUS ACULEATUS","10.1016/S0969-2126(97)00209-8 ",2,20.3,"1rmg_oligo8","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(32_A_)",53.0109,"","",""
"1RPQ","HIGH AFFINITY IGE RECEPTOR (ALPHA CHAIN) COMPLEXED WITH TIGHT-BINDING E131 'ZETA' PEPTIDE FROM PHAGE DISPLAY","10.1016/J.STR.2004.04.015 ",3,70.4,"1rpq_oligo1","DManpb1-3[DManpb1-4]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_F_)-[BMA(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(42_A_)",68.9462,"","",""
"1RPQ","HIGH AFFINITY IGE RECEPTOR (ALPHA CHAIN) COMPLEXED WITH TIGHT-BINDING E131 'ZETA' PEPTIDE FROM PHAGE DISPLAY","10.1016/J.STR.2004.04.015 ",3,70.4,"1rpq_oligo11","DManpb1-3[DManpb1-4]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_O_)-[BMA(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(42_D_)",67.6571,"","",""
"1RPQ","HIGH AFFINITY IGE RECEPTOR (ALPHA CHAIN) COMPLEXED WITH TIGHT-BINDING E131 'ZETA' PEPTIDE FROM PHAGE DISPLAY","10.1016/J.STR.2004.04.015 ",3,70.4,"1rpq_oligo2","DManpb1-3[DManpb1-4]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_I_)-[BMA(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(42_B_)",55.0589,"","",""
"1RPQ","HIGH AFFINITY IGE RECEPTOR (ALPHA CHAIN) COMPLEXED WITH TIGHT-BINDING E131 'ZETA' PEPTIDE FROM PHAGE DISPLAY","10.1016/J.STR.2004.04.015 ",3,70.4,"1rpq_oligo5","DManpb1-3[DManpb1-4]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_L_)-[BMA(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(42_C_)",82.9293,"","",""
"1S3K","CRYSTAL STRUCTURE OF A HUMANIZED FAB (HU3S193) IN COMPLEX WITH THE LEWIS Y TETRASACCHARIDE","10.1016/J.JMB.2004.05.037 ",1.9,27.6,"1s3k_oligo1","LFucpa1-2DGalpb1-4[LFucpa1-3]DGlcpNAca1-ROH","FUC(3_A_)-GAL(2_A_)-[FUC(4_A_)]-NDG(1_A_)",19.8955,"","",""
"1S4N","CRYSTAL STRUCTURE OF YEAST ALPHA1,2-MANNOSYLTRANSFERASE KRE2P/MNT1P","10.1074/JBC.M312720200 ",2.01,22.8,"1s4n_oligo1","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_C_)-[MAN(7_C_)]-MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(197_A_)",44.157,"","",""
"1S4O","CRYSTAL STRUCTURE OF YEAST ALPHA1,2-MANNOSYLTRANSFERASE KRE2P/MNT1P: BINARY COMPLEX WITH GDP/MN","10.1074/JBC.M312720200 ",2.01,24.6,"1s4o_oligo5","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAca1-4DGlcpNAcb1-ASN","MAN(8_C_)-[MAN(7_C_)]-MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NDG(2_C_)-NAG(1_C_)-ASN(197_A_)",35.1659,"","",""
"1S4P","CRYSTAL STRUCTURE OF YEAST ALPHA1,2-MANNOSYLTRANSFERASE KRE2P/MNT1P: TERNARY COMPLEX WITH GDP/MN AND METHYL-ALPHA-MANNOSIDE ACCEPTOR","10.1074/JBC.M312720200 ",2.01,25.9,"1s4p_oligo2","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_C_)-[MAN(7_C_)]-MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(197_A_)",34.584,"","",""
"1SDX","CRYSTAL STRUCTURE OF THE ZINC SATURATED C-TERMINAL HALF OF BOVINE LACTOFERRIN AT 2.0 A RESOLUTION REVEALS TWO ADDITIONAL ZINC BINDING SITES","10.1107/S0907444905016069 ",2.06,40.1,"1sdx_oligo3","DManpb1-3[DManpa1-4]DManpa1-4DManpb1-4DGlcpNAca1-4DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)]-MAN(4_C_)-BMA(3_C_)-NDG(2_C_)-NAG(1_C_)-ASN(545_A_)",85.89,"","",""
"1SIE","MURINE POLYOMAVIRUS COMPLEXED WITH A DISIALYLATED OLIGOSACCHARIDE","10.1016/S0969-2126(96)00021-4 ",3.65,0,"1sie_oligo4","DNeup5Aca2-3DGalpb1-3[DNeup5Aca2-6]DGlcpNAcb1-ROH","SIA(4_J_)-[SIA(3_J_)-GAL(2_J_)]-NAG(1_J_)",180.041,"","",""
"1SIE","MURINE POLYOMAVIRUS COMPLEXED WITH A DISIALYLATED OLIGOSACCHARIDE","10.1016/S0969-2126(96)00021-4 ",3.65,0,"1sie_oligo5","DNeup5Aca2-3DGalpb1-3[DNeup5Aca2-6]DGlcpNAcb1-ROH","SIA(4_K_)-[SIA(3_K_)-GAL(2_K_)]-NAG(1_K_)",174.896,"","",""
"1SIE","MURINE POLYOMAVIRUS COMPLEXED WITH A DISIALYLATED OLIGOSACCHARIDE","10.1016/S0969-2126(96)00021-4 ",3.65,0,"1sie_oligo3","DNeup5Aca2-3DGalpb1-3[DNeup5Aca2-6]DGlcpNAcb1-ROH","SIA(4_I_)-[SIA(3_I_)-GAL(2_I_)]-NAG(1_I_)",184.189,"","",""
"1SIE","MURINE POLYOMAVIRUS COMPLEXED WITH A DISIALYLATED OLIGOSACCHARIDE","10.1016/S0969-2126(96)00021-4 ",3.65,0,"1sie_oligo2","DNeup5Aca2-3DGalpb1-3[DNeup5Aca2-6]DGlcpNAcb1-ROH","SIA(4_H_)-[SIA(3_H_)-GAL(2_H_)]-NAG(1_H_)",176.986,"","",""
"1SIE","MURINE POLYOMAVIRUS COMPLEXED WITH A DISIALYLATED OLIGOSACCHARIDE","10.1016/S0969-2126(96)00021-4 ",3.65,0,"1sie_oligo1","DNeup5Aca2-3DGalpb1-3[DNeup5Aca2-6]DGlcpNAcb1-ROH","SIA(4_G_)-[SIA(3_G_)-GAL(2_G_)]-NAG(1_G_)",182.644,"","",""
"1SIE","MURINE POLYOMAVIRUS COMPLEXED WITH A DISIALYLATED OLIGOSACCHARIDE","10.1016/S0969-2126(96)00021-4 ",3.65,0,"1sie_oligo6","DNeup5Aca2-3DGalpb1-3[DNeup5Aca2-6]DGlcpNAcb1-ROH","SIA(4_L_)-[SIA(3_L_)-GAL(2_L_)]-NAG(1_L_)",186.755,"","",""
"1SL4","CRYSTAL STRUCTURE OF DC-SIGN CARBOHYDRATE RECOGNITION DOMAIN COMPLEXED WITH MAN4","10.1038/NSMB784 ",1.55,24.1,"1sl4_oligo1","DManpa1-3[DManpa1-6]DManpa1-6DManpa1-ROH","MAN(4_B_)-[MAN(3_B_)]-MAN(2_B_)-MAN(1_B_)",43.8945,"","",""
"1SL5","CRYSTAL STRUCTURE OF DC-SIGN CARBOHYDRATE RECOGNITION DOMAIN COMPLEXED WITH LNFP III (DEXTRA L504).","10.1038/NSMB784 ",1.8,18.4,"1sl5_oligo1","LFucpa1-3[DGalpb1-4]DGlcpNAcb1-3DGalpb1-ROH","GAL(4_B_)-[FUC(3_B_)]-NAG(2_B_)-GAL(1_B_)",19.6457,"","",""
"1SL6","CRYSTAL STRUCTURE OF A FRAGMENT OF DC-SIGNR (CONTAING THE CARBOHYDRATE RECOGNITION DOMAIN AND TWO REPEATS OF THE NECK) COMPLEXED WITH LEWIS- X.","10.1038/NSMB784 ",2.25,54.2,"1sl6_oligo6","LFucpa1-3[DGalpb1-4]DGlcpNAca1-ROH","GAL(3_L_)-[FUC(2_L_)]-NDG(1_L_)",68.5515,"","",""
"1SL6","CRYSTAL STRUCTURE OF A FRAGMENT OF DC-SIGNR (CONTAING THE CARBOHYDRATE RECOGNITION DOMAIN AND TWO REPEATS OF THE NECK) COMPLEXED WITH LEWIS- X.","10.1038/NSMB784 ",2.25,54.2,"1sl6_oligo1","LFucpa1-3[DGalpb1-4]DGlcpNAca1-ROH","GAL(3_H_)-[FUC(2_H_)]-NDG(1_H_)",65.4745,"","",""
"1SL6","CRYSTAL STRUCTURE OF A FRAGMENT OF DC-SIGNR (CONTAING THE CARBOHYDRATE RECOGNITION DOMAIN AND TWO REPEATS OF THE NECK) COMPLEXED WITH LEWIS- X.","10.1038/NSMB784 ",2.25,54.2,"1sl6_oligo2","LFucpa1-3[DGalpb1-4]DGlcpNAca1-ROH","GAL(3_G_)-[FUC(2_G_)]-NDG(1_G_)",83.5945,"","",""
"1SL6","CRYSTAL STRUCTURE OF A FRAGMENT OF DC-SIGNR (CONTAING THE CARBOHYDRATE RECOGNITION DOMAIN AND TWO REPEATS OF THE NECK) COMPLEXED WITH LEWIS- X.","10.1038/NSMB784 ",2.25,54.2,"1sl6_oligo5","LFucpa1-3[DGalpb1-4]DGlcpNAca1-ROH","GAL(3_K_)-[FUC(2_K_)]-NDG(1_K_)",65.9449,"","",""
"1SL6","CRYSTAL STRUCTURE OF A FRAGMENT OF DC-SIGNR (CONTAING THE CARBOHYDRATE RECOGNITION DOMAIN AND TWO REPEATS OF THE NECK) COMPLEXED WITH LEWIS- X.","10.1038/NSMB784 ",2.25,54.2,"1sl6_oligo3","LFucpa1-3[DGalpb1-4]DGlcpNAca1-ROH","GAL(3_I_)-[FUC(2_I_)]-NDG(1_I_)",92.487,"","",""
"1SL6","CRYSTAL STRUCTURE OF A FRAGMENT OF DC-SIGNR (CONTAING THE CARBOHYDRATE RECOGNITION DOMAIN AND TWO REPEATS OF THE NECK) COMPLEXED WITH LEWIS- X.","10.1038/NSMB784 ",2.25,54.2,"1sl6_oligo4","LFucpa1-3[DGalpb1-4]DGlcpNAca1-ROH","GAL(3_J_)-[FUC(2_J_)]-NDG(1_J_)",71.7955,"","",""
"1SLA","X-RAY CRYSTALLOGRAPHY REVEALS CROSSLINKING OF MAMMALIAN LECTIN (GALECTIN-1) BY BIANTENNARY COMPLEX TYPE SACCHARIDES","10.1038/NSB1294-863 ",2.45,0,"1sla_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-ROH","GAL(8_C_)-NAG(7_C_)-MAN(6_C_)-[GAL(5_C_)-NAG(4_C_)-MAN(3_C_)]-BMA(2_C_)-NAG(1_C_)",62.7982,"","",""
"1SLB","X-RAY CRYSTALLOGRAPHY REVEALS CROSSLINKING OF MAMMALIAN LECTIN (GALECTIN-1) BY BIANTENNARY COMPLEX TYPE SACCHARIDES","10.1038/NSB1294-863 ",2.3,0,"1slb_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-ROH","GAL(8_E_)-NAG(7_E_)-MAN(6_E_)-[GAL(5_E_)-NAG(4_E_)-MAN(3_E_)]-BMA(2_E_)-NAG(1_E_)",32.335,"","",""
"1SLB","X-RAY CRYSTALLOGRAPHY REVEALS CROSSLINKING OF MAMMALIAN LECTIN (GALECTIN-1) BY BIANTENNARY COMPLEX TYPE SACCHARIDES","10.1038/NSB1294-863 ",2.3,0,"1slb_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-ROH","GAL(7_F_)-NAG(6_F_)-MAN(5_F_)-[GAL(4_F_)-NAG(3_F_)-MAN(2_F_)]-MAN(1_F_)",43.4294,"","",""
"1SLC","X-RAY CRYSTALLOGRAPHY REVEALS CROSSLINKING OF MAMMALIAN LECTIN (GALECTIN-1) BY BIANTENNARY COMPLEX TYPE SACCHARIDES","10.1038/NSB1294-863 ",2.15,0,"1slc_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAca1-ROH","GAL(8_F_)-NAG(7_F_)-MAN(6_F_)-[GAL(5_F_)-NAG(4_F_)-MAN(3_F_)]-BMA(2_F_)-NDG(1_F_)",32.2076,"","",""
"1SLC","X-RAY CRYSTALLOGRAPHY REVEALS CROSSLINKING OF MAMMALIAN LECTIN (GALECTIN-1) BY BIANTENNARY COMPLEX TYPE SACCHARIDES","10.1038/NSB1294-863 ",2.15,0,"1slc_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-ROH","GAL(8_E_)-NAG(7_E_)-MAN(6_E_)-[GAL(5_E_)-NAG(4_E_)-MAN(3_E_)]-BMA(2_E_)-NAG(1_E_)",32.7994,"","",""
"1SR0","CRYSTAL STRUCTURE OF SIGNALLING PROTEIN FROM SHEEP(SPS-40) AT 3.0A RESOLUTION USING CRYSTAL GROWN IN THE PRESENCE OF POLYSACCHARIDES","",3.05,28.12,"1sr0_oligo1","DManpb1-4DManpb1-3DManpb1-4DGlcpNAca1-4DGlcpNAcb1-ASN","BMA(5_B_)-BMA(4_B_)-BMA(3_B_)-NDG(2_B_)-NAG(1_B_)-ASN(39_A_)",61.1516,"","",""
"1SZN","THE STRUCTURE OF ALPHA-GALACTOSIDASE","10.1016/J.JMB.2004.03.062 ",1.54,22.95,"1szn_oligo1","DManpa1-3DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_C_)-MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(157_A_)",38.4571,"","",""
"1SZN","THE STRUCTURE OF ALPHA-GALACTOSIDASE","10.1016/J.JMB.2004.03.062 ",1.54,22.95,"1szn_oligo3","DManpb1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_D_)-MAN(4_D_)-[MAN(6_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(215_A_)",51.4533,"","",""
"1T0O","THE STRUCTURE OF ALPHA-GALACTOSIDASE FROM TRICHODERMA REESEI COMPLEXED WITH BETA-D-GALACTOSE","10.1016/J.JMB.2004.03.062 ",1.96,25.21,"1t0o_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(215_A_)",40.4827,"","",""
"1T0O","THE STRUCTURE OF ALPHA-GALACTOSIDASE FROM TRICHODERMA REESEI COMPLEXED WITH BETA-D-GALACTOSE","10.1016/J.JMB.2004.03.062 ",1.96,25.21,"1t0o_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)]-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(157_A_)",33.1266,"","",""
"1T83","CRYSTAL STRUCTURE OF A HUMAN TYPE III FC GAMMA RECEPTOR IN COMPLEX WITH AN FC FRAGMENT OF IGG1 (ORTHORHOMBIC)","10.1074/JBC.M100350200 ",3,0,"1t83_oligo1","DGalpb1-4DGlcpNAca1-2DManpa1-6[DManpb1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAca1-ASN","FUL(8_D_)-[GAL(6_D_)-NDG(5_D_)-MAN(4_D_)-[BMA(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_A_)",100.864,"","",""
"1T83","CRYSTAL STRUCTURE OF A HUMAN TYPE III FC GAMMA RECEPTOR IN COMPLEX WITH AN FC FRAGMENT OF IGG1 (ORTHORHOMBIC)","10.1074/JBC.M100350200 ",3,0,"1t83_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAca1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(8_E_)-[NAG(7_E_)-MAN(6_E_)-[NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NDG(2_E_)]-NAG(1_E_)-ASN(297_B_)",112.121,"","",""
"1T89","CRYSTAL STRUCTURE OF A HUMAN TYPE III FC GAMMA RECEPTOR IN COMPLEX WITH AN FC FRAGMENT OF IGG1 (HEXAGONAL)","10.1074/JBC.M100350200 ",3.5,0,"1t89_oligo1","DGalpb1-4DGlcpNAca1-2DManpa1-6[DManpb1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAca1-ASN","FUL(8_D_)-[GAL(6_D_)-NDG(5_D_)-MAN(4_D_)-[BMA(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_A_)",72.4128,"","",""
"1T89","CRYSTAL STRUCTURE OF A HUMAN TYPE III FC GAMMA RECEPTOR IN COMPLEX WITH AN FC FRAGMENT OF IGG1 (HEXAGONAL)","10.1074/JBC.M100350200 ",3.5,0,"1t89_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAca1-4[LFucpb1-6]DGlcpNAca1-ASN","FUC(8_E_)-[NAG(7_E_)-MAN(6_E_)-[NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NDG(2_E_)]-NAG(1_E_)-ASN(297_B_)",91.035,"","",""
"1TB6","2.5A CRYSTAL STRUCTURE OF THE ANTITHROMBIN-THROMBIN-HEPARIN TERNARY COMPLEX","10.1038/NSMB811 ",2.5,0,"1tb6_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(155_I_)",90.4258,"","",""
"1TEI","STRUCTURE OF CONCANAVALIN A COMPLEXED TO BETA-D-GLCNAC (1,2)ALPHA-D- MAN-(1,6)[BETA-D-GLCNAC(1,2)ALPHA-D-MAN (1,6)]ALPHA-D-MAN","10.1093/GLYCOB/8.2.173 ",2.7,23.3,"1tei_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpa1-ROH","NAG(5_K_)-MAN(4_K_)-[NAG(3_K_)-MAN(2_K_)]-MAN(1_K_)",35.3765,"","",""
"1TEI","STRUCTURE OF CONCANAVALIN A COMPLEXED TO BETA-D-GLCNAC (1,2)ALPHA-D- MAN-(1,6)[BETA-D-GLCNAC(1,2)ALPHA-D-MAN (1,6)]ALPHA-D-MAN","10.1093/GLYCOB/8.2.173 ",2.7,23.3,"1tei_oligo3","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpa1-ROH","NAG(5_J_)-MAN(4_J_)-[NAG(3_J_)-MAN(2_J_)]-MAN(1_J_)",37.2491,"","",""
"1TEI","STRUCTURE OF CONCANAVALIN A COMPLEXED TO BETA-D-GLCNAC (1,2)ALPHA-D- MAN-(1,6)[BETA-D-GLCNAC(1,2)ALPHA-D-MAN (1,6)]ALPHA-D-MAN","10.1093/GLYCOB/8.2.173 ",2.7,23.3,"1tei_oligo4","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpa1-ROH","NAG(5_L_)-MAN(4_L_)-[NAG(3_L_)-MAN(2_L_)]-MAN(1_L_)",35.266,"","",""
"1TEI","STRUCTURE OF CONCANAVALIN A COMPLEXED TO BETA-D-GLCNAC (1,2)ALPHA-D- MAN-(1,6)[BETA-D-GLCNAC(1,2)ALPHA-D-MAN (1,6)]ALPHA-D-MAN","10.1093/GLYCOB/8.2.173 ",2.7,23.3,"1tei_oligo6","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpa1-ROH","NAG(5_N_)-MAN(4_N_)-[NAG(3_N_)-MAN(2_N_)]-MAN(1_N_)",38.9276,"","",""
"1TEI","STRUCTURE OF CONCANAVALIN A COMPLEXED TO BETA-D-GLCNAC (1,2)ALPHA-D- MAN-(1,6)[BETA-D-GLCNAC(1,2)ALPHA-D-MAN (1,6)]ALPHA-D-MAN","10.1093/GLYCOB/8.2.173 ",2.7,23.3,"1tei_oligo8","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpa1-ROH","NAG(5_P_)-MAN(4_P_)-[NAG(3_P_)-MAN(2_P_)]-MAN(1_P_)",49.7678,"","",""
"1TEI","STRUCTURE OF CONCANAVALIN A COMPLEXED TO BETA-D-GLCNAC (1,2)ALPHA-D- MAN-(1,6)[BETA-D-GLCNAC(1,2)ALPHA-D-MAN (1,6)]ALPHA-D-MAN","10.1093/GLYCOB/8.2.173 ",2.7,23.3,"1tei_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpa1-ROH","NAG(5_M_)-MAN(4_M_)-[NAG(3_M_)-MAN(2_M_)]-MAN(1_M_)",27.3398,"","",""
"1TEI","STRUCTURE OF CONCANAVALIN A COMPLEXED TO BETA-D-GLCNAC (1,2)ALPHA-D- MAN-(1,6)[BETA-D-GLCNAC(1,2)ALPHA-D-MAN (1,6)]ALPHA-D-MAN","10.1093/GLYCOB/8.2.173 ",2.7,23.3,"1tei_oligo5","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpa1-ROH","NAG(5_I_)-MAN(4_I_)-[NAG(3_I_)-MAN(2_I_)]-MAN(1_I_)",21.8505,"","",""
"1TEI","STRUCTURE OF CONCANAVALIN A COMPLEXED TO BETA-D-GLCNAC (1,2)ALPHA-D- MAN-(1,6)[BETA-D-GLCNAC(1,2)ALPHA-D-MAN (1,6)]ALPHA-D-MAN","10.1093/GLYCOB/8.2.173 ",2.7,23.3,"1tei_oligo7","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpa1-ROH","NAG(5_O_)-MAN(4_O_)-[NAG(3_O_)-MAN(2_O_)]-MAN(1_O_)",40.0495,"","",""
"1TFM","CRYSTAL STRUCTURE OF A RIBOSOME INACTIVATING PROTEIN IN ITS NATURALLY INHIBITED FORM","",2.8,58.41,"1tfm_oligo4","DManpb1-3DAltpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(132_B_)",122.004,"","",""
"1TG7","NATIVE STRUCTURE OF BETA-GALACTOSIDASE FROM PENICILLIUM SP.","10.1016/J.JMB.2004.09.012 ",1.9,0,"1tg7_oligo4","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(780_A_)",40.7991,"","",""
"1TG7","NATIVE STRUCTURE OF BETA-GALACTOSIDASE FROM PENICILLIUM SP.","10.1016/J.JMB.2004.09.012 ",1.9,0,"1tg7_oligo5","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)]-MAN(4_F_)-[MAN(7_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(917_A_)",24.2317,"","",""
"1TG7","NATIVE STRUCTURE OF BETA-GALACTOSIDASE FROM PENICILLIUM SP.","10.1016/J.JMB.2004.09.012 ",1.9,0,"1tg7_oligo2","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpb1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_C_)-MAN(7_C_)-[MAN(6_C_)-MAN(5_C_)]-MAN(4_C_)-[BMA(9_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(625_A_)",28.7491,"","",""
"1TYE","STRUCTURAL BASIS FOR ALLOSTERY IN INTEGRINS AND BINDING OF LIGAND- MIMETIC THERAPEUTICS TO THE PLATELET RECEPTOR FOR FIBRINOGEN","10.1038/NATURE02976 ",2.9,63,"1tye_oligo2","DManpb1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[BMA(4_H_)]-MAN(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(320_D_)",96.2518,"","",""
"1TYE","STRUCTURAL BASIS FOR ALLOSTERY IN INTEGRINS AND BINDING OF LIGAND- MIMETIC THERAPEUTICS TO THE PLATELET RECEPTOR FOR FIBRINOGEN","10.1038/NATURE02976 ",2.9,63,"1tye_oligo1","DManpb1-3DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_G_)-MAN(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(320_B_)",90.5636,"","",""
"1TYE","STRUCTURAL BASIS FOR ALLOSTERY IN INTEGRINS AND BINDING OF LIGAND- MIMETIC THERAPEUTICS TO THE PLATELET RECEPTOR FOR FIBRINOGEN","10.1038/NATURE02976 ",2.9,63,"1tye_oligo3","DManpb1-3DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_I_)-MAN(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(320_F_)",86.73,"","",""
"1TYU","STRUCTURE OF TAILSPIKE-PROTEIN","10.1073/PNAS.93.20.10584 ",1.8,0,"1tyu_oligo1","DGalpa1-2[DTyvpa1-3]DManpa1-4LRhapa1-3DGalpa1-2[DTyvpa1-3]DManpa1-4LRhapa1-ROH","TYV(8_B_)-[TYV(7_B_)-[GLA(6_B_)]-MAN(5_B_)-RAM(4_B_)-GLA(3_B_)]-MAN(2_B_)-RAM(1_B_)",23.6758,"","",""
"1TYW","STRUCTURE OF TAILSPIKE-PROTEIN","10.1073/PNAS.93.20.10584 ",1.8,0,"1tyw_oligo1","DGalpa1-2[DTyvpa1-3]DManpa1-4LRhapa1-3[DGlcpa1-4]DGalpa1-2[DTyvpa1-3]DManpa1-4LRhapa1-ROH","TYV(9_B_)-[GLC(8_B_)-[TYV(7_B_)-[GLA(6_B_)]-MAN(5_B_)-RAM(4_B_)]-GLA(3_B_)]-MAN(2_B_)-RAM(1_B_)",30.5634,"","",""
"1TYX","TITLE OF TAILSPIKE-PROTEIN","10.1073/PNAS.93.20.10584 ",1.8,0,"1tyx_oligo1","DGalpa1-2[DAbepa1-3]DManpa1-4LRhapa1-3DGalpa1-2[DAbepa1-3]DManpa1-4LRhapa1-ROH","ABE(8_B_)-[ABE(7_B_)-[GLA(6_B_)]-MAN(5_B_)-RAM(4_B_)-GLA(3_B_)]-MAN(2_B_)-RAM(1_B_)",24.6236,"","",""
"1U19","CRYSTAL STRUCTURE OF BOVINE RHODOPSIN AT 2.2 ANGSTROMS RESOLUTION","10.1016/J.JMB.2004.07.044 ",2.2,0,"1u19_oligo8","DManpb1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(15_B_)",75.7895,"","",""
"1UGX","CRYSTAL STRUCTURE OF JACALIN- ME-ALPHA-T-ANTIGEN (GAL-BETA(1-3)- GALNAC-ALPHA-O-ME) COMPLEX","10.1016/S0022-2836(03)00901-X ",1.6,31.4,"1ugx_oligo1","DGalpb1-3DGalpNAca1-OME","GAL(2_C_)-MGC(1_C_)",31.9905,"","",""
"1UH1","CRYSTAL STRUCTURE OF JACALIN- GALNAC-BETA(1-3)-GAL-ALPHA-O-ME COMPLEX","10.1016/S0022-2836(03)00901-X ",2.8,39.1,"1uh1_oligo4","DGalpNAcb1-3DGalpa1-OME","NGA(2_K_)-AMG(1_K_)",62.9223,"","",""
"1UH1","CRYSTAL STRUCTURE OF JACALIN- GALNAC-BETA(1-3)-GAL-ALPHA-O-ME COMPLEX","10.1016/S0022-2836(03)00901-X ",2.8,39.1,"1uh1_oligo2","DGalpNAcb1-3DGalpa1-OME","NGA(2_I_)-AMG(1_I_)",45.7623,"","",""
"1UH1","CRYSTAL STRUCTURE OF JACALIN- GALNAC-BETA(1-3)-GAL-ALPHA-O-ME COMPLEX","10.1016/S0022-2836(03)00901-X ",2.8,39.1,"1uh1_oligo3","DGalpNAcb1-3DGalpa1-OME","NGA(2_J_)-AMG(1_J_)",45.3623,"","",""
"1ULE","CGL2 IN COMPLEX WITH LINEAR B2 TRISACCHARIDE","10.1016/J.STR.2004.03.002 ",2.15,34.94,"1ule_oligo2","DGalpa1-3DGalpb1-4DGlcpNAcb1-ROH","GLA(3_D_)-GAL(2_D_)-NAG(1_D_)",45.1391,"","",""
"1ULE","CGL2 IN COMPLEX WITH LINEAR B2 TRISACCHARIDE","10.1016/J.STR.2004.03.002 ",2.15,34.94,"1ule_oligo1","DGalpa1-3DGalpb1-4DGlcpNAcb1-ROH","GLA(3_C_)-GAL(2_C_)-NAG(1_C_)",32.5233,"","",""
"1ULF","CGL2 IN COMPLEX WITH BLOOD GROUP A TETRASACCHARIDE","10.1016/J.STR.2004.03.002 ",2.36,23.68,"1ulf_oligo1","LFucpa1-2[DGalpNAca1-3]DGalpb1-4DGlcpb1-ROH","A2G(4_C_)-[FUC(3_C_)]-GAL(2_C_)-BGC(1_C_)",22.4939,"","",""
"1ULF","CGL2 IN COMPLEX WITH BLOOD GROUP A TETRASACCHARIDE","10.1016/J.STR.2004.03.002 ",2.36,23.68,"1ulf_oligo2","LFucpa1-2[DGalpNAca1-3]DGalpb1-4DGlcpb1-ROH","A2G(4_D_)-[FUC(3_D_)]-GAL(2_D_)-BGC(1_D_)",24.512,"","",""
"1UR1","XYLANASE XYN10B MUTANT (E262S) FROM CELLVIBRIO MIXTUS IN COMPLEX WITH ARABINOFURANOSE ALPHA-1,3 LINKED TO XYLOBIOSE","10.1074/JBC.M312278200 ",1.43,10.72,"1ur1_oligo1","LArafa1-3DXylpb1-4DXylpa1-ROH","AHR(3_B_)-XYP(2_B_)-XYS(1_B_)",10.9574,"","",""
"1UR2","XYLANASE XYN10B MUTANT (E262S) FROM CELLVIBRIO MIXTUS IN COMPLEX WITH ARABINOFURANOSE ALPHA 1,3 LINKED TO XYLOTRIOSE","10.1074/JBC.M312278200 ",1.6,11.84,"1ur2_oligo2","LArafa1-3[DXylpb1-4]DXylpb1-4DXylpa1-ROH","XYP(4_C_)-[AHR(3_C_)]-XYP(2_C_)-XYS(1_C_)",15.4257,"","",""
"1UZ8","ANTI-LEWIS X FAB FRAGMENT IN COMPLEX WITH LEWIS X","10.1016/J.STR.2004.05.008 ",1.8,39.17,"1uz8_oligo2","LFucpa1-3[DGalpb1-4]DGlcpNAcb1-OME","GAL(3_D_)-[FUC(2_D_)]-MAG(1_D_)",37.3552,"","",""
"1UZ8","ANTI-LEWIS X FAB FRAGMENT IN COMPLEX WITH LEWIS X","10.1016/J.STR.2004.05.008 ",1.8,39.17,"1uz8_oligo1","LFucpa1-3[DGalpb1-4]DGlcpNAcb1-OME","GAL(3_C_)-[FUC(2_C_)]-MAG(1_C_)",42.7733,"","",""
"1UZG","CRYSTAL STRUCTURE OF THE DENGUE TYPE 3 VIRUS ENVELOPE PROTEIN","10.1128/JVI.79.2.1223-1231.2005 ",3.5,75.13,"1uzg_oligo2","DManpb1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(153_A_)",127.783,"","",""
"1UZY","ERYTHRINA CRYSTAGALLI LECTIN","10.1093/GLYCOB/CWH114 ",2,28.6,"1uzy_oligo7","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_C_)-[FUC(2_C_)]-NAG(1_C_)-ASN(113_A_)",48.9161,"","",""
"1UZY","ERYTHRINA CRYSTAGALLI LECTIN","10.1093/GLYCOB/CWH114 ",2,28.6,"1uzy_oligo8","DXylpb1-2[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-3]DGlcpNAcb1-ASN","MAN(5_E_)-[XYP(4_E_)]-BMA(3_E_)-NAG(2_E_)-[FUL(6_E_)]-NAG(1_E_)-ASN(113_B_)",43.5699,"","",""
"1V0Z","STRUCTURE OF NEURAMINIDASE FROM ENGLISH DUCK SUBTYPE N6","",1.84,15.07,"1v0z_oligo3","DManpAa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_G_)-[MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(207_A_)",25.4802,"","",""
"1V0Z","STRUCTURE OF NEURAMINIDASE FROM ENGLISH DUCK SUBTYPE N6","",1.84,15.07,"1v0z_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcx1-","MAN(4_F_)-[MAN(3_F_)]-BMA(2_F_)-NAG(1_F_)",30.3318,"","",""
"1V2I","STRUCTURE OF THE HEMAGGLUTININ-NEURAMINIDASE FROM HUMAN PARAINFLUENZA VIRUS TYPE III","10.1016/J.JMB.2003.11.032 ",2.2,34.2,"1v2i_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(351_A_)",56.7611,"","",""
"1V55","BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY REDUCED STATE","10.1073/PNAS.2635097100 ",1.9,0,"1v55_oligo2","DManpa1-3DAllpb6-C10O1","DMU(3526_M_)-DMU(3526_M_)",54.7682,"","",""
"1V6U","CRYSTAL STRUCTURE OF XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86 COMPLEXED WITH 2(2)-ALPHA-L-ARABINOFURANOSYL-XYLOBIOSE","10.1074/JBC.M312293200 ",2.1,32.2,"1v6u_oligo4","LArafa1-3DXylpb1-4DXylpb1-ROH","AHR(3_F_)-XYP(2_F_)-XYP(1_F_)",38.1316,"","",""
"1V6U","CRYSTAL STRUCTURE OF XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86 COMPLEXED WITH 2(2)-ALPHA-L-ARABINOFURANOSYL-XYLOBIOSE","10.1074/JBC.M312293200 ",2.1,32.2,"1v6u_oligo3","LArafa1-3DXylpb1-4DXylpb1-ROH","AHR(3_E_)-XYP(2_E_)-XYP(1_E_)",56.835,"","",""
"1V6V","CRYSTAL STRUCTURE OF XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86 COMPLEXED WITH 3(2)-ALPHA-L-ARABINOFURANOSYL-XYLOTRIOSE","10.1074/JBC.M312293200 ",2.1,21.4,"1v6v_oligo5","LArafa1-3[DXylpb1-4]DXylpb1-4DXylpb1-ROH","XYP(4_G_)-[AHR(3_G_)]-XYP(2_G_)-XYP(1_G_)",23.8561,"","",""
"1V6V","CRYSTAL STRUCTURE OF XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86 COMPLEXED WITH 3(2)-ALPHA-L-ARABINOFURANOSYL-XYLOTRIOSE","10.1074/JBC.M312293200 ",2.1,21.4,"1v6v_oligo4","LArafa1-3[DXylpb1-4]DXylpb1-4DXylpb1-ROH","XYP(4_F_)-[AHR(3_F_)]-XYP(2_F_)-XYP(1_F_)",25.8142,"","",""
"1V6V","CRYSTAL STRUCTURE OF XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86 COMPLEXED WITH 3(2)-ALPHA-L-ARABINOFURANOSYL-XYLOTRIOSE","10.1074/JBC.M312293200 ",2.1,21.4,"1v6v_oligo1","LArafa1-3[DXylpb1-4]DXylpb1-4DXylpb1-ROH","XYP(4_C_)-[AHR(3_C_)]-XYP(2_C_)-XYP(1_C_)",24.3997,"","",""
"1VAQ","CRYSTAL STRUCTURE OF THE MG2+-(CHROMOMYCIN A3)2-D(TTGGCCAA)2 COMPLEX REVEALS GGCC BINDING SPECIFICITY OF THE DRUG DIMER CHELATED BY METAL ION","10.1093/NAR/GKH549 ",2,0,"1vaq_oligo31","LOlip[3<R1>,4Ac]a1-3DOlipb1-3DOlipb1-","ERI(3_L_)-CDR(2_L_)-CDR(1_L_)",11.1397,"","",""
"1VAQ","CRYSTAL STRUCTURE OF THE MG2+-(CHROMOMYCIN A3)2-D(TTGGCCAA)2 COMPLEX REVEALS GGCC BINDING SPECIFICITY OF THE DRUG DIMER CHELATED BY METAL ION","10.1093/NAR/GKH549 ",2,0,"1vaq_oligo40","LOlip[3<R1>,4Ac]a1-3DOlipb1-3DOlipb1-","ERI(3_J_)-CDR(2_J_)-CDR(1_J_)",8.52233,"","",""
"1VAQ","CRYSTAL STRUCTURE OF THE MG2+-(CHROMOMYCIN A3)2-D(TTGGCCAA)2 COMPLEX REVEALS GGCC BINDING SPECIFICITY OF THE DRUG DIMER CHELATED BY METAL ION","10.1093/NAR/GKH549 ",2,0,"1vaq_oligo36","LOlip[3<R1>,4Ac]a1-3DOlipb1-3DOlipb1-","ERI(3_G_)-CDR(2_G_)-CDR(1_G_)",8.90567,"","",""
"1VAQ","CRYSTAL STRUCTURE OF THE MG2+-(CHROMOMYCIN A3)2-D(TTGGCCAA)2 COMPLEX REVEALS GGCC BINDING SPECIFICITY OF THE DRUG DIMER CHELATED BY METAL ION","10.1093/NAR/GKH549 ",2,0,"1vaq_oligo37","LOlip[3<R1>,4Ac]a1-3DOlipb1-3DOlipb1-","ERI(3_H_)-CDR(2_H_)-CDR(1_H_)",9.098,"","",""
"1VBO","CRYSTAL STRUCTURE OF ARTOCARPIN-MANNOTRIOSE COMPLEX","10.1016/J.JMB.2004.03.040 ",2.35,39.9,"1vbo_oligo3","DManpa1-3[DManpa1-6]DManpb1-ROH","MAN(3_K_)-[MAN(2_K_)]-MAN(1_K_)",40.8682,"","",""
"1VBO","CRYSTAL STRUCTURE OF ARTOCARPIN-MANNOTRIOSE COMPLEX","10.1016/J.JMB.2004.03.040 ",2.35,39.9,"1vbo_oligo5","DManpa1-3[DManpa1-6]DManpa1-ROH","MAN(3_M_)-[MAN(2_M_)]-MAN(1_M_)",63.2139,"","",""
"1VBO","CRYSTAL STRUCTURE OF ARTOCARPIN-MANNOTRIOSE COMPLEX","10.1016/J.JMB.2004.03.040 ",2.35,39.9,"1vbo_oligo6","DManpa1-3[DManpa1-6]DManpa1-ROH","MAN(3_N_)-[MAN(2_N_)]-MAN(1_N_)",42.1367,"","",""
"1VBO","CRYSTAL STRUCTURE OF ARTOCARPIN-MANNOTRIOSE COMPLEX","10.1016/J.JMB.2004.03.040 ",2.35,39.9,"1vbo_oligo4","DManpa1-3[DManpa1-6]DManpa1-ROH","MAN(3_L_)-[MAN(2_L_)]-MAN(1_L_)",67.7452,"","",""
"1VBO","CRYSTAL STRUCTURE OF ARTOCARPIN-MANNOTRIOSE COMPLEX","10.1016/J.JMB.2004.03.040 ",2.35,39.9,"1vbo_oligo1","DManpa1-3[DManpa1-6]DManpb1-ROH","MAN(3_I_)-[MAN(2_I_)]-MAN(1_I_)",61.5027,"","",""
"1VBO","CRYSTAL STRUCTURE OF ARTOCARPIN-MANNOTRIOSE COMPLEX","10.1016/J.JMB.2004.03.040 ",2.35,39.9,"1vbo_oligo2","DManpa1-3[DManpa1-6]DManpb1-ROH","MAN(3_J_)-[MAN(2_J_)]-MAN(1_J_)",87.2861,"","",""
"1VBP","CRYSTAL STRUCTURE OF ARTOCARPIN-MANNOPENTOSE COMPLEX","10.1016/J.JMB.2004.03.040 ",3.5,49.7,"1vbp_oligo2","DManpa1-3DManpa1-6[DManpa1-3]DManpa1-ROH","MAN(3_C_)-MAN(2_C_)-[MAN(4_C_)]-MAN(1_C_)",90.6914,"","",""
"1VBP","CRYSTAL STRUCTURE OF ARTOCARPIN-MANNOPENTOSE COMPLEX","10.1016/J.JMB.2004.03.040 ",3.5,49.7,"1vbp_oligo1","DManpa1-3[DManpa1-6]DManpa1-ROH","MAN(3_D_)-[MAN(2_D_)]-MAN(1_D_)",92.2867,"","",""
"1VPS","POLYOMAVIRUS VP1 PENTAMER COMPLEXED WITH A DISIALYLATED HEXASACCHARIDE","10.1093/EMBOJ/16.16.5139 ",1.9,29.8,"1vps_oligo4","DNeup5Aca2-3DGalpb1-3[DNeup5Aca2-6]DGlcpNAcb1-ROH","SIA(4_I_)-[SIA(3_I_)-GAL(2_I_)]-NAG(1_I_)",41.0451,"","",""
"1VPS","POLYOMAVIRUS VP1 PENTAMER COMPLEXED WITH A DISIALYLATED HEXASACCHARIDE","10.1093/EMBOJ/16.16.5139 ",1.9,29.8,"1vps_oligo5","DNeup5Aca2-3DGalpb1-3[DNeup5Aca2-6]DGlcpNAcb1-ROH","SIA(4_J_)-[SIA(3_J_)-GAL(2_J_)]-NAG(1_J_)",58.587,"","",""
"1VPS","POLYOMAVIRUS VP1 PENTAMER COMPLEXED WITH A DISIALYLATED HEXASACCHARIDE","10.1093/EMBOJ/16.16.5139 ",1.9,29.8,"1vps_oligo3","DNeup5Aca2-3DGalpb1-3[DNeup5Aca2-6]DGlcpNAcb1-ROH","SIA(4_H_)-[SIA(3_H_)-GAL(2_H_)]-NAG(1_H_)",47.3934,"","",""
"1VPS","POLYOMAVIRUS VP1 PENTAMER COMPLEXED WITH A DISIALYLATED HEXASACCHARIDE","10.1093/EMBOJ/16.16.5139 ",1.9,29.8,"1vps_oligo1","DNeup5Aca2-3DGalpb1-3[DNeup5Aca2-6]DGlcpNAcb1-ROH","SIA(4_F_)-[SIA(3_F_)-GAL(2_F_)]-NAG(1_F_)",52.786,"","",""
"1VPS","POLYOMAVIRUS VP1 PENTAMER COMPLEXED WITH A DISIALYLATED HEXASACCHARIDE","10.1093/EMBOJ/16.16.5139 ",1.9,29.8,"1vps_oligo2","DNeup5Aca2-3DGalpb1-3[DNeup5Aca2-6]DGlcpNAcb1-ROH","SIA(4_G_)-[SIA(3_G_)-GAL(2_G_)]-NAG(1_G_)",53.8904,"","",""
"1W1I","CRYSTAL STRUCTURE OF DIPEPTIDYL PEPTIDASE IV (DPPIV OR CD26) IN COMPLEX WITH ADENOSINE DEAMINASE","10.1074/JBC.M405001200 ",3.03,52.46,"1w1i_oligo7","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_O_)-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(229_B_)",40.7302,"","",""
"1W1I","CRYSTAL STRUCTURE OF DIPEPTIDYL PEPTIDASE IV (DPPIV OR CD26) IN COMPLEX WITH ADENOSINE DEAMINASE","10.1074/JBC.M405001200 ",3.03,52.46,"1w1i_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_L_)-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(229_A_)",53.9893,"","",""
"1W1I","CRYSTAL STRUCTURE OF DIPEPTIDYL PEPTIDASE IV (DPPIV OR CD26) IN COMPLEX WITH ADENOSINE DEAMINASE","10.1074/JBC.M405001200 ",3.03,52.46,"1w1i_oligo16","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_X_)-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(229_D_)",59.8184,"","",""
"1W1I","CRYSTAL STRUCTURE OF DIPEPTIDYL PEPTIDASE IV (DPPIV OR CD26) IN COMPLEX WITH ADENOSINE DEAMINASE","10.1074/JBC.M405001200 ",3.03,52.46,"1w1i_oligo12","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_T_)-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(229_C_)",58.6286,"","",""
"1W8F","PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL)COMPLEXED WITH LACTO-N-NEO- FUCOPENTAOSE V(LNPFV)","10.1042/BJ20050079 ",1.05,7.31,"1w8f_oligo2","DGalpb1-4DGlcpNAcb1-3DGalpb1-4[LFucpa1-3]DGlcpb1-ROH","GAL(4_H_)-NAG(3_H_)-GAL(2_H_)-[FUC(5_H_)]-BGC(1_H_)",9.14527,"","",""
"1W8F","PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL)COMPLEXED WITH LACTO-N-NEO- FUCOPENTAOSE V(LNPFV)","10.1042/BJ20050079 ",1.05,7.31,"1w8f_oligo1","LFucpa1-3[DGalpb1-4]DGlcpb1-ROH","GAL(3_G_)-[FUC(2_G_)]-BGC(1_G_)",9.78727,"","",""
"1W8F","PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL)COMPLEXED WITH LACTO-N-NEO- FUCOPENTAOSE V(LNPFV)","10.1042/BJ20050079 ",1.05,7.31,"1w8f_oligo4","DGalpb1-4DGlcpNAcb1-3DGalpb1-4[LFucpa1-3]DGlcpb1-ROH","GAL(4_F_)-NAG(3_F_)-GAL(2_F_)-[FUC(5_F_)]-BGC(1_F_)",9.20618,"","",""
"1W8F","PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL)COMPLEXED WITH LACTO-N-NEO- FUCOPENTAOSE V(LNPFV)","10.1042/BJ20050079 ",1.05,7.31,"1w8f_oligo3","DGlcpNAcb1-3DGalpb1-4[LFucpa1-3]DGlcpb1-ROH","NAG(3_E_)-GAL(2_E_)-[FUC(4_E_)]-BGC(1_E_)",11.7327,"","",""
"1W8H","STRUCTURE OF PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL)COMPLEXED WITH LEWISA TRISACCHARIDE","10.1042/BJ20050079 ",1.75,9.68,"1w8h_oligo1","DGalpb1-3[LFucpa1-4]DGlcpNAcb1-ROH","FUC(3_F_)-[GAL(2_F_)]-NAG(1_F_)",11.8073,"","",""
"1W8H","STRUCTURE OF PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL)COMPLEXED WITH LEWISA TRISACCHARIDE","10.1042/BJ20050079 ",1.75,9.68,"1w8h_oligo4","DGalpb1-3[LFucpa1-4]DGlcpNAca1-ROH","FUC(3_H_)-[GAL(2_H_)]-NDG(1_H_)",12.4567,"","",""
"1W8H","STRUCTURE OF PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL)COMPLEXED WITH LEWISA TRISACCHARIDE","10.1042/BJ20050079 ",1.75,9.68,"1w8h_oligo3","DGalpb1-3[LFucpa1-4]DGlcpNAcb1-ROH","FUC(3_G_)-[GAL(2_G_)]-NAG(1_G_)",11.4442,"","",""
"1W8H","STRUCTURE OF PSEUDOMONAS AERUGINOSA LECTIN II (PA-IIL)COMPLEXED WITH LEWISA TRISACCHARIDE","10.1042/BJ20050079 ",1.75,9.68,"1w8h_oligo2","DGalpb1-3[LFucpa1-4]DGlcpNAcb1-ROH","FUC(4_E_)-[GAL(2_E_)]-NAG(1_E_)",13.1988,"","",""
"1W9B","S. ALBA MYROSINASE IN COMPLEX WITH CARBA-GLUCOTROPAEOLIN","10.1039/B502990B ",1.7,19.4,"1w9b_oligo3","DXylpb1-2[DManpa1-3][DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)]-[XYP(4_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(7_C_)]-NAG(1_C_)-ASN(292_M_)",39.8715,"","",""
"1W9B","S. ALBA MYROSINASE IN COMPLEX WITH CARBA-GLUCOTROPAEOLIN","10.1039/B502990B ",1.7,19.4,"1w9b_oligo1","DXylpb1-2DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","XYP(4_B_)-BMA(3_B_)-NAG(2_B_)-[FUC(5_B_)]-NAG(1_B_)-ASN(265_M_)",37.3985,"","",""
"1W9D","S. ALBA MYROSINASE IN COMPLEX WITH S-ETHYL PHENYLACETOTHIOHYDROXIMATE- O-SULFATE","10.1039/B502990B ",1.6,18.46,"1w9d_oligo3","DXylpb1-2[DManpa1-3][DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)]-[XYP(4_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(7_C_)]-NAG(1_C_)-ASN(292_M_)",39.6415,"","",""
"1W9D","S. ALBA MYROSINASE IN COMPLEX WITH S-ETHYL PHENYLACETOTHIOHYDROXIMATE- O-SULFATE","10.1039/B502990B ",1.6,18.46,"1w9d_oligo1","DXylpb1-2DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","XYP(4_B_)-BMA(3_B_)-NAG(2_B_)-[FUC(5_B_)]-NAG(1_B_)-ASN(265_M_)",37.1685,"","",""
"1W9W","STRUCTURE OF A BETA-1,3-GLUCAN BINDING CBM6 FROM BACILLUS HALODURANS IN COMPLEX WITH LAMINARIHEXAOSE","10.1074/JBC.M410113200 ",2.1,44.4,"1w9w_oligo1","DGlcpb1-3DGlcpb1-3DGlcpb1-3DGlcpa1-3DGlcpb1-3DGlcpb1-ROH","BGC(6_B_)-BGC(5_B_)-BGC(4_B_)-GLC(3_B_)-BGC(2_B_)-BGC(1_B_)",52.2788,"","",""
"1WBL","WINGED BEAN LECTIN COMPLEXED WITH METHYL-ALPHA-D-GALACTOSE","10.1006/JMBI.1997.1568 ",2.5,21.7,"1wbl_oligo7","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_K_)-[FUC(2_K_)]-NAG(1_K_)-ASN(44_D_)",59.9664,"","",""
"1WBL","WINGED BEAN LECTIN COMPLEXED WITH METHYL-ALPHA-D-GALACTOSE","10.1006/JMBI.1997.1568 ",2.5,21.7,"1wbl_oligo2","LFucpa1-3[DGlcpNAca1-4]DGlcpNAcb1-ASN","NAG(3_E_)-[FUC(2_E_)]-NAG(1_E_)-ASN(219_A_)",49.9812,"","",""
"1WCT","A NOVEL CONOTOXIN FROM CONUS TEXTILE WITH UNUSUAL POST-TRANSLATIONAL MODIFICATIONS REDUCES PRESYNAPTIC CALCIUM INFLUX, NMR, 1 STRUCTURE, GLYCOSYLATED PROTEIN","10.1073/PNAS.96.10.5758 ","2.95026e-39",0,"1wct_oligo2","DGalpb1-3DGalpNAcb1-THR","GAL(2_B_)-NGA(1_B_)-THR(10_A_)",0,"","",""
"1WHS","STRUCTURE OF THE COMPLEX OF L-BENZYLSUCCINATE WITH WHEAT SERINE CARBOXYPEPTIDASE II AT 2.0 ANGSTROMS RESOLUTION","10.1021/BI00203A009 ",2,0,"1whs_oligo1","LFucpa1-3[DManpNAca1-4]DGlcpNAcx1-","NAG(3_C_)-[FUC(2_C_)]-NAG(1_C_)",70.6825,"","",""
"1WHT","STRUCTURE OF THE COMPLEX OF L-BENZYLSUCCINATE WITH WHEAT SERINE CARBOXYPEPTIDASE II AT 2.0 ANGSTROMS RESOLUTION","10.1021/BI00203A009 ",2,0,"1wht_oligo1","LFucpa1-3[DManpNAca1-4]DGlcpNAcb1-ASN","NDG(3_C_)-[FUC(2_C_)]-NAG(1_C_)-ASN(105_A_)",67.2597,"","",""
"1X38","CRYSTAL STRUCTURE OF BARLEY BETA-D-GLUCAN GLUCOHYDROLASE ISOENZYME EXO1 IN COMPLEX WITH GLUCO-PHENYLIMIDAZOLE","10.1021/BI0514818 ",1.7,38.79,"1x38_oligo2","DGlcpNAcb1-2DManpa1-6[DXylpb1-2]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","NAG(5_C_)-MAN(4_C_)-[XYP(6_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(7_C_)]-NAG(1_C_)-ASN(498_A_)",57.8196,"","",""
"1X38","CRYSTAL STRUCTURE OF BARLEY BETA-D-GLUCAN GLUCOHYDROLASE ISOENZYME EXO1 IN COMPLEX WITH GLUCO-PHENYLIMIDAZOLE","10.1021/BI0514818 ",1.7,38.79,"1x38_oligo3","DXylpb1-2DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","XYP(4_D_)-BMA(3_D_)-NAG(2_D_)-[FUC(5_D_)]-NAG(1_D_)-ASN(600_A_)",51.4674,"","",""
"1X39","CRYSTAL STRUCTURE OF BARLEY BETA-D-GLUCAN GLUCOHYDROLASE ISOENZYME EXO1 IN COMPLEX WITH GLUCO-PHENYLIMIDAZOLE","10.1021/BI0514818 ",1.8,32.56,"1x39_oligo3","DXylpb1-2DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","XYP(4_D_)-BMA(3_D_)-NAG(2_D_)-[FUC(5_D_)]-NAG(1_D_)-ASN(600_A_)",52.2907,"","",""
"1X39","CRYSTAL STRUCTURE OF BARLEY BETA-D-GLUCAN GLUCOHYDROLASE ISOENZYME EXO1 IN COMPLEX WITH GLUCO-PHENYLIMIDAZOLE","10.1021/BI0514818 ",1.8,32.56,"1x39_oligo2","DGlcpNAcb1-2DManpa1-6[DXylpb1-2]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","NAG(5_C_)-MAN(4_C_)-[XYP(6_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(7_C_)]-NAG(1_C_)-ASN(498_A_)",50.8142,"","",""
"1XC6","NATIVE STRUCTURE OF BETA-GALACTOSIDASE FROM PENICILLIUM SP. IN COMPLEX WITH GALACTOSE","10.1016/J.JMB.2004.09.012 ",2.1,22.63,"1xc6_oligo1","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpb1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_C_)-MAN(7_C_)-[MAN(6_C_)-MAN(5_C_)]-MAN(4_C_)-[BMA(9_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(625_A_)",27.4606,"","",""
"1XC6","NATIVE STRUCTURE OF BETA-GALACTOSIDASE FROM PENICILLIUM SP. IN COMPLEX WITH GALACTOSE","10.1016/J.JMB.2004.09.012 ",2.1,22.63,"1xc6_oligo3","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(780_A_)",42.9416,"","",""
"1XC6","NATIVE STRUCTURE OF BETA-GALACTOSIDASE FROM PENICILLIUM SP. IN COMPLEX WITH GALACTOSE","10.1016/J.JMB.2004.09.012 ",2.1,22.63,"1xc6_oligo5","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)]-MAN(4_F_)-[MAN(7_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(917_A_)",25.6114,"","",""
"1XMN","CRYSTAL STRUCTURE OF THROMBIN BOUND TO HEPARIN","10.1074/JBC.M411606200 ",1.85,0,"1xmn_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAca1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(60_H_)",95.342,"","",""
"1XOE","N9 TERN INFLUENZA NEURAMINIDASE COMPLEXED WITH (2R,4R,5R)-5-(1- ACETYLAMINO-3-METHYL-BUTYL-PYRROLIDINE-2, 4-DICAROBYXYLIC ACID 4- METHYL ESTERDASE COMPLEXED WITH","10.1016/J.BMCL.2004.10.022 ",2.2,19.8,"1xoe_oligo2","DManpa1-2DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(6_B_)-MAN(5_B_)-MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)",20.1452,"","",""
"1XOG","N9 TERN INFLUENZA NEURAMINIDASE COMPLEXED WITH A 2,5-DISUBSTITUTED TETRAHYDROFURAN-5-CARBOXYLIC ACID","10.1016/J.BMCL.2004.10.022 ",2.8,14.8,"1xog_oligo1","DManpa1-2DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(6_B_)-MAN(5_B_)-MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)",19.7362,"","",""
"1XZW","SWEET POTATO PURPLE ACID PHOSPHATASE/PHOSPHATE COMPLEX","10.1073/PNAS.0407239102 ",2.5,30.02,"1xzw_oligo5","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_G_)-[FUC(2_G_)]-NAG(1_G_)-ASN(580_B_)",80.8124,"","",""
"1XZW","SWEET POTATO PURPLE ACID PHOSPHATASE/PHOSPHATE COMPLEX","10.1073/PNAS.0407239102 ",2.5,30.02,"1xzw_oligo2","DManpb1-4DGlcpNAca1-4[LFucpa1-3]DGlcpNAca1-ASN","MAN(3_C_)-NAG(2_C_)-[FUC(4_C_)]-NAG(1_C_)-ASN(80_A_)",92.6789,"","",""
"1Y2U","CRYSTAL STRUCTURE OF THE COMMON EDIBLE MUSHROOM (AGARICUS BISPORUS) LECTIN IN COMPLEX WITH LACTO-N-BIOSE","10.1074/JBC.M411989200 ",1.85,23.3,"1y2u_oligo2","DGalpb1-3DGlcpNAca1-ROH","GAL(2_D_)-NAG(1_D_)",29.7345,"","",""
"1Y2U","CRYSTAL STRUCTURE OF THE COMMON EDIBLE MUSHROOM (AGARICUS BISPORUS) LECTIN IN COMPLEX WITH LACTO-N-BIOSE","10.1074/JBC.M411989200 ",1.85,23.3,"1y2u_oligo1","DGalpb1-3DGlcpNAca1-ROH","GAL(2_C_)-NAG(1_C_)",30.4141,"","",""
"1Y2V","CRYSTAL STRUCTURE OF THE COMMON EDIBLE MUSHROOM (AGARICUS BISPORUS) LECTIN IN COMPLEX WITH T-ANTIGEN","10.1074/JBC.M411989200 ",1.9,24.11,"1y2v_oligo1","DGalpb1-3DGalpNAca1-SER","GAL(2_D_)-NGA(1_D_)-SER(146_B_)",29.3241,"","",""
"1Y2V","CRYSTAL STRUCTURE OF THE COMMON EDIBLE MUSHROOM (AGARICUS BISPORUS) LECTIN IN COMPLEX WITH T-ANTIGEN","10.1074/JBC.M411989200 ",1.9,24.11,"1y2v_oligo2","DGalpb1-3DGalpNAca1-SER","GAL(2_C_)-NGA(1_C_)-SER(146_A_)",28.7414,"","",""
"1Y2W","CRYSTAL STRUCTURE OF THE ORTHORHOMBIC FORM OF THE COMMON EDIBLE MUSHROOM (AGARICUS BISPORUS) LECTIN IN COMPLEX WITH T-ANTIGEN AND N- ACETYLGLUCOSAMINE","10.1074/JBC.M411989200 ",1.74,15.62,"1y2w_oligo1","DGalpb1-3DGalpNAca1-SER","GAL(2_C_)-NGA(1_C_)-SER(146_A_)",17.7732,"","",""
"1Y2W","CRYSTAL STRUCTURE OF THE ORTHORHOMBIC FORM OF THE COMMON EDIBLE MUSHROOM (AGARICUS BISPORUS) LECTIN IN COMPLEX WITH T-ANTIGEN AND N- ACETYLGLUCOSAMINE","10.1074/JBC.M411989200 ",1.74,15.62,"1y2w_oligo2","DGalpb1-3DGalpNAca1-SER","GAL(2_D_)-NGA(1_D_)-SER(146_B_)",20.4345,"","",""
"1Y2X","CRYSTAL STRUCTURE OF THE TETRAGONAL FORM OF THE COMMON EDIBLE MUSHROOM (AGARICUS BISPORUS) LECTIN IN COMPLEX WITH T-ANTIGEN AND N- ACETYLGLUCOSAMINE","10.1074/JBC.M411989200 ",2.36,26.17,"1y2x_oligo2","DGalpb1-3DGalpNAca1-SER","GAL(2_H_)-NGA(1_H_)-SER(147_D_)",32.9068,"","",""
"1Y2X","CRYSTAL STRUCTURE OF THE TETRAGONAL FORM OF THE COMMON EDIBLE MUSHROOM (AGARICUS BISPORUS) LECTIN IN COMPLEX WITH T-ANTIGEN AND N- ACETYLGLUCOSAMINE","10.1074/JBC.M411989200 ",2.36,26.17,"1y2x_oligo1","DGalpb1-3DGalpNAca1-SER","GAL(2_G_)-NGA(1_G_)-SER(147_C_)",39.4527,"","",""
"1Y2X","CRYSTAL STRUCTURE OF THE TETRAGONAL FORM OF THE COMMON EDIBLE MUSHROOM (AGARICUS BISPORUS) LECTIN IN COMPLEX WITH T-ANTIGEN AND N- ACETYLGLUCOSAMINE","10.1074/JBC.M411989200 ",2.36,26.17,"1y2x_oligo3","DGalpb1-3DGalpNAca1-SER","GAL(2_E_)-NGA(1_E_)-SER(147_A_)",29.7205,"","",""
"1Y2X","CRYSTAL STRUCTURE OF THE TETRAGONAL FORM OF THE COMMON EDIBLE MUSHROOM (AGARICUS BISPORUS) LECTIN IN COMPLEX WITH T-ANTIGEN AND N- ACETYLGLUCOSAMINE","10.1074/JBC.M411989200 ",2.36,26.17,"1y2x_oligo4","DGalpb1-3DGalpNAca1-SER","GAL(2_F_)-NGA(1_F_)-SER(147_B_)",29.6223,"","",""
"1Y9M","CRYSTAL STRUCTURE OF EXO-INULINASE FROM ASPERGILLUS AWAMORI IN SPACEGROUP P212121","10.1016/J.JMB.2004.09.024 ",1.89,24.91,"1y9m_oligo1","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-MAN(4_B_)-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(67_A_)",41.4309,"","",""
"1YF8","CRYSTAL STRUCTURE OF HIMALAYAN MISTLETOE RIP REVEALS THE PRESENCE OF A NATURAL INHIBITOR AND A NEW FUNCTIONALLY ACTIVE SUGAR-BINDING SITE","10.1074/JBC.M500735200 ",2.8,85.76,"1yf8_oligo3","DManpb1-3DAltpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_D_)-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(132_B_)",132.628,"","",""
"1YM0","CRYSTAL STRUCTURE OF EARTHWORM FIBRINOLYTIC ENZYME COMPONENT B: A NOVEL, GLYCOSYLATED TWO-CHAINED TRYPSIN","10.1016/J.JMB.2005.02.055 ",2.06,23.3,"1ym0_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(6_C_)-[MAN(4_C_)-MAN(3_C_)-NAG(2_C_)]-[FUC(5_C_)]-NAG(1_C_)-ASN(161_A_)",37.5012,"","",""
"1YWH","CRYSTAL STRUCTURE OF UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR","10.1038/SJ.EMBOJ.7600635 ",2.7,58.8,"1ywh_oligo15","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAca1-ASN","MAN(5_e_)-[MAN(4_e_)]-BMA(3_e_)-NAG(2_e_)-NAG(1_e_)-ASN(162_M_)",50.2425,"","",""
"1YWH","CRYSTAL STRUCTURE OF UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR","10.1038/SJ.EMBOJ.7600635 ",2.7,58.8,"1ywh_oligo18","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAca1-ASN","MAN(5_h_)-[MAN(4_h_)]-BMA(3_h_)-NAG(2_h_)-NAG(1_h_)-ASN(162_O_)",70.29,"","",""
"1YWH","CRYSTAL STRUCTURE OF UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR","10.1038/SJ.EMBOJ.7600635 ",2.7,58.8,"1ywh_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAca1-ASN","MAN(5_Z_)-[MAN(4_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(162_I_)",66.4147,"","",""
"1YWH","CRYSTAL STRUCTURE OF UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR","10.1038/SJ.EMBOJ.7600635 ",2.7,58.8,"1ywh_oligo13","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAca1-ASN","MAN(5_c_)-[MAN(4_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(162_K_)",52.0098,"","",""
"1YY9","STRUCTURE OF THE EXTRACELLULAR DOMAIN OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN COMPLEX WITH THE FAB FRAGMENT OF CETUXIMAB/ERBITUX/IMC- C225","10.1016/J.CCR.2005.03.003 ",2.61,33.7,"1yy9_oligo1","DRhapa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-MAN(5_B_)-[MAN(7_B_)]-MAN(4_B_)-[MAN(9_B_)-MAN(8_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(328_A_)",33.1901,"","",""
"1ZAG","HUMAN ZINC-ALPHA-2-GLYCOPROTEIN","10.1126/SCIENCE.283.5409.1914 ",2.8,54.3,"1zag_oligo4","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_E_)-MAN(6_E_)-[NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(239_A_)",48.8521,"","",""
"1ZAG","HUMAN ZINC-ALPHA-2-GLYCOPROTEIN","10.1126/SCIENCE.283.5409.1914 ",2.8,54.3,"1zag_oligo1","DNeup5Aca2-6DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","SIA(7_F_)-GAL(6_F_)-NAG(5_F_)-MAN(4_F_)-[NAG(9_F_)-MAN(8_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(239_B_)",63.8662,"","",""
"1ZHN","CRYSTAL STRUCTURE OF MOUSE CD1D BOUND TO THE SELF LIGAND PHOSPHATIDYLCHOLINE","",2.8,25.72,"1zhn_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_D_)-[MAN(5_D_)-[MAN(4_D_)]-MAN(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(165_A_)",51.7318,"","",""
"1ZHS","CRYSTAL STRUCTURE OF MVL BOUND TO MAN3GLCNAC2","10.1074/JBC.M504642200 ",1.8,19.9,"1zhs_oligo12","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","MAN(5_T_)-[MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)",20.68,"","",""
"1ZHS","CRYSTAL STRUCTURE OF MVL BOUND TO MAN3GLCNAC2","10.1074/JBC.M504642200 ",1.8,19.9,"1zhs_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)",22.6273,"","",""
"1ZHS","CRYSTAL STRUCTURE OF MVL BOUND TO MAN3GLCNAC2","10.1074/JBC.M504642200 ",1.8,19.9,"1zhs_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","MAN(5_L_)-[MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)",23.8518,"","",""
"1ZHS","CRYSTAL STRUCTURE OF MVL BOUND TO MAN3GLCNAC2","10.1074/JBC.M504642200 ",1.8,19.9,"1zhs_oligo16","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","MAN(5_X_)-[MAN(4_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)",32.3629,"","",""
"1ZHS","CRYSTAL STRUCTURE OF MVL BOUND TO MAN3GLCNAC2","10.1074/JBC.M504642200 ",1.8,19.9,"1zhs_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)",21.5691,"","",""
"1ZHS","CRYSTAL STRUCTURE OF MVL BOUND TO MAN3GLCNAC2","10.1074/JBC.M504642200 ",1.8,19.9,"1zhs_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)",38.1807,"","",""
"1ZHS","CRYSTAL STRUCTURE OF MVL BOUND TO MAN3GLCNAC2","10.1074/JBC.M504642200 ",1.8,19.9,"1zhs_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)",19.6678,"","",""
"1ZHS","CRYSTAL STRUCTURE OF MVL BOUND TO MAN3GLCNAC2","10.1074/JBC.M504642200 ",1.8,19.9,"1zhs_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)",21.7853,"","",""
"1ZHS","CRYSTAL STRUCTURE OF MVL BOUND TO MAN3GLCNAC2","10.1074/JBC.M504642200 ",1.8,19.9,"1zhs_oligo11","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)",36.1844,"","",""
"1ZHS","CRYSTAL STRUCTURE OF MVL BOUND TO MAN3GLCNAC2","10.1074/JBC.M504642200 ",1.8,19.9,"1zhs_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","MAN(5_P_)-[MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)",21.9527,"","",""
"1ZHS","CRYSTAL STRUCTURE OF MVL BOUND TO MAN3GLCNAC2","10.1074/JBC.M504642200 ",1.8,19.9,"1zhs_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","MAN(5_Q_)-[MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)",30.698,"","",""
"1ZHS","CRYSTAL STRUCTURE OF MVL BOUND TO MAN3GLCNAC2","10.1074/JBC.M504642200 ",1.8,19.9,"1zhs_oligo15","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","MAN(5_W_)-[MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)",19.0782,"","",""
"1ZHS","CRYSTAL STRUCTURE OF MVL BOUND TO MAN3GLCNAC2","10.1074/JBC.M504642200 ",1.8,19.9,"1zhs_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","MAN(5_R_)-[MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)",17.1165,"","",""
"1ZHS","CRYSTAL STRUCTURE OF MVL BOUND TO MAN3GLCNAC2","10.1074/JBC.M504642200 ",1.8,19.9,"1zhs_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)",27.6162,"","",""
"1ZHS","CRYSTAL STRUCTURE OF MVL BOUND TO MAN3GLCNAC2","10.1074/JBC.M504642200 ",1.8,19.9,"1zhs_oligo14","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","MAN(5_V_)-[MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)",23.5135,"","",""
"1ZHS","CRYSTAL STRUCTURE OF MVL BOUND TO MAN3GLCNAC2","10.1074/JBC.M504642200 ",1.8,19.9,"1zhs_oligo13","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","MAN(5_U_)-[MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)",22.9218,"","",""
"1ZI5","CRYSTAL STRUCTURE OF HUMAN N-ACETYLGALACTOSAMINYLTRANSFERASE (GTA) COMPLEXED WITH H TYPE I TRISACCHARIDE","10.1074/JBC.M507620200 ",1.55,0,"1zi5_oligo2","LFucpa1-2DGalpb1-3DGlcpNAcb1-ROH","FUC(3_B_)-GAL(2_B_)-NAG(1_B_)",54.0845,"","",""
"1ZJ2","CRYSTAL STRUCTURE OF HUMAN GALACTOSYLTRANSFERASE (GTB) COMPLEXED WITH H TYPE I TRISACCHARIDE","10.1074/JBC.M507620200 ",1.69,0,"1zj2_oligo2","LFucpa1-2DGalpb1-3DGlcpNAcb1-ROH","FUC(3_B_)-GAL(2_B_)-NAG(1_B_)",42.2209,"","",""
"1ZPU","CRYSTAL STRUCTURE OF FET3P, A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT","10.1073/PNAS.0506227102 ",2.8,69.82,"1zpu_oligo25","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAca1-ASN","MAN(6_e_)-[MAN(5_e_)]-MAN(4_e_)-[MAN(7_e_)]-BMA(3_e_)-NAG(2_e_)-NAG(1_e_)-ASN(198_E_)",83.2005,"","",""
"1ZPU","CRYSTAL STRUCTURE OF FET3P, A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT","10.1073/PNAS.0506227102 ",2.8,69.82,"1zpu_oligo21","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_R_)-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(292_B_)",79.5668,"","",""
"1ZPU","CRYSTAL STRUCTURE OF FET3P, A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT","10.1073/PNAS.0506227102 ",2.8,69.82,"1zpu_oligo24","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_d_)-[MAN(4_d_)]-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(194_E_)",81.9753,"","",""
"1ZPU","CRYSTAL STRUCTURE OF FET3P, A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT","10.1073/PNAS.0506227102 ",2.8,69.82,"1zpu_oligo14","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(194_A_)",81.47,"","",""
"1ZPU","CRYSTAL STRUCTURE OF FET3P, A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT","10.1073/PNAS.0506227102 ",2.8,69.82,"1zpu_oligo4","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_T_)-[MAN(5_T_)]-MAN(4_T_)-[MAN(7_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(198_C_)",79.4632,"","",""
"1ZPU","CRYSTAL STRUCTURE OF FET3P, A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT","10.1073/PNAS.0506227102 ",2.8,69.82,"1zpu_oligo18","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(77_B_)",73.8033,"","",""
"1ZPU","CRYSTAL STRUCTURE OF FET3P, A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT","10.1073/PNAS.0506227102 ",2.8,69.82,"1zpu_oligo26","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAca1-ASN","MAN(5_f_)-[MAN(4_f_)]-BMA(3_f_)-NAG(2_f_)-NAG(1_f_)-ASN(77_E_)",75.8482,"","",""
"1ZPU","CRYSTAL STRUCTURE OF FET3P, A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT","10.1073/PNAS.0506227102 ",2.8,69.82,"1zpu_oligo16","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(194_B_)",83.2687,"","",""
"1ZPU","CRYSTAL STRUCTURE OF FET3P, A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT","10.1073/PNAS.0506227102 ",2.8,69.82,"1zpu_oligo22","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(194_C_)",85.916,"","",""
"1ZPU","CRYSTAL STRUCTURE OF FET3P, A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT","10.1073/PNAS.0506227102 ",2.8,69.82,"1zpu_oligo3","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAca1-ASN","MAN(5_H_)-MAN(4_H_)-[MAN(6_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(198_A_)",82.0095,"","",""
"1ZPU","CRYSTAL STRUCTURE OF FET3P, A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT","10.1073/PNAS.0506227102 ",2.8,69.82,"1zpu_oligo30","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_j_)-MAN(4_j_)-[MAN(6_j_)]-BMA(3_j_)-NAG(2_j_)-NAG(1_j_)-ASN(198_F_)",80.6418,"","",""
"1ZPU","CRYSTAL STRUCTURE OF FET3P, A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT","10.1073/PNAS.0506227102 ",2.8,69.82,"1zpu_oligo31","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_k_)-[MAN(4_k_)]-BMA(3_k_)-NAG(2_k_)-NAG(1_k_)-ASN(77_F_)",68.9776,"","",""
"1ZPU","CRYSTAL STRUCTURE OF FET3P, A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT","10.1073/PNAS.0506227102 ",2.8,69.82,"1zpu_oligo10","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Z_)-MAN(4_Z_)-[MAN(6_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(198_D_)",70.0315,"","",""
"1ZPU","CRYSTAL STRUCTURE OF FET3P, A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT","10.1073/PNAS.0506227102 ",2.8,69.82,"1zpu_oligo17","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-MAN(4_N_)-[MAN(6_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(198_B_)",81.2404,"","",""
"1ZPU","CRYSTAL STRUCTURE OF FET3P, A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT","10.1073/PNAS.0506227102 ",2.8,69.82,"1zpu_oligo29","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_i_)-[MAN(4_i_)]-BMA(3_i_)-NAG(2_i_)-NAG(1_i_)-ASN(194_F_)",76.9169,"","",""
"1ZPU","CRYSTAL STRUCTURE OF FET3P, A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT","10.1073/PNAS.0506227102 ",2.8,69.82,"1zpu_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Y_)-[MAN(4_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(194_D_)",74.9596,"","",""
"1ZPU","CRYSTAL STRUCTURE OF FET3P, A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT","10.1073/PNAS.0506227102 ",2.8,69.82,"1zpu_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_U_)-[MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(77_C_)",82.1195,"","",""
"1ZPU","CRYSTAL STRUCTURE OF FET3P, A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT","10.1073/PNAS.0506227102 ",2.8,69.82,"1zpu_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(77_A_)",75.8404,"","",""
"1ZPU","CRYSTAL STRUCTURE OF FET3P, A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT","10.1073/PNAS.0506227102 ",2.8,69.82,"1zpu_oligo11","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAca1-ASN","MAN(5_a_)-[MAN(4_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(77_D_)",77.5516,"","",""
"207D","SOLUTION STRUCTURE OF MITHRAMYCIN DIMERS BOUND TO PARTIALLY OVERLAPPING SITES ON DNA","10.1006/JMBI.1995.0464 ","2.95026e-39",0,"207d_oligo24","DAltp[6H,2H,3<R1>]b1-3DTalp[6H,2H]b1-3DOlipb1-","MDA(3_J_)-DDL(2_J_)-DDA(1_J_)",0.239333,"","",""
"207D","SOLUTION STRUCTURE OF MITHRAMYCIN DIMERS BOUND TO PARTIALLY OVERLAPPING SITES ON DNA","10.1006/JMBI.1995.0464 ","2.95026e-39",0,"207d_oligo25","DAltp[6H,2H,3<R1>]b1-3DTalp[6H,2H]b1-3DOlipb1-","MDA(3_D_)-DDL(2_D_)-DDA(1_D_)",0.241,"","",""
"207D","SOLUTION STRUCTURE OF MITHRAMYCIN DIMERS BOUND TO PARTIALLY OVERLAPPING SITES ON DNA","10.1006/JMBI.1995.0464 ","2.95026e-39",0,"207d_oligo29","DAltp[6H,2H,3<R1>]b1-3DTalp[6H,2H]b1-3DOlipb1-C21O9","MDA(3_G_)-DDL(2_G_)-DDA(1_G_)",0.334333,"","",""
"207D","SOLUTION STRUCTURE OF MITHRAMYCIN DIMERS BOUND TO PARTIALLY OVERLAPPING SITES ON DNA","10.1006/JMBI.1995.0464 ","2.95026e-39",0,"207d_oligo27","DAltp[6H,2H,3<R1>]b1-3DTalp[6H,2H]b1-3DOlipb1-","MDA(3_F_)-DDL(2_F_)-DDA(1_F_)",0.334333,"","",""
"2A0Z","THE MOLECULAR STRUCTURE OF TOLL-LIKE RECEPTOR 3 LIGAND BINDING DOMAIN","10.1073/PNAS.0505077102 ",2.4,45.4,"2a0z_oligo7","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(413_A_)",77.0195,"","",""
"2AAI","CRYSTALLOGRAPHIC REFINEMENT OF RICIN TO 2.5 ANGSTROMS","10.1002/PROT.340100308 ",2.5,0,"2aai_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(95_B_)",42.6235,"","",""
"2AAI","CRYSTALLOGRAPHIC REFINEMENT OF RICIN TO 2.5 ANGSTROMS","10.1002/PROT.340100308 ",2.5,0,"2aai_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(135_B_)",43.948,"","",""
"2AC1","CRYSTAL STRUCTURE OF A CELL-WALL INVERTASE FROM ARABIDOPSIS THALIANA","10.1107/S0907444906044489 ",2.15,30.9,"2ac1_oligo1","DManpa1-2DManpa1-3[DManpb1-3DManpb1-6]DManpb1-4DGlcpNAca1-4DGlcpNAca1-ASN","MAN(7_B_)-MAN(6_B_)-[MAN(5_B_)-MAN(4_B_)]-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(299_A_)",58.7278,"","",""
"2AEP","AN EPIDEMIOLOGICALLY SIGNIFICANT EPITOPE OF A 1998 INFLUENZA VIRUS NEURAMINIDASE FORMS A HIGHLY HYDRATED INTERFACE IN THE NA-ANTIBODY COMPLEX.","10.1016/J.JMB.2005.11.061 ",2.1,32.91,"2aep_oligo2","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",37.666,"","",""
"2AES","CRYSTAL STRUCTURE OF HUMAN M340H-BETA1,4-GALACTOSYLTRANSFERASE-I (M340H-B4GAL-T1) IN COMPLEX WITH GLCNAC-BETA1,2-MAN-ALPHA1,3-MAN- BETA-OR","10.1016/J.JMB.2005.07.050 ",2,35.5,"2aes_oligo5","DGlcpNAcb1-2DManpa1-3DManpb1-ROH","NAG(3_D_)-MAN(2_D_)-BMA(1_D_)",58.3718,"","",""
"2AES","CRYSTAL STRUCTURE OF HUMAN M340H-BETA1,4-GALACTOSYLTRANSFERASE-I (M340H-B4GAL-T1) IN COMPLEX WITH GLCNAC-BETA1,2-MAN-ALPHA1,3-MAN- BETA-OR","10.1016/J.JMB.2005.07.050 ",2,35.5,"2aes_oligo7","DGlcpNAcb1-2DManpa1-3DManpb1-ROH","NAG(3_F_)-MAN(2_F_)-BMA(1_F_)",65.9076,"","",""
"2AES","CRYSTAL STRUCTURE OF HUMAN M340H-BETA1,4-GALACTOSYLTRANSFERASE-I (M340H-B4GAL-T1) IN COMPLEX WITH GLCNAC-BETA1,2-MAN-ALPHA1,3-MAN- BETA-OR","10.1016/J.JMB.2005.07.050 ",2,35.5,"2aes_oligo6","DGlcpNAcb1-2DManpa1-3DManpb1-ROH","NAG(3_E_)-MAN(2_E_)-BMA(1_E_)",50.6518,"","",""
"2AEZ","CRYSTAL STRUCTURE OF FRUCTAN 1-EXOHYDROLASE IIA (E201Q) FROM CICHORIUM INTYBUS IN COMPLEX WITH 1-KESTOSE","10.1111/J.1469-8137.2007.01988.X ",3.05,45.4,"2aez_oligo1","DManpb1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(116_A_)",83.5259,"","",""
"2AGD","CRYSTAL STRUCTURE OF HUMAN M340H-BETA-1,4-GALACTOSYLTRANSFERASE- I(M340H-B4GAL-T1) IN COMPLEX WITH GLCNAC-BETA1,4-MAN-ALPHA1,3-MAN- BETA-OR","10.1016/J.JMB.2005.07.050 ",1.9,28.9,"2agd_oligo6","DGlcpNAcb1-4DManpa1-3DManpb1-ROH","NAG(3_F_)-MAN(2_F_)-BMA(1_F_)",53.4621,"","",""
"2AGD","CRYSTAL STRUCTURE OF HUMAN M340H-BETA-1,4-GALACTOSYLTRANSFERASE- I(M340H-B4GAL-T1) IN COMPLEX WITH GLCNAC-BETA1,4-MAN-ALPHA1,3-MAN- BETA-OR","10.1016/J.JMB.2005.07.050 ",1.9,28.9,"2agd_oligo5","DGlcpNAcb1-4DManpa1-3DManpb1-ROH","NAG(3_E_)-MAN(2_E_)-BMA(1_E_)",38.1724,"","",""
"2AGD","CRYSTAL STRUCTURE OF HUMAN M340H-BETA-1,4-GALACTOSYLTRANSFERASE- I(M340H-B4GAL-T1) IN COMPLEX WITH GLCNAC-BETA1,4-MAN-ALPHA1,3-MAN- BETA-OR","10.1016/J.JMB.2005.07.050 ",1.9,28.9,"2agd_oligo4","DGlcpNAcb1-4DManpa1-3DManpb1-ROH","NAG(3_D_)-MAN(2_D_)-BMA(1_D_)",45.1542,"","",""
"2AR6","PTEROCARPUS ANGOLENSIS LECTIN (PAL) IN COMPLEX WITH THE PENTASACCHARIDE M592","10.1111/J.1742-4658.2006.05248.X ",1.8,0,"2ar6_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpa1-ROH","NAG(5_D_)-MAN(4_D_)-[NAG(3_D_)-MAN(2_D_)]-MAN(1_D_)",31.9809,"","",""
"2ARX","PTEROCARPUS ANGOLENSIS SEED LECTIN IN COMPLEX WITH THE DECASACCHARIDE NA2F","10.1111/J.1742-4658.2006.05248.X ",2,0,"2arx_oligo1","DManpa1-3DManpa1-ROH","MAN(2_C_)-MAN(1_C_)",28.1555,"","",""
"2ARX","PTEROCARPUS ANGOLENSIS SEED LECTIN IN COMPLEX WITH THE DECASACCHARIDE NA2F","10.1111/J.1742-4658.2006.05248.X ",2,0,"2arx_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAca1-ROH","NAG(7_D_)-MAN(6_D_)-[GAL(5_D_)-NAG(4_D_)-MAN(3_D_)]-BMA(2_D_)-NDG(1_D_)",41.1288,"","",""
"2AUY","PTEROCARPUS ANGOLENSIS LECTIN IN COMPLEX WITH THE TRISACCHARIDE GLCNAC(B1-2)MAN(A1-3)MAN","10.1111/J.1742-4658.2006.05248.X ",1.95,0,"2auy_oligo3","DGlcpNAcb1-2DManpa1-3DManpa1-OME","NAG(3_C_)-MAN(2_C_)-MMA(1_C_)",31.7012,"","",""
"2AUY","PTEROCARPUS ANGOLENSIS LECTIN IN COMPLEX WITH THE TRISACCHARIDE GLCNAC(B1-2)MAN(A1-3)MAN","10.1111/J.1742-4658.2006.05248.X ",1.95,0,"2auy_oligo4","DGlcpNAcb1-2DManpa1-3DManpa1-OME","NAG(3_D_)-MAN(2_D_)-MMA(1_D_)",35.197,"","",""
"2B1M","CRYSTAL STRUCTURE OF A PAPAIN-FOLD PROTEIN WITHOUT THE CATALYTIC CYSTEINE FROM SEEDS OF PACHYRHIZUS EROSUS","10.1016/J.JMB.2006.01.065 ",2,24.9,"2b1m_oligo1","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_B_)-[FUC(2_B_)]-NAG(1_B_)-ASN(159_A_)",38.3612,"","",""
"2B1N","CRYSTAL STRUCTURE OF A PAPAIN-FOLD PROTEIN WITHOUT THE CATALYTIC CYSTEINE FROM SEEDS OF PACHYRHIZUS EROSUS","10.1016/J.JMB.2006.01.065 ",2.4,33.6,"2b1n_oligo1","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_C_)-[FUC(2_C_)]-NAG(1_C_)-ASN(159_A_)",54.6597,"","",""
"2B5T","2.1 ANGSTROM STRUCTURE OF A NONPRODUCTIVE COMPLEX BETWEEN ANTITHROMBIN, SYNTHETIC HEPARIN MIMETIC SR123781 AND TWO S195A THROMBIN MOLECULES","10.1074/JBC.M607204200 ",2.1,43.3,"2b5t_oligo1","DManp[2H]a1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAca1-ASN","FUC(7_H_)-[MAN(6_H_)-MAN(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)]-NAG(1_H_)-ASN(96_I_)",102.935,"","",""
"2B8H","A/NWS/WHALE/MAINE/1/84 (H1N9) REASSORTANT INFLUENZA VIRUS NEURAMINIDASE","10.1107/S0907444906020063 ",2.2,21.16,"2b8h_oligo8","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_L_)-[MAN(8_L_)]-MAN(7_L_)-[MAN(6_L_)-MAN(5_L_)-MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(201_D_)",25.7044,"","",""
"2B8H","A/NWS/WHALE/MAINE/1/84 (H1N9) REASSORTANT INFLUENZA VIRUS NEURAMINIDASE","10.1107/S0907444906020063 ",2.2,21.16,"2b8h_oligo6","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_J_)-[MAN(8_J_)]-MAN(7_J_)-[MAN(6_J_)-MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(201_C_)",28.5894,"","",""
"2B8H","A/NWS/WHALE/MAINE/1/84 (H1N9) REASSORTANT INFLUENZA VIRUS NEURAMINIDASE","10.1107/S0907444906020063 ",2.2,21.16,"2b8h_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_F_)-[MAN(8_F_)]-MAN(7_F_)-[MAN(6_F_)-MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(201_A_)",24.7213,"","",""
"2B8H","A/NWS/WHALE/MAINE/1/84 (H1N9) REASSORTANT INFLUENZA VIRUS NEURAMINIDASE","10.1107/S0907444906020063 ",2.2,21.16,"2b8h_oligo4","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_H_)-MAN(8_H_)-[MAN(10_H_)]-MAN(7_H_)-[MAN(6_H_)-MAN(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(201_B_)",33.5904,"","",""
"2B9L","CRYSTAL STRUCTURE OF PROPHENOLOXIDASE ACTIVATING FACTOR-II FROM THE BEETLE HOLOTRICHIA DIOMPHALIA","10.1038/SJ.EMBOJ.7600891 ",2,32,"2b9l_oligo1","LFucpa1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_B_)-[NAG(3_B_)]-[FUC(2_B_)]-NAG(1_B_)-ASN(32_A_)",49.8027,"","",""
"2BAT","THE STRUCTURE OF THE COMPLEX BETWEEN INFLUENZA VIRUS NEURAMINIDASE AND SIALIC ACID, THE VIRAL RECEPTOR","10.1002/PROT.340140302 ",2,0,"2bat_oligo2","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(200_A_)",40.3709,"","",""
"2BAT","THE STRUCTURE OF THE COMPLEX BETWEEN INFLUENZA VIRUS NEURAMINIDASE AND SIALIC ACID, THE VIRAL RECEPTOR","10.1002/PROT.340140302 ",2,0,"2bat_oligo1","DGalpNAca1-4DGlcpNAcb1-4DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(7_B_)-[NGK(6_B_)-NAG(5_B_)-MAN(4_B_)-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(146_A_)",81.2249,"","",""
"2BBH","X-RAY STRUCTURE OF T.MARITIMA CORA SOLUBLE DOMAIN","10.1038/NATURE04642 ",1.85,39.12,"2bbh_oligo4","DManpb1-3DGulpb6-C10O1","DMU(403_A_)-DMU(403_A_)",61.3677,"","",""
"2BBH","X-RAY STRUCTURE OF T.MARITIMA CORA SOLUBLE DOMAIN","10.1038/NATURE04642 ",1.85,39.12,"2bbh_oligo3","LGulpa1-3DAllpb6-C10O1","DMU(402_A_)-DMU(402_A_)",81.4455,"","",""
"2BBH","X-RAY STRUCTURE OF T.MARITIMA CORA SOLUBLE DOMAIN","10.1038/NATURE04642 ",1.85,39.12,"2bbh_oligo2","DManpa1-3DGulpa6-C10O1","DMU(401_A_)-DMU(401_A_)",80.145,"","",""
"2BC4","CRYSTAL STRUCTURE OF HLA-DM","",2.27,39.84,"2bc4_oligo1","DManpb1-3DManpb1-4DGlcpNAca1-4DGlcpNAca1-ASN","BMA(4_E_)-BMA(3_E_)-NDG(2_E_)-NAG(1_E_)-ASN(15_A_)",64.0957,"","",""
"2BC4","CRYSTAL STRUCTURE OF HLA-DM","",2.27,39.84,"2bc4_oligo2","DManpb1-3DManpb1-4DGlcpNAca1-4DGlcpNAca1-ASN","BMA(4_F_)-BMA(3_F_)-NDG(2_F_)-NAG(1_F_)-ASN(15_C_)",62.7689,"","",""
"2BF1","STRUCTURE OF AN UNLIGANDED AND FULLY-GLYCOSYLATED SIV GP120 ENVELOPE GLYCOPROTEIN","10.1038/NATURE03327 ",4,128.8,"2bf1_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(475_A_)",180.899,"","",""
"2BF1","STRUCTURE OF AN UNLIGANDED AND FULLY-GLYCOSYLATED SIV GP120 ENVELOPE GLYCOPROTEIN","10.1038/NATURE03327 ",4,128.8,"2bf1_oligo4","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_I_)-[MAN(6_I_)-MAN(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(459_A_)",139.332,"","",""
"2BF1","STRUCTURE OF AN UNLIGANDED AND FULLY-GLYCOSYLATED SIV GP120 ENVELOPE GLYCOPROTEIN","10.1038/NATURE03327 ",4,128.8,"2bf1_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(6_C_)-[MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(277_A_)",123.823,"","",""
"2BF1","STRUCTURE OF AN UNLIGANDED AND FULLY-GLYCOSYLATED SIV GP120 ENVELOPE GLYCOPROTEIN","10.1038/NATURE03327 ",4,128.8,"2bf1_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(6_K_)-[MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(243_A_)",115.522,"","",""
"2BGN","HIV-1 TAT PROTEIN DERIVED N-TERMINAL NONAPEPTIDE TRP2-TAT(1-9) BOUND TO THE ACTIVE SITE OF DIPEPTIDYL PEPTIDASE IV (CD26)","10.1074/JBC.M413400200 ",3.15,64.8,"2bgn_oligo8","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_P_)-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(229_B_)",53.7675,"","",""
"2BGN","HIV-1 TAT PROTEIN DERIVED N-TERMINAL NONAPEPTIDE TRP2-TAT(1-9) BOUND TO THE ACTIVE SITE OF DIPEPTIDYL PEPTIDASE IV (CD26)","10.1074/JBC.M413400200 ",3.15,64.8,"2bgn_oligo17","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_c_)-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(229_D_)",78.9398,"","",""
"2BGN","HIV-1 TAT PROTEIN DERIVED N-TERMINAL NONAPEPTIDE TRP2-TAT(1-9) BOUND TO THE ACTIVE SITE OF DIPEPTIDYL PEPTIDASE IV (CD26)","10.1074/JBC.M413400200 ",3.15,64.8,"2bgn_oligo13","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_U_)-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(229_C_)",76.1502,"","",""
"2BGN","HIV-1 TAT PROTEIN DERIVED N-TERMINAL NONAPEPTIDE TRP2-TAT(1-9) BOUND TO THE ACTIVE SITE OF DIPEPTIDYL PEPTIDASE IV (CD26)","10.1074/JBC.M413400200 ",3.15,64.8,"2bgn_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_L_)-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(229_A_)",67.3136,"","",""
"2BNJ","THE XYLANASE TA FROM THERMOASCUS AURANTIACUS UTILIZES ARABINOSE DECORATIONS OF XYLAN AS SIGNIFICANT SUBSTRATE SPECIFICITY DETERMINANTS.","10.1016/J.JMB.2005.07.051 ",1.6,7.6,"2bnj_oligo2","LArafa1-3DXylpb1-4DXylpb1-ROH","AHR(3_B_)-XYP(2_B_)-XYP(1_B_)",8.69081,"","",""
"2C10","THE STRUCTURE OF A TRUNCATED, SOLUBLE VERSION OF SEMICARBAZIDE- SENSITIVE AMINE OXIDASE","10.1107/S0907444905028805 ",2.5,37.62,"2c10_oligo11","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAca1-ASN","FUC(5_O_)-[MAN(4_O_)-BMA(3_O_)-NAG(2_O_)]-NAG(1_O_)-ASN(592_D_)",62.2315,"","",""
"2C10","THE STRUCTURE OF A TRUNCATED, SOLUBLE VERSION OF SEMICARBAZIDE- SENSITIVE AMINE OXIDASE","10.1107/S0907444905028805 ",2.5,37.62,"2c10_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAca1-ASN","FUC(5_I_)-[MAN(4_I_)-BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(592_B_)",62.8775,"","",""
"2C11","CRYSTAL STRUCTURE OF THE 2-HYDRAZINOPYRIDINE OF SEMICARBAZIDE- SENSITIVE AMINE OXIDASE","10.1107/S0907444905028805 ",2.9,60,"2c11_oligo8","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAca1-ASN","FUC(5_L_)-[MAN(4_L_)-BMA(3_L_)-NAG(2_L_)]-NAG(1_L_)-ASN(592_D_)",91.5107,"","",""
"2C11","CRYSTAL STRUCTURE OF THE 2-HYDRAZINOPYRIDINE OF SEMICARBAZIDE- SENSITIVE AMINE OXIDASE","10.1107/S0907444905028805 ",2.9,60,"2c11_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAca1-ASN","FUC(5_H_)-[MAN(4_H_)-BMA(3_H_)-NAG(2_H_)]-NAG(1_H_)-ASN(592_B_)",94.6956,"","",""
"2C6C","MEMBRANE-BOUND GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH GPI-18431 (S)-2-(4-IODOBENZYLPHOSPHONOMETHYL)-PENTANEDIOIC ACID","10.1038/SJ.EMBOJ.7600969 ",2,32.26,"2c6c_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(638_A_)",53.0702,"","",""
"2C6G","MEMBRANE-BOUND GLUTAMATE CARBOXYPEPTIDASE II (GCPII) WITH BOUND GLUTAMATE","10.1038/SJ.EMBOJ.7600969 ",2.2,35.67,"2c6g_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(638_A_)",60.9445,"","",""
"2C8N","THE STRUCTURE OF A FAMILY 51 ARABINOFURANOSIDASE, ARAF51, FROM CLOSTRIDIUM THERMOCELLUM IN COMPLEX WITH 1,3-LINKED ARABINOSIDE OF XYLOBIOSE.","10.1042/BJ20051780 ",2.9,52.27,"2c8n_oligo3","LArafa1-3DXylpx1-","AHR(2_I_)-XYS(1_I_)",58.4789,"","",""
"2C8N","THE STRUCTURE OF A FAMILY 51 ARABINOFURANOSIDASE, ARAF51, FROM CLOSTRIDIUM THERMOCELLUM IN COMPLEX WITH 1,3-LINKED ARABINOSIDE OF XYLOBIOSE.","10.1042/BJ20051780 ",2.9,52.27,"2c8n_oligo4","LArafa1-3DXylpx1-","AHR(2_J_)-XYS(1_J_)",58.5383,"","",""
"2C8N","THE STRUCTURE OF A FAMILY 51 ARABINOFURANOSIDASE, ARAF51, FROM CLOSTRIDIUM THERMOCELLUM IN COMPLEX WITH 1,3-LINKED ARABINOSIDE OF XYLOBIOSE.","10.1042/BJ20051780 ",2.9,52.27,"2c8n_oligo5","LArafa1-3DXylpx1-","AHR(2_K_)-XYS(1_K_)",58.61,"","",""
"2C8N","THE STRUCTURE OF A FAMILY 51 ARABINOFURANOSIDASE, ARAF51, FROM CLOSTRIDIUM THERMOCELLUM IN COMPLEX WITH 1,3-LINKED ARABINOSIDE OF XYLOBIOSE.","10.1042/BJ20051780 ",2.9,52.27,"2c8n_oligo6","LArafa1-3DXylpx1-","AHR(2_L_)-XYS(1_L_)",58.5617,"","",""
"2C8N","THE STRUCTURE OF A FAMILY 51 ARABINOFURANOSIDASE, ARAF51, FROM CLOSTRIDIUM THERMOCELLUM IN COMPLEX WITH 1,3-LINKED ARABINOSIDE OF XYLOBIOSE.","10.1042/BJ20051780 ",2.9,52.27,"2c8n_oligo2","LArafa1-3DXylpx1-","AHR(2_H_)-XYS(1_H_)",58.3844,"","",""
"2C8N","THE STRUCTURE OF A FAMILY 51 ARABINOFURANOSIDASE, ARAF51, FROM CLOSTRIDIUM THERMOCELLUM IN COMPLEX WITH 1,3-LINKED ARABINOSIDE OF XYLOBIOSE.","10.1042/BJ20051780 ",2.9,52.27,"2c8n_oligo1","LArafa1-3DXylpx1-","AHR(2_G_)-XYS(1_G_)",58.7439,"","",""
"2C9A","CRYSTAL STRUCTURE OF THE MAM-IG MODULE OF RECEPTOR PROTEIN TYROSINE PHOSPHATASE MU","10.1038/SJ.EMBOJ.7600974 ",2.7,47.97,"2c9a_oligo2","DManpa1-3DManpa1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(4_B_)-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)",84.3841,"","",""
"2CGY","STRUCTURE OF HELIX POMATIA AGGLUTININ WITH FORSMANN ANTIGEN","10.1093/GLYCOB/CWM077 ",2.8,54.29,"2cgy_oligo1","DGalpNAca1-3DGalpNAcb1-ROH","A2G(2_B_)-NGA(1_B_)",55.9141,"","",""
"2CHB","CHOLERA TOXIN B-PENTAMER COMPLEXED WITH GM1 PENTASACCHARIDE","",2,22,"2chb_oligo5","DGalpb1-3DGalpNAcb1-4[DNeup5Aca2-3]DGalpx1-","GAL(3_A_)-NGA(2_A_)-[SIA(4_A_)]-GAL(1_A_)",32.1778,"","",""
"2CHB","CHOLERA TOXIN B-PENTAMER COMPLEXED WITH GM1 PENTASACCHARIDE","",2,22,"2chb_oligo3","DGalpb1-3DGalpNAcb1-4[DNeup5Aca2-3]DGalpb1-4DGlcpb1-ROH","GAL(4_J_)-NGA(3_J_)-[SIA(5_J_)]-GAL(2_J_)-BGC(1_J_)",23.6257,"","",""
"2CHB","CHOLERA TOXIN B-PENTAMER COMPLEXED WITH GM1 PENTASACCHARIDE","",2,22,"2chb_oligo2","DGalpb1-3DGalpNAcb1-4[DNeup5Aca2-3]DGalpb1-4DGlcpb1-ROH","GAL(4_I_)-NGA(3_I_)-[SIA(5_I_)]-GAL(2_I_)-BGC(1_I_)",30.9961,"","",""
"2CHB","CHOLERA TOXIN B-PENTAMER COMPLEXED WITH GM1 PENTASACCHARIDE","",2,22,"2chb_oligo1","DGalpb1-3DGalpNAcb1-4[DNeup5Aca2-3]DGalpb1-4DGlcpb1-ROH","GAL(4_B_)-NGA(3_B_)-[SIA(5_B_)]-GAL(2_B_)-BGC(1_B_)",33.4435,"","",""
"2CHB","CHOLERA TOXIN B-PENTAMER COMPLEXED WITH GM1 PENTASACCHARIDE","",2,22,"2chb_oligo4","DGalpb1-3DGalpNAcb1-4[DNeup5Aca2-3]DGalpx1-","GAL(3_C_)-NGA(2_C_)-[SIA(4_C_)]-GAL(1_C_)",39.0858,"","",""
"2CIJ","MEMBRANE-BOUND GLUTAMATE CARBOXYPEPTIDASE II (GCPII) WITH BOUND METHIONINE","",2.4,29.43,"2cij_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(638_A_)",48.8161,"","",""
"2CL2","ENDO-1,3(4)-BETA-GLUCANASE FROM PHANEROCHAETE CHRYSOSPORIUM, SOLVED USING NATIVE SULFUR SAD, EXHIBITING INTACT HEPTASACCHARIDE GLYCOSYLATION","10.1107/S0907444906036407 ",1.35,8,"2cl2_oligo1","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-MAN(5_B_)-[MAN(7_B_)]-MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(43_A_)",24.49,"","",""
"2CNC","FAMILY 10 XYLANASE","10.1016/J.JMB.2006.05.002 ",2.4,11.29,"2cnc_oligo1","LArafa1-3DXylpb1-4DXylpa1-ROH","AHR(3_B_)-XYP(2_B_)-XYS(1_B_)",14.6072,"","",""
"2CWG","CRYSTALLOGRAPHIC REFINEMENT AND STRUCTURE ANALYSIS OF THE COMPLEX OF WHEAT GERM AGGLUTININ WITH A BIVALENT SIALOGLYCOPEPTIDE FROM GLYCOPHORIN A","10.1006/JMBI.1993.1415 ",2,0,"2cwg_oligo1","DNeup5Aca2-3DGalpb1-3[DNeup5Aca2-6]DGalpNAcx1-","SIA(4_F_)-[SIA(3_F_)-GAL(2_F_)]-NDG(1_F_)",78.3461,"","",""
"2CWG","CRYSTALLOGRAPHIC REFINEMENT AND STRUCTURE ANALYSIS OF THE COMPLEX OF WHEAT GERM AGGLUTININ WITH A BIVALENT SIALOGLYCOPEPTIDE FROM GLYCOPHORIN A","10.1006/JMBI.1993.1415 ",2,0,"2cwg_oligo3","DNeup5Aca2-3DGalpb1-3[DNeup5Aca2-6]DGalpNAca1-THR","SIA(4_C_)-[SIA(3_C_)-GAL(2_C_)]-NDG(1_C_)-THR(10_D_)",24.5194,"","",""
"2D3S","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN WITH TN-ANTIGEN","10.1016/J.FEBSLET.2005.11.011 ",2.35,44.2,"2d3s_oligo9","DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","BMA(3_I_)-NAG(2_I_)-[FUC(4_I_)]-NAG(1_I_)-ASN(219_C_)",73.1123,"","",""
"2D3S","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN WITH TN-ANTIGEN","10.1016/J.FEBSLET.2005.11.011 ",2.35,44.2,"2d3s_oligo7","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_G_)-[FUC(2_G_)]-NAG(1_G_)-ASN(219_B_)",74.0212,"","",""
"2D3S","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN WITH TN-ANTIGEN","10.1016/J.FEBSLET.2005.11.011 ",2.35,44.2,"2d3s_oligo1","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_E_)-[FUC(2_E_)]-NAG(1_E_)-ASN(219_A_)",69.5936,"","",""
"2D3S","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN WITH TN-ANTIGEN","10.1016/J.FEBSLET.2005.11.011 ",2.35,44.2,"2d3s_oligo10","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_J_)-[FUC(2_J_)]-NAG(1_J_)-ASN(44_D_)",85.5836,"","",""
"2D3S","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN WITH TN-ANTIGEN","10.1016/J.FEBSLET.2005.11.011 ",2.35,44.2,"2d3s_oligo6","LFucpa1-3DGlcpNAcb1-ASN","FUC(2_F_)-NAG(1_F_)-ASN(44_A_)",73.525,"","",""
"2D3S","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN WITH TN-ANTIGEN","10.1016/J.FEBSLET.2005.11.011 ",2.35,44.2,"2d3s_oligo8","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_H_)-[FUC(2_H_)]-NAG(1_H_)-ASN(44_B_)",68.3052,"","",""
"2D80","CRYSTAL STRUCTURE OF PHB DEPOLYMERASE FROM PENICILLIUM FUNICULOSUM","10.1016/J.JMB.2005.12.028 ",1.7,18.3,"2d80_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(144_A_)",48.6967,"","",""
"2DF3","THE STRUCTURE OF SIGLEC-7 IN COMPLEX WITH ALPHA(2,3)/ALPHA(2,6) DISIALYL LACTOTETRAOSYL 2-(TRIMETHYLSILYL)ETHYL","10.1042/BJ20060103 ",1.9,20.86,"2df3_oligo2","DNeup5Aca2-3DGalpb1-3[DNeup5Aca2-6]DGlcpNAcb1-ROH","SIA(4_B_)-[SIA(3_B_)-GAL(2_B_)]-NAG(1_B_)",24.2931,"","",""
"2DJG","RE-DETERMINATION OF THE NATIVE STRUCTURE OF HUMAN DIPEPTIDYL PEPTIDASE I (CATHEPSIN C)","10.1042/BJ20061389 ",2.05,23.06,"2djg_oligo1","DManpb1-2DManpb1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_D_)-BMA(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(95_A_)",63.1211,"","",""
"2DSZ","THREE DIMENSIONAL STRUCTURE OF A GOAT SIGNALLING PROTEIN SECRETED DURING INVOLUTION","10.1107/S0907444907001631 ",2.35,39.4,"2dsz_oligo1","DManpb1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(39_A_)",52.5705,"","",""
"2DTS","CRYSTAL STRUCTURE OF THE DEFUCOSYLATED FC FRAGMENT FROM HUMAN IMMUNOGLOBULIN G1","10.1016/J.JMB.2007.02.034 ",2.2,37.02,"2dts_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(297_B_)",31.8688,"","",""
"2DTS","CRYSTAL STRUCTURE OF THE DEFUCOSYLATED FC FRAGMENT FROM HUMAN IMMUNOGLOBULIN G1","10.1016/J.JMB.2007.02.034 ",2.2,37.02,"2dts_oligo1","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(297_A_)",37.4082,"","",""
"2DTW","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN IN COMPLEX WITH 2ME-O-D- GALACTOSE","10.1107/S0907444906028198 ",2.4,38.3,"2dtw_oligo5","DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","BMA(3_I_)-NAG(2_I_)-[FUC(4_I_)]-NAG(1_I_)-ASN(219_C_)",65.0459,"","",""
"2DTW","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN IN COMPLEX WITH 2ME-O-D- GALACTOSE","10.1107/S0907444906028198 ",2.4,38.3,"2dtw_oligo1","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_G_)-[FUC(2_G_)]-NAG(1_G_)-ASN(219_B_)",68.0239,"","",""
"2DTW","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN IN COMPLEX WITH 2ME-O-D- GALACTOSE","10.1107/S0907444906028198 ",2.4,38.3,"2dtw_oligo3","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_E_)-[FUC(2_E_)]-NAG(1_E_)-ASN(219_A_)",56.6776,"","",""
"2DTW","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN IN COMPLEX WITH 2ME-O-D- GALACTOSE","10.1107/S0907444906028198 ",2.4,38.3,"2dtw_oligo7","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_K_)-[FUC(2_K_)]-NAG(1_K_)-ASN(44_D_)",69.2715,"","",""
"2DTW","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN IN COMPLEX WITH 2ME-O-D- GALACTOSE","10.1107/S0907444906028198 ",2.4,38.3,"2dtw_oligo4","LFucpa1-3[DGlcpNAca1-4]DGlcpNAcb1-ASN","NDG(3_H_)-[FUC(2_H_)]-NAG(1_H_)-ASN(44_B_)",63.5224,"","",""
"2DTY","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN COMPLEXED WITH N-ACETYL- D-GALACTOSAMINE","10.1107/S0907444906028198 ",2.65,38.5,"2dty_oligo8","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_H_)-[FUC(2_H_)]-NAG(1_H_)-ASN(44_B_)",61.1058,"","",""
"2DTY","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN COMPLEXED WITH N-ACETYL- D-GALACTOSAMINE","10.1107/S0907444906028198 ",2.65,38.5,"2dty_oligo3","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_E_)-[FUC(2_E_)]-NAG(1_E_)-ASN(219_A_)",60.7567,"","",""
"2DTY","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN COMPLEXED WITH N-ACETYL- D-GALACTOSAMINE","10.1107/S0907444906028198 ",2.65,38.5,"2dty_oligo11","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_K_)-[FUC(2_K_)]-NAG(1_K_)-ASN(219_D_)",82.3524,"","",""
"2DTY","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN COMPLEXED WITH N-ACETYL- D-GALACTOSAMINE","10.1107/S0907444906028198 ",2.65,38.5,"2dty_oligo9","DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","BMA(3_I_)-NAG(2_I_)-[FUC(4_I_)]-NAG(1_I_)-ASN(219_C_)",63.3057,"","",""
"2DTY","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN COMPLEXED WITH N-ACETYL- D-GALACTOSAMINE","10.1107/S0907444906028198 ",2.65,38.5,"2dty_oligo2","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_F_)-[FUC(2_F_)]-NAG(1_F_)-ASN(44_A_)",74.3085,"","",""
"2DTY","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN COMPLEXED WITH N-ACETYL- D-GALACTOSAMINE","10.1107/S0907444906028198 ",2.65,38.5,"2dty_oligo7","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_G_)-[FUC(2_G_)]-NAG(1_G_)-ASN(219_B_)",64.5833,"","",""
"2DTY","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN COMPLEXED WITH N-ACETYL- D-GALACTOSAMINE","10.1107/S0907444906028198 ",2.65,38.5,"2dty_oligo12","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_L_)-[FUC(2_L_)]-NAG(1_L_)-ASN(44_D_)",77.6203,"","",""
"2DU0","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN IN COMPLEX WITH ALPHA-D- GALACTOSE","10.1107/S0907444906028198 ",2.7,38.8,"2du0_oligo4","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_H_)-[FUC(2_H_)]-NAG(1_H_)-ASN(219_C_)",59.7524,"","",""
"2DU0","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN IN COMPLEX WITH ALPHA-D- GALACTOSE","10.1107/S0907444906028198 ",2.7,38.8,"2du0_oligo1","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_E_)-[FUC(2_E_)]-NAG(1_E_)-ASN(219_A_)",59.9345,"","",""
"2DU0","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN IN COMPLEX WITH ALPHA-D- GALACTOSE","10.1107/S0907444906028198 ",2.7,38.8,"2du0_oligo3","LFucpa1-3DGlcpNAcb1-ASN","FUC(2_G_)-NAG(1_G_)-ASN(44_B_)",59.6086,"","",""
"2DU0","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN IN COMPLEX WITH ALPHA-D- GALACTOSE","10.1107/S0907444906028198 ",2.7,38.8,"2du0_oligo2","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_F_)-[FUC(2_F_)]-NAG(1_F_)-ASN(219_B_)",72.3733,"","",""
"2DU1","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN IN COMPLEX WITH METHYL- ALPHA-N-ACETYL-D GALACTOSAMINE","10.1107/S0907444906028198 ",2.6,41.4,"2du1_oligo8","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_H_)-[FUC(2_H_)]-NAG(1_H_)-ASN(219_C_)",66.7551,"","",""
"2DU1","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN IN COMPLEX WITH METHYL- ALPHA-N-ACETYL-D GALACTOSAMINE","10.1107/S0907444906028198 ",2.6,41.4,"2du1_oligo5","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_E_)-[FUC(2_E_)]-NAG(1_E_)-ASN(219_A_)",59.4239,"","",""
"2DU1","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN IN COMPLEX WITH METHYL- ALPHA-N-ACETYL-D GALACTOSAMINE","10.1107/S0907444906028198 ",2.6,41.4,"2du1_oligo7","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_G_)-[FUC(2_G_)]-NAG(1_G_)-ASN(44_B_)",67.3145,"","",""
"2DU1","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN IN COMPLEX WITH METHYL- ALPHA-N-ACETYL-D GALACTOSAMINE","10.1107/S0907444906028198 ",2.6,41.4,"2du1_oligo6","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_F_)-[FUC(2_F_)]-NAG(1_F_)-ASN(219_B_)",68.7418,"","",""
"2DV9","CRYSTAL STRUCTURE OF PEANUT LECTIN GAL-BETA-1,3-GAL COMPLEX","10.1107/S0907444906035712 ",2.48,33.6,"2dv9_oligo1","DGalpb1-3DGalpa1-ROH","GAL(2_E_)-GAL(1_E_)",48.0695,"","",""
"2DV9","CRYSTAL STRUCTURE OF PEANUT LECTIN GAL-BETA-1,3-GAL COMPLEX","10.1107/S0907444906035712 ",2.48,33.6,"2dv9_oligo4","DGalpb1-3DGalpa1-ROH","GAL(2_H_)-GAL(1_H_)",51.9445,"","",""
"2DV9","CRYSTAL STRUCTURE OF PEANUT LECTIN GAL-BETA-1,3-GAL COMPLEX","10.1107/S0907444906035712 ",2.48,33.6,"2dv9_oligo2","DGalpb1-3DGalpa1-ROH","GAL(2_F_)-GAL(1_F_)",45.76,"","",""
"2DV9","CRYSTAL STRUCTURE OF PEANUT LECTIN GAL-BETA-1,3-GAL COMPLEX","10.1107/S0907444906035712 ",2.48,33.6,"2dv9_oligo3","DGalpb1-3DGalpa1-ROH","GAL(2_G_)-GAL(1_G_)",82.5577,"","",""
"2DVA","CRYSTAL STRUCTURE OF PEANUT LECTIN GAL-BETA-1,3-GALNAC-ALPHA-O-ME (METHYL-T-ANTIGEN) COMPLEX","10.1107/S0907444906035712 ",2.2,35.8,"2dva_oligo2","DGalpb1-3DGalpNAca1-OME","GAL(2_F_)-MGC(1_F_)",33.4373,"","",""
"2DVA","CRYSTAL STRUCTURE OF PEANUT LECTIN GAL-BETA-1,3-GALNAC-ALPHA-O-ME (METHYL-T-ANTIGEN) COMPLEX","10.1107/S0907444906035712 ",2.2,35.8,"2dva_oligo1","DGalpb1-3DGalpNAca1-OME","GAL(2_E_)-MGC(1_E_)",34.9264,"","",""
"2DVA","CRYSTAL STRUCTURE OF PEANUT LECTIN GAL-BETA-1,3-GALNAC-ALPHA-O-ME (METHYL-T-ANTIGEN) COMPLEX","10.1107/S0907444906035712 ",2.2,35.8,"2dva_oligo4","DGalpb1-3DGalpNAca1-OME","GAL(2_H_)-MGC(1_H_)",41.3645,"","",""
"2DVA","CRYSTAL STRUCTURE OF PEANUT LECTIN GAL-BETA-1,3-GALNAC-ALPHA-O-ME (METHYL-T-ANTIGEN) COMPLEX","10.1107/S0907444906035712 ",2.2,35.8,"2dva_oligo3","DGalpb1-3DGalpNAca1-OME","GAL(2_G_)-MGC(1_G_)",49.2132,"","",""
"2DVD","CRYSTAL STRUCTURE OF PEANUT LECTIN GAL-ALPHA-1,3-GAL COMPLEX","10.1107/S0907444906035712 ",2.25,32.3,"2dvd_oligo2","DGalpa1-3DGalpb1-ROH","GAL(2_F_)-GAL(1_F_)",38.9345,"","",""
"2DVD","CRYSTAL STRUCTURE OF PEANUT LECTIN GAL-ALPHA-1,3-GAL COMPLEX","10.1107/S0907444906035712 ",2.25,32.3,"2dvd_oligo1","DGalpa1-3DGalpb1-ROH","GAL(2_E_)-GAL(1_E_)",40.81,"","",""
"2DVD","CRYSTAL STRUCTURE OF PEANUT LECTIN GAL-ALPHA-1,3-GAL COMPLEX","10.1107/S0907444906035712 ",2.25,32.3,"2dvd_oligo4","DGalpa1-3DGalpb1-ROH","GAL(2_H_)-GAL(1_H_)",50.8627,"","",""
"2DVD","CRYSTAL STRUCTURE OF PEANUT LECTIN GAL-ALPHA-1,3-GAL COMPLEX","10.1107/S0907444906035712 ",2.25,32.3,"2dvd_oligo3","DGalpa1-3DGalpa1-ROH","GAL(2_G_)-GAL(1_G_)",49.9968,"","",""
"2DW0","CRYSTAL STRUCTURE OF VAP2 FROM CROTALUS ATROX VENOM (FORM 2-1 CRYSTAL)","10.1016/J.FEBSLET.2007.04.057 ",2.15,0,"2dw0_oligo2","DManpa1-3[DGlcpNAcb1-4][DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-[NAG(5_D_)]-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(371_B_)",53.4933,"","",""
"2DW0","CRYSTAL STRUCTURE OF VAP2 FROM CROTALUS ATROX VENOM (FORM 2-1 CRYSTAL)","10.1016/J.FEBSLET.2007.04.057 ",2.15,0,"2dw0_oligo1","DManpa1-3[DGlcpNAcb1-4]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(371_A_)",56.134,"","",""
"2DW2","CRYSTAL STRUCTURE OF VAP2 FROM CROTALUS ATROX VENOM (FORM 2-5 CRYSTAL)","10.1016/J.FEBSLET.2007.04.057 ",2.7,0,"2dw2_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6][DGlcpNAcb1-4]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(8_C_)]-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(371_A_)",35.7425,"","",""
"2DW2","CRYSTAL STRUCTURE OF VAP2 FROM CROTALUS ATROX VENOM (FORM 2-5 CRYSTAL)","10.1016/J.FEBSLET.2007.04.057 ",2.7,0,"2dw2_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6][DGlcpNAcb1-4]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(8_D_)]-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(371_B_)",38.0175,"","",""
"2E33","STRUCTURAL BASIS FOR SELECTION OF GLYCOSYLATED SUBSTRATE BY SCFFBS1 UBIQUITIN LIGASE","10.1073/PNAS.0610312104 ",2.7,54.8,"2e33_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)",70.4113,"","",""
"2E51","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN IN COMPLEX WITH A BLOOD GROUP DISACCHARIDE","10.1002/PROT.21428 ",2.5,39.8,"2e51_oligo4","DGalpNAca1-3DGalpa1-ROH","A2G(2_H_)-GLA(1_H_)",52.7009,"","",""
"2E51","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN IN COMPLEX WITH A BLOOD GROUP DISACCHARIDE","10.1002/PROT.21428 ",2.5,39.8,"2e51_oligo1","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_F_)-[FUC(2_F_)]-NAG(1_F_)-ASN(219_A_)",59.7264,"","",""
"2E51","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN IN COMPLEX WITH A BLOOD GROUP DISACCHARIDE","10.1002/PROT.21428 ",2.5,39.8,"2e51_oligo8","DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","BMA(3_L_)-NAG(2_L_)-[FUC(4_L_)]-NAG(1_L_)-ASN(219_C_)",65.7339,"","",""
"2E51","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN IN COMPLEX WITH A BLOOD GROUP DISACCHARIDE","10.1002/PROT.21428 ",2.5,39.8,"2e51_oligo11","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_O_)-[FUC(2_O_)]-NAG(1_O_)-ASN(219_D_)",76.5115,"","",""
"2E51","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN IN COMPLEX WITH A BLOOD GROUP DISACCHARIDE","10.1002/PROT.21428 ",2.5,39.8,"2e51_oligo2","DGalpNAca1-3DGalpa1-ROH","A2G(2_E_)-GLA(1_E_)",67.9241,"","",""
"2E51","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN IN COMPLEX WITH A BLOOD GROUP DISACCHARIDE","10.1002/PROT.21428 ",2.5,39.8,"2e51_oligo5","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_I_)-[FUC(2_I_)]-NAG(1_I_)-ASN(219_B_)",66.0724,"","",""
"2E51","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN IN COMPLEX WITH A BLOOD GROUP DISACCHARIDE","10.1002/PROT.21428 ",2.5,39.8,"2e51_oligo7","DGalpNAca1-3DGalpa1-ROH","A2G(2_K_)-GLA(1_K_)",67.31,"","",""
"2E51","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN IN COMPLEX WITH A BLOOD GROUP DISACCHARIDE","10.1002/PROT.21428 ",2.5,39.8,"2e51_oligo10","DGalpNAca1-3DGalpa1-ROH","A2G(2_N_)-GLA(1_N_)",65.4377,"","",""
"2E51","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN IN COMPLEX WITH A BLOOD GROUP DISACCHARIDE","10.1002/PROT.21428 ",2.5,39.8,"2e51_oligo12","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_P_)-[FUC(2_P_)]-NAG(1_P_)-ASN(44_D_)",78.2497,"","",""
"2E51","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN IN COMPLEX WITH A BLOOD GROUP DISACCHARIDE","10.1002/PROT.21428 ",2.5,39.8,"2e51_oligo6","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_J_)-[FUC(2_J_)]-NAG(1_J_)-ASN(44_B_)",64.8536,"","",""
"2E51","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN IN COMPLEX WITH A BLOOD GROUP DISACCHARIDE","10.1002/PROT.21428 ",2.5,39.8,"2e51_oligo3","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_G_)-[FUC(2_G_)]-NAG(1_G_)-ASN(44_A_)",77.9676,"","",""
"2E53","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN IN COMPLEX WITH B BLOOD GROUP DISACCHARIDE","10.1002/PROT.21428 ",2.4,39.2,"2e53_oligo6","DGalpa1-3DGalpa1-ROH","GLA(2_J_)-GLA(1_J_)",59.9841,"","",""
"2E53","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN IN COMPLEX WITH B BLOOD GROUP DISACCHARIDE","10.1002/PROT.21428 ",2.4,39.2,"2e53_oligo2","DGalpa1-3DGalpa1-ROH","GLA(2_G_)-GLA(1_G_)",61.9391,"","",""
"2E53","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN IN COMPLEX WITH B BLOOD GROUP DISACCHARIDE","10.1002/PROT.21428 ",2.4,39.2,"2e53_oligo4","DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","BMA(3_E_)-NAG(2_E_)-[FUC(4_E_)]-NAG(1_E_)-ASN(219_A_)",71.8784,"","",""
"2E53","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN IN COMPLEX WITH B BLOOD GROUP DISACCHARIDE","10.1002/PROT.21428 ",2.4,39.2,"2e53_oligo5","LFucpa1-3[DGlcpNAca1-4]DGlcpNAcb1-ASN","NDG(3_I_)-[FUC(2_I_)]-NAG(1_I_)-ASN(44_B_)",76.3094,"","",""
"2E53","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN IN COMPLEX WITH B BLOOD GROUP DISACCHARIDE","10.1002/PROT.21428 ",2.4,39.2,"2e53_oligo3","DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","BMA(3_H_)-NAG(2_H_)-[FUC(4_H_)]-NAG(1_H_)-ASN(219_B_)",72.3334,"","",""
"2E53","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN IN COMPLEX WITH B BLOOD GROUP DISACCHARIDE","10.1002/PROT.21428 ",2.4,39.2,"2e53_oligo12","DGalpa1-3DGalpa1-ROH","GLA(2_P_)-GLA(1_P_)",63.2659,"","",""
"2E53","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN IN COMPLEX WITH B BLOOD GROUP DISACCHARIDE","10.1002/PROT.21428 ",2.4,39.2,"2e53_oligo7","DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","BMA(3_K_)-NAG(2_K_)-[FUC(4_K_)]-NAG(1_K_)-ASN(219_C_)",69.8707,"","",""
"2E53","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN IN COMPLEX WITH B BLOOD GROUP DISACCHARIDE","10.1002/PROT.21428 ",2.4,39.2,"2e53_oligo1","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_F_)-[FUC(2_F_)]-NAG(1_F_)-ASN(44_A_)",77.0167,"","",""
"2E53","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN IN COMPLEX WITH B BLOOD GROUP DISACCHARIDE","10.1002/PROT.21428 ",2.4,39.2,"2e53_oligo10","DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","BMA(3_N_)-NAG(2_N_)-[FUC(4_N_)]-NAG(1_N_)-ASN(219_D_)",72.7377,"","",""
"2E53","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN IN COMPLEX WITH B BLOOD GROUP DISACCHARIDE","10.1002/PROT.21428 ",2.4,39.2,"2e53_oligo11","DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","BMA(3_O_)-NAG(2_O_)-[FUC(4_O_)]-NAG(1_O_)-ASN(44_D_)",80.6646,"","",""
"2E53","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN IN COMPLEX WITH B BLOOD GROUP DISACCHARIDE","10.1002/PROT.21428 ",2.4,39.2,"2e53_oligo9","DGalpa1-3DGalpa1-ROH","GLA(2_M_)-GLA(1_M_)",63.0691,"","",""
"2E6V","CRYSTAL STRUCTURE OF VIP36 EXOPLASMIC/LUMENAL DOMAIN, CA2+/MAN3GLCNAC- BOUND FORM","10.1074/JBC.M703064200 ",2.5,27.96,"2e6v_oligo2","DManpa1-2DManpa1-3DManpb1-ROH","MAN(3_G_)-MAN(2_G_)-BMA(1_G_)",40.0364,"","",""
"2E6V","CRYSTAL STRUCTURE OF VIP36 EXOPLASMIC/LUMENAL DOMAIN, CA2+/MAN3GLCNAC- BOUND FORM","10.1074/JBC.M703064200 ",2.5,27.96,"2e6v_oligo1","DManpa1-2DManpa1-3DManpb1-ROH","MAN(3_F_)-MAN(2_F_)-BMA(1_F_)",35.1839,"","",""
"2E7Q","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN IN COMPLEX WITH B BLOOD GROUP TRISACCHARIDE","10.1002/PROT.21428 ",2.75,32.7,"2e7q_oligo3","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_H_)-[FUC(2_H_)]-NAG(1_H_)-ASN(219_B_)",64.157,"","",""
"2E7Q","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN IN COMPLEX WITH B BLOOD GROUP TRISACCHARIDE","10.1002/PROT.21428 ",2.75,32.7,"2e7q_oligo4","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_E_)-[FUC(2_E_)]-NAG(1_E_)-ASN(219_A_)",52.2282,"","",""
"2E7Q","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN IN COMPLEX WITH B BLOOD GROUP TRISACCHARIDE","10.1002/PROT.21428 ",2.75,32.7,"2e7q_oligo9","DGalpa1-3DGalpb1-4DGlcpa1-ROH","GLA(3_M_)-GAL(2_M_)-GLC(1_M_)",64.3073,"","",""
"2E7Q","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN IN COMPLEX WITH B BLOOD GROUP TRISACCHARIDE","10.1002/PROT.21428 ",2.75,32.7,"2e7q_oligo5","LFucpa1-3[DGlcpNAca1-4]DGlcpNAcb1-ASN","NDG(3_I_)-[FUC(2_I_)]-NAG(1_I_)-ASN(44_B_)",57.8646,"","",""
"2E7Q","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN IN COMPLEX WITH B BLOOD GROUP TRISACCHARIDE","10.1002/PROT.21428 ",2.75,32.7,"2e7q_oligo11","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_O_)-[FUC(2_O_)]-NAG(1_O_)-ASN(44_D_)",63.9112,"","",""
"2E7Q","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN IN COMPLEX WITH B BLOOD GROUP TRISACCHARIDE","10.1002/PROT.21428 ",2.75,32.7,"2e7q_oligo6","DGalpa1-3DGalpb1-4DGlcpa1-ROH","GLA(3_J_)-GAL(2_J_)-GLC(1_J_)",55.6712,"","",""
"2E7Q","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN IN COMPLEX WITH B BLOOD GROUP TRISACCHARIDE","10.1002/PROT.21428 ",2.75,32.7,"2e7q_oligo2","DGalpa1-3DGalpb1-4DGlcpa1-ROH","GLA(3_G_)-GAL(2_G_)-GLC(1_G_)",59.2364,"","",""
"2E7Q","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN IN COMPLEX WITH B BLOOD GROUP TRISACCHARIDE","10.1002/PROT.21428 ",2.75,32.7,"2e7q_oligo1","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_F_)-[FUC(2_F_)]-NAG(1_F_)-ASN(44_A_)",63.3152,"","",""
"2E7Q","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN IN COMPLEX WITH B BLOOD GROUP TRISACCHARIDE","10.1002/PROT.21428 ",2.75,32.7,"2e7q_oligo7","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_K_)-[FUC(2_K_)]-NAG(1_K_)-ASN(219_C_)",51.3118,"","",""
"2E7Q","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN IN COMPLEX WITH B BLOOD GROUP TRISACCHARIDE","10.1002/PROT.21428 ",2.75,32.7,"2e7q_oligo10","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_N_)-[FUC(2_N_)]-NAG(1_N_)-ASN(219_D_)",78.0967,"","",""
"2E7T","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN IN COMPLEX WITH A BLOOD GROUP TRISACCHARIDE","10.1002/PROT.21428 ",2.65,38.7,"2e7t_oligo1","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_H_)-[FUC(2_H_)]-NAG(1_H_)-ASN(219_B_)",64.1845,"","",""
"2E7T","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN IN COMPLEX WITH A BLOOD GROUP TRISACCHARIDE","10.1002/PROT.21428 ",2.65,38.7,"2e7t_oligo2","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_E_)-[FUC(2_E_)]-NAG(1_E_)-ASN(219_A_)",56.1779,"","",""
"2E7T","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN IN COMPLEX WITH A BLOOD GROUP TRISACCHARIDE","10.1002/PROT.21428 ",2.65,38.7,"2e7t_oligo9","DGalpNAca1-3DGalpb1-4DGlcpa1-ROH","A2G(3_M_)-GAL(2_M_)-GLC(1_M_)",58.5133,"","",""
"2E7T","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN IN COMPLEX WITH A BLOOD GROUP TRISACCHARIDE","10.1002/PROT.21428 ",2.65,38.7,"2e7t_oligo10","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_N_)-[FUC(2_N_)]-NAG(1_N_)-ASN(219_D_)",74.0006,"","",""
"2E7T","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN IN COMPLEX WITH A BLOOD GROUP TRISACCHARIDE","10.1002/PROT.21428 ",2.65,38.7,"2e7t_oligo5","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_I_)-[FUC(2_I_)]-NAG(1_I_)-ASN(44_B_)",67.2155,"","",""
"2E7T","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN IN COMPLEX WITH A BLOOD GROUP TRISACCHARIDE","10.1002/PROT.21428 ",2.65,38.7,"2e7t_oligo7","DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","BMA(3_K_)-NAG(2_K_)-[FUC(4_K_)]-NAG(1_K_)-ASN(219_C_)",61.3634,"","",""
"2E7T","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN IN COMPLEX WITH A BLOOD GROUP TRISACCHARIDE","10.1002/PROT.21428 ",2.65,38.7,"2e7t_oligo6","DGalpNAca1-3DGalpb1-4DGlcpa1-ROH","A2G(3_J_)-GAL(2_J_)-GLC(1_J_)",53.4094,"","",""
"2E7T","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN IN COMPLEX WITH A BLOOD GROUP TRISACCHARIDE","10.1002/PROT.21428 ",2.65,38.7,"2e7t_oligo3","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_F_)-[FUC(2_F_)]-NAG(1_F_)-ASN(44_A_)",80.9285,"","",""
"2E7T","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN IN COMPLEX WITH A BLOOD GROUP TRISACCHARIDE","10.1002/PROT.21428 ",2.65,38.7,"2e7t_oligo4","DGalpNAca1-3DGalpb1-4DGlcpa1-ROH","A2G(3_G_)-GAL(2_G_)-GLC(1_G_)",58.5133,"","",""
"2E7T","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN IN COMPLEX WITH A BLOOD GROUP TRISACCHARIDE","10.1002/PROT.21428 ",2.65,38.7,"2e7t_oligo11","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_O_)-[FUC(2_O_)]-NAG(1_O_)-ASN(44_D_)",78.7303,"","",""
"2EAL","CRYSTAL STRUCTURE OF HUMAN GALECTIN-9 N-TERMINAL CRD IN COMPLEX WITH FORSSMAN PENTASACCHARIDE","10.1016/J.JMB.2007.09.060 ",1.85,21.84,"2eal_oligo1","DGalpNAca1-3DGalpNAcb1-3DGalpb1-ROH","A2G(3_D_)-NGA(2_D_)-GAL(1_D_)",27.6142,"","",""
"2EAL","CRYSTAL STRUCTURE OF HUMAN GALECTIN-9 N-TERMINAL CRD IN COMPLEX WITH FORSSMAN PENTASACCHARIDE","10.1016/J.JMB.2007.09.060 ",1.85,21.84,"2eal_oligo2","DGalpNAca1-3DGalpNAcb1-3DGalpb1-ROH","A2G(3_C_)-NGA(2_C_)-GAL(1_C_)",21.6033,"","",""
"2EF6","CANAVALIA GLADIATA LECTIN COMPLEXED WITH MAN1-3MAN-OME","10.1016/J.JSB.2007.07.012 ",2.1,22.92,"2ef6_oligo4","DManpa1-3DAltpb1-OME","MAN(2_H_)-MMA(1_H_)",34.9532,"","",""
"2EF6","CANAVALIA GLADIATA LECTIN COMPLEXED WITH MAN1-3MAN-OME","10.1016/J.JSB.2007.07.012 ",2.1,22.92,"2ef6_oligo3","DManpa1-3DAltpb1-OME","MAN(2_G_)-MMA(1_G_)",33.8209,"","",""
"2EF6","CANAVALIA GLADIATA LECTIN COMPLEXED WITH MAN1-3MAN-OME","10.1016/J.JSB.2007.07.012 ",2.1,22.92,"2ef6_oligo1","DManpa1-3DManpb1-OME","MAN(2_E_)-MMA(1_E_)",25.6236,"","",""
"2EF6","CANAVALIA GLADIATA LECTIN COMPLEXED WITH MAN1-3MAN-OME","10.1016/J.JSB.2007.07.012 ",2.1,22.92,"2ef6_oligo2","DManpa1-3DManpb1-OME","MAN(2_F_)-MMA(1_F_)",24.5095,"","",""
"2EIJ","BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE","10.1073/PNAS.0610031104 ",1.9,0,"2eij_oligo1","DManpa1-3DAllpb6-C10O1","DMU(1526_Z_)-DMU(1526_Z_)",59.4759,"","",""
"2ESC","CRYSTAL STRUCTURE OF A 40 KDA PROTECTIVE SIGNALLING PROTEIN FROM BOVINE (SPC-40) AT 2.1 A RESOLUTION","10.1107/S0907444906020427 ",2.1,36.15,"2esc_oligo1","DManpb1-4DManpb1-6[DManpa1-3]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-MAN(4_B_)-[MAN(6_B_)]-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(39_A_)",46.9409,"","",""
"2F9N","CRYSTAL STRUCTURE OF THE RECOMBINANT HUMAN ALPHA I TRYPTASE MUTANT K192Q/D216G IN COMPLEX WITH LEUPEPTIN","10.1016/J.JMB.2005.12.037 ",1.6,23.6,"2f9n_oligo1","LFucpa1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_I_)-[NAG(3_I_)]-[FUC(2_I_)]-NAG(1_I_)-ASN(113_B_)",54.2086,"","",""
"2F9N","CRYSTAL STRUCTURE OF THE RECOMBINANT HUMAN ALPHA I TRYPTASE MUTANT K192Q/D216G IN COMPLEX WITH LEUPEPTIN","10.1016/J.JMB.2005.12.037 ",1.6,23.6,"2f9n_oligo2","LFucpa1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_J_)-[NAG(3_J_)]-[FUC(2_J_)]-NAG(1_J_)-ASN(113_D_)",55.2086,"","",""
"2F9O","CRYSTAL STRUCTURE OF THE RECOMBINANT HUMAN ALPHA I TRYPTASE MUTANT D216G","10.1016/J.JMB.2005.12.037 ",2.1,25.4,"2f9o_oligo2","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_F_)-[FUC(2_F_)]-NAG(1_F_)-ASN(113_D_)",42.3521,"","",""
"2F9O","CRYSTAL STRUCTURE OF THE RECOMBINANT HUMAN ALPHA I TRYPTASE MUTANT D216G","10.1016/J.JMB.2005.12.037 ",2.1,25.4,"2f9o_oligo1","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_E_)-[FUC(2_E_)]-NAG(1_E_)-ASN(113_B_)",49.0515,"","",""
"2F9P","CRYSTAL STRUCTURE OF THE RECOMBINANT HUMAN ALPHA I TRYPTASE MUTANT D216G IN COMPLEX WITH LEUPEPTIN","10.1016/J.JMB.2005.12.037 ",2.3,27.1,"2f9p_oligo1","LFucpa1-3DGlcpNAcb1-ASN","FUC(2_I_)-NAG(1_I_)-ASN(113_D_)",46.9655,"","",""
"2FAW","CRYSTAL STRUCTURE OF PAPAYA GLUTAMINYL CYCLASE","10.1016/J.JMB.2005.12.029 ",1.7,23.37,"2faw_oligo2","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcx1-","NAG(3_D_)-[FUC(2_D_)]-NAG(1_D_)",37.6968,"","",""
"2FAW","CRYSTAL STRUCTURE OF PAPAYA GLUTAMINYL CYCLASE","10.1016/J.JMB.2005.12.029 ",1.7,23.37,"2faw_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","BMA(3_C_)-NAG(2_C_)-[FUC(4_C_)]-NAG(1_C_)",27.5565,"","",""
"2FCP","FERRIC HYDROXAMATE UPTAKE RECEPTOR (FHUA) FROM E.COLI","10.1126/SCIENCE.282.5397.2215 ",2.5,67.4,"2fcp_oligo1","DGalpa1-3[DGalpa1-6]DGlcpa1-3GPH1-3GMH1-5[DKdopa2-4]DKdopa2-6DGlcp[2<R1>,3<R2>,4P]a1-6DGlcp[2<R3>,3<R4>]a1-O4P1","GLA(8_B_)-[GLA(7_B_)]-GLC(6_B_)-GPH(5_B_)-GMH(4_B_)-[KDO(9_B_)]-KDO(3_B_)-GP4(2_B_)-GP1(1_B_)",78.6068,"","",""
"2FV0","UGL_D88N/DGLCA-GLC-RHA-GLC","10.1016/J.BBRC.2006.03.141 ",1.91,23.8,"2fv0_oligo1","GAD1-4DGlcpb1-4LRhapa1-3DGlcpb1-ROH","GAD(4_C_)-BGC(3_C_)-RAM(2_C_)-BGC(1_C_)",54.3565,"","",""
"2G7C","CLOSTRIDIUM DIFFICILE TOXIN A FRAGMENT BOUND TO AGAL(1,3)BGAL(1,4) BGLCNAC","10.1038/NSMB1084 ",2,0,"2g7c_oligo4","DGalpa1-3DGalpb1-4DGlcpNAcb1-ROH","GLA(3_F_)-GAL(2_F_)-NAG(1_F_)",22.0261,"","",""
"2G7C","CLOSTRIDIUM DIFFICILE TOXIN A FRAGMENT BOUND TO AGAL(1,3)BGAL(1,4) BGLCNAC","10.1038/NSMB1084 ",2,0,"2g7c_oligo1","DGalpa1-3DGalpb1-4DGlcpNAcb1-ROH","GLA(3_D_)-GAL(2_D_)-NAG(1_D_)",12.7503,"","",""
"2G7C","CLOSTRIDIUM DIFFICILE TOXIN A FRAGMENT BOUND TO AGAL(1,3)BGAL(1,4) BGLCNAC","10.1038/NSMB1084 ",2,0,"2g7c_oligo2","DGalpa1-3DGalpb1-4DGlcpNAcb1-ROH","GLA(3_C_)-GAL(2_C_)-NAG(1_C_)",31.6927,"","",""
"2G7C","CLOSTRIDIUM DIFFICILE TOXIN A FRAGMENT BOUND TO AGAL(1,3)BGAL(1,4) BGLCNAC","10.1038/NSMB1084 ",2,0,"2g7c_oligo3","DGalpa1-3DGalpb1-4DGlcpNAcb1-ROH","GLA(3_E_)-GAL(2_E_)-NAG(1_E_)",34.4885,"","",""
"2G87","CRYSTALLOGRAPHIC MODEL OF BATHORHODOPSIN","10.1002/ANIE.200600595 ",2.6,0,"2g87_oligo8","DManpb1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(15_B_)",82.6095,"","",""
"2G8Z","CRYSTAL STRUCTURE OF THE TERNARY COMPLEX OF SIGNALLING PROTEIN FROM SHEEP (SPS-40) WITH TRIMER AND DESIGNED PEPTIDE AT 2.5A RESOLUTION","",2.5,36.2,"2g8z_oligo2","DManpa1-3[DManpb1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(39_A_)",49.6591,"","",""
"2GAM","X-RAY CRYSTAL STRUCTURE OF MURINE LEUKOCYTE-TYPE CORE 2 B1,6-N- ACETYLGLUCOSAMINYLTRANSFERASE (C2GNT-L) IN COMPLEX WITH GALB1,3GALNAC","10.1074/JBC.M603534200 ",2.7,45.5,"2gam_oligo4","DGalpb1-3DGalpNAcb1-ROH","GAL(2_H_)-NGA(1_H_)",29.0959,"","",""
"2GAM","X-RAY CRYSTAL STRUCTURE OF MURINE LEUKOCYTE-TYPE CORE 2 B1,6-N- ACETYLGLUCOSAMINYLTRANSFERASE (C2GNT-L) IN COMPLEX WITH GALB1,3GALNAC","10.1074/JBC.M603534200 ",2.7,45.5,"2gam_oligo1","DGalpb1-3DGalpNAcb1-ROH","GAL(2_E_)-NGA(1_E_)",27.8045,"","",""
"2GAM","X-RAY CRYSTAL STRUCTURE OF MURINE LEUKOCYTE-TYPE CORE 2 B1,6-N- ACETYLGLUCOSAMINYLTRANSFERASE (C2GNT-L) IN COMPLEX WITH GALB1,3GALNAC","10.1074/JBC.M603534200 ",2.7,45.5,"2gam_oligo3","DGalpb1-3DGalpNAcb1-ROH","GAL(2_G_)-NGA(1_G_)",43.1845,"","",""
"2GAM","X-RAY CRYSTAL STRUCTURE OF MURINE LEUKOCYTE-TYPE CORE 2 B1,6-N- ACETYLGLUCOSAMINYLTRANSFERASE (C2GNT-L) IN COMPLEX WITH GALB1,3GALNAC","10.1074/JBC.M603534200 ",2.7,45.5,"2gam_oligo2","DGalpb1-3DGalpNAcb1-ROH","GAL(2_F_)-NGA(1_F_)",30.6868,"","",""
"2GAZ","MYCOBACTERIAL LIPOGLYCAN PRESENTATION BY CD1D","",2.61,46.13,"2gaz_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(165_A_)",63.2202,"","",""
"2GD4","CRYSTAL STRUCTURE OF THE ANTITHROMBIN-S195A FACTOR XA-PENTASACCHARIDE COMPLEX","10.1038/SJ.EMBOJ.7601089 ",3.3,36.57,"2gd4_oligo1","DManp[2H]a1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(155_I_)",127.786,"","",""
"2GH0","GROWTH FACTOR/RECEPTOR COMPLEX","10.1016/J.STR.2006.05.010 ",1.92,37.51,"2gh0_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(309_A_)",37.2489,"","",""
"2GJ7","CRYSTAL STRUCTURE OF A GE-GI/FC COMPLEX","10.1371/JOURNAL.PBIO.0040148 ",5,0,"2gj7_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",42.0837,"","",""
"2GJ7","CRYSTAL STRUCTURE OF A GE-GI/FC COMPLEX","10.1371/JOURNAL.PBIO.0040148 ",5,0,"2gj7_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",40.4411,"","",""
"2GN7","METAL-FREE (APO) P. ANGOLENSIS SEED LECTIN IN COMPLEX WITH MAN- ALPHA(1-3)MAN-ALPHA(1-6)MAN","10.1016/J.JMB.2006.06.006 ",2.9,0,"2gn7_oligo3","DManpb1-3[DManpa1-6]DManpa1-ROH","MAN(3_C_)-[BMA(2_C_)]-MAN(1_C_)",68.93,"","",""
"2GND","ONE HOUR EDTA TREATMENT, P. ANGOLENSIS LECTIN","10.1016/J.JMB.2006.06.006 ",2.25,0,"2gnd_oligo1","DManpa1-3DManpa1-OME","MAN(2_C_)-MMA(1_C_)",45.6486,"","",""
"2GSM","CATALYTIC CORE (SUBUNITS I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES","10.1073/PNAS.0606149103 ",2,36.5,"2gsm_oligo7","DGlcpa1-3DGlcpb6-ROH","DMU(6011_D_)-DMU(6011_D_)",55.45,"","",""
"2GSM","CATALYTIC CORE (SUBUNITS I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES","10.1073/PNAS.0606149103 ",2,36.5,"2gsm_oligo10","DGlcpa1-3DGlcpb6-C10O1","DMU(5002_A_)-DMU(5002_A_)",52.2536,"","",""
"2GSM","CATALYTIC CORE (SUBUNITS I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES","10.1073/PNAS.0606149103 ",2,36.5,"2gsm_oligo6","DGlcpa1-3DGlcpb6-C10O1","DMU(6004_C_)-DMU(6004_C_)",77.4118,"","",""
"2GSM","CATALYTIC CORE (SUBUNITS I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES","10.1073/PNAS.0606149103 ",2,36.5,"2gsm_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(6005_C_)-DMU(6005_C_)",54.4586,"","",""
"2GSM","CATALYTIC CORE (SUBUNITS I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES","10.1073/PNAS.0606149103 ",2,36.5,"2gsm_oligo8","DGlcpa1-3DGlcpb6-C10O1","DMU(5001_A_)-DMU(5001_A_)",31.0564,"","",""
"2GSM","CATALYTIC CORE (SUBUNITS I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES","10.1073/PNAS.0606149103 ",2,36.5,"2gsm_oligo3","DGlcpa1-3DGlcpb6-ROH","DMU(6003_D_)-DMU(6003_D_)",53.1986,"","",""
"2GSM","CATALYTIC CORE (SUBUNITS I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES","10.1073/PNAS.0606149103 ",2,36.5,"2gsm_oligo5","DGlcpa1-3DGlcpb6-C10O1","DMU(5004_A_)-DMU(5004_A_)",75.3077,"","",""
"2GSM","CATALYTIC CORE (SUBUNITS I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES","10.1073/PNAS.0606149103 ",2,36.5,"2gsm_oligo9","DGlcpa1-3DGlcpb6-C10O1","DMU(5003_B_)-DMU(5003_B_)",55.7732,"","",""
"2GSM","CATALYTIC CORE (SUBUNITS I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES","10.1073/PNAS.0606149103 ",2,36.5,"2gsm_oligo4","DGlcpa1-3DGlcpb6-ROH","DMU(6002_C_)-DMU(6002_C_)",57.1073,"","",""
"2GSM","CATALYTIC CORE (SUBUNITS I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES","10.1073/PNAS.0606149103 ",2,36.5,"2gsm_oligo1","DGlcpa1-3DGlcpb6-ROH","DMU(5011_B_)-DMU(5011_B_)",55.0391,"","",""
"2GYS","2.7 A STRUCTURE OF THE EXTRACELLULAR DOMAINS OF THE HUMAN BETA COMMON RECEPTOR INVOLVED IN IL-3, IL-5, AND GM-CSF SIGNALLING","10.1107/S1744309106016812 ",2.7,51.11,"2gys_oligo4","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAca1-ASN","NAG(3_F_)-[FUC(2_F_)]-NAG(1_F_)-ASN(167_B_)",95.5539,"","",""
"2GYS","2.7 A STRUCTURE OF THE EXTRACELLULAR DOMAINS OF THE HUMAN BETA COMMON RECEPTOR INVOLVED IN IL-3, IL-5, AND GM-CSF SIGNALLING","10.1107/S1744309106016812 ",2.7,51.11,"2gys_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","BMA(3_C_)-NAG(2_C_)-[FUC(4_C_)]-NAG(1_C_)-ASN(34_A_)",76.7395,"","",""
"2GYS","2.7 A STRUCTURE OF THE EXTRACELLULAR DOMAINS OF THE HUMAN BETA COMMON RECEPTOR INVOLVED IN IL-3, IL-5, AND GM-CSF SIGNALLING","10.1107/S1744309106016812 ",2.7,51.11,"2gys_oligo3","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_D_)-[FUC(2_D_)]-NAG(1_D_)-ASN(167_A_)",95.6618,"","",""
"2GYS","2.7 A STRUCTURE OF THE EXTRACELLULAR DOMAINS OF THE HUMAN BETA COMMON RECEPTOR INVOLVED IN IL-3, IL-5, AND GM-CSF SIGNALLING","10.1107/S1744309106016812 ",2.7,51.11,"2gys_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","BMA(3_E_)-NAG(2_E_)-[FUC(4_E_)]-NAG(1_E_)-ASN(34_B_)",92.5357,"","",""
"2H5U","CRYSTAL STRUCTURE OF LACCASE FROM CERRENA MAXIMA AT 1.9A RESOLUTION","10.1107/S1744309106036578 ",1.9,12.23,"2h5u_oligo4","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_B_)-MAN(4_B_)-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)",15.2067,"","",""
"2H6O","EPSTEIN BARR VIRUS MAJOR ENVELOPE GLYCOPROTEIN","10.1038/NSMB1161 ",3.5,0,"2h6o_oligo46","DManpa1-3DGlcpNAca1-2DManpx1-","MAN(6_f_)-NAG(5_f_)-MAN(4_f_)",129.08,"","",""
"2H6O","EPSTEIN BARR VIRUS MAJOR ENVELOPE GLYCOPROTEIN","10.1038/NSMB1161 ",3.5,0,"2h6o_oligo18","DManpa1-2DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(9_Q_)-[MAN(5_Q_)-MAN(4_Q_)]-MAN(3_Q_)-NAG(2_Q_)-NAG(1_Q_)",129.08,"","",""
"2H6O","EPSTEIN BARR VIRUS MAJOR ENVELOPE GLYCOPROTEIN","10.1038/NSMB1161 ",3.5,0,"2h6o_oligo19","DGalpb1-3DGalpb1-3DManpx1-","GAL(8_Q_)-GAL(7_Q_)-MAN(6_Q_)",129.08,"","",""
"2H6O","EPSTEIN BARR VIRUS MAJOR ENVELOPE GLYCOPROTEIN","10.1038/NSMB1161 ",3.5,0,"2h6o_oligo6","DManpb1-3DManpx1-","MAN(5_F_)-MAN(4_F_)",129.08,"","",""
"2H6O","EPSTEIN BARR VIRUS MAJOR ENVELOPE GLYCOPROTEIN","10.1038/NSMB1161 ",3.5,0,"2h6o_oligo45","DManpa1-6DManpb1-3DGlcpNAca1-4DGlcpNAcx1-","MAN(7_f_)-MAN(3_f_)-NDG(2_f_)-NAG(1_f_)",129.08,"","",""
"2H6O","EPSTEIN BARR VIRUS MAJOR ENVELOPE GLYCOPROTEIN","10.1038/NSMB1161 ",3.5,0,"2h6o_oligo32","DManpa1-3DManpx1-","MAN(4_Z_)-MAN(3_Z_)",129.08,"","",""
"2H6O","EPSTEIN BARR VIRUS MAJOR ENVELOPE GLYCOPROTEIN","10.1038/NSMB1161 ",3.5,0,"2h6o_oligo34","DManpa1-3DGlcpNAcb1-4DGlcpNAcx1-","MAN(3_b_)-NAG(2_b_)-NAG(1_b_)",129.08,"","",""
"2H6O","EPSTEIN BARR VIRUS MAJOR ENVELOPE GLYCOPROTEIN","10.1038/NSMB1161 ",3.5,0,"2h6o_oligo27","DGalpb1-3DManpb1-2DManpx1-","GAL(7_U_)-MAN(6_U_)-MAN(5_U_)",129.08,"","",""
"2H6O","EPSTEIN BARR VIRUS MAJOR ENVELOPE GLYCOPROTEIN","10.1038/NSMB1161 ",3.5,0,"2h6o_oligo13","DManpb1-3[DManpb1-6]DManpx1-","MAN(7_J_)-[MAN(5_J_)]-MAN(4_J_)",129.08,"","",""
"2H6O","EPSTEIN BARR VIRUS MAJOR ENVELOPE GLYCOPROTEIN","10.1038/NSMB1161 ",3.5,0,"2h6o_oligo12","DManpb1-2DManpa1-3DManpx1-","MAN(9_J_)-MAN(8_J_)-BMA(3_J_)",129.08,"","",""
"2H6O","EPSTEIN BARR VIRUS MAJOR ENVELOPE GLYCOPROTEIN","10.1038/NSMB1161 ",3.5,0,"2h6o_oligo29","DManpb1-3[DManpb1-6]DManpx1-","MAN(11_U_)-[MAN(10_U_)]-BMA(9_U_)",129.08,"","",""
"2H6O","EPSTEIN BARR VIRUS MAJOR ENVELOPE GLYCOPROTEIN","10.1038/NSMB1161 ",3.5,0,"2h6o_oligo17","DGalpb1-3DGalpb1-3DManpa1-2DManpx1-","GAL(8_M_)-GAL(7_M_)-MAN(6_M_)-MAN(5_M_)",129.08,"","",""
"2H6O","EPSTEIN BARR VIRUS MAJOR ENVELOPE GLYCOPROTEIN","10.1038/NSMB1161 ",3.5,0,"2h6o_oligo15","DManpb1-3DManpb1-6DManpb1-3DGlcpNAcb1-3DGlcpNAcb1-ASN","MAN(10_M_)-MAN(9_M_)-MAN(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(195_A_)",128.191,"","",""
"2H6O","EPSTEIN BARR VIRUS MAJOR ENVELOPE GLYCOPROTEIN","10.1038/NSMB1161 ",3.5,0,"2h6o_oligo3","DManpb1-3DManpx1-","BMA(5_B_)-MAN(4_B_)",129.08,"","",""
"2H6O","EPSTEIN BARR VIRUS MAJOR ENVELOPE GLYCOPROTEIN","10.1038/NSMB1161 ",3.5,0,"2h6o_oligo30","DManpa1-3DGlcpNAcb1-3DGlcpNAcx1-","MAN(3_Y_)-NAG(2_Y_)-NAG(1_Y_)",129.08,"","",""
"2H6O","EPSTEIN BARR VIRUS MAJOR ENVELOPE GLYCOPROTEIN","10.1038/NSMB1161 ",3.5,0,"2h6o_oligo2","DManpb1-2DManpa1-3DManpx1-","MAN(5_D_)-MAN(4_D_)-MAN(3_D_)",129.08,"","",""
"2HCZ","CRYSTAL STRUCTURE OF EXPB1 (ZEA M 1), A BETA-EXPANSIN AND GROUP-1 POLLEN ALLERGEN FROM MAIZE","10.1073/PNAS.0605979103 ",2.75,56.87,"2hcz_oligo1","DXylpa1-2[DManpa1-3][DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_A_)-[MAN(5_A_)]-[XYS(4_A_)]-MAN(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(10_X_)",62.9004,"","",""
"2HI2","CRYSTAL STRUCTURE OF NATIVE NEISSERIA GONORRHOEAE TYPE IV PILIN AT 2.3 ANGSTROMS RESOLUTION","10.1016/J.MOLCEL.2006.07.004 ",2.3,42.8,"2hi2_oligo1","DGalpa1-3DGlcpNAc[4NAc]b1-SER","GLA(2_B_)-DT6(1_B_)-SER(63_A_)",43.7527,"","",""
"2HIL","STRUCTURE OF THE NEISSERIA GONORRHOEAE TYPE IV PILUS FILAMENT FROM X- RAY CRYSTALLOGRAPHY AND ELECTRON CRYOMICROSCOPY","10.1016/J.MOLCEL.2006.07.004 ",12.5,0,"2hil_oligo4","DGalpa1-3DGlcpNAc[4NAc]b1-SER","GLA(2_X_)-DT6(1_X_)-SER(63_F_)",42.0523,"","",""
"2HIL","STRUCTURE OF THE NEISSERIA GONORRHOEAE TYPE IV PILUS FILAMENT FROM X- RAY CRYSTALLOGRAPHY AND ELECTRON CRYOMICROSCOPY","10.1016/J.MOLCEL.2006.07.004 ",12.5,0,"2hil_oligo11","DGalpa1-3DGlcpNAc[4NAc]b1-SER","GLA(2_c_)-DT6(1_c_)-SER(63_K_)",42.0523,"","",""
"2HIL","STRUCTURE OF THE NEISSERIA GONORRHOEAE TYPE IV PILUS FILAMENT FROM X- RAY CRYSTALLOGRAPHY AND ELECTRON CRYOMICROSCOPY","10.1016/J.MOLCEL.2006.07.004 ",12.5,0,"2hil_oligo2","DGalpa1-3DGlcpNAc[4NAc]b1-SER","GLA(2_V_)-DT6(1_V_)-SER(63_D_)",42.0523,"","",""
"2HIL","STRUCTURE OF THE NEISSERIA GONORRHOEAE TYPE IV PILUS FILAMENT FROM X- RAY CRYSTALLOGRAPHY AND ELECTRON CRYOMICROSCOPY","10.1016/J.MOLCEL.2006.07.004 ",12.5,0,"2hil_oligo14","DGalpa1-3DGlcpNAc[4NAc]b1-SER","GLA(2_f_)-DT6(1_f_)-SER(63_N_)",42.0523,"","",""
"2HIL","STRUCTURE OF THE NEISSERIA GONORRHOEAE TYPE IV PILUS FILAMENT FROM X- RAY CRYSTALLOGRAPHY AND ELECTRON CRYOMICROSCOPY","10.1016/J.MOLCEL.2006.07.004 ",12.5,0,"2hil_oligo7","DGalpa1-3DGlcpNAc[4NAc]b1-SER","GLA(2_U_)-DT6(1_U_)-SER(63_C_)",42.0523,"","",""
"2HIL","STRUCTURE OF THE NEISSERIA GONORRHOEAE TYPE IV PILUS FILAMENT FROM X- RAY CRYSTALLOGRAPHY AND ELECTRON CRYOMICROSCOPY","10.1016/J.MOLCEL.2006.07.004 ",12.5,0,"2hil_oligo9","DGalpa1-3DGlcpNAc[4NAc]b1-SER","GLA(2_a_)-DT6(1_a_)-SER(63_I_)",42.0523,"","",""
"2HIL","STRUCTURE OF THE NEISSERIA GONORRHOEAE TYPE IV PILUS FILAMENT FROM X- RAY CRYSTALLOGRAPHY AND ELECTRON CRYOMICROSCOPY","10.1016/J.MOLCEL.2006.07.004 ",12.5,0,"2hil_oligo10","DGalpa1-3DGlcpNAc[4NAc]b1-SER","GLA(2_b_)-DT6(1_b_)-SER(63_J_)",42.0523,"","",""
"2HIL","STRUCTURE OF THE NEISSERIA GONORRHOEAE TYPE IV PILUS FILAMENT FROM X- RAY CRYSTALLOGRAPHY AND ELECTRON CRYOMICROSCOPY","10.1016/J.MOLCEL.2006.07.004 ",12.5,0,"2hil_oligo1","DGalpa1-3DGlcpNAc[4NAc]b1-SER","GLA(2_W_)-DT6(1_W_)-SER(63_E_)",42.0523,"","",""
"2HIL","STRUCTURE OF THE NEISSERIA GONORRHOEAE TYPE IV PILUS FILAMENT FROM X- RAY CRYSTALLOGRAPHY AND ELECTRON CRYOMICROSCOPY","10.1016/J.MOLCEL.2006.07.004 ",12.5,0,"2hil_oligo16","DGalpa1-3DGlcpNAc[4NAc]b1-SER","GLA(2_h_)-DT6(1_h_)-SER(63_P_)",42.0523,"","",""
"2HIL","STRUCTURE OF THE NEISSERIA GONORRHOEAE TYPE IV PILUS FILAMENT FROM X- RAY CRYSTALLOGRAPHY AND ELECTRON CRYOMICROSCOPY","10.1016/J.MOLCEL.2006.07.004 ",12.5,0,"2hil_oligo3","DGalpa1-3DGlcpNAc[4NAc]b1-SER","GLA(2_S_)-DT6(1_S_)-SER(63_A_)",42.0523,"","",""
"2HIL","STRUCTURE OF THE NEISSERIA GONORRHOEAE TYPE IV PILUS FILAMENT FROM X- RAY CRYSTALLOGRAPHY AND ELECTRON CRYOMICROSCOPY","10.1016/J.MOLCEL.2006.07.004 ",12.5,0,"2hil_oligo17","DGalpa1-3DGlcpNAc[4NAc]b1-SER","GLA(2_i_)-DT6(1_i_)-SER(63_Q_)",42.0523,"","",""
"2HIL","STRUCTURE OF THE NEISSERIA GONORRHOEAE TYPE IV PILUS FILAMENT FROM X- RAY CRYSTALLOGRAPHY AND ELECTRON CRYOMICROSCOPY","10.1016/J.MOLCEL.2006.07.004 ",12.5,0,"2hil_oligo8","DGalpa1-3DGlcpNAc[4NAc]b1-SER","GLA(2_Z_)-DT6(1_Z_)-SER(63_H_)",42.0523,"","",""
"2HIL","STRUCTURE OF THE NEISSERIA GONORRHOEAE TYPE IV PILUS FILAMENT FROM X- RAY CRYSTALLOGRAPHY AND ELECTRON CRYOMICROSCOPY","10.1016/J.MOLCEL.2006.07.004 ",12.5,0,"2hil_oligo6","DGalpa1-3DGlcpNAc[4NAc]b1-SER","GLA(2_T_)-DT6(1_T_)-SER(63_B_)",42.0523,"","",""
"2HIL","STRUCTURE OF THE NEISSERIA GONORRHOEAE TYPE IV PILUS FILAMENT FROM X- RAY CRYSTALLOGRAPHY AND ELECTRON CRYOMICROSCOPY","10.1016/J.MOLCEL.2006.07.004 ",12.5,0,"2hil_oligo12","DGalpa1-3DGlcpNAc[4NAc]b1-SER","GLA(2_d_)-DT6(1_d_)-SER(63_L_)",42.0523,"","",""
"2HIL","STRUCTURE OF THE NEISSERIA GONORRHOEAE TYPE IV PILUS FILAMENT FROM X- RAY CRYSTALLOGRAPHY AND ELECTRON CRYOMICROSCOPY","10.1016/J.MOLCEL.2006.07.004 ",12.5,0,"2hil_oligo18","DGalpa1-3DGlcpNAc[4NAc]b1-SER","GLA(2_j_)-DT6(1_j_)-SER(63_R_)",42.0523,"","",""
"2HIL","STRUCTURE OF THE NEISSERIA GONORRHOEAE TYPE IV PILUS FILAMENT FROM X- RAY CRYSTALLOGRAPHY AND ELECTRON CRYOMICROSCOPY","10.1016/J.MOLCEL.2006.07.004 ",12.5,0,"2hil_oligo15","DGalpa1-3DGlcpNAc[4NAc]b1-SER","GLA(2_g_)-DT6(1_g_)-SER(63_O_)",42.0523,"","",""
"2HIL","STRUCTURE OF THE NEISSERIA GONORRHOEAE TYPE IV PILUS FILAMENT FROM X- RAY CRYSTALLOGRAPHY AND ELECTRON CRYOMICROSCOPY","10.1016/J.MOLCEL.2006.07.004 ",12.5,0,"2hil_oligo5","DGalpa1-3DGlcpNAc[4NAc]b1-SER","GLA(2_Y_)-DT6(1_Y_)-SER(63_G_)",42.0523,"","",""
"2HIL","STRUCTURE OF THE NEISSERIA GONORRHOEAE TYPE IV PILUS FILAMENT FROM X- RAY CRYSTALLOGRAPHY AND ELECTRON CRYOMICROSCOPY","10.1016/J.MOLCEL.2006.07.004 ",12.5,0,"2hil_oligo13","DGalpa1-3DGlcpNAc[4NAc]b1-SER","GLA(2_e_)-DT6(1_e_)-SER(63_M_)",42.0523,"","",""
"2HL6","STRUCTURE OF HOMOLOGOUSLY EXPRESSED FERRULATE ESTERASE OF ASPERGILLUS NIGER IN COMPLEX WITH CAPS","10.1016/J.FEBSLET.2006.09.039 ",1.55,13.15,"2hl6_oligo1","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(79_A_)",28.0729,"","",""
"2HOX","ALLIINASE FROM ALLIUM SATIVUM (GARLIC)","10.1016/J.JMB.2006.11.041 ",1.4,17.13,"2hox_oligo7","DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","BMA(3_G_)-NAG(2_G_)-[FUC(4_G_)]-NAG(1_G_)-ASN(146_C_)",41.7666,"","",""
"2HOX","ALLIINASE FROM ALLIUM SATIVUM (GARLIC)","10.1016/J.JMB.2006.11.041 ",1.4,17.13,"2hox_oligo5","DXylpb1-2[DManpb1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","BMA(5_E_)-[XYP(4_E_)]-BMA(3_E_)-NAG(2_E_)-[FUC(6_E_)]-NAG(1_E_)-ASN(146_A_)",29.5699,"","",""
"2HOX","ALLIINASE FROM ALLIUM SATIVUM (GARLIC)","10.1016/J.JMB.2006.11.041 ",1.4,17.13,"2hox_oligo6","LFucpa1-3DGlcpNAcb1-ASN","FUC(2_F_)-NAG(1_F_)-ASN(146_B_)",45.6405,"","",""
"2HOX","ALLIINASE FROM ALLIUM SATIVUM (GARLIC)","10.1016/J.JMB.2006.11.041 ",1.4,17.13,"2hox_oligo8","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_H_)-[FUC(2_H_)]-NAG(1_H_)-ASN(146_D_)",39.5852,"","",""
"2HPY","CRYSTALLOGRAPHIC MODEL OF LUMIRHODOPSIN","10.1073/PNAS.0601765103 ",2.8,0,"2hpy_oligo8","DManpb1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(15_B_)",95.5693,"","",""
"2HR7","INSULIN RECEPTOR (DOMAINS 1-3)","10.1073/PNAS.0605395103 ",2.32,47.35,"2hr7_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_J_)-[MAN(5_J_)]-MAN(4_J_)-[MAN(7_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(215_B_)",83.081,"","",""
"2HR7","INSULIN RECEPTOR (DOMAINS 1-3)","10.1073/PNAS.0605395103 ",2.32,47.35,"2hr7_oligo4","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-[MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(111_A_)",74.367,"","",""
"2HR7","INSULIN RECEPTOR (DOMAINS 1-3)","10.1073/PNAS.0605395103 ",2.32,47.35,"2hr7_oligo8","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_I_)-[MAN(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(111_B_)",85.6456,"","",""
"2I37","CRYSTAL STRUCTURE OF A PHOTOACTIVATED RHODOPSIN","10.1073/PNAS.0608022103 ",4.15,177.2,"2i37_oligo2","DGlcpNAcb1-2DManpb1-3DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_F_)-BMA(4_F_)-MAN(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(15_B_)",183,"","",""
"2I37","CRYSTAL STRUCTURE OF A PHOTOACTIVATED RHODOPSIN","10.1073/PNAS.0608022103 ",4.15,177.2,"2i37_oligo5","DManpa1-3DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_H_)-MAN(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(15_C_)",183,"","",""
"2I6S","COMPLEMENT COMPONENT C2A","10.1016/J.STR.2006.08.008 ",2.7,32.12,"2i6s_oligo2","DManpb1-3DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(4_B_)-[BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(313_A_)",61.7755,"","",""
"2I74","CRYSTAL STRUCTURE OF MOUSE PEPTIDE N-GLYCANASE C-TERMINAL DOMAIN IN COMPLEX WITH MANNOPENTAOSE","10.1073/PNAS.0602954103 ",1.75,13.84,"2i74_oligo2","DManpa1-3[DManpa1-6]DManpa1-6DManpa1-ROH","MAN(4_C_)-[MAN(3_C_)]-MAN(2_C_)-MAN(1_C_)",36.7716,"","",""
"2I74","CRYSTAL STRUCTURE OF MOUSE PEPTIDE N-GLYCANASE C-TERMINAL DOMAIN IN COMPLEX WITH MANNOPENTAOSE","10.1073/PNAS.0602954103 ",1.75,13.84,"2i74_oligo1","DManpa1-3[DManpa1-6]DManpa1-6DManpa1-ROH","MAN(4_D_)-[MAN(3_D_)]-MAN(2_D_)-MAN(1_D_)",21.7252,"","",""
"2IH8","A LOW-DOSE CRYSTAL STRUCTURE OF A RECOMBINANT MELANOCARPUS ALBOMYCES LACCASE","10.1016/J.BBRC.2006.09.144 ",2,19.26,"2ih8_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(88_A_)",45.4684,"","",""
"2IHO","CRYSTAL STRUCTURE OF MOA, A LECTIN FROM THE MUSHROOM MARASMIUS OREADES IN COMPLEX WITH THE TRISACCHARIDE GAL(1,3)GAL(1,4)GLCNAC","10.1016/J.JMB.2007.03.016 ",2.41,35.82,"2iho_oligo1","DGalpa1-3DGalpb1-4DGlcpNAcb1-ROH","GAL(3_C_)-GAL(2_C_)-NAG(1_C_)",37.0145,"","",""
"2IHO","CRYSTAL STRUCTURE OF MOA, A LECTIN FROM THE MUSHROOM MARASMIUS OREADES IN COMPLEX WITH THE TRISACCHARIDE GAL(1,3)GAL(1,4)GLCNAC","10.1016/J.JMB.2007.03.016 ",2.41,35.82,"2iho_oligo2","DGalpa1-3DGalpb1-4DGlcpNAcb1-ROH","GAL(3_B_)-GAL(2_B_)-NAG(1_B_)",43.1164,"","",""
"2IQ7","CRYSTAL STRUCTURE OF THE POLYGALACTURONASE FROM COLLETOTRICHUM LUPINI AND ITS IMPLICATIONS FOR THE INTERACTION WITH POLYGALACTURONASE- INHIBITING PROTEINS","10.1002/PROT.21610 ",1.94,14.12,"2iq7_oligo1","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-MAN(4_H_)-[MAN(6_H_)]-MAN(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(209_A_)",20.1782,"","",""
"2IT5","CRYSTAL STRUCTURE OF DCSIGN-CRD WITH MAN6","10.1074/JBC.M609689200 ",2.4,27.3,"2it5_oligo1","DManpa1-2DManpa1-3DManpa1-ROH","MAN(3_B_)-MAN(2_B_)-MAN(1_B_)",40.8221,"","",""
"2IUL","HUMAN TACE G13 MUTANT","10.1021/BI061146Z ",2.01,19.59,"2iul_oligo1","DManpb1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_B_)-[BMA(4_B_)-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(109_A_)",51.8058,"","",""
"2IWG","COMPLEX BETWEEN THE PRYSPRY DOMAIN OF TRIM21 AND IGG FC","10.1073/PNAS.0609174104 ",2.35,71.56,"2iwg_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_F_)-NAG(5_F_)-MAN(4_F_)-[MAN(7_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(297_D_)",88.8714,"","",""
"2IWG","COMPLEX BETWEEN THE PRYSPRY DOMAIN OF TRIM21 AND IGG FC","10.1073/PNAS.0609174104 ",2.35,71.56,"2iwg_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(297_A_)",88.8714,"","",""
"2J1T","STRUCTURE OF A STREPTOCOCCUS PNEUMONIAE FUCOSE BINDING MODULE IN COMPLEX WITH THE LEWIS Y ANTIGEN","10.1074/JBC.M607620200 ",1.6,20.6,"2j1t_oligo1","LFucpa1-2DGalpb1-4[LFucpa1-3]DGlcpNAcb1-ROH","FUC(3_C_)-GAL(2_C_)-[FUC(4_C_)]-NAG(1_C_)",28.42,"","",""
"2J1U","STRUCTURE OF A STREPTOCOCCUS PNEUMONIAE FUCOSE BINDING MODULE IN COMPLEX WITH THE BLOOD GROUP A-TETRASACCHARIDE","10.1074/JBC.M607620200 ",1.8,25.16,"2j1u_oligo1","LFucpa1-2[DGalpNAca1-3]DGalpb1-4DGlcpb1-ROH","A2G(4_C_)-[FUC(3_C_)]-GAL(2_C_)-BGC(1_C_)",31.3095,"","",""
"2J25","PARTIALLY DEGLYCOSYLATED GLUCOCERAMIDASE","10.1107/S0907444906038303 ",2.9,33.66,"2j25_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(19_B_)",75.5041,"","",""
"2J6E","CRYSTAL STRUCTURE OF AN AUTOIMMUNE COMPLEX BETWEEN A HUMAN IGM RHEUMATOID FACTOR AND IGG1 FC REVEALS A NOVEL FC EPITOPE AND EVIDENCE FOR AFFINITY MATURATION","10.1016/J.JMB.2007.02.085 ",3,0,"2j6e_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpb1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-BMA(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",116.527,"","",""
"2J6E","CRYSTAL STRUCTURE OF AN AUTOIMMUNE COMPLEX BETWEEN A HUMAN IGM RHEUMATOID FACTOR AND IGG1 FC REVEALS A NOVEL FC EPITOPE AND EVIDENCE FOR AFFINITY MATURATION","10.1016/J.JMB.2007.02.085 ",3,0,"2j6e_oligo1","DGalpb1-4DGlcpNAca1-2DManpa1-6[DGlcpNAcb1-2DManpb1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-BMA(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",54.9007,"","",""
"2JBJ","MEMBRANE-BOUND GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH 2-PMPA (2-PHOSPHONOMETHYL-PENTANEDIOIC ACID)","10.1107/S090744490700902X ",2.19,43.06,"2jbj_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(638_A_)",67.0909,"","",""
"2JBK","MEMBRANE-BOUND GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH QUISQUALIC ACID (QUISQUALATE, ALPHA-AMINO-3,5-DIOXO-1,2,4- OXADIAZOLIDINE-2-PROPANOIC ACID)","10.1107/S090744490700902X ",2.99,34.08,"2jbk_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(638_A_)",35,"","",""
"2JXR","STRUCTURE OF YEAST PROTEINASE A","10.1006/JMBI.1996.0880 ",2.4,37.01,"2jxr_oligo2","LIdopa1-2DManpb1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-BMA(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(67_A_)",53.9747,"","",""
"2K33","SOLUTION STRUCTURE OF AN N-GLYCOSYLATED PROTEIN USING IN VITRO GLYCOSYLATION","10.1021/JA808682V ","2.95026e-39","1.15243e-41","2k33_oligo1","DGalpNAca1-4DGalpNAca1-4[DGlcpb1-3]DGalpNAca1-4DGalpNAca1-4DGalpNAca1-3B6D1-ASN","A2G(6_B_)-A2G(5_B_)-[BGC(7_B_)]-A2G(4_B_)-A2G(3_B_)-A2G(2_B_)-B6D(1_B_)-ASN(42_A_)",37.6087,"","",""
"2K46","XENOPUS LAEVIS MALECTIN COMPLEXED WITH NIGEROSE (GLCALPHA1-3GLC)","10.1091/MBC.E08-04-0354 ","2.95026e-39",0,"2k46_oligo1","DGlcpa1-3DGlcpa1-ROH","GLC(2_B_)-GLC(1_B_)",1.575,"","",""
"2KMB","COMPLEX OF 3'-NEUAC-LEWIS-X WITH A SELECTIN-LIKE MUTANT OF MANNOSE- BINDING PROTEIN A","10.1021/BI962564E ",2,22.2,"2kmb_oligo2","DNeup5Aca2-3DGalpb1-4[LFucpa1-3]DGlcpNAcb1-OME","SIA(3_A_)-GAL(2_A_)-[FUC(4_A_)]-MAG(1_A_)",39.59,"","",""
"2KMB","COMPLEX OF 3'-NEUAC-LEWIS-X WITH A SELECTIN-LIKE MUTANT OF MANNOSE- BINDING PROTEIN A","10.1021/BI962564E ",2,22.2,"2kmb_oligo3","DNeup5Aca2-3DGalpb1-4[LFucpa1-3]DGlcpNAcb1-OME","SIA(3_B_)-GAL(2_B_)-[FUC(4_B_)]-MAG(1_B_)",41.4209,"","",""
"2KMB","COMPLEX OF 3'-NEUAC-LEWIS-X WITH A SELECTIN-LIKE MUTANT OF MANNOSE- BINDING PROTEIN A","10.1021/BI962564E ",2,22.2,"2kmb_oligo1","DNeup5Aca2-3DGalpb1-4[LFucpa1-3]DGlcpNAcb1-ROH","SIA(3_C_)-GAL(2_C_)-[FUC(4_C_)]-NAG(1_C_)",39.8501,"","",""
"2LIQ","SOLUTION STRUCTURE OF CCL2 IN COMPLEX WITH GLYCAN","10.1371/JOURNAL.PPAT.1002706 ","2.95026e-39",0,"2liq_oligo1","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-OME","NAG(3_B_)-[FUC(2_B_)]-MAG(1_B_)",0,"","",""
"2LL4","HADDOCK STRUCTURE OF TGMIC4-A5/LACTO-N-BIOSE COMPLEX, BASED ON NOE- DERIVED DISTANCE RESTRAINTS","10.1074/JBC.M111.325928 ","2.95026e-39","1.15243e-41","2ll4_oligo1","DGalpb1-3DGlcpNAcb1-ROH","GAL(2_A_)-NAG(1_A_)",2.27273,"","",""
"2MK1","SOLUTION STRUCTURE OF LACTODIFUCOTETRAOSE (LDFT) BETA ANOMER","10.1002/CHEM.201701866 ","2.95026e-39",0,"2mk1_oligo1","LFucpa1-2DGalpb1-4[LFucpa1-3]DGlcpb1-ROH","FUC(3_A_)-GAL(2_A_)-[FUC(4_A_)]-BGC(1_A_)",0,"","",""
"2MSB","STRUCTURE OF A C-TYPE MANNOSE-BINDING PROTEIN COMPLEXED WITH AN OLIGOSACCHARIDE","10.1038/360127A0 ",1.7,0,"2msb_oligo1","DManpa1-2DManpa1-3[DManpa1-3DManp[6Me]a1-6]DManpb1-OME","MAN(6_C_)-MAN(5_C_)-[MAN(4_C_)-MAN(3_C_)]-BMA(2_C_)-NAG(1_C_)",35.0245,"","",""
"2N7B","SOLUTION STRUCTURE OF THE HUMAN SIGLEC-8 LECTIN DOMAIN IN COMPLEX WITH 6'SULFO SIALYL LEWISX","10.1073/PNAS.1602214113 ","2.95026e-39",0,"2n7b_oligo1","DNeup5Aca2-3DGalp[6S]b1-4[LFucpa1-3]DGlcpNAcb1-C3N1O1","SIA(3_B_)-G6S(2_B_)-[FUC(4_B_)]-NAG(1_B_)-0D8(201_A_)",0,"","",""
"2O2L","CRYSTAL STRUCTURE OF HUMAN HEAT-LABILE ENTEROTOXIN IN COMPLEX WITH A BLOOD GROUP A ANTIGEN ANALOG","10.1016/J.JMB.2007.05.064 ",2.53,13.37,"2o2l_oligo4","LFucpa1-2[DGalpNAca1-3]DGalpb1-4[LFucpa1-3]DGlcpb1-ROH","A2G(4_R_)-[FUC(3_R_)]-GAL(2_R_)-[FUC(5_R_)]-BGC(1_R_)",20.5158,"","",""
"2O2L","CRYSTAL STRUCTURE OF HUMAN HEAT-LABILE ENTEROTOXIN IN COMPLEX WITH A BLOOD GROUP A ANTIGEN ANALOG","10.1016/J.JMB.2007.05.064 ",2.53,13.37,"2o2l_oligo7","LFucpa1-2[DGalpNAca1-3]DGalpb1-4[LFucpa1-3]DGlcpb1-ROH","A2G(4_O_)-[FUC(3_O_)]-GAL(2_O_)-[FUC(5_O_)]-BGC(1_O_)",27.9145,"","",""
"2O2L","CRYSTAL STRUCTURE OF HUMAN HEAT-LABILE ENTEROTOXIN IN COMPLEX WITH A BLOOD GROUP A ANTIGEN ANALOG","10.1016/J.JMB.2007.05.064 ",2.53,13.37,"2o2l_oligo2","LFucpa1-2[DGalpNAca1-3]DGalpb1-4[LFucpa1-3]DGlcpb1-ROH","A2G(4_P_)-[FUC(3_P_)]-GAL(2_P_)-[FUC(5_P_)]-BGC(1_P_)",22.2585,"","",""
"2O2L","CRYSTAL STRUCTURE OF HUMAN HEAT-LABILE ENTEROTOXIN IN COMPLEX WITH A BLOOD GROUP A ANTIGEN ANALOG","10.1016/J.JMB.2007.05.064 ",2.53,13.37,"2o2l_oligo9","LFucpa1-2[DGalpNAca1-3]DGalpb1-4[LFucpa1-3]DGlcpb1-ROH","A2G(4_N_)-[FUC(3_N_)]-GAL(2_N_)-[FUC(5_N_)]-BGC(1_N_)",29.3875,"","",""
"2O2L","CRYSTAL STRUCTURE OF HUMAN HEAT-LABILE ENTEROTOXIN IN COMPLEX WITH A BLOOD GROUP A ANTIGEN ANALOG","10.1016/J.JMB.2007.05.064 ",2.53,13.37,"2o2l_oligo5","LFucpa1-2[DGalpNAca1-3]DGalpb1-4[LFucpa1-3]DGlcpb1-ROH","A2G(4_S_)-[FUC(3_S_)]-GAL(2_S_)-[FUC(5_S_)]-BGC(1_S_)",21.1551,"","",""
"2O2L","CRYSTAL STRUCTURE OF HUMAN HEAT-LABILE ENTEROTOXIN IN COMPLEX WITH A BLOOD GROUP A ANTIGEN ANALOG","10.1016/J.JMB.2007.05.064 ",2.53,13.37,"2o2l_oligo8","LFucpa1-2[DGalpNAca1-3]DGalpb1-4[LFucpa1-3]DGlcpb1-ROH","A2G(4_A_)-[FUC(3_A_)]-GAL(2_A_)-[FUC(5_A_)]-BGC(1_A_)",30.0636,"","",""
"2O2L","CRYSTAL STRUCTURE OF HUMAN HEAT-LABILE ENTEROTOXIN IN COMPLEX WITH A BLOOD GROUP A ANTIGEN ANALOG","10.1016/J.JMB.2007.05.064 ",2.53,13.37,"2o2l_oligo1","LFucpa1-2[DGalpNAca1-3]DGalpb1-4[LFucpa1-3]DGlcpb1-ROH","A2G(4_B_)-[FUC(3_B_)]-GAL(2_B_)-[FUC(5_B_)]-BGC(1_B_)",30.4273,"","",""
"2O2L","CRYSTAL STRUCTURE OF HUMAN HEAT-LABILE ENTEROTOXIN IN COMPLEX WITH A BLOOD GROUP A ANTIGEN ANALOG","10.1016/J.JMB.2007.05.064 ",2.53,13.37,"2o2l_oligo10","LFucpa1-2[DGalpNAca1-3]DGalpb1-4[LFucpa1-3]DGlcpb1-ROH","A2G(4_C_)-[FUC(3_C_)]-GAL(2_C_)-[FUC(5_C_)]-BGC(1_C_)",20.2489,"","",""
"2O2L","CRYSTAL STRUCTURE OF HUMAN HEAT-LABILE ENTEROTOXIN IN COMPLEX WITH A BLOOD GROUP A ANTIGEN ANALOG","10.1016/J.JMB.2007.05.064 ",2.53,13.37,"2o2l_oligo6","LFucpa1-2[DGalpNAca1-3]DGalpb1-4[LFucpa1-3]DGlcpb1-ROH","A2G(4_T_)-[FUC(3_T_)]-GAL(2_T_)-[FUC(5_T_)]-BGC(1_T_)",29.2685,"","",""
"2O2L","CRYSTAL STRUCTURE OF HUMAN HEAT-LABILE ENTEROTOXIN IN COMPLEX WITH A BLOOD GROUP A ANTIGEN ANALOG","10.1016/J.JMB.2007.05.064 ",2.53,13.37,"2o2l_oligo3","LFucpa1-2[DGalpNAca1-3]DGalpb1-4[LFucpa1-3]DGlcpb1-ROH","A2G(4_Q_)-[FUC(3_Q_)]-GAL(2_Q_)-[FUC(5_Q_)]-BGC(1_Q_)",32.5107,"","",""
"2O9O","CRYSTAL STRUCTURE OF THE BUFFALO SECRETORY SIGNALLING GLYCOPROTEIN AT 2.8 A RESOLUTION","10.1107/S1744309107010445 ",2.8,34.29,"2o9o_oligo1","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(39_A_)",54.8635,"","",""
"2OBS","CRYSTAL STRUCTURES OF P DOMAIN OF NOROVIRUS VA387 IN COMPLEX WITH BLOOD GROUP TRISACCHARIDES TYPE A","10.1128/JVI.00219-07 ",2,0,"2obs_oligo1","LFucpa1-2[DGalpNAca1-3]DGulpb1-ROH","A2G(3_B_)-[FUC(2_B_)]-GL0(1_B_)",83.7648,"","",""
"2OBT","CRYSTAL STRUCTURES OF P DOMAIN OF NOROVIRUS VA387 IN COMPLEX WITH BLOOD GROUP TRISACCHARIDES TYPE B","10.1128/JVI.00219-07 ",2,0,"2obt_oligo1","LFucpa1-2[DGalpa1-3]DGalpb1-ROH","GLA(3_B_)-[FUC(2_B_)]-GAL(1_B_)",43.9555,"","",""
"2OK5","HUMAN COMPLEMENT FACTOR B","10.1038/NSMB1210 ",2.3,33.68,"2ok5_oligo3","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[MAN(5_B_)]-MAN(4_B_)-[MAN(7_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(97_A_)",43.3179,"","",""
"2OOT","A HIGH RESOLUTION STRUCTURE OF LIGAND-FREE HUMAN GLUTAMATE CARBOXYPEPTIDASE II","10.1107/S174430910700379X ",1.64,29.29,"2oot_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(638_A_)",36.9141,"","",""
"2OR4","A HIGH RESOLUTION CRYSTAL STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II IN COMPLEX WITH QUISQUALIC ACID","10.1021/JM070133W ",1.62,27.22,"2or4_oligo5","DManpb1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(638_A_)",35.8845,"","",""
"2OX9","MOUSE SCAVENGER RECEPTOR C-TYPE LECTIN CARBOHYDRATE-RECOGNITION DOMAIN.","10.1074/JBC.M701624200 ",1.95,24.5,"2ox9_oligo4","LFucpa1-3[DGalpb1-4]DGlcpNAcb1-ROH","GAL(3_H_)-[FUC(2_H_)]-NAG(1_H_)",38.5579,"","",""
"2OX9","MOUSE SCAVENGER RECEPTOR C-TYPE LECTIN CARBOHYDRATE-RECOGNITION DOMAIN.","10.1074/JBC.M701624200 ",1.95,24.5,"2ox9_oligo3","LFucpa1-3[DGalpb1-4]DGlcpNAcb1-ROH","GAL(3_F_)-[FUC(2_F_)]-NAG(1_F_)",28.553,"","",""
"2OX9","MOUSE SCAVENGER RECEPTOR C-TYPE LECTIN CARBOHYDRATE-RECOGNITION DOMAIN.","10.1074/JBC.M701624200 ",1.95,24.5,"2ox9_oligo1","LFucpa1-3[DGalpb1-4]DGlcpNAcb1-ROH","GAL(3_E_)-[FUC(2_E_)]-NAG(1_E_)",29.6355,"","",""
"2OX9","MOUSE SCAVENGER RECEPTOR C-TYPE LECTIN CARBOHYDRATE-RECOGNITION DOMAIN.","10.1074/JBC.M701624200 ",1.95,24.5,"2ox9_oligo2","LFucpa1-3[DGalpb1-4]DGlcpNAcb1-ROH","GAL(3_G_)-[FUC(2_G_)]-NAG(1_G_)",51.2612,"","",""
"2OXE","STRUCTURE OF THE HUMAN PANCREATIC LIPASE-RELATED PROTEIN 2","10.1021/BI8005576 ",2.8,39.62,"2oxe_oligo2","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAca1-ASN","MAN(5_D_)-[MAN(4_D_)]-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(353_B_)",103.257,"","",""
"2OXE","STRUCTURE OF THE HUMAN PANCREATIC LIPASE-RELATED PROTEIN 2","10.1021/BI8005576 ",2.8,39.62,"2oxe_oligo1","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-MAN(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(353_A_)",96.6098,"","",""
"2P1S","CRYSTAL STRUCTURE OF THE C-TERMINAL LOBE OF BOVINE LACTOFERRIN COMPLEXED WITH O-ALPHA-D-GLUCOPYRANOSYL-(1 3)-ALPHA-D- FRUCTOFURANOSYL- (2 1)- ALPHA-D-GLUCOPYRANOSIDE AT 1.93 A RESOLUTION","",1.93,33.33,"2p1s_oligo3","DGlcpa1-3DFrufa1-2DGalpa","GLC(1_D_)-Z9N(2_D_)-GLA(3_D_)",52.576,"","",""
"2P37","CRYSTAL STRUCTURE OF A LECTIN FROM CANAVALIA MARITIMA SEEDS (CML) IN COMPLEX WITH MAN1-3MAN-OME","10.1016/J.JSB.2007.07.012 ",2.1,22.47,"2p37_oligo1","DManpa1-3DManpb1-OME","MAN(2_E_)-ZEL(1_E_)",26.8491,"","",""
"2P37","CRYSTAL STRUCTURE OF A LECTIN FROM CANAVALIA MARITIMA SEEDS (CML) IN COMPLEX WITH MAN1-3MAN-OME","10.1016/J.JSB.2007.07.012 ",2.1,22.47,"2p37_oligo4","DManpa1-3DAltpb1-OME","MAN(2_H_)-ZEL(1_H_)",34.3564,"","",""
"2P37","CRYSTAL STRUCTURE OF A LECTIN FROM CANAVALIA MARITIMA SEEDS (CML) IN COMPLEX WITH MAN1-3MAN-OME","10.1016/J.JSB.2007.07.012 ",2.1,22.47,"2p37_oligo2","DManpa1-3DManpb1-OME","MAN(2_F_)-ZEL(1_F_)",26.4114,"","",""
"2P37","CRYSTAL STRUCTURE OF A LECTIN FROM CANAVALIA MARITIMA SEEDS (CML) IN COMPLEX WITH MAN1-3MAN-OME","10.1016/J.JSB.2007.07.012 ",2.1,22.47,"2p37_oligo3","DManpa1-3DManpb1-OME","MAN(2_G_)-ZEL(1_G_)",30.6664,"","",""
"2PE4","STRUCTURE OF HUMAN HYALURONIDASE 1, A HYALURONAN HYDROLYZING ENZYME INVOLVED IN TUMOR GROWTH AND ANGIOGENESIS","10.1021/BI700382G ",2,37.02,"2pe4_oligo2","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-MAN(4_B_)-[MAN(6_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(350_A_)",60.3311,"","",""
"2PED","CRYSTALLOGRAPHIC MODEL OF 9-CIS-RHODOPSIN","10.1529/BIOPHYSJ.107.108225 ",2.95,76.85,"2ped_oligo8","DManpb1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(15_B_)",88.1202,"","",""
"2PGZ","CRYSTAL STRUCTURE OF COCAINE BOUND TO AN ACH-BINDING PROTEIN","10.1016/J.JMB.2007.03.067 ",1.76,29.49,"2pgz_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(74_C_)",43.9247,"","",""
"2PHF","PTEROCARPUS ANGOLENSIS LECTIN COMPLEXED WITH MAN-6","10.1104/PP.107.100867 ",2.1,0,"2phf_oligo4","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-ROH","MAN(4_D_)-[MAN(3_D_)]-MAN(2_D_)-BMA(1_D_)",41.767,"","",""
"2PHF","PTEROCARPUS ANGOLENSIS LECTIN COMPLEXED WITH MAN-6","10.1104/PP.107.100867 ",2.1,0,"2phf_oligo2","DManpa1-3DManpa1-ROH","MAN(2_C_)-MAN(1_C_)",33.6655,"","",""
"2PHR","PTEROCARPUS ANGOLENSIS LECTIN (PAL) IN COMPLEX WITH MAN-7D1","10.1104/PP.107.100867 ",1.9,0,"2phr_oligo4","DRhapa1-3[DManpa1-6]DManpa1-OME","MAN(4_D_)-[MAN(3_D_)]-MAN(2_D_)-BMA(1_D_)",39.2294,"","",""
"2PHR","PTEROCARPUS ANGOLENSIS LECTIN (PAL) IN COMPLEX WITH MAN-7D1","10.1104/PP.107.100867 ",1.9,0,"2phr_oligo3","DManpa1-3DManpa1-ROH","MAN(2_C_)-MAN(1_C_)",26.22,"","",""
"2PHT","PTEROCARPUS ANGOLENSIS LECTIN (P L) IN COMPLEX WITH MAN-7D3","10.1104/PP.107.100867 ",2.1,0,"2pht_oligo3","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6DManpb1-ROH","MAN(4_D_)-MAN(3_D_)-[MAN(5_D_)]-MAN(2_D_)-BMA(1_D_)",39.5825,"","",""
"2PHU","PTEROCARPUS ANGOLENSIS LECTIN IN COMPLEX WITH MAN-8D1D3","10.1104/PP.107.100867 ",2.2,0,"2phu_oligo1","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6DManpb1-ROH","MAN(4_C_)-MAN(3_C_)-[MAN(5_C_)]-MAN(2_C_)-BMA(1_C_)",45.0575,"","",""
"2PHW","PTEROCARPUS ANGOLENSIS LECTIN (PAL) IN COMPLEX WITH MAN-9","10.1104/PP.107.100867 ",1.8,0,"2phw_oligo2","DManpa1-2DManpa1-6[DManp[2Me]a1-3]DManpa1-6DManpb1-ROH","MAN(7_D_)-MAN(6_D_)-MAN(4_D_)]-MAN(3_D_)-BMA(2_D_)-MAN(1_D_)",37.9593,"","",""
"2PHW","PTEROCARPUS ANGOLENSIS LECTIN (PAL) IN COMPLEX WITH MAN-9","10.1104/PP.107.100867 ",1.8,0,"2phw_oligo1","DManpa1-3DManpa1-ROH","MAN(2_C_)-MAN(1_C_)",27.2432,"","",""
"2PHX","PTEROCARPUS ANGOLENSIS LECTIN (PAL) IN COMPLEX WITH MAN-5","10.1104/PP.107.100867 ",1.8,0,"2phx_oligo4","DManpa1-3[DManpa1-6]DManpa1-6DManpa1-ROH","MAN(4_D_)-[MAN(3_D_)]-MAN(2_D_)-MAN(1_D_)",33.8918,"","",""
"2PHX","PTEROCARPUS ANGOLENSIS LECTIN (PAL) IN COMPLEX WITH MAN-5","10.1104/PP.107.100867 ",1.8,0,"2phx_oligo1","DManpa1-3DManpa1-ROH","MAN(2_C_)-MAN(1_C_)",32.3777,"","",""
"2PIL","CRYSTALLOGRAPHIC STRUCTURE OF PHOSPHORYLATED PILIN FROM NEISSERIA: PHOSPHOSERINE SITES MODIFY TYPE IV PILUS SURFACE CHEMISTRY","10.1046/J.1365-2958.1999.01184.X ",2.6,41.8,"2pil_oligo1","DGalpa1-3DGlcpNAcx1-","GLA(2_B_)-NAG(1_B_)",41.2655,"","",""
"2PVV","STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH L-SERINE-O-SULFATE","10.1021/JM070133W ",2.11,29.73,"2pvv_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-MAN(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(638_A_)",42.0661,"","",""
"2PVW","A HIGH RESOLUTION STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH 2-(PHOSPHONOMETHYL)PENTANEDIOIC ACID (2-PMPA)","10.1021/JM070133W ",1.71,34.65,"2pvw_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(638_A_)",42.2595,"","",""
"2Q7N","CRYSTAL STRUCTURE OF LEUKEMIA INHIBITORY FACTOR IN COMPLEX WITH LIF RECEPTOR (DOMAINS 1-5)","10.1073/PNAS.0705577104 ",4,102,"2q7n_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_J_)-MAN(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(378_A_)",97.8757,"","",""
"2Q7N","CRYSTAL STRUCTURE OF LEUKEMIA INHIBITORY FACTOR IN COMPLEX WITH LIF RECEPTOR (DOMAINS 1-5)","10.1073/PNAS.0705577104 ",4,102,"2q7n_oligo14","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_R_)-[MAN(4_R_)-MAN(3_R_)-NAG(2_R_)]-NAG(1_R_)-ASN(397_C_)",76.5838,"","",""
"2Q7Y","STRUCTURE OF THE ENDOGENOUS INKT CELL LIGAND IGB3 BOUND TO MCD1D","10.1016/J.JMB.2008.01.061 ",1.95,32.36,"2q7y_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(165_A_)",52.6042,"","",""
"2Q9O","NEAR-ATOMIC RESOLUTION STRUCTURE OF A MELANOCARPUS ALBOMYCES LACCASE","10.1016/J.JSB.2007.12.003 ",1.3,0,"2q9o_oligo5","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_G_)-MAN(4_G_)-MAN(3_G_)-NAG(2_G_)-NAG(1_G_)",29.9299,"","",""
"2Q9O","NEAR-ATOMIC RESOLUTION STRUCTURE OF A MELANOCARPUS ALBOMYCES LACCASE","10.1016/J.JSB.2007.12.003 ",1.3,0,"2q9o_oligo10","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_L_)-MAN(4_L_)-MAN(3_L_)-NAG(2_L_)-NAG(1_L_)",29.8617,"","",""
"2QC1","CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF THE NICOTINIC ACETYLCHOLINE RECEPTOR 1 SUBUNIT BOUND TO ALPHA-BUNGAROTOXIN AT 1.9 A RESOLUTION","10.1038/NN1942 ",1.94,30.8,"2qc1_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_C_)-MAN(8_C_)-[MAN(10_C_)]-MAN(7_C_)-[MAN(6_C_)-MAN(5_C_)-MAN(4_C_)]-MAN(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(141_B_)",32.8527,"","",""
"2QJR","DIPEPDYL PEPTIDASE IV IN COMPLEX WITH INHIBITOR PZF","10.1016/J.BMCL.2007.07.081 ",2.2,53.31,"2qjr_oligo6","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","LGU(803_A_)-[MAN(4_D_)]-LGU(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(229_A_)",83.0264,"","",""
"2QL1","STRUCTURAL CHARACTERIZATION OF A MUTATED, ADCC-ENHANCED HUMAN FC FRAGMENT","10.1016/J.MOLIMM.2007.10.042 ",2.53,36.25,"2ql1_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(9_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",74.3521,"","",""
"2QQM","CRYSTAL STRUCTURE OF THE A2B1B2 DOMAINS FROM HUMAN NEUROPILIN-1","10.1038/SJ.EMBOJ.7601906 ",2,36.27,"2qqm_oligo1","LFucpa1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_B_)-[NAG(3_B_)]-[FUC(2_B_)]-NAG(1_B_)-ASN(261_A_)",45.5705,"","",""
"2QQU","CRYSTAL STRUCTURE OF A CELL-WALL INVERTASE (D239A) FROM ARABIDOPSIS THALIANA IN COMPLEX WITH SUCROSE","10.1016/J.JMB.2007.12.074 ",2.84,39.24,"2qqu_oligo2","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[MAN(5_B_)-MAN(4_B_)]-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(299_A_)",50.4211,"","",""
"2QQV","CRYSTAL STRUCTURE OF A CELL-WALL INVERTASE (E203A) FROM ARABIDOPSIS THALIANA IN COMPLEX WITH SUCROSE","10.1016/J.JMB.2007.12.074 ",3.01,41.04,"2qqv_oligo1","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-MAN(4_B_)-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(299_A_)",48.5604,"","",""
"2QQW","CRYSTAL STRUCTURE OF A CELL-WALL INVERTASE (D23A) FROM ARABIDOPSIS THALIANA IN COMPLEX WITH SUCROSE","10.1016/J.JMB.2007.12.074 ",2.8,45.5,"2qqw_oligo2","DManpa1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-MAN(4_B_)-[MAN(6_B_)]-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(299_A_)",58.2229,"","",""
"2QT6","CRYSTAL STRUCTURE DETERMINATION OF A BLUE LACCASE FROM LENTINUS TIGRINUS","10.1186/1472-6807-7-60 ",1.5,26.09,"2qt6_oligo1","DManpb1-6DManpb1-6[DManpb1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_C_)-BMA(4_C_)-[BMA(6_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(54_A_)",33.07,"","",""
"2QT6","CRYSTAL STRUCTURE DETERMINATION OF A BLUE LACCASE FROM LENTINUS TIGRINUS","10.1186/1472-6807-7-60 ",1.5,26.09,"2qt6_oligo2","DManpb1-3DManpb1-6[DManpb1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_D_)-BMA(4_D_)-[BMA(6_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(54_B_)",37.8806,"","",""
"2QWA","THE X-RAY STRUCTURE OF A DRUG RESISTANT VARIANT R292K OF TERN N9 INFLUENZA VIRUS NEURAMINIDASE","10.1016/S0969-2126(98)00075-6 ",1.7,0,"2qwa_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",18.3477,"","",""
"2QWB","THE X-RAY STRUCTURE OF A COMPLEX OF SIALIC ACID AND A DRUG RESISTANT VARIANT R292K OF TERN N9 INFLUENZA VIRUS NEURAMINIDASE","10.1016/S0969-2126(98)00075-6 ",2,0,"2qwb_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",22.3252,"","",""
"2QWC","THE X-RAY STRUCTURE OF A COMPLEX OF NEU5AC2EN AND A DRUG RESISTANT VARIANT R292K OF TERN N9 INFLUENZA VIRUS NEURAMINIDASE","10.1016/S0969-2126(98)00075-6 ",1.6,0,"2qwc_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",20.9408,"","",""
"2QWD","THE X-RAY STRUCTURE OF A COMPLEX OF 4-AMINO-NEU5AC2EN AND A DRUG RESISTANT VARIANT R292K OF TERN N9 INFLUENZA VIRUS NEURAMINIDASE","10.1016/S0969-2126(98)00075-6 ",2,0,"2qwd_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",20.9605,"","",""
"2QWE","THE X-RAY STRUCTURE OF A COMPLEX OF 4-GUANIDINO-NEU5AC2EN AND A DRUG RESISTANT VARIANT R292K OF TERN N9 INFLUENZA VIRUS NEURAMINIDASE","10.1016/S0969-2126(98)00075-6 ",2,0,"2qwe_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",21.8071,"","",""
"2QWF","THE X-RAY STRUCTURE OF A COMPLEX OF N-ACETYL-4-GUANIDINO-6- METHYL(PROPYL)CARBOXAMIDE-4,5-DIHYDRO-2H-PYRAN-2-CARBOXYLIC ACID AND A DRUG RESISTANT VARIANT R292K OF TERN N9 INFLUENZA VIRUS NEURAMINIDASE","10.1016/S0969-2126(98)00075-6 ",1.9,0,"2qwf_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",20.9622,"","",""
"2QWG","THE X-RAY STRUCTURE OF A COMPLEX OF 5-N-ACETYL-4-AMINO-6- DIETHYLCARBOXAMIDE-4,5-DIHYDRO-2H-PYRAN-2-CARBOXYLIC ACID AND A DRUG RESISTANT VARIANT R292K OF TERN N9 INFLUENZA VIRUS NEURAMINIDASE","10.1016/S0969-2126(98)00075-6 ",1.8,0,"2qwg_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",24.9679,"","",""
"2QWH","THE X-RAY STRUCTURE OF A COMPLEX OF 5-N-ACETYL-5-AMINO-3-(1- ETHYLPROPOXY)-1-CYCLOHEXENE-1-CARBOXYLIC ACID (GS4071) AND A DRUG RESISTANT VARIANT R292K OF TERN N9 INFLUENZA VIRUS NEURAMINIDASE","10.1016/S0969-2126(98)00075-6 ",1.8,0,"2qwh_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",23.1039,"","",""
"2QWI","THE X-RAY STRUCTURE OF A COMPLEX OF N-ACETYL-4-GUANIDINO-6- METHYL(PROPYL)CARBOXAMIDE-4,5-DIHYDRO-2H-PYRAN-2-CARBOXYLIC ACID AND WILDTYPE TERN N9 INFLUENZA VIRUS NEURAMINIDASE","10.1016/S0969-2126(98)00075-6 ",2,0,"2qwi_oligo1","DManpa1-2DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-MAN(5_B_)-MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",41.5633,"","",""
"2QWJ","THE X-RAY STRUCTURE OF A COMPLEX OF 5-N-ACETYL-4-AMINO-6- DIETHYLCARBOXAMIDE-4,5-DIHYDRO-2H-PYRAN-2-CARBOXYLIC ACID AND A DRUG RESISTANT VARIANT R292K OF TERN N9 INFLUENZA VIRUS NEURAMINIDASE","10.1016/S0969-2126(98)00075-6 ",2,0,"2qwj_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",26.1005,"","",""
"2QWK","THE X-RAY STRUCTURE OF A COMPLEX OF 5-N-ACETYL-5-AMINO-3-(1- ETHYLPROPOXY)-1-CYCLOHEXENE-1-CARBOXYLIC ACID (GS4071) AND WILDTYPE TERN N9 INFLUENZA VIRUS NEURAMINIDASE","10.1016/S0969-2126(98)00075-6 ",1.8,0,"2qwk_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",27.2731,"","",""
"2R61","CRYSTAL STRUCTURE OF THE STAPHYLOCOCCAL SUPERANTIGEN-LIKE PROTEIN SSL5 IN COMPLEX WITH SIALYL-LEWIS X AT PH 7.4","10.1016/J.JMB.2007.09.091 ",2.75,16.54,"2r61_oligo1","DNeup5Aca2-3DGalpb1-4[LFucpa1-3]DGlcpNAcb1-ROH","SIA(3_B_)-GAL(2_B_)-[FUC(4_B_)]-NAG(1_B_)",33.0784,"","",""
"2R7E","CRYSTAL STRUCTURE ANALYSIS OF COAGULATION FACTOR VIII","10.1182/BLOOD-2007-08-109918 ",3.7,168.5,"2r7e_oligo3","DManpa1-2DManpb1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_E_)-MAN(6_E_)-[MAN(5_E_)-BMA(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(2118_B_)",170.793,"","",""
"2RDG","CRYSTAL STRUCTURE OF STAPHYLOCOCCAL SUPERANTIGEN-LIKE PROTEIN 11 IN COMPLEX WITH SIALYL LEWIS X","10.1111/J.1365-2958.2007.05989.X ",1.6,23.83,"2rdg_oligo1","DNeup5Aca2-3DGalpb1-4[LFucpa1-3]DGlcpNAca1-ROH","SIA(3_B_)-GAL(2_B_)-[FUC(4_B_)]-NDG(1_B_)",13.0047,"","",""
"2RFT","CRYSTAL STRUCTURE OF INFLUENZA B VIRUS HEMAGGLUTININ IN COMPLEX WITH LSTA RECEPTOR ANALOG","10.1073/PNAS.0708363104 ",2.8,47.34,"2rft_oligo3","DNeup5Aca2-3DGalpb1-3DGlcpNAca1-3DGalpb1-4DGlcpb1-ROH","SIA(5_G_)-GAL(4_G_)-NDG(3_G_)-GAL(2_G_)-BGC(1_G_)",82.5925,"","",""
"2RGS","FC-FRAGMENT OF MONOCLONAL ANTIBODY IGG2B FROM MUS MUSCULUS","10.1111/J.1365-2567.2008.02904.X ",2.13,25.87,"2rgs_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[1-6]DGlcpNAcb1-ASN","FUC(9_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-MAN(7_C_)]-MAN(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",27.267,"","",""
"2RGS","FC-FRAGMENT OF MONOCLONAL ANTIBODY IGG2B FROM MUS MUSCULUS","10.1111/J.1365-2567.2008.02904.X ",2.13,25.87,"2rgs_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[1-6]DGlcpNAcb1-ASN","FUC(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-MAN(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",27.747,"","",""
"2RI8","PENICILLIUM CITRINUM ALPHA-1,2-MANNOSIDASE COMPLEX WITH GLYCEROL","10.1107/S0907444907065572 ",2.16,28,"2ri8_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(1366_A_)",32.8576,"","",""
"2RI8","PENICILLIUM CITRINUM ALPHA-1,2-MANNOSIDASE COMPLEX WITH GLYCEROL","10.1107/S0907444907065572 ",2.16,28,"2ri8_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-MAN(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(2366_B_)",43.04,"","",""
"2RI9","PENICILLIUM CITRINUM ALPHA-1,2-MANNOSIDASE IN COMPLEX WITH A SUBSTRATE ANALOG","10.1107/S0907444907065572 ",1.95,28.3,"2ri9_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAca1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-MAN(3_D_)-NDG(2_D_)-NAG(1_D_)-ASN(1366_A_)",29.9751,"","",""
"2RI9","PENICILLIUM CITRINUM ALPHA-1,2-MANNOSIDASE IN COMPLEX WITH A SUBSTRATE ANALOG","10.1107/S0907444907065572 ",1.95,28.3,"2ri9_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAca1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-MAN(3_H_)-NDG(2_H_)-NAG(1_H_)-ASN(2366_B_)",54.9084,"","",""
"2TEP","PEANUT LECTIN COMPLEXED WITH T-ANTIGENIC DISACCHARIDE","",2.5,12.9,"2tep_oligo1","DGalpb1-3DGalpNAcb1-ROH","GAL(2_E_)-NGA(1_E_)",10.7027,"","",""
"2TEP","PEANUT LECTIN COMPLEXED WITH T-ANTIGENIC DISACCHARIDE","",2.5,12.9,"2tep_oligo4","DGalpb1-3DGalpNAcb1-ROH","GAL(2_H_)-NGA(1_H_)",21.3909,"","",""
"2TEP","PEANUT LECTIN COMPLEXED WITH T-ANTIGENIC DISACCHARIDE","",2.5,12.9,"2tep_oligo3","DGalpb1-3DGalpNAcb1-ROH","GAL(2_G_)-NGA(1_G_)",23.7777,"","",""
"2TEP","PEANUT LECTIN COMPLEXED WITH T-ANTIGENIC DISACCHARIDE","",2.5,12.9,"2tep_oligo2","DGalpb1-3DGalpNAcb1-ROH","GAL(2_F_)-NGA(1_F_)",12.1,"","",""
"2V3D","ACID-BETA-GLUCOSIDASE WITH N-BUTYL-DEOXYNOJIRIMYCIN","10.1074/JBC.M705005200 ",1.96,20.32,"2v3d_oligo3","DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","BMA(3_C_)-NAG(2_C_)-[FUC(4_C_)]-NAG(1_C_)-ASN(19_A_)",48.3034,"","",""
"2V3D","ACID-BETA-GLUCOSIDASE WITH N-BUTYL-DEOXYNOJIRIMYCIN","10.1074/JBC.M705005200 ",1.96,20.32,"2v3d_oligo4","DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","BMA(3_D_)-NAG(2_D_)-[FUC(4_D_)]-NAG(1_D_)-ASN(19_B_)",47.0445,"","",""
"2V3E","ACID-BETA-GLUCOSIDASE WITH N-NONYL-DEOXYNOJIRIMYCIN","10.1074/JBC.M705005200 ",2,18.22,"2v3e_oligo3","DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","BMA(3_C_)-NAG(2_C_)-[FUC(4_C_)]-NAG(1_C_)-ASN(19_A_)",40.665,"","",""
"2V3E","ACID-BETA-GLUCOSIDASE WITH N-NONYL-DEOXYNOJIRIMYCIN","10.1074/JBC.M705005200 ",2,18.22,"2v3e_oligo4","DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","BMA(3_D_)-NAG(2_D_)-[FUC(4_D_)]-NAG(1_D_)",48.0987,"","",""
"2V3F","ACID-BETA-GLUCOSIDASE PRODUCED IN CARROT","10.1111/J.1467-7652.2007.00263.X ",1.95,13.6,"2v3f_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(3_C_)-NAG(2_C_)-[FUC(4_C_)]-NAG(1_C_)-ASN(19_A_)",39.7409,"","",""
"2V3F","ACID-BETA-GLUCOSIDASE PRODUCED IN CARROT","10.1111/J.1467-7652.2007.00263.X ",1.95,13.6,"2v3f_oligo2","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_D_)-[FUC(2_D_)]-NAG(1_D_)-ASN(19_B_)",25.8388,"","",""
"2VBM","TAILSPIKE PROTEIN OF BACTERIOPHAGE SF6 COMPLEXED WITH TETRASACCHARIDE","10.1016/J.STR.2008.01.019 ",2,20.2,"2vbm_oligo1","LRhapa1-3DGlcpNAcb1-2LRhapa1-2LRhapa1-ROH","RAM(4_B_)-NAG(3_B_)-RAM(2_B_)-RAM(1_B_)",24.3177,"","",""
"2VC2","RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO ANTAGONIST L-739758","10.1083/JCB.200801146 ",3.1,3.21,"2vc2_oligo4","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-[MAN(5_D_)]-MAN(4_D_)-[MAN(7_D_)]-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(371_B_)",28.0539,"","",""
"2VC2","RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO ANTAGONIST L-739758","10.1083/JCB.200801146 ",3.1,3.21,"2vc2_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-MAN(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(320_B_)",33.6633,"","",""
"2VCO","CRYSTAL STRUCTURE OF THE FIMBRIAL ADHESIN FIMH IN COMPLEX WITH ITS HIGH-MANNOSE EPITOPE","10.1371/JOURNAL.PONE.0002040 ",2.1,27.63,"2vco_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","MAN(5_D_)-[MAN(4_D_)]-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)",49.7153,"","",""
"2VCO","CRYSTAL STRUCTURE OF THE FIMBRIAL ADHESIN FIMH IN COMPLEX WITH ITS HIGH-MANNOSE EPITOPE","10.1371/JOURNAL.PONE.0002040 ",2.1,27.63,"2vco_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","MAN(5_C_)-[MAN(4_C_)]-MAN(3_C_)-NAG(2_C_)-NAG(1_C_)",50.3495,"","",""
"2VDK","RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE","10.1083/JCB.200801146 ",2.8,17.09,"2vdk_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-MAN(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(320_B_)",55.9564,"","",""
"2VDK","RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE","10.1083/JCB.200801146 ",2.8,17.09,"2vdk_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-[MAN(5_D_)]-MAN(4_D_)-[MAN(7_D_)]-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(371_B_)",47.5294,"","",""
"2VDL","RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE","10.1083/JCB.200801146 ",2.75,36.91,"2vdl_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-[MAN(5_D_)]-MAN(4_D_)-[MAN(7_D_)]-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(371_B_)",77.0405,"","",""
"2VDL","RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE","10.1083/JCB.200801146 ",2.75,36.91,"2vdl_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-MAN(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(320_B_)",83.6053,"","",""
"2VDM","RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO ANTAGONIST TIROFIBAN","10.1083/JCB.200801146 ",2.9,42.7,"2vdm_oligo3","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-[MAN(5_D_)]-MAN(4_D_)-[MAN(7_D_)]-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(371_B_)",82.5252,"","",""
"2VDM","RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO ANTAGONIST TIROFIBAN","10.1083/JCB.200801146 ",2.9,42.7,"2vdm_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-MAN(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(320_B_)",88.0869,"","",""
"2VDN","RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO ANTAGONIST EPTIFIBATIDE","10.1083/JCB.200801146 ",2.9,44.6,"2vdn_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-[MAN(5_E_)]-MAN(4_E_)-[MAN(7_E_)]-MAN(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(371_B_)",89.2851,"","",""
"2VDN","RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO ANTAGONIST EPTIFIBATIDE","10.1083/JCB.200801146 ",2.9,44.6,"2vdn_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(320_B_)",97.6993,"","",""
"2VDO","INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO FIBRINOGEN GAMMA CHAIN PEPTIDE, HHLGGAKQAGDV","10.1083/JCB.200801146 ",2.51,51.55,"2vdo_oligo2","DManpb1-3[DManpb1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-[MAN(5_E_)]-MAN(4_E_)-[MAN(7_E_)]-MAN(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(371_B_)",91.3655,"","",""
"2VDO","INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO FIBRINOGEN GAMMA CHAIN PEPTIDE, HHLGGAKQAGDV","10.1083/JCB.200801146 ",2.51,51.55,"2vdo_oligo1","DManpb1-3[DManpb1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(320_B_)",108.462,"","",""
"2VDP","INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO FIBRINOGEN GAMMA CHAIN PEPTIDE,LGGAKQAGDV","10.1083/JCB.200801146 ",2.8,48.02,"2vdp_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(320_B_)",99.3907,"","",""
"2VDP","INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO FIBRINOGEN GAMMA CHAIN PEPTIDE,LGGAKQAGDV","10.1083/JCB.200801146 ",2.8,48.02,"2vdp_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-[MAN(5_E_)]-MAN(4_E_)-[MAN(7_E_)]-MAN(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(371_B_)",90.0051,"","",""
"2VDQ","INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO A CHIMERIC FIBRINOGEN GAMMA CHAIN PEPTIDE, HHLGGAKQRGDV","10.1083/JCB.200801146 ",2.59,41.15,"2vdq_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-[MAN(5_E_)]-MAN(4_E_)-[MAN(7_E_)]-MAN(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(371_B_)",85.0145,"","",""
"2VDQ","INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO A CHIMERIC FIBRINOGEN GAMMA CHAIN PEPTIDE, HHLGGAKQRGDV","10.1083/JCB.200801146 ",2.59,41.15,"2vdq_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(320_B_)",95.672,"","",""
"2VDR","INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO A CHIMERIC FIBRINOGEN GAMMA CHAIN PEPTIDE, LGGAKQRGDV","10.1083/JCB.200801146 ",2.4,43.58,"2vdr_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-[MAN(5_E_)]-MAN(4_E_)-[MAN(7_E_)]-MAN(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(371_B_)",83.9629,"","",""
"2VDR","INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO A CHIMERIC FIBRINOGEN GAMMA CHAIN PEPTIDE, LGGAKQRGDV","10.1083/JCB.200801146 ",2.4,43.58,"2vdr_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(320_B_)",94.0078,"","",""
"2VJJ","TAILSPIKE PROTEIN OF E.COLI BACTERIOPHAGE HK620 IN COMPLEX WITH HEXASACCHARIDE","10.1111/J.1365-2958.2008.06311.X ",1.59,8.74,"2vjj_oligo1","DGlcpNAcb1-3DGalp[4H]a1-3DGlcpNAcb1-ROH","NAG(5_B_)-GAL(2_B_)-NAG(1_B_)",9.46036,"","",""
"2VNG","FAMILY 51 CARBOHYDRATE BINDING MODULE FROM A FAMILY 98 GLYCOSIDE HYDROLASE PRODUCED BY CLOSTRIDIUM PERFRINGENS IN COMPLEX WITH BLOOD GROUP A-TRISACCHARIDE LIGAND.","10.1074/JBC.M709865200 ",1.4,13.18,"2vng_oligo1","LFucpa1-2[DGalpNAca1-3]DGalpb1-ROH","A2G(3_C_)-[FUC(2_C_)]-GAL(1_C_)",25.9991,"","",""
"2VNG","FAMILY 51 CARBOHYDRATE BINDING MODULE FROM A FAMILY 98 GLYCOSIDE HYDROLASE PRODUCED BY CLOSTRIDIUM PERFRINGENS IN COMPLEX WITH BLOOD GROUP A-TRISACCHARIDE LIGAND.","10.1074/JBC.M709865200 ",1.4,13.18,"2vng_oligo2","LFucpa1-2[DGalpNAca1-3]DGalpb1-ROH","A2G(3_D_)-[FUC(2_D_)]-GAL(1_D_)",25.7518,"","",""
"2VNO","FAMILY 51 CARBOHYDRATE BINDING MODULE FROM A FAMILY 98 GLYCOSIDE HYDROLASE PRODUCED BY CLOSTRIDIUM PERFRINGENS IN COMPLEX WITH BLOOD GROUP B-TRISACCHARIDE LIGAND.","10.1074/JBC.M709865200 ",1.45,12.29,"2vno_oligo2","LFucpa1-2[DGalpa1-3]DGalpb1-ROH","GAL(3_D_)-[FUC(2_D_)]-GAL(1_D_)",17.7642,"","",""
"2VNO","FAMILY 51 CARBOHYDRATE BINDING MODULE FROM A FAMILY 98 GLYCOSIDE HYDROLASE PRODUCED BY CLOSTRIDIUM PERFRINGENS IN COMPLEX WITH BLOOD GROUP B-TRISACCHARIDE LIGAND.","10.1074/JBC.M709865200 ",1.45,12.29,"2vno_oligo1","LFucpa1-2[DGalpa1-3]DGalpb1-ROH","GAL(3_C_)-[FUC(2_C_)]-GAL(1_C_)",18.5897,"","",""
"2VRQ","STRUCTURE OF AN INACTIVE MUTANT OF ARABINOFURANOSIDASE FROM THERMOBACILLUS XYLANILYTICUS IN COMPLEX WITH A PENTASACCHARIDE","10.1021/BI800424E ",2,0,"2vrq_oligo2","LArafa1-3[DXylpb1-4]DXylpb1-4DXylpb1-ROH","XYP(4_E_)-[AHR(3_E_)]-XYP(2_E_)-XYP(1_E_)",36.4268,"","",""
"2VRQ","STRUCTURE OF AN INACTIVE MUTANT OF ARABINOFURANOSIDASE FROM THERMOBACILLUS XYLANILYTICUS IN COMPLEX WITH A PENTASACCHARIDE","10.1021/BI800424E ",2,0,"2vrq_oligo1","LArafa1-3[DXylpb1-4]DXylpb1-4DXylpb1-ROH","XYP(4_D_)-[AHR(3_D_)]-XYP(2_D_)-XYP(1_D_)",40.4881,"","",""
"2VRQ","STRUCTURE OF AN INACTIVE MUTANT OF ARABINOFURANOSIDASE FROM THERMOBACILLUS XYLANILYTICUS IN COMPLEX WITH A PENTASACCHARIDE","10.1021/BI800424E ",2,0,"2vrq_oligo3","LArafa1-3DXylpb1-4DXylpb1-ROH","AHR(3_F_)-XYP(2_F_)-XYP(1_F_)",42.7727,"","",""
"2VT0","X-RAY STRUCTURE OF A CONJUGATE WITH CONDURITOL-BETA-EPOXIDE OF ACID- BETA-GLUCOSIDASE OVEREXPRESSED IN CULTURED PLANT CELLS","10.1515/BC.2008.163 ",2.15,22.18,"2vt0_oligo2","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_D_)-[FUC(2_D_)]-NAG(1_D_)-ASN(19_B_)",39.8876,"","",""
"2VT0","X-RAY STRUCTURE OF A CONJUGATE WITH CONDURITOL-BETA-EPOXIDE OF ACID- BETA-GLUCOSIDASE OVEREXPRESSED IN CULTURED PLANT CELLS","10.1515/BC.2008.163 ",2.15,22.18,"2vt0_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(3_C_)-NAG(2_C_)-[FUC(4_C_)]-NAG(1_C_)-ASN(19_A_)",62.193,"","",""
"2VU9","CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE A BINDING DOMAIN IN COMPLEX WITH GT1B","10.1371/JOURNAL.PPAT.1000129 ",1.6,13.7,"2vu9_oligo1","DNeup5Aca2-3DGalpb1-3DGalpNAcb1-4[DNeup5Aca2-3]DGalpb1-4DGlcpb1-ROH","SIA(5_B_)-GAL(4_B_)-NGA(3_B_)-[SIA(6_B_)]-GAL(2_B_)-BGC(1_B_)",34.4234,"","",""
"2VUO","CRYSTAL STRUCTURE OF THE RABBIT IGG FC FRAGMENT","10.1042/BJ20081355 ",1.95,26.63,"2vuo_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(297_B_)",40.3597,"","",""
"2VUO","CRYSTAL STRUCTURE OF THE RABBIT IGG FC FRAGMENT","10.1042/BJ20081355 ",1.95,26.63,"2vuo_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(297_A_)",42.0043,"","",""
"2VUZ","CRYSTAL STRUCTURE OF CODAKINE IN COMPLEX WITH BIANTENNARY NONASACCHARIDE AT 1.7A RESOLUTION","10.1074/JBC.M804353200 ",1.7,18.48,"2vuz_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","NAG(7_B_)-MAN(6_B_)-[NAG(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)",34.3566,"","",""
"2VXJ","CRYSTAL STRUCTURE OF PA-IL LECTIN COMPLEXED WITH AGAL13BGAL14GLC AT 1.9 A RESOLUTION","10.1016/J.JMB.2008.08.028 ",1.9,10.18,"2vxj_oligo8","DGalpa1-3DGalpb1-4DGlcpb1-ROH","GLA(3_h_)-GAL(2_h_)-BGC(1_h_)",22.2758,"","",""
"2VXJ","CRYSTAL STRUCTURE OF PA-IL LECTIN COMPLEXED WITH AGAL13BGAL14GLC AT 1.9 A RESOLUTION","10.1016/J.JMB.2008.08.028 ",1.9,10.18,"2vxj_oligo7","DGalpa1-3DGalpb1-4DGlcpb1-ROH","GLA(3_g_)-GAL(2_g_)-BGC(1_g_)",17.8439,"","",""
"2VXJ","CRYSTAL STRUCTURE OF PA-IL LECTIN COMPLEXED WITH AGAL13BGAL14GLC AT 1.9 A RESOLUTION","10.1016/J.JMB.2008.08.028 ",1.9,10.18,"2vxj_oligo22","DGalpa1-3DGalpb1-4DGlcpb1-ROH","GLA(2_l_)-GAL(1_l_)-BGC(204_N_)",25.8279,"","",""
"2VXJ","CRYSTAL STRUCTURE OF PA-IL LECTIN COMPLEXED WITH AGAL13BGAL14GLC AT 1.9 A RESOLUTION","10.1016/J.JMB.2008.08.028 ",1.9,10.18,"2vxj_oligo10","DGalpa1-3DGalpb1-4DGlcpb1-ROH","GLA(3_j_)-GAL(2_j_)-BGC(1_j_)",26.3515,"","",""
"2VXJ","CRYSTAL STRUCTURE OF PA-IL LECTIN COMPLEXED WITH AGAL13BGAL14GLC AT 1.9 A RESOLUTION","10.1016/J.JMB.2008.08.028 ",1.9,10.18,"2vxj_oligo1","DGalpa1-3DGalpb1-4DGlcpb1-ROH","GLA(3_Z_)-GAL(2_Z_)-BGC(1_Z_)",25.0161,"","",""
"2VXJ","CRYSTAL STRUCTURE OF PA-IL LECTIN COMPLEXED WITH AGAL13BGAL14GLC AT 1.9 A RESOLUTION","10.1016/J.JMB.2008.08.028 ",1.9,10.18,"2vxj_oligo19","DGalpa1-3DGalpb1-4DGlcpb1-ROH","GLA(3_t_)-GAL(2_t_)-BGC(1_t_)",24.9867,"","",""
"2VXJ","CRYSTAL STRUCTURE OF PA-IL LECTIN COMPLEXED WITH AGAL13BGAL14GLC AT 1.9 A RESOLUTION","10.1016/J.JMB.2008.08.028 ",1.9,10.18,"2vxj_oligo24","DGalpa1-3DGalpb1-4DGlcpa1-ROH","GLA(3_c_)-GAL(2_c_)-GLC(1_c_)",18.4306,"","",""
"2VXJ","CRYSTAL STRUCTURE OF PA-IL LECTIN COMPLEXED WITH AGAL13BGAL14GLC AT 1.9 A RESOLUTION","10.1016/J.JMB.2008.08.028 ",1.9,10.18,"2vxj_oligo11","DGalpa1-3DGalpb1-4DGlcpb1-ROH","GLA(3_k_)-GAL(2_k_)-BGC(1_k_)",17.6603,"","",""
"2VXJ","CRYSTAL STRUCTURE OF PA-IL LECTIN COMPLEXED WITH AGAL13BGAL14GLC AT 1.9 A RESOLUTION","10.1016/J.JMB.2008.08.028 ",1.9,10.18,"2vxj_oligo2","DGalpa1-3DGalpb1-4DGlcpb1-ROH","GLA(3_e_)-GAL(2_e_)-BGC(1_e_)",22.2918,"","",""
"2VXJ","CRYSTAL STRUCTURE OF PA-IL LECTIN COMPLEXED WITH AGAL13BGAL14GLC AT 1.9 A RESOLUTION","10.1016/J.JMB.2008.08.028 ",1.9,10.18,"2vxj_oligo21","DGalpa1-3DGalpb1-4DGlcpb1-ROH","GLA(3_v_)-GAL(2_v_)-BGC(1_v_)",23.6215,"","",""
"2VXJ","CRYSTAL STRUCTURE OF PA-IL LECTIN COMPLEXED WITH AGAL13BGAL14GLC AT 1.9 A RESOLUTION","10.1016/J.JMB.2008.08.028 ",1.9,10.18,"2vxj_oligo15","DGalpa1-3DGalpb1-4DGlcpb1-ROH","GLA(3_p_)-GAL(2_p_)-BGC(1_p_)",23.4815,"","",""
"2VXJ","CRYSTAL STRUCTURE OF PA-IL LECTIN COMPLEXED WITH AGAL13BGAL14GLC AT 1.9 A RESOLUTION","10.1016/J.JMB.2008.08.028 ",1.9,10.18,"2vxj_oligo23","DGalpa1-3DGalpb1-4DGlcpa1-ROH","GLA(3_a_)-GAL(2_a_)-GLC(1_a_)",24.8452,"","",""
"2VXJ","CRYSTAL STRUCTURE OF PA-IL LECTIN COMPLEXED WITH AGAL13BGAL14GLC AT 1.9 A RESOLUTION","10.1016/J.JMB.2008.08.028 ",1.9,10.18,"2vxj_oligo14","DGalpa1-3DGalpb1-4DGlcpb1-ROH","GLA(3_o_)-GAL(2_o_)-BGC(1_o_)",17.2779,"","",""
"2VXJ","CRYSTAL STRUCTURE OF PA-IL LECTIN COMPLEXED WITH AGAL13BGAL14GLC AT 1.9 A RESOLUTION","10.1016/J.JMB.2008.08.028 ",1.9,10.18,"2vxj_oligo20","DGalpa1-3DGalpb1-4DGlcpb1-ROH","GLA(3_u_)-GAL(2_u_)-BGC(1_u_)",22.4367,"","",""
"2VXJ","CRYSTAL STRUCTURE OF PA-IL LECTIN COMPLEXED WITH AGAL13BGAL14GLC AT 1.9 A RESOLUTION","10.1016/J.JMB.2008.08.028 ",1.9,10.18,"2vxj_oligo18","DGalpa1-3DGalpb1-4DGlcpb1-ROH","GLA(3_s_)-GAL(2_s_)-BGC(1_s_)",17.7594,"","",""
"2VXJ","CRYSTAL STRUCTURE OF PA-IL LECTIN COMPLEXED WITH AGAL13BGAL14GLC AT 1.9 A RESOLUTION","10.1016/J.JMB.2008.08.028 ",1.9,10.18,"2vxj_oligo6","DGalpa1-3DGalpb1-4DGlcpb1-ROH","GLA(3_f_)-GAL(2_f_)-BGC(1_f_)",20.5012,"","",""
"2VXJ","CRYSTAL STRUCTURE OF PA-IL LECTIN COMPLEXED WITH AGAL13BGAL14GLC AT 1.9 A RESOLUTION","10.1016/J.JMB.2008.08.028 ",1.9,10.18,"2vxj_oligo5","DGalpa1-3DGalpb1-4DGlcpb1-ROH","GLA(3_d_)-GAL(2_d_)-BGC(1_d_)",23.283,"","",""
"2VXJ","CRYSTAL STRUCTURE OF PA-IL LECTIN COMPLEXED WITH AGAL13BGAL14GLC AT 1.9 A RESOLUTION","10.1016/J.JMB.2008.08.028 ",1.9,10.18,"2vxj_oligo4","DGalpa1-3DGalpb1-4DGlcpb1-ROH","GLA(3_b_)-GAL(2_b_)-BGC(1_b_)",22.1991,"","",""
"2VXJ","CRYSTAL STRUCTURE OF PA-IL LECTIN COMPLEXED WITH AGAL13BGAL14GLC AT 1.9 A RESOLUTION","10.1016/J.JMB.2008.08.028 ",1.9,10.18,"2vxj_oligo13","DGalpa1-3DGalpb1-4DGlcpb1-ROH","GLA(3_n_)-GAL(2_n_)-BGC(1_n_)",21.3103,"","",""
"2VXJ","CRYSTAL STRUCTURE OF PA-IL LECTIN COMPLEXED WITH AGAL13BGAL14GLC AT 1.9 A RESOLUTION","10.1016/J.JMB.2008.08.028 ",1.9,10.18,"2vxj_oligo17","DGalpa1-3DGalpb1-4DGlcpb1-ROH","GLA(3_r_)-GAL(2_r_)-BGC(1_r_)",25.8885,"","",""
"2VXJ","CRYSTAL STRUCTURE OF PA-IL LECTIN COMPLEXED WITH AGAL13BGAL14GLC AT 1.9 A RESOLUTION","10.1016/J.JMB.2008.08.028 ",1.9,10.18,"2vxj_oligo12","DGalpa1-3DGalpb1-4DGlcpb1-ROH","GLA(3_m_)-GAL(2_m_)-BGC(1_m_)",27.5561,"","",""
"2VXJ","CRYSTAL STRUCTURE OF PA-IL LECTIN COMPLEXED WITH AGAL13BGAL14GLC AT 1.9 A RESOLUTION","10.1016/J.JMB.2008.08.028 ",1.9,10.18,"2vxj_oligo9","DGalpa1-3DGalpb1-4DGlcpb1-ROH","GLA(3_i_)-GAL(2_i_)-BGC(1_i_)",21.0861,"","",""
"2VXJ","CRYSTAL STRUCTURE OF PA-IL LECTIN COMPLEXED WITH AGAL13BGAL14GLC AT 1.9 A RESOLUTION","10.1016/J.JMB.2008.08.028 ",1.9,10.18,"2vxj_oligo16","DGalpa1-3DGalpb1-4DGlcpb1-ROH","GLA(3_q_)-GAL(2_q_)-BGC(1_q_)",22.2933,"","",""
"2VXJ","CRYSTAL STRUCTURE OF PA-IL LECTIN COMPLEXED WITH AGAL13BGAL14GLC AT 1.9 A RESOLUTION","10.1016/J.JMB.2008.08.028 ",1.9,10.18,"2vxj_oligo3","DGalpa1-3DGalpb1-4DGlcpb1-ROH","GLA(3_Y_)-GAL(2_Y_)-BGC(1_Y_)",15.3252,"","",""
"2W52","2 BETA-GLUCANS (6-O-GLUCOSYL-LAMINARITRIOSE) IN BOTH DONOR AND ACCEPTOR SITES OF GH16 LAMINARINASE 16A FROM PHANEROCHAETE CHRYSOSPORIUM.","10.1111/J.1742-4658.2009.07099.X ",1.56,12.69,"2w52_oligo2","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-MAN(5_B_)-[MAN(7_B_)]-MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(43_A_)",32.4496,"","",""
"2W7Y","STRUCTURE OF A STREPTOCOCCUS PNEUMONIAE SOLUTE-BINDING PROTEIN IN COMPLEX WITH THE BLOOD GROUP A-TRISACCHARIDE.","10.1016/J.JMB.2009.03.012 ",2.35,23.5,"2w7y_oligo2","LFucpa1-2[DGalpNAca1-3]DGalpb1-ROH","A2G(3_D_)-[FUC(2_D_)]-GAL(1_D_)",21.0891,"","",""
"2W7Y","STRUCTURE OF A STREPTOCOCCUS PNEUMONIAE SOLUTE-BINDING PROTEIN IN COMPLEX WITH THE BLOOD GROUP A-TRISACCHARIDE.","10.1016/J.JMB.2009.03.012 ",2.35,23.5,"2w7y_oligo1","LFucpa1-2[DGalpNAca1-3]DGalpb1-ROH","A2G(3_C_)-[FUC(2_C_)]-GAL(1_C_)",15.2655,"","",""
"2WAH","CRYSTAL STRUCTURE OF AN IGG1 FC GLYCOFORM (MAN9GLCNAC2)","10.1016/J.JMB.2009.02.033 ",2.51,19.57,"2wah_oligo1","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-MAN(5_C_)-[MAN(7_C_)]-MAN(4_C_)-[MAN(9_C_)-MAN(8_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(297_A_)",73.1347,"","",""
"2WBJ","TCR COMPLEX","10.1016/J.IMMUNI.2009.01.009 ",3,64.11,"2wbj_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAca1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(118_E_)",84.2891,"","",""
"2WII","COMPLEMENT C3B IN COMPLEX WITH FACTOR H DOMAINS 1-4","10.1038/NI.1755 ",2.7,68.2,"2wii_oligo1","DManpb1-6DManpb1-6[DManpb1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_D_)-BMA(4_D_)-[BMA(6_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(63_A_)",134.842,"","",""
"2WIN","C3 CONVERTASE (C3BBB) STABILIZED BY SCIN","10.1038/NI.1756 ",3.9,158.8,"2win_oligo12","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAca1-ASN","MAN(5_b_)-[MAN(4_b_)]-MAN(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(260_K_)",223.247,"","",""
"2WIN","C3 CONVERTASE (C3BBB) STABILIZED BY SCIN","10.1038/NI.1756 ",3.9,158.8,"2win_oligo3","DManpb1-3DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_S_)-BMA(4_S_)-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(63_C_)",216.238,"","",""
"2WIN","C3 CONVERTASE (C3BBB) STABILIZED BY SCIN","10.1038/NI.1756 ",3.9,158.8,"2win_oligo6","DManpb1-3[DManpb1-6]DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAca1-ASN","BMA(6_V_)-[BMA(5_V_)]-BMA(4_V_)-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(917_F_)",219.747,"","",""
"2WLQ","NUCLEOPHILE-DISABLED LAM16A MUTANT HOLDS LAMINARIHEPTAOSE (L7) IN A CYCLICAL CONFORMATION","10.1021/JA909129B ",1.4,13,"2wlq_oligo2","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-MAN(5_B_)-[MAN(7_B_)]-MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(43_A_)",26.7853,"","",""
"2WMG","CRYSTAL STRUCTURE OF THE CATALYTIC MODULE OF A FAMILY 98 GLYCOSIDE HYDROLASE FROM STREPTOCOCCUS PNEUMONIAE TIGR4 (SP4GH98) IN COMPLEX WITH THE LEWISY PENTASACCHARIDE BLOOD GROUP ANTIGEN.","10.1074/JBC.M109.024067 ",2.3,12.95,"2wmg_oligo1","LFucpa1-2DGalpb1-4[LFucpa1-3]DGlcpNAcb1-ROH","FUC(3_B_)-GAL(2_B_)-[FUC(4_B_)]-NAG(1_B_)",31.0514,"","",""
"2WMI","CRYSTAL STRUCTURE OF THE CATALYTIC MODULE OF A FAMILY 98 GLYCOSIDE HYDROLASE FROM STREPTOCOCCUS PNEUMONIAE SP3-BS71 IN COMPLEX WITH THE A-TRISACCHARIDE BLOOD GROUP ANTIGEN.","10.1074/JBC.M109.024067 ",1.9,16.21,"2wmi_oligo1","LFucpa1-2[DGalpNAca1-3]DGalpb1-ROH","A2G(3_C_)-[FUC(2_C_)]-GAL(1_C_)",10.9845,"","",""
"2WMI","CRYSTAL STRUCTURE OF THE CATALYTIC MODULE OF A FAMILY 98 GLYCOSIDE HYDROLASE FROM STREPTOCOCCUS PNEUMONIAE SP3-BS71 IN COMPLEX WITH THE A-TRISACCHARIDE BLOOD GROUP ANTIGEN.","10.1074/JBC.M109.024067 ",1.9,16.21,"2wmi_oligo2","LFucpa1-2[DGalpNAca1-3]DGalpb1-ROH","A2G(3_D_)-[FUC(2_D_)]-GAL(1_D_)",9.93455,"","",""
"2WMJ","CRYSTAL STRUCTURE OF THE CATALYTIC MODULE OF A FAMILY 98 GLYCOSIDE HYDROLASE FROM STREPTOCOCCUS PNEUMONIAE SP3-BS71 (SP3GH98) IN COMPLEX WITH THE B-TRISACCHARIDE BLOOD GROUP ANTIGEN.","10.1074/JBC.M109.024067 ",2,13.14,"2wmj_oligo2","LFucpa1-2[DGalpa1-3]DGalpb1-ROH","GLA(3_D_)-[FUC(2_D_)]-GAL(1_D_)",7.71394,"","",""
"2WMJ","CRYSTAL STRUCTURE OF THE CATALYTIC MODULE OF A FAMILY 98 GLYCOSIDE HYDROLASE FROM STREPTOCOCCUS PNEUMONIAE SP3-BS71 (SP3GH98) IN COMPLEX WITH THE B-TRISACCHARIDE BLOOD GROUP ANTIGEN.","10.1074/JBC.M109.024067 ",2,13.14,"2wmj_oligo1","LFucpa1-2[DGalpa1-3]DGalpb1-ROH","GLA(3_C_)-[FUC(2_C_)]-GAL(1_C_)",8.72485,"","",""
"2WMK","CRYSTAL STRUCTURE OF THE CATALYTIC MODULE OF A FAMILY 98 GLYCOSIDE HYDROLASE FROM STREPTOCOCCUS PNEUMONIAE SP3-BS71 (SP3GH98) IN COMPLEX WITH THE A-LEWISY PENTASACCHARIDE BLOOD GROUP ANTIGEN.","10.1074/JBC.M109.024067 ",1.9,12.81,"2wmk_oligo1","LFucpa1-2[DGalpNAca1-3]DGalpb1-4[LFucpa1-3]DGlcpNAcb1-ROH","A2G(4_C_)-[FUC(3_C_)]-GAL(2_C_)-[FUC(5_C_)]-NAG(1_C_)",16.7742,"","",""
"2WMK","CRYSTAL STRUCTURE OF THE CATALYTIC MODULE OF A FAMILY 98 GLYCOSIDE HYDROLASE FROM STREPTOCOCCUS PNEUMONIAE SP3-BS71 (SP3GH98) IN COMPLEX WITH THE A-LEWISY PENTASACCHARIDE BLOOD GROUP ANTIGEN.","10.1074/JBC.M109.024067 ",1.9,12.81,"2wmk_oligo2","LFucpa1-2[DGalpNAca1-3]DGalpb1-4[LFucpa1-3]DGlcpNAcb1-ROH","A2G(4_D_)-[FUC(3_D_)]-GAL(2_D_)-[FUC(5_D_)]-NAG(1_D_)",14.8545,"","",""
"2WN2","STRUCTURE OF THE DISCOIDIN I FROM DICTYOSTELIUM DISCOIDEUM IN COMPLEX WITH GALACTOSE BETA 1-3 GALNAC AT 1.8 A RESOLUTION.","10.1016/J.JMB.2010.05.042 ",1.82,9.37,"2wn2_oligo1","DGalpb1-3DGalpNAcb1-ROH","GAL(2_D_)-NGA(1_D_)",12.2764,"","",""
"2WN2","STRUCTURE OF THE DISCOIDIN I FROM DICTYOSTELIUM DISCOIDEUM IN COMPLEX WITH GALACTOSE BETA 1-3 GALNAC AT 1.8 A RESOLUTION.","10.1016/J.JMB.2010.05.042 ",1.82,9.37,"2wn2_oligo3","DGalpb1-3DGalpNAcb1-ROH","GAL(2_F_)-NGA(1_F_)",14.9123,"","",""
"2WN2","STRUCTURE OF THE DISCOIDIN I FROM DICTYOSTELIUM DISCOIDEUM IN COMPLEX WITH GALACTOSE BETA 1-3 GALNAC AT 1.8 A RESOLUTION.","10.1016/J.JMB.2010.05.042 ",1.82,9.37,"2wn2_oligo2","DGalpb1-3DGalpNAcb1-ROH","GAL(2_E_)-NGA(1_E_)",13.6123,"","",""
"2WN3","CRYSTAL STRUCTURE OF DISCOIDIN I FROM DICTYOSTELIUM DISCOIDEUM IN COMPLEX WITH THE DISACCHARIDE GALNAC BETA 1-3 GALACTOSE, AT 1.6 A RESOLUTION.","10.1016/J.JMB.2010.05.042 ",1.59,10.58,"2wn3_oligo1","DGalpNAcb1-3DGalpb1-ROH","NGA(2_D_)-GAL(1_D_)",23.6318,"","",""
"2WN3","CRYSTAL STRUCTURE OF DISCOIDIN I FROM DICTYOSTELIUM DISCOIDEUM IN COMPLEX WITH THE DISACCHARIDE GALNAC BETA 1-3 GALACTOSE, AT 1.6 A RESOLUTION.","10.1016/J.JMB.2010.05.042 ",1.59,10.58,"2wn3_oligo3","DGalpNAcb1-3DGalpb1-ROH","NGA(2_F_)-GAL(1_F_)",28.68,"","",""
"2WN3","CRYSTAL STRUCTURE OF DISCOIDIN I FROM DICTYOSTELIUM DISCOIDEUM IN COMPLEX WITH THE DISACCHARIDE GALNAC BETA 1-3 GALACTOSE, AT 1.6 A RESOLUTION.","10.1016/J.JMB.2010.05.042 ",1.59,10.58,"2wn3_oligo2","DGalpNAcb1-3DGalpb1-ROH","NGA(2_E_)-GAL(1_E_)",27.9445,"","",""
"2WN9","CRYSTAL STRUCTURE OF APLYSIA ACHBP IN COMPLEX WITH 4-0H-DMXBA","10.1038/EMBOJ.2009.227 ",1.75,32.43,"2wn9_oligo11","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(74_A_)",47.5731,"","",""
"2WNB","CRYSTAL STRUCTURE OF A MAMMALIAN SIALYLTRANSFERASE IN COMPLEX WITH DISACCHARIDE AND CMP","10.1038/NSMB.1685 ",1.55,18.63,"2wnb_oligo2","DGalpb1-3DGalpNAca1-C6N1O3","GAL(2_B_)-A2G(1_B_)-CG3(1345_A_)",15.8041,"","",""
"2WNE","MUTANT LAMINARINASE 16A CYCLIZES LAMINARIHEPTAOSE","10.1021/JA909129B ",2.12,13.02,"2wne_oligo2","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-MAN(5_C_)-[MAN(7_C_)]-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(43_A_)",36.013,"","",""
"2WNF","CRYSTAL STRUCTURE OF A MAMMALIAN SIALYLTRANSFERASE IN COMPLEX WITH GAL-BETA-1-3GALNAC-ORTHO-NITROPHENOL","10.1038/NSMB.1685 ",1.25,14.45,"2wnf_oligo1","DGalpb1-3DGalpNAca1-C6N1O3","GAL(2_B_)-A2G(1_B_)-CG3(1344_A_)",16.5055,"","",""
"2WNJ","CRYSTAL STRUCTURE OF APLYSIA ACHBP IN COMPLEX WITH DMXBA","10.1038/EMBOJ.2009.227 ",1.8,36.75,"2wnj_oligo10","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(74_A_)",59.1595,"","",""
"2WQR","THE HIGH RESOLUTION CRYSTAL STRUCTURE OF IGE FC","10.1038/NSMB.2044 ",1.9,47.98,"2wqr_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(394_A_)",104.66,"","",""
"2WQR","THE HIGH RESOLUTION CRYSTAL STRUCTURE OF IGE FC","10.1038/NSMB.2044 ",1.9,47.98,"2wqr_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(394_B_)",70.128,"","",""
"2WR0","STRUCTURES OF INFLUENZA H2 HEMAGGLUTININS","10.1073/PNAS.0906849106 ",2.45,0,"2wr0_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)",83.3924,"","",""
"2WR1","STRUCTURE OF INFLUENZA H2 HEMAGGLUTININ WITH HUMAN RECEPTOR","10.1073/PNAS.0906849106 ",2.1,0,"2wr1_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(4_H_)-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)",56.6624,"","",""
"2WR2","STRUCTURE OF INFLUENZA H2 AVIAN HEMAGGLUTININ WITH AVIAN RECEPTOR","10.1073/PNAS.0906849106 ",2.4,0,"2wr2_oligo2","DNeup5Aca2-3DGalpb1-3DGlcpNAcb1-ROH","SIA(3_E_)-GAL(2_E_)-NAG(1_E_)",66.6668,"","",""
"2WR2","STRUCTURE OF INFLUENZA H2 AVIAN HEMAGGLUTININ WITH AVIAN RECEPTOR","10.1073/PNAS.0906849106 ",2.4,0,"2wr2_oligo1","DNeup5Aca2-3DGalpb1-3DGlcpNAcb1-ROH","SIA(3_D_)-GAL(2_D_)-NAG(1_D_)",84.5097,"","",""
"2WR9","CRYSTAL STRUCTURE OF BURKHOLDERIA CENOCEPACIA LECTIN (BCLA) COMPLEXED WITH AMAN1-3MAN DISACCHARIDE","10.1093/GLYCOB/CWP151 ",1.75,12.52,"2wr9_oligo2","DManpa1-3DManpa1-ROH","MAN(2_F_)-MAN(1_F_)",12.2241,"","",""
"2WR9","CRYSTAL STRUCTURE OF BURKHOLDERIA CENOCEPACIA LECTIN (BCLA) COMPLEXED WITH AMAN1-3MAN DISACCHARIDE","10.1093/GLYCOB/CWP151 ",1.75,12.52,"2wr9_oligo1","DManpa1-3DManpa1-ROH","MAN(2_E_)-MAN(1_E_)",13.9727,"","",""
"2WRA","BCLA LECTIN FROM BURKHOLDERIA CENOCEPACIA COMPLEXED WITH AMAN1(AMAN1- 6)-3MAN TRISACCHARIDE","10.1093/GLYCOB/CWP151 ",1.1,10.22,"2wra_oligo1","DManpa1-3[DManpa1-6]DManpa1-ROH","MAN(3_B_)-[MAN(2_B_)]-MAN(1_B_)",11.7848,"","",""
"2WXD","A MICROMOLAR O-SULFATED THIOHYDROXIMATE INHIBITOR BOUND TO PLANT MYROSINASE","10.1107/S1744309109052865 ",1.6,12.44,"2wxd_oligo6","DXylpb1-2[DManpa1-3][DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","MAN(6_D_)-[MAN(5_D_)]-[XYP(4_D_)]-BMA(3_D_)-NAG(2_D_)-[FUC(7_D_)]-NAG(1_D_)",31.0797,"","",""
"2WXD","A MICROMOLAR O-SULFATED THIOHYDROXIMATE INHIBITOR BOUND TO PLANT MYROSINASE","10.1107/S1744309109052865 ",1.6,12.44,"2wxd_oligo4","DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","BMA(3_C_)-NAG(2_C_)-[FUC(5_C_)]-NAG(1_C_)-ASN(265_M_)",28.2657,"","",""
"2X2T","CRYSTAL STRUCTURE OF SCLEROTINIA SCLEROTIORUM AGGLUTININ SSA IN COMPLEX WITH GAL-BETA1,3-GALNAC","10.1016/J.JMB.2010.05.038 ",1.97,28.77,"2x2t_oligo1","DGalpb1-3DGalpNAcb1-ROH","GAL(2_B_)-NGA(1_B_)",27.2291,"","",""
"2X61","CRYSTAL STRUCTURE OF THE SIALYLTRANSFERASE CST-II IN COMPLEX WITH TRISACCHARIDE ACCEPTOR AND CMP","10.1074/JBC.M111.261172 ",1.95,36.5,"2x61_oligo3","DNeup5Aca2-3DGalpb1-3DGalpNAcb1-ROH","SIA(3_D_)-GAL(2_D_)-NGA(1_D_)",52.5452,"","",""
"2X61","CRYSTAL STRUCTURE OF THE SIALYLTRANSFERASE CST-II IN COMPLEX WITH TRISACCHARIDE ACCEPTOR AND CMP","10.1074/JBC.M111.261172 ",1.95,36.5,"2x61_oligo2","DNeup5Aca2-3DGalpb1-3DGalpNAcb1-ROH","SIA(3_C_)-GAL(2_C_)-NGA(1_C_)",42.1056,"","",""
"2X6W","TAILSPIKE PROTEIN MUTANT E372Q OF E.COLI BACTERIOPHAGE HK620 IN COMPLEX WITH HEXASACCHARIDE","10.1093/GLYCOB/CWS126 ",1.35,10.63,"2x6w_oligo1","LRhapa1-6DGlcpa1-4[DGlcpNAcb1-3]DGalpa1-3[DGlcpa1-6]DGlcpNAca1-ROH","GLC(4_B_)-[RAM(6_B_)-GLC(5_B_)-[NAG(7_B_)]-GLA(2_B_)]-NDG(1_B_)",13.0438,"","",""
"2X6Y","TAILSPIKE PROTEIN MUTANT D339A OF E.COLI BACTERIOPHAGE HK620 IN COMPLEX WITH HEXASACCHARIDE","10.1093/GLYCOB/CWS126 ",1.35,13.8,"2x6y_oligo1","LRhapa1-6DGlcpa1-4[DGlcpNAcb1-3]DGalpa1-3[DGlcpa1-6]DGlcpNAcb1-ROH","GLC(6_B_)-[RAM(4_B_)-GLC(3_B_)-[NAG(5_B_)]-GLA(2_B_)]-NAG(1_B_)",12.2433,"","",""
"2X72","CRYSTAL STRUCTURE OF THE CONSTITUTIVELY ACTIVE E113Q,D2C,D282C RHODOPSIN MUTANT WITH BOUND GALPHACT PEPTIDE.","10.1038/NATURE09795 ",3,80.4,"2x72_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(15_A_)",83.7405,"","",""
"2X85","TAILSPIKE PROTEIN OF E. COLI BACTERIOPHAGE HK620 IN COMPLEX WITH HEXASACCHARIDE","10.1093/GLYCOB/CWS126 ",1.5,14.9,"2x85_oligo1","LRhapa1-6DGlcpa1-4[DGlcpNAcb1-3]DGalpa1-3[DGlcpa1-6]DGlcpNAcb1-ROH","GLC(6_B_)-[RAM(4_B_)-GLC(3_B_)-[NAG(5_B_)]-GLA(2_B_)]-NAG(1_B_)",15.8244,"","",""
"2X8Y","CRYSTAL STRUCTURE OF ANCE","10.1016/J.JMB.2010.05.024 ",1.9,34.91,"2x8y_oligo1","DManpb1-6DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[BMA(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(196_A_)",55.2003,"","",""
"2X8Z","CRYSTAL STRUCTURE OF ANCE-CAPTOPRIL COMPLEX","10.1016/J.JMB.2010.05.024 ",1.98,30.9,"2x8z_oligo2","DManpb1-6DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[BMA(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(196_A_)",50.0815,"","",""
"2X90","CRYSTAL STRUCTURE OF ANCE-ENALAPRILAT COMPLEX","10.1016/J.JMB.2010.05.024 ",1.98,27.66,"2x90_oligo4","DManpb1-6DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[BMA(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(196_A_)",44.6505,"","",""
"2X91","CRYSTAL STRUCTURE OF ANCE-LISINOPRIL COMPLEX","10.1016/J.JMB.2010.05.024 ",1.98,29.73,"2x91_oligo4","DManpb1-6DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[BMA(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(196_A_)",53.837,"","",""
"2X92","CRYSTAL STRUCTURE OF ANCE-RAMIPRILAT COMPLEX","10.1016/J.JMB.2010.05.024 ",2.11,22.46,"2x92_oligo2","DManpb1-6DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[BMA(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(196_A_)",37.793,"","",""
"2X93","CRYSTAL STRUCTURE OF ANCE-TRANDOLAPRILAT COMPLEX","10.1016/J.JMB.2010.05.024 ",1.98,25.7,"2x93_oligo3","DManpb1-6DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[BMA(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(196_A_)",45.6244,"","",""
"2X94","CRYSTAL STRUCTURE OF ANCE-PERINDOPRILAT COMPLEX","10.1016/J.JMB.2010.05.024 ",1.88,29.53,"2x94_oligo2","DManpb1-6DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[BMA(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(196_A_)",46.5421,"","",""
"2X95","CRYSTAL STRUCTURE OF ANCE-LISINOPRIL-TRYPTOPHAN ANALOGUE, LISW-S COMPLEX","10.1016/J.JMB.2010.05.024 ",1.96,28.5,"2x95_oligo4","DManpb1-6DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[BMA(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(196_A_)",48.0124,"","",""
"2X96","CRYSTAL STRUCTURE OF ANCE-RXPA380 COMPLEX","10.1016/J.JMB.2010.05.024 ",1.85,29.84,"2x96_oligo2","DManpb1-6DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[BMA(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(196_A_)",50.0386,"","",""
"2X97","CRYSTAL STRUCTURE OF ANCE-RXP407 COMPLEX","10.1016/J.JMB.2010.05.024 ",1.85,28.46,"2x97_oligo1","DManpb1-6DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[BMA(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(196_A_)",44.8682,"","",""
"2XEF","HUMAN GLUTAMATE CARBOXYPEPTIDASE II IN COMPLEX WITH ANTIBODY- RECRUITING MOLECULE ARM-P8","10.1021/JA104591M ",1.59,26.23,"2xef_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(638_A_)",34.1968,"","",""
"2XEG","HUMAN GLUTAMATE CARBOXYPEPTIDASE II IN COMPLEX WITH ANTIBODY- RECRUITING MOLECULE ARM-P4","10.1021/JA104591M ",1.59,25.82,"2xeg_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(638_A_)",34.7427,"","",""
"2XEI","HUMAN GLUTAMATE CARBOXYPEPTIDASE II IN COMPLEX WITH ANTIBODY- RECRUITING MOLECULE ARM-P2","10.1021/JA104591M ",1.69,29.09,"2xei_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(638_A_)",39.0523,"","",""
"2XEJ","HUMAN GLUTAMATE CARBOXYPEPTIDASE II IN COMPLEX WITH ARM-M4, UREA- BASED INHIBITOR","10.1021/JA104591M ",1.78,27.09,"2xej_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(638_A_)",37.9189,"","",""
"2XHM","CRYSTAL STRUCTURE OF ANCE-K26 COMPLEX","10.1016/J.BBRC.2010.06.113 ",1.96,32.74,"2xhm_oligo2","DManpb1-6DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[BMA(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(196_A_)",53.447,"","",""
"2XJR","X-RAY STRUCTURE OF THE N-TERMINAL DOMAIN OF THE FLOCCULIN FLO5 FROM SACCHAROMYCES CEREVISIAE IN COMPLEX WITH CALCIUM AND MAN5(D2-D3)","10.1073/PNAS.1013210108 ",1.25,10.39,"2xjr_oligo1","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-ROH","MAN(4_B_)-[MAN(3_B_)-MAN(2_B_)]-MAN(1_B_)",22.6868,"","",""
"2XQR","CRYSTAL STRUCTURE OF PLANT CELL WALL INVERTASE IN COMPLEX WITH A SPECIFIC PROTEIN INHIBITOR","10.1073/PNAS.1004481107 ",2.58,31.26,"2xqr_oligo9","DManpa1-2DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAca1-4DGlcpNAca1-ASN","BMA(6_O_)-[MAN(5_O_)-MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(299_C_)",36.2789,"","",""
"2XQR","CRYSTAL STRUCTURE OF PLANT CELL WALL INVERTASE IN COMPLEX WITH A SPECIFIC PROTEIN INHIBITOR","10.1073/PNAS.1004481107 ",2.58,31.26,"2xqr_oligo11","DManpa1-2DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAca1-4DGlcpNAca1-ASN","BMA(6_Q_)-[MAN(5_Q_)-MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(299_E_)",42.0606,"","",""
"2XQR","CRYSTAL STRUCTURE OF PLANT CELL WALL INVERTASE IN COMPLEX WITH A SPECIFIC PROTEIN INHIBITOR","10.1073/PNAS.1004481107 ",2.58,31.26,"2xqr_oligo13","DManpa1-2DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAca1-4DGlcpNAca1-ASN","BMA(6_S_)-[MAN(5_S_)-MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(299_G_)",34.5776,"","",""
"2XQR","CRYSTAL STRUCTURE OF PLANT CELL WALL INVERTASE IN COMPLEX WITH A SPECIFIC PROTEIN INHIBITOR","10.1073/PNAS.1004481107 ",2.58,31.26,"2xqr_oligo15","DManpa1-2DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAca1-4DGlcpNAca1-ASN","BMA(6_U_)-[MAN(5_U_)-MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(299_I_)",32.8621,"","",""
"2XQR","CRYSTAL STRUCTURE OF PLANT CELL WALL INVERTASE IN COMPLEX WITH A SPECIFIC PROTEIN INHIBITOR","10.1073/PNAS.1004481107 ",2.58,31.26,"2xqr_oligo7","DManpa1-2DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAca1-4DGlcpNAca1-ASN","BMA(6_M_)-[MAN(5_M_)-MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(299_A_)",32.0432,"","",""
"2XQR","CRYSTAL STRUCTURE OF PLANT CELL WALL INVERTASE IN COMPLEX WITH A SPECIFIC PROTEIN INHIBITOR","10.1073/PNAS.1004481107 ",2.58,31.26,"2xqr_oligo17","DManpa1-2DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAca1-4DGlcpNAca1-ASN","BMA(6_W_)-[MAN(5_W_)-MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(299_K_)",35.6364,"","",""
"2XRQ","CRYSTAL STRUCTURES EXPLORING THE ORIGINS OF THE BROADER SPECIFICITY OF ESCHERICHIA COLI HEAT-LABILE ENTEROTOXIN COMPARED TO CHOLERA TOXIN","10.1016/J.JMB.2010.11.060 ",2.4,49.67,"2xrq_oligo2","DGalpb1-3DGalpNAcb1-4[DNeup5Aca2-3]DGalpb1-4DGlcpb1-ROH","GAL(4_B_)-NGA(3_B_)-[SIA(5_B_)]-GAL(2_B_)-BGC(1_B_)",63.7255,"","",""
"2XRQ","CRYSTAL STRUCTURES EXPLORING THE ORIGINS OF THE BROADER SPECIFICITY OF ESCHERICHIA COLI HEAT-LABILE ENTEROTOXIN COMPARED TO CHOLERA TOXIN","10.1016/J.JMB.2010.11.060 ",2.4,49.67,"2xrq_oligo5","DGalpb1-3DGalpNAcb1-4[DNeup5Aca2-3]DGalpb1-4DGlcpb1-ROH","GAL(4_I_)-NGA(3_I_)-[SIA(5_I_)]-GAL(2_I_)-BGC(1_I_)",69.775,"","",""
"2XRQ","CRYSTAL STRUCTURES EXPLORING THE ORIGINS OF THE BROADER SPECIFICITY OF ESCHERICHIA COLI HEAT-LABILE ENTEROTOXIN COMPARED TO CHOLERA TOXIN","10.1016/J.JMB.2010.11.060 ",2.4,49.67,"2xrq_oligo3","DGalpb1-3DGalpNAcb1-4[DNeup5Aca2-3]DGalpb1-4DGlcpb1-ROH","GAL(4_J_)-NGA(3_J_)-[SIA(5_J_)]-GAL(2_J_)-BGC(1_J_)",65.1885,"","",""
"2XRQ","CRYSTAL STRUCTURES EXPLORING THE ORIGINS OF THE BROADER SPECIFICITY OF ESCHERICHIA COLI HEAT-LABILE ENTEROTOXIN COMPARED TO CHOLERA TOXIN","10.1016/J.JMB.2010.11.060 ",2.4,49.67,"2xrq_oligo4","DGalpb1-3DGalpNAcb1-4[DNeup5Aca2-3]DGalpb1-4DGlcpb1-ROH","GAL(4_C_)-NGA(3_C_)-[SIA(5_C_)]-GAL(2_C_)-BGC(1_C_)",70.5275,"","",""
"2XRQ","CRYSTAL STRUCTURES EXPLORING THE ORIGINS OF THE BROADER SPECIFICITY OF ESCHERICHIA COLI HEAT-LABILE ENTEROTOXIN COMPARED TO CHOLERA TOXIN","10.1016/J.JMB.2010.11.060 ",2.4,49.67,"2xrq_oligo1","DGalpb1-3DGalpNAcb1-4[DNeup5Aca2-3]DGalpb1-4DGlcpb1-ROH","GAL(4_A_)-NGA(3_A_)-[SIA(5_A_)]-GAL(2_A_)-BGC(1_A_)",58.875,"","",""
"2XWD","X-RAY STRUCTURE OF ACID-BETA-GLUCOSIDASE WITH 5N,6O-(N'-(N-OCTYL) IMINO)NOJIRIMYCIN IN THE ACTIVE SITE","10.1039/C1OB05200D ",2.66,14.3,"2xwd_oligo1","DManpa1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(3_C_)-NAG(2_C_)-[FUC(4_C_)]-NAG(1_C_)-ASN(19_A_)",55.3898,"","",""
"2XWD","X-RAY STRUCTURE OF ACID-BETA-GLUCOSIDASE WITH 5N,6O-(N'-(N-OCTYL) IMINO)NOJIRIMYCIN IN THE ACTIVE SITE","10.1039/C1OB05200D ",2.66,14.3,"2xwd_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","BMA(3_D_)-NAG(2_D_)-[FUC(4_D_)]-NAG(1_D_)-ASN(19_B_)",41.8298,"","",""
"2XWE","X-RAY STRUCTURE OF ACID-BETA-GLUCOSIDASE WITH 5N,6S-(N'-(N-OCTYL) IMINO)-6-THIONOJIRIMYCIN IN THE ACTIVE SITE","10.1039/C1OB05200D ",2.31,21.34,"2xwe_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","BMA(3_C_)-NAG(2_C_)-[FUC(4_C_)]-NAG(1_C_)-ASN(19_A_)",54.4955,"","",""
"2XWE","X-RAY STRUCTURE OF ACID-BETA-GLUCOSIDASE WITH 5N,6S-(N'-(N-OCTYL) IMINO)-6-THIONOJIRIMYCIN IN THE ACTIVE SITE","10.1039/C1OB05200D ",2.31,21.34,"2xwe_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","BMA(3_D_)-NAG(2_D_)-[FUC(4_D_)]-NAG(1_D_)-ASN(19_B_)",49.382,"","",""
"2Y69","BOVINE HEART CYTOCHROME C OXIDASE RE-REFINED WITH MOLECULAR OXYGEN","10.1016/J.BBABIO.2010.12.016 ",1.95,45.54,"2y69_oligo2","DManpa1-3DGulpb6-C10O1","DMU(1044_M_)-DMU(1044_M_)",55.6814,"","",""
"2Y69","BOVINE HEART CYTOCHROME C OXIDASE RE-REFINED WITH MOLECULAR OXYGEN","10.1016/J.BBABIO.2010.12.016 ",1.95,45.54,"2y69_oligo1","DManpa1-3DGulpb6-C10O1","DMU(1043_Z_)-DMU(1043_Z_)",86.6659,"","",""
"2Y7Q","THE HIGH-AFFINITY COMPLEX BETWEEN IGE AND ITS RECEPTOR FC EPSILON RI","10.1038/NSMB.2044 ",3.4,0,"2y7q_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(42_A_)",76.3495,"","",""
"2YGM","THE X-RAY CRYSTAL STRUCTURE OF TANDEM CBM51 MODULES OF SP3GH98, THE FAMILY 98 GLYCOSIDE HYDROLASE FROM STREPTOCOCCUS PNEUMONIAE SP3-BS71, IN COMPLEX WITH THE BLOOD GROUP B ANTIGEN","10.1016/J.JMB.2011.06.035 ",2.35,46.31,"2ygm_oligo1","LFucpa1-2[DGalpa1-3]DGalpb1-4DGlcpNAcb1-ROH","GLA(4_C_)-[FUC(3_C_)]-GAL(2_C_)-NAG(1_C_)",57.0159,"","",""
"2YGM","THE X-RAY CRYSTAL STRUCTURE OF TANDEM CBM51 MODULES OF SP3GH98, THE FAMILY 98 GLYCOSIDE HYDROLASE FROM STREPTOCOCCUS PNEUMONIAE SP3-BS71, IN COMPLEX WITH THE BLOOD GROUP B ANTIGEN","10.1016/J.JMB.2011.06.035 ",2.35,46.31,"2ygm_oligo2","LFucpa1-2[DGalpa1-3]DGalpb1-4DGlcpNAcb1-ROH","GLA(4_D_)-[FUC(3_D_)]-GAL(2_D_)-NAG(1_D_)",52.5709,"","",""
"2YL9","INHIBITION OF THE PNEUMOCOCCAL VIRULENCE FACTOR STRH AND MOLECULAR INSIGHTS INTO N-GLYCAN RECOGNITION AND HYDROLYSIS","10.1016/J.STR.2011.08.011 ",2.65,15.6,"2yl9_oligo4","DGlcpNAcb1-2DManpa1-3DManpb1-4DGlcpNAcb1-ROH","NAG(4_H_)-MAN(3_H_)-BMA(2_H_)-NAG(1_H_)",58.663,"","",""
"2YL9","INHIBITION OF THE PNEUMOCOCCAL VIRULENCE FACTOR STRH AND MOLECULAR INSIGHTS INTO N-GLYCAN RECOGNITION AND HYDROLYSIS","10.1016/J.STR.2011.08.011 ",2.65,15.6,"2yl9_oligo1","DGlcpNAcb1-2DManpa1-3DManpb1-4DGlcpNAcb1-ROH","NAG(4_E_)-MAN(3_E_)-BMA(2_E_)-NAG(1_E_)",60.2673,"","",""
"2YL9","INHIBITION OF THE PNEUMOCOCCAL VIRULENCE FACTOR STRH AND MOLECULAR INSIGHTS INTO N-GLYCAN RECOGNITION AND HYDROLYSIS","10.1016/J.STR.2011.08.011 ",2.65,15.6,"2yl9_oligo2","DGlcpNAcb1-2DManpa1-3DManpb1-4DGlcpNAcb1-ROH","NAG(4_F_)-MAN(3_F_)-BMA(2_F_)-NAG(1_F_)",52.9502,"","",""
"2YL9","INHIBITION OF THE PNEUMOCOCCAL VIRULENCE FACTOR STRH AND MOLECULAR INSIGHTS INTO N-GLYCAN RECOGNITION AND HYDROLYSIS","10.1016/J.STR.2011.08.011 ",2.65,15.6,"2yl9_oligo3","DGlcpNAcb1-2DManpa1-3DManpb1-4DGlcpNAcb1-ROH","NAG(4_G_)-MAN(3_G_)-BMA(2_G_)-NAG(1_G_)",61.57,"","",""
"2YLA","INHIBITION OF THE PNEUMOCOCCAL VIRULENCE FACTOR STRH AND MOLECULAR INSIGHTS INTO N-GLYCAN RECOGNITION AND HYDROLYSIS","10.1016/J.STR.2011.08.011 ",2.7,14.6,"2yla_oligo3","DGlcpNAcb1-2DManpa1-3DManpb1-4DGlcpNAcb1-ROH","NAG(4_G_)-MAN(3_G_)-BMA(2_G_)-NAG(1_G_)",56.7895,"","",""
"2YLA","INHIBITION OF THE PNEUMOCOCCAL VIRULENCE FACTOR STRH AND MOLECULAR INSIGHTS INTO N-GLYCAN RECOGNITION AND HYDROLYSIS","10.1016/J.STR.2011.08.011 ",2.7,14.6,"2yla_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-4]DManpb1-4DGlcpNAcb1-ROH","NAG(5_F_)-[NAG(4_F_)-MAN(3_F_)]-BMA(2_F_)-NAG(1_F_)",59.0691,"","",""
"2YLA","INHIBITION OF THE PNEUMOCOCCAL VIRULENCE FACTOR STRH AND MOLECULAR INSIGHTS INTO N-GLYCAN RECOGNITION AND HYDROLYSIS","10.1016/J.STR.2011.08.011 ",2.7,14.6,"2yla_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-4]DManpb1-4DGlcpNAcb1-ROH","NAG(5_E_)-[NAG(4_E_)-MAN(3_E_)]-BMA(2_E_)-NAG(1_E_)",68.9054,"","",""
"2YLA","INHIBITION OF THE PNEUMOCOCCAL VIRULENCE FACTOR STRH AND MOLECULAR INSIGHTS INTO N-GLYCAN RECOGNITION AND HYDROLYSIS","10.1016/J.STR.2011.08.011 ",2.7,14.6,"2yla_oligo4","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-4]DManpb1-4DGlcpNAcb1-ROH","NAG(5_H_)-[NAG(4_H_)-MAN(3_H_)]-BMA(2_H_)-NAG(1_H_)",62.5293,"","",""
"2YOR","CRYSTALLIZATION OF A 45 KDA PEROXYGENASE- PEROXIDASE FROM THE MUSHROOM AGROCYBE AEGERITA AND STRUCTURE DETERMINATION BY SAD UTILIZING ONLY THE HAEM IRON","10.1074/JBC.M113.514521 ",2.19,23.29,"2yor_oligo3","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-MAN(5_F_)-[MAN(7_F_)]-MAN(4_F_)-[MAN(8_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(141_B_)",45.1475,"","",""
"2YOR","CRYSTALLIZATION OF A 45 KDA PEROXYGENASE- PEROXIDASE FROM THE MUSHROOM AGROCYBE AEGERITA AND STRUCTURE DETERMINATION BY SAD UTILIZING ONLY THE HAEM IRON","10.1074/JBC.M113.514521 ",2.19,23.29,"2yor_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(161_A_)",66.012,"","",""
"2YP1","CRYSTALLIZATION OF A 45 KDA PEROXYGENASE- PEROXIDASE FROM THE MUSHROOM AGROCYBE AEGERITA AND STRUCTURE DETERMINATION BY SAD UTILIZING ONLY THE HAEM IRON","10.1074/JBC.M113.514521 ",2.31,29.92,"2yp1_oligo5","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(141_B_)",59.7496,"","",""
"2YP1","CRYSTALLIZATION OF A 45 KDA PEROXYGENASE- PEROXIDASE FROM THE MUSHROOM AGROCYBE AEGERITA AND STRUCTURE DETERMINATION BY SAD UTILIZING ONLY THE HAEM IRON","10.1074/JBC.M113.514521 ",2.31,29.92,"2yp1_oligo8","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_M_)-[MAN(7_M_)]-MAN(6_M_)-[MAN(5_M_)-MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(286_B_)",38.5319,"","",""
"2YP1","CRYSTALLIZATION OF A 45 KDA PEROXYGENASE- PEROXIDASE FROM THE MUSHROOM AGROCYBE AEGERITA AND STRUCTURE DETERMINATION BY SAD UTILIZING ONLY THE HAEM IRON","10.1074/JBC.M113.514521 ",2.31,29.92,"2yp1_oligo4","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-[MAN(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(141_A_)",54.2694,"","",""
"2YP1","CRYSTALLIZATION OF A 45 KDA PEROXYGENASE- PEROXIDASE FROM THE MUSHROOM AGROCYBE AEGERITA AND STRUCTURE DETERMINATION BY SAD UTILIZING ONLY THE HAEM IRON","10.1074/JBC.M113.514521 ",2.31,29.92,"2yp1_oligo2","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_H_)-[MAN(7_H_)]-MAN(6_H_)-[MAN(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(286_A_)",52.0392,"","",""
"2Z8D","THE GALACTO-N-BIOSE-/LACTO-N-BIOSE I-BINDING PROTEIN (GL-BP) OF THE ABC TRANSPORTER FROM BIFIDOBACTERIUM LONGUM IN COMPLEX WITH LACTO-N- BIOSE","10.1074/JBC.M709777200 ",1.85,25.49,"2z8d_oligo4","DGalpb1-3DGlcpNAcb1-ROH","GAL(2_D_)-NAG(1_D_)",16.4495,"","",""
"2Z8D","THE GALACTO-N-BIOSE-/LACTO-N-BIOSE I-BINDING PROTEIN (GL-BP) OF THE ABC TRANSPORTER FROM BIFIDOBACTERIUM LONGUM IN COMPLEX WITH LACTO-N- BIOSE","10.1074/JBC.M709777200 ",1.85,25.49,"2z8d_oligo3","DGalpb1-3DGlcpNAcb1-ROH","GAL(2_C_)-NAG(1_C_)",17.0177,"","",""
"2Z8E","THE GALACTO-N-BIOSE-/LACTO-N-BIOSE I-BINDING PROTEIN (GL-BP) OF THE ABC TRANSPORTER FROM BIFIDOBACTERIUM LONGUM IN COMPLEX WITH GALACTO- N-BIOSE","10.1074/JBC.M709777200 ",1.99,25.27,"2z8e_oligo3","DGalpb1-3DGalpNAcb1-ROH","GAL(2_C_)-NGA(1_C_)",19.0195,"","",""
"2Z8E","THE GALACTO-N-BIOSE-/LACTO-N-BIOSE I-BINDING PROTEIN (GL-BP) OF THE ABC TRANSPORTER FROM BIFIDOBACTERIUM LONGUM IN COMPLEX WITH GALACTO- N-BIOSE","10.1074/JBC.M709777200 ",1.99,25.27,"2z8e_oligo4","DGalpb1-3DGalpNAcb1-ROH","GAL(2_D_)-NGA(1_D_)",16.7832,"","",""
"2Z8F","THE GALACTO-N-BIOSE-/LACTO-N-BIOSE I-BINDING PROTEIN (GL-BP) OF THE ABC TRANSPORTER FROM BIFIDOBACTERIUM LONGUM IN COMPLEX WITH LACTO-N- TETRAOSE","10.1074/JBC.M709777200 ",1.65,25.76,"2z8f_oligo2","DGalpb1-3DGlcpNAcb1-3DGalpb1-4DGlcpb1-ROH","GAL(4_D_)-NAG(3_D_)-GAL(2_D_)-BGC(1_D_)",28.0827,"","",""
"2Z8F","THE GALACTO-N-BIOSE-/LACTO-N-BIOSE I-BINDING PROTEIN (GL-BP) OF THE ABC TRANSPORTER FROM BIFIDOBACTERIUM LONGUM IN COMPLEX WITH LACTO-N- TETRAOSE","10.1074/JBC.M709777200 ",1.65,25.76,"2z8f_oligo1","DGalpb1-3DGlcpNAcb1-3DGalpb1-4DGlcpb1-ROH","GAL(4_C_)-NAG(3_C_)-GAL(2_C_)-BGC(1_C_)",20.8136,"","",""
"2Z8L","CRYSTAL STRUCTURE OF THE STAPHYLOCOCCAL SUPERANTIGEN-LIKE PROTEIN SSL5 AT PH 4.6 COMPLEXED WITH SIALYL LEWIS X","10.1016/J.JMB.2007.09.091 ",1.65,16.92,"2z8l_oligo1","DNeup5Aca2-3DGalpb1-4[LFucpa1-3]DGlcpNAcb1-ROH","SIA(3_B_)-GAL(2_B_)-[FUC(4_B_)]-NAG(1_B_)",35.2537,"","",""
"2ZL6","ATOMIC RESOLUTION STRUCTURAL CHARACTERIZATION OF RECOGNITION OF HISTO- BLOOD GROUP ANTIGENS BY NORWALK VIRUS","10.1073/PNAS.0803275105 ",1.43,18.63,"2zl6_oligo1","LFucpa1-2DGalpb1-3DGlcpNAcb1-3DGalpb1-4DGlcpb1-ROH","FUC(5_C_)-GAL(4_C_)-NAG(3_C_)-GAL(2_C_)-BGC(1_C_)",23.5916,"","",""
"2ZL7","ATOMIC RESOLUTION STRUCTURAL CHARACTERIZATION OF RECOGNITION OF HISTO- BLOOD GROUP ANTIGENS BY NORWALK VIRUS","10.1073/PNAS.0803275105 ",1.35,11.82,"2zl7_oligo1","LFucpa1-2[DGalpNAca1-3]DGalpb1-ROH","NGA(3_C_)-[FUC(2_C_)]-GAL(1_C_)",14.7258,"","",""
"2ZMK","CRYSTL STRUCTURE OF BASIC WINGED BEAN LECTIN IN COMPLEX WITH GAL- ALPHA-1,4-GAL-BETA-ETHYLENE","10.1107/S0907444908011323 ",2.5,45.4,"2zmk_oligo9","LFucpa1-3DGlcpNAcb1-ASN","FUC(2_L_)-NAG(1_L_)-ASN(44_C_)",76.5445,"","",""
"2ZMK","CRYSTL STRUCTURE OF BASIC WINGED BEAN LECTIN IN COMPLEX WITH GAL- ALPHA-1,4-GAL-BETA-ETHYLENE","10.1107/S0907444908011323 ",2.5,45.4,"2zmk_oligo2","LFucpa1-3DGlcpNAcb1-ASN","FUC(2_E_)-NAG(1_E_)-ASN(219_A_)",67.4373,"","",""
"2ZMK","CRYSTL STRUCTURE OF BASIC WINGED BEAN LECTIN IN COMPLEX WITH GAL- ALPHA-1,4-GAL-BETA-ETHYLENE","10.1107/S0907444908011323 ",2.5,45.4,"2zmk_oligo6","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_F_)-[FUC(2_F_)]-NAG(1_F_)-ASN(44_A_)",83.5185,"","",""
"2ZMK","CRYSTL STRUCTURE OF BASIC WINGED BEAN LECTIN IN COMPLEX WITH GAL- ALPHA-1,4-GAL-BETA-ETHYLENE","10.1107/S0907444908011323 ",2.5,45.4,"2zmk_oligo7","LFucpa1-3DGlcpNAcb1-ASN","FUC(2_H_)-NAG(1_H_)-ASN(219_B_)",80.4059,"","",""
"2ZMK","CRYSTL STRUCTURE OF BASIC WINGED BEAN LECTIN IN COMPLEX WITH GAL- ALPHA-1,4-GAL-BETA-ETHYLENE","10.1107/S0907444908011323 ",2.5,45.4,"2zmk_oligo10","LFucpa1-3DGlcpNAcb1-ASN","FUC(2_M_)-NAG(1_M_)-ASN(219_D_)",95.7114,"","",""
"2ZMK","CRYSTL STRUCTURE OF BASIC WINGED BEAN LECTIN IN COMPLEX WITH GAL- ALPHA-1,4-GAL-BETA-ETHYLENE","10.1107/S0907444908011323 ",2.5,45.4,"2zmk_oligo11","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_N_)-[FUC(2_N_)]-NAG(1_N_)-ASN(44_D_)",90.1809,"","",""
"2ZML","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN IN COMPLEX WITH GAL- ALPHA 1,4 GAL","10.1107/S0907444908011323 ",2.65,26.5,"2zml_oligo4","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_H_)-[FUC(2_H_)]-NAG(1_H_)-ASN(219_B_)",57.3767,"","",""
"2ZML","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN IN COMPLEX WITH GAL- ALPHA 1,4 GAL","10.1107/S0907444908011323 ",2.65,26.5,"2zml_oligo1","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_F_)-[FUC(2_F_)]-NAG(1_F_)-ASN(219_A_)",43.1148,"","",""
"2ZML","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN IN COMPLEX WITH GAL- ALPHA 1,4 GAL","10.1107/S0907444908011323 ",2.65,26.5,"2zml_oligo7","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_K_)-[FUC(2_K_)]-NAG(1_K_)-ASN(219_C_)",45.0803,"","",""
"2ZML","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN IN COMPLEX WITH GAL- ALPHA 1,4 GAL","10.1107/S0907444908011323 ",2.65,26.5,"2zml_oligo5","LFucpa1-3DGlcpNAcb1-ASN","FUC(2_I_)-NAG(1_I_)-ASN(44_B_)",48.29,"","",""
"2ZMN","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN IN COMPLEX WITH GAL- ALPHA- 1,6 GLC","10.1107/S0907444908011323 ",2.9,32.8,"2zmn_oligo6","LFucpa1-3DGlcpNAcb1-ASN","FUC(2_F_)-NAG(1_F_)-ASN(44_A_)",59.5373,"","",""
"2ZMN","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN IN COMPLEX WITH GAL- ALPHA- 1,6 GLC","10.1107/S0907444908011323 ",2.9,32.8,"2zmn_oligo11","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_N_)-[FUC(2_N_)]-NAG(1_N_)-ASN(44_D_)",74.247,"","",""
"2ZMN","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN IN COMPLEX WITH GAL- ALPHA- 1,6 GLC","10.1107/S0907444908011323 ",2.9,32.8,"2zmn_oligo8","LFucpa1-3DGlcpNAcb1-ASN","FUC(2_I_)-NAG(1_I_)-ASN(44_B_)",57.3677,"","",""
"2ZMN","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN IN COMPLEX WITH GAL- ALPHA- 1,6 GLC","10.1107/S0907444908011323 ",2.9,32.8,"2zmn_oligo2","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_E_)-[FUC(2_E_)]-NAG(1_E_)-ASN(219_A_)",58.0382,"","",""
"2ZMN","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN IN COMPLEX WITH GAL- ALPHA- 1,6 GLC","10.1107/S0907444908011323 ",2.9,32.8,"2zmn_oligo9","DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","BMA(3_K_)-NAG(2_K_)-[FUC(4_K_)]-NAG(1_K_)-ASN(219_C_)",60.7132,"","",""
"2ZMN","CRYSTAL STRUCTURE OF BASIC WINGED BEAN LECTIN IN COMPLEX WITH GAL- ALPHA- 1,6 GLC","10.1107/S0907444908011323 ",2.9,32.8,"2zmn_oligo7","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_H_)-[FUC(2_H_)]-NAG(1_H_)-ASN(219_B_)",66.4676,"","",""
"2ZXW","BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE (1-S X- RAY EXPOSURE DATASET)","10.1073/PNAS.0806391106 ",2.5,0,"2zxw_oligo3","DManpa1-3DAllpa6-C10O1","DMU(272_C_)-DMU(272_C_)",101.485,"","",""
"2ZXW","BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE (1-S X- RAY EXPOSURE DATASET)","10.1073/PNAS.0806391106 ",2.5,0,"2zxw_oligo1","DManpa1-3DAllpa6-C10O1","DMU(526_M_)-DMU(526_M_)",46.5532,"","",""
"3A0E","CRYSTAL STRUCTURE OF POLYGONATUM CYRTONEMA LECTIN (PCL) COMPLEXED WITH DIMANNOSIDE","10.1016/J.JSB.2010.05.009 ",2,24.4,"3a0e_oligo1","DManpa1-3DManpa1-ROH","MAN(2_B_)-MAN(1_B_)",28.0036,"","",""
"3A5V","CRYSTAL STRUCTURE OF ALPHA-GALACTOSIDASE I FROM MORTIERELLA VINACEA","10.1271/BBB.90604 ",2,18.99,"3a5v_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[MAN(5_B_)]-MAN(4_B_)-[MAN(7_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(155_A_)",45.0086,"","",""
"3ABG","X-RAY CRYSTAL ANALYSIS OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA AT 2.3 ANGSTROM RESOLUTION USING A TWIN CRYSTAL","10.1107/S1744309110018828 ",2.3,41.28,"3abg_oligo3","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(472_B_)",54.8151,"","",""
"3ABK","BOVINE HEART CYTOCHROME C OXIDASE AT THE NO-BOUND FULLY REDUCED STATE (50K)","10.1107/S1744309109055109 ",2,0,"3abk_oligo1","DManpa1-3DAllpa6-C10O1","DMU(1526_Z_)-DMU(1526_Z_)",62.9782,"","",""
"3ABK","BOVINE HEART CYTOCHROME C OXIDASE AT THE NO-BOUND FULLY REDUCED STATE (50K)","10.1107/S1744309109055109 ",2,0,"3abk_oligo3","DManpa1-3DAllpb6-C10O1","DMU(526_M_)-DMU(526_M_)",55.7268,"","",""
"3ABL","BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE (15-S X-RAY EXPOSURE DATASET)","10.1073/PNAS.0806391106 ",2.1,0,"3abl_oligo2","DManpa1-3DAllpa6-C10O1","DMU(1526_Z_)-DMU(1526_Z_)",56.1618,"","",""
"3ABL","BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE (15-S X-RAY EXPOSURE DATASET)","10.1073/PNAS.0806391106 ",2.1,0,"3abl_oligo4","DManpa1-3DAllpb6-C10O1","DMU(526_M_)-DMU(526_M_)",49.4254,"","",""
"3ABM","BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE (200-S X-RAY EXPOSURE DATASET)","10.1073/PNAS.0806391106 ",1.95,0,"3abm_oligo3","DManpa1-3DAllpb6-C10O1","DMU(526_M_)-DMU(526_M_)",54.6345,"","",""
"3ABM","BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE (200-S X-RAY EXPOSURE DATASET)","10.1073/PNAS.0806391106 ",1.95,0,"3abm_oligo1","DManpa1-3DAllpa6-C10O1","DMU(1526_Z_)-DMU(1526_Z_)",60.11,"","",""
"3AFK","CRYSTAL STRUCTURE OF AGROCYBE AEGERITA LECTIN AAL COMPLEXED WITH THOMSEN-FRIEDENREICH ANTIGEN","10.1096/FJ.10-159111 ",1.95,14.27,"3afk_oligo2","DGalpb1-3DGalpNAca1-THR","GAL(2_D_)-A2G(1_D_)-THR(242_B_)",11.2382,"","",""
"3AFK","CRYSTAL STRUCTURE OF AGROCYBE AEGERITA LECTIN AAL COMPLEXED WITH THOMSEN-FRIEDENREICH ANTIGEN","10.1096/FJ.10-159111 ",1.95,14.27,"3afk_oligo1","DGalpb1-3DGalpNAca1-THR","GAL(2_C_)-A2G(1_C_)-THR(242_A_)",11.5495,"","",""
"3AG1","BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND FULLY REDUCED STATE AT 280 K","10.1073/PNAS.0910410107 ",2.2,0,"3ag1_oligo3","DManpa1-3DAllpa6-C10O1","DMU(1272_T_)-DMU(1272_T_)",140.265,"","",""
"3AG2","BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND FULLY REDUCED STATE AT 100 K","10.1073/PNAS.0910410107 ",1.8,0,"3ag2_oligo10","DGlcpa1-3DGlcpb6-C10O1","DMU(101_M_)-DMU(101_M_)",61.6691,"","",""
"3AG2","BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND FULLY REDUCED STATE AT 100 K","10.1073/PNAS.0910410107 ",1.8,0,"3ag2_oligo6","DGlcpa1-3DGlcpb6-C10O1","DMU(101_T_)-DMU(101_T_)",171.562,"","",""
"3AG2","BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND FULLY REDUCED STATE AT 100 K","10.1073/PNAS.0910410107 ",1.8,0,"3ag2_oligo4","DGlcpa1-3DGlcpb6-C10O1","DMU(102_Z_)-DMU(102_Z_)",87.8405,"","",""
"3AG2","BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND FULLY REDUCED STATE AT 100 K","10.1073/PNAS.0910410107 ",1.8,0,"3ag2_oligo8","DGlcpa1-3DGlcpb6-C10O1","DMU(102_L_)-DMU(102_L_)",137.634,"","",""
"3AG2","BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND FULLY REDUCED STATE AT 100 K","10.1073/PNAS.0910410107 ",1.8,0,"3ag2_oligo3","DGlcpa1-3DGlcpb6-C10O1","DMU(314_P_)-DMU(314_P_)",146.86,"","",""
"3AG2","BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND FULLY REDUCED STATE AT 100 K","10.1073/PNAS.0910410107 ",1.8,0,"3ag2_oligo9","DGlcpa1-3DGlcpb6-C10O1","DMU(313_C_)-DMU(313_C_)",129.685,"","",""
"3AG2","BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND FULLY REDUCED STATE AT 100 K","10.1073/PNAS.0910410107 ",1.8,0,"3ag2_oligo7","DGlcpa1-3DGlcpb6-C10O1","DMU(103_L_)-DMU(103_L_)",144.583,"","",""
"3AG2","BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND FULLY REDUCED STATE AT 100 K","10.1073/PNAS.0910410107 ",1.8,0,"3ag2_oligo5","DGlcpa1-3DGlcpb6-C10O1","DMU(101_G_)-DMU(101_G_)",149.446,"","",""
"3AG2","BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND FULLY REDUCED STATE AT 100 K","10.1073/PNAS.0910410107 ",1.8,0,"3ag2_oligo11","DGlcpa1-3DGlcpb6-C10O1","DMU(314_C_)-DMU(314_C_)",105.935,"","",""
"3AG2","BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND FULLY REDUCED STATE AT 100 K","10.1073/PNAS.0910410107 ",1.8,0,"3ag2_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(103_Z_)-DMU(103_Z_)",124.367,"","",""
"3AG2","BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND FULLY REDUCED STATE AT 100 K","10.1073/PNAS.0910410107 ",1.8,0,"3ag2_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(313_P_)-DMU(313_P_)",143.831,"","",""
"3AG3","BOVINE HEART CYTOCHROME C OXIDASE IN THE NITRIC OXIDE-BOUND FULLY REDUCED STATE AT 100 K","10.1073/PNAS.0910410107 ",1.8,0,"3ag3_oligo3","DManpa1-3DAllpa6-C10O1","DMU(1272_P_)-DMU(1272_P_)",112.165,"","",""
"3AG3","BOVINE HEART CYTOCHROME C OXIDASE IN THE NITRIC OXIDE-BOUND FULLY REDUCED STATE AT 100 K","10.1073/PNAS.0910410107 ",1.8,0,"3ag3_oligo4","DManpa1-3DAllpa6-C10O1","DMU(1526_Z_)-DMU(1526_Z_)",58.6445,"","",""
"3AG3","BOVINE HEART CYTOCHROME C OXIDASE IN THE NITRIC OXIDE-BOUND FULLY REDUCED STATE AT 100 K","10.1073/PNAS.0910410107 ",1.8,0,"3ag3_oligo2","DManpa1-3DAllpb6-C10O1","DMU(526_M_)-DMU(526_M_)",50.8841,"","",""
"3AG4","BOVINE HEART CYTOCHROME C OXIDASE IN THE CYANIDE ION-BOUND FULLY REDUCED STATE AT 100 K","10.1073/PNAS.0910410107 ",2.05,0,"3ag4_oligo1","LGulpa1-3DAllpa6-C10O1","DMU(1272_P_)-DMU(1272_P_)",121.381,"","",""
"3AG4","BOVINE HEART CYTOCHROME C OXIDASE IN THE CYANIDE ION-BOUND FULLY REDUCED STATE AT 100 K","10.1073/PNAS.0910410107 ",2.05,0,"3ag4_oligo3","DManpa1-3DAllpb6-C10O1","DMU(526_M_)-DMU(526_M_)",58.43,"","",""
"3AG4","BOVINE HEART CYTOCHROME C OXIDASE IN THE CYANIDE ION-BOUND FULLY REDUCED STATE AT 100 K","10.1073/PNAS.0910410107 ",2.05,0,"3ag4_oligo4","DManpa1-3DAllpa6-C10O1","DMU(272_G_)-DMU(272_G_)",117.29,"","",""
"3AGV","CRYSTAL STRUCTURE OF A HUMAN IGG-APTAMER COMPLEX","10.1093/NAR/GKQ615 ",2.15,54.6,"3agv_oligo12","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAca1-ROH","FUL(8_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NDG(1_D_)",80.3653,"","",""
"3AL8","PLEXIN A2 / SEMAPHORIN 6A COMPLEX","10.1038/NATURE09473 ",3.6,99.66,"3al8_oligo3","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-[MAN(5_E_)]-MAN(4_E_)-[MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(327_B_)",106.743,"","",""
"3AP9","CRYSTAL STRUCTURE OF THE GALECTIN-8 N-TERMINAL CARBOHYDRATE RECOGNITION DOMAIN IN COMPLEX WITH LACTO-N-FUCOPENTAOSE III","10.1074/JBC.M110.195925 ",1.33,8.34,"3ap9_oligo1","LFucpa1-3[DGalpb1-4]DGlcpNAcb1-3DGalpb1-4DGlcpb1-ROH","GAL(5_B_)-[FUC(4_B_)]-NAG(3_B_)-GAL(2_B_)-BGC(1_B_)",12.0444,"","",""
"3ASN","BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE MEASURED AT 1.7470 ANGSTROM WAVELENGTH","10.1107/S0907444911022803 ",3,0,"3asn_oligo2","DManpa1-3DGulpb6-C10O1","DMU(1526_Z_)-DMU(1526_Z_)",46.2382,"","",""
"3ASN","BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE MEASURED AT 1.7470 ANGSTROM WAVELENGTH","10.1107/S0907444911022803 ",3,0,"3asn_oligo1","DManpa1-3DAllpb6-C10O1","DMU(526_M_)-DMU(526_M_)",38.8695,"","",""
"3ASO","BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE MEASURED AT 0.9 ANGSTROM WAVELENGTH","10.1107/S0907444911022803 ",2.3,0,"3aso_oligo2","DManpa1-3DGulpb6-C10O1","DMU(1526_Z_)-DMU(1526_Z_)",50.7882,"","",""
"3ASO","BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE MEASURED AT 0.9 ANGSTROM WAVELENGTH","10.1107/S0907444911022803 ",2.3,0,"3aso_oligo1","DManpa1-3DAllpb6-C10O1","DMU(526_M_)-DMU(526_M_)",43.7795,"","",""
"3ASP","CRYSTAL STRUCTURE OF P DOMAIN FROM NOROVIRUS FUNABASHI258 STAIN IN THE COMPLEX WITH A-ANTIGEN","10.1128/JVI.00278-12 ",1.6,18.07,"3asp_oligo1","LFucpa1-2[DGalpNAca1-3]DGalpb1-3DGlcpNAcb1-ROH","A2G(4_C_)-[FUC(3_C_)]-GAL(2_C_)-NAG(1_C_)",26.1327,"","",""
"3ASP","CRYSTAL STRUCTURE OF P DOMAIN FROM NOROVIRUS FUNABASHI258 STAIN IN THE COMPLEX WITH A-ANTIGEN","10.1128/JVI.00278-12 ",1.6,18.07,"3asp_oligo2","LFucpa1-2[DGalpNAca1-3]DGalpb1-3DGlcpNAcb1-ROH","A2G(4_D_)-[FUC(3_D_)]-GAL(2_D_)-NAG(1_D_)",27.4643,"","",""
"3ASQ","CRYSTAL STRUCTURE OF P DOMAIN FROM NOROVIRUS FUNABASHI258 STAIN IN THE COMPLEX WITH H-ANTIGEN","10.1128/JVI.00278-12 ",1.6,16.98,"3asq_oligo1","LFucpa1-2DGalpb1-3DGlcpNAcb1-C6N1O3","FUC(3_C_)-GAL(2_C_)-NAG(1_C_)-NPO(1001_A_)",13.3324,"","",""
"3ASQ","CRYSTAL STRUCTURE OF P DOMAIN FROM NOROVIRUS FUNABASHI258 STAIN IN THE COMPLEX WITH H-ANTIGEN","10.1128/JVI.00278-12 ",1.6,16.98,"3asq_oligo2","LFucpa1-2DGalpb1-3DGlcpNAcb1-C6N1O3","FUC(3_D_)-GAL(2_D_)-NAG(1_D_)-NPO(1001_B_)",16.6355,"","",""
"3ASR","CRYSTAL STRUCTURE OF P DOMAIN FROM NOROVIRUS FUNABASHI258 STAIN IN THE COMPLEX WITH LEWIS-A","10.1128/JVI.00278-12 ",1.6,27.22,"3asr_oligo2","DGalpb1-3[LFucpa1-4]DGlcpNAcb1-C6N1O3","FUC(3_D_)-[GAL(2_D_)]-NAG(1_D_)-NPO(1001_B_)",31.8542,"","",""
"3ASR","CRYSTAL STRUCTURE OF P DOMAIN FROM NOROVIRUS FUNABASHI258 STAIN IN THE COMPLEX WITH LEWIS-A","10.1128/JVI.00278-12 ",1.6,27.22,"3asr_oligo1","DGalpb1-3[LFucpa1-4]DGlcpNAcb1-ROH","FUC(3_C_)-[GAL(2_C_)]-NAG(1_C_)",40.3797,"","",""
"3ASS","CRYSTAL STRUCTURE OF P DOMAIN FROM NOROVIRUS FUNABASHI258 STAIN IN THE COMPLEX WITH LEWIS-B","10.1128/JVI.00278-12 ",1.6,20,"3ass_oligo1","LFucpa1-2DGalpb1-3[LFucpa1-4]DGlcpNAcb1-C6N1O3","FUC(4_C_)-[FUC(3_C_)-GAL(2_C_)]-NAG(1_C_)-NPO(1001_A_)",22.7775,"","",""
"3ASS","CRYSTAL STRUCTURE OF P DOMAIN FROM NOROVIRUS FUNABASHI258 STAIN IN THE COMPLEX WITH LEWIS-B","10.1128/JVI.00278-12 ",1.6,20,"3ass_oligo2","LFucpa1-2DGalpb1-3[LFucpa1-4]DGlcpNAcb1-C6N1O3","FUC(4_D_)-[FUC(3_D_)-GAL(2_D_)]-NAG(1_D_)-NPO(1001_B_)",23.6968,"","",""
"3AST","CRYSTAL STRUCTURE OF P DOMAIN Q389N MUTANT FROM NOROVIRUS FUNABASHI258 STAIN IN THE COMPLEX WITH LEWIS-B","10.1128/JVI.00278-12 ",1.4,16.73,"3ast_oligo2","LFucpa1-2DGalpb1-3[LFucpa1-4]DGlcpNAcb1-C6N1O3","FUC(4_D_)-[FUC(3_D_)-GAL(2_D_)]-NAG(1_D_)-NPO(1001_B_)",18.8609,"","",""
"3AST","CRYSTAL STRUCTURE OF P DOMAIN Q389N MUTANT FROM NOROVIRUS FUNABASHI258 STAIN IN THE COMPLEX WITH LEWIS-B","10.1128/JVI.00278-12 ",1.4,16.73,"3ast_oligo1","LFucpa1-2DGalpb1-3[LFucpa1-4]DGlcpNAcb1-C6N1O3","FUC(4_C_)-[FUC(3_C_)-GAL(2_C_)]-NAG(1_C_)-NPO(1001_A_)",14.7777,"","",""
"3AU1","CRYSTAL STRUCTURE OF MOUSE CD1D IN COMPLEX WITH GANGLIOSIDE GD3","10.1016/J.IMMUNI.2011.01.013 ",2.5,54.64,"3au1_oligo3","DManpa1-3[DManpb1-6]DGlcpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_D_)-[BMA(5_D_)-[MAN(4_D_)]-GLC(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(165_A_)",33.8345,"","",""
"3AU1","CRYSTAL STRUCTURE OF MOUSE CD1D IN COMPLEX WITH GANGLIOSIDE GD3","10.1016/J.IMMUNI.2011.01.013 ",2.5,54.64,"3au1_oligo2","DManpa1-2DManpa1-3DGlcpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-GLC(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(42_A_)",29.1347,"","",""
"3AVE","CRYSTAL STRUCTURE OF THE FUCOSYLATED FC FRAGMENT FROM HUMAN IMMUNOGLOBULIN G1","10.1016/J.JMB.2011.03.031 ",2,41.11,"3ave_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",69.476,"","",""
"3AVE","CRYSTAL STRUCTURE OF THE FUCOSYLATED FC FRAGMENT FROM HUMAN IMMUNOGLOBULIN G1","10.1016/J.JMB.2011.03.031 ",2,41.11,"3ave_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",50.4686,"","",""
"3AY4","CRYSTAL STRUCTURE OF NONFUCOSYLATED FC COMPLEXED WITH BIS-GLYCOSYLATED SOLUBLE FORM OF FC GAMMA RECEPTOR IIIA","10.1111/J.1365-2443.2011.01552.X ",2.2,43.49,"3ay4_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[NAG(8_E_)-MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(297_B_)",48.3941,"","",""
"3AY4","CRYSTAL STRUCTURE OF NONFUCOSYLATED FC COMPLEXED WITH BIS-GLYCOSYLATED SOLUBLE FORM OF FC GAMMA RECEPTOR IIIA","10.1111/J.1365-2443.2011.01552.X ",2.2,43.49,"3ay4_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(297_A_)",49.5257,"","",""
"3AY4","CRYSTAL STRUCTURE OF NONFUCOSYLATED FC COMPLEXED WITH BIS-GLYCOSYLATED SOLUBLE FORM OF FC GAMMA RECEPTOR IIIA","10.1111/J.1365-2443.2011.01552.X ",2.2,43.49,"3ay4_oligo3","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_F_)-[NAG(7_F_)-MAN(6_F_)-[NAG(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(162_C_)",75.4793,"","",""
"3AYA","CRYSTAL STRUCTURE OF GALECTIN-3 CRD DOMIAN COMPLEXED WITH THOMSEN- FRIEDENREICH ANTIGEN","10.1371/JOURNAL.PONE.0025007 ",2,21.6,"3aya_oligo2","DGalpb1-3DGalpNAca1-THR","GAL(2_D_)-A2G(1_D_)-THR(251_B_)",28.1186,"","",""
"3AYA","CRYSTAL STRUCTURE OF GALECTIN-3 CRD DOMIAN COMPLEXED WITH THOMSEN- FRIEDENREICH ANTIGEN","10.1371/JOURNAL.PONE.0025007 ",2,21.6,"3aya_oligo1","DGalpb1-3DGalpNAca1-THR","GAL(2_C_)-A2G(1_C_)-THR(251_A_)",35.0527,"","",""
"3AYC","CRYSTAL STRUCTURE OF GALECTIN-3 CRD DOMIAN COMPLEXED WITH GM1 PENTASACCHARIDE","10.1371/JOURNAL.PONE.0025007 ",1.8,14.82,"3ayc_oligo1","DGalpb1-3DGalpNAcb1-4[DNeup5Aca2-3]DGalpb1-4DGlcpb1-ROH","GAL(4_C_)-NGA(3_C_)-[SIA(5_C_)]-GAL(2_C_)-BGC(1_C_)",19.5165,"","",""
"3AYD","CRYSTAL STRUCTURE OF GALECTIN-3 CRD DOMIAN COMPLEXED WITH TFN","10.1371/JOURNAL.PONE.0025007 ",1.9,23.9,"3ayd_oligo2","DGalpb1-3DGalpNAca1-C6N1O3","GAL(2_B_)-A2G(1_B_)-NPO(251_A_)",17.3759,"","",""
"3AYD","CRYSTAL STRUCTURE OF GALECTIN-3 CRD DOMIAN COMPLEXED WITH TFN","10.1371/JOURNAL.PONE.0025007 ",1.9,23.9,"3ayd_oligo1","DGalpb1-3DGalpNAca1-C6N1O3","GAL(2_C_)-A2G(1_C_)-NPO(254_A_)",18.0395,"","",""
"3B2D","CRYSTAL STRUCTURE OF HUMAN RP105/MD-1 COMPLEX","10.1016/J.JMB.2011.09.020 ",2.8,47.5,"3b2d_oligo1","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_E_)-MAN(7_E_)-[MAN(6_E_)-MAN(5_E_)]-MAN(4_E_)-[MAN(9_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(402_A_)",38.3844,"","",""
"3B2D","CRYSTAL STRUCTURE OF HUMAN RP105/MD-1 COMPLEX","10.1016/J.JMB.2011.09.020 ",2.8,47.5,"3b2d_oligo3","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_G_)-MAN(5_G_)-[MAN(7_G_)]-MAN(4_G_)-[MAN(8_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(402_B_)",31.7182,"","",""
"3B2U","CRYSTAL STRUCTURE OF ISOLATED DOMAIN III OF THE EXTRACELLULAR REGION OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN COMPLEX WITH THE FAB FRAGMENT OF IMC-11F8","10.1016/J.STR.2007.11.009 ",2.58,29.07,"3b2u_oligo7","DManpb1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_e_)-BMA(3_e_)-NAG(2_e_)-NAG(1_e_)-ASN(328_I_)",38.9477,"","",""
"3B2U","CRYSTAL STRUCTURE OF ISOLATED DOMAIN III OF THE EXTRACELLULAR REGION OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN COMPLEX WITH THE FAB FRAGMENT OF IMC-11F8","10.1016/J.STR.2007.11.009 ",2.58,29.07,"3b2u_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_Y_)-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(328_A_)",39.9273,"","",""
"3B2U","CRYSTAL STRUCTURE OF ISOLATED DOMAIN III OF THE EXTRACELLULAR REGION OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN COMPLEX WITH THE FAB FRAGMENT OF IMC-11F8","10.1016/J.STR.2007.11.009 ",2.58,29.07,"3b2u_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_c_)-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(328_E_)",34.8948,"","",""
"3B2U","CRYSTAL STRUCTURE OF ISOLATED DOMAIN III OF THE EXTRACELLULAR REGION OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN COMPLEX WITH THE FAB FRAGMENT OF IMC-11F8","10.1016/J.STR.2007.11.009 ",2.58,29.07,"3b2u_oligo10","DManpa1-3DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_h_)-MAN(4_h_)-BMA(3_h_)-NAG(2_h_)-NAG(1_h_)-ASN(328_M_)",35.3309,"","",""
"3B7E","NEURAMINIDASE OF A/BREVIG MISSION/1/1918 H1N1 STRAIN IN COMPLEX WITH ZANAMIVIR","10.1128/JVI.00959-08 ",1.45,9.68,"3b7e_oligo1","LFucpa1-3DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(146_B_)",41.1686,"","",""
"3BEQ","NEURAMINIDASE OF A/BREVIG MISSION/1/1918 H1N1 STRAIN","10.1128/JVI.00959-08 ",1.64,19.14,"3beq_oligo1","DManpa1-3DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-MAN(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(146_B_)",71.0177,"","",""
"3BHX","X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH A TRANSITION STATE ANALOG OF ASP-GLU","10.1016/J.JMB.2007.12.066 ",1.6,26.33,"3bhx_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(638_A_)",33.0645,"","",""
"3BI0","X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH A TRANSITION STATE ANALOG OF GLU-GLU","10.1016/J.JMB.2007.12.066 ",1.67,28.82,"3bi0_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(638_A_)",35.5859,"","",""
"3BI1","X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH A TRANSITION STATE ANALOG OF METHOTREXATE-GLU","10.1016/J.JMB.2007.12.066 ",1.5,27.09,"3bi1_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(638_A_)",32.373,"","",""
"3BL8","CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF NEUROLIGIN 2A FROM MOUSE","10.1073/PNAS.0711701105 ",3.3,126.2,"3bl8_oligo2","DManpa1-3[DManpa1-6]DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_F_)-[MAN(6_F_)-[MAN(5_F_)]-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(98_B_)",100.434,"","",""
"3BVT","GOLGI MANNOSIDASE II D204A CATALYTIC NUCLEOPHILE MUTANT COMPLEX WITH METHYL (ALPHA-D-MANNOPYRANOSYL)-(1->3)-S-ALPHA-D-MANNOPYRANOSIDE","10.1021/JA711248Y ",1.3,16.95,"3bvt_oligo1","DManpa1-3DManp[3<R1>]a1-OME","MAN(2_B_)-Z4R(1_B_)",18.8018,"","",""
"3BVU","GOLGI MANNOSIDASE II D204A CATALYTIC NUCLEOPHILE MUTANT COMPLEX WITH METHYL(ALPHA-D-MANNOPYRANOSYL)-(1->3)-S-[(ALPHA-D-MANNOPYRANOSYL)-(1- >6)]-ALPHA-D-MANNOPYRANOSIDE","10.1021/JA711248Y ",1.12,"1.15243e-41","3bvu_oligo1","DManpa1-3[DManpa1-6]DManp[3<R1>]a1-OME","MAN(3_B_)-[MAN(2_B_)-",14.4573,"","",""
"3BVV","GOLGI MANNOSIDASE II D204A CATALYTIC NUCLEOPHILE MUTANT COMPLEX WITH METHYL ALPHA-D-MANNOPYRANOSYL-(1->3)-[6-THIO-ALPHA-D-MANNOPYRANOSYL- (1->6)]-BETA-D-MANNOPYRANOSIDE","10.1021/JA711248Y ",1.3,16.37,"3bvv_oligo1","DManpa1-3[DLyxpa1-6]DManpb1-OME","Z4Y(3_B_)-[MAN(2_B_)]-YZ0(1_B_)",15.8924,"","",""
"3BVW","GOLGI MANNOSIDASE II D204A CATALYTIC NUCLEOPHILE MUTANT COMPLEX WITH METHYL (2-DEOXY-2-ACETAMIDO-BETA-D-GLUCOPYRANOSYL)-(1->2)-ALPHA-D- MANNOPYRANOSYL- (1->3)-[ALPHA-D-MANNOPYRANOSYL-(1->6)-6-THIO-ALPHA-D- MANNOPYRANOSYL- (1->6)]-BETA-D-MANNOPYRANOSIDE","10.1021/JA711248Y ",1.2,"1.15243e-41","3bvw_oligo1","DGlcpNAcb1-2DManpa1-3[DLyxpa1-6]DManpb1-OME","Z4Y(4_B_)-[NAG(3_B_)-MAN(2_B_)]-YZ0(1_B_)",38.1853,"","",""
"3BVX","GOLGI MANNOSIDASE II D204A CATALYTIC NUCLEOPHILE MUTANT COMPLEX WITH METHYL (2-DEOXY-2-ACETAMIDO-BETA-D-GLUCOPYRANOSYL)-(1->2)-(ALPHA-D- MANNOPYRANOSYL)- (1->3)-[(ALPHA-D-MANNOPYRANOSYL)-(1->6)-(ALPHA-D- MANNOPYRANOSYL)-(1->6)]-BETA-D-MANNOPYRANOSIDE","10.1021/JA711248Y ",1.1,0,"3bvx_oligo1","DGlcpNAcb1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-OME","MAN(5_B_)-MAN(4_B_)-[NAG(3_B_)-MAN(2_B_)]-YZ0(1_B_)",31.9624,"","",""
"3BWH","ATOMIC RESOLUTION STRUCTURE OF CUCURMOSIN, A NOVEL TYPE 1 RIP FROM THE SARCOCARP OF CUCURBITA MOSCHATA","10.1016/J.JSB.2008.06.011 ",1,9.72,"3bwh_oligo1","DXylpb1-2[DManpa1-3][DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(6_B_)-[MAN(5_B_)]-[XYP(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)",49.1578,"","",""
"3BWR","SV40 VP1 PENTAMER IN COMPLEX WITH GM1 OLIGOSACCHARIDE","10.1073/PNAS.0710301105 ",2.25,33.59,"3bwr_oligo2","DGalpb1-3DGalpNAcb1-4[DNeup5Aca2-3]DGalpb1-4DGlcpb1-ROH","GAL(4_G_)-NGA(3_G_)-[SIA(5_G_)]-GAL(2_G_)-BGC(1_G_)",45.1231,"","",""
"3BWR","SV40 VP1 PENTAMER IN COMPLEX WITH GM1 OLIGOSACCHARIDE","10.1073/PNAS.0710301105 ",2.25,33.59,"3bwr_oligo3","DGalpb1-3DGalpNAcb1-4[DNeup5Aca2-3]DGalpb1-4DGlcpb1-ROH","GAL(4_H_)-NGA(3_H_)-[SIA(5_H_)]-GAL(2_H_)-BGC(1_H_)",37.6609,"","",""
"3BWR","SV40 VP1 PENTAMER IN COMPLEX WITH GM1 OLIGOSACCHARIDE","10.1073/PNAS.0710301105 ",2.25,33.59,"3bwr_oligo1","DGalpb1-3DGalpNAcb1-4[DNeup5Aca2-3]DGalpb1-4DGlcpb1-ROH","GAL(4_F_)-NGA(3_F_)-[SIA(5_F_)]-GAL(2_F_)-BGC(1_F_)",46.5244,"","",""
"3BXM","STRUCTURE OF AN INACTIVE MUTANT OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II [GCPII(E424A)] IN COMPLEX WITH N-ACETYL-ASP-GLU (NAAG)","10.1021/BI900220S ",1.71,30.38,"3bxm_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(638_A_)",41.4102,"","",""
"3BZ4","CRYSTAL STRUCTURE OF FAB F22-4 IN COMPLEX WITH A SHIGELLA FLEXNERI 2A O-AG DECASACCHARIDE","10.1073/PNAS.0801711105 ",1.8,19.81,"3bz4_oligo2","LRhapa1-2LRhapa1-3[DGlcpa1-4]LRhapa1-3DGlcpNAcb1-2LRhapa1-2LRhapa1-3[DGlcpa1-4]LRhapa1-3DGlcpNAcb1-OME","GLC(10_J_)-[GLC(9_J_)-[RAM(8_J_)-RAM(7_J_)]-RAM(6_J_)-NAG(5_J_)-RAM(4_J_)-RAM(3_J_)]-RAM(2_J_)-EAG(1_J_)",22.3979,"","",""
"3BZ4","CRYSTAL STRUCTURE OF FAB F22-4 IN COMPLEX WITH A SHIGELLA FLEXNERI 2A O-AG DECASACCHARIDE","10.1073/PNAS.0801711105 ",1.8,19.81,"3bz4_oligo4","LRhapa1-2LRhapa1-3[DGlcpa1-4]LRhapa1-3DGlcpNAcb1-2LRhapa1-2LRhapa1-3[DGlcpa1-4]LRhapa1-3DGlcpNAcb1-OME","GLC(10_L_)-[GLC(9_L_)-[RAM(8_L_)-RAM(7_L_)]-RAM(6_L_)-NAG(5_L_)-RAM(4_L_)-RAM(3_L_)]-RAM(2_L_)-EAG(1_L_)",26.5769,"","",""
"3BZ4","CRYSTAL STRUCTURE OF FAB F22-4 IN COMPLEX WITH A SHIGELLA FLEXNERI 2A O-AG DECASACCHARIDE","10.1073/PNAS.0801711105 ",1.8,19.81,"3bz4_oligo3","LRhapa1-2LRhapa1-3[DGlcpa1-4]LRhapa1-3DGlcpNAcb1-2LRhapa1-2LRhapa1-3[DGlcpa1-4]LRhapa1-3DGlcpNAcb1-OME","GLC(10_K_)-[GLC(9_K_)-[RAM(8_K_)-RAM(7_K_)]-RAM(6_K_)-NAG(5_K_)-RAM(4_K_)-RAM(3_K_)]-RAM(2_K_)-EAG(1_K_)",27.4321,"","",""
"3BZ4","CRYSTAL STRUCTURE OF FAB F22-4 IN COMPLEX WITH A SHIGELLA FLEXNERI 2A O-AG DECASACCHARIDE","10.1073/PNAS.0801711105 ",1.8,19.81,"3bz4_oligo1","LRhapa1-2LRhapa1-3[DGlcpa1-4]LRhapa1-3DGlcpNAcb1-2LRhapa1-2LRhapa1-3[DGlcpa1-4]LRhapa1-3DGlcpNAcb1-OME","GLC(10_I_)-[GLC(9_I_)-[RAM(8_I_)-RAM(7_I_)]-RAM(6_I_)-NAG(5_I_)-RAM(4_I_)-RAM(3_I_)]-RAM(2_I_)-EAG(1_I_)",24.3465,"","",""
"3C2S","STRUCTURAL CHARACTERIZATION OF A HUMAN FC FRAGMENT ENGINEERED FOR LACK OF EFFECTOR FUNCTIONS","10.1107/S0907444908007877 ",2.3,43.32,"3c2s_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(9_B_)-[GAL(6_B_)-NAG(5_B_)-MAN(4_B_)-[NAG(8_B_)-MAN(7_B_)]-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(297_A_)",71.3893,"","",""
"3C5X","CRYSTAL STRUCTURE OF THE PRECURSOR MEMBRANE PROTEIN- ENVELOPE PROTEIN HETERODIMER FROM THE DENGUE 2 VIRUS AT LOW PH","10.1126/SCIENCE.1153263 ",2.2,0,"3c5x_oligo2","DManpa1-3[DManpb1-6]DAltpa1-4DGlcpNAcb1-4DGlcpNAcx1-","BMA(5_D_)-[BMA(4_D_)]-SHD(3_D_)-NAG(2_D_)-NAG(1_D_)",115.248,"","",""
"3C6S","CRYSTAL STRUCTURE OF FAB F22-4 IN COMPLEX WITH A SHIGELLA FLEXNERI 2A O-AG PENTADECASACCHARIDE","10.1073/PNAS.0801711105 ",1.8,18.78,"3c6s_oligo1","LRhapa1-2LRhapa1-3[DGlcpa1-4]LRhapa1-3DGlcpNAcb1-2LRhapa1-2LRhapa1-3[DGlcpa1-4]LRhapa1-3DGlcpNAcb1-2LRhapx1-","GLC(11_I_)-[GLC(10_I_)-[RAM(9_I_)-RAM(8_I_)]-RAM(7_I_)-NAG(6_I_)-RAM(5_I_)-RAM(4_I_)]-RAM(3_I_)-NAG(2_I_)-RAM(1_I_)",31.0581,"","",""
"3C6S","CRYSTAL STRUCTURE OF FAB F22-4 IN COMPLEX WITH A SHIGELLA FLEXNERI 2A O-AG PENTADECASACCHARIDE","10.1073/PNAS.0801711105 ",1.8,18.78,"3c6s_oligo2","LRhapa1-2LRhapa1-3[DGlcpa1-4]LRhapa1-3DGlcpNAcb1-2LRhapa1-2LRhapa1-3[DGlcpa1-4]LRhapa1-3DGlcpNAcb1-2LRhapx1-","GLC(11_J_)-[GLC(10_J_)-[RAM(9_J_)-RAM(8_J_)]-RAM(7_J_)-NAG(6_J_)-RAM(5_J_)-RAM(4_J_)]-RAM(3_J_)-NAG(2_J_)-RAM(1_J_)",33.5109,"","",""
"3C6S","CRYSTAL STRUCTURE OF FAB F22-4 IN COMPLEX WITH A SHIGELLA FLEXNERI 2A O-AG PENTADECASACCHARIDE","10.1073/PNAS.0801711105 ",1.8,18.78,"3c6s_oligo4","LRhapa1-2LRhapa1-3[DGlcpa1-4]LRhapa1-3DGlcpNAcb1-2LRhapa1-2LRhapa1-3[DGlcpa1-4]LRhapa1-3DGlcpNAcb1-2LRhapx1-","GLC(11_L_)-[GLC(10_L_)-[RAM(9_L_)-RAM(8_L_)]-RAM(7_L_)-NAG(6_L_)-RAM(5_L_)-RAM(4_L_)]-RAM(3_L_)-NAG(2_L_)-RAM(1_L_)",30.6227,"","",""
"3C6S","CRYSTAL STRUCTURE OF FAB F22-4 IN COMPLEX WITH A SHIGELLA FLEXNERI 2A O-AG PENTADECASACCHARIDE","10.1073/PNAS.0801711105 ",1.8,18.78,"3c6s_oligo3","LRhapa1-2LRhapa1-3[DGlcpa1-4]LRhapa1-3DGlcpNAcb1-2LRhapa1-2LRhapa1-3[DGlcpa1-4]LRhapa1-3DGlcpNAcb1-2LRhapx1-","GLC(11_K_)-[GLC(10_K_)-[RAM(9_K_)-RAM(8_K_)]-RAM(7_K_)-NAG(6_K_)-RAM(5_K_)-RAM(4_K_)]-RAM(3_K_)-NAG(2_K_)-RAM(1_K_)",26.7355,"","",""
"3C9Z","SAMBUCUS NIGRA AGGLUTININ II (SNA-II), TETRAGONAL CRYSTAL FORM","10.1002/PROT.22222 ",1.35,24,"3c9z_oligo3","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_C_)-[FUC(2_C_)]-NAG(1_C_)-ASN(71_A_)",55.7773,"","",""
"3C9Z","SAMBUCUS NIGRA AGGLUTININ II (SNA-II), TETRAGONAL CRYSTAL FORM","10.1002/PROT.22222 ",1.35,24,"3c9z_oligo2","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_B_)-[FUC(2_B_)]-NAG(1_B_)-ASN(63_A_)",59.8327,"","",""
"3CA0","SAMBUCUS NIGRA AGGLUTININ II (SNA-II), HEXAGONAL CRYSTAL FORM","10.1002/PROT.22222 ",1.95,41.66,"3ca0_oligo4","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_E_)-[FUC(2_E_)]-NAG(1_E_)-ASN(232_A_)",102.22,"","",""
"3CA0","SAMBUCUS NIGRA AGGLUTININ II (SNA-II), HEXAGONAL CRYSTAL FORM","10.1002/PROT.22222 ",1.95,41.66,"3ca0_oligo1","LFucpa1-3DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(71_A_)",79.59,"","",""
"3CA0","SAMBUCUS NIGRA AGGLUTININ II (SNA-II), HEXAGONAL CRYSTAL FORM","10.1002/PROT.22222 ",1.95,41.66,"3ca0_oligo2","DXylpb1-2[DManpa1-3][DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(6_B_)-[MAN(5_B_)]-[XYP(4_B_)]-BMA(3_B_)-NAG(2_B_)-[FUC(7_B_)]-NAG(1_B_)-ASN(63_A_)",53.8283,"","",""
"3CA1","SAMBUCUS NIGRA AGGLUTININ II (SNA-II)- TETRAGONAL CRYSTAL FORM- COMPLEXED TO GALACTOSE","10.1002/PROT.22222 ",1.55,14.24,"3ca1_oligo2","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_B_)-[FUC(2_B_)]-NAG(1_B_)-ASN(63_A_)",53.1027,"","",""
"3CA1","SAMBUCUS NIGRA AGGLUTININ II (SNA-II)- TETRAGONAL CRYSTAL FORM- COMPLEXED TO GALACTOSE","10.1002/PROT.22222 ",1.55,14.24,"3ca1_oligo3","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_C_)-[FUC(2_C_)]-NAG(1_C_)-ASN(71_A_)",42.4045,"","",""
"3CA3","CRYSTAL STRUCTURE OF SAMBUCUS NIGRA AGGLUTININ II (SNA-II)-TETRAGONAL CRYSTAL FORM- COMPLEXED TO N-ACETYLGALACTOSAMINE","10.1002/PROT.22222 ",1.55,14.32,"3ca3_oligo5","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_B_)-[FUC(2_B_)]-NAG(1_B_)-ASN(63_A_)",36.8627,"","",""
"3CA3","CRYSTAL STRUCTURE OF SAMBUCUS NIGRA AGGLUTININ II (SNA-II)-TETRAGONAL CRYSTAL FORM- COMPLEXED TO N-ACETYLGALACTOSAMINE","10.1002/PROT.22222 ",1.55,14.32,"3ca3_oligo1","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_C_)-[FUC(2_C_)]-NAG(1_C_)-ASN(71_A_)",38.4076,"","",""
"3CA4","SAMBUCUS NIGRA AGGLUTININ II, TETRAGONAL CRYSTAL FORM- COMPLEXED TO LACTOSE","10.1002/PROT.22222 ",1.55,17.39,"3ca4_oligo5","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_B_)-[FUC(2_B_)]-NAG(1_B_)-ASN(63_A_)",40.3518,"","",""
"3CA4","SAMBUCUS NIGRA AGGLUTININ II, TETRAGONAL CRYSTAL FORM- COMPLEXED TO LACTOSE","10.1002/PROT.22222 ",1.55,17.39,"3ca4_oligo1","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_C_)-[FUC(2_C_)]-NAG(1_C_)-ASN(71_A_)",43.6461,"","",""
"3CA5","CRYSTAL STRUCTURE OF SAMBUCUS NIGRA AGGLUTININ II (SNA-II)-TETRAGONAL CRYSTAL FORM- COMPLEXED TO ALPHA1 METHYLGALACTOSE","10.1002/PROT.22222 ",1.55,25.22,"3ca5_oligo2","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_B_)-[FUC(2_B_)]-NAG(1_B_)-ASN(63_A_)",47.4476,"","",""
"3CA5","CRYSTAL STRUCTURE OF SAMBUCUS NIGRA AGGLUTININ II (SNA-II)-TETRAGONAL CRYSTAL FORM- COMPLEXED TO ALPHA1 METHYLGALACTOSE","10.1002/PROT.22222 ",1.55,25.22,"3ca5_oligo3","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_C_)-[FUC(2_C_)]-NAG(1_C_)-ASN(71_A_)",47.8809,"","",""
"3CA6","SAMBUCUS NIGRA AGGLUTININ II (SNA-II)- TETRAGONAL CRYSTAL FORM- COMPLEXED TO TN ANTIGEN","10.1002/PROT.22222 ",1.4,13.79,"3ca6_oligo1","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_B_)-[FUC(2_B_)]-NAG(1_B_)-ASN(63_A_)",48.6315,"","",""
"3CA6","SAMBUCUS NIGRA AGGLUTININ II (SNA-II)- TETRAGONAL CRYSTAL FORM- COMPLEXED TO TN ANTIGEN","10.1002/PROT.22222 ",1.4,13.79,"3ca6_oligo3","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_C_)-[FUC(2_C_)]-NAG(1_C_)-ASN(71_A_)",53.6524,"","",""
"3CAH","SAMBUCUS NIGRA AGGUTININ II. TETRAGONAL CRYSTAL FORM- COMPLEXED TO FUCOSE","10.1002/PROT.22222 ",1.55,12.67,"3cah_oligo2","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_B_)-[FUC(2_B_)]-NAG(1_B_)-ASN(63_A_)",46.5006,"","",""
"3CAH","SAMBUCUS NIGRA AGGUTININ II. TETRAGONAL CRYSTAL FORM- COMPLEXED TO FUCOSE","10.1002/PROT.22222 ",1.55,12.67,"3cah_oligo3","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_C_)-[FUC(2_C_)]-NAG(1_C_)-ASN(71_A_)",36.6606,"","",""
"3CAP","CRYSTAL STRUCTURE OF NATIVE OPSIN: THE G PROTEIN-COUPLED RECEPTOR RHODOPSIN IN ITS LIGAND-FREE STATE","10.1038/NATURE07063 ",2.9,53.52,"3cap_oligo1","DManpb1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(15_B_)",74.9009,"","",""
"3CAP","CRYSTAL STRUCTURE OF NATIVE OPSIN: THE G PROTEIN-COUPLED RECEPTOR RHODOPSIN IN ITS LIGAND-FREE STATE","10.1038/NATURE07063 ",2.9,53.52,"3cap_oligo2","DManpb1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(15_A_)",71.9539,"","",""
"3CBA","CRYSTAL STRUCTURE OF LIPOPEPTIDE DETERGENT (LPD-12) (HEXAGONAL)","",1.7,"1.15243e-41","3cba_oligo8","DGlcpa1-3DGlcpb6-C10O1","DMU(509_H_)-DMU(509_H_)",24.3332,"","",""
"3CDZ","CRYSTAL STRUCTURE OF HUMAN FACTOR VIII","10.1016/J.STR.2008.03.001 ",3.98,199.2,"3cdz_oligo2","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcx1-","MAN(4_D_)-[MAN(3_D_)]-MAN(2_D_)-NAG(1_D_)",258.64,"","",""
"3CFW","L-SELECTIN LECTIN AND EGF DOMAINS","10.1074/JBC.M116.767186 ",2.2,34.9,"3cfw_oligo1","DManpa1-3[DManpb1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_B_)-[MAN(4_B_)]-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(66_A_)",38.8387,"","",""
"3CHB","CHOLERA TOXIN B-PENTAMER COMPLEXED WITH GM1 PENTASACCHARIDE","10.1006/JMBI.1998.2076 ",1.25,0,"3chb_oligo6","DGalpb1-3DGalpNAcb1-4[DNeup5Aca2-3]DGalpb1-4DGlcpb1-ROH","GAL(4_J_)-NGA(3_J_)-[SIA(5_J_)]-GAL(2_J_)-BGC(1_J_)",23.9332,"","",""
"3CHB","CHOLERA TOXIN B-PENTAMER COMPLEXED WITH GM1 PENTASACCHARIDE","10.1006/JMBI.1998.2076 ",1.25,0,"3chb_oligo4","DGalpb1-3DGalpNAcb1-4[DNeup5Aca2-3]DGalpb1-4DGlcpb1-ROH","GAL(4_I_)-NGA(3_I_)-[SIA(5_I_)]-GAL(2_I_)-BGC(1_I_)",19.2559,"","",""
"3CHB","CHOLERA TOXIN B-PENTAMER COMPLEXED WITH GM1 PENTASACCHARIDE","10.1006/JMBI.1998.2076 ",1.25,0,"3chb_oligo1","DGalpb1-3DGalpNAcb1-4[DNeup5Aca2-3]DGalpb1-ROH","GAL(3_A_)-NGA(2_A_)-[SIA(4_A_)]-GAL(1_A_)-GLC(107_D_)",24.9764,"","",""
"3CHB","CHOLERA TOXIN B-PENTAMER COMPLEXED WITH GM1 PENTASACCHARIDE","10.1006/JMBI.1998.2076 ",1.25,0,"3chb_oligo7","DGalpb1-3DGalpNAcb1-4[DNeup5Aca2-3]DGalpb1-ROH","GAL(3_C_)-NGA(2_C_)-[SIA(4_C_)]-GAL(1_C_)-GLC(107_F_)",24.5999,"","",""
"3CHB","CHOLERA TOXIN B-PENTAMER COMPLEXED WITH GM1 PENTASACCHARIDE","10.1006/JMBI.1998.2076 ",1.25,0,"3chb_oligo3","DGalpb1-3DGalpNAcb1-4[DNeup5Aca2-3]DGalpb1-4DGlcpb1-ROH","GAL(4_B_)-NGA(3_B_)-[SIA(5_B_)]-GAL(2_B_)-BGC(1_B_)",19.8184,"","",""
"3CIG","CRYSTAL STRUCTURE OF MOUSE TLR3 ECTODOMAIN","10.1126/SCIENCE.1155406 ",2.66,64.69,"3cig_oligo4","DManpb1-3[DManpa1-6]DManpa1-4DGlcpNAca1-4DGlcpNAca1-ASN","MAN(5_F_)-[BMA(4_F_)]-MAN(3_F_)-NDG(2_F_)-NAG(1_F_)-ASN(413_A_)",100.949,"","",""
"3CIY","MOUSE TOLL-LIKE RECEPTOR 3 ECTODOMAIN COMPLEXED WITH DOUBLE-STRANDED RNA","10.1126/SCIENCE.1155406 ",3.41,154.3,"3ciy_oligo109","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAca1-ASN","MAN(5_I_)-[MAN(4_I_)]-MAN(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(413_A_)",173.161,"","",""
"3CIY","MOUSE TOLL-LIKE RECEPTOR 3 ECTODOMAIN COMPLEXED WITH DOUBLE-STRANDED RNA","10.1126/SCIENCE.1155406 ",3.41,154.3,"3ciy_oligo78","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAca1-4DGlcpNAca1-ASN","MAN(5_P_)-[MAN(4_P_)]-MAN(3_P_)-NDG(2_P_)-NAG(1_P_)-ASN(413_B_)",174.139,"","",""
"3CSY","CRYSTAL STRUCTURE OF THE TRIMERIC PREFUSION EBOLA VIRUS GLYCOPROTEIN IN COMPLEX WITH A NEUTRALIZING ANTIBODY FROM A HUMAN SURVIVOR","10.1038/NATURE07082 ",3.4,115.8,"3csy_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_R_)-[MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)",129.284,"","",""
"3CSY","CRYSTAL STRUCTURE OF THE TRIMERIC PREFUSION EBOLA VIRUS GLYCOPROTEIN IN COMPLEX WITH A NEUTRALIZING ANTIBODY FROM A HUMAN SURVIVOR","10.1038/NATURE07082 ",3.4,115.8,"3csy_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_V_)-[MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)",125.824,"","",""
"3CSY","CRYSTAL STRUCTURE OF THE TRIMERIC PREFUSION EBOLA VIRUS GLYCOPROTEIN IN COMPLEX WITH A NEUTRALIZING ANTIBODY FROM A HUMAN SURVIVOR","10.1038/NATURE07082 ",3.4,115.8,"3csy_oligo4","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(6_T_)-[NAG(5_T_)-MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)",138.302,"","",""
"3CSY","CRYSTAL STRUCTURE OF THE TRIMERIC PREFUSION EBOLA VIRUS GLYCOPROTEIN IN COMPLEX WITH A NEUTRALIZING ANTIBODY FROM A HUMAN SURVIVOR","10.1038/NATURE07082 ",3.4,115.8,"3csy_oligo8","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(6_X_)-[NAG(5_X_)-MAN(4_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)",142.661,"","",""
"3CU0","HUMAN BETA 1,3-GLUCURONYLTRANSFERASE I (GLCAT-I) IN COMPLEX WITH UDP AND GAL-GAL(6-SO4)-XYL(2-PO4)-O-SER","10.1074/JBC.M709556200 ",1.9,31,"3cu0_oligo3","DGalpb1-3DGalp[6S]b1-ROH","GAL(2_C_)-GAL(1_C_)",23.6095,"","",""
"3CU0","HUMAN BETA 1,3-GLUCURONYLTRANSFERASE I (GLCAT-I) IN COMPLEX WITH UDP AND GAL-GAL(6-SO4)-XYL(2-PO4)-O-SER","10.1074/JBC.M709556200 ",1.9,31,"3cu0_oligo4","DGalpb1-3DGalp[6S]b1-ROH","GAL(2_D_)-GAL(1_D_)",30.9759,"","",""
"3CV5","GOLGI MANNOSIDASE II D204A CATALYTIC NUCLEOPHILE MUTANT COMPLEX WITH 3ALPHA,6ALPHA-MANNOPENTAOSE","10.1073/PNAS.0802206105 ",1.6,16.8,"3cv5_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-ROH","MAN(4_B_)-[MAN(3_B_)]-MAN(2_B_)-[MAN(5_B_)]-BMA(1_B_)",29.4238,"","",""
"3CXD","CRYSTAL STRUCTURE OF ANTI-OSTEOPONTIN ANTIBODY 23C3 IN COMPLEX WITH ITS EPITOPE PEPTIDE","10.1016/J.JMB.2008.07.075 ",2.8,35.38,"3cxd_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_A_)-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(57_H_)",64.7725,"","",""
"3CY4","CRYSTAL STRUCTURE CATION-DEPENDENT MANNOSE 6-PHOSPHATE RECEPTOR AT PH 7.4","10.1074/JBC.M708994200 ",1.51,14.03,"3cy4_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(81_B_)",25.1838,"","",""
"3CY4","CRYSTAL STRUCTURE CATION-DEPENDENT MANNOSE 6-PHOSPHATE RECEPTOR AT PH 7.4","10.1074/JBC.M708994200 ",1.51,14.03,"3cy4_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-MAN(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(81_A_)",13.6535,"","",""
"3CYE","CYRSTAL STRUCTURE OF THE NATIVE 1918 H1N1 NEURAMINIDASE FROM A CRYSTAL WITH LATTICE-TRANSLOCATION DEFECTS","10.1107/S0907444908016648 ",1.65,14.73,"3cye_oligo1","DManpa1-3DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-MAN(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(146_B_)",61.6902,"","",""
"3CZN","GOLGI ALPHA-MANNOSIDASE II (D204A NUCLEOPHILE MUTANT) IN COMPLEX WITH GNMAN5GN","10.1073/PNAS.0802206105 ",1.4,17.67,"3czn_oligo1","DGlcpNAcb1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAca1-ROH","MAN(7_B_)-[MAN(6_B_)]-MAN(5_B_)-[NAG(4_B_)-MAN(3_B_)]-BMA(2_B_)-NDG(1_B_)",18.7778,"","",""
"3D11","CRYSTAL STRUCTURES OF THE NIPAH G ATTACHMENT GLYCOPROTEIN","10.1073/PNAS.0804797105 ",2.31,42.51,"3d11_oligo1","DManpb1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAca1-ASN","MAN(5_D_)-[BMA(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(306_A_)",46.7891,"","",""
"3D12","CRYSTAL STRUCTURES OF NIPAH VIRUS G ATTACHMENT GLYCOPROTEIN IN COMPLEX WITH ITS RECEPTOR EPHRIN-B3","10.1073/PNAS.0804797105 ",3.01,69.13,"3d12_oligo2","DManpb1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[BMA(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(306_A_)",78.3029,"","",""
"3D12","CRYSTAL STRUCTURES OF NIPAH VIRUS G ATTACHMENT GLYCOPROTEIN IN COMPLEX WITH ITS RECEPTOR EPHRIN-B3","10.1073/PNAS.0804797105 ",3.01,69.13,"3d12_oligo1","DGlcpb1-3[LGlcpa1-6]DGulpa1-4LGalpNAcb1-4[LGlcpa1-6][LIdopa1-3]DIdopNAca1-ASN","GLC(7_F_)-[GLC(5_F_)-[BGC(4_F_)]-GL0(3_F_)-NGA(2_F_)]-[BGC(6_F_)]-LXZ(1_F_)-ASN(529_A_)",86.7593,"","",""
"3D12","CRYSTAL STRUCTURES OF NIPAH VIRUS G ATTACHMENT GLYCOPROTEIN IN COMPLEX WITH ITS RECEPTOR EPHRIN-B3","10.1073/PNAS.0804797105 ",3.01,69.13,"3d12_oligo4","DGlcpb1-3[LGlcpa1-6]DGulpa1-4LGlcpNAcb1-4[LGlcpa1-6][LIdopa1-3]DGulpNAcb1-ASN","GXL(7_I_)-[GLC(5_I_)-[BGC(4_I_)]-GL0(3_I_)-NGZ(2_I_)]-[BGC(6_I_)]-LXB(1_I_)-ASN(529_D_)",96.8656,"","",""
"3D26","NORWALK P DOMAIN A-TRISACCHARIDE COMPLEX","10.1128/JVI.00135-08 ",2.3,0,"3d26_oligo2","LFucpa1-2[DGalpNAca1-3]DGalpb1-ROH","NGA(3_D_)-[FUC(2_D_)]-GAL(1_D_)",20,"","",""
"3D26","NORWALK P DOMAIN A-TRISACCHARIDE COMPLEX","10.1128/JVI.00135-08 ",2.3,0,"3d26_oligo1","LFucpa1-2[DGalpNAca1-3]DGulpb1-ROH","NGA(3_C_)-[FUC(2_C_)]-GAL(1_C_)",20,"","",""
"3D2D","STRUCTURE OF BERBERINE BRIDGE ENZYME IN COMPLEX WITH (S)-RETICULINE","10.1038/NCHEMBIO.123 ",2.8,31.38,"3d2d_oligo2","DManpa1-2DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-MAN(5_B_)-MAN(4_B_)-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(38_A_)",66.7308,"","",""
"3D2H","STRUCTURE OF BERBERINE BRIDGE ENZYME FROM ESCHSCHOLZIA CALIFORNICA, MONOCLINIC CRYSTAL FORM","10.1038/NCHEMBIO.123 ",1.65,21.59,"3d2h_oligo2","DManpa1-2DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-MAN(5_B_)-MAN(4_B_)-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(38_A_)",37.7133,"","",""
"3D6G","FC FRAGMENT OF IGG1 (HERCEPTIN) WITH PROTEIN-A MIMETIC PEPTIDE DENDRIMER LIGAND.","10.1021/JP909405B ",2.3,72.42,"3d6g_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",68.4889,"","",""
"3D6G","FC FRAGMENT OF IGG1 (HERCEPTIN) WITH PROTEIN-A MIMETIC PEPTIDE DENDRIMER LIGAND.","10.1021/JP909405B ",2.3,72.42,"3d6g_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",71.969,"","",""
"3D7D","A HIGH RESOLUTION CRYSTAL STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN A COMPLEX WITH DCFBD, A UREA-BASED INHIBITOR","10.1021/JM800765E ",1.69,28.48,"3d7d_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(638_A_)",37.292,"","",""
"3D7F","A HIGH RESOLUTION CRYSTAL STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN A COMPLEX WITH DCIT, A UREA-BASED INHIBITOR","10.1021/JM800765E ",1.54,27.49,"3d7f_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(638_A_)",34.8011,"","",""
"3D7G","A HIGH RESOLUTION CRYSTAL STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN A COMPLEX WITH DCMC, A UREA-BASED INHIBITOR","10.1021/JM800765E ",1.75,28.08,"3d7g_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(638_A_)",38.2455,"","",""
"3D7H","A HIGH RESOLUTION CRYSTAL STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN A COMPLEX WITH DCIBZL, A UREA-BASED INHIBITOR","10.1021/JM800765E ",1.55,29.58,"3d7h_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(638_A_)",44.8343,"","",""
"3DNI","CRYSTALLOGRAPHIC REFINEMENT AND STRUCTURE OF DNASE I AT 2 ANGSTROMS RESOLUTION","10.1016/0022-2836(86)90280-9 ",2,0,"3dni_oligo1","DGalpa1-6DManpb1-3[DManpb1-6DAltpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(7_B_)-MAN(6_B_)-[GLA(5_B_)-BMA(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(18_A_)",57.589,"","",""
"3DO3","HUMAN 1GG1 FC FRAGMENT, 2.5 ANGSTROM STRUCTURE","",2.5,0,"3do3_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",74.4228,"","",""
"3DO3","HUMAN 1GG1 FC FRAGMENT, 2.5 ANGSTROM STRUCTURE","",2.5,0,"3do3_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",55.7868,"","",""
"3DQB","CRYSTAL STRUCTURE OF THE ACTIVE G-PROTEIN-COUPLED RECEPTOR OPSIN IN COMPLEX WITH A C-TERMINAL PEPTIDE DERIVED FROM THE GALPHA SUBUNIT OF TRANSDUCIN","10.1038/NATURE07330 ",3.2,64.71,"3dqb_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(15_A_)",67.812,"","",""
"3DSF","CRYSTAL STRUCTURE OF ANTI-OSTEOPONTIN ANTIBODY 23C3 IN COMPLEX WITH W43A MUTATED EPITOPE PEPTIDE","10.1016/J.JMB.2008.07.075 ",2.8,33.45,"3dsf_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_A_)-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(57_H_)",62.52,"","",""
"3DTU","CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES COMPLEXED WITH DEOXYCHOLIC ACID","10.1021/BI8013483 ",2.15,38.52,"3dtu_oligo5","DGlcpa1-3DGlcpb6-C10O1","DMU(567_C_)-DMU(567_C_)",81.8905,"","",""
"3DTU","CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES COMPLEXED WITH DEOXYCHOLIC ACID","10.1021/BI8013483 ",2.15,38.52,"3dtu_oligo3","DGlcpa1-3DGlcpb6-ROH","DMU(1011_B_)-DMU(1011_B_)",58.0886,"","",""
"3DTU","CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES COMPLEXED WITH DEOXYCHOLIC ACID","10.1021/BI8013483 ",2.15,38.52,"3dtu_oligo9","DGlcpa1-3DGlcpb6-C10O1","DMU(567_A_)-DMU(567_A_)",64.9318,"","",""
"3DTU","CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES COMPLEXED WITH DEOXYCHOLIC ACID","10.1021/BI8013483 ",2.15,38.52,"3dtu_oligo4","DGlcpa1-3DGlcpb6-C10O1","DMU(1005_A_)-DMU(1005_A_)",59.0755,"","",""
"3DTU","CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES COMPLEXED WITH DEOXYCHOLIC ACID","10.1021/BI8013483 ",2.15,38.52,"3dtu_oligo7","DGlcpa1-3DGlcpb6-C10O1","DMU(11_D_)-DMU(11_D_)",73.665,"","",""
"3DTU","CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES COMPLEXED WITH DEOXYCHOLIC ACID","10.1021/BI8013483 ",2.15,38.52,"3dtu_oligo6","DGlcpa1-3DGlcpb6-C10O1","DMU(568_C_)-DMU(568_C_)",68.5559,"","",""
"3DZW","STRUCTURE OF NARCISSUS PSEUDONARCISSUS LECTIN COMPLEX WITH MANNOBIOSE AT 1.7 A RESOLUTION, FORM II","",1.7,18.66,"3dzw_oligo6","DManpa1-3DManpa1-ROH","MAN(2_H_)-MAN(1_H_)",33.3414,"","",""
"3DZW","STRUCTURE OF NARCISSUS PSEUDONARCISSUS LECTIN COMPLEX WITH MANNOBIOSE AT 1.7 A RESOLUTION, FORM II","",1.7,18.66,"3dzw_oligo1","DManpa1-3DManpa1-ROH","MAN(2_E_)-MAN(1_E_)",32.1673,"","",""
"3DZW","STRUCTURE OF NARCISSUS PSEUDONARCISSUS LECTIN COMPLEX WITH MANNOBIOSE AT 1.7 A RESOLUTION, FORM II","",1.7,18.66,"3dzw_oligo4","DManpa1-3DManpa1-ROH","MAN(2_C_)-MAN(1_C_)",29.0841,"","",""
"3DZW","STRUCTURE OF NARCISSUS PSEUDONARCISSUS LECTIN COMPLEX WITH MANNOBIOSE AT 1.7 A RESOLUTION, FORM II","",1.7,18.66,"3dzw_oligo5","DManpa1-3DManpa1-ROH","MAN(2_G_)-MAN(1_G_)",26.5441,"","",""
"3DZW","STRUCTURE OF NARCISSUS PSEUDONARCISSUS LECTIN COMPLEX WITH MANNOBIOSE AT 1.7 A RESOLUTION, FORM II","",1.7,18.66,"3dzw_oligo3","DManpa1-3DManpa1-ROH","MAN(2_D_)-MAN(1_D_)",26.0382,"","",""
"3DZW","STRUCTURE OF NARCISSUS PSEUDONARCISSUS LECTIN COMPLEX WITH MANNOBIOSE AT 1.7 A RESOLUTION, FORM II","",1.7,18.66,"3dzw_oligo2","DManpa1-3DManpa1-ROH","MAN(2_F_)-MAN(1_F_)",31.1923,"","",""
"3EF2","STRUCTURE OF THE MARASMIUS OREADES MUSHROOM LECTIN (MOA) IN COMPLEX WITH GALALPHA(1,3)[FUCALPHA(1,2)]GAL AND CALCIUM.","10.1016/J.JMB.2009.04.074 ",1.8,11.76,"3ef2_oligo6","LFucpa1-2[DGalpa1-3]DGalpa1-ROH","GLA(3_J_)-[FUC(2_J_)]-GLA(1_J_)",12.2682,"","",""
"3EF2","STRUCTURE OF THE MARASMIUS OREADES MUSHROOM LECTIN (MOA) IN COMPLEX WITH GALALPHA(1,3)[FUCALPHA(1,2)]GAL AND CALCIUM.","10.1016/J.JMB.2009.04.074 ",1.8,11.76,"3ef2_oligo11","LFucpa1-2[DGalpa1-3]DGalpb1-ROH","GLA(3_O_)-[FUC(2_O_)]-GAL(1_O_)",14.8088,"","",""
"3EF2","STRUCTURE OF THE MARASMIUS OREADES MUSHROOM LECTIN (MOA) IN COMPLEX WITH GALALPHA(1,3)[FUCALPHA(1,2)]GAL AND CALCIUM.","10.1016/J.JMB.2009.04.074 ",1.8,11.76,"3ef2_oligo8","LFucpa1-2[DGalpa1-3]DGalpb1-ROH","GLA(3_L_)-[FUC(2_L_)]-GAL(1_L_)",15.0609,"","",""
"3EF2","STRUCTURE OF THE MARASMIUS OREADES MUSHROOM LECTIN (MOA) IN COMPLEX WITH GALALPHA(1,3)[FUCALPHA(1,2)]GAL AND CALCIUM.","10.1016/J.JMB.2009.04.074 ",1.8,11.76,"3ef2_oligo12","LFucpa1-2[DGalpa1-3]DGalpa1-ROH","GLA(3_P_)-[FUC(2_P_)]-GLA(1_P_)",12.2139,"","",""
"3EF2","STRUCTURE OF THE MARASMIUS OREADES MUSHROOM LECTIN (MOA) IN COMPLEX WITH GALALPHA(1,3)[FUCALPHA(1,2)]GAL AND CALCIUM.","10.1016/J.JMB.2009.04.074 ",1.8,11.76,"3ef2_oligo5","LFucpa1-2[DGalpa1-3]DGalpb1-ROH","GLA(3_I_)-[FUC(2_I_)]-GAL(1_I_)",14.6306,"","",""
"3EF2","STRUCTURE OF THE MARASMIUS OREADES MUSHROOM LECTIN (MOA) IN COMPLEX WITH GALALPHA(1,3)[FUCALPHA(1,2)]GAL AND CALCIUM.","10.1016/J.JMB.2009.04.074 ",1.8,11.76,"3ef2_oligo10","LFucpa1-2[DGalpa1-3]DGalpb1-ROH","GLA(3_N_)-[FUC(2_N_)]-GAL(1_N_)",8.47273,"","",""
"3EF2","STRUCTURE OF THE MARASMIUS OREADES MUSHROOM LECTIN (MOA) IN COMPLEX WITH GALALPHA(1,3)[FUCALPHA(1,2)]GAL AND CALCIUM.","10.1016/J.JMB.2009.04.074 ",1.8,11.76,"3ef2_oligo4","LFucpa1-2[DGalpa1-3]DGalpb1-ROH","GLA(3_H_)-[FUC(2_H_)]-GAL(1_H_)",8.4103,"","",""
"3EF2","STRUCTURE OF THE MARASMIUS OREADES MUSHROOM LECTIN (MOA) IN COMPLEX WITH GALALPHA(1,3)[FUCALPHA(1,2)]GAL AND CALCIUM.","10.1016/J.JMB.2009.04.074 ",1.8,11.76,"3ef2_oligo9","LFucpa1-2[DGalpa1-3]DGalpa1-ROH","GLA(3_M_)-[FUC(2_M_)]-GLA(1_M_)",12.2709,"","",""
"3EF2","STRUCTURE OF THE MARASMIUS OREADES MUSHROOM LECTIN (MOA) IN COMPLEX WITH GALALPHA(1,3)[FUCALPHA(1,2)]GAL AND CALCIUM.","10.1016/J.JMB.2009.04.074 ",1.8,11.76,"3ef2_oligo7","LFucpa1-2[DGalpa1-3]DGalpb1-ROH","GLA(3_K_)-[FUC(2_K_)]-GAL(1_K_)",8.71697,"","",""
"3EF2","STRUCTURE OF THE MARASMIUS OREADES MUSHROOM LECTIN (MOA) IN COMPLEX WITH GALALPHA(1,3)[FUCALPHA(1,2)]GAL AND CALCIUM.","10.1016/J.JMB.2009.04.074 ",1.8,11.76,"3ef2_oligo2","LFucpa1-2[DGalpa1-3]DGalpb1-ROH","GLA(3_E_)-[FUC(2_E_)]-GAL(1_E_)",8.22182,"","",""
"3EF2","STRUCTURE OF THE MARASMIUS OREADES MUSHROOM LECTIN (MOA) IN COMPLEX WITH GALALPHA(1,3)[FUCALPHA(1,2)]GAL AND CALCIUM.","10.1016/J.JMB.2009.04.074 ",1.8,11.76,"3ef2_oligo1","LFucpa1-2[DGalpa1-3]DGalpb1-ROH","GLA(3_F_)-[FUC(2_F_)]-GAL(1_F_)",14.8315,"","",""
"3EF2","STRUCTURE OF THE MARASMIUS OREADES MUSHROOM LECTIN (MOA) IN COMPLEX WITH GALALPHA(1,3)[FUCALPHA(1,2)]GAL AND CALCIUM.","10.1016/J.JMB.2009.04.074 ",1.8,11.76,"3ef2_oligo3","LFucpa1-2[DGalpa1-3]DGalpa1-ROH","GLA(3_G_)-[FUC(2_G_)]-GLA(1_G_)",11.9736,"","",""
"3EFX","NOVEL BINDING SITE IDENTIFIED IN A HYBRID BETWEEN CHOLERA TOXIN AND HEAT-LABILE ENTEROTOXIN, 1.9A CRYSTAL STRUCTURE REVEALS THE DETAILS","10.1016/J.STR.2004.06.022 ",1.94,23.06,"3efx_oligo1","LFucpa1-2[DGalpNAca1-3]DGalpb1-4[LFucpa1-3]DGlcpb1-ROH","A2G(4_R_)-[FUC(3_R_)]-GAL(2_R_)-[FUC(5_R_)]-BGC(1_R_)",41.5073,"","",""
"3EFX","NOVEL BINDING SITE IDENTIFIED IN A HYBRID BETWEEN CHOLERA TOXIN AND HEAT-LABILE ENTEROTOXIN, 1.9A CRYSTAL STRUCTURE REVEALS THE DETAILS","10.1016/J.STR.2004.06.022 ",1.94,23.06,"3efx_oligo4","LFucpa1-2[DGalpNAca1-3]DGalpb1-4[LFucpa1-3]DGlcpb1-ROH","A2G(4_B_)-[FUC(3_B_)]-GAL(2_B_)-[FUC(5_B_)]-BGC(1_B_)",25.7293,"","",""
"3EFX","NOVEL BINDING SITE IDENTIFIED IN A HYBRID BETWEEN CHOLERA TOXIN AND HEAT-LABILE ENTEROTOXIN, 1.9A CRYSTAL STRUCTURE REVEALS THE DETAILS","10.1016/J.STR.2004.06.022 ",1.94,23.06,"3efx_oligo5","LFucpa1-2[DGalpNAca1-3]DGalpb1-4[LFucpa1-3]DGlcpb1-ROH","A2G(4_P_)-[FUC(3_P_)]-GAL(2_P_)-[FUC(5_P_)]-BGC(1_P_)",25.0395,"","",""
"3EFX","NOVEL BINDING SITE IDENTIFIED IN A HYBRID BETWEEN CHOLERA TOXIN AND HEAT-LABILE ENTEROTOXIN, 1.9A CRYSTAL STRUCTURE REVEALS THE DETAILS","10.1016/J.STR.2004.06.022 ",1.94,23.06,"3efx_oligo10","LFucpa1-2[DGalpNAca1-3]DGalpb1-4[LFucpa1-3]DGlcpb1-ROH","A2G(4_C_)-[FUC(3_C_)]-GAL(2_C_)-[FUC(5_C_)]-BGC(1_C_)",31.3378,"","",""
"3EFX","NOVEL BINDING SITE IDENTIFIED IN A HYBRID BETWEEN CHOLERA TOXIN AND HEAT-LABILE ENTEROTOXIN, 1.9A CRYSTAL STRUCTURE REVEALS THE DETAILS","10.1016/J.STR.2004.06.022 ",1.94,23.06,"3efx_oligo3","LFucpa1-2[DGalpNAca1-3]DGalpb1-4[LFucpa1-3]DGlcpb1-ROH","A2G(4_Q_)-[FUC(3_Q_)]-GAL(2_Q_)-[FUC(5_Q_)]-BGC(1_Q_)",27.5191,"","",""
"3EFX","NOVEL BINDING SITE IDENTIFIED IN A HYBRID BETWEEN CHOLERA TOXIN AND HEAT-LABILE ENTEROTOXIN, 1.9A CRYSTAL STRUCTURE REVEALS THE DETAILS","10.1016/J.STR.2004.06.022 ",1.94,23.06,"3efx_oligo9","LFucpa1-2[DGalpNAca1-3]DGalpb1-4[LFucpa1-3]DGlcpb1-ROH","A2G(4_N_)-[FUC(3_N_)]-GAL(2_N_)-[FUC(5_N_)]-BGC(1_N_)",25.1225,"","",""
"3EFX","NOVEL BINDING SITE IDENTIFIED IN A HYBRID BETWEEN CHOLERA TOXIN AND HEAT-LABILE ENTEROTOXIN, 1.9A CRYSTAL STRUCTURE REVEALS THE DETAILS","10.1016/J.STR.2004.06.022 ",1.94,23.06,"3efx_oligo6","LFucpa1-2[DGalpNAca1-3]DGalpb1-4[LFucpa1-3]DGlcpb1-ROH","A2G(4_T_)-[FUC(3_T_)]-GAL(2_T_)-[FUC(5_T_)]-BGC(1_T_)",36.9087,"","",""
"3EFX","NOVEL BINDING SITE IDENTIFIED IN A HYBRID BETWEEN CHOLERA TOXIN AND HEAT-LABILE ENTEROTOXIN, 1.9A CRYSTAL STRUCTURE REVEALS THE DETAILS","10.1016/J.STR.2004.06.022 ",1.94,23.06,"3efx_oligo2","LFucpa1-2[DGalpNAca1-3]DGalpb1-4[LFucpa1-3]DGlcpb1-ROH","A2G(4_S_)-[FUC(3_S_)]-GAL(2_S_)-[FUC(5_S_)]-BGC(1_S_)",39.4833,"","",""
"3EFX","NOVEL BINDING SITE IDENTIFIED IN A HYBRID BETWEEN CHOLERA TOXIN AND HEAT-LABILE ENTEROTOXIN, 1.9A CRYSTAL STRUCTURE REVEALS THE DETAILS","10.1016/J.STR.2004.06.022 ",1.94,23.06,"3efx_oligo8","LFucpa1-2[DGalpNAca1-3]DGalpb1-4[LFucpa1-3]DGlcpb1-ROH","A2G(4_A_)-[FUC(3_A_)]-GAL(2_A_)-[FUC(5_A_)]-BGC(1_A_)",33.0031,"","",""
"3EFX","NOVEL BINDING SITE IDENTIFIED IN A HYBRID BETWEEN CHOLERA TOXIN AND HEAT-LABILE ENTEROTOXIN, 1.9A CRYSTAL STRUCTURE REVEALS THE DETAILS","10.1016/J.STR.2004.06.022 ",1.94,23.06,"3efx_oligo7","LFucpa1-2[DGalpNAca1-3]DGalpb1-4[LFucpa1-3]DGlcpb1-ROH","A2G(4_O_)-[FUC(3_O_)]-GAL(2_O_)-[FUC(5_O_)]-BGC(1_O_)",26.2424,"","",""
"3EQA","CATALYTIC DOMAIN OF GLUCOAMYLASE FROM ASPERGILLUS NIGER COMPLEXED WITH TRIS AND GLYCEROL","10.1107/S1744309110049390 ",1.9,17.86,"3eqa_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(195_A_)",33.0864,"","",""
"3EQA","CATALYTIC DOMAIN OF GLUCOAMYLASE FROM ASPERGILLUS NIGER COMPLEXED WITH TRIS AND GLYCEROL","10.1107/S1744309110049390 ",1.9,17.86,"3eqa_oligo4","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_C_)-MAN(7_C_)-[MAN(6_C_)-MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(419_A_)",38.7802,"","",""
"3ES6","CRYSTAL STRUCTURE OF THE NOVEL COMPLEX FORMED BETWEEN ZINC 2- GLYCOPROTEIN (ZAG) AND PROLACTIN INDUCIBLE PROTEIN (PIP) FROM HUMAN SEMINAL PLASMA","10.1016/J.JMB.2008.09.072 ",3.23,33.99,"3es6_oligo2","DManp[3H]b1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(77_B_)",67.6754,"","",""
"3ES6","CRYSTAL STRUCTURE OF THE NOVEL COMPLEX FORMED BETWEEN ZINC 2- GLYCOPROTEIN (ZAG) AND PROLACTIN INDUCIBLE PROTEIN (PIP) FROM HUMAN SEMINAL PLASMA","10.1016/J.JMB.2008.09.072 ",3.23,33.99,"3es6_oligo3","DGlcpNAca1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NDG(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(239_A_)",29.1525,"","",""
"3EVJ","INTERMEDIATE STRUCTURE OF ANTITHROMBIN BOUND TO THE NATURAL PENTASACCHARIDE","",3,64.2,"3evj_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(192_L_)",79.4464,"","",""
"3EYV","ANTI-LEWIS Y FAB FRAGMENT WITH LEWIS Y ANTIGEN IN THE PRESENCE OF ZINC IONS","10.1371/JOURNAL.PONE.0007777 ",2.5,28.8,"3eyv_oligo1","LFucpa1-2DGalpb1-4[LFucpa1-3]DGlcpNAca1-ROH","FUC(3_C_)-GAL(2_C_)-[FUC(4_C_)]-NDG(1_C_)",29.6805,"","",""
"3F5A","CRYSTAL STRUCTURE OF TOXOPLASMA GONDII MICRONEMAL PROTEIN 1 BOUND TO 3'SIALACNAC1-3","10.1002/PRO.204 ",2,21.91,"3f5a_oligo1","DNeup5Aca2-3DGalpb1-3DGlcpNAcb1-ROH","SIA(3_B_)-GAL(2_B_)-NAG(1_B_)",45.3102,"","",""
"3F5E","CRYSTAL STRUCTURE OF TOXOPLASMA GONDII MICRONEMAL PROTEIN 1 BOUND TO 2'F-3'SIALACNAC1-3","10.1002/PRO.204 ",2,22.11,"3f5e_oligo1","DNeup5Aca2-3DTalp[2<R1>,2H]b1-3DGlcpNAcb1-ROH","SIA(3_B_)-2FG(2_B_)-NAG(1_B_)",47.9076,"","",""
"3F9P","CRYSTAL STRUCTURE OF MYELOPEROXIDASE FROM HUMAN LEUKOCYTES","10.1074/JBC.M109.002154 ",2.93,67.16,"3f9p_oligo2","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_E_)-[BMA(5_E_)-[BMA(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(317_C_)",66.6189,"","",""
"3F9P","CRYSTAL STRUCTURE OF MYELOPEROXIDASE FROM HUMAN LEUKOCYTES","10.1074/JBC.M109.002154 ",2.93,67.16,"3f9p_oligo1","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_F_)-[BMA(5_F_)-[BMA(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(317_D_)",65.6962,"","",""
"3FBY","THE CRYSTAL STRUCTURE OF THE SIGNATURE DOMAIN OF CARTILAGE OLIGOMERIC MATRIX PROTEIN.","10.1096/FJ.08-128090 ",3.15,55.48,"3fby_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-MAN(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(742_C_)",85.288,"","",""
"3FCS","STRUCTURE OF COMPLETE ECTODOMAIN OF INTEGRIN AIIBB3","10.1016/J.MOLCEL.2008.11.018 ",2.55,31.84,"3fcs_oligo11","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-MAN(4_I_)-MAN(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(559_B_)",86.2447,"","",""
"3FCS","STRUCTURE OF COMPLETE ECTODOMAIN OF INTEGRIN AIIBB3","10.1016/J.MOLCEL.2008.11.018 ",2.55,31.84,"3fcs_oligo8","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-MAN(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(320_B_)",82.5707,"","",""
"3FCU","STRUCTURE OF HEADPIECE OF INTEGRIN AIIBB3 IN OPEN CONFORMATION","10.1016/J.MOLCEL.2008.11.018 ",2.9,60.2,"3fcu_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-MAN(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(320_B_)",109.916,"","",""
"3FCU","STRUCTURE OF HEADPIECE OF INTEGRIN AIIBB3 IN OPEN CONFORMATION","10.1016/J.MOLCEL.2008.11.018 ",2.9,60.2,"3fcu_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_H_)-MAN(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(320_D_)",95.8666,"","",""
"3FCU","STRUCTURE OF HEADPIECE OF INTEGRIN AIIBB3 IN OPEN CONFORMATION","10.1016/J.MOLCEL.2008.11.018 ",2.9,60.2,"3fcu_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-MAN(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(320_F_)",109.861,"","",""
"3FHQ","STRUCTURE OF ENDO-BETA-N-ACETYLGLUCOSAMINIDASE A","10.1371/JOURNAL.PONE.0004658 ",2.45,36.3,"3fhq_oligo3","DManpa1-3[DManpa1-6]DManpb1-C8N1O4S1","MAN(3_G_)-[MAN(2_G_)]-BMA(1_G_)-NGT(625_D_)",20,"","",""
"3FHQ","STRUCTURE OF ENDO-BETA-N-ACETYLGLUCOSAMINIDASE A","10.1371/JOURNAL.PONE.0004658 ",2.45,36.3,"3fhq_oligo4","DManpa1-3[DManpa1-6]DManpb1-C8N1O4S1","MAN(3_H_)-[MAN(2_H_)]-BMA(1_H_)-NGT(625_F_)",20,"","",""
"3FHQ","STRUCTURE OF ENDO-BETA-N-ACETYLGLUCOSAMINIDASE A","10.1371/JOURNAL.PONE.0004658 ",2.45,36.3,"3fhq_oligo1","DManpa1-3[DManpa1-6]DManpb1-C8N1O4S1","MAN(3_C_)-[MAN(2_C_)]-BMA(1_C_)-NGT(625_A_)",20,"","",""
"3FHQ","STRUCTURE OF ENDO-BETA-N-ACETYLGLUCOSAMINIDASE A","10.1371/JOURNAL.PONE.0004658 ",2.45,36.3,"3fhq_oligo2","DManpa1-3[DManpa1-6]DManpb1-C8N1O4S1","MAN(3_E_)-[MAN(2_E_)]-BMA(1_E_)-NGT(625_B_)",20,"","",""
"3FJT","CRYSTAL STRUCTURE OF A HUMAN FC FRAGMENT ENGINEERED FOR EXTENDED SERUM HALF-LIFE","10.1016/J.MOLIMM.2009.01.026 ",2.5,63.81,"3fjt_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",98.0298,"","",""
"3FJT","CRYSTAL STRUCTURE OF A HUMAN FC FRAGMENT ENGINEERED FOR EXTENDED SERUM HALF-LIFE","10.1016/J.MOLIMM.2009.01.026 ",2.5,63.81,"3fjt_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",107.811,"","",""
"3FPX","NATIVE FUNGUS LACCASE FROM TRAMETES HIRSUTA","",1.8,31.28,"3fpx_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(217_A_)",46.4725,"","",""
"3FPX","NATIVE FUNGUS LACCASE FROM TRAMETES HIRSUTA","",1.8,31.28,"3fpx_oligo1","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-MAN(4_B_)-[MAN(6_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(54_A_)",41.1664,"","",""
"3FUS","IMPROVED STRUCTURE OF THE UNLIGANDED SIMIAN IMMUNODEFICIENCY VIRUS GP120 CORE","10.1107/S0907444909003539 ",4,131.8,"3fus_oligo9","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_J_)-[MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(475_A_)",180.282,"","",""
"3FUS","IMPROVED STRUCTURE OF THE UNLIGANDED SIMIAN IMMUNODEFICIENCY VIRUS GP120 CORE","10.1107/S0907444909003539 ",4,131.8,"3fus_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(6_K_)-[MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(243_A_)",122.215,"","",""
"3FUS","IMPROVED STRUCTURE OF THE UNLIGANDED SIMIAN IMMUNODEFICIENCY VIRUS GP120 CORE","10.1107/S0907444909003539 ",4,131.8,"3fus_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(6_C_)-[MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(277_A_)",128.633,"","",""
"3FUS","IMPROVED STRUCTURE OF THE UNLIGANDED SIMIAN IMMUNODEFICIENCY VIRUS GP120 CORE","10.1107/S0907444909003539 ",4,131.8,"3fus_oligo5","DManpb1-3DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAca1-ASN","FUL(5_B_)-[BMA(4_B_)-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(246_A_)",130.215,"","",""
"3FUS","IMPROVED STRUCTURE OF THE UNLIGANDED SIMIAN IMMUNODEFICIENCY VIRUS GP120 CORE","10.1107/S0907444909003539 ",4,131.8,"3fus_oligo3","DManpa1-3DManpb1-6DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(6_H_)-[MAN(5_H_)-BMA(4_H_)-BMA(3_H_)-NAG(2_H_)]-NAG(1_H_)-ASN(376_A_)",160.923,"","",""
"3FUS","IMPROVED STRUCTURE OF THE UNLIGANDED SIMIAN IMMUNODEFICIENCY VIRUS GP120 CORE","10.1107/S0907444909003539 ",4,131.8,"3fus_oligo4","DManpb1-2DManpa1-2DManpb1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_I_)-[BMA(6_I_)-MAN(5_I_)-BMA(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(459_A_)",134.506,"","",""
"3FYE","CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES IN THE REDUCED STATE","10.1021/BI9001387 ",2.15,45.8,"3fye_oligo9","DGlcpa1-3DGlcpb6-ROH","DMU(1011_D_)-DMU(1011_D_)",70.7768,"","",""
"3FYE","CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES IN THE REDUCED STATE","10.1021/BI9001387 ",2.15,45.8,"3fye_oligo10","DGlcpa1-3DGlcpb6-C10O1","DMU(574_A_)-DMU(574_A_)",37.1295,"","",""
"3FYE","CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES IN THE REDUCED STATE","10.1021/BI9001387 ",2.15,45.8,"3fye_oligo6","DGlcpa1-3DGlcpb6-ROH","DMU(1002_C_)-DMU(1002_C_)",99.8395,"","",""
"3FYE","CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES IN THE REDUCED STATE","10.1021/BI9001387 ",2.15,45.8,"3fye_oligo5","DGlcpa1-3DGlcpb6-ROH","DMU(11_B_)-DMU(11_B_)",74.0914,"","",""
"3FYE","CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES IN THE REDUCED STATE","10.1021/BI9001387 ",2.15,45.8,"3fye_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(577_A_)-DMU(577_A_)",53.7918,"","",""
"3FYE","CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES IN THE REDUCED STATE","10.1021/BI9001387 ",2.15,45.8,"3fye_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(1003_D_)-DMU(1003_D_)",95.9395,"","",""
"3FYE","CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES IN THE REDUCED STATE","10.1021/BI9001387 ",2.15,45.8,"3fye_oligo4","DGlcpa1-3DGlcpb6-C10O1","DMU(288_B_)-DMU(288_B_)",76.9595,"","",""
"3FYE","CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES IN THE REDUCED STATE","10.1021/BI9001387 ",2.15,45.8,"3fye_oligo7","DGlcpa1-3DGlcpb6-C10O1","DMU(1005_C_)-DMU(1005_C_)",57.1886,"","",""
"3FYE","CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES IN THE REDUCED STATE","10.1021/BI9001387 ",2.15,45.8,"3fye_oligo3","DGlcpa1-3DGlcpb6-C10O1","DMU(575_A_)-DMU(575_A_)",75.3936,"","",""
"3FYI","CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES IN THE REDUCED STATE BOUND WITH CYANIDE","10.1021/BI9001387 ",2.2,44.02,"3fyi_oligo2","DGlcpa1-3DGlcpb6-ROH","DMU(1002_C_)-DMU(1002_C_)",98.9873,"","",""
"3FYI","CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES IN THE REDUCED STATE BOUND WITH CYANIDE","10.1021/BI9001387 ",2.2,44.02,"3fyi_oligo5","DGlcpa1-3DGlcpb6-C10O1","DMU(288_B_)-DMU(288_B_)",84.6209,"","",""
"3FYI","CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES IN THE REDUCED STATE BOUND WITH CYANIDE","10.1021/BI9001387 ",2.2,44.02,"3fyi_oligo8","DGlcpa1-3DGlcpb6-C10O1","DMU(1003_D_)-DMU(1003_D_)",101.267,"","",""
"3FYI","CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES IN THE REDUCED STATE BOUND WITH CYANIDE","10.1021/BI9001387 ",2.2,44.02,"3fyi_oligo7","DGlcpa1-3DGlcpb6-C10O1","DMU(576_A_)-DMU(576_A_)",50.6532,"","",""
"3FYI","CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES IN THE REDUCED STATE BOUND WITH CYANIDE","10.1021/BI9001387 ",2.2,44.02,"3fyi_oligo10","DGlcpa1-3DGlcpb6-C10O1","DMU(574_A_)-DMU(574_A_)",72.87,"","",""
"3FYI","CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES IN THE REDUCED STATE BOUND WITH CYANIDE","10.1021/BI9001387 ",2.2,44.02,"3fyi_oligo1","DGlcpa1-3DGlcpb6-ROH","DMU(11_B_)-DMU(11_B_)",74.1877,"","",""
"3FYI","CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES IN THE REDUCED STATE BOUND WITH CYANIDE","10.1021/BI9001387 ",2.2,44.02,"3fyi_oligo4","DGlcpa1-3DGlcpb6-C10O1","DMU(573_A_)-DMU(573_A_)",32.7827,"","",""
"3FYI","CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES IN THE REDUCED STATE BOUND WITH CYANIDE","10.1021/BI9001387 ",2.2,44.02,"3fyi_oligo9","DGlcpa1-3DGlcpb6-ROH","DMU(1011_D_)-DMU(1011_D_)",69.4614,"","",""
"3FYI","CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES IN THE REDUCED STATE BOUND WITH CYANIDE","10.1021/BI9001387 ",2.2,44.02,"3fyi_oligo3","DGlcpa1-3DGlcpb6-C10O1","DMU(1005_C_)-DMU(1005_C_)",61.9082,"","",""
"3GBN","CRYSTAL STRUCTURE OF FAB CR6261 IN COMPLEX WITH THE 1918 H1N1 INFLUENZA VIRUS HEMAGGLUTININ","10.1126/SCIENCE.1171491 ",2.2,28.77,"3gbn_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(21_A_)",41.7516,"","",""
"3GD9","CRYSTAL STRUCTURE OF LAMINARIPENTAOSE-PRODUCING BETA-1,3-GLUCANASE IN COMPLEX WITH LAMINARITETRAOSE","10.1074/JBC.M109.010983 ",1.8,18.71,"3gd9_oligo1","DGlcpa1-3DGlcpb1-3DGlcpb1-3DGlcpa1-ROH","BGC(4_B_)-BGC(3_B_)-BGC(2_B_)-GLC(1_B_)",25.8755,"","",""
"3GDN","ALMOND HYDROXYNITRILE LYASE IN COMPLEX WITH BENZALDEHYDE","10.1021/BI802162S ",1.67,16.55,"3gdn_oligo4","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_D_)-[FUC(2_D_)]-NAG(1_D_)-ASN(392_A_)",42.1733,"","",""
"3GDN","ALMOND HYDROXYNITRILE LYASE IN COMPLEX WITH BENZALDEHYDE","10.1021/BI802162S ",1.67,16.55,"3gdn_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-[FUC(5_E_)]-NAG(1_E_)-ASN(392_B_)",37.4527,"","",""
"3GDP","HYDROXYNITRILE LYASE FROM ALMOND, MONOCLINIC CRYSTAL FORM","10.1021/BI802162S ",1.57,15.64,"3gdp_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-[FUC(5_E_)]-NAG(1_E_)-ASN(392_B_)",34.2735,"","",""
"3GDP","HYDROXYNITRILE LYASE FROM ALMOND, MONOCLINIC CRYSTAL FORM","10.1021/BI802162S ",1.57,15.64,"3gdp_oligo4","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_D_)-[FUC(2_D_)]-NAG(1_D_)-ASN(392_A_)",37.2385,"","",""
"3GHG","CRYSTAL STRUCTURE OF HUMAN FIBRINOGEN","10.1021/BI802205G ",2.9,80.58,"3ghg_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAca1-4DGlcpNAcb1-ASN","MAN(5_W_)-[MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(364_H_)",101.151,"","",""
"3GHG","CRYSTAL STRUCTURE OF HUMAN FIBRINOGEN","10.1021/BI802205G ",2.9,80.58,"3ghg_oligo2","DNeup5Aca2-6DGalpa1-4DGlcpNAca1-2DManpa1-3[DNeup5Aca2-6DGalpb1-4DGlcpNAca1-2DManpa1-6]DManpb1-4DGlcpNAca1-4DGlcpNAcb1-ASN","SIA(11_V_)-GAL(10_V_)-NAG(9_V_)-MAN(8_V_)-[SIA(7_V_)-GAL(6_V_)-NAG(5_V_)-MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(364_E_)",107.051,"","",""
"3GHG","CRYSTAL STRUCTURE OF HUMAN FIBRINOGEN","10.1021/BI802205G ",2.9,80.58,"3ghg_oligo1","DNeup5Aca2-6DGalpa1-4DGlcpNAca1-2DManpa1-3[DNeup5Aca2-6DGalpb1-4DGlcpNAca1-2DManpa1-6]DManpb1-4DGlcpNAca1-4DGlcpNAcx1-","SIA(11_U_)-GAL(10_U_)-NAG(9_U_)-MAN(8_U_)-[SIA(7_U_)-GAL(6_U_)-NAG(5_U_)-MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)",105.172,"","",""
"3GHG","CRYSTAL STRUCTURE OF HUMAN FIBRINOGEN","10.1021/BI802205G ",2.9,80.58,"3ghg_oligo4","DNeup5Aca2-6DGalpa1-4DGlcpNAca1-2DManpa1-3[DNeup5Aca2-6DGalpb1-4DGlcpNAca1-2DManpa1-6]DManpb1-4DGlcpNAca1-4DGlcpNAcx1-","SIA(11_X_)-GAL(10_X_)-NAG(9_X_)-MAN(8_X_)-[SIA(7_X_)-GAL(6_X_)-NAG(5_X_)-MAN(4_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)",106.19,"","",""
"3GLY","REFINED CRYSTAL STRUCTURES OF GLUCOAMYLASE FROM ASPERGILLUS AWAMORI VAR. X100","10.1006/JMBI.1994.1316 ",2.2,0,"3gly_oligo2","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_C_)-[MAN(7_C_)]-MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(395_A_)",30.4481,"","",""
"3GLY","REFINED CRYSTAL STRUCTURES OF GLUCOAMYLASE FROM ASPERGILLUS AWAMORI VAR. X100","10.1006/JMBI.1994.1316 ",2.2,0,"3gly_oligo1","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(171_A_)",27.5145,"","",""
"3GML","STRUCTURE OF MOUSE CD1D IN COMPLEX WITH C6PH","10.1016/J.JMB.2009.08.061 ",1.7,24.06,"3gml_oligo1","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(42_A_)",54.9804,"","",""
"3GML","STRUCTURE OF MOUSE CD1D IN COMPLEX WITH C6PH","10.1016/J.JMB.2009.08.061 ",1.7,24.06,"3gml_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_D_)-[MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(165_A_)",40.6138,"","",""
"3GMM","STRUCTURE OF MOUSE CD1D IN COMPLEX WITH C8PH","10.1016/J.JMB.2009.08.061 ",1.8,25.62,"3gmm_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_D_)-[MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(165_A_)",44.478,"","",""
"3GMM","STRUCTURE OF MOUSE CD1D IN COMPLEX WITH C8PH","10.1016/J.JMB.2009.08.061 ",1.8,25.62,"3gmm_oligo3","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(42_A_)",62.7567,"","",""
"3GMN","STRUCTURE OF MOUSE CD1D IN COMPLEX WITH C10PH","10.1016/J.JMB.2009.08.061 ",1.7,27.15,"3gmn_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_D_)-[MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(165_A_)",42.1379,"","",""
"3GMN","STRUCTURE OF MOUSE CD1D IN COMPLEX WITH C10PH","10.1016/J.JMB.2009.08.061 ",1.7,27.15,"3gmn_oligo3","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(42_A_)",54.9965,"","",""
"3GMO","STRUCTURE OF MOUSE CD1D IN COMPLEX WITH C8PHF","10.1016/J.JMB.2009.08.061 ",1.6,22.25,"3gmo_oligo4","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(42_A_)",49.1825,"","",""
"3GMO","STRUCTURE OF MOUSE CD1D IN COMPLEX WITH C8PHF","10.1016/J.JMB.2009.08.061 ",1.6,22.25,"3gmo_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_D_)-[MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(165_A_)",36.1602,"","",""
"3GMP","STRUCTURE OF MOUSE CD1D IN COMPLEX WITH PBS-25","10.1016/J.JMB.2009.08.061 ",1.7,23.57,"3gmp_oligo3","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(42_A_)",49.6829,"","",""
"3GMP","STRUCTURE OF MOUSE CD1D IN COMPLEX WITH PBS-25","10.1016/J.JMB.2009.08.061 ",1.7,23.57,"3gmp_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_D_)-[MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(165_A_)",36.8029,"","",""
"3GMQ","STRUCTURE OF MOUSE CD1D EXPRESSED IN SF9 CELLS, NO LIGAND ADDED","10.1016/J.JMB.2009.08.061 ",1.8,29.23,"3gmq_oligo1","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(42_A_)",60.542,"","",""
"3GMQ","STRUCTURE OF MOUSE CD1D EXPRESSED IN SF9 CELLS, NO LIGAND ADDED","10.1016/J.JMB.2009.08.061 ",1.8,29.23,"3gmq_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_D_)-[MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(165_A_)",49.5811,"","",""
"3GMR","STRUCTURE OF MOUSE CD1D IN COMPLEX WITH C8PH, DIFFERENT SPACE GROUP","10.1016/J.JMB.2009.08.061 ",1.9,16.69,"3gmr_oligo1","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_E_)-[MAN(5_E_)-MAN(4_E_)-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(165_A_)",47.5094,"","",""
"3GWJ","CRYSTAL STRUCTURE OF ANTHERAEA PERNYI ARYLPHORIN","10.1042/BJ20082170 ",2.43,36.8,"3gwj_oligo1","DGlcpa1-3DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(12_G_)-MAN(11_G_)-[MAN(10_G_)-MAN(9_G_)]-MAN(8_G_)-[GLC(7_G_)-MAN(6_G_)-MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(196_A_)",58.8424,"","",""
"3GWJ","CRYSTAL STRUCTURE OF ANTHERAEA PERNYI ARYLPHORIN","10.1042/BJ20082170 ",2.43,36.8,"3gwj_oligo11","DGlcpa1-3DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(12_Q_)-MAN(11_Q_)-[MAN(10_Q_)-MAN(9_Q_)]-MAN(8_Q_)-[GLC(7_Q_)-MAN(6_Q_)-MAN(5_Q_)-MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(196_F_)",56.6375,"","",""
"3GWJ","CRYSTAL STRUCTURE OF ANTHERAEA PERNYI ARYLPHORIN","10.1042/BJ20082170 ",2.43,36.8,"3gwj_oligo3","DGlcpa1-3DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(12_I_)-MAN(11_I_)-[MAN(10_I_)-MAN(9_I_)]-MAN(8_I_)-[GLC(7_I_)-MAN(6_I_)-MAN(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(196_B_)",58.4268,"","",""
"3GWJ","CRYSTAL STRUCTURE OF ANTHERAEA PERNYI ARYLPHORIN","10.1042/BJ20082170 ",2.43,36.8,"3gwj_oligo7","DGlcpa1-3DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(12_M_)-MAN(11_M_)-[MAN(10_M_)-MAN(9_M_)]-MAN(8_M_)-[GLC(7_M_)-MAN(6_M_)-MAN(5_M_)-MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(196_D_)",58.6183,"","",""
"3GWJ","CRYSTAL STRUCTURE OF ANTHERAEA PERNYI ARYLPHORIN","10.1042/BJ20082170 ",2.43,36.8,"3gwj_oligo9","DGlcpa1-3DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(12_O_)-MAN(11_O_)-[MAN(10_O_)-MAN(9_O_)]-MAN(8_O_)-[GLC(7_O_)-MAN(6_O_)-MAN(5_O_)-MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(196_E_)",58.6251,"","",""
"3GWJ","CRYSTAL STRUCTURE OF ANTHERAEA PERNYI ARYLPHORIN","10.1042/BJ20082170 ",2.43,36.8,"3gwj_oligo5","DGlcpa1-3DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(12_K_)-MAN(11_K_)-[MAN(10_K_)-MAN(9_K_)]-MAN(8_K_)-[GLC(7_K_)-MAN(6_K_)-MAN(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(196_C_)",57.2404,"","",""
"3GXT","CRYSTAL STRUCTURE OF ALPHA-GALACTOSIDASE A AT PH 4.5 COMPLEXED WITH 1- DEOXYGALACTONIJIRIMYCIN","10.1021/BI9002265 ",2.7,57.74,"3gxt_oligo1","DManpb1-3DManpx1-","MAN(2_E_)-MAN(1_E_)",104.221,"","",""
"3GXT","CRYSTAL STRUCTURE OF ALPHA-GALACTOSIDASE A AT PH 4.5 COMPLEXED WITH 1- DEOXYGALACTONIJIRIMYCIN","10.1021/BI9002265 ",2.7,57.74,"3gxt_oligo7","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_G_)-MAN(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(192_B_)",71.7495,"","",""
"3GXY","CRYSTAL STRUCTURE OF CYANOVIRIN-N COMPLEXED TO A SYNTHETIC HEXAMANNOSIDE","10.1074/JBC.M205909200 ",2.4,21.98,"3gxy_oligo1","DManpa1-2DManpa1-3DManpb1-C5O1","MAN(3_C_)-MAN(2_C_)-OPM(1_C_)",65.7152,"","",""
"3GXY","CRYSTAL STRUCTURE OF CYANOVIRIN-N COMPLEXED TO A SYNTHETIC HEXAMANNOSIDE","10.1074/JBC.M205909200 ",2.4,21.98,"3gxy_oligo2","DManpa1-2DManpa1-3DManpb1-C5O1","MAN(3_D_)-MAN(2_D_)-OPM(1_D_)",81.6488,"","",""
"3GXZ","CRYSTAL STRUCTURE OF CYANOVIRIN-N COMPLEXED TO OLIGOMANNOSE-9 (MAN-9)","10.1074/JBC.M205909200 ",2.5,66.73,"3gxz_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","MAN(9_C_)-MAN(8_C_)-[MAN(10_C_)]-MAN(7_C_)-[MAN(6_C_)-MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)",104.599,"","",""
"3GXZ","CRYSTAL STRUCTURE OF CYANOVIRIN-N COMPLEXED TO OLIGOMANNOSE-9 (MAN-9)","10.1074/JBC.M205909200 ",2.5,66.73,"3gxz_oligo1","DManpa1-2DManpa1-2DManpa1-3DManpb1-ROH","MAN(4_D_)-MAN(3_D_)-MAN(2_D_)-BMA(1_D_)",108.757,"","",""
"3H32","CRYSTAL STRUCTURE OF D-DIMER FROM HUMAN FIBRIN COMPLEXED WITH GLY-HIS- ARG-PRO-TYR-AMIDE","10.1021/BI900647G ",3.6,0,"3h32_oligo1","DNeup5Aca2-6DGalpb1-4DGlcpNAca1-2DManpa1-3[DManpb1-6]DManpa1-4DGlcpNAca1-4DGlcpNAcb1-ASN","MAN(8_G_)-[SIA(7_G_)-GAL(6_G_)-NAG(5_G_)-MAN(4_G_)]-MAN(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(364_B_)",110.818,"","",""
"3H32","CRYSTAL STRUCTURE OF D-DIMER FROM HUMAN FIBRIN COMPLEXED WITH GLY-HIS- ARG-PRO-TYR-AMIDE","10.1021/BI900647G ",3.6,0,"3h32_oligo2","DNeup5Acb2-6DGalpb1-4DGlcpNAca1-2DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAca1-4DGlcpNAcb1-ASN","MAN(8_H_)-[SIA(7_H_)-GAL(6_H_)-NAG(5_H_)-MAN(4_H_)]-MAN(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(364_E_)",111.526,"","",""
"3H53","CRYSTAL STRUCTURE OF HUMAN ALPHA-N-ACETYLGALACTOSAMINIDASE","10.1016/J.JMB.2009.08.021 ",2.01,29.36,"3h53_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(177_B_)",70.3025,"","",""
"3H53","CRYSTAL STRUCTURE OF HUMAN ALPHA-N-ACETYLGALACTOSAMINIDASE","10.1016/J.JMB.2009.08.021 ",2.01,29.36,"3h53_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(177_A_)",60.8011,"","",""
"3H54","CRYSTAL STRUCTURE OF HUMAN ALPHA-N-ACETYLGALACTOSAMINIDASE,COMPLEX WITH GALNAC","10.1016/J.JMB.2009.08.021 ",2.2,36.6,"3h54_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(177_B_)",86.9193,"","",""
"3H54","CRYSTAL STRUCTURE OF HUMAN ALPHA-N-ACETYLGALACTOSAMINIDASE,COMPLEX WITH GALNAC","10.1016/J.JMB.2009.08.021 ",2.2,36.6,"3h54_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(177_A_)",77.492,"","",""
"3H55","CRYSTAL STRUCTURE OF HUMAN ALPHA-N-ACETYLGALACTOSAMINIDASE, COMPLEX WITH GALACTOSE","10.1016/J.JMB.2009.08.021 ",1.91,24.91,"3h55_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(177_A_)",49.5211,"","",""
"3H55","CRYSTAL STRUCTURE OF HUMAN ALPHA-N-ACETYLGALACTOSAMINIDASE, COMPLEX WITH GALACTOSE","10.1016/J.JMB.2009.08.021 ",1.91,24.91,"3h55_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(177_B_)",61.5936,"","",""
"3H9Y","CRYSTAL STRUCTURE OF THE IGE-FC3-4 DOMAINS","10.1016/J.JMB.2009.08.012 ",2.23,37.9,"3h9y_oligo1","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(394_A_)",87.0977,"","",""
"3H9Y","CRYSTAL STRUCTURE OF THE IGE-FC3-4 DOMAINS","10.1016/J.JMB.2009.08.012 ",2.23,37.9,"3h9y_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(394_E_)",76.3102,"","",""
"3H9Y","CRYSTAL STRUCTURE OF THE IGE-FC3-4 DOMAINS","10.1016/J.JMB.2009.08.012 ",2.23,37.9,"3h9y_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(394_B_)",77.8044,"","",""
"3H9Z","CRYSTAL STRUCTURE OF THE IGE-FC3-4 DOMAINS","10.1016/J.JMB.2009.08.012 ",2.45,31.78,"3h9z_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(394_B_)",67.1174,"","",""
"3H9Z","CRYSTAL STRUCTURE OF THE IGE-FC3-4 DOMAINS","10.1016/J.JMB.2009.08.012 ",2.45,31.78,"3h9z_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(394_C_)",64.6785,"","",""
"3H9Z","CRYSTAL STRUCTURE OF THE IGE-FC3-4 DOMAINS","10.1016/J.JMB.2009.08.012 ",2.45,31.78,"3h9z_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(394_D_)",68.784,"","",""
"3HA0","CRYSTAL STRUCTURE OF THE IGE-FC3-4 DOMAINS","10.1016/J.JMB.2009.08.012 ",2.8,63.1,"3ha0_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(394_B_)",97.9304,"","",""
"3HA0","CRYSTAL STRUCTURE OF THE IGE-FC3-4 DOMAINS","10.1016/J.JMB.2009.08.012 ",2.8,63.1,"3ha0_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(394_D_)",102.173,"","",""
"3HA0","CRYSTAL STRUCTURE OF THE IGE-FC3-4 DOMAINS","10.1016/J.JMB.2009.08.012 ",2.8,63.1,"3ha0_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_L_)-[MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(394_F_)",104.417,"","",""
"3HA0","CRYSTAL STRUCTURE OF THE IGE-FC3-4 DOMAINS","10.1016/J.JMB.2009.08.012 ",2.8,63.1,"3ha0_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(394_A_)",87.2578,"","",""
"3HA0","CRYSTAL STRUCTURE OF THE IGE-FC3-4 DOMAINS","10.1016/J.JMB.2009.08.012 ",2.8,63.1,"3ha0_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(394_E_)",110.381,"","",""
"3HA0","CRYSTAL STRUCTURE OF THE IGE-FC3-4 DOMAINS","10.1016/J.JMB.2009.08.012 ",2.8,63.1,"3ha0_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(394_C_)",97.2445,"","",""
"3HDL","CRYSTAL STRUCTURE OF HIGHLY GLYCOSYLATED PEROXIDASE FROM ROYAL PALM TREE","10.1016/J.JSB.2009.10.009 ",1.85,0,"3hdl_oligo8","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_D_)-[FUC(2_D_)]-NAG(1_D_)-ASN(144_A_)",69.6197,"","",""
"3HDL","CRYSTAL STRUCTURE OF HIGHLY GLYCOSYLATED PEROXIDASE FROM ROYAL PALM TREE","10.1016/J.JSB.2009.10.009 ",1.85,0,"3hdl_oligo7","DManpa1-2DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(4_C_)-MAN(3_C_)-NAG(2_C_)-[FUC(5_C_)]-NAG(1_C_)-ASN(28_A_)",69.7016,"","",""
"3HDL","CRYSTAL STRUCTURE OF HIGHLY GLYCOSYLATED PEROXIDASE FROM ROYAL PALM TREE","10.1016/J.JSB.2009.10.009 ",1.85,0,"3hdl_oligo5","DManpa1-2[DManpb1-3]DManpa1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-MAN(3_G_)-NAG(2_G_)-[FUC(6_G_)]-NAG(1_G_)-ASN(298_A_)",73.993,"","",""
"3HDL","CRYSTAL STRUCTURE OF HIGHLY GLYCOSYLATED PEROXIDASE FROM ROYAL PALM TREE","10.1016/J.JSB.2009.10.009 ",1.85,0,"3hdl_oligo1","DManpa1-2[DManpa1-3][DXylfb1-6]DManpa1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","XYZ(6_B_)-[MAN(5_B_)]-[MAN(4_B_)]-MAN(3_B_)-NAG(2_B_)-[FUC(7_B_)]-NAG(1_B_)-ASN(8_A_)",72.6727,"","",""
"3HDL","CRYSTAL STRUCTURE OF HIGHLY GLYCOSYLATED PEROXIDASE FROM ROYAL PALM TREE","10.1016/J.JSB.2009.10.009 ",1.85,0,"3hdl_oligo3","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_E_)-[FUC(2_E_)]-NAG(1_E_)-ASN(211_A_)",90.2918,"","",""
"3HG3","HUMAN ALPHA-GALACTOSIDASE CATALYTIC MECHANISM 2. SUBSTRATE BOUND","10.1074/JBC.M109.060145 ",1.9,23.34,"3hg3_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(192_A_)",60.283,"","",""
"3HG3","HUMAN ALPHA-GALACTOSIDASE CATALYTIC MECHANISM 2. SUBSTRATE BOUND","10.1074/JBC.M109.060145 ",1.9,23.34,"3hg3_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(192_B_)",57.0184,"","",""
"3HG4","HUMAN ALPHA-GALACTOSIDASE CATALYTIC MECHANISM 3. COVALENT INTERMEDIATE","10.1074/JBC.M109.060145 ",2.3,49.85,"3hg4_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(192_A_)",79.5715,"","",""
"3HG4","HUMAN ALPHA-GALACTOSIDASE CATALYTIC MECHANISM 3. COVALENT INTERMEDIATE","10.1074/JBC.M109.060145 ",2.3,49.85,"3hg4_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(192_B_)",82.9909,"","",""
"3HG5","HUMAN ALPHA-GALACTOSIDASE CATALYTIC MECHANISM 4. PRODUCT BOUND","10.1074/JBC.M109.060145 ",2.3,43.46,"3hg5_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(192_B_)",79.5711,"","",""
"3HMX","CRYSTAL STRUCTURE OF USTEKINUMAB FAB/IL-12 COMPLEX","10.1016/J.JMB.2010.07.046 ",3,100.8,"3hmx_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(200_A_)",117.851,"","",""
"3HN3","HUMAN BETA-GLUCURONIDASE AT 1.7 A RESOLUTION","",1.7,15.53,"3hn3_oligo3","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_G_)-MAN(7_G_)-[MAN(6_G_)-MAN(5_G_)]-MAN(4_G_)-[MAN(10_G_)-MAN(9_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(173_D_)",25.8059,"","",""
"3HN3","HUMAN BETA-GLUCURONIDASE AT 1.7 A RESOLUTION","",1.7,15.53,"3hn3_oligo2","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_F_)-MAN(7_F_)-[MAN(6_F_)-MAN(5_F_)]-MAN(4_F_)-[BMA(10_F_)-MAN(9_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(173_B_)",23.925,"","",""
"3HN3","HUMAN BETA-GLUCURONIDASE AT 1.7 A RESOLUTION","",1.7,15.53,"3hn3_oligo4","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_H_)-MAN(8_H_)-[MAN(10_H_)]-MAN(7_H_)-[MAN(6_H_)-MAN(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(173_E_)",13.0892,"","",""
"3HN3","HUMAN BETA-GLUCURONIDASE AT 1.7 A RESOLUTION","",1.7,15.53,"3hn3_oligo1","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[LGulpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_C_)-MAN(7_C_)-[MAN(6_C_)-MAN(5_C_)]-MAN(4_C_)-[GUP(10_C_)-MAN(9_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(173_A_)",22.492,"","",""
"3HNS","CS-35 FAB COMPLEX WITH OLIGOARABINOFURANOSYL HEXASACCHARIDE","10.1016/J.JMB.2009.06.074 ",2,27.76,"3hns_oligo1","DArafb1-2DArafa1-3[DArafb1-2DArafa1-5]DArafa1-5DArafa1-OME","BXX(6_A_)-BXY(5_A_)-[BXX(4_A_)-BXY(3_A_)]-BXY(2_A_)-AXR(1_A_)",31.6194,"","",""
"3HNV","CS-35 FAB COMPLEX WITH OLIGOARABINOFURANOSYL TETRASACCHARIDE (BRANCH PART OF HEXASACCHARIDE)","10.1016/J.JMB.2009.06.074 ",2,27,"3hnv_oligo1","DArafb1-2DArafa1-3DArafa1-5DArafa1-OME","BXX(4_A_)-BXY(3_A_)-BXY(2_A_)-AXR(1_A_)",58.8742,"","",""
"3HTP","THE HEMAGGLUTININ STRUCTURE OF AN AVIAN H1N1 INFLUENZA A VIRUS IN COMPLEX WITH LSTA","10.1016/J.VIROL.2009.06.028 ",2.96,60.77,"3htp_oligo1","DNeup5Aca2-3DGalpb1-3DGlcpNAcb1-ROH","SIA(3_D_)-GAL(2_D_)-NAG(1_D_)",105.056,"","",""
"3HUJ","CRYSTAL STRUCTURE OF HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE IN COMPLEX WITH SEMI-INVARIANT NKT CELL RECEPTOR","10.1016/J.IMMUNI.2009.04.018 ",2.5,42.5,"3huj_oligo4","DManpb1-3DGlcpNAca1-4DGlcpNAcb1-ASN","BMA(3_J_)-NDG(2_J_)-NAG(1_J_)-ASN(42_C_)",59.3606,"","",""
"3I26","STRUCTURE OF BOVINE TOROVIRUS HEMAGGLUTININ-ESTERASE","10.1073/PNAS.0904266106 ",1.8,19.7,"3i26_oligo9","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_M_)-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(76_D_)",37.9243,"","",""
"3I26","STRUCTURE OF BOVINE TOROVIRUS HEMAGGLUTININ-ESTERASE","10.1073/PNAS.0904266106 ",1.8,19.7,"3i26_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(343_A_)",56.8405,"","",""
"3I26","STRUCTURE OF BOVINE TOROVIRUS HEMAGGLUTININ-ESTERASE","10.1073/PNAS.0904266106 ",1.8,19.7,"3i26_oligo12","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_P_)-[MAN(5_P_)]-MAN(4_P_)-[MAN(7_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(313_D_)",51.5091,"","",""
"3I26","STRUCTURE OF BOVINE TOROVIRUS HEMAGGLUTININ-ESTERASE","10.1073/PNAS.0904266106 ",1.8,19.7,"3i26_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(76_A_)",42.7664,"","",""
"3I27","STRUCTURE OF BOVINE TOROVIRUS HEMAGGLUTININ-ESTERASE IN COMPLEX WITH RECEPTOR","10.1073/PNAS.0904266106 ",2,15.26,"3i27_oligo9","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_M_)-[MAN(5_M_)]-MAN(4_M_)-[MAN(7_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(313_D_)",46.9005,"","",""
"3I6S","CRYSTAL STRUCTURE OF THE PLANT SUBTILISIN-LIKE PROTEASE SBT3","10.1073/PNAS.0907587106 ",2.5,50.1,"3i6s_oligo3","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_E_)-[FUC(2_E_)]-NAG(1_E_)-ASN(376_A_)",77.8591,"","",""
"3I6S","CRYSTAL STRUCTURE OF THE PLANT SUBTILISIN-LIKE PROTEASE SBT3","10.1073/PNAS.0907587106 ",2.5,50.1,"3i6s_oligo4","LFucpa1-3DGlcpNAca1-ASN","FUC(2_F_)-NAG(1_F_)-ASN(177_B_)",74.1582,"","",""
"3I6S","CRYSTAL STRUCTURE OF THE PLANT SUBTILISIN-LIKE PROTEASE SBT3","10.1073/PNAS.0907587106 ",2.5,50.1,"3i6s_oligo7","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_H_)-[FUC(2_H_)]-NAG(1_H_)-ASN(376_B_)",64.5091,"","",""
"3I6S","CRYSTAL STRUCTURE OF THE PLANT SUBTILISIN-LIKE PROTEASE SBT3","10.1073/PNAS.0907587106 ",2.5,50.1,"3i6s_oligo2","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_D_)-[FUC(2_D_)]-NAG(1_D_)-ASN(203_A_)",56.0336,"","",""
"3I6S","CRYSTAL STRUCTURE OF THE PLANT SUBTILISIN-LIKE PROTEASE SBT3","10.1073/PNAS.0907587106 ",2.5,50.1,"3i6s_oligo5","LFucpa1-3DGlcpNAcb1-ASN","FUC(2_G_)-NAG(1_G_)-ASN(203_B_)",53.7832,"","",""
"3I74","CRYSTAL STRUCTURE OF THE PLANT SUBTILISIN-LIKE PROTEASE SBT3 IN COMPLEX WITH A CHLOROMETHYLKETONE INHIBITOR","10.1073/PNAS.0907587106 ",2.6,40.02,"3i74_oligo4","LFucpa1-3DGlcpNAca1-ASN","FUC(2_H_)-NAG(1_H_)-ASN(177_B_)",63.9436,"","",""
"3I74","CRYSTAL STRUCTURE OF THE PLANT SUBTILISIN-LIKE PROTEASE SBT3 IN COMPLEX WITH A CHLOROMETHYLKETONE INHIBITOR","10.1073/PNAS.0907587106 ",2.6,40.02,"3i74_oligo2","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_F_)-[FUC(2_F_)]-NAG(1_F_)-ASN(203_A_)",43.8242,"","",""
"3I74","CRYSTAL STRUCTURE OF THE PLANT SUBTILISIN-LIKE PROTEASE SBT3 IN COMPLEX WITH A CHLOROMETHYLKETONE INHIBITOR","10.1073/PNAS.0907587106 ",2.6,40.02,"3i74_oligo6","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_J_)-[FUC(2_J_)]-NAG(1_J_)-ASN(376_B_)",48.5091,"","",""
"3I74","CRYSTAL STRUCTURE OF THE PLANT SUBTILISIN-LIKE PROTEASE SBT3 IN COMPLEX WITH A CHLOROMETHYLKETONE INHIBITOR","10.1073/PNAS.0907587106 ",2.6,40.02,"3i74_oligo3","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_G_)-[FUC(2_G_)]-NAG(1_G_)-ASN(376_A_)",51.9412,"","",""
"3I74","CRYSTAL STRUCTURE OF THE PLANT SUBTILISIN-LIKE PROTEASE SBT3 IN COMPLEX WITH A CHLOROMETHYLKETONE INHIBITOR","10.1073/PNAS.0907587106 ",2.6,40.02,"3i74_oligo5","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_I_)-[FUC(2_I_)]-NAG(1_I_)-ASN(203_B_)",41.843,"","",""
"3IAI","CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF THE TUMOR-ASSOCIATED HUMAN CARBONIC ANHYDRASE IX","10.1073/PNAS.0908301106 ",2.2,0,"3iai_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(213_A_)",58.9535,"","",""
"3IAI","CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF THE TUMOR-ASSOCIATED HUMAN CARBONIC ANHYDRASE IX","10.1073/PNAS.0908301106 ",2.2,0,"3iai_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(213_C_)",59.7176,"","",""
"3IAI","CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF THE TUMOR-ASSOCIATED HUMAN CARBONIC ANHYDRASE IX","10.1073/PNAS.0908301106 ",2.2,0,"3iai_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(213_B_)",60.9495,"","",""
"3IAI","CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF THE TUMOR-ASSOCIATED HUMAN CARBONIC ANHYDRASE IX","10.1073/PNAS.0908301106 ",2.2,0,"3iai_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(213_D_)",59.1924,"","",""
"3IGU","CRYSTAL STRUCTURE OF HUMAN ALPHA-N-ACETYLGALACTOSAMINIDASE, COVALENT INTERMEDIATE","10.1016/J.JMB.2009.08.021 ",2.15,28.73,"3igu_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(177_B_)",86.5465,"","",""
"3IGU","CRYSTAL STRUCTURE OF HUMAN ALPHA-N-ACETYLGALACTOSAMINIDASE, COVALENT INTERMEDIATE","10.1016/J.JMB.2009.08.021 ",2.15,28.73,"3igu_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(177_A_)",61.3198,"","",""
"3IJE","CRYSTAL STRUCTURE OF THE COMPLETE INTEGRIN ALHAVBETA3 ECTODOMAIN PLUS AN ALPHA/BETA TRANSMEMBRANE FRAGMENT","10.1083/JCB.200905085 ",2.9,45.77,"3ije_oligo7","DManpa1-4DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-MAN(4_E_)-[MAN(6_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(266_A_)",83.8674,"","",""
"3IJE","CRYSTAL STRUCTURE OF THE COMPLETE INTEGRIN ALHAVBETA3 ECTODOMAIN PLUS AN ALPHA/BETA TRANSMEMBRANE FRAGMENT","10.1083/JCB.200905085 ",2.9,45.77,"3ije_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(44_A_)",92.0582,"","",""
"3ILF","CRYSTAL STRUCTURE OF PORPHYRANASE A (PORA) IN COMPLEX WITH NEO- PORPHYROTETRAOSE","10.1038/NATURE08937 ",1.8,13.34,"3ilf_oligo1","LGalp[6S]b1-3DGalpb1-4LGalp[6S]a1-3DGalpa1-ROH","L6S(4_B_)-GAL(3_B_)-L6S(2_B_)-GLA(1_B_)",16.643,"","",""
"3IWW","CRYSTAL STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN A COMPLEX WITH DBIBZL, A UREA-BASED INHIBITOR","10.1016/J.BMCL.2009.10.061 ",2.3,23.61,"3iww_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(638_A_)",56.3007,"","",""
"3J2Q","MODEL OF MEMBRANE-BOUND FACTOR VIII ORGANIZED IN 2D CRYSTALS","10.1002/BIP.22199 ",15,0,"3j2q_oligo2","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcx1-","BMA(4_D_)-[MAN(3_D_)]-BMA(2_D_)-NAG(1_D_)",258.64,"","",""
"3J8F","CRYO-EM RECONSTRUCTION OF POLIOVIRUS-RECEPTOR COMPLEX","10.1128/JVI.03101-14 ",3.7,"2.68029e-09","3j8f_oligo2","DManpb1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_B_)-[BMA(4_B_)-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(120_7_)",295.455,"","",""
"3J9F","POLIOVIRUS COMPLEXED WITH SOLUBLE, DEGLYCOSYLATED POLIOVIRUS RECEPTOR (PVR) AT 4 DEGREES C","10.1128/JVI.03101-14 ",9,"1.35632e-19","3j9f_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_B_)-[MAN(4_B_)-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(120_7_)",50,"","",""
"3K36","CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE","10.1021/JM100621S ",2.2,17.37,"3k36_oligo1","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)]-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(284_A_)",59.6962,"","",""
"3K36","CRYSTAL STRUCTURE OF B/PERTH NEURAMINIDASE","10.1021/JM100621S ",2.2,17.37,"3k36_oligo2","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-[MAN(5_D_)]-MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(284_B_)",63.4823,"","",""
"3K6S","STRUCTURE OF INTEGRIN ALPHAXBETA2 ECTODOMAIN","10.1038/EMBOJ.2009.367 ",3.5,0,"3k6s_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-MAN(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(373_A_)",254.105,"","",""
"3K72","STRUCTURE OF INTEGRIN ALPHAX BETA2","10.1038/EMBOJ.2009.367 ",3.7,0,"3k72_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-MAN(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(373_A_)",319.833,"","",""
"3K72","STRUCTURE OF INTEGRIN ALPHAX BETA2","10.1038/EMBOJ.2009.367 ",3.7,0,"3k72_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-MAN(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(373_C_)",320.744,"","",""
"3KAS","MACHUPO VIRUS GP1 BOUND TO HUMAN TRANSFERRIN RECEPTOR 1","10.1038/NSMB.1772 ",2.4,54.78,"3kas_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-[MAN(5_D_)]-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(178_B_)",106.782,"","",""
"3KG2","AMPA SUBTYPE IONOTROPIC GLUTAMATE RECEPTOR IN COMPLEX WITH COMPETITIVE ANTAGONIST ZK 200775","10.1038/NATURE08624 ",3.6,192.7,"3kg2_oligo6","DManpb1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(355_B_)",206.329,"","",""
"3KG2","AMPA SUBTYPE IONOTROPIC GLUTAMATE RECEPTOR IN COMPLEX WITH COMPETITIVE ANTAGONIST ZK 200775","10.1038/NATURE08624 ",3.6,192.7,"3kg2_oligo5","DManpb1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(355_A_)",279.069,"","",""
"3KK6","CRYSTAL STRUCTURE OF CYCLOOXYGENASE-1 IN COMPLEX WITH CELECOXIB","10.1073/PNAS.0909765106 ",2.75,70.52,"3kk6_oligo4","DManpa1-3DManpb1-4DManpa1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_C_)-BMA(4_C_)-MAN(3_C_)-NAG(2_C_)-NAG(1_C_)",135.683,"","",""
"3KMB","COMPLEX OF 3'-SULFO-LEWIS-X WITH A SELECTIN-LIKE MUTANT OF MANNOSE- BINDING PROTEIN A","10.1021/BI962564E ",1.95,23.4,"3kmb_oligo1","LFucpa1-3[DGalp[3S]b1-4]DGlcpNAcb1-OME","SGA(3_A_)-[FUC(2_A_)]-MAG(1_A_)",33.063,"","",""
"3KMB","COMPLEX OF 3'-SULFO-LEWIS-X WITH A SELECTIN-LIKE MUTANT OF MANNOSE- BINDING PROTEIN A","10.1021/BI962564E ",1.95,23.4,"3kmb_oligo2","LFucpa1-3[DGalp[3S]b1-4]DGlcpNAcb1-ROH","SGA(3_B_)-[FUC(2_B_)]-NAG(1_B_)",38.4939,"","",""
"3KQ4","STRUCTURE OF INTRINSIC FACTOR-COBALAMIN BOUND TO ITS RECEPTOR CUBILIN","10.1038/NATURE08874 ",3.3,0,"3kq4_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(1092_D_)",173.559,"","",""
"3KQ4","STRUCTURE OF INTRINSIC FACTOR-COBALAMIN BOUND TO ITS RECEPTOR CUBILIN","10.1038/NATURE08874 ",3.3,0,"3kq4_oligo16","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(413_A_)",131.803,"","",""
"3KQ4","STRUCTURE OF INTRINSIC FACTOR-COBALAMIN BOUND TO ITS RECEPTOR CUBILIN","10.1038/NATURE08874 ",3.3,0,"3kq4_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(413_E_)",135.71,"","",""
"3KQ4","STRUCTURE OF INTRINSIC FACTOR-COBALAMIN BOUND TO ITS RECEPTOR CUBILIN","10.1038/NATURE08874 ",3.3,0,"3kq4_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(413_C_)",135.954,"","",""
"3KQ4","STRUCTURE OF INTRINSIC FACTOR-COBALAMIN BOUND TO ITS RECEPTOR CUBILIN","10.1038/NATURE08874 ",3.3,0,"3kq4_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(1092_F_)",175.146,"","",""
"3KQ4","STRUCTURE OF INTRINSIC FACTOR-COBALAMIN BOUND TO ITS RECEPTOR CUBILIN","10.1038/NATURE08874 ",3.3,0,"3kq4_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(1092_B_)",173.623,"","",""
"3L9R","CRYSTAL STRUCTURE OF BOVINE CD1B3 WITH ENDOGENOUSLY BOUND LIGANDS","10.4049/JIMMUNOL.1000042 ",2.3,42.94,"3l9r_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(5_K_)-[BMA(3_K_)-NAG(2_K_)]-[FUC(4_K_)]-NAG(1_K_)-ASN(57_E_)",47.1975,"","",""
"3L9R","CRYSTAL STRUCTURE OF BOVINE CD1B3 WITH ENDOGENOUSLY BOUND LIGANDS","10.4049/JIMMUNOL.1000042 ",2.3,42.94,"3l9r_oligo5","DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(5_J_)-[BMA(3_J_)-NAG(2_J_)]-[FUC(4_J_)]-NAG(1_J_)-ASN(57_C_)",51.0529,"","",""
"3L9R","CRYSTAL STRUCTURE OF BOVINE CD1B3 WITH ENDOGENOUSLY BOUND LIGANDS","10.4049/JIMMUNOL.1000042 ",2.3,42.94,"3l9r_oligo6","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(6_I_)-[MAN(4_I_)-BMA(3_I_)-NAG(2_I_)]-[FUC(5_I_)]-NAG(1_I_)-ASN(57_A_)",59.2968,"","",""
"3L9R","CRYSTAL STRUCTURE OF BOVINE CD1B3 WITH ENDOGENOUSLY BOUND LIGANDS","10.4049/JIMMUNOL.1000042 ",2.3,42.94,"3l9r_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(5_L_)-[BMA(3_L_)-NAG(2_L_)]-[FUC(4_L_)]-NAG(1_L_)-ASN(57_G_)",49.9053,"","",""
"3LEG","LECTIN DOMAIN OF LECTINOLYSIN COMPLEXED WITH LEWIS Y ANTIGEN","10.1016/J.STR.2011.11.017 ",2.01,22.48,"3leg_oligo1","LFucpa1-2DGalpb1-4[LFucpa1-3]DGlcpNAcb1-ROH","FUC(3_B_)-GAL(2_B_)-[FUC(4_B_)]-NAG(1_B_)",37.1793,"","",""
"3LEK","LECTIN DOMAIN OF LECTINOLYSIN COMPLEXED WITH LEWIS B ANTIGEN","10.1016/J.STR.2011.11.017 ",2,20.02,"3lek_oligo1","LFucpa1-2DGalpb1-3[LFucpa1-4]DGlcpNAca1-ROH","FUC(4_B_)-[FUC(3_B_)-GAL(2_B_)]-NDG(1_B_)",36.4789,"","",""
"3LL2","MONOMERIC GRIFFITHSIN IN COMPLEX WITH A HIGH-MANNOSE BRANCHED CARBOHYDRATE","10.1016/J.STR.2010.05.016 ",0.97,15.23,"3ll2_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6]DManpa1-ROH","MAN(8_B_)-[MAN(7_B_)-MAN(6_B_)]-MAN(5_B_)-[MAN(4_B_)-MAN(3_B_)-MAN(2_B_)]-MAN(1_B_)",17.9215,"","",""
"3LLZ","CRYSTAL STRUCTURE ANALYSIS OF MACLURA POMIFERA AGGLUTININ COMPLEX WITH GAL-BETA-1,3-GALNAC","10.1093/GLYCOB/CWQ118 ",1.55,19.41,"3llz_oligo1","DGalpb1-3DGalpNAcb1-ROH","GAL(2_C_)-NGA(1_C_)",19.2282,"","",""
"3LPO","CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN OF SUCRASE-ISOMALTASE","10.1074/JBC.M109.078980 ",3.2,48.2,"3lpo_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)",72.2636,"","",""
"3LPO","CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN OF SUCRASE-ISOMALTASE","10.1074/JBC.M109.078980 ",3.2,48.2,"3lpo_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(822_A_)",61.9931,"","",""
"3LPP","CRYSTAL COMPLEX OF N-TERMINAL SUCRASE-ISOMALTASE WITH KOTALANOL","10.1074/JBC.M109.078980 ",2.15,11.94,"3lpp_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(822_A_)",17.6898,"","",""
"3LPP","CRYSTAL COMPLEX OF N-TERMINAL SUCRASE-ISOMALTASE WITH KOTALANOL","10.1074/JBC.M109.078980 ",2.15,11.94,"3lpp_oligo6","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_H_)-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(822_C_)",15.9159,"","",""
"3LTF","CRYSTAL STRUCTURE OF THE DROSOPHILA EPIDERMAL GROWTH FACTOR RECEPTOR ECTODOMAIN IN COMPLEX WITH SPITZ","10.1016/J.CELL.2010.07.015 ",3.2,80.2,"3ltf_oligo1","DManpb1-4DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-[MAN(5_E_)-MAN(4_E_)]-MAN(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(470_A_)",84.5435,"","",""
"3LTF","CRYSTAL STRUCTURE OF THE DROSOPHILA EPIDERMAL GROWTH FACTOR RECEPTOR ECTODOMAIN IN COMPLEX WITH SPITZ","10.1016/J.CELL.2010.07.015 ",3.2,80.2,"3ltf_oligo3","DManpb1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_G_)-MAN(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(470_C_)",67.9091,"","",""
"3LX9","INTERCONVERSION OF HUMAN LYSOSOMAL ENZYME SPECIFICITIES","10.1074/JBC.M110.118588 ",2.04,37.45,"3lx9_oligo6","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(192_B_)",57.2343,"","",""
"3LX9","INTERCONVERSION OF HUMAN LYSOSOMAL ENZYME SPECIFICITIES","10.1074/JBC.M110.118588 ",2.04,37.45,"3lx9_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(192_A_)",60.5457,"","",""
"3LX9","INTERCONVERSION OF HUMAN LYSOSOMAL ENZYME SPECIFICITIES","10.1074/JBC.M110.118588 ",2.04,37.45,"3lx9_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-[FUC(5_D_)]-NAG(1_D_)-ASN(215_A_)",67.2431,"","",""
"3LXA","INTERCONVERSION OF HUMAN LYSOSOMAL ENZYME SPECIFICITIES","10.1074/JBC.M110.118588 ",3.04,34.52,"3lxa_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(192_A_)",57.5625,"","",""
"3LXA","INTERCONVERSION OF HUMAN LYSOSOMAL ENZYME SPECIFICITIES","10.1074/JBC.M110.118588 ",3.04,34.52,"3lxa_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(192_B_)",56.4177,"","",""
"3LXB","INTERCONVERSION OF HUMAN LYSOSOMAL ENZYME SPECIFICITIES","10.1074/JBC.M110.118588 ",2.85,32.49,"3lxb_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(192_A_)",51.3905,"","",""
"3LXB","INTERCONVERSION OF HUMAN LYSOSOMAL ENZYME SPECIFICITIES","10.1074/JBC.M110.118588 ",2.85,32.49,"3lxb_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(192_B_)",53.6189,"","",""
"3LXC","INTERCONVERSION OF HUMAN LYSOSOMAL ENZYME SPECIFICITIES","10.1074/JBC.M110.118588 ",2.35,45.3,"3lxc_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(192_B_)",65.9,"","",""
"3LXC","INTERCONVERSION OF HUMAN LYSOSOMAL ENZYME SPECIFICITIES","10.1074/JBC.M110.118588 ",2.35,45.3,"3lxc_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-[FUC(5_D_)]-NAG(1_D_)-ASN(215_A_)",76.7065,"","",""
"3LXC","INTERCONVERSION OF HUMAN LYSOSOMAL ENZYME SPECIFICITIES","10.1074/JBC.M110.118588 ",2.35,45.3,"3lxc_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(192_A_)",63.5955,"","",""
"3LZF","CRYSTAL STRUCTURE OF FAB 2D1 IN COMPLEX WITH THE 1918 INFLUENZA VIRUS HEMAGGLUTININ","10.1126/SCIENCE.1186430 ",2.8,82.29,"3lzf_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(95_A_)",106.681,"","",""
"3LZG","CRYSTAL STRUCTURE OF A 2009 H1N1 INFLUENZA VIRUS HEMAGGLUTININ","10.1126/SCIENCE.1186430 ",2.6,65.71,"3lzg_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_P_)-[MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(94_I_)",79.3449,"","",""
"3M3C","CRYSTAL STRUCTURE OF AGROCYBE AEGERITA LECTIN AAL COMPLEXED WITH P- NITROPHENYL TF DISACCHARIDE","10.1096/FJ.10-159111 ",2,22.78,"3m3c_oligo1","DGalpb1-3DGalpNAca1-C6N1O3","GAL(2_D_)-A2G(1_D_)-NPO(242_B_)",18.5782,"","",""
"3M3C","CRYSTAL STRUCTURE OF AGROCYBE AEGERITA LECTIN AAL COMPLEXED WITH P- NITROPHENYL TF DISACCHARIDE","10.1096/FJ.10-159111 ",2,22.78,"3m3c_oligo2","DGalpb1-3DGalpNAca1-C6N1O3","GAL(2_C_)-A2G(1_C_)-NPO(242_A_)",19.4164,"","",""
"3M3E","CRYSTAL STRUCTURE OF AGROCYBE AEGERITA LECTIN AAL MUTANT E66A COMPLEXED WITH P-NITROPHENYL THOMSEN-FRIEDENREICH DISACCHARIDE","10.1096/FJ.10-159111 ",2.1,18.87,"3m3e_oligo4","DGalpb1-3DGalpNAca1-C6N1O3","GAL(2_H_)-A2G(1_H_)-NPO(242_D_)",16.0768,"","",""
"3M3E","CRYSTAL STRUCTURE OF AGROCYBE AEGERITA LECTIN AAL MUTANT E66A COMPLEXED WITH P-NITROPHENYL THOMSEN-FRIEDENREICH DISACCHARIDE","10.1096/FJ.10-159111 ",2.1,18.87,"3m3e_oligo2","DGalpb1-3DGalpNAca1-C6N1O3","GAL(2_F_)-A2G(1_F_)-NPO(242_B_)",14.4686,"","",""
"3M3E","CRYSTAL STRUCTURE OF AGROCYBE AEGERITA LECTIN AAL MUTANT E66A COMPLEXED WITH P-NITROPHENYL THOMSEN-FRIEDENREICH DISACCHARIDE","10.1096/FJ.10-159111 ",2.1,18.87,"3m3e_oligo1","DGalpb1-3DGalpNAca1-C6N1O3","GAL(2_E_)-A2G(1_E_)-NPO(242_A_)",14.4223,"","",""
"3M3E","CRYSTAL STRUCTURE OF AGROCYBE AEGERITA LECTIN AAL MUTANT E66A COMPLEXED WITH P-NITROPHENYL THOMSEN-FRIEDENREICH DISACCHARIDE","10.1096/FJ.10-159111 ",2.1,18.87,"3m3e_oligo3","DGalpb1-3DGalpNAca1-C6N1O3","GAL(2_G_)-A2G(1_G_)-NPO(242_C_)",17.7482,"","",""
"3M3O","CRYSTAL STRUCTURE OF AGROCYBE AEGERITA LECTIN AAL MUTANT R85A COMPLEXED WITH P-NITROPHENYL TF DISACCHARIDE","10.1096/FJ.10-159111 ",2.1,37.24,"3m3o_oligo1","DGalpb1-3DGalpNAca1-C6N1O3","GAL(2_B_)-A2G(1_B_)-NPO(242_A_)",39.7482,"","",""
"3M3Q","CRYSTAL STRUCTURE OF AGROCYBE AEGERITA LECTIN AAL COMPLEXED WITH GANGLOSIDES GM1 PENTASACCHARIDE","10.1096/FJ.10-159111 ",2.2,28.02,"3m3q_oligo1","DGalpb1-3DGalpNAcb1-4[DNeup5Aca2-3]DGalpb1-4DGlcpb1-ROH","GAL(4_C_)-NGA(3_C_)-[SIA(5_C_)]-GAL(2_C_)-BGC(1_C_)",38.3258,"","",""
"3M3Q","CRYSTAL STRUCTURE OF AGROCYBE AEGERITA LECTIN AAL COMPLEXED WITH GANGLOSIDES GM1 PENTASACCHARIDE","10.1096/FJ.10-159111 ",2.2,28.02,"3m3q_oligo2","DGalpb1-3DGalpNAcb1-4[DNeup5Aca2-3]DGalpb1-4DGlcpb1-ROH","GAL(4_D_)-NGA(3_D_)-[SIA(5_D_)]-GAL(2_D_)-BGC(1_D_)",46.0115,"","",""
"3M5J","CRYSTAL STRUCTURE OF A H7 INFLUENZA VIRUS HEMAGGLUTININ COMPLEXED WITH LSTB","10.1371/JOURNAL.PPAT.1001081 ",2.6,15.6,"3m5j_oligo1","DGalpb1-3[DNeup5Aca2-6]DAllpNAcb1-3DGalpb1-ROH","SIA(4_G_)-[GAL(3_G_)]-NAG(2_G_)-GAL(1_G_)",73.288,"","",""
"3MBW","CRYSTAL STRUCTURE OF THE HUMAN EPHRIN A2 LBD AND CRD DOMAINS IN COMPLEX WITH EPHRIN A1","10.1073/PNAS.1004148107 ",2.81,80.12,"3mbw_oligo1","DRhapa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(26_B_)",88.9436,"","",""
"3MDJ","ER AMINOPEPTIDASE, ERAP1, BOUND TO THE ZINC AMINOPEPTIDASE INHIBITOR, BESTATIN","10.1038/NSMB.2021 ",2.95,0,"3mdj_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(70_A_)",112.23,"","",""
"3MDJ","ER AMINOPEPTIDASE, ERAP1, BOUND TO THE ZINC AMINOPEPTIDASE INHIBITOR, BESTATIN","10.1038/NSMB.2021 ",2.95,0,"3mdj_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(70_C_)",118.939,"","",""
"3MIU","STRUCTURE OF BANANA LECTIN-PENTAMANNOSE COMPLEX","10.1093/GLYCOB/CWQ128 ",2.63,57.02,"3miu_oligo1","DManpa1-3DManpa1-ROH","MAN(2_D_)-MAN(1_D_)",75.6886,"","",""
"3MIU","STRUCTURE OF BANANA LECTIN-PENTAMANNOSE COMPLEX","10.1093/GLYCOB/CWQ128 ",2.63,57.02,"3miu_oligo2","DManpa1-3DManpa1-ROH","MAN(2_C_)-MAN(1_C_)",85.7896,"","",""
"3MJ7","CRYSTAL STRUCTURE OF THE COMPLEX OF JAML AND COXSACKIE AND ADENOVIRUS RECEPTOR, CAR","10.1126/SCIENCE.1187996 ",2.8,68.21,"3mj7_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_C_)-[MAN(4_C_)-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(69_A_)",98.2709,"","",""
"3MJ9","CRYSTAL STRUCTURE OF JAML IN COMPLEX WITH THE STIMULATORY ANTIBODY HL4E10","10.1016/J.STR.2010.10.007 ",2.95,77.24,"3mj9_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_B_)-[MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(105_A_)",91.5379,"","",""
"3MUU","CRYSTAL STRUCTURE OF THE SINDBIS VIRUS E2-E1 HETERODIMER AT LOW PH","10.1038/NATURE09546 ",3.29,0,"3muu_oligo6","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)",214.494,"","",""
"3MUU","CRYSTAL STRUCTURE OF THE SINDBIS VIRUS E2-E1 HETERODIMER AT LOW PH","10.1038/NATURE09546 ",3.29,0,"3muu_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)",206.141,"","",""
"3MUU","CRYSTAL STRUCTURE OF THE SINDBIS VIRUS E2-E1 HETERODIMER AT LOW PH","10.1038/NATURE09546 ",3.29,0,"3muu_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_P_)-[MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)",193.789,"","",""
"3MUU","CRYSTAL STRUCTURE OF THE SINDBIS VIRUS E2-E1 HETERODIMER AT LOW PH","10.1038/NATURE09546 ",3.29,0,"3muu_oligo12","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_R_)-[MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)",213.046,"","",""
"3MUU","CRYSTAL STRUCTURE OF THE SINDBIS VIRUS E2-E1 HETERODIMER AT LOW PH","10.1038/NATURE09546 ",3.29,0,"3muu_oligo8","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(4_K_)-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)",160.368,"","",""
"3MUU","CRYSTAL STRUCTURE OF THE SINDBIS VIRUS E2-E1 HETERODIMER AT LOW PH","10.1038/NATURE09546 ",3.29,0,"3muu_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(4_M_)-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)",160.365,"","",""
"3MUU","CRYSTAL STRUCTURE OF THE SINDBIS VIRUS E2-E1 HETERODIMER AT LOW PH","10.1038/NATURE09546 ",3.29,0,"3muu_oligo7","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)",157.482,"","",""
"3MUU","CRYSTAL STRUCTURE OF THE SINDBIS VIRUS E2-E1 HETERODIMER AT LOW PH","10.1038/NATURE09546 ",3.29,0,"3muu_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(4_O_)-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)",157.69,"","",""
"3MUU","CRYSTAL STRUCTURE OF THE SINDBIS VIRUS E2-E1 HETERODIMER AT LOW PH","10.1038/NATURE09546 ",3.29,0,"3muu_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(4_L_)-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)",209.458,"","",""
"3MUU","CRYSTAL STRUCTURE OF THE SINDBIS VIRUS E2-E1 HETERODIMER AT LOW PH","10.1038/NATURE09546 ",3.29,0,"3muu_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)",162.868,"","",""
"3MUU","CRYSTAL STRUCTURE OF THE SINDBIS VIRUS E2-E1 HETERODIMER AT LOW PH","10.1038/NATURE09546 ",3.29,0,"3muu_oligo11","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(4_Q_)-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)",153.378,"","",""
"3N0I","CRYSTAL STRUCTURE OF AD37 FIBER KNOB IN COMPLEX WITH GD1A OLIGOSACCHARIDE","10.1038/NM.2267 ",1.65,27.59,"3n0i_oligo1","DNeup5Aca2-3DGalpb1-3DGalpNAcb1-4[DNeup5Aca2-3]DGalpb1-4DGlcpb1-ROH","SIA(5_D_)-GAL(4_D_)-NGA(3_D_)-[SIA(6_D_)]-GAL(2_D_)-BGC(1_D_)",33.1905,"","",""
"3NGB","CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC01 IN COMPLEX WITH HIV-1 GP120","10.1126/SCIENCE.1192819 ",2.68,57.3,"3ngb_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(72_C_)",185.104,"","",""
"3NGB","CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC01 IN COMPLEX WITH HIV-1 GP120","10.1126/SCIENCE.1192819 ",2.68,57.3,"3ngb_oligo11","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_P_)-[MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(72_K_)",208.257,"","",""
"3NGB","CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC01 IN COMPLEX WITH HIV-1 GP120","10.1126/SCIENCE.1192819 ",2.68,57.3,"3ngb_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(72_L_)",196.789,"","",""
"3NID","THE CLOSED HEADPIECE OF INTEGRIN ALPHAIIB BETA3 AND ITS COMPLEX WITH AN ALPAHIIB BETA3 -SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING","10.1182/BLOOD-2010-04-281154 ",2.3,51.82,"3nid_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-MAN(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(320_B_)",74.2518,"","",""
"3NIF","THE CLOSED HEADPIECE OF INTEGRIN IIB 3 AND ITS COMPLEX WITH AN IIB 3 - SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING","10.1182/BLOOD-2010-04-281154 ",2.4,13.72,"3nif_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_G_)-MAN(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(320_B_)",72.4893,"","",""
"3NK3","CRYSTAL STRUCTURE OF FULL-LENGTH SPERM RECEPTOR ZP3 AT 2.6 A RESOLUTION","10.1016/J.CELL.2010.09.041 ",2.6,0,"3nk3_oligo1","DGalpb1-3DGalpNAca1-THR","GAL(2_E_)-A2G(1_E_)-THR(168_A_)",159.379,"","",""
"3NKM","CRYSTAL STRUCTURE OF MOUSE AUTOTAXIN","10.1038/NSMB.1998 ",2,25.43,"3nkm_oligo2","DManpa1-2DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-MAN(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(524_A_)",31.4235,"","",""
"3NKN","CRYSTAL STRUCTURE OF MOUSE AUTOTAXIN IN COMPLEX WITH 14:0-LPA","10.1038/NSMB.1998 ",1.8,32.38,"3nkn_oligo2","DManpa1-2DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-MAN(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(524_A_)",32.6077,"","",""
"3NKO","CRYSTAL STRUCTURE OF MOUSE AUTOTAXIN IN COMPLEX WITH 16:0-LPA","10.1038/NSMB.1998 ",1.75,33.53,"3nko_oligo2","DManpa1-2DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-MAN(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(524_A_)",33.8101,"","",""
"3NKP","CRYSTAL STRUCTURE OF MOUSE AUTOTAXIN IN COMPLEX WITH 18:1-LPA","10.1038/NSMB.1998 ",1.75,32.74,"3nkp_oligo2","DManpa1-2DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-MAN(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(524_A_)",34.7789,"","",""
"3NKQ","CRYSTAL STRUCTURE OF MOUSE AUTOTAXIN IN COMPLEX WITH 18:3-LPA","10.1038/NSMB.1998 ",1.7,31.14,"3nkq_oligo2","DManpa1-2DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-MAN(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(524_A_)",33.2638,"","",""
"3NKR","CRYSTAL STRUCTURE OF MOUSE AUTOTAXIN IN COMPLEX WITH 22:6-LPA","10.1038/NSMB.1998 ",1.7,32.24,"3nkr_oligo2","DManpa1-2DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-MAN(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(524_A_)",33.5603,"","",""
"3NN9","REFINED ATOMIC STRUCTURES OF N9 SUBTYPE INFLUENZA VIRUS NEURAMINIDASE AND ESCAPE MUTANTS","10.1016/0022-2836(91)80069-7 ",2.3,0,"3nn9_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",24.5727,"","",""
"3NSS","THE 2009 PANDEMIC H1N1 NEURAMINIDASE N1 LACKS THE 150-CAVITY IN ITS ACTIVE SITES","10.1038/NSMB.1909 ",1.9,0,"3nss_oligo1","DManpa1-3DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-MAN(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(146_A_)",29.8314,"","",""
"3O0W","STRUCTURAL BASIS OF CARBOHYDRATE RECOGNITION BY CALRETICULIN","10.1074/JBC.M110.168294 ",1.95,22.71,"3o0w_oligo1","DGlcpa1-3DManpa1-2DManpa1-2DManpa1-ROH","GLC(4_B_)-MAN(3_B_)-MAN(2_B_)-MAN(1_B_)",24.3761,"","",""
"3O0X","STRUCTURAL BASIS OF CARBOHYDRATE RECOGNITION BY CALRETICULIN","10.1074/JBC.M110.168294 ",2.01,30.76,"3o0x_oligo1","DGlcpa1-3DManpa1-2DManpa1-2DManpa1-ROH","GLC(4_C_)-MAN(3_C_)-MAN(2_C_)-MAN(1_C_)",29.3043,"","",""
"3O0X","STRUCTURAL BASIS OF CARBOHYDRATE RECOGNITION BY CALRETICULIN","10.1074/JBC.M110.168294 ",2.01,30.76,"3o0x_oligo2","DGlcpa1-3DManpa1-2DManpa1-2DManpa1-ROH","GLC(4_D_)-MAN(3_D_)-MAN(2_D_)-MAN(1_D_)",24.7352,"","",""
"3OAX","CRYSTAL STRUCTURE OF BOVINE RHODOPSIN WITH BETA-IONONE","10.1016/J.BPJ.2010.08.003 ",2.6,0,"3oax_oligo8","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(15_B_)",89.8155,"","",""
"3OB0","A NON-SELF SUGAR MIMIC OF THE HIV GLYCAN SHIELD SHOWS ENHANCED ANTIGENICITY","10.1073/PNAS.1002717107 ",2.85,79.13,"3ob0_oligo1","YYH1-2DManpa1-2DManpa1-3DManpa1-ROH","YYH(4_A_)-MAN(3_A_)-MAN(2_A_)-MAN(1_A_)",76.436,"","",""
"3OB0","A NON-SELF SUGAR MIMIC OF THE HIV GLYCAN SHIELD SHOWS ENHANCED ANTIGENICITY","10.1073/PNAS.1002717107 ",2.85,79.13,"3ob0_oligo2","YYH1-2DManpa1-2DManpa1-3DManpa1-ROH","YYH(4_B_)-MAN(3_B_)-MAN(2_B_)-MAN(1_B_)",69.7818,"","",""
"3OG2","NATIVE CRYSTAL STRUCTURE OF TRICHODERMA REESEI BETA-GALACTOSIDASE","10.1016/J.JSB.2010.11.024 ",1.2,"1.15243e-41","3og2_oligo2","DGlcpa1-3DGlcpa1-3DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_C_)-MAN(10_C_)-[MAN(12_C_)]-MAN(9_C_)-[GLC(8_C_)-GLC(7_C_)-MAN(6_C_)-MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(930_A_)",34.8781,"","",""
"3OG2","NATIVE CRYSTAL STRUCTURE OF TRICHODERMA REESEI BETA-GALACTOSIDASE","10.1016/J.JSB.2010.11.024 ",1.2,"1.15243e-41","3og2_oligo1","DManpa1-2DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-MAN(5_B_)-MAN(4_B_)-[MAN(7_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(627_A_)",15.5471,"","",""
"3OG4","THE CRYSTAL STRUCTURE OF HUMAN INTERFERON LAMBDA 1 COMPLEXED WITH ITS HIGH AFFINITY RECEPTOR IN SPACE GROUP P21212","10.1016/J.JMB.2010.09.068 ",2.16,0,"3og4_oligo1","DManpb1-3DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(124_B_)",115.852,"","",""
"3OGR","COMPLEX STRUCTURE OF BETA-GALACTOSIDASE FROM TRICHODERMA REESEI WITH GALACTOSE","10.1016/J.JSB.2010.11.024 ",1.5,13.87,"3ogr_oligo1","DManpa1-2DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-MAN(5_B_)-MAN(4_B_)-[MAN(7_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(627_A_)",13.9286,"","",""
"3OGR","COMPLEX STRUCTURE OF BETA-GALACTOSIDASE FROM TRICHODERMA REESEI WITH GALACTOSE","10.1016/J.JSB.2010.11.024 ",1.5,13.87,"3ogr_oligo2","DGlcpa1-3DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(10_C_)-[MAN(9_C_)]-MAN(8_C_)-[GLC(7_C_)-MAN(6_C_)-MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(930_A_)",25.3371,"","",""
"3OGS","COMPLEX STRUCTURE OF BETA-GALACTOSIDASE FROM TRICHODERMA REESEI WITH IPTG","10.1016/J.JSB.2010.11.024 ",1.75,20.71,"3ogs_oligo1","DManpa1-2DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-MAN(5_B_)-MAN(4_B_)-[MAN(7_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(627_A_)",20.2988,"","",""
"3OGS","COMPLEX STRUCTURE OF BETA-GALACTOSIDASE FROM TRICHODERMA REESEI WITH IPTG","10.1016/J.JSB.2010.11.024 ",1.75,20.71,"3ogs_oligo2","DGlcpa1-3DManpa1-2DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_C_)-MAN(8_C_)-[GLC(7_C_)-MAN(6_C_)-MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(930_A_)",32.3339,"","",""
"3OGV","COMPLEX STRUCTURE OF BETA-GALACTOSIDASE FROM TRICHODERMA REESEI WITH PETG","10.1016/J.JSB.2010.11.024 ",1.4,15.63,"3ogv_oligo3","DGlcpa1-3DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_C_)-[GLC(7_C_)-MAN(6_C_)-MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(930_A_)",17.4128,"","",""
"3OGV","COMPLEX STRUCTURE OF BETA-GALACTOSIDASE FROM TRICHODERMA REESEI WITH PETG","10.1016/J.JSB.2010.11.024 ",1.4,15.63,"3ogv_oligo2","DManpa1-2DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-MAN(5_B_)-MAN(4_B_)-[MAN(7_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(627_A_)",14.6147,"","",""
"3OJA","CRYSTAL STRUCTURE OF LRIM1/APL1C COMPLEX","10.1073/PNAS.1010575107 ",2.7,37.56,"3oja_oligo4","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-MAN(4_F_)-[MAN(6_F_)]-MAN(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(325_B_)",44.1445,"","",""
"3OKW","MOUSE SEMAPHORIN 6A, EXTRACELLULAR DOMAINS 1-2","10.1038/NATURE09468 ",2.3,0,"3okw_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(461_B_)",138.404,"","",""
"3OM3","CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH K362M MUTATION IN THE REDUCED STATE","10.1073/PNAS.1012846108 ",2.6,55.95,"3om3_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(1_B_)-DMU(1_B_)",43.7518,"","",""
"3OM3","CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH K362M MUTATION IN THE REDUCED STATE","10.1073/PNAS.1012846108 ",2.6,55.95,"3om3_oligo4","DGlcpa1-3DGlcpb6-ROH","DMU(4_D_)-DMU(4_D_)",90.0191,"","",""
"3OM3","CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH K362M MUTATION IN THE REDUCED STATE","10.1073/PNAS.1012846108 ",2.6,55.95,"3om3_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(2_B_)-DMU(2_B_)",68.5877,"","",""
"3OM3","CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH K362M MUTATION IN THE REDUCED STATE","10.1073/PNAS.1012846108 ",2.6,55.95,"3om3_oligo5","DGlcpa1-3DGlcpb6-ROH","DMU(6_B_)-DMU(6_B_)",82.8668,"","",""
"3OM3","CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH K362M MUTATION IN THE REDUCED STATE","10.1073/PNAS.1012846108 ",2.6,55.95,"3om3_oligo7","DGlcpa1-3DGlcpb6-ROH","DMU(8_D_)-DMU(8_D_)",91.0982,"","",""
"3OM3","CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH K362M MUTATION IN THE REDUCED STATE","10.1073/PNAS.1012846108 ",2.6,55.95,"3om3_oligo6","DGlcpa1-3DGlcpb6-C10O1","DMU(10_C_)-DMU(10_C_)",54.2954,"","",""
"3OM3","CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH K362M MUTATION IN THE REDUCED STATE","10.1073/PNAS.1012846108 ",2.6,55.95,"3om3_oligo10","DGlcpa1-3DGlcpb6-ROH","DMU(5_C_)-DMU(5_C_)",100.66,"","",""
"3OM3","CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH K362M MUTATION IN THE REDUCED STATE","10.1073/PNAS.1012846108 ",2.6,55.95,"3om3_oligo3","DGlcpa1-3DGlcpb6-C10O1","DMU(3_B_)-DMU(3_B_)",100.111,"","",""
"3OMA","CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH K362M MUTATION","10.1073/PNAS.1012846108 ",2.3,47.13,"3oma_oligo2","DGlcpa1-3DGlcpb6-ROH","DMU(9_C_)-DMU(9_C_)",100.322,"","",""
"3OMA","CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH K362M MUTATION","10.1073/PNAS.1012846108 ",2.3,47.13,"3oma_oligo8","DGlcpa1-3DGlcpb6-C10O1","DMU(1_B_)-DMU(1_B_)",38.4668,"","",""
"3OMA","CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH K362M MUTATION","10.1073/PNAS.1012846108 ",2.3,47.13,"3oma_oligo10","DGlcpa1-3DGlcpb6-ROH","DMU(4_D_)-DMU(4_D_)",82.6373,"","",""
"3OMA","CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH K362M MUTATION","10.1073/PNAS.1012846108 ",2.3,47.13,"3oma_oligo4","DGlcpa1-3DGlcpb6-C10O1","DMU(2_B_)-DMU(2_B_)",68.7664,"","",""
"3OMA","CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH K362M MUTATION","10.1073/PNAS.1012846108 ",2.3,47.13,"3oma_oligo3","DGlcpa1-3DGlcpb6-C10O1","DMU(3_B_)-DMU(3_B_)",90.7955,"","",""
"3OMA","CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH K362M MUTATION","10.1073/PNAS.1012846108 ",2.3,47.13,"3oma_oligo5","DGlcpa1-3DGlcpb6-ROH","DMU(6_B_)-DMU(6_B_)",77.3077,"","",""
"3OMA","CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH K362M MUTATION","10.1073/PNAS.1012846108 ",2.3,47.13,"3oma_oligo9","DGlcpa1-3DGlcpb6-ROH","DMU(8_D_)-DMU(8_D_)",95.0945,"","",""
"3OMA","CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH K362M MUTATION","10.1073/PNAS.1012846108 ",2.3,47.13,"3oma_oligo1","DGlcpa1-3DGlcpb6-ROH","DMU(5_C_)-DMU(5_C_)",95.8632,"","",""
"3OMA","CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH K362M MUTATION","10.1073/PNAS.1012846108 ",2.3,47.13,"3oma_oligo6","DGlcpa1-3DGlcpb6-C10O1","DMU(10_C_)-DMU(10_C_)",83.9877,"","",""
"3OMI","CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH D132A MUTATION","10.1073/PNAS.1012846108 ",2.15,38.49,"3omi_oligo5","DGlcpa1-3DGlcpb6-ROH","DMU(304_B_)-DMU(304_B_)",69.7527,"","",""
"3OMI","CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH D132A MUTATION","10.1073/PNAS.1012846108 ",2.15,38.49,"3omi_oligo1","DGlcpa1-3DGlcpb6-ROH","DMU(603_C_)-DMU(603_C_)",85.885,"","",""
"3OMI","CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH D132A MUTATION","10.1073/PNAS.1012846108 ",2.15,38.49,"3omi_oligo4","DGlcpa1-3DGlcpb6-C10O1","DMU(303_B_)-DMU(303_B_)",54.2473,"","",""
"3OMI","CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH D132A MUTATION","10.1073/PNAS.1012846108 ",2.15,38.49,"3omi_oligo9","DGlcpa1-3DGlcpb6-ROH","DMU(302_D_)-DMU(302_D_)",73.7359,"","",""
"3OMI","CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH D132A MUTATION","10.1073/PNAS.1012846108 ",2.15,38.49,"3omi_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(602_C_)-DMU(602_C_)",44.7995,"","",""
"3OMI","CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH D132A MUTATION","10.1073/PNAS.1012846108 ",2.15,38.49,"3omi_oligo3","DGlcpa1-3DGlcpb6-C10O1","DMU(302_B_)-DMU(302_B_)",49.3268,"","",""
"3OMI","CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH D132A MUTATION","10.1073/PNAS.1012846108 ",2.15,38.49,"3omi_oligo10","DGlcpa1-3DGlcpb6-ROH","DMU(604_C_)-DMU(604_C_)",46.0441,"","",""
"3OMI","CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH D132A MUTATION","10.1073/PNAS.1012846108 ",2.15,38.49,"3omi_oligo6","DGlcpa1-3DGlcpb6-C10O1","DMU(301_B_)-DMU(301_B_)",28.7995,"","",""
"3OMI","CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH D132A MUTATION","10.1073/PNAS.1012846108 ",2.15,38.49,"3omi_oligo8","DGlcpa1-3DGlcpb6-ROH","DMU(301_D_)-DMU(301_D_)",64.7345,"","",""
"3OMN","CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH D132A MUTATION IN THE REDUCED STATE","10.1073/PNAS.1012846108 ",2.15,43.95,"3omn_oligo9","DGlcpa1-3DGlcpb6-ROH","DMU(8_D_)-DMU(8_D_)",91.5732,"","",""
"3OMN","CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH D132A MUTATION IN THE REDUCED STATE","10.1073/PNAS.1012846108 ",2.15,43.95,"3omn_oligo10","DGlcpa1-3DGlcpb6-C10O1","DMU(10_C_)-DMU(10_C_)",75.5305,"","",""
"3OMN","CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH D132A MUTATION IN THE REDUCED STATE","10.1073/PNAS.1012846108 ",2.15,43.95,"3omn_oligo7","DGlcpa1-3DGlcpb6-C10O1","DMU(1_B_)-DMU(1_B_)",33.0945,"","",""
"3OMN","CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH D132A MUTATION IN THE REDUCED STATE","10.1073/PNAS.1012846108 ",2.15,43.95,"3omn_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(2_B_)-DMU(2_B_)",55.0227,"","",""
"3OMN","CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH D132A MUTATION IN THE REDUCED STATE","10.1073/PNAS.1012846108 ",2.15,43.95,"3omn_oligo3","DGlcpa1-3DGlcpb6-C10O1","DMU(3_B_)-DMU(3_B_)",80.1968,"","",""
"3OMN","CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH D132A MUTATION IN THE REDUCED STATE","10.1073/PNAS.1012846108 ",2.15,43.95,"3omn_oligo5","DGlcpa1-3DGlcpb6-ROH","DMU(9_C_)-DMU(9_C_)",87.475,"","",""
"3OMN","CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH D132A MUTATION IN THE REDUCED STATE","10.1073/PNAS.1012846108 ",2.15,43.95,"3omn_oligo1","DGlcpa1-3DGlcpb6-ROH","DMU(6_B_)-DMU(6_B_)",77.7245,"","",""
"3OMN","CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH D132A MUTATION IN THE REDUCED STATE","10.1073/PNAS.1012846108 ",2.15,43.95,"3omn_oligo8","DGlcpa1-3DGlcpb6-ROH","DMU(4_D_)-DMU(4_D_)",91.4077,"","",""
"3OMN","CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH D132A MUTATION IN THE REDUCED STATE","10.1073/PNAS.1012846108 ",2.15,43.95,"3omn_oligo4","DGlcpa1-3DGlcpb6-ROH","DMU(5_C_)-DMU(5_C_)",98.5005,"","",""
"3P5D","STRUCTURE OF THE CARBOHYDRATE-RECOGNITION DOMAIN OF HUMAN LANGERIN WITH MAN5 (MAN ALPHA1-3(MAN ALPHA1-6)MAN ALPHA1-6)(MAN- ALPHA1-3)MAN","10.1016/J.JMB.2010.11.039 ",1.8,26.7,"3p5d_oligo1","DManpa1-3DManpa1-ROH","MAN(2_E_)-MAN(1_E_)",44.3918,"","",""
"3P5G","STRUCTURE OF THE CARBOHYDRATE-RECOGNITION DOMAIN OF HUMAN LANGERIN WITH BLOOD GROUP B TRISACCHARIDE (GAL ALPHA1-3(FUC ALPHA1-2)GAL)","10.1016/J.JMB.2010.11.039 ",1.6,23.5,"3p5g_oligo2","LFucpa1-2[DGalpa1-3]DGalpa1-ROH","GLA(3_F_)-[FUC(2_F_)]-GLA(1_F_)",34.6864,"","",""
"3P5G","STRUCTURE OF THE CARBOHYDRATE-RECOGNITION DOMAIN OF HUMAN LANGERIN WITH BLOOD GROUP B TRISACCHARIDE (GAL ALPHA1-3(FUC ALPHA1-2)GAL)","10.1016/J.JMB.2010.11.039 ",1.6,23.5,"3p5g_oligo1","LFucpa1-2[DGalpa1-3]DGalpb1-ROH","GLA(3_E_)-[FUC(2_E_)]-GAL(1_E_)",32.8012,"","",""
"3PA1","CRYSTAL STRUCTURE OF P DOMAIN FROM NORWALK VIRUS STRAIN VIETNAM 026 IN COMPLEX WITH HBGA TYPE A","10.1128/JVI.00246-11 ",1.48,0,"3pa1_oligo3","LFucpa1-2[DGalpNAca1-3]DGalpb1-ROH","A2G(3_C_)-[FUC(2_C_)]-GAL(1_C_)",28.7564,"","",""
"3PA2","CRYSTAL STRUCTURE OF P DOMAIN FROM NORWALK VIRUS STRAIN VIETNAM 026 IN COMPLEX WITH HBGA TYPE LEY","10.1128/JVI.00246-11 ",1.48,0,"3pa2_oligo1","LFucpa1-2DGalpb1-4[LFucpa1-3]DGlcpNAcb1-ROH","FUC(3_C_)-GAL(2_C_)-[FUC(4_C_)]-NAG(1_C_)",19.185,"","",""
"3PFX","CRYSTAL STRUCTURE OF CEL7A FROM TALAROMYCES EMERSONII IN COMPLEX WITH CELLOBIOSE","",1.26,0,"3pfx_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(267_A_)",13.9518,"","",""
"3PFZ","CRYSTAL STRUCTURE OF CEL7A FROM TALAROMYCES EMERSONII IN COMPLEX WITH CELLOTETRAOSE","",1.1,0,"3pfz_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(267_A_)",16.388,"","",""
"3PGB","CRYSTAL STRUCTURE OF ASPERGILLUS NIDULANS AMINE OXIDASE","10.1021/BI200555C ",2.45,17.41,"3pgb_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)",34.7883,"","",""
"3PMH","MECHANISM OF SULFOTYROSINE-MEDIATED GLYCOPROTEIN IB INTERACTION WITH TWO DISTINCT ALPHA-THROMBIN SITES","10.1073/PNAS.1017042108 ",3.2,0,"3pmh_oligo3","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-MAN(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(60_B_)",109.447,"","",""
"3PPS","CRYSTAL STRUCTURE OF AN ASCOMYCETE FUNGAL LACCASE FROM THIELAVIA ARENARIA","10.1111/J.1742-4658.2011.08146.X ",2.5,0,"3pps_oligo5","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(202_B_)",24.6616,"","",""
"3PPS","CRYSTAL STRUCTURE OF AN ASCOMYCETE FUNGAL LACCASE FROM THIELAVIA ARENARIA","10.1111/J.1742-4658.2011.08146.X ",2.5,0,"3pps_oligo12","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_P_)-MAN(4_P_)-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(202_D_)",41.942,"","",""
"3PPS","CRYSTAL STRUCTURE OF AN ASCOMYCETE FUNGAL LACCASE FROM THIELAVIA ARENARIA","10.1111/J.1742-4658.2011.08146.X ",2.5,0,"3pps_oligo2","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(202_A_)",24.1999,"","",""
"3PQR","CRYSTAL STRUCTURE OF METARHODOPSIN II IN COMPLEX WITH A C-TERMINAL PEPTIDE DERIVED FROM THE GALPHA SUBUNIT OF TRANSDUCIN","10.1038/NATURE09789 ",2.85,0,"3pqr_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(15_A_)",75.8816,"","",""
"3PUN","CRYSTAL STRUCTURE OF P DOMAIN DIMER OF NOROVIRUS VA207 WITH LEWIS Y TETRASACCHARIDE","10.1371/JOURNAL.PPAT.1002152 ",2.05,36.99,"3pun_oligo2","LFucpa1-2DGalpb1-4[LFucpa1-3]DGlcpNAca1-ROH","FUC(3_D_)-GAL(2_D_)-[FUC(4_D_)]-NDG(1_D_)",41.9739,"","",""
"3PUN","CRYSTAL STRUCTURE OF P DOMAIN DIMER OF NOROVIRUS VA207 WITH LEWIS Y TETRASACCHARIDE","10.1371/JOURNAL.PPAT.1002152 ",2.05,36.99,"3pun_oligo1","LFucpa1-2DGalpb1-4[LFucpa1-3]DGlcpNAca1-ROH","FUC(3_C_)-GAL(2_C_)-[FUC(4_C_)]-NDG(1_C_)",48.6127,"","",""
"3PVD","CRYSTAL STRUCTURE OF P DOMAIN DIMER OF NOROVIRUS VA207 COMPLEXED WITH 3'-SIALYL-LEWIS X TETRASACCHARIDE","10.1371/JOURNAL.PPAT.1002152 ",1.9,37.66,"3pvd_oligo1","DNeup5Aca2-3DGalpb1-4[LFucpa1-3]DGlcpNAca1-ROH","SIA(3_D_)-GAL(2_D_)-[FUC(4_D_)]-NDG(1_D_)",49.7963,"","",""
"3PVD","CRYSTAL STRUCTURE OF P DOMAIN DIMER OF NOROVIRUS VA207 COMPLEXED WITH 3'-SIALYL-LEWIS X TETRASACCHARIDE","10.1371/JOURNAL.PPAT.1002152 ",1.9,37.66,"3pvd_oligo2","DNeup5Aca2-3DGalpb1-4[LFucpa1-3]DGlcpNAca1-ROH","SIA(3_C_)-GAL(2_C_)-[FUC(4_C_)]-NDG(1_C_)",54.8675,"","",""
"3PXL","TYPE-2 CU-DEPLETED FUNGUS LACCASE FROM TRAMETES HIRSUTA","",1.2,17.36,"3pxl_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[MAN(5_B_)]-MAN(4_B_)-[MAN(7_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(54_A_)",25.8564,"","",""
"3PXO","CRYSTAL STRUCTURE OF METARHODOPSIN II","10.1038/NATURE09789 ",3,69.07,"3pxo_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(15_A_)",82.1159,"","",""
"3Q38","CRYSTAL STRUCTURE OF P DOMAIN FROM NORWALK VIRUS STRAIN VIETNAM 026 IN COMPLEX WITH HBGA TYPE B (TRIGLYCAN)","10.1128/JVI.00246-11 ",1.28,21.43,"3q38_oligo7","LFucpa1-2[DGalpa1-3]DGalpb1-ROH","GLA(3_C_)-[FUC(2_C_)]-GAL(1_C_)",40.5155,"","",""
"3QBJ","CRYSTAL STRUCTURE OF DIPEPTIDYL PEPTIDASE IV IN COMPLEX WITH INHIBITOR","",2.21,72.23,"3qbj_oligo8","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(229_A_)",89.9009,"","",""
"3QDT","STRUCTURE OF BOLETUS EDULIS LECTIN IN COMPLEX WITH T-ANTIGEN DISACCHARIDE","10.1093/GLYCOB/CWR012 ",1.3,9.03,"3qdt_oligo1","DGalpb1-3DGalpNAca1-ROH","GAL(2_C_)-A2G(1_C_)",10.7145,"","",""
"3QDT","STRUCTURE OF BOLETUS EDULIS LECTIN IN COMPLEX WITH T-ANTIGEN DISACCHARIDE","10.1093/GLYCOB/CWR012 ",1.3,9.03,"3qdt_oligo2","DGalpb1-3DGalpNAca1-ROH","GAL(2_D_)-A2G(1_D_)",10.2182,"","",""
"3QDX","STRUCTURE OF THE ORTHORHOMBIC FORM OF THE BOLETUS EDULIS LECTIN IN COMPLEX WITH T-ANTIGEN DISACCHARIDE AND N,N-DIACETYL CHITOBIOSE","10.1093/GLYCOB/CWR012 ",1.7,11.71,"3qdx_oligo1","DGalpb1-3DGalpNAca1-ROH","GAL(2_D_)-A2G(1_D_)",11.125,"","",""
"3QDX","STRUCTURE OF THE ORTHORHOMBIC FORM OF THE BOLETUS EDULIS LECTIN IN COMPLEX WITH T-ANTIGEN DISACCHARIDE AND N,N-DIACETYL CHITOBIOSE","10.1093/GLYCOB/CWR012 ",1.7,11.71,"3qdx_oligo2","DGalpb1-3DGalpNAca1-ROH","GAL(2_C_)-A2G(1_C_)",10.9277,"","",""
"3QDY","STRUCTURE OF THE HEXAGONAL FORM OF THE BOLETUS EDULIS LECTIN IN COMPLEX WITH T-ANTIGEN DISACCHARIDE AND N,N-DIACETYL CHITOBIOSE","10.1093/GLYCOB/CWR012 ",2,22.5,"3qdy_oligo1","DGalpb1-3DGalpNAca1-ROH","GAL(2_D_)-A2G(1_D_)",23.035,"","",""
"3QDY","STRUCTURE OF THE HEXAGONAL FORM OF THE BOLETUS EDULIS LECTIN IN COMPLEX WITH T-ANTIGEN DISACCHARIDE AND N,N-DIACETYL CHITOBIOSE","10.1093/GLYCOB/CWR012 ",2,22.5,"3qdy_oligo2","DGalpb1-3DGalpNAca1-ROH","GAL(2_C_)-A2G(1_C_)",33.8805,"","",""
"3QEL","CRYSTAL STRUCTURE OF AMINO TERMINAL DOMAINS OF THE NMDA RECEPTOR SUBUNIT GLUN1 AND GLUN2B IN COMPLEX WITH IFENPRODIL","10.1038/NATURE10180 ",2.6,0,"3qel_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-3]DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-[FUC(6_E_)]-NAG(1_E_)-ASN(389_A_)",61.7232,"","",""
"3QEM","CRYSTAL STRUCTURE OF AMINO TERMINAL DOMAINS OF THE NMDA RECEPTOR SUBUNIT GLUN1 AND GLUN2B IN COMPLEX WITH RO 25-6981","10.1038/NATURE10180 ",3,0,"3qem_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(389_A_)",67.8358,"","",""
"3QNQ","CRYSTAL STRUCTURE OF THE TRANSPORTER CHBC, THE IIC COMPONENT FROM THE N,N'-DIACETYLCHITOBIOSE-SPECIFIC PHOSPHOTRANSFERASE SYSTEM","10.1038/NATURE09939 ",3.3,106,"3qnq_oligo2","DGlcpa1-3DGlcpb6-C7O1","ZDM(600_A_)-ZDM(600_A_)",98.7791,"","",""
"3QNQ","CRYSTAL STRUCTURE OF THE TRANSPORTER CHBC, THE IIC COMPONENT FROM THE N,N'-DIACETYLCHITOBIOSE-SPECIFIC PHOSPHOTRANSFERASE SYSTEM","10.1038/NATURE09939 ",3.3,106,"3qnq_oligo4","DGlcpa1-3DGlcpb6-C7O1","ZDM(600_C_)-ZDM(600_C_)",91.1341,"","",""
"3QNQ","CRYSTAL STRUCTURE OF THE TRANSPORTER CHBC, THE IIC COMPONENT FROM THE N,N'-DIACETYLCHITOBIOSE-SPECIFIC PHOSPHOTRANSFERASE SYSTEM","10.1038/NATURE09939 ",3.3,106,"3qnq_oligo1","DGlcpa1-3DGlcpb6-C7O1","ZDM(443_A_)-ZDM(443_A_)",92.2073,"","",""
"3QNQ","CRYSTAL STRUCTURE OF THE TRANSPORTER CHBC, THE IIC COMPONENT FROM THE N,N'-DIACETYLCHITOBIOSE-SPECIFIC PHOSPHOTRANSFERASE SYSTEM","10.1038/NATURE09939 ",3.3,106,"3qnq_oligo3","DGlcpa1-3DGlcpb6-C7O1","ZDM(443_C_)-ZDM(443_C_)",90.1332,"","",""
"3QUM","CRYSTAL STRUCTURE OF HUMAN PROSTATE SPECIFIC ANTIGEN (PSA) IN FAB SANDWICH WITH A HIGH AFFINITY AND A PCA SELECTIVE ANTIBODY","10.1016/J.JMB.2011.10.007 ",3.2,73.27,"3qum_oligo3","DNeup5Aca2-3DGalpb1-4DGlcpNAcb1-6DManpa1-3[DNeup5Aca2-3DGalpb1-4DGlcpNAcb1-6DManp[2<R1>]a1-6]DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(15_G_)-[SIA(14_G_)-GAL(13_G_)-NAG(12_G_)-MAN(8_G_)-[SIA(7_G_)-GAL(6_G_)-NAG(5_G_)-MAN(4_G_)]-MAN(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(61_Q_)",122.697,"","",""
"3QUM","CRYSTAL STRUCTURE OF HUMAN PROSTATE SPECIFIC ANTIGEN (PSA) IN FAB SANDWICH WITH A HIGH AFFINITY AND A PCA SELECTIVE ANTIBODY","10.1016/J.JMB.2011.10.007 ",3.2,73.27,"3qum_oligo2","DNeup5Aca2-3DGalpb1-4DGlcpNAcb1-4DManpa1-3[DNeup5Aca2-3DGalpb1-4DGlcpNAcb1-2[DNeup5Aca2-3DGalpb1-4DGlcpNAcb1-6]DManpa1-6]DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(15_E_)-[SIA(14_E_)-GAL(13_E_)-NAG(12_E_)-[SIA(11_E_)-GAL(10_E_)-NAG(9_E_)]-MAN(8_E_)-[SIA(7_E_)-GAL(6_E_)-NAG(5_E_)-MAN(4_E_)]-MAN(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(61_P_)",112.455,"","",""
"3QUM","CRYSTAL STRUCTURE OF HUMAN PROSTATE SPECIFIC ANTIGEN (PSA) IN FAB SANDWICH WITH A HIGH AFFINITY AND A PCA SELECTIVE ANTIBODY","10.1016/J.JMB.2011.10.007 ",3.2,73.27,"3qum_oligo1","DGalpb1-3DGalpNAca1-THR","GAL(2_F_)-A2G(1_F_)-THR(125_P_)",64.1754,"","",""
"3QVP","CRYSTAL STRUCTURE OF GLUCOSE OXIDASE FOR SPACE GROUP C2221 AT 1.2 A RESOLUTION","10.1021/BI200388G ",1.2,17.5,"3qvp_oligo2","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(89_A_)",24.4733,"","",""
"3QVR","CRYSTAL STRUCTURE OF GLUCOSE OXIDASE FOR SPACE GROUP P3121 AT 1.3 A RESOLUTION.","10.1021/BI200388G ",1.3,17.5,"3qvr_oligo2","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(89_A_)",23.1813,"","",""
"3QW9","CRYSTAL STRUCTURE OF BETAGLYCAN ZP-C DOMAIN","10.1073/PNAS.1010689108 ",2,39.45,"3qw9_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(5_C_)-[BMA(3_C_)-NAG(2_C_)]-[FUC(4_C_)]-NAG(1_C_)-ASN(14_A_)",43.6036,"","",""
"3QW9","CRYSTAL STRUCTURE OF BETAGLYCAN ZP-C DOMAIN","10.1073/PNAS.1010689108 ",2,39.45,"3qw9_oligo2","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(7_D_)-[MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-[FUC(6_D_)]-NAG(1_D_)-ASN(14_B_)",58.0687,"","",""
"3QWQ","CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN COMPLEX WITH AN ADNECTIN","10.1016/J.STR.2011.11.016 ",2.75,64.63,"3qwq_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_F_)-[MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(504_A_)",97.8162,"","",""
"3QWQ","CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN COMPLEX WITH AN ADNECTIN","10.1016/J.STR.2011.11.016 ",2.75,64.63,"3qwq_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_C_)-[MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(32_A_)",88.1097,"","",""
"3QWR","CRYSTAL STRUCTURE OF IL-23 IN COMPLEX WITH AN ADNECTIN","10.1016/J.STR.2011.11.016 ",3.25,100.7,"3qwr_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(200_A_)",115.203,"","",""
"3R2X","CRYSTAL STRUCTURE OF THE DE NOVO DESIGNED BINDING PROTEIN HB36.3 IN COMPLEX THE THE 1918 INFLUENZA VIRUS HEMAGGLUTININ","10.1126/SCIENCE.1202617 ",3.1,0,"3r2x_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(95_A_)",212.826,"","",""
"3R6K","CRYSTAL STRUCTURE OF THE CAPSID P DOMAIN FROM NORWALK VIRUS STRAIN HIROSHIMA/1999 IN COMPLEX WITH HBGA TYPE B (TRIGLYCAN)","10.1128/JVI.00246-11 ",1.6,0,"3r6k_oligo1","LFucpa1-2[DGalpa1-3]DGalpb1-ROH","GLA(3_B_)-[FUC(2_B_)]-GAL(1_B_)",74.7721,"","",""
"3RBU","N-TERMINALLY AVITEV-TAGGED HUMAN GLUTAMATE CARBOXYPEPTIDASE II IN COMPLEX WITH 2-PMPA","10.1016/J.PEP.2011.11.016 ",1.6,30.31,"3rbu_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(638_A_)",39.7132,"","",""
"3RG1","CRYSTAL STRUCTURE OF THE RP105/MD-1 COMPLEX","10.1038/NSMB.2106 ",2.91,61.23,"3rg1_oligo3","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_R_)-MAN(5_R_)-[MAN(7_R_)]-MAN(4_R_)-[MAN(8_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(402_A_)",48.696,"","",""
"3RG1","CRYSTAL STRUCTURE OF THE RP105/MD-1 COMPLEX","10.1038/NSMB.2106 ",2.91,61.23,"3rg1_oligo16","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_f_)-MAN(5_f_)-[MAN(7_f_)]-MAN(4_f_)-[MAN(8_f_)]-BMA(3_f_)-NAG(2_f_)-NAG(1_f_)-ASN(402_N_)",48.5487,"","",""
"3RG1","CRYSTAL STRUCTURE OF THE RP105/MD-1 COMPLEX","10.1038/NSMB.2106 ",2.91,61.23,"3rg1_oligo14","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_d_)-MAN(5_d_)-[MAN(7_d_)]-MAN(4_d_)-[MAN(8_d_)]-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(402_J_)",49.0244,"","",""
"3RG1","CRYSTAL STRUCTURE OF THE RP105/MD-1 COMPLEX","10.1038/NSMB.2106 ",2.91,61.23,"3rg1_oligo8","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_X_)-MAN(5_X_)-[MAN(7_X_)]-MAN(4_X_)-[MAN(8_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(402_M_)",48.731,"","",""
"3RG1","CRYSTAL STRUCTURE OF THE RP105/MD-1 COMPLEX","10.1038/NSMB.2106 ",2.91,61.23,"3rg1_oligo4","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_T_)-MAN(5_T_)-[MAN(7_T_)]-MAN(4_T_)-[MAN(8_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(402_E_)",49.0734,"","",""
"3RG1","CRYSTAL STRUCTURE OF THE RP105/MD-1 COMPLEX","10.1038/NSMB.2106 ",2.91,61.23,"3rg1_oligo6","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_V_)-MAN(5_V_)-[MAN(7_V_)]-MAN(4_V_)-[MAN(8_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(402_I_)",49.3895,"","",""
"3RG1","CRYSTAL STRUCTURE OF THE RP105/MD-1 COMPLEX","10.1038/NSMB.2106 ",2.91,61.23,"3rg1_oligo10","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Z_)-MAN(5_Z_)-[MAN(7_Z_)]-MAN(4_Z_)-[MAN(8_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(402_B_)",48.4424,"","",""
"3RG1","CRYSTAL STRUCTURE OF THE RP105/MD-1 COMPLEX","10.1038/NSMB.2106 ",2.91,61.23,"3rg1_oligo12","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_b_)-MAN(5_b_)-[MAN(7_b_)]-MAN(4_b_)-[MAN(8_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(402_F_)",48.9718,"","",""
"3RIZ","CRYSTAL STRUCTURE OF THE PLANT STEROID RECEPTOR BRI1 ECTODOMAIN","10.1038/NATURE10153 ",2.52,0,"3riz_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(154_A_)",94.0648,"","",""
"3RIZ","CRYSTAL STRUCTURE OF THE PLANT STEROID RECEPTOR BRI1 ECTODOMAIN","10.1038/NATURE10153 ",2.52,0,"3riz_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(545_A_)",104.637,"","",""
"3RJ0","PLANT STEROID RECEPTOR BRI1 ECTODOMAIN IN COMPLEX WITH BRASSINOLIDE","10.1038/NATURE10153 ",2.54,51.8,"3rj0_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(545_A_)",100.02,"","",""
"3RJ0","PLANT STEROID RECEPTOR BRI1 ECTODOMAIN IN COMPLEX WITH BRASSINOLIDE","10.1038/NATURE10153 ",2.54,51.8,"3rj0_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(154_A_)",96.3889,"","",""
"3RJ0","PLANT STEROID RECEPTOR BRI1 ECTODOMAIN IN COMPLEX WITH BRASSINOLIDE","10.1038/NATURE10153 ",2.54,51.8,"3rj0_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(275_A_)",75.675,"","",""
"3RSJ","STRUCTURE OF HCRF IN COMPLEX WITH GANGLIOSIDE GD1A","10.1074/JBC.M111.272054 ",2,41.5,"3rsj_oligo4","DNeup5Aca2-3DGalpb1-3DGalpNAcb1-ROH","SIA(3_H_)-GAL(2_H_)-NGA(1_H_)",74.3801,"","",""
"3RSJ","STRUCTURE OF HCRF IN COMPLEX WITH GANGLIOSIDE GD1A","10.1074/JBC.M111.272054 ",2,41.5,"3rsj_oligo3","DNeup5Aca2-3DGalpb1-3DGalpNAcb1-4DGalpb1-ROH","SIA(4_G_)-GAL(3_G_)-NGA(2_G_)-GAL(1_G_)",69.3774,"","",""
"3RSJ","STRUCTURE OF HCRF IN COMPLEX WITH GANGLIOSIDE GD1A","10.1074/JBC.M111.272054 ",2,41.5,"3rsj_oligo1","DNeup5Aca2-3DGalpb1-3DGalpNAcb1-ROH","SIA(3_E_)-GAL(2_E_)-NGA(1_E_)",67.0327,"","",""
"3RSJ","STRUCTURE OF HCRF IN COMPLEX WITH GANGLIOSIDE GD1A","10.1074/JBC.M111.272054 ",2,41.5,"3rsj_oligo2","DNeup5Aca2-3DGalpb1-3DGalpNAcb1-4[DNeup5Aca2-3]DGalpb1-ROH","SIA(4_F_)-GAL(3_F_)-NGA(2_F_)-[SIA(5_F_)]-GAL(1_F_)",63.3476,"","",""
"3RWK","FIRST CRYSTAL STRUCTURE OF AN ENDO-INULINASE, FROM ASPERGILLUS FICUUM: STRUCTURAL ANALYSIS AND COMPARISON WITH OTHER GH32 ENZYMES.","10.1016/J.BIOCHI.2012.06.020 ",2.1,34.59,"3rwk_oligo1","DManpa1-3DManpx1-","MAN(3_A_)-MAN(2_A_)",39.1568,"","",""
"3RY6","COMPLEX OF FCGAMMARIIA (CD32) AND THE FC OF HUMAN IGG1","10.4049/JIMMUNOL.1101467 ",3.8,0,"3ry6_oligo3","DManpb1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAca1-ASN","FUL(6_F_)-[MAN(5_F_)-[BMA(4_F_)]-MAN(3_F_)-NAG(2_F_)]-NDG(1_F_)-ASN(145_C_)",65.053,"","",""
"3RY6","COMPLEX OF FCGAMMARIIA (CD32) AND THE FC OF HUMAN IGG1","10.4049/JIMMUNOL.1101467 ",3.8,0,"3ry6_oligo2","DNeup5Aca2-6DGalpb1-4DGlcpNAcb1-2DManpa1-3[DNeup5Aca2-6DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(12_E_)-[SIA(11_E_)-GAL(10_E_)-NAG(9_E_)-MAN(8_E_)-[SIA(7_E_)-GAL(6_E_)-NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_B_)",58.4448,"","",""
"3RY6","COMPLEX OF FCGAMMARIIA (CD32) AND THE FC OF HUMAN IGG1","10.4049/JIMMUNOL.1101467 ",3.8,0,"3ry6_oligo1","DNeup5Aca2-6DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAca1-ASN","FUL(10_D_)-[NAG(9_D_)-MAN(8_D_)-[SIA(7_D_)-GAL(6_D_)-NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NDG(1_D_)-ASN(297_A_)",60.0921,"","",""
"3S26","CRYSTAL STRUCTURE OF MURINE SIDEROCALIN (LIPOCALIN 2, 24P3)","10.1093/NAR/GKR706 ",1.8,37.5,"3s26_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(65_A_)",65.1298,"","",""
"3S5X","STRUCTURE OF THE CYANOBACTERIAL OSCILLATORIA AGARDHII AGGLUTININ (OAA) IN COMPLEX WITH A3,A6 MANNOPENTAOSE","10.1016/J.STR.2011.05.010 ",1.65,18.37,"3s5x_oligo4","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-ROH","MAN(3_B_)-MAN(2_B_)-[MAN(4_B_)]-BMA(1_B_)",14.5595,"","",""
"3S5X","STRUCTURE OF THE CYANOBACTERIAL OSCILLATORIA AGARDHII AGGLUTININ (OAA) IN COMPLEX WITH A3,A6 MANNOPENTAOSE","10.1016/J.STR.2011.05.010 ",1.65,18.37,"3s5x_oligo1","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-ROH","MAN(3_C_)-MAN(2_C_)-[MAN(4_C_)]-BMA(1_C_)",18.9239,"","",""
"3S5Y","PHARMACOLOGICAL CHAPERONING IN HUMAN ALPHA-GALACTOSIDASE","10.1016/J.CHEMBIOL.2011.10.012 ",2.11,38.34,"3s5y_oligo6","DXylpb1-2[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[XYP(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(192_B_)",69.113,"","",""
"3S5Y","PHARMACOLOGICAL CHAPERONING IN HUMAN ALPHA-GALACTOSIDASE","10.1016/J.CHEMBIOL.2011.10.012 ",2.11,38.34,"3s5y_oligo5","DXylpb1-2DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","XYP(4_D_)-BMA(3_D_)-NAG(2_D_)-[FUC(5_D_)]-NAG(1_D_)-ASN(192_A_)",72.6659,"","",""
"3S5Y","PHARMACOLOGICAL CHAPERONING IN HUMAN ALPHA-GALACTOSIDASE","10.1016/J.CHEMBIOL.2011.10.012 ",2.11,38.34,"3s5y_oligo7","DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","BMA(3_G_)-NAG(2_G_)-[FUC(4_G_)]-NAG(1_G_)-ASN(215_B_)",72.3095,"","",""
"3S5Y","PHARMACOLOGICAL CHAPERONING IN HUMAN ALPHA-GALACTOSIDASE","10.1016/J.CHEMBIOL.2011.10.012 ",2.11,38.34,"3s5y_oligo1","DXylpb1-2[DManpa1-3][DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)]-[XYP(4_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(7_C_)]-NAG(1_C_)-ASN(139_A_)",100.866,"","",""
"3S5Y","PHARMACOLOGICAL CHAPERONING IN HUMAN ALPHA-GALACTOSIDASE","10.1016/J.CHEMBIOL.2011.10.012 ",2.11,38.34,"3s5y_oligo3","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_E_)-[FUC(2_E_)]-NAG(1_E_)-ASN(215_A_)",91.5767,"","",""
"3S5Z","PHARMACOLOGICAL CHAPERONING IN HUMAN ALPHA-GALACTOSIDASE","10.1016/J.CHEMBIOL.2011.10.012 ",2,33.72,"3s5z_oligo4","DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","BMA(3_F_)-NAG(2_F_)-[FUC(4_F_)]-NAG(1_F_)-ASN(215_B_)",55.9923,"","",""
"3S5Z","PHARMACOLOGICAL CHAPERONING IN HUMAN ALPHA-GALACTOSIDASE","10.1016/J.CHEMBIOL.2011.10.012 ",2,33.72,"3s5z_oligo1","DXylpb1-2[DManpa1-3][DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)]-[XYP(4_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(7_C_)]-NAG(1_C_)-ASN(192_A_)",78.3548,"","",""
"3S5Z","PHARMACOLOGICAL CHAPERONING IN HUMAN ALPHA-GALACTOSIDASE","10.1016/J.CHEMBIOL.2011.10.012 ",2,33.72,"3s5z_oligo2","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_D_)-[FUC(2_D_)]-NAG(1_D_)-ASN(215_A_)",89.5676,"","",""
"3S5Z","PHARMACOLOGICAL CHAPERONING IN HUMAN ALPHA-GALACTOSIDASE","10.1016/J.CHEMBIOL.2011.10.012 ",2,33.72,"3s5z_oligo3","DXylpb1-2[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[XYP(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(192_B_)",80.7607,"","",""
"3S8K","CRYSTAL STRUCTURE OF A PAPAYA LATEX SERINE PROTEASE INHIBITOR (PPI) AT 1.7A RESOLUTION","10.1074/JBC.M111.291310 ",1.7,0,"3s8k_oligo2","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_D_)-[FUC(2_D_)]-NAG(1_D_)-ASN(84_B_)",47.6276,"","",""
"3S8K","CRYSTAL STRUCTURE OF A PAPAYA LATEX SERINE PROTEASE INHIBITOR (PPI) AT 1.7A RESOLUTION","10.1074/JBC.M111.291310 ",1.7,0,"3s8k_oligo1","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_C_)-[FUC(2_C_)]-NAG(1_C_)-ASN(84_A_)",51.3812,"","",""
"3SAJ","CRYSTAL STRUCTURE OF GLUTAMATE RECEPTOR GLUA1 AMINO TERMINAL DOMAIN","10.1042/BJ20110801 ",2.5,70.83,"3saj_oligo9","DManpa1-2DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_M_)-MAN(5_M_)-MAN(4_M_)-[MAN(7_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(345_C_)",186.472,"","",""
"3SC2","REFINED ATOMIC MODEL OF WHEAT SERINE CARBOXYPEPTIDASE II AT 2.2- ANGSTROMS RESOLUTION","10.1021/BI00155A037 ",2.2,0,"3sc2_oligo1","DGlcpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","MAN(3_D_)-NAG(2_D_)-[FUC(4_D_)]-NAG(1_D_)",79.39,"","",""
"3SC7","FIRST CRYSTAL STRUCTURE OF AN ENDO-INULINASE, FROM ASPERGILLUS FICUUM: STRUCTURAL ANALYSIS AND COMPARISON WITH OTHER GH32 ENZYMES.","10.1016/J.BIOCHI.2012.06.020 ",1.5,19.18,"3sc7_oligo3","DManpa1-3DManpx1-","MAN(3_A_)-MAN(2_A_)",39.1568,"","",""
"3SDY","CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CR8020 BOUND TO THE INFLUENZA A H3 HEMAGGLUTININ","10.1126/SCIENCE.1204839 ",2.85,0,"3sdy_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(6_D_)-[MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(81_A_)",132.243,"","",""
"3SDY","CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CR8020 BOUND TO THE INFLUENZA A H3 HEMAGGLUTININ","10.1126/SCIENCE.1204839 ",2.85,0,"3sdy_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(165_A_)",192.847,"","",""
"3SEJ","STRUCTURAL CHARACTERIZATION OF A GII.4 2004 NOROVIRUS VARIANT (TCH05) BOUND TO SECRETOR LEWIS HBGA (LEB)","10.1128/JVI.00848-11 ",3.04,39.91,"3sej_oligo7","LFucpa1-2DGalpb1-3[LFucpa1-4]DGlcpNAcb1-3DGalpb1-4DGlcpb1-ROH","FUC(6_Q_)-[FUC(5_Q_)-GAL(4_Q_)]-NAG(3_Q_)-GAL(2_Q_)-BGC(1_Q_)",101.393,"","",""
"3SEJ","STRUCTURAL CHARACTERIZATION OF A GII.4 2004 NOROVIRUS VARIANT (TCH05) BOUND TO SECRETOR LEWIS HBGA (LEB)","10.1128/JVI.00848-11 ",3.04,39.91,"3sej_oligo6","LFucpa1-2DGalpb1-3[LFucpa1-4]DGlcpNAcb1-3DGalpb1-4DGlcpb1-ROH","FUC(6_P_)-[FUC(5_P_)-GAL(4_P_)]-NAG(3_P_)-GAL(2_P_)-BGC(1_P_)",120.909,"","",""
"3SEJ","STRUCTURAL CHARACTERIZATION OF A GII.4 2004 NOROVIRUS VARIANT (TCH05) BOUND TO SECRETOR LEWIS HBGA (LEB)","10.1128/JVI.00848-11 ",3.04,39.91,"3sej_oligo4","LFucpa1-2DGalpb1-3[LFucpa1-4]DGlcpNAcb1-3DGalpb1-4DGlcpb1-ROH","FUC(6_K_)-[FUC(5_K_)-GAL(4_K_)]-NAG(3_K_)-GAL(2_K_)-BGC(1_K_)",104.38,"","",""
"3SEJ","STRUCTURAL CHARACTERIZATION OF A GII.4 2004 NOROVIRUS VARIANT (TCH05) BOUND TO SECRETOR LEWIS HBGA (LEB)","10.1128/JVI.00848-11 ",3.04,39.91,"3sej_oligo5","LFucpa1-2DGalpb1-3[LFucpa1-4]DGlcpNAcb1-3DGalpb1-4DGlcpb1-ROH","FUC(6_N_)-[FUC(5_N_)-GAL(4_N_)]-NAG(3_N_)-GAL(2_N_)-BGC(1_N_)",104.913,"","",""
"3SEJ","STRUCTURAL CHARACTERIZATION OF A GII.4 2004 NOROVIRUS VARIANT (TCH05) BOUND TO SECRETOR LEWIS HBGA (LEB)","10.1128/JVI.00848-11 ",3.04,39.91,"3sej_oligo1","LFucpa1-2DGalpb1-3[LFucpa1-4]DGlcpNAcb1-3DGalpb1-4DGlcpb1-ROH","FUC(6_M_)-[FUC(5_M_)-GAL(4_M_)]-NAG(3_M_)-GAL(2_M_)-BGC(1_M_)",99.8921,"","",""
"3SEJ","STRUCTURAL CHARACTERIZATION OF A GII.4 2004 NOROVIRUS VARIANT (TCH05) BOUND TO SECRETOR LEWIS HBGA (LEB)","10.1128/JVI.00848-11 ",3.04,39.91,"3sej_oligo8","LFucpa1-2DGalpb1-3[LFucpa1-4]DGlcpNAcb1-3DGalpb1-4DGlcpb1-ROH","FUC(6_R_)-[FUC(5_R_)-GAL(4_R_)]-NAG(3_R_)-GAL(2_R_)-BGC(1_R_)",110.028,"","",""
"3SEJ","STRUCTURAL CHARACTERIZATION OF A GII.4 2004 NOROVIRUS VARIANT (TCH05) BOUND TO SECRETOR LEWIS HBGA (LEB)","10.1128/JVI.00848-11 ",3.04,39.91,"3sej_oligo2","LFucpa1-2DGalpb1-3[LFucpa1-4]DGlcpNAcb1-3DGalpb1-4DGlcpb1-ROH","FUC(6_O_)-[FUC(5_O_)-GAL(4_O_)]-NAG(3_O_)-GAL(2_O_)-BGC(1_O_)",84.0915,"","",""
"3SEJ","STRUCTURAL CHARACTERIZATION OF A GII.4 2004 NOROVIRUS VARIANT (TCH05) BOUND TO SECRETOR LEWIS HBGA (LEB)","10.1128/JVI.00848-11 ",3.04,39.91,"3sej_oligo3","LFucpa1-2DGalpb1-3[LFucpa1-4]DGlcpNAcb1-3DGalpb1-4DGlcpb1-ROH","FUC(6_L_)-[FUC(5_L_)-GAL(4_L_)]-NAG(3_L_)-GAL(2_L_)-BGC(1_L_)",102.327,"","",""
"3SGJ","UNIQUE CARBOHYDRATE-CARBOHYDRATE INTERACTIONS ARE REQUIRED FOR HIGH AFFINITY BINDING BETWEEN FCGIII AND ANTIBODIES LACKING CORE FUCOSE","10.1073/PNAS.1108455108 ",2.2,41.35,"3sgj_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_A_)",49.3643,"","",""
"3SGJ","UNIQUE CARBOHYDRATE-CARBOHYDRATE INTERACTIONS ARE REQUIRED FOR HIGH AFFINITY BINDING BETWEEN FCGIII AND ANTIBODIES LACKING CORE FUCOSE","10.1073/PNAS.1108455108 ",2.2,41.35,"3sgj_oligo4","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(162_C_)",77.6204,"","",""
"3SGK","UNIQUE CARBOHYDRATE/CARBOHYDRATE INTERACTIONS ARE REQUIRED FOR HIGH AFFINITY BINDING OF FCGIII AND ANTIBODIES LACKING CORE FUCOSE","10.1073/PNAS.1108455108 ",2.4,63.58,"3sgk_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6][DGlcpNAcb1-4]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_D_)-MAN(6_D_)-[NAG(8_D_)]-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(297_A_)",47.0327,"","",""
"3SGK","UNIQUE CARBOHYDRATE/CARBOHYDRATE INTERACTIONS ARE REQUIRED FOR HIGH AFFINITY BINDING OF FCGIII AND ANTIBODIES LACKING CORE FUCOSE","10.1073/PNAS.1108455108 ",2.4,63.58,"3sgk_oligo1","DManpa1-2DManpb1-3[DManpb1-3[DManpb1-6]DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_F_)-[MAN(7_F_)]-MAN(6_F_)-[MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(162_C_)",56.5764,"","",""
"3SGK","UNIQUE CARBOHYDRATE/CARBOHYDRATE INTERACTIONS ARE REQUIRED FOR HIGH AFFINITY BINDING OF FCGIII AND ANTIBODIES LACKING CORE FUCOSE","10.1073/PNAS.1108455108 ",2.4,63.58,"3sgk_oligo3","DGlcpNAcb1-2DManpb1-3[DGlcpNAcb1-2DManpa1-6][DGlcpNAcb1-4]DManpb1-4DGlcpNAcb1-4DGlcpNAca1-ASN","NAG(7_E_)-MAN(6_E_)-[NAG(8_E_)]-[NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(297_B_)",61.4043,"","",""
"3SIO","AC-ACHBP LIGAND BINDING DOMAIN (NOT INCLUDING BETA 9-10 LINKER) MUTATED TO HUMAN ALPHA-7 NACHR","10.1074/JBC.M111.286583 ",2.32,39,"3sio_oligo4","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_L_)-[MAN(5_L_)]-MAN(4_L_)-[MAN(7_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(74_B_)",82.9218,"","",""
"3SIO","AC-ACHBP LIGAND BINDING DOMAIN (NOT INCLUDING BETA 9-10 LINKER) MUTATED TO HUMAN ALPHA-7 NACHR","10.1074/JBC.M111.286583 ",2.32,39,"3sio_oligo21","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_P_)-[MAN(5_P_)]-MAN(4_P_)-[MAN(7_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(74_G_)",84.5226,"","",""
"3SIO","AC-ACHBP LIGAND BINDING DOMAIN (NOT INCLUDING BETA 9-10 LINKER) MUTATED TO HUMAN ALPHA-7 NACHR","10.1074/JBC.M111.286583 ",2.32,39,"3sio_oligo3","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-MAN(4_N_)-[MAN(6_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(110_E_)",79.812,"","",""
"3SIO","AC-ACHBP LIGAND BINDING DOMAIN (NOT INCLUDING BETA 9-10 LINKER) MUTATED TO HUMAN ALPHA-7 NACHR","10.1074/JBC.M111.286583 ",2.32,39,"3sio_oligo8","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Q_)-MAN(4_Q_)-[MAN(6_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(110_J_)",87.2856,"","",""
"3SJE","X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (THE E424A INACTIVE MUTANT) IN COMPLEX WITH N-ACETYL-ASPARTYL-AMINONONANOIC ACID","10.1021/JM200807M ",1.7,33.33,"3sje_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(638_A_)",31.6945,"","",""
"3SJF","X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II IN COMPLEX WITH A UREA-BASED INHIBITOR (A25)","10.1021/JM200807M ",1.65,28.46,"3sjf_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(638_A_)",24.5216,"","",""
"3SJG","HUMAN GLUTAMATE CARBOXYPEPTIDASE II (E424A INACTIVE MUTANT ) IN COMPLEX WITH N-ACETYL-ASPARTYL-AMINOOCTANOIC ACID","10.1021/JM200807M ",1.65,31.87,"3sjg_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(638_A_)",31.5664,"","",""
"3SJX","X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (THE E424A INACTIVE MUTANT) IN COMPLEX WITH N-ACETYL-ASPARTYL-METHIONINE","10.1021/JM200807M ",1.66,30.9,"3sjx_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(638_A_)",29.5095,"","",""
"3SLD","STRUCTURAL CHARACTERIZATION OF A GII.4 2004 NOROVIRUS VARIANT (TCH05) BOUND TO A TRISACCHARIDE","10.1128/JVI.00848-11 ",2.68,37.12,"3sld_oligo5","LFucpa1-2[DGalpNAca1-3]DGalpb1-ROH","A2G(3_O_)-[FUC(2_O_)]-GAL(1_O_)",95.6733,"","",""
"3SLD","STRUCTURAL CHARACTERIZATION OF A GII.4 2004 NOROVIRUS VARIANT (TCH05) BOUND TO A TRISACCHARIDE","10.1128/JVI.00848-11 ",2.68,37.12,"3sld_oligo8","LFucpa1-2[DGalpNAca1-3]DGalpb1-ROH","A2G(3_R_)-[FUC(2_R_)]-GAL(1_R_)",86.3097,"","",""
"3SLD","STRUCTURAL CHARACTERIZATION OF A GII.4 2004 NOROVIRUS VARIANT (TCH05) BOUND TO A TRISACCHARIDE","10.1128/JVI.00848-11 ",2.68,37.12,"3sld_oligo3","LFucpa1-2[DGalpNAca1-3]DGalpb1-ROH","A2G(3_M_)-[FUC(2_M_)]-GAL(1_M_)",93.3706,"","",""
"3SLD","STRUCTURAL CHARACTERIZATION OF A GII.4 2004 NOROVIRUS VARIANT (TCH05) BOUND TO A TRISACCHARIDE","10.1128/JVI.00848-11 ",2.68,37.12,"3sld_oligo6","LFucpa1-2[DGalpNAca1-3]DGalpb1-ROH","A2G(3_P_)-[FUC(2_P_)]-GAL(1_P_)",104.367,"","",""
"3SLD","STRUCTURAL CHARACTERIZATION OF A GII.4 2004 NOROVIRUS VARIANT (TCH05) BOUND TO A TRISACCHARIDE","10.1128/JVI.00848-11 ",2.68,37.12,"3sld_oligo2","LFucpa1-2[DGalpNAca1-3]DGalpb1-ROH","A2G(3_L_)-[FUC(2_L_)]-GAL(1_L_)",79.5118,"","",""
"3SLD","STRUCTURAL CHARACTERIZATION OF A GII.4 2004 NOROVIRUS VARIANT (TCH05) BOUND TO A TRISACCHARIDE","10.1128/JVI.00848-11 ",2.68,37.12,"3sld_oligo7","LFucpa1-2[DGalpNAca1-3]DGalpb1-ROH","A2G(3_Q_)-[FUC(2_Q_)]-GAL(1_Q_)",106.028,"","",""
"3SLD","STRUCTURAL CHARACTERIZATION OF A GII.4 2004 NOROVIRUS VARIANT (TCH05) BOUND TO A TRISACCHARIDE","10.1128/JVI.00848-11 ",2.68,37.12,"3sld_oligo1","LFucpa1-2[DGalpNAca1-3]DGalpb1-ROH","A2G(3_K_)-[FUC(2_K_)]-GAL(1_K_)",88.5524,"","",""
"3SLD","STRUCTURAL CHARACTERIZATION OF A GII.4 2004 NOROVIRUS VARIANT (TCH05) BOUND TO A TRISACCHARIDE","10.1128/JVI.00848-11 ",2.68,37.12,"3sld_oligo4","LFucpa1-2[DGalpNAca1-3]DGalpb1-ROH","A2G(3_N_)-[FUC(2_N_)]-GAL(1_N_)",99.7664,"","",""
"3SLN","STRUCTURAL CHARACTERIZATION OF A GII.4 2004 NOROVIRUS VARIANT (TCH05) BOUND TO H PENTASACCHARIDE","10.1128/JVI.00848-11 ",2.84,57.14,"3sln_oligo4","LFucpa1-2DGalpb1-3DGlcpNAcb1-3DGalpb1-4DGlcpb1-ROH","FUC(5_M_)-GAL(4_M_)-NAG(3_M_)-GAL(2_M_)-BGC(1_M_)",141.006,"","",""
"3SLN","STRUCTURAL CHARACTERIZATION OF A GII.4 2004 NOROVIRUS VARIANT (TCH05) BOUND TO H PENTASACCHARIDE","10.1128/JVI.00848-11 ",2.84,57.14,"3sln_oligo5","LFucpa1-2DGalpb1-3DGlcpNAcb1-3DGalpb1-4DGlcpb1-ROH","FUC(5_K_)-GAL(4_K_)-NAG(3_K_)-GAL(2_K_)-BGC(1_K_)",126.427,"","",""
"3SLN","STRUCTURAL CHARACTERIZATION OF A GII.4 2004 NOROVIRUS VARIANT (TCH05) BOUND TO H PENTASACCHARIDE","10.1128/JVI.00848-11 ",2.84,57.14,"3sln_oligo6","LFucpa1-2DGalpb1-3DGlcpNAcb1-3DGalpb1-4DGlcpb1-ROH","FUC(5_Q_)-GAL(4_Q_)-NAG(3_Q_)-GAL(2_Q_)-BGC(1_Q_)",139.211,"","",""
"3SLN","STRUCTURAL CHARACTERIZATION OF A GII.4 2004 NOROVIRUS VARIANT (TCH05) BOUND TO H PENTASACCHARIDE","10.1128/JVI.00848-11 ",2.84,57.14,"3sln_oligo8","LFucpa1-2DGalpb1-3DGlcpNAcb1-3DGalpb1-4DGlcpb1-ROH","FUC(5_P_)-GAL(4_P_)-NAG(3_P_)-GAL(2_P_)-BGC(1_P_)",150.316,"","",""
"3SLN","STRUCTURAL CHARACTERIZATION OF A GII.4 2004 NOROVIRUS VARIANT (TCH05) BOUND TO H PENTASACCHARIDE","10.1128/JVI.00848-11 ",2.84,57.14,"3sln_oligo2","LFucpa1-2DGalpb1-3DGlcpNAcb1-3DGalpb1-4DGlcpb1-ROH","FUC(5_N_)-GAL(4_N_)-NAG(3_N_)-GAL(2_N_)-BGC(1_N_)",126.427,"","",""
"3SLN","STRUCTURAL CHARACTERIZATION OF A GII.4 2004 NOROVIRUS VARIANT (TCH05) BOUND TO H PENTASACCHARIDE","10.1128/JVI.00848-11 ",2.84,57.14,"3sln_oligo7","LFucpa1-2DGalpb1-3DGlcpNAcb1-3DGalpb1-4DGlcpb1-ROH","FUC(5_R_)-GAL(4_R_)-NAG(3_R_)-GAL(2_R_)-BGC(1_R_)",145.533,"","",""
"3SLN","STRUCTURAL CHARACTERIZATION OF A GII.4 2004 NOROVIRUS VARIANT (TCH05) BOUND TO H PENTASACCHARIDE","10.1128/JVI.00848-11 ",2.84,57.14,"3sln_oligo1","LFucpa1-2DGalpb1-3DGlcpNAcb1-3DGalpb1-4DGlcpb1-ROH","FUC(5_L_)-GAL(4_L_)-NAG(3_L_)-GAL(2_L_)-BGC(1_L_)",158.571,"","",""
"3SLN","STRUCTURAL CHARACTERIZATION OF A GII.4 2004 NOROVIRUS VARIANT (TCH05) BOUND TO H PENTASACCHARIDE","10.1128/JVI.00848-11 ",2.84,57.14,"3sln_oligo3","LFucpa1-2DGalpb1-3DGlcpNAcb1-3DGalpb1-4DGlcpb1-ROH","FUC(5_O_)-GAL(4_O_)-NAG(3_O_)-GAL(2_O_)-BGC(1_O_)",135.448,"","",""
"3T3M","A NOVEL HIGH AFFINITY INTEGRIN ALPHAIIBBETA3 RECEPTOR ANTAGONIST THAT UNEXPECTEDLY DISPLACES MG2+ FROM THE BETA3 MIDAS","10.1126/SCITRANSLMED.3003576 ",2.6,0,"3t3m_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(320_D_)",105.508,"","",""
"3T3M","A NOVEL HIGH AFFINITY INTEGRIN ALPHAIIBBETA3 RECEPTOR ANTAGONIST THAT UNEXPECTEDLY DISPLACES MG2+ FROM THE BETA3 MIDAS","10.1126/SCITRANSLMED.3003576 ",2.6,0,"3t3m_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(320_B_)",100.032,"","",""
"3T3P","A NOVEL HIGH AFFINITY INTEGRIN ALPHAIIBBETA3 RECEPTOR ANTAGONIST THAT UNEXPECTEDLY DISPLACES MG2+ FROM THE BETA3 MIDAS","10.1126/SCITRANSLMED.3003576 ",2.2,0,"3t3p_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(320_B_)",70.8718,"","",""
"3T3P","A NOVEL HIGH AFFINITY INTEGRIN ALPHAIIBBETA3 RECEPTOR ANTAGONIST THAT UNEXPECTEDLY DISPLACES MG2+ FROM THE BETA3 MIDAS","10.1126/SCITRANSLMED.3003576 ",2.2,0,"3t3p_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(320_D_)",77.1116,"","",""
"3T6Q","CRYSTAL STRUCTURE OF MOUSE RP105/MD-1 COMPLEX","10.1016/J.JMB.2011.09.020 ",1.9,34.67,"3t6q_oligo4","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-MAN(5_H_)-[MAN(7_H_)]-MAN(4_H_)-[MAN(8_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(402_B_)",32.4485,"","",""
"3T6Q","CRYSTAL STRUCTURE OF MOUSE RP105/MD-1 COMPLEX","10.1016/J.JMB.2011.09.020 ",1.9,34.67,"3t6q_oligo1","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_E_)-MAN(7_E_)-[MAN(6_E_)-MAN(5_E_)]-MAN(4_E_)-[MAN(9_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(402_A_)",29.1212,"","",""
"3TH0","P22 TAILSPIKE COMPLEXED WITH S.PARATYPHI O ANTIGEN OCTASACCHARIDE","10.1093/GLYCOB/CWS224 ",1.75,10.31,"3th0_oligo1","DGalpa1-2[DParpa1-3]DManpa1-4LRhapa1-3DGalpa1-2[DParpa1-3]DManpa1-4LRhapa1-ROH","PZU(8_B_)-[PZU(7_B_)-[GLA(6_B_)]-MAN(5_B_)-RAM(4_B_)-GLA(3_B_)]-MAN(2_B_)-RAM(1_B_)",20.9342,"","",""
"3TI4","CRYSTAL STRUCTURE OF 2009 PANDEMIC H1N1 NEURAMINIDASE COMPLEXED WITH LANINAMIVIR OCTANOATE","10.1371/JOURNAL.PPAT.1002249 ",1.6,12.23,"3ti4_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(146_A_)",20.7266,"","",""
"3TI6","CRYSTAL STRUCTURE OF 2009 PANDEMIC H1N1 NEURAMINIDASE COMPLEXED WITH OSELTAMIVIR","10.1371/JOURNAL.PPAT.1002249 ",1.69,12.35,"3ti6_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(146_A_)",22.9182,"","",""
"3TIA","CRYSTAL STRUCTURE OF 1957 PANDEMIC H2N2 NEURAMINIDASE COMPLEXED WITH LANINAMIVIR","10.1371/JOURNAL.PPAT.1002249 ",1.8,15.64,"3tia_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(200_C_)",16.6061,"","",""
"3TIA","CRYSTAL STRUCTURE OF 1957 PANDEMIC H2N2 NEURAMINIDASE COMPLEXED WITH LANINAMIVIR","10.1371/JOURNAL.PPAT.1002249 ",1.8,15.64,"3tia_oligo7","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_K_)-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(200_D_)",13.9366,"","",""
"3TIA","CRYSTAL STRUCTURE OF 1957 PANDEMIC H2N2 NEURAMINIDASE COMPLEXED WITH LANINAMIVIR","10.1371/JOURNAL.PPAT.1002249 ",1.8,15.64,"3tia_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(200_A_)",17.0995,"","",""
"3TIA","CRYSTAL STRUCTURE OF 1957 PANDEMIC H2N2 NEURAMINIDASE COMPLEXED WITH LANINAMIVIR","10.1371/JOURNAL.PPAT.1002249 ",1.8,15.64,"3tia_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(200_B_)",13.9445,"","",""
"3TIB","CRYSTAL STRUCTURE OF 1957 PANDEMIC H2N2 NEURAMINIDASE COMPLEXED WITH LANINAMIVIR OCTANOATE","10.1371/JOURNAL.PPAT.1002249 ",2.2,15.73,"3tib_oligo6","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(200_C_)",17.12,"","",""
"3TIB","CRYSTAL STRUCTURE OF 1957 PANDEMIC H2N2 NEURAMINIDASE COMPLEXED WITH LANINAMIVIR OCTANOATE","10.1371/JOURNAL.PPAT.1002249 ",2.2,15.73,"3tib_oligo8","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_L_)-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(200_D_)",16.9416,"","",""
"3TIB","CRYSTAL STRUCTURE OF 1957 PANDEMIC H2N2 NEURAMINIDASE COMPLEXED WITH LANINAMIVIR OCTANOATE","10.1371/JOURNAL.PPAT.1002249 ",2.2,15.73,"3tib_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_H_)-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(200_B_)",19.1014,"","",""
"3TIB","CRYSTAL STRUCTURE OF 1957 PANDEMIC H2N2 NEURAMINIDASE COMPLEXED WITH LANINAMIVIR OCTANOATE","10.1371/JOURNAL.PPAT.1002249 ",2.2,15.73,"3tib_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(200_A_)",19.7914,"","",""
"3TIC","CRYSTAL STRUCTURE OF 1957 PANDEMIC H2N2 NEURAMINIDASE COMPLEXED WITH ZANAMIVIR","10.1371/JOURNAL.PPAT.1002249 ",1.89,17.64,"3tic_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(200_A_)",19.8332,"","",""
"3TIC","CRYSTAL STRUCTURE OF 1957 PANDEMIC H2N2 NEURAMINIDASE COMPLEXED WITH ZANAMIVIR","10.1371/JOURNAL.PPAT.1002249 ",1.89,17.64,"3tic_oligo7","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_K_)-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(200_D_)",18.7023,"","",""
"3TIC","CRYSTAL STRUCTURE OF 1957 PANDEMIC H2N2 NEURAMINIDASE COMPLEXED WITH ZANAMIVIR","10.1371/JOURNAL.PPAT.1002249 ",1.89,17.64,"3tic_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(200_C_)",19.7259,"","",""
"3TIC","CRYSTAL STRUCTURE OF 1957 PANDEMIC H2N2 NEURAMINIDASE COMPLEXED WITH ZANAMIVIR","10.1371/JOURNAL.PPAT.1002249 ",1.89,17.64,"3tic_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(200_B_)",19.0627,"","",""
"3TV3","CRYSTAL STRUCTURE OF BROAD AND POTENT HIV-1 NEUTRALIZING ANTIBODY PGT128 IN COMPLEX WITH MAN9","10.1126/SCIENCE.1213256 ",1.29,20.6,"3tv3_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]MAN1-C1","MAN(7_A_)-MAN(6_A_)-[MAN(8_A_)]-MAN(5_A_)-[MAN(4_A_)-MAN(3_A_)-MAN(2_A_)--AML(300_H_)",25.1499,"","",""
"3TV8","PHARMACOLOGICAL CHAPERONING IN HUMAN ALPHA-GALACTOSIDASE","10.1016/J.CHEMBIOL.2011.10.012 ",2.64,36.35,"3tv8_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(192_B_)",68.7525,"","",""
"3TWC","CRYSTAL STRUCTURE OF BROAD AND POTENT HIV-1 NEUTRALIZING ANTIBODY PGT127 IN COMPLEX WITH MAN9","10.1126/SCIENCE.1213256 ",1.65,29,"3twc_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]MAN1-C1","MAN(7_A_)-MAN(6_A_)-[MAN(8_A_)]-MAN(5_A_)-[MAN(4_A_)-MAN(3_A_)-MAN(2_A_)--AML(300_H_)",36.8832,"","",""
"3TYG","CRYSTAL STRUCTURE OF BROAD AND POTENT HIV-1 NEUTRALIZING ANTIBODY PGT128 IN COMPLEX WITH A GLYCOSYLATED ENGINEERED GP120 OUTER DOMAIN WITH MINIV3 (EODMV3)","10.1126/SCIENCE.1213256 ",3.25,117.5,"3tyg_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)]-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(104_A_)",76.0156,"","",""
"3TYG","CRYSTAL STRUCTURE OF BROAD AND POTENT HIV-1 NEUTRALIZING ANTIBODY PGT128 IN COMPLEX WITH A GLYCOSYLATED ENGINEERED GP120 OUTER DOMAIN WITH MINIV3 (EODMV3)","10.1126/SCIENCE.1213256 ",3.25,117.5,"3tyg_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_B_)-MAN(8_B_)-[MAN(10_B_)]-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(121_A_)",72.8814,"","",""
"3U0P","CRYSTAL STRUCTURE OF HUMAN CD1D-LYSOPHOSPHATIDYLCHOLINE","10.1038/EMBOJ.2012.54 ",2.8,0,"3u0p_oligo1","LFucpa1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_G_)-[NAG(3_G_)]-[FUC(2_G_)]-NAG(1_G_)-ASN(20_A_)",121.871,"","",""
"3U0P","CRYSTAL STRUCTURE OF HUMAN CD1D-LYSOPHOSPHATIDYLCHOLINE","10.1038/EMBOJ.2012.54 ",2.8,0,"3u0p_oligo2","LFucpa1-3[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_H_)-[FUC(2_H_)]-NAG(1_H_)-ASN(20_C_)",127.993,"","",""
"3U2S","CRYSTAL STRUCTURE OF PG9 FAB IN COMPLEX WITH V1V2 REGION FROM HIV-1 STRAIN ZM109","10.1038/NATURE10696 ",1.8,0,"3u2s_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-[MAN(5_D_)]-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(160_G_)",34.9742,"","",""
"3U2S","CRYSTAL STRUCTURE OF PG9 FAB IN COMPLEX WITH V1V2 REGION FROM HIV-1 STRAIN ZM109","10.1038/NATURE10696 ",1.8,0,"3u2s_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-[MAN(5_E_)]-MAN(4_E_)-[MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(160_C_)",40.1351,"","",""
"3U4E","CRYSTAL STRUCTURE OF PG9 FAB IN COMPLEX WITH V1V2 REGION FROM HIV-1 STRAIN CAP45","10.1038/NATURE10696 ",2.19,0,"3u4e_oligo3","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-MAN(4_D_)-[MAN(6_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(156_G_)",109.907,"","",""
"3U4E","CRYSTAL STRUCTURE OF PG9 FAB IN COMPLEX WITH V1V2 REGION FROM HIV-1 STRAIN CAP45","10.1038/NATURE10696 ",2.19,0,"3u4e_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)]-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(160_G_)",51.7638,"","",""
"3U4E","CRYSTAL STRUCTURE OF PG9 FAB IN COMPLEX WITH V1V2 REGION FROM HIV-1 STRAIN CAP45","10.1038/NATURE10696 ",2.19,0,"3u4e_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-[MAN(5_E_)]-MAN(4_E_)-[MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(160_J_)",52.296,"","",""
"3U4E","CRYSTAL STRUCTURE OF PG9 FAB IN COMPLEX WITH V1V2 REGION FROM HIV-1 STRAIN CAP45","10.1038/NATURE10696 ",2.19,0,"3u4e_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(2_I_)-BMA(1_I_)-NAG(2_F_)-NAG(1_F_)-ASN(156_J_)",94.9364,"","",""
"3U7B","A NEW CRYSTAL STRUCTURE OF A FUSARIUM OXYSPORUM GH10 XYLANASE REVEALS THE PRESENCE OF AN EXTENDED LOOP ON TOP OF THE CATALYTIC CLEFT","10.1107/S0907444912007044 ",1.94,16.34,"3u7b_oligo2","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(101_B_)",31.5216,"","",""
"3U7Y","STRUCTURE OF NIH45-46 FAB IN COMPLEX WITH GP120 OF 93TH057 HIV","10.1126/SCIENCE.1213782 ",2.45,0,"3u7y_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_A_)-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(262_G_)",110.07,"","",""
"3UEQ","CRYSTAL STRUCTURE OF AMYLOSUCRASE FROM NEISSERIA POLYSACCHAREA IN COMPLEX WITH TURANOSE","10.1074/JBC.M111.322917 ",1.85,11.56,"3ueq_oligo1","DGlcpa1-3DFrufb2-ROH","GLC(2_B_)-FRU(1_B_)",14.9557,"","",""
"3UER","CRYSTAL STRUCTURE OF AMYLOSUCRASE FROM DEINOCOCCUS GEOTHERMALIS IN COMPLEX WITH TURANOSE","10.1074/JBC.M111.322917 ",2.1,20.68,"3uer_oligo1","DGlcpa1-3DFrufa2-ROH","GLC(2_B_)-Z9N(1_B_)",30.0686,"","",""
"3UET","CRYSTAL STRUCTURE OF ALPHA-1,3/4-FUCOSIDASE FROM BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS D172A/E217A MUTANT COMPLEXED WITH LACTO-N- FUCOPENTAOSE II","10.1074/JBC.M111.333781 ",2.1,29.84,"3uet_oligo2","DGalpb1-3DGlcpNAcb1-ROH","GAL(2_D_)-NAG(1_D_)",33.9168,"","",""
"3UET","CRYSTAL STRUCTURE OF ALPHA-1,3/4-FUCOSIDASE FROM BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS D172A/E217A MUTANT COMPLEXED WITH LACTO-N- FUCOPENTAOSE II","10.1074/JBC.M111.333781 ",2.1,29.84,"3uet_oligo1","DGalpb1-3[LFucpa1-4]DGlcpNAcb1-ROH","FUC(3_C_)-[GAL(2_C_)]-NAG(1_C_)",29.9076,"","",""
"3UGF","CRYSTAL STRUCTURE OF A 6-SST/6-SFT FROM PACHYSANDRA TERMINALIS","10.1111/J.1365-313X.2011.04858.X ",1.7,20.03,"3ugf_oligo4","LFucpa1-3DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(59_A_)",35.8986,"","",""
"3UGF","CRYSTAL STRUCTURE OF A 6-SST/6-SFT FROM PACHYSANDRA TERMINALIS","10.1111/J.1365-313X.2011.04858.X ",1.7,20.03,"3ugf_oligo3","DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","BMA(3_F_)-NAG(2_F_)-[FUC(4_F_)]-NAG(1_F_)-ASN(400_A_)",36.7695,"","",""
"3UGF","CRYSTAL STRUCTURE OF A 6-SST/6-SFT FROM PACHYSANDRA TERMINALIS","10.1111/J.1365-313X.2011.04858.X ",1.7,20.03,"3ugf_oligo6","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_H_)-[FUC(2_H_)]-NAG(1_H_)-ASN(59_B_)",39.8185,"","",""
"3UGF","CRYSTAL STRUCTURE OF A 6-SST/6-SFT FROM PACHYSANDRA TERMINALIS","10.1111/J.1365-313X.2011.04858.X ",1.7,20.03,"3ugf_oligo7","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-[FUC(5_I_)]-NAG(1_I_)-ASN(178_B_)",28.7258,"","",""
"3UGF","CRYSTAL STRUCTURE OF A 6-SST/6-SFT FROM PACHYSANDRA TERMINALIS","10.1111/J.1365-313X.2011.04858.X ",1.7,20.03,"3ugf_oligo8","DGlcpNAcb1-2DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","NAG(5_J_)-MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-[FUC(6_J_)]-NAG(1_J_)-ASN(400_B_)",37.3547,"","",""
"3UGF","CRYSTAL STRUCTURE OF A 6-SST/6-SFT FROM PACHYSANDRA TERMINALIS","10.1111/J.1365-313X.2011.04858.X ",1.7,20.03,"3ugf_oligo1","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_D_)-[FUC(2_D_)]-NAG(1_D_)-ASN(178_A_)",23.8324,"","",""
"3UGG","CRYSTAL STRUCTURE OF A 6-SST/6-SFT FROM PACHYSANDRA TERMINALIS IN COMPLEX WITH 1-KESTOSE","10.1111/J.1365-313X.2011.04858.X ",2.9,17.68,"3ugg_oligo7","DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","BMA(3_I_)-NAG(2_I_)-[FUC(4_I_)]-NAG(1_I_)-ASN(178_B_)",34.4916,"","",""
"3UGG","CRYSTAL STRUCTURE OF A 6-SST/6-SFT FROM PACHYSANDRA TERMINALIS IN COMPLEX WITH 1-KESTOSE","10.1111/J.1365-313X.2011.04858.X ",2.9,17.68,"3ugg_oligo2","LFucpa1-3DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(59_A_)",29.8841,"","",""
"3UGG","CRYSTAL STRUCTURE OF A 6-SST/6-SFT FROM PACHYSANDRA TERMINALIS IN COMPLEX WITH 1-KESTOSE","10.1111/J.1365-313X.2011.04858.X ",2.9,17.68,"3ugg_oligo6","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_H_)-[FUC(2_H_)]-NAG(1_H_)-ASN(59_B_)",40.9394,"","",""
"3UGG","CRYSTAL STRUCTURE OF A 6-SST/6-SFT FROM PACHYSANDRA TERMINALIS IN COMPLEX WITH 1-KESTOSE","10.1111/J.1365-313X.2011.04858.X ",2.9,17.68,"3ugg_oligo8","DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","BMA(3_J_)-NAG(2_J_)-[FUC(4_J_)]-NAG(1_J_)-ASN(400_B_)",45.9286,"","",""
"3UGG","CRYSTAL STRUCTURE OF A 6-SST/6-SFT FROM PACHYSANDRA TERMINALIS IN COMPLEX WITH 1-KESTOSE","10.1111/J.1365-313X.2011.04858.X ",2.9,17.68,"3ugg_oligo3","DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","BMA(3_D_)-NAG(2_D_)-[FUC(4_D_)]-NAG(1_D_)-ASN(178_A_)",29.4198,"","",""
"3UGG","CRYSTAL STRUCTURE OF A 6-SST/6-SFT FROM PACHYSANDRA TERMINALIS IN COMPLEX WITH 1-KESTOSE","10.1111/J.1365-313X.2011.04858.X ",2.9,17.68,"3ugg_oligo4","DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","BMA(3_F_)-NAG(2_F_)-[FUC(4_F_)]-NAG(1_F_)-ASN(400_A_)",49.4484,"","",""
"3UGH","CRYSTAL STRUCTURE OF A 6-SST/6-SFT FROM PACHYSANDRA TERMINALIS IN COMPLEX WITH 6-KESTOSE","10.1111/J.1365-313X.2011.04858.X ",2.9,20.36,"3ugh_oligo5","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_G_)-[FUC(2_G_)]-NAG(1_G_)-ASN(59_B_)",41.1548,"","",""
"3UGH","CRYSTAL STRUCTURE OF A 6-SST/6-SFT FROM PACHYSANDRA TERMINALIS IN COMPLEX WITH 6-KESTOSE","10.1111/J.1365-313X.2011.04858.X ",2.9,20.36,"3ugh_oligo6","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(4_H_)-BMA(3_H_)-NAG(2_H_)-[FUC(5_H_)]-NAG(1_H_)-ASN(178_B_)",39.7075,"","",""
"3UGH","CRYSTAL STRUCTURE OF A 6-SST/6-SFT FROM PACHYSANDRA TERMINALIS IN COMPLEX WITH 6-KESTOSE","10.1111/J.1365-313X.2011.04858.X ",2.9,20.36,"3ugh_oligo7","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-[FUC(5_I_)]-NAG(1_I_)-ASN(400_B_)",54.0902,"","",""
"3UGH","CRYSTAL STRUCTURE OF A 6-SST/6-SFT FROM PACHYSANDRA TERMINALIS IN COMPLEX WITH 6-KESTOSE","10.1111/J.1365-313X.2011.04858.X ",2.9,20.36,"3ugh_oligo4","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_C_)-[FUC(2_C_)]-NAG(1_C_)-ASN(178_A_)",34.5788,"","",""
"3UGH","CRYSTAL STRUCTURE OF A 6-SST/6-SFT FROM PACHYSANDRA TERMINALIS IN COMPLEX WITH 6-KESTOSE","10.1111/J.1365-313X.2011.04858.X ",2.9,20.36,"3ugh_oligo3","DXylpa1-2[DManpa1-3][DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(6_E_)-[MAN(5_E_)]-[XYS(4_E_)]-BMA(3_E_)-NAG(2_E_)-[FUC(7_E_)]-NAG(1_E_)-ASN(400_A_)",55.6746,"","",""
"3USU","CRYSTAL STRUCTURE OF BUTEA MONOSPERMA SEED LECTIN","",2.46,23.45,"3usu_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-[FUC(5_J_)]-NAG(1_J_)-ASN(118_B_)",31.6773,"","",""
"3USU","CRYSTAL STRUCTURE OF BUTEA MONOSPERMA SEED LECTIN","",2.46,23.45,"3usu_oligo4","DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","BMA(3_L_)-NAG(2_L_)-[FUC(4_L_)]-NAG(1_L_)-ASN(118_E_)",34.6298,"","",""
"3USU","CRYSTAL STRUCTURE OF BUTEA MONOSPERMA SEED LECTIN","",2.46,23.45,"3usu_oligo3","DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","BMA(3_K_)-NAG(2_K_)-[FUC(4_K_)]-NAG(1_K_)-ASN(118_C_)",37.4795,"","",""
"3USU","CRYSTAL STRUCTURE OF BUTEA MONOSPERMA SEED LECTIN","",2.46,23.45,"3usu_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","BMA(3_I_)-NAG(2_I_)-[FUC(4_I_)]-NAG(1_I_)-ASN(118_A_)",35.1427,"","",""
"3USU","CRYSTAL STRUCTURE OF BUTEA MONOSPERMA SEED LECTIN","",2.46,23.45,"3usu_oligo6","LFucpa1-3DGlcpNAcx1-","FUC(2_N_)-NAG(1_N_)",54.8302,"","",""
"3UUE","CRYSTAL STRUCTURE OF MONO- AND DIACYLGLYCEROL LIPASE FROM MALASSEZIA GLOBOSA","10.1016/J.JSB.2012.03.006 ",1.45,9.39,"3uue_oligo1","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(253_A_)",14.3267,"","",""
"3V0W","CRYSTAL STRUCTURE OF FAB WN1 222-5 IN COMPLEX WITH LPS","10.1073/PNAS.1209253109 ",1.73,25.01,"3v0w_oligo1","DGlcpNa1-2DGlcpa1-2DGlcpa1-3[DGalpa1-6]DGlcpa1-3[GMH1-7]GM01-3GM01-5[DKdopa2-4]DKdopa2-ROH","GMH(9_A_)-[GLA(8_A_)-[PA1(7_A_)-GLC(6_A_)-GLC(5_A_)]-GLC(4_A_)]-GM0(3_A_)-GM0(2_A_)-[KDO(10_A_)]-KDO(1_A_)",23.9209,"","",""
"3V4P","CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB ACT-1","10.1083/JCB.201110023 ",3.15,0,"3v4p_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(196_C_)",190.412,"","",""
"3V4P","CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB ACT-1","10.1083/JCB.201110023 ",3.15,0,"3v4p_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(196_A_)",160.053,"","",""
"3V4V","CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB ACT-1 AND RO0505376","10.1083/JCB.201110023 ",3.1,0,"3v4v_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(196_C_)",216.836,"","",""
"3V4V","CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB ACT-1 AND RO0505376","10.1083/JCB.201110023 ",3.1,0,"3v4v_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(196_A_)",179.511,"","",""
"3V7M","CRYSTAL STRUCTURE OF MONOCLONAL HUMAN ANTI-RHESUS D FC IGG1 T125(YB2/0) IN THE PRESENCE OF ZN2+","",2.02,47.93,"3v7m_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_B_)-NAG(5_B_)-MAN(4_B_)-[NAG(8_B_)-MAN(7_B_)]-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(297_A_)",70.5152,"","",""
"3V8X","THE CRYSTAL STRUCTURE OF TRANSFERRIN BINDING PROTEIN A (TBPA) FROM NEISSERIAL MENINGITIDIS SEROGROUP B IN COMPLEX WITH FULL LENGTH HUMAN TRANSFERRIN","10.1038/NATURE10823 ",2.6,0,"3v8x_oligo1","DNeup5Aca2-6DGalpb1-4DGlcpNAcb1-4DManpa1-3[DGalpb1-4DGlcpNAcb1-4DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(10_C_)-NAG(9_C_)-MAN(8_C_)-[SIA(7_C_)-GAL(6_C_)-NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(413_B_)",110.842,"","",""
"3V8X","THE CRYSTAL STRUCTURE OF TRANSFERRIN BINDING PROTEIN A (TBPA) FROM NEISSERIAL MENINGITIDIS SEROGROUP B IN COMPLEX WITH FULL LENGTH HUMAN TRANSFERRIN","10.1038/NATURE10823 ",2.6,0,"3v8x_oligo2","DNeup5Aca2-6DGalpb1-4DGlcpNAcb1-4DManpa1-6[DGlcpNAcb1-4DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","SIA(7_D_)-GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(9_D_)-MAN(8_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(611_B_)",147.147,"","",""
"3V95","CRYSTAL STRUCTURE OF MONOCLONAL HUMAN ANTI-RHESUS D FC AND IGG1 T125(YB2/0) IN THE PRESENCE OF EDTA","",2.7,39.73,"3v95_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-MAN(7_C_)]-MAN(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(297_A_)",38.9226,"","",""
"3V95","CRYSTAL STRUCTURE OF MONOCLONAL HUMAN ANTI-RHESUS D FC AND IGG1 T125(YB2/0) IN THE PRESENCE OF EDTA","",2.7,39.73,"3v95_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(297_B_)",67.4025,"","",""
"3V9C","TYPE-2 CU-DEPLETED FUNGUS LACCASE FROM TRAMETES HIRSUTA AT LOW DOSE OF IONIZATION RADIATION","",2,26.62,"3v9c_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[MAN(5_B_)]-MAN(4_B_)-[MAN(7_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(54_A_)",37.4868,"","",""
"3VGG","CRYSTAL STRUCTURE OF GLYCOSYLTREHALOSE TREHALOHYDROLASE (E283Q) COMPLEXED WITH MALTOHEPTAOSE","10.1002/PRO.2039 ",2.66,40.69,"3vgg_oligo1","DGlcpa1-4DGlcpa1-4DGlcpa1-4DGlcpa1-3DGlcpa1-ROH","GLC(5_B_)-GLC(4_B_)-GLC(3_B_)-GLC(2_B_)-GLC(1_B_)",59.8867,"","",""
"3VI3","CRYSTAL STRUCTURE OF ALPHA5BETA1 INTEGRIN HEADPIECE (LIGAND-FREE FORM)","10.1083/JCB.201111077 ",2.9,71.74,"3vi3_oligo1","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-MAN(4_G_)-[MAN(6_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(275_A_)",82.1147,"","",""
"3VI3","CRYSTAL STRUCTURE OF ALPHA5BETA1 INTEGRIN HEADPIECE (LIGAND-FREE FORM)","10.1083/JCB.201111077 ",2.9,71.74,"3vi3_oligo4","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-MAN(4_K_)-[MAN(6_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(275_C_)",73.7908,"","",""
"3VI4","CRYSTAL STRUCTURE OF ALPHA5BETA1 INTEGRIN HEADPIECE IN COMPLEX WITH RGD PEPTIDE","10.1083/JCB.201111077 ",2.9,69.94,"3vi4_oligo4","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-MAN(4_N_)-[MAN(6_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(275_C_)",76.1756,"","",""
"3VI4","CRYSTAL STRUCTURE OF ALPHA5BETA1 INTEGRIN HEADPIECE IN COMPLEX WITH RGD PEPTIDE","10.1083/JCB.201111077 ",2.9,69.94,"3vi4_oligo2","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-MAN(4_K_)-[MAN(6_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(275_A_)",78.6789,"","",""
"3VSZ","CRYSTAL STRUCTURE OF CT1,3GAL43A IN COMPLEX WITH GALACTAN","10.1016/J.JSB.2012.08.005 ",2.89,72.32,"3vsz_oligo2","DGalpb1-3DGalpb1-3DGalpb1-ROH","GAL(3_H_)-GAL(2_H_)-GAL(1_H_)",56.6836,"","",""
"3VSZ","CRYSTAL STRUCTURE OF CT1,3GAL43A IN COMPLEX WITH GALACTAN","10.1016/J.JSB.2012.08.005 ",2.89,72.32,"3vsz_oligo5","DGalpb1-3DGalpb1-3DGalpb1-ROH","GAL(3_K_)-GAL(2_K_)-GAL(1_K_)",54.8336,"","",""
"3VSZ","CRYSTAL STRUCTURE OF CT1,3GAL43A IN COMPLEX WITH GALACTAN","10.1016/J.JSB.2012.08.005 ",2.89,72.32,"3vsz_oligo3","DGalpb1-3DGalpb1-3DGalpb1-ROH","GAL(3_I_)-GAL(2_I_)-GAL(1_I_)",52.6255,"","",""
"3VSZ","CRYSTAL STRUCTURE OF CT1,3GAL43A IN COMPLEX WITH GALACTAN","10.1016/J.JSB.2012.08.005 ",2.89,72.32,"3vsz_oligo4","DGalpb1-3DGalpb1-3DGalpb1-ROH","GAL(3_J_)-GAL(2_J_)-GAL(1_J_)",56.3424,"","",""
"3VSZ","CRYSTAL STRUCTURE OF CT1,3GAL43A IN COMPLEX WITH GALACTAN","10.1016/J.JSB.2012.08.005 ",2.89,72.32,"3vsz_oligo6","DGalpb1-3DGalpb1-ROH","GAL(2_L_)-GAL(1_L_)",20,"","",""
"3VSZ","CRYSTAL STRUCTURE OF CT1,3GAL43A IN COMPLEX WITH GALACTAN","10.1016/J.JSB.2012.08.005 ",2.89,72.32,"3vsz_oligo1","DGalpb1-3DGalpb1-3DGalpb1-ROH","GAL(3_G_)-GAL(2_G_)-GAL(1_G_)",52.8406,"","",""
"3VTA","CRYSTAL STRUCTURE OF CUCUMISIN, A SUBTILISIN-LIKE ENDOPROTEASE FROM CUCUMIS MELO L","10.1016/J.JMB.2012.07.013 ",2.75,49.3,"3vta_oligo2","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-[FUC(5_D_)]-NAG(1_D_)-ASN(466_B_)",63.5513,"","",""
"3VTA","CRYSTAL STRUCTURE OF CUCUMISIN, A SUBTILISIN-LIKE ENDOPROTEASE FROM CUCUMIS MELO L","10.1016/J.JMB.2012.07.013 ",2.75,49.3,"3vta_oligo3","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_E_)-[FUC(2_E_)]-NAG(1_E_)-ASN(652_B_)",79.9736,"","",""
"3VTA","CRYSTAL STRUCTURE OF CUCUMISIN, A SUBTILISIN-LIKE ENDOPROTEASE FROM CUCUMIS MELO L","10.1016/J.JMB.2012.07.013 ",2.75,49.3,"3vta_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-[FUC(5_C_)]-NAG(1_C_)-ASN(466_A_)",55.7076,"","",""
"3VUN","CRYSTAL STRUCTURE OF A INFLUENZA A VIRUS (A/AICHI/2/1968 H3N2) HEMAGGLUTININ IN C2 SPACE GROUP.","",3,84.66,"3vun_oligo7","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_M_)-[GAL(6_M_)-NAG(5_M_)-MAN(4_M_)-[NAG(8_M_)-MAN(7_M_)]-BMA(3_M_)-NAG(2_M_)]-NAG(1_M_)-ASN(81_E_)",91.0734,"","",""
"3VUN","CRYSTAL STRUCTURE OF A INFLUENZA A VIRUS (A/AICHI/2/1968 H3N2) HEMAGGLUTININ IN C2 SPACE GROUP.","",3,84.66,"3vun_oligo6","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_J_)-[GAL(6_J_)-NAG(5_J_)-MAN(4_J_)-[NAG(8_J_)-MAN(7_J_)]-BMA(3_J_)-NAG(2_J_)]-NAG(1_J_)-ASN(81_C_)",87.8973,"","",""
"3VUN","CRYSTAL STRUCTURE OF A INFLUENZA A VIRUS (A/AICHI/2/1968 H3N2) HEMAGGLUTININ IN C2 SPACE GROUP.","",3,84.66,"3vun_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_G_)-[GAL(6_G_)-NAG(5_G_)-MAN(4_G_)-[NAG(8_G_)-MAN(7_G_)]-BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(81_A_)",90.6585,"","",""
"3VYK","CRYSTAL STRUCTURE OF C-TYPE LECTIN DOMAIN OF MURINE DENDRITIC CELL INHIBITORY RECEPTOR 2 IN COMPLEX WITH N-GLYCAN","10.1074/JBC.M113.513572 ",1.5,19.15,"3vyk_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6][DGlcpNAcb1-4]DManpa1-OME","NAG(5_B_)-MAN(4_B_)-[NAG(6_B_)]-[NAG(3_B_)-MAN(2_B_)]-MMA(1_B_)",20.6395,"","",""
"3VZE","CRYSTAL STRUCTURE OF HUMAN PANCREATIC SECRETORY PROTEIN ZG16P WITH ALPHA1,3-MANNOBIOSE","10.1074/JBC.M113.539114 ",1.9,16.44,"3vze_oligo1","DManpa1-3DManpa1-ROH","MAN(2_B_)-MAN(1_B_)",29.0759,"","",""
"3W09","INFLUENZA VIRUS NEURAMINIDASE SUBTYPE N9 (TERN) COMPLEXED WITH 2,3-DIF GUANIDINO-NEU5AC2EN INHIBITOR","10.1126/SCIENCE.1232552 ",2,34.89,"3w09_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_B_)-[MAN(8_B_)]-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",48.5631,"","",""
"3W11","INSULIN RECEPTOR ECTODOMAIN CONSTRUCT COMPRISING DOMAINS L1-CR IN COMPLEX WITH HUMAN INSULIN, ALPHA-CT PEPTIDE(704-719) AND FAB 83-7","10.1038/NATURE11781 ",3.9,228.9,"3w11_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(111_E_)",236.292,"","",""
"3W12","INSULIN RECEPTOR ECTODOMAIN CONSTRUCT COMPRISING DOMAINS L1-CR IN COMPLEX WITH HIGH-AFFINITY INSULIN ANALOGUE [D-PRO-B26]-DTI-NH2, ALPHA-CT PEPTIDE(704-719) AND FAB 83-7","10.1038/NATURE11781 ",4.3,238.7,"3w12_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(111_E_)",263.114,"","",""
"3W13","INSULIN RECEPTOR ECTODOMAIN CONSTRUCT COMPRISING DOMAINS L1-CR IN COMPLEX WITH HIGH-AFFINITY INSULIN ANALOGUE [D-PRO-B26]-DTI-NH2, ALPHACT PEPTIDE(693-719) AND FAB 83-7","10.1038/NATURE11781 ",4.3,226.5,"3w13_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(111_E_)",239.585,"","",""
"3W37","SUGAR BEET ALPHA-GLUCOSIDASE WITH ACARBOSE","10.1074/JBC.M113.465211 ",1.7,23.08,"3w37_oligo2","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_C_)-[FUC(2_C_)]-NAG(1_C_)-ASN(404_A_)",41.8427,"","",""
"3W38","SUGAR BEET ALPHA-GLUCOSIDASE","10.1074/JBC.M113.465211 ",2.79,30.74,"3w38_oligo1","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_B_)-[FUC(2_B_)]-NAG(1_B_)-ASN(404_A_)",45.0103,"","",""
"3W3D","CRYSTAL STRUCTURE OF SMOOTH MUSCLE G ACTIN DNASE I COMPLEX","",1.8,31.09,"3w3d_oligo2","DManpa1-6DManpb1-3[DManpb1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(7_C_)-MAN(6_C_)-[MAN(5_C_)-BMA(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(18_B_)",61.1696,"","",""
"3W3J","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH CL097","10.1126/SCIENCE.1229159 ",2,39.26,"3w3j_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(293_B_)",37.68,"","",""
"3W3J","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH CL097","10.1126/SCIENCE.1229159 ",2,39.26,"3w3j_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(293_A_)",41.5273,"","",""
"3W3K","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH CL075","10.1126/SCIENCE.1229159 ",2.3,55.72,"3w3k_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(293_A_)",59.2047,"","",""
"3W3K","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH CL075","10.1126/SCIENCE.1229159 ",2.3,55.72,"3w3k_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(590_B_)",66.1249,"","",""
"3W3K","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH CL075","10.1126/SCIENCE.1229159 ",2.3,55.72,"3w3k_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(590_A_)",65.6862,"","",""
"3W3K","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH CL075","10.1126/SCIENCE.1229159 ",2.3,55.72,"3w3k_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(293_B_)",63.7425,"","",""
"3W3L","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH RESIQUIMOD (R848) CRYSTAL FORM 1","10.1126/SCIENCE.1229159 ",2.33,43.79,"3w3l_oligo12","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_P_)-[MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(590_D_)",50.9695,"","",""
"3W3L","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH RESIQUIMOD (R848) CRYSTAL FORM 1","10.1126/SCIENCE.1229159 ",2.33,43.79,"3w3l_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(590_B_)",50.4325,"","",""
"3W3L","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH RESIQUIMOD (R848) CRYSTAL FORM 1","10.1126/SCIENCE.1229159 ",2.33,43.79,"3w3l_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(590_C_)",47.6475,"","",""
"3W3L","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH RESIQUIMOD (R848) CRYSTAL FORM 1","10.1126/SCIENCE.1229159 ",2.33,43.79,"3w3l_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(293_D_)",56.6027,"","",""
"3W3L","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH RESIQUIMOD (R848) CRYSTAL FORM 1","10.1126/SCIENCE.1229159 ",2.33,43.79,"3w3l_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(293_A_)",38.4331,"","",""
"3W3L","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH RESIQUIMOD (R848) CRYSTAL FORM 1","10.1126/SCIENCE.1229159 ",2.33,43.79,"3w3l_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(293_C_)",53.3511,"","",""
"3W3L","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH RESIQUIMOD (R848) CRYSTAL FORM 1","10.1126/SCIENCE.1229159 ",2.33,43.79,"3w3l_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(590_A_)",47.9751,"","",""
"3W3L","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH RESIQUIMOD (R848) CRYSTAL FORM 1","10.1126/SCIENCE.1229159 ",2.33,43.79,"3w3l_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(293_B_)",36.3069,"","",""
"3W3M","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH RESIQUIMOD (R848) CRYSTAL FORM 2","10.1126/SCIENCE.1229159 ",2.7,57.04,"3w3m_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(590_A_)",61.2389,"","",""
"3W3M","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH RESIQUIMOD (R848) CRYSTAL FORM 2","10.1126/SCIENCE.1229159 ",2.7,57.04,"3w3m_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(293_A_)",52.8213,"","",""
"3W3N","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH RESIQUIMOD (R848) CRYSTAL FORM 3","10.1126/SCIENCE.1229159 ",2.1,43.99,"3w3n_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(293_A_)",40.1222,"","",""
"3W3N","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH RESIQUIMOD (R848) CRYSTAL FORM 3","10.1126/SCIENCE.1229159 ",2.1,43.99,"3w3n_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(590_B_)",57.1625,"","",""
"3W3N","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH RESIQUIMOD (R848) CRYSTAL FORM 3","10.1126/SCIENCE.1229159 ",2.1,43.99,"3w3n_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(590_A_)",49.6907,"","",""
"3W3N","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH RESIQUIMOD (R848) CRYSTAL FORM 3","10.1126/SCIENCE.1229159 ",2.1,43.99,"3w3n_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(293_B_)",50.4042,"","",""
"3W81","HUMAN ALPHA-L-IDURONIDASE","10.1073/PNAS.1306939110 ",2.3,34.51,"3w81_oligo8","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-MAN(5_E_)-[MAN(7_E_)]-MAN(4_E_)-[MAN(9_E_)-MAN(8_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(372_B_)",54.5497,"","",""
"3W81","HUMAN ALPHA-L-IDURONIDASE","10.1073/PNAS.1306939110 ",2.3,34.51,"3w81_oligo6","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_C_)-MAN(7_C_)-[MAN(6_C_)-MAN(5_C_)]-MAN(4_C_)-[MAN(10_C_)-MAN(9_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(372_A_)",46.1867,"","",""
"3W82","HUMAN ALPHA-L-IDURONIDASE IN COMPLEX WITH IDURONIC ACID","10.1073/PNAS.1306939110 ",2.76,28.14,"3w82_oligo9","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-MAN(5_E_)-[MAN(7_E_)]-MAN(4_E_)-[MAN(9_E_)-MAN(8_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(372_B_)",50.6829,"","",""
"3W82","HUMAN ALPHA-L-IDURONIDASE IN COMPLEX WITH IDURONIC ACID","10.1073/PNAS.1306939110 ",2.76,28.14,"3w82_oligo7","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_C_)-MAN(7_C_)-[MAN(6_C_)-MAN(5_C_)]-MAN(4_C_)-[MAN(10_C_)-MAN(9_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(372_A_)",29.6338,"","",""
"3W9E","STRUCTURE OF HUMAN MONOCLONAL ANTIBODY E317 FAB COMPLEX WITH HSV-2 GD","10.1107/S0907444913016776 ",2.3,52.34,"3w9e_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(94_C_)",84.0141,"","",""
"3WAV","CRYSTAL STRUCTURE OF AUTOTAXIN IN COMPLEX WITH COMPOUND 10","10.1021/CB400150C ",1.8,35.45,"3wav_oligo3","DManpa1-2DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-MAN(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(524_A_)",37.3873,"","",""
"3WAW","CRYSTAL STRUCTURE OF AUTOTAXIN IN COMPLEX WITH 2BOA","10.1021/CB400150C ",1.95,38.54,"3waw_oligo3","DManpa1-2DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-MAN(5_C_)-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(524_A_)",48.2187,"","",""
"3WAX","CRYSTAL STRUCTURE OF AUTOTAXIN IN COMPLEX WITH 3BOA","10.1021/CB400150C ",1.9,35.71,"3wax_oligo3","DManpa1-2DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-MAN(5_C_)-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(524_A_)",47.38,"","",""
"3WAY","CRYSTAL STRUCTURE OF AUTOTAXIN IN COMPLEX WITH 4BOA","10.1021/CB400150C ",1.75,30.21,"3way_oligo4","DManpa1-2DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-MAN(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(524_A_)",32.962,"","",""
"3WCT","THE STRUCTURE OF A DEOXYGENATED 400 KDA HEMOGLOBIN PROVIDES A MORE ACCURATE DESCRIPTION OF THE COOPERATIVE MECHANISM OF GIANT HEMOGLOBINS: OXYGENATED FORM","10.1107/S1399004714008475 ",2.4,48.1,"3wct_oligo1","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_J_)-[MAN(5_J_)-[MAN(4_J_)]-MAN(3_J_)-NAG(2_J_)]-NAG(1_J_)-ASN(58_H_)",137.269,"","",""
"3WCT","THE STRUCTURE OF A DEOXYGENATED 400 KDA HEMOGLOBIN PROVIDES A MORE ACCURATE DESCRIPTION OF THE COOPERATIVE MECHANISM OF GIANT HEMOGLOBINS: OXYGENATED FORM","10.1107/S1399004714008475 ",2.4,48.1,"3wct_oligo2","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_I_)-[MAN(5_I_)-[MAN(4_I_)]-MAN(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(58_D_)",138.051,"","",""
"3WCU","THE STRUCTURE OF A DEOXYGENATED 400 KDA HEMOGLOBIN PROVIDES A MORE ACCURATE DESCRIPTION OF THE COOPERATIVE MECHANISM OF GIANT HEMOGLOBINS: DEOXYGENATED FORM","10.1107/S1399004714008475 ",2.9,70.75,"3wcu_oligo1","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_J_)-[MAN(5_J_)-[MAN(4_J_)]-MAN(3_J_)-NAG(2_J_)]-NAG(1_J_)-ASN(58_H_)",184.658,"","",""
"3WCU","THE STRUCTURE OF A DEOXYGENATED 400 KDA HEMOGLOBIN PROVIDES A MORE ACCURATE DESCRIPTION OF THE COOPERATIVE MECHANISM OF GIANT HEMOGLOBINS: DEOXYGENATED FORM","10.1107/S1399004714008475 ",2.9,70.75,"3wcu_oligo2","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_I_)-[MAN(5_I_)-[MAN(4_I_)]-MAN(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(58_D_)",184.658,"","",""
"3WCV","THE STRUCTURE OF A DEOXYGENATED 400 KDA HEMOGLOBIN PROVIDES A MORE ACCURATE DESCRIPTION OF THE COOPERATIVE MECHANISM OF GIANT HEMOGLOBINS: CA BOUND FORM","10.1107/S1399004714008475 ",2.6,61.72,"3wcv_oligo2","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_I_)-[MAN(5_I_)-[MAN(4_I_)]-MAN(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(58_D_)",146.525,"","",""
"3WCV","THE STRUCTURE OF A DEOXYGENATED 400 KDA HEMOGLOBIN PROVIDES A MORE ACCURATE DESCRIPTION OF THE COOPERATIVE MECHANISM OF GIANT HEMOGLOBINS: CA BOUND FORM","10.1107/S1399004714008475 ",2.6,61.72,"3wcv_oligo1","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_J_)-[MAN(5_J_)-[MAN(4_J_)]-MAN(3_J_)-NAG(2_J_)]-NAG(1_J_)-ASN(58_H_)",143.834,"","",""
"3WCW","THE STRUCTURE OF A DEOXYGENATED 400 KDA HEMOGLOBIN PROVIDES A MORE ACCURATE DESCRIPTION OF THE COOPERATIVE MECHANISM OF GIANT HEMOGLOBINS: MG BOUND FORM","10.1107/S1399004714008475 ",2.5,42.04,"3wcw_oligo1","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_J_)-[MAN(5_J_)-[MAN(4_J_)]-MAN(3_J_)-NAG(2_J_)]-NAG(1_J_)-ASN(58_H_)",126.94,"","",""
"3WCW","THE STRUCTURE OF A DEOXYGENATED 400 KDA HEMOGLOBIN PROVIDES A MORE ACCURATE DESCRIPTION OF THE COOPERATIVE MECHANISM OF GIANT HEMOGLOBINS: MG BOUND FORM","10.1107/S1399004714008475 ",2.5,42.04,"3wcw_oligo2","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_I_)-[MAN(5_I_)-[MAN(4_I_)]-MAN(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(58_D_)",104.769,"","",""
"3WEL","SUGAR BEET ALPHA-GLUCOSIDASE WITH ACARVIOSYL-MALTOTRIOSE","10.1074/JBC.M114.606939 ",1.84,25.36,"3wel_oligo2","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_C_)-[FUC(2_C_)]-NAG(1_C_)-ASN(728_A_)",59.6612,"","",""
"3WEL","SUGAR BEET ALPHA-GLUCOSIDASE WITH ACARVIOSYL-MALTOTRIOSE","10.1074/JBC.M114.606939 ",1.84,25.36,"3wel_oligo1","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_B_)-[FUC(2_B_)]-NAG(1_B_)-ASN(404_A_)",32.9036,"","",""
"3WEM","SUGAR BEET ALPHA-GLUCOSIDASE WITH ACARVIOSYL-MALTOTETRAOSE","10.1074/JBC.M114.606939 ",2.59,33.4,"3wem_oligo1","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_B_)-[FUC(2_B_)]-NAG(1_B_)-ASN(404_A_)",44.6888,"","",""
"3WEN","SUGAR BEET ALPHA-GLUCOSIDASE WITH ACARVIOSYL-MALTOPENTAOSE","10.1074/JBC.M114.606939 ",2.59,37.45,"3wen_oligo1","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_B_)-[FUC(2_B_)]-NAG(1_B_)-ASN(404_A_)",42.9809,"","",""
"3WEO","SUGAR BEET ALPHA-GLUCOSIDASE WITH ACARVIOSYL-MALTOHEXAOSE","10.1074/JBC.M114.606939 ",1.45,19.2,"3weo_oligo1","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_B_)-[FUC(2_B_)]-NAG(1_B_)-ASN(404_A_)",31.3882,"","",""
"3WG3","CRYSTAL STRUCTURE OF AGROCYBE CYLINDRACEA GALECTIN WITH BLOOD TYPE A ANTIGEN TETRAOSE","10.1016/J.FEBSLET.2013.08.046 ",1.35,17.28,"3wg3_oligo2","LFucpa1-2[DGalpNAca1-3]DGalpb1-4DGlcpNAcb1-ROH","A2G(4_D_)-[FUC(3_D_)]-GAL(2_D_)-NAG(1_D_)",17.0468,"","",""
"3WG3","CRYSTAL STRUCTURE OF AGROCYBE CYLINDRACEA GALECTIN WITH BLOOD TYPE A ANTIGEN TETRAOSE","10.1016/J.FEBSLET.2013.08.046 ",1.35,17.28,"3wg3_oligo1","LFucpa1-2[DGalpNAca1-3]DGalpb1-4DGlcpNAcb1-ROH","A2G(4_C_)-[FUC(3_C_)]-GAL(2_C_)-NAG(1_C_)",13.5448,"","",""
"3WG4","CRYSTAL STRUCTURE OF AGROCYBE CYLINDRACEA GALECTIN MUTANT (N46A) WITH BLOOD TYPE A ANTIGEN TETRAOSE","10.1016/J.FEBSLET.2013.08.046 ",1.6,22.33,"3wg4_oligo2","LFucpa1-2[DGalpNAca1-3]DGalpb1-4DGlcpNAcb1-ROH","A2G(4_D_)-[FUC(3_D_)]-GAL(2_D_)-NAG(1_D_)",22.8582,"","",""
"3WG4","CRYSTAL STRUCTURE OF AGROCYBE CYLINDRACEA GALECTIN MUTANT (N46A) WITH BLOOD TYPE A ANTIGEN TETRAOSE","10.1016/J.FEBSLET.2013.08.046 ",1.6,22.33,"3wg4_oligo1","LFucpa1-2[DGalpNAca1-3]DGalpb1-4DGlcpNAcb1-ROH","A2G(4_C_)-[FUC(3_C_)]-GAL(2_C_)-NAG(1_C_)",20.0223,"","",""
"3WJJ","CRYSTAL STRUCTURE OF IIB SELECTIVE FC VARIANT, FC(P238D), IN COMPLEX WITH FCGRIIB","10.1093/PROTEIN/GZT022 ",2.6,63.49,"3wjj_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[NAG(8_E_)-MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_B_)",81.7589,"","",""
"3WJJ","CRYSTAL STRUCTURE OF IIB SELECTIVE FC VARIANT, FC(P238D), IN COMPLEX WITH FCGRIIB","10.1093/PROTEIN/GZT022 ",2.6,63.49,"3wjj_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_A_)",80.7042,"","",""
"3WJL","CRYSTAL STRUCTURE OF IIB SELECTIVE FC VARIANT, FC(V12), IN COMPLEX WITH FCGRIIB","10.1093/PROTEIN/GZT022 ",2.86,65.55,"3wjl_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(297_A_)",119.817,"","",""
"3WJL","CRYSTAL STRUCTURE OF IIB SELECTIVE FC VARIANT, FC(V12), IN COMPLEX WITH FCGRIIB","10.1093/PROTEIN/GZT022 ",2.86,65.55,"3wjl_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[NAG(8_E_)-MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_B_)",64.4536,"","",""
"3WJM","CRYSTAL STRUCTURE OF BOMBYX MORI SP2/SP3 HETEROHEXAMER","10.1002/PRO.2457 ",2.8,53.4,"3wjm_oligo6","DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_J_)-MAN(6_J_)-[MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(208_D_)",83.3209,"","",""
"3WJM","CRYSTAL STRUCTURE OF BOMBYX MORI SP2/SP3 HETEROHEXAMER","10.1002/PRO.2457 ",2.8,53.4,"3wjm_oligo7","DManpb1-3DManpb1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_K_)-[BMA(5_K_)-BMA(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(211_E_)",70.4524,"","",""
"3WJM","CRYSTAL STRUCTURE OF BOMBYX MORI SP2/SP3 HETEROHEXAMER","10.1002/PRO.2457 ",2.8,53.4,"3wjm_oligo8","DManpb1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_L_)-MAN(4_L_)-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(211_F_)",81.6827,"","",""
"3WJM","CRYSTAL STRUCTURE OF BOMBYX MORI SP2/SP3 HETEROHEXAMER","10.1002/PRO.2457 ",2.8,53.4,"3wjm_oligo1","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(211_A_)",57.6647,"","",""
"3WJM","CRYSTAL STRUCTURE OF BOMBYX MORI SP2/SP3 HETEROHEXAMER","10.1002/PRO.2457 ",2.8,53.4,"3wjm_oligo5","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-MAN(4_I_)-[MAN(6_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(208_C_)",81.06,"","",""
"3WKN","CRYSTAL STRUCTURE OF THE ARTIFICIAL PROTEIN AFFINGER P17 (AF.P17) COMPLEXED WITH FC FRAGMENT OF HUMAN IGG","10.1016/J.CHEMBIOL.2015.07.015 ",2.9,50.22,"3wkn_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_S_)-[GAL(6_S_)-NAG(5_S_)-MAN(4_S_)-[NAG(8_S_)-MAN(7_S_)]-BMA(3_S_)-NAG(2_S_)]-NAG(1_S_)-ASN(297_A_)",62.0332,"","",""
"3WKN","CRYSTAL STRUCTURE OF THE ARTIFICIAL PROTEIN AFFINGER P17 (AF.P17) COMPLEXED WITH FC FRAGMENT OF HUMAN IGG","10.1016/J.CHEMBIOL.2015.07.015 ",2.9,50.22,"3wkn_oligo7","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_W_)-[GAL(6_W_)-NAG(5_W_)-MAN(4_W_)-[NAG(8_W_)-MAN(7_W_)]-BMA(3_W_)-NAG(2_W_)]-NAG(1_W_)-ASN(297_M_)",69.9621,"","",""
"3WKN","CRYSTAL STRUCTURE OF THE ARTIFICIAL PROTEIN AFFINGER P17 (AF.P17) COMPLEXED WITH FC FRAGMENT OF HUMAN IGG","10.1016/J.CHEMBIOL.2015.07.015 ",2.9,50.22,"3wkn_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_R_)-[GAL(6_R_)-NAG(5_R_)-MAN(4_R_)-[NAG(8_R_)-MAN(7_R_)]-BMA(3_R_)-NAG(2_R_)]-NAG(1_R_)-ASN(297_B_)",83.8199,"","",""
"3WKN","CRYSTAL STRUCTURE OF THE ARTIFICIAL PROTEIN AFFINGER P17 (AF.P17) COMPLEXED WITH FC FRAGMENT OF HUMAN IGG","10.1016/J.CHEMBIOL.2015.07.015 ",2.9,50.22,"3wkn_oligo6","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_V_)-[GAL(6_V_)-NAG(5_V_)-MAN(4_V_)-[NAG(8_V_)-MAN(7_V_)]-BMA(3_V_)-NAG(2_V_)]-NAG(1_V_)-ASN(297_J_)",83.2386,"","",""
"3WKN","CRYSTAL STRUCTURE OF THE ARTIFICIAL PROTEIN AFFINGER P17 (AF.P17) COMPLEXED WITH FC FRAGMENT OF HUMAN IGG","10.1016/J.CHEMBIOL.2015.07.015 ",2.9,50.22,"3wkn_oligo8","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_X_)-[GAL(6_X_)-NAG(5_X_)-MAN(4_X_)-[NAG(8_X_)-MAN(7_X_)]-BMA(3_X_)-NAG(2_X_)]-NAG(1_X_)-ASN(297_N_)",89.819,"","",""
"3WKN","CRYSTAL STRUCTURE OF THE ARTIFICIAL PROTEIN AFFINGER P17 (AF.P17) COMPLEXED WITH FC FRAGMENT OF HUMAN IGG","10.1016/J.CHEMBIOL.2015.07.015 ",2.9,50.22,"3wkn_oligo4","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_Q_)-[GAL(6_Q_)-NAG(5_Q_)-MAN(4_Q_)-[NAG(8_Q_)-MAN(7_Q_)]-BMA(3_Q_)-NAG(2_Q_)]-NAG(1_Q_)-ASN(297_C_)",77.8989,"","",""
"3WKN","CRYSTAL STRUCTURE OF THE ARTIFICIAL PROTEIN AFFINGER P17 (AF.P17) COMPLEXED WITH FC FRAGMENT OF HUMAN IGG","10.1016/J.CHEMBIOL.2015.07.015 ",2.9,50.22,"3wkn_oligo3","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_T_)-[GAL(6_T_)-NAG(5_T_)-MAN(4_T_)-[NAG(8_T_)-MAN(7_T_)]-BMA(3_T_)-NAG(2_T_)]-NAG(1_T_)-ASN(297_D_)",59.0888,"","",""
"3WKN","CRYSTAL STRUCTURE OF THE ARTIFICIAL PROTEIN AFFINGER P17 (AF.P17) COMPLEXED WITH FC FRAGMENT OF HUMAN IGG","10.1016/J.CHEMBIOL.2015.07.015 ",2.9,50.22,"3wkn_oligo5","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_U_)-[GAL(6_U_)-NAG(5_U_)-MAN(4_U_)-[NAG(8_U_)-MAN(7_U_)]-BMA(3_U_)-NAG(2_U_)]-NAG(1_U_)-ASN(297_I_)",66.7113,"","",""
"3WLL","CRYSTAL STRUCTURE OF BARLEY BETA-D-GLUCAN GLUCOHYDROLASE ISOENZYME EXO1 IN COMPLEX WITH PEG400","10.1038/S41467-019-09691-Z ",1.8,30.34,"3wll_oligo2","DGlcpNAcb1-2DManpa1-6[DXylpb1-2]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","NAG(5_C_)-MAN(4_C_)-[XYP(6_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(7_C_)]-NAG(1_C_)-ASN(498_A_)",54.6636,"","",""
"3WLL","CRYSTAL STRUCTURE OF BARLEY BETA-D-GLUCAN GLUCOHYDROLASE ISOENZYME EXO1 IN COMPLEX WITH PEG400","10.1038/S41467-019-09691-Z ",1.8,30.34,"3wll_oligo3","DXylpb1-2DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","XYP(4_D_)-BMA(3_D_)-NAG(2_D_)-[FUC(5_D_)]-NAG(1_D_)-ASN(600_A_)",63.4634,"","",""
"3WLM","CRYSTAL STRUCTURE OF BARLEY BETA-D-GLUCAN GLUCOHYDROLASE ISOENZYME EXO1 IN COMPLEX WITH OCTYL-O-GLUCOSIDE","10.1038/S41467-019-09691-Z ",1.9,25.57,"3wlm_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","BMA(3_C_)-NAG(2_C_)-[FUC(4_C_)]-NAG(1_C_)-ASN(600_A_)",80.5589,"","",""
"3WLN","CRYSTAL STRUCTURE OF BARLEY BETA-D-GLUCAN GLUCOHYDROLASE ISOENZYME EXO1 IN COMPLEX WITH OCTYL-S-GLUCOSIDE","10.1038/S41467-019-09691-Z ",2,32.21,"3wln_oligo3","DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","BMA(3_D_)-NAG(2_D_)-[FUC(4_D_)]-NAG(1_D_)-ASN(600_A_)",69.0989,"","",""
"3WME","CRYSTAL STRUCTURE OF AN INWARD-FACING EUKARYOTIC ABC MULTIDRUG TRANSPORTER","10.1073/PNAS.1321562111 ",2.75,88.32,"3wme_oligo1","DGlcpa1-3DGlcpb6-ROH","DMU(801_A_)-DMU(801_A_)",149.638,"","",""
"3WMF","CRYSTAL STRUCTURE OF AN INWARD-FACING EUKARYOTIC ABC MULTITRUG TRANSPORTER G277V/A278V/A279V MUTANT","10.1073/PNAS.1321562111 ",2.6,86.34,"3wmf_oligo1","DGlcpa1-3DGlcpb6-ROH","DMU(801_A_)-DMU(801_A_)",141.57,"","",""
"3WMG","CRYSTAL STRUCTURE OF AN INWARD-FACING EUKARYOTIC ABC MULTIDRUG TRANSPORTER G277V/A278V/A279V MUTANT IN COMPLEX WITH AN CYCLIC PEPTIDE INHIBITOR, ACAP","10.1073/PNAS.1321562111 ",2.4,60.1,"3wmg_oligo2","DGlcpa1-3DMU6-OME","DMU(804_A_)-DMU(804_A_)",123.885,"","",""
"3WMG","CRYSTAL STRUCTURE OF AN INWARD-FACING EUKARYOTIC ABC MULTIDRUG TRANSPORTER G277V/A278V/A279V MUTANT IN COMPLEX WITH AN CYCLIC PEPTIDE INHIBITOR, ACAP","10.1073/PNAS.1321562111 ",2.4,60.1,"3wmg_oligo3","DGlcpa1-3DGlcpb6-C5O1","DMU(101_B_)-DMU(101_B_)",116.465,"","",""
"3WMG","CRYSTAL STRUCTURE OF AN INWARD-FACING EUKARYOTIC ABC MULTIDRUG TRANSPORTER G277V/A278V/A279V MUTANT IN COMPLEX WITH AN CYCLIC PEPTIDE INHIBITOR, ACAP","10.1073/PNAS.1321562111 ",2.4,60.1,"3wmg_oligo1","DGlcpa1-3DGlcpb6-C3O1","DMU(801_A_)-DMU(801_A_)",110.365,"","",""
"3WN5","CRYSTAL STRUCTURE OF ASYMMETRICALLY ENGINEERED FC VARIANT IN COMPLEX WITH FCGRIIIA","10.1016/J.MOLIMM.2013.11.017 ",2.78,54.66,"3wn5_oligo5","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(8_K_)-[NAG(7_K_)-MAN(6_K_)-[NAG(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(297_D_)",57.258,"","",""
"3WN5","CRYSTAL STRUCTURE OF ASYMMETRICALLY ENGINEERED FC VARIANT IN COMPLEX WITH FCGRIIIA","10.1016/J.MOLIMM.2013.11.017 ",2.78,54.66,"3wn5_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_G_)-[GAL(6_G_)-NAG(5_G_)-MAN(4_G_)-[NAG(8_G_)-MAN(7_G_)]-BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(297_A_)",54.1912,"","",""
"3WN5","CRYSTAL STRUCTURE OF ASYMMETRICALLY ENGINEERED FC VARIANT IN COMPLEX WITH FCGRIIIA","10.1016/J.MOLIMM.2013.11.017 ",2.78,54.66,"3wn5_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(159_C_)",70.6342,"","",""
"3WN5","CRYSTAL STRUCTURE OF ASYMMETRICALLY ENGINEERED FC VARIANT IN COMPLEX WITH FCGRIIIA","10.1016/J.MOLIMM.2013.11.017 ",2.78,54.66,"3wn5_oligo6","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_L_)-[GAL(6_L_)-NAG(5_L_)-MAN(4_L_)-[NAG(8_L_)-MAN(7_L_)]-BMA(3_L_)-NAG(2_L_)]-NAG(1_L_)-ASN(297_E_)",70.6244,"","",""
"3WN5","CRYSTAL STRUCTURE OF ASYMMETRICALLY ENGINEERED FC VARIANT IN COMPLEX WITH FCGRIIIA","10.1016/J.MOLIMM.2013.11.017 ",2.78,54.66,"3wn5_oligo3","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_H_)-[GAL(6_H_)-NAG(5_H_)-MAN(4_H_)-[NAG(8_H_)-MAN(7_H_)]-BMA(3_H_)-NAG(2_H_)]-NAG(1_H_)-ASN(297_B_)",67.0639,"","",""
"3WO3","CRYSTAL STRUCTURE OF IL-18 IN COMPLEX WITH IL-18 RECEPTOR ALPHA","10.1038/NCOMMS6340 ",3.1,81.11,"3wo3_oligo6","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_W_)-MAN(4_W_)-[MAN(6_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(197_F_)",134.905,"","",""
"3WO3","CRYSTAL STRUCTURE OF IL-18 IN COMPLEX WITH IL-18 RECEPTOR ALPHA","10.1038/NCOMMS6340 ",3.1,81.11,"3wo3_oligo9","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-MAN(4_N_)-[MAN(6_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(197_B_)",136.092,"","",""
"3WO3","CRYSTAL STRUCTURE OF IL-18 IN COMPLEX WITH IL-18 RECEPTOR ALPHA","10.1038/NCOMMS6340 ",3.1,81.11,"3wo3_oligo13","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(197_D_)",117.753,"","",""
"3WO3","CRYSTAL STRUCTURE OF IL-18 IN COMPLEX WITH IL-18 RECEPTOR ALPHA","10.1038/NCOMMS6340 ",3.1,81.11,"3wo3_oligo15","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_a_)-[MAN(4_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(197_H_)",141.877,"","",""
"3WO4","CRYSTAL STRUCTURE OF THE IL-18 SIGNALING TERNARY COMPLEX","10.1038/NCOMMS6340 ",3.1,77.81,"3wo4_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(197_B_)",156.914,"","",""
"3WO4","CRYSTAL STRUCTURE OF THE IL-18 SIGNALING TERNARY COMPLEX","10.1038/NCOMMS6340 ",3.1,77.81,"3wo4_oligo6","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(152_C_)",175.348,"","",""
"3WSR","CRYSTAL STRUCTURE OF CLEC-2 IN COMPLEX WITH O-GLYCOSYLATED PODOPLANIN","10.1016/J.STR.2014.09.009 ",1.91,28.01,"3wsr_oligo1","DGalpb1-3[DNeup5Aca2-6]DGalpNAca1-THR","SIA(3_F_)-[GAL(2_F_)]-A2G(1_F_)-THR(52_D_)",27.3954,"","",""
"3WSR","CRYSTAL STRUCTURE OF CLEC-2 IN COMPLEX WITH O-GLYCOSYLATED PODOPLANIN","10.1016/J.STR.2014.09.009 ",1.91,28.01,"3wsr_oligo2","DGalpb1-3[DNeup5Aca2-6]DGalpNAca1-THR","SIA(3_E_)-[GAL(2_E_)]-A2G(1_E_)-THR(52_C_)",30.9119,"","",""
"3X1B","CRYSTAL STRUCTURE OF LACCASE FROM LENTINUS SP. AT 1.8 A RESOLUTION","",1.8,29.62,"3x1b_oligo1","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)]-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(75_A_)",30.1538,"","",""
"3X1B","CRYSTAL STRUCTURE OF LACCASE FROM LENTINUS SP. AT 1.8 A RESOLUTION","",1.8,29.62,"3x1b_oligo3","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-MAN(4_E_)-[MAN(6_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(75_B_)",53.1377,"","",""
"3X1B","CRYSTAL STRUCTURE OF LACCASE FROM LENTINUS SP. AT 1.8 A RESOLUTION","",1.8,29.62,"3x1b_oligo2","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-[MAN(5_D_)]-MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(458_A_)",48.6839,"","",""
"3X1B","CRYSTAL STRUCTURE OF LACCASE FROM LENTINUS SP. AT 1.8 A RESOLUTION","",1.8,29.62,"3x1b_oligo4","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)]-MAN(4_F_)-[MAN(7_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(458_B_)",66.8857,"","",""
"3X2Q","X-RAY STRUCTURE OF CYANIDE-BOUND BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE AT 2.0 ANGSTROM RESOLUTION","10.1107/S2053230X15007025 ",2,45.03,"3x2q_oligo3","DGlcpa1-3DGlcpb6-C10O1","DMU(101_G_)-DMU(101_G_)",149.364,"","",""
"3X2Q","X-RAY STRUCTURE OF CYANIDE-BOUND BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE AT 2.0 ANGSTROM RESOLUTION","10.1107/S2053230X15007025 ",2,45.03,"3x2q_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(101_M_)-DMU(101_M_)",57.6059,"","",""
"3X2Q","X-RAY STRUCTURE OF CYANIDE-BOUND BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE AT 2.0 ANGSTROM RESOLUTION","10.1107/S2053230X15007025 ",2,45.03,"3x2q_oligo4","DGlcpa1-3DGlcpb6-C10O1","DMU(101_Z_)-DMU(101_Z_)",78.9682,"","",""
"3X2Q","X-RAY STRUCTURE OF CYANIDE-BOUND BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE AT 2.0 ANGSTROM RESOLUTION","10.1107/S2053230X15007025 ",2,45.03,"3x2q_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(301_P_)-DMU(301_P_)",167.477,"","",""
"3ZDX","INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX","10.1083/JCB.201212037 ",2.45,59.8,"3zdx_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(320_D_)",93.5834,"","",""
"3ZDX","INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX","10.1083/JCB.201212037 ",2.45,59.8,"3zdx_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(320_B_)",87.558,"","",""
"3ZDY","INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX","10.1083/JCB.201212037 ",2.45,77.3,"3zdy_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(320_B_)",100.819,"","",""
"3ZDY","INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX","10.1083/JCB.201212037 ",2.45,77.3,"3zdy_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_M_)-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(320_D_)",110.215,"","",""
"3ZDZ","INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX","10.1083/JCB.201212037 ",2.75,91.9,"3zdz_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_M_)-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(320_D_)",131.909,"","",""
"3ZDZ","INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX","10.1083/JCB.201212037 ",2.75,91.9,"3zdz_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(320_B_)",94.4518,"","",""
"3ZE0","INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX","10.1083/JCB.201212037 ",2.95,103.2,"3ze0_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_M_)-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(320_D_)",137.09,"","",""
"3ZE0","INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX","10.1083/JCB.201212037 ",2.95,103.2,"3ze0_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(320_B_)",99.2748,"","",""
"3ZE1","INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX","10.1083/JCB.201212037 ",3,115.3,"3ze1_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(320_B_)",118.962,"","",""
"3ZE1","INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX","10.1083/JCB.201212037 ",3,115.3,"3ze1_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_M_)-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(320_D_)",159.676,"","",""
"3ZE2","INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX","10.1083/JCB.201212037 ",2.35,66.4,"3ze2_oligo1","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-MAN(4_G_)-[MAN(6_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(320_B_)",61.6473,"","",""
"3ZE2","INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX","10.1083/JCB.201212037 ",2.35,66.4,"3ze2_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_M_)-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(320_D_)",86.8741,"","",""
"3ZK1","CRYSTAL STRUCTURE OF THE SODIUM BINDING ROTOR RING AT PH 5.3","10.1371/JOURNAL.PBIO.1001596 ",2.2,0,"3zk1_oligo25","DGlcpb1-3DGlcpa1-","DMU(92_V_)-DMU(92_V_)",146.691,"","",""
"3ZK1","CRYSTAL STRUCTURE OF THE SODIUM BINDING ROTOR RING AT PH 5.3","10.1371/JOURNAL.PBIO.1001596 ",2.2,0,"3zk1_oligo21","DGlcpb1-3DGlcpa1-","DMU(92_J_)-DMU(92_J_)",134.05,"","",""
"3ZK1","CRYSTAL STRUCTURE OF THE SODIUM BINDING ROTOR RING AT PH 5.3","10.1371/JOURNAL.PBIO.1001596 ",2.2,0,"3zk1_oligo20","DGlcpb1-3DGlcpa1-","DMU(92_H_)-DMU(92_H_)",118.318,"","",""
"3ZK1","CRYSTAL STRUCTURE OF THE SODIUM BINDING ROTOR RING AT PH 5.3","10.1371/JOURNAL.PBIO.1001596 ",2.2,0,"3zk1_oligo18","DGlcpb1-3DGlcpa1-","DMU(92_C_)-DMU(92_C_)",103.163,"","",""
"3ZK1","CRYSTAL STRUCTURE OF THE SODIUM BINDING ROTOR RING AT PH 5.3","10.1371/JOURNAL.PBIO.1001596 ",2.2,0,"3zk1_oligo23","DGlcpb1-3DGlcpa1-","DMU(92_P_)-DMU(92_P_)",141.888,"","",""
"3ZK1","CRYSTAL STRUCTURE OF THE SODIUM BINDING ROTOR RING AT PH 5.3","10.1371/JOURNAL.PBIO.1001596 ",2.2,0,"3zk1_oligo17","DGlcpb1-3DGlcpa1-","DMU(92_A_)-DMU(92_A_)",130.673,"","",""
"3ZK1","CRYSTAL STRUCTURE OF THE SODIUM BINDING ROTOR RING AT PH 5.3","10.1371/JOURNAL.PBIO.1001596 ",2.2,0,"3zk1_oligo22","DGlcpb1-3DGlcpa1-","DMU(92_N_)-DMU(92_N_)",108.208,"","",""
"3ZK1","CRYSTAL STRUCTURE OF THE SODIUM BINDING ROTOR RING AT PH 5.3","10.1371/JOURNAL.PBIO.1001596 ",2.2,0,"3zk1_oligo19","DGlcpb1-3DGlcpa1-","DMU(92_G_)-DMU(92_G_)",120.056,"","",""
"3ZK2","CRYSTAL STRUCTURE OF THE SODIUM BINDING ROTOR RING AT PH 8.7","10.1371/JOURNAL.PBIO.1001596 ",2.63,0,"3zk2_oligo7","DGlcpa1-3DGlcpb6-C10O1","DMU(92_O_)-DMU(92_O_)",123.262,"","",""
"3ZK2","CRYSTAL STRUCTURE OF THE SODIUM BINDING ROTOR RING AT PH 8.7","10.1371/JOURNAL.PBIO.1001596 ",2.63,0,"3zk2_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(93_A_)-DMU(93_A_)",83.2641,"","",""
"3ZK4","STRUCTURE OF PURPLE ACID PHOSPHATASE PPD1 ISOLATED FROM YELLOW LUPIN (LUPINUS LUTEUS) SEEDS","10.1107/S205225251400400X ",1.65,21.92,"3zk4_oligo6","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_I_)-[FUC(2_I_)]-NAG(1_I_)-ASN(242_B_)",67.2882,"","",""
"3ZK4","STRUCTURE OF PURPLE ACID PHOSPHATASE PPD1 ISOLATED FROM YELLOW LUPIN (LUPINUS LUTEUS) SEEDS","10.1107/S205225251400400X ",1.65,21.92,"3zk4_oligo8","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_K_)-[FUC(2_K_)]-NAG(1_K_)-ASN(526_C_)",73.7582,"","",""
"3ZNL","H5 HAEMAGGLUTININ IN COMPLEX WITH 6-O-SULFO-SIALYL-LEWIS X (SULFATED LEWIS X)","10.1016/J.VIRUSRES.2013.08.007 ",2.5,45.06,"3znl_oligo4","DNeup5Aca2-3DGalpa1-4[LFucpa1-3]DGlcpNAc[6S]b1-ROH","SIA(3_G_)-GLA(2_G_)-[FUC(4_G_)-",60.7289,"","",""
"3ZNL","H5 HAEMAGGLUTININ IN COMPLEX WITH 6-O-SULFO-SIALYL-LEWIS X (SULFATED LEWIS X)","10.1016/J.VIRUSRES.2013.08.007 ",2.5,45.06,"3znl_oligo6","DNeup5Aca2-3DGalpa1-4[LFucpa1-3]DGlcpNAc[6S]b1-ROH","SIA(3_I_)-GLA(2_I_)-[FUC(4_I_)-",58.7903,"","",""
"3ZNL","H5 HAEMAGGLUTININ IN COMPLEX WITH 6-O-SULFO-SIALYL-LEWIS X (SULFATED LEWIS X)","10.1016/J.VIRUSRES.2013.08.007 ",2.5,45.06,"3znl_oligo5","DNeup5Aca2-3DGalpa1-4[LFucpa1-3]DGlcpNAc[6S]b1-ROH","SIA(3_H_)-GLA(2_H_)-[FUC(4_H_)-",59.7058,"","",""
"3ZNM","H5 HAEMAGGLUTININ IN COMPLEX WITH SIALYL-LEWIS X","10.1016/J.VIRUSRES.2013.08.007 ",2.4,47.1,"3znm_oligo6","DNeup5Aca2-3DGalpa1-4[LFucpa1-3]DGlcpNAcb1-ROH","SIA(3_I_)-GLA(2_I_)-[FUC(4_I_)]-NAG(1_I_)",67.6704,"","",""
"3ZNM","H5 HAEMAGGLUTININ IN COMPLEX WITH SIALYL-LEWIS X","10.1016/J.VIRUSRES.2013.08.007 ",2.4,47.1,"3znm_oligo4","DNeup5Aca2-3DGalpa1-4[LFucpa1-3]DGlcpNAcb1-ROH","SIA(3_G_)-GLA(2_G_)-[FUC(4_G_)]-NAG(1_G_)",65.9693,"","",""
"3ZNM","H5 HAEMAGGLUTININ IN COMPLEX WITH SIALYL-LEWIS X","10.1016/J.VIRUSRES.2013.08.007 ",2.4,47.1,"3znm_oligo5","DNeup5Aca2-3DGalpa1-4[LFucpa1-3]DGlcpNAcb1-ROH","SIA(3_H_)-GLA(2_H_)-[FUC(4_H_)]-NAG(1_H_)",65.6944,"","",""
"3ZQZ","CRYSTAL STRUCTURE OF ANCE IN COMPLEX WITH A SELENIUM ANALOGUE OF CAPTOPRIL","10.1111/J.1742-4658.2011.08276.X ",2.35,57,"3zqz_oligo1","DManpb1-6DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[BMA(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(196_A_)",90.8656,"","",""
"3ZS0","HUMAN MYELOPEROXIDASE INACTIVATED BY TX2","10.1074/JBC.M111.266981 ",2.3,20.63,"3zs0_oligo1","DManpb1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_E_)-[MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(317_C_)",30.3838,"","",""
"3ZVX","STRUCTURE OF THE LECTIN FROM PLATYPODIUM ELEGANS IN COMPLEX WITH A TRIMANNOSIDE","10.1074/JBC.M112.375816 ",2.1,24.05,"3zvx_oligo1","DManpa1-3[DManpa1-6]DManpa1-ROH","MAN(3_C_)-[MAN(2_C_)]-MAN(1_C_)",22.723,"","",""
"3ZW1","STRUCTURE OF BAMBL LECTINE IN COMPLEX WITH LEWIX X ANTIGEN","10.1371/JOURNAL.PONE.0071149 ",1.6,12.28,"3zw1_oligo1","LFucpa1-3[DGalpb1-4]DGlcpNAcb1-3DGalpb1-ROH","GAL(4_D_)-[FUC(3_D_)]-NAG(2_D_)-GAL(1_D_)",17.9632,"","",""
"3ZW1","STRUCTURE OF BAMBL LECTINE IN COMPLEX WITH LEWIX X ANTIGEN","10.1371/JOURNAL.PONE.0071149 ",1.6,12.28,"3zw1_oligo4","LFucpa1-3DGlcpNAcb1-ROH","FUC(2_F_)-NAG(1_F_)",20.3973,"","",""
"3ZW1","STRUCTURE OF BAMBL LECTINE IN COMPLEX WITH LEWIX X ANTIGEN","10.1371/JOURNAL.PONE.0071149 ",1.6,12.28,"3zw1_oligo3","LFucpa1-3[DGalpb1-4]DGlcpNAcb1-3DGalpb1-ROH","GAL(4_E_)-[FUC(3_E_)]-NAG(2_E_)-GAL(1_E_)",17.1407,"","",""
"3ZW1","STRUCTURE OF BAMBL LECTINE IN COMPLEX WITH LEWIX X ANTIGEN","10.1371/JOURNAL.PONE.0071149 ",1.6,12.28,"3zw1_oligo2","LFucpa1-3DGlcpNAcb1-ROH","FUC(2_C_)-NAG(1_C_)",23.0577,"","",""
"3ZW2","STRUCTURE OF THE LECTIN BAMBL FROM BURKHOLDERIA AMBIFARIA IN COMPLEX WITH BLOOD GROUP H TYPE 1 TETRASACCHARIDE","10.1074/JBC.M111.314831 ",1.6,14.24,"3zw2_oligo3","LFucpa1-2DGalpb1-3DGlcpNAcb1-ROH","FUC(3_G_)-GAL(2_G_)-NAG(1_G_)",25.7276,"","",""
"3ZW2","STRUCTURE OF THE LECTIN BAMBL FROM BURKHOLDERIA AMBIFARIA IN COMPLEX WITH BLOOD GROUP H TYPE 1 TETRASACCHARIDE","10.1074/JBC.M111.314831 ",1.6,14.24,"3zw2_oligo4","LFucpa1-2DGalpb1-3DGlcpNAcb1-ROH","FUC(3_D_)-GAL(2_D_)-NAG(1_D_)",18.28,"","",""
"3ZW2","STRUCTURE OF THE LECTIN BAMBL FROM BURKHOLDERIA AMBIFARIA IN COMPLEX WITH BLOOD GROUP H TYPE 1 TETRASACCHARIDE","10.1074/JBC.M111.314831 ",1.6,14.24,"3zw2_oligo2","LFucpa1-2DGalpb1-3DGlcpNAcb1-ROH","FUC(3_F_)-GAL(2_F_)-NAG(1_F_)",25.5303,"","",""
"3ZW2","STRUCTURE OF THE LECTIN BAMBL FROM BURKHOLDERIA AMBIFARIA IN COMPLEX WITH BLOOD GROUP H TYPE 1 TETRASACCHARIDE","10.1074/JBC.M111.314831 ",1.6,14.24,"3zw2_oligo6","LFucpa1-2DGalpb1-3DGlcpNAcb1-ROH","FUC(3_I_)-GAL(2_I_)-NAG(1_I_)",21.1809,"","",""
"3ZW2","STRUCTURE OF THE LECTIN BAMBL FROM BURKHOLDERIA AMBIFARIA IN COMPLEX WITH BLOOD GROUP H TYPE 1 TETRASACCHARIDE","10.1074/JBC.M111.314831 ",1.6,14.24,"3zw2_oligo5","LFucpa1-2DGalpb1-3DGlcpNAcb1-3DGalpa1-ROH","FUC(4_H_)-GAL(3_H_)-NAG(2_H_)-GLA(1_H_)",17.2125,"","",""
"3ZWE","STRUCTURE OF BAMBL, A LECTIN FROM BURKHOLDERIA AMBIFARIA, COMPLEXED WITH BLOOD GROUP B EPITOPE","10.1074/JBC.M111.314831 ",1.75,25.22,"3zwe_oligo3","LFucpa1-2[DGalpa1-3]DGalpb1-4DGlcpb1-ROH","GLA(4_E_)-[FUC(3_E_)]-GAL(2_E_)-BGC(1_E_)",31.8461,"","",""
"3ZWE","STRUCTURE OF BAMBL, A LECTIN FROM BURKHOLDERIA AMBIFARIA, COMPLEXED WITH BLOOD GROUP B EPITOPE","10.1074/JBC.M111.314831 ",1.75,25.22,"3zwe_oligo1","LFucpa1-2[DGalpa1-3]DGalpb1-4DGlcpb1-ROH","GLA(4_F_)-[FUC(3_F_)]-GAL(2_F_)-BGC(1_F_)",20.8989,"","",""
"3ZYR","STRUCTURE OF THE LECTIN FROM PLATYPODIUM ELEGANS IN COMPLEX WITH HEPTASACCHARIDE","10.1074/JBC.M112.375816 ",1.65,11.04,"3zyr_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)",15.7529,"","",""
"3ZYR","STRUCTURE OF THE LECTIN FROM PLATYPODIUM ELEGANS IN COMPLEX WITH HEPTASACCHARIDE","10.1074/JBC.M112.375816 ",1.65,11.04,"3zyr_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(299_A_)",13.1886,"","",""
"4A01","CRYSTAL STRUCTURE OF THE H-TRANSLOCATING PYROPHOSPHATASE","10.1038/NATURE10963 ",2.35,42.995,"4a01_oligo2","LGalpa1-3DGalpb6-C10O1","DMU(1775_A_)-DMU(1775_A_)",103.066,"","",""
"4A45","CPGH89CBM32-5, FROM CLOSTRIDIUM PERFRINGENS, IN COMPLEX WITH GALNAC- BETA-1,3-GALACTOSE","10.1371/JOURNAL.PONE.0033524 ",1.75,26.39,"4a45_oligo1","DGalpNAcb1-3DGalpb1-ROH","NGA(2_B_)-GAL(1_B_)",58.805,"","",""
"4A5G","RAPHANUS SATIVUS ANIONIC PEROXIDASE.","",2.05,29.53,"4a5g_oligo7","DXylpb1-2[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(5_C_)-[XYP(4_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(6_C_)]-NAG(1_C_)-ASN(5_A_)",37.563,"","",""
"4A5G","RAPHANUS SATIVUS ANIONIC PEROXIDASE.","",2.05,29.53,"4a5g_oligo10","DManpa1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAca1-ASN","MAN(3_L_)-NAG(2_L_)-[FUC(4_L_)]-NAG(1_L_)-ASN(15_B_)",61.2225,"","",""
"4A5G","RAPHANUS SATIVUS ANIONIC PEROXIDASE.","",2.05,29.53,"4a5g_oligo3","DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","BMA(3_D_)-NAG(2_D_)-[FUC(4_D_)]-NAG(1_D_)-ASN(137_A_)",52.3227,"","",""
"4A5G","RAPHANUS SATIVUS ANIONIC PEROXIDASE.","",2.05,29.53,"4a5g_oligo1","DManpa1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(3_F_)-NAG(2_F_)-[FUC(4_F_)]-NAG(1_F_)-ASN(269_A_)",39.762,"","",""
"4A5G","RAPHANUS SATIVUS ANIONIC PEROXIDASE.","",2.05,29.53,"4a5g_oligo9","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_K_)-[FUC(2_K_)]-NAG(1_K_)-ASN(269_B_)",66.9873,"","",""
"4A5G","RAPHANUS SATIVUS ANIONIC PEROXIDASE.","",2.05,29.53,"4a5g_oligo5","DXylpb1-2DManp[3<R1>]b1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","XYP(4_I_)-BMA(3_I_)-NAG(2_I_)-[FUC(6_I_)]-NAG(1_I_)",47.7823,"","",""
"4A5G","RAPHANUS SATIVUS ANIONIC PEROXIDASE.","",2.05,29.53,"4a5g_oligo2","DXylpb1-2[DManpb1-3]DManpb1-4DGlcpNAca1-4[LFucpb1-3]DGlcpNAcb1-ASN","BMA(5_G_)-[XYP(4_G_)]-BMA(3_G_)-NAG(2_G_)-[FUL(6_G_)]-NAG(1_G_)-ASN(187_A_)",60.9746,"","",""
"4A5S","CRYSTAL STRUCTURE OF HUMAN DPP4 IN COMPLEX WITH A NOVAL HETEROCYCLIC DPP4 INHIBITOR","10.1016/J.BMCL.2011.11.054 ",1.62,25.12,"4a5s_oligo3","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-MAN(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(85_A_)",29.2645,"","",""
"4A5T","STRUCTURAL BASIS FOR THE CONFORMATIONAL MODULATION","10.1111/J.1538-7836.2012.04765.X ",3.49,98.58,"4a5t_oligo1","DNeup5Aca2-3DGalpb1-3DGalpNAcb1-THR","SIA(3_A_)-GAL(2_A_)-NGA(1_A_)-THR(346_S_)",108.848,"","",""
"4AA1","CRYSTAL STRUCTURE OF ANCE IN COMPLEX WITH ANGIOTENSIN-II","10.1111/FEBS.12038 ",1.99,35.55,"4aa1_oligo1","DManpb1-6DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[BMA(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(196_A_)",53.5591,"","",""
"4AA2","CRYSTAL STRUCTURE OF ANCE IN COMPLEX WITH BRADYKININ POTENTIATING PEPTIDE B","10.1111/FEBS.12038 ",1.99,37.56,"4aa2_oligo1","DManpb1-6DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[BMA(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(196_A_)",57.2048,"","",""
"4ADF","CRYSTAL STRUCTURE OF THE HUMAN COLONY-STIMULATING FACTOR 1 (HCSF-1) CYTOKINE IN COMPLEX WITH THE VIRAL RECEPTOR BARF1","10.1038/NSMB.2367 ",4.4,216.8,"4adf_oligo8","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_f_)-MAN(4_f_)-[MAN(6_f_)]-BMA(3_f_)-NAG(2_f_)-NAG(1_f_)-ASN(95_N_)",223.533,"","",""
"4ADF","CRYSTAL STRUCTURE OF THE HUMAN COLONY-STIMULATING FACTOR 1 (HCSF-1) CYTOKINE IN COMPLEX WITH THE VIRAL RECEPTOR BARF1","10.1038/NSMB.2367 ",4.4,216.8,"4adf_oligo1","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Y_)-MAN(4_Y_)-[MAN(6_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(95_A_)",241.915,"","",""
"4ADF","CRYSTAL STRUCTURE OF THE HUMAN COLONY-STIMULATING FACTOR 1 (HCSF-1) CYTOKINE IN COMPLEX WITH THE VIRAL RECEPTOR BARF1","10.1038/NSMB.2367 ",4.4,216.8,"4adf_oligo7","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_e_)-MAN(4_e_)-[MAN(6_e_)]-BMA(3_e_)-NAG(2_e_)-NAG(1_e_)-ASN(95_M_)",239.43,"","",""
"4ADF","CRYSTAL STRUCTURE OF THE HUMAN COLONY-STIMULATING FACTOR 1 (HCSF-1) CYTOKINE IN COMPLEX WITH THE VIRAL RECEPTOR BARF1","10.1038/NSMB.2367 ",4.4,216.8,"4adf_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_b_)-[MAN(4_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(95_D_)",241.949,"","",""
"4ADF","CRYSTAL STRUCTURE OF THE HUMAN COLONY-STIMULATING FACTOR 1 (HCSF-1) CYTOKINE IN COMPLEX WITH THE VIRAL RECEPTOR BARF1","10.1038/NSMB.2367 ",4.4,216.8,"4adf_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_d_)-[MAN(4_d_)]-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(95_F_)",254.849,"","",""
"4ADF","CRYSTAL STRUCTURE OF THE HUMAN COLONY-STIMULATING FACTOR 1 (HCSF-1) CYTOKINE IN COMPLEX WITH THE VIRAL RECEPTOR BARF1","10.1038/NSMB.2367 ",4.4,216.8,"4adf_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Z_)-[MAN(5_Z_)]-MAN(4_Z_)-[MAN(7_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(95_B_)",243.121,"","",""
"4ADF","CRYSTAL STRUCTURE OF THE HUMAN COLONY-STIMULATING FACTOR 1 (HCSF-1) CYTOKINE IN COMPLEX WITH THE VIRAL RECEPTOR BARF1","10.1038/NSMB.2367 ",4.4,216.8,"4adf_oligo12","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_j_)-[MAN(5_j_)]-MAN(4_j_)-[MAN(7_j_)]-BMA(3_j_)-NAG(2_j_)-NAG(1_j_)-ASN(95_R_)",252.145,"","",""
"4ADF","CRYSTAL STRUCTURE OF THE HUMAN COLONY-STIMULATING FACTOR 1 (HCSF-1) CYTOKINE IN COMPLEX WITH THE VIRAL RECEPTOR BARF1","10.1038/NSMB.2367 ",4.4,216.8,"4adf_oligo10","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_h_)-MAN(4_h_)-[MAN(6_h_)]-BMA(3_h_)-NAG(2_h_)-NAG(1_h_)-ASN(95_P_)",251.851,"","",""
"4ADF","CRYSTAL STRUCTURE OF THE HUMAN COLONY-STIMULATING FACTOR 1 (HCSF-1) CYTOKINE IN COMPLEX WITH THE VIRAL RECEPTOR BARF1","10.1038/NSMB.2367 ",4.4,216.8,"4adf_oligo3","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_a_)-[MAN(5_a_)]-MAN(4_a_)-[MAN(7_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(95_C_)",283.17,"","",""
"4ADF","CRYSTAL STRUCTURE OF THE HUMAN COLONY-STIMULATING FACTOR 1 (HCSF-1) CYTOKINE IN COMPLEX WITH THE VIRAL RECEPTOR BARF1","10.1038/NSMB.2367 ",4.4,216.8,"4adf_oligo11","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_i_)-[MAN(5_i_)]-MAN(4_i_)-[MAN(7_i_)]-BMA(3_i_)-NAG(2_i_)-NAG(1_i_)-ASN(95_Q_)",252.18,"","",""
"4ADF","CRYSTAL STRUCTURE OF THE HUMAN COLONY-STIMULATING FACTOR 1 (HCSF-1) CYTOKINE IN COMPLEX WITH THE VIRAL RECEPTOR BARF1","10.1038/NSMB.2367 ",4.4,216.8,"4adf_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_c_)-[MAN(4_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(95_E_)",268.379,"","",""
"4ADF","CRYSTAL STRUCTURE OF THE HUMAN COLONY-STIMULATING FACTOR 1 (HCSF-1) CYTOKINE IN COMPLEX WITH THE VIRAL RECEPTOR BARF1","10.1038/NSMB.2367 ",4.4,216.8,"4adf_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_g_)-[MAN(4_g_)]-BMA(3_g_)-NAG(2_g_)-NAG(1_g_)-ASN(95_O_)",218.91,"","",""
"4ADQ","CRYSTAL STRUCTURE OF THE MOUSE COLONY-STIMULATING FACTOR 1 (MCSF-1) CYTOKINE IN COMPLEX WITH THE VIRAL RECEPTOR BARF1","10.1038/NSMB.2367 ",4.5,187.4,"4adq_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(95_B_)",187.419,"","",""
"4AF9","CRYSTAL STRUCTURE OF EPITHELIAL ADHESIN 1 A DOMAIN (EPA1A) FROM CANDIDA GLABRATA IN COMPLEX WITH GALB1-3GLC","10.1073/PNAS.1207653109 ",1.5,18.01,"4af9_oligo1","DGalpb1-3DGlcpb1-ROH","GAL(2_B_)-BGC(1_B_)",20.0541,"","",""
"4AFA","CRYSTAL STRUCTURE OF SUBTYPE-SWITCHED EPITHELIAL ADHESIN 1 TO 2 A DOMAIN (EPA1TO2A) FROM CANDIDA GLABRATA IN COMPLEX WITH GLYCEROL","10.1073/PNAS.1207653109 ",2.05,17.25,"4afa_oligo1","DGalpb1-3DGlcpa1-ROH","GAL(2_B_)-GLC(1_B_)",30.7641,"","",""
"4AFC","CRYSTAL STRUCTURE OF SUBTYPE-SWITCHED EPITHELIAL ADHESIN 1 TO 6 A DOMAIN (EPA1TO6A) FROM CANDIDA GLABRATA IN COMPLEX WITH GALB1-3GLC","10.1073/PNAS.1207653109 ",1.55,20.64,"4afc_oligo1","DGalpb1-3DGlcpa1-ROH","GAL(2_B_)-GLC(1_B_)",23.305,"","",""
"4AFG","CAPITELLA TELETA ACHBP IN COMPLEX WITH VARENICLINE","10.1073/PNAS.1116397109 ",2,0,"4afg_oligo4","DManpb1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(122_D_)",85.0516,"","",""
"4AFG","CAPITELLA TELETA ACHBP IN COMPLEX WITH VARENICLINE","10.1073/PNAS.1116397109 ",2,0,"4afg_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(122_B_)",93.5711,"","",""
"4AFH","CAPITELLA TELETA ACHBP IN COMPLEX WITH LOBELINE","10.1073/PNAS.1116397109 ",1.88,0,"4afh_oligo7","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(122_B_)",98.1734,"","",""
"4AFH","CAPITELLA TELETA ACHBP IN COMPLEX WITH LOBELINE","10.1073/PNAS.1116397109 ",1.88,0,"4afh_oligo8","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_H_)-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(122_C_)",71.4146,"","",""
"4AFH","CAPITELLA TELETA ACHBP IN COMPLEX WITH LOBELINE","10.1073/PNAS.1116397109 ",1.88,0,"4afh_oligo9","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(122_D_)",81.5482,"","",""
"4AFH","CAPITELLA TELETA ACHBP IN COMPLEX WITH LOBELINE","10.1073/PNAS.1116397109 ",1.88,0,"4afh_oligo10","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(122_E_)",84.2836,"","",""
"4AH4","CRYSTAL STRUCTURE OF FUCOSE BINDING LECTIN FROM ASPERGILLUS FUMIGATUS (AFL) IN COMPLEX WITH BGA OLIGOSACCHARIDE.","10.1107/S1399004714026595 ",1.75,16.01,"4ah4_oligo3","LFucpa1-2[DGalpNAca1-3]DGalpb1-ROH","A2G(3_C_)-[FUC(2_C_)]-GAL(1_C_)",29.0018,"","",""
"4AH4","CRYSTAL STRUCTURE OF FUCOSE BINDING LECTIN FROM ASPERGILLUS FUMIGATUS (AFL) IN COMPLEX WITH BGA OLIGOSACCHARIDE.","10.1107/S1399004714026595 ",1.75,16.01,"4ah4_oligo9","LFucpa1-2[DGalpNAca1-3]DGalpa1-ROH","A2G(3_K_)-[FUC(2_K_)]-GAL(1_K_)",40.0379,"","",""
"4AH4","CRYSTAL STRUCTURE OF FUCOSE BINDING LECTIN FROM ASPERGILLUS FUMIGATUS (AFL) IN COMPLEX WITH BGA OLIGOSACCHARIDE.","10.1107/S1399004714026595 ",1.75,16.01,"4ah4_oligo4","LFucpa1-2[DGalpNAca1-3]DGalpa1-ROH","A2G(3_F_)-[FUC(2_F_)]-GAL(1_F_)",37.8812,"","",""
"4AH4","CRYSTAL STRUCTURE OF FUCOSE BINDING LECTIN FROM ASPERGILLUS FUMIGATUS (AFL) IN COMPLEX WITH BGA OLIGOSACCHARIDE.","10.1107/S1399004714026595 ",1.75,16.01,"4ah4_oligo2","LFucpa1-2[DGalpNAca1-3]DGalpa1-ROH","A2G(3_E_)-[FUC(2_E_)]-GAL(1_E_)",36.2118,"","",""
"4AH4","CRYSTAL STRUCTURE OF FUCOSE BINDING LECTIN FROM ASPERGILLUS FUMIGATUS (AFL) IN COMPLEX WITH BGA OLIGOSACCHARIDE.","10.1107/S1399004714026595 ",1.75,16.01,"4ah4_oligo8","LFucpa1-2[DGalpNAca1-3]DGalpa1-ROH","A2G(3_J_)-[FUC(2_J_)]-GAL(1_J_)",33.1076,"","",""
"4AH4","CRYSTAL STRUCTURE OF FUCOSE BINDING LECTIN FROM ASPERGILLUS FUMIGATUS (AFL) IN COMPLEX WITH BGA OLIGOSACCHARIDE.","10.1107/S1399004714026595 ",1.75,16.01,"4ah4_oligo6","LFucpa1-2[DGalpNAca1-3]DGalpa1-ROH","A2G(3_H_)-[FUC(2_H_)]-GAL(1_H_)",36.1788,"","",""
"4AH4","CRYSTAL STRUCTURE OF FUCOSE BINDING LECTIN FROM ASPERGILLUS FUMIGATUS (AFL) IN COMPLEX WITH BGA OLIGOSACCHARIDE.","10.1107/S1399004714026595 ",1.75,16.01,"4ah4_oligo5","LFucpa1-2[DGalpNAca1-3]DGalpb1-ROH","A2G(3_G_)-[FUC(2_G_)]-GAL(1_G_)",32.8658,"","",""
"4AH4","CRYSTAL STRUCTURE OF FUCOSE BINDING LECTIN FROM ASPERGILLUS FUMIGATUS (AFL) IN COMPLEX WITH BGA OLIGOSACCHARIDE.","10.1107/S1399004714026595 ",1.75,16.01,"4ah4_oligo1","LFucpa1-2[DGalpNAca1-3]DGalpb1-ROH","A2G(3_D_)-[FUC(2_D_)]-GAL(1_D_)",31.65,"","",""
"4AH4","CRYSTAL STRUCTURE OF FUCOSE BINDING LECTIN FROM ASPERGILLUS FUMIGATUS (AFL) IN COMPLEX WITH BGA OLIGOSACCHARIDE.","10.1107/S1399004714026595 ",1.75,16.01,"4ah4_oligo7","LFucpa1-2[DGalpNAca1-3]DGalpa1-ROH","A2G(3_I_)-[FUC(2_I_)]-GAL(1_I_)",32.5479,"","",""
"4AKC","STRUCTURE OF GALACTOSE BINDING LECTIN FROM CHAMPEDAK (CGB) WITH GAL(BETA)1,3-GALNAC","10.1107/S2053230X14008966 ",2.3,44.84,"4akc_oligo3","DGalpb1-3DGalpNAca1-ROH","GAL(2_I_)-A2G(1_I_)",69.5027,"","",""
"4AKC","STRUCTURE OF GALACTOSE BINDING LECTIN FROM CHAMPEDAK (CGB) WITH GAL(BETA)1,3-GALNAC","10.1107/S2053230X14008966 ",2.3,44.84,"4akc_oligo4","DGalpb1-3DGalpNAca1-ROH","GAL(2_L_)-A2G(1_L_)",58.9359,"","",""
"4AKC","STRUCTURE OF GALACTOSE BINDING LECTIN FROM CHAMPEDAK (CGB) WITH GAL(BETA)1,3-GALNAC","10.1107/S2053230X14008966 ",2.3,44.84,"4akc_oligo2","DGalpb1-3DGalpNAca1-ROH","GAL(2_K_)-A2G(1_K_)",58.5241,"","",""
"4AKC","STRUCTURE OF GALACTOSE BINDING LECTIN FROM CHAMPEDAK (CGB) WITH GAL(BETA)1,3-GALNAC","10.1107/S2053230X14008966 ",2.3,44.84,"4akc_oligo1","DGalpb1-3DGalpNAca1-ROH","GAL(2_J_)-A2G(1_J_)",77.4477,"","",""
"4AQB","MBL-FICOLIN ASSOCIATED PROTEIN-1, MAP-1 AKA MAP44","10.1074/JBC.M112.386680 ",4.2,145.5,"4aqb_oligo1","DManpa1-3DManpb1-4DGlcpNAca1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(178_A_)",208.566,"","",""
"4AQB","MBL-FICOLIN ASSOCIATED PROTEIN-1, MAP-1 AKA MAP44","10.1074/JBC.M112.386680 ",4.2,145.5,"4aqb_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAca1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(49_A_)",268.584,"","",""
"4AQS","LAMININ BETA1 LN-LE1-4 STRUCTURE","10.1371/JOURNAL.PONE.0042473 ",3.11,90.8,"4aqs_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(5_B_)-[MAN(4_B_)-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(356_A_)",133.035,"","",""
"4ARN","CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN OF DROSOPHILA TOLL RECEPTOR","10.1016/J.STR.2012.11.003 ",2.41,66.68,"4arn_oligo3","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(7_G_)-[BMA(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)]-[FUC(6_G_)]-NAG(1_G_)-ASN(140_C_)",97.6677,"","",""
"4ASL","STRUCTURE OF EPA1A IN COMPLEX WITH THE T-ANTIGEN (GAL-B1-3- GALNAC)","10.1073/PNAS.1207653109 ",1.24,14.97,"4asl_oligo1","DGalpb1-3DGalpNAcb1-ROH","GAL(2_B_)-NGA(1_B_)",32.4368,"","",""
"4ASQ","CRYSTAL STRUCTURE OF ANCE IN COMPLEX WITH BRADYKININ","10.1111/FEBS.12038 ",1.99,29.32,"4asq_oligo1","DManpb1-6DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[BMA(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(196_A_)",44.4294,"","",""
"4ASR","CRYSTAL STRUCTURE OF ANCE IN COMPLEX WITH THR6-BRADYKININ","10.1111/FEBS.12038 ",1.9,26.7,"4asr_oligo1","DManpb1-6DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[BMA(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(196_A_)",40.9314,"","",""
"4AVV","STRUCTURE OF CPHPC BOUND TO SERUM AMYLOID P COMPONENT","10.1107/S1399004714013455 ",1.6,18.9,"4avv_oligo12","DNeup5Aca2-6DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(9_G_)-MAN(8_G_)-[SIA(7_G_)-GAL(6_G_)-NAG(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(32_D_)",33.5094,"","",""
"4AW7","BPGH86A: A BETA-PORPHYRANASE OF GLYCOSIDE HYDROLASE FAMILY 86 FROM THE HUMAN GUT BACTERIUM BACTEROIDES PLEBEIUS","10.1073/PNAS.1211002109 ",1.33,11.55,"4aw7_oligo1","DGalp[3<R1>]b1-4LGalp[6S]a1-3DGalpa1-ROH","GAL(3_B_)-L6S(2_B_)-GLA(1_B_)",15.2382,"","",""
"4AW7","BPGH86A: A BETA-PORPHYRANASE OF GLYCOSIDE HYDROLASE FAMILY 86 FROM THE HUMAN GUT BACTERIUM BACTEROIDES PLEBEIUS","10.1073/PNAS.1211002109 ",1.33,11.55,"4aw7_oligo2","LGalp[6S]a1-3DGalpb1-","L6S(6_B_)-GAL(5_B_)-AAL(4_B_)",24.9423,"","",""
"4B1Q","NMR STRUCTURE OF THE GLYCOSYLATED CONOTOXIN CCTX FROM CONUS CONSORS","10.1002/CHEM.201202713 ","2.95026e-39",0,"4b1q_oligo1","LGalpa1-2DGalpb1-3[LGalpa1-4DGlcpNAca1-6]DGalpNAcx1-","GXL(5_A_)-NDG(4_A_)-[GXL(3_A_)-GAL(2_A_)]-A2G(1_A_)",36.6727,"","",""
"4B4Q","CRYSTAL STRUCTURE OF THE LECTIN DOMAIN OF F18 FIMBRIAL ADHESIN FEDF IN COMPLEX WITH BLOOD GROUP A TYPE 1 HEXASACCHARIDE","10.1111/J.1365-2958.2012.08174.X ",2,24.89,"4b4q_oligo2","LFucpa1-2[DGalpNAca1-3]DGalpb1-3DGlcpNAcb1-3DGalpb1-4DGlcpa1-ROH","A2G(6_D_)-[FUC(5_D_)]-GAL(4_D_)-NAG(3_D_)-GAL(2_D_)-GLC(1_D_)",25.7983,"","",""
"4B4Q","CRYSTAL STRUCTURE OF THE LECTIN DOMAIN OF F18 FIMBRIAL ADHESIN FEDF IN COMPLEX WITH BLOOD GROUP A TYPE 1 HEXASACCHARIDE","10.1111/J.1365-2958.2012.08174.X ",2,24.89,"4b4q_oligo1","LFucpa1-2[DGalpNAca1-3]DGalpb1-3DGlcpNAcb1-3DGalpb1-4DGlcpa1-ROH","A2G(6_C_)-[FUC(5_C_)]-GAL(4_C_)-NAG(3_C_)-GAL(2_C_)-GLC(1_C_)",23.677,"","",""
"4B4R","CRYSTAL STRUCTURE OF THE LECTIN DOMAIN OF F18 FIMBRIAL ADHESIN FEDF IN COMPLEX WITH BLOOD GROUP B TYPE 1 HEXASACCHARIDE","10.1111/J.1365-2958.2012.08174.X ",1.8,32.75,"4b4r_oligo1","LFucpa1-2[DGalpa1-3]DGalpb1-3DGlcpNAcb1-3DGalpb1-4DGlcpa1-ROH","GLA(6_C_)-[FUC(5_C_)]-GAL(4_C_)-NAG(3_C_)-GAL(2_C_)-GLC(1_C_)",31.2197,"","",""
"4B4R","CRYSTAL STRUCTURE OF THE LECTIN DOMAIN OF F18 FIMBRIAL ADHESIN FEDF IN COMPLEX WITH BLOOD GROUP B TYPE 1 HEXASACCHARIDE","10.1111/J.1365-2958.2012.08174.X ",1.8,32.75,"4b4r_oligo2","LFucpa1-2[DGalpa1-3]DGalpb1-3DGlcpNAcb1-3DGalpb1-4DGlcpa1-ROH","GLA(6_D_)-[FUC(5_D_)]-GAL(4_D_)-NAG(3_D_)-GAL(2_D_)-GLC(1_D_)",30.7883,"","",""
"4B56","STRUCTURE OF ECTONUCLEOTIDE PYROPHOSPHATASE-PHOSPHODIESTERASE-1 (NPP1)","10.1016/J.STR.2012.09.001 ",3,116.1,"4b56_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(567_B_)",152.127,"","",""
"4B56","STRUCTURE OF ECTONUCLEOTIDE PYROPHOSPHATASE-PHOSPHODIESTERASE-1 (NPP1)","10.1016/J.STR.2012.09.001 ",3,116.1,"4b56_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(567_A_)",130.868,"","",""
"4B7I","CRYSTAL STRUCTURE OF HUMAN IGG FC BEARING HYBRID-TYPE GLYCANS","10.1021/JA306068G ",2.36,43.41,"4b7i_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[MAN(6_C_)-[MAN(5_C_)]-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",85.9662,"","",""
"4BDV","CRYSTAL STRUCTURE OF A TRUNCATED B-DOMAIN HUMAN FACTOR VIII","10.1515/HSZ-2012-0298 ",3.98,160.4,"4bdv_oligo2","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_D_)-[BMA(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(2118_B_)",232.889,"","",""
"4BEY","NIGHT BLINDNESS CAUSING G90D RHODOPSIN IN COMPLEX WITH GACT2 PEPTIDE","10.1038/EMBOR.2013.44 ",2.9,56.08,"4bey_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(15_A_)",47.6493,"","",""
"4BEZ","NIGHT BLINDNESS CAUSING G90D RHODOPSIN IN THE ACTIVE CONFORMATION","10.1038/EMBOR.2013.44 ",3.3,55.66,"4bez_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(15_A_)",48.1241,"","",""
"4BH2","CRYSTAL STRUCTURE OF THE HAEMAGGLUTININ FROM A TRANSMISSIBLE MUTANT H5 INFLUENZA VIRUS","10.1038/NATURE12144 ",2.12,45.5,"4bh2_oligo2","DManpb1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[BMA(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(165_A_)",66.8815,"","",""
"4BH3","HAEMAGGLUTININ FROM A TRANSMISSIBLE MUTANT H5 INFLUENZA VIRUS IN COMPLEX WITH HUMAN RECEPTOR ANALOGUE 6'-SLN","10.1038/NATURE12144 ",2,38.24,"4bh3_oligo2","DManpb1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(6_C_)-[MAN(5_C_)-[BMA(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(165_A_)",47.2706,"","",""
"4BH4","HAEMAGGLUTININ FROM A TRANSMISSIBLE MUTANT H5 INFLUENZA VIRUS IN COMPLEX WITH AVIAN RECEPTOR ANALOGUE 3'-SLN","10.1038/NATURE12144 ",1.9,38.74,"4bh4_oligo2","DManpb1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(6_C_)-[MAN(5_C_)-[BMA(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(165_A_)",45.6453,"","",""
"4BM7","CRYSTAL STRUCTURE OF IGG FC F241A MUTANT WITH NATIVE GLYCOSYLATION","10.1021/JA4014375 ",1.95,45.81,"4bm7_oligo1","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(7_C_)-[NAG(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",73.9148,"","",""
"4BSV","HETERODIMERIC FC ANTIBODY AZYMETRIC VARIANT 1","10.4161/MABS.25632 ",1.75,25.78,"4bsv_oligo4","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(9_F_)-[GAL(6_F_)-NAG(5_F_)-MAN(4_F_)-[NAG(8_F_)-MAN(7_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)",73.5696,"","",""
"4BSW","HETERODIMERIC FC ANTIBODY AZYMETRIC VARIANT 2","10.4161/MABS.25632 ",2.15,45.51,"4bsw_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",64.1684,"","",""
"4BTW","CRYSTAL STRUCTURE OF HUMAN VASCULAR ADHESION PROTEIN-1 IN COMPLEX WITH PYRIDAZINONE INHIBITORS","10.1021/JM401372D ",2.8,0,"4btw_oligo2","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","BMA(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)",111.674,"","",""
"4BTY","CRYSTAL STRUCTURE OF HUMAN VASCULAR ADHESION PROTEIN-1 IN COMPLEX WITH PYRIDAZINONE INHIBITORS","10.1021/JM401372D ",3.1,0,"4bty_oligo9","DManpb1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)",112.036,"","",""
"4BV4","STRUCTURE AND ALLOSTERY IN TOLL-SPATZLE RECOGNITION","10.1073/PNAS.1317002110 ",2.35,59.74,"4bv4_oligo1","DManpa1-2DManpa1-3[DManpa1-3[DManpb1-6]DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(8_A_)-[MAN(7_A_)]-BMA(6_A_)-[MAN(5_A_)-MAN(4_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(346_R_)",68.4011,"","",""
"4BXS","CRYSTAL STRUCTURE OF THE PROTHROMBINASE COMPLEX FROM THE VENOM OF PSEUDONAJA TEXTILIS","10.1182/BLOOD-2013-06-511733 ",3.32,117.5,"4bxs_oligo2","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_C_)-[MAN(7_C_)]-MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(212_V_)",148.042,"","",""
"4BYH","CRYSTAL STRUCTURE OF SIALYLATED IGG FC","10.1073/PNAS.1310657110 ",2.3,66.11,"4byh_oligo1","DNeup5Aca2-6DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(10_C_)-[SIA(7_C_)-GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(9_C_)-MAN(8_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",91.0439,"","",""
"4BYH","CRYSTAL STRUCTURE OF SIALYLATED IGG FC","10.1073/PNAS.1310657110 ",2.3,66.11,"4byh_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(10_D_)-[GAL(9_D_)-NAG(8_D_)-MAN(7_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",61.7989,"","",""
"4C1U","STRUCTURE OF THE XYLO-OLIGOSACCHARIDE SPECIFIC SOLUTE BINDING PROTEIN FROM BIFIDOBACTERIUM ANIMALIS SUBSP. LACTIS BL-04 IN COMPLEX WITH ARABINOXYLOBIOSE","10.1111/MMI.12419 ",2,0,"4c1u_oligo1","LArafa1-3DXylpb1-4DXylpb1-ROH","AHR(3_B_)-XYP(2_B_)-XYP(1_B_)",19.4881,"","",""
"4C53","CRYSTAL STRUCTURE OF GUANARITO VIRUS GP2 IN THE POST-FUSION CONFORMATION","10.1128/JVI.02298-13 ",4.14,222.8,"4c53_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_G_)-[MAN(5_G_)]-MAN(4_G_)-[MAN(7_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(381_C_)",295.647,"","",""
"4C53","CRYSTAL STRUCTURE OF GUANARITO VIRUS GP2 IN THE POST-FUSION CONFORMATION","10.1128/JVI.02298-13 ",4.14,222.8,"4c53_oligo5","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)]-MAN(4_F_)-[MAN(7_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(351_B_)",294.068,"","",""
"4C53","CRYSTAL STRUCTURE OF GUANARITO VIRUS GP2 IN THE POST-FUSION CONFORMATION","10.1128/JVI.02298-13 ",4.14,222.8,"4c53_oligo3","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-[MAN(5_H_)]-MAN(4_H_)-[MAN(7_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(314_C_)",295.576,"","",""
"4C54","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN IGG4 FC","10.1016/J.JMB.2013.10.039 ",1.9,0,"4c54_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",59.663,"","",""
"4C54","CRYSTAL STRUCTURE OF RECOMBINANT HUMAN IGG4 FC","10.1016/J.JMB.2013.10.039 ",1.9,0,"4c54_oligo3","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",44.019,"","",""
"4C55","CRYSTAL STRUCTURE OF SERUM-DERIVED HUMAN IGG4 FC","10.1016/J.JMB.2013.10.039 ",2.35,0,"4c55_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(297_B_)",82.7285,"","",""
"4C55","CRYSTAL STRUCTURE OF SERUM-DERIVED HUMAN IGG4 FC","10.1016/J.JMB.2013.10.039 ",2.35,0,"4c55_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[NAG1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",52.4188,"","",""
"4C7L","CRYSTAL STRUCTURE OF MOUSE HEPATITIS VIRUS STRAIN S HEMAGGLUTININ- ESTERASE","10.1371/JOURNAL.PPAT.1002492 ",2.1,45.72,"4c7l_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(374_A_)",72.8427,"","",""
"4C7L","CRYSTAL STRUCTURE OF MOUSE HEPATITIS VIRUS STRAIN S HEMAGGLUTININ- ESTERASE","10.1371/JOURNAL.PPAT.1002492 ",2.1,45.72,"4c7l_oligo8","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_J_)-[MAN(5_J_)]-MAN(4_J_)-[MAN(7_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(374_B_)",48.7514,"","",""
"4C7W","CRYSTAL STRUCTURE OF MOUSE HEPATITIS VIRUS STRAIN S HEMAGGLUTININ- ESTERASE IN COMPLEX WITH 4-O-ACETYLATED SIALIC ACID","10.1371/JOURNAL.PPAT.1002492 ",2.5,45.02,"4c7w_oligo10","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_J_)-[MAN(5_J_)]-MAN(4_J_)-[MAN(7_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(374_B_)",41.7751,"","",""
"4CA7","DROSOPHILA ANGIOTENSIN CONVERTING ENZYME (ANCE) IN COMPLEX WITH A PHOSPHINIC TRIPEPTIDE FI","10.1111/FEBS.12660 ",1.82,28.86,"4ca7_oligo1","DManpb1-6DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[BMA(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(196_A_)",52.1352,"","",""
"4CA8","DROSOPHILA ANGIOTENSIN CONVERTING ENZYME (ANCE) IN COMPLEX WITH A PHOSPHINIC TRIPEPTIDE FII","10.1111/FEBS.12660 ",1.99,30,"4ca8_oligo2","DManpb1-6DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[BMA(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(196_A_)",56.2638,"","",""
"4CDH","CRYSTALLOGRAPHIC STRUCTURE OF THE HUMAN IGG1 ALPHA 2-6 SIALILATED FC- FRAGMENT","10.1016/J.STR.2014.09.001 ",2.3,43.12,"4cdh_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(78_B_)",68.154,"","",""
"4CDH","CRYSTALLOGRAPHIC STRUCTURE OF THE HUMAN IGG1 ALPHA 2-6 SIALILATED FC- FRAGMENT","10.1016/J.STR.2014.09.001 ",2.3,43.12,"4cdh_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(10_C_)-[GAL(9_C_)-NAG(8_C_)-MAN(7_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(78_A_)",55.2306,"","",""
"4COV","CRYSTAL STRUCTURE OF EPITHELIAL ADHESIN 6 A DOMAIN (EPA6A) FROM CANDIDA GLABRATA IN COMPLEX WITH GALA1-3GAL","10.1074/JBC.M115.655654 ",1.5,20.24,"4cov_oligo1","DGalpa1-3DGalpb1-ROH","GLA(2_B_)-GAL(1_B_)",25.3614,"","",""
"4COW","CRYSTAL STRUCTURE OF EPITHELIAL ADHESIN 6 A DOMAIN (EPA6A) FROM CANDIDA GLABRATA IN COMPLEX WITH THE T-ANTIGEN (GALB1-3GALNAC)","10.1074/JBC.M115.655654 ",2.15,25.14,"4cow_oligo1","DGalpb1-3DGalpNAcb1-ROH","GAL(2_B_)-NGA(1_B_)",26.7045,"","",""
"4COZ","CRYSTAL STRUCTURE OF EPITHELIAL ADHESIN 6 A DOMAIN (EPA6A) FROM CANDIDA GLABRATA IN COMPLEX WITH GALB1-3GLCNAC","10.1074/JBC.M115.655654 ",2.3,23.92,"4coz_oligo1","DGalpb1-3DGlcpNAcb1-ROH","GAL(2_B_)-NAG(1_B_)",24.6841,"","",""
"4CP1","CRYSTAL STRUCTURE OF EPITHELIAL ADHESIN 9 A DOMAIN (EPA9A) FROM CANDIDA GLABRATA IN COMPLEX WITH GALB1-3GLCNAC","",2.5,21.83,"4cp1_oligo1","DGalpb1-3DGlcpNAcb1-ROH","GAL(2_B_)-NAG(1_B_)",38.1859,"","",""
"4CPM","STRUCTURE OF THE NEURAMINIDASE FROM THE B/BRISBANE/60/2008 VIRUS IN COMPLEX WITH OSELTAMIVIR","10.1093/INFDIS/JIU244 ",2.75,46.6,"4cpm_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(283_A_)",101.562,"","",""
"4CQP","CRYSTAL STRUCTURE OF H5 (VN1194) SER227ASN/GLN196ARG MUTANT HAEMAGGLUTININ","10.1016/J.VIROL.2014.03.008 ",2.65,101.6,"4cqp_oligo3","DManpb1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[BMA(4_D_)]-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(165_A_)",195.055,"","",""
"4CQQ","H5 (VN1194) SER227ASN/GLN196ARG MUTANT HAEMAGGLUTININ IN COMPLEX WITH AVIAN RECEPTOR ANALOGUE 3'SLN","10.1016/J.VIROL.2014.03.008 ",2.55,87.51,"4cqq_oligo4","DManpb1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[BMA(4_D_)]-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(165_A_)",153.499,"","",""
"4CQR","H5 (VN1194) SER227ASN/GLN196ARG MUTANT HAEMAGGLUTININ IN COMPLEX WITH HUMAN RECEPTOR ANALOGUE 6'SLN","10.1016/J.VIROL.2014.03.008 ",2.45,88.76,"4cqr_oligo4","DManpb1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[BMA(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(165_A_)",155.548,"","",""
"4CQS","H5 (VN1194) ASN186LYS MUTANT HAEMAGGLUTININ IN COMPLEX WITH AVIAN RECEPTOR ANALOGUE 3'SLN","10.1016/J.VIROL.2014.03.008 ",2.55,78.98,"4cqs_oligo1","DManpb1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[BMA(4_D_)]-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(165_A_)",144.656,"","",""
"4CQU","H5 (VN1194) ASN186LYS MUTANT HAEMAGGLUTININ IN COMPLEX WITH HUMAN RECEPTOR ANALOGUE 6'SLN","10.1016/J.VIROL.2014.03.008 ",2.48,85.13,"4cqu_oligo4","DManpb1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[BMA(4_D_)]-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(165_A_)",151.433,"","",""
"4CQY","H5 (TYTY) DEL133/ILE155THR MUTANT HAEMAGGLUTININ IN COMPLEX WITH AVIAN RECEPTOR ANALOGUE LSTA","10.1016/J.VIROL.2014.03.008 ",2.05,42.04,"4cqy_oligo1","DNeup5Aca2-3DGalpb1-3DGlcpNAcb1-ROH","SIA(3_G_)-GAL(2_G_)-NAG(1_G_)",56.4881,"","",""
"4CQY","H5 (TYTY) DEL133/ILE155THR MUTANT HAEMAGGLUTININ IN COMPLEX WITH AVIAN RECEPTOR ANALOGUE LSTA","10.1016/J.VIROL.2014.03.008 ",2.05,42.04,"4cqy_oligo2","DNeup5Aca2-3DGalpb1-3DGlcpNAcb1-ROH","SIA(3_H_)-GAL(2_H_)-NAG(1_H_)",41.0493,"","",""
"4CQY","H5 (TYTY) DEL133/ILE155THR MUTANT HAEMAGGLUTININ IN COMPLEX WITH AVIAN RECEPTOR ANALOGUE LSTA","10.1016/J.VIROL.2014.03.008 ",2.05,42.04,"4cqy_oligo3","DNeup5Aca2-3DGalpb1-3DGlcpNAcb1-ROH","SIA(3_I_)-GAL(2_I_)-NAG(1_I_)",41.3945,"","",""
"4CQZ","CRYSTAL STRUCTURE OF H5 (VN1194) GLN196ARG MUTANT HAEMAGGLUTININ","10.1016/J.VIROL.2014.03.008 ",2.7,74.89,"4cqz_oligo2","DNeup5Aca2-3DGalpb1-3DGlcpNAcb1-ROH","SIA(3_C_)-GAL(2_C_)-NAG(1_C_)",91.9847,"","",""
"4CSY","E-SELECTIN LECTIN, EGF-LIKE AND TWO SCR DOMAINS COMPLEXED WITH SIALYL LEWIS X","10.1093/JMCB/MJV046 ",2.41,79.3,"4csy_oligo1","DNeup5Aca2-3DGalpb1-4[LFucpa1-3]DGlcpNAcb1-OME","SIA(3_C_)-GAL(2_C_)-[FUC(4_C_)]-MAG(1_C_)",111.988,"","",""
"4CSY","E-SELECTIN LECTIN, EGF-LIKE AND TWO SCR DOMAINS COMPLEXED WITH SIALYL LEWIS X","10.1093/JMCB/MJV046 ",2.41,79.3,"4csy_oligo2","DNeup5Aca2-3DGalpb1-4[LFucpa1-3]DGlcpNAcb1-OME","SIA(3_D_)-GAL(2_D_)-[FUC(4_D_)]-MAG(1_D_)",110.533,"","",""
"4CUO","BANYAN PEROXIDASE WITH GLYCOSYLATION","10.1111/FEBS.12900 ",1.67,41.56,"4cuo_oligo1","LFucpa1-3DGlcpNAcx1-","FUC(2_B_)-NAG(1_B_)",86.1749,"","",""
"4CUO","BANYAN PEROXIDASE WITH GLYCOSYLATION","10.1111/FEBS.12900 ",1.67,41.56,"4cuo_oligo4","DXylpa1-2[DManpa1-3][DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","MAN(6_C_)-[MAN(5_C_)]-[XYS(4_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(7_C_)]-NAG(1_C_)",51.3664,"","",""
"4CUO","BANYAN PEROXIDASE WITH GLYCOSYLATION","10.1111/FEBS.12900 ",1.67,41.56,"4cuo_oligo2","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcx1-","NAG(3_D_)-[FUC(2_D_)]-NAG(1_D_)",88.8643,"","",""
"4CUO","BANYAN PEROXIDASE WITH GLYCOSYLATION","10.1111/FEBS.12900 ",1.67,41.56,"4cuo_oligo3","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcx1-","NAG(3_E_)-[FUC(2_E_)]-NAG(1_E_)",72.7325,"","",""
"4CVU","STRUCTURE OF FUNGAL BETA-MANNOSIDASE FROM GLYCOSIDE HYDROLASE FAMILY 2 OF TRICHODERMA HARZIANUM","10.1111/FEBS.12894 ",1.9,46.08,"4cvu_oligo2","DManpa1-2DManpa1-6DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-MAN(5_C_)-MAN(4_C_)-[MAN(8_C_)-MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(86_A_)",57.4459,"","",""
"4CVU","STRUCTURE OF FUNGAL BETA-MANNOSIDASE FROM GLYCOSIDE HYDROLASE FAMILY 2 OF TRICHODERMA HARZIANUM","10.1111/FEBS.12894 ",1.9,46.08,"4cvu_oligo4","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_E_)-MAN(10_E_)-[MAN(9_E_)-MAN(8_E_)]-MAN(7_E_)-[MAN(6_E_)-MAN(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(255_A_)",50.1096,"","",""
"4CVU","STRUCTURE OF FUNGAL BETA-MANNOSIDASE FROM GLYCOSIDE HYDROLASE FAMILY 2 OF TRICHODERMA HARZIANUM","10.1111/FEBS.12894 ",1.9,46.08,"4cvu_oligo1","DManpa1-2DManpa1-3[DManp[2<R1>]a]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-[MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(560_A_)",51.5592,"","",""
"4CWM","HIGH-GLYCOSYLATION CRYSTAL STRUCTURE OF THE BIFUNCTIONAL ENDONUCLEASE (ATBFN2) FROM ARABIDOPSIS THALIANA","10.1371/JOURNAL.PONE.0105821 ",2.09,27.39,"4cwm_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(91_A_)",36.4491,"","",""
"4CWM","HIGH-GLYCOSYLATION CRYSTAL STRUCTURE OF THE BIFUNCTIONAL ENDONUCLEASE (ATBFN2) FROM ARABIDOPSIS THALIANA","10.1371/JOURNAL.PONE.0105821 ",2.09,27.39,"4cwm_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(91_B_)",44.0424,"","",""
"4CXO","BIFUNCTIONAL ENDONUCLEASE IN COMPLEX WITH SSDNA","10.1371/JOURNAL.PONE.0105821 ",1.67,27.7,"4cxo_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(91_A_)",42.6776,"","",""
"4CXO","BIFUNCTIONAL ENDONUCLEASE IN COMPLEX WITH SSDNA","10.1371/JOURNAL.PONE.0105821 ",1.67,27.7,"4cxo_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(110_A_)",44.1702,"","",""
"4CXP","STRUCTURE OF BIFUNCTIONAL ENDONUCLEASE (ATBFN2) FROM ARABIDOPSIS THALIANA IN COMPLEX WITH SULFATE","10.1371/JOURNAL.PONE.0105821 ",1.22,16.19,"4cxp_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-[FUC(5_C_)]-NAG(1_C_)-ASN(110_A_)",27.5971,"","",""
"4CXP","STRUCTURE OF BIFUNCTIONAL ENDONUCLEASE (ATBFN2) FROM ARABIDOPSIS THALIANA IN COMPLEX WITH SULFATE","10.1371/JOURNAL.PONE.0105821 ",1.22,16.19,"4cxp_oligo2","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_B_)-[MAN(7_B_)]-MAN(6_B_)-[MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(91_A_)",22.3191,"","",""
"4CXV","STRUCTURE OF BIFUNCTIONAL ENDONUCLEASE (ATBFN2) IN COMPLEX WITH PHOSPHATE.","10.1371/JOURNAL.PONE.0105821 ",2,28.36,"4cxv_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(91_A_)",30.3234,"","",""
"4CXV","STRUCTURE OF BIFUNCTIONAL ENDONUCLEASE (ATBFN2) IN COMPLEX WITH PHOSPHATE.","10.1371/JOURNAL.PONE.0105821 ",2,28.36,"4cxv_oligo1","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-MAN(4_E_)-[MAN(6_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(91_B_)",42.2477,"","",""
"4CYV","STRUCTURE OF THE A_MALLARD_SWEDEN_51_2002 H10 AVIAN HAEMMAGLUTININ","10.1038/NATURE13443 ",2.3,57.08,"4cyv_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(82_D_)",73.5427,"","",""
"4CYV","STRUCTURE OF THE A_MALLARD_SWEDEN_51_2002 H10 AVIAN HAEMMAGLUTININ","10.1038/NATURE13443 ",2.3,57.08,"4cyv_oligo5","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(82_F_)",96.4684,"","",""
"4CYV","STRUCTURE OF THE A_MALLARD_SWEDEN_51_2002 H10 AVIAN HAEMMAGLUTININ","10.1038/NATURE13443 ",2.3,57.08,"4cyv_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcp[2<R1>]x1-","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)",67.3417,"","",""
"4CYW","STRUCTURE OF THE A_MALLARD_SWEDEN_51_2002 H10 AVIAN HAEMMAGLUTININ IN COMPLEX WITH HUMAN RECEPTOR ANALOG 6-SLN","10.1038/NATURE13443 ",2.6,60.89,"4cyw_oligo4","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[BMA(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(82_D_)",89.8085,"","",""
"4CYW","STRUCTURE OF THE A_MALLARD_SWEDEN_51_2002 H10 AVIAN HAEMMAGLUTININ IN COMPLEX WITH HUMAN RECEPTOR ANALOG 6-SLN","10.1038/NATURE13443 ",2.6,60.89,"4cyw_oligo6","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_L_)-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(82_F_)",89.203,"","",""
"4CYW","STRUCTURE OF THE A_MALLARD_SWEDEN_51_2002 H10 AVIAN HAEMMAGLUTININ IN COMPLEX WITH HUMAN RECEPTOR ANALOG 6-SLN","10.1038/NATURE13443 ",2.6,60.89,"4cyw_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(82_B_)",97.7984,"","",""
"4CYZ","STRUCTURE OF THE A_MALLARD_SWEDEN_51_2002 H10 AVIAN HAEMMAGLUTININ IN COMPLEX WITH AVIAN RECEPTOR ANALOG LSTA","10.1038/NATURE13443 ",2.4,47.62,"4cyz_oligo1","DNeup5Aca2-3DGalpb1-3DGlcpNAcb1-ROH","SIA(3_G_)-GAL(2_G_)-NAG(1_G_)",68.5976,"","",""
"4CYZ","STRUCTURE OF THE A_MALLARD_SWEDEN_51_2002 H10 AVIAN HAEMMAGLUTININ IN COMPLEX WITH AVIAN RECEPTOR ANALOG LSTA","10.1038/NATURE13443 ",2.4,47.62,"4cyz_oligo6","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_L_)-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(82_F_)",53.4454,"","",""
"4CYZ","STRUCTURE OF THE A_MALLARD_SWEDEN_51_2002 H10 AVIAN HAEMMAGLUTININ IN COMPLEX WITH AVIAN RECEPTOR ANALOG LSTA","10.1038/NATURE13443 ",2.4,47.62,"4cyz_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(82_D_)",77.4642,"","",""
"4CYZ","STRUCTURE OF THE A_MALLARD_SWEDEN_51_2002 H10 AVIAN HAEMMAGLUTININ IN COMPLEX WITH AVIAN RECEPTOR ANALOG LSTA","10.1038/NATURE13443 ",2.4,47.62,"4cyz_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcp[2<R1>]b1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(82_B_)",69.9162,"","",""
"4CZ0","STRUCTURE OF THE A_MALLARD_SWEDEN_51_2002 H10 AVIAN HAEMMAGLUTININ IN COMPLEX WITH AVIAN RECEPTOR ANALOG SU-3SLN","10.1038/NATURE13443 ",3.2,97.39,"4cz0_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(82_D_)",122.121,"","",""
"4CZ0","STRUCTURE OF THE A_MALLARD_SWEDEN_51_2002 H10 AVIAN HAEMMAGLUTININ IN COMPLEX WITH AVIAN RECEPTOR ANALOG SU-3SLN","10.1038/NATURE13443 ",3.2,97.39,"4cz0_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(82_B_)",112.866,"","",""
"4CZ0","STRUCTURE OF THE A_MALLARD_SWEDEN_51_2002 H10 AVIAN HAEMMAGLUTININ IN COMPLEX WITH AVIAN RECEPTOR ANALOG SU-3SLN","10.1038/NATURE13443 ",3.2,97.39,"4cz0_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_L_)-[MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(82_F_)",132.055,"","",""
"4D3W","CRYSTAL STRUCTURE OF EPITHELIAL ADHESIN 1 A DOMAIN (EPA1A) FROM CANDIDA GLABRATA IN COMPLEX WITH THE T-ANTIGEN (GALB1-3GALNAC)","10.1074/JBC.M115.655654 ",1.5,15.63,"4d3w_oligo1","DGalpb1-3DGalpNAcb1-ROH","GAL(2_B_)-NGA(1_B_)",8.58091,"","",""
"4D4U","CRYSTAL STRUCTURE OF FUCOSE BINDING LECTIN FROM ASPERGILLUS FUMIGATUS (AFL) IN COMPLEX WITH LEWISY TETRASACCHARIDE.","10.1107/S1399004714026595 ",1.99,24.82,"4d4u_oligo7","LFucpa1-2DGalpb1-4[LFucpa1-3]DGlcpNAca1-ROH","FUC(3_I_)-GAL(2_I_)-[FUC(4_I_)]-NDG(1_I_)",42.9468,"","",""
"4D4U","CRYSTAL STRUCTURE OF FUCOSE BINDING LECTIN FROM ASPERGILLUS FUMIGATUS (AFL) IN COMPLEX WITH LEWISY TETRASACCHARIDE.","10.1107/S1399004714026595 ",1.99,24.82,"4d4u_oligo2","LFucpa1-2DGalpb1-4[LFucpa1-3]DGlcpNAca1-ROH","FUC(3_F_)-GAL(2_F_)-[FUC(4_F_)]-NDG(1_F_)",30.2216,"","",""
"4D4U","CRYSTAL STRUCTURE OF FUCOSE BINDING LECTIN FROM ASPERGILLUS FUMIGATUS (AFL) IN COMPLEX WITH LEWISY TETRASACCHARIDE.","10.1107/S1399004714026595 ",1.99,24.82,"4d4u_oligo3","LFucpa1-2DGalpb1-4[LFucpa1-3]DGlcpNAca1-ROH","FUC(3_E_)-GAL(2_E_)-[FUC(4_E_)]-NDG(1_E_)",35.2398,"","",""
"4D6D","CRYSTAL STRUCTURE OF A FAMILY 98 GLYCOSIDE HYDROLASE CATALYTIC MODULE (SP3GH98) IN COMPLEX WITH THE BLOOD GROUP A-TRISACCHARIDE (X02 MUTANT)","10.1021/JA5116088 ",1.52,9.46,"4d6d_oligo1","LFucpa1-2[DGalpNAca1-3]DGalpa1-ROH","A2G(3_B_)-[FUC(2_B_)]-GLA(1_B_)",6.51788,"","",""
"4D6E","CRYSTAL STRUCTURE OF A FAMILY 98 GLYCOSIDE HYDROLASE CATALYTIC MODULE (SP3GH98) IN COMPLEX WITH THE BLOOD GROUP A-TRISACCHARIDE (X01 MUTANT)","10.1021/JA5116088 ",1.45,9.01,"4d6e_oligo1","LFucpa1-2[DGalpNAca1-3]DGalpb1-ROH","A2G(3_B_)-[FUC(2_B_)]-GAL(1_B_)",6.05242,"","",""
"4D6F","CRYSTAL STRUCTURE OF A FAMILY 98 GLYCOSIDE HYDROLASE CATALYTIC MODULE (SP3GH98) IN COMPLEX WITH THE TYPE 1 BLOOD GROUP A-TETRASACCHARIDE (E558A, X01 MUTANT)","10.1021/JA5116088 ",2.03,14.64,"4d6f_oligo2","LFucpa1-2DGalpb1-3DGlcpNAcb1-ROH","FUC(3_B_)-GAL(2_B_)-NAG(1_B_)",14.4073,"","",""
"4D6G","CRYSTAL STRUCTURE OF A FAMILY 98 GLYCOSIDE HYDROLASE CATALYTIC MODULE (SP3GH98) IN COMPLEX WITH THE BLOOD GROUP A-TRISACCHARIDE (L19 MUTANT)","10.1021/JA5116088 ",1.24,9.73,"4d6g_oligo1","LFucpa1-2[DGalpNAca1-3]DGalpa1-ROH","A2G(3_B_)-[FUC(2_B_)]-GLA(1_B_)",6.90121,"","",""
"4D6H","CRYSTAL STRUCTURE OF A FAMILY 98 GLYCOSIDE HYDROLASE CATALYTIC MODULE (SP3GH98) IN COMPLEX WITH THE TYPE 1 BLOOD GROUP A-TETRASACCHARIDE (E558A X02 MUTANT)","10.1021/JA5116088 ",1.65,11.26,"4d6h_oligo1","LFucpa1-2DGalpb1-3DGlcpNAcb1-ROH","FUC(3_B_)-GAL(2_B_)-NAG(1_B_)",21.6339,"","",""
"4D6I","CRYSTAL STRUCTURE OF A FAMILY 98 GLYCOSIDE HYDROLASE CATALYTIC MODULE (SP3GH98) IN COMPLEX WITH THE TYPE 1 BLOOD GROUP A-TETRASACCHARIDE (E558A L19 MUTANT)","10.1021/JA5116088 ",1.99,15.9,"4d6i_oligo2","LFucpa1-2DGalpb1-3DGlcpNAcb1-ROH","FUC(3_B_)-GAL(2_B_)-NAG(1_B_)",20.2282,"","",""
"4DAG","STRUCTURE OF THE HUMAN METAPNEUMOVIRUS FUSION PROTEIN WITH NEUTRALIZING ANTIBODY IDENTIFIES A PNEUMOVIRUS ANTIGENIC SITE","10.1038/NSMB.2250 ",3.39,0,"4dag_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(353_A_)",135.588,"","",""
"4DAG","STRUCTURE OF THE HUMAN METAPNEUMOVIRUS FUSION PROTEIN WITH NEUTRALIZING ANTIBODY IDENTIFIES A PNEUMOVIRUS ANTIGENIC SITE","10.1038/NSMB.2250 ",3.39,0,"4dag_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(57_A_)",170.121,"","",""
"4DBM","APLYSIA CALIFORNICA-ACHBP IN COMPLEX WITH TRIAZOLE 18","10.1021/JA3001858 ",2.3,36.15,"4dbm_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(74_E_)",74.8498,"","",""
"4DGR","INFLUENZA SUBTYPE 9 NEURAMINIDASE BENZOIC ACID INHIBITOR COMPLEX","10.1186/1472-6807-12-7 ",1.55,0,"4dgr_oligo4","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_B_)-[MAN(8_B_)]-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",22.4599,"","",""
"4DHL","CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH MAYBRIDGE FRAGMENT MO07123","10.1111/CBDD.12001 ",2.3,0,"4dhl_oligo6","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_J_)-[FUC(2_J_)]-NAG(1_J_)-ASN(396_D_)",44.713,"","",""
"4DHL","CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH MAYBRIDGE FRAGMENT MO07123","10.1111/CBDD.12001 ",2.3,0,"4dhl_oligo8","LFucpa1-3DGlcpNAcb1-ASN","FUC(2_L_)-NAG(1_L_)-ASN(109_C_)",61.8782,"","",""
"4DHL","CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH MAYBRIDGE FRAGMENT MO07123","10.1111/CBDD.12001 ",2.3,0,"4dhl_oligo9","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_M_)-[FUC(2_M_)]-NAG(1_M_)-ASN(396_C_)",45.1988,"","",""
"4DHL","CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH MAYBRIDGE FRAGMENT MO07123","10.1111/CBDD.12001 ",2.3,0,"4dhl_oligo1","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_E_)-[FUC(2_E_)]-NAG(1_E_)-ASN(81_A_)",53.0918,"","",""
"4DHL","CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH MAYBRIDGE FRAGMENT MO07123","10.1111/CBDD.12001 ",2.3,0,"4dhl_oligo7","LFucpa1-3DGlcpNAcb1-ASN","FUC(2_K_)-NAG(1_K_)-ASN(109_D_)",71.73,"","",""
"4DHL","CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH MAYBRIDGE FRAGMENT MO07123","10.1111/CBDD.12001 ",2.3,0,"4dhl_oligo5","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_I_)-[FUC(2_I_)]-NAG(1_I_)-ASN(396_B_)",29.5555,"","",""
"4DHL","CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH MAYBRIDGE FRAGMENT MO07123","10.1111/CBDD.12001 ",2.3,0,"4dhl_oligo4","LFucpa1-3DGlcpNAcb1-ASN","FUC(2_H_)-NAG(1_H_)-ASN(109_B_)",53.9764,"","",""
"4DHL","CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH MAYBRIDGE FRAGMENT MO07123","10.1111/CBDD.12001 ",2.3,0,"4dhl_oligo2","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_F_)-[FUC(2_F_)]-NAG(1_F_)-ASN(109_A_)",48.7639,"","",""
"4DHL","CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH MAYBRIDGE FRAGMENT MO07123","10.1111/CBDD.12001 ",2.3,0,"4dhl_oligo3","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_G_)-[FUC(2_G_)]-NAG(1_G_)-ASN(396_A_)",31.0591,"","",""
"4DJ4","X-RAY STRUCTURE OF MUTANT N211D OF BIFUNCTIONAL NUCLEASE TBN1 FROM SOLANUM LYCOPERSICUM (TOMATO)","10.1107/S0907444912043697 ",2.35,40.61,"4dj4_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(119_B_)",71.1452,"","",""
"4DJ4","X-RAY STRUCTURE OF MUTANT N211D OF BIFUNCTIONAL NUCLEASE TBN1 FROM SOLANUM LYCOPERSICUM (TOMATO)","10.1107/S0907444912043697 ",2.35,40.61,"4dj4_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(137_B_)",77.544,"","",""
"4DJ4","X-RAY STRUCTURE OF MUTANT N211D OF BIFUNCTIONAL NUCLEASE TBN1 FROM SOLANUM LYCOPERSICUM (TOMATO)","10.1107/S0907444912043697 ",2.35,40.61,"4dj4_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(137_A_)",61.9916,"","",""
"4DKE","CRYSTAL STRUCTURE OF HUMAN INTERLEUKIN-34 BOUND TO FAB1.1","10.1016/J.STR.2012.02.010 ",3,67.84,"4dke_oligo1","DManpa1-3[DManpb1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_C_)-[MAN(4_C_)]-MAN(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(76_A_)",100.573,"","",""
"4DKF","CRYSTAL STRUCTURE OF HUMAN INTERLEUKIN-34 BOUND TO FAB2","10.1016/J.STR.2012.02.010 ",2.61,63.75,"4dkf_oligo2","DManpa1-3[DManpb1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_D_)-[MAN(4_D_)]-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(76_B_)",96.8184,"","",""
"4DKF","CRYSTAL STRUCTURE OF HUMAN INTERLEUKIN-34 BOUND TO FAB2","10.1016/J.STR.2012.02.010 ",2.61,63.75,"4dkf_oligo1","DManpa1-3[DManpb1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_C_)-[MAN(4_C_)]-MAN(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(76_A_)",83.5982,"","",""
"4DL1","CRYSTAL STRUCTURE OF HUMAN MYELOPEROXIDASE WITH COVALENT THIOXANTHINE ANALOG","10.1021/BI201872J ",2,8.8,"4dl1_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_V_)-[MAN(5_V_)-[MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)]-NAG(1_V_)-ASN(317_L_)",28.3247,"","",""
"4DL1","CRYSTAL STRUCTURE OF HUMAN MYELOPEROXIDASE WITH COVALENT THIOXANTHINE ANALOG","10.1021/BI201872J ",2,8.8,"4dl1_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_X_)-[MAN(5_X_)-[MAN(4_X_)]-BMA(3_X_)-NAG(2_X_)]-NAG(1_X_)-ASN(317_P_)",34.2679,"","",""
"4DL1","CRYSTAL STRUCTURE OF HUMAN MYELOPEROXIDASE WITH COVALENT THIOXANTHINE ANALOG","10.1021/BI201872J ",2,8.8,"4dl1_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_T_)-[MAN(5_T_)-[MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)]-NAG(1_T_)-ASN(317_H_)",31.9327,"","",""
"4DL1","CRYSTAL STRUCTURE OF HUMAN MYELOPEROXIDASE WITH COVALENT THIOXANTHINE ANALOG","10.1021/BI201872J ",2,8.8,"4dl1_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_W_)-[MAN(5_W_)-[MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)]-NAG(1_W_)-ASN(317_O_)",38.8638,"","",""
"4DL1","CRYSTAL STRUCTURE OF HUMAN MYELOPEROXIDASE WITH COVALENT THIOXANTHINE ANALOG","10.1021/BI201872J ",2,8.8,"4dl1_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Y_)-[MAN(4_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(189_P_)",37.6947,"","",""
"4DL1","CRYSTAL STRUCTURE OF HUMAN MYELOPEROXIDASE WITH COVALENT THIOXANTHINE ANALOG","10.1021/BI201872J ",2,8.8,"4dl1_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_S_)-[MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)]-NAG(1_S_)-ASN(317_G_)",40.9082,"","",""
"4DL1","CRYSTAL STRUCTURE OF HUMAN MYELOPEROXIDASE WITH COVALENT THIOXANTHINE ANALOG","10.1021/BI201872J ",2,8.8,"4dl1_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_Q_)-[MAN(5_Q_)-[MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)]-NAG(1_Q_)-ASN(317_C_)",30.2408,"","",""
"4DL1","CRYSTAL STRUCTURE OF HUMAN MYELOPEROXIDASE WITH COVALENT THIOXANTHINE ANALOG","10.1021/BI201872J ",2,8.8,"4dl1_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_R_)-[MAN(5_R_)-[MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)]-NAG(1_R_)-ASN(317_D_)",27.3439,"","",""
"4DL1","CRYSTAL STRUCTURE OF HUMAN MYELOPEROXIDASE WITH COVALENT THIOXANTHINE ANALOG","10.1021/BI201872J ",2,8.8,"4dl1_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_U_)-[MAN(5_U_)-[MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)]-NAG(1_U_)-ASN(317_K_)",31.3267,"","",""
"4DO4","PHARMACOLOGICAL CHAPERONES FOR HUMAN ALPHA-N-ACETYLGALACTOSAMINIDASE","10.1073/PNAS.1203924109 ",1.4,31.11,"4do4_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(177_B_)",72.9245,"","",""
"4DO4","PHARMACOLOGICAL CHAPERONES FOR HUMAN ALPHA-N-ACETYLGALACTOSAMINIDASE","10.1073/PNAS.1203924109 ",1.4,31.11,"4do4_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(177_A_)",65.2056,"","",""
"4DO5","PHARMACOLOGICAL CHAPERONES FOR HUMAN ALPHA-N-ACETYLGALACTOSAMINIDASE","10.1073/PNAS.1203924109 ",1.51,29.56,"4do5_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(177_B_)",67.6104,"","",""
"4DO5","PHARMACOLOGICAL CHAPERONES FOR HUMAN ALPHA-N-ACETYLGALACTOSAMINIDASE","10.1073/PNAS.1203924109 ",1.51,29.56,"4do5_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(177_A_)",57.1147,"","",""
"4DO6","PHARMACOLOGICAL CHAPERONES FOR HUMAN ALPHA-N-ACETYLGALACTOSAMINIDASE","10.1073/PNAS.1203924109 ",1.6,30.99,"4do6_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(177_A_)",59.6395,"","",""
"4DO6","PHARMACOLOGICAL CHAPERONES FOR HUMAN ALPHA-N-ACETYLGALACTOSAMINIDASE","10.1073/PNAS.1203924109 ",1.6,30.99,"4do6_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(177_B_)",67.1178,"","",""
"4DQO","CRYSTAL STRUCTURE OF PG16 FAB IN COMPLEX WITH V1V2 REGION FROM HIV-1 STRAIN ZM109","10.1038/NSMB.2600 ",2.44,0,"4dqo_oligo1","DNeup5Aca2-6DGalpb1-4DGlcpNAcb1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(10_B_)-[MAN(9_B_)]-MAN(8_B_)-[SIA(7_B_)-GAL(6_B_)-NAG(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(173_C_)",69.023,"","",""
"4DQO","CRYSTAL STRUCTURE OF PG16 FAB IN COMPLEX WITH V1V2 REGION FROM HIV-1 STRAIN ZM109","10.1038/NSMB.2600 ",2.44,0,"4dqo_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_A_)-[MAN(5_A_)]-MAN(4_A_)-[MAN(7_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(160_C_)",60.5177,"","",""
"4DRV","CELL ATTACHMENT PROTEIN VP8* OF A HUMAN ROTAVIRUS SPECIFICALLY INTERACTS WITH A-TYPE HISTO-BLOOD GROUP ANTIGEN","10.1038/NATURE10996 ",1.56,0,"4drv_oligo1","LFucpa1-2[DGalpNAca1-3]DGalpa1-ROH","A2G(3_B_)-[FUC(2_B_)]-GLA(1_B_)",9.40091,"","",""
"4DS0","CELL ATTACHMENT PROTEIN VP8* OF A HUMAN ROTAVIRUS SPECIFICALLY INTERACTS WITH A-TYPE HISTO-BLOOD GROUP ANTIGEN","10.1038/NATURE10996 ",1.56,0,"4ds0_oligo1","LFucpa1-2[DGalpNAca1-3]DGalpb1-4DGlcpNAcb1-ROH","A2G(4_B_)-[FUC(3_B_)]-GAL(2_B_)-NAG(1_B_)",32.3318,"","",""
"4DSY","CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH MAYBRIDGE FRAGMENT CC24201","10.1111/CBDD.12001 ",2.3,0,"4dsy_oligo9","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_L_)-[FUC(2_L_)]-NAG(1_L_)-ASN(109_D_)",73.4491,"","",""
"4DSY","CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH MAYBRIDGE FRAGMENT CC24201","10.1111/CBDD.12001 ",2.3,0,"4dsy_oligo6","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_I_)-[FUC(2_I_)]-NAG(1_I_)-ASN(396_B_)",36.5964,"","",""
"4DSY","CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH MAYBRIDGE FRAGMENT CC24201","10.1111/CBDD.12001 ",2.3,0,"4dsy_oligo5","LFucpa1-3DGlcpNAcb1-ASN","FUC(2_H_)-NAG(1_H_)-ASN(109_B_)",65.4146,"","",""
"4DSY","CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH MAYBRIDGE FRAGMENT CC24201","10.1111/CBDD.12001 ",2.3,0,"4dsy_oligo10","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_M_)-[FUC(2_M_)]-NAG(1_M_)-ASN(396_D_)",48.0688,"","",""
"4DSY","CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH MAYBRIDGE FRAGMENT CC24201","10.1111/CBDD.12001 ",2.3,0,"4dsy_oligo8","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_K_)-[FUC(2_K_)]-NAG(1_K_)-ASN(396_C_)",50.4255,"","",""
"4DSY","CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH MAYBRIDGE FRAGMENT CC24201","10.1111/CBDD.12001 ",2.3,0,"4dsy_oligo3","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_F_)-[FUC(2_F_)]-NAG(1_F_)-ASN(109_A_)",59.1394,"","",""
"4DSY","CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH MAYBRIDGE FRAGMENT CC24201","10.1111/CBDD.12001 ",2.3,0,"4dsy_oligo2","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_E_)-[FUC(2_E_)]-NAG(1_E_)-ASN(81_A_)",56.6736,"","",""
"4DSY","CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH MAYBRIDGE FRAGMENT CC24201","10.1111/CBDD.12001 ",2.3,0,"4dsy_oligo7","LFucpa1-3DGlcpNAcb1-ASN","FUC(2_J_)-NAG(1_J_)-ASN(109_C_)",67.0805,"","",""
"4DSY","CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH MAYBRIDGE FRAGMENT CC24201","10.1111/CBDD.12001 ",2.3,0,"4dsy_oligo4","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_G_)-[FUC(2_G_)]-NAG(1_G_)-ASN(396_A_)",33.7276,"","",""
"4DT2","CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH MAYBRIDGE FRAGMENT CC27209","10.1111/CBDD.12001 ",2.7,0,"4dt2_oligo2","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_E_)-[FUC(2_E_)]-NAG(1_E_)-ASN(109_A_)",61.6127,"","",""
"4DT2","CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH MAYBRIDGE FRAGMENT CC27209","10.1111/CBDD.12001 ",2.7,0,"4dt2_oligo9","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_M_)-[FUC(2_M_)]-NAG(1_M_)-ASN(396_D_)",62.8085,"","",""
"4DT2","CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH MAYBRIDGE FRAGMENT CC27209","10.1111/CBDD.12001 ",2.7,0,"4dt2_oligo1","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_G_)-[FUC(2_G_)]-NAG(1_G_)-ASN(81_A_)",58.6824,"","",""
"4DT2","CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH MAYBRIDGE FRAGMENT CC27209","10.1111/CBDD.12001 ",2.7,0,"4dt2_oligo4","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_H_)-[FUC(2_H_)]-NAG(1_H_)-ASN(396_B_)",50.9248,"","",""
"4DT2","CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH MAYBRIDGE FRAGMENT CC27209","10.1111/CBDD.12001 ",2.7,0,"4dt2_oligo8","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_L_)-[FUC(2_L_)]-NAG(1_L_)-ASN(109_D_)",81.493,"","",""
"4DT2","CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH MAYBRIDGE FRAGMENT CC27209","10.1111/CBDD.12001 ",2.7,0,"4dt2_oligo7","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_K_)-[FUC(2_K_)]-NAG(1_K_)-ASN(396_C_)",65.4833,"","",""
"4DT2","CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH MAYBRIDGE FRAGMENT CC27209","10.1111/CBDD.12001 ",2.7,0,"4dt2_oligo5","LFucpa1-3DGlcpNAcb1-ASN","FUC(2_I_)-NAG(1_I_)-ASN(109_B_)",69.6,"","",""
"4DT2","CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH MAYBRIDGE FRAGMENT CC27209","10.1111/CBDD.12001 ",2.7,0,"4dt2_oligo6","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_J_)-[FUC(2_J_)]-NAG(1_J_)-ASN(109_C_)",65.683,"","",""
"4DT2","CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH MAYBRIDGE FRAGMENT CC27209","10.1111/CBDD.12001 ",2.7,0,"4dt2_oligo3","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_F_)-[FUC(2_F_)]-NAG(1_F_)-ASN(396_A_)",41.72,"","",""
"4DUR","THE X-RAY CRYSTAL STRUCTURE OF FULL-LENGTH TYPE II HUMAN PLASMINOGEN","10.1016/J.CELREP.2012.02.012 ",2.45,34.19,"4dur_oligo1","DNeup5Aca2-3DGalpb1-3DGlcpNAcb1-THR","SIA(3_D_)-GAL(2_D_)-NAG(1_D_)-THR(346_B_)",84.2399,"","",""
"4DUR","THE X-RAY CRYSTAL STRUCTURE OF FULL-LENGTH TYPE II HUMAN PLASMINOGEN","10.1016/J.CELREP.2012.02.012 ",2.45,34.19,"4dur_oligo2","DNeup5Aca2-3DGalpb1-3DGlcpNAcb1-THR","SIA(3_C_)-GAL(2_C_)-NAG(1_C_)-THR(346_A_)",82.2564,"","",""
"4DVK","CRYSTAL STRUCTURE OF THE GLYCOPROTEIN ERNS FROM THE PESTIVIRUS BVDV-1 STRAIN NCP-7","10.1016/J.STR.2012.03.018 ",2.21,42.29,"4dvk_oligo3","DManpb1-6DManpb1-3[DManpa1-4DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_E_)-MAN(6_E_)-[BMA(5_E_)-BMA(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(4_B_)",54.4716,"","",""
"4DVK","CRYSTAL STRUCTURE OF THE GLYCOPROTEIN ERNS FROM THE PESTIVIRUS BVDV-1 STRAIN NCP-7","10.1016/J.STR.2012.03.018 ",2.21,42.29,"4dvk_oligo1","DManpa1-4DManpa1-6[DManpb1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-[BMA(6_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(4_A_)",51.8759,"","",""
"4DVL","CRYSTAL STRUCTURE OF THE GLYCOPROTEIN ERNS FROM THE PESTIVIRUS BVDV-1 IN COMPLEX WITH 2'-3'-CYCLO-UMP","10.1016/J.STR.2012.03.018 ",2.75,62.41,"4dvl_oligo6","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(4_A_)",64.992,"","",""
"4DVL","CRYSTAL STRUCTURE OF THE GLYCOPROTEIN ERNS FROM THE PESTIVIRUS BVDV-1 IN COMPLEX WITH 2'-3'-CYCLO-UMP","10.1016/J.STR.2012.03.018 ",2.75,62.41,"4dvl_oligo2","DManpb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-[BMA(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(4_B_)",63.0053,"","",""
"4DVL","CRYSTAL STRUCTURE OF THE GLYCOPROTEIN ERNS FROM THE PESTIVIRUS BVDV-1 IN COMPLEX WITH 2'-3'-CYCLO-UMP","10.1016/J.STR.2012.03.018 ",2.75,62.41,"4dvl_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(13_A_)",82.3284,"","",""
"4DVN","CRYSTAL STRUCTURE OF THE GLYCOPROTEIN ERNS FROM THE PESTIVIRUS BVDV-1 IN COMPLEX WITH 2'-UMP","10.1016/J.STR.2012.03.018 ",2.38,33.59,"4dvn_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(4_B_)",42.4427,"","",""
"4DVN","CRYSTAL STRUCTURE OF THE GLYCOPROTEIN ERNS FROM THE PESTIVIRUS BVDV-1 IN COMPLEX WITH 2'-UMP","10.1016/J.STR.2012.03.018 ",2.38,33.59,"4dvn_oligo6","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(4_A_)",43.696,"","",""
"4DVN","CRYSTAL STRUCTURE OF THE GLYCOPROTEIN ERNS FROM THE PESTIVIRUS BVDV-1 IN COMPLEX WITH 2'-UMP","10.1016/J.STR.2012.03.018 ",2.38,33.59,"4dvn_oligo9","DManpb1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[BMA(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(13_A_)",51.3482,"","",""
"4DW0","CRYSTAL STRUCTURE OF THE ATP-GATED P2X4 ION CHANNEL IN THE CLOSED, APO STATE AT 2.9 ANGSTROMS","10.1038/NATURE11010 ",2.9,0,"4dw0_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(213_A_)",121.21,"","",""
"4DW1","CRYSTAL STRUCTURE OF THE ATP-GATED P2X4 ION CHANNEL IN THE ATP-BOUND, OPEN STATE AT 2.8 ANGSTROMS","10.1038/NATURE11010 ",2.8,0,"4dw1_oligo3","DManpa1-3DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(213_A_)",96.7509,"","",""
"4DW3","CRYSTAL STRUCTURE OF THE GLYCOPROTEIN ERNS FROM THE PESTIVIRUS BVDV-1 IN COMPLEX WITH 5'-CMP","10.1016/J.STR.2012.03.018 ",2.35,38.96,"4dw3_oligo7","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(13_A_)",49.4885,"","",""
"4DW3","CRYSTAL STRUCTURE OF THE GLYCOPROTEIN ERNS FROM THE PESTIVIRUS BVDV-1 IN COMPLEX WITH 5'-CMP","10.1016/J.STR.2012.03.018 ",2.35,38.96,"4dw3_oligo3","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(4_B_)",44.0882,"","",""
"4DW3","CRYSTAL STRUCTURE OF THE GLYCOPROTEIN ERNS FROM THE PESTIVIRUS BVDV-1 IN COMPLEX WITH 5'-CMP","10.1016/J.STR.2012.03.018 ",2.35,38.96,"4dw3_oligo6","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(4_A_)",45.8547,"","",""
"4DW4","CRYSTAL STRUCTURE OF THE GLYCOPROTEIN ERNS FROM THE PESTIVIRUS BVDV-1 IN COMPLEX WITH 5'-UMP","10.1016/J.STR.2012.03.018 ",2.23,28.63,"4dw4_oligo11","DManpa1-2DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(6_G_)-[MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(4_B_)",37.4459,"","",""
"4DW4","CRYSTAL STRUCTURE OF THE GLYCOPROTEIN ERNS FROM THE PESTIVIRUS BVDV-1 IN COMPLEX WITH 5'-UMP","10.1016/J.STR.2012.03.018 ",2.23,28.63,"4dw4_oligo5","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(4_A_)",39.7051,"","",""
"4DW4","CRYSTAL STRUCTURE OF THE GLYCOPROTEIN ERNS FROM THE PESTIVIRUS BVDV-1 IN COMPLEX WITH 5'-UMP","10.1016/J.STR.2012.03.018 ",2.23,28.63,"4dw4_oligo8","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(13_A_)",35.8104,"","",""
"4DW5","CRYSTAL STRUCTURE OF THE GLYCOPROTEIN ERNS FROM THE PESTIVIRUS BVDV-1 IN COMPLEX WITH A NON-CLEAVABLE CPU DINUCLEOTIDE","10.1016/J.STR.2012.03.018 ",2.21,49.18,"4dw5_oligo8","DManpb1-6DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(6_C_)-[BMA(5_C_)-BMA(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(4_A_)",53.6144,"","",""
"4DW5","CRYSTAL STRUCTURE OF THE GLYCOPROTEIN ERNS FROM THE PESTIVIRUS BVDV-1 IN COMPLEX WITH A NON-CLEAVABLE CPU DINUCLEOTIDE","10.1016/J.STR.2012.03.018 ",2.21,49.18,"4dw5_oligo3","DManpb1-6DManpb1-3[DManpb1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(7_F_)-MAN(6_F_)-[BMA(5_F_)-BMA(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(4_B_)",56.4982,"","",""
"4DW7","CRYSTAL STRUCTURE OF AN ACTIVE-SITE MUTANT OF THE GLYCOPROTEIN ERNS FROM THE PESTIVIRUS BVDV-1 IN COMPLEX WITH A CPU DINUCLEOTIDE","10.1016/J.STR.2012.03.018 ",3.08,79.18,"4dw7_oligo5","DManpb1-6DManpb1-3[DManpa1-4DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_E_)-MAN(6_E_)-[BMA(5_E_)-BMA(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(4_B_)",112.431,"","",""
"4DW7","CRYSTAL STRUCTURE OF AN ACTIVE-SITE MUTANT OF THE GLYCOPROTEIN ERNS FROM THE PESTIVIRUS BVDV-1 IN COMPLEX WITH A CPU DINUCLEOTIDE","10.1016/J.STR.2012.03.018 ",3.08,79.18,"4dw7_oligo6","DManpb1-6DManpb1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_C_)-BMA(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(4_A_)",86.0696,"","",""
"4DWA","CRYSTAL STRUCTURE OF AN ACTIVE-SITE MUTANT OF THE GLYCOPROTEIN ERNS FROM THE PESTIVIRUS BVDV-1 IN COMPLEX WITH A CPUPC TRINUCLEOTIDE","10.1016/J.STR.2012.03.018 ",3.01,47.86,"4dwa_oligo4","DManpb1-6DManpb1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_G_)-[BMA(5_G_)-BMA(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(4_B_)",66.3174,"","",""
"4DWA","CRYSTAL STRUCTURE OF AN ACTIVE-SITE MUTANT OF THE GLYCOPROTEIN ERNS FROM THE PESTIVIRUS BVDV-1 IN COMPLEX WITH A CPUPC TRINUCLEOTIDE","10.1016/J.STR.2012.03.018 ",3.01,47.86,"4dwa_oligo12","DManpb1-6DManpb1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_C_)-BMA(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(4_A_)",56.0309,"","",""
"4DWC","CRYSTAL STRUCTURE OF THE GLYCOPROTEIN ERNS FROM THE PESTIVIRUS BVDV-1 IN COMPLEX WITH ZN IONS","10.1016/J.STR.2012.03.018 ",2.89,52.74,"4dwc_oligo4","DManpa1-6DManpb1-3[DManpb1-4DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(7_F_)-MAN(6_F_)-[MAN(5_F_)-BMA(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(4_B_)",63.0664,"","",""
"4DWC","CRYSTAL STRUCTURE OF THE GLYCOPROTEIN ERNS FROM THE PESTIVIRUS BVDV-1 IN COMPLEX WITH ZN IONS","10.1016/J.STR.2012.03.018 ",2.89,52.74,"4dwc_oligo1","DManpa1-6DManpb1-3[DManpb1-4DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(7_C_)-MAN(6_C_)-[MAN(5_C_)-BMA(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(4_A_)",71.7091,"","",""
"4DXG","CRYSTAL STRUCTURE OF STAPHYLOCOCCAL SUPERANTIGEN-LIKE PROTEIN 4 COMPLEXED WITH SIALYL LEWIS X","10.1128/IAI.00764-12 ",2.5,25.62,"4dxg_oligo1","DNeup5Aca2-3DGalpb1-4[LFucpa1-3]DGlcpNAca1-ROH","SIA(3_B_)-GAL(2_B_)-[FUC(4_B_)]-NDG(1_B_)",17.0882,"","",""
"4DZ8","HUMAN IGG1 FC FRAGMENT HETERODIMER","10.1016/J.JMB.2012.04.020 ",1.91,32.06,"4dz8_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",34.3539,"","",""
"4DZ8","HUMAN IGG1 FC FRAGMENT HETERODIMER","10.1016/J.JMB.2012.04.020 ",1.91,32.06,"4dz8_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",59.2558,"","",""
"4EBZ","CRYSTAL STRUCTURE OF THE ECTODOMAIN OF A RECEPTOR LIKE KINASE","10.1126/SCIENCE.1218867 ",1.79,0,"4ebz_oligo1","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(102_A_)",57.1115,"","",""
"4EC3","STRUCTURE OF BERBERINE BRIDGE ENZYME, H174A VARIANT IN COMPLEX WITH (S)-RETICULINE","10.1021/BI300411N ",2.65,0,"4ec3_oligo3","DManpa1-2DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-MAN(5_B_)-MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(38_A_)",54.6136,"","",""
"4EE3","CRYSTAL STRUCTURE OF HUMAN M340H-BETA-1,4-GALACTOSYLTRANSFERASE-1 (M340H-B4GAL-T1) IN COMPLEX WITH PENTASACCHARIDE","10.1074/JBC.M112.373514 ",2.3,32.05,"4ee3_oligo5","DGalpb1-3DGlcpNAcb1-3[DGlcpNAcb1-6]DGalpb1-4DGlcpb1-ROH","NAG(5_F_)-[GAL(4_F_)-NAG(3_F_)]-GAL(2_F_)-BGC(1_F_)",73.6733,"","",""
"4EE3","CRYSTAL STRUCTURE OF HUMAN M340H-BETA-1,4-GALACTOSYLTRANSFERASE-1 (M340H-B4GAL-T1) IN COMPLEX WITH PENTASACCHARIDE","10.1074/JBC.M112.373514 ",2.3,32.05,"4ee3_oligo4","DGalp[4H]b1-3DGlcpNAcb1-3[DGlcpNAcb1-6]DGalpb1-4DGlcpb1-ROH","NAG(5_E_)-GAL(4_E_)-NAG(3_E_)]-GAL(2_E_)-BGC(1_E_)",56.5583,"","",""
"4EE3","CRYSTAL STRUCTURE OF HUMAN M340H-BETA-1,4-GALACTOSYLTRANSFERASE-1 (M340H-B4GAL-T1) IN COMPLEX WITH PENTASACCHARIDE","10.1074/JBC.M112.373514 ",2.3,32.05,"4ee3_oligo1","DGalpb1-3DGlcpNAcb1-3[DGlcpNAcb1-6]DGalpb1-4DGlcpb1-ROH","NAG(5_D_)-[GAL(4_D_)-NAG(3_D_)]-GAL(2_D_)-BGC(1_D_)",62.1015,"","",""
"4EI5","CRYSTAL STRUCTURE OF XV19 TCR IN COMPLEX WITH CD1D-SULFATIDE C24:1","10.1038/NI.2372 ",3.1,100.8,"4ei5_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(165_A_)",114.962,"","",""
"4ENE","STRUCTURE OF THE N- AND C-TERMINAL TRIMMED CLC-EC1 CL-/H+ ANTIPORTER AND FAB COMPLEX","10.1371/JOURNAL.PBIO.1001441 ",2.4,0,"4ene_oligo5","DGlcpa1-3DGlcpb6-C10O1","DMU(505_B_)-DMU(505_B_)",78.1782,"","",""
"4ENE","STRUCTURE OF THE N- AND C-TERMINAL TRIMMED CLC-EC1 CL-/H+ ANTIPORTER AND FAB COMPLEX","10.1371/JOURNAL.PBIO.1001441 ",2.4,0,"4ene_oligo6","DGlcpa1-3DGlcpb6-C10O1","DMU(506_B_)-DMU(506_B_)",69.9864,"","",""
"4ENE","STRUCTURE OF THE N- AND C-TERMINAL TRIMMED CLC-EC1 CL-/H+ ANTIPORTER AND FAB COMPLEX","10.1371/JOURNAL.PBIO.1001441 ",2.4,0,"4ene_oligo3","DGlcpa1-3DGlcpb6-C10O1","DMU(505_A_)-DMU(505_A_)",74.4895,"","",""
"4ENE","STRUCTURE OF THE N- AND C-TERMINAL TRIMMED CLC-EC1 CL-/H+ ANTIPORTER AND FAB COMPLEX","10.1371/JOURNAL.PBIO.1001441 ",2.4,0,"4ene_oligo4","DGlcpa1-3DGlcpb6-C10O1","DMU(506_A_)-DMU(506_A_)",84.3909,"","",""
"4ENE","STRUCTURE OF THE N- AND C-TERMINAL TRIMMED CLC-EC1 CL-/H+ ANTIPORTER AND FAB COMPLEX","10.1371/JOURNAL.PBIO.1001441 ",2.4,0,"4ene_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(504_A_)-DMU(504_A_)",80.8109,"","",""
"4ENE","STRUCTURE OF THE N- AND C-TERMINAL TRIMMED CLC-EC1 CL-/H+ ANTIPORTER AND FAB COMPLEX","10.1371/JOURNAL.PBIO.1001441 ",2.4,0,"4ene_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(503_A_)-DMU(503_A_)",72.82,"","",""
"4EXN","CRYSTAL STRUCTURE OF MOUSE INTERLEUKIN-34","10.1016/J.BBAPAP.2012.04.012 ",2.7,91.52,"4exn_oligo2","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(76_B_)",125.708,"","",""
"4EXN","CRYSTAL STRUCTURE OF MOUSE INTERLEUKIN-34","10.1016/J.BBAPAP.2012.04.012 ",2.7,91.52,"4exn_oligo7","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_K_)-[BMA(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(76_F_)",126.989,"","",""
"4EXN","CRYSTAL STRUCTURE OF MOUSE INTERLEUKIN-34","10.1016/J.BBAPAP.2012.04.012 ",2.7,91.52,"4exn_oligo5","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(76_E_)",137.419,"","",""
"4EXN","CRYSTAL STRUCTURE OF MOUSE INTERLEUKIN-34","10.1016/J.BBAPAP.2012.04.012 ",2.7,91.52,"4exn_oligo4","DManpb1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[BMA(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(76_A_)",104.646,"","",""
"4EZM","CRYSTAL STRUCTURE OF THE HUMAN IGE-FC(EPSILON)3-4 BOUND TO ITS B CELL RECEPTOR DERCD23","10.1073/PNAS.1207278109 ",3.1,110.9,"4ezm_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_R_)-[MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)",147.718,"","",""
"4EZM","CRYSTAL STRUCTURE OF THE HUMAN IGE-FC(EPSILON)3-4 BOUND TO ITS B CELL RECEPTOR DERCD23","10.1073/PNAS.1207278109 ",3.1,110.9,"4ezm_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)",151.795,"","",""
"4EZM","CRYSTAL STRUCTURE OF THE HUMAN IGE-FC(EPSILON)3-4 BOUND TO ITS B CELL RECEPTOR DERCD23","10.1073/PNAS.1207278109 ",3.1,110.9,"4ezm_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_P_)-[MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)",130.967,"","",""
"4EZM","CRYSTAL STRUCTURE OF THE HUMAN IGE-FC(EPSILON)3-4 BOUND TO ITS B CELL RECEPTOR DERCD23","10.1073/PNAS.1207278109 ",3.1,110.9,"4ezm_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)",148.886,"","",""
"4EZM","CRYSTAL STRUCTURE OF THE HUMAN IGE-FC(EPSILON)3-4 BOUND TO ITS B CELL RECEPTOR DERCD23","10.1073/PNAS.1207278109 ",3.1,110.9,"4ezm_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)",151.017,"","",""
"4EZM","CRYSTAL STRUCTURE OF THE HUMAN IGE-FC(EPSILON)3-4 BOUND TO ITS B CELL RECEPTOR DERCD23","10.1073/PNAS.1207278109 ",3.1,110.9,"4ezm_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_Q_)-[MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)",148.671,"","",""
"4F0A","CRYSTAL STRUCTURE OF XWNT8 IN COMPLEX WITH THE CYSTEINE-RICH DOMAIN OF FRIZZLED 8","10.1126/SCIENCE.1222879 ",3.25,0,"4f0a_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(104_B_)",142.802,"","",""
"4F4C","THE CRYSTAL STRUCTURE OF THE MULTI-DRUG TRANSPORTER","10.1038/NATURE11448 ",3.4,145.9,"4f4c_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAca1-ASN","MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(125_A_)",199.646,"","",""
"4F7B","STRUCTURE OF THE LYSOSOMAL DOMAIN OF LIMP-2","10.1038/NATURE12684 ",3,84.68,"4f7b_oligo10","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Y_)-[NAG(5_Y_)-MAN(4_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(412_E_)",97.8735,"","",""
"4F7B","STRUCTURE OF THE LYSOSOMAL DOMAIN OF LIMP-2","10.1038/NATURE12684 ",3,84.68,"4f7b_oligo23","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_c_)-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(68_F_)",83.6927,"","",""
"4F7B","STRUCTURE OF THE LYSOSOMAL DOMAIN OF LIMP-2","10.1038/NATURE12684 ",3,84.68,"4f7b_oligo22","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_b_)-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(304_E_)",103.826,"","",""
"4F7B","STRUCTURE OF THE LYSOSOMAL DOMAIN OF LIMP-2","10.1038/NATURE12684 ",3,84.68,"4f7b_oligo19","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_M_)-[NAG(5_M_)-MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(412_B_)",124.786,"","",""
"4F7B","STRUCTURE OF THE LYSOSOMAL DOMAIN OF LIMP-2","10.1038/NATURE12684 ",3,84.68,"4f7b_oligo11","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(68_A_)",87.3598,"","",""
"4F7B","STRUCTURE OF THE LYSOSOMAL DOMAIN OF LIMP-2","10.1038/NATURE12684 ",3,84.68,"4f7b_oligo24","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_d_)-[MAN(4_d_)]-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(412_F_)",96.1684,"","",""
"4F7B","STRUCTURE OF THE LYSOSOMAL DOMAIN OF LIMP-2","10.1038/NATURE12684 ",3,84.68,"4f7b_oligo2","DGlcpNAcb1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_H_)-MAN(4_H_)-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(412_A_)",82.9984,"","",""
"4F7B","STRUCTURE OF THE LYSOSOMAL DOMAIN OF LIMP-2","10.1038/NATURE12684 ",3,84.68,"4f7b_oligo9","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_X_)-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(68_E_)",67.3536,"","",""
"4F7B","STRUCTURE OF THE LYSOSOMAL DOMAIN OF LIMP-2","10.1038/NATURE12684 ",3,84.68,"4f7b_oligo5","DGlcpNAcb1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_T_)-MAN(4_T_)-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(412_D_)",96.1451,"","",""
"4F7C","CRYSTAL STRUCTURE OF BOVINE CD1D WITH BOUND C12-DI-SULFATIDE","10.1371/JOURNAL.PONE.0047989 ",2.86,46.08,"4f7c_oligo3","DManpb1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_H_)-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(42_C_)",83.6034,"","",""
"4F9U","STRUCTURE OF GLYCOSYLATED GLUTAMINYL CYCLASE FROM DROSOPHILA MELANOGASTER","10.1021/BI300687G ",1.8,17.77,"4f9u_oligo4","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-MAN(5_D_)-[MAN(7_D_)]-MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(42_B_)",40.3517,"","",""
"4F9V","STRUCTURE OF C113A/C136A MUTANT VARIANT OF GLYCOSYLATED GLUTAMINYL CYCLASE FROM DROSOPHILA MELANOGASTER","10.1021/BI300687G ",2.1,21.13,"4f9v_oligo4","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_C_)-MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(42_A_)",63.6726,"","",""
"4FBV","CRYSTAL STRUCTURE OF THE MYXOCOCCUS XANTHUS HEMAGGLUTININ IN COMPLEX WITH A3,A6-MANNOPENTAOSE","10.1074/JBC.M112.388579 ",1.76,24.26,"4fbv_oligo3","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-ROH","MAN(4_B_)-[MAN(3_B_)]-MAN(2_B_)-BMA(1_B_)",35.3327,"","",""
"4FBV","CRYSTAL STRUCTURE OF THE MYXOCOCCUS XANTHUS HEMAGGLUTININ IN COMPLEX WITH A3,A6-MANNOPENTAOSE","10.1074/JBC.M112.388579 ",1.76,24.26,"4fbv_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-ROH","MAN(4_C_)-[MAN(3_C_)]-MAN(2_C_)-[MAN(5_C_)]-BMA(1_C_)",21.8129,"","",""
"4FMK","CRYSTAL STRUCTURE OF MOUSE NECTIN-2 EXTRACELLULAR FRAGMENT D1-D2","10.1038/NSMB.2366 ",2.56,88.03,"4fmk_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_B_)-[MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(138_A_)",154.553,"","",""
"4FMK","CRYSTAL STRUCTURE OF MOUSE NECTIN-2 EXTRACELLULAR FRAGMENT D1-D2","10.1038/NSMB.2366 ",2.56,88.03,"4fmk_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_C_)-[MAN(4_C_)-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(128_A_)",146.853,"","",""
"4FNK","CRYSTAL STRUCTURE OF THE A/HONG KONG/1/1968 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ","10.1038/NATURE11414 ",1.9,0,"4fnk_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(165_E_)",59.8676,"","",""
"4FOM","CRYSTAL STRUCTURE OF HUMAN NECTIN-3 FULL ECTODOMAIN (D1-D3)","10.1038/NSMB.2366 ",3.93,170.5,"4fom_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(222_A_)",133.415,"","",""
"4FOM","CRYSTAL STRUCTURE OF HUMAN NECTIN-3 FULL ECTODOMAIN (D1-D3)","10.1038/NSMB.2366 ",3.93,170.5,"4fom_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(73_A_)",206.898,"","",""
"4FOM","CRYSTAL STRUCTURE OF HUMAN NECTIN-3 FULL ECTODOMAIN (D1-D3)","10.1038/NSMB.2366 ",3.93,170.5,"4fom_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(6_D_)-[MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)",166.612,"","",""
"4FQC","CRYSTAL STRUCTURE OF PGT121 FAB BOUND TO A COMPLEX-TYPE SIALYLATED N- GLYCAN","10.1073/PNAS.1217207109 ",2.4,32.26,"4fqc_oligo1","DNeup5Aca2-6DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(10_A_)-[NAG(9_A_)-MAN(8_A_)-[SIA(7_A_)-GAL(6_A_)-NAG(5_A_)-MAN(4_A_)]-BMA(3_A_)-NAG(2_A_)]-NAG(1_A_)-ASN(105_H_)",38.303,"","",""
"4FQP","CRYSTAL STRUCTURE OF HUMAN NECTIN-LIKE 5 FULL ECTODOMAIN (D1-D3)","10.1038/NSMB.2366 ",3.6,116.4,"4fqp_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_C_)-[MAN(4_C_)-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(120_A_)",141.572,"","",""
"4FWW","CRYSTAL STRUCTURE OF THE SEMA-PSI EXTRACELLULAR DOMAINS OF HUMAN RON RECEPTOR TYROSINE KINASE","10.1371/JOURNAL.PONE.0041912 ",1.85,51.63,"4fww_oligo1","DManpb1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(488_A_)",56.0077,"","",""
"4G1E","CRYSTAL STRUCTURE OF INTEGRIN ALPHA V BETA 3 WITH COIL-COILED TAG.","10.1021/BI300734N ",3,0,"4g1e_oligo1","DManpa1-2DManpa1-3DManpa1-6[DManpa1-3DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-MAN(5_E_)-MAN(4_E_)-[MAN(8_E_)-MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(266_A_)",151.434,"","",""
"4G1E","CRYSTAL STRUCTURE OF INTEGRIN ALPHA V BETA 3 WITH COIL-COILED TAG.","10.1021/BI300734N ",3,0,"4g1e_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(458_A_)",166.185,"","",""
"4G1E","CRYSTAL STRUCTURE OF INTEGRIN ALPHA V BETA 3 WITH COIL-COILED TAG.","10.1021/BI300734N ",3,0,"4g1e_oligo7","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-MAN(4_I_)-[MAN(6_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(844_A_)",198.364,"","",""
"4G1M","RE-REFINEMENT OF ALPHA V BETA 3 STRUCTURE","10.1021/BI300734N ",2.9,0,"4g1m_oligo2","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_E_)-MAN(6_E_)-[MAN(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(266_A_)",118.856,"","",""
"4G1M","RE-REFINEMENT OF ALPHA V BETA 3 STRUCTURE","10.1021/BI300734N ",2.9,0,"4g1m_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(44_A_)",151.33,"","",""
"4GC2","CRYSTAL STRUCTURE OF THE BACTERIOCIN LLPA FROM PSEUDOMONAS SP. IN COMPLEX WITH GLCNAC BETA(1-2)MAN ALPHA(1-3)[GLCNAC BETA(1-2)MAN ALPHA(1-6)]MAN","10.1371/JOURNAL.PPAT.1003199 ",2.12,0,"4gc2_oligo1","DGlcpNAcb1-2DRhapa1-3[DGlcpNAcb1-2DManpa1-6]DManpa1-ROH","NAG(5_C_)-MAN(4_C_)-[NAG(3_C_)-MAN(2_C_)]-MAN(1_C_)",60.7284,"","",""
"4GDI","A SUBTYPE N10 NEURAMINIDASE-LIKE PROTEIN OF A/LITTLE YELLOW-SHOULDERED BAT/GUATEMALA/164/2009","10.1073/PNAS.1212579109 ",1.95,0,"4gdi_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpb1-3]DGlcpNAcb1-ASN","FUC(6_H_)-[MAN(4_H_)-BMA(3_H_)-NAG(2_H_)]-[FUL(5_H_)]-NAG(1_H_)-ASN(269_B_)",75.5186,"","",""
"4GEY","HIGH PH STRUCTURE OF PSEUDOMONAS PUTIDA OPRB","10.1074/JBC.M112.408518 ",2.7,0,"4gey_oligo3","DGlcpa1-3DGlcpb6-C7O1","DMU(510_A_)-DMU(510_A_)",69.3723,"","",""
"4GEY","HIGH PH STRUCTURE OF PSEUDOMONAS PUTIDA OPRB","10.1074/JBC.M112.408518 ",2.7,0,"4gey_oligo5","DGlcpa1-3DGlcpb6-C6O1","DMU(513_A_)-DMU(513_A_)",87.6559,"","",""
"4GEY","HIGH PH STRUCTURE OF PSEUDOMONAS PUTIDA OPRB","10.1074/JBC.M112.408518 ",2.7,0,"4gey_oligo2","DGlcpa1-3DGlcpb6-C8O1","DMU(511_A_)-DMU(511_A_)",57.0236,"","",""
"4GEY","HIGH PH STRUCTURE OF PSEUDOMONAS PUTIDA OPRB","10.1074/JBC.M112.408518 ",2.7,0,"4gey_oligo4","DGlcpa1-3DGlcpb6-C7O1","DMU(512_A_)-DMU(512_A_)",75.8986,"","",""
"4GK9","CRYSTAL STRUCTURE OF BURKHOLDERIA OKLAHOMENSIS AGGLUTININ (BOA) BOUND TO 3A,6A-MANNOPENTAOSE","10.1111/FEBS.12229 ",1.9,28.58,"4gk9_oligo4","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-ROH","MAN(4_B_)-[MAN(3_B_)]-MAN(2_B_)-[MAN(5_B_)]-BMA(1_B_)",34.1764,"","",""
"4GK9","CRYSTAL STRUCTURE OF BURKHOLDERIA OKLAHOMENSIS AGGLUTININ (BOA) BOUND TO 3A,6A-MANNOPENTAOSE","10.1111/FEBS.12229 ",1.9,28.58,"4gk9_oligo3","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-ROH","MAN(4_C_)-[MAN(3_C_)]-MAN(2_C_)-[MAN(5_C_)]-BMA(1_C_)",41.2527,"","",""
"4GK9","CRYSTAL STRUCTURE OF BURKHOLDERIA OKLAHOMENSIS AGGLUTININ (BOA) BOUND TO 3A,6A-MANNOPENTAOSE","10.1111/FEBS.12229 ",1.9,28.58,"4gk9_oligo5","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-ROH","MAN(4_E_)-[MAN(3_E_)]-MAN(2_E_)-[MAN(5_E_)]-BMA(1_E_)",42.3096,"","",""
"4GK9","CRYSTAL STRUCTURE OF BURKHOLDERIA OKLAHOMENSIS AGGLUTININ (BOA) BOUND TO 3A,6A-MANNOPENTAOSE","10.1111/FEBS.12229 ",1.9,28.58,"4gk9_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-ROH","MAN(4_D_)-[MAN(3_D_)]-MAN(2_D_)-[MAN(5_D_)]-BMA(1_D_)",33.3205,"","",""
"4GKO","CRYSTAL STRUCTURE OF THE CALCIUM2+-BOUND HUMAN IGE-FC(EPSILON)3-4 BOUND TO ITS B CELL RECEPTOR DERCD23","10.1074/JBC.M113.480657 ",3.3,150.8,"4gko_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_Q_)-[MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)",162.098,"","",""
"4GKO","CRYSTAL STRUCTURE OF THE CALCIUM2+-BOUND HUMAN IGE-FC(EPSILON)3-4 BOUND TO ITS B CELL RECEPTOR DERCD23","10.1074/JBC.M113.480657 ",3.3,150.8,"4gko_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)",150.779,"","",""
"4GKO","CRYSTAL STRUCTURE OF THE CALCIUM2+-BOUND HUMAN IGE-FC(EPSILON)3-4 BOUND TO ITS B CELL RECEPTOR DERCD23","10.1074/JBC.M113.480657 ",3.3,150.8,"4gko_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)",153.008,"","",""
"4GKO","CRYSTAL STRUCTURE OF THE CALCIUM2+-BOUND HUMAN IGE-FC(EPSILON)3-4 BOUND TO ITS B CELL RECEPTOR DERCD23","10.1074/JBC.M113.480657 ",3.3,150.8,"4gko_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_R_)-[MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)",172.228,"","",""
"4GKO","CRYSTAL STRUCTURE OF THE CALCIUM2+-BOUND HUMAN IGE-FC(EPSILON)3-4 BOUND TO ITS B CELL RECEPTOR DERCD23","10.1074/JBC.M113.480657 ",3.3,150.8,"4gko_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_P_)-[MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)",138.07,"","",""
"4GKO","CRYSTAL STRUCTURE OF THE CALCIUM2+-BOUND HUMAN IGE-FC(EPSILON)3-4 BOUND TO ITS B CELL RECEPTOR DERCD23","10.1074/JBC.M113.480657 ",3.3,150.8,"4gko_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)",203.398,"","",""
"4GMS","CRYSTAL STRUCTURE OF HETEROSUBTYPIC FAB S139/1 IN COMPLEX WITH INFLUENZA A H3 HEMAGGLUTININ","10.1073/PNAS.1212371109 ",2.95,0,"4gms_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(165_A_)",151.305,"","",""
"4GMS","CRYSTAL STRUCTURE OF HETEROSUBTYPIC FAB S139/1 IN COMPLEX WITH INFLUENZA A H3 HEMAGGLUTININ","10.1073/PNAS.1212371109 ",2.95,0,"4gms_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Q_)-[MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(165_C_)",147.973,"","",""
"4GMS","CRYSTAL STRUCTURE OF HETEROSUBTYPIC FAB S139/1 IN COMPLEX WITH INFLUENZA A H3 HEMAGGLUTININ","10.1073/PNAS.1212371109 ",2.95,0,"4gms_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_S_)-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(38_E_)",153.294,"","",""
"4GMS","CRYSTAL STRUCTURE OF HETEROSUBTYPIC FAB S139/1 IN COMPLEX WITH INFLUENZA A H3 HEMAGGLUTININ","10.1073/PNAS.1212371109 ",2.95,0,"4gms_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_V_)-[MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(165_E_)",134.161,"","",""
"4GMS","CRYSTAL STRUCTURE OF HETEROSUBTYPIC FAB S139/1 IN COMPLEX WITH INFLUENZA A H3 HEMAGGLUTININ","10.1073/PNAS.1212371109 ",2.95,0,"4gms_oligo11","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_W_)-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(285_E_)",163.96,"","",""
"4GOS","CRYSTAL STRUCTURE OF HUMAN B7-H4 IGV-LIKE DOMAIN","10.1016/J.CELREP.2014.09.053 ",1.59,15.87,"4gos_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(112_A_)",13.3144,"","",""
"4GRW","STRUCTURE OF A COMPLEX OF HUMAN IL-23 WITH 3 NANOBODIES (LLAMA VHHS)","10.3389/FIMMU.2017.00884 ",2.55,50.5,"4grw_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_L_)-[MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)",78.7338,"","",""
"4GRW","STRUCTURE OF A COMPLEX OF HUMAN IL-23 WITH 3 NANOBODIES (LLAMA VHHS)","10.3389/FIMMU.2017.00884 ",2.55,50.5,"4grw_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)",86.3782,"","",""
"4GT7","AN ENGINEERED DISULFIDE BOND REVERSIBLY TRAPS THE IGE-FC3-4 IN A CLOSED, NON-RECEPTOR BINDING CONFORMATION","10.1074/JBC.M112.407502 ",2.61,0,"4gt7_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(394_A_)",92.7842,"","",""
"4GT7","AN ENGINEERED DISULFIDE BOND REVERSIBLY TRAPS THE IGE-FC3-4 IN A CLOSED, NON-RECEPTOR BINDING CONFORMATION","10.1074/JBC.M112.407502 ",2.61,0,"4gt7_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(394_C_)",95.4333,"","",""
"4GT7","AN ENGINEERED DISULFIDE BOND REVERSIBLY TRAPS THE IGE-FC3-4 IN A CLOSED, NON-RECEPTOR BINDING CONFORMATION","10.1074/JBC.M112.407502 ",2.61,0,"4gt7_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(394_B_)",84.6169,"","",""
"4GTW","CRYSTAL STRUCTURE OF MOUSE ENPP1 IN COMPLEX WITH AMP","10.1073/PNAS.1208017109 ",2.7,48.3,"4gtw_oligo2","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)",61.7561,"","",""
"4GTX","CRYSTAL STRUCTURE OF MOUSE ENPP1 IN COMPLEX WITH TMP","10.1073/PNAS.1208017109 ",3.2,81.4,"4gtx_oligo2","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(567_A_)",92.6433,"","",""
"4GTY","CRYSTAL STRUCTURE OF MOUSE ENPP1 IN COMPLEX WITH GMP","10.1073/PNAS.1208017109 ",3.19,92.83,"4gty_oligo3","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(567_A_)",87.8226,"","",""
"4GTZ","CRYSTAL STRUCTURE OF MOUSE ENPP1 IN COMPLEX WITH CMP","10.1073/PNAS.1208017109 ",3.19,98.12,"4gtz_oligo5","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(567_A_)",112.192,"","",""
"4GWI","HIS 62 MUTANT OF THE LECTIN BINDING DOMAIN OF LECTINOLYSIN COMPLEXED WITH LEWIS Y","10.3389/FIMMU.2012.00330 ",1.6,27.54,"4gwi_oligo1","LFucpa1-2DGalpb1-4[LFucpa1-3]DGlcpNAcb1-ROH","FUC(3_B_)-GAL(2_B_)-[FUC(4_B_)]-NAG(1_B_)",47.4757,"","",""
"4GWJ","HIS 62 MUTANT OF THE LECTIN BINDING DOMAIN OF LECTINOLYSIN COMPLEXED WITH LEWIS B","10.3389/FIMMU.2012.00330 ",1.6,31.14,"4gwj_oligo1","LFucpa1-2DGalpb1-3[LFucpa1-4]DGlcpNAcb1-ROH","FUC(4_B_)-[FUC(3_B_)-GAL(2_B_)]-NAG(1_B_)",41.8064,"","",""
"4GWM","CRYSTAL STRUCTURE OF HUMAN PROMEPRIN BETA","10.1073/PNAS.1211076109 ",1.85,39.52,"4gwm_oligo1","LFucpa1-3DGlcpNAcb1-ASN","FUC(2_E_)-NAG(1_E_)-ASN(445_A_)",93.2827,"","",""
"4GWM","CRYSTAL STRUCTURE OF HUMAN PROMEPRIN BETA","10.1073/PNAS.1211076109 ",1.85,39.52,"4gwm_oligo7","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(6_I_)-[MAN(4_I_)-BMA(3_I_)-NAG(2_I_)]-[FUC(5_I_)]-NAG(1_I_)-ASN(370_B_)",74.617,"","",""
"4GWM","CRYSTAL STRUCTURE OF HUMAN PROMEPRIN BETA","10.1073/PNAS.1211076109 ",1.85,39.52,"4gwm_oligo8","LFucpa1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_J_)-[NAG(3_J_)]-[FUC(2_J_)]-NAG(1_J_)-ASN(445_B_)",52.712,"","",""
"4GWM","CRYSTAL STRUCTURE OF HUMAN PROMEPRIN BETA","10.1073/PNAS.1211076109 ",1.85,39.52,"4gwm_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(7_D_)-[MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-[FUC(6_D_)]-NAG(1_D_)-ASN(370_A_)",66.696,"","",""
"4GWM","CRYSTAL STRUCTURE OF HUMAN PROMEPRIN BETA","10.1073/PNAS.1211076109 ",1.85,39.52,"4gwm_oligo10","LFucpa1-3DGlcpNAcb1-ASN","FUC(2_L_)-NAG(1_L_)-ASN(436_B_)",81.6627,"","",""
"4GWM","CRYSTAL STRUCTURE OF HUMAN PROMEPRIN BETA","10.1073/PNAS.1211076109 ",1.85,39.52,"4gwm_oligo9","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_K_)-MAN(7_K_)-[MAN(6_K_)-MAN(5_K_)]-MAN(4_K_)-[MAN(9_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(547_B_)",61.5964,"","",""
"4GWM","CRYSTAL STRUCTURE OF HUMAN PROMEPRIN BETA","10.1073/PNAS.1211076109 ",1.85,39.52,"4gwm_oligo4","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_F_)-MAN(7_F_)-[MAN(6_F_)-MAN(5_F_)]-MAN(4_F_)-[MAN(9_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(547_A_)",73.6989,"","",""
"4GWN","CRYSTAL STRUCTURE OF HUMAN MATURE MEPRIN BETA","10.1073/PNAS.1211076109 ",3,113.2,"4gwn_oligo4","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_D_)-MAN(7_D_)-[MAN(6_D_)-MAN(5_D_)]-MAN(4_D_)-[MAN(10_D_)-MAN(9_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(547_A_)",131.164,"","",""
"4GWN","CRYSTAL STRUCTURE OF HUMAN MATURE MEPRIN BETA","10.1073/PNAS.1211076109 ",3,113.2,"4gwn_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(7_C_)-[MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-[FUC(6_C_)]-NAG(1_C_)-ASN(370_A_)",146.371,"","",""
"4GXX","CRYSTAL STRUCTURE OF THE ""AVIANIZED"" 1918 INFLUENZA VIRUS HEMAGGLUTININ","10.1371/JOURNAL.PPAT.1003067 ",1.8,51.52,"4gxx_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(95_A_)",66.4964,"","",""
"4GXX","CRYSTAL STRUCTURE OF THE ""AVIANIZED"" 1918 INFLUENZA VIRUS HEMAGGLUTININ","10.1371/JOURNAL.PPAT.1003067 ",1.8,51.52,"4gxx_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(95_C_)",71.4038,"","",""
"4GZ8","MOUSE SEMAPHORIN 3A, DOMAINS SEMA-PSI-IG","10.1038/NSMB.2416 ",3.3,55.9,"4gz8_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(53_A_)",80.7814,"","",""
"4GZO","N2 NEURAMINIDASE OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH HEPES","10.1128/JVI.01426-12 ",2.6,46.32,"4gzo_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",71.7114,"","",""
"4GZP","N2 NEURAMINIDASE OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH OSELTAMIVIR CARBOXYLATE","10.1128/JVI.01426-12 ",2.3,38.82,"4gzp_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",52.3113,"","",""
"4GZQ","N2 NEURAMINIDASE OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH SIALIC ACID","10.1128/JVI.01426-12 ",2.2,33.43,"4gzq_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",46.262,"","",""
"4GZS","N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH HEPES","10.1128/JVI.01426-12 ",2.35,29.91,"4gzs_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(200_B_)",42.7075,"","",""
"4GZS","N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH HEPES","10.1128/JVI.01426-12 ",2.35,29.91,"4gzs_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(200_A_)",42.322,"","",""
"4GZS","N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH HEPES","10.1128/JVI.01426-12 ",2.35,29.91,"4gzs_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(200_C_)",42.9418,"","",""
"4GZS","N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH HEPES","10.1128/JVI.01426-12 ",2.35,29.91,"4gzs_oligo11","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(200_D_)",44.9502,"","",""
"4GZT","N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH OSELTAMIVIR CARBOXYLATE","10.1128/JVI.01426-12 ",2.19,33.6,"4gzt_oligo6","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_E_)-[BMA(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(200_A_)",44.2975,"","",""
"4GZT","N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH OSELTAMIVIR CARBOXYLATE","10.1128/JVI.01426-12 ",2.19,33.6,"4gzt_oligo7","LFucpa1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_K_)-[NAG(3_K_)]-[FUC(2_K_)]-NAG(1_K_)-ASN(146_D_)",65.0284,"","",""
"4GZT","N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH OSELTAMIVIR CARBOXYLATE","10.1128/JVI.01426-12 ",2.19,33.6,"4gzt_oligo1","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_G_)-[BMA(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(200_B_)",43.2925,"","",""
"4GZT","N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH OSELTAMIVIR CARBOXYLATE","10.1128/JVI.01426-12 ",2.19,33.6,"4gzt_oligo2","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_H_)-[BMA(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(200_C_)",42.7575,"","",""
"4GZT","N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH OSELTAMIVIR CARBOXYLATE","10.1128/JVI.01426-12 ",2.19,33.6,"4gzt_oligo5","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_J_)-[BMA(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(200_D_)",44.9751,"","",""
"4GZW","N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH AVIAN SIALIC ACID RECEPTOR","10.1128/JVI.01426-12 ",2.45,28.67,"4gzw_oligo7","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_H_)-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(200_B_)",35.5918,"","",""
"4GZW","N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH AVIAN SIALIC ACID RECEPTOR","10.1128/JVI.01426-12 ",2.45,28.67,"4gzw_oligo6","DNeup5Aca2-3DGalpb1-3DGlcpNAcb1-ROH","SIA(3_G_)-GAL(2_G_)-NAG(1_G_)",63.165,"","",""
"4GZW","N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH AVIAN SIALIC ACID RECEPTOR","10.1128/JVI.01426-12 ",2.45,28.67,"4gzw_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_L_)-[MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(200_D_)",42.0722,"","",""
"4GZW","N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH AVIAN SIALIC ACID RECEPTOR","10.1128/JVI.01426-12 ",2.45,28.67,"4gzw_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(200_C_)",40.5615,"","",""
"4GZW","N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH AVIAN SIALIC ACID RECEPTOR","10.1128/JVI.01426-12 ",2.45,28.67,"4gzw_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(200_A_)",38.4856,"","",""
"4GZX","N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH HUMAN SIALIC ACID RECEPTOR","10.1128/JVI.01426-12 ",2.45,28.56,"4gzx_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(200_D_)",42.4858,"","",""
"4GZX","N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH HUMAN SIALIC ACID RECEPTOR","10.1128/JVI.01426-12 ",2.45,28.56,"4gzx_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(200_B_)",40.5431,"","",""
"4GZX","N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH HUMAN SIALIC ACID RECEPTOR","10.1128/JVI.01426-12 ",2.45,28.56,"4gzx_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(200_C_)",42.3964,"","",""
"4GZX","N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH HUMAN SIALIC ACID RECEPTOR","10.1128/JVI.01426-12 ",2.45,28.56,"4gzx_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(200_A_)",41.1193,"","",""
"4H04","LACTO-N-BIOSIDASE FROM BIFIDOBACTERIUM BIFIDUM","10.1074/JBC.M112.420109 ",1.8,17.14,"4h04_oligo1","DGalpb1-3DGlcpNAcb1-ROH","GAL(2_C_)-NAG(1_C_)",11.5873,"","",""
"4H04","LACTO-N-BIOSIDASE FROM BIFIDOBACTERIUM BIFIDUM","10.1074/JBC.M112.420109 ",1.8,17.14,"4h04_oligo2","DGalpb1-3DGlcpNAcb1-ROH","GAL(2_D_)-NAG(1_D_)",10.0686,"","",""
"4H52","WILD-TYPE INFLUENZA N2 NEURAMINIDASE COVALENT COMPLEX WITH 3-FLUORO- NEU5AC","10.1038/NCOMMS2487 ",1.8,19.51,"4h52_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(200_A_)",21.0382,"","",""
"4H52","WILD-TYPE INFLUENZA N2 NEURAMINIDASE COVALENT COMPLEX WITH 3-FLUORO- NEU5AC","10.1038/NCOMMS2487 ",1.8,19.51,"4h52_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(200_B_)",18.2868,"","",""
"4H53","INFLUENZA N2-TYR406ASP NEURAMINIDASE IN COMPLEX WITH BETA-NEU5AC","10.1038/NCOMMS2487 ",1.5,12.35,"4h53_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-[MAN(5_E_)]-MAN(4_E_)-[MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(200_A_)",12.8038,"","",""
"4H53","INFLUENZA N2-TYR406ASP NEURAMINIDASE IN COMPLEX WITH BETA-NEU5AC","10.1038/NCOMMS2487 ",1.5,12.35,"4h53_oligo10","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-MAN(4_N_)-[MAN(6_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(200_D_)",11.7938,"","",""
"4H53","INFLUENZA N2-TYR406ASP NEURAMINIDASE IN COMPLEX WITH BETA-NEU5AC","10.1038/NCOMMS2487 ",1.5,12.35,"4h53_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_H_)-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(200_B_)",13.4316,"","",""
"4H53","INFLUENZA N2-TYR406ASP NEURAMINIDASE IN COMPLEX WITH BETA-NEU5AC","10.1038/NCOMMS2487 ",1.5,12.35,"4h53_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(146_B_)",19.5795,"","",""
"4H53","INFLUENZA N2-TYR406ASP NEURAMINIDASE IN COMPLEX WITH BETA-NEU5AC","10.1038/NCOMMS2487 ",1.5,12.35,"4h53_oligo7","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_K_)-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(200_C_)",11.8698,"","",""
"4H53","INFLUENZA N2-TYR406ASP NEURAMINIDASE IN COMPLEX WITH BETA-NEU5AC","10.1038/NCOMMS2487 ",1.5,12.35,"4h53_oligo6","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(146_C_)",19.578,"","",""
"4HAF","CRYSTAL STRUCTURE OF FC-FRAGMENT OF HUMAN IGG2 ANTIBODY (PRIMITIVE CRYSTAL FORM)","10.1016/J.MOLIMM.2013.03.018 ",2.04,35.1,"4haf_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",64.2141,"","",""
"4HAG","CRYSTAL STRUCTURE OF FC-FRAGMENT OF HUMAN IGG2 ANTIBODY (CENTERED CRYSTAL FORM)","10.1016/J.MOLIMM.2013.03.018 ",3.4,193.5,"4hag_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_B_)-MAN(6_B_)-[NAG(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(297_A_)",227.074,"","",""
"4HJ1","CRYSTAL STRUCTURE OF GLYCOPROTEIN C FROM RIFT VALLEY FEVER VIRUS (GLYCOSYLATED)","10.1073/PNAS.1217780110 ",1.9,57,"4hj1_oligo8","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_G_)-[BMA(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(1035_C_)",97.1602,"","",""
"4HJ1","CRYSTAL STRUCTURE OF GLYCOPROTEIN C FROM RIFT VALLEY FEVER VIRUS (GLYCOSYLATED)","10.1073/PNAS.1217780110 ",1.9,57,"4hj1_oligo9","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_H_)-[BMA(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(1035_D_)",62.8318,"","",""
"4HLZ","CRYSTAL STRUCTURE OF FAB C179 IN COMPLEX WITH A H2N2 INFLUENZA VIRUS HEMAGGLUTININ","10.1128/JVI.02975-12 ",2.9,0,"4hlz_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_N_)-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(289_C_)",127.88,"","",""
"4HPG","CRYSTAL STRUCTURE OF A GLYCOSYLATED BETA-1,3-GLUCANASE (HEV B 2), AN ALLERGEN FROM HEVEA BRASILIENSIS","10.1107/S1399004713027673 ",2.54,0,"4hpg_oligo7","LFucpa1-3DGlcpNAcb1-ASN","FUC(2_F_)-NAG(1_F_)-ASN(27_C_)",53.9791,"","",""
"4HPG","CRYSTAL STRUCTURE OF A GLYCOSYLATED BETA-1,3-GLUCANASE (HEV B 2), AN ALLERGEN FROM HEVEA BRASILIENSIS","10.1107/S1399004713027673 ",2.54,0,"4hpg_oligo6","LFucpa1-3DGlcpNAcb1-ASN","FUC(2_E_)-NAG(1_E_)-ASN(27_B_)",59.3741,"","",""
"4HQ1","CRYSTAL STRUCTURE OF AN LRR PROTEIN WITH TWO SOLENOIDS","10.1038/CR.2012.159 ",1.55,20.68,"4hq1_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_B_)-[MAN(4_B_)-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(158_A_)",28.7464,"","",""
"4HSA","STRUCTURE OF INTERLEUKIN 17A IN COMPLEX WITH IL17RA RECEPTOR","10.1038/NCOMMS2880 ",3.15,106.3,"4hsa_oligo1","DManpa1-3DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_G_)-[MAN(4_G_)-MAN(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(194_C_)",180.885,"","",""
"4HSA","STRUCTURE OF INTERLEUKIN 17A IN COMPLEX WITH IL17RA RECEPTOR","10.1038/NCOMMS2880 ",3.15,106.3,"4hsa_oligo4","DManpa1-3DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_J_)-[MAN(4_J_)-MAN(3_J_)-NAG(2_J_)]-NAG(1_J_)-ASN(194_F_)",212.222,"","",""
"4I4X","BEL BETA-TREFOIL COMPLEX WITH T-ANTIGEN DISACCHARIDE","10.1093/GLYCOB/CWS164 ",1.72,10.79,"4i4x_oligo6","DGalpb1-3DGalpNAca1-ROH","GAL(2_J_)-A2G(1_J_)",24.3459,"","",""
"4I4X","BEL BETA-TREFOIL COMPLEX WITH T-ANTIGEN DISACCHARIDE","10.1093/GLYCOB/CWS164 ",1.72,10.79,"4i4x_oligo2","DGalpb1-3DGalpNAca1-ROH","GAL(2_F_)-A2G(1_F_)",10.8473,"","",""
"4I4X","BEL BETA-TREFOIL COMPLEX WITH T-ANTIGEN DISACCHARIDE","10.1093/GLYCOB/CWS164 ",1.72,10.79,"4i4x_oligo7","DGalpb1-3DGalpNAca1-ROH","GAL(2_K_)-A2G(1_K_)",17.9432,"","",""
"4I4X","BEL BETA-TREFOIL COMPLEX WITH T-ANTIGEN DISACCHARIDE","10.1093/GLYCOB/CWS164 ",1.72,10.79,"4i4x_oligo4","DGalpb1-3DGalpNAca1-ROH","GAL(2_H_)-A2G(1_H_)",12.0177,"","",""
"4I4X","BEL BETA-TREFOIL COMPLEX WITH T-ANTIGEN DISACCHARIDE","10.1093/GLYCOB/CWS164 ",1.72,10.79,"4i4x_oligo1","DGalpb1-3DGalpNAca1-ROH","GAL(2_E_)-A2G(1_E_)",13.8155,"","",""
"4I4X","BEL BETA-TREFOIL COMPLEX WITH T-ANTIGEN DISACCHARIDE","10.1093/GLYCOB/CWS164 ",1.72,10.79,"4i4x_oligo5","DGalpb1-3DGalpNAca1-ROH","GAL(2_I_)-A2G(1_I_)",9.11545,"","",""
"4I4X","BEL BETA-TREFOIL COMPLEX WITH T-ANTIGEN DISACCHARIDE","10.1093/GLYCOB/CWS164 ",1.72,10.79,"4i4x_oligo3","DGalpb1-3DGalpNAca1-ROH","GAL(2_G_)-A2G(1_G_)",21.9436,"","",""
"4I4Y","BEL BETA-TREFOIL COMPLEX WITH T-ANTIGEN","10.1093/GLYCOB/CWS164 ",1.9,20.6,"4i4y_oligo6","DGalpb1-3DGalpNAca1-SER","GAL(2_J_)-A2G(1_J_)-SER(206_D_)",40.3036,"","",""
"4I4Y","BEL BETA-TREFOIL COMPLEX WITH T-ANTIGEN","10.1093/GLYCOB/CWS164 ",1.9,20.6,"4i4y_oligo4","DGalpb1-3DGalpNAca1-SER","GAL(2_F_)-A2G(1_F_)-SER(206_B_)",31.5377,"","",""
"4I4Y","BEL BETA-TREFOIL COMPLEX WITH T-ANTIGEN","10.1093/GLYCOB/CWS164 ",1.9,20.6,"4i4y_oligo1","DGalpb1-3DGalpNAca1-SER","GAL(2_G_)-A2G(1_G_)-SER(209_B_)",40.9705,"","",""
"4I4Y","BEL BETA-TREFOIL COMPLEX WITH T-ANTIGEN","10.1093/GLYCOB/CWS164 ",1.9,20.6,"4i4y_oligo2","DGalpb1-3DGalpNAca1-SER","GAL(2_H_)-A2G(1_H_)-SER(203_C_)",24.3745,"","",""
"4I4Y","BEL BETA-TREFOIL COMPLEX WITH T-ANTIGEN","10.1093/GLYCOB/CWS164 ",1.9,20.6,"4i4y_oligo5","DGalpb1-3DGalpNAca1-SER","GAL(2_I_)-A2G(1_I_)-SER(203_D_)",43.5936,"","",""
"4I8D","CRYSTAL STRUCTURE OF BETA-D-GLUCOSIDE GLUCOHYDROLASE FROM TRICHODERMA REESEI","10.1074/JBC.M114.587766 ",2.48,48.42,"4i8d_oligo3","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_C_)-[MAN(7_C_)]-MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(208_A_)",82.5772,"","",""
"4I8D","CRYSTAL STRUCTURE OF BETA-D-GLUCOSIDE GLUCOHYDROLASE FROM TRICHODERMA REESEI","10.1074/JBC.M114.587766 ",2.48,48.42,"4i8d_oligo4","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_D_)-[MAN(7_D_)]-MAN(6_D_)-[MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(208_B_)",67.0916,"","",""
"4I8D","CRYSTAL STRUCTURE OF BETA-D-GLUCOSIDE GLUCOHYDROLASE FROM TRICHODERMA REESEI","10.1074/JBC.M114.587766 ",2.48,48.42,"4i8d_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(310_B_)",96.2291,"","",""
"4IHZ","CRYSTAL STRUCTURE OF CRATABL, A TRYPSIN INHIBITOR FROM CRATAEVA TAPIA","10.1371/JOURNAL.PONE.0064426 ",1.5,28.77,"4ihz_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","BMA(3_C_)-NAG(2_C_)-[FUC(4_C_)]-NAG(1_C_)",48.9152,"","",""
"4II0","CRYSTAL STRUCTURE OF CRATABL, A TRYPSIN INHIBITOR FROM CRATAEVA TAPIA","10.1371/JOURNAL.PONE.0064426 ",1.75,29.69,"4ii0_oligo2","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcx1-","NAG(3_C_)-[FUC(2_C_)]-NAG(1_C_)",58.8421,"","",""
"4IIB","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS","10.1042/BJ20130054 ",1.8,14.54,"4iib_oligo9","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_J_)-[MAN(6_J_)-MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(61_B_)",20.0062,"","",""
"4IIB","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS","10.1042/BJ20130054 ",1.8,14.54,"4iib_oligo7","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(61_A_)",27.5032,"","",""
"4IIB","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS","10.1042/BJ20130054 ",1.8,14.54,"4iib_oligo6","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_I_)-[MAN(6_I_)-MAN(5_I_)]-MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(564_A_)",25.467,"","",""
"4IIB","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS","10.1042/BJ20130054 ",1.8,14.54,"4iib_oligo5","DManpa1-2DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-MAN(5_H_)-MAN(4_H_)-[MAN(7_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(523_A_)",23.8221,"","",""
"4IIB","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS","10.1042/BJ20130054 ",1.8,14.54,"4iib_oligo11","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_L_)-MAN(7_L_)-[MAN(6_L_)-MAN(5_L_)]-MAN(4_L_)-[MAN(10_L_)-MAN(9_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(322_B_)",14.1725,"","",""
"4IIB","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS","10.1042/BJ20130054 ",1.8,14.54,"4iib_oligo2","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_F_)-MAN(7_F_)-[MAN(5_F_)]-MAN(4_F_)-[MAN(10_F_)-MAN(9_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(322_A_)",17.7161,"","",""
"4IIB","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS","10.1042/BJ20130054 ",1.8,14.54,"4iib_oligo15","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_P_)-[MAN(6_P_)-MAN(5_P_)]-MAN(4_P_)-[MAN(8_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(564_B_)",30.0343,"","",""
"4IIB","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS","10.1042/BJ20130054 ",1.8,14.54,"4iib_oligo13","DManpa1-2DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(6_N_)-MAN(5_N_)-MAN(4_N_)-[MAN(7_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)",25.4592,"","",""
"4IIB","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS","10.1042/BJ20130054 ",1.8,14.54,"4iib_oligo14","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_O_)-MAN(4_O_)-[MAN(6_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)",28.6177,"","",""
"4IIC","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH ISOFAGOMINE","10.1042/BJ20130054 ",1.9,19.2,"4iic_oligo8","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_I_)-[MAN(6_I_)-MAN(5_I_)]-MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(564_A_)",36.5064,"","",""
"4IIC","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH ISOFAGOMINE","10.1042/BJ20130054 ",1.9,19.2,"4iic_oligo15","DManpa1-2DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_O_)-MAN(5_O_)-MAN(4_O_)-[MAN(7_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(523_B_)",31.201,"","",""
"4IIC","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH ISOFAGOMINE","10.1042/BJ20130054 ",1.9,19.2,"4iic_oligo13","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_M_)-MAN(7_M_)-[MAN(6_M_)-MAN(5_M_)]-MAN(4_M_)-[MAN(10_M_)-MAN(9_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(322_B_)",20.0635,"","",""
"4IIC","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH ISOFAGOMINE","10.1042/BJ20130054 ",1.9,19.2,"4iic_oligo16","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_P_)-[MAN(6_P_)-MAN(5_P_)]-MAN(4_P_)-[MAN(8_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(564_B_)",40.5639,"","",""
"4IIC","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH ISOFAGOMINE","10.1042/BJ20130054 ",1.9,19.2,"4iic_oligo5","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_F_)-MAN(7_F_)-[MAN(6_F_)-MAN(5_F_)]-MAN(4_F_)-[MAN(10_F_)-MAN(9_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(322_A_)",24.5409,"","",""
"4IIC","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH ISOFAGOMINE","10.1042/BJ20130054 ",1.9,19.2,"4iic_oligo7","DManpa1-2DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-MAN(5_H_)-MAN(4_H_)-[MAN(7_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(523_A_)",29.9751,"","",""
"4IIC","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH ISOFAGOMINE","10.1042/BJ20130054 ",1.9,19.2,"4iic_oligo10","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_J_)-[MAN(6_J_)-MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(61_B_)",24.0031,"","",""
"4IIC","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH ISOFAGOMINE","10.1042/BJ20130054 ",1.9,19.2,"4iic_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(61_A_)",43.2304,"","",""
"4IID","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH 1-DEOXYNOJIRIMYCIN","10.1042/BJ20130054 ",2.3,22.81,"4iid_oligo2","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_F_)-MAN(7_F_)-[MAN(6_F_)-MAN(5_F_)]-MAN(4_F_)-[MAN(10_F_)-MAN(9_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(322_A_)",30.195,"","",""
"4IID","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH 1-DEOXYNOJIRIMYCIN","10.1042/BJ20130054 ",2.3,22.81,"4iid_oligo11","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(252_B_)",51.3945,"","",""
"4IID","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH 1-DEOXYNOJIRIMYCIN","10.1042/BJ20130054 ",2.3,22.81,"4iid_oligo16","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_P_)-[MAN(6_P_)-MAN(5_P_)]-MAN(4_P_)-[MAN(8_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(564_B_)",46.8316,"","",""
"4IID","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH 1-DEOXYNOJIRIMYCIN","10.1042/BJ20130054 ",2.3,22.81,"4iid_oligo9","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_I_)-[MAN(6_I_)-MAN(5_I_)]-MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(564_A_)",41.997,"","",""
"4IID","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH 1-DEOXYNOJIRIMYCIN","10.1042/BJ20130054 ",2.3,22.81,"4iid_oligo13","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_M_)-MAN(7_M_)-[MAN(6_M_)-MAN(5_M_)]-MAN(4_M_)-[MAN(10_M_)-MAN(9_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(322_B_)",24.709,"","",""
"4IID","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH 1-DEOXYNOJIRIMYCIN","10.1042/BJ20130054 ",2.3,22.81,"4iid_oligo10","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_J_)-[MAN(6_J_)-MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(61_B_)",30.6323,"","",""
"4IID","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH 1-DEOXYNOJIRIMYCIN","10.1042/BJ20130054 ",2.3,22.81,"4iid_oligo15","DManpa1-2DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_O_)-MAN(5_O_)-MAN(4_O_)-[MAN(7_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(523_B_)",38.5771,"","",""
"4IID","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH 1-DEOXYNOJIRIMYCIN","10.1042/BJ20130054 ",2.3,22.81,"4iid_oligo7","DManpa1-2DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-MAN(5_H_)-MAN(4_H_)-[MAN(7_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(523_A_)",37.3352,"","",""
"4IIE","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH CALYSTEGINE B(2)","10.1042/BJ20130054 ",2,21.14,"4iie_oligo14","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_P_)-[MAN(6_P_)-MAN(5_P_)]-MAN(4_P_)-[MAN(8_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(564_B_)",43.7843,"","",""
"4IIE","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH CALYSTEGINE B(2)","10.1042/BJ20130054 ",2,21.14,"4iie_oligo9","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-MAN(4_K_)-[MAN(6_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(252_B_)",49.642,"","",""
"4IIE","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH CALYSTEGINE B(2)","10.1042/BJ20130054 ",2,21.14,"4iie_oligo3","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_F_)-MAN(7_F_)-[MAN(6_F_)-MAN(5_F_)]-MAN(4_F_)-[MAN(10_F_)-MAN(9_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(322_A_)",29.4585,"","",""
"4IIE","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH CALYSTEGINE B(2)","10.1042/BJ20130054 ",2,21.14,"4iie_oligo7","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_I_)-[MAN(6_I_)-MAN(5_I_)]-MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(564_A_)",39.3431,"","",""
"4IIE","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH CALYSTEGINE B(2)","10.1042/BJ20130054 ",2,21.14,"4iie_oligo11","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_M_)-MAN(7_M_)-[MAN(6_M_)-MAN(5_M_)]-MAN(4_M_)-[MAN(10_M_)-MAN(9_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(322_B_)",22.0026,"","",""
"4IIE","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH CALYSTEGINE B(2)","10.1042/BJ20130054 ",2,21.14,"4iie_oligo6","DManpa1-2DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-MAN(5_H_)-MAN(4_H_)-[MAN(7_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(523_A_)",31.9227,"","",""
"4IIE","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH CALYSTEGINE B(2)","10.1042/BJ20130054 ",2,21.14,"4iie_oligo13","DManpa1-2DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_O_)-MAN(5_O_)-MAN(4_O_)-[MAN(7_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(523_B_)",32.3396,"","",""
"4IIE","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH CALYSTEGINE B(2)","10.1042/BJ20130054 ",2,21.14,"4iie_oligo8","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_J_)-[MAN(6_J_)-MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(61_B_)",27.0173,"","",""
"4IIF","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH CASTANOSPERMINE","10.1042/BJ20130054 ",2.45,27.25,"4iif_oligo7","DManpa1-2DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_I_)-MAN(5_I_)-MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(564_A_)",42.9252,"","",""
"4IIF","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH CASTANOSPERMINE","10.1042/BJ20130054 ",2.45,27.25,"4iif_oligo11","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_M_)-MAN(7_M_)-[MAN(6_M_)-MAN(5_M_)]-MAN(4_M_)-[MAN(10_M_)-MAN(9_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(322_B_)",30.0085,"","",""
"4IIF","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH CASTANOSPERMINE","10.1042/BJ20130054 ",2.45,27.25,"4iif_oligo5","DManpa1-2DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-MAN(5_H_)-MAN(4_H_)-[MAN(7_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(523_A_)",41.1492,"","",""
"4IIF","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH CASTANOSPERMINE","10.1042/BJ20130054 ",2.45,27.25,"4iif_oligo13","DManpa1-2DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_O_)-MAN(5_O_)-MAN(4_O_)-[MAN(7_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(523_B_)",43.8439,"","",""
"4IIF","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH CASTANOSPERMINE","10.1042/BJ20130054 ",2.45,27.25,"4iif_oligo14","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_P_)-[MAN(6_P_)-MAN(5_P_)]-MAN(4_P_)-[MAN(8_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(564_B_)",50.9044,"","",""
"4IIF","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH CASTANOSPERMINE","10.1042/BJ20130054 ",2.45,27.25,"4iif_oligo6","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_F_)-MAN(7_F_)-[MAN(6_F_)-MAN(5_F_)]-MAN(4_F_)-[MAN(10_F_)-MAN(9_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(322_A_)",35.1524,"","",""
"4IIF","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH CASTANOSPERMINE","10.1042/BJ20130054 ",2.45,27.25,"4iif_oligo8","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_J_)-[MAN(6_J_)-MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(61_B_)",36.1693,"","",""
"4IIG","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH D-GLUCOSE","10.1042/BJ20130054 ",2.3,24.24,"4iig_oligo17","DManpa1-2DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_O_)-MAN(5_O_)-MAN(4_O_)-[MAN(7_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(523_B_)",39.8387,"","",""
"4IIG","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH D-GLUCOSE","10.1042/BJ20130054 ",2.3,24.24,"4iig_oligo9","DManpa1-2DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-MAN(5_H_)-MAN(4_H_)-[MAN(7_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(523_A_)",38.4318,"","",""
"4IIG","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH D-GLUCOSE","10.1042/BJ20130054 ",2.3,24.24,"4iig_oligo12","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_J_)-[MAN(6_J_)-MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(61_B_)",32.6139,"","",""
"4IIG","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH D-GLUCOSE","10.1042/BJ20130054 ",2.3,24.24,"4iig_oligo13","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-MAN(4_K_)-[MAN(6_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(252_B_)",59.2486,"","",""
"4IIG","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH D-GLUCOSE","10.1042/BJ20130054 ",2.3,24.24,"4iig_oligo15","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_M_)-MAN(7_M_)-[MAN(6_M_)-MAN(5_M_)]-MAN(4_M_)-[MAN(10_M_)-MAN(9_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(322_B_)",27.0105,"","",""
"4IIG","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH D-GLUCOSE","10.1042/BJ20130054 ",2.3,24.24,"4iig_oligo10","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_I_)-[MAN(6_I_)-MAN(5_I_)]-MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(564_A_)",44.4231,"","",""
"4IIG","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH D-GLUCOSE","10.1042/BJ20130054 ",2.3,24.24,"4iig_oligo7","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_F_)-MAN(7_F_)-[MAN(6_F_)-MAN(5_F_)]-MAN(4_F_)-[MAN(10_F_)-MAN(9_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(322_A_)",29.7901,"","",""
"4IIG","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH D-GLUCOSE","10.1042/BJ20130054 ",2.3,24.24,"4iig_oligo11","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(61_A_)",50.9671,"","",""
"4IIG","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH D-GLUCOSE","10.1042/BJ20130054 ",2.3,24.24,"4iig_oligo18","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_P_)-[MAN(6_P_)-MAN(5_P_)]-MAN(4_P_)-[MAN(8_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(564_B_)",47.0197,"","",""
"4IIH","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH THIOCELLOBIOSE","10.1042/BJ20130054 ",2,14.33,"4iih_oligo8","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_J_)-[MAN(6_J_)-MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(61_B_)",18.6712,"","",""
"4IIH","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH THIOCELLOBIOSE","10.1042/BJ20130054 ",2,14.33,"4iih_oligo9","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-MAN(4_K_)-[MAN(6_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(252_B_)",29.3738,"","",""
"4IIH","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH THIOCELLOBIOSE","10.1042/BJ20130054 ",2,14.33,"4iih_oligo13","DManpa1-2DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_O_)-MAN(5_O_)-MAN(4_O_)-[MAN(7_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(523_B_)",31.2708,"","",""
"4IIH","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH THIOCELLOBIOSE","10.1042/BJ20130054 ",2,14.33,"4iih_oligo3","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_F_)-MAN(7_F_)-[MAN(6_F_)-MAN(5_F_)]-MAN(4_F_)-[MAN(10_F_)-MAN(9_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(322_A_)",18.8849,"","",""
"4IIH","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH THIOCELLOBIOSE","10.1042/BJ20130054 ",2,14.33,"4iih_oligo7","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_C_)-[MAN(6_C_)-MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(61_A_)",44.1347,"","",""
"4IIH","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH THIOCELLOBIOSE","10.1042/BJ20130054 ",2,14.33,"4iih_oligo14","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_P_)-[MAN(6_P_)-MAN(5_P_)]-MAN(4_P_)-[MAN(8_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(564_B_)",35.8414,"","",""
"4IIH","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH THIOCELLOBIOSE","10.1042/BJ20130054 ",2,14.33,"4iih_oligo11","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_M_)-MAN(7_M_)-[MAN(6_M_)-MAN(5_M_)]-MAN(4_M_)-[MAN(10_M_)-MAN(9_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(322_B_)",14.876,"","",""
"4IIH","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH THIOCELLOBIOSE","10.1042/BJ20130054 ",2,14.33,"4iih_oligo5","DManpa1-2DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-MAN(5_H_)-MAN(4_H_)-[MAN(7_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(523_A_)",30.5023,"","",""
"4IIH","CRYSTAL STRUCTURE OF BETA-GLUCOSIDASE 1 FROM ASPERGILLUS ACULEATUS IN COMPLEX WITH THIOCELLOBIOSE","10.1042/BJ20130054 ",2,14.33,"4iih_oligo6","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_I_)-[MAN(6_I_)-MAN(5_I_)]-MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(564_A_)",29.8397,"","",""
"4IUG","CRYSTAL STRUCTURE OF BETA-GALACTOSIDASE FROM ASPERGILLUS ORYZAE IN COMPLEX WITH GALACTOSE","10.1016/J.IJBIOMAC.2013.05.003 ",2.6,0,"4iug_oligo1","DGlcpNAcb1-4DManpb1-3DGlcpNAcb1-4DManp[6P]b1-3DGlcpNAcb1-4DManpb1-3DGlcpNAcb1-4DManpb1-4DManpb1-ROH","NAG(9_G_)-BMA(8_G_)-NAG(7_G_)-M6D(6_G_)-NAG(5_G_)-BMA(4_G_)-NAG(3_G_)-BMA(2_G_)-BMA(1_G_)",47.5542,"","",""
"4IUG","CRYSTAL STRUCTURE OF BETA-GALACTOSIDASE FROM ASPERGILLUS ORYZAE IN COMPLEX WITH GALACTOSE","10.1016/J.IJBIOMAC.2013.05.003 ",2.6,0,"4iug_oligo4","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_C_)-MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(622_A_)",35.3595,"","",""
"4IUG","CRYSTAL STRUCTURE OF BETA-GALACTOSIDASE FROM ASPERGILLUS ORYZAE IN COMPLEX WITH GALACTOSE","10.1016/J.IJBIOMAC.2013.05.003 ",2.6,0,"4iug_oligo8","DManpa1-2DManpa1-2[DManpa1-6]DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(10_F_)-[MAN(9_F_)]-MAN(8_F_)-[MAN(7_F_)-[MAN(6_F_)-MAN(5_F_)]-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(914_A_)",36.2238,"","",""
"4IUG","CRYSTAL STRUCTURE OF BETA-GALACTOSIDASE FROM ASPERGILLUS ORYZAE IN COMPLEX WITH GALACTOSE","10.1016/J.IJBIOMAC.2013.05.003 ",2.6,0,"4iug_oligo5","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_B_)-MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)",38.9815,"","",""
"4J0M","CRYSTAL STRUCTURE OF BRL1 (LRR) IN COMPLEX WITH BRASSINOLIDE","10.1007/S13238-013-3027-8 ",2.5,25.82,"4j0m_oligo7","DManpa1-2DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_I_)-MAN(5_I_)-MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(257_B_)",24.37,"","",""
"4J0M","CRYSTAL STRUCTURE OF BRL1 (LRR) IN COMPLEX WITH BRASSINOLIDE","10.1007/S13238-013-3027-8 ",2.5,25.82,"4j0m_oligo1","DManpa1-2DRhapa1-3DManpa1-6DManpb1-4DGlcpNb1-4DGlcpNAcb1-ASN","MAN(6_D_)-MAN(5_D_)-MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(257_A_)",24.6055,"","",""
"4J12","MONOMERIC FC","10.1074/JBC.M113.457689 ",1.9,49.35,"4j12_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_B_)-MAN(6_B_)-[NAG(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(297_A_)",95.8401,"","",""
"4J4P","THE COMPLEX OF HUMAN IGE-FC WITH TWO BOUND FAB FRAGMENTS","10.1038/NSMB.2795 ",2.91,104.7,"4j4p_oligo1","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_E_)-[BMA(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(394_A_)",103.719,"","",""
"4J4P","THE COMPLEX OF HUMAN IGE-FC WITH TWO BOUND FAB FRAGMENTS","10.1038/NSMB.2795 ",2.91,104.7,"4j4p_oligo2","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_F_)-[BMA(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(394_B_)",114.223,"","",""
"4J4Q","CRYSTAL STRUCTURE OF ACTIVE CONFORMATION OF GPCR OPSIN STABILIZED BY OCTYLGLUCOSIDE","10.1002/ANIE.201302374 ",2.65,55.82,"4j4q_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(15_A_)",74.1677,"","",""
"4J6G","CRYSTAL STRUCTURE OF LIGHT AND DCR3 COMPLEX","10.1016/J.STR.2014.06.013 ",2.4,41.91,"4j6g_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(173_C_)",67.9679,"","",""
"4JHV","T2-DEPLETED LACCASE FROM CORIOLOPSIS CAPERATA","10.1107/S1399004715001595 ",1.6,17.89,"4jhv_oligo2","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-MAN(4_B_)-[MAN(6_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(54_A_)",30.9898,"","",""
"4JKP","RESTRICTING HIV-1 PATHWAYS FOR ESCAPE USING RATIONALLY-DESIGNED ANTI- HIV-1 ANTIBODIES","10.1084/JEM.20130221 ",2.82,0,"4jkp_oligo3","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_A_)-MAN(4_A_)-[MAN(6_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(276_G_)",146.906,"","",""
"4JKP","RESTRICTING HIV-1 PATHWAYS FOR ESCAPE USING RATIONALLY-DESIGNED ANTI- HIV-1 ANTIBODIES","10.1084/JEM.20130221 ",2.82,0,"4jkp_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(262_G_)",102.461,"","",""
"4JM2","CRYSTAL STRUCTURE OF PGT 135 FAB IN COMPLEX WITH GP120 CORE PROTEIN FROM HIV-1 STRAIN JR-FL BOUND TO CD4 AND 17B FAB","10.1038/NSMB.2594 ",3.1,0,"4jm2_oligo1","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_G_)-[MAN(7_G_)]-MAN(6_G_)-[MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(332_E_)",104.132,"","",""
"4JM2","CRYSTAL STRUCTURE OF PGT 135 FAB IN COMPLEX WITH GP120 CORE PROTEIN FROM HIV-1 STRAIN JR-FL BOUND TO CD4 AND 17B FAB","10.1038/NSMB.2594 ",3.1,0,"4jm2_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_H_)-MAN(8_H_)-[MAN(10_H_)]-MAN(7_H_)-[MAN(6_H_)-MAN(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(392_E_)",101.841,"","",""
"4JS1","CRYSTAL STRUCTURE OF HUMAN BETA-GALACTOSIDE ALPHA-2,6- SIALYLTRANSFERASE 1 IN COMPLEX WITH CYTIDINE AND PHOSPHATE","10.1107/S0907444913015412 ",2.09,0,"4js1_oligo3","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(9_B_)-NAG(8_B_)-MAN(7_B_)-[GAL(6_B_)-NAG(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(149_A_)",99.1286,"","",""
"4JS2","CRYSTAL STRUCTURE OF HUMAN BETA-GALACTOSIDE ALPHA-2,6- SIALYLTRANSFERASE 1 IN COMPLEX WITH CMP","10.1107/S0907444913015412 ",2.3,0,"4js2_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(9_B_)-NAG(8_B_)-MAN(7_B_)-[GAL(6_B_)-NAG(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(149_A_)",96.6658,"","",""
"4JY4","CRYSTAL STRUCTURE OF HUMAN FAB PGT121, A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY","10.1371/JOURNAL.PPAT.1003342 ",2.8,0,"4jy4_oligo1","DNeup5Aca2-6DGalpb1-4DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_C_)-[MAN(8_C_)-[SIA(7_C_)-GAL(6_C_)-NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(103_B_)",73.8247,"","",""
"4JYW","X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH CTT1057","",1.73,22.91,"4jyw_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(638_A_)",27.1751,"","",""
"4JZ0","X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH CTT1055","",1.83,38.81,"4jz0_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(638_A_)",52.8027,"","",""
"4JZJ","CRYSTAL STRUCTURE OF RECEPTOR-FAB COMPLEX","10.1016/J.CELREP.2014.06.038 ",2.8,50.31,"4jzj_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6][LFucpb1-3]DGlcpNAcx1-","FUL(7_E_)-[MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-[FUL(6_E_)]-NAG(1_E_)",83.4233,"","",""
"4JZJ","CRYSTAL STRUCTURE OF RECEPTOR-FAB COMPLEX","10.1016/J.CELREP.2014.06.038 ",2.8,50.31,"4jzj_oligo3","LFucpa1-3[LFucpb1-6]DGlcpNAcx1-","FUL(3_G_)-[FUC(2_G_)]-NAG(1_G_)",111.065,"","",""
"4K1H","INDUCED OPENING OF INFLUENZA VIRUS NEURAMINIDASE N2 150-LOOP SUGGESTS AN IMPORTANT ROLE IN INHIBITOR BINDING","10.1038/SREP01551 ",1.8,24.68,"4k1h_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(200_B_)",32.8284,"","",""
"4K1H","INDUCED OPENING OF INFLUENZA VIRUS NEURAMINIDASE N2 150-LOOP SUGGESTS AN IMPORTANT ROLE IN INHIBITOR BINDING","10.1038/SREP01551 ",1.8,24.68,"4k1h_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(200_A_)",31.1129,"","",""
"4K1I","INDUCED OPENING OF INFLUENZA VIRUS NEURAMINIDASE N2 150-LOOP SUGGESTS AN IMPORTANT ROLE IN INHIBITOR BINDING","10.1038/SREP01551 ",1.8,20.05,"4k1i_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(200_B_)",22.7289,"","",""
"4K1I","INDUCED OPENING OF INFLUENZA VIRUS NEURAMINIDASE N2 150-LOOP SUGGESTS AN IMPORTANT ROLE IN INHIBITOR BINDING","10.1038/SREP01551 ",1.8,20.05,"4k1i_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(200_A_)",21.222,"","",""
"4K1J","INDUCED OPENING OF INFLUENZA VIRUS NEURAMINIDASE N2 150-LOOP SUGGESTS AN IMPORTANT ROLE IN INHIBITOR BINDING","10.1038/SREP01551 ",2.2,13.96,"4k1j_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(200_A_)",16.1425,"","",""
"4K1J","INDUCED OPENING OF INFLUENZA VIRUS NEURAMINIDASE N2 150-LOOP SUGGESTS AN IMPORTANT ROLE IN INHIBITOR BINDING","10.1038/SREP01551 ",2.2,13.96,"4k1j_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(200_B_)",16.5934,"","",""
"4K1K","INDUCED OPENING OF INFLUENZA VIRUS NEURAMINIDASE N2 150-LOOP SUGGESTS AN IMPORTANT ROLE IN INHIBITOR BINDING","10.1038/SREP01551 ",1.6,20.71,"4k1k_oligo2","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(200_A_)",24.3984,"","",""
"4K1K","INDUCED OPENING OF INFLUENZA VIRUS NEURAMINIDASE N2 150-LOOP SUGGESTS AN IMPORTANT ROLE IN INHIBITOR BINDING","10.1038/SREP01551 ",1.6,20.71,"4k1k_oligo4","DManpa1-2DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-MAN(5_F_)-MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(200_B_)",28.5656,"","",""
"4K1Y","CRYSTAL STRUCTURE OF CANAVALIA BOLIVIANA LECTIN IN COMPLEX WITH MAN1- 3MAN-OME","10.1371/JOURNAL.PONE.0097015 ",2.5,32.1,"4k1y_oligo4","DManpa1-3DManpa1-OME","MAN(2_H_)-MMA(1_H_)",39.7373,"","",""
"4K1Y","CRYSTAL STRUCTURE OF CANAVALIA BOLIVIANA LECTIN IN COMPLEX WITH MAN1- 3MAN-OME","10.1371/JOURNAL.PONE.0097015 ",2.5,32.1,"4k1y_oligo3","DManpa1-3DManpa1-OME","MAN(2_G_)-MMA(1_G_)",37.8218,"","",""
"4K1Y","CRYSTAL STRUCTURE OF CANAVALIA BOLIVIANA LECTIN IN COMPLEX WITH MAN1- 3MAN-OME","10.1371/JOURNAL.PONE.0097015 ",2.5,32.1,"4k1y_oligo1","DManpa1-3DManpa1-OME","MAN(2_E_)-MMA(1_E_)",32.2132,"","",""
"4K1Y","CRYSTAL STRUCTURE OF CANAVALIA BOLIVIANA LECTIN IN COMPLEX WITH MAN1- 3MAN-OME","10.1371/JOURNAL.PONE.0097015 ",2.5,32.1,"4k1y_oligo2","DManpa1-3DManpa1-OME","MAN(2_F_)-MMA(1_F_)",34.2641,"","",""
"4K3X","CRYSTAL STRUCTURE OF A SUBTYPE H18 HEMAGGLUTININ HOMOLOGUE FROM A/FLAT-FACED BAT/PERU/033/2010 (H18N11)","10.1371/JOURNAL.PPAT.1003657 ",2.15,0,"4k3x_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpb1-3]DGlcpNAcb1-ASN","FUC(7_K_)-[MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)]-[FUL(6_K_)]-NAG(1_K_)-ASN(242_C_)",76.5977,"","",""
"4K3X","CRYSTAL STRUCTURE OF A SUBTYPE H18 HEMAGGLUTININ HOMOLOGUE FROM A/FLAT-FACED BAT/PERU/033/2010 (H18N11)","10.1371/JOURNAL.PPAT.1003657 ",2.15,0,"4k3x_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpb1-3]DGlcpNAcb1-ASN","FUC(7_H_)-[MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)]-[FUL(6_H_)]-NAG(1_H_)-ASN(21_A_)",87.7256,"","",""
"4K3X","CRYSTAL STRUCTURE OF A SUBTYPE H18 HEMAGGLUTININ HOMOLOGUE FROM A/FLAT-FACED BAT/PERU/033/2010 (H18N11)","10.1371/JOURNAL.PPAT.1003657 ",2.15,0,"4k3x_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpb1-3]DGlcpNAcb1-ASN","FUC(7_G_)-[MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)]-[FUL(6_G_)]-NAG(1_G_)-ASN(242_A_)",65.6516,"","",""
"4K3Y","CRYSTAL STRUCTURE OF A SUBTYPE N11 NEURAMINIDASE-LIKE PROTEIN OF A/FLAT-FACED BAT/PERU/033/2010 (H18N11)","10.1371/JOURNAL.PPAT.1003657 ",2.68,0,"4k3y_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_I_)-[MAN(4_I_)-BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(401_C_)",125.798,"","",""
"4K79","RECOGNITION OF THE THOMSEN-FRIEDENREICH ANTIGEN BY A LAMPREY VARIABLE LYMPHOCYTE RECEPTOR","10.1074/JBC.M113.480467 ",2.2,28.6,"4k79_oligo2","DGalpb1-3DGalpNAca1-ROH","GAL(2_F_)-A2G(1_F_)",30.2427,"","",""
"4K79","RECOGNITION OF THE THOMSEN-FRIEDENREICH ANTIGEN BY A LAMPREY VARIABLE LYMPHOCYTE RECEPTOR","10.1074/JBC.M113.480467 ",2.2,28.6,"4k79_oligo1","DGalpb1-3DGalpNAca1-ROH","GAL(2_E_)-A2G(1_E_)",32.6991,"","",""
"4K79","RECOGNITION OF THE THOMSEN-FRIEDENREICH ANTIGEN BY A LAMPREY VARIABLE LYMPHOCYTE RECEPTOR","10.1074/JBC.M113.480467 ",2.2,28.6,"4k79_oligo3","DGalpb1-3DGalpNAca1-ROH","GAL(2_G_)-A2G(1_G_)",34.4296,"","",""
"4KBB","STRUCTURE OF BOTULINUM NEUROTOXIN B BINDING DOMAIN IN COMPLEX WITH BOTH SYNAPTOTAGMIN II AND GD1A","10.1038/NCOMMS3058 ",2.3,24.72,"4kbb_oligo1","DNeup5Aca2-3DGalpb1-3DGalpNAcb1-4DGalp[3<R1>]b1-4DGlcpb1-ROH","SIA(5_E_)-GAL(4_E_)-NGA(3_E_)-GAL(2_E_)-BGC(1_E_)",31.5623,"","",""
"4KBB","STRUCTURE OF BOTULINUM NEUROTOXIN B BINDING DOMAIN IN COMPLEX WITH BOTH SYNAPTOTAGMIN II AND GD1A","10.1038/NCOMMS3058 ",2.3,24.72,"4kbb_oligo2","DNeup5Aca2-3DGalpb1-3DGalpNAcb1-4[DNeup5Aca2-3]DGalpb1-4DGlcpb1-ROH","SIA(5_F_)-GAL(4_F_)-NGA(3_F_)-[SIA(6_F_)]-GAL(2_F_)-BGC(1_F_)",22.5063,"","",""
"4KGG","CRYSTAL STRUCTURE OF LIGHT MUTANT2 AND DCR3 COMPLEX","10.1016/J.STR.2014.06.013 ",2.78,45.05,"4kgg_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(173_C_)",71.1311,"","",""
"4KGJ","CRYSTAL STRUCTURE OF HUMAN ALPHA-L-IDURONIDASE COMPLEX WITH 5-FLUORO- ALPHA-L-IDOPYRANOSYLURONIC ACID FLUORIDE","10.1038/NCHEMBIO.1357 ",2.99,39.85,"4kgj_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(372_A_)",61.7836,"","",""
"4KGJ","CRYSTAL STRUCTURE OF HUMAN ALPHA-L-IDURONIDASE COMPLEX WITH 5-FLUORO- ALPHA-L-IDOPYRANOSYLURONIC ACID FLUORIDE","10.1038/NCHEMBIO.1357 ",2.99,39.85,"4kgj_oligo6","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-MAN(5_F_)-[MAN(7_F_)]-MAN(4_F_)-[MAN(9_F_)-MAN(8_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(372_B_)",68.9756,"","",""
"4KGL","CRYSTAL STRUCTURE OF HUMAN ALPHA-L-IDURONIDASE COMPLEX WITH [2R,3R,4R, 5S]-2-CARBOXY-3,4,5-TRIHYDROXY-PIPERIDINE","10.1038/NCHEMBIO.1357 ",2.7,53.22,"4kgl_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(372_A_)",77.252,"","",""
"4KGL","CRYSTAL STRUCTURE OF HUMAN ALPHA-L-IDURONIDASE COMPLEX WITH [2R,3R,4R, 5S]-2-CARBOXY-3,4,5-TRIHYDROXY-PIPERIDINE","10.1038/NCHEMBIO.1357 ",2.7,53.22,"4kgl_oligo6","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-MAN(5_F_)-[MAN(7_F_)]-MAN(4_F_)-[MAN(9_F_)-MAN(8_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(372_B_)",73.9774,"","",""
"4KGQ","CRYSTAL STRUCTURE OF A HUMAN LIGHT LOOP MUTANT IN COMPLEX WITH DCR3","10.1016/J.STR.2014.06.013 ",2.27,45.55,"4kgq_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(173_C_)",66.8125,"","",""
"4KH2","CRYSTAL STRUCTURE OF HUMAN ALPHA-L-IDURONIDASE COMPLEX WITH 2-DEOXY-2- FLUORO-ALPHA-L-IDOPYRANOSYLURONIC ACID FLUORIDE","10.1038/NCHEMBIO.1357 ",2.36,37.32,"4kh2_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(372_A_)",64.8293,"","",""
"4KH2","CRYSTAL STRUCTURE OF HUMAN ALPHA-L-IDURONIDASE COMPLEX WITH 2-DEOXY-2- FLUORO-ALPHA-L-IDOPYRANOSYLURONIC ACID FLUORIDE","10.1038/NCHEMBIO.1357 ",2.36,37.32,"4kh2_oligo6","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-MAN(5_F_)-[MAN(7_F_)]-MAN(4_F_)-[MAN(9_F_)-MAN(8_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(372_B_)",50.6132,"","",""
"4KI1","PRIMITIVE TRICLINIC CRYSTAL FORM OF THE HUMAN IGE-FC(EPSILON)3-4 BOUND TO ITS B CELL RECEPTOR DERCD23","10.1107/S2053230X14003355 ",3.2,79.91,"4ki1_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(394_B_)",98.6207,"","",""
"4KI1","PRIMITIVE TRICLINIC CRYSTAL FORM OF THE HUMAN IGE-FC(EPSILON)3-4 BOUND TO ITS B CELL RECEPTOR DERCD23","10.1107/S2053230X14003355 ",3.2,79.91,"4ki1_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(394_C_)",95.5311,"","",""
"4KI1","PRIMITIVE TRICLINIC CRYSTAL FORM OF THE HUMAN IGE-FC(EPSILON)3-4 BOUND TO ITS B CELL RECEPTOR DERCD23","10.1107/S2053230X14003355 ",3.2,79.91,"4ki1_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_L_)-[MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(394_D_)",109.352,"","",""
"4KI1","PRIMITIVE TRICLINIC CRYSTAL FORM OF THE HUMAN IGE-FC(EPSILON)3-4 BOUND TO ITS B CELL RECEPTOR DERCD23","10.1107/S2053230X14003355 ",3.2,79.91,"4ki1_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(394_A_)",98.8144,"","",""
"4KKN","CRYSTAL STRUCTURE OF BOVINE CTLA-4, PSI-NYSGRC-012704","",2.25,40.63,"4kkn_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(111_A_)",40.6461,"","",""
"4KMB","COMPLEX OF 4'-SULFO-LEWIS-X WITH A SELECTIN-LIKE MUTANT OF MANNOSE- BINDING PROTEIN A","10.1021/BI962564E ",2,23.2,"4kmb_oligo2","LFucpa1-3[DGalp[4S]b1-4]DGlcpNAcb1-OME","G4S(3_B_)-[FUC(2_B_)]-MAG(1_B_)",38.7555,"","",""
"4KMB","COMPLEX OF 4'-SULFO-LEWIS-X WITH A SELECTIN-LIKE MUTANT OF MANNOSE- BINDING PROTEIN A","10.1021/BI962564E ",2,23.2,"4kmb_oligo1","LFucpa1-3[DGalp[4S]b1-4]DGlcpNAcb1-OME","G4S(3_A_)-[FUC(2_A_)]-MAG(1_A_)",47.2476,"","",""
"4KRM","NANOBODY/VHH DOMAIN 7D12 IN COMPLEX WITH DOMAIN III OF THE EXTRACELLULAR REGION OF EGFR, PH 3.5","10.1016/J.STR.2013.05.008 ",2.66,62.62,"4krm_oligo6","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_R_)-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(328_I_)",76.617,"","",""
"4KRM","NANOBODY/VHH DOMAIN 7D12 IN COMPLEX WITH DOMAIN III OF THE EXTRACELLULAR REGION OF EGFR, PH 3.5","10.1016/J.STR.2013.05.008 ",2.66,62.62,"4krm_oligo7","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_S_)-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(328_K_)",84.0973,"","",""
"4KRM","NANOBODY/VHH DOMAIN 7D12 IN COMPLEX WITH DOMAIN III OF THE EXTRACELLULAR REGION OF EGFR, PH 3.5","10.1016/J.STR.2013.05.008 ",2.66,62.62,"4krm_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_Q_)-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(328_G_)",79.4402,"","",""
"4KRM","NANOBODY/VHH DOMAIN 7D12 IN COMPLEX WITH DOMAIN III OF THE EXTRACELLULAR REGION OF EGFR, PH 3.5","10.1016/J.STR.2013.05.008 ",2.66,62.62,"4krm_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_M_)-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(328_A_)",77.5809,"","",""
"4KRM","NANOBODY/VHH DOMAIN 7D12 IN COMPLEX WITH DOMAIN III OF THE EXTRACELLULAR REGION OF EGFR, PH 3.5","10.1016/J.STR.2013.05.008 ",2.66,62.62,"4krm_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(4_P_)-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)",83.6887,"","",""
"4KRM","NANOBODY/VHH DOMAIN 7D12 IN COMPLEX WITH DOMAIN III OF THE EXTRACELLULAR REGION OF EGFR, PH 3.5","10.1016/J.STR.2013.05.008 ",2.66,62.62,"4krm_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_N_)-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(328_C_)",77.9448,"","",""
"4KU1","ROLE OF THE HINGE AND C-GAMMA-2/C-GAMMA-3 INTERFACE IN IMMUNOGLOBIN G1 FC DOMAIN MOTIONS: IMPLICATIONS FOR FC ENGINEERING","10.1016/J.JMB.2014.01.011 ",1.9,31.64,"4ku1_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",40.4316,"","",""
"4KU1","ROLE OF THE HINGE AND C-GAMMA-2/C-GAMMA-3 INTERFACE IN IMMUNOGLOBIN G1 FC DOMAIN MOTIONS: IMPLICATIONS FOR FC ENGINEERING","10.1016/J.JMB.2014.01.011 ",1.9,31.64,"4ku1_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcx1-","FUL(10_C_)-[GAL(9_C_)-NAG(8_C_)-MAN(7_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)",63.871,"","",""
"4KVJ","CRYSTAL STRUCTURE OF ORYZA SATIVA FATTY ACID ALPHA-DIOXYGENASE WITH HYDROGEN PEROXIDE","10.1002/PRO.2327 ",2.12,44.2,"4kvj_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(702_A_)-DMU(702_A_)",75.3886,"","",""
"4KVK","CRYSTAL STRUCTURE OF ORYZA SATIVA FATTY ACID ALPHA-DIOXYGENASE","10.1002/PRO.2327 ",1.98,34.44,"4kvk_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(702_A_)-DMU(702_A_)",63.0441,"","",""
"4KW1","STRUCTURE OF A/EGYPT/N03072/2010 H5 HA","10.1371/JOURNAL.PONE.0075209 ",2.5,57.84,"4kw1_oligo1","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-MAN(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(164_A_)",87.8578,"","",""
"4KW1","STRUCTURE OF A/EGYPT/N03072/2010 H5 HA","10.1371/JOURNAL.PONE.0075209 ",2.5,57.84,"4kw1_oligo3","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-MAN(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(164_C_)",79.7711,"","",""
"4KZN","CRYSTAL STRUCTURE OF HUMAN VEGF-A RECEPTOR BINDING DOMAIN","",1.71,5.52,"4kzn_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_B_)-[MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(75_A_)",46.0808,"","",""
"4L37","SP2-SP3 - A COMPLEX OF TWO STORAGE PROTEINS FROM BOMBYX MORI HEMOLYMPH","10.1107/S0907444913021823 ",2.9,51.41,"4l37_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(195_B_)",85.1016,"","",""
"4L37","SP2-SP3 - A COMPLEX OF TWO STORAGE PROTEINS FROM BOMBYX MORI HEMOLYMPH","10.1107/S0907444913021823 ",2.9,51.41,"4l37_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(192_A_)",82.6987,"","",""
"4L4J","CRYSTAL STRUCTURE OF FC-FRAGMENT OF HUMAN IGG2-SIGMA ANTIBODY","10.1016/J.YMETH.2013.06.035 ",1.92,39.9,"4l4j_oligo1","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_C_)-[NAG(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",43.027,"","",""
"4L6T","GM1 BOUND FORM OF THE ECX AB5 HOLOTOXIN","10.1016/J.STR.2013.08.024 ",1.86,0,"4l6t_oligo4","DGalpb1-3DGalpNAcb1-4[DNeup5Aca2-3]DGalpb1-4DGlcpb1-ROH","GAL(4_J_)-NGA(3_J_)-[SIA(5_J_)]-GAL(2_J_)-BGC(1_J_)",28.6294,"","",""
"4L6T","GM1 BOUND FORM OF THE ECX AB5 HOLOTOXIN","10.1016/J.STR.2013.08.024 ",1.86,0,"4l6t_oligo5","DGalpb1-3DGalpNAcb1-4[DNeup5Aca2-3]DGalpb1-4DGlcpb1-ROH","GAL(4_K_)-NGA(3_K_)-[SIA(5_K_)]-GAL(2_K_)-BGC(1_K_)",39.1456,"","",""
"4L6T","GM1 BOUND FORM OF THE ECX AB5 HOLOTOXIN","10.1016/J.STR.2013.08.024 ",1.86,0,"4l6t_oligo1","DGalpb1-3DGalpNAcb1-4[DNeup5Aca2-3]DGalpb1-4DGlcpb1-ROH","GAL(4_G_)-NGA(3_G_)-[SIA(5_G_)]-GAL(2_G_)-BGC(1_G_)",26.1748,"","",""
"4L6T","GM1 BOUND FORM OF THE ECX AB5 HOLOTOXIN","10.1016/J.STR.2013.08.024 ",1.86,0,"4l6t_oligo3","DGalpb1-3DGalpNAcb1-4[DNeup5Aca2-3]DGalpb1-4DGlcpb1-ROH","GAL(4_I_)-NGA(3_I_)-[SIA(5_I_)]-GAL(2_I_)-BGC(1_I_)",25.4531,"","",""
"4L6T","GM1 BOUND FORM OF THE ECX AB5 HOLOTOXIN","10.1016/J.STR.2013.08.024 ",1.86,0,"4l6t_oligo2","DGalpb1-3DGalpNAcb1-4[DNeup5Aca2-3]DGalpb1-4DGlcpb1-ROH","GAL(4_H_)-NGA(3_H_)-[SIA(5_H_)]-GAL(2_H_)-BGC(1_H_)",26.5524,"","",""
"4LBJ","CRYSTAL STRUCTURE OF HUMAN GALECTIN-3 CRD K176L MUTANT IN COMPLEX WITH LNT","10.1016/J.JMB.2013.12.004 ",1.8,12.78,"4lbj_oligo1","DGalpb1-3DGlcpNAcb1-3DGalpb1-4DGlcpb1-ROH","GAL(4_B_)-NAG(3_B_)-GAL(2_B_)-BGC(1_B_)",20.9975,"","",""
"4LBM","CRYSTAL STRUCTURE OF HUMAN GALECTIN-3 CRD IN COMPLEX WITH LNT","10.1016/J.JMB.2013.12.004 ",1.55,19.53,"4lbm_oligo1","DGalpb1-3DGlcpNAcb1-3DGalpb1-4DGlcpb1-ROH","GAL(4_B_)-NAG(3_B_)-GAL(2_B_)-BGC(1_B_)",31.2425,"","",""
"4LN8","THE CRYSTAL STRUCTURE OF HEMAGGLUTININ FROM A H7N9 INFLUENZA VIRUS (A/SHANGHAI/2/2013) IN COMPLEX WITH LSTB","10.1128/JVI.01854-13 ",2.5,62.63,"4ln8_oligo15","DGalpb1-3[DNeup5Aca2-6]DGlcpNAcb1-3DGalpb1-ROH","SIA(4_a_)-[GAL(3_a_)]-NAG(2_a_)-GAL(1_a_)",109.057,"","",""
"4LN8","THE CRYSTAL STRUCTURE OF HEMAGGLUTININ FROM A H7N9 INFLUENZA VIRUS (A/SHANGHAI/2/2013) IN COMPLEX WITH LSTB","10.1128/JVI.01854-13 ",2.5,62.63,"4ln8_oligo3","DGalpb1-3[DNeup5Aca2-6]DGlcpNAcb1-3DGalpb1-ROH","SIA(4_O_)-[GAL(3_O_)]-NAG(2_O_)-GAL(1_O_)",118.689,"","",""
"4LN8","THE CRYSTAL STRUCTURE OF HEMAGGLUTININ FROM A H7N9 INFLUENZA VIRUS (A/SHANGHAI/2/2013) IN COMPLEX WITH LSTB","10.1128/JVI.01854-13 ",2.5,62.63,"4ln8_oligo6","DGalpb1-3[DNeup5Aca2-6]DGlcpNAcx1-","SIA(3_R_)-[GAL(2_R_)]-NAG(1_R_)",115.757,"","",""
"4LN8","THE CRYSTAL STRUCTURE OF HEMAGGLUTININ FROM A H7N9 INFLUENZA VIRUS (A/SHANGHAI/2/2013) IN COMPLEX WITH LSTB","10.1128/JVI.01854-13 ",2.5,62.63,"4ln8_oligo13","DGalpb1-3[DNeup5Aca2-6]DGlcpNAcx1-","SIA(3_Y_)-[GAL(2_Y_)]-NAG(1_Y_)",103.33,"","",""
"4LN8","THE CRYSTAL STRUCTURE OF HEMAGGLUTININ FROM A H7N9 INFLUENZA VIRUS (A/SHANGHAI/2/2013) IN COMPLEX WITH LSTB","10.1128/JVI.01854-13 ",2.5,62.63,"4ln8_oligo11","DGalpb1-3[DNeup5Aca2-6]DGlcpNAcb1-3DGalpb1-ROH","SIA(4_W_)-[GAL(3_W_)]-NAG(2_W_)-GAL(1_W_)",112.876,"","",""
"4LQG","X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH A PHOSPHORAMIDATE INHIBITOR CTT1056","10.1021/ACS.JMEDCHEM.5B01850 ",1.77,23.43,"4lqg_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(638_A_)",38.1018,"","",""
"4LSA","CRYSTAL STRUCTURE OF BRI1 SUD1 (GLY643GLU) BOUND TO BRASSINOLIDE","10.1126/SCIENCE.1242468 ",2.5,0,"4lsa_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(275_A_)",115.633,"","",""
"4LSA","CRYSTAL STRUCTURE OF BRI1 SUD1 (GLY643GLU) BOUND TO BRASSINOLIDE","10.1126/SCIENCE.1242468 ",2.5,0,"4lsa_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(154_A_)",98.7736,"","",""
"4LSA","CRYSTAL STRUCTURE OF BRI1 SUD1 (GLY643GLU) BOUND TO BRASSINOLIDE","10.1126/SCIENCE.1242468 ",2.5,0,"4lsa_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(545_A_)",99.8589,"","",""
"4LSX","PLANT STEROID RECEPTOR ECTODOMAIN BOUND TO BRASSINOLIDE AND SERK1 CO- RECEPTOR ECTODOMAIN","10.1126/SCIENCE.1242468 ",3.3,0,"4lsx_oligo6","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(545_B_)",113.363,"","",""
"4LSX","PLANT STEROID RECEPTOR ECTODOMAIN BOUND TO BRASSINOLIDE AND SERK1 CO- RECEPTOR ECTODOMAIN","10.1126/SCIENCE.1242468 ",3.3,0,"4lsx_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(154_A_)",98.775,"","",""
"4LSX","PLANT STEROID RECEPTOR ECTODOMAIN BOUND TO BRASSINOLIDE AND SERK1 CO- RECEPTOR ECTODOMAIN","10.1126/SCIENCE.1242468 ",3.3,0,"4lsx_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_H_)-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(154_B_)",136.435,"","",""
"4LSX","PLANT STEROID RECEPTOR ECTODOMAIN BOUND TO BRASSINOLIDE AND SERK1 CO- RECEPTOR ECTODOMAIN","10.1126/SCIENCE.1242468 ",3.3,0,"4lsx_oligo2","DManpa1-3[DManpa1-4]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(545_A_)",118.501,"","",""
"4LU3","THE CRYSTAL STRUCTURE OF THE HUMAN CARBONIC ANHYDRASE XIV","10.1002/BIP.22456 ",2,0,"4lu3_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(195_A_)",38.5315,"","",""
"4LXR","STRUCTURE OF THE TOLL - SPATZLE COMPLEX, A MOLECULAR HUB IN DROSOPHILA DEVELOPMENT AND INNATE IMMUNITY","10.1073/PNAS.1320678111 ",2.2,45.34,"4lxr_oligo2","DManpa1-3DManpb1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-BMA(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(346_A_)",56.0764,"","",""
"4LXS","STRUCTURE OF THE TOLL - SPATZLE COMPLEX, A MOLECULAR HUB IN DROSOPHILA DEVELOPMENT AND INNATE IMMUNITY (GLYCOSYLATED FORM)","10.1073/PNAS.1320678111 ",3.3,34.88,"4lxs_oligo2","DManpa1-3DManpb1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-BMA(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(346_A_)",30.9409,"","",""
"4M44","CRYSTAL STRUCTURE OF HEMAGGLUTININ OF INFLUENZA VIRUS B/YAMANASHI/166/1998 IN COMPLEX WITH AVIAN-LIKE RECEPTOR LSTA","10.1016/J.VIROL.2013.07.035 ",2.5,0,"4m44_oligo12","DNeup5Aca2-3DGalpb1-3DGlcp[2<R1>]b1-3DGalpx1-","SIA(4_R_)-GAL(3_R_)-NAG(2_R_)-GAL(1_R_)",71.7305,"","",""
"4M44","CRYSTAL STRUCTURE OF HEMAGGLUTININ OF INFLUENZA VIRUS B/YAMANASHI/166/1998 IN COMPLEX WITH AVIAN-LIKE RECEPTOR LSTA","10.1016/J.VIROL.2013.07.035 ",2.5,0,"4m44_oligo8","DNeup5Aca2-3DGalpb1-3DGlcpNAcb1-3DGalpx1-","SIA(4_N_)-GAL(3_N_)-NAG(2_N_)-GAL(1_N_)",67.9954,"","",""
"4M44","CRYSTAL STRUCTURE OF HEMAGGLUTININ OF INFLUENZA VIRUS B/YAMANASHI/166/1998 IN COMPLEX WITH AVIAN-LIKE RECEPTOR LSTA","10.1016/J.VIROL.2013.07.035 ",2.5,0,"4m44_oligo3","DNeup5Aca2-3DGalpb1-3DGlcpNAcb1-3DGalpx1-","SIA(4_J_)-GAL(3_J_)-NAG(2_J_)-GAL(1_J_)",66.2243,"","",""
"4M4Y","CRYSTAL STRUCTURE OF A 2009 H1N1 INFLUENZA VIRUS HEMAGGLUTININ WITH A STABILIZATION MUTATION HA2 E47G","10.1128/JVI.01388-13 ",2.2,0,"4m4y_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(33_C_)",63.032,"","",""
"4MA1","UNLIGANDED 3 CRYSTAL STRUCTURE OF S25-26 FAB","10.1074/JBC.M113.528224 ",2.32,48.25,"4ma1_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_D_)-[MAN(4_D_)-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(85_E_)",100.281,"","",""
"4MA1","UNLIGANDED 3 CRYSTAL STRUCTURE OF S25-26 FAB","10.1074/JBC.M113.528224 ",2.32,48.25,"4ma1_oligo4","DGalpa1-3DGalpb1-4DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcx1-","MAN(8_G_)-[GLA(7_G_)-GAL(6_G_)-NAG(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)",94.7876,"","",""
"4MC5","CRYSTAL STRUCTURE OF A SUBTYPE H18 HEMAGGLUTININ HOMOLOGUE FROM A/FLAT-FACED BAT/PERU/033/2010 (H18N11)","10.1371/JOURNAL.PPAT.1003657 ",2.24,0,"4mc5_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUL(7_G_)-[MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)]-[FUC(6_G_)]-NAG(1_G_)-ASN(240_B_)",73.7017,"","",""
"4MC5","CRYSTAL STRUCTURE OF A SUBTYPE H18 HEMAGGLUTININ HOMOLOGUE FROM A/FLAT-FACED BAT/PERU/033/2010 (H18N11)","10.1371/JOURNAL.PPAT.1003657 ",2.24,0,"4mc5_oligo6","LFucpa1-3[DGlcpNAcb1-4][LFucpb1-6]DGlcpNAcb1-ASN","FUL(4_I_)-[NAG(3_I_)]-[FUC(2_I_)]-NAG(1_I_)-ASN(240_C_)",104.851,"","",""
"4MC5","CRYSTAL STRUCTURE OF A SUBTYPE H18 HEMAGGLUTININ HOMOLOGUE FROM A/FLAT-FACED BAT/PERU/033/2010 (H18N11)","10.1371/JOURNAL.PPAT.1003657 ",2.24,0,"4mc5_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUL(7_E_)-[MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-[FUC(6_E_)]-NAG(1_E_)-ASN(240_A_)",67.153,"","",""
"4MC5","CRYSTAL STRUCTURE OF A SUBTYPE H18 HEMAGGLUTININ HOMOLOGUE FROM A/FLAT-FACED BAT/PERU/033/2010 (H18N11)","10.1371/JOURNAL.PPAT.1003657 ",2.24,0,"4mc5_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(15_A_)",79.8329,"","",""
"4MCP","A HIGH RESOLUTION STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH FOLYL-GAMMA-L-GLUTAMIC ACID (PTEROYLDI-GAMMA- L-GLUTAMIC ACID)","10.1111/FEBS.12857 ",1.65,29.55,"4mcp_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(638_A_)",51.7441,"","",""
"4MCQ","A HIGH RESOLUTION STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH FOLYLDI-GAMMA-L-GLUTAMIC ACID (PTEROYLTRI- GAMMA-L-GLUTAMIC ACID)","10.1111/FEBS.12857 ",2,27.58,"4mcq_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(638_A_)",43.2618,"","",""
"4MCR","A HIGH RESOLUTION STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH FOLYLTRI-GAMMA-L-GLUTAMIC ACID (PTEROYLTETRA- GAMMA-L-GLUTAMIC ACID)","10.1111/FEBS.12857 ",1.65,26.13,"4mcr_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(638_A_)",35.6466,"","",""
"4MCS","A HIGH RESOLUTION STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) HIS475TYR VARIANT IN COMPLEX WITH GLUTAMIC ACID","10.1111/FEBS.12857 ",1.83,31.48,"4mcs_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(638_A_)",50.6118,"","",""
"4MHH","CRYSTAL STRUCTURE OF FAB H5M9 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/VIET NAM/1203/2004 (H5N1)","10.1128/JVI.01577-13 ",3.56,0,"4mhh_oligo12","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_X_)-[MAN(4_X_)]-MAN(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(169_E_)",204.921,"","",""
"4MHH","CRYSTAL STRUCTURE OF FAB H5M9 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/VIET NAM/1203/2004 (H5N1)","10.1128/JVI.01577-13 ",3.56,0,"4mhh_oligo17","DManpa1-3DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_c_)-MAN(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(154_D_)",227.876,"","",""
"4MHH","CRYSTAL STRUCTURE OF FAB H5M9 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/VIET NAM/1203/2004 (H5N1)","10.1128/JVI.01577-13 ",3.56,0,"4mhh_oligo1","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-MAN(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(169_A_)",217.835,"","",""
"4MHH","CRYSTAL STRUCTURE OF FAB H5M9 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/VIET NAM/1203/2004 (H5N1)","10.1128/JVI.01577-13 ",3.56,0,"4mhh_oligo7","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-[MAN(4_S_)]-MAN(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(169_C_)",216.499,"","",""
"4MHJ","CRYSTAL STRUCTURE OF FAB H5M9 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/GOOSE/GUANGDONG/1/96 (H5N1)","10.1128/JVI.01577-13 ",6.98,89.86,"4mhj_oligo7","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_e_)-BMA(3_e_)-NAG(2_e_)-NAG(1_e_)-ASN(289_O_)",44.9191,"","",""
"4MHJ","CRYSTAL STRUCTURE OF FAB H5M9 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/GOOSE/GUANGDONG/1/96 (H5N1)","10.1128/JVI.01577-13 ",6.98,89.86,"4mhj_oligo2","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_Z_)-MAN(7_Z_)-[MAN(6_Z_)-MAN(5_Z_)]-MAN(4_Z_)-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(33_C_)",90,"","",""
"4MJ2","CRYSTAL STRUCTURE OF APO-IDURONIDASE IN THE R3 FORM","10.1038/NCHEMBIO.1357 ",2.1,36.06,"4mj2_oligo4","DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_F_)-MAN(6_F_)-[MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(372_B_)",55.0188,"","",""
"4MJ2","CRYSTAL STRUCTURE OF APO-IDURONIDASE IN THE R3 FORM","10.1038/NCHEMBIO.1357 ",2.1,36.06,"4mj2_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(372_A_)",62.7431,"","",""
"4MJ4","HUMAN IDURONIDASE APO STRUCTURE P21 FORM","10.1038/NCHEMBIO.1357 ",2.17,37.71,"4mj4_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(372_A_)",60.0711,"","",""
"4MMX","INTEGRIN ALPHAVBETA3 ECTODOMAIN BOUND TO THE TENTH DOMAIN OF FIBRONECTIN","10.1038/NSMB.2797 ",3.32,0,"4mmx_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(44_A_)",131.031,"","",""
"4MMX","INTEGRIN ALPHAVBETA3 ECTODOMAIN BOUND TO THE TENTH DOMAIN OF FIBRONECTIN","10.1038/NSMB.2797 ",3.32,0,"4mmx_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(458_A_)",147.437,"","",""
"4MMX","INTEGRIN ALPHAVBETA3 ECTODOMAIN BOUND TO THE TENTH DOMAIN OF FIBRONECTIN","10.1038/NSMB.2797 ",3.32,0,"4mmx_oligo2","DManpa1-4DManpb1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-BMA(4_F_)-[MAN(6_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(266_A_)",95.9556,"","",""
"4MMY","INTEGRIN ALPHAVBETA3 ECTODOMAIN BOUND TO THE TENTH DOMAIN OF FIBRONECTIN WITH THE IAKGDWND MOTIF","10.1038/NSMB.2797 ",3.18,0,"4mmy_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(458_A_)",168.514,"","",""
"4MMY","INTEGRIN ALPHAVBETA3 ECTODOMAIN BOUND TO THE TENTH DOMAIN OF FIBRONECTIN WITH THE IAKGDWND MOTIF","10.1038/NSMB.2797 ",3.18,0,"4mmy_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(44_A_)",159.911,"","",""
"4MMY","INTEGRIN ALPHAVBETA3 ECTODOMAIN BOUND TO THE TENTH DOMAIN OF FIBRONECTIN WITH THE IAKGDWND MOTIF","10.1038/NSMB.2797 ",3.18,0,"4mmy_oligo3","DManpa1-4DManpb1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-BMA(4_F_)-[MAN(6_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(266_A_)",133.258,"","",""
"4MMZ","INTEGRIN ALPHAVBETA3 ECTODOMAIN BOUND TO AN ANTAGONISTIC TENTH DOMAIN OF FIBRONECTIN","10.1038/NSMB.2797 ",3.1,0,"4mmz_oligo2","DManpa1-4DManpb1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-BMA(4_E_)-[MAN(6_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(266_A_)",123.124,"","",""
"4MQE","CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF HUMAN GABA(B) RECEPTOR IN THE APO FORM","10.1038/NATURE12725 ",2.35,69.77,"4mqe_oligo1","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_C_)-[MAN(5_C_)-[MAN(4_C_)]-MAN(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(323_A_)",91.8908,"","",""
"4MQF","CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF HUMAN GABA(B) RECEPTOR BOUND TO THE ANTAGONIST 2-HYDROXYSACLOFEN","10.1038/NATURE12725 ",2.22,38.88,"4mqf_oligo1","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_C_)-[MAN(5_C_)-[MAN(4_C_)]-MAN(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(323_A_)",79.8459,"","",""
"4MR7","CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF HUMAN GABA(B) RECEPTOR BOUND TO THE ANTAGONIST CGP54626","10.1038/NATURE12725 ",2.15,39.04,"4mr7_oligo1","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_C_)-[MAN(5_C_)-[MAN(4_C_)]-MAN(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(323_A_)",70.5114,"","",""
"4MR8","CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF HUMAN GABA(B) RECEPTOR BOUND TO THE ANTAGONIST CGP35348","10.1038/NATURE12725 ",2.15,53.26,"4mr8_oligo1","DManpb1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_C_)-[BMA(4_C_)-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(323_A_)",90.4054,"","",""
"4MRM","CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF HUMAN GABA(B) RECEPTOR BOUND TO THE ANTAGONIST PHACLOFEN","10.1038/NATURE12725 ",2.86,42.77,"4mrm_oligo1","DManpb1-3DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_C_)-MAN(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(323_A_)",86.2352,"","",""
"4MS1","CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF HUMAN GABA(B) RECEPTOR BOUND TO THE ANTAGONIST CGP46381","10.1038/NATURE12725 ",2.25,63.49,"4ms1_oligo1","DManpb1-3DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_C_)-MAN(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(323_A_)",93.9836,"","",""
"4MWF","STRUCTURE OF HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 CORE BOUND TO BROADLY NEUTRALIZING ANTIBODY AR3C","10.1126/SCIENCE.1243876 ",2.65,0,"4mwf_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_E_)-MAN(7_E_)-[MAN(6_E_)-MAN(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(430_C_)",92.2426,"","",""
"4MWJ","ANHUI N9","10.1038/CR.2013.144 ",1.8,15.17,"4mwj_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_B_)-[MAN(8_B_)]-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(202_A_)",20.6165,"","",""
"4MWL","SHANGHAI N9","10.1038/CR.2013.144 ",1.8,12.64,"4mwl_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_B_)-[MAN(8_B_)]-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(202_A_)",17.6664,"","",""
"4MWQ","ANHUI N9-OSELTAMIVIR CARBOXYLATE","10.1038/CR.2013.144 ",2,19.03,"4mwq_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_B_)-[MAN(8_B_)]-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(202_A_)",28.8249,"","",""
"4MWR","ANHUI N9-ZANAMIVIR","10.1038/CR.2013.144 ",1.8,20.21,"4mwr_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_B_)-[MAN(8_B_)]-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(202_A_)",26.4366,"","",""
"4MWS","CRYSTAL STRUCTURE OF HUMAN PPCA (TRIGONAL CRYSTAL FORM 1)","10.1074/JBC.M113.524280 ",2.8,67.87,"4mws_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","BMA(3_D_)-NAG(2_D_)-[FUC(4_D_)]-NAG(1_D_)-ASN(117_B_)",93.5941,"","",""
"4MWS","CRYSTAL STRUCTURE OF HUMAN PPCA (TRIGONAL CRYSTAL FORM 1)","10.1074/JBC.M113.524280 ",2.8,67.87,"4mws_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-[FUC(5_C_)]-NAG(1_C_)-ASN(117_A_)",85.9515,"","",""
"4MWU","ANHUI N9-LANINAMIVIR","10.1038/CR.2013.144 ",1.8,13.9,"4mwu_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_B_)-[MAN(8_B_)]-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(202_A_)",19.8616,"","",""
"4MWV","ANHUI N9-PERAMIVIR","10.1038/CR.2013.144 ",2,19.09,"4mwv_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_B_)-[MAN(8_B_)]-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(202_A_)",26.6057,"","",""
"4MWW","SHANGHAI N9-OSELTAMIVIR CARBOXYLATE","10.1038/CR.2013.144 ",1.9,17.02,"4mww_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_B_)-[MAN(8_B_)]-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(202_A_)",23.3598,"","",""
"4MWX","SHANGHAI N9-ZANAMIVIR","10.1038/CR.2013.144 ",1.8,16.13,"4mwx_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_B_)-[MAN(8_B_)]-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(202_A_)",22.7272,"","",""
"4MWY","SHANGHAI N9-LANINAMIVIR","10.1038/CR.2013.144 ",1.8,14.29,"4mwy_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_B_)-[MAN(8_B_)]-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(202_A_)",19.4712,"","",""
"4MX0","SHANGHAI N9-PERAMIVIR","10.1038/CR.2013.144 ",2.1,24.44,"4mx0_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_B_)-[MAN(8_B_)]-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(202_A_)",36.1485,"","",""
"4MZA","CRYSTAL STRUCTURE OF HPIV3 HEMAGGLUTININ-NEURAMINIDASE","10.1128/MBIO.00803-13 ",1.65,31.02,"4mza_oligo1","DManpa1-3DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-MAN(5_C_)-[MAN(7_C_)]-MAN(4_C_)-[MAN(9_C_)-MAN(8_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(351_A_)",53.9457,"","",""
"4MZE","CRYSTAL STRUCTURE OF HPIV3 HEMAGGLUTININ-NEURAMINIDASE, H552Q/Q559R MUTANT","10.1128/MBIO.00803-13 ",1.8,29.87,"4mze_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(308_B_)",46.9233,"","",""
"4MZE","CRYSTAL STRUCTURE OF HPIV3 HEMAGGLUTININ-NEURAMINIDASE, H552Q/Q559R MUTANT","10.1128/MBIO.00803-13 ",1.8,29.87,"4mze_oligo1","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_C_)-[MAN(7_C_)]-MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(351_A_)",65.6023,"","",""
"4MZV","CRYSTAL STRUCTURE OF EXTRACELLULAR PART OF HUMAN EPCAM","10.1038/NCOMMS5764 ",1.87,0,"4mzv_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(301_A_)-DMU(301_A_)",46.6477,"","",""
"4N0U","TERNARY COMPLEX BETWEEN NEONATAL FC RECEPTOR, SERUM ALBUMIN AND FC","10.1074/JBC.M113.537563 ",3.8,143.8,"4n0u_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_E_)",124.464,"","",""
"4N4W","STRUCTURE OF THE HUMAN SMOOTHENED RECEPTOR IN COMPLEX WITH SANT-1.","10.1038/NCOMMS5355 ",2.8,81.12,"4n4w_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)",120.182,"","",""
"4N5Y","CRYSTAL STRUCTURE OF H5 HEMAGGLUTININ MUTANT (N158D, N224K AND Q226L) FROM THE INFLUENZA VIRUS A/VIET NAM/1203/2004 (H5N1)","10.1128/JVI.02690-13 ",3.16,0,"4n5y_oligo15","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_s_)-BMA(3_s_)-NAG(2_s_)-NAG(1_s_)-ASN(169_Q_)",106.681,"","",""
"4N79","STRUCTURE OF CATHEPSIN K-DERMATAN SULFATE COMPLEX","10.1073/PNAS.1414126111 ",2.62,29.38,"4n79_oligo1","LIdopAa1-3DGalpNAc[4S]b1-4LIdopAa1-3DGalpNAc[4S]b1-4LIdopAa1-3DGalpNAc[4S]b1-ROH","IDR(6_B_)-ASG(5_B_)-IDR(4_B_)-ASG(3_B_)-IDR(2_B_)-ASG(1_B_)",65.1727,"","",""
"4N8D","DPP4 COMPLEXED WITH SYN-7AA","10.1016/J.BMCL.2013.12.118 ",1.65,28.15,"4n8d_oligo1","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-MAN(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(85_A_)",36.1689,"","",""
"4N8E","DPP4 COMPLEXED WITH COMPOUND 12A","10.1016/J.BMCL.2013.12.118 ",2.3,25.67,"4n8e_oligo3","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-MAN(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(85_A_)",41.8364,"","",""
"4NCO","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122","10.1126/SCIENCE.1245625 ",4.7,0,"4nco_oligo13","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_a_)-[MAN(5_a_)]-MAN(4_a_)-[MAN(7_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(262_I_)",393.501,"","",""
"4NCO","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122","10.1126/SCIENCE.1245625 ",4.7,0,"4nco_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_Q_)-MAN(8_Q_)-MAN(7_Q_)-[MAN(6_Q_)-MAN(5_Q_)-MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(332_A_)",365.319,"","",""
"4NCO","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122","10.1126/SCIENCE.1245625 ",4.7,0,"4nco_oligo8","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_V_)-[MAN(5_V_)]-MAN(4_V_)-[MAN(7_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(301_E_)",405.684,"","",""
"4NCO","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122","10.1126/SCIENCE.1245625 ",4.7,0,"4nco_oligo5","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_S_)-[MAN(5_S_)]-MAN(4_S_)-[MAN(7_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(137_E_)",522.187,"","",""
"4NCO","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122","10.1126/SCIENCE.1245625 ",4.7,0,"4nco_oligo17","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_c_)-MAN(8_c_)-MAN(7_c_)-[MAN(6_c_)-MAN(5_c_)-MAN(4_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(332_I_)",372.38,"","",""
"4NCO","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122","10.1126/SCIENCE.1245625 ",4.7,0,"4nco_oligo14","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_M_)-[MAN(5_M_)]-MAN(4_M_)-[MAN(7_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(137_A_)",457.677,"","",""
"4NCO","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122","10.1126/SCIENCE.1245625 ",4.7,0,"4nco_oligo7","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_U_)-[MAN(5_U_)]-MAN(4_U_)-[MAN(7_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(262_E_)",410.657,"","",""
"4NCO","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122","10.1126/SCIENCE.1245625 ",4.7,0,"4nco_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_N_)-[MAN(5_N_)]-MAN(4_N_)-[MAN(7_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(156_A_)",429.176,"","",""
"4NCO","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122","10.1126/SCIENCE.1245625 ",4.7,0,"4nco_oligo9","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_W_)-MAN(8_W_)-MAN(7_W_)-[MAN(6_W_)-MAN(5_W_)-MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(332_E_)",406.521,"","",""
"4NCO","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122","10.1126/SCIENCE.1245625 ",4.7,0,"4nco_oligo6","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_T_)-[MAN(5_T_)]-MAN(4_T_)-[MAN(7_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(156_E_)",415.661,"","",""
"4NCO","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122","10.1126/SCIENCE.1245625 ",4.7,0,"4nco_oligo15","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_O_)-[MAN(5_O_)]-MAN(4_O_)-[MAN(7_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(262_A_)",437.974,"","",""
"4NCO","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122","10.1126/SCIENCE.1245625 ",4.7,0,"4nco_oligo12","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Z_)-[MAN(5_Z_)]-MAN(4_Z_)-[MAN(7_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(156_I_)",447.876,"","",""
"4NCO","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122","10.1126/SCIENCE.1245625 ",4.7,0,"4nco_oligo11","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Y_)-[MAN(5_Y_)]-MAN(4_Y_)-[MAN(7_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(137_I_)",490.109,"","",""
"4NCO","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122","10.1126/SCIENCE.1245625 ",4.7,0,"4nco_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_P_)-[MAN(5_P_)]-MAN(4_P_)-[MAN(7_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(301_A_)",394.297,"","",""
"4NCO","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122","10.1126/SCIENCE.1245625 ",4.7,0,"4nco_oligo16","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_b_)-[MAN(5_b_)]-MAN(4_b_)-[MAN(7_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(301_I_)",409.167,"","",""
"4NEH","AN INTERNAL LIGAND-BOUND, METASTABLE STATE OF A LEUKOCYTE INTEGRIN, AXB2","10.1083/JCB.201308083 ",2.75,0,"4neh_oligo3","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_E_)-MAN(6_E_)-[MAN(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(373_A_)",130.365,"","",""
"4NEN","AN INTERNAL LIGAND-BOUND, METASTABLE STATE OF A LEUKOCYTE INTEGRIN, AXB2","10.1083/JCB.201308083 ",2.9,0,"4nen_oligo3","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-MAN(4_E_)-[MAN(6_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(373_A_)",120.544,"","",""
"4NGM","CRYSTAL STRUCTURE OF GLUTAMATE CARBOXYPEPTIDASE II IN A COMPLEX WITH UREA-BASED INHIBITOR","10.1016/J.BMC.2014.05.061 ",1.84,27.4,"4ngm_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(638_A_)",45.4364,"","",""
"4NGN","CRYSTAL STRUCTURE OF GLUTAMATE CARBOXYPEPTIDASE II IN A COMPLEX WITH UREA-BASED INHIBITOR","10.1016/J.BMC.2014.05.061 ",1.64,24.78,"4ngn_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(638_A_)",37.7773,"","",""
"4NGP","CRYSTAL STRUCTURE OF GLUTAMATE CARBOXYPEPTIDASE II IN A COMPLEX WITH UREA-BASED INHIBITOR","10.1016/J.BMC.2014.05.061 ",1.63,24.12,"4ngp_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(638_A_)",39.9125,"","",""
"4NGQ","CRYSTAL STRUCTURE OF GLUTAMATE CARBOXYPEPTIDASE II IN A COMPLEX WITH UREA-BASED INHIBITOR","10.1016/J.BMC.2014.05.061 ",2.08,25.61,"4ngq_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(638_A_)",43.1056,"","",""
"4NGR","CRYSTAL STRUCTURE OF GLUTAMATE CARBOXYPEPTIDASE II IN A COMPLEX WITH UREA-BASED INHIBITOR","10.1016/J.BMC.2014.05.061 ",1.9,26.14,"4ngr_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(638_A_)",39.8852,"","",""
"4NGS","CRYSTAL STRUCTURE OF GLUTAMATE CARBOXYPEPTIDASE II IN A COMPLEX WITH UREA-BASED INHIBITOR","10.1016/J.BMC.2014.05.061 ",1.68,25.17,"4ngs_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(638_A_)",38.4848,"","",""
"4NI3","CRYSTAL STRUCTURE OF GH29 FAMILY ALPHA-L-FUCOSIDASE FROM FUSARIUM GRAMINEARUM IN THE CLOSED FORM","10.1074/JBC.M114.583286 ",1.4,21.8,"4ni3_oligo2","DManpa1-2DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-MAN(5_D_)-MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(280_B_)",24.85,"","",""
"4NI3","CRYSTAL STRUCTURE OF GH29 FAMILY ALPHA-L-FUCOSIDASE FROM FUSARIUM GRAMINEARUM IN THE CLOSED FORM","10.1074/JBC.M114.583286 ",1.4,21.8,"4ni3_oligo1","DManpa1-2DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-MAN(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(280_A_)",26.2853,"","",""
"4NN9","REFINED ATOMIC STRUCTURES OF N9 SUBTYPE INFLUENZA VIRUS NEURAMINIDASE AND ESCAPE MUTANTS","10.1016/0022-2836(91)80069-7 ",2.3,0,"4nn9_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",26.333,"","",""
"4NRL","STRUCTURE OF HEMAGGLUTININ WITH F95Y MUTATION OF INFLUENZA VIRUS B/LEE/40","10.1016/J.VIROL.2013.11.038 ",2.72,0,"4nrl_oligo10","DNeup5Aca2-3DGalpb1-3DGlcpNAcb1-3DGalpb1-4DGlcpb1-ROH","SIA(5_G_)-GAL(4_G_)-NAG(3_G_)-GAL(2_G_)-BGC(1_G_)",64.5107,"","",""
"4NRL","STRUCTURE OF HEMAGGLUTININ WITH F95Y MUTATION OF INFLUENZA VIRUS B/LEE/40","10.1016/J.VIROL.2013.11.038 ",2.72,0,"4nrl_oligo6","DNeup5Aca2-3DGalpb1-3DGlcpNAcb1-3DGalpb1-4DGlcpb1-ROH","SIA(5_L_)-GAL(4_L_)-NAG(3_L_)-GAL(2_L_)-BGC(1_L_)",77.9975,"","",""
"4NRL","STRUCTURE OF HEMAGGLUTININ WITH F95Y MUTATION OF INFLUENZA VIRUS B/LEE/40","10.1016/J.VIROL.2013.11.038 ",2.72,0,"4nrl_oligo2","DNeup5Aca2-3DGalpb1-3DGlcpNAcb1-3DGalpb1-4DGlcpb1-ROH","SIA(5_Q_)-GAL(4_Q_)-NAG(3_Q_)-GAL(2_Q_)-BGC(1_Q_)",65.8869,"","",""
"4O02","ALPHAVBETA3 INTEGRIN IN COMPLEX WITH MONOCLONAL ANTIBODY FAB FRAGMENT.","10.1074/JBC.M113.546929 ",3.61,0,"4o02_oligo5","DManpa1-3DManpa1-3DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_G_)-MAN(5_G_)-MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(943_A_)",235.169,"","",""
"4O02","ALPHAVBETA3 INTEGRIN IN COMPLEX WITH MONOCLONAL ANTIBODY FAB FRAGMENT.","10.1074/JBC.M113.546929 ",3.61,0,"4o02_oligo3","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-MAN(4_E_)-[MAN(6_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(266_A_)",134.084,"","",""
"4O02","ALPHAVBETA3 INTEGRIN IN COMPLEX WITH MONOCLONAL ANTIBODY FAB FRAGMENT.","10.1074/JBC.M113.546929 ",3.61,0,"4o02_oligo1","DManpb1-4DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(44_A_)",165.455,"","",""
"4O3T","ZYMOGEN HGF-BETA/MET WITH ZYMOGEN ACTIVATOR PEPTIDE ZAP.14","10.1038/NCHEMBIO.1533 ",2.99,66.81,"4o3t_oligo1","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_C_)-[FUC(2_C_)]-NAG(1_C_)-ASN(106_B_)",86.2661,"","",""
"4O58","CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY F045-092 IN COMPLEX WITH A/VICTORIA/3/1975 (H3N2) INFLUENZA HEMAGGLUTININ","10.1038/NCOMMS4614 ",2.75,0,"4o58_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(165_A_)",85.7227,"","",""
"4O5I","CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY F045-092 IN COMPLEX WITH A/VICTORIA/361/2011 (H3N2) INFLUENZA HEMAGGLUTININ","10.1038/NCOMMS4614 ",6.5,0,"4o5i_oligo16","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_n_)-[MAN(4_n_)]-BMA(3_n_)-NAG(2_n_)-NAG(1_n_)-ASN(165_E_)",157.439,"","",""
"4O5I","CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY F045-092 IN COMPLEX WITH A/VICTORIA/361/2011 (H3N2) INFLUENZA HEMAGGLUTININ","10.1038/NCOMMS4614 ",6.5,0,"4o5i_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_b_)-[MAN(4_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(165_A_)",151.281,"","",""
"4O5I","CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY F045-092 IN COMPLEX WITH A/VICTORIA/361/2011 (H3N2) INFLUENZA HEMAGGLUTININ","10.1038/NCOMMS4614 ",6.5,0,"4o5i_oligo15","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_m_)-BMA(3_m_)-NAG(2_m_)-NAG(1_m_)-ASN(133_E_)",152.183,"","",""
"4O5I","CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY F045-092 IN COMPLEX WITH A/VICTORIA/361/2011 (H3N2) INFLUENZA HEMAGGLUTININ","10.1038/NCOMMS4614 ",6.5,0,"4o5i_oligo7","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_e_)-BMA(3_e_)-NAG(2_e_)-NAG(1_e_)-ASN(38_C_)",198.754,"","",""
"4O5I","CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY F045-092 IN COMPLEX WITH A/VICTORIA/361/2011 (H3N2) INFLUENZA HEMAGGLUTININ","10.1038/NCOMMS4614 ",6.5,0,"4o5i_oligo9","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_g_)-BMA(3_g_)-NAG(2_g_)-NAG(1_g_)-ASN(133_C_)",148.304,"","",""
"4O5I","CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY F045-092 IN COMPLEX WITH A/VICTORIA/361/2011 (H3N2) INFLUENZA HEMAGGLUTININ","10.1038/NCOMMS4614 ",6.5,0,"4o5i_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_h_)-[MAN(4_h_)]-BMA(3_h_)-NAG(2_h_)-NAG(1_h_)-ASN(165_C_)",145.323,"","",""
"4O5I","CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY F045-092 IN COMPLEX WITH A/VICTORIA/361/2011 (H3N2) INFLUENZA HEMAGGLUTININ","10.1038/NCOMMS4614 ",6.5,0,"4o5i_oligo13","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_k_)-[MAN(4_k_)]-BMA(3_k_)-NAG(2_k_)-NAG(1_k_)-ASN(38_E_)",192.001,"","",""
"4O6D","WEST NILE VIRUS NON-STRUCTURAL PROTEIN 1 (NS1) FORM 1 CRYSTAL","10.1126/SCIENCE.1247749 ",2.59,98.18,"4o6d_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(207_B_)",151.467,"","",""
"4OBR","CRYSTAL STRUCTURE OF HUMAN ALPHA-L-IDURONIDASE COMPLEX WITH ALPHA-L- IDURONIC ACID","",2.46,39.55,"4obr_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(372_A_)",62.8695,"","",""
"4OBR","CRYSTAL STRUCTURE OF HUMAN ALPHA-L-IDURONIDASE COMPLEX WITH ALPHA-L- IDURONIC ACID","",2.46,39.55,"4obr_oligo4","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-MAN(5_F_)-[MAN(7_F_)]-MAN(4_F_)-[MAN(9_F_)-MAN(8_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(372_B_)",64.4858,"","",""
"4OBS","CRYSTAL STRUCTURE OF HUMAN ALPHA-L-IDURONIDASE IN THE P212121 FORM","",2.26,17.69,"4obs_oligo1","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(372_A_)",37.0609,"","",""
"4OC0","X-RAY STRUCTURE OF OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN A COMPLEX WITH CCIBZL, A UREA-BASED INHIBITOR N~2~-[(1- CARBOXYCYCLOPROPYL)CARBAMOYL]-N~6~-(4-IODOBENZOYL)-L-LYSINE","10.1016/J.BMCL.2014.03.066 ",1.85,36.43,"4oc0_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(638_A_)",47.502,"","",""
"4OC1","X-RAY STRUCTURE OF OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN A COMPLEX WITH COIBZL, A UREA-BASED INHIBITOR (2S)-2-[({(1S)-1-CARBOXY- 2-[(2S)-OXIRAN-2-YL]ETHYL}CARBAMOYL)AMINO]-6-[(4-IODOBENZOYL) AMINO]HEXANOIC ACID","10.1016/J.BMCL.2014.03.066 ",1.75,28.69,"4oc1_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(638_A_)",36.892,"","",""
"4OC2","X-RAY STRUCTURE OF OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN A COMPLEX WITH CEIBZL, A UREA-BASED INHIBITOR N~2~-{[(1S)-1-CARBOXYBUT- 3-YN-1-YL]CARBAMOYL}-N~6~-(4-IODOBENZOYL)-L-LYSINE","10.1016/J.BMCL.2014.03.066 ",1.65,32.03,"4oc2_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(638_A_)",38.0457,"","",""
"4OC3","X-RAY STRUCTURE OF OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN A COMPLEX WITH CFIBZL, A UREA-BASED INHIBITOR N~2~-{[(1S)-1-CARBOXY-2- (FURAN-2-YL)ETHYL]CARBAMOYL}-N~6~-(4-IODOBENZOYL)-L-LYSINE","10.1016/J.BMCL.2014.03.066 ",1.79,29.2,"4oc3_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(638_A_)",38.6577,"","",""
"4OC4","X-RAY STRUCTURE OF OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN A COMPLEX WITH CPIBZL, A UREA-BASED INHIBITOR N~2~-{[(1S)-1-CARBOXY-2- (PYRIDIN-4-YL)ETHYL]CARBAMOYL}-N~6~-(4-IODOBENZOYL)-L-LYSINE","10.1016/J.BMCL.2014.03.066 ",1.66,31.25,"4oc4_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(638_A_)",37.9177,"","",""
"4OC5","X-RAY STRUCTURE OF OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN A COMPLEX WITH CHIBZL, A UREA-BASED INHIBITOR N~2~-{[(S)-CARBOXY(4- HYDROXYPHENYL)METHYL]CARBAMOYL}-N~6~-(4-IODOBENZOYL)-L-LYSINE","10.1016/J.BMCL.2014.03.066 ",1.7,31.93,"4oc5_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(638_A_)",43.0734,"","",""
"4OF3","CRYSTAL STRUCTURE OF SYG-1 D1-D2, GLYCOSYLATED","10.1016/J.CELL.2014.01.004 ",2.5,0,"4of3_oligo1","LFucpa1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_D_)-[NAG(3_D_)]-[FUC(2_D_)]-NAG(1_D_)-ASN(206_A_)",112.161,"","",""
"4OF6","CRYSTAL STRUCTURE OF SYG-1 D1, CRYSTAL FORM 1","10.1016/J.CELL.2014.01.004 ",1.7,0,"4of6_oligo1","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_C_)-[FUC(2_C_)]-NAG(1_C_)-ASN(93_A_)",75.6197,"","",""
"4OGA","INSULIN IN COMPLEX WITH SITE 1 OF THE HUMAN INSULIN RECEPTOR","10.1073/PNAS.1412897111 ",3.5,238.4,"4oga_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(111_E_)",243.077,"","",""
"4OI9","CRYSTAL STRUCTURE OF ICAM-5 D1-D4 ECTODOMAIN FRAGMENT, SPACE GROUP P21","10.1107/S1399004714009468 ",2.5,0,"4oi9_oligo8","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(285_A_)",143.966,"","",""
"4OIB","CRYSTAL STRUCTURE OF ICAM-5 D1-D4 ECTODOMAIN FRAGMENT, SPACE GROUP R3","10.1107/S1399004714009468 ",3.5,0,"4oib_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(106_A_)",251.512,"","",""
"4OIB","CRYSTAL STRUCTURE OF ICAM-5 D1-D4 ECTODOMAIN FRAGMENT, SPACE GROUP R3","10.1107/S1399004714009468 ",3.5,0,"4oib_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(272_A_)",261.057,"","",""
"4OME","X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II IN COMPLEX WITH DCCBL, A UREA BASED INHIBITOR WITH DISTAL CARBORANE MOIETY","",1.79,25.96,"4ome_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(638_A_)",30.1386,"","",""
"4OP7","CRYSTAL STRUCTURE OF P DOMAIN FROM NOROVIRUS STRAIN NSW0514 IN COMPLEX WITH HBGA TYPE B (TRIGLYCAN)","10.1128/JVI.02968-14 ",1.92,27.51,"4op7_oligo3","LFucpa1-2[DGalpa1-3]DGalpa1-ROH","GLA(3_C_)-[FUC(2_C_)]-GLA(1_C_)",34.1685,"","",""
"4OP7","CRYSTAL STRUCTURE OF P DOMAIN FROM NOROVIRUS STRAIN NSW0514 IN COMPLEX WITH HBGA TYPE B (TRIGLYCAN)","10.1128/JVI.02968-14 ",1.92,27.51,"4op7_oligo4","LFucpa1-2[DGalpa1-3]DGalpa1-ROH","GLA(3_D_)-[FUC(2_D_)]-GLA(1_D_)",34.9673,"","",""
"4OPO","CRYSTAL STRUCTURE OF P DOMAIN FROM NOROVIRUS STRAIN SAGA4 IN COMPLEX WITH HBGA TYPE LEB (TETRAGLYCAN)","10.1128/JVI.02968-14 ",1.4,15.25,"4opo_oligo2","LFucpa1-2DGalpb1-3[LFucpa1-4]DGlcpNAcb1-ROH","FUC(4_D_)-[FUC(3_D_)-GAL(2_D_)]-NAG(1_D_)",36.5157,"","",""
"4OPO","CRYSTAL STRUCTURE OF P DOMAIN FROM NOROVIRUS STRAIN SAGA4 IN COMPLEX WITH HBGA TYPE LEB (TETRAGLYCAN)","10.1128/JVI.02968-14 ",1.4,15.25,"4opo_oligo1","LFucpa1-2DGalpb1-3[LFucpa1-4]DGlcpNAcb1-ROH","FUC(4_C_)-[FUC(3_C_)-GAL(2_C_)]-NAG(1_C_)",26.7132,"","",""
"4OPS","CRYSTAL STRUCTURE OF P DOMAIN FROM NOROVIRUS STRAIN FARMINGTON HILLS 2004 IN COMPLEX WITH HBGA TYPE LEB (TETRAGLYCAN)","10.1128/JVI.02968-14 ",1.76,23.89,"4ops_oligo1","LFucpa1-2DGalpb1-3[LFucpa1-4]DGlcpNAcb1-ROH","FUC(4_C_)-[FUC(3_C_)-GAL(2_C_)]-NAG(1_C_)",56.4914,"","",""
"4OVE","X-RAY CRYSTAL STRUCTURE OF MOUSE NETRIN-1","10.1016/J.CCELL.2016.01.001 ",2.64,64.55,"4ove_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(95_A_)",132.773,"","",""
"4P25","STRUCTURE OF THE P DOMAIN FROM A GI.7 NOROVIRUS VARIANT IN COMPLEX WITH LEY HBGA.","10.1128/JVI.00201-14 ",1.5,0,"4p25_oligo1","LFucpa1-2DGalpb1-4[LFucpa1-3]DGlcpNAcb1-ROH","FUC(3_E_)-GAL(2_E_)-[FUC(4_E_)]-NAG(1_E_)",20.6577,"","",""
"4P25","STRUCTURE OF THE P DOMAIN FROM A GI.7 NOROVIRUS VARIANT IN COMPLEX WITH LEY HBGA.","10.1128/JVI.00201-14 ",1.5,0,"4p25_oligo2","LFucpa1-2DGalpb1-4[LFucpa1-3]DGlcpNAcb1-ROH","FUC(3_F_)-GAL(2_F_)-[FUC(4_F_)]-NAG(1_F_)",23.5716,"","",""
"4P25","STRUCTURE OF THE P DOMAIN FROM A GI.7 NOROVIRUS VARIANT IN COMPLEX WITH LEY HBGA.","10.1128/JVI.00201-14 ",1.5,0,"4p25_oligo3","LFucpa1-2DGalpb1-4[LFucpa1-3]DGlcpNAcb1-ROH","FUC(3_G_)-GAL(2_G_)-[FUC(4_G_)]-NAG(1_G_)",16.6982,"","",""
"4P25","STRUCTURE OF THE P DOMAIN FROM A GI.7 NOROVIRUS VARIANT IN COMPLEX WITH LEY HBGA.","10.1128/JVI.00201-14 ",1.5,0,"4p25_oligo4","LFucpa1-2DGalpb1-4[LFucpa1-3]DGlcpNAcb1-ROH","FUC(3_H_)-GAL(2_H_)-[FUC(4_H_)]-NAG(1_H_)",20.853,"","",""
"4P26","STRUCTURE OF THE P DOMAIN FROM A GI.7 NOROVIRUS VARIANT IN COMPLEX WITH A-TYPE 2 HBGA","10.1128/JVI.00201-14 ",1.9,0,"4p26_oligo1","LFucpa1-2[DGalpNAca1-3]DGalpb1-4DGlcpNAcb1-ROH","A2G(4_E_)-[FUC(3_E_)]-GAL(2_E_)-NAG(1_E_)",53.4914,"","",""
"4P26","STRUCTURE OF THE P DOMAIN FROM A GI.7 NOROVIRUS VARIANT IN COMPLEX WITH A-TYPE 2 HBGA","10.1128/JVI.00201-14 ",1.9,0,"4p26_oligo2","LFucpa1-2[DGalpNAca1-3]DGalpb1-4DGlcpNAcb1-ROH","A2G(4_F_)-[FUC(3_F_)]-GAL(2_F_)-NAG(1_F_)",27.3902,"","",""
"4P26","STRUCTURE OF THE P DOMAIN FROM A GI.7 NOROVIRUS VARIANT IN COMPLEX WITH A-TYPE 2 HBGA","10.1128/JVI.00201-14 ",1.9,0,"4p26_oligo3","LFucpa1-2[DGalpNAca1-3]DGalpb1-4DGlcpNAcb1-ROH","A2G(4_G_)-[FUC(3_G_)]-GAL(2_G_)-NAG(1_G_)",34.0782,"","",""
"4P2N","STRUCTURE OF THE P DOMAIN FROM A GI.7 NOROVIRUS VARIANT IN COMPLEX WITH LEX HBGA","10.1128/JVI.00201-14 ",1.7,0,"4p2n_oligo1","LFucpa1-3[DGalpb1-4]DGlcpNAcb1-ROH","GAL(3_E_)-[FUC(2_E_)]-NAG(1_E_)",26.6485,"","",""
"4P2N","STRUCTURE OF THE P DOMAIN FROM A GI.7 NOROVIRUS VARIANT IN COMPLEX WITH LEX HBGA","10.1128/JVI.00201-14 ",1.7,0,"4p2n_oligo2","LFucpa1-3[DGalpb1-4]DGlcpNAcb1-ROH","GAL(3_F_)-[FUC(2_F_)]-NAG(1_F_)",28.0973,"","",""
"4P2N","STRUCTURE OF THE P DOMAIN FROM A GI.7 NOROVIRUS VARIANT IN COMPLEX WITH LEX HBGA","10.1128/JVI.00201-14 ",1.7,0,"4p2n_oligo3","LFucpa1-3[DGalpb1-4]DGlcpNAcb1-ROH","GAL(3_G_)-[FUC(2_G_)]-NAG(1_G_)",33.9767,"","",""
"4P2N","STRUCTURE OF THE P DOMAIN FROM A GI.7 NOROVIRUS VARIANT IN COMPLEX WITH LEX HBGA","10.1128/JVI.00201-14 ",1.7,0,"4p2n_oligo4","LFucpa1-3[DGalpb1-4]DGlcpNAcb1-ROH","GAL(3_H_)-[FUC(2_H_)]-NAG(1_H_)",27.523,"","",""
"4P2O","CRYSTAL STRUCTURE OF THE 2B4 TCR IN COMPLEX WITH 2A/I-EK","10.1016/J.CELL.2014.03.047 ",2.6,0,"4p2o_oligo1","LFucpa1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_E_)-[NAG(3_E_)]-[FUC(2_E_)]-NAG(1_E_)-ASN(19_B_)",96.2232,"","",""
"4P3I","STRUCTURE OF THE P DOMAIN FROM A GI.7 NOROVIRUS VARIANT IN COMPLEX WITH LEA HBGA.","10.1128/JVI.00201-14 ",1.69,0,"4p3i_oligo3","DGalpb1-3[LFucpa1-4]DGlcpNAcb1-ROH","FUC(3_G_)-[GAL(2_G_)]-NAG(1_G_)",35.6655,"","",""
"4P3I","STRUCTURE OF THE P DOMAIN FROM A GI.7 NOROVIRUS VARIANT IN COMPLEX WITH LEA HBGA.","10.1128/JVI.00201-14 ",1.69,0,"4p3i_oligo2","DGalpb1-3[LFucpa1-4]DGlcpNAcb1-ROH","FUC(3_F_)-[GAL(2_F_)]-NAG(1_F_)",45.7988,"","",""
"4P3I","STRUCTURE OF THE P DOMAIN FROM A GI.7 NOROVIRUS VARIANT IN COMPLEX WITH LEA HBGA.","10.1128/JVI.00201-14 ",1.69,0,"4p3i_oligo1","DGalpb1-3[LFucpa1-4]DGlcpNAcb1-ROH","FUC(3_E_)-[GAL(2_E_)]-NAG(1_E_)",35.5818,"","",""
"4P3I","STRUCTURE OF THE P DOMAIN FROM A GI.7 NOROVIRUS VARIANT IN COMPLEX WITH LEA HBGA.","10.1128/JVI.00201-14 ",1.69,0,"4p3i_oligo4","DGalpb1-3[LFucpa1-4]DGlcpNAcb1-ROH","FUC(3_H_)-[GAL(2_H_)]-NAG(1_H_)",25.3861,"","",""
"4P44","X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH A PHOSPHORAMIDATE INHIBITOR JRB-4-81","10.1111/FEBS.13557 ",1.75,26.41,"4p44_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(638_A_)",36.8773,"","",""
"4P45","X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH A PHOSPHORAMIDATE INHIBITOR JRB-4-73","10.1111/FEBS.13557 ",1.87,27.13,"4p45_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(638_A_)",38.4841,"","",""
"4P4B","X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH A PHOSPHORAMIDATE INHIBITOR CTT54","10.1111/FEBS.13557 ",1.93,28.98,"4p4b_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(638_A_)",42.9034,"","",""
"4P4D","X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH A PHOSPHORAMIDATE INHIBITOR MP1C","10.1111/FEBS.13557 ",1.65,28.77,"4p4d_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(638_A_)",36.4227,"","",""
"4P4E","X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH A PHOSPHORAMIDATE INHIBITOR MP1D","10.1111/FEBS.13557 ",1.67,31.83,"4p4e_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(638_A_)",40.8311,"","",""
"4P4F","X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH A PHOSPHORAMIDATE INHIBITOR NC-2-40","10.1111/FEBS.13557 ",1.86,30.76,"4p4f_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(638_A_)",43.7716,"","",""
"4P4I","X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH A PHOSPHORAMIDATE INHIBITOR T33","10.1111/FEBS.13557 ",1.87,30.53,"4p4i_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(638_A_)",42.2902,"","",""
"4P4J","X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH A PHOSPHORAMIDATE INHIBITOR T33D","10.1111/FEBS.13557 ",1.66,27.7,"4p4j_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(638_A_)",39.5864,"","",""
"4P5M","STRUCTURAL BASIS OF CHRONIC BERYLLIUM DISEASE: BRIDGING THE GAP BETWEEN ALLERGIC HYPERSENSITIVITY AND AUTOIMMUNITY","10.1016/J.CELL.2014.04.048 ",1.7,24.32,"4p5m_oligo7","DManpb1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_O_)-[BMA(2_O_)]-NAG(1_O_)-ASN(19_H_)",24.553,"","",""
"4P5M","STRUCTURAL BASIS OF CHRONIC BERYLLIUM DISEASE: BRIDGING THE GAP BETWEEN ALLERGIC HYPERSENSITIVITY AND AUTOIMMUNITY","10.1016/J.CELL.2014.04.048 ",1.7,24.32,"4p5m_oligo5","DGlcpNAcb1-4DGlcpNAcb1-4[DManpb1-3]DGlcpNAcb1-ASN","NAG(3_M_)-NAG(2_M_)-[BMA(4_M_)]-NAG(1_M_)-ASN(19_F_)",31.3493,"","",""
"4P9H","CRYSTAL STRUCTURE OF 8ANC195 FAB IN COMPLEX WITH GP120 OF 93TH057 HIV- 1 AND SOLUBLE CD4 D1D2","10.1016/J.CELREP.2014.04.001 ",3,66.79,"4p9h_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(262_G_)",97.0589,"","",""
"4P9H","CRYSTAL STRUCTURE OF 8ANC195 FAB IN COMPLEX WITH GP120 OF 93TH057 HIV- 1 AND SOLUBLE CD4 D1D2","10.1016/J.CELREP.2014.04.001 ",3,66.79,"4p9h_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(276_G_)",85.8438,"","",""
"4P9H","CRYSTAL STRUCTURE OF 8ANC195 FAB IN COMPLEX WITH GP120 OF 93TH057 HIV- 1 AND SOLUBLE CD4 D1D2","10.1016/J.CELREP.2014.04.001 ",3,66.79,"4p9h_oligo4","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_B_)-MAN(8_B_)-[MAN(10_B_)]-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(234_G_)",70.6277,"","",""
"4PB1","STRUCTURE OF VCCNT-7C8C BOUND TO RIBAVIRIN","10.7554/ELIFE.03604 ",2.8,58.84,"4pb1_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(503_A_)-DMU(503_A_)",72.31,"","",""
"4PB2","STRUCTURE OF VCCNT-7C8C BOUND TO 5-FLUOROURIDINE","10.7554/ELIFE.03604 ",2.3,54.57,"4pb2_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(503_A_)-DMU(503_A_)",67.93,"","",""
"4PD5","CRYSTAL STRUCTURE OF VCCNT-7C8C BOUND TO GEMCITABINE","10.7554/ELIFE.03604 ",2.91,76.81,"4pd5_oligo3","DGlcpa1-3DGlcpb6-C10O1","DMU(503_A_)-DMU(503_A_)",101.44,"","",""
"4PD6","CRYSTAL STRUCTURE OF VCCNT-7C8C BOUND TO URIDINE","10.7554/ELIFE.03604 ",2.08,44.72,"4pd6_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(503_A_)-DMU(503_A_)",62.63,"","",""
"4PD7","STRUCTURE OF VCCNT BOUND TO ZEBULARINE","10.7554/ELIFE.03604 ",2.91,45.59,"4pd7_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(503_A_)-DMU(503_A_)",56.4,"","",""
"4PD8","STRUCTURE OF VCCNT-7C8C BOUND TO PYRROLO-CYTIDINE","10.7554/ELIFE.03604 ",2.75,60.97,"4pd8_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(503_A_)-DMU(503_A_)",72.68,"","",""
"4PD9","STRUCTURE OF VCCNT-7C8C BOUND TO ADENOSINE","10.7554/ELIFE.03604 ",3.1,72.18,"4pd9_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(503_A_)-DMU(503_A_)",89.01,"","",""
"4PDA","STRUCTURE OF VCCNT-7C8C BOUND TO CYTIDINE","10.7554/ELIFE.03604 ",2.61,59.12,"4pda_oligo3","DGlcpa1-3DGlcpb6-C10O1","DMU(503_A_)-DMU(503_A_)",62.63,"","",""
"4PE5","CRYSTAL STRUCTURE OF GLUN1A/GLUN2B NMDA RECEPTOR ION CHANNEL","10.1126/SCIENCE.1251915 ",3.96,0,"4pe5_oligo4","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-MAN(4_F_)-[MAN(6_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(203_A_)",354.378,"","",""
"4PPH","CRYSTAL STRUCTURE OF CONGLUTIN GAMMA, A UNIQUE BASIC 7S GLOBULIN FROM LUPINE SEEDS","10.1107/S1399004714025073 ",2.01,45.18,"4pph_oligo1","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_G_)-[FUC(2_G_)]-NAG(1_G_)-ASN(98_A_)",78.3733,"","",""
"4PSP","CRYSTAL STRUCTURE OF GH29 FAMILY ALPHA-L-FUCOSIDASE FROM FUSARIUM GRAMINEARUM IN THE OPEN FORM","10.1074/JBC.M114.583286 ",1.56,19.74,"4psp_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_C_)-[MAN(6_C_)-MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(280_A_)",27.1403,"","",""
"4PSP","CRYSTAL STRUCTURE OF GH29 FAMILY ALPHA-L-FUCOSIDASE FROM FUSARIUM GRAMINEARUM IN THE OPEN FORM","10.1074/JBC.M114.583286 ",1.56,19.74,"4psp_oligo2","DManpa1-2DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-MAN(5_D_)-MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(280_B_)",22.1611,"","",""
"4PSR","CRYSTAL STRUCTURE OF ALPHA-L-FUCOSIDASE FROM FUSARIUM GRAMINEARUM IN THE OPEN FORM IN COMPLEX WITH L-FUCOSE","10.1074/JBC.M114.583286 ",1.38,19.34,"4psr_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_C_)-[MAN(6_C_)-MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(280_A_)",26.1953,"","",""
"4PSR","CRYSTAL STRUCTURE OF ALPHA-L-FUCOSIDASE FROM FUSARIUM GRAMINEARUM IN THE OPEN FORM IN COMPLEX WITH L-FUCOSE","10.1074/JBC.M114.583286 ",1.38,19.34,"4psr_oligo2","DManpa1-2DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-MAN(5_D_)-MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(280_B_)",20.2873,"","",""
"4PXF","CRYSTAL STRUCTURE OF THE ACTIVE G-PROTEIN-COUPLED RECEPTOR OPSIN IN COMPLEX WITH THE FINGER-LOOP PEPTIDE DERIVED FROM THE FULL-LENGTH ARRESTIN-1","10.1038/NCOMMS5801 ",2.75,84.9,"4pxf_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(15_A_)",138.308,"","",""
"4Q4B","CRYSTAL STRUCTURE OF LIMP-2 (SPACE GROUP C2221)","10.1038/NCOMMS5321 ",2.82,63.81,"4q4b_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(68_A_)",70.04,"","",""
"4Q4B","CRYSTAL STRUCTURE OF LIMP-2 (SPACE GROUP C2221)","10.1038/NCOMMS5321 ",2.82,63.81,"4q4b_oligo4","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_F_)-MAN(10_F_)-[MAN(9_F_)-MAN(8_F_)]-MAN(7_F_)-[MAN(6_F_)-MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(325_A_)",79.6334,"","",""
"4Q4B","CRYSTAL STRUCTURE OF LIMP-2 (SPACE GROUP C2221)","10.1038/NCOMMS5321 ",2.82,63.81,"4q4b_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(412_A_)",73.4855,"","",""
"4Q4F","CRYSTAL STRUCTURE OF LIMP-2 (SPACE GROUP C2)","10.1038/NCOMMS5321 ",2.8,71.18,"4q4f_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(412_A_)",83.5969,"","",""
"4Q4F","CRYSTAL STRUCTURE OF LIMP-2 (SPACE GROUP C2)","10.1038/NCOMMS5321 ",2.8,71.18,"4q4f_oligo3","DManp[6P]b1-2DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","M6D(6_F_)-MAN(5_F_)-MAN(4_F_)-[MAN(7_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(325_A_)",93.016,"","",""
"4Q4F","CRYSTAL STRUCTURE OF LIMP-2 (SPACE GROUP C2)","10.1038/NCOMMS5321 ",2.8,71.18,"4q4f_oligo4","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(206_A_)",103.01,"","",""
"4Q4F","CRYSTAL STRUCTURE OF LIMP-2 (SPACE GROUP C2)","10.1038/NCOMMS5321 ",2.8,71.18,"4q4f_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(68_A_)",77.2996,"","",""
"4Q56","STRUCTURE OF HELIX ASPERSA AGGLUTININ WITH NATURAL GLYCOSYLATION AND N-ACETYL-ALPHA-D-GALACTOSAMINE (GALNAC)","10.1016/J.IJBIOMAC.2015.09.044 ",1.38,31.07,"4q56_oligo2","LFucpa1-2DGalpb1-4LFucpa1-3[DManpb1-4DGlcpNAcb1-4]DGlcpNAcb1-ASN","BMA(6_B_)-NAG(5_B_)-[FUC(4_B_)-GAL(3_B_)-FUC(2_B_)]-NAG(1_B_)-ASN(35_A_)",41.2914,"","",""
"4Q7D","WILD TYPE FC (WTFC)","10.1016/J.JMB.2014.07.006 ",2.35,0,"4q7d_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",69.09,"","",""
"4Q7D","WILD TYPE FC (WTFC)","10.1016/J.JMB.2014.07.006 ",2.35,0,"4q7d_oligo2","DGlcpNAcb1-2DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(8_C_)-[NAG(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)",52.2443,"","",""
"4QC0","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH XG-1-236","10.1021/JM500744F ",2.1,37.09,"4qc0_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(293_B_)",39.6307,"","",""
"4QGT","THE CRYSTAL STRUCTURE OF HUMAN IGG FC DOMAIN WITH ENHANCED AROMATIC SEQUON","10.1021/ACSCHEMBIO.5B01035 ",2.99,0,"4qgt_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",101.025,"","",""
"4QN4","CRYSTAL STRUCTURE OF NEURAMINIDASE N6","10.1128/JVI.00805-14 ",1.8,13.41,"4qn4_oligo4","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)]-MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(122_B_)",22.267,"","",""
"4QN4","CRYSTAL STRUCTURE OF NEURAMINIDASE N6","10.1128/JVI.00805-14 ",1.8,13.41,"4qn4_oligo2","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-[MAN(5_D_)]-MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(122_A_)",19.9985,"","",""
"4QN6","CRYSTAL STRUCTURE OF NEURAMINIDASE N6 COMPLEXED WITH LANINAMIVIR","10.1128/JVI.00805-14 ",1.95,22.08,"4qn6_oligo2","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-[MAN(5_D_)]-MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(122_A_)",31.2268,"","",""
"4QN6","CRYSTAL STRUCTURE OF NEURAMINIDASE N6 COMPLEXED WITH LANINAMIVIR","10.1128/JVI.00805-14 ",1.95,22.08,"4qn6_oligo4","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)]-MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(122_B_)",28.6067,"","",""
"4QWW","CRYSTAL STRUCTURE OF THE FAB410-BFACHE COMPLEX","10.1074/JBC.M114.603902 ",2.7,60.76,"4qww_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(453_B_)",74.0353,"","",""
"4QWW","CRYSTAL STRUCTURE OF THE FAB410-BFACHE COMPLEX","10.1074/JBC.M114.603902 ",2.7,60.76,"4qww_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(453_A_)",64.7571,"","",""
"4QWW","CRYSTAL STRUCTURE OF THE FAB410-BFACHE COMPLEX","10.1074/JBC.M114.603902 ",2.7,60.76,"4qww_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_G_)-[MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(343_A_)",87.1011,"","",""
"4QWW","CRYSTAL STRUCTURE OF THE FAB410-BFACHE COMPLEX","10.1074/JBC.M114.603902 ",2.7,60.76,"4qww_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_I_)-[MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(343_B_)",79.0986,"","",""
"4R07","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH ORN06","10.1038/NSMB.2943 ",2,41.97,"4r07_oligo9","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(293_A_)",34.9443,"","",""
"4R09","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH ORN06S","10.1038/NSMB.2943 ",2.62,63.34,"4r09_oligo16","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(293_A_)",52.0724,"","",""
"4R09","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH ORN06S","10.1038/NSMB.2943 ",2.62,63.34,"4r09_oligo22","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(293_C_)",58.8509,"","",""
"4R0A","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH URIDINE MONONUCLEOSIDE","10.1038/NSMB.2943 ",1.9,36.79,"4r0a_oligo1","[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(293_A_)",33.5475,"","",""
"4R2G","CRYSTAL STRUCTURE OF PGT124 FAB BOUND TO HIV-1 JRCSF GP120 CORE AND TO CD4","10.1016/J.CELL.2014.09.009 ",3.28,0,"4r2g_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_G_)-MAN(8_G_)-[MAN(10_G_)]-MAN(7_G_)-[MAN(6_G_)-MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(332_E_)",44.2849,"","",""
"4R2G","CRYSTAL STRUCTURE OF PGT124 FAB BOUND TO HIV-1 JRCSF GP120 CORE AND TO CD4","10.1016/J.CELL.2014.09.009 ",3.28,0,"4r2g_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(9_S_)-MAN(8_S_)-[MAN(10_S_)]-MAN(7_S_)-[MAN(6_S_)-MAN(5_S_)-MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)",49.5149,"","",""
"4R2G","CRYSTAL STRUCTURE OF PGT124 FAB BOUND TO HIV-1 JRCSF GP120 CORE AND TO CD4","10.1016/J.CELL.2014.09.009 ",3.28,0,"4r2g_oligo6","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_V_)-MAN(8_V_)-[MAN(10_V_)]-MAN(7_V_)-[MAN(6_V_)-MAN(5_V_)-MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(332_K_)",54.2975,"","",""
"4R2G","CRYSTAL STRUCTURE OF PGT124 FAB BOUND TO HIV-1 JRCSF GP120 CORE AND TO CD4","10.1016/J.CELL.2014.09.009 ",3.28,0,"4r2g_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(9_R_)-MAN(8_R_)-[MAN(10_R_)]-MAN(7_R_)-[MAN(6_R_)-MAN(5_R_)-MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)",54.3256,"","",""
"4R6A","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH HYBRID-2","",2.1,38.48,"4r6a_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(293_A_)",32.9745,"","",""
"4RBP","CRYSTAL STRUCTURE OF HIV NEUTRALIZING ANTIBODY 2G12 IN COMPLEX WITH A BACTERIAL OLIGOSACCHARIDE ANALOG OF MAMMALIAN OLIGOMANOSE","10.1093/GLYCOB/CWU123 ",1.85,0,"4rbp_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpa1-5DKdopa2-ROH","MAN(6_B_)-[MAN(5_B_)-MAN(4_B_)-MAN(3_B_)]-MAN(2_B_)-KDO(1_B_)",39.7385,"","",""
"4RBP","CRYSTAL STRUCTURE OF HIV NEUTRALIZING ANTIBODY 2G12 IN COMPLEX WITH A BACTERIAL OLIGOSACCHARIDE ANALOG OF MAMMALIAN OLIGOMANOSE","10.1093/GLYCOB/CWU123 ",1.85,0,"4rbp_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpa1-5DKdopa2-ROH","MAN(6_A_)-[MAN(5_A_)-MAN(4_A_)-MAN(3_A_)]-MAN(2_A_)-KDO(1_A_)",42.7628,"","",""
"4RCO","1.9 ANGSTROM CRYSTAL STRUCTURE OF SUPERANTIGEN-LIKE PROTEIN, EXOTOXIN FROM STAPHYLOCOCCUS AUREUS, IN COMPLEX WITH SIALYL-LEWISX.","",1.9,37.69,"4rco_oligo1","DNeup5Aca2-3DGalpb1-4[LFucpa1-3]DGlcpNAca1-ROH","SIA(3_C_)-GAL(2_C_)-[FUC(4_C_)]-NDG(1_C_)",25.0615,"","",""
"4RCO","1.9 ANGSTROM CRYSTAL STRUCTURE OF SUPERANTIGEN-LIKE PROTEIN, EXOTOXIN FROM STAPHYLOCOCCUS AUREUS, IN COMPLEX WITH SIALYL-LEWISX.","",1.9,37.69,"4rco_oligo2","DNeup5Aca2-3DGalpb1-4[LFucpa1-3]DGlcpNAca1-ROH","SIA(3_D_)-GAL(2_D_)-[FUC(4_D_)]-NDG(1_D_)",36.1678,"","",""
"4RDK","CRYSTAL STRUCTURE OF NOROVIRUS BOXER P DOMAIN IN COMPLEX WITH LEWIS B TETRASACCHARIDE","10.1007/S13238-014-0126-0 ",1.63,27.1,"4rdk_oligo2","LFucpa1-2DGalpb1-3[LFucpa1-4]DGlcpNAca1-ROH","FUC(4_D_)-[FUC(3_D_)-GAL(2_D_)]-NDG(1_D_)",29.93,"","",""
"4RDK","CRYSTAL STRUCTURE OF NOROVIRUS BOXER P DOMAIN IN COMPLEX WITH LEWIS B TETRASACCHARIDE","10.1007/S13238-014-0126-0 ",1.63,27.1,"4rdk_oligo1","LFucpa1-2DGalpb1-3[LFucpa1-4]DGlcpNAca1-ROH","FUC(4_C_)-[FUC(3_C_)-GAL(2_C_)]-NDG(1_C_)",25.3198,"","",""
"4RDL","CRYSTAL STRUCTURE OF NOROVIRUS BOXER P DOMAIN IN COMPLEX WITH LEWIS Y TETRASACCHARIDE","10.1007/S13238-014-0126-0 ",1.45,20.1,"4rdl_oligo2","LFucpa1-2DGalpb1-4[LFucpa1-3]DGlcpNAca1-ROH","FUC(3_D_)-GAL(2_D_)-[FUC(4_D_)]-NDG(1_D_)",24.1925,"","",""
"4RDL","CRYSTAL STRUCTURE OF NOROVIRUS BOXER P DOMAIN IN COMPLEX WITH LEWIS Y TETRASACCHARIDE","10.1007/S13238-014-0126-0 ",1.45,20.1,"4rdl_oligo1","LFucpa1-2DGalpb1-4[LFucpa1-3]DGlcpNAca1-ROH","FUC(3_C_)-GAL(2_C_)-[FUC(4_C_)]-NDG(1_C_)",27.1323,"","",""
"4RFB","1.93 ANGSTROM CRYSTAL STRUCTURE OF SUPERANTIGEN-LIKE PROTEIN FROM STAPHYLOCOCCUS AUREUS IN COMPLEX WITH SIALYL-LEWIS X.","",1.93,34.3,"4rfb_oligo3","DNeup5Aca2-3DGalpb1-4[LFucpa1-3]DGlcpNAcb1-ROH","SIA(3_G_)-GAL(2_G_)-[FUC(4_G_)]-NAG(1_G_)",30.0353,"","",""
"4RFB","1.93 ANGSTROM CRYSTAL STRUCTURE OF SUPERANTIGEN-LIKE PROTEIN FROM STAPHYLOCOCCUS AUREUS IN COMPLEX WITH SIALYL-LEWIS X.","",1.93,34.3,"4rfb_oligo4","DNeup5Aca2-3DGalpb1-4[LFucpa1-3]DGlcpNAcb1-ROH","SIA(3_H_)-GAL(2_H_)-[FUC(4_H_)]-NAG(1_H_)",28.1138,"","",""
"4RFB","1.93 ANGSTROM CRYSTAL STRUCTURE OF SUPERANTIGEN-LIKE PROTEIN FROM STAPHYLOCOCCUS AUREUS IN COMPLEX WITH SIALYL-LEWIS X.","",1.93,34.3,"4rfb_oligo1","DNeup5Aca2-3DGalpb1-4[LFucpa1-3]DGlcpNAcb1-ROH","SIA(3_E_)-GAL(2_E_)-[FUC(4_E_)]-NAG(1_E_)",28.576,"","",""
"4RFB","1.93 ANGSTROM CRYSTAL STRUCTURE OF SUPERANTIGEN-LIKE PROTEIN FROM STAPHYLOCOCCUS AUREUS IN COMPLEX WITH SIALYL-LEWIS X.","",1.93,34.3,"4rfb_oligo2","DNeup5Aca2-3DGalpb1-4[LFucpa1-3]DGlcpNAcb1-ROH","SIA(3_F_)-GAL(2_F_)-[FUC(4_F_)]-NAG(1_F_)",30.0134,"","",""
"4RM0","CRYSTAL STRUCTURE OF NOROVIRUS OIF P DOMAIN IN COMPLEX WITH LEWIS A TRISACCHARIDE","10.1371/JOURNAL.PPAT.1005025 ",2,0,"4rm0_oligo2","DGalpb1-3[LFucpa1-4]DGlcpNAca1-ROH","FUC(3_D_)-[GAL(2_D_)]-NDG(1_D_)",22.4367,"","",""
"4RM0","CRYSTAL STRUCTURE OF NOROVIRUS OIF P DOMAIN IN COMPLEX WITH LEWIS A TRISACCHARIDE","10.1371/JOURNAL.PPAT.1005025 ",2,0,"4rm0_oligo1","DGalpb1-3[LFucpa1-4]DGlcpNAcb1-ROH","FUC(3_C_)-[GAL(2_C_)]-NAG(1_C_)",28.2282,"","",""
"4RQS","CRYSTAL STRUCTURE OF FULLY GLYCOSYLATED HIV-1 GP120 CORE BOUND TO CD4 AND 17B FAB","10.1002/PROT.24747 ",4.49,0,"4rqs_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_A_)-[MAN(8_A_)]-MAN(7_A_)-[MAN(6_A_)-MAN(5_A_)-MAN(4_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(262_G_)",172.279,"","",""
"4TPL","WEST NILE VIRUS NON-STRUCTURAL PROTEIN 1 (NS1) FORM 1 CRYSTAL","10.1107/S1399004714017556 ",2.9,100.3,"4tpl_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(207_B_)",151.528,"","",""
"4TVP","CRYSTAL STRUCTURE OF THE HIV-1 BG505 SOSIP.664 ENV TRIMER ECTODOMAIN, COMPRISING ATOMIC-LEVEL DEFINITION OF PRE-FUSION GP120 AND GP41, IN COMPLEX WITH HUMAN ANTIBODIES PGT122 AND 35O22","10.1038/NATURE13808 ",3.1,0,"4tvp_oligo6","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(10_T_)-[MAN(9_T_)-MAN(8_T_)]-MAN(7_T_)-[MAN(6_T_)-MAN(5_T_)-MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(332_G_)",102.019,"","",""
"4TVP","CRYSTAL STRUCTURE OF THE HIV-1 BG505 SOSIP.664 ENV TRIMER ECTODOMAIN, COMPRISING ATOMIC-LEVEL DEFINITION OF PRE-FUSION GP120 AND GP41, IN COMPLEX WITH HUMAN ANTIBODIES PGT122 AND 35O22","10.1038/NATURE13808 ",3.1,0,"4tvp_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_A_)-[MAN(5_A_)]-MAN(4_A_)-[MAN(7_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(88_G_)",88.2486,"","",""
"4TVP","CRYSTAL STRUCTURE OF THE HIV-1 BG505 SOSIP.664 ENV TRIMER ECTODOMAIN, COMPRISING ATOMIC-LEVEL DEFINITION OF PRE-FUSION GP120 AND GP41, IN COMPLEX WITH HUMAN ANTIBODIES PGT122 AND 35O22","10.1038/NATURE13808 ",3.1,0,"4tvp_oligo7","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(137_G_)",131.404,"","",""
"4TVP","CRYSTAL STRUCTURE OF THE HIV-1 BG505 SOSIP.664 ENV TRIMER ECTODOMAIN, COMPRISING ATOMIC-LEVEL DEFINITION OF PRE-FUSION GP120 AND GP41, IN COMPLEX WITH HUMAN ANTIBODIES PGT122 AND 35O22","10.1038/NATURE13808 ",3.1,0,"4tvp_oligo14","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(156_G_)",119.641,"","",""
"4TVP","CRYSTAL STRUCTURE OF THE HIV-1 BG505 SOSIP.664 ENV TRIMER ECTODOMAIN, COMPRISING ATOMIC-LEVEL DEFINITION OF PRE-FUSION GP120 AND GP41, IN COMPLEX WITH HUMAN ANTIBODIES PGT122 AND 35O22","10.1038/NATURE13808 ",3.1,0,"4tvp_oligo9","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_I_)-[MAN(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(262_G_)",114.15,"","",""
"4TVZ","CRYSTAL STRUCTURE OF SCARB2 IN NEURAL CONDITION (PH7.5)","10.1007/S13238-014-0087-3 ",3.01,39.88,"4tvz_oligo10","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_L_)-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(412_B_)",62.8371,"","",""
"4TVZ","CRYSTAL STRUCTURE OF SCARB2 IN NEURAL CONDITION (PH7.5)","10.1007/S13238-014-0087-3 ",3.01,39.88,"4tvz_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(68_A_)",60.2264,"","",""
"4TVZ","CRYSTAL STRUCTURE OF SCARB2 IN NEURAL CONDITION (PH7.5)","10.1007/S13238-014-0087-3 ",3.01,39.88,"4tvz_oligo6","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_K_)-MAN(7_K_)-[MAN(6_K_)-MAN(5_K_)]-MAN(4_K_)-[MAN(10_K_)-MAN(9_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(325_B_)",82.3019,"","",""
"4TVZ","CRYSTAL STRUCTURE OF SCARB2 IN NEURAL CONDITION (PH7.5)","10.1007/S13238-014-0087-3 ",3.01,39.88,"4tvz_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(412_A_)",58.8758,"","",""
"4TVZ","CRYSTAL STRUCTURE OF SCARB2 IN NEURAL CONDITION (PH7.5)","10.1007/S13238-014-0087-3 ",3.01,39.88,"4tvz_oligo8","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_F_)-MAN(7_F_)-[MAN(6_F_)-MAN(5_F_)]-MAN(4_F_)-[MAN(9_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(325_A_)",75.3942,"","",""
"4TW0","CRYSTAL STRUCTURE OF SCARB2 IN ACIDIC CONDITION (PH4.8)","10.1007/S13238-014-0087-3 ",3.65,60.28,"4tw0_oligo11","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(68_B_)",81.2025,"","",""
"4TW0","CRYSTAL STRUCTURE OF SCARB2 IN ACIDIC CONDITION (PH4.8)","10.1007/S13238-014-0087-3 ",3.65,60.28,"4tw0_oligo12","DGlcpNAcb1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_K_)-MAN(4_K_)-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(412_B_)",82.1698,"","",""
"4TW0","CRYSTAL STRUCTURE OF SCARB2 IN ACIDIC CONDITION (PH4.8)","10.1007/S13238-014-0087-3 ",3.65,60.28,"4tw0_oligo5","DGlcpNAcb1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_P_)-MAN(4_P_)-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(412_C_)",80.1247,"","",""
"4TW0","CRYSTAL STRUCTURE OF SCARB2 IN ACIDIC CONDITION (PH4.8)","10.1007/S13238-014-0087-3 ",3.65,60.28,"4tw0_oligo17","DGlcpNAcb1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_U_)-MAN(4_U_)-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(412_D_)",82.5742,"","",""
"4TW0","CRYSTAL STRUCTURE OF SCARB2 IN ACIDIC CONDITION (PH4.8)","10.1007/S13238-014-0087-3 ",3.65,60.28,"4tw0_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_O_)-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(68_C_)",82.2114,"","",""
"4TW0","CRYSTAL STRUCTURE OF SCARB2 IN ACIDIC CONDITION (PH4.8)","10.1007/S13238-014-0087-3 ",3.65,60.28,"4tw0_oligo7","DGlcpNAcb1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_F_)-MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(412_A_)",79.772,"","",""
"4TW0","CRYSTAL STRUCTURE OF SCARB2 IN ACIDIC CONDITION (PH4.8)","10.1007/S13238-014-0087-3 ",3.65,60.28,"4tw0_oligo6","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(68_A_)",81.4216,"","",""
"4TW0","CRYSTAL STRUCTURE OF SCARB2 IN ACIDIC CONDITION (PH4.8)","10.1007/S13238-014-0087-3 ",3.65,60.28,"4tw0_oligo16","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_T_)-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(68_D_)",82.5332,"","",""
"4TW2","CRYSTAL STRUCTURE OF SCARB2 IN NEURAL CONDITION (PH7.5)","10.1007/S13238-014-0087-3 ",2.89,53.32,"4tw2_oligo10","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_L_)-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(412_B_)",53.7864,"","",""
"4TW2","CRYSTAL STRUCTURE OF SCARB2 IN NEURAL CONDITION (PH7.5)","10.1007/S13238-014-0087-3 ",2.89,53.32,"4tw2_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(68_B_)",50.9466,"","",""
"4TW2","CRYSTAL STRUCTURE OF SCARB2 IN NEURAL CONDITION (PH7.5)","10.1007/S13238-014-0087-3 ",2.89,53.32,"4tw2_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(68_A_)",59.4471,"","",""
"4TW2","CRYSTAL STRUCTURE OF SCARB2 IN NEURAL CONDITION (PH7.5)","10.1007/S13238-014-0087-3 ",2.89,53.32,"4tw2_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_H_)-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(412_A_)",54.7502,"","",""
"4U4G","STRUCTURE OF GLUA2* IN COMPLEX WITH COMPETITIVE ANTAGONIST ZK 200775","10.1126/SCIENCE.1256508 ",4.49,0,"4u4g_oligo6","DManpb1-3DManpb1-4DGlcpNAcb1-4DGlcpNAca1-ASN","BMA(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(355_B_)",200.945,"","",""
"4U4G","STRUCTURE OF GLUA2* IN COMPLEX WITH COMPETITIVE ANTAGONIST ZK 200775","10.1126/SCIENCE.1256508 ",4.49,0,"4u4g_oligo8","DManpb1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_H_)-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(355_D_)",280.359,"","",""
"4U4G","STRUCTURE OF GLUA2* IN COMPLEX WITH COMPETITIVE ANTAGONIST ZK 200775","10.1126/SCIENCE.1256508 ",4.49,0,"4u4g_oligo7","DManpb1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(355_C_)",241.495,"","",""
"4U4G","STRUCTURE OF GLUA2* IN COMPLEX WITH COMPETITIVE ANTAGONIST ZK 200775","10.1126/SCIENCE.1256508 ",4.49,0,"4u4g_oligo5","DManpb1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(355_A_)",260.192,"","",""
"4U60","TRICHODYSPLASIA SPINULOSA-ASSOCIATED POLYOMAVIRUS (TSPYV) VP1 IN COMPLEX WITH GM1 OLIGOSACCHARIDE","10.1371/JOURNAL.PPAT.1005112 ",1.5,17.96,"4u60_oligo1","DGalpb1-3DGalpNAcb1-4[DNeup5Aca2-3]DGalpb1-4DGlcpb1-ROH","GAL(4_H_)-NGA(3_H_)-[SIA(5_H_)]-GAL(2_H_)-BGC(1_H_)",29.5132,"","",""
"4U60","TRICHODYSPLASIA SPINULOSA-ASSOCIATED POLYOMAVIRUS (TSPYV) VP1 IN COMPLEX WITH GM1 OLIGOSACCHARIDE","10.1371/JOURNAL.PPAT.1005112 ",1.5,17.96,"4u60_oligo2","DGalpb1-3DGalpNAcb1-4[DNeup5Aca2-3]DGalpb1-4DGlcpb1-ROH","GAL(4_I_)-NGA(3_I_)-[SIA(5_I_)]-GAL(2_I_)-BGC(1_I_)",16.2779,"","",""
"4UBD","CRYSTAL STRUCTURE OF A NEUTRALIZING HUMAN MONOCLONAL ANTIBODY WITH 1968 H3 HA","10.1038/NCOMMS8708 ",3.5,116.1,"4ubd_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_b_)-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(165_U_)",132,"","",""
"4UBD","CRYSTAL STRUCTURE OF A NEUTRALIZING HUMAN MONOCLONAL ANTIBODY WITH 1968 H3 HA","10.1038/NCOMMS8708 ",3.5,116.1,"4ubd_oligo6","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_d_)-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(165_M_)",116.227,"","",""
"4UBD","CRYSTAL STRUCTURE OF A NEUTRALIZING HUMAN MONOCLONAL ANTIBODY WITH 1968 H3 HA","10.1038/NCOMMS8708 ",3.5,116.1,"4ubd_oligo7","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_e_)-BMA(3_e_)-NAG(2_e_)-NAG(1_e_)-ASN(165_Q_)",122.781,"","",""
"4UBD","CRYSTAL STRUCTURE OF A NEUTRALIZING HUMAN MONOCLONAL ANTIBODY WITH 1968 H3 HA","10.1038/NCOMMS8708 ",3.5,116.1,"4ubd_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_W_)-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(165_A_)",128.092,"","",""
"4UBD","CRYSTAL STRUCTURE OF A NEUTRALIZING HUMAN MONOCLONAL ANTIBODY WITH 1968 H3 HA","10.1038/NCOMMS8708 ",3.5,116.1,"4ubd_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_c_)-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(165_I_)",112.886,"","",""
"4UBD","CRYSTAL STRUCTURE OF A NEUTRALIZING HUMAN MONOCLONAL ANTIBODY WITH 1968 H3 HA","10.1038/NCOMMS8708 ",3.5,116.1,"4ubd_oligo9","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_g_)-BMA(3_g_)-NAG(2_g_)-NAG(1_g_)-ASN(165_E_)",125.58,"","",""
"4UM8","CRYSTAL STRUCTURE OF ALPHA V BETA 6","10.1038/NSMB.2905 ",2.85,86.6,"4um8_oligo2","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(260_A_)",145.249,"","",""
"4UM8","CRYSTAL STRUCTURE OF ALPHA V BETA 6","10.1038/NSMB.2905 ",2.85,86.6,"4um8_oligo10","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_N_)-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(458_C_)",142.674,"","",""
"4UM8","CRYSTAL STRUCTURE OF ALPHA V BETA 6","10.1038/NSMB.2905 ",2.85,86.6,"4um8_oligo6","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-MAN(4_G_)-[MAN(6_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(266_A_)",106.841,"","",""
"4UM8","CRYSTAL STRUCTURE OF ALPHA V BETA 6","10.1038/NSMB.2905 ",2.85,86.6,"4um8_oligo9","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-MAN(4_M_)-[MAN(6_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(266_C_)",129.504,"","",""
"4UM8","CRYSTAL STRUCTURE OF ALPHA V BETA 6","10.1038/NSMB.2905 ",2.85,86.6,"4um8_oligo11","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_O_)-[MAN(5_O_)]-MAN(4_O_)-[MAN(7_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(524_C_)",138.646,"","",""
"4UM9","CRYSTAL STRUCTURE OF ALPHA V BETA 6 WITH PEPTIDE","10.1038/NSMB.2905 ",2.5,74.31,"4um9_oligo7","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-MAN(4_N_)-[MAN(6_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(266_C_)",115.868,"","",""
"4UM9","CRYSTAL STRUCTURE OF ALPHA V BETA 6 WITH PEPTIDE","10.1038/NSMB.2905 ",2.5,74.31,"4um9_oligo8","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-MAN(4_I_)-[MAN(6_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(266_A_)",120.063,"","",""
"4UNW","STRUCTURE OF THE A_EQUINE_NEWMARKET_2_93 H3 HAEMAGGLUTININ","10.1073/PNAS.1406606111 ",2.6,64.83,"4unw_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(285_A_)",98.0962,"","",""
"4UNW","STRUCTURE OF THE A_EQUINE_NEWMARKET_2_93 H3 HAEMAGGLUTININ","10.1073/PNAS.1406606111 ",2.6,64.83,"4unw_oligo12","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_R_)-[MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(165_E_)",126.265,"","",""
"4UNW","STRUCTURE OF THE A_EQUINE_NEWMARKET_2_93 H3 HAEMAGGLUTININ","10.1073/PNAS.1406606111 ",2.6,64.83,"4unw_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(165_C_)",111.649,"","",""
"4UNW","STRUCTURE OF THE A_EQUINE_NEWMARKET_2_93 H3 HAEMAGGLUTININ","10.1073/PNAS.1406606111 ",2.6,64.83,"4unw_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(285_C_)",119.677,"","",""
"4UNW","STRUCTURE OF THE A_EQUINE_NEWMARKET_2_93 H3 HAEMAGGLUTININ","10.1073/PNAS.1406606111 ",2.6,64.83,"4unw_oligo13","DGlcpNAca1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_S_)-MAN(4_S_)-[MAN(6_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(285_E_)",119.569,"","",""
"4UNX","STRUCTURE OF THE A_EQUINE_NEWMARKET_2_93 H3 HAEMAGGLUTININ IN COMPLEX WITH 3SLN","10.1073/PNAS.1406606111 ",3.2,109.7,"4unx_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)",95.9628,"","",""
"4UNX","STRUCTURE OF THE A_EQUINE_NEWMARKET_2_93 H3 HAEMAGGLUTININ IN COMPLEX WITH 3SLN","10.1073/PNAS.1406606111 ",3.2,109.7,"4unx_oligo12","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_R_)-[MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)",137.896,"","",""
"4UNY","STRUCTURE OF THE A_EQUINE_NEWMARKET_2_93 H3 HAEMAGGLUTININ IN COMPLEX WITH 6SO4-3SLN","10.1073/PNAS.1406606111 ",2.9,67.81,"4uny_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(6_N_)-[MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)]-NAG(1_N_)-ASN(22_C_)",93.4209,"","",""
"4UNZ","STRUCTURE OF THE A_EQUINE_NEWMARKET_2_93 H3 HAEMAGGLUTININ IN COMPLEX WITH 6SO4-SIALYL LEWIS X","10.1073/PNAS.1406606111 ",2.9,73.96,"4unz_oligo6","DNeup5Aca2-3DGalpb1-4[LFucpa1-3]DGlcpNAc[6S]b1-ROH","SIA(3_H_)-GAL(2_H_)-[FUC(4_H_)-",88.5973,"","",""
"4UNZ","STRUCTURE OF THE A_EQUINE_NEWMARKET_2_93 H3 HAEMAGGLUTININ IN COMPLEX WITH 6SO4-SIALYL LEWIS X","10.1073/PNAS.1406606111 ",2.9,73.96,"4unz_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(6_N_)-[MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)]-NAG(1_N_)-ASN(22_C_)",105.096,"","",""
"4UO0","STRUCTURE OF THE A_EQUINE_RICHMOND_07 H3 HAEMAGGLUTININ","10.1073/PNAS.1406606111 ",1.9,33.21,"4uo0_oligo18","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_X_)-[MAN(4_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(165_E_)",63.8605,"","",""
"4UO0","STRUCTURE OF THE A_EQUINE_RICHMOND_07 H3 HAEMAGGLUTININ","10.1073/PNAS.1406606111 ",1.9,33.21,"4uo0_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_P_)-[MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(63_C_)",80.234,"","",""
"4UO0","STRUCTURE OF THE A_EQUINE_RICHMOND_07 H3 HAEMAGGLUTININ","10.1073/PNAS.1406606111 ",1.9,33.21,"4uo0_oligo11","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(165_A_)",66.5993,"","",""
"4UO0","STRUCTURE OF THE A_EQUINE_RICHMOND_07 H3 HAEMAGGLUTININ","10.1073/PNAS.1406606111 ",1.9,33.21,"4uo0_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Q_)-[MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(165_C_)",63.2887,"","",""
"4UO0","STRUCTURE OF THE A_EQUINE_RICHMOND_07 H3 HAEMAGGLUTININ","10.1073/PNAS.1406606111 ",1.9,33.21,"4uo0_oligo13","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(6_S_)-[MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)]-NAG(1_S_)-ASN(22_C_)",52.1642,"","",""
"4UO1","STRUCTURE OF THE A_EQUINE_RICHMOND_07 H3 HAEMAGGLUTININ IN COMPLEX WITH 3SLN","10.1073/PNAS.1406606111 ",3,81.45,"4uo1_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(165_C_)",101.585,"","",""
"4UO1","STRUCTURE OF THE A_EQUINE_RICHMOND_07 H3 HAEMAGGLUTININ IN COMPLEX WITH 3SLN","10.1073/PNAS.1406606111 ",3,81.45,"4uo1_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Q_)-[MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(165_E_)",119.96,"","",""
"4UO1","STRUCTURE OF THE A_EQUINE_RICHMOND_07 H3 HAEMAGGLUTININ IN COMPLEX WITH 3SLN","10.1073/PNAS.1406606111 ",3,81.45,"4uo1_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(165_A_)",134.572,"","",""
"4UO2","STRUCTURE OF THE A_EQUINE_RICHMOND_07 H3 HAEMAGGLUTININ IN COMPLEX WITH SIALYL LEWIS X","10.1073/PNAS.1406606111 ",2.7,59.14,"4uo2_oligo6","DNeup5Aca2-3DGalpb1-4[LFucpa1-3]DGlcpNAcb1-ROH","SIA(3_S_)-GAL(2_S_)-[FUC(4_S_)]-NAG(1_S_)",81.9972,"","",""
"4UO2","STRUCTURE OF THE A_EQUINE_RICHMOND_07 H3 HAEMAGGLUTININ IN COMPLEX WITH SIALYL LEWIS X","10.1073/PNAS.1406606111 ",2.7,59.14,"4uo2_oligo17","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_W_)-[MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(165_E_)",91.2593,"","",""
"4UO2","STRUCTURE OF THE A_EQUINE_RICHMOND_07 H3 HAEMAGGLUTININ IN COMPLEX WITH SIALYL LEWIS X","10.1073/PNAS.1406606111 ",2.7,59.14,"4uo2_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(165_A_)",104.758,"","",""
"4UO2","STRUCTURE OF THE A_EQUINE_RICHMOND_07 H3 HAEMAGGLUTININ IN COMPLEX WITH SIALYL LEWIS X","10.1073/PNAS.1406606111 ",2.7,59.14,"4uo2_oligo13","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_N_)-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(63_C_)",110.87,"","",""
"4UO2","STRUCTURE OF THE A_EQUINE_RICHMOND_07 H3 HAEMAGGLUTININ IN COMPLEX WITH SIALYL LEWIS X","10.1073/PNAS.1406606111 ",2.7,59.14,"4uo2_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(165_C_)",89.2498,"","",""
"4UO2","STRUCTURE OF THE A_EQUINE_RICHMOND_07 H3 HAEMAGGLUTININ IN COMPLEX WITH SIALYL LEWIS X","10.1073/PNAS.1406606111 ",2.7,59.14,"4uo2_oligo10","DNeup5Aca2-3DGalpb1-4[LFucpa1-3]DGlcpNAcb1-ROH","SIA(3_K_)-GAL(2_K_)-[FUC(4_K_)]-NAG(1_K_)",74.5103,"","",""
"4UO3","STRUCTURE OF THE A_EQUINE_RICHMOND_07 H3 HAEMAGGLUTININ MUTANT SER30THR","10.1073/PNAS.1406606111 ",2.87,57.05,"4uo3_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(165_A_)",80.106,"","",""
"4UO3","STRUCTURE OF THE A_EQUINE_RICHMOND_07 H3 HAEMAGGLUTININ MUTANT SER30THR","10.1073/PNAS.1406606111 ",2.87,57.05,"4uo3_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_I_)-[MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(22_C_)",73.6771,"","",""
"4UO3","STRUCTURE OF THE A_EQUINE_RICHMOND_07 H3 HAEMAGGLUTININ MUTANT SER30THR","10.1073/PNAS.1406606111 ",2.87,57.05,"4uo3_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(165_C_)",94.9764,"","",""
"4UO3","STRUCTURE OF THE A_EQUINE_RICHMOND_07 H3 HAEMAGGLUTININ MUTANT SER30THR","10.1073/PNAS.1406606111 ",2.87,57.05,"4uo3_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(38_C_)",100.583,"","",""
"4UO4","STRUCTURE OF THE A_CANINE_COLORADO_17864_06 H3 HAEMAGGLUTININ","10.1073/PNAS.1406606111 ",2.6,74.11,"4uo4_oligo1","DManpa1-3DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(285_A_)",124.739,"","",""
"4UO5","STRUCTURE OF THE A_CANINE_COLORADO_17864_06 H3 HAEMAGGLUTININ IN COMPLEX WITH 3SLN","10.1073/PNAS.1406606111 ",2.7,72.05,"4uo5_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(165_A_)",124.8,"","",""
"4UO5","STRUCTURE OF THE A_CANINE_COLORADO_17864_06 H3 HAEMAGGLUTININ IN COMPLEX WITH 3SLN","10.1073/PNAS.1406606111 ",2.7,72.05,"4uo5_oligo3","DGlcpNAcb1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","NAG(5_O_)-MAN(4_O_)-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)",140.111,"","",""
"4UO5","STRUCTURE OF THE A_CANINE_COLORADO_17864_06 H3 HAEMAGGLUTININ IN COMPLEX WITH 3SLN","10.1073/PNAS.1406606111 ",2.7,72.05,"4uo5_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(165_C_)",114.852,"","",""
"4UO5","STRUCTURE OF THE A_CANINE_COLORADO_17864_06 H3 HAEMAGGLUTININ IN COMPLEX WITH 3SLN","10.1073/PNAS.1406606111 ",2.7,72.05,"4uo5_oligo13","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(165_E_)",121.944,"","",""
"4UO6","STRUCTURE OF THE A_CANINE_COLORADO_17864_06 H3 HAEMAGGLUTININ IN COMPLEX WITH SIALYL LEWIS X","10.1073/PNAS.1406606111 ",2.9,88.61,"4uo6_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(165_A_)",133.157,"","",""
"4UO7","STRUCTURE OF THE A_CANINE_COLORADO_17864_06 H3 HAEMAGGLUTININ IN COMPLEX WITH 6SO4 SIALYL LEWIS X","10.1073/PNAS.1406606111 ",3,67.19,"4uo7_oligo10","DNeup5Aca2-3DGalpb1-4[LFucpa1-3]DGlcpNAc[6S]b1-ROH","SIA(3_P_)-GAL(2_P_)-[FUC(4_P_)-",91.5716,"","",""
"4UO7","STRUCTURE OF THE A_CANINE_COLORADO_17864_06 H3 HAEMAGGLUTININ IN COMPLEX WITH 6SO4 SIALYL LEWIS X","10.1073/PNAS.1406606111 ",3,67.19,"4uo7_oligo13","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(165_E_)",101.609,"","",""
"4UO7","STRUCTURE OF THE A_CANINE_COLORADO_17864_06 H3 HAEMAGGLUTININ IN COMPLEX WITH 6SO4 SIALYL LEWIS X","10.1073/PNAS.1406606111 ",3,67.19,"4uo7_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(165_C_)",97.3336,"","",""
"4UO7","STRUCTURE OF THE A_CANINE_COLORADO_17864_06 H3 HAEMAGGLUTININ IN COMPLEX WITH 6SO4 SIALYL LEWIS X","10.1073/PNAS.1406606111 ",3,67.19,"4uo7_oligo4","DNeup5Aca2-3DGalpb1-4[LFucpa1-3]DGlcpNAc[6S]b1-ROH","SIA(3_K_)-GAL(2_K_)-[FUC(4_K_)-",84.1265,"","",""
"4UO7","STRUCTURE OF THE A_CANINE_COLORADO_17864_06 H3 HAEMAGGLUTININ IN COMPLEX WITH 6SO4 SIALYL LEWIS X","10.1073/PNAS.1406606111 ",3,67.19,"4uo7_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(165_A_)",94.6709,"","",""
"4UO7","STRUCTURE OF THE A_CANINE_COLORADO_17864_06 H3 HAEMAGGLUTININ IN COMPLEX WITH 6SO4 SIALYL LEWIS X","10.1073/PNAS.1406606111 ",3,67.19,"4uo7_oligo15","DNeup5Aca2-3DGalpb1-4[LFucpa1-3]DGlcpNAc[6S]b1-ROH","SIA(3_U_)-GAL(2_U_)-[FUC(4_U_)-",86.5475,"","",""
"4UO8","STRUCTURE OF THE A_CANINE_COLORADO_17864_06 H3 HAEMAGGLUTININ IN COMPLEX WITH 6SO4-3SLN","10.1073/PNAS.1406606111 ",3,83.04,"4uo8_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(165_A_)",131.378,"","",""
"4UO8","STRUCTURE OF THE A_CANINE_COLORADO_17864_06 H3 HAEMAGGLUTININ IN COMPLEX WITH 6SO4-3SLN","10.1073/PNAS.1406606111 ",3,83.04,"4uo8_oligo2","DManpb1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_F_)-MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(285_A_)",139.408,"","",""
"4UO8","STRUCTURE OF THE A_CANINE_COLORADO_17864_06 H3 HAEMAGGLUTININ IN COMPLEX WITH 6SO4-3SLN","10.1073/PNAS.1406606111 ",3,83.04,"4uo8_oligo1","DManpb1-3DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAca1-ASN","MAN(5_D_)-MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(38_A_)",142.121,"","",""
"4UOJ","STRUCTURE OF FUNGAL BETA-MANNOSIDASE (GH2) FROM TRICHODERMA HARZIANUM","10.1111/FEBS.12894 ",2.5,50.5,"4uoj_oligo4","DManpa1-2DManpa1-3[DManp[2<R1>]x]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-MAN(4_J_)-[NAG(1_J_)-NAG(2_J_)]-BMA(3_J_)-MAN(6_J_)",42.7813,"","",""
"4UOJ","STRUCTURE OF FUNGAL BETA-MANNOSIDASE (GH2) FROM TRICHODERMA HARZIANUM","10.1111/FEBS.12894 ",2.5,50.5,"4uoj_oligo8","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_I_)-MAN(8_I_)-MAN(7_I_)-[MAN(6_I_)-MAN(5_I_)-MAN(4_I_)]-MAN(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(86_B_)",63.0052,"","",""
"4UOJ","STRUCTURE OF FUNGAL BETA-MANNOSIDASE (GH2) FROM TRICHODERMA HARZIANUM","10.1111/FEBS.12894 ",2.5,50.5,"4uoj_oligo9","DManpa1-2DManpa1-2DManpb1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_K_)-MAN(10_K_)-[MAN(9_K_)-MAN(8_K_)]-MAN(7_K_)-[MAN(6_K_)-MAN(5_K_)-BMA(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(255_B_)",49.5038,"","",""
"4UOJ","STRUCTURE OF FUNGAL BETA-MANNOSIDASE (GH2) FROM TRICHODERMA HARZIANUM","10.1111/FEBS.12894 ",2.5,50.5,"4uoj_oligo6","DManpa1-2DManpa1-6DManpa1-6[DManpa1-2DManpa1-3]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_G_)-MAN(5_G_)-MAN(4_G_)-[MAN(8_G_)-MAN(7_G_)]-MAN(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(86_A_)",61.8599,"","",""
"4UOJ","STRUCTURE OF FUNGAL BETA-MANNOSIDASE (GH2) FROM TRICHODERMA HARZIANUM","10.1111/FEBS.12894 ",2.5,50.5,"4uoj_oligo2","DManpa1-2DManpa1-2DManpb1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_F_)-MAN(10_F_)-[MAN(9_F_)-MAN(8_F_)]-MAN(7_F_)-[MAN(6_F_)-MAN(5_F_)-BMA(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(255_A_)",51.9064,"","",""
"4UOJ","STRUCTURE OF FUNGAL BETA-MANNOSIDASE (GH2) FROM TRICHODERMA HARZIANUM","10.1111/FEBS.12894 ",2.5,50.5,"4uoj_oligo3","DManpa1-2DManpa1-3[DManp[2<R1>]a]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-[NAG(1_C_)-NAG(2_C_)]-BMA(3_C_)-MAN(6_C_)",51.2442,"","",""
"4URR","TAILSPIKE PROTEIN OF SF6 BACTERIOPHAGE BOUND TO SHIGELLA FLEXNERI O- ANTIGEN OCTASACCHARIDE FRAGMENT","10.1021/JACS.6B00240 ",1.95,18.92,"4urr_oligo6","LRhapa1-3DGlcpNAcb1-2LRhapa1-2LRhapa1-3LRhapa1-3DGlcpNAcb1-2LRhapa1-2LRhapa1-ROH","RAM(8_L_)-NAG(7_L_)-RAM(6_L_)-RAM(5_L_)-RAM(4_L_)-NAG(3_L_)-RAM(2_L_)-RAM(1_L_)",30.1734,"","",""
"4URR","TAILSPIKE PROTEIN OF SF6 BACTERIOPHAGE BOUND TO SHIGELLA FLEXNERI O- ANTIGEN OCTASACCHARIDE FRAGMENT","10.1021/JACS.6B00240 ",1.95,18.92,"4urr_oligo3","LRhapa1-3DGlcpNAcb1-2LRhapa1-2LRhapa1-3LRhapa1-3DGlcpNAcb1-2LRhapa1-2LRhapa1-ROH","RAM(8_I_)-NAG(7_I_)-RAM(6_I_)-RAM(5_I_)-RAM(4_I_)-NAG(3_I_)-RAM(2_I_)-RAM(1_I_)",21.1801,"","",""
"4URR","TAILSPIKE PROTEIN OF SF6 BACTERIOPHAGE BOUND TO SHIGELLA FLEXNERI O- ANTIGEN OCTASACCHARIDE FRAGMENT","10.1021/JACS.6B00240 ",1.95,18.92,"4urr_oligo4","LRhapa1-3DGlcpNAcb1-2LRhapa1-2LRhapa1-3LRhapa1-3DGlcpNAcb1-2LRhapa1-2LRhapa1-ROH","RAM(8_J_)-NAG(7_J_)-RAM(6_J_)-RAM(5_J_)-RAM(4_J_)-NAG(3_J_)-RAM(2_J_)-RAM(1_J_)",33.6956,"","",""
"4URR","TAILSPIKE PROTEIN OF SF6 BACTERIOPHAGE BOUND TO SHIGELLA FLEXNERI O- ANTIGEN OCTASACCHARIDE FRAGMENT","10.1021/JACS.6B00240 ",1.95,18.92,"4urr_oligo2","LRhapa1-3DGlcpNAcb1-2LRhapa1-2LRhapa1-3LRhapa1-3DGlcpNAcb1-2LRhapa1-2LRhapa1-ROH","RAM(8_H_)-NAG(7_H_)-RAM(6_H_)-RAM(5_H_)-RAM(4_H_)-NAG(3_H_)-RAM(2_H_)-RAM(1_H_)",29.3958,"","",""
"4URR","TAILSPIKE PROTEIN OF SF6 BACTERIOPHAGE BOUND TO SHIGELLA FLEXNERI O- ANTIGEN OCTASACCHARIDE FRAGMENT","10.1021/JACS.6B00240 ",1.95,18.92,"4urr_oligo5","LRhapa1-3DGlcpNAcb1-2LRhapa1-2LRhapa1-3LRhapa1-3DGlcpNAcb1-2LRhapa1-2LRhapa1-ROH","RAM(8_K_)-NAG(7_K_)-RAM(6_K_)-RAM(5_K_)-RAM(4_K_)-NAG(3_K_)-RAM(2_K_)-RAM(1_K_)",25.9244,"","",""
"4URR","TAILSPIKE PROTEIN OF SF6 BACTERIOPHAGE BOUND TO SHIGELLA FLEXNERI O- ANTIGEN OCTASACCHARIDE FRAGMENT","10.1021/JACS.6B00240 ",1.95,18.92,"4urr_oligo1","LRhapa1-3DGlcpNAcb1-2LRhapa1-2LRhapa1-3LRhapa1-3DGlcpNAcb1-2LRhapa1-2LRhapa1-ROH","RAM(8_G_)-NAG(7_G_)-RAM(6_G_)-RAM(5_G_)-RAM(4_G_)-NAG(3_G_)-RAM(2_G_)-RAM(1_G_)",26.8045,"","",""
"4USC","CRYSTAL STRUCTURE OF PEROXIDASE FROM PALM TREE CHAMAEROPS EXCELSA","10.1016/J.BIOCHI.2015.01.014 ",2.6,54.79,"4usc_oligo7","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_E_)-[FUC(2_E_)]-NAG(1_E_)-ASN(8_B_)",96.3058,"","",""
"4USC","CRYSTAL STRUCTURE OF PEROXIDASE FROM PALM TREE CHAMAEROPS EXCELSA","10.1016/J.BIOCHI.2015.01.014 ",2.6,54.79,"4usc_oligo6","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_D_)-[FUC(2_D_)]-NAG(1_D_)-ASN(267_A_)",71.3482,"","",""
"4USC","CRYSTAL STRUCTURE OF PEROXIDASE FROM PALM TREE CHAMAEROPS EXCELSA","10.1016/J.BIOCHI.2015.01.014 ",2.6,54.79,"4usc_oligo1","DManpb1-4DGlcpNAca1-3DGlcpNAcb1-ASN","MAN(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(298_A_)",79.847,"","",""
"4USO","X-RAY STRUCTURE OF THE CCL2 LECTIN IN COMPLEX WITH SIALYL LEWIS X","10.1093/GLYCOB/CWW113 ",1.95,48.16,"4uso_oligo1","DNeup5Aca2-3DGalpb1-4[LFucpa1-3]DGlcpNAcb1-ROH","SIA(3_E_)-GAL(2_E_)-[FUC(4_E_)]-NAG(1_E_)",40.3279,"","",""
"4UT5","CRYSTAL STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA7 IN COMPLEX WITH LEWIS A TETRASACCHARIDE","10.3389/FMICB.2016.00811 ",1.75,12.49,"4ut5_oligo3","DGalpb1-3[LFucpa1-4]DGlcpNAcb1-3DGalpa1-ROH","FUC(4_G_)-[GAL(3_G_)]-NAG(2_G_)-GLA(1_G_)",18.512,"","",""
"4UT5","CRYSTAL STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA7 IN COMPLEX WITH LEWIS A TETRASACCHARIDE","10.3389/FMICB.2016.00811 ",1.75,12.49,"4ut5_oligo4","DGalpb1-3[LFucpa1-4]DGlcpNAcb1-ROH","FUC(3_H_)-[GAL(2_H_)]-NAG(1_H_)",16.0085,"","",""
"4UT5","CRYSTAL STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA7 IN COMPLEX WITH LEWIS A TETRASACCHARIDE","10.3389/FMICB.2016.00811 ",1.75,12.49,"4ut5_oligo1","DGalpb1-3[LFucpa1-4]DGlcpNAcb1-3DGalpb1-ROH","FUC(4_E_)-[GAL(3_E_)]-NAG(2_E_)-GAL(1_E_)",18.655,"","",""
"4UT5","CRYSTAL STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA7 IN COMPLEX WITH LEWIS A TETRASACCHARIDE","10.3389/FMICB.2016.00811 ",1.75,12.49,"4ut5_oligo2","DGalpb1-3[LFucpa1-4]DGlcpNAcb1-3DGalpa1-ROH","FUC(4_F_)-[GAL(3_F_)]-NAG(2_F_)-GLA(1_F_)",17.6491,"","",""
"4UT6","CRYSTAL STRUCTURE OF DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN IN COMPLEX WITH THE FAB FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 B7","10.1038/NATURE14130 ",3.2,92.81,"4ut6_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_C_)-[MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(153_A_)",91.8967,"","",""
"4UT6","CRYSTAL STRUCTURE OF DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN IN COMPLEX WITH THE FAB FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 B7","10.1038/NATURE14130 ",3.2,92.81,"4ut6_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_D_)-[MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(153_B_)",107.364,"","",""
"4UTA","CRYSTAL STRUCTURE OF DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN IN COMPLEX WITH THE FAB FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE1 C8","10.1038/NATURE14130 ",3,88.63,"4uta_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_D_)-[MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(67_B_)",113.708,"","",""
"4UTB","CRYSTAL STRUCTURE OF DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN IN COMPLEX WITH THE FAB FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11","10.1038/NATURE14130 ",3.85,129.3,"4utb_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_E_)-[MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(153_B_)",132.016,"","",""
"4UTB","CRYSTAL STRUCTURE OF DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN IN COMPLEX WITH THE FAB FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11","10.1038/NATURE14130 ",3.85,129.3,"4utb_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_C_)-[MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(153_A_)",130.293,"","",""
"4UTC","CRYSTAL STRUCTURE OF DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN","10.1038/NATURE14130 ",3.08,85.62,"4utc_oligo2","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_E_)-[BMA(5_E_)-[BMA(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(153_B_)",88.3062,"","",""
"4V28","STRUCTURE OF AN E333Q VARIANT OF THE GH99 ENDO-ALPHA-MANNANASE FROM BACTEROIDES XYLANISOLVENS IN COMPLEX WITH MAN-MAN-METHYLUMBELLIFERONE","10.1002/CHEM.201405539 ",1.2,16.54,"4v28_oligo1","DManpa1-3DManpa1-C10O3","MAN(2_B_)-MAN(1_B_)-4MU(500_A_)",15.8909,"","",""
"4W4N","CRYSTAL STRUCTURE OF HUMAN FC AT 1.80 A","10.1038/NCOMMS7866 ",1.8,43.23,"4w4n_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",31.415,"","",""
"4W4N","CRYSTAL STRUCTURE OF HUMAN FC AT 1.80 A","10.1038/NCOMMS7866 ",1.8,43.23,"4w4n_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(297_A_)",61.1245,"","",""
"4W4O","HIGH-RESOLUTION CRYSTAL STRUCTURE OF FC BOUND TO ITS HUMAN RECEPTOR FC-GAMMA-RI","10.1038/NCOMMS7866 ",1.8,42.26,"4w4o_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[NAG(8_E_)-MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_B_)",54.0719,"","",""
"4W4O","HIGH-RESOLUTION CRYSTAL STRUCTURE OF FC BOUND TO ITS HUMAN RECEPTOR FC-GAMMA-RI","10.1038/NCOMMS7866 ",1.8,42.26,"4w4o_oligo4","DManpa1-2DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_G_)-MAN(5_G_)-MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(159_C_)",58.58,"","",""
"4W4O","HIGH-RESOLUTION CRYSTAL STRUCTURE OF FC BOUND TO ITS HUMAN RECEPTOR FC-GAMMA-RI","10.1038/NCOMMS7866 ",1.8,42.26,"4w4o_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_A_)",47.3679,"","",""
"4W9Y","X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH A GLUTAMYL SULFAMIDE INHIBITOR CJC47","",1.64,26.89,"4w9y_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(638_A_)",36.3436,"","",""
"4WA2","THE CRYSTAL STRUCTURE OF HEMAGGLUTININ FROM A H3N8 INFLUENZA VIRUS ISOLATED FROM NEW ENGLAND HARBOR SEALS IN COMPLEX WITH 3'SLN","10.1128/JVI.02723-14 ",2.5,36.46,"4wa2_oligo5","DNeup5Aca2-3DGalpb1-3DGlcpNAcb1-ROH","SIA(3_K_)-GAL(2_K_)-NAG(1_K_)",43.1376,"","",""
"4WA2","THE CRYSTAL STRUCTURE OF HEMAGGLUTININ FROM A H3N8 INFLUENZA VIRUS ISOLATED FROM NEW ENGLAND HARBOR SEALS IN COMPLEX WITH 3'SLN","10.1128/JVI.02723-14 ",2.5,36.46,"4wa2_oligo10","DNeup5Aca2-3DGalpb1-3DGlcpNAcb1-ROH","SIA(3_P_)-GAL(2_P_)-NAG(1_P_)",45.8747,"","",""
"4WA2","THE CRYSTAL STRUCTURE OF HEMAGGLUTININ FROM A H3N8 INFLUENZA VIRUS ISOLATED FROM NEW ENGLAND HARBOR SEALS IN COMPLEX WITH 3'SLN","10.1128/JVI.02723-14 ",2.5,36.46,"4wa2_oligo3","DNeup5Aca2-3DGalpb1-3DGlcpNAcb1-ROH","SIA(3_I_)-GAL(2_I_)-NAG(1_I_)",59.9283,"","",""
"4WA2","THE CRYSTAL STRUCTURE OF HEMAGGLUTININ FROM A H3N8 INFLUENZA VIRUS ISOLATED FROM NEW ENGLAND HARBOR SEALS IN COMPLEX WITH 3'SLN","10.1128/JVI.02723-14 ",2.5,36.46,"4wa2_oligo1","DNeup5Aca2-3DGalpb1-3DGlcpNAcb1-ROH","SIA(3_G_)-GAL(2_G_)-NAG(1_G_)",57.6858,"","",""
"4WE4","THE CRYSTAL STRUCTURE OF HEMAGGLUTININ FROM 1968 H3N2 INFLUENZA VIRUS","10.1016/J.VIROL.2014.12.024 ",2.35,0,"4we4_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(165_A_)",72.7062,"","",""
"4WE4","THE CRYSTAL STRUCTURE OF HEMAGGLUTININ FROM 1968 H3N2 INFLUENZA VIRUS","10.1016/J.VIROL.2014.12.024 ",2.35,0,"4we4_oligo3","DGlcpNAca1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(38_A_)",80.6393,"","",""
"4WEF","STRUCTURE OF THE HEMAGGLUTININ-NEURAMINIDASE FROM HUMAN PARAINFLUENZA VIRUS TYPE III: COMPLEX WITH DIFLUOROSIALIC ACID","10.1016/J.ANTIVIRAL.2015.08.014 ",2.5,36.06,"4wef_oligo6","DManpb1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(351_B_)",90.343,"","",""
"4WEF","STRUCTURE OF THE HEMAGGLUTININ-NEURAMINIDASE FROM HUMAN PARAINFLUENZA VIRUS TYPE III: COMPLEX WITH DIFLUOROSIALIC ACID","10.1016/J.ANTIVIRAL.2015.08.014 ",2.5,36.06,"4wef_oligo1","DManpb1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(351_A_)",92.2814,"","",""
"4WEG","INFLUENZA VIRUS NEURAMINIDASE N9 IN COMPLEX 2,3-DIFLUOROSIALIC ACID","10.1016/J.ANTIVIRAL.2015.08.014 ",2.1,32.49,"4weg_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_B_)-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(201_A_)",42.4535,"","",""
"4WI2","STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC (WILD-TYPE)","",1.9,0,"4wi2_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",92.3777,"","",""
"4WI2","STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC (WILD-TYPE)","",1.9,0,"4wi2_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",64.86,"","",""
"4WI3","STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION I253A","",2.7,0,"4wi3_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",160.251,"","",""
"4WI3","STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION I253A","",2.7,0,"4wi3_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",161.436,"","",""
"4WI4","STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION S254A","",2.8,0,"4wi4_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",134.939,"","",""
"4WI4","STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION S254A","",2.8,0,"4wi4_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAca1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",150.74,"","",""
"4WI5","STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION H310A","",2.8,0,"4wi5_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",178.87,"","",""
"4WI5","STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION H310A","",2.8,0,"4wi5_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",182.481,"","",""
"4WI6","STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION N434A","",2.2,0,"4wi6_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",72.1728,"","",""
"4WI6","STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION N434A","",2.2,0,"4wi6_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",102.249,"","",""
"4WI7","STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION H435A","",1.9,0,"4wi7_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",57.2102,"","",""
"4WI7","STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION H435A","",1.9,0,"4wi7_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",69.8317,"","",""
"4WI8","STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION Y436A","",2.8,0,"4wi8_oligo1","DGlcpNAcb1-2DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(6_D_)-[NAG(5_D_)-MAN(4_D_)-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)",144.051,"","",""
"4WI8","STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION Y436A","",2.8,0,"4wi8_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",87.8138,"","",""
"4WI9","STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION I253A/H310A","",2.65,0,"4wi9_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAca1-ASN","FUC(8_E_)-[NAG(7_E_)-MAN(6_E_)-[NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_B_)",131.71,"","",""
"4WI9","STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION I253A/H310A","",2.65,0,"4wi9_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcx1-","NAG(6_D_)-MAN(5_D_)-[NAG(4_D_)-MAN(3_D_)]-BMA(2_D_)-NAG(1_D_)",125.241,"","",""
"4WJK","METAL ION AND LIGAND BINDING OF INTEGRIN","10.1073/PNAS.1420645111 ",1.85,60.35,"4wjk_oligo1","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(275_A_)",96.9492,"","",""
"4WJK","METAL ION AND LIGAND BINDING OF INTEGRIN","10.1073/PNAS.1420645111 ",1.85,60.35,"4wjk_oligo3","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-[MAN(5_E_)]-MAN(4_E_)-[MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(43_A_)",77.9331,"","",""
"4WJK","METAL ION AND LIGAND BINDING OF INTEGRIN","10.1073/PNAS.1420645111 ",1.85,60.35,"4wjk_oligo7","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(397_B_)",98.7934,"","",""
"4WJL","STRUCTURE OF HUMAN DIPEPTIDYL PEPTIDASE 10 (DPPY): A MODULATOR OF NEURONAL KV4 CHANNELS","10.1038/SREP08769 ",3.4,0,"4wjl_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(257_A_)",101.986,"","",""
"4WK0","METAL ION AND LIGAND BINDING OF INTEGRIN","10.1073/PNAS.1420645111 ",1.78,50.29,"4wk0_oligo1","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-MAN(4_D_)-[MAN(6_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(275_A_)",70.8288,"","",""
"4WK2","METAL ION AND LIGAND BINDING OF INTEGRIN","10.1073/PNAS.1420645111 ",2.5,99.46,"4wk2_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(275_A_)",102.344,"","",""
"4WK2","METAL ION AND LIGAND BINDING OF INTEGRIN","10.1073/PNAS.1420645111 ",2.5,99.46,"4wk2_oligo2","DManpa1-3[DManpa1-6]DManpx1-","MAN(6_D_)-[MAN(5_D_)]-MAN(4_D_)",130.003,"","",""
"4WK4","METAL ION AND LIGAND BINDING OF INTEGRIN","10.1073/PNAS.1420645111 ",2.5,104,"4wk4_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)",139.558,"","",""
"4WK4","METAL ION AND LIGAND BINDING OF INTEGRIN","10.1073/PNAS.1420645111 ",2.5,104,"4wk4_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-[MAN(5_H_)]-MAN(4_H_)-[MAN(7_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(141_A_)",152.975,"","",""
"4WK4","METAL ION AND LIGAND BINDING OF INTEGRIN","10.1073/PNAS.1420645111 ",2.5,104,"4wk4_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(256_A_)",169.775,"","",""
"4WK4","METAL ION AND LIGAND BINDING OF INTEGRIN","10.1073/PNAS.1420645111 ",2.5,104,"4wk4_oligo5","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-MAN(4_D_)-[MAN(6_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(275_A_)",138.434,"","",""
"4WM0","CRYSTAL STRUCTURE OF MOUSE XYLOSIDE XYLOSYLTRANSFERASE 1 COMPLEXED WITH ACCEPTOR LIGAND","10.1038/NCHEMBIO.1927 ",2.37,35.67,"4wm0_oligo1","DXylpa1-3DGlcpx1-","XYS(2_B_)-BGC(1_B_)",27.484,"","",""
"4WMA","CRYSTAL STRUCTURE OF MOUSE XYLOSIDE XYLOSYLTRANSFERASE 1 COMPLEXED WITH MANGANESE,ACCEPTOR LIGAND AND UDP-GLUCOSE","10.1038/NCHEMBIO.1927 ",1.62,31.98,"4wma_oligo1","DXylpa1-3DGlcpb1-SER","XYS(2_B_)-BGC(1_B_)-SER(53_D_)",22.8543,"","",""
"4WMB","CRYSTAL STRUCTURE OF MOUSE XYLOSIDE XYLOSYLTRANSFERASE 1 COMPLEXED WITH MANGANESE, ACCEPTOR LIGAND AND UDP","10.1038/NCHEMBIO.1927 ",2.05,38.51,"4wmb_oligo1","DXylpa1-3DGlcpb1-SER","XYS(2_B_)-BGC(1_B_)-SER(53_D_)",30.4285,"","",""
"4WMI","CRYSTAL STRUCTURE OF MOUSE XYLOSIDE XYLOSYLTRANSFERASE 1 COMPLEXED WITH MANGANESE, PRODUCT LIGAND AND UDP (PRODUCT COMPLEX I)","10.1038/NCHEMBIO.1927 ",1.87,30.48,"4wmi_oligo1","DXylpa1-3DXylpa1-3DGlcpb1-SER","XYS(3_B_)-XYS(2_B_)-BGC(1_B_)-SER(53_D_)",28.8691,"","",""
"4WMK","CRYSTAL STRUCTURE OF MOUSE XYLOSIDE XYLOSYLTRANSFERASE 1 COMPLEXED WITH MANGANESE, PRODUCT LIGAND AND UDP (PRODUCT COMPLEX II)","10.1038/NCHEMBIO.1927 ",2.08,32.35,"4wmk_oligo1","DXylpa1-3DXylpa1-3DGlcpb1-SER","XYS(3_B_)-XYS(2_B_)-BGC(1_B_)-SER(53_D_)",32.5591,"","",""
"4WN2","CRYSTAL STRUCTURE OF MOUSE XYLOSIDE XYLOSYLTRANSFERASE 1 COMPLEXED WITH MANGANESE, PRODUCT LIGAND AND UDP (PRODUCT COMPLEX III)","10.1038/NCHEMBIO.1927 ",1.95,36.39,"4wn2_oligo1","DXylpa1-3DXylpa1-3DGlcpb1-SER","XYS(3_B_)-XYS(2_B_)-BGC(1_B_)-SER(53_D_)",32.4751,"","",""
"4WNH","CRYSTAL STRUCTURE OF MOUSE XYLOSIDE XYLOSYLTRANSFERASE 1 COMPLEXED WITH MANGANESE,ACCEPTOR LIGAND AND UDP-XYLOSE","",1.95,33.55,"4wnh_oligo1","DXylpa1-3DGlcpb1-SER","XYS(2_B_)-BGC(1_B_)-SER(53_D_)",24.1687,"","",""
"4WSU","THE CRYSTAL STRUCTURE OF HEMAGGLUTININ FROM A/TAIWAN/1/2013 IN COMPLEX WITH 3'SLN","10.1128/JVI.03456-14 ",2.7,42.09,"4wsu_oligo1","DNeup5Aca2-3DGalpb1-3DGlcpNAcb1-ROH","SIA(404_A_)-GAL(2_G_)-NAG(1_G_)",80.0922,"","",""
"4WZE","CRYSTAL STRUCTURE OF P DOMAIN FROM NOROVIRUS STRAIN SAGA4 IN COMPLEX WITH HBGA TYPE LEY (TETRAGLYCAN)","10.1128/JVI.02968-14 ",1.46,25.23,"4wze_oligo1","LFucpa1-2DGalpb1-4[LFucpa1-3]DGlcpNAca1-ROH","FUC(3_C_)-GAL(2_C_)-[FUC(4_C_)]-NDG(1_C_)",40.0509,"","",""
"4WZE","CRYSTAL STRUCTURE OF P DOMAIN FROM NOROVIRUS STRAIN SAGA4 IN COMPLEX WITH HBGA TYPE LEY (TETRAGLYCAN)","10.1128/JVI.02968-14 ",1.46,25.23,"4wze_oligo2","LFucpa1-2DGalpb1-4[LFucpa1-3]DGlcpNAca1-ROH","FUC(3_D_)-GAL(2_D_)-[FUC(4_D_)]-NDG(1_D_)",40.2125,"","",""
"4WZL","CRYSTAL STRUCTURE OF P DOMAIN FROM NOROVIRUS STRAIN SAGA4 IN COMPLEX WITH HBGA TYPE LEA (TRIGLYCAN)","10.1128/JVI.02968-14 ",1.7,18.75,"4wzl_oligo1","DGalpb1-3[LFucpa1-4]DGlcpNAca1-ROH","FUC(3_C_)-[GAL(2_C_)]-NDG(1_C_)",44.0718,"","",""
"4WZL","CRYSTAL STRUCTURE OF P DOMAIN FROM NOROVIRUS STRAIN SAGA4 IN COMPLEX WITH HBGA TYPE LEA (TRIGLYCAN)","10.1128/JVI.02968-14 ",1.7,18.75,"4wzl_oligo2","DGalpb1-3[LFucpa1-4]DGlcpNAca1-ROH","FUC(3_D_)-[GAL(2_D_)]-NDG(1_D_)",44.3491,"","",""
"4WZT","CRYSTAL STRUCTURE OF P DOMAIN FROM NOROVIRUS STRAIN NSW0514 IN COMPLEX WITH HBGA TYPE A (TRIGLYCAN)","10.1128/JVI.02968-14 ",1.91,27.63,"4wzt_oligo1","LFucpa1-2[DGalpNAca1-3]DGalpa1-ROH","A2G(3_C_)-[FUC(2_C_)]-GLA(1_C_)",41.4964,"","",""
"4WZT","CRYSTAL STRUCTURE OF P DOMAIN FROM NOROVIRUS STRAIN NSW0514 IN COMPLEX WITH HBGA TYPE A (TRIGLYCAN)","10.1128/JVI.02968-14 ",1.91,27.63,"4wzt_oligo2","LFucpa1-2[DGalpNAca1-3]DGalpa1-ROH","A2G(3_D_)-[FUC(2_D_)]-GLA(1_D_)",41.7248,"","",""
"4X05","CRYSTAL STRUCTURE OF P DOMAIN FROM NOROVIRUS STRAIN FARMINGTON HILLS 2004 IN COMPLEX WITH HBGA TYPE B (TRIGLYCAN)","10.1128/JVI.02968-14 ",1.98,23.93,"4x05_oligo1","LFucpa1-2[DGalpa1-3]DGalpa1-ROH","GLA(3_E_)-[FUC(2_E_)]-GLA(1_E_)",54.1042,"","",""
"4X05","CRYSTAL STRUCTURE OF P DOMAIN FROM NOROVIRUS STRAIN FARMINGTON HILLS 2004 IN COMPLEX WITH HBGA TYPE B (TRIGLYCAN)","10.1128/JVI.02968-14 ",1.98,23.93,"4x05_oligo2","LFucpa1-2[DGalpa1-3]DGalpa1-ROH","GLA(3_F_)-[FUC(2_F_)]-GLA(1_F_)",32.5051,"","",""
"4X05","CRYSTAL STRUCTURE OF P DOMAIN FROM NOROVIRUS STRAIN FARMINGTON HILLS 2004 IN COMPLEX WITH HBGA TYPE B (TRIGLYCAN)","10.1128/JVI.02968-14 ",1.98,23.93,"4x05_oligo3","LFucpa1-2[DGalpa1-3]DGalpa1-ROH","GLA(3_G_)-[FUC(2_G_)]-GLA(1_G_)",50.7821,"","",""
"4X05","CRYSTAL STRUCTURE OF P DOMAIN FROM NOROVIRUS STRAIN FARMINGTON HILLS 2004 IN COMPLEX WITH HBGA TYPE B (TRIGLYCAN)","10.1128/JVI.02968-14 ",1.98,23.93,"4x05_oligo4","LFucpa1-2[DGalpa1-3]DGalpa1-ROH","GLA(3_H_)-[FUC(2_H_)]-GLA(1_H_)",31.4385,"","",""
"4X06","CRYSTAL STRUCTURE OF P DOMAIN FROM NOROVIRUS STRAIN SAGA4 IN COMPLEX WITH HBGA TYPE B (TRIGLYCAN)","10.1128/JVI.02968-14 ",1.22,17.94,"4x06_oligo1","LFucpa1-2[DGalpa1-3]DGalpa1-ROH","GLA(3_C_)-[FUC(2_C_)]-GLA(1_C_)",22.167,"","",""
"4X06","CRYSTAL STRUCTURE OF P DOMAIN FROM NOROVIRUS STRAIN SAGA4 IN COMPLEX WITH HBGA TYPE B (TRIGLYCAN)","10.1128/JVI.02968-14 ",1.22,17.94,"4x06_oligo2","LFucpa1-2[DGalpa1-3]DGalpa1-ROH","GLA(3_D_)-[FUC(2_D_)]-GLA(1_D_)",31.49,"","",""
"4X07","CRYSTAL STRUCTURE OF P DOMAIN FROM NOROVIRUS STRAIN SAGA4 IN COMPLEX WITH HBGA TYPE A (TRIGLYCAN)","10.1128/JVI.02968-14 ",1.46,17.47,"4x07_oligo2","LFucpa1-2[DGalpNAca1-3]DGalpa1-ROH","A2G(3_D_)-[FUC(2_D_)]-GLA(1_D_)",34.1088,"","",""
"4X07","CRYSTAL STRUCTURE OF P DOMAIN FROM NOROVIRUS STRAIN SAGA4 IN COMPLEX WITH HBGA TYPE A (TRIGLYCAN)","10.1128/JVI.02968-14 ",1.46,17.47,"4x07_oligo1","LFucpa1-2[DGalpNAca1-3]DGalpa1-ROH","A2G(3_C_)-[FUC(2_C_)]-GLA(1_C_)",34.2915,"","",""
"4X0C","CRYSTAL STRUCTURE OF P DOMAIN FROM NOROVIRUS STRAIN NSW0514 IN COMPLEX WITH HBGA TYPE LEX (TRIGLYCAN)","10.1128/JVI.02968-14 ",1.72,25.16,"4x0c_oligo2","LFucpa1-3[DGalpb1-4]DGlcpNAca1-ROH","GAL(3_D_)-[FUC(2_D_)]-NDG(1_D_)",44.0009,"","",""
"4X0C","CRYSTAL STRUCTURE OF P DOMAIN FROM NOROVIRUS STRAIN NSW0514 IN COMPLEX WITH HBGA TYPE LEX (TRIGLYCAN)","10.1128/JVI.02968-14 ",1.72,25.16,"4x0c_oligo1","LFucpa1-3[DGalpb1-4]DGlcpNAca1-ROH","GAL(3_C_)-[FUC(2_C_)]-NDG(1_C_)",46.0864,"","",""
"4X0Z","JC POLYOMAVIRUS GENOTYPE 3 VP1 IN COMPLEX WITH GM1 OLIGOSACCHARIDE","10.1128/JVI.00489-15 ",1.85,19.7,"4x0z_oligo1","DGalpb1-3DGalpNAcb1-4[DNeup5Aca2-3]DGalpb1-4DGlcpb1-ROH","GAL(4_H_)-NGA(3_H_)-[SIA(5_H_)]-GAL(2_H_)-BGC(1_H_)",32.7533,"","",""
"4X0Z","JC POLYOMAVIRUS GENOTYPE 3 VP1 IN COMPLEX WITH GM1 OLIGOSACCHARIDE","10.1128/JVI.00489-15 ",1.85,19.7,"4x0z_oligo2","DGalpb1-3DGalpNAcb1-4[DNeup5Aca2-3]DGalpb1-ROH","GAL(3_G_)-NGA(2_G_)-[SIA(4_G_)]-GAL(1_G_)",31.8009,"","",""
"4X0Z","JC POLYOMAVIRUS GENOTYPE 3 VP1 IN COMPLEX WITH GM1 OLIGOSACCHARIDE","10.1128/JVI.00489-15 ",1.85,19.7,"4x0z_oligo3","DGalpb1-3DGalpNAcb1-4[DNeup5Aca2-3]DGalpb1-ROH","GAL(3_F_)-NGA(2_F_)-[SIA(4_F_)]-GAL(1_F_)",32.5475,"","",""
"4X14","JC MAD-1 POLYOMAVIRUS VP1 IN COMPLEX WITH GM1 OLIGOSACCHARIDE","10.1128/JVI.00489-15 ",2.3,27.16,"4x14_oligo2","DGalpb1-3DGalpNAcb1-4[DNeup5Aca2-3]DGalpb1-4DGlcpb1-ROH","GAL(4_H_)-NGA(3_H_)-[SIA(5_H_)]-GAL(2_H_)-BGC(1_H_)",39.3478,"","",""
"4X14","JC MAD-1 POLYOMAVIRUS VP1 IN COMPLEX WITH GM1 OLIGOSACCHARIDE","10.1128/JVI.00489-15 ",2.3,27.16,"4x14_oligo1","DGalpb1-3DGalpNAcb1-4[DNeup5Aca2-3]DGalpb1-4DGlcpb1-ROH","GAL(4_G_)-NGA(3_G_)-[SIA(5_G_)]-GAL(2_G_)-BGC(1_G_)",43.7635,"","",""
"4X14","JC MAD-1 POLYOMAVIRUS VP1 IN COMPLEX WITH GM1 OLIGOSACCHARIDE","10.1128/JVI.00489-15 ",2.3,27.16,"4x14_oligo3","DGalpb1-3DGalpNAcb1-4[DNeup5Aca2-3]DGalpb1-ROH","GAL(3_F_)-NGA(2_F_)-[SIA(4_F_)]-GAL(1_F_)",48.9863,"","",""
"4X3R","AVI-GCPII STRUCTURE IN COMPLEX WITH FITC-CONJUGATED GCPII-SPECIFIC INHIBITOR","10.1021/ACS.JMEDCHEM.5B00278 ",1.86,31.07,"4x3r_oligo6","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(638_A_)",45.8907,"","",""
"4X4M","STRUCTURE OF FCGAMMARI IN COMPLEX WITH FC REVEALS THE IMPORTANCE OF GLYCAN RECOGNITION FOR HIGH AFFINITY IGG BINDING","10.1073/PNAS.1418812112 ",3.49,0,"4x4m_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(6_J_)-MAN(5_J_)-[NAG(4_J_)-MAN(3_J_)]-BMA(2_J_)-NAG(1_J_)-NAG(1001_D_)-ASN(297_D_)",186.422,"","",""
"4X4M","STRUCTURE OF FCGAMMARI IN COMPLEX WITH FC REVEALS THE IMPORTANCE OF GLYCAN RECOGNITION FOR HIGH AFFINITY IGG BINDING","10.1073/PNAS.1418812112 ",3.49,0,"4x4m_oligo3","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(8_G_)-[NAG(7_G_)-MAN(6_G_)-[NAG(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(297_A_)",122.935,"","",""
"4X4M","STRUCTURE OF FCGAMMARI IN COMPLEX WITH FC REVEALS THE IMPORTANCE OF GLYCAN RECOGNITION FOR HIGH AFFINITY IGG BINDING","10.1073/PNAS.1418812112 ",3.49,0,"4x4m_oligo4","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_I_)-[GAL(6_I_)-NAG(5_I_)-MAN(4_I_)-[NAG(8_I_)-MAN(7_I_)]-BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(297_C_)",145.232,"","",""
"4X4M","STRUCTURE OF FCGAMMARI IN COMPLEX WITH FC REVEALS THE IMPORTANCE OF GLYCAN RECOGNITION FOR HIGH AFFINITY IGG BINDING","10.1073/PNAS.1418812112 ",3.49,0,"4x4m_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(8_H_)-[NAG(7_H_)-MAN(6_H_)-[NAG(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)]-NAG(1_H_)-ASN(297_B_)",152.959,"","",""
"4X8X","CRYSTAL STRUCTURE OF DSCAM1 ISOFORM 1.9, N-TERMINAL FOUR IG DOMAINS","10.1126/SCIADV.1501118 ",2.5,0,"4x8x_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(18_A_)",99.7782,"","",""
"4X8X","CRYSTAL STRUCTURE OF DSCAM1 ISOFORM 1.9, N-TERMINAL FOUR IG DOMAINS","10.1126/SCIADV.1501118 ",2.5,0,"4x8x_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(291_B_)",112.597,"","",""
"4X8X","CRYSTAL STRUCTURE OF DSCAM1 ISOFORM 1.9, N-TERMINAL FOUR IG DOMAINS","10.1126/SCIADV.1501118 ",2.5,0,"4x8x_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(291_A_)",97.1539,"","",""
"4X98","IMMUNOGLOBULIN FC HETERODIMER VARIANT","10.1016/J.MOLIMM.2015.02.017 ",2.5,0,"4x98_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",98.6668,"","",""
"4X98","IMMUNOGLOBULIN FC HETERODIMER VARIANT","10.1016/J.MOLIMM.2015.02.017 ",2.5,0,"4x98_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",64.2932,"","",""
"4X99","IMMUNOGLOBULIN FC HETERODIMERS VARIANT","10.1016/J.MOLIMM.2015.02.017 ",2.5,0,"4x99_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)",105.177,"","",""
"4X99","IMMUNOGLOBULIN FC HETERODIMERS VARIANT","10.1016/J.MOLIMM.2015.02.017 ",2.5,0,"4x99_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)",62.246,"","",""
"4X9F","CRYSTAL STRUCTURE OF DSCAM1 ISOFORM 6.9, N-TERMINAL FOUR IG DOMAINS","10.1126/SCIADV.1501118 ",2.35,0,"4x9f_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(291_B_)",91.1329,"","",""
"4X9F","CRYSTAL STRUCTURE OF DSCAM1 ISOFORM 6.9, N-TERMINAL FOUR IG DOMAINS","10.1126/SCIADV.1501118 ",2.35,0,"4x9f_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(18_A_)",70.6225,"","",""
"4X9G","CRYSTAL STRUCTURE OF DSCAM1 ISOFORM 6.44, N-TERMINAL FOUR IG DOMAINS","10.1126/SCIADV.1501118 ",3.4,0,"4x9g_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(291_B_)",119.556,"","",""
"4X9G","CRYSTAL STRUCTURE OF DSCAM1 ISOFORM 6.44, N-TERMINAL FOUR IG DOMAINS","10.1126/SCIADV.1501118 ",3.4,0,"4x9g_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(291_A_)",128.585,"","",""
"4X9G","CRYSTAL STRUCTURE OF DSCAM1 ISOFORM 6.44, N-TERMINAL FOUR IG DOMAINS","10.1126/SCIADV.1501118 ",3.4,0,"4x9g_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(18_A_)",83.9731,"","",""
"4X9H","CRYSTAL STRUCTURE OF DSCAM1 ISOFORM 8.4, N-TERMINAL FOUR IG DOMAINS","10.1126/SCIADV.1501118 ",2.95,0,"4x9h_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(18_B_)",78.8611,"","",""
"4X9H","CRYSTAL STRUCTURE OF DSCAM1 ISOFORM 8.4, N-TERMINAL FOUR IG DOMAINS","10.1126/SCIADV.1501118 ",2.95,0,"4x9h_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(18_A_)",107.473,"","",""
"4X9I","CRYSTAL STRUCTURE OF DSCAM1 ISOFORM 9.44, N-TERMINAL FOUR IG DOMAINS","10.1126/SCIADV.1501118 ",2.9,0,"4x9i_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(18_A_)",79.7332,"","",""
"4XBL","CRYSTAL STRUCTURE OF HUMAN GALECTIN-1 IN COMPLEX WITH TYPE 1 N- ACETYLLACTOSAMINE","10.1371/JOURNAL.PONE.0125946 ",1.93,0,"4xbl_oligo2","DGalpb1-3DGlcpNAcb1-ROH","GAL(2_D_)-NAG(1_D_)",36.6723,"","",""
"4XBL","CRYSTAL STRUCTURE OF HUMAN GALECTIN-1 IN COMPLEX WITH TYPE 1 N- ACETYLLACTOSAMINE","10.1371/JOURNAL.PONE.0125946 ",1.93,0,"4xbl_oligo1","DGalpb1-3DGlcpNAcb1-ROH","GAL(2_C_)-NAG(1_C_)",34.3873,"","",""
"4XBN","CRYSTAL STRUCTURE OF HUMAN GALECTIN-3 CRD IN COMPLEX WITH TYPE 1 N- ACETYLLACTOSAMINE","10.1371/JOURNAL.PONE.0125946 ",2.21,0,"4xbn_oligo1","DGalpb1-3DGlcpNAcb1-ROH","GAL(2_B_)-NAG(1_B_)",39.7245,"","",""
"4XBQ","CRYSTAL STRUCTURE OF HUMAN GALECTIN-7 IN COMPLEX WITH TYPE 1 N- ACETYLLACTOSAMINE","10.1371/JOURNAL.PONE.0125946 ",2.23,0,"4xbq_oligo1","DGalpb1-3DGlcpNAcb1-ROH","GAL(2_C_)-NAG(1_C_)",30.0318,"","",""
"4XBQ","CRYSTAL STRUCTURE OF HUMAN GALECTIN-7 IN COMPLEX WITH TYPE 1 N- ACETYLLACTOSAMINE","10.1371/JOURNAL.PONE.0125946 ",2.23,0,"4xbq_oligo2","DGalpb1-3DGlcpNAcb1-ROH","GAL(2_D_)-NAG(1_D_)",32.0468,"","",""
"4XHJ","GHGL OF VARICELLA-ZOSTER VIRUS IN COMPLEX WITH HUMAN NEUTRALIZING ANTIBODIES.","10.1073/PNAS.1501176112 ",3.16,0,"4xhj_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(66_F_)",125.264,"","",""
"4XHJ","GHGL OF VARICELLA-ZOSTER VIRUS IN COMPLEX WITH HUMAN NEUTRALIZING ANTIBODIES.","10.1073/PNAS.1501176112 ",3.16,0,"4xhj_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(66_B_)",160.804,"","",""
"4XHQ","RE-REFINEMENT THE CRYSTAL STRUCTURE OF DSCAM1 ISOFORM 1.34, N-TERMINAL FOUR IG DOMAINS","10.1126/SCIADV.1501118 ",1.95,0,"4xhq_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(290_A_)",68.6631,"","",""
"4XI5","GHGL OF VARICELLA-ZOSTER VIRUS IN COMPLEX WITH HUMAN NEUTRALIZING ANTIBODIES","10.1073/PNAS.1501176112 ",3.9,0,"4xi5_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(66_B_)",105.689,"","",""
"4XJQ","THE CATALYTIC MECHANISM OF HUMAN PARAINFLUENZA VIRUS TYPE 3 HAEMAGGLUTININ-NEURAMINIDASE REVEALED","10.1002/ANIE.201412243 ",1.9,23.32,"4xjq_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(351_A_)",38.3839,"","",""
"4XJR","THE CATALYTIC MECHANISM OF HUMAN PARAINFLUENZA VIRUS TYPE 3 HAEMAGGLUTININ-NEURAMINIDASE REVEALED","10.1002/ANIE.201412243 ",3,46.25,"4xjr_oligo2","DManpb1-3DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(351_B_)",56.9439,"","",""
"4XKF","CRYSTAL STRUCTURE OF HEMAGGLUTININ FROM TAIWAN (2013) H6N1 INFLUENZA VIRUS IN COMPLEX WITH LSTA","10.1016/J.CHOM.2015.02.005 ",2.45,47.87,"4xkf_oligo1","DNeup5Aca2-3DGalpb1-3DGlcpNAcb1-ROH","SIA(3_G_)-GAL(2_G_)-NAG(1_G_)",76.3258,"","",""
"4XKW","TAILSPIKE PROTEIN MUTANT D339N OF E. COLI BACTERIOPHAGE HK620 IN COMPLEX WITH PENTASACCHARIDE","",1.45,15.13,"4xkw_oligo1","LRhapa1-6DGlcpa1-4[DGlcpNAcb1-3]DGalpa1-3DGlcpNAca1-ROH","RAM(4_B_)-GLC(3_B_)-[NAG(5_B_)]-GLA(2_B_)-NDG(1_B_)",15.5498,"","",""
"4XLA","TAILSPIKE PROTEIN MUTANT D339A OF E. COLI BACTERIOPHAGE HK620 IN COMPLEX WITH PENTASACCHARIDE","",1.47,16.4,"4xla_oligo1","LRhapa1-6DGlcpa1-4[DGlcpNAcb1-3]DGalpa1-3DGlcpNAcb1-ROH","RAM(4_B_)-GLC(3_B_)-[NAG(5_B_)]-GLA(2_B_)-NAG(1_B_)",16.4418,"","",""
"4XLE","TAILSPIKE PROTEIN DOUBLE MUTANT D339N/E372A OF E. COLI BACTERIOPHAGE HK620 IN COMPLEX WITH HEXASACCHARIDE","",1.45,14.36,"4xle_oligo1","LRhapa1-6DGlcpa1-4[DGlcpNAcb1-3]DGalpa1-3[DGlcpa1-6]DGlcpNAca1-ROH","GLC(6_B_)-[RAM(4_B_)-GLC(3_B_)-[NAG(5_B_)]-GLA(2_B_)]-NDG(1_B_)",13.7458,"","",""
"4XLF","TAILSPIKE PROTEIN DOUBLE MUTANT D339N/E372A OF E. COLI BACTERIOPHAGE HK620 IN COMPLEX WITH PENTASACCHARIDE","",1.75,14.86,"4xlf_oligo1","LRhapa1-6DGlcpa1-4[DGlcpNAcb1-3]DGalpa1-3DGlcpNAca1-ROH","RAM(4_B_)-GLC(3_B_)-[NAG(5_B_)]-GLA(2_B_)-NDG(1_B_)",13.9275,"","",""
"4XM3","TAILSPIKE PROTEIN MUTANT E372A OF E. COLI BACTERIOPHAGE HK620 IN COMPLEX WITH PENTASACCHARIDE","",1.27,12.76,"4xm3_oligo1","LRhapa1-6DGlcpa1-4[DGlcpNAcb1-3]DGalpa1-3DGlcpNAca1-ROH","RAM(4_B_)-GLC(3_B_)-[NAG(5_B_)]-GLA(2_B_)-NDG(1_B_)",12.5916,"","",""
"4XMY","TAILSPIKE PROTEIN DOUBLE MUTANT D339A/E372A OF E. COLI BACTERIOPHAGE HK620 IN COMPLEX WITH PENTASACCHARIDE","",1.45,14.57,"4xmy_oligo1","LRhapa1-6DGlcpa1-4[DGlcpNAcb1-3]DGalpa1-3DGlcpNAca1-ROH","RAM(4_B_)-GLC(3_B_)-[NAG(5_B_)]-GLA(2_B_)-NDG(1_B_)",14.0305,"","",""
"4XN3","TAILSPIKE PROTEIN MUTANT E372A OF E. COLI BACTERIOPHAGE HK620 IN COMPLEX WITH HEXASACCHARIDE","",1.65,14.94,"4xn3_oligo1","LRhapa1-6DGlcpa1-4[DGlcpNAcb1-3]DGalpa1-3[DGlcpa1-6]DGlcpNAca1-ROH","GLC(6_B_)-[RAM(4_B_)-GLC(3_B_)-[NAG(5_B_)]-GLA(2_B_)]-NDG(1_B_)",13.7791,"","",""
"4XOP","TAILSPIKE PROTEIN DOUBLE MUTANT D339N/E372Q OF E. COLI BACTERIOPHAGE HK620 IN COMPLEX WITH HEXASACCHARIDE","",1.59,15.57,"4xop_oligo1","LRhapa1-6DGlcpa1-4[DGlcpNAcb1-3]DGalpa1-3[DGlcpa1-6]DGlcpNAca1-ROH","GLC(6_B_)-[RAM(4_B_)-GLC(3_B_)-[NAG(5_B_)]-GLA(2_B_)]-NDG(1_B_)",13.4732,"","",""
"4XOR","TAILSPIKE PROTEIN DOUBLE MUTANT D339N/E372Q OF E. COLI BACTERIOPHAGE HK620 IN COMPLEX WITH PENTASACCHARIDE","",1.5,15.11,"4xor_oligo1","LRhapa1-6DGlcpa1-4[DGlcpNAcb1-3]DGalpa1-3DGlcpNAca1-ROH","RAM(4_B_)-GLC(3_B_)-[NAG(5_B_)]-GLA(2_B_)-NDG(1_B_)",14.4802,"","",""
"4XOT","TAILSPIKE PROTEIN MUTANT E372Q OF E. COLI BACTERIOPHAGE HK620 IN COMPLEX WITH PENTASACCHARIDE","",1.06,11.58,"4xot_oligo1","LRhapa1-6DGlcpa1-4[DGlcpNAcb1-3]DGalpa1-3DGlcpNAca1-ROH","RAM(4_B_)-GLC(3_B_)-[NAG(5_B_)]-GLA(2_B_)-NDG(1_B_)",9.92636,"","",""
"4XPF","X-RAY STRUCTURE OF DROSOPHILA DOPAMINE TRANSPORTER WITH SUBSITEB MUTATIONS (D121G/S426M) BOUND TO RTI-55","10.1038/NATURE14431 ",3.27,110.3,"4xpf_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(701_A_)-DMU(701_A_)",137.731,"","",""
"4XR6","TAILSPIKE PROTEIN DOUBLE MUTANT D339A/E372Q OF E. COLI BACTERIOPHAGE HK620 IN COMPLEX WITH HEXASACCHARIDE","",1.78,17.61,"4xr6_oligo1","LRhapa1-6DGlcpa1-4[DGlcpNAcb1-3]DGalpa1-3[DGlcpa1-6]DGlcpNAca1-ROH","GLC(6_B_)-[RAM(4_B_)-GLC(3_B_)-[NAG(5_B_)]-GLA(2_B_)]-NDG(1_B_)",17.1306,"","",""
"4XX6","CRYSTAL STRUCTURE OF A GLYCOSYLATED ENDO-BETA-1,4-XYLANASE (GLYCOSIDE HYDROLASE FAMILY 10/GH10) ENZYME FROM GLOEOPHYLLUM TRABEUM","",1.95,0,"4xx6_oligo1","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_D_)-MAN(7_D_)-[MAN(6_D_)-MAN(5_D_)]-MAN(4_D_)-[MAN(9_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(91_A_)",40.9033,"","",""
"4XX6","CRYSTAL STRUCTURE OF A GLYCOSYLATED ENDO-BETA-1,4-XYLANASE (GLYCOSIDE HYDROLASE FAMILY 10/GH10) ENZYME FROM GLOEOPHYLLUM TRABEUM","",1.95,0,"4xx6_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(166_A_)",67.1748,"","",""
"4XX6","CRYSTAL STRUCTURE OF A GLYCOSYLATED ENDO-BETA-1,4-XYLANASE (GLYCOSIDE HYDROLASE FAMILY 10/GH10) ENZYME FROM GLOEOPHYLLUM TRABEUM","",1.95,0,"4xx6_oligo5","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_C_)-[MAN(7_C_)]-MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(54_A_)",34.8257,"","",""
"4XX6","CRYSTAL STRUCTURE OF A GLYCOSYLATED ENDO-BETA-1,4-XYLANASE (GLYCOSIDE HYDROLASE FAMILY 10/GH10) ENZYME FROM GLOEOPHYLLUM TRABEUM","",1.95,0,"4xx6_oligo4","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_G_)-MAN(7_G_)-[MAN(6_G_)-MAN(5_G_)]-MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(91_B_)",33.1431,"","",""
"4Y19","IMMUNE COMPLEX","10.1038/NI.3271 ",2.5,34.62,"4y19_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)]-MAN(4_F_)-[MAN(7_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(78_A_)",52.3916,"","",""
"4Y1V","COMPLEX OF HUMAN GALECTIN-1 AND GALBETA1-3GLCNAC","",2.32,38.4,"4y1v_oligo1","DGalpb1-3DGlcpNAcb1-OME","GAL(2_D_)-MAG(1_D_)",47.8677,"","",""
"4Y1V","COMPLEX OF HUMAN GALECTIN-1 AND GALBETA1-3GLCNAC","",2.32,38.4,"4y1v_oligo2","DGalpb1-3DGlcpNAcb1-OME","GAL(2_C_)-MAG(1_C_)",53.7059,"","",""
"4Y1Y","COMPLEX OF HUMAN GALECTIN-1 AND (6OSO3)GALBETA1-3GLCNAC","",1.86,31.9,"4y1y_oligo1","DGalpb1-3DGlcpNAc[6S]b1-OME","GAL(2_C_)-6S2(1_C_)",55.5905,"","",""
"4Y1Y","COMPLEX OF HUMAN GALECTIN-1 AND (6OSO3)GALBETA1-3GLCNAC","",1.86,31.9,"4y1y_oligo2","DGalpb1-3DGlcpNAc[6S]b1-OME","GAL(2_D_)-6S2(1_D_)",34.785,"","",""
"4Y22","COMPLEX OF HUMAN GALECTIN-1 AND (3OSO3)GALBETA1-3GLCNAC","",2.5,41.93,"4y22_oligo1","DGalp[3S]b1-3DGlcpNAcb1-OME","SGA(2_C_)-MAG(1_C_)",53.2791,"","",""
"4Y26","COMPLEX OF HUMAN GALECTIN-7 AND GALBETA1-3(6OSO3)GLCNAC","",2.61,28.43,"4y26_oligo2","DGalpb1-3DGlcpNAc[6S]b1-OME","GAL(2_C_)-6S2(1_C_)",27.1377,"","",""
"4Y26","COMPLEX OF HUMAN GALECTIN-7 AND GALBETA1-3(6OSO3)GLCNAC","",2.61,28.43,"4y26_oligo1","DGalpb1-3DGlcpNAc[6S]b1-OME","GAL(2_D_)-6S2(1_D_)",33.1441,"","",""
"4YEJ","TAILSPIKE PROTEIN DOUBLE MUTANT D339A/E372Q OF E. COLI BACTERIOPHAGE HK620 IN COMPLEX WITH PENTASACCHARIDE","",1.4,13.79,"4yej_oligo1","LRhapa1-6DGlcpa1-4[DGlcpNAcb1-3]DGalpa1-3DGlcpNAca1-ROH","RAM(4_B_)-GLC(3_B_)-[NAG(5_B_)]-GLA(2_B_)-NDG(1_B_)",13.3558,"","",""
"4YEL","TAILSPIKE PROTEIN DOUBLE MUTANT D339A/E372A OF E. COLI BACTERIOPHAGE HK620 IN COMPLEX WITH HEXASACCHARIDE","",1.72,16.16,"4yel_oligo1","LRhapa1-6DGlcpa1-4[DGlcpNAcb1-3]DGalpa1-3[DGlcpa1-6]DGlcpNAca1-ROH","GLC(6_B_)-[RAM(4_B_)-GLC(3_B_)-[NAG(5_B_)]-GLA(2_B_)]-NDG(1_B_)",15.0444,"","",""
"4YFZ","STRUCTURAL BASIS OF GLYCAN RECOGNITION IN NEONATE-SPECIFIC ROTAVIRUSES","10.1038/NCOMMS9346 ",1.5,0,"4yfz_oligo1","DGalpb1-3DGlcpNAcb1-3DGalpb1-4DGlcpb1-ROH","GAL(4_B_)-NAG(3_B_)-GAL(2_B_)-BGC(1_B_)",12.3534,"","",""
"4YH6","CRYSTAL STRUCTURE OF IL1RAPL1 ECTODOMAIN","10.1038/NCOMMS7926 ",3,0,"4yh6_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(213_B_)",101.162,"","",""
"4YH6","CRYSTAL STRUCTURE OF IL1RAPL1 ECTODOMAIN","10.1038/NCOMMS7926 ",3,0,"4yh6_oligo6","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_H_)-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(264_B_)",79.7041,"","",""
"4YH6","CRYSTAL STRUCTURE OF IL1RAPL1 ECTODOMAIN","10.1038/NCOMMS7926 ",3,0,"4yh6_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(213_A_)",113.037,"","",""
"4YH6","CRYSTAL STRUCTURE OF IL1RAPL1 ECTODOMAIN","10.1038/NCOMMS7926 ",3,0,"4yh6_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(264_A_)",119.287,"","",""
"4YH7","CRYSTAL STRUCTURE OF PTPDELTA ECTODOMAIN IN COMPLEX WITH IL1RAPL1","10.1038/NCOMMS7926 ",4.4,0,"4yh7_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(264_B_)",163.819,"","",""
"4YLQ","CRYSTAL STRUCTURE OF A FVIIA-TRYPSIN CHIMERA (FT) IN COMPLEX WITH SOLUBLE TISSUE FACTOR","10.1074/JBC.M115.698613 ",1.4,26.46,"4ylq_oligo2","DXylpa1-3DXylpa1-3DGlcpb1-SER","XYS(3_A_)-XYS(2_A_)-BGC(1_A_)-SER(52_L_)",42.0596,"","",""
"4YM0","CRYSTAL STRUCTURE OF THE HUMAN GALECTIN-4 C-TERMINAL CARBOHYDRATE RECOGNITION DOMAIN IN COMPLEX WITH LACTO-N-TETRAOSE (LNT)","10.1111/FEBS.13348 ",2.3,28.38,"4ym0_oligo3","DGalpb1-3DGlcpNAcb1-3DGalpb1-4DGlcpb1-ROH","GAL(4_G_)-NAG(3_G_)-GAL(2_G_)-BGC(1_G_)",40.2325,"","",""
"4YM0","CRYSTAL STRUCTURE OF THE HUMAN GALECTIN-4 C-TERMINAL CARBOHYDRATE RECOGNITION DOMAIN IN COMPLEX WITH LACTO-N-TETRAOSE (LNT)","10.1111/FEBS.13348 ",2.3,28.38,"4ym0_oligo2","DGalpb1-3DGlcpNAcb1-3DGalpb1-4DGlcpb1-ROH","GAL(4_F_)-NAG(3_F_)-GAL(2_F_)-BGC(1_F_)",32.2027,"","",""
"4YM0","CRYSTAL STRUCTURE OF THE HUMAN GALECTIN-4 C-TERMINAL CARBOHYDRATE RECOGNITION DOMAIN IN COMPLEX WITH LACTO-N-TETRAOSE (LNT)","10.1111/FEBS.13348 ",2.3,28.38,"4ym0_oligo1","DGalpb1-3DGlcpNAcb1-ROH","GAL(2_E_)-NAG(1_E_)",33.2064,"","",""
"4YN3","CRYSTAL STRUCTURE OF CUCUMISIN COMPLEX WITH PRO-PEPTIDE","10.1093/JB/MVW053 ",1.95,41.3,"4yn3_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-[FUC(5_C_)]-NAG(1_C_)-ASN(466_A_)",44.7035,"","",""
"4YN3","CRYSTAL STRUCTURE OF CUCUMISIN COMPLEX WITH PRO-PEPTIDE","10.1093/JB/MVW053 ",1.95,41.3,"4yn3_oligo2","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_D_)-[FUC(2_D_)]-NAG(1_D_)-ASN(652_A_)",78.8906,"","",""
"4YQX","MOUSE IL-2 BOUND TO JES6-1 SCFV FRAGMENT","10.1016/J.IMMUNI.2015.04.015 ",2.83,63.58,"4yqx_oligo1","LFucpa1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_B_)-[NAG(3_B_)]-[FUC(2_B_)]-NAG(1_B_)-ASN(31_H_)",114.323,"","",""
"4Z3E","CRYSTAL STRUCTURE OF THE LECTIN DOMAIN OF PAPG FROM E. COLI BI47 IN COMPLEX WITH SSEA4 IN SPACE GROUP P212121","10.1002/CBIC.201600615 ",1.8,28.14,"4z3e_oligo1","DGalpb1-3DGalpNAcb1-3DGalpa1-4DGalpb1-4DGlcpb1-ROH","GAL(5_B_)-NGA(4_B_)-GLA(3_B_)-GAL(2_B_)-BGC(1_B_)",20.0391,"","",""
"4Z3F","CRYSTAL STRUCTURE OF THE LECTIN DOMAIN OF PAPG FROM E. COLI BI47 IN COMPLEX WITH SSEA4 IN SPACE GROUP P21","",1.8,28.48,"4z3f_oligo1","DNeup5Aca2-3DGalpb1-3DGalpNAcb1-3DGalpa1-4DGalpb1-4DGlcpb1-ROH","SIA(6_B_)-GAL(5_B_)-NGA(4_B_)-GLA(3_B_)-GAL(2_B_)-BGC(1_B_)",22.6063,"","",""
"4Z4Y","CRYSTAL STRUCTURE OF GII.10 P DOMAIN IN COMPLEX WITH 7.5MM B ANTIGEN (TRISACCHARIDE)","10.1016/J.VIROL.2015.04.006 ",1.8,19.37,"4z4y_oligo1","LFucpa1-2[DGalpa1-3]DGalpa1-ROH","GLA(3_C_)-[FUC(2_C_)]-GLA(1_C_)",20.9439,"","",""
"4Z4Z","CRYSTAL STRUCTURE OF GII.10 P DOMAIN IN COMPLEX WITH 30MM B ANTIGEN (TRISACCHARIDE)","10.1016/J.VIROL.2015.04.006 ",1.8,22.34,"4z4z_oligo2","LFucpa1-2[DGalpa1-3]DGalpa1-ROH","GLA(3_D_)-[FUC(2_D_)]-GLA(1_D_)",20.2473,"","",""
"4Z4Z","CRYSTAL STRUCTURE OF GII.10 P DOMAIN IN COMPLEX WITH 30MM B ANTIGEN (TRISACCHARIDE)","10.1016/J.VIROL.2015.04.006 ",1.8,22.34,"4z4z_oligo1","LFucpa1-2[DGalpa1-3]DGalpa1-ROH","GLA(3_C_)-[FUC(2_C_)]-GLA(1_C_)",29.2897,"","",""
"4Z7N","INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV PEPTIDE","10.1074/JBC.M115.705624 ",2.6,0,"4z7n_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_M_)-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(320_D_)",84.8423,"","",""
"4Z7N","INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV PEPTIDE","10.1074/JBC.M115.705624 ",2.6,0,"4z7n_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(320_B_)",82.1713,"","",""
"4Z7O","INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV PEPTIDE","10.1074/JBC.M115.705624 ",2.85,0,"4z7o_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(320_B_)",113.191,"","",""
"4Z7O","INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV PEPTIDE","10.1074/JBC.M115.705624 ",2.85,0,"4z7o_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_M_)-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(320_D_)",133.533,"","",""
"4Z7Q","INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV-NH2 PEPTIDE","10.1074/JBC.M115.705624 ",2.7,0,"4z7q_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(505_C_)-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(320_D_)",111.968,"","",""
"4Z7Q","INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV-NH2 PEPTIDE","10.1074/JBC.M115.705624 ",2.7,0,"4z7q_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(320_B_)",106.219,"","",""
"4Z7U","S13 COMPLEX","10.4049/JIMMUNOL.1500161 ",2.7,67.59,"4z7u_oligo1","LFucpa1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_K_)-[NAG(3_K_)]-[FUC(2_K_)]-NAG(1_K_)-ASN(19_B_)",121.575,"","",""
"4Z7U","S13 COMPLEX","10.4049/JIMMUNOL.1500161 ",2.7,67.59,"4z7u_oligo2","LFucpa1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_L_)-[NAG(3_L_)]-[FUC(2_L_)]-NAG(1_L_)-ASN(19_D_)",108.29,"","",""
"4Z7V","L3-12 COMPLEX","10.4049/JIMMUNOL.1500161 ",2.65,61.71,"4z7v_oligo2","LFucpa1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_L_)-[NAG(3_L_)]-[FUC(2_L_)]-NAG(1_L_)-ASN(19_D_)",108.408,"","",""
"4Z7V","L3-12 COMPLEX","10.4049/JIMMUNOL.1500161 ",2.65,61.71,"4z7v_oligo1","DManpa1-4DManpa1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(6_K_)-[MAN(4_K_)-MAN(3_K_)-NAG(2_K_)]-[FUC(5_K_)]-NAG(1_K_)-ASN(19_B_)",134.342,"","",""
"4Z7W","T316 COMPLEX","10.4049/JIMMUNOL.1500161 ",2.89,59.64,"4z7w_oligo1","DManpa1-6DManpa1-3DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(6_K_)-[MAN(4_K_)-MAN(3_K_)-NAG(2_K_)]-[FUC(5_K_)]-NAG(1_K_)-ASN(78_A_)",60.7742,"","",""
"4Z7W","T316 COMPLEX","10.4049/JIMMUNOL.1500161 ",2.89,59.64,"4z7w_oligo2","DManpa1-6DManpa1-3DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(6_L_)-[MAN(4_L_)-MAN(3_L_)-NAG(2_L_)]-[FUC(5_L_)]-NAG(1_L_)-ASN(78_C_)",70.8189,"","",""
"4Z8S","STRUCTURAL STUDIES ON A NON-TOXIC HOMOLOGUE OF TYPE II RIPS FROM MOMORDICA CHARANTIA (BITTER GOURD)-NATIVE-1","10.1007/S12038-015-9573-X ",2.36,28.97,"4z8s_oligo2","DXylpb1-2DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","XYP(4_D_)-BMA(3_D_)-NAG(2_D_)-[FUC(5_D_)]-NAG(1_D_)-ASN(114_B_)",42.7549,"","",""
"4Z9W","STRUCTURAL STUDIES ON A NON-TOXIC HOMOLOGUE OF TYPE II RIPS FROM MOMORDICA CHARANTIA (BITTER GOURD)-NATIVE-2","10.1007/S12038-015-9573-X ",1.77,23.55,"4z9w_oligo1","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcx1-","NAG(3_C_)-[FUC(2_C_)]-NAG(1_C_)",51.3804,"","",""
"4ZA3","STRUCTURAL STUDIES ON A NON-TOXIC HOMOLOGUE OF TYPE II RIPS FROM MOMORDICA CHARANTIA (BITTER GOURD)-NATIVE-3","10.1007/S12038-015-9573-X ",1.67,20.52,"4za3_oligo1","LFucpa1-3DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(114_B_)",38.3982,"","",""
"4ZBV","STRUCTURAL STUDIES ON A NON-TOXIC HOMOLOGUE OF TYPE II RIPS FROM MOMORDICA CHARANTIA (BITTER GOURD) IN COMPLEX WITH BENZYL T-ANTIGEN","10.1007/S12038-015-9573-X ",2,28.65,"4zbv_oligo3","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(303_B_)-[FUC(2_C_)]-NAG(1_C_)-ASN(114_B_)",55.6903,"","",""
"4ZFU","STRUCTURAL STUDIES ON A NON-TOXIC HOMOLOGUE OF TYPE II RIPS FROM MOMORDICA CHARANTIA (BITTER GOURD) IN COMPLEX WITH N-ACETYL D GALACTOSAMINE","10.1007/S12038-015-9573-X ",2.53,23.74,"4zfu_oligo1","DXylpb1-2DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","XYP(4_D_)-BMA(3_D_)-NAG(2_D_)-[FUC(5_D_)]-NAG(1_D_)-ASN(114_B_)",52.245,"","",""
"4ZFW","STRUCTURAL STUDIES ON A NON-TOXIC HOMOLOGUE OF TYPE II RIPS FROM MOMORDICA CHARANTIA (BITTER GOURD) IN COMPLEX WITH GALACTOSE.","10.1007/S12038-015-9573-X ",2.54,24.24,"4zfw_oligo1","DXylpb1-2DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","XYP(4_D_)-BMA(3_D_)-NAG(2_D_)-[FUC(5_D_)]-NAG(1_D_)",52.3271,"","",""
"4ZGR","STRUCTURAL STUDIES ON A NON-TOXIC HOMOLOGUE OF TYPE II RIPS FROM MOMORDICA CHARANTIA (BITTER GOURD) IN COMPLEX WITH T-ANTIGEN.","10.1007/S12038-015-9573-X ",1.97,28.77,"4zgr_oligo2","DGalpb1-3DGalpNAcb1-ROH","GAL(2_C_)-NGA(1_C_)",46.4718,"","",""
"4ZGR","STRUCTURAL STUDIES ON A NON-TOXIC HOMOLOGUE OF TYPE II RIPS FROM MOMORDICA CHARANTIA (BITTER GOURD) IN COMPLEX WITH T-ANTIGEN.","10.1007/S12038-015-9573-X ",1.97,28.77,"4zgr_oligo3","LFucpa1-3DGlcpNAcb1-ASN","FUC(2_E_)-NAG(1_E_)-ASN(114_B_)",41.1586,"","",""
"4ZH1","COMPLEMENT FACTOR H IN COMPLEX WITH THE GM1 GLYCAN","10.1093/GLYCOB/CWV170 ",2.24,68.98,"4zh1_oligo1","DGalpb1-3DGalpNAcb1-4[DNeup5Aca2-3]DGalpb1-4DGlcpb1-ROH","GAL(4_H_)-NGA(3_H_)-[SIA(5_H_)]-GAL(2_H_)-BGC(1_H_)",76.2319,"","",""
"4ZH7","STRUCTURAL BASIS OF LEWISB ANTIGEN BINDING BY THE HELICOBACTER PYLORI ADHESIN BABA","10.1126/SCIADV.1500315 ",2.12,27.89,"4zh7_oligo1","LFucpa1-2DGalpb1-3[LFucpa1-4]DGlcpNAcb1-3DGalpb1-ROH","FUC(5_B_)-[FUC(4_B_)-GAL(3_B_)]-NAG(2_B_)-GAL(1_B_)",35.3735,"","",""
"4ZLB","STRUCTURAL STUDIES ON A NON-TOXIC HOMOLOGUE OF TYPE II RIPS FROM MOMORDICA CHARANTIA (BITTER GOURD) IN COMPLEX WITH LACTOSE","10.1007/S12038-015-9573-X ",2.55,31.36,"4zlb_oligo4","[LFucpa1-3]DGlcpNAcx1-","FUC(2_D_)-NAG(1_D_)",55.621,"","",""
"4ZMJ","CRYSTAL STRUCTURE OF LIGAND-FREE BG505 SOSIP.664 HIV-1 ENV TRIMER","10.1038/NSMB.3051 ",3.31,0,"4zmj_oligo1","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_A_)-[MAN(5_A_)-MAN(4_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(262_G_)",119.188,"","",""
"4ZNE","IGG1 FC-FCGAMMARI ECD COMPLEX","10.1107/S1399004715018015 ",2.42,34.24,"4zne_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(8_G_)-[NAG(7_G_)-MAN(6_G_)-[NAG(5_G_)-MAN(4_G_)]-MAN(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(297_J_)",72.298,"","",""
"4ZNE","IGG1 FC-FCGAMMARI ECD COMPLEX","10.1107/S1399004715018015 ",2.42,34.24,"4zne_oligo5","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(8_F_)-[NAG(7_F_)-MAN(6_F_)-[NAG(5_F_)-MAN(4_F_)]-MAN(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(297_E_)",63.5537,"","",""
"4ZNE","IGG1 FC-FCGAMMARI ECD COMPLEX","10.1107/S1399004715018015 ",2.42,34.24,"4zne_oligo3","DManpa1-3DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(59_A_)",101.679,"","",""
"4ZNR","CRYSTAL STRUCTURE OF DLN1 COMPLEXED WITH MAN(ALPHA1-3)MAN","10.15252/EMBR.201540851 ",2.1,37.18,"4znr_oligo2","DManpa1-3DManpa1-ROH","MAN(2_C_)-MAN(1_C_)",48.1527,"","",""
"4ZNR","CRYSTAL STRUCTURE OF DLN1 COMPLEXED WITH MAN(ALPHA1-3)MAN","10.15252/EMBR.201540851 ",2.1,37.18,"4znr_oligo3","DManpa1-3DManpa1-ROH","MAN(2_D_)-MAN(1_D_)",49.4623,"","",""
"5A56","THE STRUCTURE OF GH101 FROM STREPTOCOCCUS PNEUMONIAE TIGR4 IN COMPLEX WITH 1-O-METHYL-T-ANTIGEN","10.1074/JBC.M115.680470 ",1.8,18.42,"5a56_oligo1","DGalpb1-3DGalpNAca1-OME","GAL(2_B_)-MGC(1_B_)",29.0195,"","",""
"5A58","THE STRUCTURE OF GH101 D764N MUTANT FROM STREPTOCOCCUS PNEUMONIAE TIGR4 IN COMPLEX WITH SERINYL T-ANTIGEN","10.1074/JBC.M115.680470 ",1.8,17.69,"5a58_oligo1","DGalpb1-3DGalpNAca1-SER","GAL(2_B_)-A2G(1_B_)-SER(2435_A_)",13.9773,"","",""
"5A59","THE STRUCTURE OF GH101 E796Q MUTANT FROM STREPTOCOCCUS PNEUMONIAE TIGR4 IN COMPLEX WITH T-ANTIGEN","10.1074/JBC.M115.680470 ",2.5,19.69,"5a59_oligo1","DGalpb1-3DGalpNAca1-ROH","GAL(2_B_)-A2G(1_B_)",19.0427,"","",""
"5A5A","THE STRUCTURE OF GH101 E796Q MUTANT FROM STREPTOCOCCUS PNEUMONIAE TIGR4 IN COMPLEX WITH PNP-T-ANTIGEN","10.1074/JBC.M115.680470 ",1.75,19.48,"5a5a_oligo1","DGalpb1-3DGalpNAca1-ROH","GAL(2_B_)-A2G(1_B_)",14.505,"","",""
"5A63","CRYO-EM STRUCTURE OF THE HUMAN GAMMA-SECRETASE COMPLEX AT 3.4 ANGSTROM RESOLUTION.","10.1038/NATURE14892 ",3.4,"1.35632e-19","5a63_oligo2","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_F_)-[BMA(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(55_A_)",390.712,"","",""
"5A6Y","STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH MANNOSE-ALPHA1,3MANNOSIDE","10.1039/C6SC00696E ",1.4,9.47,"5a6y_oligo1","DManpa1-3DManpa1-ROH","MAN(2_E_)-MAN(1_E_)",15.5941,"","",""
"5A6Y","STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH MANNOSE-ALPHA1,3MANNOSIDE","10.1039/C6SC00696E ",1.4,9.47,"5a6y_oligo2","DManpa1-3DManpa1-ROH","MAN(2_F_)-MAN(1_F_)",14.1873,"","",""
"5A6Y","STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH MANNOSE-ALPHA1,3MANNOSIDE","10.1039/C6SC00696E ",1.4,9.47,"5a6y_oligo3","DManpa1-3DManpa1-ROH","MAN(2_G_)-MAN(1_G_)",13.8073,"","",""
"5A6Z","STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH LEWIS A","10.1039/C6SC00696E ",1.5,11.34,"5a6z_oligo3","DGalpb1-3[LFucpa1-4]DGlcpNAcb1-3DGalpb1-ROH","FUC(4_G_)-[GAL(3_G_)]-NAG(2_G_)-GAL(1_G_)",14.597,"","",""
"5A6Z","STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH LEWIS A","10.1039/C6SC00696E ",1.5,11.34,"5a6z_oligo2","DGalpb1-3[LFucpa1-4]DGlcpNAcb1-ROH","FUC(3_F_)-[GAL(2_F_)]-NAG(1_F_)",15.7721,"","",""
"5A6Z","STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH LEWIS A","10.1039/C6SC00696E ",1.5,11.34,"5a6z_oligo1","DGalpb1-3[LFucpa1-4]DGlcpNAcb1-3LArapb1-ROH","FUC(4_E_)-[GAL(3_E_)]-NAG(2_E_)-GLA(1_E_)",19.9516,"","",""
"5A6Z","STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH LEWIS A","10.1039/C6SC00696E ",1.5,11.34,"5a6z_oligo4","DGalpb1-3[LFucpa1-4]DGlcpNAcb1-3DGalpa1-ROH","FUC(4_H_)-[GAL(3_H_)]-NAG(2_H_)-GLA(1_H_)",17.2782,"","",""
"5A70","STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH LEWIS X TETRASACCHARIDE","10.1016/J.EJMECH.2019.05.049 ",1.6,14.43,"5a70_oligo4","LFucpa1-3[DGalpb1-4]DGlcpNAcb1-3DGalpb1-ROH","GAL(4_H_)-[FUC(3_H_)]-NAG(2_H_)-GAL(1_H_)",20.05,"","",""
"5A70","STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH LEWIS X TETRASACCHARIDE","10.1016/J.EJMECH.2019.05.049 ",1.6,14.43,"5a70_oligo3","LFucpa1-3[DGalpb1-4]DGlcpNAcb1-3DGalpb1-ROH","GAL(4_G_)-[FUC(3_G_)]-NAG(2_G_)-GAL(1_G_)",16.1566,"","",""
"5A70","STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH LEWIS X TETRASACCHARIDE","10.1016/J.EJMECH.2019.05.049 ",1.6,14.43,"5a70_oligo2","LFucpa1-3[DGalpb1-4]DGlcpNAcb1-3DGalpb1-ROH","GAL(4_F_)-[FUC(3_F_)]-NAG(2_F_)-GAL(1_F_)",24.3943,"","",""
"5A70","STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PA14 IN COMPLEX WITH LEWIS X TETRASACCHARIDE","10.1016/J.EJMECH.2019.05.049 ",1.6,14.43,"5a70_oligo1","LFucpa1-3[DGalpb1-4]DGlcpNAcb1-3DGalpb1-ROH","GAL(4_E_)-[FUC(3_E_)]-NAG(2_E_)-GAL(1_E_)",18.295,"","",""
"5A7M","THE STRUCTURE OF HYPOCREA JECORINA BETA-XYLOSIDASE XYL3A (BXL1)","",1.8,15.48,"5a7m_oligo3","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_C_)-MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(123_A_)",23.9825,"","",""
"5A7M","THE STRUCTURE OF HYPOCREA JECORINA BETA-XYLOSIDASE XYL3A (BXL1)","",1.8,15.48,"5a7m_oligo8","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_H_)-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(333_B_)",28.1268,"","",""
"5A7M","THE STRUCTURE OF HYPOCREA JECORINA BETA-XYLOSIDASE XYL3A (BXL1)","",1.8,15.48,"5a7m_oligo9","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(384_B_)",19.5675,"","",""
"5A7M","THE STRUCTURE OF HYPOCREA JECORINA BETA-XYLOSIDASE XYL3A (BXL1)","",1.8,15.48,"5a7m_oligo5","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(384_A_)",29.1213,"","",""
"5AE6","THE STRUCTURE OF HYPOCREA JECORINA BETA-XYLOSIDASE XYL3A (BXL1) IN COMPLEX WITH 4-THIOXYLOBIOSE","",2.1,22.87,"5ae6_oligo11","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(384_B_)",36.2024,"","",""
"5AE6","THE STRUCTURE OF HYPOCREA JECORINA BETA-XYLOSIDASE XYL3A (BXL1) IN COMPLEX WITH 4-THIOXYLOBIOSE","",2.1,22.87,"5ae6_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(123_A_)",33.4277,"","",""
"5AFH","ALPHA7-ACHBP IN COMPLEX WITH LOBELINE","10.1073/PNAS.1418289112 ",2.4,0,"5afh_oligo6","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(108_A_)",85.6045,"","",""
"5AFK","ALPHA7-ACHBP IN COMPLEX WITH LOBELINE AND FRAGMENT 2","10.1073/PNAS.1418289112 ",2.38,0,"5afk_oligo5","DManpb1-3DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(108_A_)",72.8307,"","",""
"5AFL","ALPHA7-ACHBP IN COMPLEX WITH LOBELINE AND FRAGMENT 3","10.1073/PNAS.1418289112 ",2.39,0,"5afl_oligo2","DManpb1-3DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(108_A_)",57.4257,"","",""
"5AJB","X-RAY STRUCTURE OF THE RSL LECTIN IN COMPLEX WITH LEWIS X TETRASACCAHRIDE","10.1021/ACSCHEMBIO.6B00333 ",1.8,11.75,"5ajb_oligo5","LFucpa1-3DGlcpNAcx1-","FUC(2_H_)-NAG(1_H_)",18.9775,"","",""
"5AJB","X-RAY STRUCTURE OF THE RSL LECTIN IN COMPLEX WITH LEWIS X TETRASACCAHRIDE","10.1021/ACSCHEMBIO.6B00333 ",1.8,11.75,"5ajb_oligo1","LFucpa1-3[DGalpb1-4]DGlcpNAcb1-ROH","GAL(3_F_)-[FUC(2_F_)]-NAG(1_F_)",19.4318,"","",""
"5AJB","X-RAY STRUCTURE OF THE RSL LECTIN IN COMPLEX WITH LEWIS X TETRASACCAHRIDE","10.1021/ACSCHEMBIO.6B00333 ",1.8,11.75,"5ajb_oligo3","LFucpa1-3[DGalpb1-4]DGlcpNAcb1-3LArapb1-ROH","GAL(4_E_)-[FUC(3_E_)]-NAG(2_E_)-GLA(1_E_)",11.479,"","",""
"5AJB","X-RAY STRUCTURE OF THE RSL LECTIN IN COMPLEX WITH LEWIS X TETRASACCAHRIDE","10.1021/ACSCHEMBIO.6B00333 ",1.8,11.75,"5ajb_oligo2","LFucpa1-3[DGalpb1-4]DGlcpNAcb1-ROH","GAL(3_D_)-[FUC(2_D_)]-NAG(1_D_)",18.7688,"","",""
"5AJB","X-RAY STRUCTURE OF THE RSL LECTIN IN COMPLEX WITH LEWIS X TETRASACCAHRIDE","10.1021/ACSCHEMBIO.6B00333 ",1.8,11.75,"5ajb_oligo6","LFucpa1-3[DGalpb1-4]DGlcpNAcb1-ROH","GAL(3_I_)-[FUC(2_I_)]-NAG(1_I_)",19.8255,"","",""
"5AJB","X-RAY STRUCTURE OF THE RSL LECTIN IN COMPLEX WITH LEWIS X TETRASACCAHRIDE","10.1021/ACSCHEMBIO.6B00333 ",1.8,11.75,"5ajb_oligo4","LFucpa1-3[DGalpb1-4]DGlcpNAcx1-","GAL(3_G_)-[FUC(2_G_)]-NAG(1_G_)",19.9464,"","",""
"5AJC","X-RAY STRUCTURE OF RSL LECTIN IN COMPLEX WITH SIALYL LEWIS X TETRASACCHARIDE","10.1021/ACSCHEMBIO.6B00333 ",1.7,15.41,"5ajc_oligo3","LFucpa1-3[DGalpb1-4]DGlcpNAca1-ROH","GAL(3_D_)-[FUC(2_D_)]-NDG(1_D_)",23.3188,"","",""
"5AJC","X-RAY STRUCTURE OF RSL LECTIN IN COMPLEX WITH SIALYL LEWIS X TETRASACCHARIDE","10.1021/ACSCHEMBIO.6B00333 ",1.7,15.41,"5ajc_oligo2","LFucpa1-3DGlcpNAcb1-ROH","FUC(2_E_)-NAG(1_E_)",20.4336,"","",""
"5AJC","X-RAY STRUCTURE OF RSL LECTIN IN COMPLEX WITH SIALYL LEWIS X TETRASACCHARIDE","10.1021/ACSCHEMBIO.6B00333 ",1.7,15.41,"5ajc_oligo1","DNeup5Aca2-3DGalpb1-4[LFucpa1-3]DGlcpNAca1-ROH","SIA(3_F_)-GAL(2_F_)-[FUC(4_F_)]-NDG(1_F_)",15.8681,"","",""
"5AJM","H5 (VN1194) ASN186LYS MUTANT HAEMAGGLUTININ IN COMPLEX WITH AVIAN RECEPTOR ANALOGUE 3'SLN","10.1016/J.VIROL.2014.03.008 ",2.45,78.35,"5ajm_oligo1","DManpb1-3[DManpa1-6]DManpa1-4DGlcpNAca1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(165_A_)",146.112,"","",""
"5ANM","CRYSTAL STRUCTURE OF IGE FC IN COMPLEX WITH A NEUTRALIZING ANTIBODY","10.4161/MABS.28394 ",2.85,68.61,"5anm_oligo2","DManpb1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[BMA(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(394_F_)",79.6876,"","",""
"5ANM","CRYSTAL STRUCTURE OF IGE FC IN COMPLEX WITH A NEUTRALIZING ANTIBODY","10.4161/MABS.28394 ",2.85,68.61,"5anm_oligo3","DManpa1-3DManpa1-6[DManpb1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-MAN(4_K_)-[BMA(6_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(394_G_)",71.3477,"","",""
"5ANM","CRYSTAL STRUCTURE OF IGE FC IN COMPLEX WITH A NEUTRALIZING ANTIBODY","10.4161/MABS.28394 ",2.85,68.61,"5anm_oligo1","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-MAN(4_I_)-[MAN(6_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(394_E_)",94.5333,"","",""
"5ANN","STRUCTURE OF FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS","10.1074/JBC.M115.708495 ",2.14,21.19,"5ann_oligo31","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-MAN(4_F_)-[MAN(6_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(58_B_)",40.9809,"","",""
"5ANN","STRUCTURE OF FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS","10.1074/JBC.M115.708495 ",2.14,21.19,"5ann_oligo25","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(58_A_)",36.3092,"","",""
"5ANN","STRUCTURE OF FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS","10.1074/JBC.M115.708495 ",2.14,21.19,"5ann_oligo29","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_D_)-MAN(8_D_)-[MAN(10_D_)]-MAN(7_D_)-[MAN(6_D_)-MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(107_A_)",28.0687,"","",""
"5ANN","STRUCTURE OF FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS","10.1074/JBC.M115.708495 ",2.14,21.19,"5ann_oligo32","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_G_)-MAN(8_G_)-[MAN(10_G_)]-MAN(7_G_)-[MAN(6_G_)-MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(107_B_)",30.41,"","",""
"5AOG","STRUCTURE OF SORGHUM PEROXIDASE","10.1007/S00775-015-1313-Z ",1.27,27.05,"5aog_oligo1","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_B_)-[FUC(2_B_)]-NAG(1_B_)-ASN(332_A_)",48.8558,"","",""
"5AOG","STRUCTURE OF SORGHUM PEROXIDASE","10.1007/S00775-015-1313-Z ",1.27,27.05,"5aog_oligo2","DXylpb1-2[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(5_C_)-[XYP(4_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(6_C_)]-NAG(1_C_)-ASN(234_A_)",33.715,"","",""
"5AV7","CRYSTAL STRUCTURE OF CALSEPA LECTIN IN COMPLEX WITH BISECTED GLYCAN","10.1038/SREP22973 ",1.85,23.1,"5av7_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6][DGlcpNAcb1-4]DManpa1-OME","NAG(5_E_)-MAN(4_E_)-[NAG(6_E_)]-[NAG(3_E_)-MAN(2_E_)]-MMA(1_E_)",27.2962,"","",""
"5AV7","CRYSTAL STRUCTURE OF CALSEPA LECTIN IN COMPLEX WITH BISECTED GLYCAN","10.1038/SREP22973 ",1.85,23.1,"5av7_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6][DGlcpNAcb1-4]DManpa1-OME","NAG(5_F_)-MAN(4_F_)-[NAG(6_F_)]-[NAG(3_F_)-MAN(2_F_)]-MMA(1_F_)",26.8536,"","",""
"5AVA","CRYSTAL STRUCTURE OF PHA-E LECTIN IN COMPLEX WITH BISECTED GLYCAN","10.1038/SREP22973 ",3,42.11,"5ava_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3][DGlcpNAcb1-4]DManpb1-4DGlcpNAcx1-","GAL(5_J_)-NAG(4_J_)-MAN(3_J_)-[NAG(8_J_)]-[NAG(7_J_)-MAN(6_J_)]-BMA(2_J_)-NAG(1_J_)",44.5369,"","",""
"5AVA","CRYSTAL STRUCTURE OF PHA-E LECTIN IN COMPLEX WITH BISECTED GLYCAN","10.1038/SREP22973 ",3,42.11,"5ava_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3][DGlcpNAcb1-4]DManpb1-4DGlcpNAcx1-","GAL(5_K_)-NAG(4_K_)-MAN(3_K_)-[NAG(8_K_)]-[NAG(7_K_)-MAN(6_K_)]-BMA(2_K_)-NAG(1_K_)",56.6309,"","",""
"5AVA","CRYSTAL STRUCTURE OF PHA-E LECTIN IN COMPLEX WITH BISECTED GLYCAN","10.1038/SREP22973 ",3,42.11,"5ava_oligo3","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3][DGlcpNAcb1-4]DManpb1-4DGlcpNAcx1-","GAL(5_I_)-NAG(4_I_)-MAN(3_I_)-[NAG(8_I_)]-[NAG(7_I_)-MAN(6_I_)]-BMA(2_I_)-NAG(1_I_)",45.0045,"","",""
"5AVA","CRYSTAL STRUCTURE OF PHA-E LECTIN IN COMPLEX WITH BISECTED GLYCAN","10.1038/SREP22973 ",3,42.11,"5ava_oligo8","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3][DGlcpNAcb1-4]DManpb1-4DGlcpNAcx1-","GAL(5_P_)-NAG(4_P_)-MAN(3_P_)-[NAG(8_P_)]-[NAG(7_P_)-MAN(6_P_)]-BMA(2_P_)-NAG(1_P_)",79.072,"","",""
"5AVA","CRYSTAL STRUCTURE OF PHA-E LECTIN IN COMPLEX WITH BISECTED GLYCAN","10.1038/SREP22973 ",3,42.11,"5ava_oligo5","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3][DGlcpNAcb1-4]DManpb1-4DGlcpNAcx1-","GAL(5_M_)-NAG(4_M_)-MAN(3_M_)-[NAG(8_M_)]-[NAG(7_M_)-MAN(6_M_)]-BMA(2_M_)-NAG(1_M_)",54.1475,"","",""
"5AVA","CRYSTAL STRUCTURE OF PHA-E LECTIN IN COMPLEX WITH BISECTED GLYCAN","10.1038/SREP22973 ",3,42.11,"5ava_oligo7","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3][DGlcpNAcb1-4]DManpb1-4DGlcpNAcx1-","GAL(5_O_)-NAG(4_O_)-MAN(3_O_)-[NAG(8_O_)]-[NAG(7_O_)-MAN(6_O_)]-BMA(2_O_)-NAG(1_O_)",67.8809,"","",""
"5AVA","CRYSTAL STRUCTURE OF PHA-E LECTIN IN COMPLEX WITH BISECTED GLYCAN","10.1038/SREP22973 ",3,42.11,"5ava_oligo4","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3][DGlcpNAcb1-4]DManpb1-4DGlcpNAcx1-","GAL(5_L_)-NAG(4_L_)-MAN(3_L_)-[NAG(8_L_)]-[NAG(7_L_)-MAN(6_L_)]-BMA(2_L_)-NAG(1_L_)",56.638,"","",""
"5AVA","CRYSTAL STRUCTURE OF PHA-E LECTIN IN COMPLEX WITH BISECTED GLYCAN","10.1038/SREP22973 ",3,42.11,"5ava_oligo6","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3][DGlcpNAcb1-4]DManpb1-4DGlcpNAcx1-","GAL(5_N_)-NAG(4_N_)-MAN(3_N_)-[NAG(8_N_)]-[NAG(7_N_)-MAN(6_N_)]-BMA(2_N_)-NAG(1_N_)",65.7048,"","",""
"5AWA","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH MB-568","",2.2,57.74,"5awa_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(293_A_)",64.5118,"","",""
"5AWB","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH N1-3-AMINOMETHYLBENZYL (META-AMINE)","10.1021/ACS.JMEDCHEM.5B01087 ",2.1,50.11,"5awb_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(293_A_)",50.4905,"","",""
"5AZ5","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH MB-343","",2.4,61.96,"5az5_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(293_A_)",50.3818,"","",""
"5AZ5","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH MB-343","",2.4,61.96,"5az5_oligo8","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_H_)-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(293_B_)",58.9014,"","",""
"5AZ5","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH MB-343","",2.4,61.96,"5az5_oligo7","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(590_A_)",62.098,"","",""
"5B0K","STRUCTURE OF MOEN5-SSO7D FUSION PROTEIN IN COMPLEX WITH BETA-DECYL MALTOSIDE","10.1002/ANIE.201511388 ",2.75,0,"5b0k_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(502_A_)-DMU(502_A_)",66.8673,"","",""
"5B0K","STRUCTURE OF MOEN5-SSO7D FUSION PROTEIN IN COMPLEX WITH BETA-DECYL MALTOSIDE","10.1002/ANIE.201511388 ",2.75,0,"5b0k_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(501_A_)-DMU(501_A_)",115.927,"","",""
"5B0K","STRUCTURE OF MOEN5-SSO7D FUSION PROTEIN IN COMPLEX WITH BETA-DECYL MALTOSIDE","10.1002/ANIE.201511388 ",2.75,0,"5b0k_oligo4","DGlcpa1-3DGlcpb6-C10O1","DMU(502_B_)-DMU(502_B_)",68.2436,"","",""
"5B0K","STRUCTURE OF MOEN5-SSO7D FUSION PROTEIN IN COMPLEX WITH BETA-DECYL MALTOSIDE","10.1002/ANIE.201511388 ",2.75,0,"5b0k_oligo6","DGlcpa1-3DGlcpb6-C10O1","DMU(401_D_)-DMU(401_D_)",64.9155,"","",""
"5B0K","STRUCTURE OF MOEN5-SSO7D FUSION PROTEIN IN COMPLEX WITH BETA-DECYL MALTOSIDE","10.1002/ANIE.201511388 ",2.75,0,"5b0k_oligo5","DGlcpa1-3DGlcpb6-C10O1","DMU(401_C_)-DMU(401_C_)",67.1686,"","",""
"5B0K","STRUCTURE OF MOEN5-SSO7D FUSION PROTEIN IN COMPLEX WITH BETA-DECYL MALTOSIDE","10.1002/ANIE.201511388 ",2.75,0,"5b0k_oligo3","DGlcpa1-3DGlcpb6-C10O1","DMU(501_B_)-DMU(501_B_)",92.1886,"","",""
"5B1A","BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE AT 1.5 ANGSTROM RESOLUTION","10.1074/JBC.M115.711770 ",1.5,38.01,"5b1a_oligo3","DGlcpa1-3DGlcpb6-C10O1","DMU(101_J_)-DMU(101_J_)",99.7818,"","",""
"5B1A","BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE AT 1.5 ANGSTROM RESOLUTION","10.1074/JBC.M115.711770 ",1.5,38.01,"5b1a_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(101_Z_)-DMU(101_Z_)",51.0973,"","",""
"5B1A","BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE AT 1.5 ANGSTROM RESOLUTION","10.1074/JBC.M115.711770 ",1.5,38.01,"5b1a_oligo4","DGlcpa1-3DGlcpb6-C10O1","DMU(306_P_)-DMU(306_P_)",142.254,"","",""
"5B1A","BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE AT 1.5 ANGSTROM RESOLUTION","10.1074/JBC.M115.711770 ",1.5,38.01,"5b1a_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(101_M_)-DMU(101_M_)",41.0014,"","",""
"5B1B","BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE AT 1.6 ANGSTROM RESOLUTION","10.1074/JBC.M115.711770 ",1.6,0,"5b1b_oligo5","DGlcpa1-3DGlcpb6-C10O1","DMU(303_P_)-DMU(303_P_)",112.765,"","",""
"5B1B","BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE AT 1.6 ANGSTROM RESOLUTION","10.1074/JBC.M115.711770 ",1.6,0,"5b1b_oligo4","DGlcpa1-3DGlcpb6-C10O1","DMU(103_K_)-DMU(103_K_)",145.924,"","",""
"5B1B","BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE AT 1.6 ANGSTROM RESOLUTION","10.1074/JBC.M115.711770 ",1.6,0,"5b1b_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(101_X_)-DMU(101_X_)",139.454,"","",""
"5B1B","BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE AT 1.6 ANGSTROM RESOLUTION","10.1074/JBC.M115.711770 ",1.6,0,"5b1b_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(101_Z_)-DMU(101_Z_)",49.3173,"","",""
"5B1B","BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE AT 1.6 ANGSTROM RESOLUTION","10.1074/JBC.M115.711770 ",1.6,0,"5b1b_oligo6","DGlcpa1-3DGlcpb6-C10O1","DMU(101_M_)-DMU(101_M_)",42.085,"","",""
"5B3S","BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND MIXED- VALENCE STATE AT 1.68 ANGSTROM RESOLUTION (50 K)","",1.68,0,"5b3s_oligo4","DGlcpa1-3DGlcpb6-C10O1","DMU(309_P_)-DMU(309_P_)",113.893,"","",""
"5B3S","BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND MIXED- VALENCE STATE AT 1.68 ANGSTROM RESOLUTION (50 K)","",1.68,0,"5b3s_oligo7","DGlcpa1-3DGlcpb6-C10O1","DMU(201_X_)-DMU(201_X_)",132.38,"","",""
"5B3S","BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND MIXED- VALENCE STATE AT 1.68 ANGSTROM RESOLUTION (50 K)","",1.68,0,"5b3s_oligo23","DGlcpa1-3DGlcpb6-C10O1","DMU(308_C_)-DMU(308_C_)",112.597,"","",""
"5B3S","BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND MIXED- VALENCE STATE AT 1.68 ANGSTROM RESOLUTION (50 K)","",1.68,0,"5b3s_oligo20","DGlcpa1-3DGlcpb6-C10O1","DMU(307_C_)-DMU(307_C_)",122.645,"","",""
"5B3S","BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND MIXED- VALENCE STATE AT 1.68 ANGSTROM RESOLUTION (50 K)","",1.68,0,"5b3s_oligo3","DGlcpa1-3DGlcpb6-C10O1","DMU(307_P_)-DMU(307_P_)",116.71,"","",""
"5B3S","BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND MIXED- VALENCE STATE AT 1.68 ANGSTROM RESOLUTION (50 K)","",1.68,0,"5b3s_oligo10","DGlcpa1-3DGlcpb6-C10O1","DMU(104_K_)-DMU(104_K_)",156.548,"","",""
"5B3S","BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND MIXED- VALENCE STATE AT 1.68 ANGSTROM RESOLUTION (50 K)","",1.68,0,"5b3s_oligo21","DGlcpa1-3DGlcpb6-C10O1","DMU(105_K_)-DMU(105_K_)",163.157,"","",""
"5B3S","BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND MIXED- VALENCE STATE AT 1.68 ANGSTROM RESOLUTION (50 K)","",1.68,0,"5b3s_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(101_M_)-DMU(101_M_)",48.5968,"","",""
"5B3S","BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND MIXED- VALENCE STATE AT 1.68 ANGSTROM RESOLUTION (50 K)","",1.68,0,"5b3s_oligo11","DGlcpa1-3DGlcpb6-C10O1","DMU(204_X_)-DMU(204_X_)",163.935,"","",""
"5B3S","BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND MIXED- VALENCE STATE AT 1.68 ANGSTROM RESOLUTION (50 K)","",1.68,0,"5b3s_oligo5","DGlcpa1-3DGlcpb6-C10O1","DMU(316_P_)-DMU(316_P_)",65.2873,"","",""
"5B3S","BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND MIXED- VALENCE STATE AT 1.68 ANGSTROM RESOLUTION (50 K)","",1.68,0,"5b3s_oligo16","DGlcpa1-3DGlcpb6-C10O1","DMU(102_L_)-DMU(102_L_)",120.32,"","",""
"5B3S","BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND MIXED- VALENCE STATE AT 1.68 ANGSTROM RESOLUTION (50 K)","",1.68,0,"5b3s_oligo8","DGlcpa1-3DGlcpb6-C10O1","DMU(202_X_)-DMU(202_X_)",175.135,"","",""
"5B3S","BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND MIXED- VALENCE STATE AT 1.68 ANGSTROM RESOLUTION (50 K)","",1.68,0,"5b3s_oligo13","DGlcpa1-3DGlcpb6-C10O1","DMU(101_Z_)-DMU(101_Z_)",54.9932,"","",""
"5B3S","BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND MIXED- VALENCE STATE AT 1.68 ANGSTROM RESOLUTION (50 K)","",1.68,0,"5b3s_oligo22","DGlcpa1-3DGlcpb6-C10O1","DMU(106_K_)-DMU(106_K_)",89.85,"","",""
"5B3S","BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND MIXED- VALENCE STATE AT 1.68 ANGSTROM RESOLUTION (50 K)","",1.68,0,"5b3s_oligo18","DGlcpa1-3DGlcpb6-C10O1","DMU(102_G_)-DMU(102_G_)",129.121,"","",""
"5B3S","BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND MIXED- VALENCE STATE AT 1.68 ANGSTROM RESOLUTION (50 K)","",1.68,0,"5b3s_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(106_M_)-DMU(106_M_)",84.015,"","",""
"5B3S","BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND MIXED- VALENCE STATE AT 1.68 ANGSTROM RESOLUTION (50 K)","",1.68,0,"5b3s_oligo19","DGlcpa1-3DGlcpb6-C10O1","DMU(103_K_)-DMU(103_K_)",149.675,"","",""
"5B57","INWARD-FACING CONFORMATION OF ABC HEME IMPORTER BHUUV FROM BURKHOLDERIA CENOCEPACIA","10.1038/NCOMMS13411 ",2.8,43.35,"5b57_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(401_B_)-DMU(401_B_)",77.3036,"","",""
"5B57","INWARD-FACING CONFORMATION OF ABC HEME IMPORTER BHUUV FROM BURKHOLDERIA CENOCEPACIA","10.1038/NCOMMS13411 ",2.8,43.35,"5b57_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(401_A_)-DMU(401_A_)",80.4309,"","",""
"5BK3","CRYSTAL STRUCTURE OF THE NEUTRALIZING ANTI-CIRCUMSPOROZOITE PROTEIN 580 ANTIBODY","10.1016/J.IMMUNI.2017.11.007 ",2.8,0,"5bk3_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_K_)-[MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(29_F_)",71.0411,"","",""
"5BQY","CRYSTAL STRUCTURE OF HEMAGGLUTININ OF A/CHICKEN/GUANGDONG/S1311/2010 (H6N6) IN COMPLEX WITH AVIAN-LIKE RECEPTOR LSTA","10.1371/JOURNAL.PONE.0134576 ",2.78,46.92,"5bqy_oligo5","DNeup5Aca2-3DGalpb1-3DGlcpNAcx1-","SIA(3_K_)-GAL(2_K_)-NAG(1_K_)",78.6089,"","",""
"5BR0","CRYSTAL STRUCTURE OF HEMAGGLUTININ OF A/TAIWAN/2/2013 (H6N1)","10.1371/JOURNAL.PONE.0134576 ",2.39,38.05,"5br0_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-3]DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-[FUC(6_E_)]-NAG(1_E_)-ASN(154_B_)",89.88,"","",""
"5BR0","CRYSTAL STRUCTURE OF HEMAGGLUTININ OF A/TAIWAN/2/2013 (H6N1)","10.1371/JOURNAL.PONE.0134576 ",2.39,38.05,"5br0_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-3]DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-[FUC(6_F_)]-NAG(1_F_)-ASN(154_D_)",91.5727,"","",""
"5BR3","CRYSTAL STRUCTURE OF HEMAGGLUTININ OF A/TAIWAN/2/2013 (H6N1) IN COMPLEX WITH LSTA","10.1371/JOURNAL.PONE.0134576 ",2.55,39.84,"5br3_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-3]DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-[FUC(6_H_)]-NAG(1_H_)-ASN(154_D_)",61.5486,"","",""
"5BR3","CRYSTAL STRUCTURE OF HEMAGGLUTININ OF A/TAIWAN/2/2013 (H6N1) IN COMPLEX WITH LSTA","10.1371/JOURNAL.PONE.0134576 ",2.55,39.84,"5br3_oligo3","DNeup5Aca2-3DGalpb1-3DGlcpNAcb1-3DGalpx1-","SIA(4_G_)-GAL(3_G_)-NAG(2_G_)-GAL(1_G_)",80.2511,"","",""
"5BR3","CRYSTAL STRUCTURE OF HEMAGGLUTININ OF A/TAIWAN/2/2013 (H6N1) IN COMPLEX WITH LSTA","10.1371/JOURNAL.PONE.0134576 ",2.55,39.84,"5br3_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-3]DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-[FUC(6_F_)]-NAG(1_F_)-ASN(154_B_)",80.7542,"","",""
"5BR3","CRYSTAL STRUCTURE OF HEMAGGLUTININ OF A/TAIWAN/2/2013 (H6N1) IN COMPLEX WITH LSTA","10.1371/JOURNAL.PONE.0134576 ",2.55,39.84,"5br3_oligo1","DNeup5Aca2-3DGalpb1-3DGlcpNAcx1-","SIA(3_E_)-GAL(2_E_)-NAG(1_E_)",70.0415,"","",""
"5BR6","CRYSTAL STRUCTURE OF HEMAGGLUTININ OF A/TAIWAN/2/2013 (H6N1) IN COMPLEX WITH LSTC","10.1371/JOURNAL.PONE.0134576 ",2.43,37.54,"5br6_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-3]DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-[FUC(6_F_)]-NAG(1_F_)-ASN(154_B_)",49.5821,"","",""
"5BR6","CRYSTAL STRUCTURE OF HEMAGGLUTININ OF A/TAIWAN/2/2013 (H6N1) IN COMPLEX WITH LSTC","10.1371/JOURNAL.PONE.0134576 ",2.43,37.54,"5br6_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-3]DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-[FUC(6_H_)]-NAG(1_H_)-ASN(154_D_)",48.8662,"","",""
"5BV7","CRYSTAL STRUCTURE OF HUMAN LCAT (L4F, N5D) IN COMPLEX WITH FAB OF AN AGONISTIC ANTIBODY","10.1074/JBC.M115.672790 ",2.45,53.13,"5bv7_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-[MAN(5_D_)]-MAN(4_D_)-[MAN(7_D_)]-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(272_A_)",59.6548,"","",""
"5BW7","CRYSTAL STRUCTURE OF NONFUCOSYLATED FC Y296W MUTANT COMPLEXED WITH BIS-GLYCOSYLATED SOLUBLE FORM OF FC GAMMA RECEPTOR IIIA","10.1371/JOURNAL.PONE.0140120 ",3,62.43,"5bw7_oligo3","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_F_)-[NAG(5_F_)-MAN(4_F_)-[MAN(6_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(162_C_)",93.4722,"","",""
"5BW7","CRYSTAL STRUCTURE OF NONFUCOSYLATED FC Y296W MUTANT COMPLEXED WITH BIS-GLYCOSYLATED SOLUBLE FORM OF FC GAMMA RECEPTOR IIIA","10.1371/JOURNAL.PONE.0140120 ",3,62.43,"5bw7_oligo4","DGlcpNAcb1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_G_)-MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(45_C_)",126.292,"","",""
"5BW7","CRYSTAL STRUCTURE OF NONFUCOSYLATED FC Y296W MUTANT COMPLEXED WITH BIS-GLYCOSYLATED SOLUBLE FORM OF FC GAMMA RECEPTOR IIIA","10.1371/JOURNAL.PONE.0140120 ",3,62.43,"5bw7_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_E_)-MAN(6_E_)-[NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(297_B_)",72.0614,"","",""
"5BW7","CRYSTAL STRUCTURE OF NONFUCOSYLATED FC Y296W MUTANT COMPLEXED WITH BIS-GLYCOSYLATED SOLUBLE FORM OF FC GAMMA RECEPTOR IIIA","10.1371/JOURNAL.PONE.0140120 ",3,62.43,"5bw7_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(297_A_)",77.391,"","",""
"5BXP","LNBASE IN COMPLEX WITH LNB-LOGNAC","10.1039/C5CC05494J ",1.7,20.31,"5bxp_oligo2","DGalpb1-3DGlcpNAcb1-N1O1","GAL(2_D_)-LOG(1_D_)",19.5918,"","",""
"5BXP","LNBASE IN COMPLEX WITH LNB-LOGNAC","10.1039/C5CC05494J ",1.7,20.31,"5bxp_oligo1","DGalpb1-3DGlcpNAca1-N1O1","GAL(2_C_)-LOG(1_C_)",21.8791,"","",""
"5C7K","CRYSTAL STRUCTURE BG505 SOSIP GP140 HIV-1 ENV TRIMER BOUND TO BROADLY NEUTRALIZING ANTIBODIES PGT128 AND 8ANC195","10.1107/S1399004715013917 ",4.6,0,"5c7k_oligo9","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_M_)-[MAN(8_M_)]-MAN(7_M_)-[MAN(6_M_)-MAN(5_M_)-MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(301_C_)",193.467,"","",""
"5C7K","CRYSTAL STRUCTURE BG505 SOSIP GP140 HIV-1 ENV TRIMER BOUND TO BROADLY NEUTRALIZING ANTIBODIES PGT128 AND 8ANC195","10.1107/S1399004715013917 ",4.6,0,"5c7k_oligo8","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_L_)-MAN(8_L_)-[MAN(10_L_)]-MAN(7_L_)-[MAN(6_L_)-MAN(5_L_)-MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(332_C_)",182.839,"","",""
"5C7K","CRYSTAL STRUCTURE BG505 SOSIP GP140 HIV-1 ENV TRIMER BOUND TO BROADLY NEUTRALIZING ANTIBODIES PGT128 AND 8ANC195","10.1107/S1399004715013917 ",4.6,0,"5c7k_oligo10","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_K_)-[MAN(8_K_)]-MAN(7_K_)-[MAN(6_K_)-MAN(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(276_C_)",177.149,"","",""
"5C7K","CRYSTAL STRUCTURE BG505 SOSIP GP140 HIV-1 ENV TRIMER BOUND TO BROADLY NEUTRALIZING ANTIBODIES PGT128 AND 8ANC195","10.1107/S1399004715013917 ",4.6,0,"5c7k_oligo14","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_T_)-MAN(10_T_)-[MAN(9_T_)-MAN(8_T_)]-MAN(7_T_)-[MAN(6_T_)-MAN(5_T_)-MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(234_C_)",149.229,"","",""
"5C7K","CRYSTAL STRUCTURE BG505 SOSIP GP140 HIV-1 ENV TRIMER BOUND TO BROADLY NEUTRALIZING ANTIBODIES PGT128 AND 8ANC195","10.1107/S1399004715013917 ",4.6,0,"5c7k_oligo3","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-MAN(4_O_)-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(295_C_)",210.319,"","",""
"5C7K","CRYSTAL STRUCTURE BG505 SOSIP GP140 HIV-1 ENV TRIMER BOUND TO BROADLY NEUTRALIZING ANTIBODIES PGT128 AND 8ANC195","10.1107/S1399004715013917 ",4.6,0,"5c7k_oligo7","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_S_)-[MAN(6_S_)-MAN(5_S_)]-MAN(4_S_)-[MAN(8_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(637_D_)",174.899,"","",""
"5C7K","CRYSTAL STRUCTURE BG505 SOSIP GP140 HIV-1 ENV TRIMER BOUND TO BROADLY NEUTRALIZING ANTIBODIES PGT128 AND 8ANC195","10.1107/S1399004715013917 ",4.6,0,"5c7k_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_N_)-[MAN(6_N_)-MAN(5_N_)-MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(262_C_)",186.752,"","",""
"5CB7","CRYSTALLOGRAPHIC STRUCTURE OF HUMAN ROTAVIRUS K8 VP8* IN COMPLEX WITH A-TYPE HBGA","10.1002/CBIC.201500360 ",1.35,9.28,"5cb7_oligo1","LFucpa1-2[DGalpNAca1-3]DGalpa1-ROH","A2G(3_C_)-[FUC(2_C_)]-GLA(1_C_)",14.0867,"","",""
"5CB7","CRYSTALLOGRAPHIC STRUCTURE OF HUMAN ROTAVIRUS K8 VP8* IN COMPLEX WITH A-TYPE HBGA","10.1002/CBIC.201500360 ",1.35,9.28,"5cb7_oligo2","LFucpa1-2[DGalpNAca1-3]DGalpa1-ROH","A2G(3_D_)-[FUC(2_D_)]-GLA(1_D_)",6.23152,"","",""
"5CBG","CALCIUM ACTIVATED NON-SELECTIVE CATION CHANNEL","10.1038/NCOMMS12753 ",3.14,65.95,"5cbg_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(201_D_)-DMU(201_D_)",45.2627,"","",""
"5CBG","CALCIUM ACTIVATED NON-SELECTIVE CATION CHANNEL","10.1038/NCOMMS12753 ",3.14,65.95,"5cbg_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(203_E_)-DMU(203_E_)",45.4341,"","",""
"5CBG","CALCIUM ACTIVATED NON-SELECTIVE CATION CHANNEL","10.1038/NCOMMS12753 ",3.14,65.95,"5cbg_oligo3","DGlcpa1-3DGlcpb6-C10O1","DMU(202_E_)-DMU(202_E_)",47.9045,"","",""
"5CEZ","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH AN EARLY PUTATIVE PRECURSOR OF THE PGT121 FAMILY AT 3.0 ANGSTROM","10.1016/J.IMMUNI.2015.11.007 ",3.03,0,"5cez_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(156_G_)",215.609,"","",""
"5CEZ","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH AN EARLY PUTATIVE PRECURSOR OF THE PGT121 FAMILY AT 3.0 ANGSTROM","10.1016/J.IMMUNI.2015.11.007 ",3.03,0,"5cez_oligo11","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_Q_)-MAN(8_Q_)-[MAN(301_H_)]-MAN(7_Q_)-[MAN(6_Q_)-MAN(5_Q_)-MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(332_G_)",115.06,"","",""
"5CEZ","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH AN EARLY PUTATIVE PRECURSOR OF THE PGT121 FAMILY AT 3.0 ANGSTROM","10.1016/J.IMMUNI.2015.11.007 ",3.03,0,"5cez_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_A_)-[MAN(6_A_)-MAN(5_A_)-MAN(4_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(262_G_)",178.833,"","",""
"5CEZ","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH AN EARLY PUTATIVE PRECURSOR OF THE PGT121 FAMILY AT 3.0 ANGSTROM","10.1016/J.IMMUNI.2015.11.007 ",3.03,0,"5cez_oligo3","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(301_D_)-[MAN(5_P_)]-MAN(4_P_)-[MAN(6_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(88_G_)",109.625,"","",""
"5CEZ","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH AN EARLY PUTATIVE PRECURSOR OF THE PGT121 FAMILY AT 3.0 ANGSTROM","10.1016/J.IMMUNI.2015.11.007 ",3.03,0,"5cez_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_O_)-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(301_G_)",174.755,"","",""
"5CJF","THE CRYSTAL STRUCTURE OF THE HUMAN CARBONIC ANHYDRASE XIV IN COMPLEX WITH A 1,1'-BIPHENYL-4-SULFONAMIDE INHIBITOR.","10.1021/ACS.JMEDCHEM.5B01144 ",1.83,20.99,"5cjf_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(195_A_)",35.2364,"","",""
"5CJX","CRYSTAL STRUCTURE OF 8ANC195 FAB IN COMPLEX WITH BG505 SOSIP.664 HIV-1 ENV TRIMER","10.1016/J.CELL.2015.08.035 ",3.58,0,"5cjx_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(637_B_)",127.056,"","",""
"5CJX","CRYSTAL STRUCTURE OF 8ANC195 FAB IN COMPLEX WITH BG505 SOSIP.664 HIV-1 ENV TRIMER","10.1016/J.CELL.2015.08.035 ",3.58,0,"5cjx_oligo9","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_S_)-MAN(8_S_)-[MAN(10_S_)]-MAN(7_S_)-[MAN(6_S_)-MAN(5_S_)-MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(234_K_)",108.82,"","",""
"5CJX","CRYSTAL STRUCTURE OF 8ANC195 FAB IN COMPLEX WITH BG505 SOSIP.664 HIV-1 ENV TRIMER","10.1016/J.CELL.2015.08.035 ",3.58,0,"5cjx_oligo13","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_W_)-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(637_X_)",142.142,"","",""
"5CJX","CRYSTAL STRUCTURE OF 8ANC195 FAB IN COMPLEX WITH BG505 SOSIP.664 HIV-1 ENV TRIMER","10.1016/J.CELL.2015.08.035 ",3.58,0,"5cjx_oligo11","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_U_)-[MAN(5_U_)-MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(276_K_)",168.826,"","",""
"5CJX","CRYSTAL STRUCTURE OF 8ANC195 FAB IN COMPLEX WITH BG505 SOSIP.664 HIV-1 ENV TRIMER","10.1016/J.CELL.2015.08.035 ",3.58,0,"5cjx_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_R_)-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(637_J_)",133.353,"","",""
"5CJX","CRYSTAL STRUCTURE OF 8ANC195 FAB IN COMPLEX WITH BG505 SOSIP.664 HIV-1 ENV TRIMER","10.1016/J.CELL.2015.08.035 ",3.58,0,"5cjx_oligo16","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_b_)-[MAN(4_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(276_Y_)",170.571,"","",""
"5CJX","CRYSTAL STRUCTURE OF 8ANC195 FAB IN COMPLEX WITH BG505 SOSIP.664 HIV-1 ENV TRIMER","10.1016/J.CELL.2015.08.035 ",3.58,0,"5cjx_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_N_)-MAN(8_N_)-[MAN(10_N_)]-MAN(7_N_)-[MAN(6_N_)-MAN(5_N_)-MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(234_G_)",122.847,"","",""
"5CJX","CRYSTAL STRUCTURE OF 8ANC195 FAB IN COMPLEX WITH BG505 SOSIP.664 HIV-1 ENV TRIMER","10.1016/J.CELL.2015.08.035 ",3.58,0,"5cjx_oligo14","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_Z_)-MAN(8_Z_)-[MAN(10_Z_)]-MAN(7_Z_)-[MAN(6_Z_)-MAN(5_Z_)-MAN(4_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(234_Y_)",118.244,"","",""
"5CJX","CRYSTAL STRUCTURE OF 8ANC195 FAB IN COMPLEX WITH BG505 SOSIP.664 HIV-1 ENV TRIMER","10.1016/J.CELL.2015.08.035 ",3.58,0,"5cjx_oligo2","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_O_)-[MAN(5_O_)-MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(276_G_)",162.803,"","",""
"5CPW","CRYSTAL STRUCTURE OF MURINE POLYOMAVIRUS PTA STRAIN VP1 IN COMPLEX WITH THE GT1A GLYCAN","10.1371/JOURNAL.PPAT.1005104 ",1.75,22.41,"5cpw_oligo3","DNeup5Aca2-8DNeup5Aca2-3DGalpb1-3DGalpNAcb1-4DGalpb1-ROH","SIA(5_H_)-SIA(4_H_)-GAL(3_H_)-NGA(2_H_)-GAL(1_H_)",29.8441,"","",""
"5CPW","CRYSTAL STRUCTURE OF MURINE POLYOMAVIRUS PTA STRAIN VP1 IN COMPLEX WITH THE GT1A GLYCAN","10.1371/JOURNAL.PPAT.1005104 ",1.75,22.41,"5cpw_oligo5","DNeup5Aca2-8DNeup5Aca2-3DGalpb1-3DGalpNAcb1-4[DNeup5Aca2-3]DGalpb1-ROH","SIA(5_J_)-SIA(4_J_)-GAL(3_J_)-NGA(2_J_)-[SIA(6_J_)]-GAL(1_J_)",29.1598,"","",""
"5CPW","CRYSTAL STRUCTURE OF MURINE POLYOMAVIRUS PTA STRAIN VP1 IN COMPLEX WITH THE GT1A GLYCAN","10.1371/JOURNAL.PPAT.1005104 ",1.75,22.41,"5cpw_oligo1","DNeup5Aca2-8DNeup5Aca2-3DGalpb1-3DGalpNAcb1-4DGalpb1-ROH","SIA(5_F_)-SIA(4_F_)-GAL(3_F_)-NGA(2_F_)-GAL(1_F_)",26.5267,"","",""
"5CPW","CRYSTAL STRUCTURE OF MURINE POLYOMAVIRUS PTA STRAIN VP1 IN COMPLEX WITH THE GT1A GLYCAN","10.1371/JOURNAL.PPAT.1005104 ",1.75,22.41,"5cpw_oligo2","DNeup5Aca2-8DNeup5Aca2-3DGalpb1-3DGalpNAcb1-4DGalpb1-ROH","SIA(5_G_)-SIA(4_G_)-GAL(3_G_)-NGA(2_G_)-GAL(1_G_)",30.4734,"","",""
"5CPW","CRYSTAL STRUCTURE OF MURINE POLYOMAVIRUS PTA STRAIN VP1 IN COMPLEX WITH THE GT1A GLYCAN","10.1371/JOURNAL.PPAT.1005104 ",1.75,22.41,"5cpw_oligo4","DNeup5Aca2-8DNeup5Aca2-3DGalpb1-3DGalpNAcb1-4[DNeup5Aca2-3]DGalpb1-ROH","SIA(5_I_)-SIA(4_I_)-GAL(3_I_)-NGA(2_I_)-[SIA(6_I_)]-GAL(1_I_)",30.3634,"","",""
"5CPX","CRYSTAL STRUCTURE OF MURINE POLYOMAVIRUS PTA STRAIN VP1 IN COMPLEX WITH THE DSLNT GLYCAN","10.1371/JOURNAL.PPAT.1005104 ",1.87,21.62,"5cpx_oligo4","DNeup5Aca2-3DGalpb1-3DGlcpNAcb1-ROH","SIA(3_I_)-GAL(2_I_)-NAG(1_I_)",38.4532,"","",""
"5CPX","CRYSTAL STRUCTURE OF MURINE POLYOMAVIRUS PTA STRAIN VP1 IN COMPLEX WITH THE DSLNT GLYCAN","10.1371/JOURNAL.PPAT.1005104 ",1.87,21.62,"5cpx_oligo5","DNeup5Aca2-3DGalpb1-3DGlcpNAcb1-ROH","SIA(3_J_)-GAL(2_J_)-NAG(1_J_)",32.4053,"","",""
"5CPX","CRYSTAL STRUCTURE OF MURINE POLYOMAVIRUS PTA STRAIN VP1 IN COMPLEX WITH THE DSLNT GLYCAN","10.1371/JOURNAL.PPAT.1005104 ",1.87,21.62,"5cpx_oligo1","DNeup5Aca2-3DGalpb1-3DGlcpNAcb1-ROH","SIA(3_F_)-GAL(2_F_)-NAG(1_F_)",41.5543,"","",""
"5CPY","CRYSTAL STRUCTURE OF MURINE POLYOMAVIRUS PTA STRAIN VP1 IN COMPLEX WITH THE GD1A GLYCAN","10.1371/JOURNAL.PPAT.1005104 ",1.93,23.15,"5cpy_oligo3","DNeup5Aca2-3DGalpb1-3DGalpNAcb1-4DGalpb1-ROH","SIA(4_H_)-GAL(3_H_)-NGA(2_H_)-GAL(1_H_)",38.4155,"","",""
"5CPY","CRYSTAL STRUCTURE OF MURINE POLYOMAVIRUS PTA STRAIN VP1 IN COMPLEX WITH THE GD1A GLYCAN","10.1371/JOURNAL.PPAT.1005104 ",1.93,23.15,"5cpy_oligo1","DNeup5Aca2-3DGalpb1-3DGalpNAcb1-4DGalpb1-ROH","SIA(4_F_)-GAL(3_F_)-NGA(2_F_)-GAL(1_F_)",33.5575,"","",""
"5CPY","CRYSTAL STRUCTURE OF MURINE POLYOMAVIRUS PTA STRAIN VP1 IN COMPLEX WITH THE GD1A GLYCAN","10.1371/JOURNAL.PPAT.1005104 ",1.93,23.15,"5cpy_oligo5","DNeup5Aca2-3DGalpb1-3DGalpNAcb1-4DGalpb1-ROH","SIA(4_J_)-GAL(3_J_)-NGA(2_J_)-GAL(1_J_)",30.8832,"","",""
"5CPY","CRYSTAL STRUCTURE OF MURINE POLYOMAVIRUS PTA STRAIN VP1 IN COMPLEX WITH THE GD1A GLYCAN","10.1371/JOURNAL.PPAT.1005104 ",1.93,23.15,"5cpy_oligo2","DNeup5Aca2-3DGalpb1-3DGalpNAcb1-4DGalpb1-ROH","SIA(4_G_)-GAL(3_G_)-NGA(2_G_)-GAL(1_G_)",39.2975,"","",""
"5CPY","CRYSTAL STRUCTURE OF MURINE POLYOMAVIRUS PTA STRAIN VP1 IN COMPLEX WITH THE GD1A GLYCAN","10.1371/JOURNAL.PPAT.1005104 ",1.93,23.15,"5cpy_oligo4","DNeup5Aca2-3DGalpb1-3DGalpNAcb1-4DGalpb1-ROH","SIA(4_I_)-GAL(3_I_)-NGA(2_I_)-GAL(1_I_)",34.8236,"","",""
"5CPZ","CRYSTAL STRUCTURE OF MURINE POLYOMAVIRUS RA STRAIN VP1 IN COMPLEX WITH THE GT1A GLYCAN","10.1371/JOURNAL.PPAT.1005104 ",1.71,23.25,"5cpz_oligo4","DNeup5Aca2-8DNeup5Aca2-3DGalpb1-3DGalpNAcb1-4DGalpb1-ROH","SIA(5_I_)-SIA(4_I_)-GAL(3_I_)-NGA(2_I_)-GAL(1_I_)",35.5094,"","",""
"5CPZ","CRYSTAL STRUCTURE OF MURINE POLYOMAVIRUS RA STRAIN VP1 IN COMPLEX WITH THE GT1A GLYCAN","10.1371/JOURNAL.PPAT.1005104 ",1.71,23.25,"5cpz_oligo5","DNeup5Aca2-8DNeup5Aca2-3DGalpb1-3DGalpNAcb1-4DGalpb1-ROH","SIA(5_J_)-SIA(4_J_)-GAL(3_J_)-NGA(2_J_)-GAL(1_J_)",37.9663,"","",""
"5CPZ","CRYSTAL STRUCTURE OF MURINE POLYOMAVIRUS RA STRAIN VP1 IN COMPLEX WITH THE GT1A GLYCAN","10.1371/JOURNAL.PPAT.1005104 ",1.71,23.25,"5cpz_oligo3","DNeup5Aca2-8DNeup5Aca2-3DGalpb1-3DGalpNAcb1-4DGalpb1-ROH","SIA(5_H_)-SIA(4_H_)-GAL(3_H_)-NGA(2_H_)-GAL(1_H_)",37.8373,"","",""
"5CPZ","CRYSTAL STRUCTURE OF MURINE POLYOMAVIRUS RA STRAIN VP1 IN COMPLEX WITH THE GT1A GLYCAN","10.1371/JOURNAL.PPAT.1005104 ",1.71,23.25,"5cpz_oligo2","DNeup5Aca2-8DNeup5Aca2-3DGalpb1-3DGalpNAcb1-4DGalpb1-ROH","SIA(5_G_)-SIA(4_G_)-GAL(3_G_)-NGA(2_G_)-GAL(1_G_)",40.3827,"","",""
"5CPZ","CRYSTAL STRUCTURE OF MURINE POLYOMAVIRUS RA STRAIN VP1 IN COMPLEX WITH THE GT1A GLYCAN","10.1371/JOURNAL.PPAT.1005104 ",1.71,23.25,"5cpz_oligo1","DNeup5Aca2-8DNeup5Aca2-3DGalpb1-3DGalpNAcb1-4DGalpb1-ROH","SIA(5_F_)-SIA(4_F_)-GAL(3_F_)-NGA(2_F_)-GAL(1_F_)",34.4534,"","",""
"5CQ0","CRYSTAL STRUCTURE OF MURINE POLYOMAVIRUS RA STRAIN VP1 IN COMPLEX WITH THE GD1A GLYCAN","10.1371/JOURNAL.PPAT.1005104 ",1.9,21.96,"5cq0_oligo5","DNeup5Aca2-3DGalpb1-3DGalpNAcb1-4DGalpb1-ROH","SIA(4_J_)-GAL(3_J_)-NGA(2_J_)-GAL(1_J_)",33.2481,"","",""
"5CQ0","CRYSTAL STRUCTURE OF MURINE POLYOMAVIRUS RA STRAIN VP1 IN COMPLEX WITH THE GD1A GLYCAN","10.1371/JOURNAL.PPAT.1005104 ",1.9,21.96,"5cq0_oligo4","DNeup5Aca2-3DGalpb1-3DGalpNAcb1-4DGalpb1-ROH","SIA(4_I_)-GAL(3_I_)-NGA(2_I_)-GAL(1_I_)",41.0722,"","",""
"5CQ0","CRYSTAL STRUCTURE OF MURINE POLYOMAVIRUS RA STRAIN VP1 IN COMPLEX WITH THE GD1A GLYCAN","10.1371/JOURNAL.PPAT.1005104 ",1.9,21.96,"5cq0_oligo3","DNeup5Aca2-3DGalpb1-3DGalpNAcb1-4DGalpb1-ROH","SIA(4_H_)-GAL(3_H_)-NGA(2_H_)-GAL(1_H_)",43.2275,"","",""
"5CQ0","CRYSTAL STRUCTURE OF MURINE POLYOMAVIRUS RA STRAIN VP1 IN COMPLEX WITH THE GD1A GLYCAN","10.1371/JOURNAL.PPAT.1005104 ",1.9,21.96,"5cq0_oligo2","DNeup5Aca2-3DGalpb1-3DGalpNAcb1-4DGalpb1-ROH","SIA(4_G_)-GAL(3_G_)-NGA(2_G_)-GAL(1_G_)",42.5674,"","",""
"5CQ0","CRYSTAL STRUCTURE OF MURINE POLYOMAVIRUS RA STRAIN VP1 IN COMPLEX WITH THE GD1A GLYCAN","10.1371/JOURNAL.PPAT.1005104 ",1.9,21.96,"5cq0_oligo1","DNeup5Aca2-3DGalpb1-3DGalpNAcb1-4DGalpb1-ROH","SIA(4_F_)-GAL(3_F_)-NGA(2_F_)-GAL(1_F_)",36.0751,"","",""
"5CXF","CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF GLYCOPROTEIN B FROM HUMAN CYTOMEGALOVIRUS","10.1371/JOURNAL.PPAT.1005227 ",3.6,0,"5cxf_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(208_C_)",116.602,"","",""
"5CXF","CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF GLYCOPROTEIN B FROM HUMAN CYTOMEGALOVIRUS","10.1371/JOURNAL.PPAT.1005227 ",3.6,0,"5cxf_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(208_A_)",136.174,"","",""
"5D28","COMPLEX OF GM-CSF/IL-2 INHIBITION FACTOR WITH GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR","10.1038/NCOMMS13228 ",2.85,0,"5d28_oligo3","DManpb1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(82_A_)",84.9143,"","",""
"5D28","COMPLEX OF GM-CSF/IL-2 INHIBITION FACTOR WITH GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR","10.1038/NCOMMS13228 ",2.85,0,"5d28_oligo2","DManpb1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(82_D_)",94.957,"","",""
"5D29","X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH A HYDROXAMATE INHIBITOR JHU241","10.1021/ACS.JMEDCHEM.5B01806 ",1.8,31.97,"5d29_oligo3","DManpb1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(638_A_)",47.8773,"","",""
"5D4Q","CRYSTAL STRUCTURE OF GASDALIE IGG1 FC","10.1016/J.JSB.2016.02.001 ",2.39,0,"5d4q_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)",72.2706,"","",""
"5D4Q","CRYSTAL STRUCTURE OF GASDALIE IGG1 FC","10.1016/J.JSB.2016.02.001 ",2.39,0,"5d4q_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)",99.5748,"","",""
"5D61","MOA-Z-VAD-FMK COMPLEX, DIRECT ORIENTATION","10.1371/JOURNAL.PONE.0149407 ",1.6,19.32,"5d61_oligo3","LFucpa1-2[DGalpa1-3]DGalpa1-ROH","GLA(3_C_)-[FUC(2_C_)]-GLA(1_C_)",26.1339,"","",""
"5D61","MOA-Z-VAD-FMK COMPLEX, DIRECT ORIENTATION","10.1371/JOURNAL.PONE.0149407 ",1.6,19.32,"5d61_oligo1","LFucpa1-2[DGalpa1-3]DGalpa1-ROH","GLA(3_D_)-[FUC(2_D_)]-GLA(1_D_)",20.4876,"","",""
"5D61","MOA-Z-VAD-FMK COMPLEX, DIRECT ORIENTATION","10.1371/JOURNAL.PONE.0149407 ",1.6,19.32,"5d61_oligo2","LFucpa1-2[DGalpa1-3]DGalpb1-ROH","GLA(3_B_)-[FUC(2_B_)]-GAL(1_B_)",14.7885,"","",""
"5D62","MOA-Z-VAD-FMK COMPLEX, INVERTED ORIENTATION","10.1371/JOURNAL.PONE.0149407 ",1.7,17.57,"5d62_oligo2","LFucpa1-2[DGalpa1-3]DGalpb1-ROH","GLA(3_B_)-[FUC(2_B_)]-GAL(1_B_)",12.8715,"","",""
"5D62","MOA-Z-VAD-FMK COMPLEX, INVERTED ORIENTATION","10.1371/JOURNAL.PONE.0149407 ",1.7,17.57,"5d62_oligo3","LFucpa1-2[DGalpa1-3]DGalpa1-ROH","GLA(2_C_)-[FUC(304_A_)]-GLA(1_C_)",25.9288,"","",""
"5D62","MOA-Z-VAD-FMK COMPLEX, INVERTED ORIENTATION","10.1371/JOURNAL.PONE.0149407 ",1.7,17.57,"5d62_oligo1","LFucpa1-2[DGalpa1-3]DGalpa1-ROH","GLA(2_D_)-[FUC(307_A_)]-GLA(1_D_)",21.1491,"","",""
"5D63","MOA-Z-VAD-FMK INHIBITOR COMPLEX, DIRECT/INVERTED DUAL ORIENTATION","10.1371/JOURNAL.PONE.0149407 ",1.65,14.13,"5d63_oligo3","LFucpa1-2[DGalpa1-3]DGalpa1-ROH","GLA(3_D_)-[FUC(2_D_)]-GLA(1_D_)",16.3294,"","",""
"5D63","MOA-Z-VAD-FMK INHIBITOR COMPLEX, DIRECT/INVERTED DUAL ORIENTATION","10.1371/JOURNAL.PONE.0149407 ",1.65,14.13,"5d63_oligo2","LFucpa1-2[DGalpa1-3]DGalpa1-ROH","GLA(3_C_)-[FUC(2_C_)]-GLA(1_C_)",20.6758,"","",""
"5D63","MOA-Z-VAD-FMK INHIBITOR COMPLEX, DIRECT/INVERTED DUAL ORIENTATION","10.1371/JOURNAL.PONE.0149407 ",1.65,14.13,"5d63_oligo1","LFucpa1-2[DGalpa1-3]DGalpb1-ROH","GLA(3_B_)-[FUC(2_B_)]-GAL(1_B_)",10.0427,"","",""
"5D6D","CRYSTAL STRUCTURE OF GASDALIE IGG1 FC IN COMPLEX WITH FCGRIIIA","10.1016/J.JSB.2016.02.001 ",3.13,0,"5d6d_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcx1-","FUL(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)",49.7178,"","",""
"5D6D","CRYSTAL STRUCTURE OF GASDALIE IGG1 FC IN COMPLEX WITH FCGRIIIA","10.1016/J.JSB.2016.02.001 ",3.13,0,"5d6d_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[NAG(8_E_)-MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(297_B_)",56.2964,"","",""
"5D9Q","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122 AND SCFV NIH45-46","10.1371/JOURNAL.PPAT.1005815 ",4.4,0,"5d9q_oligo16","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_P_)-[MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(88_G_)",261.824,"","",""
"5D9Q","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122 AND SCFV NIH45-46","10.1371/JOURNAL.PPAT.1005815 ",4.4,0,"5d9q_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_Q_)-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(137_G_)",314.392,"","",""
"5D9Q","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122 AND SCFV NIH45-46","10.1371/JOURNAL.PPAT.1005815 ",4.4,0,"5d9q_oligo4","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_T_)-[MAN(5_T_)]-MAN(4_T_)-[MAN(7_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(197_G_)",260.434,"","",""
"5D9Q","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122 AND SCFV NIH45-46","10.1371/JOURNAL.PPAT.1005815 ",4.4,0,"5d9q_oligo21","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_X_)-[MAN(5_X_)]-MAN(4_X_)-[MAN(7_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(301_G_)",260.061,"","",""
"5D9Q","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122 AND SCFV NIH45-46","10.1371/JOURNAL.PPAT.1005815 ",4.4,0,"5d9q_oligo18","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_V_)-[MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(262_G_)",261.033,"","",""
"5D9Q","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122 AND SCFV NIH45-46","10.1371/JOURNAL.PPAT.1005815 ",4.4,0,"5d9q_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_R_)-[MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(156_G_)",303.776,"","",""
"5D9Q","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122 AND SCFV NIH45-46","10.1371/JOURNAL.PPAT.1005815 ",4.4,0,"5d9q_oligo36","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_v_)-[MAN(5_v_)]-MAN(4_v_)-[MAN(7_v_)]-BMA(3_v_)-NAG(2_v_)-NAG(1_v_)-ASN(197_J_)",260.395,"","",""
"5D9Q","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122 AND SCFV NIH45-46","10.1371/JOURNAL.PPAT.1005815 ",4.4,0,"5d9q_oligo22","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(10_Y_)-[MAN(9_Y_)-MAN(8_Y_)]-MAN(7_Y_)-[MAN(6_Y_)-MAN(5_Y_)-MAN(4_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(332_G_)",287.755,"","",""
"5D9Q","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122 AND SCFV NIH45-46","10.1371/JOURNAL.PPAT.1005815 ",4.4,0,"5d9q_oligo40","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_z_)-[MAN(5_z_)]-MAN(4_z_)-[MAN(7_z_)]-BMA(3_z_)-NAG(2_z_)-NAG(1_z_)-ASN(301_J_)",260.369,"","",""
"5D9Q","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122 AND SCFV NIH45-46","10.1371/JOURNAL.PPAT.1005815 ",4.4,0,"5d9q_oligo37","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_w_)-MAN(10_w_)-[MAN(9_w_)-MAN(8_w_)]-MAN(7_w_)-[MAN(6_w_)-MAN(5_w_)-MAN(4_w_)]-BMA(3_w_)-NAG(2_w_)-NAG(1_w_)-ASN(234_J_)",260.645,"","",""
"5D9Q","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122 AND SCFV NIH45-46","10.1371/JOURNAL.PPAT.1005815 ",4.4,0,"5d9q_oligo33","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_s_)-BMA(3_s_)-NAG(2_s_)-NAG(1_s_)-ASN(137_J_)",314.132,"","",""
"5D9Q","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122 AND SCFV NIH45-46","10.1371/JOURNAL.PPAT.1005815 ",4.4,0,"5d9q_oligo41","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(10_0_)-[MAN(9_0_)-MAN(8_0_)]-MAN(7_0_)-[MAN(6_0_)-MAN(5_0_)-MAN(4_0_)]-BMA(3_0_)-NAG(2_0_)-NAG(1_0_)-ASN(332_J_)",287.524,"","",""
"5D9Q","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122 AND SCFV NIH45-46","10.1371/JOURNAL.PPAT.1005815 ",4.4,0,"5d9q_oligo10","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_h_)-[MAN(5_h_)]-MAN(4_h_)-[MAN(7_h_)]-BMA(3_h_)-NAG(2_h_)-NAG(1_h_)-ASN(197_A_)",260.643,"","",""
"5D9Q","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122 AND SCFV NIH45-46","10.1371/JOURNAL.PPAT.1005815 ",4.4,0,"5d9q_oligo34","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_t_)-[MAN(4_t_)]-BMA(3_t_)-NAG(2_t_)-NAG(1_t_)-ASN(156_J_)",304.145,"","",""
"5D9Q","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122 AND SCFV NIH45-46","10.1371/JOURNAL.PPAT.1005815 ",4.4,0,"5d9q_oligo7","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_e_)-BMA(3_e_)-NAG(2_e_)-NAG(1_e_)-ASN(137_A_)",314.802,"","",""
"5D9Q","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122 AND SCFV NIH45-46","10.1371/JOURNAL.PPAT.1005815 ",4.4,0,"5d9q_oligo15","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(10_m_)-[MAN(9_m_)-MAN(8_m_)]-MAN(7_m_)-[MAN(6_m_)-MAN(5_m_)-MAN(4_m_)]-BMA(3_m_)-NAG(2_m_)-NAG(1_m_)-ASN(332_A_)",287.337,"","",""
"5D9Q","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122 AND SCFV NIH45-46","10.1371/JOURNAL.PPAT.1005815 ",4.4,0,"5d9q_oligo11","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_i_)-MAN(10_i_)-[MAN(9_i_)-MAN(8_i_)]-MAN(7_i_)-[MAN(6_i_)-MAN(5_i_)-MAN(4_i_)]-BMA(3_i_)-NAG(2_i_)-NAG(1_i_)-ASN(234_A_)",260.955,"","",""
"5D9Q","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122 AND SCFV NIH45-46","10.1371/JOURNAL.PPAT.1005815 ",4.4,0,"5d9q_oligo38","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_x_)-[MAN(4_x_)]-BMA(3_x_)-NAG(2_x_)-NAG(1_x_)-ASN(262_J_)",260.621,"","",""
"5D9Q","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122 AND SCFV NIH45-46","10.1371/JOURNAL.PPAT.1005815 ",4.4,0,"5d9q_oligo14","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_l_)-[MAN(5_l_)]-MAN(4_l_)-[MAN(7_l_)]-BMA(3_l_)-NAG(2_l_)-NAG(1_l_)-ASN(301_A_)",259.994,"","",""
"5D9Q","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122 AND SCFV NIH45-46","10.1371/JOURNAL.PPAT.1005815 ",4.4,0,"5d9q_oligo32","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_r_)-[MAN(4_r_)]-BMA(3_r_)-NAG(2_r_)-NAG(1_r_)-ASN(88_J_)",261.595,"","",""
"5D9Q","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122 AND SCFV NIH45-46","10.1371/JOURNAL.PPAT.1005815 ",4.4,0,"5d9q_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_f_)-[MAN(4_f_)]-BMA(3_f_)-NAG(2_f_)-NAG(1_f_)-ASN(156_A_)",303.609,"","",""
"5D9Q","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122 AND SCFV NIH45-46","10.1371/JOURNAL.PPAT.1005815 ",4.4,0,"5d9q_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_d_)-[MAN(4_d_)]-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(88_A_)",261.176,"","",""
"5D9Q","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122 AND SCFV NIH45-46","10.1371/JOURNAL.PPAT.1005815 ",4.4,0,"5d9q_oligo12","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_j_)-[MAN(4_j_)]-BMA(3_j_)-NAG(2_j_)-NAG(1_j_)-ASN(262_A_)",261.173,"","",""
"5D9Q","CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING FAB PGT122 AND SCFV NIH45-46","10.1371/JOURNAL.PPAT.1005815 ",4.4,0,"5d9q_oligo17","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_U_)-MAN(10_U_)-[MAN(9_U_)-MAN(8_U_)]-MAN(7_U_)-[MAN(6_U_)-MAN(5_U_)-MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(234_G_)",260.58,"","",""
"5DA0","STRUCTURE OF THE THE SLC26 TRANSPORTER SLC26DG IN COMPLEX WITH A NANOBODY","10.1038/NSMB.3091 ",3.2,0,"5da0_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(602_A_)-DMU(602_A_)",150.878,"","",""
"5DA0","STRUCTURE OF THE THE SLC26 TRANSPORTER SLC26DG IN COMPLEX WITH A NANOBODY","10.1038/NSMB.3091 ",3.2,0,"5da0_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(601_A_)-DMU(601_A_)",132.475,"","",""
"5DI8","FC KNOB-HOLE HETERODIMER T366W + T366S/L368A/Y407V","10.1016/J.STR.2016.02.013 ",1.9,32.81,"5di8_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_B_)",42.6784,"","",""
"5DI8","FC KNOB-HOLE HETERODIMER T366W + T366S/L368A/Y407V","10.1016/J.STR.2016.02.013 ",1.9,32.81,"5di8_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_A_)",48.1348,"","",""
"5DJ0","FC HETERODIMER DESIGN 11.2 Y349S/K370Y + E357D/S364Q","10.1016/J.STR.2016.02.013 ",2.28,35.83,"5dj0_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_B_)",52.1898,"","",""
"5DJ0","FC HETERODIMER DESIGN 11.2 Y349S/K370Y + E357D/S364Q","10.1016/J.STR.2016.02.013 ",2.28,35.83,"5dj0_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_A_)",56.1274,"","",""
"5DJ2","FC HETERODIMER DESIGN 7.4 Y407A + T366V/K409V","10.1016/J.STR.2016.02.013 ",2.56,33.38,"5dj2_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_B_)",49.7502,"","",""
"5DJ2","FC HETERODIMER DESIGN 7.4 Y407A + T366V/K409V","10.1016/J.STR.2016.02.013 ",2.56,33.38,"5dj2_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_A_)",53.9367,"","",""
"5DJ6","FC HETERODIMER DESIGN 6.1 F405W/Y407A + T366M","10.1016/J.STR.2016.02.013 ",2,33.23,"5dj6_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_A_)",48.6548,"","",""
"5DJ6","FC HETERODIMER DESIGN 6.1 F405W/Y407A + T366M","10.1016/J.STR.2016.02.013 ",2,33.23,"5dj6_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_B_)",44.8356,"","",""
"5DJ8","FC HETERODIMER DESIGN 7.7 D399M/Y407A + T366V/K409I","10.1016/J.STR.2016.02.013 ",2.4,35.3,"5dj8_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_B_)",49.2726,"","",""
"5DJ8","FC HETERODIMER DESIGN 7.7 D399M/Y407A + T366V/K409I","10.1016/J.STR.2016.02.013 ",2.4,35.3,"5dj8_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_A_)",53.3258,"","",""
"5DJA","FC HETERODIMER DESIGN 9.1 Y407M + T366I","10.1016/J.STR.2016.02.013 ",2.9,36.93,"5dja_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_A_)",55.4084,"","",""
"5DJA","FC HETERODIMER DESIGN 9.1 Y407M + T366I","10.1016/J.STR.2016.02.013 ",2.9,36.93,"5dja_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_B_)",51.2286,"","",""
"5DJC","FC HETERODIMER DESIGN 8.1 L368V/Y407A + T366V/K409F","10.1016/J.STR.2016.02.013 ",2.1,43.67,"5djc_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_H_)-[GAL(6_H_)-NAG(5_H_)-MAN(4_H_)-[MAN(7_H_)]-BMA(3_H_)-NAG(2_H_)]-NAG(1_H_)-ASN(297_B_)",66.0385,"","",""
"5DJC","FC HETERODIMER DESIGN 8.1 L368V/Y407A + T366V/K409F","10.1016/J.STR.2016.02.013 ",2.1,43.67,"5djc_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_G_)-[GAL(6_G_)-NAG(5_G_)-MAN(4_G_)-[MAN(7_G_)]-BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(297_A_)",49.1042,"","",""
"5DJC","FC HETERODIMER DESIGN 8.1 L368V/Y407A + T366V/K409F","10.1016/J.STR.2016.02.013 ",2.1,43.67,"5djc_oligo4","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_J_)-[GAL(6_J_)-NAG(5_J_)-MAN(4_J_)-[MAN(7_J_)]-BMA(3_J_)-NAG(2_J_)]-NAG(1_J_)-ASN(297_E_)",65.4632,"","",""
"5DJC","FC HETERODIMER DESIGN 8.1 L368V/Y407A + T366V/K409F","10.1016/J.STR.2016.02.013 ",2.1,43.67,"5djc_oligo3","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_I_)-[GAL(6_I_)-NAG(5_I_)-MAN(4_I_)-[MAN(7_I_)]-BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(297_D_)",47.2822,"","",""
"5DJD","FC HETERODIMER DESIGN 5.1 T366V + Y407F","10.1016/J.STR.2016.02.013 ",2.3,37.32,"5djd_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_B_)",54.7122,"","",""
"5DJD","FC HETERODIMER DESIGN 5.1 T366V + Y407F","10.1016/J.STR.2016.02.013 ",2.3,37.32,"5djd_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_A_)",59.0298,"","",""
"5DJX","FC HETERODIMER DESIGN 2.9 L368M/K370E + E357A/S364G","10.1016/J.STR.2016.02.013 ",2.25,27.74,"5djx_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_H_)-[GAL(6_H_)-NAG(5_H_)-MAN(4_H_)-[MAN(7_H_)]-BMA(3_H_)-NAG(2_H_)]-NAG(1_H_)-ASN(297_B_)",59.0361,"","",""
"5DJX","FC HETERODIMER DESIGN 2.9 L368M/K370E + E357A/S364G","10.1016/J.STR.2016.02.013 ",2.25,27.74,"5djx_oligo4","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_J_)-[GAL(6_J_)-NAG(5_J_)-MAN(4_J_)-[MAN(7_J_)]-BMA(3_J_)-NAG(2_J_)]-NAG(1_J_)-ASN(297_E_)",50.4009,"","",""
"5DJX","FC HETERODIMER DESIGN 2.9 L368M/K370E + E357A/S364G","10.1016/J.STR.2016.02.013 ",2.25,27.74,"5djx_oligo3","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_I_)-[GAL(6_I_)-NAG(5_I_)-MAN(4_I_)-[MAN(7_I_)]-BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(297_D_)",37.675,"","",""
"5DJX","FC HETERODIMER DESIGN 2.9 L368M/K370E + E357A/S364G","10.1016/J.STR.2016.02.013 ",2.25,27.74,"5djx_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_G_)-[GAL(6_G_)-NAG(5_G_)-MAN(4_G_)-[MAN(7_G_)]-BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(297_A_)",41.2795,"","",""
"5DJY","FC HETERODIMER DESIGN 20.8 Y349S/T366V/K370Y/K409V + E357D/S364Q/Y407A","10.1016/J.STR.2016.02.013 ",2.15,36.44,"5djy_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_B_)",47.1226,"","",""
"5DJY","FC HETERODIMER DESIGN 20.8 Y349S/T366V/K370Y/K409V + E357D/S364Q/Y407A","10.1016/J.STR.2016.02.013 ",2.15,36.44,"5djy_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_A_)",51.116,"","",""
"5DJZ","FC HETERODIMER DESIGN 7.8 D399M/Y407A + T366V/K409V","10.1016/J.STR.2016.02.013 ",1.9,35.23,"5djz_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_A_)",44.7762,"","",""
"5DK0","FC HETERODIMER DESIGN 20.8.34 Y349S/T366M/K370Y/K409V + E356G/E357D/S364Q/Y407A","10.1016/J.STR.2016.02.013 ",2.3,46.09,"5dk0_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_A_)",55.3636,"","",""
"5DK0","FC HETERODIMER DESIGN 20.8.34 Y349S/T366M/K370Y/K409V + E356G/E357D/S364Q/Y407A","10.1016/J.STR.2016.02.013 ",2.3,46.09,"5dk0_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_B_)",65.5225,"","",""
"5DK2","FC HETERODIMER E356K/D399K + K392D/K409D","10.1016/J.STR.2016.02.013 ",2.6,52.12,"5dk2_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_G_)-[GAL(6_G_)-NAG(5_G_)-MAN(4_G_)-[MAN(7_G_)]-BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(297_B_)",51.3615,"","",""
"5DK2","FC HETERODIMER E356K/D399K + K392D/K409D","10.1016/J.STR.2016.02.013 ",2.6,52.12,"5dk2_oligo3","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_H_)-NAG(5_H_)-MAN(4_H_)-[MAN(7_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(297_E_)",97.8827,"","",""
"5DK2","FC HETERODIMER E356K/D399K + K392D/K409D","10.1016/J.STR.2016.02.013 ",2.6,52.12,"5dk2_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_F_)-[GAL(6_F_)-NAG(5_F_)-MAN(4_F_)-[MAN(7_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(297_A_)",54.0703,"","",""
"5DK3","CRYSTAL STRUCTURE OF PEMBROLIZUMAB, A FULL LENGTH IGG4 ANTIBODY","10.1038/NSMB.3129 ",2.28,64.17,"5dk3_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)",101.243,"","",""
"5DK3","CRYSTAL STRUCTURE OF PEMBROLIZUMAB, A FULL LENGTH IGG4 ANTIBODY","10.1038/NSMB.3129 ",2.28,64.17,"5dk3_oligo2","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_D_)-[NAG(5_D_)-MAN(4_D_)-[MAN(6_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_G_)",88.2457,"","",""
"5DKZ","CRYSTAL STRUCTURE OF GLUCOSIDASE II ALPHA SUBUNIT (ALPHA3-GLC2-BOUND FROM)","10.1038/SREP20575 ",2.4,33.84,"5dkz_oligo1","DGlcpa1-3DGlcpa1-ROH","GLC(2_B_)-GLC(1_B_)",31.0986,"","",""
"5DL0","CRYSTAL STRUCTURE OF GLUCOSIDASE II ALPHA SUBUNIT (GLC1MAN2-BOUND FROM)","10.1038/SREP20575 ",2.3,25.87,"5dl0_oligo1","DGlcpa1-3DManpa1-ROH","GLC(2_B_)-MAN(1_B_)",21.4314,"","",""
"5DLP","ACETYLCHOLINESTERASE METHYLENE BLUE NO PEG","10.1002/PRO.2923 ",2.7,52.02,"5dlp_oligo2","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(457_A_)",80.5451,"","",""
"5DLV","CRYSTAL STRUCTURE OF AUTOTAXIN (ENPP2) WITH TAUROURSODEOXYCHOLIC ACID (TUDCA)","10.1038/NCOMMS11248 ",2,35.51,"5dlv_oligo1","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_C_)-MAN(7_C_)-[MAN(6_C_)-MAN(5_C_)]-MAN(4_C_)-[MAN(9_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(524_A_)",38.1012,"","",""
"5DLV","CRYSTAL STRUCTURE OF AUTOTAXIN (ENPP2) WITH TAUROURSODEOXYCHOLIC ACID (TUDCA)","10.1038/NCOMMS11248 ",2,35.51,"5dlv_oligo2","DManpa1-2DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-MAN(5_D_)-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(524_B_)",50.1538,"","",""
"5DLW","CRYSTAL STRUCTURE OF AUTOTAXIN (ENPP2) WITH TAUROURSODEOXYCHOLIC ACID (TUDCA) AND LYSOPHOSPHATIDIC ACID (LPA)","10.1038/NCOMMS11248 ",1.8,32.91,"5dlw_oligo1","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)]-MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(524_A_)",46.9844,"","",""
"5DYS","CRYSTAL STRUCTURE OF T94I RHODOPSIN MUTANT","10.15252/EMBR.201642671 ",2.3,66.09,"5dys_oligo3","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(15_A_)",81.56,"","",""
"5DZV","PROTOCADHERIN ALPHA 7 EXTRACELLULAR CADHERIN DOMAINS 1-5","10.1016/J.NEURON.2016.04.004 ",3.6,0,"5dzv_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_E_)-[MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(228_B_)",175.41,"","",""
"5DZY","PROTOCADHERIN BETA 8 EXTRACELLULAR CADHERIN DOMAINS 1-4","10.1016/J.NEURON.2016.04.004 ",2.9,0,"5dzy_oligo1","DGalpb1-4DGlcpNAcb1-4DManpa1-3[DGlcpNAcb1-4DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_I_)-[NAG(8_I_)-MAN(7_I_)-[GAL(6_I_)-NAG(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(389_B_)",139.324,"","",""
"5DZY","PROTOCADHERIN BETA 8 EXTRACELLULAR CADHERIN DOMAINS 1-4","10.1016/J.NEURON.2016.04.004 ",2.9,0,"5dzy_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_L_)-[MAN(4_L_)-BMA(3_L_)-NAG(2_L_)]-NAG(1_L_)-ASN(389_E_)",141.137,"","",""
"5E2Z","CRYSTAL STRUCTURE OF H5 HEMAGGLUTININ Q226L MUTANT FROM THE INFLUENZA VIRUS A/DUCK/EGYPT/10185SS/2010 (H5N1) WITH LSTA","10.1016/J.CELREP.2015.10.027 ",2.62,0,"5e2z_oligo4","DNeup5Aca2-3DGalpb1-3DGlcpNAcb1-ROH","SIA(3_J_)-GAL(2_J_)-NAG(1_J_)",65.3228,"","",""
"5E34","CRYSTAL STRUCTURE OF H5 HEMAGGLUTININ MUTANT (N224K, Q226L, N158D AND L133A DELETION) FROM THE INFLUENZA VIRUS A/CHICKEN/VIETNAM/NCVD- 093/2008 (H5N1) WITH LSTA","10.1016/J.CELREP.2015.10.027 ",2.7,0,"5e34_oligo1","DNeup5Aca2-3DGalpb1-3DGlcpNAcb1-ROH","SIA(3_C_)-GAL(2_C_)-NAG(1_C_)",71.0925,"","",""
"5E4J","ACETYLCHOLINESTERASE METHYLENE BLUE NO PEG","10.1002/PRO.2923 ",2.54,59.39,"5e4j_oligo3","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(457_A_)",62.774,"","",""
"5E4T","ACETYLCHOLINESTERASE METHYLENE BLUE WITH PEG","10.1002/PRO.2923 ",2.43,47.6,"5e4t_oligo3","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(457_A_)",67.202,"","",""
"5E4T","ACETYLCHOLINESTERASE METHYLENE BLUE WITH PEG","10.1002/PRO.2923 ",2.43,47.6,"5e4t_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(416_A_)",54.5627,"","",""
"5E5W","HEMAGGLUTININ-ESTERASE-FUSION MUTANT STRUCTURE OF INFLUENZA D VIRUS","10.1371/JOURNAL.PPAT.1005411 ",2.4,0,"5e5w_oligo3","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-[MAN(5_E_)]-MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(130_A_)",34.363,"","",""
"5E5W","HEMAGGLUTININ-ESTERASE-FUSION MUTANT STRUCTURE OF INFLUENZA D VIRUS","10.1371/JOURNAL.PPAT.1005411 ",2.4,0,"5e5w_oligo5","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_I_)-[MAN(5_I_)]-MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(130_C_)",42.4927,"","",""
"5E5W","HEMAGGLUTININ-ESTERASE-FUSION MUTANT STRUCTURE OF INFLUENZA D VIRUS","10.1371/JOURNAL.PPAT.1005411 ",2.4,0,"5e5w_oligo2","DManpa1-3DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(330_A_)",41.9086,"","",""
"5E62","HEF-MUT WITH TR323 COMPLEX","10.1371/JOURNAL.PPAT.1005411 ",2.2,48.05,"5e62_oligo6","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_J_)-[MAN(5_J_)]-MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(130_C_)",38.377,"","",""
"5E62","HEF-MUT WITH TR323 COMPLEX","10.1371/JOURNAL.PPAT.1005411 ",2.2,48.05,"5e62_oligo9","DNeup5Aca2-3DGalpb1-3DGlcpNAcb1-C2N3O1","5N6(3_M_)-GAL(2_M_)-Z3Q(1_M_)",91.0764,"","",""
"5E62","HEF-MUT WITH TR323 COMPLEX","10.1371/JOURNAL.PPAT.1005411 ",2.2,48.05,"5e62_oligo1","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-[MAN(5_E_)]-MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(130_A_)",39.2076,"","",""
"5E62","HEF-MUT WITH TR323 COMPLEX","10.1371/JOURNAL.PPAT.1005411 ",2.2,48.05,"5e62_oligo4","DNeup5Aca2-3DGalpb1-3DGlcpNAcb1-C2N3O1","5N6(3_H_)-GAL(2_H_)-Z3Q(1_H_)",111.749,"","",""
"5E62","HEF-MUT WITH TR323 COMPLEX","10.1371/JOURNAL.PPAT.1005411 ",2.2,48.05,"5e62_oligo2","DManpa1-3DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(330_A_)",45.38,"","",""
"5E64","HEMAGGLUTININ-ESTERASE-FUSION PROTEIN STRUCTURE OF INFLUENZA D VIRUS","10.1371/JOURNAL.PPAT.1005411 ",2.4,0,"5e64_oligo3","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-[MAN(5_E_)]-MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(130_A_)",24.4382,"","",""
"5E64","HEMAGGLUTININ-ESTERASE-FUSION PROTEIN STRUCTURE OF INFLUENZA D VIRUS","10.1371/JOURNAL.PPAT.1005411 ",2.4,0,"5e64_oligo1","DManpa1-3DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(330_A_)",37.6208,"","",""
"5E64","HEMAGGLUTININ-ESTERASE-FUSION PROTEIN STRUCTURE OF INFLUENZA D VIRUS","10.1371/JOURNAL.PPAT.1005411 ",2.4,0,"5e64_oligo5","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_I_)-[MAN(5_I_)]-MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(130_C_)",31.6962,"","",""
"5E65","THE COMPLEX STRUCTURE OF HEMAGGLUTININ-ESTERASE-FUSION MUTANT PROTEIN FROM THE INFLUENZA D VIRUS WITH RECEPTOR ANALOG 9-O-AC-3'SLN (TR322)","10.1371/JOURNAL.PPAT.1005411 ",2.2,0,"5e65_oligo1","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-[MAN(5_E_)]-MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(130_A_)",34.5509,"","",""
"5E65","THE COMPLEX STRUCTURE OF HEMAGGLUTININ-ESTERASE-FUSION MUTANT PROTEIN FROM THE INFLUENZA D VIRUS WITH RECEPTOR ANALOG 9-O-AC-3'SLN (TR322)","10.1371/JOURNAL.PPAT.1005411 ",2.2,0,"5e65_oligo6","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_J_)-[MAN(5_J_)]-MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(130_C_)",34.2953,"","",""
"5E65","THE COMPLEX STRUCTURE OF HEMAGGLUTININ-ESTERASE-FUSION MUTANT PROTEIN FROM THE INFLUENZA D VIRUS WITH RECEPTOR ANALOG 9-O-AC-3'SLN (TR322)","10.1371/JOURNAL.PPAT.1005411 ",2.2,0,"5e65_oligo2","DManpa1-3DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(330_A_)",41.6989,"","",""
"5E66","THE COMPLEX STRUCTURE OF HEMAGGLUTININ-ESTERASE-FUSION MUTANT PROTEIN FROM THE INFLUENZA D VIRUS WITH RECEPTOR ANALOG 9-N-AC-SIA","10.1371/JOURNAL.PPAT.1005411 ",3.1,0,"5e66_oligo4","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)]-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(130_A_)",98.3601,"","",""
"5E9S","CRYSTAL STRUCTURE OF SUBSTRATE-BOUND GLUTAMATE TRANSPORTER HOMOLOGUE GLTTK","10.1038/NCOMMS13420 ",2.8,0,"5e9s_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(505_C_)-DMU(505_C_)",144.302,"","",""
"5E9S","CRYSTAL STRUCTURE OF SUBSTRATE-BOUND GLUTAMATE TRANSPORTER HOMOLOGUE GLTTK","10.1038/NCOMMS13420 ",2.8,0,"5e9s_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(505_A_)-DMU(505_A_)",161.387,"","",""
"5E9S","CRYSTAL STRUCTURE OF SUBSTRATE-BOUND GLUTAMATE TRANSPORTER HOMOLOGUE GLTTK","10.1038/NCOMMS13420 ",2.8,0,"5e9s_oligo3","DGlcpa1-3DGlcpb6-C10O1","DMU(505_B_)-DMU(505_B_)",148.087,"","",""
"5EFI","CRYSTAL STRUCTURE OF MOUSE CD1D IN COMPLEX WITH THE P99P LIPOPEPTIDE","10.1074/JBC.M115.702118 ",1.8,34.97,"5efi_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_E_)-[MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(165_A_)",55.0388,"","",""
"5EGI","STRUCTURE OF A TRIMERIC INTRACELLULAR CATION CHANNEL FROM C. ELEGANS WITH BOUND CA2+","10.1038/NATURE19767 ",3.3,116.8,"5egi_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(302_C_)-DMU(302_C_)",145.499,"","",""
"5EIK","STRUCTURE OF A TRIMERIC INTRACELLULAR CATION CHANNEL FROM C. ELEGANS IN THE ABSENCE OF CA2+","10.1038/NATURE19767 ",2.3,63.02,"5eik_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(309_A_)-DMU(309_A_)",120.158,"","",""
"5EIK","STRUCTURE OF A TRIMERIC INTRACELLULAR CATION CHANNEL FROM C. ELEGANS IN THE ABSENCE OF CA2+","10.1038/NATURE19767 ",2.3,63.02,"5eik_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(310_A_)-DMU(310_A_)",107.693,"","",""
"5EIK","STRUCTURE OF A TRIMERIC INTRACELLULAR CATION CHANNEL FROM C. ELEGANS IN THE ABSENCE OF CA2+","10.1038/NATURE19767 ",2.3,63.02,"5eik_oligo3","DGlcpa1-3DGlcpb6-C10O1","DMU(312_A_)-DMU(312_A_)",97.0841,"","",""
"5EIK","STRUCTURE OF A TRIMERIC INTRACELLULAR CATION CHANNEL FROM C. ELEGANS IN THE ABSENCE OF CA2+","10.1038/NATURE19767 ",2.3,63.02,"5eik_oligo4","DGlcpa1-3DGlcpb6-C10O1","DMU(311_A_)-DMU(311_A_)",115.045,"","",""
"5ELB","CHOLERA TOXIN CLASSICAL B-PENTAMER IN COMPLEX WITH LEWIS-Y","10.1371/JOURNAL.PPAT.1005567 ",1.08,14.55,"5elb_oligo9","LFucpa1-2DGalpb1-4[LFucpa1-3]DGlcpNAca1-ROH","FUC(3_Q_)-GAL(2_Q_)-[FUC(4_Q_)]-NDG(1_Q_)",16.282,"","",""
"5ELB","CHOLERA TOXIN CLASSICAL B-PENTAMER IN COMPLEX WITH LEWIS-Y","10.1371/JOURNAL.PPAT.1005567 ",1.08,14.55,"5elb_oligo8","LFucpa1-2DGalpb1-4[LFucpa1-3]DGlcpNAca1-ROH","FUC(3_P_)-GAL(2_P_)-[FUC(4_P_)]-NDG(1_P_)",27.2982,"","",""
"5ELB","CHOLERA TOXIN CLASSICAL B-PENTAMER IN COMPLEX WITH LEWIS-Y","10.1371/JOURNAL.PPAT.1005567 ",1.08,14.55,"5elb_oligo4","LFucpa1-2DGalpb1-4[LFucpa1-3]DGlcpNAca1-ROH","FUC(3_K_)-GAL(2_K_)-[FUC(4_K_)]-NDG(1_K_)",23.6534,"","",""
"5ELB","CHOLERA TOXIN CLASSICAL B-PENTAMER IN COMPLEX WITH LEWIS-Y","10.1371/JOURNAL.PPAT.1005567 ",1.08,14.55,"5elb_oligo1","LFucpa1-2DGalpb1-4[LFucpa1-3]DGlcpNAca1-ROH","FUC(5_S_)-GAL(4_S_)-[FUC(2_S_)]-NDG(3_S_)",14.0993,"","",""
"5ELB","CHOLERA TOXIN CLASSICAL B-PENTAMER IN COMPLEX WITH LEWIS-Y","10.1371/JOURNAL.PPAT.1005567 ",1.08,14.55,"5elb_oligo2","LFucpa1-2DGalpb1-4[LFucpa1-3]DGlcpNAca1-ROH","FUC(3_L_)-GAL(2_L_)-[FUC(4_L_)]-NDG(1_L_)",18.1298,"","",""
"5ELB","CHOLERA TOXIN CLASSICAL B-PENTAMER IN COMPLEX WITH LEWIS-Y","10.1371/JOURNAL.PPAT.1005567 ",1.08,14.55,"5elb_oligo6","LFucpa1-2DGalpb1-4[LFucpa1-3]DGlcpNAca1-ROH","FUC(3_N_)-GAL(2_N_)-[FUC(4_N_)]-NDG(1_N_)",23.4243,"","",""
"5ELB","CHOLERA TOXIN CLASSICAL B-PENTAMER IN COMPLEX WITH LEWIS-Y","10.1371/JOURNAL.PPAT.1005567 ",1.08,14.55,"5elb_oligo10","LFucpa1-2DGalpb1-4[LFucpa1-3]DGlcpNAca1-ROH","FUC(3_R_)-GAL(2_R_)-[FUC(4_R_)]-NDG(1_R_)",26.097,"","",""
"5ELB","CHOLERA TOXIN CLASSICAL B-PENTAMER IN COMPLEX WITH LEWIS-Y","10.1371/JOURNAL.PPAT.1005567 ",1.08,14.55,"5elb_oligo3","LFucpa1-2DGalpb1-4[LFucpa1-3]DGlcpNAca1-ROH","FUC(5_T_)-GAL(4_T_)-[FUC(2_T_)]-NDG(3_T_)",12.4834,"","",""
"5ELB","CHOLERA TOXIN CLASSICAL B-PENTAMER IN COMPLEX WITH LEWIS-Y","10.1371/JOURNAL.PPAT.1005567 ",1.08,14.55,"5elb_oligo5","LFucpa1-2DGalpb1-4[LFucpa1-3]DGlcpNAca1-ROH","FUC(3_M_)-GAL(2_M_)-[FUC(4_M_)]-NDG(1_M_)",22.5266,"","",""
"5ELB","CHOLERA TOXIN CLASSICAL B-PENTAMER IN COMPLEX WITH LEWIS-Y","10.1371/JOURNAL.PPAT.1005567 ",1.08,14.55,"5elb_oligo7","LFucpa1-2DGalpb1-4[LFucpa1-3]DGlcpNAca1-ROH","FUC(3_O_)-GAL(2_O_)-[FUC(4_O_)]-NDG(1_O_)",31.8861,"","",""
"5ELC","CHOLERA TOXIN EL TOR B-PENTAMER IN COMPLEX WITH LEWIS-Y","10.1371/JOURNAL.PPAT.1005567 ",1.5,19.09,"5elc_oligo7","LFucpa1-2DGalpb1-4[LFucpa1-3]DGlcpNAca1-ROH","FUC(3_Q_)-GAL(2_Q_)-[FUC(4_Q_)]-NDG(1_Q_)",29.662,"","",""
"5ELC","CHOLERA TOXIN EL TOR B-PENTAMER IN COMPLEX WITH LEWIS-Y","10.1371/JOURNAL.PPAT.1005567 ",1.5,19.09,"5elc_oligo6","LFucpa1-2DGalpb1-4[LFucpa1-3]DGlcpNAcb1-ROH","FUC(3_P_)-GAL(2_P_)-[FUC(4_P_)]-NAG(1_P_)",24.9395,"","",""
"5ELC","CHOLERA TOXIN EL TOR B-PENTAMER IN COMPLEX WITH LEWIS-Y","10.1371/JOURNAL.PPAT.1005567 ",1.5,19.09,"5elc_oligo9","LFucpa1-2DGalpb1-4[LFucpa1-3]DGlcpNAca1-ROH","FUC(3_S_)-GAL(2_S_)-[FUC(4_S_)]-NDG(1_S_)",31.2407,"","",""
"5ELC","CHOLERA TOXIN EL TOR B-PENTAMER IN COMPLEX WITH LEWIS-Y","10.1371/JOURNAL.PPAT.1005567 ",1.5,19.09,"5elc_oligo2","LFucpa1-2DGalpb1-4[LFucpa1-3]DGlcpNAcb1-ROH","FUC(3_N_)-GAL(2_N_)-[FUC(4_N_)]-NAG(1_N_)",22.3648,"","",""
"5ELC","CHOLERA TOXIN EL TOR B-PENTAMER IN COMPLEX WITH LEWIS-Y","10.1371/JOURNAL.PPAT.1005567 ",1.5,19.09,"5elc_oligo8","LFucpa1-2DGalpb1-4[LFucpa1-3]DGlcpNAca1-ROH","FUC(3_R_)-GAL(2_R_)-[FUC(4_R_)]-NDG(1_R_)",18.9957,"","",""
"5ELC","CHOLERA TOXIN EL TOR B-PENTAMER IN COMPLEX WITH LEWIS-Y","10.1371/JOURNAL.PPAT.1005567 ",1.5,19.09,"5elc_oligo5","LFucpa1-2DGalpb1-4[LFucpa1-3]DGlcpNAca1-ROH","FUC(3_O_)-GAL(2_O_)-[FUC(4_O_)]-NDG(1_O_)",27.4139,"","",""
"5ELC","CHOLERA TOXIN EL TOR B-PENTAMER IN COMPLEX WITH LEWIS-Y","10.1371/JOURNAL.PPAT.1005567 ",1.5,19.09,"5elc_oligo1","LFucpa1-2DGalpb1-4[LFucpa1-3]DGlcpNAca1-ROH","FUC(3_K_)-GAL(2_K_)-[FUC(4_K_)]-NDG(1_K_)",32.493,"","",""
"5ELC","CHOLERA TOXIN EL TOR B-PENTAMER IN COMPLEX WITH LEWIS-Y","10.1371/JOURNAL.PPAT.1005567 ",1.5,19.09,"5elc_oligo3","LFucpa1-2DGalpb1-4[LFucpa1-3]DGlcpNAca1-ROH","FUC(3_M_)-GAL(2_M_)-[FUC(4_M_)]-NDG(1_M_)",16.6257,"","",""
"5ELC","CHOLERA TOXIN EL TOR B-PENTAMER IN COMPLEX WITH LEWIS-Y","10.1371/JOURNAL.PPAT.1005567 ",1.5,19.09,"5elc_oligo4","LFucpa1-2DGalpb1-4[LFucpa1-3]DGlcpNAca1-ROH","FUC(3_L_)-GAL(2_L_)-[FUC(4_L_)]-NDG(1_L_)",16.318,"","",""
"5ELD","CHOLERA TOXIN CLASSICAL B-PENTAMER IN COMPLEX WITH A LEWIS-Y","10.1371/JOURNAL.PPAT.1005567 ",1.4,17.13,"5eld_oligo5","LFucpa1-2[DGalpNAca1-3]DGalpb1-4[LFucpa1-3]DGlcpNAca1-ROH","A2G(4_I_)-[FUC(3_I_)]-GAL(2_I_)-[FUC(5_I_)]-NDG(1_I_)",28.6618,"","",""
"5ELD","CHOLERA TOXIN CLASSICAL B-PENTAMER IN COMPLEX WITH A LEWIS-Y","10.1371/JOURNAL.PPAT.1005567 ",1.4,17.13,"5eld_oligo3","LFucpa1-2[DGalpNAca1-3]DGalpb1-4[LFucpa1-3]DGlcpNAca1-ROH","A2G(4_G_)-[FUC(3_G_)]-GAL(2_G_)-[FUC(5_G_)]-NDG(1_G_)",24.8093,"","",""
"5ELD","CHOLERA TOXIN CLASSICAL B-PENTAMER IN COMPLEX WITH A LEWIS-Y","10.1371/JOURNAL.PPAT.1005567 ",1.4,17.13,"5eld_oligo1","LFucpa1-2[DGalpNAca1-3]DGalpb1-4[LFucpa1-3]DGlcpNAca1-ROH","A2G(4_F_)-[FUC(3_F_)]-GAL(2_F_)-[FUC(5_F_)]-NDG(1_F_)",13.6249,"","",""
"5ELD","CHOLERA TOXIN CLASSICAL B-PENTAMER IN COMPLEX WITH A LEWIS-Y","10.1371/JOURNAL.PPAT.1005567 ",1.4,17.13,"5eld_oligo4","LFucpa1-2[DGalpNAca1-3]DGalpb1-4[LFucpa1-3]DGlcpNAca1-ROH","A2G(4_H_)-[FUC(3_H_)]-GAL(2_H_)-[FUC(5_H_)]-NDG(1_H_)",12.7124,"","",""
"5ELE","CHOLERA TOXIN EL TOR B-PENTAMER IN COMPLEX WITH A LEWIS-Y","10.1371/JOURNAL.PPAT.1005567 ",1.6,21.34,"5ele_oligo2","LFucpa1-2[DGalpNAca1-3]DGalpb1-4[LFucpa1-3]DGlcpNAca1-ROH","A2G(4_L_)-[FUC(3_L_)]-GAL(2_L_)-[FUC(5_L_)]-NDG(1_L_)",21.9225,"","",""
"5ELE","CHOLERA TOXIN EL TOR B-PENTAMER IN COMPLEX WITH A LEWIS-Y","10.1371/JOURNAL.PPAT.1005567 ",1.6,21.34,"5ele_oligo1","LFucpa1-2[DGalpNAca1-3]DGalpb1-4[LFucpa1-3]DGlcpNAca1-ROH","A2G(4_K_)-[FUC(3_K_)]-GAL(2_K_)-[FUC(5_K_)]-NDG(1_K_)",29.7585,"","",""
"5ELE","CHOLERA TOXIN EL TOR B-PENTAMER IN COMPLEX WITH A LEWIS-Y","10.1371/JOURNAL.PPAT.1005567 ",1.6,21.34,"5ele_oligo3","LFucpa1-2[DGalpNAca1-3]DGalpb1-4[LFucpa1-3]DGlcpNAca1-ROH","A2G(4_M_)-[FUC(3_M_)]-GAL(2_M_)-[FUC(5_M_)]-NDG(1_M_)",33.5058,"","",""
"5ELF","CHOLERA TOXIN EL TOR B-PENTAMER IN COMPLEX WITH A-PENTASACCHARIDE","10.1371/JOURNAL.PPAT.1005567 ",1.55,20.24,"5elf_oligo5","LFucpa1-2[DGalpNAca1-3]DGalpb1-4[LFucpa1-3]DGlcpa1-ROH","A2G(4_M_)-[FUC(3_M_)]-GAL(2_M_)-[FUC(5_M_)]-GLC(1_M_)",37.0547,"","",""
"5ELF","CHOLERA TOXIN EL TOR B-PENTAMER IN COMPLEX WITH A-PENTASACCHARIDE","10.1371/JOURNAL.PPAT.1005567 ",1.55,20.24,"5elf_oligo4","LFucpa1-2[DGalpNAca1-3]DGalpb1-4[LFucpa1-3]DGlcpa1-ROH","A2G(4_K_)-[FUC(3_K_)]-GAL(2_K_)-[FUC(5_K_)]-GLC(1_K_)",37.6816,"","",""
"5ELF","CHOLERA TOXIN EL TOR B-PENTAMER IN COMPLEX WITH A-PENTASACCHARIDE","10.1371/JOURNAL.PPAT.1005567 ",1.55,20.24,"5elf_oligo2","LFucpa1-2[DGalpNAca1-3]DGalpb1-4[LFucpa1-3]DGlcpb1-ROH","A2G(4_N_)-[FUC(3_N_)]-GAL(2_N_)-[FUC(5_N_)]-BGC(1_N_)",28.8884,"","",""
"5ELF","CHOLERA TOXIN EL TOR B-PENTAMER IN COMPLEX WITH A-PENTASACCHARIDE","10.1371/JOURNAL.PPAT.1005567 ",1.55,20.24,"5elf_oligo7","LFucpa1-2[DGalpNAca1-3]DGalpb1-4[LFucpa1-3]DGlcpa1-ROH","A2G(4_Q_)-[FUC(3_Q_)]-GAL(2_Q_)-[FUC(5_Q_)]-GLC(1_Q_)",22.1269,"","",""
"5ELF","CHOLERA TOXIN EL TOR B-PENTAMER IN COMPLEX WITH A-PENTASACCHARIDE","10.1371/JOURNAL.PPAT.1005567 ",1.55,20.24,"5elf_oligo3","LFucpa1-2[DGalpNAca1-3]DGalpb1-4[LFucpa1-3]DGlcpa1-ROH","A2G(4_O_)-[FUC(3_O_)]-GAL(2_O_)-[FUC(5_O_)]-GLC(206_G_)",18.3427,"","",""
"5ELF","CHOLERA TOXIN EL TOR B-PENTAMER IN COMPLEX WITH A-PENTASACCHARIDE","10.1371/JOURNAL.PPAT.1005567 ",1.55,20.24,"5elf_oligo1","LFucpa1-2[DGalpNAca1-3]DGalpb1-4[LFucpa1-3]DGlcpb1-ROH","A2G(4_L_)-[FUC(3_L_)]-GAL(2_L_)-[FUC(5_L_)]-BGC(1_L_)",16.5727,"","",""
"5ELF","CHOLERA TOXIN EL TOR B-PENTAMER IN COMPLEX WITH A-PENTASACCHARIDE","10.1371/JOURNAL.PPAT.1005567 ",1.55,20.24,"5elf_oligo6","LFucpa1-2[DGalpNAca1-3]DGalpb1-4[LFucpa1-3]DGlcpa1-ROH","A2G(4_P_)-[FUC(3_P_)]-GAL(2_P_)-[FUC(5_P_)]-GLC(1_P_)",24.5007,"","",""
"5ELY","X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH A HYDROXAMATE INHIBITOR JHU242","10.1021/ACS.JMEDCHEM.5B01806 ",1.81,32.89,"5ely_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(638_A_)",45.3807,"","",""
"5EN0","CRYSTAL STRUCTURE OF T94I RHODOPSIN MUTANT","10.15252/EMBR.201642671 ",2.81,58.99,"5en0_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(15_A_)",56.7909,"","",""
"5EN2","MOLECULAR BASIS FOR ANTIBODY-MEDIATED NEUTRALIZATION OF NEW WORLD HEMORRHAGIC FEVER MAMMARENAVIRUSES","10.1016/J.CHOM.2015.11.005 ",1.82,25.51,"5en2_oligo1","DManpa1-3[DManp[2H]a1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-[MAN(5_D_)]-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(178_C_)",52.7025,"","",""
"5ERP","CRYSTAL STRUCTURE OF HUMAN DESMOCOLLIN-2 ECTODOMAIN FRAGMENT EC2-5","10.1073/PNAS.1606272113 ",2.7,0,"5erp_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(494_B_)",141.53,"","",""
"5ERP","CRYSTAL STRUCTURE OF HUMAN DESMOCOLLIN-2 ECTODOMAIN FRAGMENT EC2-5","10.1073/PNAS.1606272113 ",2.7,0,"5erp_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(411_B_)",139.223,"","",""
"5ERP","CRYSTAL STRUCTURE OF HUMAN DESMOCOLLIN-2 ECTODOMAIN FRAGMENT EC2-5","10.1073/PNAS.1606272113 ",2.7,0,"5erp_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(411_A_)",163.874,"","",""
"5ES4","RE-REFINEMENT OF INTEGRIN ALPHAXBETA2 ECTODOMAIN IN THE CLOSED/BENT CONFORMATION","10.1073/PNAS.1601379113 ",3.3,0,"5es4_oligo8","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_P_)-MAN(4_P_)-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(716_C_)",270.583,"","",""
"5ES4","RE-REFINEMENT OF INTEGRIN ALPHAXBETA2 ECTODOMAIN IN THE CLOSED/BENT CONFORMATION","10.1073/PNAS.1601379113 ",3.3,0,"5es4_oligo11","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_S_)-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(373_E_)",302.753,"","",""
"5ES4","RE-REFINEMENT OF INTEGRIN ALPHAXBETA2 ECTODOMAIN IN THE CLOSED/BENT CONFORMATION","10.1073/PNAS.1601379113 ",3.3,0,"5es4_oligo13","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_U_)-[MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(880_E_)",277.153,"","",""
"5ES4","RE-REFINEMENT OF INTEGRIN ALPHAXBETA2 ECTODOMAIN IN THE CLOSED/BENT CONFORMATION","10.1073/PNAS.1601379113 ",3.3,0,"5es4_oligo17","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Y_)-MAN(4_Y_)-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(880_G_)",274.759,"","",""
"5ES4","RE-REFINEMENT OF INTEGRIN ALPHAXBETA2 ECTODOMAIN IN THE CLOSED/BENT CONFORMATION","10.1073/PNAS.1601379113 ",3.3,0,"5es4_oligo14","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_V_)-[MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(70_G_)",289.133,"","",""
"5ES4","RE-REFINEMENT OF INTEGRIN ALPHAXBETA2 ECTODOMAIN IN THE CLOSED/BENT CONFORMATION","10.1073/PNAS.1601379113 ",3.3,0,"5es4_oligo6","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_N_)-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(70_C_)",296.749,"","",""
"5ES4","RE-REFINEMENT OF INTEGRIN ALPHAXBETA2 ECTODOMAIN IN THE CLOSED/BENT CONFORMATION","10.1073/PNAS.1601379113 ",3.3,0,"5es4_oligo10","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_R_)-MAN(4_R_)-[MAN(6_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(70_E_)",266.359,"","",""
"5ES4","RE-REFINEMENT OF INTEGRIN ALPHAXBETA2 ECTODOMAIN IN THE CLOSED/BENT CONFORMATION","10.1073/PNAS.1601379113 ",3.3,0,"5es4_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Q_)-[MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(880_C_)",273.395,"","",""
"5ES4","RE-REFINEMENT OF INTEGRIN ALPHAXBETA2 ECTODOMAIN IN THE CLOSED/BENT CONFORMATION","10.1073/PNAS.1601379113 ",3.3,0,"5es4_oligo7","DManpa1-2DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_O_)-MAN(5_O_)-MAN(4_O_)-[MAN(7_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(373_C_)",314.399,"","",""
"5ES4","RE-REFINEMENT OF INTEGRIN ALPHAXBETA2 ECTODOMAIN IN THE CLOSED/BENT CONFORMATION","10.1073/PNAS.1601379113 ",3.3,0,"5es4_oligo15","DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_W_)-MAN(6_W_)-[MAN(5_W_)-MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(373_G_)",317.799,"","",""
"5ES4","RE-REFINEMENT OF INTEGRIN ALPHAXBETA2 ECTODOMAIN IN THE CLOSED/BENT CONFORMATION","10.1073/PNAS.1601379113 ",3.3,0,"5es4_oligo1","DManpa1-6DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_J_)-MAN(8_J_)-[MAN(10_J_)]-MAN(7_J_)-[MAN(6_J_)-MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(373_A_)",291.692,"","",""
"5ESV","CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CH03, ISOLATED FROM DONOR CH0219, IN COMPLEX WITH SCAFFOLDED TRIMERIC HIV-1 ENV V1V2 DOMAIN FROM THE CLADE C SUPERINFECTING STRAIN OF DONOR CAP256.","10.1038/NSMB.3144 ",3.11,0,"5esv_oligo9","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_R_)-MAN(4_R_)-[MAN(6_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(130_G_)",119.419,"","",""
"5ESV","CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CH03, ISOLATED FROM DONOR CH0219, IN COMPLEX WITH SCAFFOLDED TRIMERIC HIV-1 ENV V1V2 DOMAIN FROM THE CLADE C SUPERINFECTING STRAIN OF DONOR CAP256.","10.1038/NSMB.3144 ",3.11,0,"5esv_oligo8","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Q_)-[MAN(5_Q_)]-MAN(4_Q_)-[MAN(7_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(160_F_)",109.805,"","",""
"5ESV","CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CH03, ISOLATED FROM DONOR CH0219, IN COMPLEX WITH SCAFFOLDED TRIMERIC HIV-1 ENV V1V2 DOMAIN FROM THE CLADE C SUPERINFECTING STRAIN OF DONOR CAP256.","10.1038/NSMB.3144 ",3.11,0,"5esv_oligo11","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_T_)-[MAN(5_T_)]-MAN(4_T_)-[MAN(7_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(160_G_)",76.956,"","",""
"5ESV","CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CH03, ISOLATED FROM DONOR CH0219, IN COMPLEX WITH SCAFFOLDED TRIMERIC HIV-1 ENV V1V2 DOMAIN FROM THE CLADE C SUPERINFECTING STRAIN OF DONOR CAP256.","10.1038/NSMB.3144 ",3.11,0,"5esv_oligo10","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-MAN(4_S_)-[MAN(6_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(139_G_)",106.868,"","",""
"5ESV","CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CH03, ISOLATED FROM DONOR CH0219, IN COMPLEX WITH SCAFFOLDED TRIMERIC HIV-1 ENV V1V2 DOMAIN FROM THE CLADE C SUPERINFECTING STRAIN OF DONOR CAP256.","10.1038/NSMB.3144 ",3.11,0,"5esv_oligo6","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAca1-ASN","MAN(6_P_)-[MAN(5_P_)]-MAN(4_P_)-[MAN(7_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(139_F_)",74.3506,"","",""
"5ESV","CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CH03, ISOLATED FROM DONOR CH0219, IN COMPLEX WITH SCAFFOLDED TRIMERIC HIV-1 ENV V1V2 DOMAIN FROM THE CLADE C SUPERINFECTING STRAIN OF DONOR CAP256.","10.1038/NSMB.3144 ",3.11,0,"5esv_oligo3","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_M_)-[MAN(5_M_)]-MAN(4_M_)-[MAN(7_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(160_E_)",59.5684,"","",""
"5ESV","CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CH03, ISOLATED FROM DONOR CH0219, IN COMPLEX WITH SCAFFOLDED TRIMERIC HIV-1 ENV V1V2 DOMAIN FROM THE CLADE C SUPERINFECTING STRAIN OF DONOR CAP256.","10.1038/NSMB.3144 ",3.11,0,"5esv_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(130_E_)",109.508,"","",""
"5ESV","CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CH03, ISOLATED FROM DONOR CH0219, IN COMPLEX WITH SCAFFOLDED TRIMERIC HIV-1 ENV V1V2 DOMAIN FROM THE CLADE C SUPERINFECTING STRAIN OF DONOR CAP256.","10.1038/NSMB.3144 ",3.11,0,"5esv_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_K_)-[MAN(5_K_)]-MAN(4_K_)-[MAN(7_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(139_E_)",90.8969,"","",""
"5ESZ","CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CH04, ISOLATED FROM DONOR CH0219, IN COMPLEX WITH SCAFFOLDED TRIMERIC HIV-1 ENV V1V2 DOMAIN FROM THE CLADE AE STRAIN A244","10.1038/NSMB.3144 ",4.19,0,"5esz_oligo6","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(4_K_)-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)",68.334,"","",""
"5ESZ","CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CH04, ISOLATED FROM DONOR CH0219, IN COMPLEX WITH SCAFFOLDED TRIMERIC HIV-1 ENV V1V2 DOMAIN FROM THE CLADE AE STRAIN A244","10.1038/NSMB.3144 ",4.19,0,"5esz_oligo2","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-MAN(4_F_)-[MAN(6_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(160_C_)",68.825,"","",""
"5ESZ","CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CH04, ISOLATED FROM DONOR CH0219, IN COMPLEX WITH SCAFFOLDED TRIMERIC HIV-1 ENV V1V2 DOMAIN FROM THE CLADE AE STRAIN A244","10.1038/NSMB.3144 ",4.19,0,"5esz_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)",61.7344,"","",""
"5ESZ","CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CH04, ISOLATED FROM DONOR CH0219, IN COMPLEX WITH SCAFFOLDED TRIMERIC HIV-1 ENV V1V2 DOMAIN FROM THE CLADE AE STRAIN A244","10.1038/NSMB.3144 ",4.19,0,"5esz_oligo5","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_J_)-[MAN(5_J_)]-MAN(4_J_)-[MAN(7_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(160_G_)",63.4745,"","",""
"5EVM","CRYSTAL STRUCTURE OF NIPAH VIRUS FUSION GLYCOPROTEIN IN THE PREFUSION STATE","10.1371/JOURNAL.PPAT.1005322 ",3.37,0,"5evm_oligo14","DManpa1-3DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_T_)-MAN(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(464_E_)",170.887,"","",""
"5EVM","CRYSTAL STRUCTURE OF NIPAH VIRUS FUSION GLYCOPROTEIN IN THE PREFUSION STATE","10.1371/JOURNAL.PPAT.1005322 ",3.37,0,"5evm_oligo11","DManpa1-3DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_Q_)-MAN(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(464_D_)",172.315,"","",""
"5EVM","CRYSTAL STRUCTURE OF NIPAH VIRUS FUSION GLYCOPROTEIN IN THE PREFUSION STATE","10.1371/JOURNAL.PPAT.1005322 ",3.37,0,"5evm_oligo6","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_L_)-[MAN(4_L_)]-MAN(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(464_B_)",180.794,"","",""
"5EVM","CRYSTAL STRUCTURE OF NIPAH VIRUS FUSION GLYCOPROTEIN IN THE PREFUSION STATE","10.1371/JOURNAL.PPAT.1005322 ",3.37,0,"5evm_oligo18","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_X_)-[MAN(4_X_)]-MAN(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(414_F_)",177.385,"","",""
"5EWJ","CRYSTAL STRUCTURE OF AMINO TERMINAL DOMAINS OF THE NMDA RECEPTOR SUBUNIT GLUN1 AND GLUN2B IN COMPLEX WITH IFENPRODIL","10.1124/MOL.115.103036 ",2.77,75.14,"5ewj_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(389_A_)",67.4113,"","",""
"5EWL","CRYSTAL STRUCTURE OF AMINO TERMINAL DOMAINS OF THE NMDA RECEPTOR SUBUNIT GLUN1 AND GLUN2B IN COMPLEX WITH MK-22","10.1124/MOL.115.103036 ",2.98,72.87,"5ewl_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(389_A_)",72.8169,"","",""
"5EWM","CRYSTAL STRUCTURE OF AMINO TERMINAL DOMAINS OF THE NMDA RECEPTOR SUBUNIT GLUN1 AND GLUN2B IN COMPLEX WITH EVT-101","10.1124/MOL.115.103036 ",2.76,77.45,"5ewm_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(389_A_)",70.3275,"","",""
"5EYX","MONOCLINIC FORM OF CENTROLOBIUM TOMENTOSUM SEED LECTIN (CTL) COMPLEXED WITH MAN1-3MAN-OME.","10.1016/J.ABB.2016.03.001 ",2.25,21.57,"5eyx_oligo2","DManpa1-3DManpa1-OME","MAN(2_D_)-MMA(1_D_)",22.9741,"","",""
"5EYX","MONOCLINIC FORM OF CENTROLOBIUM TOMENTOSUM SEED LECTIN (CTL) COMPLEXED WITH MAN1-3MAN-OME.","10.1016/J.ABB.2016.03.001 ",2.25,21.57,"5eyx_oligo1","DManpa1-3DManpa1-OME","MAN(2_C_)-MMA(1_C_)",21.0095,"","",""
"5EYY","TETRAGONAL FORM OF CENTROLOBIUM TOMENTOSUM SEED LECTIN (CTL) COMPLEXED WITH MAN1-3MAN-OME.","10.1016/J.ABB.2016.03.001 ",1.9,17.12,"5eyy_oligo2","DManpa1-3DManpa1-OME","MAN(2_B_)-MMA(1_B_)",15.0605,"","",""
"5EZI","CRYSTAL STRUCTURE OF FAB OF PARASITE INVASION INHIBITORY ANTIBODY C1 - HEXAGONAL FORM","10.7554/ELIFE.20383 ",1.61,0,"5ezi_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_A_)-[NAG(8_A_)-MAN(7_A_)-[GAL(6_A_)-NAG(5_A_)-MAN(4_A_)]-BMA(3_A_)-NAG(2_A_)]-NAG(1_A_)-ASN(33_H_)",63.5516,"","",""
"5F09","STRUCTURE OF INACTIVE GCPII MUTANT IN COMPLEX WITH BETA-CITRYL GLUTAMATE","10.1111/FEBS.13761 ",1.85,40.58,"5f09_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(638_A_)",57.3718,"","",""
"5F7M","BLOOD GROUP ANTIGEN BINDING ADHESIN BABA OF HELICOBACTER PYLORI STRAIN 17875 IN COMPLEX WITH BLOOD GROUP H LEWIS B HEXASACCHARIDE","10.1016/J.CHOM.2015.12.004 ",2.72,49.47,"5f7m_oligo1","LFucpa1-2DGalpb1-3[LFucpa1-4]DGlcpNAcb1-3DGalpb1-4DGlcpb1-ROH","FUC(6_E_)-[FUC(5_E_)-GAL(4_E_)]-NAG(3_E_)-GAL(2_E_)-BGC(1_E_)",34.3295,"","",""
"5F7M","BLOOD GROUP ANTIGEN BINDING ADHESIN BABA OF HELICOBACTER PYLORI STRAIN 17875 IN COMPLEX WITH BLOOD GROUP H LEWIS B HEXASACCHARIDE","10.1016/J.CHOM.2015.12.004 ",2.72,49.47,"5f7m_oligo2","LFucpa1-2DGalpb1-3[LFucpa1-4]DGlcpNAcb1-3DGalpb1-4DGlcpb1-ROH","FUC(6_F_)-[FUC(5_F_)-GAL(4_F_)]-NAG(3_F_)-GAL(2_F_)-BGC(1_F_)",32.5555,"","",""
"5F7N","BLOOD GROUP ANTIGEN BINDING ADHESIN BABA OF HELICOBACTER PYLORI STRAIN 17875 IN COMPLEX WITH BLOOD GROUP A LEWIS B PENTASACCHARIDE","10.1016/J.CHOM.2015.12.004 ",2.28,57.67,"5f7n_oligo1","LFucpa1-2[DGalpNAca1-3]DGalpb1-3[LFucpa1-4]DGlcpNAcb1-ROH","FUC(5_E_)-[A2G(4_E_)-[FUC(3_E_)]-GAL(2_E_)]-NAG(1_E_)",44.8951,"","",""
"5F7N","BLOOD GROUP ANTIGEN BINDING ADHESIN BABA OF HELICOBACTER PYLORI STRAIN 17875 IN COMPLEX WITH BLOOD GROUP A LEWIS B PENTASACCHARIDE","10.1016/J.CHOM.2015.12.004 ",2.28,57.67,"5f7n_oligo2","LFucpa1-2[DGalpNAca1-3]DGalpb1-3[LFucpa1-4]DGlcpNAcb1-ROH","FUC(5_F_)-[A2G(4_F_)-[FUC(3_F_)]-GAL(2_F_)]-NAG(1_F_)",46.4276,"","",""
"5F7U","CYCLOALTERNAN-FORMING ENZYME FROM LISTERIA MONOCYTOGENES IN COMPLEX WITH PENTASACCHARIDE SUBSTRATE","10.1038/NMICROBIOL.2016.202 ",1.7,22.33,"5f7u_oligo1","DGlcpa1-6DGlcpa1-3[DGlcpa1-6]DGlcpa1-ROH","GLC(4_B_)-[GLC(3_B_)-GLC(2_B_)]-GLC(1_B_)",31.7161,"","",""
"5F7W","BLOOD GROUP ANTIGEN BINDING ADHESIN BABA OF HELICOBACTER PYLORI STRAIN 17875 IN COMPLEX WITH BLOOD GROUP B LEWIS B HEPTASACCHARIDE","10.1016/J.CHOM.2015.12.004 ",2.81,74.22,"5f7w_oligo2","LFucpa1-2[DGalpa1-3]DGalpb1-3[LFucpa1-4]DGlcpNAcb1-3DGalpb1-4DGlcpb1-ROH","FUC(7_F_)-[GLA(6_F_)-[FUC(5_F_)]-GAL(4_F_)]-NAG(3_F_)-GAL(2_F_)-BGC(1_F_)",50.8225,"","",""
"5F7W","BLOOD GROUP ANTIGEN BINDING ADHESIN BABA OF HELICOBACTER PYLORI STRAIN 17875 IN COMPLEX WITH BLOOD GROUP B LEWIS B HEPTASACCHARIDE","10.1016/J.CHOM.2015.12.004 ",2.81,74.22,"5f7w_oligo1","LFucpa1-2[DGalpa1-3]DGalpb1-3[LFucpa1-4]DGlcpNAcb1-3DGalpb1-4DGlcpb1-ROH","FUC(7_E_)-[GLA(6_E_)-[FUC(5_E_)]-GAL(4_E_)]-NAG(3_E_)-GAL(2_E_)-BGC(1_E_)",51.4101,"","",""
"5F7Y","BLOOD GROUP ANTIGEN BINDING ADHESIN BABA OF HELICOBACTER PYLORI STRAIN 17875 IN COMPLEX WITH BLOOD GROUP A TYPE-1 HEXASACCHARIDE","10.1016/J.CHOM.2015.12.004 ",2.44,58.31,"5f7y_oligo1","LFucpa1-2[DGalpNAca1-3]DGalpb1-3DGlcpNAcb1-3DGalpb1-4DGlcpa1-ROH","A2G(6_E_)-[FUC(5_E_)]-GAL(4_E_)-NAG(3_E_)-GAL(2_E_)-GLC(1_E_)",48.2898,"","",""
"5F7Y","BLOOD GROUP ANTIGEN BINDING ADHESIN BABA OF HELICOBACTER PYLORI STRAIN 17875 IN COMPLEX WITH BLOOD GROUP A TYPE-1 HEXASACCHARIDE","10.1016/J.CHOM.2015.12.004 ",2.44,58.31,"5f7y_oligo2","LFucpa1-2[DGalpNAca1-3]DGalpb1-3DGlcpNAcb1-3DGalpb1-4DGlcpa1-ROH","A2G(6_F_)-[FUC(5_F_)]-GAL(4_F_)-NAG(3_F_)-GAL(2_F_)-GLC(1_F_)",50.5523,"","",""
"5F8R","BLOOD GROUP ANTIGEN BINDING ADHESIN BABA OF HELICOBACTER PYLORI STRAIN S831 IN COMPLEX WITH BLOOD GROUP H LEWIS B HEXASACCHARIDE","10.1016/J.CHOM.2015.12.004 ",2.44,66.73,"5f8r_oligo1","LFucpa1-2DGalpb1-3[LFucpa1-4]DGlcpNAcb1-3DGalpb1-4DGlcpb1-ROH","FUC(6_E_)-[FUC(5_E_)-GAL(4_E_)]-NAG(3_E_)-GAL(2_E_)-BGC(1_E_)",41.7582,"","",""
"5F8R","BLOOD GROUP ANTIGEN BINDING ADHESIN BABA OF HELICOBACTER PYLORI STRAIN S831 IN COMPLEX WITH BLOOD GROUP H LEWIS B HEXASACCHARIDE","10.1016/J.CHOM.2015.12.004 ",2.44,66.73,"5f8r_oligo2","LFucpa1-2DGalpb1-3[LFucpa1-4]DGlcpNAcb1-3DGalpb1-4DGlcpb1-ROH","FUC(6_F_)-[FUC(5_F_)-GAL(4_F_)]-NAG(3_F_)-GAL(2_F_)-BGC(1_F_)",41.1794,"","",""
"5F93","BLOOD GROUP ANTIGEN BINDING ADHESIN BABA OF HELICOBACTER PYLORI STRAIN A730 IN COMPLEX WITH BLOOD GROUP H LEWIS B HEXASACCHARIDE","10.1016/J.CHOM.2015.12.004 ",2.99,71.09,"5f93_oligo4","LFucpa1-2DGalpb1-3[LFucpa1-4]DGlcpNAcb1-3DGalpb1-4DGlcpa1-ROH","FUC(6_L_)-[FUC(5_L_)-GAL(4_L_)]-NAG(3_L_)-GAL(2_L_)-GLC(1_L_)",98.7453,"","",""
"5F93","BLOOD GROUP ANTIGEN BINDING ADHESIN BABA OF HELICOBACTER PYLORI STRAIN A730 IN COMPLEX WITH BLOOD GROUP H LEWIS B HEXASACCHARIDE","10.1016/J.CHOM.2015.12.004 ",2.99,71.09,"5f93_oligo3","LFucpa1-2DGalpb1-3[LFucpa1-4]DGlcpNAcb1-3DGalpb1-4DGlcpa1-ROH","FUC(6_K_)-[FUC(5_K_)-GAL(4_K_)]-NAG(3_K_)-GAL(2_K_)-GLC(1_K_)",96.3968,"","",""
"5F93","BLOOD GROUP ANTIGEN BINDING ADHESIN BABA OF HELICOBACTER PYLORI STRAIN A730 IN COMPLEX WITH BLOOD GROUP H LEWIS B HEXASACCHARIDE","10.1016/J.CHOM.2015.12.004 ",2.99,71.09,"5f93_oligo2","LFucpa1-2DGalpb1-3[LFucpa1-4]DGlcpNAcb1-3DGalpb1-4DGlcpa1-ROH","FUC(6_J_)-[FUC(5_J_)-GAL(4_J_)]-NAG(3_J_)-GAL(2_J_)-GLC(1_J_)",81.0177,"","",""
"5F93","BLOOD GROUP ANTIGEN BINDING ADHESIN BABA OF HELICOBACTER PYLORI STRAIN A730 IN COMPLEX WITH BLOOD GROUP H LEWIS B HEXASACCHARIDE","10.1016/J.CHOM.2015.12.004 ",2.99,71.09,"5f93_oligo1","LFucpa1-2DGalpb1-3[LFucpa1-4]DGlcpNAcb1-3DGalpb1-4DGlcpa1-ROH","FUC(6_I_)-[FUC(5_I_)-GAL(4_I_)]-NAG(3_I_)-GAL(2_I_)-GLC(1_I_)",72.808,"","",""
"5F97","BLOOD GROUP ANTIGEN BINDING ADHESIN BABA OF HELICOBACTER PYLORI STRAIN A730 IN COMPLEX WITH BLOOD GROUP A TYPE 1 HEXASACCHARIDE","10.1016/J.CHOM.2015.12.004 ",2.62,64.99,"5f97_oligo1","LFucpa1-2[DGalpNAca1-3]DGalpb1-3DGlcpNAcb1-3DGalpb1-4DGlcpa1-ROH","A2G(6_I_)-[FUC(5_I_)]-GAL(4_I_)-NAG(3_I_)-GAL(2_I_)-BGC(1_I_)",68.5568,"","",""
"5F97","BLOOD GROUP ANTIGEN BINDING ADHESIN BABA OF HELICOBACTER PYLORI STRAIN A730 IN COMPLEX WITH BLOOD GROUP A TYPE 1 HEXASACCHARIDE","10.1016/J.CHOM.2015.12.004 ",2.62,64.99,"5f97_oligo2","LFucpa1-2[DGalpNAca1-3]DGalpb1-3DGlcpNAcb1-3DGalpb1-4DGlcpa1-ROH","A2G(6_J_)-[FUC(5_J_)]-GAL(4_J_)-NAG(3_J_)-GAL(2_J_)-BGC(1_J_)",76.8976,"","",""
"5F97","BLOOD GROUP ANTIGEN BINDING ADHESIN BABA OF HELICOBACTER PYLORI STRAIN A730 IN COMPLEX WITH BLOOD GROUP A TYPE 1 HEXASACCHARIDE","10.1016/J.CHOM.2015.12.004 ",2.62,64.99,"5f97_oligo4","LFucpa1-2[DGalpNAca1-3]DGalpb1-3DGlcpNAcb1-3DGalpb1-4DGlcpa1-ROH","A2G(6_L_)-[FUC(5_L_)]-GAL(4_L_)-NAG(3_L_)-GAL(2_L_)-BGC(1_L_)",87.5555,"","",""
"5F97","BLOOD GROUP ANTIGEN BINDING ADHESIN BABA OF HELICOBACTER PYLORI STRAIN A730 IN COMPLEX WITH BLOOD GROUP A TYPE 1 HEXASACCHARIDE","10.1016/J.CHOM.2015.12.004 ",2.62,64.99,"5f97_oligo3","LFucpa1-2[DGalpNAca1-3]DGalpb1-3DGlcpNAcb1-3DGalpb1-4DGlcpa1-ROH","A2G(6_K_)-[FUC(5_K_)]-GAL(4_K_)-NAG(3_K_)-GAL(2_K_)-BGC(1_K_)",84.0983,"","",""
"5F9A","BLOOD GROUP ANTIGEN BINDING ADHESIN BABA OF HELICOBACTER PYLORI STRAIN P436 IN COMPLEX WITH BLOOD GROUP H LEWIS B HEXASACCHARIDE","10.1016/J.CHOM.2015.12.004 ",2.44,57.44,"5f9a_oligo1","LFucpa1-2DGalpb1-3[LFucpa1-4]DGlcpNAcb1-3DGalpb1-4DGlcpa1-ROH","FUC(6_B_)-[FUC(5_B_)-GAL(4_B_)]-NAG(3_B_)-GAL(2_B_)-GLC(1_B_)",71.7426,"","",""
"5F9D","BLOOD GROUP ANTIGEN BINDING ADHESIN BABA OF HELICOBACTER PYLORI STRAIN P436 IN COMPLEX WITH LEWIS B BLOOD GROUP B HEPTASACCHARIDE","10.1016/J.CHOM.2015.12.004 ",2.59,70.46,"5f9d_oligo1","LFucpa1-2[DGalpa1-3]DGalpb1-3[LFucpa1-4]DGlcpNAcb1-3DGalpb1-4DGlcpb1-ROH","FUC(7_B_)-[GLA(6_B_)-[FUC(5_B_)]-GAL(4_B_)]-NAG(3_B_)-GAL(2_B_)-BGC(1_B_)",142.099,"","",""
"5FA2","CRYSTAL STRUCTURE OF 426C.TM4DELTAV1-3 P120","10.7554/ELIFE.13783 ",2,48.66,"5fa2_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(262_A_)",77.1645,"","",""
"5FA2","CRYSTAL STRUCTURE OF 426C.TM4DELTAV1-3 P120","10.7554/ELIFE.13783 ",2,48.66,"5fa2_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(262_B_)",84.8964,"","",""
"5FC1","MURINE SMPDL3A IN COMPLEX WITH SULFATE","10.1074/JBC.M115.711085 ",1.39,0,"5fc1_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(353_A_)",60.8862,"","",""
"5FC5","MURINE SMPDL3A IN COMPLEX WITH PHOSPHOCHOLINE","10.1074/JBC.M115.711085 ",1.68,0,"5fc5_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(353_A_)",83.8298,"","",""
"5FC6","MURINE SMPDL3A IN COMPLEX WITH ADP ANALOG AMPCP","10.1074/JBC.M115.711085 ",1.66,0,"5fc6_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(353_A_)",74.9669,"","",""
"5FCA","MURINE SMPDL3A IN PRESENCE OF EXCESS ZINC","10.1074/JBC.M115.711085 ",1.92,0,"5fca_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(353_A_)",107.68,"","",""
"5FCA","MURINE SMPDL3A IN PRESENCE OF EXCESS ZINC","10.1074/JBC.M115.711085 ",1.92,0,"5fca_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(353_B_)",92.9222,"","",""
"5FCB","MURINE SMPDL3A IN COMPLEX WITH AMP","10.1074/JBC.M115.711085 ",1.55,0,"5fcb_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(353_A_)",71.2053,"","",""
"5FEC","CRYSTAL STRUCTURE OF 3BNC60 FAB GERMLINE PRECURSOR IN COMPLEX WITH 426C.TM4DELTAV1-3 GP120","10.7554/ELIFE.13783 ",3.17,0,"5fec_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_J_)-MAN(7_J_)-[MAN(6_J_)-MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(262_G_)",75.7517,"","",""
"5FEC","CRYSTAL STRUCTURE OF 3BNC60 FAB GERMLINE PRECURSOR IN COMPLEX WITH 426C.TM4DELTAV1-3 GP120","10.7554/ELIFE.13783 ",3.17,0,"5fec_oligo1","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(262_C_)",67.786,"","",""
"5FEC","CRYSTAL STRUCTURE OF 3BNC60 FAB GERMLINE PRECURSOR IN COMPLEX WITH 426C.TM4DELTAV1-3 GP120","10.7554/ELIFE.13783 ",3.17,0,"5fec_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(262_D_)",78.3473,"","",""
"5FFG","CRYSTAL STRUCTURE OF INTEGRIN ALPHA V BETA 6 HEAD","10.1038/NATURE21035 ",2.25,0,"5ffg_oligo6","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_G_)-[MAN(7_G_)]-MAN(6_G_)-[MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(525_A_)",106.944,"","",""
"5FFG","CRYSTAL STRUCTURE OF INTEGRIN ALPHA V BETA 6 HEAD","10.1038/NATURE21035 ",2.25,0,"5ffg_oligo3","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-MAN(4_E_)-[MAN(6_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(266_A_)",73.4533,"","",""
"5FFO","INTEGRIN ALPHA V BETA 6 IN COMPLEX WITH PRO-TGF-BETA","10.1038/NATURE21035 ",3.49,0,"5ffo_oligo3","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_K_)-[MAN(5_K_)]-MAN(4_K_)-[MAN(7_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(266_A_)",215.247,"","",""
"5FFO","INTEGRIN ALPHA V BETA 6 IN COMPLEX WITH PRO-TGF-BETA","10.1038/NATURE21035 ",3.49,0,"5ffo_oligo13","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_U_)-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(53_G_)",257.613,"","",""
"5FFO","INTEGRIN ALPHA V BETA 6 IN COMPLEX WITH PRO-TGF-BETA","10.1038/NATURE21035 ",3.49,0,"5ffo_oligo6","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_N_)-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(53_C_)",264.396,"","",""
"5FFO","INTEGRIN ALPHA V BETA 6 IN COMPLEX WITH PRO-TGF-BETA","10.1038/NATURE21035 ",3.49,0,"5ffo_oligo9","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Q_)-MAN(4_Q_)-[MAN(6_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(260_E_)",258.779,"","",""
"5FFO","INTEGRIN ALPHA V BETA 6 IN COMPLEX WITH PRO-TGF-BETA","10.1038/NATURE21035 ",3.49,0,"5ffo_oligo14","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_V_)-[MAN(5_V_)-MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(53_H_)",253.66,"","",""
"5FFO","INTEGRIN ALPHA V BETA 6 IN COMPLEX WITH PRO-TGF-BETA","10.1038/NATURE21035 ",3.49,0,"5ffo_oligo10","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_R_)-[MAN(5_R_)]-MAN(4_R_)-[MAN(7_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(266_E_)",224.999,"","",""
"5FFO","INTEGRIN ALPHA V BETA 6 IN COMPLEX WITH PRO-TGF-BETA","10.1038/NATURE21035 ",3.49,0,"5ffo_oligo1","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-MAN(4_J_)-[MAN(6_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(260_A_)",265.001,"","",""
"5FFO","INTEGRIN ALPHA V BETA 6 IN COMPLEX WITH PRO-TGF-BETA","10.1038/NATURE21035 ",3.49,0,"5ffo_oligo7","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_O_)-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(53_D_)",226.137,"","",""
"5FI9","CLOSED FORM OF MURINE ACID SPHINGOMYELINASE IN COMPLEX WITH BISPHOSPHONATE INHIBITOR ABPA","10.1038/NCOMMS12196 ",2.54,0,"5fi9_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_F_)-[MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(84_A_)",60.0767,"","",""
"5FIB","OPEN FORM OF MURINE ACID SPHINGOMYELINASE","10.1038/NCOMMS12196 ",2.8,0,"5fib_oligo8","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_J_)-[MAN(4_J_)-BMA(3_J_)-NAG(2_J_)]-NAG(1_J_)-ASN(84_B_)",125.399,"","",""
"5FIB","OPEN FORM OF MURINE ACID SPHINGOMYELINASE","10.1038/NCOMMS12196 ",2.8,0,"5fib_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(518_B_)",107.394,"","",""
"5FIB","OPEN FORM OF MURINE ACID SPHINGOMYELINASE","10.1038/NCOMMS12196 ",2.8,0,"5fib_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_H_)-[MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)]-NAG(1_H_)-ASN(393_B_)",58.8897,"","",""
"5FIB","OPEN FORM OF MURINE ACID SPHINGOMYELINASE","10.1038/NCOMMS12196 ",2.8,0,"5fib_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_E_)-[MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(393_A_)",97.1917,"","",""
"5FIH","SACCHAROMYCES CEREVISIAE GAS2P (E176Q MUTANT) IN COMPLEX WITH LAMINARITETRAOSE AND LAMINARIPENTAOSE","10.1021/JACS.5B10092 ",1.8,25.85,"5fih_oligo3","DGlcpb1-3DGlcpb1-3DGlcpa1-3DGlcpb1-3DGlcpb1-ROH","BGC(5_C_)-BGC(4_C_)-GLC(3_C_)-BGC(2_C_)-BGC(1_C_)",50.1856,"","",""
"5FIX","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH SUCROSE","10.1074/JBC.M115.708495 ",2.01,31.72,"5fix_oligo33","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_C_)-MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(58_A_)",52.2549,"","",""
"5FIX","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH SUCROSE","10.1074/JBC.M115.708495 ",2.01,31.72,"5fix_oligo34","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_D_)-MAN(8_D_)-[MAN(10_D_)]-MAN(7_D_)-[MAN(6_D_)-MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(107_A_)",43.7795,"","",""
"5FIX","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH SUCROSE","10.1074/JBC.M115.708495 ",2.01,31.72,"5fix_oligo36","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-MAN(4_F_)-[MAN(6_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(58_B_)",56.495,"","",""
"5FIX","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH SUCROSE","10.1074/JBC.M115.708495 ",2.01,31.72,"5fix_oligo37","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_G_)-MAN(8_G_)-[MAN(10_G_)]-MAN(7_G_)-[MAN(6_G_)-MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(107_B_)",45.2536,"","",""
"5FJI","THREE-DIMENSIONAL STRUCTURES OF TWO HEAVILY N-GLYCOSYLATED ASPERGILLUS SP. FAMILY GH3 BETA-D-GLUCOSIDASES","10.1107/S2059798315024237 ",1.95,23.65,"5fji_oligo19","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-MAN(4_N_)-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(443_B_)",45.6522,"","",""
"5FJI","THREE-DIMENSIONAL STRUCTURES OF TWO HEAVILY N-GLYCOSYLATED ASPERGILLUS SP. FAMILY GH3 BETA-D-GLUCOSIDASES","10.1107/S2059798315024237 ",1.95,23.65,"5fji_oligo11","DManpa1-2DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-MAN(5_C_)-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(61_A_)",38.7421,"","",""
"5FJI","THREE-DIMENSIONAL STRUCTURES OF TWO HEAVILY N-GLYCOSYLATED ASPERGILLUS SP. FAMILY GH3 BETA-D-GLUCOSIDASES","10.1107/S2059798315024237 ",1.95,23.65,"5fji_oligo18","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_M_)-MAN(10_M_)-[MAN(9_M_)-MAN(8_M_)]-MAN(7_M_)-[MAN(6_M_)-MAN(5_M_)-MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(323_B_)",36.5474,"","",""
"5FJI","THREE-DIMENSIONAL STRUCTURES OF TWO HEAVILY N-GLYCOSYLATED ASPERGILLUS SP. FAMILY GH3 BETA-D-GLUCOSIDASES","10.1107/S2059798315024237 ",1.95,23.65,"5fji_oligo8","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_F_)-MAN(10_F_)-[MAN(9_F_)-MAN(8_F_)]-MAN(7_F_)-[MAN(6_F_)-MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(323_A_)",29.3727,"","",""
"5FJI","THREE-DIMENSIONAL STRUCTURES OF TWO HEAVILY N-GLYCOSYLATED ASPERGILLUS SP. FAMILY GH3 BETA-D-GLUCOSIDASES","10.1107/S2059798315024237 ",1.95,23.65,"5fji_oligo16","DManpa1-2DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_K_)-MAN(5_K_)-MAN(4_K_)-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(253_B_)",32.6582,"","",""
"5FJI","THREE-DIMENSIONAL STRUCTURES OF TWO HEAVILY N-GLYCOSYLATED ASPERGILLUS SP. FAMILY GH3 BETA-D-GLUCOSIDASES","10.1107/S2059798315024237 ",1.95,23.65,"5fji_oligo12","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(443_A_)",44.3018,"","",""
"5FJI","THREE-DIMENSIONAL STRUCTURES OF TWO HEAVILY N-GLYCOSYLATED ASPERGILLUS SP. FAMILY GH3 BETA-D-GLUCOSIDASES","10.1107/S2059798315024237 ",1.95,23.65,"5fji_oligo20","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_O_)-MAN(5_O_)-[MAN(7_O_)]-MAN(4_O_)-[MAN(9_O_)-MAN(8_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(524_B_)",36.854,"","",""
"5FJI","THREE-DIMENSIONAL STRUCTURES OF TWO HEAVILY N-GLYCOSYLATED ASPERGILLUS SP. FAMILY GH3 BETA-D-GLUCOSIDASES","10.1107/S2059798315024237 ",1.95,23.65,"5fji_oligo1","DManpa1-2DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-MAN(5_D_)-MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(253_A_)",34.6711,"","",""
"5FJI","THREE-DIMENSIONAL STRUCTURES OF TWO HEAVILY N-GLYCOSYLATED ASPERGILLUS SP. FAMILY GH3 BETA-D-GLUCOSIDASES","10.1107/S2059798315024237 ",1.95,23.65,"5fji_oligo15","DManpa1-2DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_J_)-MAN(5_J_)-MAN(4_J_)-[MAN(7_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(61_B_)",36.1621,"","",""
"5FJI","THREE-DIMENSIONAL STRUCTURES OF TWO HEAVILY N-GLYCOSYLATED ASPERGILLUS SP. FAMILY GH3 BETA-D-GLUCOSIDASES","10.1107/S2059798315024237 ",1.95,23.65,"5fji_oligo13","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-MAN(5_H_)-[MAN(7_H_)]-MAN(4_H_)-[MAN(9_H_)-MAN(8_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(524_A_)",35.6111,"","",""
"5FJJ","THREE-DIMENSIONAL STRUCTURES OF TWO HEAVILY N-GLYCOSYLATED ASPERGILLUS SP. FAMILY GH3 BETA-D-GLUCOSIDASES","10.1107/S2059798315024237 ",1.95,30.51,"5fjj_oligo4","DManpa1-2DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_K_)-MAN(5_K_)-MAN(4_K_)-[MAN(7_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(565_A_)",45.6044,"","",""
"5FJJ","THREE-DIMENSIONAL STRUCTURES OF TWO HEAVILY N-GLYCOSYLATED ASPERGILLUS SP. FAMILY GH3 BETA-D-GLUCOSIDASES","10.1107/S2059798315024237 ",1.95,30.51,"5fjj_oligo27","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_e_)-BMA(3_e_)-NAG(2_e_)-NAG(1_e_)-ASN(316_D_)",44.9723,"","",""
"5FJJ","THREE-DIMENSIONAL STRUCTURES OF TWO HEAVILY N-GLYCOSYLATED ASPERGILLUS SP. FAMILY GH3 BETA-D-GLUCOSIDASES","10.1107/S2059798315024237 ",1.95,30.51,"5fjj_oligo11","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_R_)-MAN(5_R_)-[MAN(7_R_)]-MAN(4_R_)-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(524_B_)",48.1373,"","",""
"5FJJ","THREE-DIMENSIONAL STRUCTURES OF TWO HEAVILY N-GLYCOSYLATED ASPERGILLUS SP. FAMILY GH3 BETA-D-GLUCOSIDASES","10.1107/S2059798315024237 ",1.95,30.51,"5fjj_oligo9","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_P_)-MAN(10_P_)-[MAN(9_P_)-MAN(8_P_)]-MAN(7_P_)-[MAN(6_P_)-MAN(5_P_)-MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(323_B_)",37.0198,"","",""
"5FJJ","THREE-DIMENSIONAL STRUCTURES OF TWO HEAVILY N-GLYCOSYLATED ASPERGILLUS SP. FAMILY GH3 BETA-D-GLUCOSIDASES","10.1107/S2059798315024237 ",1.95,30.51,"5fjj_oligo23","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_a_)-MAN(5_a_)-[MAN(7_a_)]-MAN(4_a_)-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(565_C_)",47.1865,"","",""
"5FJJ","THREE-DIMENSIONAL STRUCTURES OF TWO HEAVILY N-GLYCOSYLATED ASPERGILLUS SP. FAMILY GH3 BETA-D-GLUCOSIDASES","10.1107/S2059798315024237 ",1.95,30.51,"5fjj_oligo7","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_N_)-[MAN(5_N_)-MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(253_B_)",45.3868,"","",""
"5FJJ","THREE-DIMENSIONAL STRUCTURES OF TWO HEAVILY N-GLYCOSYLATED ASPERGILLUS SP. FAMILY GH3 BETA-D-GLUCOSIDASES","10.1107/S2059798315024237 ",1.95,30.51,"5fjj_oligo20","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_X_)-MAN(7_X_)-[MAN(6_X_)-MAN(5_X_)]-MAN(4_X_)-[MAN(9_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(323_C_)",31.0926,"","",""
"5FJJ","THREE-DIMENSIONAL STRUCTURES OF TWO HEAVILY N-GLYCOSYLATED ASPERGILLUS SP. FAMILY GH3 BETA-D-GLUCOSIDASES","10.1107/S2059798315024237 ",1.95,30.51,"5fjj_oligo13","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_H_)-MAN(10_H_)-[MAN(9_H_)-MAN(8_H_)]-MAN(7_H_)-[MAN(6_H_)-MAN(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(323_A_)",43.7348,"","",""
"5FJJ","THREE-DIMENSIONAL STRUCTURES OF TWO HEAVILY N-GLYCOSYLATED ASPERGILLUS SP. FAMILY GH3 BETA-D-GLUCOSIDASES","10.1107/S2059798315024237 ",1.95,30.51,"5fjj_oligo30","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_h_)-MAN(5_h_)-[MAN(7_h_)]-MAN(4_h_)-BMA(3_h_)-NAG(2_h_)-NAG(1_h_)-ASN(524_D_)",41.0305,"","",""
"5FJJ","THREE-DIMENSIONAL STRUCTURES OF TWO HEAVILY N-GLYCOSYLATED ASPERGILLUS SP. FAMILY GH3 BETA-D-GLUCOSIDASES","10.1107/S2059798315024237 ",1.95,30.51,"5fjj_oligo22","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Z_)-MAN(5_Z_)-[MAN(7_Z_)]-MAN(4_Z_)-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(524_C_)",45.2118,"","",""
"5FJJ","THREE-DIMENSIONAL STRUCTURES OF TWO HEAVILY N-GLYCOSYLATED ASPERGILLUS SP. FAMILY GH3 BETA-D-GLUCOSIDASES","10.1107/S2059798315024237 ",1.95,30.51,"5fjj_oligo18","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_V_)-MAN(4_V_)-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(253_C_)",42.3236,"","",""
"5FJJ","THREE-DIMENSIONAL STRUCTURES OF TWO HEAVILY N-GLYCOSYLATED ASPERGILLUS SP. FAMILY GH3 BETA-D-GLUCOSIDASES","10.1107/S2059798315024237 ",1.95,30.51,"5fjj_oligo31","DManpa1-2DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_i_)-MAN(5_i_)-MAN(4_i_)-[MAN(7_i_)]-BMA(3_i_)-NAG(2_i_)-NAG(1_i_)-ASN(565_D_)",40.1617,"","",""
"5FJJ","THREE-DIMENSIONAL STRUCTURES OF TWO HEAVILY N-GLYCOSYLATED ASPERGILLUS SP. FAMILY GH3 BETA-D-GLUCOSIDASES","10.1107/S2059798315024237 ",1.95,30.51,"5fjj_oligo12","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-MAN(4_S_)-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(565_B_)",40.6624,"","",""
"5FJJ","THREE-DIMENSIONAL STRUCTURES OF TWO HEAVILY N-GLYCOSYLATED ASPERGILLUS SP. FAMILY GH3 BETA-D-GLUCOSIDASES","10.1107/S2059798315024237 ",1.95,30.51,"5fjj_oligo28","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_f_)-MAN(7_f_)-[MAN(6_f_)-MAN(5_f_)]-MAN(4_f_)-BMA(3_f_)-NAG(2_f_)-NAG(1_f_)-ASN(323_D_)",41.2128,"","",""
"5FK7","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH NEOKESTOSE","10.1074/JBC.M115.708495 ",2.05,32.44,"5fk7_oligo34","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_I_)-MAN(5_I_)-[MAN(7_I_)]-MAN(4_I_)-[MAN(9_I_)-MAN(8_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(107_B_)",43.532,"","",""
"5FK7","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH NEOKESTOSE","10.1074/JBC.M115.708495 ",2.05,32.44,"5fk7_oligo33","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-MAN(4_H_)-[MAN(6_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(58_B_)",53.0939,"","",""
"5FK7","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH NEOKESTOSE","10.1074/JBC.M115.708495 ",2.05,32.44,"5fk7_oligo30","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-MAN(5_E_)-[MAN(7_E_)]-MAN(4_E_)-[MAN(9_E_)-MAN(8_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(107_A_)",41.3349,"","",""
"5FK7","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH NEOKESTOSE","10.1074/JBC.M115.708495 ",2.05,32.44,"5fk7_oligo29","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-MAN(4_D_)-[MAN(6_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(58_A_)",42.9641,"","",""
"5FK8","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH NEO-ERLOSE","10.1074/JBC.M115.708495 ",1.88,27.76,"5fk8_oligo35","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_I_)-MAN(8_I_)-[MAN(10_I_)]-MAN(7_I_)-[MAN(6_I_)-MAN(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(107_B_)",41.3224,"","",""
"5FK8","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH NEO-ERLOSE","10.1074/JBC.M115.708495 ",1.88,27.76,"5fk8_oligo30","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_D_)-MAN(6_D_)-[MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(58_A_)",45.4607,"","",""
"5FK8","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH NEO-ERLOSE","10.1074/JBC.M115.708495 ",1.88,27.76,"5fk8_oligo34","DManpa1-3DManpb1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-MAN(4_H_)-[MAN(6_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(58_B_)",47.6364,"","",""
"5FK8","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH NEO-ERLOSE","10.1074/JBC.M115.708495 ",1.88,27.76,"5fk8_oligo31","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_E_)-MAN(8_E_)-[MAN(10_E_)]-MAN(7_E_)-[MAN(6_E_)-MAN(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(107_A_)",38.1225,"","",""
"5FKB","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH 1-KESTOSE","10.1074/JBC.M115.708495 ",1.78,26.57,"5fkb_oligo32","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_D_)-MAN(8_D_)-[MAN(10_D_)]-MAN(7_D_)-[MAN(6_D_)-MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(107_A_)",34.7685,"","",""
"5FKB","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH 1-KESTOSE","10.1074/JBC.M115.708495 ",1.78,26.57,"5fkb_oligo31","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_C_)-MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(58_A_)",44.4392,"","",""
"5FKB","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH 1-KESTOSE","10.1074/JBC.M115.708495 ",1.78,26.57,"5fkb_oligo36","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-MAN(4_G_)-[MAN(6_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(58_B_)",48.7968,"","",""
"5FKB","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH 1-KESTOSE","10.1074/JBC.M115.708495 ",1.78,26.57,"5fkb_oligo37","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_H_)-MAN(8_H_)-[MAN(10_H_)]-MAN(7_H_)-[MAN(6_H_)-MAN(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(107_B_)",37.6797,"","",""
"5FKC","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH RAFFINOSE","10.1074/JBC.M115.708495 ",1.82,25.8,"5fkc_oligo34","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-MAN(4_G_)-[MAN(6_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(58_B_)",46.765,"","",""
"5FKC","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH RAFFINOSE","10.1074/JBC.M115.708495 ",1.82,25.8,"5fkc_oligo31","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_D_)-MAN(8_D_)-[MAN(10_D_)]-MAN(7_D_)-[MAN(6_D_)-MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(107_A_)",34.068,"","",""
"5FKC","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH RAFFINOSE","10.1074/JBC.M115.708495 ",1.82,25.8,"5fkc_oligo35","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_H_)-MAN(8_H_)-[MAN(10_H_)]-MAN(7_H_)-[MAN(6_H_)-MAN(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(107_B_)",36.7635,"","",""
"5FKC","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH RAFFINOSE","10.1074/JBC.M115.708495 ",1.82,25.8,"5fkc_oligo30","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(58_A_)",37.5336,"","",""
"5FMB","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH FRUCTOSE AND HEPES BUFFER","10.1074/JBC.M115.708495 ",1.91,27.27,"5fmb_oligo36","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-MAN(4_F_)-[MAN(6_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(58_B_)",52.7911,"","",""
"5FMB","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH FRUCTOSE AND HEPES BUFFER","10.1074/JBC.M115.708495 ",1.91,27.27,"5fmb_oligo33","DManpb1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_C_)-MAN(6_C_)-[BMA(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(58_A_)",48.5129,"","",""
"5FMB","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH FRUCTOSE AND HEPES BUFFER","10.1074/JBC.M115.708495 ",1.91,27.27,"5fmb_oligo34","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_D_)-MAN(8_D_)-[MAN(10_D_)]-MAN(7_D_)-[MAN(6_D_)-MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(107_A_)",37.0936,"","",""
"5FMB","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH FRUCTOSE AND HEPES BUFFER","10.1074/JBC.M115.708495 ",1.91,27.27,"5fmb_oligo37","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_G_)-MAN(8_G_)-[MAN(10_G_)]-MAN(7_G_)-[MAN(6_G_)-MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(107_B_)",39.3928,"","",""
"5FMC","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH FRUCTOSE AND BIS-TRIS PROPANE BUFFER","10.1074/JBC.M115.708495 ",1.84,25.2,"5fmc_oligo36","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_G_)-MAN(8_G_)-[MAN(10_G_)]-MAN(7_G_)-[MAN(6_G_)-MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(107_B_)",38.6798,"","",""
"5FMC","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH FRUCTOSE AND BIS-TRIS PROPANE BUFFER","10.1074/JBC.M115.708495 ",1.84,25.2,"5fmc_oligo33","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_D_)-MAN(8_D_)-[MAN(10_D_)]-MAN(7_D_)-[MAN(6_D_)-MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(107_A_)",36.8668,"","",""
"5FMC","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH FRUCTOSE AND BIS-TRIS PROPANE BUFFER","10.1074/JBC.M115.708495 ",1.84,25.2,"5fmc_oligo35","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-MAN(4_F_)-[MAN(6_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(58_B_)",46.5648,"","",""
"5FMC","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH FRUCTOSE AND BIS-TRIS PROPANE BUFFER","10.1074/JBC.M115.708495 ",1.84,25.2,"5fmc_oligo30","DManpb1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_C_)-MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(58_A_)",45.3161,"","",""
"5FMD","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH NYSTOSE","10.1074/JBC.M115.708495 ",1.78,25.93,"5fmd_oligo38","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-MAN(4_F_)-[MAN(6_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(58_B_)",42.9545,"","",""
"5FMD","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH NYSTOSE","10.1074/JBC.M115.708495 ",1.78,25.93,"5fmd_oligo36","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_D_)-MAN(8_D_)-[MAN(10_D_)]-MAN(7_D_)-[MAN(6_D_)-MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(107_A_)",36.3393,"","",""
"5FMD","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH NYSTOSE","10.1074/JBC.M115.708495 ",1.78,25.93,"5fmd_oligo39","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_G_)-MAN(8_G_)-[MAN(10_G_)]-MAN(7_G_)-[MAN(6_G_)-MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(107_B_)",38.1226,"","",""
"5FMD","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH NYSTOSE","10.1074/JBC.M115.708495 ",1.78,25.93,"5fmd_oligo35","DManpb1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_C_)-MAN(6_C_)-[BMA(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(58_A_)",43.8558,"","",""
"5FQG","THE DETAILS OF GLYCOLIPID GLYCAN HYDROLYSIS BY THE STRUCTURAL ANALYSIS OF A FAMILY 123 GLYCOSIDE HYDROLASE FROM CLOSTRIDIUM PERFRINGENS","10.1016/J.JMB.2016.03.020 ",2.3,46.98,"5fqg_oligo1","DGalpNAcb1-3DGalpb1-ROH","NGA(2_B_)-GAL(1_B_)",50.5841,"","",""
"5FUF","CRYSTAL STRUCTURE OF THE MEP2 MUTANT S453D FROM CANDIDA ALBICANS","10.1038/NCOMMS11337 ",2.07,50.5,"5fuf_oligo3","DGlcpa1-3DGlcpb6-C5O1","DMU(1458_A_)-DMU(1458_A_)",85.6664,"","",""
"5FUF","CRYSTAL STRUCTURE OF THE MEP2 MUTANT S453D FROM CANDIDA ALBICANS","10.1038/NCOMMS11337 ",2.07,50.5,"5fuf_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(1456_A_)-DMU(1456_A_)",102.028,"","",""
"5FUF","CRYSTAL STRUCTURE OF THE MEP2 MUTANT S453D FROM CANDIDA ALBICANS","10.1038/NCOMMS11337 ",2.07,50.5,"5fuf_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(1457_A_)-DMU(1457_A_)",98.4505,"","",""
"5FUK","CRYSTALLIZATION OF A DIMERIC HEME PEROXYGENASE FROM THE FUNGUS MARASMIUS ROTULA","",1.55,23.48,"5fuk_oligo1","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-MAN(4_D_)-[MAN(6_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(122_B_)",46.5739,"","",""
"5FUK","CRYSTALLIZATION OF A DIMERIC HEME PEROXYGENASE FROM THE FUNGUS MARASMIUS ROTULA","",1.55,23.48,"5fuk_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(122_A_)",39.2327,"","",""
"5FXU","CRYSTAL STRUCTURE OF PUUMALA VIRUS GN GLYCOPROTEIN ECTODOMAIN","10.1016/J.CELREP.2016.03.082 ",2.28,48.9,"5fxu_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(142_A_)",78.538,"","",""
"5FYJ","CRYSTAL STRUCTURE AT 3.4 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE G X1193.C1 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122, 35O22 AND VRC01","10.1016/J.CELL.2016.04.010 ",3.11,0,"5fyj_oligo19","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_a_)-MAN(7_a_)-[MAN(6_a_)-MAN(5_a_)]-MAN(4_a_)-[MAN(9_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(386_G_)",168.417,"","",""
"5FYJ","CRYSTAL STRUCTURE AT 3.4 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE G X1193.C1 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122, 35O22 AND VRC01","10.1016/J.CELL.2016.04.010 ",3.11,0,"5fyj_oligo14","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_T_)-MAN(5_T_)-[MAN(7_T_)]-MAN(4_T_)-[MAN(9_T_)-MAN(8_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(293_G_)",166.95,"","",""
"5FYJ","CRYSTAL STRUCTURE AT 3.4 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE G X1193.C1 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122, 35O22 AND VRC01","10.1016/J.CELL.2016.04.010 ",3.11,0,"5fyj_oligo17","DManpa1-2DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Y_)-MAN(5_Y_)-MAN(4_Y_)-[MAN(7_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(344_G_)",178.651,"","",""
"5FYJ","CRYSTAL STRUCTURE AT 3.4 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE G X1193.C1 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122, 35O22 AND VRC01","10.1016/J.CELL.2016.04.010 ",3.11,0,"5fyj_oligo9","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_Q_)-MAN(6_Q_)-[MAN(5_Q_)-MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(241_G_)",151.474,"","",""
"5FYJ","CRYSTAL STRUCTURE AT 3.4 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE G X1193.C1 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122, 35O22 AND VRC01","10.1016/J.CELL.2016.04.010 ",3.11,0,"5fyj_oligo24","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_f_)-MAN(4_f_)-[MAN(6_f_)]-BMA(3_f_)-NAG(2_f_)-NAG(1_f_)-ASN(72_V_)",206.778,"","",""
"5FYJ","CRYSTAL STRUCTURE AT 3.4 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE G X1193.C1 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122, 35O22 AND VRC01","10.1016/J.CELL.2016.04.010 ",3.11,0,"5fyj_oligo6","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(10_N_)-[MAN(9_N_)-MAN(8_N_)]-MAN(7_N_)-[MAN(6_N_)-MAN(5_N_)-MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(188_G_)",186.881,"","",""
"5FYJ","CRYSTAL STRUCTURE AT 3.4 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE G X1193.C1 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122, 35O22 AND VRC01","10.1016/J.CELL.2016.04.010 ",3.11,0,"5fyj_oligo21","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_c_)-[MAN(6_c_)-MAN(5_c_)-MAN(4_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(442_G_)",184.853,"","",""
"5FYJ","CRYSTAL STRUCTURE AT 3.4 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE G X1193.C1 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122, 35O22 AND VRC01","10.1016/J.CELL.2016.04.010 ",3.11,0,"5fyj_oligo8","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_P_)-[MAN(5_P_)-MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(234_G_)",172.485,"","",""
"5FYJ","CRYSTAL STRUCTURE AT 3.4 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE G X1193.C1 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122, 35O22 AND VRC01","10.1016/J.CELL.2016.04.010 ",3.11,0,"5fyj_oligo1","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_J_)-[MAN(7_J_)]-MAN(6_J_)-[MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(88_G_)",99.6225,"","",""
"5FYJ","CRYSTAL STRUCTURE AT 3.4 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE G X1193.C1 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122, 35O22 AND VRC01","10.1016/J.CELL.2016.04.010 ",3.11,0,"5fyj_oligo12","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_R_)-MAN(10_R_)-[MAN(9_R_)-MAN(8_R_)]-MAN(7_R_)-[MAN(6_R_)-MAN(5_R_)-MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(262_G_)",105.178,"","",""
"5FYJ","CRYSTAL STRUCTURE AT 3.4 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE G X1193.C1 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122, 35O22 AND VRC01","10.1016/J.CELL.2016.04.010 ",3.11,0,"5fyj_oligo13","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_S_)-MAN(8_S_)-MAN(7_S_)-[MAN(6_S_)-MAN(5_S_)-MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(276_G_)",133.007,"","",""
"5FYJ","CRYSTAL STRUCTURE AT 3.4 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE G X1193.C1 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122, 35O22 AND VRC01","10.1016/J.CELL.2016.04.010 ",3.11,0,"5fyj_oligo15","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_W_)-MAN(4_W_)-[MAN(6_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(301_G_)",149.828,"","",""
"5FYJ","CRYSTAL STRUCTURE AT 3.4 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE G X1193.C1 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122, 35O22 AND VRC01","10.1016/J.CELL.2016.04.010 ",3.11,0,"5fyj_oligo4","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_K_)-MAN(10_K_)-[MAN(9_K_)-MAN(8_K_)]-MAN(7_K_)-[MAN(6_K_)-MAN(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(156_G_)",174.865,"","",""
"5FYJ","CRYSTAL STRUCTURE AT 3.4 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE G X1193.C1 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122, 35O22 AND VRC01","10.1016/J.CELL.2016.04.010 ",3.11,0,"5fyj_oligo16","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(10_X_)-[MAN(9_X_)-MAN(8_X_)]-MAN(7_X_)-[MAN(6_X_)-MAN(5_X_)-MAN(4_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(332_G_)",118.047,"","",""
"5FYJ","CRYSTAL STRUCTURE AT 3.4 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE G X1193.C1 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122, 35O22 AND VRC01","10.1016/J.CELL.2016.04.010 ",3.11,0,"5fyj_oligo5","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(10_M_)-[MAN(9_M_)-MAN(8_M_)]-MAN(7_M_)-[MAN(6_M_)-MAN(5_M_)-MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(160_G_)",194.512,"","",""
"5FYJ","CRYSTAL STRUCTURE AT 3.4 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE G X1193.C1 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122, 35O22 AND VRC01","10.1016/J.CELL.2016.04.010 ",3.11,0,"5fyj_oligo23","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_e_)-MAN(4_e_)-[MAN(6_e_)]-BMA(3_e_)-NAG(2_e_)-NAG(1_e_)-ASN(23_H_)",185.879,"","",""
"5FYJ","CRYSTAL STRUCTURE AT 3.4 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE G X1193.C1 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122, 35O22 AND VRC01","10.1016/J.CELL.2016.04.010 ",3.11,0,"5fyj_oligo20","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_b_)-MAN(7_b_)-[MAN(6_b_)-MAN(5_b_)]-MAN(4_b_)-[MAN(10_b_)-MAN(9_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(413_G_)",165.571,"","",""
"5FYK","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE B JR-FL SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122, 35O22 AND VRC01","10.1016/J.CELL.2016.04.010 ",3.11,0,"5fyk_oligo13","DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_S_)-MAN(6_S_)-[MAN(5_S_)-MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(355_G_)",214.982,"","",""
"5FYK","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE B JR-FL SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122, 35O22 AND VRC01","10.1016/J.CELL.2016.04.010 ",3.11,0,"5fyk_oligo12","DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_R_)-MAN(6_R_)-[MAN(5_R_)-MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(339_G_)",209.694,"","",""
"5FYK","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE B JR-FL SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122, 35O22 AND VRC01","10.1016/J.CELL.2016.04.010 ",3.11,0,"5fyk_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(295_G_)",190.332,"","",""
"5FYK","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE B JR-FL SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122, 35O22 AND VRC01","10.1016/J.CELL.2016.04.010 ",3.11,0,"5fyk_oligo8","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)]-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(88_G_)",125.012,"","",""
"5FYK","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE B JR-FL SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122, 35O22 AND VRC01","10.1016/J.CELL.2016.04.010 ",3.11,0,"5fyk_oligo15","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_W_)-MAN(5_W_)-[MAN(7_W_)]-MAN(4_W_)-[MAN(8_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(386_G_)",210.642,"","",""
"5FYK","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE B JR-FL SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122, 35O22 AND VRC01","10.1016/J.CELL.2016.04.010 ",3.11,0,"5fyk_oligo20","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_b_)-MAN(4_b_)-[MAN(6_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(72_V_)",252.938,"","",""
"5FYK","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE B JR-FL SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122, 35O22 AND VRC01","10.1016/J.CELL.2016.04.010 ",3.11,0,"5fyk_oligo10","DManpa1-2DManpa1-3DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_P_)-MAN(5_P_)-MAN(4_P_)-[MAN(8_P_)-MAN(7_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(301_G_)",201.351,"","",""
"5FYK","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE B JR-FL SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122, 35O22 AND VRC01","10.1016/J.CELL.2016.04.010 ",3.11,0,"5fyk_oligo18","DManpa1-2DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Z_)-MAN(5_Z_)-MAN(4_Z_)-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(448_G_)",178.435,"","",""
"5FYK","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE B JR-FL SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122, 35O22 AND VRC01","10.1016/J.CELL.2016.04.010 ",3.11,0,"5fyk_oligo14","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_T_)-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(362_G_)",189.539,"","",""
"5FYK","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE B JR-FL SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122, 35O22 AND VRC01","10.1016/J.CELL.2016.04.010 ",3.11,0,"5fyk_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_K_)-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(241_G_)",145.707,"","",""
"5FYK","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE B JR-FL SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122, 35O22 AND VRC01","10.1016/J.CELL.2016.04.010 ",3.11,0,"5fyk_oligo16","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_X_)-MAN(4_X_)-[MAN(6_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(392_G_)",198.407,"","",""
"5FYK","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE B JR-FL SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122, 35O22 AND VRC01","10.1016/J.CELL.2016.04.010 ",3.11,0,"5fyk_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_F_)-[MAN(8_F_)]-MAN(7_F_)-[MAN(6_F_)-MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(156_G_)",194.613,"","",""
"5FYK","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE B JR-FL SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122, 35O22 AND VRC01","10.1016/J.CELL.2016.04.010 ",3.11,0,"5fyk_oligo11","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(10_Q_)-[MAN(9_Q_)-MAN(8_Q_)]-MAN(7_Q_)-[MAN(6_Q_)-MAN(5_Q_)-MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(332_G_)",135.796,"","",""
"5FYK","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE B JR-FL SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122, 35O22 AND VRC01","10.1016/J.CELL.2016.04.010 ",3.11,0,"5fyk_oligo5","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_M_)-[MAN(8_M_)]-MAN(7_M_)-[MAN(6_M_)-MAN(5_M_)-MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(262_G_)",153.131,"","",""
"5FYK","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE B JR-FL SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122, 35O22 AND VRC01","10.1016/J.CELL.2016.04.010 ",3.11,0,"5fyk_oligo3","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_J_)-MAN(5_J_)-[MAN(7_J_)]-MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(187_G_)",233.019,"","",""
"5FYK","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE B JR-FL SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122, 35O22 AND VRC01","10.1016/J.CELL.2016.04.010 ",3.11,0,"5fyk_oligo2","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_I_)-[MAN(6_I_)-MAN(5_I_)]-MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(160_G_)",209.568,"","",""
"5FYK","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE B JR-FL SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122, 35O22 AND VRC01","10.1016/J.CELL.2016.04.010 ",3.11,0,"5fyk_oligo6","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_N_)-MAN(7_N_)-[MAN(6_N_)-MAN(5_N_)-MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(276_G_)",172.965,"","",""
"5FYL","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE A BG505 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122 AND 35O22","10.1016/J.CELL.2016.04.010 ",3.1,0,"5fyl_oligo15","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_U_)-[MAN(5_U_)-MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(386_G_)",149.172,"","",""
"5FYL","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE A BG505 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122 AND 35O22","10.1016/J.CELL.2016.04.010 ",3.1,0,"5fyl_oligo18","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_X_)-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(23_H_)",198.95,"","",""
"5FYL","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE A BG505 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122 AND 35O22","10.1016/J.CELL.2016.04.010 ",3.1,0,"5fyl_oligo12","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(234_G_)",158.146,"","",""
"5FYL","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE A BG505 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122 AND 35O22","10.1016/J.CELL.2016.04.010 ",3.1,0,"5fyl_oligo9","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_J_)-MAN(5_J_)-[MAN(7_J_)]-MAN(4_J_)-[MAN(9_J_)-MAN(8_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(156_G_)",154.604,"","",""
"5FYL","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE A BG505 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122 AND 35O22","10.1016/J.CELL.2016.04.010 ",3.1,0,"5fyl_oligo3","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_Q_)-MAN(6_Q_)-[MAN(5_Q_)-MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(295_G_)",154.935,"","",""
"5FYL","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE A BG505 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122 AND 35O22","10.1016/J.CELL.2016.04.010 ",3.1,0,"5fyl_oligo10","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_K_)-MAN(7_K_)-[MAN(6_K_)-MAN(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(160_G_)",169.419,"","",""
"5FYL","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE A BG505 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122 AND 35O22","10.1016/J.CELL.2016.04.010 ",3.1,0,"5fyl_oligo5","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(10_S_)-[MAN(9_S_)-MAN(8_S_)]-MAN(7_S_)-[MAN(6_S_)-MAN(5_S_)-MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(332_G_)",102.294,"","",""
"5FYL","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE A BG505 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122 AND 35O22","10.1016/J.CELL.2016.04.010 ",3.1,0,"5fyl_oligo4","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_R_)-[MAN(7_R_)]-MAN(6_R_)-[MAN(5_R_)-MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(301_G_)",171.064,"","",""
"5FYL","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE A BG505 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122 AND 35O22","10.1016/J.CELL.2016.04.010 ",3.1,0,"5fyl_oligo8","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_I_)-[MAN(5_I_)]-MAN(4_I_)-[MAN(7_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(137_G_)",161.521,"","",""
"5FYL","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE A BG505 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122 AND 35O22","10.1016/J.CELL.2016.04.010 ",3.1,0,"5fyl_oligo11","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-MAN(4_M_)-[MAN(6_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(197_G_)",167.726,"","",""
"5FYL","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE A BG505 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122 AND 35O22","10.1016/J.CELL.2016.04.010 ",3.1,0,"5fyl_oligo6","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)]-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(88_G_)",118.272,"","",""
"5FYL","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE A BG505 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122 AND 35O22","10.1016/J.CELL.2016.04.010 ",3.1,0,"5fyl_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_P_)-[MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(276_G_)",179.967,"","",""
"5FYL","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE A BG505 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122 AND 35O22","10.1016/J.CELL.2016.04.010 ",3.1,0,"5fyl_oligo16","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_V_)-[MAN(5_V_)-MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(392_G_)",169.107,"","",""
"5FYL","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE A BG505 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122 AND 35O22","10.1016/J.CELL.2016.04.010 ",3.1,0,"5fyl_oligo13","DManpa1-2DManpa1-3DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_O_)-MAN(5_O_)-MAN(4_O_)-[MAN(8_O_)-MAN(7_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(262_G_)",135.994,"","",""
"5FYN","SUB-TOMOGRAM AVERAGING OF TULA VIRUS GLYCOPROTEIN SPIKE","10.1016/J.CELREP.2016.03.082 ",15.6,0,"5fyn_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(142_A_)",78.538,"","",""
"5G64","THE COMPLEX BETWEEN HUMAN IGE-FC AND TWO ANTI-IGE FAB FRAGMENTS","10.1074/JBC.M117.776476 ",3.72,0,"5g64_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(394_A_)",160.04,"","",""
"5G64","THE COMPLEX BETWEEN HUMAN IGE-FC AND TWO ANTI-IGE FAB FRAGMENTS","10.1074/JBC.M117.776476 ",3.72,0,"5g64_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(394_B_)",142.165,"","",""
"5GGO","CRYSTAL STRUCTURE OF N-TERMINAL DOMAIN OF HUMAN PROTEIN O-MANNOSE BETA-1,2-N-ACETYLGLUCOSAMINYLTRANSFERASE IN COMPLEX WITH GALNAC- BETA1,3-GLCNAC-BETA-PNP","10.1073/PNAS.1525545113 ",1.5,0,"5ggo_oligo1","DGalpNAcb1-3DGlcpNAcb1-C6N1O3","NGA(2_D_)-LEC(1_D_)",27.7014,"","",""
"5GGO","CRYSTAL STRUCTURE OF N-TERMINAL DOMAIN OF HUMAN PROTEIN O-MANNOSE BETA-1,2-N-ACETYLGLUCOSAMINYLTRANSFERASE IN COMPLEX WITH GALNAC- BETA1,3-GLCNAC-BETA-PNP","10.1073/PNAS.1525545113 ",1.5,0,"5ggo_oligo2","DGalpNAcb1-3DGlcpNAcb1-C6N1O3","NGA(2_C_)-LEC(1_C_)",32.1886,"","",""
"5GLT","TL-GAL WITH LNT","10.1074/JBC.M116.743773 ",2,30.56,"5glt_oligo2","DGalpb1-3DGlcpNAcb1-3DGalpb1-4DGlcpb1-ROH","GAL(4_D_)-NAG(3_D_)-GAL(2_D_)-BGC(1_D_)",74.9134,"","",""
"5GLT","TL-GAL WITH LNT","10.1074/JBC.M116.743773 ",2,30.56,"5glt_oligo1","DGalpb1-3DGlcpNAcb1-3DGalpb1-4DGlcpb1-ROH","GAL(4_E_)-NAG(3_E_)-GAL(2_E_)-BGC(1_E_)",75.4007,"","",""
"5GLT","TL-GAL WITH LNT","10.1074/JBC.M116.743773 ",2,30.56,"5glt_oligo3","DGalpb1-3DGlcpNAcb1-3DGalpb1-4DGlcpb1-ROH","GAL(4_C_)-NAG(3_C_)-GAL(2_C_)-BGC(1_C_)",74.9354,"","",""
"5GMQ","STRUCTURE OF MERS-COV RBD IN COMPLEX WITH A FULLY HUMAN ANTIBODY MCA1","10.1093/INFDIS/JIX209 ",2.7,0,"5gmq_oligo1","DManpa1-3DManpa1-4DGlcpNAcx1-","MAN(3_D_)-MAN(2_D_)-NAG(1_D_)",57.1875,"","",""
"5GQF","CRYSTAL STRUCTURE OF LACTO-N-BIOSIDASE LNBX FROM BIFIDOBACTERIUM LONGUM SUBSP. LONGUM, LACTO-N-BIOSE COMPLEX","10.1016/J.CHEMBIOL.2017.03.012 ",1.82,35.3,"5gqf_oligo2","DGalpb1-3DGlcpNAcb1-ROH","GAL(2_D_)-NAG(1_D_)",30.87,"","",""
"5GQF","CRYSTAL STRUCTURE OF LACTO-N-BIOSIDASE LNBX FROM BIFIDOBACTERIUM LONGUM SUBSP. LONGUM, LACTO-N-BIOSE COMPLEX","10.1016/J.CHEMBIOL.2017.03.012 ",1.82,35.3,"5gqf_oligo1","DGalpb1-3DGlcpNAcb1-ROH","GAL(2_C_)-NAG(1_C_)",27.6473,"","",""
"5GQG","CRYSTAL STRUCTURE OF LACTO-N-BIOSIDASE LNBX FROM BIFIDOBACTERIUM LONGUM SUBSP. LONGUM, GALACTO-N-BIOSE COMPLEX","10.1016/J.CHEMBIOL.2017.03.012 ",2.7,50.16,"5gqg_oligo1","DGalpb1-3DGalpNAcb1-ROH","GAL(2_C_)-NGA(1_C_)",43.5559,"","",""
"5GQG","CRYSTAL STRUCTURE OF LACTO-N-BIOSIDASE LNBX FROM BIFIDOBACTERIUM LONGUM SUBSP. LONGUM, GALACTO-N-BIOSE COMPLEX","10.1016/J.CHEMBIOL.2017.03.012 ",2.7,50.16,"5gqg_oligo2","DGalpb1-3DGalpNAcb1-ROH","GAL(2_D_)-NGA(1_D_)",42.5059,"","",""
"5GSQ","CRYSTAL STRUCTURE OF IGG FC WITH A HOMOGENEOUS GLYCOFORM AND ANTIBODY- DEPENDENT CELLULAR CYTOTOXICITY","10.1021/ACSCHEMBIO.7B00140 ",1.85,28.21,"5gsq_oligo3","DNeup5Aca2-6DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","SIA(7_G_)-GAL(6_G_)-NAG(5_G_)-MAN(4_G_)-[MAN(8_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(297_C_)",33.4821,"","",""
"5GSQ","CRYSTAL STRUCTURE OF IGG FC WITH A HOMOGENEOUS GLYCOFORM AND ANTIBODY- DEPENDENT CELLULAR CYTOTOXICITY","10.1021/ACSCHEMBIO.7B00140 ",1.85,28.21,"5gsq_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_F_)-NAG(5_F_)-MAN(4_F_)-[MAN(7_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(297_B_)",34.3694,"","",""
"5GSQ","CRYSTAL STRUCTURE OF IGG FC WITH A HOMOGENEOUS GLYCOFORM AND ANTIBODY- DEPENDENT CELLULAR CYTOTOXICITY","10.1021/ACSCHEMBIO.7B00140 ",1.85,28.21,"5gsq_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(297_A_)",29.2103,"","",""
"5GZ4","CRYSTAL STRUCTURE OF SNAKE VENOM PHOSPHODIESTERASE (PDE) FROM TAIWAN COBRA (NAJA ATRA ATRA)","",2.55,0,"5gz4_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(512_A_)",52.4624,"","",""
"5GZ5","CRYSTAL STRUCTURE OF SNAKE VENOM PHOSPHODIESTERASE (PDE) FROM TAIWAN COBRA (NAJA ATRA ATRA) IN COMPLEX WITH AMP","",2.09,0,"5gz5_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(512_A_)",53.353,"","",""
"5GZA","PROTEIN O-MANNOSE KINASE","10.7554/ELIFE.22238 ",2,52.25,"5gza_oligo2","DGalpNAcb1-3DGlcpNAcb1-4DManpa1-C10O3","NGA(3_B_)-NAG(2_B_)-MAN(1_B_)",51.9667,"","",""
"5HBT","COMPLEX STRUCTURE OF FAB35 AND HUMAN NACHR ALPHA1","10.7554/ELIFE.23043 ",2.61,56.34,"5hbt_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_E_)-[MAN(8_E_)]-MAN(7_E_)-[MAN(6_E_)-MAN(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(141_B_)",83.4052,"","",""
"5HBV","COMPLEX STRUCTURE OF FAB35 AND MOUSE NACHR ALPHA1","10.7554/ELIFE.23043 ",2.7,67.87,"5hbv_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_E_)-[MAN(8_E_)]-MAN(7_E_)-[MAN(6_E_)-MAN(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(141_B_)",79.6292,"","",""
"5HDB","INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH RO-435054","10.1074/JBC.M115.705624 ",2.7,0,"5hdb_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(320_D_)",128.404,"","",""
"5HDB","INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH RO-435054","10.1074/JBC.M115.705624 ",2.7,0,"5hdb_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(320_B_)",117.188,"","",""
"5HDH","CRYSTAL STRUCTURE OF HUMAN TLR8 WITH AN UNCLEAVED Z-LOOP","10.1073/PNAS.1516000113 ",2.6,80.14,"5hdh_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(590_A_)",84.6678,"","",""
"5HJ3","CRYSTAL STRUCTURE OF HOST-PRIMED EBOLA VIRUS GP, GPCL.","10.1128/MBIO.02154-15 ",3.3,144.6,"5hj3_oligo3","DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_S_)-MAN(6_S_)-[MAN(5_S_)-MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(563_L_)",201.54,"","",""
"5HJ3","CRYSTAL STRUCTURE OF HOST-PRIMED EBOLA VIRUS GP, GPCL.","10.1128/MBIO.02154-15 ",3.3,144.6,"5hj3_oligo1","DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_Q_)-MAN(6_Q_)-[MAN(5_Q_)-MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(563_D_)",200.743,"","",""
"5HJ3","CRYSTAL STRUCTURE OF HOST-PRIMED EBOLA VIRUS GP, GPCL.","10.1128/MBIO.02154-15 ",3.3,144.6,"5hj3_oligo4","DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_T_)-MAN(6_T_)-[MAN(5_T_)-MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(563_P_)",201.012,"","",""
"5HJ3","CRYSTAL STRUCTURE OF HOST-PRIMED EBOLA VIRUS GP, GPCL.","10.1128/MBIO.02154-15 ",3.3,144.6,"5hj3_oligo2","DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_R_)-MAN(6_R_)-[MAN(5_R_)-MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(563_H_)",201.356,"","",""
"5HJO","MURINE ENDOPLASMIC RETICULUM ALPHA-GLUCOSIDASE II WITH BOUND SUBSTRATE ANALOGUE","10.1073/PNAS.1604463113 ",2.29,46.79,"5hjo_oligo6","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(97_C_)",72.0734,"","",""
"5HJO","MURINE ENDOPLASMIC RETICULUM ALPHA-GLUCOSIDASE II WITH BOUND SUBSTRATE ANALOGUE","10.1073/PNAS.1604463113 ",2.29,46.79,"5hjo_oligo1","DManp[2H]a1-3DManp[2H]x1-","Z61(2_G_)-DGO(1_G_)",39.5388,"","",""
"5HJO","MURINE ENDOPLASMIC RETICULUM ALPHA-GLUCOSIDASE II WITH BOUND SUBSTRATE ANALOGUE","10.1073/PNAS.1604463113 ",2.29,46.79,"5hjo_oligo2","DManp[2H]a1-3DManp[2H]x1-","Z61(2_H_)-DGO(1_H_)",41.2517,"","",""
"5HJO","MURINE ENDOPLASMIC RETICULUM ALPHA-GLUCOSIDASE II WITH BOUND SUBSTRATE ANALOGUE","10.1073/PNAS.1604463113 ",2.29,46.79,"5hjo_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(97_A_)",79.0486,"","",""
"5HJR","MURINE ENDOPLASMIC RETICULUM ALPHA-GLUCOSIDASE II WITH BOUND COVALENT INTERMEDIATE","10.1073/PNAS.1604463113 ",2.4,59.28,"5hjr_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(97_C_)",95.2473,"","",""
"5HJR","MURINE ENDOPLASMIC RETICULUM ALPHA-GLUCOSIDASE II WITH BOUND COVALENT INTERMEDIATE","10.1073/PNAS.1604463113 ",2.4,59.28,"5hjr_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(97_A_)",104.339,"","",""
"5HNS","STRUCTURE OF GLYCOSYLATED NPC1 LUMINAL DOMAIN C","10.1002/1873-3468.12089 ",2.45,73.01,"5hns_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(557_B_)",113.04,"","",""
"5HRT","CRYSTAL STRUCTURE OF MOUSE AUTOTAXIN IN COMPLEX WITH A DNA APTAMER","10.1038/NSMB.3200 ",2,0,"5hrt_oligo12","DManpa1-2DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-MAN(5_C_)-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(524_A_)",54.101,"","",""
"5HRT","CRYSTAL STRUCTURE OF MOUSE AUTOTAXIN IN COMPLEX WITH A DNA APTAMER","10.1038/NSMB.3200 ",2,0,"5hrt_oligo9","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(410_A_)",52.7202,"","",""
"5HUK","THE CRYSTAL STRUCTURE OF NEURAMINIDASE FROM A/NORTHERN PINTAIL/WASHINGTON/40964/2014 INFLUENZA VIRUS","10.1128/JVI.00180-16 ",2.45,46,"5huk_oligo5","DManpa1-2DManpa1-3[DManpa1-3DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_I_)-MAN(6_I_)-[MAN(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(200_B_)",88.1809,"","",""
"5HUK","THE CRYSTAL STRUCTURE OF NEURAMINIDASE FROM A/NORTHERN PINTAIL/WASHINGTON/40964/2014 INFLUENZA VIRUS","10.1128/JVI.00180-16 ",2.45,46,"5huk_oligo3","DManpa1-2DManpa1-3[DManpa1-3DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_G_)-MAN(6_G_)-[MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(200_A_)",60.9379,"","",""
"5HUK","THE CRYSTAL STRUCTURE OF NEURAMINIDASE FROM A/NORTHERN PINTAIL/WASHINGTON/40964/2014 INFLUENZA VIRUS","10.1128/JVI.00180-16 ",2.45,46,"5huk_oligo9","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_M_)-MAN(6_M_)-[MAN(5_M_)-MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(200_D_)",66.1547,"","",""
"5HUK","THE CRYSTAL STRUCTURE OF NEURAMINIDASE FROM A/NORTHERN PINTAIL/WASHINGTON/40964/2014 INFLUENZA VIRUS","10.1128/JVI.00180-16 ",2.45,46,"5huk_oligo7","DManpa1-2DManpa1-3[DManpa1-3DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_K_)-MAN(6_K_)-[MAN(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(200_C_)",70.9693,"","",""
"5HVF","CRYSTAL STRUCTURE OF THROMBIN-ACTIVATABLE FIBRINOLYSIS INHIBITOR IN COMPLEX WITH AN INHIBITORY NANOBODY (VHH-I83)","10.1111/JTH.13381 ",2.85,62.45,"5hvf_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(22_A_)",61.5645,"","",""
"5HVG","CRYSTAL STRUCTURE OF THROMBIN-ACTIVATABLE FIBRINOLYSIS INHIBITOR IN COMPLEX WITH AN INHIBITORY NANOBODY (VHH-A204)","10.1111/JTH.13381 ",3.05,85.02,"5hvg_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(22_A_)",152.841,"","",""
"5HVW","MONOMERIC IGG4 FC","10.1371/JOURNAL.PONE.0160345 ",1.95,66.13,"5hvw_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(9_B_)-[GAL(6_B_)-NAG(5_B_)-MAN(4_B_)-[NAG(8_B_)-MAN(7_B_)]-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(297_A_)",103.175,"","",""
"5HY9","GLYCOSYLATED, DISULFIDE-LINKED KNOB-INTO-HOLE FC FRAGMENT","10.1093/PROTEIN/GZX041 ",2.7,92.03,"5hy9_oligo1","DGalpb1-4DGlcpNAcb1-2DManpb1-6[DGlcpNAcb1-2DManpb1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_C_)-[GAL(6_C_)-NAG(5_C_)-BMA(4_C_)-[NAG(8_C_)-BMA(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",47.8242,"","",""
"5HY9","GLYCOSYLATED, DISULFIDE-LINKED KNOB-INTO-HOLE FC FRAGMENT","10.1093/PROTEIN/GZX041 ",2.7,92.03,"5hy9_oligo2","DGlcpNAcb1-2DManpb1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_D_)-[NAG(5_D_)-BMA(4_D_)-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",94.4974,"","",""
"5HYE","GLYCOSYLATED KNOB-KNOB FC FRAGMENT (P212121)","10.1093/PROTEIN/GZX041 ",1.89,62.68,"5hye_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpb1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_B_)-[GAL(6_B_)-NAG(5_B_)-BMA(4_B_)-[NAG(8_B_)-BMA(7_B_)]-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(297_A_)",49.8034,"","",""
"5HYE","GLYCOSYLATED KNOB-KNOB FC FRAGMENT (P212121)","10.1093/PROTEIN/GZX041 ",1.89,62.68,"5hye_oligo1","DGalpb1-4DGlcpNAcb1-2DManpb1-6[DGlcpNAcb1-2DManpb1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_D_)-[GAL(6_D_)-NAG(5_D_)-BMA(4_D_)-[NAG(8_D_)-BMA(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_C_)",109.557,"","",""
"5HYF","GLYCOSYLATED KNOB-KNOB FC FRAGMENT (P6122)","10.1093/PROTEIN/GZX041 ",1.8,39.51,"5hyf_oligo1","DGalpb1-4DGlcpNAcb1-2DManpb1-6[DGlcpNAcb1-2DManpb1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_B_)-[GAL(6_B_)-NAG(5_B_)-BMA(4_B_)-[NAG(8_B_)-BMA(7_B_)]-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(297_A_)",54.3523,"","",""
"5HYI","GLYCOSYLATED, DISULFIDE-LINKED HOLE-HOLE FC FRAGMENT","10.1093/PROTEIN/GZX041 ",2.9,95.59,"5hyi_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[NAG(8_E_)-MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_A_)",115.86,"","",""
"5HYI","GLYCOSYLATED, DISULFIDE-LINKED HOLE-HOLE FC FRAGMENT","10.1093/PROTEIN/GZX041 ",2.9,95.59,"5hyi_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_F_)-[GAL(6_F_)-NAG(5_F_)-MAN(4_F_)-[NAG(8_F_)-MAN(7_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(297_B_)",132.336,"","",""
"5HYI","GLYCOSYLATED, DISULFIDE-LINKED HOLE-HOLE FC FRAGMENT","10.1093/PROTEIN/GZX041 ",2.9,95.59,"5hyi_oligo3","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_G_)-[GAL(6_G_)-NAG(5_G_)-MAN(4_G_)-[NAG(8_G_)-MAN(7_G_)]-BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(297_C_)",134.99,"","",""
"5HYI","GLYCOSYLATED, DISULFIDE-LINKED HOLE-HOLE FC FRAGMENT","10.1093/PROTEIN/GZX041 ",2.9,95.59,"5hyi_oligo4","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_H_)-[GAL(6_H_)-NAG(5_H_)-MAN(4_H_)-[NAG(8_H_)-MAN(7_H_)]-BMA(3_H_)-NAG(2_H_)]-NAG(1_H_)-ASN(297_D_)",118.569,"","",""
"5HYS","STRUCTURE OF IGE COMPLEXED WITH OMALIZUMAB","10.1038/NCOMMS11610 ",2.5,71.06,"5hys_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_P_)-[MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(394_K_)",107.903,"","",""
"5HYS","STRUCTURE OF IGE COMPLEXED WITH OMALIZUMAB","10.1038/NCOMMS11610 ",2.5,71.06,"5hys_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(394_G_)",96.3784,"","",""
"5HYS","STRUCTURE OF IGE COMPLEXED WITH OMALIZUMAB","10.1038/NCOMMS11610 ",2.5,71.06,"5hys_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(394_I_)",105.043,"","",""
"5HYS","STRUCTURE OF IGE COMPLEXED WITH OMALIZUMAB","10.1038/NCOMMS11610 ",2.5,71.06,"5hys_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(394_J_)",108.731,"","",""
"5HZA","CRYSTAL STRUCTURE OF GII.10 P DOMAIN IN COMPLEX WITH 3-FUCOSYLLACTOSE (3 FL)","10.1128/JVI.03223-15 ",1.35,0,"5hza_oligo1","LFucpa1-3[DGalpb1-4]DGlcpb1-ROH","GAL(3_C_)-[FUC(2_C_)]-BGC(1_C_)",17.5655,"","",""
"5I0D","CYCLOALTERNAN-FORMING ENZYME FROM LISTERIA MONOCYTOGENES IN COMPLEX WITH CYCLOALTERNAN","10.1016/J.STR.2016.12.007 ",1.77,20.2,"5i0d_oligo3","DGlcpa1-3DGlcpa1-6DGlcpa1-ROH","GLC(3_G_)-GLC(2_G_)-GLC(1_G_)",32.6876,"","",""
"5I81","ASMASE WITH ZINC","10.1038/NCOMMS13082 ",2.25,0,"5i81_oligo4","DManpb1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(2_D_)-MAN(1_D_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(395_A_)",96.4687,"","",""
"5I85","ASMASE WITH ZINC AND PHOSPHOCHOLINE","10.1038/NCOMMS13082 ",2.5,0,"5i85_oligo2","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(395_A_)",83.4347,"","",""
"5I8H","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH V3 LOOP-TARGETING ANTIBODY PGT122 FAB AND FUSION PEPTIDE-TARGETING ANTIBODY VRC34.01 FAB","10.1126/SCIENCE.AAE0474 ",4.3,215.7,"5i8h_oligo10","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Z_)-[MAN(5_Z_)]-MAN(4_Z_)-[MAN(7_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(88_C_)",206.227,"","",""
"5I8H","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH V3 LOOP-TARGETING ANTIBODY PGT122 FAB AND FUSION PEPTIDE-TARGETING ANTIBODY VRC34.01 FAB","10.1126/SCIENCE.AAE0474 ",4.3,215.7,"5i8h_oligo4","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(10_U_)-[MAN(9_U_)-MAN(8_U_)]-MAN(7_U_)-[MAN(6_U_)-MAN(5_U_)-MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(332_A_)",215.123,"","",""
"5I8H","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH V3 LOOP-TARGETING ANTIBODY PGT122 FAB AND FUSION PEPTIDE-TARGETING ANTIBODY VRC34.01 FAB","10.1126/SCIENCE.AAE0474 ",4.3,215.7,"5i8h_oligo27","DTalpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_m_)-BMA(3_m_)-NAG(2_m_)-NAG(1_m_)-ASN(137_A_)",261.496,"","",""
"5I8H","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH V3 LOOP-TARGETING ANTIBODY PGT122 FAB AND FUSION PEPTIDE-TARGETING ANTIBODY VRC34.01 FAB","10.1126/SCIENCE.AAE0474 ",4.3,215.7,"5i8h_oligo5","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_M_)-[MAN(5_M_)]-MAN(4_M_)-[MAN(7_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(88_A_)",206.958,"","",""
"5I8H","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH V3 LOOP-TARGETING ANTIBODY PGT122 FAB AND FUSION PEPTIDE-TARGETING ANTIBODY VRC34.01 FAB","10.1126/SCIENCE.AAE0474 ",4.3,215.7,"5i8h_oligo11","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_a_)-[MAN(4_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(156_C_)",240.049,"","",""
"5I8H","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH V3 LOOP-TARGETING ANTIBODY PGT122 FAB AND FUSION PEPTIDE-TARGETING ANTIBODY VRC34.01 FAB","10.1126/SCIENCE.AAE0474 ",4.3,215.7,"5i8h_oligo19","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(6_R_)-[MAN(5_R_)-MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)",218.41,"","",""
"5I8H","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH V3 LOOP-TARGETING ANTIBODY PGT122 FAB AND FUSION PEPTIDE-TARGETING ANTIBODY VRC34.01 FAB","10.1126/SCIENCE.AAE0474 ",4.3,215.7,"5i8h_oligo22","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(10_h_)-[MAN(9_h_)-MAN(8_h_)]-MAN(7_h_)-[MAN(6_h_)-MAN(5_h_)-MAN(4_h_)]-BMA(3_h_)-NAG(2_h_)-NAG(1_h_)-ASN(332_C_)",217.212,"","",""
"5I8H","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH V3 LOOP-TARGETING ANTIBODY PGT122 FAB AND FUSION PEPTIDE-TARGETING ANTIBODY VRC34.01 FAB","10.1126/SCIENCE.AAE0474 ",4.3,215.7,"5i8h_oligo20","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(156_A_)",248.067,"","",""
"5I8H","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH V3 LOOP-TARGETING ANTIBODY PGT122 FAB AND FUSION PEPTIDE-TARGETING ANTIBODY VRC34.01 FAB","10.1126/SCIENCE.AAE0474 ",4.3,215.7,"5i8h_oligo15","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_e_)-[MAN(5_e_)-MAN(4_e_)]-BMA(3_e_)-NAG(2_e_)-NAG(1_e_)-ASN(262_C_)",234.518,"","",""
"5I8O","HMM5 FAB IN COMPLEX WITH DISACCHARIDE","",1.8,20.15,"5i8o_oligo1","LFucpa1-3DGlcpNAca1-OME","FUC(2_A_)-2F8(1_A_)",32.6318,"","",""
"5I9Q","CRYSTAL STRUCTURE OF 3BNC55 FAB IN COMPLEX WITH 426C.TM4DELTAV1-3 GP120","10.7554/ELIFE.13783 ",3,0,"5i9q_oligo1","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(6_D_)-[MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)",58.856,"","",""
"5I9Q","CRYSTAL STRUCTURE OF 3BNC55 FAB IN COMPLEX WITH 426C.TM4DELTAV1-3 GP120","10.7554/ELIFE.13783 ",3,0,"5i9q_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(262_G_)",109.447,"","",""
"5IFP","STRUCTURE OF BETA-GALACTOSIDASE FROM ASPERGILLUS NIGER","10.1111/FEBS.14083 ",1.71,12.62,"5ifp_oligo4","DManpa1-2DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-MAN(5_E_)-MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(914_A_)",24.308,"","",""
"5IFP","STRUCTURE OF BETA-GALACTOSIDASE FROM ASPERGILLUS NIGER","10.1111/FEBS.14083 ",1.71,12.62,"5ifp_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_C_)-MAN(7_C_)-[MAN(6_C_)-MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(622_A_)",21.0531,"","",""
"5IFP","STRUCTURE OF BETA-GALACTOSIDASE FROM ASPERGILLUS NIGER","10.1111/FEBS.14083 ",1.71,12.62,"5ifp_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_B_)-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(373_A_)",24.8777,"","",""
"5IFT","STRUCTURE OF E298Q-BETA-GALACTOSIDASE FROM ASPERGILLUS NIGER IN COMPLEX WITH 3-B-GALACTOPYRANOSYL GLUCOSE","10.1111/FEBS.14083 ",2.45,21.24,"5ift_oligo3","DManpa1-2DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-MAN(5_D_)-MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(914_A_)",42.5905,"","",""
"5IFT","STRUCTURE OF E298Q-BETA-GALACTOSIDASE FROM ASPERGILLUS NIGER IN COMPLEX WITH 3-B-GALACTOPYRANOSYL GLUCOSE","10.1111/FEBS.14083 ",2.45,21.24,"5ift_oligo2","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(373_A_)",29.9229,"","",""
"5IFT","STRUCTURE OF E298Q-BETA-GALACTOSIDASE FROM ASPERGILLUS NIGER IN COMPLEX WITH 3-B-GALACTOPYRANOSYL GLUCOSE","10.1111/FEBS.14083 ",2.45,21.24,"5ift_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_C_)-MAN(7_C_)-[MAN(6_C_)-MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(622_A_)",40.2291,"","",""
"5IFT","STRUCTURE OF E298Q-BETA-GALACTOSIDASE FROM ASPERGILLUS NIGER IN COMPLEX WITH 3-B-GALACTOPYRANOSYL GLUCOSE","10.1111/FEBS.14083 ",2.45,21.24,"5ift_oligo4","DGalpb1-3DGlcpa1-ROH","GAL(2_E_)-GLC(1_E_)",28.905,"","",""
"5IHR","STRUCTURE OF E298Q-BETA-GALACTOSIDASE FROM ASPERGILLUS NIGER IN COMPLEX WITH ALLOLACTOSE","10.1111/FEBS.14083 ",2.4,21.7,"5ihr_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_B_)-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(373_A_)",43.0142,"","",""
"5IHR","STRUCTURE OF E298Q-BETA-GALACTOSIDASE FROM ASPERGILLUS NIGER IN COMPLEX WITH ALLOLACTOSE","10.1111/FEBS.14083 ",2.4,21.7,"5ihr_oligo2","DManpa1-2DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-MAN(5_D_)-MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(914_A_)",40.8088,"","",""
"5IHR","STRUCTURE OF E298Q-BETA-GALACTOSIDASE FROM ASPERGILLUS NIGER IN COMPLEX WITH ALLOLACTOSE","10.1111/FEBS.14083 ",2.4,21.7,"5ihr_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_C_)-MAN(7_C_)-[MAN(6_C_)-MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(622_A_)",31.1824,"","",""
"5IJ3","SRPA ADHESIN IN COMPLEX WITH SIALYL T ANTIGEN","10.1021/ACS.BIOCHEM.6B00704 ",1.7,27.47,"5ij3_oligo1","DNeup5Aca2-3DGalpb1-3DGalpNAca1-ROH","SIA(3_C_)-GAL(2_C_)-A2G(1_C_)",33.3451,"","",""
"5IK5","LAMININ A2LG45 C-FORM, G6/7 BOUND.","10.1038/NCHEMBIO.2146 ",1.39,0,"5ik5_oligo3","DXylpa1-3DGlcpAb1-3DXylpa1-3DGlcpAb1-C10O3","XYS(4_D_)-BDP(3_D_)-XYS(2_D_)-BDP(1_D_)-4MU(4013_A_)",38.9433,"","",""
"5IK5","LAMININ A2LG45 C-FORM, G6/7 BOUND.","10.1038/NCHEMBIO.2146 ",1.39,0,"5ik5_oligo1","DGalpb1-3DGalpNAca1-THR","GAL(2_B_)-A2G(1_B_)-THR(2741_A_)",73.8432,"","",""
"5IK8","LAMININ A2LG45 I-FORM, G6/7 BOUND.","10.1038/NCHEMBIO.2146 ",2,0,"5ik8_oligo1","DXylpa1-3DGlcpAb1-3DXylpa1-3DGlcpAb1-C10O3","XYS(4_C_)-BDP(3_C_)-XYS(2_C_)-BDP(1_C_)-4MU(4004_B_)",93.4574,"","",""
"5INE","CRYSTAL STRUCTURE OF THE PREFUSION GLYCOPROTEIN OF LCMV","10.1038/NSMB.3210 ",3.5,185.2,"5ine_oligo12","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_N_)-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(371_B_)",218.562,"","",""
"5INE","CRYSTAL STRUCTURE OF THE PREFUSION GLYCOPROTEIN OF LCMV","10.1038/NSMB.3210 ",3.5,185.2,"5ine_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(114_A_)",253.798,"","",""
"5INE","CRYSTAL STRUCTURE OF THE PREFUSION GLYCOPROTEIN OF LCMV","10.1038/NSMB.3210 ",3.5,185.2,"5ine_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(95_A_)",250.532,"","",""
"5INE","CRYSTAL STRUCTURE OF THE PREFUSION GLYCOPROTEIN OF LCMV","10.1038/NSMB.3210 ",3.5,185.2,"5ine_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(95_B_)",252.46,"","",""
"5INE","CRYSTAL STRUCTURE OF THE PREFUSION GLYCOPROTEIN OF LCMV","10.1038/NSMB.3210 ",3.5,185.2,"5ine_oligo11","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_M_)-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(232_B_)",243.535,"","",""
"5INH","CRYSTAL STRUCTURE OF AUTOTAXIN/ENPP2 WITH A COVALENT FRAGMENT","10.1021/ACS.JMEDCHEM.6B01224 ",1.84,34.97,"5inh_oligo1","DManpa1-2DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-MAN(5_B_)-MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(524_A_)",30.9977,"","",""
"5IUC","CRYSTAL STRUCTURE OF THE GSPB SIGLEC DOMAIN WITH SIALYL T ANTIGEN BOUND","10.1371/JOURNAL.PPAT.1002112 ",1.25,16.46,"5iuc_oligo2","DNeup5Aca2-3DGalpb1-3DGalpNAca1-ROH","SIA(3_D_)-GAL(2_D_)-A2G(1_D_)",13.2376,"","",""
"5IUC","CRYSTAL STRUCTURE OF THE GSPB SIGLEC DOMAIN WITH SIALYL T ANTIGEN BOUND","10.1371/JOURNAL.PPAT.1002112 ",1.25,16.46,"5iuc_oligo1","DNeup5Aca2-3DGalpb1-3DGalpNAca1-ROH","SIA(3_C_)-GAL(2_C_)-A2G(1_C_)",11.6649,"","",""
"5IW3","ANTI-CD20 MONOCLONAL ANTIBODY FC FRAGMENT","",2.05,26.87,"5iw3_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_B_)-NAG(5_B_)-MAN(4_B_)-[NAG(8_B_)-MAN(7_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(320_A_)",41.8844,"","",""
"5IW6","ANTI-CD20 MONOCLONAL ANTIBODY FC FRAGMENT","",2.34,58.38,"5iw6_oligo2","DGalpb1-4DGlcpNAcb1-2DManpb1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_D_)-NAG(5_D_)-BMA(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(320_B_)",98.8407,"","",""
"5IW6","ANTI-CD20 MONOCLONAL ANTIBODY FC FRAGMENT","",2.34,58.38,"5iw6_oligo1","DGalpb1-4DGlcpNAcb1-2DManpb1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_C_)-NAG(5_C_)-BMA(4_C_)-[NAG(8_C_)-MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(320_A_)",85.8538,"","",""
"5IXQ","CRYSTAL STRUCTURE OF THE ARABIDOPSIS RECEPTOR KINASE HAESA LRR ECTDOMAIN IN COMPLEX WITH THE PEPTIDE HORMONE IDA.","10.7554/ELIFE.15075 ",1.86,79.08,"5ixq_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(269_A_)",121.708,"","",""
"5IXT","THE CRYSTAL STRUCTURE OF THE ARABIDOPSIS RECEPTOR KINASE HAESA LRR ECTDOMAIN IN COMPLEX WITH A N-TERMINAL EXTENDED IDA PEPTIDE HORMONE LIGAND.","10.7554/ELIFE.15075 ",1.94,80.66,"5ixt_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(269_A_)",129.93,"","",""
"5IY5","ELECTRON TRANSFER COMPLEX OF CYTOCHROME C AND CYTOCHROME C OXIDASE AT 2.0 ANGSTROM RESOLUTION","10.15252/EMBJ.201695021 ",2,48.15,"5iy5_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(101_Z_)-DMU(101_Z_)",89.7782,"","",""
"5IY5","ELECTRON TRANSFER COMPLEX OF CYTOCHROME C AND CYTOCHROME C OXIDASE AT 2.0 ANGSTROM RESOLUTION","10.15252/EMBJ.201695021 ",2,48.15,"5iy5_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(101_M_)-DMU(101_M_)",51.24,"","",""
"5IYP","PROTRUDING DOMAIN OF GII.4 HUMAN NOROVIRUS CHDC2094 IN COMPLEX WITH HBGA TYPE A (TRIGLYCAN)","",1.27,16.9,"5iyp_oligo1","LFucpa1-2[DGalpNAca1-3]DGalpa1-ROH","A2G(3_C_)-[FUC(2_C_)]-GLA(1_C_)",45.1549,"","",""
"5IYP","PROTRUDING DOMAIN OF GII.4 HUMAN NOROVIRUS CHDC2094 IN COMPLEX WITH HBGA TYPE A (TRIGLYCAN)","",1.27,16.9,"5iyp_oligo2","LFucpa1-2[DGalpNAca1-3]DGalpa1-ROH","A2G(3_D_)-[FUC(2_D_)]-GLA(1_D_)",31.8358,"","",""
"5IYQ","PROTRUDING DOMAIN OF GII.4 HUMAN NOROVIRUS CHDC2094 IN COMPLEX WITH HBGA TYPE B (TRIGLYCAN)","",1.41,16.8,"5iyq_oligo2","LFucpa1-2[DGalpa1-3]DGalpa1-ROH","GLA(3_D_)-[FUC(2_D_)]-GLA(1_D_)",20.9803,"","",""
"5IYQ","PROTRUDING DOMAIN OF GII.4 HUMAN NOROVIRUS CHDC2094 IN COMPLEX WITH HBGA TYPE B (TRIGLYCAN)","",1.41,16.8,"5iyq_oligo1","LFucpa1-2[DGalpa1-3]DGalpa1-ROH","GLA(3_C_)-[FUC(2_C_)]-GLA(1_C_)",27.0021,"","",""
"5IYV","CRYSTAL STRUCTURE OF THE ARABIDOPSIS RECEPTOR KINASE HAESA LRR ECTDOMAIN IN COMPLEX WITH THE PEPTIDE HORMONE IDL1.","10.7554/ELIFE.15075 ",2.56,89.4,"5iyv_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(269_A_)",158.213,"","",""
"5IYW","PROTRUDING DOMAIN OF GII.4 HUMAN NOROVIRUS CHDC2094 IN COMPLEX WITH 3- FUCOSYLLACTOSE (3FL)","",1.41,19.43,"5iyw_oligo1","LFucpa1-3[DGalpb1-4]DGlcpa1-ROH","GAL(3_C_)-[FUC(2_C_)]-GLC(1_C_)",33.5085,"","",""
"5IYW","PROTRUDING DOMAIN OF GII.4 HUMAN NOROVIRUS CHDC2094 IN COMPLEX WITH 3- FUCOSYLLACTOSE (3FL)","",1.41,19.43,"5iyw_oligo2","LFucpa1-3[DGalpb1-4]DGlcpa1-ROH","GAL(3_D_)-[FUC(2_D_)]-GLC(1_D_)",31.7112,"","",""
"5J3H","HUMAN INSULIN RECEPTOR DOMAINS L1-CR IN COMPLEX WITH PEPTIDE S519C16 AND 83-7 FV","10.1074/JBC.M116.732180 ",3.27,122.8,"5j3h_oligo3","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_G_)-[MAN(6_G_)-[NAG(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(255_E_)",118.412,"","",""
"5J3J","CRYSTAL STRUCTURE OF HUMAN DPP-IV IN COMPLEX WITH HL1","",2.75,33.36,"5j3j_oligo1","DManpa1-3DManpa1-3DManpa1-4DGlcpNAcb1-ASN","MAN(4_C_)-MAN(3_C_)-MAN(2_C_)-NAG(1_C_)-ASN(229_B_)",51.533,"","",""
"5J4X","STRUCTURE OF TETRAMERIC JACALIN COMPLEXED WITH GAL BETA-(1,3) GAL- BETA-OME","10.1002/IUB.1593 ",1.65,14.19,"5j4x_oligo1","DGalpb1-3DGalpb1-OME","GAL(2_I_)-MBG(1_I_)",21.9805,"","",""
"5J50","STRUCTURE OF TETRAMERIC JACALIN COMPLEXED WITH GAL BETA-(1,3) GALNAC- ALPHA-OPNP","",2.05,14.14,"5j50_oligo1","DGalpb1-3DGalpNAca1-C6N1O3","GAL(2_K_)-A2G(1_K_)-NPO(206_E_)",18.4514,"","",""
"5J50","STRUCTURE OF TETRAMERIC JACALIN COMPLEXED WITH GAL BETA-(1,3) GALNAC- ALPHA-OPNP","",2.05,14.14,"5j50_oligo3","DGalpb1-3DGalpNAca1-C6N1O3","GAL(2_I_)-A2G(1_I_)-NPO(206_A_)",17.2773,"","",""
"5J50","STRUCTURE OF TETRAMERIC JACALIN COMPLEXED WITH GAL BETA-(1,3) GALNAC- ALPHA-OPNP","",2.05,14.14,"5j50_oligo4","DGalpb1-3DGalpNAca1-C6N1O3","GAL(2_L_)-A2G(1_L_)-NPO(204_G_)",19.2832,"","",""
"5J50","STRUCTURE OF TETRAMERIC JACALIN COMPLEXED WITH GAL BETA-(1,3) GALNAC- ALPHA-OPNP","",2.05,14.14,"5j50_oligo2","DGalpb1-3DGalpNAca1-C6N1O2","GAL(2_J_)-A2G(1_J_)-NPO(203_C_)",16.1768,"","",""
"5J5J","CRYSTAL STRUCTURE OF A CHIMERA OF HUMAN DESMOCOLLIN-2 EC1 AND HUMAN DESMOGLEIN-2 EC2-EC5","10.1073/PNAS.1606272113 ",3.29,0,"5j5j_oligo1","DGalpb1-4DGlcpNAcb1-3DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_B_)-NAG(5_B_)-MAN(4_B_)-[NAG(8_B_)-MAN(7_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(31_A_)",205.562,"","",""
"5J5J","CRYSTAL STRUCTURE OF A CHIMERA OF HUMAN DESMOCOLLIN-2 EC1 AND HUMAN DESMOGLEIN-2 EC2-EC5","10.1073/PNAS.1606272113 ",3.29,0,"5j5j_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_C_)-[MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(463_A_)",196.697,"","",""
"5J67","STRUCTURE OF ASTROTACTIN-2, A CONSERVED VERTEBRATE-SPECIFIC AND PERFORIN-LIKE MEMBRANE PROTEIN INVOLVED IN NEURONAL DEVELOPMENT","10.1098/RSOB.160053 ",3.16,136.3,"5j67_oligo2","DManpa1-2DManpa1-3[DManpb1-2DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_E_)-MAN(7_E_)-[MAN(6_E_)-MAN(5_E_)]-MAN(4_E_)-[MAN(10_E_)-MAN(9_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(732_A_)",129.625,"","",""
"5J67","STRUCTURE OF ASTROTACTIN-2, A CONSERVED VERTEBRATE-SPECIFIC AND PERFORIN-LIKE MEMBRANE PROTEIN INVOLVED IN NEURONAL DEVELOPMENT","10.1098/RSOB.160053 ",3.16,136.3,"5j67_oligo4","DManpa1-2DManpa1-3[DManpb1-2DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_H_)-MAN(7_H_)-[MAN(6_H_)-MAN(5_H_)]-MAN(4_H_)-[MAN(10_H_)-MAN(9_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(732_D_)",131.109,"","",""
"5J67","STRUCTURE OF ASTROTACTIN-2, A CONSERVED VERTEBRATE-SPECIFIC AND PERFORIN-LIKE MEMBRANE PROTEIN INVOLVED IN NEURONAL DEVELOPMENT","10.1098/RSOB.160053 ",3.16,136.3,"5j67_oligo1","DManpa1-2DManpa1-3[DManpb1-2DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_G_)-MAN(7_G_)-[MAN(6_G_)-MAN(5_G_)]-MAN(4_G_)-[MAN(10_G_)-MAN(9_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(732_C_)",116.384,"","",""
"5J67","STRUCTURE OF ASTROTACTIN-2, A CONSERVED VERTEBRATE-SPECIFIC AND PERFORIN-LIKE MEMBRANE PROTEIN INVOLVED IN NEURONAL DEVELOPMENT","10.1098/RSOB.160053 ",3.16,136.3,"5j67_oligo3","DManpa1-2DManpa1-3[DManpb1-2DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_F_)-MAN(7_F_)-[MAN(6_F_)-MAN(5_F_)]-MAN(4_F_)-[MAN(10_F_)-MAN(9_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(732_B_)",134.432,"","",""
"5J68","STRUCTURE OF ASTROTACTIN-2, A CONSERVED VERTEBRATE-SPECIFIC AND PERFORIN-LIKE MEMBRANE PROTEIN INVOLVED IN NEURONAL DEVELOPMENT","10.1098/RSOB.160053 ",5.22,0,"5j68_oligo1","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_B_)-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)]-MAN(4_B_)-[MAN(10_B_)-MAN(9_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(732_A_)",346.214,"","",""
"5J6S","CRYSTAL STRUCTURE OF ENDOPLASMIC RETICULUM AMINOPEPTIDASE 2 (ERAP2) IN COMPLEX WITH A HYDROXAMIC DERIVATIVE LIGAND","10.1021/ACSMEDCHEMLETT.6B00505 ",2.8,0,"5j6s_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(85_B_)",86.7636,"","",""
"5J7Z","CRYSTAL STRUCTURE OF ENDOGLYCOCERAMIDASE I FROM RHODOCOC-CUS EQUI IN COMPLEX WITH GM1","10.1074/JBC.M116.763821 ",2.15,24.94,"5j7z_oligo1","DGalpb1-3DGalpNAcb1-4[DNeup5Aca2-3]DGalpb1-4DGlcpb1-C22N1O3","GAL(4_C_)-NGA(3_C_)-[SIA(5_C_)]-GAL(2_C_)-BGC(1_C_)",27.5521,"","",""
"5JIF","CRYSTAL STRUCTURE OF MOUSE HEPATITIS VIRUS STRAIN DVIM HEMAGGLUTININ- ESTERASE","10.1073/PNAS.1519881113 ",2,51.65,"5jif_oligo1","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-MAN(5_F_)-[MAN(7_F_)]-MAN(4_F_)-[MAN(8_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(309_A_)",56.3314,"","",""
"5JIF","CRYSTAL STRUCTURE OF MOUSE HEPATITIS VIRUS STRAIN DVIM HEMAGGLUTININ- ESTERASE","10.1073/PNAS.1519881113 ",2,51.65,"5jif_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(324_A_)",80.5802,"","",""
"5JIH","CRYSTAL STRUCTURE OF HER2 BINDING IGG1-FC (FCAB STAB19)","10.1016/J.STR.2017.04.014 ",1.66,0,"5jih_oligo1","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_D_)-MAN(4_D_)-[MAN(6_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(297_B_)",97.3946,"","",""
"5JIH","CRYSTAL STRUCTURE OF HER2 BINDING IGG1-FC (FCAB STAB19)","10.1016/J.STR.2017.04.014 ",1.66,0,"5jih_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",70.2827,"","",""
"5JII","CRYSTAL STRUCTURE OF HUMAN IGG1-FC","10.1016/J.STR.2017.04.014 ",1.79,49.2,"5jii_oligo1","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(297_A_)",68.3536,"","",""
"5JII","CRYSTAL STRUCTURE OF HUMAN IGG1-FC","10.1016/J.STR.2017.04.014 ",1.79,49.2,"5jii_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",81.111,"","",""
"5JIK","CRYSTAL STRUCTURE OF HER2 BINDING IGG1-FC (FCAB H10-03-6)","10.1016/J.STR.2017.04.014 ",1.82,0,"5jik_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(297_B_)",132.317,"","",""
"5JIK","CRYSTAL STRUCTURE OF HER2 BINDING IGG1-FC (FCAB H10-03-6)","10.1016/J.STR.2017.04.014 ",1.82,0,"5jik_oligo1","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","NAG(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)",86.5242,"","",""
"5JKA","CRYSTAL STRUCTURE OF HUMAN JUNO (CRYSTAL FORM 1)","10.1038/NATURE18596 ",2,44.83,"5jka_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(73_B_)",60.8243,"","",""
"5JM1","STRUCTURE OF TETRAMERIC JACALIN COMPLEXED WITH A TRISACCHARIDE, GAL ALPHA-(1,3) GAL BETA-(1,4) GAL","10.1002/IUB.1572 ",1.95,13.2,"5jm1_oligo1","DGalpa1-3DGalpb1-4DGalpb1-ROH","GLA(3_I_)-GAL(2_I_)-GAL(1_I_)",32.6164,"","",""
"5JPN","STRUCTURE OF HUMAN COMPLEMENT C4 REBUILT USING IMDFF","10.1107/S2059798316012201 ",3.6,130.4,"5jpn_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(1391_B_)",196.113,"","",""
"5JPN","STRUCTURE OF HUMAN COMPLEMENT C4 REBUILT USING IMDFF","10.1107/S2059798316012201 ",3.6,130.4,"5jpn_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(862_B_)",186.06,"","",""
"5JQ3","CRYSTAL STRUCTURE OF EBOLA GLYCOPROTEIN","10.1038/NATURE18615 ",2.23,72.48,"5jq3_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(563_B_)",103.568,"","",""
"5JS9","UNCLEAVED PREFUSION OPTIMIZED GP140 TRIMER WITH AN ENGINEERED 8- RESIDUE HR1 TURN BOUND TO BROADLY NEUTRALIZING ANTIBODIES 8ANC195 AND PGT128","10.1038/NCOMMS12040 ",6.92,0,"5js9_oligo13","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_S_)-MAN(10_S_)-[MAN(9_S_)-MAN(8_S_)]-MAN(7_S_)-[MAN(6_S_)-MAN(5_S_)-MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(233_C_)",248.861,"","",""
"5JS9","UNCLEAVED PREFUSION OPTIMIZED GP140 TRIMER WITH AN ENGINEERED 8- RESIDUE HR1 TURN BOUND TO BROADLY NEUTRALIZING ANTIBODIES 8ANC195 AND PGT128","10.1038/NCOMMS12040 ",6.92,0,"5js9_oligo9","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-MAN(4_O_)-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(294_C_)",344.254,"","",""
"5JS9","UNCLEAVED PREFUSION OPTIMIZED GP140 TRIMER WITH AN ENGINEERED 8- RESIDUE HR1 TURN BOUND TO BROADLY NEUTRALIZING ANTIBODIES 8ANC195 AND PGT128","10.1038/NCOMMS12040 ",6.92,0,"5js9_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_L_)-MAN(8_L_)-[MAN(10_L_)]-MAN(7_L_)-[MAN(6_L_)-MAN(5_L_)-MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(330_C_)",297.15,"","",""
"5JS9","UNCLEAVED PREFUSION OPTIMIZED GP140 TRIMER WITH AN ENGINEERED 8- RESIDUE HR1 TURN BOUND TO BROADLY NEUTRALIZING ANTIBODIES 8ANC195 AND PGT128","10.1038/NCOMMS12040 ",6.92,0,"5js9_oligo4","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_M_)-MAN(7_M_)-[MAN(6_M_)-MAN(5_M_)-MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(300_C_)",305.157,"","",""
"5JS9","UNCLEAVED PREFUSION OPTIMIZED GP140 TRIMER WITH AN ENGINEERED 8- RESIDUE HR1 TURN BOUND TO BROADLY NEUTRALIZING ANTIBODIES 8ANC195 AND PGT128","10.1038/NCOMMS12040 ",6.92,0,"5js9_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(261_C_)",303.832,"","",""
"5JS9","UNCLEAVED PREFUSION OPTIMIZED GP140 TRIMER WITH AN ENGINEERED 8- RESIDUE HR1 TURN BOUND TO BROADLY NEUTRALIZING ANTIBODIES 8ANC195 AND PGT128","10.1038/NCOMMS12040 ",6.92,0,"5js9_oligo1","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_K_)-[MAN(7_K_)]-MAN(6_K_)-[MAN(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(275_C_)",284.059,"","",""
"5JSA","UNCLEAVED PREFUSION OPTIMIZED GP140 TRIMER WITH AN ENGINEERED 10- RESIDUE HR1 TURN BOUND TO BROADLY NEUTRALIZING ANTIBODIES 8ANC195 AND PGT128","10.1038/NCOMMS12040 ",6.31,0,"5jsa_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_L_)-[MAN(8_L_)]-MAN(7_L_)-[MAN(6_L_)-MAN(5_L_)-MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(300_C_)",356.789,"","",""
"5JSA","UNCLEAVED PREFUSION OPTIMIZED GP140 TRIMER WITH AN ENGINEERED 10- RESIDUE HR1 TURN BOUND TO BROADLY NEUTRALIZING ANTIBODIES 8ANC195 AND PGT128","10.1038/NCOMMS12040 ",6.31,0,"5jsa_oligo7","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_M_)-[MAN(6_M_)-MAN(5_M_)-MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(261_C_)",342.043,"","",""
"5JSA","UNCLEAVED PREFUSION OPTIMIZED GP140 TRIMER WITH AN ENGINEERED 10- RESIDUE HR1 TURN BOUND TO BROADLY NEUTRALIZING ANTIBODIES 8ANC195 AND PGT128","10.1038/NCOMMS12040 ",6.31,0,"5jsa_oligo8","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-MAN(4_N_)-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(294_C_)",384.023,"","",""
"5JSA","UNCLEAVED PREFUSION OPTIMIZED GP140 TRIMER WITH AN ENGINEERED 10- RESIDUE HR1 TURN BOUND TO BROADLY NEUTRALIZING ANTIBODIES 8ANC195 AND PGT128","10.1038/NCOMMS12040 ",6.31,0,"5jsa_oligo5","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_J_)-[MAN(7_J_)]-MAN(6_J_)-[MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(275_C_)",353.387,"","",""
"5JSA","UNCLEAVED PREFUSION OPTIMIZED GP140 TRIMER WITH AN ENGINEERED 10- RESIDUE HR1 TURN BOUND TO BROADLY NEUTRALIZING ANTIBODIES 8ANC195 AND PGT128","10.1038/NCOMMS12040 ",6.31,0,"5jsa_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_K_)-MAN(8_K_)-[MAN(10_K_)]-MAN(7_K_)-[MAN(6_K_)-MAN(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(330_C_)",340.696,"","",""
"5JSA","UNCLEAVED PREFUSION OPTIMIZED GP140 TRIMER WITH AN ENGINEERED 10- RESIDUE HR1 TURN BOUND TO BROADLY NEUTRALIZING ANTIBODIES 8ANC195 AND PGT128","10.1038/NCOMMS12040 ",6.31,0,"5jsa_oligo15","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_U_)-MAN(10_U_)-[MAN(9_U_)-MAN(8_U_)]-MAN(7_U_)-[MAN(6_U_)-MAN(5_U_)-MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(233_C_)",329.918,"","",""
"5JSD","CRYSTAL STRUCTURE OF PHIAB6 TAILSPIKE IN COMPLEX WITH FIVE-REPEATED OLIGOSACCHARIDES OF ACINETOBACTER BAUMANNII SURFACE POLYSACCHARIDE","10.1038/SREP42711 ",1.48,16.89,"5jsd_oligo6","DGalpb1-3DGalpNAcb1-3[6PZ2-6DGlcpb1-6]DGalpb1-3DGalpNAcb1-3[DGlcpb1-6]DGalpb1-ROH","BGC(8_H_)-[6PZ(7_H_)-BGC(6_H_)-[GAL(5_H_)-1GN(4_H_)]-GAL(3_H_)-1GN(2_H_)]-GAL(1_H_)",28.1861,"","",""
"5JSD","CRYSTAL STRUCTURE OF PHIAB6 TAILSPIKE IN COMPLEX WITH FIVE-REPEATED OLIGOSACCHARIDES OF ACINETOBACTER BAUMANNII SURFACE POLYSACCHARIDE","10.1038/SREP42711 ",1.48,16.89,"5jsd_oligo3","DGlcpb1-6DGalpb1-3DGalpNAcb1-3[DGlcpb1-6]DGalpb1-3DGalpNAcb1-ROH","BGC(6_E_)-[BGC(5_E_)-GAL(4_E_)-1GN(3_E_)]-GAL(2_E_)-1GN(1_E_)",34.4485,"","",""
"5JSD","CRYSTAL STRUCTURE OF PHIAB6 TAILSPIKE IN COMPLEX WITH FIVE-REPEATED OLIGOSACCHARIDES OF ACINETOBACTER BAUMANNII SURFACE POLYSACCHARIDE","10.1038/SREP42711 ",1.48,16.89,"5jsd_oligo5","DGalpb1-3DGalpNAcb1-3[6PZ2-6DGlcpb1-6]DGalpb1-3DGalpNAcb1-3[DGlcpb1-6]DGalpb1-ROH","BGC(8_G_)-[6PZ(7_G_)-BGC(6_G_)-[GAL(5_G_)-1GN(4_G_)]-GAL(3_G_)-1GN(2_G_)]-GAL(1_G_)",28.32,"","",""
"5JSD","CRYSTAL STRUCTURE OF PHIAB6 TAILSPIKE IN COMPLEX WITH FIVE-REPEATED OLIGOSACCHARIDES OF ACINETOBACTER BAUMANNII SURFACE POLYSACCHARIDE","10.1038/SREP42711 ",1.48,16.89,"5jsd_oligo4","DGalpb1-3DGalpNAcb1-3[6PZ2-6DGlcpb1-6]DGalpb1-3DGalpNAcb1-3[DGlcpb1-6]DGalpb1-ROH","BGC(8_D_)-[6PZ(7_D_)-BGC(6_D_)-[GAL(5_D_)-1GN(4_D_)]-GAL(3_D_)-1GN(2_D_)]-GAL(1_D_)",28.0623,"","",""
"5JSD","CRYSTAL STRUCTURE OF PHIAB6 TAILSPIKE IN COMPLEX WITH FIVE-REPEATED OLIGOSACCHARIDES OF ACINETOBACTER BAUMANNII SURFACE POLYSACCHARIDE","10.1038/SREP42711 ",1.48,16.89,"5jsd_oligo2","DGlcpb1-6DGalpb1-3DGalpNAcb1-3[DGlcpb1-6]DGalpb1-3DGalpNAcb1-ROH","BGC(6_I_)-[BGC(5_I_)-GAL(4_I_)-1GN(3_I_)]-GAL(2_I_)-1GN(1_I_)",34.9621,"","",""
"5JSD","CRYSTAL STRUCTURE OF PHIAB6 TAILSPIKE IN COMPLEX WITH FIVE-REPEATED OLIGOSACCHARIDES OF ACINETOBACTER BAUMANNII SURFACE POLYSACCHARIDE","10.1038/SREP42711 ",1.48,16.89,"5jsd_oligo1","DGlcpb1-6DGalpb1-3DGalpNAcb1-3[DGlcpb1-6]DGalpb1-3DGalpNAcb1-ROH","BGC(6_F_)-[BGC(5_F_)-GAL(4_F_)-1GN(3_F_)]-GAL(2_F_)-1GN(1_F_)",35.0727,"","",""
"5JSE","CRYSTAL STRUCTURE OF PHIAB6 TAILSPIKE IN COMPLEX WITH THREE-REPEATED OLIGOSACCHARIDES OF ACINETOBACTER BAUMANNII SURFACE POLYSACCHARIDE","10.1038/SREP42711 ",1.89,22.22,"5jse_oligo2","DGalpb1-3DGalpNAcb1-3[6PZ2-6DGlcpb1-6]DGalpb1-3DGalpNAcb1-3[DGlcpb1-6]DGalpb1-ROH","BGC(8_E_)-[6PZ(7_E_)-BGC(6_E_)-[GAL(5_E_)-1GN(4_E_)]-GAL(3_E_)-1GN(2_E_)]-GAL(1_E_)",49.378,"","",""
"5JSE","CRYSTAL STRUCTURE OF PHIAB6 TAILSPIKE IN COMPLEX WITH THREE-REPEATED OLIGOSACCHARIDES OF ACINETOBACTER BAUMANNII SURFACE POLYSACCHARIDE","10.1038/SREP42711 ",1.89,22.22,"5jse_oligo3","DGalpb1-3DGalpNAcb1-3[6PZ2-6DGlcpb1-6]DGalpb1-3DGalpNAcb1-3[DGlcpb1-6]DGalpb1-ROH","BGC(8_F_)-[6PZ(7_F_)-BGC(6_F_)-[GAL(5_F_)-1GN(4_F_)]-GAL(3_F_)-1GN(2_F_)]-GAL(1_F_)",49.1276,"","",""
"5JSE","CRYSTAL STRUCTURE OF PHIAB6 TAILSPIKE IN COMPLEX WITH THREE-REPEATED OLIGOSACCHARIDES OF ACINETOBACTER BAUMANNII SURFACE POLYSACCHARIDE","10.1038/SREP42711 ",1.89,22.22,"5jse_oligo1","DGalpb1-3DGalpNAcb1-3[6PZ2-6DGlcpb1-6]DGalpb1-3DGalpNAcb1-3[DGlcpb1-6]DGalpb1-ROH","BGC(8_D_)-[6PZ(7_D_)-BGC(6_D_)-[GAL(5_D_)-1GN(4_D_)]-GAL(3_D_)-1GN(2_D_)]-GAL(1_D_)",49.7548,"","",""
"5JU6","STRUCTURAL AND FUNCTIONAL STUDIES OF GLYCOSIDE HYDROLASE FAMILY 3 BETA-GLUCOSIDASE CEL3A FROM THE MODERATELY THERMOPHILIC FUNGUS RASAMSONIA EMERSONII","10.1107/S2059798316008482 ",2.2,28.52,"5ju6_oligo30","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_d_)-MAN(7_d_)-[MAN(6_d_)-MAN(5_d_)]-MAN(4_d_)-[MAN(10_d_)-MAN(9_d_)]-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(319_D_)",38.3576,"","",""
"5JU6","STRUCTURAL AND FUNCTIONAL STUDIES OF GLYCOSIDE HYDROLASE FAMILY 3 BETA-GLUCOSIDASE CEL3A FROM THE MODERATELY THERMOPHILIC FUNGUS RASAMSONIA EMERSONII","10.1107/S2059798316008482 ",2.2,28.52,"5ju6_oligo24","DManpa1-2DManpa1-6DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_X_)-MAN(5_X_)-MAN(4_X_)-[MAN(8_X_)-MAN(7_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(519_C_)",40.2414,"","",""
"5JU6","STRUCTURAL AND FUNCTIONAL STUDIES OF GLYCOSIDE HYDROLASE FAMILY 3 BETA-GLUCOSIDASE CEL3A FROM THE MODERATELY THERMOPHILIC FUNGUS RASAMSONIA EMERSONII","10.1107/S2059798316008482 ",2.2,28.52,"5ju6_oligo17","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_Q_)-MAN(8_Q_)-[MAN(10_Q_)]-MAN(7_Q_)-[MAN(6_Q_)-MAN(5_Q_)-MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(519_B_)",50.6045,"","",""
"5JU6","STRUCTURAL AND FUNCTIONAL STUDIES OF GLYCOSIDE HYDROLASE FAMILY 3 BETA-GLUCOSIDASE CEL3A FROM THE MODERATELY THERMOPHILIC FUNGUS RASAMSONIA EMERSONII","10.1107/S2059798316008482 ",2.2,28.52,"5ju6_oligo11","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(61_A_)",55.9491,"","",""
"5JU6","STRUCTURAL AND FUNCTIONAL STUDIES OF GLYCOSIDE HYDROLASE FAMILY 3 BETA-GLUCOSIDASE CEL3A FROM THE MODERATELY THERMOPHILIC FUNGUS RASAMSONIA EMERSONII","10.1107/S2059798316008482 ",2.2,28.52,"5ju6_oligo22","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_V_)-MAN(5_V_)-[MAN(7_V_)]-MAN(4_V_)-[MAN(9_V_)-MAN(8_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(319_C_)",40.2642,"","",""
"5JU6","STRUCTURAL AND FUNCTIONAL STUDIES OF GLYCOSIDE HYDROLASE FAMILY 3 BETA-GLUCOSIDASE CEL3A FROM THE MODERATELY THERMOPHILIC FUNGUS RASAMSONIA EMERSONII","10.1107/S2059798316008482 ",2.2,28.52,"5ju6_oligo21","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_U_)-[MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(312_C_)",65.1376,"","",""
"5JU6","STRUCTURAL AND FUNCTIONAL STUDIES OF GLYCOSIDE HYDROLASE FAMILY 3 BETA-GLUCOSIDASE CEL3A FROM THE MODERATELY THERMOPHILIC FUNGUS RASAMSONIA EMERSONII","10.1107/S2059798316008482 ",2.2,28.52,"5ju6_oligo28","DGlcpa1-3DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_b_)-[GLC(7_b_)-MAN(6_b_)-MAN(5_b_)-MAN(4_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(249_D_)",55.0106,"","",""
"5JU6","STRUCTURAL AND FUNCTIONAL STUDIES OF GLYCOSIDE HYDROLASE FAMILY 3 BETA-GLUCOSIDASE CEL3A FROM THE MODERATELY THERMOPHILIC FUNGUS RASAMSONIA EMERSONII","10.1107/S2059798316008482 ",2.2,28.52,"5ju6_oligo19","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_S_)-MAN(8_S_)-MAN(7_S_)-[MAN(6_S_)-MAN(5_S_)-MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(61_C_)",58.2094,"","",""
"5JU6","STRUCTURAL AND FUNCTIONAL STUDIES OF GLYCOSIDE HYDROLASE FAMILY 3 BETA-GLUCOSIDASE CEL3A FROM THE MODERATELY THERMOPHILIC FUNGUS RASAMSONIA EMERSONII","10.1107/S2059798316008482 ",2.2,28.52,"5ju6_oligo2","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-MAN(5_H_)-[MAN(7_H_)]-MAN(4_H_)-[MAN(9_H_)-MAN(8_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(319_A_)",39.8963,"","",""
"5JU6","STRUCTURAL AND FUNCTIONAL STUDIES OF GLYCOSIDE HYDROLASE FAMILY 3 BETA-GLUCOSIDASE CEL3A FROM THE MODERATELY THERMOPHILIC FUNGUS RASAMSONIA EMERSONII","10.1107/S2059798316008482 ",2.2,28.52,"5ju6_oligo20","DGlcpa1-3DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_T_)-[GLC(7_T_)-MAN(6_T_)-MAN(5_T_)-MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(249_C_)",45.8285,"","",""
"5JU6","STRUCTURAL AND FUNCTIONAL STUDIES OF GLYCOSIDE HYDROLASE FAMILY 3 BETA-GLUCOSIDASE CEL3A FROM THE MODERATELY THERMOPHILIC FUNGUS RASAMSONIA EMERSONII","10.1107/S2059798316008482 ",2.2,28.52,"5ju6_oligo27","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_a_)-[MAN(5_a_)-MAN(4_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(61_D_)",61.4762,"","",""
"5JU6","STRUCTURAL AND FUNCTIONAL STUDIES OF GLYCOSIDE HYDROLASE FAMILY 3 BETA-GLUCOSIDASE CEL3A FROM THE MODERATELY THERMOPHILIC FUNGUS RASAMSONIA EMERSONII","10.1107/S2059798316008482 ",2.2,28.52,"5ju6_oligo9","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_J_)-MAN(8_J_)-MAN(7_J_)-[MAN(6_J_)-MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(519_A_)",47.2477,"","",""
"5JU6","STRUCTURAL AND FUNCTIONAL STUDIES OF GLYCOSIDE HYDROLASE FAMILY 3 BETA-GLUCOSIDASE CEL3A FROM THE MODERATELY THERMOPHILIC FUNGUS RASAMSONIA EMERSONII","10.1107/S2059798316008482 ",2.2,28.52,"5ju6_oligo13","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-MAN(4_M_)-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(249_B_)",53.3011,"","",""
"5JU6","STRUCTURAL AND FUNCTIONAL STUDIES OF GLYCOSIDE HYDROLASE FAMILY 3 BETA-GLUCOSIDASE CEL3A FROM THE MODERATELY THERMOPHILIC FUNGUS RASAMSONIA EMERSONII","10.1107/S2059798316008482 ",2.2,28.52,"5ju6_oligo29","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_c_)-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(312_D_)",57.4032,"","",""
"5JU6","STRUCTURAL AND FUNCTIONAL STUDIES OF GLYCOSIDE HYDROLASE FAMILY 3 BETA-GLUCOSIDASE CEL3A FROM THE MODERATELY THERMOPHILIC FUNGUS RASAMSONIA EMERSONII","10.1107/S2059798316008482 ",2.2,28.52,"5ju6_oligo16","DManpb1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_P_)-[BMA(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(438_B_)",72.6018,"","",""
"5JU6","STRUCTURAL AND FUNCTIONAL STUDIES OF GLYCOSIDE HYDROLASE FAMILY 3 BETA-GLUCOSIDASE CEL3A FROM THE MODERATELY THERMOPHILIC FUNGUS RASAMSONIA EMERSONII","10.1107/S2059798316008482 ",2.2,28.52,"5ju6_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(312_A_)",53.0986,"","",""
"5JU6","STRUCTURAL AND FUNCTIONAL STUDIES OF GLYCOSIDE HYDROLASE FAMILY 3 BETA-GLUCOSIDASE CEL3A FROM THE MODERATELY THERMOPHILIC FUNGUS RASAMSONIA EMERSONII","10.1107/S2059798316008482 ",2.2,28.52,"5ju6_oligo12","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_L_)-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(61_B_)",49.87,"","",""
"5JU6","STRUCTURAL AND FUNCTIONAL STUDIES OF GLYCOSIDE HYDROLASE FAMILY 3 BETA-GLUCOSIDASE CEL3A FROM THE MODERATELY THERMOPHILIC FUNGUS RASAMSONIA EMERSONII","10.1107/S2059798316008482 ",2.2,28.52,"5ju6_oligo14","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_N_)-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(312_B_)",64.1239,"","",""
"5JU6","STRUCTURAL AND FUNCTIONAL STUDIES OF GLYCOSIDE HYDROLASE FAMILY 3 BETA-GLUCOSIDASE CEL3A FROM THE MODERATELY THERMOPHILIC FUNGUS RASAMSONIA EMERSONII","10.1107/S2059798316008482 ",2.2,28.52,"5ju6_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_F_)-[MAN(6_F_)-MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(249_A_)",62.5021,"","",""
"5JU6","STRUCTURAL AND FUNCTIONAL STUDIES OF GLYCOSIDE HYDROLASE FAMILY 3 BETA-GLUCOSIDASE CEL3A FROM THE MODERATELY THERMOPHILIC FUNGUS RASAMSONIA EMERSONII","10.1107/S2059798316008482 ",2.2,28.52,"5ju6_oligo15","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_O_)-MAN(7_O_)-[MAN(6_O_)-MAN(5_O_)]-MAN(4_O_)-[MAN(10_O_)-MAN(9_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(319_B_)",37.5741,"","",""
"5JU6","STRUCTURAL AND FUNCTIONAL STUDIES OF GLYCOSIDE HYDROLASE FAMILY 3 BETA-GLUCOSIDASE CEL3A FROM THE MODERATELY THERMOPHILIC FUNGUS RASAMSONIA EMERSONII","10.1107/S2059798316008482 ",2.2,28.52,"5ju6_oligo32","DManpa1-2DManpa1-6DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_f_)-MAN(5_f_)-MAN(4_f_)-[MAN(8_f_)-MAN(7_f_)]-BMA(3_f_)-NAG(2_f_)-NAG(1_f_)-ASN(519_D_)",44.981,"","",""
"5JUV","STRUCTURE OF E298Q-BETA-GALACTOSIDASE FROM ASPERGILLUS NIGER IN COMPLEX WITH 6-B-GALACTOPYRANOSYL GALACTOSE","10.1111/FEBS.14083 ",2.27,23.5,"5juv_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_C_)-MAN(8_C_)-[MAN(10_C_)]-MAN(7_C_)-[MAN(6_C_)-MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(622_A_)",32.8768,"","",""
"5JUV","STRUCTURE OF E298Q-BETA-GALACTOSIDASE FROM ASPERGILLUS NIGER IN COMPLEX WITH 6-B-GALACTOPYRANOSYL GALACTOSE","10.1111/FEBS.14083 ",2.27,23.5,"5juv_oligo3","DManpa1-2DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-MAN(5_D_)-MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(914_A_)",47.6829,"","",""
"5JUV","STRUCTURE OF E298Q-BETA-GALACTOSIDASE FROM ASPERGILLUS NIGER IN COMPLEX WITH 6-B-GALACTOPYRANOSYL GALACTOSE","10.1111/FEBS.14083 ",2.27,23.5,"5juv_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_B_)-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(373_A_)",45.897,"","",""
"5JW3","STRUCTURE OF MEDI8852 FAB FRAGMENT IN COMPLEX WITH H7 HA","10.1016/J.CELL.2016.05.073 ",3.75,151.4,"5jw3_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(28_A_)",125.336,"","",""
"5JYY","STRUCTURE-BASED TETRAVALENT ZANAMIVIR WITH POTENT INHIBITORY ACTIVITY AGAINST DRUG-RESISTANT INFLUENZA VIRUSES","10.1021/ACS.JMEDCHEM.6B00537 ",2.1,0,"5jyy_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_B_)-[MAN(8_B_)]-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(120_A_)",37.978,"","",""
"5K33","CRYSTAL STRUCTURE OF EXTRACELLULAR DOMAIN OF HER2 IN COMPLEX WITH FCAB STAB19","10.1016/J.STR.2017.04.014 ",3.3,120.4,"5k33_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(297_A_)",132.099,"","",""
"5K33","CRYSTAL STRUCTURE OF EXTRACELLULAR DOMAIN OF HER2 IN COMPLEX WITH FCAB STAB19","10.1016/J.STR.2017.04.014 ",3.3,120.4,"5k33_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(237_C_)",149.858,"","",""
"5K64","CRYSTAL STRUCTURE OF VEGF BINDING IGG1-FC (FCAB 448)","10.1080/19420862.2017.1364825 ",2.44,100.5,"5k64_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(297_A_)",135.456,"","",""
"5K64","CRYSTAL STRUCTURE OF VEGF BINDING IGG1-FC (FCAB 448)","10.1080/19420862.2017.1364825 ",2.44,100.5,"5k64_oligo3","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_D_)-MAN(4_D_)-[MAN(6_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(297_B_)",108.831,"","",""
"5K65","CRYSTAL STRUCTURE OF VEGF BINDING IGG1-FC (FCAB CT6)","10.1080/19420862.2017.1364825 ",2.5,0,"5k65_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)",116.089,"","",""
"5K65","CRYSTAL STRUCTURE OF VEGF BINDING IGG1-FC (FCAB CT6)","10.1080/19420862.2017.1364825 ",2.5,0,"5k65_oligo1","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_C_)-[NAG(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",80.7227,"","",""
"5K8D","CRYSTAL STRUCTURE OF RFVIIIFC","10.1111/JTH.13700 ",4.19,205.9,"5k8d_oligo2","DManpa1-2DManpb1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_E_)-MAN(6_E_)-[MAN(5_E_)-BMA(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(2118_B_)",275.876,"","",""
"5K9K","CRYSTAL STRUCTURE OF MULTIDONOR HV6-1-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 56.A.09 IN COMPLEX WITH HEMAGGLUTININ HONG KONG 1968.","10.1016/J.CELL.2016.06.043 ",2.97,0,"5k9k_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(483_I_)",127.636,"","",""
"5K9K","CRYSTAL STRUCTURE OF MULTIDONOR HV6-1-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 56.A.09 IN COMPLEX WITH HEMAGGLUTININ HONG KONG 1968.","10.1016/J.CELL.2016.06.043 ",2.97,0,"5k9k_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(38_I_)",67.616,"","",""
"5K9K","CRYSTAL STRUCTURE OF MULTIDONOR HV6-1-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 56.A.09 IN COMPLEX WITH HEMAGGLUTININ HONG KONG 1968.","10.1016/J.CELL.2016.06.043 ",2.97,0,"5k9k_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_P_)-[MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(285_F_)",117.498,"","",""
"5K9K","CRYSTAL STRUCTURE OF MULTIDONOR HV6-1-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 56.A.09 IN COMPLEX WITH HEMAGGLUTININ HONG KONG 1968.","10.1016/J.CELL.2016.06.043 ",2.97,0,"5k9k_oligo7","DManpa1-4DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-MAN(4_M_)-[MAN(6_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(38_F_)",87.607,"","",""
"5K9K","CRYSTAL STRUCTURE OF MULTIDONOR HV6-1-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 56.A.09 IN COMPLEX WITH HEMAGGLUTININ HONG KONG 1968.","10.1016/J.CELL.2016.06.043 ",2.97,0,"5k9k_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(22_F_)",183.404,"","",""
"5KAR","MURINE ACID SPHINGOMYELINASE-LIKE PHOSPHODIESTERASE 3B (SMPDL3B)","10.1074/JBC.M116.755801 ",1.14,0,"5kar_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(223_A_)",31.8942,"","",""
"5KAS","MURINE ACID SPHINGOMYELINASE-LIKE PHOSPHODIESTERASE 3B (SMPDL3B) WITH PHOSPHOCHOLINE","10.1074/JBC.M116.755801 ",1.62,0,"5kas_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(223_A_)",56.9816,"","",""
"5KBN","THE CRYSTAL STRUCTURE OF FLUORIDE CHANNEL FLUC EC2 F80I MUTANT","10.7554/ELIFE.18767 ",2.48,70.55,"5kbn_oligo3","DGlcpa1-3DGlcpb6-C10O1","DMU(202_A_)-DMU(202_A_)",77.4541,"","",""
"5KBN","THE CRYSTAL STRUCTURE OF FLUORIDE CHANNEL FLUC EC2 F80I MUTANT","10.7554/ELIFE.18767 ",2.48,70.55,"5kbn_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(201_B_)-DMU(201_B_)",73.405,"","",""
"5KBN","THE CRYSTAL STRUCTURE OF FLUORIDE CHANNEL FLUC EC2 F80I MUTANT","10.7554/ELIFE.18767 ",2.48,70.55,"5kbn_oligo4","DGlcpa1-3DGlcpb6-C10O1","DMU(203_A_)-DMU(203_A_)",82.2591,"","",""
"5KBN","THE CRYSTAL STRUCTURE OF FLUORIDE CHANNEL FLUC EC2 F80I MUTANT","10.7554/ELIFE.18767 ",2.48,70.55,"5kbn_oligo5","DGlcpa1-3DGlcpb6-C10O1","DMU(204_A_)-DMU(204_A_)",102.436,"","",""
"5KBN","THE CRYSTAL STRUCTURE OF FLUORIDE CHANNEL FLUC EC2 F80I MUTANT","10.7554/ELIFE.18767 ",2.48,70.55,"5kbn_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(101_C_)-DMU(101_C_)",105.836,"","",""
"5KDU","ZMPB METALLOPEPTIDASE IN COMPLEX WITH A2,6-SIALYL T-ANTIGEN","10.1073/PNAS.1615141114 ",2,33.11,"5kdu_oligo1","DGalpb1-3[DNeup5Aca2-6]DGalpNAca1-SER","SIA(3_B_)-[GAL(2_B_)]-A2G(1_B_)-SER(1114_A_)",50.0362,"","",""
"5KDX","IMPA METALLOPEPTIDASE IN COMPLEX WITH T-ANTIGEN","10.1073/PNAS.1615141114 ",2.4,27.42,"5kdx_oligo2","DGalpb1-3DGalpNAca1-SER","GAL(2_D_)-A2G(1_D_)-SER(1018_B_)",43.9195,"","",""
"5KDX","IMPA METALLOPEPTIDASE IN COMPLEX WITH T-ANTIGEN","10.1073/PNAS.1615141114 ",2.4,27.42,"5kdx_oligo1","DGalpb1-3DGalpNAca1-SER","GAL(2_C_)-A2G(1_C_)-SER(1021_A_)",39.8345,"","",""
"5KEL","EBOV GP IN COMPLEX WITH VARIABLE FAB DOMAINS OF IGGS C2G4 AND C13C6","10.1038/NMICROBIOL.2016.128 ",4.3,"1.35632e-19","5kel_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_V_)-[MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(563_B_)",1.38636,"","",""
"5KEL","EBOV GP IN COMPLEX WITH VARIABLE FAB DOMAINS OF IGGS C2G4 AND C13C6","10.1038/NMICROBIOL.2016.128 ",4.3,"1.35632e-19","5kel_oligo7","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_Y_)-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(257_E_)",0,"","",""
"5KEL","EBOV GP IN COMPLEX WITH VARIABLE FAB DOMAINS OF IGGS C2G4 AND C13C6","10.1038/NMICROBIOL.2016.128 ",4.3,"1.35632e-19","5kel_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Z_)-[MAN(4_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(563_G_)",1.38636,"","",""
"5KEL","EBOV GP IN COMPLEX WITH VARIABLE FAB DOMAINS OF IGGS C2G4 AND C13C6","10.1038/NMICROBIOL.2016.128 ",4.3,"1.35632e-19","5kel_oligo11","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_c_)-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(257_F_)",0,"","",""
"5KEL","EBOV GP IN COMPLEX WITH VARIABLE FAB DOMAINS OF IGGS C2G4 AND C13C6","10.1038/NMICROBIOL.2016.128 ",4.3,"1.35632e-19","5kel_oligo12","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_d_)-[MAN(4_d_)]-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(563_I_)",1.38636,"","",""
"5KEL","EBOV GP IN COMPLEX WITH VARIABLE FAB DOMAINS OF IGGS C2G4 AND C13C6","10.1038/NMICROBIOL.2016.128 ",4.3,"1.35632e-19","5kel_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_S_)-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(257_A_)",0,"","",""
"5KEN","EBOV GP IN COMPLEX WITH VARIABLE FAB DOMAINS OF IGGS C4G7 AND C13C6","10.1038/NMICROBIOL.2016.128 ",4.3,"1.35632e-19","5ken_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAca1-ASN","MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(563_F_)",3.52927,"","",""
"5KEN","EBOV GP IN COMPLEX WITH VARIABLE FAB DOMAINS OF IGGS C4G7 AND C13C6","10.1038/NMICROBIOL.2016.128 ",4.3,"1.35632e-19","5ken_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_L_)-[MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)",0,"","",""
"5KEN","EBOV GP IN COMPLEX WITH VARIABLE FAB DOMAINS OF IGGS C4G7 AND C13C6","10.1038/NMICROBIOL.2016.128 ",4.3,"1.35632e-19","5ken_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_T_)-[MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)",0,"","",""
"5KIJ","CRYSTAL STRUCTURE OF THE CLASS I HUMAN ENDOPLASMIC RETICULUM 1,2- ALPHA-MANNOSIDASE AND MAN9GLCNAC2-PA COMPLEX","10.1073/PNAS.1611213113 ",1.65,0,"5kij_oligo2","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcx1-","MAN(7_B_)-MAN(6_B_)-[MAN(5_B_)-MAN(4_B_)]-MAN(3_B_)-[MAN(9_B_)-MAN(8_B_)]-BMA(2_B_)-NAG(1_B_)",13.9538,"","",""
"5KIQ","SRPA WITH SIALYL LEWISX","10.1021/ACS.BIOCHEM.6B00704 ",1.64,34.71,"5kiq_oligo1","DNeup5Aca2-3DGalpb1-4[LFucpa1-3]DGlcpNAcb1-ROH","SIA(3_C_)-GAL(2_C_)-[FUC(4_C_)]-NAG(1_C_)",48.2335,"","",""
"5KKB","STRUCTURE OF MOUSE GOLGI ALPHA-1,2-MANNOSIDASE IA AND MAN9GLCNAC2-PA COMPLEX","10.1073/PNAS.1611213113 ",1.77,0,"5kkb_oligo4","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-ROH","MAN(9_D_)-[MAN(8_D_)-MAN(7_D_)]-MAN(6_D_)-[MAN(5_D_)-MAN(4_D_)-MAN(3_D_)]-BMA(2_D_)-NAG(1_D_)",35.0126,"","",""
"5KKB","STRUCTURE OF MOUSE GOLGI ALPHA-1,2-MANNOSIDASE IA AND MAN9GLCNAC2-PA COMPLEX","10.1073/PNAS.1611213113 ",1.77,0,"5kkb_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-ROH","MAN(9_C_)-[MAN(8_C_)-MAN(7_C_)]-MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)-MAN(3_C_)]-BMA(2_C_)-NAG(1_C_)",34.6234,"","",""
"5KOM","THE CRYSTAL STRUCTURE OF FLUORIDE CHANNEL FLUC EC2 F83I MUTANT","10.7554/ELIFE.18767 ",2.69,75.04,"5kom_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(202_A_)-DMU(202_A_)",82.5691,"","",""
"5KOM","THE CRYSTAL STRUCTURE OF FLUORIDE CHANNEL FLUC EC2 F83I MUTANT","10.7554/ELIFE.18767 ",2.69,75.04,"5kom_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(101_C_)-DMU(101_C_)",115.836,"","",""
"5KOM","THE CRYSTAL STRUCTURE OF FLUORIDE CHANNEL FLUC EC2 F83I MUTANT","10.7554/ELIFE.18767 ",2.69,75.04,"5kom_oligo3","DGlcpa1-3DGlcpb6-C10O1","DMU(201_B_)-DMU(201_B_)",73.3245,"","",""
"5KUK","CRYSTAL STRUCTURE OF INWARD RECTIFIER KIR2.2 K62W MUTANT","10.1085/JGP.201611616 ",2,35.07,"5kuk_oligo1","DGlcpa1-3DGlcpb6-C3O1","DMU(510_A_)-DMU(510_A_)",67.8595,"","",""
"5KUM","CRYSTAL STRUCTURE OF INWARD RECTIFIER KIR2.2 K62W MUTANT IN COMPLEX WITH PIP2","10.1085/JGP.201611616 ",2.8,74.39,"5kum_oligo1","DGlcpa1-3DGlcpb6-OME","DMU(410_A_)-DMU(410_A_)",141.91,"","",""
"5KWR","CRYSTAL STRUCTURE OF RAT CEREBELLIN-1","10.1016/J.STR.2016.11.004 ",1.8,0,"5kwr_oligo1","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_B_)-[FUC(2_B_)]-NAG(1_B_)-ASN(79_A_)",89.1697,"","",""
"5KXB","WISTERIA FLORIBUNDA LECTIN IN COMPLEX WITH GALNAC","10.1074/JBC.M116.750463 ",2.33,38.27,"5kxb_oligo3","DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","BMA(3_G_)-NAG(2_G_)-[FUC(4_G_)]-NAG(1_G_)-ASN(146_C_)",70.2432,"","",""
"5KXB","WISTERIA FLORIBUNDA LECTIN IN COMPLEX WITH GALNAC","10.1074/JBC.M116.750463 ",2.33,38.27,"5kxb_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","BMA(3_F_)-NAG(2_F_)-[FUC(4_F_)]-NAG(1_F_)-ASN(146_B_)",77.8461,"","",""
"5KXB","WISTERIA FLORIBUNDA LECTIN IN COMPLEX WITH GALNAC","10.1074/JBC.M116.750463 ",2.33,38.27,"5kxb_oligo1","DXylpb1-2[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(5_E_)-[XYP(4_E_)]-BMA(3_E_)-NAG(2_E_)-[FUC(6_E_)]-NAG(1_E_)-ASN(146_A_)",54.8266,"","",""
"5KXC","WISTERIA FLORIBUNDA LECTIN IN COMPLEX WITH GALNAC(BETA1-4)GLCNAC (LACDINAC) AT PH 8.5.","10.1074/JBC.M116.750463 ",1.8,30.99,"5kxc_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","BMA(3_F_)-NAG(2_F_)-[FUC(4_F_)]-NAG(1_F_)-ASN(146_C_)",47.843,"","",""
"5KXC","WISTERIA FLORIBUNDA LECTIN IN COMPLEX WITH GALNAC(BETA1-4)GLCNAC (LACDINAC) AT PH 8.5.","10.1074/JBC.M116.750463 ",1.8,30.99,"5kxc_oligo1","LFucpa1-3DGlcpNAcb1-ASN","FUC(2_E_)-NAG(1_E_)-ASN(146_A_)",81.4055,"","",""
"5KXD","WISTERIA FLORIBUNDA LECTIN IN COMPLEX WITH GALNAC(BETA1-4)GLCNAC (LACDINAC) AT PH 6.5","10.1074/JBC.M116.750463 ",1.95,22.83,"5kxd_oligo2","DXylpb1-2[DManpa1-3][DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)]-[XYP(4_F_)]-BMA(3_F_)-NAG(2_F_)-[FUC(7_F_)]-NAG(1_F_)-ASN(146_C_)",50.0965,"","",""
"5KXD","WISTERIA FLORIBUNDA LECTIN IN COMPLEX WITH GALNAC(BETA1-4)GLCNAC (LACDINAC) AT PH 6.5","10.1074/JBC.M116.750463 ",1.95,22.83,"5kxd_oligo1","LFucpa1-3DGlcpNAcb1-ASN","FUC(2_E_)-NAG(1_E_)-ASN(146_A_)",51.0586,"","",""
"5KXD","WISTERIA FLORIBUNDA LECTIN IN COMPLEX WITH GALNAC(BETA1-4)GLCNAC (LACDINAC) AT PH 6.5","10.1074/JBC.M116.750463 ",1.95,22.83,"5kxd_oligo3","LFucpa1-3DGlcpNAcb1-ASN","FUC(2_G_)-NAG(1_G_)-ASN(146_D_)",59.4186,"","",""
"5KXE","WISTERIA FLORIBUNDA LECTIN IN COMPLEX WITH GALNAC(BETA1-4)GLCNAC (LACDINAC) AT PH 4.2","10.1074/JBC.M116.750463 ",2.09,28.47,"5kxe_oligo3","LFucpa1-3DGlcpNAcb1-ASN","FUC(2_G_)-NAG(1_G_)-ASN(146_C_)",73.3432,"","",""
"5KXE","WISTERIA FLORIBUNDA LECTIN IN COMPLEX WITH GALNAC(BETA1-4)GLCNAC (LACDINAC) AT PH 4.2","10.1074/JBC.M116.750463 ",2.09,28.47,"5kxe_oligo4","LFucpa1-3DGlcpNAcb1-ASN","FUC(2_H_)-NAG(1_H_)-ASN(146_D_)",60.2741,"","",""
"5KXE","WISTERIA FLORIBUNDA LECTIN IN COMPLEX WITH GALNAC(BETA1-4)GLCNAC (LACDINAC) AT PH 4.2","10.1074/JBC.M116.750463 ",2.09,28.47,"5kxe_oligo2","DXylpb1-2[DManpa1-3][DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)]-[XYP(4_F_)]-BMA(3_F_)-NAG(2_F_)-[FUC(7_F_)]-NAG(1_F_)-ASN(146_B_)",57.9507,"","",""
"5KXE","WISTERIA FLORIBUNDA LECTIN IN COMPLEX WITH GALNAC(BETA1-4)GLCNAC (LACDINAC) AT PH 4.2","10.1074/JBC.M116.750463 ",2.09,28.47,"5kxe_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-[FUC(5_E_)]-NAG(1_E_)-ASN(146_A_)",72.9836,"","",""
"5KZC","CRYSTAL STRUCTURE OF AN HIV-1 GP120 ENGINEERED OUTER DOMAIN WITH A MAN9 GLYCAN AT POSITION N276, IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODY VRC01","10.1371/JOURNAL.PPAT.1005815 ",3.25,0,"5kzc_oligo3","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_K_)-[MAN(5_K_)]-MAN(4_K_)-[MAN(7_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(79_F_)",118.779,"","",""
"5KZC","CRYSTAL STRUCTURE OF AN HIV-1 GP120 ENGINEERED OUTER DOMAIN WITH A MAN9 GLYCAN AT POSITION N276, IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODY VRC01","10.1371/JOURNAL.PPAT.1005815 ",3.25,0,"5kzc_oligo2","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_J_)-[MAN(6_J_)-MAN(5_J_)]-MAN(4_J_)-[MAN(9_J_)-MAN(8_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(79_C_)",92.7856,"","",""
"5KZC","CRYSTAL STRUCTURE OF AN HIV-1 GP120 ENGINEERED OUTER DOMAIN WITH A MAN9 GLYCAN AT POSITION N276, IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODY VRC01","10.1371/JOURNAL.PPAT.1005815 ",3.25,0,"5kzc_oligo1","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_I_)-[MAN(6_I_)-MAN(5_I_)]-MAN(4_I_)-[MAN(9_I_)-MAN(8_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(79_A_)",104.71,"","",""
"5L0B","CRYSTAL STRUCTURE OF AUTOTAXIN AND COMPOUND 1","10.1021/ACSMEDCHEMLETT.6B00207 ",2.41,44.35,"5l0b_oligo1","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_C_)-MAN(7_C_)-[MAN(6_C_)-MAN(5_C_)]-MAN(4_C_)-[MAN(9_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(524_A_)",68.6571,"","",""
"5L0B","CRYSTAL STRUCTURE OF AUTOTAXIN AND COMPOUND 1","10.1021/ACSMEDCHEMLETT.6B00207 ",2.41,44.35,"5l0b_oligo2","DManpa1-2DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-MAN(5_D_)-MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(524_B_)",66.7759,"","",""
"5L0E","CRYSTAL STRUCTURE OF AUTOTAXIN AND COMPOUND 1","10.1021/ACSMEDCHEMLETT.6B00207 ",3.06,50.37,"5l0e_oligo2","DManpa1-2DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-MAN(5_D_)-MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(524_B_)",79.0526,"","",""
"5L0E","CRYSTAL STRUCTURE OF AUTOTAXIN AND COMPOUND 1","10.1021/ACSMEDCHEMLETT.6B00207 ",3.06,50.37,"5l0e_oligo1","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_C_)-MAN(7_C_)-[MAN(6_C_)-MAN(5_C_)]-MAN(4_C_)-[MAN(9_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(524_A_)",75.2708,"","",""
"5L14","THE CRYSTAL STRUCTURE OF NEURAMINIDASE FROM A/SHANGHAI/2/2013 (H7N9) INFLUENZA VIRUS","10.1093/INFDIS/JIW625 ",1.9,0,"5l14_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_B_)-[MAN(8_B_)]-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(202_A_)",37.2303,"","",""
"5L15","THE CRYSTAL STRUCTURE OF NEURAMINIDASE IN COMPLEX WITH OSELTAMIVIR FROM A/SHANGHAI/2/2013 (H7N9) INFLUENZA VIRUS","10.1093/INFDIS/JIW625 ",2.4,0,"5l15_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_B_)-[MAN(8_B_)]-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(202_A_)",52.6181,"","",""
"5L17","THE CRYSTAL STRUCTURE OF NEURAMINIDASE IN COMPLEX WITH ZANAMIVIR FROM A/SHANGHAI/2/2013 (H7N9) INFLUENZA VIRUS","10.1093/INFDIS/JIW625 ",2.4,0,"5l17_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_B_)-[MAN(8_B_)]-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(202_A_)",51.6364,"","",""
"5L18","THE CRYSTAL STRUCTURE OF NEURAMINIDASE IN COMPLEX WITH SIALIC ACID FROM A/SHANGHAI/2/2013 (H7N9) INFLUENZA VIRUS","10.1093/INFDIS/JIW625 ",1.8,0,"5l18_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_B_)-[MAN(8_B_)]-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(202_A_)",23.938,"","",""
"5L2J","CRYSTAL STRUCTURE OF HUMAN CD1B IN COMPLEX WITH C36-GMM","10.1038/NCOMMS13257 ",1.65,24.53,"5l2j_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(7_C_)-[MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-[FUC(6_C_)]-NAG(1_C_)-ASN(57_A_)",20.3438,"","",""
"5L56","PLEXIN A1 FULL EXTRACELLULAR REGION, DOMAINS 1 TO 10, TO 4 ANGSTROM","10.1016/J.NEURON.2016.06.018 ",4,133.7,"5l56_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(595_A_)",224.892,"","",""
"5L56","PLEXIN A1 FULL EXTRACELLULAR REGION, DOMAINS 1 TO 10, TO 4 ANGSTROM","10.1016/J.NEURON.2016.06.018 ",4,133.7,"5l56_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)]-MAN(4_F_)-[MAN(7_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(670_A_)",240.299,"","",""
"5L56","PLEXIN A1 FULL EXTRACELLULAR REGION, DOMAINS 1 TO 10, TO 4 ANGSTROM","10.1016/J.NEURON.2016.06.018 ",4,133.7,"5l56_oligo4","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-[MAN(5_E_)]-MAN(4_E_)-[MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(658_A_)",225.62,"","",""
"5L56","PLEXIN A1 FULL EXTRACELLULAR REGION, DOMAINS 1 TO 10, TO 4 ANGSTROM","10.1016/J.NEURON.2016.06.018 ",4,133.7,"5l56_oligo9","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAca1-ASN","MAN(6_J_)-[MAN(5_J_)]-MAN(4_J_)-[MAN(7_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(1096_A_)",274.611,"","",""
"5L56","PLEXIN A1 FULL EXTRACELLULAR REGION, DOMAINS 1 TO 10, TO 4 ANGSTROM","10.1016/J.NEURON.2016.06.018 ",4,133.7,"5l56_oligo8","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-MAN(4_I_)-[MAN(6_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(1041_A_)",253.544,"","",""
"5L56","PLEXIN A1 FULL EXTRACELLULAR REGION, DOMAINS 1 TO 10, TO 4 ANGSTROM","10.1016/J.NEURON.2016.06.018 ",4,133.7,"5l56_oligo2","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(570_A_)",225.851,"","",""
"5L56","PLEXIN A1 FULL EXTRACELLULAR REGION, DOMAINS 1 TO 10, TO 4 ANGSTROM","10.1016/J.NEURON.2016.06.018 ",4,133.7,"5l56_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(75_A_)",227.202,"","",""
"5L56","PLEXIN A1 FULL EXTRACELLULAR REGION, DOMAINS 1 TO 10, TO 4 ANGSTROM","10.1016/J.NEURON.2016.06.018 ",4,133.7,"5l56_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(759_A_)",198.978,"","",""
"5L59","PLEXIN A1 FULL EXTRACELLULAR REGION, DOMAINS 1 TO 10, TO 6 ANGSTROM, SPACEGROUP P2(1)","10.1016/J.NEURON.2016.06.018 ",6,0,"5l59_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(75_A_)",242.83,"","",""
"5L59","PLEXIN A1 FULL EXTRACELLULAR REGION, DOMAINS 1 TO 10, TO 6 ANGSTROM, SPACEGROUP P2(1)","10.1016/J.NEURON.2016.06.018 ",6,0,"5l59_oligo16","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAca1-ASN","MAN(6_R_)-[MAN(5_R_)]-MAN(4_R_)-[MAN(7_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(1096_B_)",365.03,"","",""
"5L59","PLEXIN A1 FULL EXTRACELLULAR REGION, DOMAINS 1 TO 10, TO 6 ANGSTROM, SPACEGROUP P2(1)","10.1016/J.NEURON.2016.06.018 ",6,0,"5l59_oligo6","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)]-MAN(4_F_)-[MAN(7_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(658_A_)",271.09,"","",""
"5L59","PLEXIN A1 FULL EXTRACELLULAR REGION, DOMAINS 1 TO 10, TO 6 ANGSTROM, SPACEGROUP P2(1)","10.1016/J.NEURON.2016.06.018 ",6,0,"5l59_oligo11","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_M_)-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(595_B_)",282.96,"","",""
"5L59","PLEXIN A1 FULL EXTRACELLULAR REGION, DOMAINS 1 TO 10, TO 6 ANGSTROM, SPACEGROUP P2(1)","10.1016/J.NEURON.2016.06.018 ",6,0,"5l59_oligo15","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Q_)-MAN(4_Q_)-[MAN(6_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(1041_B_)",308.4,"","",""
"5L59","PLEXIN A1 FULL EXTRACELLULAR REGION, DOMAINS 1 TO 10, TO 6 ANGSTROM, SPACEGROUP P2(1)","10.1016/J.NEURON.2016.06.018 ",6,0,"5l59_oligo3","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(570_A_)",271.09,"","",""
"5L59","PLEXIN A1 FULL EXTRACELLULAR REGION, DOMAINS 1 TO 10, TO 6 ANGSTROM, SPACEGROUP P2(1)","10.1016/J.NEURON.2016.06.018 ",6,0,"5l59_oligo4","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(1041_A_)",314.45,"","",""
"5L59","PLEXIN A1 FULL EXTRACELLULAR REGION, DOMAINS 1 TO 10, TO 6 ANGSTROM, SPACEGROUP P2(1)","10.1016/J.NEURON.2016.06.018 ",6,0,"5l59_oligo12","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_N_)-[MAN(5_N_)]-MAN(4_N_)-[MAN(7_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(658_B_)",282.96,"","",""
"5L59","PLEXIN A1 FULL EXTRACELLULAR REGION, DOMAINS 1 TO 10, TO 6 ANGSTROM, SPACEGROUP P2(1)","10.1016/J.NEURON.2016.06.018 ",6,0,"5l59_oligo10","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_L_)-MAN(4_L_)-[MAN(6_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(570_B_)",282.96,"","",""
"5L59","PLEXIN A1 FULL EXTRACELLULAR REGION, DOMAINS 1 TO 10, TO 6 ANGSTROM, SPACEGROUP P2(1)","10.1016/J.NEURON.2016.06.018 ",6,0,"5l59_oligo13","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_O_)-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(759_B_)",270.13,"","",""
"5L59","PLEXIN A1 FULL EXTRACELLULAR REGION, DOMAINS 1 TO 10, TO 6 ANGSTROM, SPACEGROUP P2(1)","10.1016/J.NEURON.2016.06.018 ",6,0,"5l59_oligo9","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_K_)-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(75_B_)",243.01,"","",""
"5L59","PLEXIN A1 FULL EXTRACELLULAR REGION, DOMAINS 1 TO 10, TO 6 ANGSTROM, SPACEGROUP P2(1)","10.1016/J.NEURON.2016.06.018 ",6,0,"5l59_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(595_A_)",271.09,"","",""
"5L59","PLEXIN A1 FULL EXTRACELLULAR REGION, DOMAINS 1 TO 10, TO 6 ANGSTROM, SPACEGROUP P2(1)","10.1016/J.NEURON.2016.06.018 ",6,0,"5l59_oligo5","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAca1-ASN","MAN(6_J_)-[MAN(5_J_)]-MAN(4_J_)-[MAN(7_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(1096_A_)",359.83,"","",""
"5L5C","PLEXIN A1 FULL EXTRACELLULAR REGION, DOMAINS 1 TO 10, TO 6 ANGSTROM, SPACEGROUP P4(3)2(1)2","10.1016/J.NEURON.2016.06.018 ",6,0,"5l5c_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(759_A_)",252.79,"","",""
"5L5C","PLEXIN A1 FULL EXTRACELLULAR REGION, DOMAINS 1 TO 10, TO 6 ANGSTROM, SPACEGROUP P4(3)2(1)2","10.1016/J.NEURON.2016.06.018 ",6,0,"5l5c_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(595_A_)",269.04,"","",""
"5L5C","PLEXIN A1 FULL EXTRACELLULAR REGION, DOMAINS 1 TO 10, TO 6 ANGSTROM, SPACEGROUP P4(3)2(1)2","10.1016/J.NEURON.2016.06.018 ",6,0,"5l5c_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(75_A_)",262.87,"","",""
"5L5C","PLEXIN A1 FULL EXTRACELLULAR REGION, DOMAINS 1 TO 10, TO 6 ANGSTROM, SPACEGROUP P4(3)2(1)2","10.1016/J.NEURON.2016.06.018 ",6,0,"5l5c_oligo8","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAca1-ASN","MAN(5_I_)-MAN(4_I_)-[MAN(6_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(1096_A_)",431.97,"","",""
"5L5C","PLEXIN A1 FULL EXTRACELLULAR REGION, DOMAINS 1 TO 10, TO 6 ANGSTROM, SPACEGROUP P4(3)2(1)2","10.1016/J.NEURON.2016.06.018 ",6,0,"5l5c_oligo3","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-MAN(4_E_)-[MAN(6_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(658_A_)",269.04,"","",""
"5L5C","PLEXIN A1 FULL EXTRACELLULAR REGION, DOMAINS 1 TO 10, TO 6 ANGSTROM, SPACEGROUP P4(3)2(1)2","10.1016/J.NEURON.2016.06.018 ",6,0,"5l5c_oligo1","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(570_A_)",269.04,"","",""
"5LA2","THE MECHANISM BY WHICH ARABINOXYLANASES CAN RECOGNISE HIGHLY DECORATED XYLANS","10.1074/JBC.M116.743948 ",1.65,21.7,"5la2_oligo2","DXylpb1-4DXylpb1-4DXylpb1-4[LArafa1-3]DXylpa1-ROH","XYP(4_D_)-XYP(3_D_)-XYP(2_D_)-[AHR(5_D_)]-XYS(1_D_)",38.6885,"","",""
"5LA2","THE MECHANISM BY WHICH ARABINOXYLANASES CAN RECOGNISE HIGHLY DECORATED XYLANS","10.1074/JBC.M116.743948 ",1.65,21.7,"5la2_oligo1","DXylpb1-4DXylpb1-4DXylpb1-4[LArafa1-3]DXylpa1-ROH","XYP(4_C_)-XYP(3_C_)-XYP(2_C_)-[AHR(5_C_)]-XYS(1_C_)",32.7592,"","",""
"5LAL","STRUCTURE OF ARABIDOPSIS DIRIGENT PROTEIN ATDIR6","10.1104/PP.16.01281 ",1.4,29.51,"5lal_oligo3","DXylpb1-2[DManpa1-3][DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(207_B_)]-[XYP(4_E_)]-BMA(3_E_)-NAG(2_E_)-[FUC(6_E_)]-NAG(1_E_)-ASN(59_B_)",30.3717,"","",""
"5LAL","STRUCTURE OF ARABIDOPSIS DIRIGENT PROTEIN ATDIR6","10.1104/PP.16.01281 ",1.4,29.51,"5lal_oligo4","DXylpb1-2[DManpa1-3][DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","MAN(6_F_)-[MAN(5_F_)]-[XYP(4_F_)]-BMA(3_F_)-NAG(2_F_)-[FUC(7_F_)]-NAG(1_F_)",66.741,"","",""
"5LAL","STRUCTURE OF ARABIDOPSIS DIRIGENT PROTEIN ATDIR6","10.1104/PP.16.01281 ",1.4,29.51,"5lal_oligo1","DXylpb1-2[DManpa1-3][DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(206_A_)]-[XYP(4_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(207_A_)]-NAG(1_C_)-ASN(59_A_)",31.8898,"","",""
"5LBV","STRUCTURAL BASIS OF ZIKA AND DENGUE VIRUS POTENT ANTIBODY CROSS- NEUTRALIZATION","10.1038/NATURE18938 ",2.2,64.34,"5lbv_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_C_)-[MAN(4_C_)-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(154_B_)",76.8276,"","",""
"5LDS","STRUCTURE OF THE PORCINE AMINOPEPTIDASE N ECTODOMAIN","10.1038/SREP46045 ",2,0,"5lds_oligo11","DIdopa1-3DGlcpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_O_)-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(328_D_)",33.8059,"","",""
"5LDS","STRUCTURE OF THE PORCINE AMINOPEPTIDASE N ECTODOMAIN","10.1038/SREP46045 ",2,0,"5lds_oligo1","DIdopa1-3DIdopa1-6[DIdopa1-3]DGlcpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_E_)-BMA(4_E_)-[BMA(6_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(646_A_)",55.8736,"","",""
"5LDU","RECOMBINANT HIGH-REDOX POTENTIAL LACCASE FROM BASIDIOMYCETE TRAMETES HIRSUTA","",2.3,23.07,"5ldu_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(436_A_)",44.378,"","",""
"5LF5","MYELIN-ASSOCIATED GLYCOPROTEIN (MAG) DEGLYCOSYLATED FULL EXTRACELLULAR DOMAIN WITH CO-PURIFIED LIGAND","10.1038/NCOMMS13584 ",3.8,0,"5lf5_oligo1","DNeup5Aca2-3DGalpb1-3DGalpNAcb1-ROH","SIA(3_C_)-GAL(2_C_)-NGA(1_C_)",131.289,"","",""
"5LFE","PROTRUDING DOMAIN OF GII.4 HUMAN NOROVIRUS ISOLATE 8-14 IN COMPLEX WITH HBGA TYPE B (TRIGLYCAN)","",2.3,37.88,"5lfe_oligo1","LFucpa1-2[DGalpa1-3]DGalpa1-ROH","GLA(3_C_)-[FUC(2_C_)]-GLA(1_C_)",35.9555,"","",""
"5LFR","CRYSTAL STRUCTURE OF GLYCOSYLATED MYELIN-ASSOCIATED GLYCOPROTEIN (MAG) IG1-3","10.1038/NCOMMS13584 ",2.12,0,"5lfr_oligo5","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(99_A_)",98.3893,"","",""
"5LFR","CRYSTAL STRUCTURE OF GLYCOSYLATED MYELIN-ASSOCIATED GLYCOPROTEIN (MAG) IG1-3","10.1038/NCOMMS13584 ",2.12,0,"5lfr_oligo6","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(99_B_)",98.4627,"","",""
"5LFU","MYELIN-ASSOCIATED GLYCOPROTEIN (MAG) GLYCOSYLATED AND LYSINE- METHYLATED FULL EXTRACELLULAR DOMAIN","10.1038/NCOMMS13584 ",4.3,0,"5lfu_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(99_A_)",373.07,"","",""
"5LG1","ROOM TEMPERATURE STRUCTURE OF HUMAN IGG4-FC FROM CRYSTALS ANALYSED IN SITU","10.1016/J.MOLIMM.2016.11.021 ",2.7,0,"5lg1_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",144.153,"","",""
"5LG1","ROOM TEMPERATURE STRUCTURE OF HUMAN IGG4-FC FROM CRYSTALS ANALYSED IN SITU","10.1016/J.MOLIMM.2016.11.021 ",2.7,0,"5lg1_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",86.3385,"","",""
"5LGJ","THE CRYSTAL STRUCTURE OF IGE FC MUTANT - P333C","",2.6,57.46,"5lgj_oligo2","DManpa1-3[DManpa1-4]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-[MAN(5_D_)]-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(394_B_)",86.5186,"","",""
"5LGJ","THE CRYSTAL STRUCTURE OF IGE FC MUTANT - P333C","",2.6,57.46,"5lgj_oligo1","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(394_A_)",121.48,"","",""
"5LHD","STRUCTURE OF GLYCOSYLATED HUMAN AMINOPEPTIDASE N","10.1038/SREP46045 ",2.6,0,"5lhd_oligo14","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_L_)-[BMA(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(234_B_)",88.8476,"","",""
"5LHD","STRUCTURE OF GLYCOSYLATED HUMAN AMINOPEPTIDASE N","10.1038/SREP46045 ",2.6,0,"5lhd_oligo23","DManpb1-3DManpb1-6[DManpb1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_a_)-BMA(4_a_)-[BMA(6_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(234_D_)",93.4405,"","",""
"5LHD","STRUCTURE OF GLYCOSYLATED HUMAN AMINOPEPTIDASE N","10.1038/SREP46045 ",2.6,0,"5lhd_oligo12","DManpb1-3DManpb1-6[DManpb1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_W_)-BMA(4_W_)-[BMA(6_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(625_C_)",119.506,"","",""
"5LHD","STRUCTURE OF GLYCOSYLATED HUMAN AMINOPEPTIDASE N","10.1038/SREP46045 ",2.6,0,"5lhd_oligo21","DManpb1-3[DManpb1-6]DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAca1-ASN","BMA(6_Y_)-[BMA(5_Y_)]-BMA(4_Y_)-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(735_C_)",137.27,"","",""
"5LHD","STRUCTURE OF GLYCOSYLATED HUMAN AMINOPEPTIDASE N","10.1038/SREP46045 ",2.6,0,"5lhd_oligo9","DManpb1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_T_)-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(265_C_)",106.443,"","",""
"5LHD","STRUCTURE OF GLYCOSYLATED HUMAN AMINOPEPTIDASE N","10.1038/SREP46045 ",2.6,0,"5lhd_oligo8","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_S_)-[BMA(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(234_C_)",85.7215,"","",""
"5LHD","STRUCTURE OF GLYCOSYLATED HUMAN AMINOPEPTIDASE N","10.1038/SREP46045 ",2.6,0,"5lhd_oligo6","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_F_)-[BMA(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(234_A_)",85.4498,"","",""
"5LIA","CRYSTAL STRUCTURE OF MURINE AUTOTAXIN IN COMPLEX WITH A SMALL MOLECULE INHIBITOR","10.1016/J.BMCL.2016.10.036 ",1.92,35.32,"5lia_oligo1","DManpa1-2DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-MAN(5_B_)-MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(524_A_)",38.85,"","",""
"5LKC","PROTRUDING DOMAIN OF GII.17 NOROVIRUS KAWASAKI308 IN COMPLEX WITH HBGA TYPE A (TRIGLYCAN)","10.1016/J.VIROL.2017.04.032 ",1.81,26.34,"5lkc_oligo2","LFucpa1-2[DGalpNAca1-3]DGalpa1-ROH","A2G(3_D_)-[FUC(2_D_)]-GLA(1_D_)",38.9921,"","",""
"5LKC","PROTRUDING DOMAIN OF GII.17 NOROVIRUS KAWASAKI308 IN COMPLEX WITH HBGA TYPE A (TRIGLYCAN)","10.1016/J.VIROL.2017.04.032 ",1.81,26.34,"5lkc_oligo1","LFucpa1-2[DGalpNAca1-3]DGalpa1-ROH","A2G(3_C_)-[FUC(2_C_)]-GLA(1_C_)",51.0979,"","",""
"5LKK","PROTRUDING DOMAIN OF GII.17 NOROVIRUS KAWASAKI308 IN COMPLEX WITH 3- FUCOSYLLACTOSE (3FL)","",1.49,23.93,"5lkk_oligo1","LFucpa1-3[DGalpb1-4]DGlcpa1-ROH","GAL(3_C_)-[FUC(2_C_)]-GLC(1_C_)",43.0388,"","",""
"5LKK","PROTRUDING DOMAIN OF GII.17 NOROVIRUS KAWASAKI308 IN COMPLEX WITH 3- FUCOSYLLACTOSE (3FL)","",1.49,23.93,"5lkk_oligo2","LFucpa1-3[DGalpb1-4]DGlcpa1-ROH","GAL(3_D_)-[FUC(2_D_)]-GLC(1_D_)",39.22,"","",""
"5LM8","CRYSTAL STRUCTURE OF A LACCASE-LIKE MULTICOPPER OXIDASE MCOG FROM FROM ASPERGILLUS NIGER","10.1515/BOCA-2017-0001 ",1.7,29.29,"5lm8_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(103_A_)",35.982,"","",""
"5LNE","E. COLI F9 PILUS ADHESIN FMLH BOUND TO THE THOMSEN-FRIEDENREICH (TF) ANTIGEN","10.1016/J.CHOM.2016.08.013 ",2.2,36.23,"5lne_oligo1","DGalpb1-3DGalpNAca1-ROH","GAL(2_C_)-A2G(1_C_)",37.5527,"","",""
"5LNE","E. COLI F9 PILUS ADHESIN FMLH BOUND TO THE THOMSEN-FRIEDENREICH (TF) ANTIGEN","10.1016/J.CHOM.2016.08.013 ",2.2,36.23,"5lne_oligo2","DGalpb1-3DGalpNAca1-ROH","GAL(2_D_)-A2G(1_D_)",32.2227,"","",""
"5LQQ","STRUCTURE OF AUTOTAXIN (ENPP2) WITH LM350","10.1021/ACS.JMEDCHEM.6B01597 ",2.4,61.5,"5lqq_oligo1","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)]-MAN(4_B_)-[MAN(8_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(524_A_)",61.6194,"","",""
"5LR0","BINDING DOMAIN OF BOTULINUM NEUROTOXIN DC IN COMPLEX WITH SIALYLT","10.1038/S41467-017-01534-Z ",2.59,40.98,"5lr0_oligo1","DNeup5Aca2-3DGalpb1-3DGalpNAcb1-ROH","SIA(3_C_)-GAL(2_C_)-NGA(1_C_)",38.0262,"","",""
"5LR0","BINDING DOMAIN OF BOTULINUM NEUROTOXIN DC IN COMPLEX WITH SIALYLT","10.1038/S41467-017-01534-Z ",2.59,40.98,"5lr0_oligo2","DGalpb1-3DGalpNAcb1-ROH","GAL(2_D_)-NGA(1_D_)",110.374,"","",""
"5LSH","HUMAN LYSOZYME IN COMPLEX WITH A TETRASACCHARIDE FRAGMENT OF THE O- CHAIN OF LPS FROM KLEBSIELLA PNEUMONIAE","10.1017/S0033583517000075 ",1.06,0,"5lsh_oligo1","DGalpa1-3DGalfb1-3DGalpa1-3DGalfb1-C3O1","GLA(4_B_)-GZL(3_B_)-GLA(2_B_)-TVG(1_B_)",16.1664,"","",""
"5LVX","CRYSTAL STRUCTURE OF GLUCOCEREBROSIDASE WITH AN INHIBITORY QUINAZOLINE MODULATOR","10.1021/JACS.7B13003 ",2.2,39.37,"5lvx_oligo8","DManpa1-2DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-MAN(5_H_)-MAN(4_H_)-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(19_D_)",72.2355,"","",""
"5LVX","CRYSTAL STRUCTURE OF GLUCOCEREBROSIDASE WITH AN INHIBITORY QUINAZOLINE MODULATOR","10.1021/JACS.7B13003 ",2.2,39.37,"5lvx_oligo5","DManpa1-2DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-MAN(5_E_)-MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(19_A_)",59.9982,"","",""
"5LVX","CRYSTAL STRUCTURE OF GLUCOCEREBROSIDASE WITH AN INHIBITORY QUINAZOLINE MODULATOR","10.1021/JACS.7B13003 ",2.2,39.37,"5lvx_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(19_C_)",50.9502,"","",""
"5LY9","STRUCTURE OF MITAT 1.1","10.1038/S41564-017-0013-6 ",1.65,28.86,"5ly9_oligo3","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(266_B_)",39.4231,"","",""
"5LY9","STRUCTURE OF MITAT 1.1","10.1038/S41564-017-0013-6 ",1.65,28.86,"5ly9_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(266_A_)",38.4173,"","",""
"5M0D","STRUCTURE-BASED EVOLUTION OF A HYBRID STEROID SERIES OF AUTOTAXIN INHIBITORS","10.1021/ACS.JMEDCHEM.6B01743 ",2.4,59.66,"5m0d_oligo2","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)]-MAN(4_B_)-[MAN(8_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(524_A_)",58.3186,"","",""
"5M0M","STRUCTURE-BASED EVOLUTION OF A HYBRID STEROID SERIES OF AUTOTAXIN INHIBITORS","10.1021/ACS.JMEDCHEM.6B01743 ",2.1,37.02,"5m0m_oligo2","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_B_)-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)]-MAN(4_B_)-[MAN(9_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(524_A_)",37.4718,"","",""
"5M0S","STRUCTURE-BASED EVOLUTION OF A HYBRID STEROID SERIES OF AUTOTAXIN INHIBITORS","10.1021/ACS.JMEDCHEM.6B01743 ",2.1,47.44,"5m0s_oligo1","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_B_)-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)]-MAN(4_B_)-[MAN(9_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(524_A_)",47.4522,"","",""
"5M17","STRUCTURE OF THE GH99 ENDO-ALPHA-MANNANASE FROM BACTEROIDES XYLANISOLVENS IN COMPLEX WITH MANNOSE-ALPHA-1,3-1,2-DIDEOXYMANNOSE","10.1021/JACS.6B10075 ",1.03,15.82,"5m17_oligo1","DManpa1-3DManp[2H]x1-","MAN(2_B_)-7D1(1_B_)",12.4241,"","",""
"5M3V","BEAT FC","10.1074/JBC.M117.782433 ",1.97,56.56,"5m3v_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcx1-","FUL(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)",127.389,"","",""
"5M3V","BEAT FC","10.1074/JBC.M117.782433 ",1.97,56.56,"5m3v_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",64.1388,"","",""
"5M3W","STRUCTURE OF THE GH99 ENDO-ALPHA-MANNANASE FROM BACTEROIDES XYLANISOLVENS IN COMPLEX WITH MANNOSE-ALPHA-1,3-1,2-DIDEOXYMANNOSE AND ALPHA-1,2-MANNOBIOSE","10.1021/JACS.6B10075 ",1.04,16.11,"5m3w_oligo1","DManpa1-3DManp[2H]x1-","MAN(2_B_)-7D1(1_B_)",12.7461,"","",""
"5M5D","STRUCTURE OF THE GH99 ENDO-ALPHA-MANNANASE FROM BACTEROIDES XYLANISOLVENS IN COMPLEX WITH MANNOSE-ALPHA-1,3-D-GLUCAL","10.1021/JACS.6B10075 ",1.07,17.85,"5m5d_oligo1","DManpa1-3DManp[2H]x1-","MAN(2_B_)-DGO(1_B_)",14.5129,"","",""
"5M7M","NOVEL IMIDAZO[1,2-A]PYRIDINE DERIVATIVES WITH POTENT AUTOTAXIN/ENPP2 INHIBITOR ACTIVITY","10.1021/ACS.JMEDCHEM.7B00647 ",2.7,25.37,"5m7m_oligo2","DManpa1-2DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-MAN(5_B_)-MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(525_A_)",34.1958,"","",""
"5M87","CRYSTAL STRUCTURE OF EREMOCOCCUS COLEOCOLA MANGANESE TRANSPORTER","10.1038/NCOMMS14033 ",3.3,0,"5m87_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(601_A_)-DMU(601_A_)",179.098,"","",""
"5M8L","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1","10.1002/ANIE.201704616 ",2.35,39.8,"5m8l_oligo16","DManpa1-3DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_T_)-[MAN(4_T_)-MAN(3_T_)-NAG(2_T_)]-NAG(1_T_)-ASN(181_D_)",62.1244,"","",""
"5M8L","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1","10.1002/ANIE.201704616 ",2.35,39.8,"5m8l_oligo18","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_V_)-[MAN(4_V_)]-MAN(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(350_D_)",46.2573,"","",""
"5M8L","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1","10.1002/ANIE.201704616 ",2.35,39.8,"5m8l_oligo6","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_M_)-[MAN(5_M_)-[MAN(4_M_)]-MAN(3_M_)-NAG(2_M_)]-NAG(1_M_)-ASN(350_B_)",49.2818,"","",""
"5M8M","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 IN COMPLEX WITH KOJIC ACID","10.1002/ANIE.201704616 ",2.65,39.6,"5m8m_oligo12","DManpa1-3DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_P_)-[MAN(4_P_)-MAN(3_P_)-NAG(2_P_)]-NAG(1_P_)-ASN(181_C_)",57.78,"","",""
"5M8M","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 IN COMPLEX WITH KOJIC ACID","10.1002/ANIE.201704616 ",2.65,39.6,"5m8m_oligo5","DManpa1-3DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_M_)-MAN(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(350_B_)",45.9175,"","",""
"5M8M","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 IN COMPLEX WITH KOJIC ACID","10.1002/ANIE.201704616 ",2.65,39.6,"5m8m_oligo14","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_R_)-[MAN(4_R_)]-MAN(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(350_C_)",51.2815,"","",""
"5M8N","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 IN COMPLEX WITH MIMOSINE","10.1002/ANIE.201704616 ",2.6,45.67,"5m8n_oligo15","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-MAN(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(350_C_)",50.0109,"","",""
"5M8N","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 IN COMPLEX WITH MIMOSINE","10.1002/ANIE.201704616 ",2.6,45.67,"5m8n_oligo10","DManpa1-3DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_J_)-MAN(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(350_B_)",49.1332,"","",""
"5M8O","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 IN COMPLEX WITH TROPOLONE","10.1002/ANIE.201704616 ",2.5,25.19,"5m8o_oligo5","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_M_)-[MAN(5_M_)-[MAN(4_M_)]-MAN(3_M_)-NAG(2_M_)]-NAG(1_M_)-ASN(350_B_)",45.9126,"","",""
"5M8O","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 IN COMPLEX WITH TROPOLONE","10.1002/ANIE.201704616 ",2.5,25.19,"5m8o_oligo20","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_X_)-[MAN(4_X_)]-MAN(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(350_D_)",32.0249,"","",""
"5M8O","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 IN COMPLEX WITH TROPOLONE","10.1002/ANIE.201704616 ",2.5,25.19,"5m8o_oligo12","DManpa1-3DGlcpNAcb1-3DGlcpNAcb1-ASN","MAN(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(104_C_)",53.5791,"","",""
"5M8O","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 IN COMPLEX WITH TROPOLONE","10.1002/ANIE.201704616 ",2.5,25.19,"5m8o_oligo18","DManpa1-3DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_V_)-[MAN(4_V_)-MAN(3_V_)-NAG(2_V_)]-NAG(1_V_)-ASN(181_D_)",35.1375,"","",""
"5M8O","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 IN COMPLEX WITH TROPOLONE","10.1002/ANIE.201704616 ",2.5,25.19,"5m8o_oligo16","DManpa1-3DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(385_C_)",64.0915,"","",""
"5M8P","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 IN COMPLEX WITH TYROSINE","10.1002/ANIE.201704616 ",2.8,54.76,"5m8p_oligo5","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-MAN(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(350_B_)",60.5765,"","",""
"5M8P","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 IN COMPLEX WITH TYROSINE","10.1002/ANIE.201704616 ",2.8,54.76,"5m8p_oligo20","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_X_)-[MAN(4_X_)]-MAN(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(350_D_)",71.9153,"","",""
"5M8P","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 IN COMPLEX WITH TYROSINE","10.1002/ANIE.201704616 ",2.8,54.76,"5m8p_oligo16","DManpa1-3DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(385_C_)",105.267,"","",""
"5M8Q","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 MUTANT (T391V- R374S-Y362F) IN COMPLEX WITH KOJIC ACID","10.1002/ANIE.201704616 ",2.85,57.12,"5m8q_oligo1","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-MAN(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(350_A_)",59.9506,"","",""
"5M8Q","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 MUTANT (T391V- R374S-Y362F) IN COMPLEX WITH KOJIC ACID","10.1002/ANIE.201704616 ",2.85,57.12,"5m8q_oligo8","DManpa1-3[DManpa1-6]DManpa1-3DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_L_)-[MAN(4_L_)]-MAN(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(350_C_)",54.5511,"","",""
"5M8R","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 (T391V-R374S- Y362F) IN COMPLEX WITH MIMOSINE","10.1002/ANIE.201704616 ",2.4,39.01,"5m8r_oligo7","DManpa1-3DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_H_)-MAN(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(350_B_)",50.3914,"","",""
"5M8R","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 (T391V-R374S- Y362F) IN COMPLEX WITH MIMOSINE","10.1002/ANIE.201704616 ",2.4,39.01,"5m8r_oligo12","DManpa1-3DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_L_)-MAN(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(350_C_)",44.6439,"","",""
"5M8S","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 MUTANT (T391V- R374S-Y362F) IN COMPLEX WITH PHENYLTHIOUREA (PTU)","10.3390/IJMS21030915 ",2.2,44.26,"5m8s_oligo15","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-[MAN(4_S_)]-MAN(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(350_D_)",58.6664,"","",""
"5M8S","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 MUTANT (T391V- R374S-Y362F) IN COMPLEX WITH PHENYLTHIOUREA (PTU)","10.3390/IJMS21030915 ",2.2,44.26,"5m8s_oligo7","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_K_)-[MAN(5_K_)-[MAN(4_K_)]-MAN(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(350_B_)",59.1388,"","",""
"5M8S","CRYSTAL STRUCTURE OF HUMAN TYROSINASE RELATED PROTEIN 1 MUTANT (T391V- R374S-Y362F) IN COMPLEX WITH PHENYLTHIOUREA (PTU)","10.3390/IJMS21030915 ",2.2,44.26,"5m8s_oligo13","DManpa1-3DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_Q_)-[MAN(4_Q_)-MAN(3_Q_)-NAG(2_Q_)]-NAG(1_Q_)-ASN(181_D_)",52.4835,"","",""
"5MAN","STRUCTURE OF SUCROSE PHOSPHORYLASE FROM BIFIDOBACTERIUM ADOLESCENTIS BOUND TO NIGEROSE","10.1039/C7CC05993K ",2.04,66.64,"5man_oligo1","DGlcpa1-3DGlcpa1-ROH","GLC(2_A_)-GLC(1_A_)",77.1286,"","",""
"5MC8","STRUCTURE OF THE GH99 ENDO-ALPHA-MANNANASE FROM BACTEROIDES XYLANISOLVENS IN COMPLEX WITH MANNOSE-ALPHA-1,3-D-GLUCAL AND ALPHA-1, 2-MANNOBIOSE","10.1021/JACS.6B10075 ",1.18,17.48,"5mc8_oligo1","DManpa1-3DManp[2H]x1-","MAN(2_B_)-DGO(1_B_)",14.688,"","",""
"5MFA","CRYSTAL STRUCTURE OF HUMAN PROMYELOPEROXIDASE (PROMPO)","10.1074/JBC.M117.775031 ",1.2,0,"5mfa_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(355_A_)",58.0065,"","",""
"5MGC","STRUCTURE OF E298Q-BETA-GALACTOSIDASE FROM ASPERGILLUS NIGER IN COMPLEX WITH 4-GALACTOSYL-LACTOSE","10.1111/FEBS.14083 ",2.3,34.22,"5mgc_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_B_)-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(373_A_)",55.3106,"","",""
"5MGC","STRUCTURE OF E298Q-BETA-GALACTOSIDASE FROM ASPERGILLUS NIGER IN COMPLEX WITH 4-GALACTOSYL-LACTOSE","10.1111/FEBS.14083 ",2.3,34.22,"5mgc_oligo3","DManpa1-2DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-MAN(5_D_)-MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(914_A_)",52.5385,"","",""
"5MGC","STRUCTURE OF E298Q-BETA-GALACTOSIDASE FROM ASPERGILLUS NIGER IN COMPLEX WITH 4-GALACTOSYL-LACTOSE","10.1111/FEBS.14083 ",2.3,34.22,"5mgc_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_C_)-MAN(8_C_)-[MAN(10_C_)]-MAN(7_C_)-[MAN(6_C_)-MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(622_A_)",51.1089,"","",""
"5MGD","STRUCTURE OF E298Q-BETA-GALACTOSIDASE FROM ASPERGILLUS NIGER IN COMPLEX WITH 6-GALACTOSYL-LACTOSE","10.1111/FEBS.14083 ",2.15,28.76,"5mgd_oligo3","DManpa1-2DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-MAN(5_D_)-MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(914_A_)",47.6485,"","",""
"5MGD","STRUCTURE OF E298Q-BETA-GALACTOSIDASE FROM ASPERGILLUS NIGER IN COMPLEX WITH 6-GALACTOSYL-LACTOSE","10.1111/FEBS.14083 ",2.15,28.76,"5mgd_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_B_)-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(373_A_)",45.5798,"","",""
"5MGD","STRUCTURE OF E298Q-BETA-GALACTOSIDASE FROM ASPERGILLUS NIGER IN COMPLEX WITH 6-GALACTOSYL-LACTOSE","10.1111/FEBS.14083 ",2.15,28.76,"5mgd_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_C_)-MAN(8_C_)-[MAN(10_C_)]-MAN(7_C_)-[MAN(6_C_)-MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(622_A_)",41.5227,"","",""
"5MGR","HUMAN RECEPTOR NKR-P1 IN GLYCOSYLATED FORM, EXTRACELLULAR DOMAIN","10.1038/S41467-022-32577-6 ",1.8,33.5,"5mgr_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(169_B_)",49.63,"","",""
"5MGR","HUMAN RECEPTOR NKR-P1 IN GLYCOSYLATED FORM, EXTRACELLULAR DOMAIN","10.1038/S41467-022-32577-6 ",1.8,33.5,"5mgr_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)]-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(169_A_)",43.0055,"","",""
"5MHP","NOVEL IMIDAZO[1,2-A]PYRIDINE DERIVATIVES WITH POTENT AUTOTAXIN/ENPP2 INHIBITOR ACTIVITY","10.1021/ACS.JMEDCHEM.7B00032 ",2.43,41.35,"5mhp_oligo2","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)]-MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(525_A_)",45.219,"","",""
"5MJ3","INTERLEUKIN-23 COMPLEX WITH AN ANTAGONISTIC ALPHABODY, CRYSTAL FORM 1","10.1038/NCOMMS6237 ",1.74,0,"5mj3_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(222_A_)",68.294,"","",""
"5MJ4","INTERLEUKIN-23 COMPLEX WITH AN ANTAGONISTIC ALPHABODY, CRYSTAL FORM 2","10.1038/NCOMMS6237 ",3.4,0,"5mj4_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(222_A_)",132.038,"","",""
"5MJ6","LIGAND-INDUCED CONFORMATIONAL CHANGE OF INSULIN-REGULATED AMINOPEPTIDASE: INSIGHTS ON CATALYTIC MECHANISM AND ACTIVE SITE PLASTICITY.","10.1021/ACS.JMEDCHEM.6B01890 ",2.53,0,"5mj6_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(184_A_)",93.1248,"","",""
"5MJ6","LIGAND-INDUCED CONFORMATIONAL CHANGE OF INSULIN-REGULATED AMINOPEPTIDASE: INSIGHTS ON CATALYTIC MECHANISM AND ACTIVE SITE PLASTICITY.","10.1021/ACS.JMEDCHEM.6B01890 ",2.53,0,"5mj6_oligo16","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_R_)-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(850_B_)",116.424,"","",""
"5MJ6","LIGAND-INDUCED CONFORMATIONAL CHANGE OF INSULIN-REGULATED AMINOPEPTIDASE: INSIGHTS ON CATALYTIC MECHANISM AND ACTIVE SITE PLASTICITY.","10.1021/ACS.JMEDCHEM.6B01890 ",2.53,0,"5mj6_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(850_A_)",66.9173,"","",""
"5MJ6","LIGAND-INDUCED CONFORMATIONAL CHANGE OF INSULIN-REGULATED AMINOPEPTIDASE: INSIGHTS ON CATALYTIC MECHANISM AND ACTIVE SITE PLASTICITY.","10.1021/ACS.JMEDCHEM.6B01890 ",2.53,0,"5mj6_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(374_A_)",102.143,"","",""
"5MOI","CRYSTAL STRUCTURE OF HUMAN IGE-FC EPSILON 3-4","10.1016/J.BBAPAP.2017.08.005 ",2.2,0,"5moi_oligo6","DManpa1-3[DManpa1-6]DManpx1-","MAN(3_L_)-[MAN(2_L_)]-BMA(1_L_)",127.646,"","",""
"5MOI","CRYSTAL STRUCTURE OF HUMAN IGE-FC EPSILON 3-4","10.1016/J.BBAPAP.2017.08.005 ",2.2,0,"5moi_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(394_E_)",90.8911,"","",""
"5MOI","CRYSTAL STRUCTURE OF HUMAN IGE-FC EPSILON 3-4","10.1016/J.BBAPAP.2017.08.005 ",2.2,0,"5moi_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcx1-","MAN(4_G_)-[MAN(3_G_)]-BMA(2_G_)-NAG(1_G_)",101.244,"","",""
"5MOI","CRYSTAL STRUCTURE OF HUMAN IGE-FC EPSILON 3-4","10.1016/J.BBAPAP.2017.08.005 ",2.2,0,"5moi_oligo4","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_J_)-[MAN(5_J_)]-MAN(4_J_)-[MAN(7_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(394_D_)",80.7969,"","",""
"5MOI","CRYSTAL STRUCTURE OF HUMAN IGE-FC EPSILON 3-4","10.1016/J.BBAPAP.2017.08.005 ",2.2,0,"5moi_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(394_C_)",88.8571,"","",""
"5MOJ","CRYSTAL STRUCTURE OF IGE-FC EPSILON 3-4","10.1016/J.BBAPAP.2017.08.005 ",2.26,0,"5moj_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(394_A_)",89.3675,"","",""
"5MOJ","CRYSTAL STRUCTURE OF IGE-FC EPSILON 3-4","10.1016/J.BBAPAP.2017.08.005 ",2.26,0,"5moj_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(394_B_)",96.7433,"","",""
"5MOK","CRYSTAL STRUCTURE OF HUMAN IGE-FC EPSILON 3-4","10.1016/J.BBAPAP.2017.08.005 ",2,0,"5mok_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcx1-","MAN(4_G_)-[MAN(3_G_)]-BMA(2_G_)-NAG(1_G_)",87.9571,"","",""
"5MOK","CRYSTAL STRUCTURE OF HUMAN IGE-FC EPSILON 3-4","10.1016/J.BBAPAP.2017.08.005 ",2,0,"5mok_oligo4","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-[MAN(5_H_)]-MAN(4_H_)-[MAN(7_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(394_D_)",63.9979,"","",""
"5MOK","CRYSTAL STRUCTURE OF HUMAN IGE-FC EPSILON 3-4","10.1016/J.BBAPAP.2017.08.005 ",2,0,"5mok_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)]-MAN(4_F_)-[MAN(7_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(394_B_)",81.8871,"","",""
"5MOL","HUMAN IGE-FC CRYSTAL STRUCTURE","10.1016/J.BBAPAP.2017.08.005 ",1.75,0,"5mol_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-[MAN(5_D_)]-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(394_B_)",56.0429,"","",""
"5MU1","UDP-GLUCOSE GLYCOPROTEIN GLUCOSYLTRANSFERASE FROM CHAETOMIUM THERMOPHILUM SOAKED WITH K2PTI6","10.1073/PNAS.1703682114 ",3.48,151.7,"5mu1_oligo4","DManpa1-3[DManpa1-6]DManpa1-6DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_E_)-[MAN(6_E_)]-MAN(5_E_)-MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(1227_A_)",239.261,"","",""
"5MU1","UDP-GLUCOSE GLYCOPROTEIN GLUCOSYLTRANSFERASE FROM CHAETOMIUM THERMOPHILUM SOAKED WITH K2PTI6","10.1073/PNAS.1703682114 ",3.48,151.7,"5mu1_oligo1","DManpa1-3DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_B_)-MAN(6_B_)-[MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(638_A_)",279.919,"","",""
"5MU1","UDP-GLUCOSE GLYCOPROTEIN GLUCOSYLTRANSFERASE FROM CHAETOMIUM THERMOPHILUM SOAKED WITH K2PTI6","10.1073/PNAS.1703682114 ",3.48,151.7,"5mu1_oligo2","DManpa1-6DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(56_A_)",221.364,"","",""
"5MU1","UDP-GLUCOSE GLYCOPROTEIN GLUCOSYLTRANSFERASE FROM CHAETOMIUM THERMOPHILUM SOAKED WITH K2PTI6","10.1073/PNAS.1703682114 ",3.48,151.7,"5mu1_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(894_A_)",250.231,"","",""
"5MU9","MOA-E-64 COMPLEX","10.1021/ACS.BIOCHEM.7B00317 ",1.3,13.17,"5mu9_oligo1","LFucpa1-2[DGalpa1-3]DGalpa1-ROH","GLA(3_D_)-[FUC(2_D_)]-GLA(1_D_)",11.2612,"","",""
"5MU9","MOA-E-64 COMPLEX","10.1021/ACS.BIOCHEM.7B00317 ",1.3,13.17,"5mu9_oligo3","LFucpa1-2[DGalpa1-3]DGalpa1-ROH","GLA(3_C_)-[FUC(2_C_)]-GLA(1_C_)",17.4548,"","",""
"5MU9","MOA-E-64 COMPLEX","10.1021/ACS.BIOCHEM.7B00317 ",1.3,13.17,"5mu9_oligo2","LFucpa1-2[DGalpa1-3]DGalpb1-ROH","GLA(3_B_)-[FUC(2_B_)]-GAL(1_B_)",7.75515,"","",""
"5MUJ","BT0996 RGII CHAIN B COMPLEX","10.1038/NATURE21725 ",1.37,16.85,"5muj_oligo1","LRhapa1-2[LRhapa1-3]LArapa1-4[LFucp[2Me,4Ac]a1-2]DGalpb1-2DXylf[5H,3<R1>]a1-4LRhapa1-3DEryf[3<R2>]a1-ROH","RAM(7_B_)-[RAM(6_B_)]-ARA(5_B_)-8PK(8_B_)]-GAL(4_B_)-8OQ(3_B_)-RAM(2_B_)-XXM(1_B_)",25.5304,"","",""
"5MXA","STRUCTURE OF UNBOUND INTERLEUKIN-23","10.1016/J.IMMUNI.2017.12.008 ",2.5,0,"5mxa_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(222_A_)",88.1541,"","",""
"5MYA","HOMODIMERIZATION OF TIE2 FIBRONECTIN-LIKE DOMAINS 1-3 IN SPACE GROUP C2","10.1073/PNAS.1616166114 ",2.9,139.9,"5mya_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(560_A_)",170.596,"","",""
"5MYB","HOMODIMERIZATION OF TIE2 FIBRONECTIN-LIKE DOMAINS 2 AND 3 IN SPACE GROUP P21","10.1073/PNAS.1616166114 ",2.6,0,"5myb_oligo4","DManp[3<R1>]b1-3DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(560_A_)",132.671,"","",""
"5MZO","UDP-GLUCOSE GLYCOPROTEIN GLUCOSYLTRANSFERASE FROM CHAETOMIUM THERMOPHILUM (OPEN CONFORMATION)","10.1073/PNAS.1703682114 ",3.48,171.1,"5mzo_oligo2","DManpa1-6DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(56_A_)",228.438,"","",""
"5MZV","IL-23:IL-23R:NB22E11 COMPLEX","10.1016/J.IMMUNI.2017.12.008 ",2.8,84.47,"5mzv_oligo1","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_E_)-MAN(6_E_)-[MAN(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(222_A_)",108.285,"","",""
"5N09","CRYSTAL STRUCTURE OF L107C/A313C COVALENTLY LINKED DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN DIMER IN COMPLEX WITH THE FAB FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11","10.1038/NCOMMS15411 ",3.9,0,"5n09_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_C_)-[MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(153_A_)",95.6753,"","",""
"5N09","CRYSTAL STRUCTURE OF L107C/A313C COVALENTLY LINKED DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN DIMER IN COMPLEX WITH THE FAB FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11","10.1038/NCOMMS15411 ",3.9,0,"5n09_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_D_)-[MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(153_B_)",113.562,"","",""
"5N0A","CRYSTAL STRUCTURE OF A259C COVALENTLY LINKED DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN DIMER IN COMPLEX WITH THE FAB FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11","10.1038/NCOMMS15411 ",3.9,145,"5n0a_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_D_)-[MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(153_B_)",136.831,"","",""
"5N0A","CRYSTAL STRUCTURE OF A259C COVALENTLY LINKED DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN DIMER IN COMPLEX WITH THE FAB FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11","10.1038/NCOMMS15411 ",3.9,145,"5n0a_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_C_)-[MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(153_A_)",136.618,"","",""
"5N0B","CRYSTAL STRUCTURE OF THE TETANUS NEUROTOXIN IN COMPLEX WITH GD1A","10.15252/EMBR.201744198 ",2.6,64.74,"5n0b_oligo1","DNeup5Aca2-3DGalpb1-3DGalpNAcb1-4[DNeup5Aca2-3]DGalpb1-4DGlcpb1-ROH","SIA(5_B_)-GAL(4_B_)-NGA(3_B_)-[SIA(6_B_)]-GAL(2_B_)-BGC(1_B_)",64.4122,"","",""
"5N0C","CRYSTAL STRUCTURE OF THE TETANUS NEUROTOXIN IN COMPLEX WITH GM1A","10.15252/EMBR.201744198 ",2.6,48.32,"5n0c_oligo2","DGalpb1-3DGalpNAcb1-4[DNeup5Aca2-3]DGalpb1-4DGlcpb1-ROH","GAL(4_D_)-NGA(3_D_)-[SIA(5_D_)]-GAL(2_D_)-BGC(1_D_)",48.5702,"","",""
"5N0C","CRYSTAL STRUCTURE OF THE TETANUS NEUROTOXIN IN COMPLEX WITH GM1A","10.15252/EMBR.201744198 ",2.6,48.32,"5n0c_oligo1","DGalpb1-3DGalpNAcb1-4[DNeup5Aca2-3]DGalpb1-4DGlcpb1-ROH","GAL(4_C_)-NGA(3_C_)-[SIA(5_C_)]-GAL(2_C_)-BGC(1_C_)",45.0367,"","",""
"5N11","CRYSTAL STRUCTURE OF HUMAN BETA1-CORONAVIRUS OC43 NL/A/2005 HEMAGGLUTININ-ESTERASE","10.1016/J.CHOM.2017.02.008 ",2.45,56.48,"5n11_oligo8","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(315_A_)",88.5347,"","",""
"5N11","CRYSTAL STRUCTURE OF HUMAN BETA1-CORONAVIRUS OC43 NL/A/2005 HEMAGGLUTININ-ESTERASE","10.1016/J.CHOM.2017.02.008 ",2.45,56.48,"5n11_oligo3","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-MAN(4_I_)-[MAN(6_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(89_B_)",64.67,"","",""
"5N11","CRYSTAL STRUCTURE OF HUMAN BETA1-CORONAVIRUS OC43 NL/A/2005 HEMAGGLUTININ-ESTERASE","10.1016/J.CHOM.2017.02.008 ",2.45,56.48,"5n11_oligo10","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_L_)-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(315_B_)",89.9459,"","",""
"5N2J","UDP-GLUCOSE GLYCOPROTEIN GLUCOSYLTRANSFERASE FROM CHAETOMIUM THERMOPHILUM (CLOSED FORM)","10.1073/PNAS.1703682114 ",4.4,243.3,"5n2j_oligo5","DManpa1-6DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(56_B_)",280.398,"","",""
"5N2J","UDP-GLUCOSE GLYCOPROTEIN GLUCOSYLTRANSFERASE FROM CHAETOMIUM THERMOPHILUM (CLOSED FORM)","10.1073/PNAS.1703682114 ",4.4,243.3,"5n2j_oligo2","DManpa1-6DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(56_A_)",290.552,"","",""
"5NAP","TORPEDO CALIFORNICA ACETYLCHOLINESTERASE IN COMPLEX WITH A NON-CHIRAL DONEPEZIL-LIKE INHIBITOR 17","10.1080/14756366.2018.1458030 ",2.17,30.66,"5nap_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(457_A_)",67.7441,"","",""
"5NAP","TORPEDO CALIFORNICA ACETYLCHOLINESTERASE IN COMPLEX WITH A NON-CHIRAL DONEPEZIL-LIKE INHIBITOR 17","10.1080/14756366.2018.1458030 ",2.17,30.66,"5nap_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(416_A_)",89.5809,"","",""
"5NAU","TORPEDO CALIFORNICA ACETYLCHOLINESTERASE IN COMPLEX WITH A NON-CHIRAL DONEPEZIL-LIKE COMPOUND 20","10.1080/14756366.2018.1458030 ",2.25,38.09,"5nau_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(457_A_)",82.3595,"","",""
"5NAU","TORPEDO CALIFORNICA ACETYLCHOLINESTERASE IN COMPLEX WITH A NON-CHIRAL DONEPEZIL-LIKE COMPOUND 20","10.1080/14756366.2018.1458030 ",2.25,38.09,"5nau_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)",92.083,"","",""
"5NBS","STRUCTURAL STUDIES OF A GLYCOSIDE HYDROLASE FAMILY 3 BETA-GLUCOSIDASE FROM THE MODEL FUNGUS NEUROSPORA CRASSA","10.1107/S2053230X18015662 ",2.25,34.93,"5nbs_oligo6","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-MAN(4_J_)-[MAN(6_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(57_B_)",55.3995,"","",""
"5NBS","STRUCTURAL STUDIES OF A GLYCOSIDE HYDROLASE FAMILY 3 BETA-GLUCOSIDASE FROM THE MODEL FUNGUS NEUROSPORA CRASSA","10.1107/S2053230X18015662 ",2.25,34.93,"5nbs_oligo10","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_L_)-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(311_B_)",64.6873,"","",""
"5NBS","STRUCTURAL STUDIES OF A GLYCOSIDE HYDROLASE FAMILY 3 BETA-GLUCOSIDASE FROM THE MODEL FUNGUS NEUROSPORA CRASSA","10.1107/S2053230X18015662 ",2.25,34.93,"5nbs_oligo12","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_N_)-MAN(5_N_)-[MAN(7_N_)]-MAN(4_N_)-[MAN(8_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(519_B_)",55.9123,"","",""
"5NBS","STRUCTURAL STUDIES OF A GLYCOSIDE HYDROLASE FAMILY 3 BETA-GLUCOSIDASE FROM THE MODEL FUNGUS NEUROSPORA CRASSA","10.1107/S2053230X18015662 ",2.25,34.93,"5nbs_oligo8","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-MAN(5_F_)-[MAN(7_F_)]-MAN(4_F_)-[MAN(8_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(318_A_)",28.7231,"","",""
"5NBS","STRUCTURAL STUDIES OF A GLYCOSIDE HYDROLASE FAMILY 3 BETA-GLUCOSIDASE FROM THE MODEL FUNGUS NEUROSPORA CRASSA","10.1107/S2053230X18015662 ",2.25,34.93,"5nbs_oligo11","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_M_)-MAN(5_M_)-[MAN(7_M_)]-MAN(4_M_)-[MAN(8_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(318_B_)",51.3714,"","",""
"5NBS","STRUCTURAL STUDIES OF A GLYCOSIDE HYDROLASE FAMILY 3 BETA-GLUCOSIDASE FROM THE MODEL FUNGUS NEUROSPORA CRASSA","10.1107/S2053230X18015662 ",2.25,34.93,"5nbs_oligo9","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-MAN(4_K_)-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(248_B_)",60.0758,"","",""
"5NBS","STRUCTURAL STUDIES OF A GLYCOSIDE HYDROLASE FAMILY 3 BETA-GLUCOSIDASE FROM THE MODEL FUNGUS NEUROSPORA CRASSA","10.1107/S2053230X18015662 ",2.25,34.93,"5nbs_oligo2","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(57_A_)",55.4845,"","",""
"5NBS","STRUCTURAL STUDIES OF A GLYCOSIDE HYDROLASE FAMILY 3 BETA-GLUCOSIDASE FROM THE MODEL FUNGUS NEUROSPORA CRASSA","10.1107/S2053230X18015662 ",2.25,34.93,"5nbs_oligo7","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(311_A_)",46.5216,"","",""
"5NBS","STRUCTURAL STUDIES OF A GLYCOSIDE HYDROLASE FAMILY 3 BETA-GLUCOSIDASE FROM THE MODEL FUNGUS NEUROSPORA CRASSA","10.1107/S2053230X18015662 ",2.25,34.93,"5nbs_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_D_)-MAN(7_D_)-[MAN(6_D_)-MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(248_A_)",44.9074,"","",""
"5NBS","STRUCTURAL STUDIES OF A GLYCOSIDE HYDROLASE FAMILY 3 BETA-GLUCOSIDASE FROM THE MODEL FUNGUS NEUROSPORA CRASSA","10.1107/S2053230X18015662 ",2.25,34.93,"5nbs_oligo4","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-MAN(5_H_)-[MAN(7_H_)]-MAN(4_H_)-[MAN(9_H_)-MAN(8_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(519_A_)",45.7786,"","",""
"5NEM","LOCALISED RECONSTRUCTION OF ALPHA V BETA 6 BOUND TO FOOT AND MOUTH DISEASE VIRUS O PANASIA - POSE A.","10.1038/NCOMMS15408 ",10.8,"8.66969e+14","5nem_oligo4","DManpb1-3DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-MAN(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(458_A_)",123.017,"","",""
"5NER","LOCALISED RECONSTRUCTION OF ALPHA V BETA 6 BOUND TO FOOT AND MOUTH DISEASE VIRUS O PANASIA - POSE A PRIME.","10.1038/NCOMMS15408 ",11.5,"2.23709e+11","5ner_oligo4","DManpb1-3DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-MAN(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(458_A_)",123.017,"","",""
"5NET","LOCALISED RECONSTRUCTION OF INTEGRIN ALPHA V BETA 6 BOUND TO FOOT AND MOUTH DISEASE VIRUS O1 MANISA - POSE A.","10.1038/NCOMMS15408 ",8.6,"8.66969e+14","5net_oligo4","DManpb1-3DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-MAN(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(458_A_)",123.017,"","",""
"5NFF","CRYSTAL STRUCTURE OF GP1 RECEPTOR BINDING DOMAIN FROM MOROGORO VIRUS","10.1371/JOURNAL.PPAT.1006337 ",2.62,55.71,"5nff_oligo4","DManpa1-2DManpa1-3DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_T_)-MAN(4_T_)-MAN(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(222_O_)",98.7633,"","",""
"5NFG","STRUCTURE OF RECOMBINANT CARDOSIN B FROM CYNARA CARDUNCULUS","10.1007/S00253-017-8445-8 ",2.38,0,"5nfg_oligo2","DManpa1-2[DManpa1-6]DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-[MAN(5_E_)]-MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(116_B_)",58.8056,"","",""
"5NFG","STRUCTURE OF RECOMBINANT CARDOSIN B FROM CYNARA CARDUNCULUS","10.1007/S00253-017-8445-8 ",2.38,0,"5nfg_oligo1","DManpa1-2[DManpa1-6]DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)]-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(116_A_)",53.365,"","",""
"5NJD","STRUCTURE OF INTERLEUKIN 23 IN COMPLEX WITH BRIAKINUMAB FAB","10.1016/J.IMMUNI.2017.12.008 ",3.9,0,"5njd_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_d_)-[MAN(4_d_)]-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(222_K_)",113.999,"","",""
"5NJD","STRUCTURE OF INTERLEUKIN 23 IN COMPLEX WITH BRIAKINUMAB FAB","10.1016/J.IMMUNI.2017.12.008 ",3.9,0,"5njd_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_c_)-[MAN(4_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(222_I_)",88.6898,"","",""
"5NJD","STRUCTURE OF INTERLEUKIN 23 IN COMPLEX WITH BRIAKINUMAB FAB","10.1016/J.IMMUNI.2017.12.008 ",3.9,0,"5njd_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_a_)-[MAN(4_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(222_E_)",106.861,"","",""
"5NJD","STRUCTURE OF INTERLEUKIN 23 IN COMPLEX WITH BRIAKINUMAB FAB","10.1016/J.IMMUNI.2017.12.008 ",3.9,0,"5njd_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Z_)-[MAN(4_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(222_C_)",77.6809,"","",""
"5NJD","STRUCTURE OF INTERLEUKIN 23 IN COMPLEX WITH BRIAKINUMAB FAB","10.1016/J.IMMUNI.2017.12.008 ",3.9,0,"5njd_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Y_)-[MAN(4_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(222_A_)",102.636,"","",""
"5NJD","STRUCTURE OF INTERLEUKIN 23 IN COMPLEX WITH BRIAKINUMAB FAB","10.1016/J.IMMUNI.2017.12.008 ",3.9,0,"5njd_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_b_)-[MAN(4_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(222_G_)",89.5707,"","",""
"5NN3","CRYSTAL STRUCTURE OF HUMAN LYSOSOMAL ACID-ALPHA-GLUCOSIDASE, GAA","10.1038/S41467-017-01263-3 ",1.9,33.14,"5nn3_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)",58.7215,"","",""
"5NN4","CRYSTAL STRUCTURE OF HUMAN LYSOSOMAL ACID-ALPHA-GLUCOSIDASE, GAA, IN COMPLEX WITH N-ACETYL-CYSTEINE","10.1038/S41467-017-01263-3 ",1.83,26.42,"5nn4_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(470_A_)",52.3218,"","",""
"5NN5","CRYSTAL STRUCTURE OF HUMAN LYSOSOMAL ACID-ALPHA-GLUCOSIDASE, GAA, IN COMPLEX WITH 1-DEOXYNOJIRIMYCIN","10.1038/S41467-017-01263-3 ",2,19.49,"5nn5_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)",44.5898,"","",""
"5NN9","REFINED ATOMIC STRUCTURES OF N9 SUBTYPE INFLUENZA VIRUS NEURAMINIDASE AND ESCAPE MUTANTS","10.1016/0022-2836(91)80069-7 ",2.3,0,"5nn9_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",24.4766,"","",""
"5NO7","CRYSTAL STRUCTURE OF A XYLAN-ACTIVE LYTIC POLYSACCHARIDE MONOOXYGENASE FROM PYCNOPORUS COCCINEUS.","10.1038/NCHEMBIO.2558 ",3.01,96.77,"5no7_oligo2","DManpa1-2[DManpa1-6]DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_G_)-[MAN(6_G_)-[MAN(5_G_)]-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(217_A_)",131.404,"","",""
"5NO7","CRYSTAL STRUCTURE OF A XYLAN-ACTIVE LYTIC POLYSACCHARIDE MONOOXYGENASE FROM PYCNOPORUS COCCINEUS.","10.1038/NCHEMBIO.2558 ",3.01,96.77,"5no7_oligo8","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(183_A_)",152.906,"","",""
"5NO7","CRYSTAL STRUCTURE OF A XYLAN-ACTIVE LYTIC POLYSACCHARIDE MONOOXYGENASE FROM PYCNOPORUS COCCINEUS.","10.1038/NCHEMBIO.2558 ",3.01,96.77,"5no7_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(133_A_)",119.778,"","",""
"5NO7","CRYSTAL STRUCTURE OF A XYLAN-ACTIVE LYTIC POLYSACCHARIDE MONOOXYGENASE FROM PYCNOPORUS COCCINEUS.","10.1038/NCHEMBIO.2558 ",3.01,96.77,"5no7_oligo10","DManpa1-2[DManpa1-6]DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_L_)-[MAN(6_L_)-[MAN(5_L_)]-MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(217_B_)",129.336,"","",""
"5NO7","CRYSTAL STRUCTURE OF A XYLAN-ACTIVE LYTIC POLYSACCHARIDE MONOOXYGENASE FROM PYCNOPORUS COCCINEUS.","10.1038/NCHEMBIO.2558 ",3.01,96.77,"5no7_oligo1","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-MAN(4_D_)-[MAN(6_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(76_A_)",162.004,"","",""
"5NQ7","CRYSTAL STRUCTURE OF LACCASES FROM PYCNOPORUS SANGUINEUS, IZOFORM I","10.1016/J.IJBIOMAC.2017.10.024 ",2.75,52.63,"5nq7_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(455_A_)",105.301,"","",""
"5NQ7","CRYSTAL STRUCTURE OF LACCASES FROM PYCNOPORUS SANGUINEUS, IZOFORM I","10.1016/J.IJBIOMAC.2017.10.024 ",2.75,52.63,"5nq7_oligo1","DManpa1-3DManpa1-6[DManpb1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-MAN(4_B_)-[BMA(6_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(75_A_)",100.858,"","",""
"5NQ7","CRYSTAL STRUCTURE OF LACCASES FROM PYCNOPORUS SANGUINEUS, IZOFORM I","10.1016/J.IJBIOMAC.2017.10.024 ",2.75,52.63,"5nq7_oligo2","DManpa1-3[DManpb1-6]DManp[2H]b1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(6_C_)-[MAN(5_C_)--BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(398_A_)",134.018,"","",""
"5NQW","IGE-FC IN COMPLEX WITH SINGLE DOMAIN ANTIBODY 026","10.1038/S41467-017-02312-7 ",3.4,0,"5nqw_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)]-MAN(4_F_)-[MAN(7_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(394_B_)",117.87,"","",""
"5NQW","IGE-FC IN COMPLEX WITH SINGLE DOMAIN ANTIBODY 026","10.1038/S41467-017-02312-7 ",3.4,0,"5nqw_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-[MAN(5_E_)]-MAN(4_E_)-[MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(394_A_)",125.447,"","",""
"5NSC","FC DEKK HETERODIMER VARIANT","10.1074/JBC.M117.793497 ",2.3,0,"5nsc_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(297_A_)",54.7873,"","",""
"5NSC","FC DEKK HETERODIMER VARIANT","10.1074/JBC.M117.793497 ",2.3,0,"5nsc_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(8_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_B_)",41.9274,"","",""
"5NSL","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH FRUCTOSE AND HYDROXYTYROSOL","10.1002/CCTC.201801171 ",1.7,23.95,"5nsl_oligo21","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-MAN(5_C_)-[MAN(7_C_)]-MAN(4_C_)-[MAN(9_C_)-MAN(8_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(58_A_)",50.3146,"","",""
"5NSL","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH FRUCTOSE AND HYDROXYTYROSOL","10.1002/CCTC.201801171 ",1.7,23.95,"5nsl_oligo26","DManpa1-2DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-MAN(5_F_)-MAN(4_F_)-[MAN(7_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(58_B_)",46.9283,"","",""
"5NSL","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH FRUCTOSE AND HYDROXYTYROSOL","10.1002/CCTC.201801171 ",1.7,23.95,"5nsl_oligo22","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_D_)-[MAN(8_D_)]-MAN(7_D_)-[MAN(6_D_)-MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(107_A_)",30.3098,"","",""
"5NSL","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH FRUCTOSE AND HYDROXYTYROSOL","10.1002/CCTC.201801171 ",1.7,23.95,"5nsl_oligo27","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_G_)-[MAN(8_G_)]-MAN(7_G_)-[MAN(6_G_)-MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(107_B_)",30.5934,"","",""
"5NUU","TORPEDO CALIFORNICA ACETYLCHOLINESTERASE IN COMPLEX WITH A CHLOROTACRINE-TRYPTOPHAN HYBRID INHIBITOR","10.1016/J.EJMECH.2019.02.021 ",2.5,51.32,"5nuu_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(457_A_)",99.6143,"","",""
"5NUU","TORPEDO CALIFORNICA ACETYLCHOLINESTERASE IN COMPLEX WITH A CHLOROTACRINE-TRYPTOPHAN HYBRID INHIBITOR","10.1016/J.EJMECH.2019.02.021 ",2.5,51.32,"5nuu_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(416_A_)",122.018,"","",""
"5NUZ","JUNIN VIRUS GP1 GLYCOPROTEIN IN COMPLEX WITH AN ANTIBODY FAB FRAGMENT","10.1073/PNAS.1702127114 ",1.85,36.18,"5nuz_oligo1","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-MAN(4_E_)-[MAN(6_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(178_C_)",80.1117,"","",""
"5NUZ","JUNIN VIRUS GP1 GLYCOPROTEIN IN COMPLEX WITH AN ANTIBODY FAB FRAGMENT","10.1073/PNAS.1702127114 ",1.85,36.18,"5nuz_oligo2","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-MAN(5_F_)-[MAN(7_F_)]-MAN(4_F_)-[MAN(9_F_)-MAN(8_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(178_D_)",68.4889,"","",""
"5NZ4","COMPLEX OF I223V MUTANT VARIANT OF NEURAMINIDASE FROM H1N1 INFLUENZA VIRUS WITH OSELTAMIVIR","10.3390/V10070339 ",1.36,12.89,"5nz4_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(146_B_)",20.9661,"","",""
"5NZE","COMPLEX OF S247N MUTANT VARIANT OF NEURAMINIDASE FROM H1N1 INFLUENZA VIRUS WITH OSELTAMIVIR","10.3390/V10070339 ",1.69,16.96,"5nze_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(146_B_)",29.2341,"","",""
"5NZF","COMPLEX OF H275Y/I223V MUTANT VARIANT OF NEURAMINIDASE FROM H1N1 INFLUENZA VIRUS WITH OSELTAMIVIR","10.3390/V10070339 ",1.75,18.78,"5nzf_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(146_C_)",38.5745,"","",""
"5O0N","DEGLYCOSYLATED NOGO RECEPTOR WITH NATIVE DISULFIDE STRUCTURE 4","10.1107/S2059798317013791 ",2.5,0,"5o0n_oligo2","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)]-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(179_A_)",130.898,"","",""
"5O0N","DEGLYCOSYLATED NOGO RECEPTOR WITH NATIVE DISULFIDE STRUCTURE 4","10.1107/S2059798317013791 ",2.5,0,"5o0n_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(82_A_)",155.653,"","",""
"5O32","THE STRUCTURE OF COMPLEMENT COMPLEX","10.1038/NSMB.3427 ",4.21,108.2,"5o32_oligo1","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_K_)-[BMA(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(85_A_)",133.796,"","",""
"5O32","THE STRUCTURE OF COMPLEMENT COMPLEX","10.1038/NSMB.3427 ",4.21,108.2,"5o32_oligo3","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_M_)-[BMA(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(85_E_)",153.757,"","",""
"5O47","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH FRUCTOSYL-HYDROXYTYROSOL","10.1002/CCTC.201801171 ",1.91,25.67,"5o47_oligo37","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_G_)-MAN(8_G_)-[MAN(10_G_)]-MAN(7_G_)-[MAN(6_G_)-MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(107_B_)",39.1188,"","",""
"5O47","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH FRUCTOSYL-HYDROXYTYROSOL","10.1002/CCTC.201801171 ",1.91,25.67,"5o47_oligo30","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_D_)-MAN(8_D_)-[MAN(10_D_)]-MAN(7_D_)-[MAN(6_D_)-MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(107_A_)",38.5508,"","",""
"5O47","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH FRUCTOSYL-HYDROXYTYROSOL","10.1002/CCTC.201801171 ",1.91,25.67,"5o47_oligo29","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(58_A_)",41.6773,"","",""
"5O47","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH FRUCTOSYL-HYDROXYTYROSOL","10.1002/CCTC.201801171 ",1.91,25.67,"5o47_oligo36","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-MAN(4_F_)-[MAN(6_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(58_B_)",44.115,"","",""
"5O4E","CRYSTAL STRUCTURE OF VEGF IN COMPLEX WITH HETERODIMERIC FCAB JANUSCT6","10.1080/19420862.2017.1364825 ",2.15,0,"5o4e_oligo4","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_J_)-MAN(4_J_)-[MAN(6_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(297_D_)",117.143,"","",""
"5O4E","CRYSTAL STRUCTURE OF VEGF IN COMPLEX WITH HETERODIMERIC FCAB JANUSCT6","10.1080/19420862.2017.1364825 ",2.15,0,"5o4e_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_G_)-[NAG(7_G_)-MAN(6_G_)-[NAG(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(297_A_)",88.7826,"","",""
"5O4E","CRYSTAL STRUCTURE OF VEGF IN COMPLEX WITH HETERODIMERIC FCAB JANUSCT6","10.1080/19420862.2017.1364825 ",2.15,0,"5o4e_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_H_)-[NAG(7_H_)-MAN(6_H_)-[NAG(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)]-NAG(1_H_)-ASN(297_B_)",93.0537,"","",""
"5O4G","HER2 IN COMPLEX WITH FAB MF3958","10.1016/J.CCELL.2018.04.003 ",3,0,"5o4g_oligo1","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-MAN(4_D_)-[MAN(6_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(46_C_)",102.603,"","",""
"5O5R","X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH A UREA BASED INHIBITOR PSMA 1023","",1.65,37,"5o5r_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(638_A_)",51.8129,"","",""
"5O5T","X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH A UREA BASED INHIBITOR PSMA 1007","",1.43,32.75,"5o5t_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(638_A_)",41.3625,"","",""
"5O5U","X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH A UREA BASED INHIBITOR PSMA 1027","",1.53,34.1,"5o5u_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(638_A_)",48.4309,"","",""
"5O7W","CRYSTAL STRUCTURE OF THE 4-FLUORO RSL LECTIN IN COMPLEX WITH LEWIS X TETRASACCHARIDE","10.1021/ACSCHEMBIO.8B00377 ",1.35,6.17,"5o7w_oligo3","LFucpa1-3[DGalp[2<R1>]b1-4]DGlcpNAcb1-3DGalpb1-O2","GAL(4_E_)-[FUC(3_E_)]-NAG(2_E_)-GAL(1_E_)",8.84341,"","",""
"5O7W","CRYSTAL STRUCTURE OF THE 4-FLUORO RSL LECTIN IN COMPLEX WITH LEWIS X TETRASACCHARIDE","10.1021/ACSCHEMBIO.8B00377 ",1.35,6.17,"5o7w_oligo2","LFucpa1-3DGlcpNAcb1-ROH","FUC(2_C_)-NAG(1_C_)",12.3291,"","",""
"5O7W","CRYSTAL STRUCTURE OF THE 4-FLUORO RSL LECTIN IN COMPLEX WITH LEWIS X TETRASACCHARIDE","10.1021/ACSCHEMBIO.8B00377 ",1.35,6.17,"5o7w_oligo1","LFucpa1-3[DGalpb1-4]DGlcpNAcb1-3DGalpa1-ROH","GAL(4_D_)-[FUC(3_D_)]-NAG(2_D_)-GLA(1_D_)",8.29659,"","",""
"5O8F","STRUCTURE OF A CHIMAERIC BETA3-ALPHA5 GABAA RECEPTOR IN COMPLEX WITH NANOBODY NB25 AND PREGNANOLONE","10.1038/NSMB.3484 ",3.2,70.75,"5o8f_oligo4","DManpa1-2DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_I_)-MAN(5_I_)-MAN(4_I_)-[MAN(7_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(149_D_)",89.8691,"","",""
"5O8F","STRUCTURE OF A CHIMAERIC BETA3-ALPHA5 GABAA RECEPTOR IN COMPLEX WITH NANOBODY NB25 AND PREGNANOLONE","10.1038/NSMB.3484 ",3.2,70.75,"5o8f_oligo5","DManpa1-2DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_J_)-MAN(5_J_)-MAN(4_J_)-[MAN(7_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(149_E_)",93.8865,"","",""
"5O8F","STRUCTURE OF A CHIMAERIC BETA3-ALPHA5 GABAA RECEPTOR IN COMPLEX WITH NANOBODY NB25 AND PREGNANOLONE","10.1038/NSMB.3484 ",3.2,70.75,"5o8f_oligo1","DManpa1-2DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_G_)-MAN(5_G_)-MAN(4_G_)-[MAN(7_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(149_B_)",90.0297,"","",""
"5O8F","STRUCTURE OF A CHIMAERIC BETA3-ALPHA5 GABAA RECEPTOR IN COMPLEX WITH NANOBODY NB25 AND PREGNANOLONE","10.1038/NSMB.3484 ",3.2,70.75,"5o8f_oligo2","DManpa1-2DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-MAN(5_F_)-MAN(4_F_)-[MAN(7_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(149_A_)",89.6908,"","",""
"5O8F","STRUCTURE OF A CHIMAERIC BETA3-ALPHA5 GABAA RECEPTOR IN COMPLEX WITH NANOBODY NB25 AND PREGNANOLONE","10.1038/NSMB.3484 ",3.2,70.75,"5o8f_oligo3","DManpa1-2DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-MAN(5_H_)-MAN(4_H_)-[MAN(7_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(149_C_)",87.5253,"","",""
"5OF0","X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII), THE E424M INACTIVE MUTANT, IN COMPLEX WITH A INHIBITOR CFBZOG","10.1021/ACSMEDCHEMLETT.8B00318 ",1.48,38.48,"5of0_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(476_A_)",53.1402,"","",""
"5OF0","X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII), THE E424M INACTIVE MUTANT, IN COMPLEX WITH A INHIBITOR CFBZOG","10.1021/ACSMEDCHEMLETT.8B00318 ",1.48,38.48,"5of0_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(638_A_)",53.6511,"","",""
"5OHI","CRYSTAL STRUCTURE OF AUTOTAXIN IN COMPLEX WITH BI-2545","10.1021/ACSMEDCHEMLETT.7B00312 ",1.66,39.56,"5ohi_oligo3","DManpa1-2DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-MAN(5_D_)-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(524_A_)",49.8456,"","",""
"5OJ2","CRYSTAL STRUCTURE OF THE CHICKEN MDGA1 ECTODOMAIN","10.1016/J.NEURON.2017.07.040 ",3.2,0,"5oj2_oligo8","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)",161.021,"","",""
"5OJM","STRUCTURE OF A CHIMAERIC BETA3-ALPHA5 GABAA RECEPTOR IN COMPLEX WITH NANOBODY NB25","10.1038/NSMB.3484 ",3.3,70.04,"5ojm_oligo5","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-MAN(4_J_)-[MAN(6_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(149_E_)",91.9908,"","",""
"5OJM","STRUCTURE OF A CHIMAERIC BETA3-ALPHA5 GABAA RECEPTOR IN COMPLEX WITH NANOBODY NB25","10.1038/NSMB.3484 ",3.3,70.04,"5ojm_oligo4","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-MAN(4_I_)-[MAN(6_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(149_D_)",99.6474,"","",""
"5OJM","STRUCTURE OF A CHIMAERIC BETA3-ALPHA5 GABAA RECEPTOR IN COMPLEX WITH NANOBODY NB25","10.1038/NSMB.3484 ",3.3,70.04,"5ojm_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(149_A_)",88.5176,"","",""
"5OJM","STRUCTURE OF A CHIMAERIC BETA3-ALPHA5 GABAA RECEPTOR IN COMPLEX WITH NANOBODY NB25","10.1038/NSMB.3484 ",3.3,70.04,"5ojm_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(149_B_)",100.341,"","",""
"5OJM","STRUCTURE OF A CHIMAERIC BETA3-ALPHA5 GABAA RECEPTOR IN COMPLEX WITH NANOBODY NB25","10.1038/NSMB.3484 ",3.3,70.04,"5ojm_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(149_C_)",103.983,"","",""
"5OLB","CRYSTAL STRUCTURE OF AUTOTAXIN IN COMPLEX WITH PF-8380","10.1021/ACSMEDCHEMLETT.7B00312 ",1.82,25.36,"5olb_oligo4","DManpa1-2DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-MAN(5_D_)-MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(524_A_)",45.0582,"","",""
"5OLB","CRYSTAL STRUCTURE OF AUTOTAXIN IN COMPLEX WITH PF-8380","10.1021/ACSMEDCHEMLETT.7B00312 ",1.82,25.36,"5olb_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(6_B_)-[MAN(4_B_)-BMA(3_B_)-NAG(2_B_)]-[FUC(5_B_)]-NAG(1_B_)-ASN(53_A_)",39.8809,"","",""
"5OUG","HUMANIZED ALPHA-ACHBP (ACETYLCHOLINE BINDING PROTEIN) IN COMPLEX WITH LOBELINE AND ALLOSTERIC BINDER FRAGMENT 4.","10.1074/JBC.M117.815316 ",2.57,75.54,"5oug_oligo13","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(108_B_)",82.5771,"","",""
"5OUH","HUMANIZED ALPHA-ACHBP (ACETYLCHOLINE BINDING PROTEIN) IN COMPLEX WITH LOBELINE.","10.1074/JBC.M117.815316 ",2.5,69.37,"5ouh_oligo6","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(108_A_)",79.473,"","",""
"5OUI","HUMANIZED ALPHA-ACHBP (ACETYLCHOLINE BINDING PROTEIN) IN COMPLEX WITH ALLOSTERIC BINDER FRAGMENT CU2017","10.1074/JBC.M117.815316 ",3.1,81.9,"5oui_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(108_A_)",104.035,"","",""
"5QJ3","CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) COMPLEX WITH COMPOUND-24 AKA 7-({4-CHLORO-3'-FLUORO-[1,1'- BIPHENYL]-3- YL}METHOXY)-3H-[1,2,3]TRIAZOLO[4,5-B]PYRIDIN- 5-AMINE","10.1021/ACSMEDCHEMLETT.8B00308 ",2.76,37.4,"5qj3_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(6_F_)-[MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)",42.4816,"","",""
"5QJ3","CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) COMPLEX WITH COMPOUND-24 AKA 7-({4-CHLORO-3'-FLUORO-[1,1'- BIPHENYL]-3- YL}METHOXY)-3H-[1,2,3]TRIAZOLO[4,5-B]PYRIDIN- 5-AMINE","10.1021/ACSMEDCHEMLETT.8B00308 ",2.76,37.4,"5qj3_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(6_H_)-[MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)]-NAG(1_H_)",42.7338,"","",""
"5S9L","AUTOTAXIN, 4-[3-OXO-3-(2-OXO-2,3-DIHYDRO-BENZOOXAZOL-6-YL)-PROPYL]- PIPERAZINE-1-CARBOXYLIC ACID 3,5-DICHLORO-BENZYL ESTER, 1.90A, P212121, RFREE=19.1%","",1.9,30.62,"5s9l_oligo2","DManpa1-2DManpa1-3DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-MAN(5_B_)-MAN(4_B_)-[MAN(8_B_)-MAN(7_B_)]-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(524_A_)",49.5315,"","",""
"5S9M","AUTOTAXIN, (3,5-DICHLOROPHENYL)METHYL (3AS,8AR)-2-(1H-BENZOTRIAZOLE-5- CARBONYL)-1,3,3A,4,5,7,8,8A-OCTAHYDROPYRROLO[3,4-D]AZEPINE-6- CARBOXYLATE, 1.80A, P212121, RFREE=21.1%","",1.8,31.64,"5s9m_oligo1","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)]-MAN(4_B_)-[MAN(9_B_)-MAN(8_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(524_A_)",49.5715,"","",""
"5S9N","AUTOTAXIN, [4-(TRIFLUOROMETHOXY)PHENYL]METHYL (3AS,6AS)-2-(1H- BENZOTRIAZOLE-5-CARBONYL)-1,3,3A,4,6,6A-HEXAHYDROPYRROLO[3,4- C]PYRROLE-5-CARBOXYLATE, 1.80A, P212121, RFREE=23.3%","",1.8,33.72,"5s9n_oligo1","DManpa1-2DManpa1-3DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-MAN(5_B_)-MAN(4_B_)-[MAN(8_B_)-MAN(7_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(524_A_)",56.893,"","",""
"5SWB","CRYSTAL STRUCTURE OF N-GLYCAN TRANSPORT SOLUTE BINDING PROTEIN (NGTS) FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH MAN5GLCNAC","10.1371/JOURNAL.PPAT.1006090 ",1.73,29.96,"5swb_oligo2","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-ROH","MAN(4_E_)-MAN(3_E_)-[MAN(6_E_)]-BMA(2_E_)-NAG(1_E_)",20.8745,"","",""
"5SWB","CRYSTAL STRUCTURE OF N-GLYCAN TRANSPORT SOLUTE BINDING PROTEIN (NGTS) FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH MAN5GLCNAC","10.1371/JOURNAL.PPAT.1006090 ",1.73,29.96,"5swb_oligo5","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-ROH","MAN(5_H_)-[MAN(4_H_)]-MAN(3_H_)-[MAN(6_H_)]-BMA(2_H_)-NAG(1_H_)",18.5315,"","",""
"5SWB","CRYSTAL STRUCTURE OF N-GLYCAN TRANSPORT SOLUTE BINDING PROTEIN (NGTS) FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH MAN5GLCNAC","10.1371/JOURNAL.PPAT.1006090 ",1.73,29.96,"5swb_oligo4","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-ROH","MAN(5_F_)-[MAN(4_F_)]-MAN(3_F_)-[MAN(6_F_)]-BMA(2_F_)-NAG(1_F_)",20.5773,"","",""
"5SWB","CRYSTAL STRUCTURE OF N-GLYCAN TRANSPORT SOLUTE BINDING PROTEIN (NGTS) FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH MAN5GLCNAC","10.1371/JOURNAL.PPAT.1006090 ",1.73,29.96,"5swb_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-ROH","MAN(5_B_)-[MAN(4_B_)]-MAN(3_B_)-[MAN(6_B_)]-BMA(2_B_)-NAG(1_B_)",20.1171,"","",""
"5T20","CRYSTAL STRUCTURE OF TARIN LECTIN BOUND TO TRIMANNOSE","10.1093/GLYCOB/CWW083 ",1.91,18.88,"5t20_oligo8","DManpa1-3[DManpa1-6]DManpa1-ROH","MAN(3_X_)-[MAN(2_X_)]-MAN(1_X_)",26.4433,"","",""
"5T20","CRYSTAL STRUCTURE OF TARIN LECTIN BOUND TO TRIMANNOSE","10.1093/GLYCOB/CWW083 ",1.91,18.88,"5t20_oligo14","DManpa1-3[DManpa1-6]DManpa1-ROH","MAN(3_d_)-[MAN(2_d_)]-MAN(1_d_)",34.0085,"","",""
"5T20","CRYSTAL STRUCTURE OF TARIN LECTIN BOUND TO TRIMANNOSE","10.1093/GLYCOB/CWW083 ",1.91,18.88,"5t20_oligo16","DManpa1-3[DManpa1-6]DManpa1-ROH","MAN(3_f_)-[MAN(2_f_)]-MAN(1_f_)",30.8664,"","",""
"5T20","CRYSTAL STRUCTURE OF TARIN LECTIN BOUND TO TRIMANNOSE","10.1093/GLYCOB/CWW083 ",1.91,18.88,"5t20_oligo12","DManpa1-3[DManpa1-6]DManpa1-ROH","MAN(3_b_)-[MAN(2_b_)]-MAN(1_b_)",31.7836,"","",""
"5T20","CRYSTAL STRUCTURE OF TARIN LECTIN BOUND TO TRIMANNOSE","10.1093/GLYCOB/CWW083 ",1.91,18.88,"5t20_oligo11","DManpa1-3[DManpa1-6]DManpa1-ROH","MAN(3_a_)-[MAN(2_a_)]-MAN(1_a_)",28.907,"","",""
"5T20","CRYSTAL STRUCTURE OF TARIN LECTIN BOUND TO TRIMANNOSE","10.1093/GLYCOB/CWW083 ",1.91,18.88,"5t20_oligo7","DManpa1-3[DManpa1-6]DManpa1-ROH","MAN(3_W_)-[MAN(2_W_)]-MAN(1_W_)",22.4758,"","",""
"5T20","CRYSTAL STRUCTURE OF TARIN LECTIN BOUND TO TRIMANNOSE","10.1093/GLYCOB/CWW083 ",1.91,18.88,"5t20_oligo13","DManpa1-3[DManpa1-6]DManpa1-ROH","MAN(3_c_)-[MAN(2_c_)]-MAN(1_c_)",25.0348,"","",""
"5T20","CRYSTAL STRUCTURE OF TARIN LECTIN BOUND TO TRIMANNOSE","10.1093/GLYCOB/CWW083 ",1.91,18.88,"5t20_oligo5","DManpa1-3[DManpa1-6]DManpa1-ROH","MAN(3_U_)-[MAN(2_U_)]-MAN(1_U_)",22.3715,"","",""
"5T20","CRYSTAL STRUCTURE OF TARIN LECTIN BOUND TO TRIMANNOSE","10.1093/GLYCOB/CWW083 ",1.91,18.88,"5t20_oligo10","DManpa1-3[DManpa1-6]DManpa1-ROH","MAN(3_Z_)-[MAN(2_Z_)]-MAN(1_Z_)",33.8676,"","",""
"5T20","CRYSTAL STRUCTURE OF TARIN LECTIN BOUND TO TRIMANNOSE","10.1093/GLYCOB/CWW083 ",1.91,18.88,"5t20_oligo3","DManpa1-3[DManpa1-6]DManpa1-ROH","MAN(3_S_)-[MAN(2_S_)]-MAN(1_S_)",23.2342,"","",""
"5T20","CRYSTAL STRUCTURE OF TARIN LECTIN BOUND TO TRIMANNOSE","10.1093/GLYCOB/CWW083 ",1.91,18.88,"5t20_oligo4","DManpa1-3[DManpa1-6]DManpa1-ROH","MAN(3_T_)-[MAN(2_T_)]-MAN(1_T_)",30.8433,"","",""
"5T20","CRYSTAL STRUCTURE OF TARIN LECTIN BOUND TO TRIMANNOSE","10.1093/GLYCOB/CWW083 ",1.91,18.88,"5t20_oligo9","DManpa1-3[DManpa1-6]DManpa1-ROH","MAN(3_Y_)-[MAN(2_Y_)]-MAN(1_Y_)",18.5909,"","",""
"5T20","CRYSTAL STRUCTURE OF TARIN LECTIN BOUND TO TRIMANNOSE","10.1093/GLYCOB/CWW083 ",1.91,18.88,"5t20_oligo15","DManpa1-3[DManpa1-6]DManpa1-ROH","MAN(3_e_)-[MAN(2_e_)]-MAN(1_e_)",18.9345,"","",""
"5T20","CRYSTAL STRUCTURE OF TARIN LECTIN BOUND TO TRIMANNOSE","10.1093/GLYCOB/CWW083 ",1.91,18.88,"5t20_oligo2","DManpa1-3[DManpa1-6]DManpa1-ROH","MAN(3_R_)-[MAN(2_R_)]-MAN(1_R_)",27.6524,"","",""
"5T20","CRYSTAL STRUCTURE OF TARIN LECTIN BOUND TO TRIMANNOSE","10.1093/GLYCOB/CWW083 ",1.91,18.88,"5t20_oligo1","DManpa1-3[DManpa1-6]DManpa1-ROH","MAN(3_Q_)-[MAN(2_Q_)]-MAN(1_Q_)",24.5039,"","",""
"5T33","CRYSTAL STRUCTURE OF STRAIN-SPECIFIC GLYCAN-DEPENDENT CD4 BINDING SITE-DIRECTED NEUTRALIZING ANTIBODY CAP257-RH1, IN COMPLEX WITH HIV-1 STRAIN RHPA GP120 CORE WITH AN OLIGOMANNOSE N276 GLYCAN.","10.1128/JVI.01357-16 ",3.21,116.9,"5t33_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)]-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(276_G_)",114.515,"","",""
"5T3S","HIV GP140 TRIMER MD39-10MUTA IN COMPLEX WITH FABS PGT124 AND 35022","10.1016/J.IMMUNI.2016.08.016 ",4.5,187.7,"5t3s_oligo10","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_P_)-MAN(8_P_)-[MAN(10_P_)]-MAN(7_P_)-[MAN(6_P_)-MAN(5_P_)-MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(332_G_)",168.216,"","",""
"5T3S","HIV GP140 TRIMER MD39-10MUTA IN COMPLEX WITH FABS PGT124 AND 35022","10.1016/J.IMMUNI.2016.08.016 ",4.5,187.7,"5t3s_oligo4","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_O_)-[MAN(5_O_)]-MAN(4_O_)-[MAN(7_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(88_G_)",203.58,"","",""
"5T3S","HIV GP140 TRIMER MD39-10MUTA IN COMPLEX WITH FABS PGT124 AND 35022","10.1016/J.IMMUNI.2016.08.016 ",4.5,187.7,"5t3s_oligo9","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-MAN(4_K_)-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(197_G_)",234.096,"","",""
"5T3S","HIV GP140 TRIMER MD39-10MUTA IN COMPLEX WITH FABS PGT124 AND 35022","10.1016/J.IMMUNI.2016.08.016 ",4.5,187.7,"5t3s_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_A_)-[MAN(6_A_)-MAN(5_A_)-MAN(4_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(262_G_)",198.03,"","",""
"5T3S","HIV GP140 TRIMER MD39-10MUTA IN COMPLEX WITH FABS PGT124 AND 35022","10.1016/J.IMMUNI.2016.08.016 ",4.5,187.7,"5t3s_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_N_)-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(301_G_)",253.538,"","",""
"5T3S","HIV GP140 TRIMER MD39-10MUTA IN COMPLEX WITH FABS PGT124 AND 35022","10.1016/J.IMMUNI.2016.08.016 ",4.5,187.7,"5t3s_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_M_)-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(156_G_)",232.579,"","",""
"5T3X","3.9 ANGSTROM CRYSTAL STRUCTURE OF A FULLY AND NATIVELY GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING ANTIBODIES IOMA AND 10-1074.","10.1038/NSMB.3291 ",3.9,0,"5t3x_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_R_)-MAN(6_R_)-[NAG(5_R_)-MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(301_G_)",336.253,"","",""
"5T3X","3.9 ANGSTROM CRYSTAL STRUCTURE OF A FULLY AND NATIVELY GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING ANTIBODIES IOMA AND 10-1074.","10.1038/NSMB.3291 ",3.9,0,"5t3x_oligo17","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_W_)-[MAN(5_W_)-[MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)]-NAG(1_W_)-ASN(392_G_)",326.786,"","",""
"5T3X","3.9 ANGSTROM CRYSTAL STRUCTURE OF A FULLY AND NATIVELY GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING ANTIBODIES IOMA AND 10-1074.","10.1038/NSMB.3291 ",3.9,0,"5t3x_oligo14","DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_O_)-MAN(6_O_)-[MAN(5_O_)-MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(262_G_)",291.675,"","",""
"5T3X","3.9 ANGSTROM CRYSTAL STRUCTURE OF A FULLY AND NATIVELY GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING ANTIBODIES IOMA AND 10-1074.","10.1038/NSMB.3291 ",3.9,0,"5t3x_oligo10","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(10_K_)-[GAL(9_K_)-NAG(8_K_)-MAN(7_K_)-[GAL(6_K_)-NAG(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(160_G_)",336.057,"","",""
"5T3X","3.9 ANGSTROM CRYSTAL STRUCTURE OF A FULLY AND NATIVELY GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING ANTIBODIES IOMA AND 10-1074.","10.1038/NSMB.3291 ",3.9,0,"5t3x_oligo9","DGalpb1-4DGlcpNAcb1-4[DGlcpNAcb1-2]DManpa1-3[DGalpb1-4DGlcpNAcb1-2[DGalpb1-4DGlcpNAcb1-4]DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(13_J_)-[GAL(12_J_)-NAG(11_J_)-[GAL(10_J_)-NAG(9_J_)]-MAN(8_J_)-[GAL(6_J_)-NAG(5_J_)-[NAG(7_J_)]-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)]-NAG(1_J_)-ASN(156_G_)",325.076,"","",""
"5T3X","3.9 ANGSTROM CRYSTAL STRUCTURE OF A FULLY AND NATIVELY GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING ANTIBODIES IOMA AND 10-1074.","10.1038/NSMB.3291 ",3.9,0,"5t3x_oligo5","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_U_)-[MAN(5_U_)]-MAN(4_U_)-[MAN(7_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(363_G_)",373.667,"","",""
"5T3X","3.9 ANGSTROM CRYSTAL STRUCTURE OF A FULLY AND NATIVELY GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING ANTIBODIES IOMA AND 10-1074.","10.1038/NSMB.3291 ",3.9,0,"5t3x_oligo15","DNeup5Aca2-6DGalpb1-4DGlcpNAcb1-2[DGlcpNAcb1-4]DManpa1-3[DNeup5Aca2-6DGalpb1-4DGlcpNAcb1-2[DGalpb1-4DGlcpNAcb1-4]DManpa1-6][DGlcpNAcb1-4]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(16_P_)-[GAL(14_P_)-NAG(13_P_)-[SIA(12_P_)-GAL(11_P_)-NAG(10_P_)]-MAN(9_P_)-[NAG(15_P_)]-[NAG(8_P_)-[SIA(7_P_)-GAL(6_P_)-NAG(5_P_)]-MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)]-NAG(1_P_)-ASN(276_G_)",374.56,"","",""
"5T3X","3.9 ANGSTROM CRYSTAL STRUCTURE OF A FULLY AND NATIVELY GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING ANTIBODIES IOMA AND 10-1074.","10.1038/NSMB.3291 ",3.9,0,"5t3x_oligo12","DNeup5Aca2-6DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(9_M_)-MAN(8_M_)-[SIA(7_M_)-GAL(6_M_)-NAG(5_M_)-MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(197_G_)",304.839,"","",""
"5T3X","3.9 ANGSTROM CRYSTAL STRUCTURE OF A FULLY AND NATIVELY GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING ANTIBODIES IOMA AND 10-1074.","10.1038/NSMB.3291 ",3.9,0,"5t3x_oligo16","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_V_)-[MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(386_G_)",317.026,"","",""
"5T3X","3.9 ANGSTROM CRYSTAL STRUCTURE OF A FULLY AND NATIVELY GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING ANTIBODIES IOMA AND 10-1074.","10.1038/NSMB.3291 ",3.9,0,"5t3x_oligo18","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_X_)-MAN(4_X_)-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(448_G_)",322.505,"","",""
"5T3X","3.9 ANGSTROM CRYSTAL STRUCTURE OF A FULLY AND NATIVELY GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING ANTIBODIES IOMA AND 10-1074.","10.1038/NSMB.3291 ",3.9,0,"5t3x_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_S_)-MAN(8_S_)-[MAN(10_S_)]-MAN(7_S_)-[MAN(6_S_)-MAN(5_S_)-MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(332_G_)",218.953,"","",""
"5T3Z","3.5 ANGSTROM CRYSTAL STRUCTURE OF A FULLY AND NATIVELY GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING ANTIBODIES IOMA AND 10-1074","10.1038/NSMB.3291 ",3.5,0,"5t3z_oligo6","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_R_)-[NAG(5_R_)-MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(301_G_)",217.53,"","",""
"5T3Z","3.5 ANGSTROM CRYSTAL STRUCTURE OF A FULLY AND NATIVELY GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING ANTIBODIES IOMA AND 10-1074","10.1038/NSMB.3291 ",3.5,0,"5t3z_oligo14","DManpa1-2DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_T_)-MAN(5_T_)-MAN(4_T_)-[MAN(7_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(363_G_)",223.814,"","",""
"5T3Z","3.5 ANGSTROM CRYSTAL STRUCTURE OF A FULLY AND NATIVELY GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING ANTIBODIES IOMA AND 10-1074","10.1038/NSMB.3291 ",3.5,0,"5t3z_oligo7","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_S_)-MAN(8_S_)-[MAN(10_S_)]-MAN(7_S_)-[MAN(6_S_)-MAN(5_S_)-MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(332_G_)",166.778,"","",""
"5T3Z","3.5 ANGSTROM CRYSTAL STRUCTURE OF A FULLY AND NATIVELY GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING ANTIBODIES IOMA AND 10-1074","10.1038/NSMB.3291 ",3.5,0,"5t3z_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(160_G_)",246.507,"","",""
"5T3Z","3.5 ANGSTROM CRYSTAL STRUCTURE OF A FULLY AND NATIVELY GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING ANTIBODIES IOMA AND 10-1074","10.1038/NSMB.3291 ",3.5,0,"5t3z_oligo4","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_P_)-[MAN(7_P_)-[GAL(6_P_)-NAG(5_P_)-MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)]-NAG(1_P_)-ASN(276_G_)",265.286,"","",""
"5T3Z","3.5 ANGSTROM CRYSTAL STRUCTURE OF A FULLY AND NATIVELY GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING ANTIBODIES IOMA AND 10-1074","10.1038/NSMB.3291 ",3.5,0,"5t3z_oligo1","DGalpb1-4DGlcpNAcb1-4[DGlcpNAcb1-2]DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(11_J_)-[GAL(10_J_)-NAG(9_J_)-MAN(8_J_)-[GAL(6_J_)-NAG(5_J_)-[NAG(7_J_)]-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)]-NAG(1_J_)-ASN(156_G_)",240.369,"","",""
"5T3Z","3.5 ANGSTROM CRYSTAL STRUCTURE OF A FULLY AND NATIVELY GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING ANTIBODIES IOMA AND 10-1074","10.1038/NSMB.3291 ",3.5,0,"5t3z_oligo9","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(8_M_)-MAN(7_M_)-[GAL(6_M_)-NAG(5_M_)-MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(197_G_)",232.465,"","",""
"5T3Z","3.5 ANGSTROM CRYSTAL STRUCTURE OF A FULLY AND NATIVELY GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING ANTIBODIES IOMA AND 10-1074","10.1038/NSMB.3291 ",3.5,0,"5t3z_oligo15","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_U_)-[MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(386_G_)",218.258,"","",""
"5T3Z","3.5 ANGSTROM CRYSTAL STRUCTURE OF A FULLY AND NATIVELY GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING ANTIBODIES IOMA AND 10-1074","10.1038/NSMB.3291 ",3.5,0,"5t3z_oligo11","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_O_)-MAN(6_O_)-[MAN(5_O_)-MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(262_G_)",208.783,"","",""
"5T4Z","STRUCTURE OF THE ANTI-HIV ANTIBODY DH501 THAT BINDS GP120 V3 GLYCAN AND THE BASE OF V3 WITH FREE MAN9 GLYCAN","10.1016/J.CELREP.2017.02.003 ",1.99,0,"5t4z_oligo1","DManpa1-2DManpa1-3DManpa1-ROH","MAN(3_C_)-MAN(2_C_)-MAN(1_C_)",59.6515,"","",""
"5T54","LECTIN FROM BAUHINIA FORFICATA IN COMPLEX WITH BLOOD GROUP A ANTIGEN","10.1111/FEBS.13989 ",1.65,15.92,"5t54_oligo1","LFucpa1-2[DGalpNAca1-3]DGalpa1-ROH","A2G(3_C_)-[FUC(2_C_)]-GLA(1_C_)",17.1658,"","",""
"5T54","LECTIN FROM BAUHINIA FORFICATA IN COMPLEX WITH BLOOD GROUP A ANTIGEN","10.1111/FEBS.13989 ",1.65,15.92,"5t54_oligo2","LFucpa1-2[DGalpNAca1-3]DGalpa1-ROH","A2G(3_D_)-[FUC(2_D_)]-GLA(1_D_)",24.6585,"","",""
"5T55","LECTIN FROM BAUHINIA FORFICATA IN COMPLEX WITH GLOBOTETRAOSE","10.1111/FEBS.13989 ",1.43,17.14,"5t55_oligo1","DGalpNAcb1-3DGalpx1-","NGA(2_C_)-GAL(1_C_)",23.8875,"","",""
"5T55","LECTIN FROM BAUHINIA FORFICATA IN COMPLEX WITH GLOBOTETRAOSE","10.1111/FEBS.13989 ",1.43,17.14,"5t55_oligo2","DGalpNAcb1-3DGalpa1-4DGalpb1-4DGlcpb1-ROH","NGA(4_D_)-GLA(3_D_)-GAL(2_D_)-BGC(1_D_)",28.7175,"","",""
"5T6N","CRYSTAL STRUCTURE OF THE A/HONG KONG/1/1968 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ IN COMPLEX WITH THE ANTIVIRAL DRUG ARBIDOL","10.1073/PNAS.1617020114 ",2.54,0,"5t6n_oligo8","DRhapa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(165_E_)",103.15,"","",""
"5T7T","GALECTIN-8 N TERMINAL DOMAIN IN COMPLEX WITH LNT","10.1038/SREP39556 ",1.96,13.97,"5t7t_oligo1","DGalpb1-3DGlcpNAcb1-ROH","GAL(2_B_)-NAG(1_B_)",17.3959,"","",""
"5TE3","CRYSTAL STRUCTURE OF BOS TAURUS OPSIN AT 2.7 ANGSTROM","10.1073/PNAS.1617446114 ",2.7,94.94,"5te3_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(15_A_)",100.297,"","",""
"5THR","CRYO-EM STRUCTURE OF A BG505 ENV-SCD4-17B-8ANC195 COMPLEX","10.1073/PNAS.1615939113 ",8.9,512.502,"5thr_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_a_)-[MAN(4_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(386_E_)",165.906,"","",""
"5THR","CRYO-EM STRUCTURE OF A BG505 ENV-SCD4-17B-8ANC195 COMPLEX","10.1073/PNAS.1615939113 ",8.9,512.502,"5thr_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_X_)-[MAN(4_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(386_D_)",165.906,"","",""
"5THR","CRYO-EM STRUCTURE OF A BG505 ENV-SCD4-17B-8ANC195 COMPLEX","10.1073/PNAS.1615939113 ",8.9,512.502,"5thr_oligo7","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_b_)-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(234_F_)",188.538,"","",""
"5THR","CRYO-EM STRUCTURE OF A BG505 ENV-SCD4-17B-8ANC195 COMPLEX","10.1073/PNAS.1615939113 ",8.9,512.502,"5thr_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_V_)-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(234_D_)",177.635,"","",""
"5THR","CRYO-EM STRUCTURE OF A BG505 ENV-SCD4-17B-8ANC195 COMPLEX","10.1073/PNAS.1615939113 ",8.9,512.502,"5thr_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Z_)-[MAN(4_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(276_E_)",187.068,"","",""
"5THR","CRYO-EM STRUCTURE OF A BG505 ENV-SCD4-17B-8ANC195 COMPLEX","10.1073/PNAS.1615939113 ",8.9,512.502,"5thr_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_W_)-[MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(276_D_)",187.068,"","",""
"5THR","CRYO-EM STRUCTURE OF A BG505 ENV-SCD4-17B-8ANC195 COMPLEX","10.1073/PNAS.1615939113 ",8.9,512.502,"5thr_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_d_)-[MAN(4_d_)]-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(386_F_)",166.412,"","",""
"5THR","CRYO-EM STRUCTURE OF A BG505 ENV-SCD4-17B-8ANC195 COMPLEX","10.1073/PNAS.1615939113 ",8.9,512.502,"5thr_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_Y_)-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(234_E_)",177.635,"","",""
"5THR","CRYO-EM STRUCTURE OF A BG505 ENV-SCD4-17B-8ANC195 COMPLEX","10.1073/PNAS.1615939113 ",8.9,512.502,"5thr_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_c_)-[MAN(4_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(276_F_)",197.329,"","",""
"5TIP","THE STRUCTURE OF THE MAJOR CAPSID PROTEIN OF PBCV-1","10.1073/PNAS.1613432115 ",2,0,"5tip_oligo7","[DGalpa1-2][DRhapa1-3]LFucpa1-3[DXylpb1-4]DGlcpb1-ASN","XYP(7_I_)-[RM4(4_I_)-XYP(3_I_)-[XXR(6_I_)]-[GLA(5_I_)]-FUC(2_I_)]-BGC(1_I_)-ASN(280_B_)",41.9038,"","",""
"5TIP","THE STRUCTURE OF THE MAJOR CAPSID PROTEIN OF PBCV-1","10.1073/PNAS.1613432115 ",2,0,"5tip_oligo3","[DGalpa1-2][DXylpb1-4]LFucpa1-3[DXylpb1-4]DGlcpb1-ASN","XYP(7_R_)-[XYP(6_R_)-[MAN(4_R_)-XXR(3_R_)]-[GLA(5_R_)]-FUC(2_R_)]-BGC(1_R_)-ASN(399_D_)",43.1933,"","",""
"5TIP","THE STRUCTURE OF THE MAJOR CAPSID PROTEIN OF PBCV-1","10.1073/PNAS.1613432115 ",2,0,"5tip_oligo8","LRhap[2Me,3Me]a1-2LRhapb1-4DXylpb1-4[DManpa1-3DRhapa1-3][DGalpa1-2]LFucpa1-3[DXylpb1-4]DGlcpb1-ASN","XYP(9_F_)-7CV(5_F_)-RM4(4_F_)-XYP(3_F_)-[MAN(7_F_)-XXR(6_F_)]-[GLA(8_F_)]-FUC(2_F_)]-BGC(1_F_)-ASN(302_A_)",35.5224,"","",""
"5TIP","THE STRUCTURE OF THE MAJOR CAPSID PROTEIN OF PBCV-1","10.1073/PNAS.1613432115 ",2,0,"5tip_oligo16","[DGalpa1-2][DXylpb1-4]LFucpa1-3[DXylpb1-4]DGlcpb1-ASN","XYP(7_M_)-[XYP(6_M_)-[MAN(4_M_)-XXR(3_M_)]-[GLA(5_M_)]-FUC(2_M_)]-BGC(1_M_)-ASN(280_C_)",48.3865,"","",""
"5TIP","THE STRUCTURE OF THE MAJOR CAPSID PROTEIN OF PBCV-1","10.1073/PNAS.1613432115 ",2,0,"5tip_oligo2","[DGalpa1-2][DXylpb1-4]LFucpa1-3[DXylpb1-4]DGlcpb1-ASN","XYP(7_O_)-[XYP(6_O_)-[MAN(4_O_)-XXR(3_O_)]-[GLA(5_O_)]-FUC(2_O_)]-BGC(1_O_)-ASN(399_C_)",47.4565,"","",""
"5TIP","THE STRUCTURE OF THE MAJOR CAPSID PROTEIN OF PBCV-1","10.1073/PNAS.1613432115 ",2,0,"5tip_oligo14","LRhap[2Me,3Me]a1-2LRhapb1-4DXylpb1-4[DManpa1-3DRhapa1-3][DGalpa1-2]LFucpa1-3[DXylpb1-4]DGlcpb1-ASN","XYP(9_E_)-7CV(5_E_)-RM4(4_E_)-XYP(3_E_)-[MAN(7_E_)-XXR(6_E_)]-[GLA(8_E_)]-FUC(2_E_)]-BGC(1_E_)-ASN(280_A_)",46.0851,"","",""
"5TIP","THE STRUCTURE OF THE MAJOR CAPSID PROTEIN OF PBCV-1","10.1073/PNAS.1613432115 ",2,0,"5tip_oligo6","LFucpa1-3DGlcpb1-ASN","FUC(2_H_)-BGC(1_H_)-ASN(406_A_)",63.7523,"","",""
"5TIP","THE STRUCTURE OF THE MAJOR CAPSID PROTEIN OF PBCV-1","10.1073/PNAS.1613432115 ",2,0,"5tip_oligo4","LFucpa1-3DGlcpb1-ASN","FUC(2_S_)-BGC(1_S_)-ASN(406_D_)",68.4895,"","",""
"5TIP","THE STRUCTURE OF THE MAJOR CAPSID PROTEIN OF PBCV-1","10.1073/PNAS.1613432115 ",2,0,"5tip_oligo11","DManpa1-3DRhapa1-3[LRhapb1-4DXylpb1-4][DGalpa1-2]LFucpa1-3[DXylpb1-4]DGlcpb1-ASN","XYP(8_P_)-[RM4(6_P_)-XYP(5_P_)-[MAN(4_P_)-XXR(3_P_)]-[GLA(7_P_)]-FUC(2_P_)]-BGC(1_P_)-ASN(280_D_)",55.5241,"","",""
"5TIP","THE STRUCTURE OF THE MAJOR CAPSID PROTEIN OF PBCV-1","10.1073/PNAS.1613432115 ",2,0,"5tip_oligo13","[DGalpa1-2][DXylpb1-4]LFucpa1-3[DXylpb1-4]DGlcpb1-ASN","XYP(7_G_)-[XYP(6_G_)-[MAN(4_G_)-XXR(3_G_)]-[GLA(5_G_)]-FUC(2_G_)]-BGC(1_G_)-ASN(399_A_)",38.7971,"","",""
"5TIP","THE STRUCTURE OF THE MAJOR CAPSID PROTEIN OF PBCV-1","10.1073/PNAS.1613432115 ",2,0,"5tip_oligo9","LRhap[2Me,3Me]a1-2LRhapb1-4DXylpb1-4[DManpa1-3DRhapa1-3][DGalpa1-2]LFucpa1-3[DXylpb1-4]DGlcpb1-ASN","XYP(9_J_)-7CV(5_J_)-RM4(4_J_)-XYP(3_J_)-[MAN(7_J_)-XXR(6_J_)]-[GLA(8_J_)]-FUC(2_J_)]-BGC(1_J_)-ASN(302_B_)",40.8595,"","",""
"5TIP","THE STRUCTURE OF THE MAJOR CAPSID PROTEIN OF PBCV-1","10.1073/PNAS.1613432115 ",2,0,"5tip_oligo1","LRhap[2Me,3Me]a1-2LRhapb1-4DXylpb1-4[DManpa1-3DRhapa1-3][DGalpa1-2]LFucpa1-3[DXylpb1-4]DGlcpb1-ASN","XYP(9_N_)-7CV(5_N_)-RM4(4_N_)-XYP(3_N_)-[MAN(7_N_)-XXR(6_N_)]-[GLA(8_N_)]-FUC(2_N_)]-BGC(1_N_)-ASN(302_C_)",45.6831,"","",""
"5TIP","THE STRUCTURE OF THE MAJOR CAPSID PROTEIN OF PBCV-1","10.1073/PNAS.1613432115 ",2,0,"5tip_oligo15","[DGalpa1-2][DXylpb1-4]LFucpa1-3[DXylpb1-4]DGlcpb1-ASN","XYP(7_K_)-[XYP(6_K_)-[MAN(4_K_)-XXR(3_K_)]-[GLA(5_K_)]-FUC(2_K_)]-BGC(1_K_)-ASN(399_B_)",43.1707,"","",""
"5TIP","THE STRUCTURE OF THE MAJOR CAPSID PROTEIN OF PBCV-1","10.1073/PNAS.1613432115 ",2,0,"5tip_oligo12","LRhap[2Me,3Me]a1-2LRhapb1-4DXylpb1-4[DManpa1-3DRhapa1-3][DGalpa1-2]LFucpa1-3[DXylpb1-4]DGlcpb1-ASN","XYP(9_Q_)-7CV(5_Q_)-RM4(4_Q_)-XYP(3_Q_)-[MAN(7_Q_)-XXR(6_Q_)]-[GLA(8_Q_)]-FUC(2_Q_)]-BGC(1_Q_)-ASN(302_D_)",42.7161,"","",""
"5TIP","THE STRUCTURE OF THE MAJOR CAPSID PROTEIN OF PBCV-1","10.1073/PNAS.1613432115 ",2,0,"5tip_oligo10","LFucpa1-3DGlcpb1-ASN","FUC(2_L_)-BGC(1_L_)-ASN(406_B_)",62.8223,"","",""
"5TIQ","THE STRUCTURE OF THE MAJOR CAPSID PROTEIN OF PBCV-1","10.1073/PNAS.1613432115 ",2.54,0,"5tiq_oligo1","LFucpa1-3DGlcpb1-ASN","FUC(2_J_)-BGC(1_J_)-ASN(406_B_)",80.8759,"","",""
"5TIQ","THE STRUCTURE OF THE MAJOR CAPSID PROTEIN OF PBCV-1","10.1073/PNAS.1613432115 ",2.54,0,"5tiq_oligo7","LRhap[2Me,3Me]a1-2LRhapb1-4DXylpb1-4[DManpa1-3DRhapa1-3][DGalpa1-2]LFucpa1-3[DXylpb1-4]DGlcpb1-ASN","XYP(9_H_)-7CV(5_H_)-RM4(4_H_)-XYP(3_H_)-[MAN(7_H_)-XXR(6_H_)]-[GLA(8_H_)]-FUC(2_H_)]-BGC(1_H_)-ASN(302_B_)",47.3039,"","",""
"5TIQ","THE STRUCTURE OF THE MAJOR CAPSID PROTEIN OF PBCV-1","10.1073/PNAS.1613432115 ",2.54,0,"5tiq_oligo2","LRhap[2Me,3Me]a1-2LRhapb1-4DXylpb1-4[DManpa1-3DRhapa1-3][DGalpa1-2]LFucpa1-3[DXylpb1-4]DGlcpb1-ASN","XYP(9_D_)-7CV(5_D_)-RM4(4_D_)-XYP(3_D_)-[MAN(7_D_)-XXR(6_D_)]-[GLA(8_D_)]-FUC(2_D_)]-BGC(1_D_)-ASN(302_A_)",46.2553,"","",""
"5TIQ","THE STRUCTURE OF THE MAJOR CAPSID PROTEIN OF PBCV-1","10.1073/PNAS.1613432115 ",2.54,0,"5tiq_oligo4","[DGalpa1-2][DXylpb1-4]LFucpa1-3[DXylpb1-4]DGlcpb1-ASN","XYP(7_E_)-[XYP(6_E_)-[MAN(4_E_)-XXR(3_E_)]-[GLA(5_E_)]-FUC(2_E_)]-BGC(1_E_)-ASN(399_A_)",47.1757,"","",""
"5TIQ","THE STRUCTURE OF THE MAJOR CAPSID PROTEIN OF PBCV-1","10.1073/PNAS.1613432115 ",2.54,0,"5tiq_oligo8","LRhap[2Me,3Me]a1-2LRhapb1-4DXylpb1-4[DManpa1-3DRhapa1-3][DGalpa1-2]LFucpa1-3[DXylpb1-4]DGlcpb1-ASN","XYP(9_C_)-7CV(5_C_)-RM4(4_C_)-XYP(3_C_)-[MAN(7_C_)-XXR(6_C_)]-[GLA(8_C_)]-FUC(2_C_)]-BGC(1_C_)-ASN(280_A_)",60.4795,"","",""
"5TIQ","THE STRUCTURE OF THE MAJOR CAPSID PROTEIN OF PBCV-1","10.1073/PNAS.1613432115 ",2.54,0,"5tiq_oligo3","LRhap[2Me,3Me]a1-2LRhapb1-4DXylpb1-4[DManpa1-3DRhapa1-3][DGalpa1-2]LFucpa1-3[DXylpb1-4]DGlcpb1-ASN","XYP(9_G_)-7CV(5_G_)-RM4(4_G_)-XYP(3_G_)-[MAN(7_G_)-XXR(6_G_)]-[GLA(8_G_)]-FUC(2_G_)]-BGC(1_G_)-ASN(280_B_)",65.945,"","",""
"5TIQ","THE STRUCTURE OF THE MAJOR CAPSID PROTEIN OF PBCV-1","10.1073/PNAS.1613432115 ",2.54,0,"5tiq_oligo5","LRhap[2Me,3Me]a1-2LRhapb1-4DXylpb1-4[DManpa1-3DRhapa1-3][DGalpa1-2]LFucpa1-3[DXylpb1-4]DGlcpb1-ASN","XYP(9_I_)-7CV(5_I_)-RM4(4_I_)-XYP(3_I_)-[MAN(7_I_)-XXR(6_I_)]-[GLA(8_I_)]-FUC(2_I_)]-BGC(1_I_)-ASN(399_B_)",62.0874,"","",""
"5TIQ","THE STRUCTURE OF THE MAJOR CAPSID PROTEIN OF PBCV-1","10.1073/PNAS.1613432115 ",2.54,0,"5tiq_oligo6","LFucpa1-3DGlcpb1-ASN","FUC(2_F_)-BGC(1_F_)-ASN(406_A_)",66.7018,"","",""
"5TJK","CRYSTAL STRUCTURE OF GTA + A TRISACCHARIDE (NATIVE)","10.1093/GLYCOB/CWX053 ",1.45,21.19,"5tjk_oligo1","LFucpa1-2[DGalpNAca1-3]DGalpb1-C6O1","A2G(3_B_)-[FUC(2_B_)]-HSH(1_B_)",38.2455,"","",""
"5TJL","CRYSTAL STRUCTURE OF GTA + A TRISACCHARIDE (MERCURY DERIVATIVE)","10.1093/GLYCOB/CWX053 ",1.89,31.27,"5tjl_oligo1","LFucpa1-2[DGalpNAca1-3]DGalpb1-C6O1","A2G(3_B_)-[FUC(2_B_)]-HSH(1_B_)",48.3461,"","",""
"5TJN","CRYSTAL STRUCTURE OF GTB + B TRISACCHARIDE (NATIVE)","10.1093/GLYCOB/CWX053 ",1.47,21.14,"5tjn_oligo1","LFucpa1-2[DGalpa1-3]DGalpb1-C6O1","GLA(3_B_)-[FUC(2_B_)]-HSH(1_B_)",25.4452,"","",""
"5TJO","CRYSTAL STRUCTURE OF GTB + B TRISACCHARIDE (MERCURY DERIVATIVE)","10.1093/GLYCOB/CWX053 ",1.57,24.01,"5tjo_oligo1","LFucpa1-2[DGalpa1-3]DGalpb1-C6O1","GLA(3_B_)-[FUC(2_B_)]-HSH(1_B_)",28.4961,"","",""
"5TKF","NEUROSPORA CRASSA POLYSACCHARIDE MONOOXYGENASE 2 HIGH MANNOSYLATION","10.1107/S2053230X16020318 ",2.1,22.12,"5tkf_oligo3","DManpa1-3DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_G_)-MAN(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(60_C_)",46.4034,"","",""
"5TKF","NEUROSPORA CRASSA POLYSACCHARIDE MONOOXYGENASE 2 HIGH MANNOSYLATION","10.1107/S2053230X16020318 ",2.1,22.12,"5tkf_oligo1","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_E_)-MAN(6_E_)-[MAN(5_E_)-MAN(4_E_)]-MAN(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(60_A_)",42.3764,"","",""
"5TPB","BINDING DOMAIN OF BONT/A COMPLEXED WITH GANGLIOSIDE VARIANT","10.1021/JACS.6B09534 ",2.6,54.06,"5tpb_oligo1","DGalpb1-3DGalpNAcb1-ROH","GAL(2_C_)-NGA(1_C_)",74.7241,"","",""
"5TPC","BINDING DOMAIN OF BONT/A COMPLEXED WITH GANGLIOSIDE","10.1021/JACS.6B09534 ",2,27.22,"5tpc_oligo1","DNeup5Aca2-3DGalpb1-3DGalpNAcb1-4[DNeup5Aca2-3]DGalpb1-ROH","SIA(3_C_)-GAL(2_C_)-NGA(1_C_)-[SIA(2_B_)]-GAL(1_B_)",65.1491,"","",""
"5TPS","STRUCTURE OF A FC HETERODIMER","",2.7,0,"5tps_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(297_B_)",95.754,"","",""
"5TPS","STRUCTURE OF A FC HETERODIMER","",2.7,0,"5tps_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_A_)",64.6678,"","",""
"5TZN","STRUCTURE OF THE VIRAL IMMUNOEVASIN M12 (SMITH) BOUND TO THE NATURAL KILLER CELL RECEPTOR NKR-P1B (B6)","10.1016/J.CELL.2017.03.002 ",2.6,40.65,"5tzn_oligo5","DManpb1-6DManpb1-3DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_H_)-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(97_G_)",78.7393,"","",""
"5TZU","CRYSTAL STRUCTURE OF HUMAN CD47 ECD BOUND TO FAB OF B6H12.2","10.1038/BCJ.2017.7 ",2.1,36.88,"5tzu_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(32_C_)",79.5384,"","",""
"5U38","CRYSTAL STRUCTURE OF NATIVE LECTIN FROM PLATYPODIUM ELEGANS SEEDS (PELA) COMPLEXED WITH MAN1-3MAN-OME.","10.1016/J.IJBIOMAC.2017.08.174 ",1.6,15.22,"5u38_oligo2","DManpa1-3DManpa1-OME","MAN(2_B_)-MMA(1_B_)",26.5095,"","",""
"5U4Y","IGG FC BOUND TO 3 HELIX OF THE B-DOMAIN FROM PROTEIN A","10.1093/PROTEIN/GZX029 ",2.5,53.9,"5u4y_oligo1","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_F_)-[NAG(5_F_)-MAN(4_F_)-[MAN(6_F_)]-MAN(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(297_B_)",76.7339,"","",""
"5U4Y","IGG FC BOUND TO 3 HELIX OF THE B-DOMAIN FROM PROTEIN A","10.1093/PROTEIN/GZX029 ",2.5,53.9,"5u4y_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[MAN(7_E_)]-MAN(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_A_)",107.693,"","",""
"5U52","2 HELIX MINIMIZED VERSION OF THE B-DOMAIN FROM PROTEIN A (Z34C0 BOUND TO IGG1 FC (MONOCLINIC FORM)","10.1093/PROTEIN/GZX029 ",1.94,0,"5u52_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[MAN(7_D_)]-MAN(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",47.7893,"","",""
"5U52","2 HELIX MINIMIZED VERSION OF THE B-DOMAIN FROM PROTEIN A (Z34C0 BOUND TO IGG1 FC (MONOCLINIC FORM)","10.1093/PROTEIN/GZX029 ",1.94,0,"5u52_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[MAN(7_C_)]-MAN(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",48.6973,"","",""
"5U66","MODIFIED SINGLE HELIX FROM THE B-DOMAIN OF PROTEIN A BOUND TO IGG1 FC","10.1093/PROTEIN/GZX029 ",1.7,35.31,"5u66_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(297_A_)",68.1113,"","",""
"5U74","STRUCTURE OF HUMAN NIEMANN-PICK C1 PROTEIN","10.1073/PNAS.1711716114 ",3.34,0,"5u74_oligo1","DManpa1-3DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(557_A_)",110.496,"","",""
"5U75","THE STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN-LIKE X (SELX), A UNIQUE SUPERANTIGEN","10.1371/JOURNAL.PPAT.1006549 ",1.66,21.54,"5u75_oligo1","DNeup5Aca2-3DGalpb1-4[LFucpa1-3]DGlcpNAca1-ROH","SIA(3_B_)-GAL(2_B_)-[FUC(4_B_)]-NDG(1_B_)",25.9698,"","",""
"5U7M","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-378806 IN COMPLEX WITH HUMAN ANTIBODIES PGT122 AND 35O22 AT 3.8 ANGSTROM","10.1038/NCHEMBIO.2460 ",3.03,0,"5u7m_oligo7","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_A_)-[MAN(5_A_)]-MAN(4_A_)-[MAN(7_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(88_G_)",141.926,"","",""
"5U7M","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-378806 IN COMPLEX WITH HUMAN ANTIBODIES PGT122 AND 35O22 AT 3.8 ANGSTROM","10.1038/NCHEMBIO.2460 ",3.03,0,"5u7m_oligo10","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(10_O_)-[MAN(9_O_)-MAN(8_O_)]-MAN(7_O_)-[MAN(6_O_)-MAN(5_O_)-MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(332_G_)",119.097,"","",""
"5U7M","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-378806 IN COMPLEX WITH HUMAN ANTIBODIES PGT122 AND 35O22 AT 3.8 ANGSTROM","10.1038/NCHEMBIO.2460 ",3.03,0,"5u7m_oligo6","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_K_)-[MAN(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(262_G_)",145.044,"","",""
"5U7M","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-378806 IN COMPLEX WITH HUMAN ANTIBODIES PGT122 AND 35O22 AT 3.8 ANGSTROM","10.1038/NCHEMBIO.2460 ",3.03,0,"5u7m_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(156_G_)",137.016,"","",""
"5U7O","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-626529 IN COMPLEX WITH HUMAN ANTIBODIES PGT122 AND 35O22 AT 3.8 ANGSTROM","10.1038/NCHEMBIO.2460 ",3.03,0,"5u7o_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_A_)-[MAN(5_A_)]-MAN(4_A_)-[MAN(7_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(88_G_)",113.776,"","",""
"5U7O","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-626529 IN COMPLEX WITH HUMAN ANTIBODIES PGT122 AND 35O22 AT 3.8 ANGSTROM","10.1038/NCHEMBIO.2460 ",3.03,0,"5u7o_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(137_G_)",124.929,"","",""
"5U7O","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-626529 IN COMPLEX WITH HUMAN ANTIBODIES PGT122 AND 35O22 AT 3.8 ANGSTROM","10.1038/NCHEMBIO.2460 ",3.03,0,"5u7o_oligo12","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(10_P_)-[MAN(9_P_)-MAN(8_P_)]-MAN(7_P_)-[MAN(6_P_)-MAN(5_P_)-MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(332_G_)",104.842,"","",""
"5U7O","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-626529 IN COMPLEX WITH HUMAN ANTIBODIES PGT122 AND 35O22 AT 3.8 ANGSTROM","10.1038/NCHEMBIO.2460 ",3.03,0,"5u7o_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(156_G_)",102.454,"","",""
"5U7O","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-626529 IN COMPLEX WITH HUMAN ANTIBODIES PGT122 AND 35O22 AT 3.8 ANGSTROM","10.1038/NCHEMBIO.2460 ",3.03,0,"5u7o_oligo7","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_M_)-[MAN(5_M_)-MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(262_G_)",113.962,"","",""
"5U81","ACID CERAMIDASE (ASAH1, ACDASE) FROM NAKED MOLE RAT, CYS143ALA, UNCLEAVED","10.1038/S41467-018-03844-2 ",1.4,0,"5u81_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_B_)-[MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(173_A_)",26.637,"","",""
"5U81","ACID CERAMIDASE (ASAH1, ACDASE) FROM NAKED MOLE RAT, CYS143ALA, UNCLEAVED","10.1038/S41467-018-03844-2 ",1.4,0,"5u81_oligo3","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(259_A_)",33.5249,"","",""
"5UBX","CRYSTAL STRUCTURE OF A MUTANT MIGG2B FC HETERODIMER IN COMPLEX WITH PROTEIN A PEPTIDE ANALOG Z34C","10.1080/19420862.2017.1375639 ",2.7,0,"5ubx_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcx1-","NAG(6_C_)-MAN(5_C_)-[NAG(4_C_)-MAN(3_C_)]-BMA(2_C_)-NAG(1_C_)",134.542,"","",""
"5UBX","CRYSTAL STRUCTURE OF A MUTANT MIGG2B FC HETERODIMER IN COMPLEX WITH PROTEIN A PEPTIDE ANALOG Z34C","10.1080/19420862.2017.1375639 ",2.7,0,"5ubx_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",83.5589,"","",""
"5UDC","CRYSTAL STRUCTURE OF RSV F A2 BOUND TO MEDI8897","10.1126/SCITRANSLMED.AAJ1928 ",3.45,138.6,"5udc_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_I_)-MAN(10_I_)-[MAN(9_I_)-MAN(8_I_)]-MAN(7_I_)-[MAN(6_I_)-MAN(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(70_F_)",160.552,"","",""
"5UEM","CRYSTAL STRUCTURE OF 354NC37 FAB IN COMPLEX WITH HIV-1 CLADE AE STRAIN 93TH057 GP120","10.1126/SCITRANSLMED.AAL2144 ",2.7,0,"5uem_oligo1","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_C_)-MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(289_G_)",52.1044,"","",""
"5UEM","CRYSTAL STRUCTURE OF 354NC37 FAB IN COMPLEX WITH HIV-1 CLADE AE STRAIN 93TH057 GP120","10.1126/SCITRANSLMED.AAL2144 ",2.7,0,"5uem_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(262_G_)",66.5344,"","",""
"5UK5","COMPLEX OF NOTCH1(EGF8-12) BOUND TO JAGGED1(N-EGF3)","10.1126/SCIENCE.AAF9739 ",2.51,0,"5uk5_oligo2","DXylpa1-3DGlcpb1-SER","XYS(2_C_)-BGC(1_C_)-SER(458_A_)",94.5897,"","",""
"5UM8","CRYSTAL STRUCTURE OF HIV-1 ENVELOPE TRIMER 16055 NFL TD CC (T569G) IN COMPLEX WITH FABS 35022 AND PGT124","10.1016/J.IMMUNI.2017.04.014 ",3.94,0,"5um8_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(156_G_)",175.968,"","",""
"5UM8","CRYSTAL STRUCTURE OF HIV-1 ENVELOPE TRIMER 16055 NFL TD CC (T569G) IN COMPLEX WITH FABS 35022 AND PGT124","10.1016/J.IMMUNI.2017.04.014 ",3.94,0,"5um8_oligo10","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_P_)-MAN(8_P_)-[MAN(10_P_)]-MAN(7_P_)-[MAN(6_P_)-MAN(5_P_)-MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(332_G_)",156.809,"","",""
"5UM8","CRYSTAL STRUCTURE OF HIV-1 ENVELOPE TRIMER 16055 NFL TD CC (T569G) IN COMPLEX WITH FABS 35022 AND PGT124","10.1016/J.IMMUNI.2017.04.014 ",3.94,0,"5um8_oligo11","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Q_)-[MAN(5_Q_)]-MAN(4_Q_)-[MAN(7_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(88_G_)",152.526,"","",""
"5UM8","CRYSTAL STRUCTURE OF HIV-1 ENVELOPE TRIMER 16055 NFL TD CC (T569G) IN COMPLEX WITH FABS 35022 AND PGT124","10.1016/J.IMMUNI.2017.04.014 ",3.94,0,"5um8_oligo12","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_R_)-MAN(4_R_)-[MAN(6_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(262_G_)",174.045,"","",""
"5UPH","LIPIDS BOUND LYSOSOMAL INTEGRAL MEMBRANE PROTEIN 2","10.1038/S41467-017-02044-8 ",3,130.7,"5uph_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(412_B_)",151.05,"","",""
"5UPH","LIPIDS BOUND LYSOSOMAL INTEGRAL MEMBRANE PROTEIN 2","10.1038/S41467-017-02044-8 ",3,130.7,"5uph_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(325_B_)",170.927,"","",""
"5UPH","LIPIDS BOUND LYSOSOMAL INTEGRAL MEMBRANE PROTEIN 2","10.1038/S41467-017-02044-8 ",3,130.7,"5uph_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(412_A_)",152.434,"","",""
"5UPH","LIPIDS BOUND LYSOSOMAL INTEGRAL MEMBRANE PROTEIN 2","10.1038/S41467-017-02044-8 ",3,130.7,"5uph_oligo6","DManp[6P]b1-2DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","M6D(6_E_)-MAN(5_E_)-MAN(4_E_)-[MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(325_A_)",186.153,"","",""
"5UPH","LIPIDS BOUND LYSOSOMAL INTEGRAL MEMBRANE PROTEIN 2","10.1038/S41467-017-02044-8 ",3,130.7,"5uph_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(68_B_)",163.936,"","",""
"5UPH","LIPIDS BOUND LYSOSOMAL INTEGRAL MEMBRANE PROTEIN 2","10.1038/S41467-017-02044-8 ",3,130.7,"5uph_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(68_A_)",157.063,"","",""
"5UQY","CRYSTAL STRUCTURE OF MARBURG VIRUS GP IN COMPLEX WITH THE HUMAN SURVIVOR ANTIBODY MR78","10.1016/J.CELL.2015.01.041 ",3.6,0,"5uqy_oligo8","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_X_)-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(564_J_)",126.458,"","",""
"5UQY","CRYSTAL STRUCTURE OF MARBURG VIRUS GP IN COMPLEX WITH THE HUMAN SURVIVOR ANTIBODY MR78","10.1016/J.CELL.2015.01.041 ",3.6,0,"5uqy_oligo6","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_V_)-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(94_I_)",144.026,"","",""
"5UQY","CRYSTAL STRUCTURE OF MARBURG VIRUS GP IN COMPLEX WITH THE HUMAN SURVIVOR ANTIBODY MR78","10.1016/J.CELL.2015.01.041 ",3.6,0,"5uqy_oligo5","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_U_)-[MAN(5_U_)-MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(564_F_)",127.816,"","",""
"5UQY","CRYSTAL STRUCTURE OF MARBURG VIRUS GP IN COMPLEX WITH THE HUMAN SURVIVOR ANTIBODY MR78","10.1016/J.CELL.2015.01.041 ",3.6,0,"5uqy_oligo3","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_S_)-[MAN(5_S_)-MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(564_B_)",121.786,"","",""
"5UQY","CRYSTAL STRUCTURE OF MARBURG VIRUS GP IN COMPLEX WITH THE HUMAN SURVIVOR ANTIBODY MR78","10.1016/J.CELL.2015.01.041 ",3.6,0,"5uqy_oligo11","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_a_)-MAN(4_a_)-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(564_N_)",149.391,"","",""
"5URY","CRYSTAL STRUCTURE OF FRIZZLED 5 CRD IN COMPLEX WITH PAM","10.1073/PNAS.1618293114 ",2.1,0,"5ury_oligo1","LFucpa1-3[LFucpa1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_C_)-[FUC(3_C_)]-[FUC(2_C_)]-NAG(1_C_)-ASN(22_A_)",58.9236,"","",""
"5UTF","CRYSTAL STRUCTURE OF A STABILIZED DS-SOSIP.6MUT BG505 GP140 HIV-1 ENV TRIMER, CONTAINING MUTATIONS I201C-P433C (DS), L154M, Y177W, N300M, N302M, T320L, I420M IN COMPLEX WITH HUMAN ANTIBODIES PGT122 AND 35O22 AT 4.3 A","10.1128/JVI.02268-16 ",3.5,0,"5utf_oligo14","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(10_T_)-[MAN(9_T_)-MAN(8_T_)]-MAN(7_T_)-[MAN(6_T_)-MAN(5_T_)-MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(332_G_)",102.535,"","",""
"5UTF","CRYSTAL STRUCTURE OF A STABILIZED DS-SOSIP.6MUT BG505 GP140 HIV-1 ENV TRIMER, CONTAINING MUTATIONS I201C-P433C (DS), L154M, Y177W, N300M, N302M, T320L, I420M IN COMPLEX WITH HUMAN ANTIBODIES PGT122 AND 35O22 AT 4.3 A","10.1128/JVI.02268-16 ",3.5,0,"5utf_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(156_G_)",111.758,"","",""
"5UTF","CRYSTAL STRUCTURE OF A STABILIZED DS-SOSIP.6MUT BG505 GP140 HIV-1 ENV TRIMER, CONTAINING MUTATIONS I201C-P433C (DS), L154M, Y177W, N300M, N302M, T320L, I420M IN COMPLEX WITH HUMAN ANTIBODIES PGT122 AND 35O22 AT 4.3 A","10.1128/JVI.02268-16 ",3.5,0,"5utf_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_A_)-MAN(8_A_)-[MAN(10_A_)]-MAN(7_A_)-[MAN(6_A_)-MAN(5_A_)-MAN(4_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(88_G_)",100.148,"","",""
"5UTF","CRYSTAL STRUCTURE OF A STABILIZED DS-SOSIP.6MUT BG505 GP140 HIV-1 ENV TRIMER, CONTAINING MUTATIONS I201C-P433C (DS), L154M, Y177W, N300M, N302M, T320L, I420M IN COMPLEX WITH HUMAN ANTIBODIES PGT122 AND 35O22 AT 4.3 A","10.1128/JVI.02268-16 ",3.5,0,"5utf_oligo3","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_I_)-[MAN(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(262_G_)",108.888,"","",""
"5UTY","CRYSTAL STRUCTURE OF A STABILIZED DS-SOSIP.MUT4 BG505 GP140 HIV-1 ENV TRIMER, CONTAINING MUTATIONS I201C-P433C (DS), L154M, N300M, N302M, T320L IN COMPLEX WITH HUMAN ANTIBODIES PGT122 AND 35O22 AT 4.1 ANGSTROM","10.1128/JVI.02268-16 ",3.41,0,"5uty_oligo5","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(10_P_)-[MAN(9_P_)-MAN(8_P_)]-MAN(7_P_)-[MAN(6_P_)-MAN(5_P_)-MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(332_G_)",129.245,"","",""
"5UTY","CRYSTAL STRUCTURE OF A STABILIZED DS-SOSIP.MUT4 BG505 GP140 HIV-1 ENV TRIMER, CONTAINING MUTATIONS I201C-P433C (DS), L154M, N300M, N302M, T320L IN COMPLEX WITH HUMAN ANTIBODIES PGT122 AND 35O22 AT 4.1 ANGSTROM","10.1128/JVI.02268-16 ",3.41,0,"5uty_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(156_G_)",129.201,"","",""
"5UTY","CRYSTAL STRUCTURE OF A STABILIZED DS-SOSIP.MUT4 BG505 GP140 HIV-1 ENV TRIMER, CONTAINING MUTATIONS I201C-P433C (DS), L154M, N300M, N302M, T320L IN COMPLEX WITH HUMAN ANTIBODIES PGT122 AND 35O22 AT 4.1 ANGSTROM","10.1128/JVI.02268-16 ",3.41,0,"5uty_oligo2","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_A_)-MAN(4_A_)-[MAN(6_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(88_G_)",125.816,"","",""
"5UTY","CRYSTAL STRUCTURE OF A STABILIZED DS-SOSIP.MUT4 BG505 GP140 HIV-1 ENV TRIMER, CONTAINING MUTATIONS I201C-P433C (DS), L154M, N300M, N302M, T320L IN COMPLEX WITH HUMAN ANTIBODIES PGT122 AND 35O22 AT 4.1 ANGSTROM","10.1128/JVI.02268-16 ",3.41,0,"5uty_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(137_G_)",167.234,"","",""
"5UTY","CRYSTAL STRUCTURE OF A STABILIZED DS-SOSIP.MUT4 BG505 GP140 HIV-1 ENV TRIMER, CONTAINING MUTATIONS I201C-P433C (DS), L154M, N300M, N302M, T320L IN COMPLEX WITH HUMAN ANTIBODIES PGT122 AND 35O22 AT 4.1 ANGSTROM","10.1128/JVI.02268-16 ",3.41,0,"5uty_oligo9","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_M_)-[MAN(5_M_)-MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(262_G_)",127.942,"","",""
"5UV8","INTERLEUKIN-3 RECEPTOR COMPLEX","10.1038/S41467-017-02633-7 ",2.7,44.01,"5uv8_oligo3","DManpb1-3DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_E_)-[BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(80_G_)",69.9625,"","",""
"5V4E","ENGINEERED HUMAN IGG FC DOMAIN GLYCO801 (FC801)","10.1038/NI.3770 ",3.22,0,"5v4e_oligo3","DGlcpNAcb1-2DManpa1-3DManpx1-","NAG(3_J_)-MAN(2_J_)-BMA(1_J_)",118.436,"","",""
"5V4E","ENGINEERED HUMAN IGG FC DOMAIN GLYCO801 (FC801)","10.1038/NI.3770 ",3.22,0,"5v4e_oligo4","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_L_)-[NAG(5_L_)-MAN(4_L_)-[MAN(6_L_)]-BMA(3_L_)-NAG(2_L_)]-NAG(1_L_)-ASN(297_E_)",105.421,"","",""
"5V4E","ENGINEERED HUMAN IGG FC DOMAIN GLYCO801 (FC801)","10.1038/NI.3770 ",3.22,0,"5v4e_oligo5","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_M_)-[NAG(7_M_)-MAN(6_M_)-[NAG(5_M_)-MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)]-NAG(1_M_)-ASN(297_G_)",77.144,"","",""
"5V4E","ENGINEERED HUMAN IGG FC DOMAIN GLYCO801 (FC801)","10.1038/NI.3770 ",3.22,0,"5v4e_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_I_)-[NAG(7_I_)-MAN(6_I_)-[NAG(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(297_A_)",90.4752,"","",""
"5V4M","STRUCTURE OF HLA-DR15 WITH BOUND ALPHA3(135-145) PEPTIDE","10.1038/NATURE22329 ",2.1,0,"5v4m_oligo3","LFucpa1-3[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_H_)-[FUC(2_H_)]-NAG(1_H_)-ASN(78_G_)",65.7761,"","",""
"5V4M","STRUCTURE OF HLA-DR15 WITH BOUND ALPHA3(135-145) PEPTIDE","10.1038/NATURE22329 ",2.1,0,"5v4m_oligo1","LFucpa1-3[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[FUC(2_B_)]-NAG(1_B_)-ASN(78_D_)",59.1676,"","",""
"5V6F","CRYSTAL STRUCTURE OF THE SECOND BETA-PRISM DOMAIN OF RBMC FROM V. CHOLERAE BOUND TO MANNOTRIOSE","10.1371/JOURNAL.PPAT.1006841 ",1.5,9.28,"5v6f_oligo1","DManpa1-3[DManpa1-6]DManpb1-ROH","MAN(3_B_)-[MAN(2_B_)]-BMA(1_B_)",8.24636,"","",""
"5V7J","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF GLYCOSYLATED HIV-1 CLADE A BG505 SOSIP.664 PREFUSION ENV TRIMER WITH FOUR GLYCANS (N197, N276, N362, AND N462) REMOVED IN COMPLEX WITH NEUTRALIZING ANTIBODIES 3H+109L AND 35O22.","10.1016/J.CELREP.2017.04.013 ",2.91,0,"5v7j_oligo4","DManpa1-2DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_N_)-MAN(5_N_)-MAN(4_N_)-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(301_G_)",201.806,"","",""
"5V7J","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF GLYCOSYLATED HIV-1 CLADE A BG505 SOSIP.664 PREFUSION ENV TRIMER WITH FOUR GLYCANS (N197, N276, N362, AND N462) REMOVED IN COMPLEX WITH NEUTRALIZING ANTIBODIES 3H+109L AND 35O22.","10.1016/J.CELREP.2017.04.013 ",2.91,0,"5v7j_oligo8","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_F_)-[MAN(6_F_)-MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(295_G_)",142.688,"","",""
"5V7J","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF GLYCOSYLATED HIV-1 CLADE A BG505 SOSIP.664 PREFUSION ENV TRIMER WITH FOUR GLYCANS (N197, N276, N362, AND N462) REMOVED IN COMPLEX WITH NEUTRALIZING ANTIBODIES 3H+109L AND 35O22.","10.1016/J.CELREP.2017.04.013 ",2.91,0,"5v7j_oligo10","DManpa1-2DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(6_P_)-MAN(5_P_)-MAN(4_P_)-[MAN(7_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)",226.815,"","",""
"5V7J","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF GLYCOSYLATED HIV-1 CLADE A BG505 SOSIP.664 PREFUSION ENV TRIMER WITH FOUR GLYCANS (N197, N276, N362, AND N462) REMOVED IN COMPLEX WITH NEUTRALIZING ANTIBODIES 3H+109L AND 35O22.","10.1016/J.CELREP.2017.04.013 ",2.91,0,"5v7j_oligo9","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_O_)-MAN(8_O_)-[MAN(10_O_)]-MAN(7_O_)-[MAN(6_O_)-MAN(5_O_)-MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(332_G_)",137.991,"","",""
"5V7J","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF GLYCOSYLATED HIV-1 CLADE A BG505 SOSIP.664 PREFUSION ENV TRIMER WITH FOUR GLYCANS (N197, N276, N362, AND N462) REMOVED IN COMPLEX WITH NEUTRALIZING ANTIBODIES 3H+109L AND 35O22.","10.1016/J.CELREP.2017.04.013 ",2.91,0,"5v7j_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(7_K_)-[MAN(6_K_)-MAN(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)",222.8,"","",""
"5V7J","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF GLYCOSYLATED HIV-1 CLADE A BG505 SOSIP.664 PREFUSION ENV TRIMER WITH FOUR GLYCANS (N197, N276, N362, AND N462) REMOVED IN COMPLEX WITH NEUTRALIZING ANTIBODIES 3H+109L AND 35O22.","10.1016/J.CELREP.2017.04.013 ",2.91,0,"5v7j_oligo5","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_A_)-MAN(4_A_)-[MAN(6_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(160_G_)",156.685,"","",""
"5V7J","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF GLYCOSYLATED HIV-1 CLADE A BG505 SOSIP.664 PREFUSION ENV TRIMER WITH FOUR GLYCANS (N197, N276, N362, AND N462) REMOVED IN COMPLEX WITH NEUTRALIZING ANTIBODIES 3H+109L AND 35O22.","10.1016/J.CELREP.2017.04.013 ",2.91,0,"5v7j_oligo6","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_J_)-MAN(7_J_)-[MAN(6_J_)-MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(156_G_)",220.518,"","",""
"5V7J","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF GLYCOSYLATED HIV-1 CLADE A BG505 SOSIP.664 PREFUSION ENV TRIMER WITH FOUR GLYCANS (N197, N276, N362, AND N462) REMOVED IN COMPLEX WITH NEUTRALIZING ANTIBODIES 3H+109L AND 35O22.","10.1016/J.CELREP.2017.04.013 ",2.91,0,"5v7j_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_M_)-MAN(7_M_)-[MAN(6_M_)-MAN(5_M_)-MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(262_G_)",214.187,"","",""
"5V7J","CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF GLYCOSYLATED HIV-1 CLADE A BG505 SOSIP.664 PREFUSION ENV TRIMER WITH FOUR GLYCANS (N197, N276, N362, AND N462) REMOVED IN COMPLEX WITH NEUTRALIZING ANTIBODIES 3H+109L AND 35O22.","10.1016/J.CELREP.2017.04.013 ",2.91,0,"5v7j_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)]-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(88_G_)",154.488,"","",""
"5V8L","BG505 SOSIP.664 TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING HIV ANTIBODIES 3BNC117 AND PGT145","10.1016/J.IMMUNI.2017.03.017 ",4.3,"2.23709e+11","5v8l_oligo14","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_f_)-MAN(6_f_)-[MAN(5_f_)-MAN(4_f_)]-BMA(3_f_)-NAG(2_f_)-NAG(1_f_)-ASN(262_C_)",0.851169,"","",""
"5V8L","BG505 SOSIP.664 TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING HIV ANTIBODIES 3BNC117 AND PGT145","10.1016/J.IMMUNI.2017.03.017 ",4.3,"2.23709e+11","5v8l_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Y_)-[MAN(4_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(363_A_)",1.42727,"","",""
"5V8L","BG505 SOSIP.664 TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING HIV ANTIBODIES 3BNC117 AND PGT145","10.1016/J.IMMUNI.2017.03.017 ",4.3,"2.23709e+11","5v8l_oligo31","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_s_)-MAN(6_s_)-[MAN(5_s_)-MAN(4_s_)]-BMA(3_s_)-NAG(2_s_)-NAG(1_s_)-ASN(262_D_)",0.902987,"","",""
"5V8L","BG505 SOSIP.664 TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING HIV ANTIBODIES 3BNC117 AND PGT145","10.1016/J.IMMUNI.2017.03.017 ",4.3,"2.23709e+11","5v8l_oligo2","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_T_)-[MAN(5_T_)-MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(262_A_)",1.07939,"","",""
"5V8L","BG505 SOSIP.664 TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING HIV ANTIBODIES 3BNC117 AND PGT145","10.1016/J.IMMUNI.2017.03.017 ",4.3,"2.23709e+11","5v8l_oligo23","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_k_)-[MAN(4_k_)]-BMA(3_k_)-NAG(2_k_)-NAG(1_k_)-ASN(363_C_)",1.46073,"","",""
"5V8L","BG505 SOSIP.664 TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING HIV ANTIBODIES 3BNC117 AND PGT145","10.1016/J.IMMUNI.2017.03.017 ",4.3,"2.23709e+11","5v8l_oligo29","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_q_)-[MAN(7_q_)]-MAN(6_q_)-[MAN(5_q_)-MAN(4_q_)]-BMA(3_q_)-NAG(2_q_)-NAG(1_q_)-ASN(160_D_)",1.11989,"","",""
"5V8L","BG505 SOSIP.664 TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING HIV ANTIBODIES 3BNC117 AND PGT145","10.1016/J.IMMUNI.2017.03.017 ",4.3,"2.23709e+11","5v8l_oligo15","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_g_)-[MAN(7_g_)]-MAN(6_g_)-[MAN(5_g_)-MAN(4_g_)]-BMA(3_g_)-NAG(2_g_)-NAG(1_g_)-ASN(276_C_)",0.937159,"","",""
"5V8L","BG505 SOSIP.664 TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING HIV ANTIBODIES 3BNC117 AND PGT145","10.1016/J.IMMUNI.2017.03.017 ",4.3,"2.23709e+11","5v8l_oligo32","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_t_)-[MAN(7_t_)]-MAN(6_t_)-[MAN(5_t_)-MAN(4_t_)]-BMA(3_t_)-NAG(2_t_)-NAG(1_t_)-ASN(276_D_)",0.932045,"","",""
"5V8L","BG505 SOSIP.664 TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING HIV ANTIBODIES 3BNC117 AND PGT145","10.1016/J.IMMUNI.2017.03.017 ",4.3,"2.23709e+11","5v8l_oligo36","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_x_)-[MAN(4_x_)]-BMA(3_x_)-NAG(2_x_)-NAG(1_x_)-ASN(363_D_)",1.51036,"","",""
"5V8L","BG505 SOSIP.664 TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING HIV ANTIBODIES 3BNC117 AND PGT145","10.1016/J.IMMUNI.2017.03.017 ",4.3,"2.23709e+11","5v8l_oligo17","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_U_)-[MAN(5_U_)]-MAN(4_U_)-[MAN(7_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(276_A_)",1.14325,"","",""
"5V8M","BG505 SOSIP.664 TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING HIV ANTIBODY 3BNC117","10.1016/J.IMMUNI.2017.03.017 ",4.4,"2.23709e+11","5v8m_oligo15","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_i_)-MAN(4_i_)-[MAN(6_i_)]-BMA(3_i_)-NAG(2_i_)-NAG(1_i_)-ASN(363_F_)",1.20924,"","",""
"5V8M","BG505 SOSIP.664 TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING HIV ANTIBODY 3BNC117","10.1016/J.IMMUNI.2017.03.017 ",4.4,"2.23709e+11","5v8m_oligo36","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_v_)-MAN(4_v_)-[MAN(6_v_)]-BMA(3_v_)-NAG(2_v_)-NAG(1_v_)-ASN(363_G_)",1.20924,"","",""
"5V8M","BG505 SOSIP.664 TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING HIV ANTIBODY 3BNC117","10.1016/J.IMMUNI.2017.03.017 ",4.4,"2.23709e+11","5v8m_oligo10","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_d_)-MAN(6_d_)-[MAN(5_d_)-MAN(4_d_)]-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(262_F_)",0.997273,"","",""
"5V8M","BG505 SOSIP.664 TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING HIV ANTIBODY 3BNC117","10.1016/J.IMMUNI.2017.03.017 ",4.4,"2.23709e+11","5v8m_oligo32","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_r_)-[MAN(7_r_)]-MAN(6_r_)-[MAN(5_r_)-MAN(4_r_)]-BMA(3_r_)-NAG(2_r_)-NAG(1_r_)-ASN(276_G_)",0.9475,"","",""
"5V8M","BG505 SOSIP.664 TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING HIV ANTIBODY 3BNC117","10.1016/J.IMMUNI.2017.03.017 ",4.4,"2.23709e+11","5v8m_oligo23","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_N_)-[MAN(7_N_)]-MAN(6_N_)-[MAN(5_N_)-MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(276_A_)",0.9475,"","",""
"5V8M","BG505 SOSIP.664 TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING HIV ANTIBODY 3BNC117","10.1016/J.IMMUNI.2017.03.017 ",4.4,"2.23709e+11","5v8m_oligo11","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_e_)-[MAN(7_e_)]-MAN(6_e_)-[MAN(5_e_)-MAN(4_e_)]-BMA(3_e_)-NAG(2_e_)-NAG(1_e_)-ASN(276_F_)",0.9475,"","",""
"5V8M","BG505 SOSIP.664 TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING HIV ANTIBODY 3BNC117","10.1016/J.IMMUNI.2017.03.017 ",4.4,"2.23709e+11","5v8m_oligo1","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_M_)-MAN(6_M_)-[MAN(5_M_)-MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(262_A_)",0.997273,"","",""
"5V8M","BG505 SOSIP.664 TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING HIV ANTIBODY 3BNC117","10.1016/J.IMMUNI.2017.03.017 ",4.4,"2.23709e+11","5v8m_oligo20","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_V_)-MAN(4_V_)-[MAN(6_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(363_A_)",1.20924,"","",""
"5V8M","BG505 SOSIP.664 TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING HIV ANTIBODY 3BNC117","10.1016/J.IMMUNI.2017.03.017 ",4.4,"2.23709e+11","5v8m_oligo31","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_q_)-MAN(6_q_)-[MAN(5_q_)-MAN(4_q_)]-BMA(3_q_)-NAG(2_q_)-NAG(1_q_)-ASN(262_G_)",0.997273,"","",""
"5VAA","CRYSTAL STRUCTURE OF MOUSE IGG2A FC T370K MUTANT","10.1038/S41598-017-02823-9 ",1.55,28.45,"5vaa_oligo3","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",49.3079,"","",""
"5VAA","CRYSTAL STRUCTURE OF MOUSE IGG2A FC T370K MUTANT","10.1038/S41598-017-02823-9 ",1.55,28.45,"5vaa_oligo4","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",29.6555,"","",""
"5VC1","CRYSTAL STRUCTURE OF L-SELECTIN LECTIN/EGF DOMAINS","10.1002/CBIC.201700220 ",1.94,0,"5vc1_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_B_)-[BMA(4_B_)]-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(66_A_)",30.3942,"","",""
"5VCJ","STRUCTURE OF ALPHA-GALACTOSYLPHYTOSPHINGOSINE BOUND BY CD1D AND IN COMPLEX WITH THE VA14VB8.2 TCR","10.1039/C8OB02982B ",3.16,51.62,"5vcj_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_E_)-[MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(165_A_)",90.9648,"","",""
"5VCS","ALPHA-1,6-MANNOSYL-GLYCOPROTEIN 2-BETA-N-ACETYLGLUCOSAMINYLTRANSFERASE WITH BOUND ACCEPTOR","10.1073/PNAS.1716988115 ",2.8,51.78,"5vcs_oligo2","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-ROH","MAN(5_D_)-[NAG(4_D_)-MAN(3_D_)]-BMA(2_D_)-NAG(1_D_)",52.8076,"","",""
"5VCS","ALPHA-1,6-MANNOSYL-GLYCOPROTEIN 2-BETA-N-ACETYLGLUCOSAMINYLTRANSFERASE WITH BOUND ACCEPTOR","10.1073/PNAS.1716988115 ",2.8,51.78,"5vcs_oligo1","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-ROH","MAN(5_C_)-[NAG(4_C_)-MAN(3_C_)]-BMA(2_C_)-NAG(1_C_)",48.2335,"","",""
"5VEN","MURINE ECTONUCLEOTIDE PYROPHOSPHATASE / PHOSPHODIESTERASE 5 (ENPP5, NPP5)","10.1111/FEBS.14266 ",1.69,0,"5ven_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(292_A_)",35.4104,"","",""
"5VEN","MURINE ECTONUCLEOTIDE PYROPHOSPHATASE / PHOSPHODIESTERASE 5 (ENPP5, NPP5)","10.1111/FEBS.14266 ",1.69,0,"5ven_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(292_B_)",24.4691,"","",""
"5VEO","MURINE ECTONUCLEOTIDE PYROPHOSPHATASE / PHOSPHODIESTERASE 5 (ENPP5, NPP5), INACTIVE (T72A), IN COMPLEX WITH AMP","10.1111/FEBS.14266 ",1.53,0,"5veo_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_C_)-[MAN(4_C_)-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(101_A_)",29.0682,"","",""
"5VEO","MURINE ECTONUCLEOTIDE PYROPHOSPHATASE / PHOSPHODIESTERASE 5 (ENPP5, NPP5), INACTIVE (T72A), IN COMPLEX WITH AMP","10.1111/FEBS.14266 ",1.53,0,"5veo_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(292_A_)",28.1275,"","",""
"5VGJ","CRYSTAL STRUCTURE OF THE HUMAN FAB VRC38.01, AN HIV-1 V1V2-DIRECTED NEUTRALIZING ANTIBODY ISOLATED FROM DONOR N90, BOUND TO A SCAFFOLDED WITO V1V2 DOMAIN","10.1016/J.IMMUNI.2017.04.011 ",3.46,0,"5vgj_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_A_)-[MAN(5_A_)]-MAN(4_A_)-[MAN(7_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(156_G_)",136.862,"","",""
"5VGJ","CRYSTAL STRUCTURE OF THE HUMAN FAB VRC38.01, AN HIV-1 V1V2-DIRECTED NEUTRALIZING ANTIBODY ISOLATED FROM DONOR N90, BOUND TO A SCAFFOLDED WITO V1V2 DOMAIN","10.1016/J.IMMUNI.2017.04.011 ",3.46,0,"5vgj_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(165_G_)",185.757,"","",""
"5VGJ","CRYSTAL STRUCTURE OF THE HUMAN FAB VRC38.01, AN HIV-1 V1V2-DIRECTED NEUTRALIZING ANTIBODY ISOLATED FROM DONOR N90, BOUND TO A SCAFFOLDED WITO V1V2 DOMAIN","10.1016/J.IMMUNI.2017.04.011 ",3.46,0,"5vgj_oligo3","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[MAN(5_B_)]-MAN(4_B_)-[MAN(7_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(160_G_)",132.112,"","",""
"5VGP","FC FRAGMENT OF HUMAN IGG1 ANTIBODY, FROM NIST MAB","10.1107/S2053230X18009834 ",2.12,56.63,"5vgp_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(300_B_)",82.6261,"","",""
"5VGP","FC FRAGMENT OF HUMAN IGG1 ANTIBODY, FROM NIST MAB","10.1107/S2053230X18009834 ",2.12,56.63,"5vgp_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(300_A_)",54.129,"","",""
"5VIY","BG505 SOSIP.664 IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES BG1 AND 8ANC195","10.7554/ELIFE.27389 ",6.2,2563.57,"5viy_oligo36","DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_z_)-MAN(6_z_)-[MAN(5_z_)-MAN(4_z_)]-BMA(3_z_)-NAG(2_z_)-NAG(1_z_)-ASN(262_F_)",440.938,"","",""
"5VIY","BG505 SOSIP.664 IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES BG1 AND 8ANC195","10.7554/ELIFE.27389 ",6.2,2563.57,"5viy_oligo25","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_R_)-[MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(637_B_)",253.846,"","",""
"5VIY","BG505 SOSIP.664 IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES BG1 AND 8ANC195","10.7554/ELIFE.27389 ",6.2,2563.57,"5viy_oligo33","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_w_)-[MAN(4_w_)]-BMA(3_w_)-NAG(2_w_)-NAG(1_w_)-ASN(160_F_)",313.418,"","",""
"5VIY","BG505 SOSIP.664 IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES BG1 AND 8ANC195","10.7554/ELIFE.27389 ",6.2,2563.57,"5viy_oligo26","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(637_C_)",238.739,"","",""
"5VIY","BG505 SOSIP.664 IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES BG1 AND 8ANC195","10.7554/ELIFE.27389 ",6.2,2563.57,"5viy_oligo24","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Q_)-[MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(637_A_)",271.1,"","",""
"5VIY","BG505 SOSIP.664 IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES BG1 AND 8ANC195","10.7554/ELIFE.27389 ",6.2,2563.57,"5viy_oligo19","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_l_)-BMA(3_l_)-NAG(2_l_)-NAG(1_l_)-ASN(234_E_)",641.407,"","",""
"5VIY","BG505 SOSIP.664 IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES BG1 AND 8ANC195","10.7554/ELIFE.27389 ",6.2,2563.57,"5viy_oligo21","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_n_)-[MAN(4_n_)]-BMA(3_n_)-NAG(2_n_)-NAG(1_n_)-ASN(276_E_)",541.221,"","",""
"5VIY","BG505 SOSIP.664 IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES BG1 AND 8ANC195","10.7554/ELIFE.27389 ",6.2,2563.57,"5viy_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_W_)-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(234_D_)",825.543,"","",""
"5VIY","BG505 SOSIP.664 IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES BG1 AND 8ANC195","10.7554/ELIFE.27389 ",6.2,2563.57,"5viy_oligo5","DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_X_)-MAN(6_X_)-[MAN(5_X_)-MAN(4_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(262_D_)",921.421,"","",""
"5VIY","BG505 SOSIP.664 IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES BG1 AND 8ANC195","10.7554/ELIFE.27389 ",6.2,2563.57,"5viy_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_U_)-[MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(156_D_)",863.478,"","",""
"5VIY","BG505 SOSIP.664 IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES BG1 AND 8ANC195","10.7554/ELIFE.27389 ",6.2,2563.57,"5viy_oligo44","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_7_)-[MAN(4_7_)]-BMA(3_7_)-NAG(2_7_)-NAG(1_7_)-ASN(160_D_)",890.392,"","",""
"5VIY","BG505 SOSIP.664 IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES BG1 AND 8ANC195","10.7554/ELIFE.27389 ",6.2,2563.57,"5viy_oligo30","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_t_)-MAN(4_t_)-BMA(3_t_)-NAG(2_t_)-NAG(1_t_)-ASN(448_E_)",327.064,"","",""
"5VIY","BG505 SOSIP.664 IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES BG1 AND 8ANC195","10.7554/ELIFE.27389 ",6.2,2563.57,"5viy_oligo32","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_v_)-[MAN(4_v_)]-BMA(3_v_)-NAG(2_v_)-NAG(1_v_)-ASN(156_F_)",291.606,"","",""
"5VIY","BG505 SOSIP.664 IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES BG1 AND 8ANC195","10.7554/ELIFE.27389 ",6.2,2563.57,"5viy_oligo35","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_y_)-BMA(3_y_)-NAG(2_y_)-NAG(1_y_)-ASN(234_F_)",261.357,"","",""
"5VIY","BG505 SOSIP.664 IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES BG1 AND 8ANC195","10.7554/ELIFE.27389 ",6.2,2563.57,"5viy_oligo37","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_0_)-[MAN(4_0_)]-BMA(3_0_)-NAG(2_0_)-NAG(1_0_)-ASN(276_F_)",365.69,"","",""
"5VIY","BG505 SOSIP.664 IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES BG1 AND 8ANC195","10.7554/ELIFE.27389 ",6.2,2563.57,"5viy_oligo20","DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_m_)-MAN(6_m_)-[MAN(5_m_)-MAN(4_m_)]-BMA(3_m_)-NAG(2_m_)-NAG(1_m_)-ASN(262_E_)",351.581,"","",""
"5VK2","STRUCTURAL BASIS FOR ANTIBODY-MEDIATED NEUTRALIZATION OF LASSA VIRUS","10.1126/SCIENCE.AAM7260 ",3.2,0,"5vk2_oligo11","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_T_)-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(365_b_)",137.575,"","",""
"5VK2","STRUCTURAL BASIS FOR ANTIBODY-MEDIATED NEUTRALIZATION OF LASSA VIRUS","10.1126/SCIENCE.AAM7260 ",3.2,0,"5vk2_oligo18","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_d_)-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(365_c_)",147.831,"","",""
"5VK2","STRUCTURAL BASIS FOR ANTIBODY-MEDIATED NEUTRALIZATION OF LASSA VIRUS","10.1126/SCIENCE.AAM7260 ",3.2,0,"5vk2_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_N_)-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(365_a_)",124.589,"","",""
"5VKI","CRYSTAL STRUCTURE OF P[19] ROTAVIRUS VP8* COMPLEXED WITH MUCIN CORE 2","10.1371/JOURNAL.PPAT.1006707 ",1.9,26.89,"5vki_oligo2","DGalpb1-3[DGlcpNAcb1-6]DGalpNAcb1-THR","NAG(3_D_)-[GAL(2_D_)]-NGA(1_D_)-THR(303_B_)",41.343,"","",""
"5VKI","CRYSTAL STRUCTURE OF P[19] ROTAVIRUS VP8* COMPLEXED WITH MUCIN CORE 2","10.1371/JOURNAL.PPAT.1006707 ",1.9,26.89,"5vki_oligo1","DGalpb1-3[DGlcpNAcb1-6]DGalpNAcb1-THR","NAG(3_C_)-[GAL(2_C_)]-NGA(1_C_)-THR(303_A_)",41.5703,"","",""
"5VKJ","CRYSTAL STRUCTURE OF HUMAN CD22 IG DOMAINS 1-3","10.1038/S41467-017-00836-6 ",2.12,0,"5vkj_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(101_A_)",56.0738,"","",""
"5VKM","CRYSTAL STRUCTURE OF HUMAN CD22 IG DOMAINS 1-3 IN COMPLEX WITH ALPHA 2-6 SIALYLLACTOSE","10.1038/S41467-017-00836-6 ",2.2,0,"5vkm_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(101_A_)",71.5856,"","",""
"5VKS","CRYSTAL STRUCTURE OF P[19] ROTAVIRUS VP8* COMPLEXED WITH LNFPI","10.1371/JOURNAL.PPAT.1006707 ",1.94,26.04,"5vks_oligo2","LFucpa1-2DGalpb1-3DGlcpNAcb1-3DGalpb1-4DGlcpa1-ROH","FUC(5_D_)-GAL(4_D_)-NAG(3_D_)-GAL(2_D_)-GLC(1_D_)",40.132,"","",""
"5VKS","CRYSTAL STRUCTURE OF P[19] ROTAVIRUS VP8* COMPLEXED WITH LNFPI","10.1371/JOURNAL.PPAT.1006707 ",1.94,26.04,"5vks_oligo1","LFucpa1-2DGalpb1-3DGlcpNAcb1-3DGalpb1-4DGlcpa1-ROH","FUC(5_C_)-GAL(4_C_)-NAG(3_C_)-GAL(2_C_)-GLC(1_C_)",40.1036,"","",""
"5VL3","CD22 D1-D3 IN COMPLEX WITH THERAPEUTIC FAB EPRATUZUMAB","10.1038/S41467-017-00836-6 ",3.1,0,"5vl3_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(101_Q_)",90.7811,"","",""
"5VL3","CD22 D1-D3 IN COMPLEX WITH THERAPEUTIC FAB EPRATUZUMAB","10.1038/S41467-017-00836-6 ",3.1,0,"5vl3_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_K_)-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(101_R_)",89.9802,"","",""
"5VL3","CD22 D1-D3 IN COMPLEX WITH THERAPEUTIC FAB EPRATUZUMAB","10.1038/S41467-017-00836-6 ",3.1,0,"5vl3_oligo8","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_P_)-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(101_T_)",114.204,"","",""
"5VME","CRYSTAL STRUCTURE OF HUMAN IGG1 FC K248E, T437R MUTANT","10.1080/19420862.2017.1358838 ",3.1,0,"5vme_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",118.47,"","",""
"5VME","CRYSTAL STRUCTURE OF HUMAN IGG1 FC K248E, T437R MUTANT","10.1080/19420862.2017.1358838 ",3.1,0,"5vme_oligo2","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_D_)-[NAG(5_D_)-MAN(4_D_)-[MAN(6_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",159.271,"","",""
"5VN3","CRYO-EM MODEL OF B41 SOSIP.664 IN COMPLEX WITH SOLUBLE CD4 (D1-D2) AND FRAGMENT ANTIGEN BINDING VARIABLE DOMAIN OF 17B","10.1038/NATURE23010 ",3.7,"1.35632e-19","5vn3_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_V_)-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(362_G_)",69.5866,"","",""
"5VN3","CRYO-EM MODEL OF B41 SOSIP.664 IN COMPLEX WITH SOLUBLE CD4 (D1-D2) AND FRAGMENT ANTIGEN BINDING VARIABLE DOMAIN OF 17B","10.1038/NATURE23010 ",3.7,"1.35632e-19","5vn3_oligo29","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_r_)-BMA(3_r_)-NAG(2_r_)-NAG(1_r_)-ASN(362_J_)",93.0639,"","",""
"5VN3","CRYO-EM MODEL OF B41 SOSIP.664 IN COMPLEX WITH SOLUBLE CD4 (D1-D2) AND FRAGMENT ANTIGEN BINDING VARIABLE DOMAIN OF 17B","10.1038/NATURE23010 ",3.7,"1.35632e-19","5vn3_oligo9","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_c_)-[MAN(6_c_)-MAN(5_c_)-MAN(4_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(262_I_)",43.3444,"","",""
"5VN3","CRYO-EM MODEL OF B41 SOSIP.664 IN COMPLEX WITH SOLUBLE CD4 (D1-D2) AND FRAGMENT ANTIGEN BINDING VARIABLE DOMAIN OF 17B","10.1038/NATURE23010 ",3.7,"1.35632e-19","5vn3_oligo5","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcp[2<R1>]b1-ASN","MAN(7_R_)-[MAN(6_R_)-MAN(5_R_)-MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(262_G_)",31.6909,"","",""
"5VN3","CRYO-EM MODEL OF B41 SOSIP.664 IN COMPLEX WITH SOLUBLE CD4 (D1-D2) AND FRAGMENT ANTIGEN BINDING VARIABLE DOMAIN OF 17B","10.1038/NATURE23010 ",3.7,"1.35632e-19","5vn3_oligo25","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_n_)-[MAN(6_n_)-MAN(5_n_)-MAN(4_n_)]-BMA(3_n_)-NAG(2_n_)-NAG(1_n_)-ASN(262_J_)",45.3979,"","",""
"5VN3","CRYO-EM MODEL OF B41 SOSIP.664 IN COMPLEX WITH SOLUBLE CD4 (D1-D2) AND FRAGMENT ANTIGEN BINDING VARIABLE DOMAIN OF 17B","10.1038/NATURE23010 ",3.7,"1.35632e-19","5vn3_oligo13","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_g_)-BMA(3_g_)-NAG(2_g_)-NAG(1_g_)-ASN(362_I_)",67.5943,"","",""
"5VN8","CRYO-EM MODEL OF B41 SOSIP.664 IN COMPLEX WITH FRAGMENT ANTIGEN BINDING VARIABLE DOMAIN OF B12","10.1038/NATURE23010 ",3.6,"1.35632e-19","5vn8_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_P_)-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(262_G_)",57.7968,"","",""
"5VN8","CRYO-EM MODEL OF B41 SOSIP.664 IN COMPLEX WITH FRAGMENT ANTIGEN BINDING VARIABLE DOMAIN OF B12","10.1038/NATURE23010 ",3.6,"1.35632e-19","5vn8_oligo11","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_a_)-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(262_D_)",40.6191,"","",""
"5VN8","CRYO-EM MODEL OF B41 SOSIP.664 IN COMPLEX WITH FRAGMENT ANTIGEN BINDING VARIABLE DOMAIN OF B12","10.1038/NATURE23010 ",3.6,"1.35632e-19","5vn8_oligo26","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_l_)-BMA(3_l_)-NAG(2_l_)-NAG(1_l_)-ASN(262_E_)",70.8966,"","",""
"5VOD","CRYSTAL STRUCTURE OF HCMV PENTAMER IN COMPLEX WITH NEUTRALIZING ANTIBODY 9I6","10.1126/SCIIMMUNOL.AAN1457 ",5.9,75.52,"5vod_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(81_E_)",51.13,"","",""
"5VOD","CRYSTAL STRUCTURE OF HCMV PENTAMER IN COMPLEX WITH NEUTRALIZING ANTIBODY 9I6","10.1126/SCIIMMUNOL.AAN1457 ",5.9,75.52,"5vod_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(67_A_)",51.8136,"","",""
"5VTQ","CRYSTAL STRUCTURE OF THE A/HONG KONG/1/1968 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ G225L/L226S MUTANT IN COMPLEX WITH 3'-SLN","10.1016/J.CHOM.2017.05.011 ",2.95,60.87,"5vtq_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(165_E_)",84.9636,"","",""
"5VTR","CRYSTAL STRUCTURE OF THE A/HONG KONG/1/1968 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ G225L/L226S MUTANT IN COMPLEX WITH 6'-SLN","10.1016/J.CHOM.2017.05.011 ",2.5,58.27,"5vtr_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(165_E_)",89.7753,"","",""
"5VTU","CRYSTAL STRUCTURE OF THE A/HONG KONG/1/1968 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ G225L/L226S MUTANT APO FORM","10.1016/J.CHOM.2017.05.011 ",2.45,61.35,"5vtu_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_K_)-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(165_E_)",93.9032,"","",""
"5VTV","CRYSTAL STRUCTURE OF THE A/HONG KONG/1/1968 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ G225M/L226T/S228A MUTANT IN COMPLEX WITH 3'-SLN","10.1016/J.CHOM.2017.05.011 ",2.25,59.99,"5vtv_oligo9","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_O_)-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(165_E_)",81.0109,"","",""
"5VTW","CRYSTAL STRUCTURE OF THE A/HONG KONG/1/1968 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ G225M/L226T/S228A MUTANT IN COMPLEX WITH 6'-SLN","10.1016/J.CHOM.2017.05.011 ",2.35,48.52,"5vtw_oligo7","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_M_)-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(165_E_)",63.7127,"","",""
"5VTX","CRYSTAL STRUCTURE OF THE A/HONG KONG/1/1968 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ G225M/L226T/S228A MUTANT APO FORM","10.1016/J.CHOM.2017.05.011 ",2.65,48.38,"5vtx_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_K_)-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(165_E_)",70.3189,"","",""
"5VTY","CRYSTAL STRUCTURE OF THE A/HONG KONG/1/1968 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ G225Q/L226A MUTANT IN COMPLEX WITH 3'-SLN","10.1016/J.CHOM.2017.05.011 ",2.36,53.07,"5vty_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(165_C_)",74.6342,"","",""
"5VTY","CRYSTAL STRUCTURE OF THE A/HONG KONG/1/1968 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ G225Q/L226A MUTANT IN COMPLEX WITH 3'-SLN","10.1016/J.CHOM.2017.05.011 ",2.36,53.07,"5vty_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(165_A_)",74.8566,"","",""
"5VTY","CRYSTAL STRUCTURE OF THE A/HONG KONG/1/1968 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ G225Q/L226A MUTANT IN COMPLEX WITH 3'-SLN","10.1016/J.CHOM.2017.05.011 ",2.36,53.07,"5vty_oligo7","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_M_)-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(165_E_)",88.6568,"","",""
"5VTZ","CRYSTAL STRUCTURE OF THE A/HONG KONG/1/1968 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ G225Q/L226A MUTANT APO FORM","10.1016/J.CHOM.2017.05.011 ",2.15,52.34,"5vtz_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_L_)-[MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(165_E_)",71.6235,"","",""
"5VU0","CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN AFUCOSYLATED/GALACTOSYLATED HUMAN IGG1 FC AND FC GAMMA RECEPTOR IIIA (CD16A) WITH MAN5 N-GLYCANS","10.1021/ACSCHEMBIO.8B00342 ",2.26,47.18,"5vu0_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[NAG(8_E_)-MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(297_B_)",63.5374,"","",""
"5VU0","CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN AFUCOSYLATED/GALACTOSYLATED HUMAN IGG1 FC AND FC GAMMA RECEPTOR IIIA (CD16A) WITH MAN5 N-GLYCANS","10.1021/ACSCHEMBIO.8B00342 ",2.26,47.18,"5vu0_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(297_A_)",45.5687,"","",""
"5VU4","CRYSTAL STRUCTURE OF THE A/HONG KONG/1/1968 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ G225Q/L226A MUTANT IN COMPLEX WITH 6'-SLN","10.1016/J.CHOM.2017.05.011 ",2.25,55.45,"5vu4_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(165_C_)",77.5462,"","",""
"5VU4","CRYSTAL STRUCTURE OF THE A/HONG KONG/1/1968 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ G225Q/L226A MUTANT IN COMPLEX WITH 6'-SLN","10.1016/J.CHOM.2017.05.011 ",2.25,55.45,"5vu4_oligo6","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_L_)-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(165_E_)",90.8145,"","",""
"5VX5","VP8* OF A G2P[4] HUMAN ROTAVIRUS IN COMPLEX WITH LNFP1","10.1038/S41467-018-05098-4 ",1.29,0,"5vx5_oligo1","LFucpa1-2DGalpb1-3DGlcpNAcb1-3DGalpb1-4DGlcpb1-ROH","FUC(5_B_)-GAL(4_B_)-NAG(3_B_)-GAL(2_B_)-BGC(1_B_)",15.1796,"","",""
"5VX9","VP8* OF P[6] HUMAN ROTAVIRUS RV3 IN COMPLEX WITH LNFP1","10.1038/S41467-018-05098-4 ",1.82,0,"5vx9_oligo1","LFucpa1-2DGalpb1-3DGlcpNAcb1-3DGalpb1-4DGlcpb1-ROH","FUC(5_B_)-GAL(4_B_)-NAG(3_B_)-GAL(2_B_)-BGC(1_B_)",9.72527,"","",""
"5VXX","CRYO-EM RECONSTRUCTION OF NEISSERIA GONORRHOEAE TYPE IV PILUS","10.1016/J.STR.2017.07.016 ",5.1,0,"5vxx_oligo10","DGalpa1-3B6D1-SER","GLA(2_e_)-B6D(1_e_)-SER(63_J_)",100,"","",""
"5VXX","CRYO-EM RECONSTRUCTION OF NEISSERIA GONORRHOEAE TYPE IV PILUS","10.1016/J.STR.2017.07.016 ",5.1,0,"5vxx_oligo16","DGalpa1-3B6D1-SER","GLA(2_k_)-B6D(1_k_)-SER(63_P_)",100,"","",""
"5VXX","CRYO-EM RECONSTRUCTION OF NEISSERIA GONORRHOEAE TYPE IV PILUS","10.1016/J.STR.2017.07.016 ",5.1,0,"5vxx_oligo12","DGalpa1-3B6D1-SER","GLA(2_g_)-B6D(1_g_)-SER(63_L_)",100,"","",""
"5VXX","CRYO-EM RECONSTRUCTION OF NEISSERIA GONORRHOEAE TYPE IV PILUS","10.1016/J.STR.2017.07.016 ",5.1,0,"5vxx_oligo17","DGalpa1-3B6D1-SER","GLA(2_l_)-B6D(1_l_)-SER(63_Q_)",100,"","",""
"5VXX","CRYO-EM RECONSTRUCTION OF NEISSERIA GONORRHOEAE TYPE IV PILUS","10.1016/J.STR.2017.07.016 ",5.1,0,"5vxx_oligo5","DGalpa1-3B6D1-SER","GLA(2_Z_)-B6D(1_Z_)-SER(63_E_)",100,"","",""
"5VXX","CRYO-EM RECONSTRUCTION OF NEISSERIA GONORRHOEAE TYPE IV PILUS","10.1016/J.STR.2017.07.016 ",5.1,0,"5vxx_oligo7","DGalpa1-3B6D1-SER","GLA(2_b_)-B6D(1_b_)-SER(63_G_)",100,"","",""
"5VXX","CRYO-EM RECONSTRUCTION OF NEISSERIA GONORRHOEAE TYPE IV PILUS","10.1016/J.STR.2017.07.016 ",5.1,0,"5vxx_oligo1","DGalpa1-3B6D1-SER","GLA(2_V_)-B6D(1_V_)-SER(63_A_)",100,"","",""
"5VXX","CRYO-EM RECONSTRUCTION OF NEISSERIA GONORRHOEAE TYPE IV PILUS","10.1016/J.STR.2017.07.016 ",5.1,0,"5vxx_oligo20","DGalpa1-3B6D1-SER","GLA(2_o_)-B6D(1_o_)-SER(63_T_)",100,"","",""
"5VXX","CRYO-EM RECONSTRUCTION OF NEISSERIA GONORRHOEAE TYPE IV PILUS","10.1016/J.STR.2017.07.016 ",5.1,0,"5vxx_oligo6","DGalpa1-3B6D1-SER","GLA(2_a_)-B6D(1_a_)-SER(63_F_)",100,"","",""
"5VXX","CRYO-EM RECONSTRUCTION OF NEISSERIA GONORRHOEAE TYPE IV PILUS","10.1016/J.STR.2017.07.016 ",5.1,0,"5vxx_oligo13","DGalpa1-3B6D1-SER","GLA(2_h_)-B6D(1_h_)-SER(63_M_)",100,"","",""
"5VXX","CRYO-EM RECONSTRUCTION OF NEISSERIA GONORRHOEAE TYPE IV PILUS","10.1016/J.STR.2017.07.016 ",5.1,0,"5vxx_oligo2","DGalpa1-3B6D1-SER","GLA(2_W_)-B6D(1_W_)-SER(63_B_)",100,"","",""
"5VXX","CRYO-EM RECONSTRUCTION OF NEISSERIA GONORRHOEAE TYPE IV PILUS","10.1016/J.STR.2017.07.016 ",5.1,0,"5vxx_oligo14","DGalpa1-3B6D1-SER","GLA(2_i_)-B6D(1_i_)-SER(63_N_)",100,"","",""
"5VXX","CRYO-EM RECONSTRUCTION OF NEISSERIA GONORRHOEAE TYPE IV PILUS","10.1016/J.STR.2017.07.016 ",5.1,0,"5vxx_oligo4","DGalpa1-3B6D1-SER","GLA(2_Y_)-B6D(1_Y_)-SER(63_D_)",100,"","",""
"5VXX","CRYO-EM RECONSTRUCTION OF NEISSERIA GONORRHOEAE TYPE IV PILUS","10.1016/J.STR.2017.07.016 ",5.1,0,"5vxx_oligo8","DGalpa1-3B6D1-SER","GLA(2_c_)-B6D(1_c_)-SER(63_H_)",100,"","",""
"5VXX","CRYO-EM RECONSTRUCTION OF NEISSERIA GONORRHOEAE TYPE IV PILUS","10.1016/J.STR.2017.07.016 ",5.1,0,"5vxx_oligo3","DGalpa1-3B6D1-SER","GLA(2_X_)-B6D(1_X_)-SER(63_C_)",100,"","",""
"5VXX","CRYO-EM RECONSTRUCTION OF NEISSERIA GONORRHOEAE TYPE IV PILUS","10.1016/J.STR.2017.07.016 ",5.1,0,"5vxx_oligo11","DGalpa1-3B6D1-SER","GLA(2_f_)-B6D(1_f_)-SER(63_K_)",100,"","",""
"5VXX","CRYO-EM RECONSTRUCTION OF NEISSERIA GONORRHOEAE TYPE IV PILUS","10.1016/J.STR.2017.07.016 ",5.1,0,"5vxx_oligo15","DGalpa1-3B6D1-SER","GLA(2_j_)-B6D(1_j_)-SER(63_O_)",100,"","",""
"5VXX","CRYO-EM RECONSTRUCTION OF NEISSERIA GONORRHOEAE TYPE IV PILUS","10.1016/J.STR.2017.07.016 ",5.1,0,"5vxx_oligo19","DGalpa1-3B6D1-SER","GLA(2_n_)-B6D(1_n_)-SER(63_S_)",100,"","",""
"5VXX","CRYO-EM RECONSTRUCTION OF NEISSERIA GONORRHOEAE TYPE IV PILUS","10.1016/J.STR.2017.07.016 ",5.1,0,"5vxx_oligo9","DGalpa1-3B6D1-SER","GLA(2_d_)-B6D(1_d_)-SER(63_I_)",100,"","",""
"5VXX","CRYO-EM RECONSTRUCTION OF NEISSERIA GONORRHOEAE TYPE IV PILUS","10.1016/J.STR.2017.07.016 ",5.1,0,"5vxx_oligo18","DGalpa1-3B6D1-SER","GLA(2_m_)-B6D(1_m_)-SER(63_R_)",100,"","",""
"5VXX","CRYO-EM RECONSTRUCTION OF NEISSERIA GONORRHOEAE TYPE IV PILUS","10.1016/J.STR.2017.07.016 ",5.1,0,"5vxx_oligo21","DGalpa1-3B6D1-SER","GLA(2_p_)-B6D(1_p_)-SER(63_U_)",100,"","",""
"5VYB","STRUCTURE OF THE CARBOHYDRATE RECOGNITION DOMAIN OF DECTIN-2 COMPLEXED WITH A MAMMALIAN-TYPE HIGH MANNOSE MAN9GLCNAC2 OLIGOSACCHARIDE","10.1074/JBC.M117.799080 ",2.4,45.71,"5vyb_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3DManpa1-6]DManpb1-ROH","MAN(7_B_)-MAN(6_B_)-MAN(5_B_)-[MAN(4_B_)-MAN(3_B_)-MAN(2_B_)]-BMA(1_B_)",48.04,"","",""
"5VYG","CRYSTAL STRUCTURE OF HFA9 EGF REPEAT WITH O-GLUCOSE TRISACCHARIDE","10.1074/JBC.M117.800102 ",2.2,37,"5vyg_oligo2","DXylpa1-3DXylpa1-3DGlcpb1-SER","XYS(3_E_)-XYS(2_E_)-BGC(1_E_)-SER(53_A_)",37.4343,"","",""
"5VYG","CRYSTAL STRUCTURE OF HFA9 EGF REPEAT WITH O-GLUCOSE TRISACCHARIDE","10.1074/JBC.M117.800102 ",2.2,37,"5vyg_oligo1","DXylpa1-3DXylpa1-3DGlcpb1-SER","XYS(3_F_)-XYS(2_F_)-BGC(1_F_)-SER(53_C_)",47.682,"","",""
"5VYG","CRYSTAL STRUCTURE OF HFA9 EGF REPEAT WITH O-GLUCOSE TRISACCHARIDE","10.1074/JBC.M117.800102 ",2.2,37,"5vyg_oligo3","DXylpa1-3DXylpa1-3DGlcpb1-SER","XYS(3_D_)-XYS(2_D_)-BGC(1_D_)-SER(53_B_)",40.449,"","",""
"5W26","INFLUENZA VIRUS NEURAMINIDASE N9 IN COMPLEX WITH 4-DEOXYGENATED 2,3- DIFLUORO-N-ACETYLNEURAMINIC ACID","10.1021/ACS.JMEDCHEM.7B01467 ",1.9,23.83,"5w26_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_B_)-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(201_A_)",30.8531,"","",""
"5W2U","INFLUENZA VIRUS NEURAMINIDASE N9 IN COMPLEX WITH 7-DEOXYGENATED 2,3- DIFLUORO-N-ACETYLNEURAMINIC ACID","10.1021/ACS.JMEDCHEM.7B01467 ",2,25.92,"5w2u_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_B_)-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(201_A_)",32.6517,"","",""
"5W2W","INFLUENZA VIRUS NEURAMINIDASE N9 IN COMPLEX WITH 8-DEOXYGENATED 2,3- DIFLUORO-N-ACETYLNEURAMINIC ACID","10.1021/ACS.JMEDCHEM.7B01467 ",1.85,24.1,"5w2w_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_B_)-[MAN(8_B_)]-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(201_A_)",32.2164,"","",""
"5W2Y","INFLUENZA VIRUS NEURAMINIDASE N9 IN COMPLEX WITH 9-DEOXYGENATED 2,3- DIFLUORO-N-ACETYLNEURAMINIC ACID","10.1021/ACS.JMEDCHEM.7B01467 ",2.39,22.81,"5w2y_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_B_)-[MAN(8_B_)]-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(201_A_)",33.6626,"","",""
"5W42","CRYSTAL STRUCTURE OF HUMAN MONOCLONAL ANTIBODY H3V-47 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/MINNESOTA/11/2010 (H3N2)","10.1038/S41467-018-04704-9 ",3.57,0,"5w42_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(246_A_)",234.999,"","",""
"5W42","CRYSTAL STRUCTURE OF HUMAN MONOCLONAL ANTIBODY H3V-47 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/MINNESOTA/11/2010 (H3N2)","10.1038/S41467-018-04704-9 ",3.57,0,"5w42_oligo4","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-[MAN(5_E_)-MAN(4_E_)]-MAN(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(165_A_)",211.34,"","",""
"5W42","CRYSTAL STRUCTURE OF HUMAN MONOCLONAL ANTIBODY H3V-47 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/MINNESOTA/11/2010 (H3N2)","10.1038/S41467-018-04704-9 ",3.57,0,"5w42_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(38_A_)",212.532,"","",""
"5W42","CRYSTAL STRUCTURE OF HUMAN MONOCLONAL ANTIBODY H3V-47 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/MINNESOTA/11/2010 (H3N2)","10.1038/S41467-018-04704-9 ",3.57,0,"5w42_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(63_A_)",245.463,"","",""
"5W5L","CRYSTAL STRUCTURE OF HUMAN IGG1-SIGMA FC FRAGMENT","10.3390/ANTIB6030012 ",1.9,0,"5w5l_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",45.4652,"","",""
"5W5L","CRYSTAL STRUCTURE OF HUMAN IGG1-SIGMA FC FRAGMENT","10.3390/ANTIB6030012 ",1.9,0,"5w5l_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",69.578,"","",""
"5W5M","CRYSTAL STRUCTURE OF HUMAN IGG4-SIGMA1 FC FRAGMENT","10.3390/ANTIB6030012 ",1.9,0,"5w5m_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",57.9635,"","",""
"5W5M","CRYSTAL STRUCTURE OF HUMAN IGG4-SIGMA1 FC FRAGMENT","10.3390/ANTIB6030012 ",1.9,0,"5w5m_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",91.9092,"","",""
"5W5N","CRYSTAL STRUCTURE OF HUMAN IGG4-SIGMA2 FC FRAGMENT","10.3390/ANTIB6030012 ",1.85,0,"5w5n_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(297_A_)",85.4825,"","",""
"5W5N","CRYSTAL STRUCTURE OF HUMAN IGG4-SIGMA2 FC FRAGMENT","10.3390/ANTIB6030012 ",1.85,0,"5w5n_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",45.7772,"","",""
"5W6D","CRYSTAL STRUCTURE OF BG505-SOSIP.V4.1-GT1-N137A IN COMPLEX WITH FABS 35022 AND 9H/109L","10.1084/JEM.20161160 ",3.2,0,"5w6d_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(448_G_)",160.895,"","",""
"5W6D","CRYSTAL STRUCTURE OF BG505-SOSIP.V4.1-GT1-N137A IN COMPLEX WITH FABS 35022 AND 9H/109L","10.1084/JEM.20161160 ",3.2,0,"5w6d_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)]-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(88_G_)",130.005,"","",""
"5W6D","CRYSTAL STRUCTURE OF BG505-SOSIP.V4.1-GT1-N137A IN COMPLEX WITH FABS 35022 AND 9H/109L","10.1084/JEM.20161160 ",3.2,0,"5w6d_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_F_)-MAN(7_F_)-[MAN(6_F_)-MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(262_G_)",148.701,"","",""
"5W6D","CRYSTAL STRUCTURE OF BG505-SOSIP.V4.1-GT1-N137A IN COMPLEX WITH FABS 35022 AND 9H/109L","10.1084/JEM.20161160 ",3.2,0,"5w6d_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_A_)-MAN(8_A_)-[MAN(10_A_)]-MAN(7_A_)-[MAN(6_A_)-MAN(5_A_)-MAN(4_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(332_G_)",119.974,"","",""
"5W97","CRYSTAL STRUCTURE OF CO-BOUND CYTOCHROME C OXIDASE DETERMINED BY SERIAL FEMTOSECOND X-RAY CRYSTALLOGRAPHY AT ROOM TEMPERATURE","10.1073/PNAS.1705628114 ",2.3,50.78,"5w97_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(101_M_)-DMU(101_M_)",57.5795,"","",""
"5W97","CRYSTAL STRUCTURE OF CO-BOUND CYTOCHROME C OXIDASE DETERMINED BY SERIAL FEMTOSECOND X-RAY CRYSTALLOGRAPHY AT ROOM TEMPERATURE","10.1073/PNAS.1705628114 ",2.3,50.78,"5w97_oligo3","DGlcpa1-3DGlcpb6-C10O1","DMU(307_c_)-DMU(307_c_)",143.744,"","",""
"5W97","CRYSTAL STRUCTURE OF CO-BOUND CYTOCHROME C OXIDASE DETERMINED BY SERIAL FEMTOSECOND X-RAY CRYSTALLOGRAPHY AT ROOM TEMPERATURE","10.1073/PNAS.1705628114 ",2.3,50.78,"5w97_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(401_m_)-DMU(401_m_)",99.7082,"","",""
"5W97","CRYSTAL STRUCTURE OF CO-BOUND CYTOCHROME C OXIDASE DETERMINED BY SERIAL FEMTOSECOND X-RAY CRYSTALLOGRAPHY AT ROOM TEMPERATURE","10.1073/PNAS.1705628114 ",2.3,50.78,"5w97_oligo4","DGlcpa1-3DGlcpb6-C10O1","DMU(307_C_)-DMU(307_C_)",134.037,"","",""
"5WAU","CRYSTAL STRUCTURE OF CO-BOUND CYTOCHROME C OXIDASE DETERMINED BY SYNCHROTRON X-RAY CRYSTALLOGRAPHY AT 100 K","10.1073/PNAS.1705628114 ",1.95,45.53,"5wau_oligo3","DGlcpa1-3DGlcpb6-C10O1","DMU(309_c_)-DMU(309_c_)",124.655,"","",""
"5WAU","CRYSTAL STRUCTURE OF CO-BOUND CYTOCHROME C OXIDASE DETERMINED BY SYNCHROTRON X-RAY CRYSTALLOGRAPHY AT 100 K","10.1073/PNAS.1705628114 ",1.95,45.53,"5wau_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(308_C_)-DMU(308_C_)",101.998,"","",""
"5WAU","CRYSTAL STRUCTURE OF CO-BOUND CYTOCHROME C OXIDASE DETERMINED BY SYNCHROTRON X-RAY CRYSTALLOGRAPHY AT 100 K","10.1073/PNAS.1705628114 ",1.95,45.53,"5wau_oligo4","DGlcpa1-3DGlcpb6-C10O1","DMU(101_M_)-DMU(101_M_)",51.0045,"","",""
"5WAU","CRYSTAL STRUCTURE OF CO-BOUND CYTOCHROME C OXIDASE DETERMINED BY SYNCHROTRON X-RAY CRYSTALLOGRAPHY AT 100 K","10.1073/PNAS.1705628114 ",1.95,45.53,"5wau_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(101_m_)-DMU(101_m_)",84.6395,"","",""
"5WAV","FC ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION-MAKING IN ANTIBODY DRUG DISCOVERY.","",2.6,58.2,"5wav_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpa1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-MAN(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",98.6161,"","",""
"5WAV","FC ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION-MAKING IN ANTIBODY DRUG DISCOVERY.","",2.6,58.2,"5wav_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpa1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-MAN(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",63.6848,"","",""
"5WB0","CRYSTAL STRUCTURE OF HUMAN METAPNEUMOVIRUS FUSION GLYCOPROTEIN STABILIZED IN THE PREFUSION STATE","10.1038/S41467-017-01708-9 ",2.6,59.57,"5wb0_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(353_F_)",121.354,"","",""
"5WB7","CRYSTAL STRUCTURE OF THE EPIDERMAL GROWTH FACTOR RECEPTOR EXTRACELLULAR REGION IN COMPLEX WITH EPIREGULIN","10.1016/J.CELL.2017.09.017 ",2.94,92.86,"5wb7_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(328_B_)",124.81,"","",""
"5WB7","CRYSTAL STRUCTURE OF THE EPIDERMAL GROWTH FACTOR RECEPTOR EXTRACELLULAR REGION IN COMPLEX WITH EPIREGULIN","10.1016/J.CELL.2017.09.017 ",2.94,92.86,"5wb7_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_M_)-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(328_C_)",134.071,"","",""
"5WB7","CRYSTAL STRUCTURE OF THE EPIDERMAL GROWTH FACTOR RECEPTOR EXTRACELLULAR REGION IN COMPLEX WITH EPIREGULIN","10.1016/J.CELL.2017.09.017 ",2.94,92.86,"5wb7_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(328_A_)",117.003,"","",""
"5WB7","CRYSTAL STRUCTURE OF THE EPIDERMAL GROWTH FACTOR RECEPTOR EXTRACELLULAR REGION IN COMPLEX WITH EPIREGULIN","10.1016/J.CELL.2017.09.017 ",2.94,92.86,"5wb7_oligo7","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_O_)-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(328_D_)",143.002,"","",""
"5WB8","CRYSTAL STRUCTURE OF THE EPIDERMAL GROWTH FACTOR RECEPTOR EXTRACELLULAR REGION IN COMPLEX WITH EPIGEN","10.1016/J.CELL.2017.09.017 ",3,53.79,"5wb8_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(328_D_)",92.0755,"","",""
"5WDU","HIV-1 ENV BG505 SOSIP.664 H72C-H564C TRIMER IN COMPLEX WITH BNABS PGT122 FAB, 35O22 FAB AND NIH45-46 SCFV","10.1016/J.CELREP.2017.07.077 ",7,0,"5wdu_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_c_)-[MAN(4_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(301_G_)",465.195,"","",""
"5WDU","HIV-1 ENV BG505 SOSIP.664 H72C-H564C TRIMER IN COMPLEX WITH BNABS PGT122 FAB, 35O22 FAB AND NIH45-46 SCFV","10.1016/J.CELREP.2017.07.077 ",7,0,"5wdu_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_X_)-[MAN(4_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(156_G_)",492.563,"","",""
"5WDU","HIV-1 ENV BG505 SOSIP.664 H72C-H564C TRIMER IN COMPLEX WITH BNABS PGT122 FAB, 35O22 FAB AND NIH45-46 SCFV","10.1016/J.CELREP.2017.07.077 ",7,0,"5wdu_oligo21","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_n_)-[MAN(4_n_)]-BMA(3_n_)-NAG(2_n_)-NAG(1_n_)-ASN(88_Q_)",455.553,"","",""
"5WDU","HIV-1 ENV BG505 SOSIP.664 H72C-H564C TRIMER IN COMPLEX WITH BNABS PGT122 FAB, 35O22 FAB AND NIH45-46 SCFV","10.1016/J.CELREP.2017.07.077 ",7,0,"5wdu_oligo25","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_r_)-[MAN(5_r_)]-MAN(4_r_)-[MAN(7_r_)]-BMA(3_r_)-NAG(2_r_)-NAG(1_r_)-ASN(234_Q_)",527.68,"","",""
"5WDU","HIV-1 ENV BG505 SOSIP.664 H72C-H564C TRIMER IN COMPLEX WITH BNABS PGT122 FAB, 35O22 FAB AND NIH45-46 SCFV","10.1016/J.CELREP.2017.07.077 ",7,0,"5wdu_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(88_G_)",424.47,"","",""
"5WDU","HIV-1 ENV BG505 SOSIP.664 H72C-H564C TRIMER IN COMPLEX WITH BNABS PGT122 FAB, 35O22 FAB AND NIH45-46 SCFV","10.1016/J.CELREP.2017.07.077 ",7,0,"5wdu_oligo12","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_e_)-[MAN(4_e_)]-BMA(3_e_)-NAG(2_e_)-NAG(1_e_)-ASN(88_F_)",515.67,"","",""
"5WDU","HIV-1 ENV BG505 SOSIP.664 H72C-H564C TRIMER IN COMPLEX WITH BNABS PGT122 FAB, 35O22 FAB AND NIH45-46 SCFV","10.1016/J.CELREP.2017.07.077 ",7,0,"5wdu_oligo19","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_l_)-[MAN(4_l_)]-BMA(3_l_)-NAG(2_l_)-NAG(1_l_)-ASN(301_F_)",522.181,"","",""
"5WDU","HIV-1 ENV BG505 SOSIP.664 H72C-H564C TRIMER IN COMPLEX WITH BNABS PGT122 FAB, 35O22 FAB AND NIH45-46 SCFV","10.1016/J.CELREP.2017.07.077 ",7,0,"5wdu_oligo11","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Z_)-[MAN(5_Z_)]-MAN(4_Z_)-[MAN(7_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(234_G_)",541.914,"","",""
"5WDU","HIV-1 ENV BG505 SOSIP.664 H72C-H564C TRIMER IN COMPLEX WITH BNABS PGT122 FAB, 35O22 FAB AND NIH45-46 SCFV","10.1016/J.CELREP.2017.07.077 ",7,0,"5wdu_oligo16","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_i_)-[MAN(5_i_)]-MAN(4_i_)-[MAN(7_i_)]-BMA(3_i_)-NAG(2_i_)-NAG(1_i_)-ASN(234_F_)",472.915,"","",""
"5WDU","HIV-1 ENV BG505 SOSIP.664 H72C-H564C TRIMER IN COMPLEX WITH BNABS PGT122 FAB, 35O22 FAB AND NIH45-46 SCFV","10.1016/J.CELREP.2017.07.077 ",7,0,"5wdu_oligo1","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_a_)-[MAN(5_a_)-MAN(4_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(262_G_)",426.328,"","",""
"5WDU","HIV-1 ENV BG505 SOSIP.664 H72C-H564C TRIMER IN COMPLEX WITH BNABS PGT122 FAB, 35O22 FAB AND NIH45-46 SCFV","10.1016/J.CELREP.2017.07.077 ",7,0,"5wdu_oligo26","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_s_)-[MAN(5_s_)-MAN(4_s_)]-BMA(3_s_)-NAG(2_s_)-NAG(1_s_)-ASN(262_Q_)",497.964,"","",""
"5WDU","HIV-1 ENV BG505 SOSIP.664 H72C-H564C TRIMER IN COMPLEX WITH BNABS PGT122 FAB, 35O22 FAB AND NIH45-46 SCFV","10.1016/J.CELREP.2017.07.077 ",7,0,"5wdu_oligo14","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_g_)-[MAN(4_g_)]-BMA(3_g_)-NAG(2_g_)-NAG(1_g_)-ASN(156_F_)",563.43,"","",""
"5WDU","HIV-1 ENV BG505 SOSIP.664 H72C-H564C TRIMER IN COMPLEX WITH BNABS PGT122 FAB, 35O22 FAB AND NIH45-46 SCFV","10.1016/J.CELREP.2017.07.077 ",7,0,"5wdu_oligo20","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_m_)-[MAN(7_m_)]-MAN(6_m_)-[MAN(5_m_)-MAN(4_m_)]-BMA(3_m_)-NAG(2_m_)-NAG(1_m_)-ASN(332_F_)",446.552,"","",""
"5WDU","HIV-1 ENV BG505 SOSIP.664 H72C-H564C TRIMER IN COMPLEX WITH BNABS PGT122 FAB, 35O22 FAB AND NIH45-46 SCFV","10.1016/J.CELREP.2017.07.077 ",7,0,"5wdu_oligo28","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_u_)-[MAN(4_u_)]-BMA(3_u_)-NAG(2_u_)-NAG(1_u_)-ASN(301_Q_)",435.296,"","",""
"5WDU","HIV-1 ENV BG505 SOSIP.664 H72C-H564C TRIMER IN COMPLEX WITH BNABS PGT122 FAB, 35O22 FAB AND NIH45-46 SCFV","10.1016/J.CELREP.2017.07.077 ",7,0,"5wdu_oligo29","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_v_)-[MAN(7_v_)]-MAN(6_v_)-[MAN(5_v_)-MAN(4_v_)]-BMA(3_v_)-NAG(2_v_)-NAG(1_v_)-ASN(332_Q_)",453.839,"","",""
"5WDU","HIV-1 ENV BG505 SOSIP.664 H72C-H564C TRIMER IN COMPLEX WITH BNABS PGT122 FAB, 35O22 FAB AND NIH45-46 SCFV","10.1016/J.CELREP.2017.07.077 ",7,0,"5wdu_oligo17","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_j_)-[MAN(5_j_)-MAN(4_j_)]-BMA(3_j_)-NAG(2_j_)-NAG(1_j_)-ASN(262_F_)",447.777,"","",""
"5WDU","HIV-1 ENV BG505 SOSIP.664 H72C-H564C TRIMER IN COMPLEX WITH BNABS PGT122 FAB, 35O22 FAB AND NIH45-46 SCFV","10.1016/J.CELREP.2017.07.077 ",7,0,"5wdu_oligo9","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_d_)-[MAN(7_d_)]-MAN(6_d_)-[MAN(5_d_)-MAN(4_d_)]-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(332_G_)",449.737,"","",""
"5WDU","HIV-1 ENV BG505 SOSIP.664 H72C-H564C TRIMER IN COMPLEX WITH BNABS PGT122 FAB, 35O22 FAB AND NIH45-46 SCFV","10.1016/J.CELREP.2017.07.077 ",7,0,"5wdu_oligo23","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_p_)-[MAN(4_p_)]-BMA(3_p_)-NAG(2_p_)-NAG(1_p_)-ASN(156_Q_)",509.257,"","",""
"5WI8","CRYSTAL STRUCTURE OF MURINE 4-1BB FROM HEK293T CELLS IN P21 SPACE GROUP","10.1074/JBC.M117.814905 ",2.95,71.58,"5wi8_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(138_C_)",124.905,"","",""
"5WIW","CRYSTAL STRUCTURE OF MURINE 4-1BB N128A MUTANT FROM HEK293T CELLS IN P43 SPACE GROUP","10.1074/JBC.M117.814905 ",2.3,51.94,"5wiw_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_C_)-[MAN(4_C_)-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(138_B_)",76.5925,"","",""
"5WKE","CRYSTAL STRUCTURE OF HUMAN CD1B IN COMPLEX WITH PS","10.1126/SCIIMMUNOL.AAO1384 ",1.69,26.27,"5wke_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(7_D_)-[MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-[FUC(6_D_)]-NAG(1_D_)-ASN(57_A_)",21.3251,"","",""
"5WKE","CRYSTAL STRUCTURE OF HUMAN CD1B IN COMPLEX WITH PS","10.1126/SCIIMMUNOL.AAO1384 ",1.69,26.27,"5wke_oligo1","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_C_)-[FUC(2_C_)]-NAG(1_C_)-ASN(128_A_)",58.6106,"","",""
"5WKG","CRYSTAL STRUCTURE OF HUMAN CD1B IN COMPLEX WITH PA","10.1126/SCIIMMUNOL.AAO1384 ",2.06,22.23,"5wkg_oligo1","LFucpa1-3DGlcpNAcb1-ASN","FUC(2_D_)-NAG(1_D_)-ASN(128_A_)",42.9864,"","",""
"5WKG","CRYSTAL STRUCTURE OF HUMAN CD1B IN COMPLEX WITH PA","10.1126/SCIIMMUNOL.AAO1384 ",2.06,22.23,"5wkg_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(7_C_)-[MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-[FUC(6_C_)]-NAG(1_C_)-ASN(57_A_)",19.8019,"","",""
"5WKI","CRYSTAL STRUCTURE OF PG90 TCR-CD1B-PG COMPLEX","10.1126/SCIIMMUNOL.AAO1384 ",2.75,53.27,"5wki_oligo1","LFucpa1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_C_)-[NAG(3_C_)]-[FUC(2_C_)]-NAG(1_C_)-ASN(57_A_)",73.8634,"","",""
"5WKT","3.2-ANGSTROM IN SITU MYLAR STRUCTURE OF BOVINE OPSIN AT 100 K","10.1038/NPROT.2017.135 ",3.2,0,"5wkt_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(15_A_)",100.706,"","",""
"5WL1","CRYSTAL STRUCTURE OF HUMAN CD1B IN COMPLEX WITH PG","10.1126/SCIIMMUNOL.AAO1384 ",1.38,22.36,"5wl1_oligo1","LFucpa1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_C_)-[NAG(3_C_)]-[FUC(2_C_)]-NAG(1_C_)-ASN(20_A_)",47.8432,"","",""
"5WL1","CRYSTAL STRUCTURE OF HUMAN CD1B IN COMPLEX WITH PG","10.1126/SCIIMMUNOL.AAO1384 ",1.38,22.36,"5wl1_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_D_)-[MAN(4_D_)-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(128_A_)",42.8102,"","",""
"5WL1","CRYSTAL STRUCTURE OF HUMAN CD1B IN COMPLEX WITH PG","10.1126/SCIIMMUNOL.AAO1384 ",1.38,22.36,"5wl1_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(7_E_)-[MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-[FUC(6_E_)]-NAG(1_E_)-ASN(57_A_)",15.8592,"","",""
"5WY8","CRYSTAL STRUCTURE OF PTP DELTA IG1-IG3 IN COMPLEX WITH IL1RAPL1 IG1- IG3","10.3389/FNMOL.2017.00327 ",3.07,91.27,"5wy8_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(138_B_)",129.312,"","",""
"5WY8","CRYSTAL STRUCTURE OF PTP DELTA IG1-IG3 IN COMPLEX WITH IL1RAPL1 IG1- IG3","10.3389/FNMOL.2017.00327 ",3.07,91.27,"5wy8_oligo3","LFucpa1-3DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(254_A_)",127.136,"","",""
"5WYX","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH CU-CPT8M","10.1038/NCHEMBIO.2518 ",2.4,59.58,"5wyx_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(590_A_)",62.6507,"","",""
"5WYX","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH CU-CPT8M","10.1038/NCHEMBIO.2518 ",2.4,59.58,"5wyx_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(293_A_)",60.0498,"","",""
"5WYZ","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH CU-CPT9B","10.1038/NCHEMBIO.2518 ",2.3,60.22,"5wyz_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(293_A_)",59.4339,"","",""
"5WYZ","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH CU-CPT9B","10.1038/NCHEMBIO.2518 ",2.3,60.22,"5wyz_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(590_A_)",63.3705,"","",""
"5WZY","CRYSTAL STRUCTURE OF THE P2X4 RECEPTOR FROM ZEBRAFISH IN THE PRESENCE OF CTP AT 2.8 ANGSTROMS","10.1038/SREP45208 ",2.8,78.59,"5wzy_oligo2","DManpa1-3DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(213_A_)",98.0133,"","",""
"5X0M","STRUCTURE OF A EUKARYOTIC VOLTAGE-GATED SODIUM CHANNEL AT NEAR ATOMIC RESOLUTION","10.1126/SCIENCE.AAL4326 ",3.8,0,"5x0m_oligo1","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_B_)-[BMA(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(330_A_)",166.845,"","",""
"5X19","CO BOUND CYTOCHROME C OXIDASE AT 100 MICRO SEC AFTER PUMP LASER IRRADIATION TO RELEASE CO FROM O2 REDUCTION CENTER","10.1126/SCIADV.1603042 ",2.2,68.01,"5x19_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(101_Z_)-DMU(101_Z_)",118.375,"","",""
"5X19","CO BOUND CYTOCHROME C OXIDASE AT 100 MICRO SEC AFTER PUMP LASER IRRADIATION TO RELEASE CO FROM O2 REDUCTION CENTER","10.1126/SCIADV.1603042 ",2.2,68.01,"5x19_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(101_M_)-DMU(101_M_)",90.9995,"","",""
"5X1B","CO BOUND CYTOCHROME C OXIDASE AT 20 NSEC AFTER PUMP LASER IRRADIATION TO RELEASE CO FROM O2 REDUCTION CENTER","10.1126/SCIADV.1603042 ",2.4,72.7,"5x1b_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(101_M_)-DMU(101_M_)",113.735,"","",""
"5X1B","CO BOUND CYTOCHROME C OXIDASE AT 20 NSEC AFTER PUMP LASER IRRADIATION TO RELEASE CO FROM O2 REDUCTION CENTER","10.1126/SCIADV.1603042 ",2.4,72.7,"5x1b_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(101_Z_)-DMU(101_Z_)",137.319,"","",""
"5X1F","CO BOUND CYTOCHROME C OXIDASE WITHOUT PUMP LASER IRRADIATION AT 278K","10.1126/SCIADV.1603042 ",2.2,61.11,"5x1f_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(102_Z_)-DMU(102_Z_)",92.8273,"","",""
"5X1F","CO BOUND CYTOCHROME C OXIDASE WITHOUT PUMP LASER IRRADIATION AT 278K","10.1126/SCIADV.1603042 ",2.2,61.11,"5x1f_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(101_M_)-DMU(101_M_)",76.4514,"","",""
"5X4A","SLL-2-FORSSMAN ANTIGEN TETRASACCHARIDES COMPLEX","10.1093/GLYCOB/CWX043 ",3.4,0,"5x4a_oligo13","DGalpNAca1-3DGalpNAcb1-3DGalpa1-4DGalpb1-ROH","A2G(4_Y_)-NGA(3_Y_)-GLA(2_Y_)-GAL(1_Y_)",100.748,"","",""
"5X4A","SLL-2-FORSSMAN ANTIGEN TETRASACCHARIDES COMPLEX","10.1093/GLYCOB/CWX043 ",3.4,0,"5x4a_oligo20","DGalpNAca1-3DGalpNAcb1-3DGalpa1-4DGalpb1-ROH","A2G(4_f_)-NGA(3_f_)-GLA(2_f_)-GAL(1_f_)",168.737,"","",""
"5X4A","SLL-2-FORSSMAN ANTIGEN TETRASACCHARIDES COMPLEX","10.1093/GLYCOB/CWX043 ",3.4,0,"5x4a_oligo8","DGalpNAca1-3DGalpNAcb1-3DGalpa1-4DGalpb1-ROH","A2G(4_N_)-NGA(3_N_)-GLA(2_N_)-GAL(1_N_)",85.1691,"","",""
"5X4A","SLL-2-FORSSMAN ANTIGEN TETRASACCHARIDES COMPLEX","10.1093/GLYCOB/CWX043 ",3.4,0,"5x4a_oligo10","DGalpNAca1-3DGalpNAcb1-3DGalpa1-4DGalpb1-ROH","A2G(4_P_)-NGA(3_P_)-GLA(2_P_)-GAL(1_P_)",89.5545,"","",""
"5X4A","SLL-2-FORSSMAN ANTIGEN TETRASACCHARIDES COMPLEX","10.1093/GLYCOB/CWX043 ",3.4,0,"5x4a_oligo18","DGalpNAca1-3DGalpNAcb1-3DGalpa1-4DGalpb1-ROH","A2G(4_d_)-NGA(3_d_)-GLA(2_d_)-GAL(1_d_)",157.237,"","",""
"5X4A","SLL-2-FORSSMAN ANTIGEN TETRASACCHARIDES COMPLEX","10.1093/GLYCOB/CWX043 ",3.4,0,"5x4a_oligo22","DGalpNAca1-3DGalpNAcb1-3DGalpa1-4DGalpb1-ROH","A2G(4_h_)-NGA(3_h_)-GLA(2_h_)-GAL(1_h_)",134.335,"","",""
"5X4A","SLL-2-FORSSMAN ANTIGEN TETRASACCHARIDES COMPLEX","10.1093/GLYCOB/CWX043 ",3.4,0,"5x4a_oligo7","DGalpNAca1-3DGalpNAcb1-3DGalpa1-4DGalpb1-ROH","A2G(4_W_)-NGA(3_W_)-GLA(2_W_)-GAL(1_W_)",88.8198,"","",""
"5X4A","SLL-2-FORSSMAN ANTIGEN TETRASACCHARIDES COMPLEX","10.1093/GLYCOB/CWX043 ",3.4,0,"5x4a_oligo5","DGalpNAca1-3DGalpNAcb1-3DGalpa1-4DGalpb1-ROH","A2G(4_U_)-NGA(3_U_)-GLA(2_U_)-GAL(1_U_)",93.9434,"","",""
"5X4A","SLL-2-FORSSMAN ANTIGEN TETRASACCHARIDES COMPLEX","10.1093/GLYCOB/CWX043 ",3.4,0,"5x4a_oligo3","DGalpNAca1-3DGalpNAcb1-3DGalpa1-4DGalpb1-ROH","A2G(4_S_)-NGA(3_S_)-GLA(2_S_)-GAL(1_S_)",95.5884,"","",""
"5X4A","SLL-2-FORSSMAN ANTIGEN TETRASACCHARIDES COMPLEX","10.1093/GLYCOB/CWX043 ",3.4,0,"5x4a_oligo15","DGalpNAca1-3DGalpNAcb1-3DGalpa1-4DGalpb1-ROH","A2G(4_a_)-NGA(3_a_)-GLA(2_a_)-GAL(1_a_)",86.7896,"","",""
"5XBM","STRUCTURE OF SCARB2-JL2 COMPLEX","10.1007/S13238-017-0405-7 ",3.5,0,"5xbm_oligo11","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Q_)-[MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(325_F_)",122.29,"","",""
"5XBM","STRUCTURE OF SCARB2-JL2 COMPLEX","10.1007/S13238-017-0405-7 ",3.5,0,"5xbm_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(68_C_)",114.801,"","",""
"5XBM","STRUCTURE OF SCARB2-JL2 COMPLEX","10.1007/S13238-017-0405-7 ",3.5,0,"5xbm_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_L_)-[MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(412_C_)",103.797,"","",""
"5XBM","STRUCTURE OF SCARB2-JL2 COMPLEX","10.1007/S13238-017-0405-7 ",3.5,0,"5xbm_oligo12","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_R_)-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(412_F_)",94.9314,"","",""
"5XBM","STRUCTURE OF SCARB2-JL2 COMPLEX","10.1007/S13238-017-0405-7 ",3.5,0,"5xbm_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(325_C_)",114.532,"","",""
"5XBM","STRUCTURE OF SCARB2-JL2 COMPLEX","10.1007/S13238-017-0405-7 ",3.5,0,"5xbm_oligo7","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_M_)-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(68_F_)",106.12,"","",""
"5XC2","CRYSTAL STRUCTURE OF GH FAMILY 81 BETA-1,3-GLUCANASE FROM RHIZOMUCR MIEHEI COMPLEXED WITH LAMINARIHEXAOSE","",2.7,0,"5xc2_oligo6","DManp[2H]b1-3DGlcpx1-","BGC(2_J_)-BGC(1_J_)",31.926,"","",""
"5XDQ","BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE WITH PH 7.3 AT 1.77 ANGSTROM RESOLUTION","10.1107/S2053230X17008834 ",1.77,45.06,"5xdq_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(104_W_)-DMU(104_W_)",139.127,"","",""
"5XDQ","BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE WITH PH 7.3 AT 1.77 ANGSTROM RESOLUTION","10.1107/S2053230X17008834 ",1.77,45.06,"5xdq_oligo3","DGlcpa1-3DGlcpb6-C10O1","DMU(101_M_)-DMU(101_M_)",57.2164,"","",""
"5XDQ","BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE WITH PH 7.3 AT 1.77 ANGSTROM RESOLUTION","10.1107/S2053230X17008834 ",1.77,45.06,"5xdq_oligo4","DGlcpa1-3DGlcpb6-C10O1","DMU(313_P_)-DMU(313_P_)",143.647,"","",""
"5XDQ","BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE WITH PH 7.3 AT 1.77 ANGSTROM RESOLUTION","10.1107/S2053230X17008834 ",1.77,45.06,"5xdq_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(313_C_)-DMU(313_C_)",141.396,"","",""
"5XDQ","BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE WITH PH 7.3 AT 1.77 ANGSTROM RESOLUTION","10.1107/S2053230X17008834 ",1.77,45.06,"5xdq_oligo5","DGlcpa1-3DGlcpb6-C10O1","DMU(312_C_)-DMU(312_C_)",128.365,"","",""
"5XDQ","BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE WITH PH 7.3 AT 1.77 ANGSTROM RESOLUTION","10.1107/S2053230X17008834 ",1.77,45.06,"5xdq_oligo6","DGlcpa1-3DGlcpb6-C10O1","DMU(101_Z_)-DMU(101_Z_)",76.2346,"","",""
"5XDX","BOVINE HEART CYTOCHROME C OXIDASE IN THE REDUCED STATE WITH PH 7.3 AT 1.99 ANGSTROM RESOLUTION","10.1107/S2053230X17018532 ",1.99,49.37,"5xdx_oligo5","DGlcpa1-3DGlcpb6-C10O1","DMU(102_M_)-DMU(102_M_)",65.7059,"","",""
"5XDX","BOVINE HEART CYTOCHROME C OXIDASE IN THE REDUCED STATE WITH PH 7.3 AT 1.99 ANGSTROM RESOLUTION","10.1107/S2053230X17018532 ",1.99,49.37,"5xdx_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(313_C_)-DMU(313_C_)",137.95,"","",""
"5XDX","BOVINE HEART CYTOCHROME C OXIDASE IN THE REDUCED STATE WITH PH 7.3 AT 1.99 ANGSTROM RESOLUTION","10.1107/S2053230X17018532 ",1.99,49.37,"5xdx_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(101_Z_)-DMU(101_Z_)",85.0023,"","",""
"5XDX","BOVINE HEART CYTOCHROME C OXIDASE IN THE REDUCED STATE WITH PH 7.3 AT 1.99 ANGSTROM RESOLUTION","10.1107/S2053230X17018532 ",1.99,49.37,"5xdx_oligo3","DGlcpa1-3DGlcpb6-C10O1","DMU(308_P_)-DMU(308_P_)",133.075,"","",""
"5XDX","BOVINE HEART CYTOCHROME C OXIDASE IN THE REDUCED STATE WITH PH 7.3 AT 1.99 ANGSTROM RESOLUTION","10.1107/S2053230X17018532 ",1.99,49.37,"5xdx_oligo6","DGlcpa1-3DGlcpb6-C10O1","DMU(309_P_)-DMU(309_P_)",136.65,"","",""
"5XDX","BOVINE HEART CYTOCHROME C OXIDASE IN THE REDUCED STATE WITH PH 7.3 AT 1.99 ANGSTROM RESOLUTION","10.1107/S2053230X17018532 ",1.99,49.37,"5xdx_oligo4","DGlcpa1-3DGlcpb6-C10O1","DMU(312_C_)-DMU(312_C_)",117.402,"","",""
"5XEW","CRYSTAL STRUCTURE OF THE [NI2+-(CHROMOMYCIN A3)2]-CCG REPEATS COMPLEX","10.1002/ANIE.201703989 ",1.75,39.68,"5xew_oligo30","LOlip[3<R1>,4Ac]a1-3DOlipb1-3DOlipb1-","ERI(3_F_)-CDR(2_F_)-CDR(1_F_)",28.1903,"","",""
"5XEW","CRYSTAL STRUCTURE OF THE [NI2+-(CHROMOMYCIN A3)2]-CCG REPEATS COMPLEX","10.1002/ANIE.201703989 ",1.75,39.68,"5xew_oligo33","LOlip[3<R1>,4Ac]a1-3DOlipb1-3DOlipb1-C21O9","ERI(3_C_)-CDR(2_C_)-CDR(1_C_)",28.5457,"","",""
"5XFD","SERIAL FEMTOSECOND X-RAY STRUCTURE OF AGROCYBE CYLINDRACEA GALECTIN WITH LACTOSE SOLVED BY SE-SAD USING XFEL (REFINED AGAINST 60,000 PATTERNS)","10.1107/S2052252517008557 ",1.5,24.3,"5xfd_oligo1","LFucpa1-2[DGalpNAca1-3]DGalpb1-4DGlcpNAca1-ROH","A2G(4_C_)-[FUC(3_C_)]-GAL(2_C_)-NDG(1_C_)",19.4566,"","",""
"5XFD","SERIAL FEMTOSECOND X-RAY STRUCTURE OF AGROCYBE CYLINDRACEA GALECTIN WITH LACTOSE SOLVED BY SE-SAD USING XFEL (REFINED AGAINST 60,000 PATTERNS)","10.1107/S2052252517008557 ",1.5,24.3,"5xfd_oligo2","LFucpa1-2[DGalpNAca1-3]DGalpb1-4DGlcpNAca1-ROH","A2G(4_D_)-[FUC(3_D_)]-GAL(2_D_)-NDG(1_D_)",24.0805,"","",""
"5XFH","CRYSTAL STRUCTURE OF ORYSATA LECTIN IN COMPLEX WITH BIANTENNARY N- GLYCAN","10.1093/GLYCOB/CWX081 ",1.9,0,"5xfh_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-ROH","NAG(6_C_)-MAN(5_C_)-[GAL(4_C_)-NAG(3_C_)-MAN(2_C_)]-BMA(1_C_)",33.5074,"","",""
"5XFI","CRYSTAL STRUCTURE OF CALSEPA LECTIN IN COMPLEX WITH BIANTENNARY N- GLYCAN","10.1093/GLYCOB/CWX081 ",1.65,0,"5xfi_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","NAG(8_D_)-MAN(7_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)",26.4665,"","",""
"5XFI","CRYSTAL STRUCTURE OF CALSEPA LECTIN IN COMPLEX WITH BIANTENNARY N- GLYCAN","10.1093/GLYCOB/CWX081 ",1.65,0,"5xfi_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","NAG(8_C_)-MAN(7_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)",26.2062,"","",""
"5XJE","CRYSTAL STRUCTURE OF FUCOSYLATED IGG1 FC COMPLEXED WITH BIS- GLYCOSYLATED SOLUBLE FORM OF FC GAMMA RECEPTOR IIIA","10.1038/S41598-017-13845-8 ",2.4,55.11,"5xje_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_A_)",66.3192,"","",""
"5XJE","CRYSTAL STRUCTURE OF FUCOSYLATED IGG1 FC COMPLEXED WITH BIS- GLYCOSYLATED SOLUBLE FORM OF FC GAMMA RECEPTOR IIIA","10.1038/S41598-017-13845-8 ",2.4,55.11,"5xje_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[NAG(8_E_)-MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_B_)",63.0309,"","",""
"5XJF","CRYSTAL STRUCTURE OF FUCOSYLATED IGG FC Y296W MUTANT COMPLEXED WITH BIS-GLYCOSYLATED SOLUBLE FORM OF FC GAMMA RECEPTOR IIIA","10.1038/S41598-017-13845-8 ",2.5,66.32,"5xjf_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_A_)",76.3318,"","",""
"5XJF","CRYSTAL STRUCTURE OF FUCOSYLATED IGG FC Y296W MUTANT COMPLEXED WITH BIS-GLYCOSYLATED SOLUBLE FORM OF FC GAMMA RECEPTOR IIIA","10.1038/S41598-017-13845-8 ",2.5,66.32,"5xjf_oligo1","DGlcpNAcb1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_F_)-MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(45_C_)",138.449,"","",""
"5XJF","CRYSTAL STRUCTURE OF FUCOSYLATED IGG FC Y296W MUTANT COMPLEXED WITH BIS-GLYCOSYLATED SOLUBLE FORM OF FC GAMMA RECEPTOR IIIA","10.1038/S41598-017-13845-8 ",2.5,66.32,"5xjf_oligo3","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[NAG(8_E_)-MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_B_)",76.8007,"","",""
"5XJW","CRYSTAL STRUCTURE OF THE [CO2+-(CHROMOMYCIN A3)2]-CCG REPEATS COMPLEX","",2.1,55.61,"5xjw_oligo35","LOlip[3<R1>,4Ac]a1-3DOlipb1-3DOlipb1-C21O9","ERI(3_C_)-DDA(2_C_)-DDA(1_C_)",42.8387,"","",""
"5XJW","CRYSTAL STRUCTURE OF THE [CO2+-(CHROMOMYCIN A3)2]-CCG REPEATS COMPLEX","",2.1,55.61,"5xjw_oligo32","LOlip[3<R1>,4Ac]a1-3DOlipb1-3DOlipb1-","ERI(3_F_)-DDA(2_F_)-DDA(1_F_)",42.0663,"","",""
"5XJY","CRYO-EM STRUCTURE OF HUMAN ABCA1","10.1016/J.CELL.2017.05.020 ",4.1,0,"5xjy_oligo1","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_B_)-[BMA(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(1504_A_)",60.3313,"","",""
"5XMH","CRYSTAL STRUCTURE OF AN IGM RHEUMATOID FACTOR YES8C IN COMPLEX WITH IGG1 FC","10.1074/JBC.M117.814475 ",2.8,52,"5xmh_oligo2","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_F_)-MAN(4_F_)-[MAN(6_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(297_B_)",86.2577,"","",""
"5XMH","CRYSTAL STRUCTURE OF AN IGM RHEUMATOID FACTOR YES8C IN COMPLEX WITH IGG1 FC","10.1074/JBC.M117.814475 ",2.8,52,"5xmh_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_E_)-[NAG(7_E_)-MAN(6_E_)-[NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_A_)",65.8827,"","",""
"5XRS","CRYSTAL STRUCTURE OF A/MINNESOTA/11/2010 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ IN COMPLEX WITH LSTC","10.1038/S41467-018-04704-9 ",2.91,0,"5xrs_oligo23","DManpa1-2DManpa1-3DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_d_)-MAN(4_d_)-MAN(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(165_G_)",154.318,"","",""
"5XRS","CRYSTAL STRUCTURE OF A/MINNESOTA/11/2010 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ IN COMPLEX WITH LSTC","10.1038/S41467-018-04704-9 ",2.91,0,"5xrs_oligo12","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_K_)-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(246_A_)",146.298,"","",""
"5XRS","CRYSTAL STRUCTURE OF A/MINNESOTA/11/2010 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ IN COMPLEX WITH LSTC","10.1038/S41467-018-04704-9 ",2.91,0,"5xrs_oligo9","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_R_)-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(246_C_)",154.002,"","",""
"5XRS","CRYSTAL STRUCTURE OF A/MINNESOTA/11/2010 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ IN COMPLEX WITH LSTC","10.1038/S41467-018-04704-9 ",2.91,0,"5xrs_oligo14","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_T_)-[MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(285_C_)",159.499,"","",""
"5XRS","CRYSTAL STRUCTURE OF A/MINNESOTA/11/2010 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ IN COMPLEX WITH LSTC","10.1038/S41467-018-04704-9 ",2.91,0,"5xrs_oligo22","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_c_)-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(246_G_)",166.608,"","",""
"5XRS","CRYSTAL STRUCTURE OF A/MINNESOTA/11/2010 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ IN COMPLEX WITH LSTC","10.1038/S41467-018-04704-9 ",2.91,0,"5xrs_oligo17","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_X_)-[MAN(4_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(246_E_)",134.334,"","",""
"5XRS","CRYSTAL STRUCTURE OF A/MINNESOTA/11/2010 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ IN COMPLEX WITH LSTC","10.1038/S41467-018-04704-9 ",2.91,0,"5xrs_oligo10","DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_S_)-MAN(6_S_)-[MAN(5_S_)-MAN(4_S_)]-MAN(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(165_C_)",143.608,"","",""
"5XRS","CRYSTAL STRUCTURE OF A/MINNESOTA/11/2010 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ IN COMPLEX WITH LSTC","10.1038/S41467-018-04704-9 ",2.91,0,"5xrs_oligo1","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_L_)-[MAN(5_L_)-MAN(4_L_)]-MAN(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(165_A_)",145.469,"","",""
"5XRS","CRYSTAL STRUCTURE OF A/MINNESOTA/11/2010 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ IN COMPLEX WITH LSTC","10.1038/S41467-018-04704-9 ",2.91,0,"5xrs_oligo16","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_W_)-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(38_E_)",172.359,"","",""
"5XRS","CRYSTAL STRUCTURE OF A/MINNESOTA/11/2010 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ IN COMPLEX WITH LSTC","10.1038/S41467-018-04704-9 ",2.91,0,"5xrs_oligo8","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_Q_)-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(38_C_)",171.125,"","",""
"5XRT","CRYSTAL STRUCTURE OF A/MINNESOTA/11/2010 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ","10.1038/S41467-018-04704-9 ",3.15,0,"5xrt_oligo13","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_U_)-[MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(38_E_)",175.498,"","",""
"5XRT","CRYSTAL STRUCTURE OF A/MINNESOTA/11/2010 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ","10.1038/S41467-018-04704-9 ",3.15,0,"5xrt_oligo8","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(38_A_)",147.826,"","",""
"5XRT","CRYSTAL STRUCTURE OF A/MINNESOTA/11/2010 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ","10.1038/S41467-018-04704-9 ",3.15,0,"5xrt_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_P_)-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(246_C_)",161.155,"","",""
"5XRT","CRYSTAL STRUCTURE OF A/MINNESOTA/11/2010 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ","10.1038/S41467-018-04704-9 ",3.15,0,"5xrt_oligo5","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Q_)-[MAN(5_Q_)-MAN(4_Q_)]-MAN(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(165_C_)",156.687,"","",""
"5XRT","CRYSTAL STRUCTURE OF A/MINNESOTA/11/2010 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ","10.1038/S41467-018-04704-9 ",3.15,0,"5xrt_oligo23","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_e_)-[MAN(4_e_)]-BMA(3_e_)-NAG(2_e_)-NAG(1_e_)-ASN(63_G_)",201.197,"","",""
"5XRT","CRYSTAL STRUCTURE OF A/MINNESOTA/11/2010 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ","10.1038/S41467-018-04704-9 ",3.15,0,"5xrt_oligo15","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_W_)-[MAN(5_W_)-MAN(4_W_)]-MAN(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(165_E_)",150.77,"","",""
"5XRT","CRYSTAL STRUCTURE OF A/MINNESOTA/11/2010 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ","10.1038/S41467-018-04704-9 ",3.15,0,"5xrt_oligo21","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_c_)-MAN(6_c_)-[MAN(5_c_)-MAN(4_c_)]-MAN(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(165_G_)",168.133,"","",""
"5XRT","CRYSTAL STRUCTURE OF A/MINNESOTA/11/2010 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ","10.1038/S41467-018-04704-9 ",3.15,0,"5xrt_oligo9","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_L_)-[MAN(5_L_)-MAN(4_L_)]-MAN(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(165_A_)",156.94,"","",""
"5XRT","CRYSTAL STRUCTURE OF A/MINNESOTA/11/2010 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ","10.1038/S41467-018-04704-9 ",3.15,0,"5xrt_oligo14","DManpa1-3DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_V_)-MAN(4_V_)-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(246_E_)",171.362,"","",""
"5XRT","CRYSTAL STRUCTURE OF A/MINNESOTA/11/2010 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ","10.1038/S41467-018-04704-9 ",3.15,0,"5xrt_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(285_A_)",171.63,"","",""
"5XRT","CRYSTAL STRUCTURE OF A/MINNESOTA/11/2010 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ","10.1038/S41467-018-04704-9 ",3.15,0,"5xrt_oligo16","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_X_)-[MAN(4_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(285_E_)",175.717,"","",""
"5XRT","CRYSTAL STRUCTURE OF A/MINNESOTA/11/2010 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ","10.1038/S41467-018-04704-9 ",3.15,0,"5xrt_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_K_)-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(246_A_)",166.609,"","",""
"5XSY","STRUCTURE OF THE NAV1.4-BETA1 COMPLEX FROM ELECTRIC EEL","10.1016/J.CELL.2017.06.039 ",4,0,"5xsy_oligo1","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_C_)-[BMA(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(317_A_)",185.607,"","",""
"5XWD","CRYSTAL STRUCTURE OF THE COMPLEX OF 059-152-FV AND EGFR-ECD","10.1371/JOURNAL.PONE.0193158 ",2.89,0,"5xwd_oligo3","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_B_)-MAN(6_B_)-[NAG(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(328_A_)",121.818,"","",""
"5Y2A","CRYSTAL STRUCTURE OF OSTRINIA FURNACALIS GROUP II CHITINASE CATALYTIC DOMAIN 2","10.1074/JBC.RA117.000119 ",1.9,22.26,"5y2a_oligo2","DManpa1-2DManpa1-2DManpa1-3DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-MAN(5_D_)-MAN(4_D_)-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(2280_B_)",39.7559,"","",""
"5Y2A","CRYSTAL STRUCTURE OF OSTRINIA FURNACALIS GROUP II CHITINASE CATALYTIC DOMAIN 2","10.1074/JBC.RA117.000119 ",1.9,22.26,"5y2a_oligo1","DManpa1-2DManpa1-2DManpa1-3DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-MAN(5_C_)-MAN(4_C_)-MAN(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(2280_A_)",38.9311,"","",""
"5Y2C","CRYSTAL STRUCTURE OF OSTRINIA FURNACALIS GROUP II CHITINASE CATALYTIC DOMAIN 2 E2180L MUTANT IN COMPLEX WITH PENTA-N-ACETYLCHITOOCTAOSE (NAG)5","10.1074/JBC.RA117.000119 ",2.45,35.62,"5y2c_oligo2","DManpa1-2DManpa1-2DManpa1-3DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-MAN(5_D_)-MAN(4_D_)-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(2280_A_)",60.8224,"","",""
"5Y2C","CRYSTAL STRUCTURE OF OSTRINIA FURNACALIS GROUP II CHITINASE CATALYTIC DOMAIN 2 E2180L MUTANT IN COMPLEX WITH PENTA-N-ACETYLCHITOOCTAOSE (NAG)5","10.1074/JBC.RA117.000119 ",2.45,35.62,"5y2c_oligo4","DManpa1-2DManpa1-2DManpa1-3DManpa1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(6_F_)-MAN(5_F_)-MAN(4_F_)-MAN(3_F_)-NAG(2_F_)-NAG(1_F_)",63.9901,"","",""
"5Y56","FC MUTANT (K392D/K409D/D399K)","10.1074/JBC.M116.771188 ",2.65,0,"5y56_oligo1","DGalpb1-4DGlcpNAca1-2DManpa1-6[DManpb1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_D_)-NDG(5_D_)-MAN(4_D_)-[BMA(7_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(297_B_)",160.569,"","",""
"5Y56","FC MUTANT (K392D/K409D/D399K)","10.1074/JBC.M116.771188 ",2.65,0,"5y56_oligo2","DGalpb1-4DGlcpNAca1-2DManpa1-6[DGlcpNAcb1-2DManpb1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_C_)-[GAL(6_C_)-NDG(5_C_)-MAN(4_C_)-[NAG(8_C_)-BMA(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",121.516,"","",""
"5YC5","CRYSTAL STRUCTURE OF HUMAN IGG-FC IN COMPLEX WITH AGLYCAN AND OPTIMIZED FC GAMMA RECEPTOR IIIA","10.1038/S41598-018-22199-8 ",2.71,54.1,"5yc5_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_A_)",59.185,"","",""
"5YC5","CRYSTAL STRUCTURE OF HUMAN IGG-FC IN COMPLEX WITH AGLYCAN AND OPTIMIZED FC GAMMA RECEPTOR IIIA","10.1038/S41598-018-22199-8 ",2.71,54.1,"5yc5_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_E_)-[NAG(7_E_)-MAN(6_E_)-[NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_B_)",61.4107,"","",""
"5YDH","CRYSTAL STRUCTURE OF ACETYLCHOLINESTERASE CATALYTIC SUBUNITS OF THE MALARIA VECTOR ANOPHELES GAMBIAE, 3.2 A","",3.21,84.29,"5ydh_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(220_A_)",163.946,"","",""
"5YDH","CRYSTAL STRUCTURE OF ACETYLCHOLINESTERASE CATALYTIC SUBUNITS OF THE MALARIA VECTOR ANOPHELES GAMBIAE, 3.2 A","",3.21,84.29,"5ydh_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(220_B_)",160.423,"","",""
"5YDI","CRYSTAL STRUCTURE OF ACETYLCHOLINESTERASE CATALYTIC SUBUNITS OF THE MALARIA VECTOR ANOPHELES GAMBIAE, NEW CRYSTAL PACKING","",3.45,62.64,"5ydi_oligo2","DManpa1-6DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-[MAN(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(670_B_)",168.725,"","",""
"5YMS","STRUCTURAL BASIS OF GLYCAN SPECIFICITY AND IDENTIFICATION OF A NOVEL GLYCAN BINDING CAVITY IN HUMAN P[19] ROTAVIRUS","10.1128/JVI.00538-18 ",2.1,31.9,"5yms_oligo2","DGalpb1-3[DGlcpNAcb1-6]DGalpNAca1-ROH","NAG(3_J_)-[GAL(2_J_)]-A2G(1_J_)",67.2421,"","",""
"5YMS","STRUCTURAL BASIS OF GLYCAN SPECIFICITY AND IDENTIFICATION OF A NOVEL GLYCAN BINDING CAVITY IN HUMAN P[19] ROTAVIRUS","10.1128/JVI.00538-18 ",2.1,31.9,"5yms_oligo1","DGalpb1-3[DGlcpNAcb1-6]DGalpNAca1-ROH","NAG(3_I_)-[GAL(2_I_)]-A2G(1_I_)",68.3485,"","",""
"5YMT","FUNCTIONAL AND STRUCTURAL CHARACTERIZATION OF P[19] ROTAVIRUS VP8* INTERACTION WITH HISTO-BLOOD GROUP ANTIGENS","10.1128/JVI.00538-18 ",2.2,35.44,"5ymt_oligo1","DGalpb1-3DGlcpNAcb1-3DGalpb1-4DGlcpa1-ROH","GAL(4_O_)-NAG(3_O_)-GAL(2_O_)-GLC(1_O_)",49.5316,"","",""
"5YMT","FUNCTIONAL AND STRUCTURAL CHARACTERIZATION OF P[19] ROTAVIRUS VP8* INTERACTION WITH HISTO-BLOOD GROUP ANTIGENS","10.1128/JVI.00538-18 ",2.2,35.44,"5ymt_oligo2","DGalpb1-3DGlcpNAcb1-3DGalpb1-4DGlcpa1-ROH","GAL(4_P_)-NAG(3_P_)-GAL(2_P_)-GLC(1_P_)",68.7645,"","",""
"5YMT","FUNCTIONAL AND STRUCTURAL CHARACTERIZATION OF P[19] ROTAVIRUS VP8* INTERACTION WITH HISTO-BLOOD GROUP ANTIGENS","10.1128/JVI.00538-18 ",2.2,35.44,"5ymt_oligo3","DGalpb1-3DGlcpNAcb1-3DGalpb1-4DGlcpa1-ROH","GAL(4_Q_)-NAG(3_Q_)-GAL(2_Q_)-GLC(1_Q_)",46.365,"","",""
"5YOW","THE POST-FUSION STRUCTURE OF THE HEARTLAND VIRUS GC GLYCOPROTEIN","10.1128/JVI.01558-17 ",2.1,0,"5yow_oligo1","LFucpa1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_B_)-[NAG(3_B_)]-[FUC(2_B_)]-NAG(1_B_)-ASN(374_A_)",91.9675,"","",""
"5YZE","CRYSTAL STRUCTURE OF THE [CO2+-(CHROMOMYCIN A3)2]-D(CCG)3 COMPLEX","10.3390/IJMS19092796 ",1.87,47.48,"5yze_oligo15","LOlip[3<R1>,4Ac]a1-3DOlipb1-3DOlipb1-C21O9","ERI(3_C_)-CDR(2_C_)-CDR(1_C_)",33.5773,"","",""
"5YZE","CRYSTAL STRUCTURE OF THE [CO2+-(CHROMOMYCIN A3)2]-D(CCG)3 COMPLEX","10.3390/IJMS19092796 ",1.87,47.48,"5yze_oligo26","LOlip[3<R1>,4Ac]a1-3DOlipb1-3DOlipb1-","ERI(3_F_)-CDR(2_F_)-CDR(1_F_)",32.662,"","",""
"5Z14","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH CU-CPT9A","",2.8,70.79,"5z14_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(590_A_)",71.5778,"","",""
"5Z15","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH CU-CPT9C","",2.9,82.22,"5z15_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(293_A_)",72.9159,"","",""
"5Z15","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH CU-CPT9C","",2.9,82.22,"5z15_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(590_A_)",76.1855,"","",""
"5Z84","THE STRUCTURE OF AZIDE-BOUND CYTOCHROME C OXIDASE DETERMINED USING THE CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 4 DAYS","10.1074/JBC.RA118.003123 ",1.85,45.31,"5z84_oligo6","DGlcpa1-3DGlcpb6-C10O1","DMU(311_C_)-DMU(311_C_)",96.0318,"","",""
"5Z84","THE STRUCTURE OF AZIDE-BOUND CYTOCHROME C OXIDASE DETERMINED USING THE CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 4 DAYS","10.1074/JBC.RA118.003123 ",1.85,45.31,"5z84_oligo4","DGlcpa1-3DGlcpb6-C10O1","DMU(306_P_)-DMU(306_P_)",98.24,"","",""
"5Z84","THE STRUCTURE OF AZIDE-BOUND CYTOCHROME C OXIDASE DETERMINED USING THE CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 4 DAYS","10.1074/JBC.RA118.003123 ",1.85,45.31,"5z84_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(309_P_)-DMU(309_P_)",95.0773,"","",""
"5Z84","THE STRUCTURE OF AZIDE-BOUND CYTOCHROME C OXIDASE DETERMINED USING THE CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 4 DAYS","10.1074/JBC.RA118.003123 ",1.85,45.31,"5z84_oligo9","DGlcpa1-3DGlcpb6-C10O1","DMU(101_M_)-DMU(101_M_)",52.8959,"","",""
"5Z84","THE STRUCTURE OF AZIDE-BOUND CYTOCHROME C OXIDASE DETERMINED USING THE CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 4 DAYS","10.1074/JBC.RA118.003123 ",1.85,45.31,"5z84_oligo8","DGlcpa1-3DGlcpb6-C10O1","DMU(102_L_)-DMU(102_L_)",114.53,"","",""
"5Z84","THE STRUCTURE OF AZIDE-BOUND CYTOCHROME C OXIDASE DETERMINED USING THE CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 4 DAYS","10.1074/JBC.RA118.003123 ",1.85,45.31,"5z84_oligo5","DGlcpa1-3DGlcpb6-C10O1","DMU(308_P_)-DMU(308_P_)",82.645,"","",""
"5Z84","THE STRUCTURE OF AZIDE-BOUND CYTOCHROME C OXIDASE DETERMINED USING THE CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 4 DAYS","10.1074/JBC.RA118.003123 ",1.85,45.31,"5z84_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(102_Z_)-DMU(102_Z_)",65.9191,"","",""
"5Z84","THE STRUCTURE OF AZIDE-BOUND CYTOCHROME C OXIDASE DETERMINED USING THE CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 4 DAYS","10.1074/JBC.RA118.003123 ",1.85,45.31,"5z84_oligo3","DGlcpa1-3DGlcpb6-C10O1","DMU(310_C_)-DMU(310_C_)",91.5477,"","",""
"5Z84","THE STRUCTURE OF AZIDE-BOUND CYTOCHROME C OXIDASE DETERMINED USING THE CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 4 DAYS","10.1074/JBC.RA118.003123 ",1.85,45.31,"5z84_oligo7","DGlcpa1-3DGlcpb6-C10O1","DMU(302_C_)-DMU(302_C_)",94.47,"","",""
"5Z85","THE STRUCTURE OF AZIDE-BOUND CYTOCHROME C OXIDASE DETERMINED USING THE ANOTHER BATCH CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 2 DAYS","10.1074/JBC.RA118.003123 ",1.85,40.34,"5z85_oligo5","DGlcpa1-3DGlcpb6-C10O1","DMU(310_P_)-DMU(310_P_)",83.0614,"","",""
"5Z85","THE STRUCTURE OF AZIDE-BOUND CYTOCHROME C OXIDASE DETERMINED USING THE ANOTHER BATCH CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 2 DAYS","10.1074/JBC.RA118.003123 ",1.85,40.34,"5z85_oligo8","DGlcpa1-3DGlcpb6-C10O1","DMU(102_M_)-DMU(102_M_)",49.1141,"","",""
"5Z85","THE STRUCTURE OF AZIDE-BOUND CYTOCHROME C OXIDASE DETERMINED USING THE ANOTHER BATCH CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 2 DAYS","10.1074/JBC.RA118.003123 ",1.85,40.34,"5z85_oligo3","DGlcpa1-3DGlcpb6-C10O1","DMU(311_P_)-DMU(311_P_)",90.9186,"","",""
"5Z85","THE STRUCTURE OF AZIDE-BOUND CYTOCHROME C OXIDASE DETERMINED USING THE ANOTHER BATCH CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 2 DAYS","10.1074/JBC.RA118.003123 ",1.85,40.34,"5z85_oligo6","DGlcpa1-3DGlcpb6-C10O1","DMU(309_C_)-DMU(309_C_)",82.9986,"","",""
"5Z85","THE STRUCTURE OF AZIDE-BOUND CYTOCHROME C OXIDASE DETERMINED USING THE ANOTHER BATCH CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 2 DAYS","10.1074/JBC.RA118.003123 ",1.85,40.34,"5z85_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(101_Z_)-DMU(101_Z_)",62.7441,"","",""
"5Z85","THE STRUCTURE OF AZIDE-BOUND CYTOCHROME C OXIDASE DETERMINED USING THE ANOTHER BATCH CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 2 DAYS","10.1074/JBC.RA118.003123 ",1.85,40.34,"5z85_oligo4","DGlcpa1-3DGlcpb6-C10O1","DMU(308_P_)-DMU(308_P_)",92.5695,"","",""
"5Z85","THE STRUCTURE OF AZIDE-BOUND CYTOCHROME C OXIDASE DETERMINED USING THE ANOTHER BATCH CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 2 DAYS","10.1074/JBC.RA118.003123 ",1.85,40.34,"5z85_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(310_C_)-DMU(310_C_)",92.4227,"","",""
"5Z85","THE STRUCTURE OF AZIDE-BOUND CYTOCHROME C OXIDASE DETERMINED USING THE ANOTHER BATCH CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 2 DAYS","10.1074/JBC.RA118.003123 ",1.85,40.34,"5z85_oligo7","DGlcpa1-3DGlcpb6-C10O1","DMU(302_C_)-DMU(302_C_)",84.1482,"","",""
"5Z86","AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 3 DAYS","10.1074/JBC.RA118.003123 ",1.85,43.4,"5z86_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(102_Z_)-DMU(102_Z_)",63.5591,"","",""
"5Z86","AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 3 DAYS","10.1074/JBC.RA118.003123 ",1.85,43.4,"5z86_oligo8","DGlcpa1-3DGlcpb6-C10O1","DMU(308_P_)-DMU(308_P_)",96.3486,"","",""
"5Z86","AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 3 DAYS","10.1074/JBC.RA118.003123 ",1.85,43.4,"5z86_oligo3","DGlcpa1-3DGlcpb6-C10O1","DMU(311_P_)-DMU(311_P_)",93.1382,"","",""
"5Z86","AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 3 DAYS","10.1074/JBC.RA118.003123 ",1.85,43.4,"5z86_oligo5","DGlcpa1-3DGlcpb6-C10O1","DMU(310_C_)-DMU(310_C_)",88.5091,"","",""
"5Z86","AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 3 DAYS","10.1074/JBC.RA118.003123 ",1.85,43.4,"5z86_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(310_P_)-DMU(310_P_)",81.5614,"","",""
"5Z86","AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 3 DAYS","10.1074/JBC.RA118.003123 ",1.85,43.4,"5z86_oligo7","DGlcpa1-3DGlcpb6-C10O1","DMU(101_M_)-DMU(101_M_)",50.2718,"","",""
"5Z86","AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 3 DAYS","10.1074/JBC.RA118.003123 ",1.85,43.4,"5z86_oligo6","DGlcpa1-3DGlcpb6-C10O1","DMU(311_C_)-DMU(311_C_)",91.2364,"","",""
"5Z86","AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 3 DAYS","10.1074/JBC.RA118.003123 ",1.85,43.4,"5z86_oligo4","DGlcpa1-3DGlcpb6-C10O1","DMU(302_C_)-DMU(302_C_)",89.3764,"","",""
"5ZCO","AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 2 MM AZIDE SOLUTION FOR 2 DAYS","10.1074/JBC.RA118.003123 ",1.9,42.93,"5zco_oligo6","DGlcpa1-3DGlcpb6-C10O1","DMU(302_C_)-DMU(302_C_)",99.2709,"","",""
"5ZCO","AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 2 MM AZIDE SOLUTION FOR 2 DAYS","10.1074/JBC.RA118.003123 ",1.9,42.93,"5zco_oligo8","DGlcpa1-3DGlcpb6-C10O1","DMU(308_P_)-DMU(308_P_)",83.9382,"","",""
"5ZCO","AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 2 MM AZIDE SOLUTION FOR 2 DAYS","10.1074/JBC.RA118.003123 ",1.9,42.93,"5zco_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(310_C_)-DMU(310_C_)",85.5236,"","",""
"5ZCO","AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 2 MM AZIDE SOLUTION FOR 2 DAYS","10.1074/JBC.RA118.003123 ",1.9,42.93,"5zco_oligo3","DGlcpa1-3DGlcpb6-C10O1","DMU(102_Z_)-DMU(102_Z_)",62.3882,"","",""
"5ZCO","AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 2 MM AZIDE SOLUTION FOR 2 DAYS","10.1074/JBC.RA118.003123 ",1.9,42.93,"5zco_oligo5","DGlcpa1-3DGlcpb6-C10O1","DMU(311_C_)-DMU(311_C_)",86.5995,"","",""
"5ZCO","AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 2 MM AZIDE SOLUTION FOR 2 DAYS","10.1074/JBC.RA118.003123 ",1.9,42.93,"5zco_oligo7","DGlcpa1-3DGlcpb6-C10O1","DMU(306_P_)-DMU(306_P_)",99.0123,"","",""
"5ZCO","AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 2 MM AZIDE SOLUTION FOR 2 DAYS","10.1074/JBC.RA118.003123 ",1.9,42.93,"5zco_oligo4","DGlcpa1-3DGlcpb6-C10O1","DMU(101_M_)-DMU(101_M_)",49.5664,"","",""
"5ZCO","AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 2 MM AZIDE SOLUTION FOR 2 DAYS","10.1074/JBC.RA118.003123 ",1.9,42.93,"5zco_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(309_P_)-DMU(309_P_)",92.6859,"","",""
"5ZCP","AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 2 DAYS","10.1074/JBC.RA118.003123 ",1.65,41.32,"5zcp_oligo8","DGlcpa1-3DGlcpb6-C10O1","DMU(309_P_)-DMU(309_P_)",75.2568,"","",""
"5ZCP","AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 2 DAYS","10.1074/JBC.RA118.003123 ",1.65,41.32,"5zcp_oligo6","DGlcpa1-3DGlcpb6-C10O1","DMU(302_C_)-DMU(302_C_)",88.9182,"","",""
"5ZCP","AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 2 DAYS","10.1074/JBC.RA118.003123 ",1.65,41.32,"5zcp_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(310_C_)-DMU(310_C_)",81.6814,"","",""
"5ZCP","AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 2 DAYS","10.1074/JBC.RA118.003123 ",1.65,41.32,"5zcp_oligo4","DGlcpa1-3DGlcpb6-C10O1","DMU(101_M_)-DMU(101_M_)",47.9191,"","",""
"5ZCP","AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 2 DAYS","10.1074/JBC.RA118.003123 ",1.65,41.32,"5zcp_oligo5","DGlcpa1-3DGlcpb6-C10O1","DMU(311_C_)-DMU(311_C_)",83.0809,"","",""
"5ZCP","AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 2 DAYS","10.1074/JBC.RA118.003123 ",1.65,41.32,"5zcp_oligo3","DGlcpa1-3DGlcpb6-C10O1","DMU(101_Z_)-DMU(101_Z_)",59.2305,"","",""
"5ZCP","AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 2 DAYS","10.1074/JBC.RA118.003123 ",1.65,41.32,"5zcp_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(310_P_)-DMU(310_P_)",92.9982,"","",""
"5ZCP","AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 2 DAYS","10.1074/JBC.RA118.003123 ",1.65,41.32,"5zcp_oligo7","DGlcpa1-3DGlcpb6-C10O1","DMU(307_P_)-DMU(307_P_)",92.3032,"","",""
"5ZCQ","AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 10 MM AZIDE SOLUTION FOR 2 DAYS","10.1074/JBC.RA118.003123 ",1.65,37.48,"5zcq_oligo6","DGlcpa1-3DGlcpb6-C10O1","DMU(310_C_)-DMU(310_C_)",84.91,"","",""
"5ZCQ","AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 10 MM AZIDE SOLUTION FOR 2 DAYS","10.1074/JBC.RA118.003123 ",1.65,37.48,"5zcq_oligo3","DGlcpa1-3DGlcpb6-C10O1","DMU(309_C_)-DMU(309_C_)",75.5618,"","",""
"5ZCQ","AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 10 MM AZIDE SOLUTION FOR 2 DAYS","10.1074/JBC.RA118.003123 ",1.65,37.48,"5zcq_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(310_P_)-DMU(310_P_)",80.7568,"","",""
"5ZCQ","AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 10 MM AZIDE SOLUTION FOR 2 DAYS","10.1074/JBC.RA118.003123 ",1.65,37.48,"5zcq_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(101_Z_)-DMU(101_Z_)",55.4586,"","",""
"5ZCQ","AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 10 MM AZIDE SOLUTION FOR 2 DAYS","10.1074/JBC.RA118.003123 ",1.65,37.48,"5zcq_oligo9","DGlcpa1-3DGlcpb6-C10O1","DMU(101_M_)-DMU(101_M_)",44.2614,"","",""
"5ZCQ","AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 10 MM AZIDE SOLUTION FOR 2 DAYS","10.1074/JBC.RA118.003123 ",1.65,37.48,"5zcq_oligo4","DGlcpa1-3DGlcpb6-C10O1","DMU(307_P_)-DMU(307_P_)",76.9064,"","",""
"5ZCQ","AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 10 MM AZIDE SOLUTION FOR 2 DAYS","10.1074/JBC.RA118.003123 ",1.65,37.48,"5zcq_oligo7","DGlcpa1-3DGlcpb6-C10O1","DMU(302_C_)-DMU(302_C_)",79.8232,"","",""
"5ZCQ","AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 10 MM AZIDE SOLUTION FOR 2 DAYS","10.1074/JBC.RA118.003123 ",1.65,37.48,"5zcq_oligo5","DGlcpa1-3DGlcpb6-C10O1","DMU(309_P_)-DMU(309_P_)",75.52,"","",""
"5ZCQ","AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 10 MM AZIDE SOLUTION FOR 2 DAYS","10.1074/JBC.RA118.003123 ",1.65,37.48,"5zcq_oligo8","DGlcpa1-3DGlcpb6-C10O1","DMU(102_L_)-DMU(102_L_)",95.4032,"","",""
"5ZHO","HUMAN GROUP C ROTAVIRUS VP8*S RECOGNIZE TYPE A HISTO-BLOOD GROUP ANTIGENS AS LIGANDS","10.1128/JVI.00442-18 ",1.4,20.18,"5zho_oligo1","LFucpa1-2[DGalpNAca1-3]DGalpa1-ROH","A2G(3_B_)-[FUC(2_B_)]-GLA(1_B_)",20.8661,"","",""
"5ZID","CRYSTAL STRUCTURE OF HUMAN DPP-IV IN COMPLEX WITH HL2","",3,30.88,"5zid_oligo1","DManpa1-3DManpa1-3DManpa1-4DGlcpNAcb1-ASN","MAN(4_C_)-MAN(3_C_)-MAN(2_C_)-NAG(1_C_)-ASN(229_B_)",51.3641,"","",""
"5ZMW","CRYSTAL STRUCTURE OF THE E309Q MUTANT OF SR CA2+-ATPASE IN E2(TG)","10.1073/PNAS.1815472115 ",2.5,0,"5zmw_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(1004_A_)-DMU(1004_A_)",95.2255,"","",""
"5ZMW","CRYSTAL STRUCTURE OF THE E309Q MUTANT OF SR CA2+-ATPASE IN E2(TG)","10.1073/PNAS.1815472115 ",2.5,0,"5zmw_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(1005_A_)-DMU(1005_A_)",75.3759,"","",""
"5ZV5","P DOMAIN OF GII.17-2014/15 COMPLEXED WITH A-TRISACCHARIDE","10.1128/JVI.01655-18 ",2.1,25.16,"5zv5_oligo1","LFucpa1-2[DGalpNAca1-3]DGalpa1-ROH","A2G(3_C_)-[FUC(2_C_)]-GLA(1_C_)",55.4418,"","",""
"5ZV5","P DOMAIN OF GII.17-2014/15 COMPLEXED WITH A-TRISACCHARIDE","10.1128/JVI.01655-18 ",2.1,25.16,"5zv5_oligo2","LFucpa1-2[DGalpNAca1-3]DGalpa1-ROH","A2G(3_D_)-[FUC(2_D_)]-GLA(1_D_)",37.3539,"","",""
"5ZV7","P DOMAIN OF GII.17-2014/15 COMPLEXED WITH B-TRISACCHARIDE","10.1128/JVI.01655-18 ",1.95,0,"5zv7_oligo1","LFucpa1-2[DGalpa1-3]DGalpa1-ROH","GLA(3_C_)-[FUC(2_C_)]-GLA(1_C_)",54.1088,"","",""
"5ZV7","P DOMAIN OF GII.17-2014/15 COMPLEXED WITH B-TRISACCHARIDE","10.1128/JVI.01655-18 ",1.95,0,"5zv7_oligo2","LFucpa1-2[DGalpa1-3]DGalpa1-ROH","GLA(3_D_)-[FUC(2_D_)]-GLA(1_D_)",62.9485,"","",""
"5ZVC","P DOMAIN OF GII.13 NOROVIRUS CAPSID COMPLEXED WITH LEWIS A TRISACCHARIDE","10.1128/JVI.01655-18 ",1.8,23.24,"5zvc_oligo1","DGalpb1-3[LFucpa1-4]DGlcpNAcb1-ROH","FUC(3_C_)-[GAL(2_C_)]-NAG(1_C_)",41.1009,"","",""
"5ZVC","P DOMAIN OF GII.13 NOROVIRUS CAPSID COMPLEXED WITH LEWIS A TRISACCHARIDE","10.1128/JVI.01655-18 ",1.8,23.24,"5zvc_oligo2","DGalpb1-3[LFucpa1-4]DGlcpNAcb1-ROH","FUC(3_D_)-[GAL(2_D_)]-NAG(1_D_)",34.0794,"","",""
"6A5D","CRYSTAL STRUCTURE OF PLANT GLYCOSYLPHOSPHATIDYLINOSITOL-ANCHORED PROTEIN LLG1","10.1038/S41586-019-1409-7 ",1.4,15.85,"6a5d_oligo1","LFucpa1-3[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[FUC(2_C_)]-NAG(1_C_)-ASN(57_A_)",15.8164,"","",""
"6A5D","CRYSTAL STRUCTURE OF PLANT GLYCOSYLPHOSPHATIDYLINOSITOL-ANCHORED PROTEIN LLG1","10.1038/S41586-019-1409-7 ",1.4,15.85,"6a5d_oligo2","LFucpa1-3[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[FUC(2_D_)]-NAG(1_D_)-ASN(57_B_)",15.8164,"","",""
"6A6M","CRYSTAL STRUCTURE OF AN OUTWARD-OPEN NUCLEOTIDE-BOUND STATE OF THE EUKARYOTIC ABC MULTIDRUG TRANSPORTER CMABCB1","10.1038/S41467-018-08007-X ",1.9,59.61,"6a6m_oligo3","DGlcpa1-3DGlcpb6-C3O1","DMU(804_A_)-DMU(804_A_)",91.6709,"","",""
"6A6M","CRYSTAL STRUCTURE OF AN OUTWARD-OPEN NUCLEOTIDE-BOUND STATE OF THE EUKARYOTIC ABC MULTIDRUG TRANSPORTER CMABCB1","10.1038/S41467-018-08007-X ",1.9,59.61,"6a6m_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(803_A_)-DMU(803_A_)",53.1714,"","",""
"6A6N","CRYSTAL STRUCTURE OF AN INWARD-OPEN APO STATE OF THE EUKARYOTIC ABC MULTIDRUG TRANSPORTER CMABCB1","10.1038/S41467-018-08007-X ",3.02,90.31,"6a6n_oligo1","DGlcpa1-3DGlcpb6-C3O1","DMU(801_A_)-DMU(801_A_)",117.631,"","",""
"6A6N","CRYSTAL STRUCTURE OF AN INWARD-OPEN APO STATE OF THE EUKARYOTIC ABC MULTIDRUG TRANSPORTER CMABCB1","10.1038/S41467-018-08007-X ",3.02,90.31,"6a6n_oligo2","DGlcpa1-3DMU6-OME","DMU(802_A_)-DMU(802_A_)",133.176,"","",""
"6A96","CRYO-EM STRUCTURE OF THE HUMAN ALPHA5BETA3 GABAA RECEPTOR IN COMPLEX WITH GABA AND NB25","10.1038/S41422-018-0077-8 ",3.51,0,"6a96_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(114_A_)",250.437,"","",""
"6A96","CRYO-EM STRUCTURE OF THE HUMAN ALPHA5BETA3 GABAA RECEPTOR IN COMPLEX WITH GABA AND NB25","10.1038/S41422-018-0077-8 ",3.51,0,"6a96_oligo1","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcp[2<R1>]b1-4DGlcpNAcb1-ASN","MAN(5_F_)-MAN(4_F_)-[MAN(6_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(149_B_)",230.159,"","",""
"6A96","CRYO-EM STRUCTURE OF THE HUMAN ALPHA5BETA3 GABAA RECEPTOR IN COMPLEX WITH GABA AND NB25","10.1038/S41422-018-0077-8 ",3.51,0,"6a96_oligo5","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcp[2<R1>]b1-4DGlcpNAcb1-ASN","MAN(5_J_)-MAN(4_J_)-[MAN(6_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(149_E_)",187.564,"","",""
"6A96","CRYO-EM STRUCTURE OF THE HUMAN ALPHA5BETA3 GABAA RECEPTOR IN COMPLEX WITH GABA AND NB25","10.1038/S41422-018-0077-8 ",3.51,0,"6a96_oligo9","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcp[2<R1>]b1-4DGlcpNAcb1-ASN","MAN(5_Q_)-MAN(4_Q_)-[MAN(6_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(149_D_)",193.836,"","",""
"6A96","CRYO-EM STRUCTURE OF THE HUMAN ALPHA5BETA3 GABAA RECEPTOR IN COMPLEX WITH GABA AND NB25","10.1038/S41422-018-0077-8 ",3.51,0,"6a96_oligo7","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcp[2<R1>]b1-4DGlcpNAcb1-ASN","MAN(5_N_)-MAN(4_N_)-[MAN(6_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(149_C_)",197.57,"","",""
"6ANY","STRUCTURE OF BMVAL-1","10.1016/J.IJPARA.2017.12.003 ",2.25,20.95,"6any_oligo2","LFucpa1-3DGlcpNAcb1-ASN","FUC(2_B_)-NAG(1_B_)-ASN(52_A_)",29.9868,"","",""
"6ANY","STRUCTURE OF BMVAL-1","10.1016/J.IJPARA.2017.12.003 ",2.25,20.95,"6any_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","BMA(3_C_)-NAG(2_C_)-[FUC(4_C_)]-NAG(1_C_)-ASN(138_A_)",29.8989,"","",""
"6AOP","CRYSTAL STRUCTURE OF THE A/BRISBANE/10/2007 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ L194P MUTANT APO FORM","10.1371/JOURNAL.PPAT.1006682 ",2.3,60.36,"6aop_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(38_A_)",83.9157,"","",""
"6AOP","CRYSTAL STRUCTURE OF THE A/BRISBANE/10/2007 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ L194P MUTANT APO FORM","10.1371/JOURNAL.PPAT.1006682 ",2.3,60.36,"6aop_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(165_A_)",128.086,"","",""
"6AOQ","CRYSTAL STRUCTURE OF THE A/BRISBANE/10/2007 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ APO FORM","10.1371/JOURNAL.PPAT.1006682 ",2.35,66.44,"6aoq_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(38_A_)",98.1736,"","",""
"6AOR","CRYSTAL STRUCTURE OF THE A/BRISBANE/10/2007 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ APO FORM","10.1371/JOURNAL.PPAT.1006682 ",1.7,37.18,"6aor_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(38_A_)",51.8565,"","",""
"6AOS","CRYSTAL STRUCTURE OF THE A/BRISBANE/10/2007 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ L194P MUTANT IN COMPLEX WITH 3'-SLNLN","10.1371/JOURNAL.PPAT.1006682 ",2.3,56.47,"6aos_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(38_A_)",96.0571,"","",""
"6AOT","CRYSTAL STRUCTURE OF THE A/BRISBANE/10/2007 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ L194P MUTANT IN COMPLEX WITH 6'-SLNLN","10.1371/JOURNAL.PPAT.1006682 ",1.95,42.62,"6aot_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(38_A_)",75.5545,"","",""
"6AOU","CRYSTAL STRUCTURE OF THE A/BRISBANE/10/2007 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ IN COMPLEX WITH 3'-SLNLN","10.1371/JOURNAL.PPAT.1006682 ",1.75,38.38,"6aou_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(38_A_)",54.0207,"","",""
"6AOV","CRYSTAL STRUCTURE OF THE A/BRISBANE/10/2007 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ IN COMPLEX WITH 6'-SLNLN","10.1371/JOURNAL.PPAT.1006682 ",1.75,40.44,"6aov_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(38_A_)",60.4962,"","",""
"6AOX","F9 PILUS ADHESIN FMLH LECTIN DOMAIN FROM E. COLI UTI89 CO-CRYSTALLIZED WITH TF ANTIGEN","10.1073/PNAS.1720140115 ",2.1,0,"6aox_oligo2","DGalpb1-3DGalpNAca1-ROH","GAL(2_D_)-A2G(1_D_)",28.2536,"","",""
"6AOX","F9 PILUS ADHESIN FMLH LECTIN DOMAIN FROM E. COLI UTI89 CO-CRYSTALLIZED WITH TF ANTIGEN","10.1073/PNAS.1720140115 ",2.1,0,"6aox_oligo1","DGalpb1-3DGalpNAca1-ROH","GAL(2_C_)-A2G(1_C_)",33.54,"","",""
"6AQ5","X-RAY CRYSTAL STRUCTURE OF ERYTHRINA CRISTA-GALLI LECTIN IN COMPLEX WITH EPILACTOSE","",2.19,0,"6aq5_oligo1","DXylpb1-2[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(5_D_)-[XYP(4_D_)]-BMA(3_D_)-NAG(2_D_)-[FUC(6_D_)]-NAG(1_D_)-ASN(113_A_)",50.841,"","",""
"6AQ6","X-RAY CRYSTAL STRUCTURE OF ERYTHRINA CRISTA-GALLI LECTIN IN COMPLEX WITH N-ACETYLLACTOSAMINE","10.1021/ACS.JCIM.8B00120 ",1.9,0,"6aq6_oligo1","DXylpb1-2[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(5_D_)-[XYP(4_D_)]-BMA(3_D_)-NAG(2_D_)-[FUC(6_D_)]-NAG(1_D_)-ASN(113_A_)",36.4621,"","",""
"6ARU","STRUCTURE OF CETUXIMAB FAB MUTANT IN COMPLEX WITH EGFR EXTRACELLULAR DOMAIN","",3.2,0,"6aru_oligo1","DManpa1-3DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_D_)-[MAN(7_D_)]-MAN(6_D_)-[MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(328_A_)",63.5727,"","",""
"6B0N","CRYSTAL STRUCTURE OF THE CLEAVAGE-INDEPENDENT PREFUSION HIV ENV GLYCOPROTEIN TRIMER OF THE CLADE A BG505 ISOLATE (NFL CONSTRUCT) IN COMPLEX WITH FABS PGT122 AND PGV19 AT 3.39 A","10.1038/S41467-018-04272-Y ",3.4,0,"6b0n_oligo15","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_S_)-[MAN(7_S_)]-MAN(6_S_)-[MAN(5_S_)-MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(448_G_)",144.044,"","",""
"6B0N","CRYSTAL STRUCTURE OF THE CLEAVAGE-INDEPENDENT PREFUSION HIV ENV GLYCOPROTEIN TRIMER OF THE CLADE A BG505 ISOLATE (NFL CONSTRUCT) IN COMPLEX WITH FABS PGT122 AND PGV19 AT 3.39 A","10.1038/S41467-018-04272-Y ",3.4,0,"6b0n_oligo9","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_A_)-MAN(6_A_)-[MAN(5_A_)-MAN(4_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(156_G_)",122.551,"","",""
"6B0N","CRYSTAL STRUCTURE OF THE CLEAVAGE-INDEPENDENT PREFUSION HIV ENV GLYCOPROTEIN TRIMER OF THE CLADE A BG505 ISOLATE (NFL CONSTRUCT) IN COMPLEX WITH FABS PGT122 AND PGV19 AT 3.39 A","10.1038/S41467-018-04272-Y ",3.4,0,"6b0n_oligo10","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_F_)-MAN(7_F_)-[MAN(6_F_)-MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(262_G_)",120.07,"","",""
"6B0N","CRYSTAL STRUCTURE OF THE CLEAVAGE-INDEPENDENT PREFUSION HIV ENV GLYCOPROTEIN TRIMER OF THE CLADE A BG505 ISOLATE (NFL CONSTRUCT) IN COMPLEX WITH FABS PGT122 AND PGV19 AT 3.39 A","10.1038/S41467-018-04272-Y ",3.4,0,"6b0n_oligo3","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_M_)-MAN(7_M_)-[MAN(6_M_)-MAN(5_M_)]-MAN(4_M_)-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(332_G_)",121.475,"","",""
"6B0N","CRYSTAL STRUCTURE OF THE CLEAVAGE-INDEPENDENT PREFUSION HIV ENV GLYCOPROTEIN TRIMER OF THE CLADE A BG505 ISOLATE (NFL CONSTRUCT) IN COMPLEX WITH FABS PGT122 AND PGV19 AT 3.39 A","10.1038/S41467-018-04272-Y ",3.4,0,"6b0n_oligo11","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(276_G_)",158.373,"","",""
"6B0N","CRYSTAL STRUCTURE OF THE CLEAVAGE-INDEPENDENT PREFUSION HIV ENV GLYCOPROTEIN TRIMER OF THE CLADE A BG505 ISOLATE (NFL CONSTRUCT) IN COMPLEX WITH FABS PGT122 AND PGV19 AT 3.39 A","10.1038/S41467-018-04272-Y ",3.4,0,"6b0n_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcp[2<R1>]b1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(363_G_)",83.9627,"","",""
"6B24","CRYSTAL STRUCTURE OF FLUORIDE CHANNEL FLUC EC2 F80Y MUTANT","10.7554/ELIFE.31259 ",2.75,93.52,"6b24_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(101_D_)-DMU(101_D_)",128.896,"","",""
"6B24","CRYSTAL STRUCTURE OF FLUORIDE CHANNEL FLUC EC2 F80Y MUTANT","10.7554/ELIFE.31259 ",2.75,93.52,"6b24_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(201_A_)-DMU(201_A_)",96.4136,"","",""
"6B24","CRYSTAL STRUCTURE OF FLUORIDE CHANNEL FLUC EC2 F80Y MUTANT","10.7554/ELIFE.31259 ",2.75,93.52,"6b24_oligo3","DGlcpa1-3DGlcpb6-C10O1","DMU(201_B_)-DMU(201_B_)",105.917,"","",""
"6B2A","CRYSTAL STRUCTURE OF FLUORIDE CHANNEL FLUC EC2 F80M MUTANT","10.7554/ELIFE.31259 ",2.65,78.97,"6b2a_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(101_C_)-DMU(101_C_)",115.912,"","",""
"6B2A","CRYSTAL STRUCTURE OF FLUORIDE CHANNEL FLUC EC2 F80M MUTANT","10.7554/ELIFE.31259 ",2.65,78.97,"6b2a_oligo3","DGlcpa1-3DGlcpb6-C10O1","DMU(201_B_)-DMU(201_B_)",79.1514,"","",""
"6B2A","CRYSTAL STRUCTURE OF FLUORIDE CHANNEL FLUC EC2 F80M MUTANT","10.7554/ELIFE.31259 ",2.65,78.97,"6b2a_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(202_A_)-DMU(202_A_)",92.2323,"","",""
"6B2B","CRYSTAL STRUCTURE OF FLUORIDE CHANNEL FLUC EC2 F83M MUTANT","10.7554/ELIFE.31259 ",2.6,82.65,"6b2b_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(201_B_)-DMU(201_B_)",86.6505,"","",""
"6B2B","CRYSTAL STRUCTURE OF FLUORIDE CHANNEL FLUC EC2 F83M MUTANT","10.7554/ELIFE.31259 ",2.6,82.65,"6b2b_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(201_A_)-DMU(201_A_)",98.6159,"","",""
"6B2B","CRYSTAL STRUCTURE OF FLUORIDE CHANNEL FLUC EC2 F83M MUTANT","10.7554/ELIFE.31259 ",2.6,82.65,"6b2b_oligo3","DGlcpa1-3DGlcpb6-C10O1","DMU(202_A_)-DMU(202_A_)",144.966,"","",""
"6B2D","CRYSTAL STRUCTURE OF FLUORIDE CHANNEL FLUC EC2 T114S MUTANT","10.7554/ELIFE.31259 ",3.01,108.6,"6b2d_oligo3","DGlcpa1-3DGlcpb6-C10O1","DMU(101_C_)-DMU(101_C_)",150.403,"","",""
"6B2D","CRYSTAL STRUCTURE OF FLUORIDE CHANNEL FLUC EC2 T114S MUTANT","10.7554/ELIFE.31259 ",3.01,108.6,"6b2d_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(201_B_)-DMU(201_B_)",106.22,"","",""
"6B2D","CRYSTAL STRUCTURE OF FLUORIDE CHANNEL FLUC EC2 T114S MUTANT","10.7554/ELIFE.31259 ",3.01,108.6,"6b2d_oligo1","DGlcpa1-3DGlcpb6-C7O1","DMU(202_A_)-DMU(202_A_)",121.825,"","",""
"6B3D","CRYSTAL STRUCTURE OF ANTI-HIV ANTIBODY PGT128 IN COMPLEX WITH A BACTERIALLY DERIVED SYNTHETIC MIMETIC OF MAN9.","10.1038/S41467-017-01640-Y ",2.27,0,"6b3d_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6DManpa1-6]DManpa1-ROH","MAN(7_A_)-MAN(6_A_)-MAN(5_A_)-[MAN(4_A_)-MAN(3_A_)-MAN(2_A_)]-MAN(1_A_)",50.3658,"","",""
"6B3M","THE CRYSTAL STRUCTURE OF A BROADLY-REACTIVE HUMAN ANTI-HEMAGGLUTININ STALK ANTIBODY (70-1F02) IN COMPLEX WITH H5 HEMAGGLUTININ","10.1128/JVI.00949-18 ",3.92,60.36,"6b3m_oligo13","DManpa1-3DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_k_)-MAN(3_k_)-NAG(2_k_)-NAG(1_k_)-ASN(286_G_)",111.09,"","",""
"6B3M","THE CRYSTAL STRUCTURE OF A BROADLY-REACTIVE HUMAN ANTI-HEMAGGLUTININ STALK ANTIBODY (70-1F02) IN COMPLEX WITH H5 HEMAGGLUTININ","10.1128/JVI.00949-18 ",3.92,60.36,"6b3m_oligo18","DManpa1-3DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_p_)-MAN(3_p_)-NAG(2_p_)-NAG(1_p_)-ASN(165_S_)",163.728,"","",""
"6B3M","THE CRYSTAL STRUCTURE OF A BROADLY-REACTIVE HUMAN ANTI-HEMAGGLUTININ STALK ANTIBODY (70-1F02) IN COMPLEX WITH H5 HEMAGGLUTININ","10.1128/JVI.00949-18 ",3.92,60.36,"6b3m_oligo17","DManpa1-3DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_o_)-MAN(3_o_)-NAG(2_o_)-NAG(1_o_)-ASN(286_S_)",79.6736,"","",""
"6B3M","THE CRYSTAL STRUCTURE OF A BROADLY-REACTIVE HUMAN ANTI-HEMAGGLUTININ STALK ANTIBODY (70-1F02) IN COMPLEX WITH H5 HEMAGGLUTININ","10.1128/JVI.00949-18 ",3.92,60.36,"6b3m_oligo14","DManpa1-3[DManpb1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAca1-ASN","BMA(5_l_)-[MAN(4_l_)]-MAN(3_l_)-NAG(2_l_)-NAG(1_l_)-ASN(286_Q_)",72.0587,"","",""
"6B3S","CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF NECITUMUMAB (FAB11F8) IN COMPLEX WITH DOMAIN III FROM A CETUXIMAB RESISTANT VARIANT OF EGFR (SEGFRD3-S468R)","10.1158/1535-7163.MCT-17-0575 ",2.8,73.81,"6b3s_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_P_)-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(328_B_)",100.203,"","",""
"6B3S","CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF NECITUMUMAB (FAB11F8) IN COMPLEX WITH DOMAIN III FROM A CETUXIMAB RESISTANT VARIANT OF EGFR (SEGFRD3-S468R)","10.1158/1535-7163.MCT-17-0575 ",2.8,73.81,"6b3s_oligo6","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_R_)-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(328_E_)",99.7277,"","",""
"6B9O","STRUCTURE OF GH 38 JACK BEAN ALPHA-MANNOSIDASE","10.1002/ANIE.201801202 ",1.84,0,"6b9o_oligo3","DManpa1-3DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(12_E_)-MAN(11_E_)-[MAN(10_E_)-MAN(9_E_)]-MAN(8_E_)-[MAN(7_E_)-MAN(6_E_)-MAN(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(446_B_)",31.4421,"","",""
"6B9O","STRUCTURE OF GH 38 JACK BEAN ALPHA-MANNOSIDASE","10.1002/ANIE.201801202 ",1.84,0,"6b9o_oligo1","DManpa1-3DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(12_C_)-MAN(11_C_)-[MAN(10_C_)-MAN(9_C_)]-MAN(8_C_)-[MAN(7_C_)-MAN(6_C_)-MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(446_A_)",28.9786,"","",""
"6B9P","STRUCTURE OF GH 38 JACK BEAN ALPHA-MANNOSIDASE IN COMPLEX WITH A 36- VALENT IMINOSUGAR CLUSTER INHIBITOR","10.1002/ANIE.201801202 ",2,0,"6b9p_oligo5","DManpa1-3DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(12_C_)-MAN(11_C_)-[MAN(10_C_)-MAN(9_C_)]-MAN(8_C_)-[MAN(7_C_)-MAN(6_C_)-MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(446_A_)",32.879,"","",""
"6B9P","STRUCTURE OF GH 38 JACK BEAN ALPHA-MANNOSIDASE IN COMPLEX WITH A 36- VALENT IMINOSUGAR CLUSTER INHIBITOR","10.1002/ANIE.201801202 ",2,0,"6b9p_oligo7","DManpa1-3DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(12_E_)-MAN(11_E_)-[MAN(10_E_)-MAN(9_E_)]-MAN(8_E_)-[MAN(7_E_)-MAN(6_E_)-MAN(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(446_B_)",33.5281,"","",""
"6BBE","STRUCTURE OF N-GLYCOSYLATED PORCINE SURFACTANT PROTEIN-D","10.1074/JBC.RA117.001430 ",1.9,47.45,"6bbe_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_B_)-MAN(6_B_)-[NAG(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(303_A_)",63.2997,"","",""
"6BE1","CRYO-EM STRUCTURE OF SEROTONIN RECEPTOR","10.1038/S41467-018-02997-4 ",4.31,0,"6be1_oligo9","DManpb1-3DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(164_D_)",112.673,"","",""
"6BE6","ADAM10 EXTRACELLULAR DOMAIN","10.1016/J.CELL.2017.11.014 ",2.8,0,"6be6_oligo3","DManpa1-2DManpa1-3DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-MAN(4_G_)-MAN(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(278_C_)",50.3313,"","",""
"6BE6","ADAM10 EXTRACELLULAR DOMAIN","10.1016/J.CELL.2017.11.014 ",2.8,0,"6be6_oligo4","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_H_)-[MAN(7_H_)]-MAN(6_H_)-[MAN(5_H_)-MAN(4_H_)]-MAN(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(278_D_)",69.1525,"","",""
"6BE6","ADAM10 EXTRACELLULAR DOMAIN","10.1016/J.CELL.2017.11.014 ",2.8,0,"6be6_oligo1","DManpa1-3DManpa1-3DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-MAN(4_E_)-MAN(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(278_A_)",55.7436,"","",""
"6BE6","ADAM10 EXTRACELLULAR DOMAIN","10.1016/J.CELL.2017.11.014 ",2.8,0,"6be6_oligo2","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_F_)-MAN(6_F_)-[MAN(5_F_)-MAN(4_F_)]-MAN(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(278_B_)",63.866,"","",""
"6BF4","CRYSTAL STRUCTURE OF HIV-1 CLADE AE STRAIN CNE55 GP120 CORE IN COMPLEX WITH NEUTRALIZING ANTIBODY VRC-PG05 THAT TARGETS THE CENTER OF THE SILENT FACE ON THE OUTER DOMAIN OF GP120","10.1016/J.IMMUNI.2018.02.013 ",2.38,90.14,"6bf4_oligo8","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)-MAN(4_F_)]-MAN(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(295_A_)",98.7605,"","",""
"6BF4","CRYSTAL STRUCTURE OF HIV-1 CLADE AE STRAIN CNE55 GP120 CORE IN COMPLEX WITH NEUTRALIZING ANTIBODY VRC-PG05 THAT TARGETS THE CENTER OF THE SILENT FACE ON THE OUTER DOMAIN OF GP120","10.1016/J.IMMUNI.2018.02.013 ",2.38,90.14,"6bf4_oligo6","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_N_)-[MAN(8_N_)]-MAN(7_N_)-[MAN(6_N_)-MAN(5_N_)-MAN(4_N_)]-MAN(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(448_G_)",68.9015,"","",""
"6BF4","CRYSTAL STRUCTURE OF HIV-1 CLADE AE STRAIN CNE55 GP120 CORE IN COMPLEX WITH NEUTRALIZING ANTIBODY VRC-PG05 THAT TARGETS THE CENTER OF THE SILENT FACE ON THE OUTER DOMAIN OF GP120","10.1016/J.IMMUNI.2018.02.013 ",2.38,90.14,"6bf4_oligo5","DManpa1-2DManpa1-3DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-MAN(4_M_)-MAN(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(295_G_)",87.616,"","",""
"6BF4","CRYSTAL STRUCTURE OF HIV-1 CLADE AE STRAIN CNE55 GP120 CORE IN COMPLEX WITH NEUTRALIZING ANTIBODY VRC-PG05 THAT TARGETS THE CENTER OF THE SILENT FACE ON THE OUTER DOMAIN OF GP120","10.1016/J.IMMUNI.2018.02.013 ",2.38,90.14,"6bf4_oligo1","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_D_)-MAN(7_D_)-[MAN(6_D_)-MAN(5_D_)]-MAN(4_D_)-[MAN(10_D_)-MAN(9_D_)]-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(262_A_)",77.4074,"","",""
"6BF4","CRYSTAL STRUCTURE OF HIV-1 CLADE AE STRAIN CNE55 GP120 CORE IN COMPLEX WITH NEUTRALIZING ANTIBODY VRC-PG05 THAT TARGETS THE CENTER OF THE SILENT FACE ON THE OUTER DOMAIN OF GP120","10.1016/J.IMMUNI.2018.02.013 ",2.38,90.14,"6bf4_oligo4","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-MAN(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(289_G_)",120.837,"","",""
"6BF4","CRYSTAL STRUCTURE OF HIV-1 CLADE AE STRAIN CNE55 GP120 CORE IN COMPLEX WITH NEUTRALIZING ANTIBODY VRC-PG05 THAT TARGETS THE CENTER OF THE SILENT FACE ON THE OUTER DOMAIN OF GP120","10.1016/J.IMMUNI.2018.02.013 ",2.38,90.14,"6bf4_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_J_)-MAN(10_J_)-[MAN(9_J_)-MAN(8_J_)]-MAN(7_J_)-[MAN(6_J_)-MAN(5_J_)-MAN(4_J_)]-MAN(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(262_G_)",61.5408,"","",""
"6BF4","CRYSTAL STRUCTURE OF HIV-1 CLADE AE STRAIN CNE55 GP120 CORE IN COMPLEX WITH NEUTRALIZING ANTIBODY VRC-PG05 THAT TARGETS THE CENTER OF THE SILENT FACE ON THE OUTER DOMAIN OF GP120","10.1016/J.IMMUNI.2018.02.013 ",2.38,90.14,"6bf4_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_I_)-[MAN(8_I_)]-MAN(7_I_)-[MAN(6_I_)-MAN(5_I_)-MAN(4_I_)]-MAN(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(448_A_)",88.3234,"","",""
"6BFU","GLYCAN SHIELD AND FUSION ACTIVATION OF A DELTACORONAVIRUS SPIKE GLYCOPROTEIN FINE-TUNED FOR ENTERIC INFECTIONS","10.1128/JVI.01628-17 ",3.5,0,"6bfu_oligo16","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(472_A_)",110.471,"","",""
"6BFU","GLYCAN SHIELD AND FUSION ACTIVATION OF A DELTACORONAVIRUS SPIKE GLYCOPROTEIN FINE-TUNED FOR ENTERIC INFECTIONS","10.1128/JVI.01628-17 ",3.5,0,"6bfu_oligo14","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_d_)-[MAN(5_d_)-MAN(4_d_)]-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(74_C_)",78.9352,"","",""
"6BFU","GLYCAN SHIELD AND FUSION ACTIVATION OF A DELTACORONAVIRUS SPIKE GLYCOPROTEIN FINE-TUNED FOR ENTERIC INFECTIONS","10.1128/JVI.01628-17 ",3.5,0,"6bfu_oligo24","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Q_)-[MAN(5_Q_)-MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(74_B_)",78.9352,"","",""
"6BFU","GLYCAN SHIELD AND FUSION ACTIVATION OF A DELTACORONAVIRUS SPIKE GLYCOPROTEIN FINE-TUNED FOR ENTERIC INFECTIONS","10.1128/JVI.01628-17 ",3.5,0,"6bfu_oligo27","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(241_A_)",109.422,"","",""
"6BFU","GLYCAN SHIELD AND FUSION ACTIVATION OF A DELTACORONAVIRUS SPIKE GLYCOPROTEIN FINE-TUNED FOR ENTERIC INFECTIONS","10.1128/JVI.01628-17 ",3.5,0,"6bfu_oligo32","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_i_)-[MAN(4_i_)]-BMA(3_i_)-NAG(2_i_)-NAG(1_i_)-ASN(472_C_)",110.471,"","",""
"6BFU","GLYCAN SHIELD AND FUSION ACTIVATION OF A DELTACORONAVIRUS SPIKE GLYCOPROTEIN FINE-TUNED FOR ENTERIC INFECTIONS","10.1128/JVI.01628-17 ",3.5,0,"6bfu_oligo29","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_f_)-[MAN(5_f_)-MAN(4_f_)]-BMA(3_f_)-NAG(2_f_)-NAG(1_f_)-ASN(241_C_)",109.422,"","",""
"6BFU","GLYCAN SHIELD AND FUSION ACTIVATION OF A DELTACORONAVIRUS SPIKE GLYCOPROTEIN FINE-TUNED FOR ENTERIC INFECTIONS","10.1128/JVI.01628-17 ",3.5,0,"6bfu_oligo2","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-[MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(74_A_)",78.9352,"","",""
"6BFU","GLYCAN SHIELD AND FUSION ACTIVATION OF A DELTACORONAVIRUS SPIKE GLYCOPROTEIN FINE-TUNED FOR ENTERIC INFECTIONS","10.1128/JVI.01628-17 ",3.5,0,"6bfu_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_V_)-[MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(472_B_)",110.471,"","",""
"6BFU","GLYCAN SHIELD AND FUSION ACTIVATION OF A DELTACORONAVIRUS SPIKE GLYCOPROTEIN FINE-TUNED FOR ENTERIC INFECTIONS","10.1128/JVI.01628-17 ",3.5,0,"6bfu_oligo22","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_O_)-[MAN(5_O_)-MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(914_A_)",63.1094,"","",""
"6BFU","GLYCAN SHIELD AND FUSION ACTIVATION OF A DELTACORONAVIRUS SPIKE GLYCOPROTEIN FINE-TUNED FOR ENTERIC INFECTIONS","10.1128/JVI.01628-17 ",3.5,0,"6bfu_oligo12","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_b_)-[MAN(5_b_)-MAN(4_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(914_B_)",63.1094,"","",""
"6BFU","GLYCAN SHIELD AND FUSION ACTIVATION OF A DELTACORONAVIRUS SPIKE GLYCOPROTEIN FINE-TUNED FOR ENTERIC INFECTIONS","10.1128/JVI.01628-17 ",3.5,0,"6bfu_oligo38","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_o_)-[MAN(5_o_)-MAN(4_o_)]-BMA(3_o_)-NAG(2_o_)-NAG(1_o_)-ASN(914_C_)",63.1094,"","",""
"6BFU","GLYCAN SHIELD AND FUSION ACTIVATION OF A DELTACORONAVIRUS SPIKE GLYCOPROTEIN FINE-TUNED FOR ENTERIC INFECTIONS","10.1128/JVI.01628-17 ",3.5,0,"6bfu_oligo3","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_S_)-[MAN(5_S_)-MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(241_B_)",109.422,"","",""
"6BHQ","MOUSE IMMUNOGLOBULIN G 2C FC FRAGMENT WITH COMPLEX-TYPE GLYCAN","10.1371/JOURNAL.PONE.0192123 ",2.05,0,"6bhq_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(8_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",59.9193,"","",""
"6BHQ","MOUSE IMMUNOGLOBULIN G 2C FC FRAGMENT WITH COMPLEX-TYPE GLYCAN","10.1371/JOURNAL.PONE.0192123 ",2.05,0,"6bhq_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcx1-","FUL(8_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)",99.2546,"","",""
"6BKM","CRYSTAL STRUCTURE OF THE A/HONG KONG/1/1968 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ E190D MUTANT APO FORM","10.1038/S41467-018-03663-5 ",2.2,49.69,"6bkm_oligo6","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_L_)-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(165_E_)",81.3316,"","",""
"6BKN","CRYSTAL STRUCTURE OF THE A/WYOMING/3/2003 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ APO FORM","10.1038/S41467-018-03663-5 ",1.85,40.17,"6bkn_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(38_A_)",57.0916,"","",""
"6BKO","CRYSTAL STRUCTURE OF THE A/WYOMING/3/2003 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ D190E MUTANT APO FORM","10.1038/S41467-018-03663-5 ",1.85,33.27,"6bko_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(38_A_)",45.8743,"","",""
"6BKQ","CRYSTAL STRUCTURE OF THE A/HONG KONG/1/1968 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ E190D MUTANT IN COMPLEX WITH 6'-SLN","10.1038/S41467-018-03663-5 ",2.25,49.48,"6bkq_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(165_E_)",82.9898,"","",""
"6BKQ","CRYSTAL STRUCTURE OF THE A/HONG KONG/1/1968 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ E190D MUTANT IN COMPLEX WITH 6'-SLN","10.1038/S41467-018-03663-5 ",2.25,49.48,"6bkq_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(165_C_)",72,"","",""
"6BKR","CRYSTAL STRUCTURE OF THE A/WYOMING/3/2003 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ IN COMPLEX WITH 6'-SLN","10.1038/S41467-018-03663-5 ",1.76,33.6,"6bkr_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(38_A_)",49.0015,"","",""
"6BKS","CRYSTAL STRUCTURE OF THE A/WYOMING/3/2003 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ D190E MUTANT IN COMPLEX WITH 6'-SLN","10.1038/S41467-018-03663-5 ",1.8,33.17,"6bks_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(38_A_)",56.9004,"","",""
"6BP2","THERAPEUTIC HUMAN MONOCLONAL ANTIBODY MR191 BOUND TO A MARBURGVIRUS GLYCOPROTEIN","10.1016/J.CHOM.2017.12.003 ",3.17,0,"6bp2_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(3_E_)-[MAN(2_E_)]-BMA(1_E_)-NAG(2_F_)-NAG(1_F_)",120.37,"","",""
"6BPL","E. COLI MSBA IN COMPLEX WITH LPS AND INHIBITOR G907","10.1038/S41586-018-0083-5 ",2.91,0,"6bpl_oligo2","DGlcpa1-3[DGlcpa1-6]DGlcpa1-3[GMH1-7]GMH1-","GMH(5_C_)-[GLC(4_C_)-[GLC(3_C_)]-GLC(2_C_)]-GMH(1_C_)",160.065,"","",""
"6BPP","E. COLI MSBA IN COMPLEX WITH LPS AND INHIBITOR G092","10.1038/S41586-018-0083-5 ",2.92,0,"6bpp_oligo1","DGlcpa1-3[DGlcpa1-6]DGlcpa1-3[GMH1-7]GMH1-3GMH1-5[DKdopa2-4]DKdopa2-6DGlcp[2<R1>,3<R2>,4P]b1-6DGlcp[2<R3>,3<R4>]a1-O4P1","GMH(9_C_)-[GLC(8_C_)-[GLC(7_C_)]-GLC(6_C_)]-GMH(5_C_)-GMH(4_C_)-[KDO(10_C_)]-KDO(3_C_)-GCS(2_C_)-PA1(1_C_)",142.913,"","",""
"6BR5","N2 NEURAMINIDASE IN COMPLEX WITH A NOVEL ANTIVIRAL COMPOUND","10.1002/CMDC.201800092 ",2.04,41.91,"6br5_oligo3","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(200_A_)",60.8159,"","",""
"6BR6","N2 NEURAMINIDASE IN COMPLEX WITH A NOVEL ANTIVIRAL COMPOUND","10.1002/CMDC.201800092 ",2.04,34.15,"6br6_oligo1","DManpa1-2DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-MAN(5_B_)-MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",51.875,"","",""
"6BX4","THE CRYSTAL STRUCTURE OF FLUORIDE CHANNEL FLUC EC2 WITH MONOBODY S9","10.1021/ACS.BIOCHEM.7B01272 ",2.55,73.65,"6bx4_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(203_A_)-DMU(203_A_)",73.39,"","",""
"6BX4","THE CRYSTAL STRUCTURE OF FLUORIDE CHANNEL FLUC EC2 WITH MONOBODY S9","10.1021/ACS.BIOCHEM.7B01272 ",2.55,73.65,"6bx4_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(203_B_)-DMU(203_B_)",81.9759,"","",""
"6BZ4","HUMAN IGG1 LACKING COMPLEMENT-DEPENDENT CYTOTOXICITY: HU3S193 FC MUTANT K322A","10.1042/BCJ20180139 ",2.4,0,"6bz4_oligo1","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_D_)-MAN(4_D_)-[MAN(6_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(297_B_)",120.514,"","",""
"6BZ4","HUMAN IGG1 LACKING COMPLEMENT-DEPENDENT CYTOTOXICITY: HU3S193 FC MUTANT K322A","10.1042/BCJ20180139 ",2.4,0,"6bz4_oligo2","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_C_)-[NAG(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",105.338,"","",""
"6C01","HUMAN ECTONUCLEOTIDE PYROPHOSPHATASE / PHOSPHODIESTERASE 3 (ENPP3, NPP3, CD203C)","10.1111/FEBS.14489 ",2.3,0,"6c01_oligo6","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_G_)-[MAN(4_G_)-BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(699_A_)",64.0786,"","",""
"6C01","HUMAN ECTONUCLEOTIDE PYROPHOSPHATASE / PHOSPHODIESTERASE 3 (ENPP3, NPP3, CD203C)","10.1111/FEBS.14489 ",2.3,0,"6c01_oligo14","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_P_)-[MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(594_B_)",51.0462,"","",""
"6C01","HUMAN ECTONUCLEOTIDE PYROPHOSPHATASE / PHOSPHODIESTERASE 3 (ENPP3, NPP3, CD203C)","10.1111/FEBS.14489 ",2.3,0,"6c01_oligo10","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_L_)-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(279_B_)",64.8439,"","",""
"6C0M","THE SYNTHESIS, BIOLOGICAL EVALUATION AND STRUCTURAL INSIGHTS OF UNSATURATED 3-N-SUBSTITUTED SIALIC ACIDS AS PROBES OF HUMAN PARAINFLUENZA VIRUS-3 HAEMAGGLUTININ-NEURAMINIDASE","10.1021/ACSCHEMBIO.8B00150 ",1.83,35.27,"6c0m_oligo7","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(351_A_)",58.4218,"","",""
"6C13","CRYOEM STRUCTURE OF MOUSE PCDH15-4EC-LHFPL5 COMPLEX","10.7554/ELIFE.38770 ",11.33,"1.15243e-41","6c13_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(1089_A_)",728.227,"","",""
"6C13","CRYOEM STRUCTURE OF MOUSE PCDH15-4EC-LHFPL5 COMPLEX","10.7554/ELIFE.38770 ",11.33,"1.15243e-41","6c13_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(1180_A_)",646.185,"","",""
"6C13","CRYOEM STRUCTURE OF MOUSE PCDH15-4EC-LHFPL5 COMPLEX","10.7554/ELIFE.38770 ",11.33,"1.15243e-41","6c13_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(1069_B_)",916.966,"","",""
"6C13","CRYOEM STRUCTURE OF MOUSE PCDH15-4EC-LHFPL5 COMPLEX","10.7554/ELIFE.38770 ",11.33,"1.15243e-41","6c13_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(1180_B_)",551.682,"","",""
"6C13","CRYOEM STRUCTURE OF MOUSE PCDH15-4EC-LHFPL5 COMPLEX","10.7554/ELIFE.38770 ",11.33,"1.15243e-41","6c13_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(1069_A_)",887.17,"","",""
"6C13","CRYOEM STRUCTURE OF MOUSE PCDH15-4EC-LHFPL5 COMPLEX","10.7554/ELIFE.38770 ",11.33,"1.15243e-41","6c13_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(1089_B_)",650.966,"","",""
"6C5M","STRUCTURE OF GLYCOLIPID AGSA[8,9] IN COMPLEX WITH MOUSE CD1D","10.1074/JBC.RA119.009963 ",2.45,40.77,"6c5m_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_D_)-[MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(165_A_)",49.2726,"","",""
"6C5V","AN ANTI-GH/GL ANTIBODY THAT NEUTRALIZES DUAL-TROPIC INFECTION DEFINES A SITE OF VULNERABILITY ON EPSTEIN-BARR VIRUS","10.1016/J.IMMUNI.2018.03.026 ",4.8,"3.72823e-08","6c5v_oligo2","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-[MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(60_A_)",171.986,"","",""
"6C6C","STRUCTURE OF GLYCOLIPID AGSA[20,6P] IN COMPLEX WITH MOUSE CD1D","10.1074/JBC.RA119.009963 ",2.08,39.61,"6c6c_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_C_)-[MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(165_A_)",43.7442,"","",""
"6C6F","STRUCTURE OF GLYCOLIPID AGSA[26,P5P] IN COMPLEX WITH MOUSE CD1D","",1.67,31.77,"6c6f_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_C_)-[MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(165_A_)",37.2041,"","",""
"6C6H","STRUCTURE OF GLYCOLIPID AGSA[8,P5M] IN COMPLEX WITH MOUSE CD1D","10.1074/JBC.RA119.009963 ",2,37.91,"6c6h_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_C_)-[MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(165_A_)",39.86,"","",""
"6C6J","STRUCTURE OF GLYCOLIPID AGSA[8,P5P] IN COMPLEX WITH MOUSE CD1D","10.1074/JBC.RA119.009963 ",1.79,33.48,"6c6j_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_C_)-[MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(165_A_)",36.807,"","",""
"6CBJ","CRYSTAL STRUCTURE OF DH270.3 FAB IN COMPLEX WITH MAN9","10.1038/S41467-018-03565-6 ",2.85,62.62,"6cbj_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(11_A_)-MAN(10_A_)-[MAN(9_A_)-MAN(8_A_)]-MAN(7_A_)-[MAN(6_A_)-MAN(5_A_)-MAN(4_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)",40.358,"","",""
"6CBP","CRYSTAL STRUCTURE OF THE SINGLE CHAIN VARIABLE FRAGMENT OF THE DH270.6 BNAB IN COMPLEX WITH THE MAN9-V3 GLYCOPEPTIDE","10.1038/S41467-018-03565-6 ",2.17,39.92,"6cbp_oligo3","DManpa1-2DManpa1-3DManpx1-","MAN(3_D_)-MAN(2_D_)-MAN(1_D_)",30,"","",""
"6CBP","CRYSTAL STRUCTURE OF THE SINGLE CHAIN VARIABLE FRAGMENT OF THE DH270.6 BNAB IN COMPLEX WITH THE MAN9-V3 GLYCOPEPTIDE","10.1038/S41467-018-03565-6 ",2.17,39.92,"6cbp_oligo2","DManpa1-2DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(6_C_)-MAN(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)",30,"","",""
"6CCB","CRYSTAL STRUCTURE OF 253-11 SOSIP TRIMER IN COMPLEX WITH 10-1074 FAB","10.1128/JVI.02261-17 ",6.5,0,"6ccb_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_I_)-MAN(8_I_)-[MAN(10_I_)]-MAN(7_I_)-[MAN(6_I_)-MAN(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(332_C_)",456.253,"","",""
"6CCB","CRYSTAL STRUCTURE OF 253-11 SOSIP TRIMER IN COMPLEX WITH 10-1074 FAB","10.1128/JVI.02261-17 ",6.5,0,"6ccb_oligo1","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-MAN(4_F_)-[MAN(6_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(262_C_)",486.559,"","",""
"6CCB","CRYSTAL STRUCTURE OF 253-11 SOSIP TRIMER IN COMPLEX WITH 10-1074 FAB","10.1128/JVI.02261-17 ",6.5,0,"6ccb_oligo4","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_K_)-[MAN(7_K_)]-MAN(6_K_)-[MAN(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(332_G_)",469.68,"","",""
"6CE0","CRYSTAL STRUCTURE OF A HIV-1 CLADE B TIER-3 ISOLATE H078.14 UFO-BG ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING FABS PGT124 AND 35O22 AT 4.6 ANGSTROM","10.1126/SCIADV.AAU6769 ",4.6,0,"6ce0_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_M_)-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(386_G_)",387.46,"","",""
"6CE0","CRYSTAL STRUCTURE OF A HIV-1 CLADE B TIER-3 ISOLATE H078.14 UFO-BG ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING FABS PGT124 AND 35O22 AT 4.6 ANGSTROM","10.1126/SCIADV.AAU6769 ",4.6,0,"6ce0_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(262_G_)",340.259,"","",""
"6CE0","CRYSTAL STRUCTURE OF A HIV-1 CLADE B TIER-3 ISOLATE H078.14 UFO-BG ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING FABS PGT124 AND 35O22 AT 4.6 ANGSTROM","10.1126/SCIADV.AAU6769 ",4.6,0,"6ce0_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(88_G_)",301.663,"","",""
"6CE0","CRYSTAL STRUCTURE OF A HIV-1 CLADE B TIER-3 ISOLATE H078.14 UFO-BG ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING FABS PGT124 AND 35O22 AT 4.6 ANGSTROM","10.1126/SCIADV.AAU6769 ",4.6,0,"6ce0_oligo9","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_O_)-MAN(6_O_)-[MAN(5_O_)-MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(332_G_)",267.429,"","",""
"6CEX","CRYSTAL STRUCTURE OF THE A/HONG KONG/1/1968 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ IN COMPLEX WITH SMALL MOLECULE N-CYCLOHEXYLTAURINE","10.1073/PNAS.1801999115 ",2.57,0,"6cex_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(165_E_)",78.9036,"","",""
"6CF7","CRYSTAL STRUCTURE OF THE A/SOLOMON ISLANDS/3/2006(H1N1) INFLUENZA VIRUS HEMAGGLUTININ IN COMPLEX WITH SMALL MOLECULE JNJ4796","10.1126/SCIENCE.AAR6221 ",2.72,0,"6cf7_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(289_A_)",77.9914,"","",""
"6CH7","XFEL CRYSTAL STRUCTURE OF A NATIVELY-GLYCOSYLATED BG505 SOSIP.664 HIV- 1 ENVELOPE TRIMER IN COMPLEX WITH THE BROADLY-NEUTRALIZING ANTIBODIES BG18 AND 35O22","10.1038/S41467-018-03632-Y ",3.8,210,"6ch7_oligo11","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_O_)-[MAN(5_O_)]-MAN(4_O_)-[MAN(7_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(386_G_)",307.187,"","",""
"6CH7","XFEL CRYSTAL STRUCTURE OF A NATIVELY-GLYCOSYLATED BG505 SOSIP.664 HIV- 1 ENVELOPE TRIMER IN COMPLEX WITH THE BROADLY-NEUTRALIZING ANTIBODIES BG18 AND 35O22","10.1038/S41467-018-03632-Y ",3.8,210,"6ch7_oligo8","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_L_)-MAN(4_L_)-[MAN(6_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(276_G_)",301.744,"","",""
"6CH7","XFEL CRYSTAL STRUCTURE OF A NATIVELY-GLYCOSYLATED BG505 SOSIP.664 HIV- 1 ENVELOPE TRIMER IN COMPLEX WITH THE BROADLY-NEUTRALIZING ANTIBODIES BG18 AND 35O22","10.1038/S41467-018-03632-Y ",3.8,210,"6ch7_oligo5","DManpa1-3DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_K_)-MAN(6_K_)-[MAN(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(262_G_)",287.382,"","",""
"6CH7","XFEL CRYSTAL STRUCTURE OF A NATIVELY-GLYCOSYLATED BG505 SOSIP.664 HIV- 1 ENVELOPE TRIMER IN COMPLEX WITH THE BROADLY-NEUTRALIZING ANTIBODIES BG18 AND 35O22","10.1038/S41467-018-03632-Y ",3.8,210,"6ch7_oligo7","DGlcpNAcb1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_F_)-[MAN(7_F_)-MAN(6_F_)-[NAG(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(156_G_)",305.989,"","",""
"6CH7","XFEL CRYSTAL STRUCTURE OF A NATIVELY-GLYCOSYLATED BG505 SOSIP.664 HIV- 1 ENVELOPE TRIMER IN COMPLEX WITH THE BROADLY-NEUTRALIZING ANTIBODIES BG18 AND 35O22","10.1038/S41467-018-03632-Y ",3.8,210,"6ch7_oligo14","DManpa1-3DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_T_)-[MAN(6_T_)-MAN(5_T_)]-MAN(4_T_)-[MAN(9_T_)-MAN(8_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(332_G_)",235.459,"","",""
"6CH7","XFEL CRYSTAL STRUCTURE OF A NATIVELY-GLYCOSYLATED BG505 SOSIP.664 HIV- 1 ENVELOPE TRIMER IN COMPLEX WITH THE BROADLY-NEUTRALIZING ANTIBODIES BG18 AND 35O22","10.1038/S41467-018-03632-Y ",3.8,210,"6ch7_oligo12","DManpa1-6DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_P_)-MAN(5_P_)-MAN(4_P_)-[MAN(7_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(392_G_)",277.518,"","",""
"6CH7","XFEL CRYSTAL STRUCTURE OF A NATIVELY-GLYCOSYLATED BG505 SOSIP.664 HIV- 1 ENVELOPE TRIMER IN COMPLEX WITH THE BROADLY-NEUTRALIZING ANTIBODIES BG18 AND 35O22","10.1038/S41467-018-03632-Y ",3.8,210,"6ch7_oligo13","DManpa1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-MAN(4_S_)-[MAN(6_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(448_G_)",297.833,"","",""
"6CH7","XFEL CRYSTAL STRUCTURE OF A NATIVELY-GLYCOSYLATED BG505 SOSIP.664 HIV- 1 ENVELOPE TRIMER IN COMPLEX WITH THE BROADLY-NEUTRALIZING ANTIBODIES BG18 AND 35O22","10.1038/S41467-018-03632-Y ",3.8,210,"6ch7_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(88_G_)",260.109,"","",""
"6CH8","CRYSTAL STRUCTURE OF A NATIVELY-GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENVELOPE TRIMER IN COMPLEX WITH THE BROADLY-NEUTRALIZING ANTIBODIES BG18 AND 35O22","10.1038/S41467-018-03632-Y ",4.1,229.7,"6ch8_oligo1","DManpa1-6DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_F_)-MAN(6_F_)-[MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(88_G_)",248.408,"","",""
"6CH8","CRYSTAL STRUCTURE OF A NATIVELY-GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENVELOPE TRIMER IN COMPLEX WITH THE BROADLY-NEUTRALIZING ANTIBODIES BG18 AND 35O22","10.1038/S41467-018-03632-Y ",4.1,229.7,"6ch8_oligo14","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_T_)-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(392_G_)",283.239,"","",""
"6CH8","CRYSTAL STRUCTURE OF A NATIVELY-GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENVELOPE TRIMER IN COMPLEX WITH THE BROADLY-NEUTRALIZING ANTIBODIES BG18 AND 35O22","10.1038/S41467-018-03632-Y ",4.1,229.7,"6ch8_oligo10","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_K_)-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(197_G_)",299.396,"","",""
"6CH8","CRYSTAL STRUCTURE OF A NATIVELY-GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENVELOPE TRIMER IN COMPLEX WITH THE BROADLY-NEUTRALIZING ANTIBODIES BG18 AND 35O22","10.1038/S41467-018-03632-Y ",4.1,229.7,"6ch8_oligo16","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-6DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_V_)-MAN(5_V_)-[MAN(7_V_)]-MAN(4_V_)-[MAN(9_V_)-MAN(8_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(332_G_)",236.741,"","",""
"6CH8","CRYSTAL STRUCTURE OF A NATIVELY-GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENVELOPE TRIMER IN COMPLEX WITH THE BROADLY-NEUTRALIZING ANTIBODIES BG18 AND 35O22","10.1038/S41467-018-03632-Y ",4.1,229.7,"6ch8_oligo5","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_P_)-MAN(4_P_)-[MAN(6_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(301_G_)",331.698,"","",""
"6CH8","CRYSTAL STRUCTURE OF A NATIVELY-GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENVELOPE TRIMER IN COMPLEX WITH THE BROADLY-NEUTRALIZING ANTIBODIES BG18 AND 35O22","10.1038/S41467-018-03632-Y ",4.1,229.7,"6ch8_oligo6","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(8_S_)-[MAN(7_S_)]-MAN(6_S_)-[MAN(5_S_)-MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)",311.548,"","",""
"6CH8","CRYSTAL STRUCTURE OF A NATIVELY-GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENVELOPE TRIMER IN COMPLEX WITH THE BROADLY-NEUTRALIZING ANTIBODIES BG18 AND 35O22","10.1038/S41467-018-03632-Y ",4.1,229.7,"6ch8_oligo3","DManpa1-6DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(7_N_)-[MAN(6_N_)-MAN(5_N_)]-MAN(4_N_)-[MAN(8_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)",318.833,"","",""
"6CH8","CRYSTAL STRUCTURE OF A NATIVELY-GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENVELOPE TRIMER IN COMPLEX WITH THE BROADLY-NEUTRALIZING ANTIBODIES BG18 AND 35O22","10.1038/S41467-018-03632-Y ",4.1,229.7,"6ch8_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(133_G_)",309.752,"","",""
"6CH8","CRYSTAL STRUCTURE OF A NATIVELY-GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENVELOPE TRIMER IN COMPLEX WITH THE BROADLY-NEUTRALIZING ANTIBODIES BG18 AND 35O22","10.1038/S41467-018-03632-Y ",4.1,229.7,"6ch8_oligo12","DManpa1-3[DManpa1-6]DManpa1-6[DManp[2<R1>]a1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_M_)-[MAN(5_M_)]-MAN(4_M_)-MAN(7_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(262_G_)",279.778,"","",""
"6CH8","CRYSTAL STRUCTURE OF A NATIVELY-GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENVELOPE TRIMER IN COMPLEX WITH THE BROADLY-NEUTRALIZING ANTIBODIES BG18 AND 35O22","10.1038/S41467-018-03632-Y ",4.1,229.7,"6ch8_oligo15","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_U_)-[MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(448_G_)",311.695,"","",""
"6CH8","CRYSTAL STRUCTURE OF A NATIVELY-GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENVELOPE TRIMER IN COMPLEX WITH THE BROADLY-NEUTRALIZING ANTIBODIES BG18 AND 35O22","10.1038/S41467-018-03632-Y ",4.1,229.7,"6ch8_oligo8","DManpa1-6DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_I_)-[MAN(6_I_)-MAN(5_I_)]-MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(156_G_)",342.365,"","",""
"6CH9","CRYSTAL STRUCTURE OF A NATIVELY-GLYCOSYLATED B41 SOSIP.664 HIV-1 ENVELOPE TRIMER IN COMPLEX WITH THE BROADLY-NEUTRALIZING ANTIBODIES BG18 AND 35O22","10.1038/S41467-018-03632-Y ",4.85,281.8,"6ch9_oligo9","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_M_)-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(276_G_)",418.488,"","",""
"6CH9","CRYSTAL STRUCTURE OF A NATIVELY-GLYCOSYLATED B41 SOSIP.664 HIV-1 ENVELOPE TRIMER IN COMPLEX WITH THE BROADLY-NEUTRALIZING ANTIBODIES BG18 AND 35O22","10.1038/S41467-018-03632-Y ",4.85,281.8,"6ch9_oligo8","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_L_)-MAN(4_L_)-[MAN(6_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(262_G_)",382.337,"","",""
"6CH9","CRYSTAL STRUCTURE OF A NATIVELY-GLYCOSYLATED B41 SOSIP.664 HIV-1 ENVELOPE TRIMER IN COMPLEX WITH THE BROADLY-NEUTRALIZING ANTIBODIES BG18 AND 35O22","10.1038/S41467-018-03632-Y ",4.85,281.8,"6ch9_oligo13","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(392_G_)",375.973,"","",""
"6CH9","CRYSTAL STRUCTURE OF A NATIVELY-GLYCOSYLATED B41 SOSIP.664 HIV-1 ENVELOPE TRIMER IN COMPLEX WITH THE BROADLY-NEUTRALIZING ANTIBODIES BG18 AND 35O22","10.1038/S41467-018-03632-Y ",4.85,281.8,"6ch9_oligo15","DManpa1-6DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(6_U_)-[MAN(5_U_)-MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)",352.813,"","",""
"6CHF","CRYSTAL STRUCTURE OF A FC FRAGMENT LALA MUTANT (L234A, L235A) OF HUMAN IGG1 (CRYSTAL FORM 1)","10.1016/J.STR.2020.03.001 ",2.4,0,"6chf_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",77.8394,"","",""
"6CHF","CRYSTAL STRUCTURE OF A FC FRAGMENT LALA MUTANT (L234A, L235A) OF HUMAN IGG1 (CRYSTAL FORM 1)","10.1016/J.STR.2020.03.001 ",2.4,0,"6chf_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",130.212,"","",""
"6CI0","CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH E101A (II) MUTATION","10.1016/J.BBABIO.2018.03.017 ",2.4,66.46,"6ci0_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(605_A_)-DMU(605_A_)",67.6195,"","",""
"6CI0","CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH E101A (II) MUTATION","10.1016/J.BBABIO.2018.03.017 ",2.4,66.46,"6ci0_oligo4","DGlcpa1-3DGlcpb6-C10O1","DMU(603_A_)-DMU(603_A_)",76.5045,"","",""
"6CI0","CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH E101A (II) MUTATION","10.1016/J.BBABIO.2018.03.017 ",2.4,66.46,"6ci0_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(604_A_)-DMU(604_A_)",73.875,"","",""
"6CI0","CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH E101A (II) MUTATION","10.1016/J.BBABIO.2018.03.017 ",2.4,66.46,"6ci0_oligo9","DGlcpa1-3DGlcpb6-C10O1","DMU(601_A_)-DMU(601_A_)",102.6,"","",""
"6CI0","CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH E101A (II) MUTATION","10.1016/J.BBABIO.2018.03.017 ",2.4,66.46,"6ci0_oligo3","DGlcpa1-3DGlcpb6-C7O1","DMU(301_D_)-DMU(301_D_)",107.644,"","",""
"6CI0","CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH E101A (II) MUTATION","10.1016/J.BBABIO.2018.03.017 ",2.4,66.46,"6ci0_oligo5","DGlcpa1-3DGlcpb6-C10O1","DMU(602_A_)-DMU(602_A_)",51.5886,"","",""
"6CJC","CRYSTAL STRUCTURE OF A FC FRAGMENT LALA MUTANT (L234A, L235A) OF HUMAN IGG1 (CRYSTAL FORM 3)","10.1016/J.STR.2020.03.001 ",2.58,0,"6cjc_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",96.2532,"","",""
"6CJC","CRYSTAL STRUCTURE OF A FC FRAGMENT LALA MUTANT (L234A, L235A) OF HUMAN IGG1 (CRYSTAL FORM 3)","10.1016/J.STR.2020.03.001 ",2.58,0,"6cjc_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",104.43,"","",""
"6CJX","CRYSTAL STRUCTURE OF A FC FRAGMENT LALA MUTANT (L234A, L235A) OF HUMAN IGG1 (CRYSTAL FORM 2)","10.1016/J.STR.2020.03.001 ",2.44,0,"6cjx_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",140.362,"","",""
"6CJX","CRYSTAL STRUCTURE OF A FC FRAGMENT LALA MUTANT (L234A, L235A) OF HUMAN IGG1 (CRYSTAL FORM 2)","10.1016/J.STR.2020.03.001 ",2.44,0,"6cjx_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",167.937,"","",""
"6CK9","CRYSTAL STRUCTURE OF HIV-1 CONC_BASE0 PREFUSION ENV TRIMER IN COMPLEX WITH HUMAN ANTIBODY FRAGMENT 3H109L AND 35O22 VARIANTS AT 3.5 ANGSTROM","10.1016/J.CELREP.2018.03.061 ",2.71,59.06,"6ck9_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(156_G_)",93.7596,"","",""
"6CK9","CRYSTAL STRUCTURE OF HIV-1 CONC_BASE0 PREFUSION ENV TRIMER IN COMPLEX WITH HUMAN ANTIBODY FRAGMENT 3H109L AND 35O22 VARIANTS AT 3.5 ANGSTROM","10.1016/J.CELREP.2018.03.061 ",2.71,59.06,"6ck9_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_A_)-[MAN(4_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(262_G_)",84.8133,"","",""
"6CK9","CRYSTAL STRUCTURE OF HIV-1 CONC_BASE0 PREFUSION ENV TRIMER IN COMPLEX WITH HUMAN ANTIBODY FRAGMENT 3H109L AND 35O22 VARIANTS AT 3.5 ANGSTROM","10.1016/J.CELREP.2018.03.061 ",2.71,59.06,"6ck9_oligo12","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_N_)-MAN(8_N_)-[MAN(10_N_)]-MAN(7_N_)-[MAN(6_N_)-MAN(5_N_)-MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(332_G_)",65.5145,"","",""
"6CK9","CRYSTAL STRUCTURE OF HIV-1 CONC_BASE0 PREFUSION ENV TRIMER IN COMPLEX WITH HUMAN ANTIBODY FRAGMENT 3H109L AND 35O22 VARIANTS AT 3.5 ANGSTROM","10.1016/J.CELREP.2018.03.061 ",2.71,59.06,"6ck9_oligo3","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(88_G_)",63.2815,"","",""
"6CM3","BG505 SOSIP IN COMPLEX WITH SCD4, 17B, 8ANC195","10.1016/J.CHOM.2018.09.003 ",3.54,"1.45136e+10","6cm3_oligo6","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_Y_)-MAN(8_Y_)-[MAN(10_Y_)]-MAN(7_Y_)-[MAN(6_Y_)-MAN(5_Y_)-MAN(4_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(234_D_)",56.5979,"","",""
"6CM3","BG505 SOSIP IN COMPLEX WITH SCD4, 17B, 8ANC195","10.1016/J.CHOM.2018.09.003 ",3.54,"1.45136e+10","6cm3_oligo9","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_d_)-MAN(4_d_)-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(262_E_)",65.9431,"","",""
"6CM3","BG505 SOSIP IN COMPLEX WITH SCD4, 17B, 8ANC195","10.1016/J.CHOM.2018.09.003 ",3.54,"1.45136e+10","6cm3_oligo14","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_i_)-[MAN(4_i_)]-BMA(3_i_)-NAG(2_i_)-NAG(1_i_)-ASN(276_F_)",62.9638,"","",""
"6CM3","BG505 SOSIP IN COMPLEX WITH SCD4, 17B, 8ANC195","10.1016/J.CHOM.2018.09.003 ",3.54,"1.45136e+10","6cm3_oligo12","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_g_)-MAN(8_g_)-[MAN(10_g_)]-MAN(7_g_)-[MAN(6_g_)-MAN(5_g_)-MAN(4_g_)]-BMA(3_g_)-NAG(2_g_)-NAG(1_g_)-ASN(234_F_)",56.7279,"","",""
"6CM3","BG505 SOSIP IN COMPLEX WITH SCD4, 17B, 8ANC195","10.1016/J.CHOM.2018.09.003 ",3.54,"1.45136e+10","6cm3_oligo13","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_h_)-MAN(4_h_)-BMA(3_h_)-NAG(2_h_)-NAG(1_h_)-ASN(262_F_)",67.3804,"","",""
"6CM3","BG505 SOSIP IN COMPLEX WITH SCD4, 17B, 8ANC195","10.1016/J.CHOM.2018.09.003 ",3.54,"1.45136e+10","6cm3_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_e_)-[MAN(4_e_)]-BMA(3_e_)-NAG(2_e_)-NAG(1_e_)-ASN(276_E_)",64.0936,"","",""
"6CM3","BG505 SOSIP IN COMPLEX WITH SCD4, 17B, 8ANC195","10.1016/J.CHOM.2018.09.003 ",3.54,"1.45136e+10","6cm3_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_a_)-[MAN(4_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(276_D_)",62.4956,"","",""
"6CM3","BG505 SOSIP IN COMPLEX WITH SCD4, 17B, 8ANC195","10.1016/J.CHOM.2018.09.003 ",3.54,"1.45136e+10","6cm3_oligo8","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_c_)-MAN(8_c_)-[MAN(10_c_)]-MAN(7_c_)-[MAN(6_c_)-MAN(5_c_)-MAN(4_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(234_E_)",56.4601,"","",""
"6CM3","BG505 SOSIP IN COMPLEX WITH SCD4, 17B, 8ANC195","10.1016/J.CHOM.2018.09.003 ",3.54,"1.45136e+10","6cm3_oligo4","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Z_)-MAN(4_Z_)-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(262_D_)",65.1931,"","",""
"6CMG","CRYSTAL STRUCTURE OF THE HENDRA VIRUS ATTACHMENT G GLYCOPROTEIN BOUND TO A POTENT CROSS-REACTIVE NEUTRALIZING HUMAN MONOCLONAL ANTIBODY M102.3","10.1371/JOURNAL.PPAT.1003684 ",2.7,0,"6cmg_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(6_G_)-[MAN(4_G_)-BMA(3_G_)-NAG(2_G_)]-[FUC(5_G_)]-NAG(1_G_)-ASN(529_A_)",57.5723,"","",""
"6CMI","CRYSTAL STRUCTURE OF THE HENDRA VIRUS ATTACHMENT G GLYCOPROTEIN BOUND TO A POTENT CROSS-REACTIVE NEUTRALIZING HUMAN MONOCLONAL ANTIBODY M102.3","10.1371/JOURNAL.PPAT.1003684 ",2.72,0,"6cmi_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(6_G_)-[MAN(4_G_)-BMA(3_G_)-NAG(2_G_)]-[FUC(5_G_)]-NAG(1_G_)-ASN(529_B_)",72.0376,"","",""
"6CRD","INFLUENZA VIRUS NEURAMINIDASE SUBTYPE N9 (TERN) WITH TETRABRACHION (TB) DOMAIN STALK","10.1107/S2053230X18017892 ",2.57,22.51,"6crd_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_I_)-[MAN(8_I_)]-MAN(7_I_)-[MAN(6_I_)-MAN(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(200_A_)",23.9075,"","",""
"6CRD","INFLUENZA VIRUS NEURAMINIDASE SUBTYPE N9 (TERN) WITH TETRABRACHION (TB) DOMAIN STALK","10.1107/S2053230X18017892 ",2.57,22.51,"6crd_oligo9","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_Q_)-[MAN(8_Q_)]-MAN(7_Q_)-[MAN(6_Q_)-MAN(5_Q_)-MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(200_D_)",33.5902,"","",""
"6CRD","INFLUENZA VIRUS NEURAMINIDASE SUBTYPE N9 (TERN) WITH TETRABRACHION (TB) DOMAIN STALK","10.1107/S2053230X18017892 ",2.57,22.51,"6crd_oligo15","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_W_)-[MAN(8_W_)]-MAN(7_W_)-[MAN(6_W_)-MAN(5_W_)-MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(200_F_)",30.7528,"","",""
"6CRD","INFLUENZA VIRUS NEURAMINIDASE SUBTYPE N9 (TERN) WITH TETRABRACHION (TB) DOMAIN STALK","10.1107/S2053230X18017892 ",2.57,22.51,"6crd_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_K_)-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(146_A_)",35.762,"","",""
"6CRD","INFLUENZA VIRUS NEURAMINIDASE SUBTYPE N9 (TERN) WITH TETRABRACHION (TB) DOMAIN STALK","10.1107/S2053230X18017892 ",2.57,22.51,"6crd_oligo12","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_T_)-[MAN(8_T_)]-MAN(7_T_)-[MAN(6_T_)-MAN(5_T_)-MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(200_E_)",26.9694,"","",""
"6CRD","INFLUENZA VIRUS NEURAMINIDASE SUBTYPE N9 (TERN) WITH TETRABRACHION (TB) DOMAIN STALK","10.1107/S2053230X18017892 ",2.57,22.51,"6crd_oligo6","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_N_)-[MAN(8_N_)]-MAN(7_N_)-[MAN(6_N_)-MAN(5_N_)-MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(200_C_)",33.4303,"","",""
"6CRD","INFLUENZA VIRUS NEURAMINIDASE SUBTYPE N9 (TERN) WITH TETRABRACHION (TB) DOMAIN STALK","10.1107/S2053230X18017892 ",2.57,22.51,"6crd_oligo4","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_L_)-[MAN(8_L_)]-MAN(7_L_)-[MAN(6_L_)-MAN(5_L_)-MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(200_B_)",34.5055,"","",""
"6CRD","INFLUENZA VIRUS NEURAMINIDASE SUBTYPE N9 (TERN) WITH TETRABRACHION (TB) DOMAIN STALK","10.1107/S2053230X18017892 ",2.57,22.51,"6crd_oligo21","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_c_)-[MAN(8_c_)]-MAN(7_c_)-[MAN(6_c_)-MAN(5_c_)-MAN(4_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(200_H_)",24.9172,"","",""
"6CRD","INFLUENZA VIRUS NEURAMINIDASE SUBTYPE N9 (TERN) WITH TETRABRACHION (TB) DOMAIN STALK","10.1107/S2053230X18017892 ",2.57,22.51,"6crd_oligo18","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_Z_)-[MAN(8_Z_)]-MAN(7_Z_)-[MAN(6_Z_)-MAN(5_Z_)-MAN(4_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(200_G_)",32.5985,"","",""
"6CRQ","GLUTARALDEHYDE-TREATED BG505 SOSIP.664 ENV IN COMPLEX WITH PGV04 FAB","10.1371/JOURNAL.PPAT.1006986 ",4.2,0,"6crq_oligo25","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_k_)-BMA(3_k_)-NAG(2_k_)-NAG(1_k_)-ASN(262_F_)",99.3398,"","",""
"6CRQ","GLUTARALDEHYDE-TREATED BG505 SOSIP.664 ENV IN COMPLEX WITH PGV04 FAB","10.1371/JOURNAL.PPAT.1006986 ",4.2,0,"6crq_oligo23","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_Y_)-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(262_B_)",100.567,"","",""
"6CRQ","GLUTARALDEHYDE-TREATED BG505 SOSIP.664 ENV IN COMPLEX WITH PGV04 FAB","10.1371/JOURNAL.PPAT.1006986 ",4.2,0,"6crq_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_M_)-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(262_A_)",93.3248,"","",""
"6CRW","SARS SPIKE GLYCOPROTEIN, STABILIZED VARIANT, SINGLE UPWARDS S1 CTD CONFORMATION","10.1038/S41598-018-34171-7 ",3.9,0,"6crw_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(602_A_)",281.254,"","",""
"6CRW","SARS SPIKE GLYCOPROTEIN, STABILIZED VARIANT, SINGLE UPWARDS S1 CTD CONFORMATION","10.1038/S41598-018-34171-7 ",3.9,0,"6crw_oligo17","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_T_)-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(602_C_)",230.764,"","",""
"6CRW","SARS SPIKE GLYCOPROTEIN, STABILIZED VARIANT, SINGLE UPWARDS S1 CTD CONFORMATION","10.1038/S41598-018-34171-7 ",3.9,0,"6crw_oligo19","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_V_)-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(783_C_)",228.211,"","",""
"6CRW","SARS SPIKE GLYCOPROTEIN, STABILIZED VARIANT, SINGLE UPWARDS S1 CTD CONFORMATION","10.1038/S41598-018-34171-7 ",3.9,0,"6crw_oligo12","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_O_)-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(783_B_)",189.114,"","",""
"6CRW","SARS SPIKE GLYCOPROTEIN, STABILIZED VARIANT, SINGLE UPWARDS S1 CTD CONFORMATION","10.1038/S41598-018-34171-7 ",3.9,0,"6crw_oligo15","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_R_)-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(119_C_)",321.446,"","",""
"6CRW","SARS SPIKE GLYCOPROTEIN, STABILIZED VARIANT, SINGLE UPWARDS S1 CTD CONFORMATION","10.1038/S41598-018-34171-7 ",3.9,0,"6crw_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(699_A_)",218.604,"","",""
"6CRX","SARS SPIKE GLYCOPROTEIN, STABILIZED VARIANT, TWO S1 CTDS IN THE UPWARDS CONFORMATION","10.1038/S41598-018-34171-7 ",3.9,0,"6crx_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(783_B_)",185.901,"","",""
"6CRX","SARS SPIKE GLYCOPROTEIN, STABILIZED VARIANT, TWO S1 CTDS IN THE UPWARDS CONFORMATION","10.1038/S41598-018-34171-7 ",3.9,0,"6crx_oligo24","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_a_)-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(783_A_)",221.152,"","",""
"6CRX","SARS SPIKE GLYCOPROTEIN, STABILIZED VARIANT, TWO S1 CTDS IN THE UPWARDS CONFORMATION","10.1038/S41598-018-34171-7 ",3.9,0,"6crx_oligo21","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_X_)-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(602_A_)",253.374,"","",""
"6CRX","SARS SPIKE GLYCOPROTEIN, STABILIZED VARIANT, TWO S1 CTDS IN THE UPWARDS CONFORMATION","10.1038/S41598-018-34171-7 ",3.9,0,"6crx_oligo12","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_O_)-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(699_C_)",213.326,"","",""
"6CRX","SARS SPIKE GLYCOPROTEIN, STABILIZED VARIANT, TWO S1 CTDS IN THE UPWARDS CONFORMATION","10.1038/S41598-018-34171-7 ",3.9,0,"6crx_oligo11","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_N_)-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(602_C_)",333.715,"","",""
"6CRZ","SARS SPIKE GLYCOPROTEIN, TRYPSIN-CLEAVED, STABILIZED VARIANT, C3 SYMMETRY","10.1038/S41598-018-34171-7 ",3.3,0,"6crz_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(602_A_)",200.063,"","",""
"6CS0","SARS SPIKE GLYCOPROTEIN, TRYPSIN-CLEAVED, STABILIZED VARIANT, ONE S1 CTD IN AN UPWARDS CONFORMATION","10.1038/S41598-018-34171-7 ",3.8,0,"6cs0_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(602_A_)",200.063,"","",""
"6CS1","SARS SPIKE GLYCOPROTEIN, TRYPSIN-CLEAVED, STABILIZED VARIANT, TWO S1 CTDS IN AN UPWARDS CONFORMATION","10.1038/S41598-018-34171-7 ",4.6,0,"6cs1_oligo13","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_P_)-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(783_C_)",202.204,"","",""
"6CS1","SARS SPIKE GLYCOPROTEIN, TRYPSIN-CLEAVED, STABILIZED VARIANT, TWO S1 CTDS IN AN UPWARDS CONFORMATION","10.1038/S41598-018-34171-7 ",4.6,0,"6cs1_oligo11","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_N_)-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(602_C_)",386.635,"","",""
"6CS1","SARS SPIKE GLYCOPROTEIN, TRYPSIN-CLEAVED, STABILIZED VARIANT, TWO S1 CTDS IN AN UPWARDS CONFORMATION","10.1038/S41598-018-34171-7 ",4.6,0,"6cs1_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(699_B_)",267.93,"","",""
"6CS1","SARS SPIKE GLYCOPROTEIN, TRYPSIN-CLEAVED, STABILIZED VARIANT, TWO S1 CTDS IN AN UPWARDS CONFORMATION","10.1038/S41598-018-34171-7 ",4.6,0,"6cs1_oligo16","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(269_A_)",283.217,"","",""
"6CS1","SARS SPIKE GLYCOPROTEIN, TRYPSIN-CLEAVED, STABILIZED VARIANT, TWO S1 CTDS IN AN UPWARDS CONFORMATION","10.1038/S41598-018-34171-7 ",4.6,0,"6cs1_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(783_B_)",283.525,"","",""
"6CS1","SARS SPIKE GLYCOPROTEIN, TRYPSIN-CLEAVED, STABILIZED VARIANT, TWO S1 CTDS IN AN UPWARDS CONFORMATION","10.1038/S41598-018-34171-7 ",4.6,0,"6cs1_oligo12","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_O_)-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(699_C_)",331.951,"","",""
"6CS2","SARS SPIKE GLYCOPROTEIN - HUMAN ACE2 COMPLEX, STABILIZED VARIANT, ALL ACE2-BOUND PARTICLES","10.1038/S41598-018-34171-7 ",4.4,0,"6cs2_oligo15","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_S_)-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(783_B_)",245.105,"","",""
"6CS2","SARS SPIKE GLYCOPROTEIN - HUMAN ACE2 COMPLEX, STABILIZED VARIANT, ALL ACE2-BOUND PARTICLES","10.1038/S41598-018-34171-7 ",4.4,0,"6cs2_oligo24","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_b_)-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(783_C_)",246.598,"","",""
"6CS2","SARS SPIKE GLYCOPROTEIN - HUMAN ACE2 COMPLEX, STABILIZED VARIANT, ALL ACE2-BOUND PARTICLES","10.1038/S41598-018-34171-7 ",4.4,0,"6cs2_oligo12","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_P_)-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(318_B_)",277.997,"","",""
"6CS2","SARS SPIKE GLYCOPROTEIN - HUMAN ACE2 COMPLEX, STABILIZED VARIANT, ALL ACE2-BOUND PARTICLES","10.1038/S41598-018-34171-7 ",4.4,0,"6cs2_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_H_)-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(699_A_)",219.623,"","",""
"6CS2","SARS SPIKE GLYCOPROTEIN - HUMAN ACE2 COMPLEX, STABILIZED VARIANT, ALL ACE2-BOUND PARTICLES","10.1038/S41598-018-34171-7 ",4.4,0,"6cs2_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(783_A_)",224.56,"","",""
"6CS2","SARS SPIKE GLYCOPROTEIN - HUMAN ACE2 COMPLEX, STABILIZED VARIANT, ALL ACE2-BOUND PARTICLES","10.1038/S41598-018-34171-7 ",4.4,0,"6cs2_oligo6","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_K_)-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(1080_A_)",259.431,"","",""
"6CS2","SARS SPIKE GLYCOPROTEIN - HUMAN ACE2 COMPLEX, STABILIZED VARIANT, ALL ACE2-BOUND PARTICLES","10.1038/S41598-018-34171-7 ",4.4,0,"6cs2_oligo7","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_L_)-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(1116_A_)",298.218,"","",""
"6CS2","SARS SPIKE GLYCOPROTEIN - HUMAN ACE2 COMPLEX, STABILIZED VARIANT, ALL ACE2-BOUND PARTICLES","10.1038/S41598-018-34171-7 ",4.4,0,"6cs2_oligo26","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_d_)-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(602_C_)",215.126,"","",""
"6CS2","SARS SPIKE GLYCOPROTEIN - HUMAN ACE2 COMPLEX, STABILIZED VARIANT, ALL ACE2-BOUND PARTICLES","10.1038/S41598-018-34171-7 ",4.4,0,"6cs2_oligo23","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_a_)-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(699_C_)",220.926,"","",""
"6CS2","SARS SPIKE GLYCOPROTEIN - HUMAN ACE2 COMPLEX, STABILIZED VARIANT, ALL ACE2-BOUND PARTICLES","10.1038/S41598-018-34171-7 ",4.4,0,"6cs2_oligo27","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_e_)-BMA(3_e_)-NAG(2_e_)-NAG(1_e_)-ASN(1080_C_)",215.52,"","",""
"6CXA","STRUCTURE OF ALPHA-GSA[20,6P] BOUND BY CD1D AND IN COMPLEX WITH THE VA14VB8.2 TCR","10.1074/JBC.RA119.009963 ",2.65,52.62,"6cxa_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_E_)-[MAN(4_E_)-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(165_A_)",94.3502,"","",""
"6CXF","STRUCTURE OF ALPHA-GSA[26,P5P] BOUND BY CD1D AND IN COMPLEX WITH THE VA14VB8.2 TCR","10.1074/JBC.RA119.009963 ",2.5,42.13,"6cxf_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_E_)-[MAN(4_E_)-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(165_A_)",85.3584,"","",""
"6CXG","ANTI-HIV-1 FAB 2G12 IN COMPLEX WITH GLYCOPEPTIDE 10V1S","10.1021/ACSCENTSCI.8B00588 ",2.3,0,"6cxg_oligo2","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpx1-","MAN(4_D_)-MAN(3_D_)-[MAN(5_D_)]-MAN(2_D_)-[MAN(7_D_)-MAN(6_D_)]-BMA(1_D_)",47.9012,"","",""
"6CXG","ANTI-HIV-1 FAB 2G12 IN COMPLEX WITH GLYCOPEPTIDE 10V1S","10.1021/ACSCENTSCI.8B00588 ",2.3,0,"6cxg_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpx1-","MAN(9_B_)-MAN(8_B_)-[MAN(7_B_)-MAN(6_B_)]-MAN(5_B_)-[MAN(4_B_)-MAN(3_B_)-MAN(2_B_)]-BMA(1_B_)",47.9755,"","",""
"6CXL","ANTI-HIV-1 FAB 2G12 IN COMPLEX WITH GLYCOPEPTIDE 10F5","10.1021/ACSCENTSCI.8B00588 ",3.59,0,"6cxl_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpx1-","MAN(9_B_)-MAN(8_B_)-[MAN(7_B_)-MAN(6_B_)]-MAN(5_B_)-[MAN(4_B_)-MAN(3_B_)-MAN(2_B_)]-BMA(1_B_)",94.9361,"","",""
"6CXL","ANTI-HIV-1 FAB 2G12 IN COMPLEX WITH GLYCOPEPTIDE 10F5","10.1021/ACSCENTSCI.8B00588 ",3.59,0,"6cxl_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpx1-","MAN(9_A_)-MAN(8_A_)-[MAN(7_A_)-MAN(6_A_)]-MAN(5_A_)-[MAN(4_A_)-MAN(3_A_)-MAN(2_A_)]-BMA(1_A_)",89.3802,"","",""
"6CZK","CRYSTAL STRUCTURE OF WILD-TYPE HUMAN PRO-CATHEPSIN H","10.1371/JOURNAL.PONE.0200374 ",2,0,"6czk_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(208_A_)",41.3411,"","",""
"6CZS","CRYSTAL STRUCTURE OF HUMAN PRO-CATHEPSIN H C26S MUTANT","10.1371/JOURNAL.PONE.0200374 ",1.66,0,"6czs_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(230_A_)",37.7451,"","",""
"6D0J","CRYSTAL STRUCTURE OF A CLC-TYPE FLUORIDE/PROTON ANTIPORTER","10.1038/S41594-018-0082-0 ",3,153.3,"6d0j_oligo3","DGlcpa1-3DGlcpb6-C10O1","DMU(501_B_)-DMU(501_B_)",172.91,"","",""
"6D0J","CRYSTAL STRUCTURE OF A CLC-TYPE FLUORIDE/PROTON ANTIPORTER","10.1038/S41594-018-0082-0 ",3,153.3,"6d0j_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(504_A_)-DMU(504_A_)",238.422,"","",""
"6D0J","CRYSTAL STRUCTURE OF A CLC-TYPE FLUORIDE/PROTON ANTIPORTER","10.1038/S41594-018-0082-0 ",3,153.3,"6d0j_oligo4","DGlcpa1-3DGlcpb6-C10O1","DMU(502_A_)-DMU(502_A_)",185.033,"","",""
"6D0J","CRYSTAL STRUCTURE OF A CLC-TYPE FLUORIDE/PROTON ANTIPORTER","10.1038/S41594-018-0082-0 ",3,153.3,"6d0j_oligo6","DGlcpa1-3DGlcpb6-C3O1","DMU(502_B_)-DMU(502_B_)",218.55,"","",""
"6D0J","CRYSTAL STRUCTURE OF A CLC-TYPE FLUORIDE/PROTON ANTIPORTER","10.1038/S41594-018-0082-0 ",3,153.3,"6d0j_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(503_A_)-DMU(503_A_)",192.799,"","",""
"6D0J","CRYSTAL STRUCTURE OF A CLC-TYPE FLUORIDE/PROTON ANTIPORTER","10.1038/S41594-018-0082-0 ",3,153.3,"6d0j_oligo5","DGlcpa1-3DGlcpb6-C10O1","DMU(501_A_)-DMU(501_A_)",189.181,"","",""
"6D0K","CRYSTAL STRUCTURE OF A CLC-TYPE FLUORIDE/PROTON ANTIPORTER, E118Q MUTANT","10.1038/S41594-018-0082-0 ",3.35,192.6,"6d0k_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(504_A_)-DMU(504_A_)",272.208,"","",""
"6D0K","CRYSTAL STRUCTURE OF A CLC-TYPE FLUORIDE/PROTON ANTIPORTER, E118Q MUTANT","10.1038/S41594-018-0082-0 ",3.35,192.6,"6d0k_oligo5","DGlcpa1-3DGlcpb6-C10O1","DMU(502_A_)-DMU(502_A_)",228.565,"","",""
"6D0K","CRYSTAL STRUCTURE OF A CLC-TYPE FLUORIDE/PROTON ANTIPORTER, E118Q MUTANT","10.1038/S41594-018-0082-0 ",3.35,192.6,"6d0k_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(503_A_)-DMU(503_A_)",228.409,"","",""
"6D0K","CRYSTAL STRUCTURE OF A CLC-TYPE FLUORIDE/PROTON ANTIPORTER, E118Q MUTANT","10.1038/S41594-018-0082-0 ",3.35,192.6,"6d0k_oligo3","DGlcpa1-3DGlcpb6-C10O1","DMU(501_B_)-DMU(501_B_)",220.896,"","",""
"6D0K","CRYSTAL STRUCTURE OF A CLC-TYPE FLUORIDE/PROTON ANTIPORTER, E118Q MUTANT","10.1038/S41594-018-0082-0 ",3.35,192.6,"6d0k_oligo6","DGlcpa1-3DGlcpb6-C10O1","DMU(501_A_)-DMU(501_A_)",240.646,"","",""
"6D0K","CRYSTAL STRUCTURE OF A CLC-TYPE FLUORIDE/PROTON ANTIPORTER, E118Q MUTANT","10.1038/S41594-018-0082-0 ",3.35,192.6,"6d0k_oligo4","DGlcpa1-3DGlcpb6-C3O1","DMU(502_B_)-DMU(502_B_)",265.839,"","",""
"6D0N","CRYSTAL STRUCTURE OF A CLC-TYPE FLUORIDE/PROTON ANTIPORTER, V319G MUTANT","10.1038/S41594-018-0082-0 ",3.12,169.9,"6d0n_oligo3","DGlcpa1-3DGlcpb6-C10O1","DMU(502_B_)-DMU(502_B_)",181.158,"","",""
"6D0N","CRYSTAL STRUCTURE OF A CLC-TYPE FLUORIDE/PROTON ANTIPORTER, V319G MUTANT","10.1038/S41594-018-0082-0 ",3.12,169.9,"6d0n_oligo4","DGlcpa1-3DGlcpb6-C10O1","DMU(502_A_)-DMU(502_A_)",194.613,"","",""
"6D0N","CRYSTAL STRUCTURE OF A CLC-TYPE FLUORIDE/PROTON ANTIPORTER, V319G MUTANT","10.1038/S41594-018-0082-0 ",3.12,169.9,"6d0n_oligo5","DGlcpa1-3DGlcpb6-C10O1","DMU(501_A_)-DMU(501_A_)",232.166,"","",""
"6D0N","CRYSTAL STRUCTURE OF A CLC-TYPE FLUORIDE/PROTON ANTIPORTER, V319G MUTANT","10.1038/S41594-018-0082-0 ",3.12,169.9,"6d0n_oligo6","DGlcpa1-3DGlcpb6-C3O1","DMU(503_B_)-DMU(503_B_)",249.02,"","",""
"6D0N","CRYSTAL STRUCTURE OF A CLC-TYPE FLUORIDE/PROTON ANTIPORTER, V319G MUTANT","10.1038/S41594-018-0082-0 ",3.12,169.9,"6d0n_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(501_B_)-DMU(501_B_)",183.24,"","",""
"6D0N","CRYSTAL STRUCTURE OF A CLC-TYPE FLUORIDE/PROTON ANTIPORTER, V319G MUTANT","10.1038/S41594-018-0082-0 ",3.12,169.9,"6d0n_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(503_A_)-DMU(503_A_)",268.748,"","",""
"6D3B","INFLUENZA VIRUS NEURAMINIDASE SUBTYPE N9 (TERN) APO FORM","10.1107/S2053230X18017892 ",1.4,16.52,"6d3b_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_B_)-[MAN(8_B_)]-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",21.1986,"","",""
"6D4E","CRYSTAL STRUCTURE OF A FC FRAGMENT OF RHESUS MACAQUE (MACACA MULATTA) IGG1.","10.1080/19420862.2019.1589852 ",2.8,0,"6d4e_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",111.014,"","",""
"6D4E","CRYSTAL STRUCTURE OF A FC FRAGMENT OF RHESUS MACAQUE (MACACA MULATTA) IGG1.","10.1080/19420862.2019.1589852 ",2.8,0,"6d4e_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",110.489,"","",""
"6D4I","CRYSTAL STRUCTURE OF A FC FRAGMENT OF RHESUS MACAQUE (MACACA MULATTA) IGG2","10.1080/19420862.2019.1589852 ",2.95,0,"6d4i_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",95.5868,"","",""
"6D4I","CRYSTAL STRUCTURE OF A FC FRAGMENT OF RHESUS MACAQUE (MACACA MULATTA) IGG2","10.1080/19420862.2019.1589852 ",2.95,0,"6d4i_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",95.3006,"","",""
"6D4M","CRYSTAL STRUCTURE OF A FC FRAGMENT OF RHESUS MACAQUE (MACACA MULATTA) IGG3","10.1080/19420862.2019.1589852 ",3.47,0,"6d4m_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",107.192,"","",""
"6D4M","CRYSTAL STRUCTURE OF A FC FRAGMENT OF RHESUS MACAQUE (MACACA MULATTA) IGG3","10.1080/19420862.2019.1589852 ",3.47,0,"6d4m_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",99.9066,"","",""
"6D4N","CRYSTAL STRUCTURE OF A FC FRAGMENT OF RHESUS MACAQUE (MACACA MULATTA) IGG4","10.1080/19420862.2019.1589852 ",3.25,0,"6d4n_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",150.107,"","",""
"6D4N","CRYSTAL STRUCTURE OF A FC FRAGMENT OF RHESUS MACAQUE (MACACA MULATTA) IGG4","10.1080/19420862.2019.1589852 ",3.25,0,"6d4n_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",154.221,"","",""
"6D58","CRYSTAL STRUCTURE OF A FC FRAGMENT OF HUMAN IGG3","",2.39,0,"6d58_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",137.351,"","",""
"6D58","CRYSTAL STRUCTURE OF A FC FRAGMENT OF HUMAN IGG3","",2.39,0,"6d58_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",148.324,"","",""
"6D64","CRYSTAL STRUCTURE OF HUMAN CD1B IN COMPLEX WITH POPC","10.1038/S41467-018-07898-0 ",1.7,27.99,"6d64_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(7_C_)-[MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-[FUC(6_C_)]-NAG(1_C_)-ASN(57_A_)",21.0556,"","",""
"6D64","CRYSTAL STRUCTURE OF HUMAN CD1B IN COMPLEX WITH POPC","10.1038/S41467-018-07898-0 ",1.7,27.99,"6d64_oligo2","LFucpa1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_D_)-[NAG(3_D_)]-[FUC(2_D_)]-NAG(1_D_)-ASN(20_A_)",63.6391,"","",""
"6D64","CRYSTAL STRUCTURE OF HUMAN CD1B IN COMPLEX WITH POPC","10.1038/S41467-018-07898-0 ",1.7,27.99,"6d64_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4[DManpa1-3]DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-[MAN(5_E_)]-NAG(1_E_)-ASN(128_A_)",62.3656,"","",""
"6D6T","HUMAN GABA-A RECEPTOR ALPHA1-BETA2-GAMMA2 SUBTYPE IN COMPLEX WITH GABA AND FLUMAZENIL, CONFORMATION B","10.1038/S41586-018-0255-3 ",3.8,"1.35632e-19","6d6t_oligo4","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_G_)-[MAN(7_G_)]-MAN(6_G_)-[MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(111_B_)",58.4757,"","",""
"6D6T","HUMAN GABA-A RECEPTOR ALPHA1-BETA2-GAMMA2 SUBTYPE IN COMPLEX WITH GABA AND FLUMAZENIL, CONFORMATION B","10.1038/S41586-018-0255-3 ",3.8,"1.35632e-19","6d6t_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(111_D_)",93.8427,"","",""
"6D6U","HUMAN GABA-A RECEPTOR ALPHA1-BETA2-GAMMA2 SUBTYPE IN COMPLEX WITH GABA AND FLUMAZENIL, CONFORMATION A","10.1038/S41586-018-0255-3 ",3.8,"1.35632e-19","6d6u_oligo1","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_G_)-[MAN(7_G_)]-MAN(6_G_)-[MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(111_B_)",52.6052,"","",""
"6D6U","HUMAN GABA-A RECEPTOR ALPHA1-BETA2-GAMMA2 SUBTYPE IN COMPLEX WITH GABA AND FLUMAZENIL, CONFORMATION A","10.1038/S41586-018-0255-3 ",3.8,"1.35632e-19","6d6u_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(111_D_)",79.2356,"","",""
"6D8D","THE CRYSTAL STRUCTURE OF HEMAGGLUTININ FROM A/HONG KONG/125/2017 INFLUENZA VIRUS IN COMPLEX WITH LSTB","10.1128/JVI.00375-18 ",3.55,69.55,"6d8d_oligo3","DGalpb1-3DGlcpNAcx1-","GAL(2_I_)-NAG(1_I_)",153.283,"","",""
"6D8D","THE CRYSTAL STRUCTURE OF HEMAGGLUTININ FROM A/HONG KONG/125/2017 INFLUENZA VIRUS IN COMPLEX WITH LSTB","10.1128/JVI.00375-18 ",3.55,69.55,"6d8d_oligo2","DGalpb1-3[DNeup5Aca2-6]DGlcpNAcx1-","SIA(3_H_)-[GAL(2_H_)]-NAG(1_H_)",140.114,"","",""
"6D8D","THE CRYSTAL STRUCTURE OF HEMAGGLUTININ FROM A/HONG KONG/125/2017 INFLUENZA VIRUS IN COMPLEX WITH LSTB","10.1128/JVI.00375-18 ",3.55,69.55,"6d8d_oligo1","DGalpb1-3[DNeup5Aca2-6]DGlcpNAcx1-","SIA(3_G_)-[GAL(2_G_)]-NAG(1_G_)",140.114,"","",""
"6DCQ","ECTODOMAIN OF FULL LENGTH, WILD TYPE HIV-1 GLYCOPROTEIN CLONE PC64M18C043 IN COMPLEX WITH PGT151 FAB","10.1016/J.CELREP.2018.05.046 ",3.1,"8.10669e+08","6dcq_oligo34","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_k_)-MAN(6_k_)-[MAN(5_k_)-MAN(4_k_)]-BMA(3_k_)-NAG(2_k_)-NAG(1_k_)-ASN(262_E_)",100.304,"","",""
"6DCQ","ECTODOMAIN OF FULL LENGTH, WILD TYPE HIV-1 GLYCOPROTEIN CLONE PC64M18C043 IN COMPLEX WITH PGT151 FAB","10.1016/J.CELREP.2018.05.046 ",3.1,"8.10669e+08","6dcq_oligo35","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_S_)-[MAN(5_S_)-MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(262_A_)",117.212,"","",""
"6DCQ","ECTODOMAIN OF FULL LENGTH, WILD TYPE HIV-1 GLYCOPROTEIN CLONE PC64M18C043 IN COMPLEX WITH PGT151 FAB","10.1016/J.CELREP.2018.05.046 ",3.1,"8.10669e+08","6dcq_oligo17","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_c_)-[MAN(4_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(262_C_)",94.8387,"","",""
"6DCQ","ECTODOMAIN OF FULL LENGTH, WILD TYPE HIV-1 GLYCOPROTEIN CLONE PC64M18C043 IN COMPLEX WITH PGT151 FAB","10.1016/J.CELREP.2018.05.046 ",3.1,"8.10669e+08","6dcq_oligo26","DGlcpNAcb1-2[DGlcpNAcb1-4]DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_r_)-[NAG(8_r_)-MAN(7_r_)-[NAG(6_r_)-[NAG(5_r_)]-MAN(4_r_)]-BMA(3_r_)-NAG(2_r_)]-NAG(1_r_)-ASN(637_F_)",97.8233,"","",""
"6DCQ","ECTODOMAIN OF FULL LENGTH, WILD TYPE HIV-1 GLYCOPROTEIN CLONE PC64M18C043 IN COMPLEX WITH PGT151 FAB","10.1016/J.CELREP.2018.05.046 ",3.1,"8.10669e+08","6dcq_oligo28","DGalpb1-4DGlcpNAcb1-2[DGalpb1-4DGlcpNAcb1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(10_f_)-[GAL(8_f_)-NAG(7_f_)-[GAL(6_f_)-NAG(5_f_)]-MAN(4_f_)-[MAN(9_f_)]-BMA(3_f_)-NAG(2_f_)]-NAG(1_f_)-ASN(611_D_)",69.7595,"","",""
"6DCQ","ECTODOMAIN OF FULL LENGTH, WILD TYPE HIV-1 GLYCOPROTEIN CLONE PC64M18C043 IN COMPLEX WITH PGT151 FAB","10.1016/J.CELREP.2018.05.046 ",3.1,"8.10669e+08","6dcq_oligo30","DGlcpNAcb1-2[DGlcpNAcb1-4]DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_g_)-[NAG(8_g_)-MAN(7_g_)-[NAG(6_g_)-[NAG(5_g_)]-MAN(4_g_)]-BMA(3_g_)-NAG(2_g_)]-NAG(1_g_)-ASN(637_D_)",80.832,"","",""
"6DE7","CRYSTAL STRUCTURE AT 4.3 A RESOLUTION OF GLYCOSYLATED HIV-1 CLADE A BG505 SOSIP.664 PREFUSION ENV TRIMER WITH INTERDOMAIN STABILIZATION 113C-429GCG IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122 AND 35O22","10.1016/J.CHOM.2018.05.002 ",4.12,0,"6de7_oligo15","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_U_)-[MAN(8_U_)]-MAN(7_U_)-[MAN(6_U_)-MAN(5_U_)-MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(332_G_)",95.6592,"","",""
"6DE7","CRYSTAL STRUCTURE AT 4.3 A RESOLUTION OF GLYCOSYLATED HIV-1 CLADE A BG505 SOSIP.664 PREFUSION ENV TRIMER WITH INTERDOMAIN STABILIZATION 113C-429GCG IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122 AND 35O22","10.1016/J.CHOM.2018.05.002 ",4.12,0,"6de7_oligo8","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(137_G_)",94.4002,"","",""
"6DE7","CRYSTAL STRUCTURE AT 4.3 A RESOLUTION OF GLYCOSYLATED HIV-1 CLADE A BG505 SOSIP.664 PREFUSION ENV TRIMER WITH INTERDOMAIN STABILIZATION 113C-429GCG IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122 AND 35O22","10.1016/J.CHOM.2018.05.002 ",4.12,0,"6de7_oligo2","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_J_)-[MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(262_G_)",96.4859,"","",""
"6DE7","CRYSTAL STRUCTURE AT 4.3 A RESOLUTION OF GLYCOSYLATED HIV-1 CLADE A BG505 SOSIP.664 PREFUSION ENV TRIMER WITH INTERDOMAIN STABILIZATION 113C-429GCG IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122 AND 35O22","10.1016/J.CHOM.2018.05.002 ",4.12,0,"6de7_oligo7","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)]-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(88_G_)",93.0773,"","",""
"6DE7","CRYSTAL STRUCTURE AT 4.3 A RESOLUTION OF GLYCOSYLATED HIV-1 CLADE A BG505 SOSIP.664 PREFUSION ENV TRIMER WITH INTERDOMAIN STABILIZATION 113C-429GCG IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122 AND 35O22","10.1016/J.CHOM.2018.05.002 ",4.12,0,"6de7_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_P_)-[MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(156_G_)",105.345,"","",""
"6DFG","BG505 MD39 SOSIP TRIMER IN COMPLEX WITH MATURE BG18 FRAGMENT ANTIGEN BINDING","10.1126/SCIENCE.AAX4380 ",4.42,"1.35632e-19","6dfg_oligo27","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_m_)-MAN(8_m_)-[MAN(10_m_)]-MAN(7_m_)-[MAN(6_m_)-MAN(5_m_)-MAN(4_m_)]-BMA(3_m_)-NAG(2_m_)-NAG(1_m_)-ASN(332_D_)",158.471,"","",""
"6DFG","BG505 MD39 SOSIP TRIMER IN COMPLEX WITH MATURE BG18 FRAGMENT ANTIGEN BINDING","10.1126/SCIENCE.AAX4380 ",4.42,"1.35632e-19","6dfg_oligo29","DManpa1-2DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_o_)-MAN(5_o_)-MAN(4_o_)-BMA(3_o_)-NAG(2_o_)-NAG(1_o_)-ASN(392_D_)",181.931,"","",""
"6DFG","BG505 MD39 SOSIP TRIMER IN COMPLEX WITH MATURE BG18 FRAGMENT ANTIGEN BINDING","10.1126/SCIENCE.AAX4380 ",4.42,"1.35632e-19","6dfg_oligo7","DManpa1-2DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_U_)-MAN(5_U_)-MAN(4_U_)-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(392_A_)",196.359,"","",""
"6DFG","BG505 MD39 SOSIP TRIMER IN COMPLEX WITH MATURE BG18 FRAGMENT ANTIGEN BINDING","10.1126/SCIENCE.AAX4380 ",4.42,"1.35632e-19","6dfg_oligo8","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_P_)-[MAN(5_P_)-MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(262_A_)",178.303,"","",""
"6DFG","BG505 MD39 SOSIP TRIMER IN COMPLEX WITH MATURE BG18 FRAGMENT ANTIGEN BINDING","10.1126/SCIENCE.AAX4380 ",4.42,"1.35632e-19","6dfg_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_W_)-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(133_C_)",217.669,"","",""
"6DFG","BG505 MD39 SOSIP TRIMER IN COMPLEX WITH MATURE BG18 FRAGMENT ANTIGEN BINDING","10.1126/SCIENCE.AAX4380 ",4.42,"1.35632e-19","6dfg_oligo24","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_j_)-[MAN(5_j_)-MAN(4_j_)]-BMA(3_j_)-NAG(2_j_)-NAG(1_j_)-ASN(262_D_)",181.364,"","",""
"6DFG","BG505 MD39 SOSIP TRIMER IN COMPLEX WITH MATURE BG18 FRAGMENT ANTIGEN BINDING","10.1126/SCIENCE.AAX4380 ",4.42,"1.35632e-19","6dfg_oligo10","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_S_)-MAN(8_S_)-[MAN(10_S_)]-MAN(7_S_)-[MAN(6_S_)-MAN(5_S_)-MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(332_A_)",183.544,"","",""
"6DFG","BG505 MD39 SOSIP TRIMER IN COMPLEX WITH MATURE BG18 FRAGMENT ANTIGEN BINDING","10.1126/SCIENCE.AAX4380 ",4.42,"1.35632e-19","6dfg_oligo17","DManpa1-2DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_e_)-MAN(5_e_)-MAN(4_e_)-BMA(3_e_)-NAG(2_e_)-NAG(1_e_)-ASN(392_C_)",182.84,"","",""
"6DFG","BG505 MD39 SOSIP TRIMER IN COMPLEX WITH MATURE BG18 FRAGMENT ANTIGEN BINDING","10.1126/SCIENCE.AAX4380 ",4.42,"1.35632e-19","6dfg_oligo13","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_M_)-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(133_A_)",195.745,"","",""
"6DFG","BG505 MD39 SOSIP TRIMER IN COMPLEX WITH MATURE BG18 FRAGMENT ANTIGEN BINDING","10.1126/SCIENCE.AAX4380 ",4.42,"1.35632e-19","6dfg_oligo9","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Z_)-[MAN(5_Z_)-MAN(4_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(262_C_)",198.368,"","",""
"6DFG","BG505 MD39 SOSIP TRIMER IN COMPLEX WITH MATURE BG18 FRAGMENT ANTIGEN BINDING","10.1126/SCIENCE.AAX4380 ",4.42,"1.35632e-19","6dfg_oligo15","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_c_)-MAN(8_c_)-[MAN(10_c_)]-MAN(7_c_)-[MAN(6_c_)-MAN(5_c_)-MAN(4_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(332_C_)",173.049,"","",""
"6DFG","BG505 MD39 SOSIP TRIMER IN COMPLEX WITH MATURE BG18 FRAGMENT ANTIGEN BINDING","10.1126/SCIENCE.AAX4380 ",4.42,"1.35632e-19","6dfg_oligo19","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_g_)-BMA(3_g_)-NAG(2_g_)-NAG(1_g_)-ASN(133_D_)",209.65,"","",""
"6DFH","BG505 MD64 N332-GT2 SOSIP TRIMER IN COMPLEX WITH GERMLINE-REVERTED BG18 FRAGMENT ANTIGEN BINDING","10.1126/SCIENCE.AAX4380 ",3.85,"1.35632e-19","6dfh_oligo2","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_R_)-MAN(4_R_)-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(262_A_)",165.115,"","",""
"6DFH","BG505 MD64 N332-GT2 SOSIP TRIMER IN COMPLEX WITH GERMLINE-REVERTED BG18 FRAGMENT ANTIGEN BINDING","10.1126/SCIENCE.AAX4380 ",3.85,"1.35632e-19","6dfh_oligo22","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_h_)-MAN(4_h_)-BMA(3_h_)-NAG(2_h_)-NAG(1_h_)-ASN(262_D_)",171.05,"","",""
"6DFH","BG505 MD64 N332-GT2 SOSIP TRIMER IN COMPLEX WITH GERMLINE-REVERTED BG18 FRAGMENT ANTIGEN BINDING","10.1126/SCIENCE.AAX4380 ",3.85,"1.35632e-19","6dfh_oligo23","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_i_)-[MAN(6_i_)-MAN(5_i_)-MAN(4_i_)]-BMA(3_i_)-NAG(2_i_)-NAG(1_i_)-ASN(332_D_)",164.422,"","",""
"6DFH","BG505 MD64 N332-GT2 SOSIP TRIMER IN COMPLEX WITH GERMLINE-REVERTED BG18 FRAGMENT ANTIGEN BINDING","10.1126/SCIENCE.AAX4380 ",3.85,"1.35632e-19","6dfh_oligo15","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_a_)-[MAN(6_a_)-MAN(5_a_)-MAN(4_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(332_C_)",167.903,"","",""
"6DFH","BG505 MD64 N332-GT2 SOSIP TRIMER IN COMPLEX WITH GERMLINE-REVERTED BG18 FRAGMENT ANTIGEN BINDING","10.1126/SCIENCE.AAX4380 ",3.85,"1.35632e-19","6dfh_oligo13","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_S_)-[MAN(6_S_)-MAN(5_S_)-MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(332_A_)",162.815,"","",""
"6DFH","BG505 MD64 N332-GT2 SOSIP TRIMER IN COMPLEX WITH GERMLINE-REVERTED BG18 FRAGMENT ANTIGEN BINDING","10.1126/SCIENCE.AAX4380 ",3.85,"1.35632e-19","6dfh_oligo14","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Z_)-MAN(4_Z_)-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(262_C_)",161.919,"","",""
"6DG5","STRUCTURE OF A DE NOVO DESIGNED INTERLEUKIN-2/INTERLEUKIN-15 MIMETIC COMPLEX WITH IL-2RB AND IL-2RG","10.1038/S41586-018-0830-7 ",2.52,47.05,"6dg5_oligo2","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_E_)-[MAN(5_E_)-MAN(4_E_)-[MAN(6_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(43_B_)",73.2055,"","",""
"6DID","HIV ENV BG505 SOSIP WITH POLYCLONAL FABS FROM IMMUNIZED RABBIT #3417 POST-BOOST#1","10.1016/J.IMMUNI.2018.07.009 ",4.71,512.502,"6did_oligo13","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_c_)-MAN(6_c_)-[MAN(5_c_)-MAN(4_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(262_F_)",0.997273,"","",""
"6DID","HIV ENV BG505 SOSIP WITH POLYCLONAL FABS FROM IMMUNIZED RABBIT #3417 POST-BOOST#1","10.1016/J.IMMUNI.2018.07.009 ",4.71,512.502,"6did_oligo22","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_h_)-MAN(4_h_)-[MAN(6_h_)]-BMA(3_h_)-NAG(2_h_)-NAG(1_h_)-ASN(363_F_)",1.20924,"","",""
"6DID","HIV ENV BG505 SOSIP WITH POLYCLONAL FABS FROM IMMUNIZED RABBIT #3417 POST-BOOST#1","10.1016/J.IMMUNI.2018.07.009 ",4.71,512.502,"6did_oligo14","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_R_)-[MAN(7_R_)]-MAN(6_R_)-[MAN(5_R_)-MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(276_A_)",0.9475,"","",""
"6DID","HIV ENV BG505 SOSIP WITH POLYCLONAL FABS FROM IMMUNIZED RABBIT #3417 POST-BOOST#1","10.1016/J.IMMUNI.2018.07.009 ",4.71,512.502,"6did_oligo17","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_Q_)-MAN(6_Q_)-[MAN(5_Q_)-MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(262_A_)",0.997273,"","",""
"6DID","HIV ENV BG505 SOSIP WITH POLYCLONAL FABS FROM IMMUNIZED RABBIT #3417 POST-BOOST#1","10.1016/J.IMMUNI.2018.07.009 ",4.71,512.502,"6did_oligo34","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_t_)-MAN(4_t_)-[MAN(6_t_)]-BMA(3_t_)-NAG(2_t_)-NAG(1_t_)-ASN(363_G_)",1.20924,"","",""
"6DID","HIV ENV BG505 SOSIP WITH POLYCLONAL FABS FROM IMMUNIZED RABBIT #3417 POST-BOOST#1","10.1016/J.IMMUNI.2018.07.009 ",4.71,512.502,"6did_oligo29","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_o_)-MAN(6_o_)-[MAN(5_o_)-MAN(4_o_)]-BMA(3_o_)-NAG(2_o_)-NAG(1_o_)-ASN(262_G_)",0.997273,"","",""
"6DID","HIV ENV BG505 SOSIP WITH POLYCLONAL FABS FROM IMMUNIZED RABBIT #3417 POST-BOOST#1","10.1016/J.IMMUNI.2018.07.009 ",4.71,512.502,"6did_oligo6","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_V_)-MAN(4_V_)-[MAN(6_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(363_A_)",1.20924,"","",""
"6DID","HIV ENV BG505 SOSIP WITH POLYCLONAL FABS FROM IMMUNIZED RABBIT #3417 POST-BOOST#1","10.1016/J.IMMUNI.2018.07.009 ",4.71,512.502,"6did_oligo18","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_d_)-[MAN(7_d_)]-MAN(6_d_)-[MAN(5_d_)-MAN(4_d_)]-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(276_F_)",0.9475,"","",""
"6DID","HIV ENV BG505 SOSIP WITH POLYCLONAL FABS FROM IMMUNIZED RABBIT #3417 POST-BOOST#1","10.1016/J.IMMUNI.2018.07.009 ",4.71,512.502,"6did_oligo30","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_p_)-[MAN(7_p_)]-MAN(6_p_)-[MAN(5_p_)-MAN(4_p_)]-BMA(3_p_)-NAG(2_p_)-NAG(1_p_)-ASN(276_G_)",0.9475,"","",""
"6DJP","INTEGRIN ALPHA-V BETA-8 IN COMPLEX WITH THE FABS 8B8 AND 68","10.1038/S41594-018-0093-X ",4.8,"1.49247e-19","6djp_oligo2","DManpa1-4DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-MAN(4_I_)-[MAN(6_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(266_A_)",139.687,"","",""
"6DLD","CRYSTAL STRUCTURE OF IGLON5/NEGR1 HETERODIMER","",3.3,0,"6dld_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(67_A_)",146.749,"","",""
"6DRU","XYLOSIDASE FROM ASPERGILLUS NIGER","10.1021/ACSSUSCHEMENG.9B07073 ",2.7,67.01,"6dru_oligo4","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_D_)-[MAN(8_D_)]-MAN(7_D_)-[MAN(6_D_)-MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(358_A_)",88.0072,"","",""
"6DRU","XYLOSIDASE FROM ASPERGILLUS NIGER","10.1021/ACSSUSCHEMENG.9B07073 ",2.7,67.01,"6dru_oligo2","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(261_A_)",89.7897,"","",""
"6DRU","XYLOSIDASE FROM ASPERGILLUS NIGER","10.1021/ACSSUSCHEMENG.9B07073 ",2.7,67.01,"6dru_oligo8","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_I_)-MAN(8_I_)-[MAN(10_I_)]-MAN(7_I_)-[MAN(6_I_)-MAN(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(637_B_)",73.2126,"","",""
"6DRU","XYLOSIDASE FROM ASPERGILLUS NIGER","10.1021/ACSSUSCHEMENG.9B07073 ",2.7,67.01,"6dru_oligo7","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_H_)-[MAN(7_H_)]-MAN(6_H_)-[MAN(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(358_B_)",89.5056,"","",""
"6DRU","XYLOSIDASE FROM ASPERGILLUS NIGER","10.1021/ACSSUSCHEMENG.9B07073 ",2.7,67.01,"6dru_oligo5","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_E_)-MAN(8_E_)-[MAN(10_E_)]-MAN(7_E_)-[MAN(6_E_)-MAN(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(637_A_)",75.2987,"","",""
"6DW0","CRYO-EM STRUCTURE OF THE BENZODIAZEPINE-SENSITIVE ALPHA1BETA1GAMMA2S TRI-HETEROMERIC GABAA RECEPTOR IN COMPLEX WITH GABA (WHOLE MAP)","10.7554/ELIFE.39383 ",3.8,"1.08527e-19","6dw0_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(110_C_)",214.63,"","",""
"6DW0","CRYO-EM STRUCTURE OF THE BENZODIAZEPINE-SENSITIVE ALPHA1BETA1GAMMA2S TRI-HETEROMERIC GABAA RECEPTOR IN COMPLEX WITH GABA (WHOLE MAP)","10.7554/ELIFE.39383 ",3.8,"1.08527e-19","6dw0_oligo2","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_G_)-MAN(6_G_)-[MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(110_A_)",203.011,"","",""
"6DW1","CRYO-EM STRUCTURE OF THE BENZODIAZEPINE-SENSITIVE ALPHA1BETA1GAMMA2S TRI-HETEROMERIC GABAA RECEPTOR IN COMPLEX WITH GABA (ECD MAP)","10.7554/ELIFE.39383 ",3.1,"1.08527e-19","6dw1_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(110_C_)",93.558,"","",""
"6DW1","CRYO-EM STRUCTURE OF THE BENZODIAZEPINE-SENSITIVE ALPHA1BETA1GAMMA2S TRI-HETEROMERIC GABAA RECEPTOR IN COMPLEX WITH GABA (ECD MAP)","10.7554/ELIFE.39383 ",3.1,"1.08527e-19","6dw1_oligo1","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_G_)-MAN(6_G_)-[MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(110_A_)",85.1723,"","",""
"6DZL","EBOLA VIRUS MAKONA VARIANT GP (MUCIN-DELETED) IN COMPLEX WITH PAN- EBOLAVIRUS HUMAN ANTIBODY ADI-15878 FAB","10.1016/J.CELREP.2018.08.009 ",4.14,"2.23709e+11","6dzl_oligo1","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_N_)-[MAN(5_N_)-MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(563_D_)",175.647,"","",""
"6DZL","EBOLA VIRUS MAKONA VARIANT GP (MUCIN-DELETED) IN COMPLEX WITH PAN- EBOLAVIRUS HUMAN ANTIBODY ADI-15878 FAB","10.1016/J.CELREP.2018.08.009 ",4.14,"2.23709e+11","6dzl_oligo6","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_R_)-[MAN(5_R_)-MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(563_F_)",175.647,"","",""
"6DZL","EBOLA VIRUS MAKONA VARIANT GP (MUCIN-DELETED) IN COMPLEX WITH PAN- EBOLAVIRUS HUMAN ANTIBODY ADI-15878 FAB","10.1016/J.CELREP.2018.08.009 ",4.14,"2.23709e+11","6dzl_oligo4","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_P_)-[MAN(5_P_)-MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(563_E_)",175.647,"","",""
"6DZM","BUNDIBUGYO VIRUS GP (MUCIN-DELETED) IN COMPLEX WITH PAN-EBOLAVIRUS HUMAN ANTIBODY ADI-15878 FAB","10.1016/J.CELREP.2018.08.009 ",4.29,0,"6dzm_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_R_)-[MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(563_F_)",164.015,"","",""
"6DZM","BUNDIBUGYO VIRUS GP (MUCIN-DELETED) IN COMPLEX WITH PAN-EBOLAVIRUS HUMAN ANTIBODY ADI-15878 FAB","10.1016/J.CELREP.2018.08.009 ",4.29,0,"6dzm_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(563_D_)",164.015,"","",""
"6DZM","BUNDIBUGYO VIRUS GP (MUCIN-DELETED) IN COMPLEX WITH PAN-EBOLAVIRUS HUMAN ANTIBODY ADI-15878 FAB","10.1016/J.CELREP.2018.08.009 ",4.29,0,"6dzm_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_P_)-[MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(563_E_)",164.015,"","",""
"6E0W","CRYSTAL STRUCTURE OF THE COLANIDASE TAILSPIKE PROTEIN GP150 OF PHAGE PHI92 COMPLEXED WITH ONE REPEATING UNIT OF COLANIC ACID","",1.8,0,"6e0w_oligo1","DGlcpAb1-3DGalpa1-3LFucpa1-4LFucpa1-3DGlcpb1-ROH","BDP(5_C_)-GLA(4_C_)-FUC(3_C_)-FUC(2_C_)-BGC(1_C_)",67.5116,"","",""
"6E0W","CRYSTAL STRUCTURE OF THE COLANIDASE TAILSPIKE PROTEIN GP150 OF PHAGE PHI92 COMPLEXED WITH ONE REPEATING UNIT OF COLANIC ACID","",1.8,0,"6e0w_oligo2","DGlcpAb1-3DGalpa1-3LFucpa1-4LFucpa1-3DGlcpb1-ROH","BDP(5_D_)-GLA(4_D_)-FUC(3_D_)-FUC(2_D_)-BGC(1_D_)",42.7407,"","",""
"6E3K","INTERFERON GAMMA SIGNALLING COMPLEX WITH IFNGR1 AND IFNGR2","10.1038/S41586-019-0988-7 ",3.25,0,"6e3k_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(110_I_)",216.895,"","",""
"6E3L","INTERFERON GAMMA SIGNALLING COMPLEX WITH IFNGR1 AND IFNGR2","10.1038/S41586-019-0988-7 ",3.8,0,"6e3l_oligo6","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_L_)-MAN(4_L_)-[MAN(6_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(137_I_)",228.266,"","",""
"6E4X","HUMAN ANTIBODY S5V2-29 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ A/TEXAS/50/2012 (H3N2)","10.1016/J.CELL.2019.03.048 ",2.25,0,"6e4x_oligo3","DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","BMA(3_D_)-NAG(2_D_)-[FUC(4_D_)]-NAG(1_D_)-ASN(38_B_)",124.624,"","",""
"6E4X","HUMAN ANTIBODY S5V2-29 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ A/TEXAS/50/2012 (H3N2)","10.1016/J.CELL.2019.03.048 ",2.25,0,"6e4x_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_A_)-[MAN(4_A_)-BMA(3_A_)-NAG(2_A_)]-NAG(1_A_)-ASN(63_B_)",70.3638,"","",""
"6E5P","BACKBONE MODEL BASED ON CRYO-EM MAP AT 8.5 A OF DOMAIN-SWAPPED, GLYCAN-REACTIVE, NEUTRALIZING ANTIBODY 2G12 BOUND TO HIV-1 ENV BG505 DS-SOSIP, WHICH WAS ALSO BOUND TO CD4-BINDING SITE ANTIBODY VRC03","10.1016/J.STR.2018.10.007 ",8.8,"1.08527e-19","6e5p_oligo9","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(4_c_)-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)",20.5383,"","",""
"6E5P","BACKBONE MODEL BASED ON CRYO-EM MAP AT 8.5 A OF DOMAIN-SWAPPED, GLYCAN-REACTIVE, NEUTRALIZING ANTIBODY 2G12 BOUND TO HIV-1 ENV BG505 DS-SOSIP, WHICH WAS ALSO BOUND TO CD4-BINDING SITE ANTIBODY VRC03","10.1016/J.STR.2018.10.007 ",8.8,"1.08527e-19","6e5p_oligo7","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(4_a_)-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)",20.5383,"","",""
"6E5P","BACKBONE MODEL BASED ON CRYO-EM MAP AT 8.5 A OF DOMAIN-SWAPPED, GLYCAN-REACTIVE, NEUTRALIZING ANTIBODY 2G12 BOUND TO HIV-1 ENV BG505 DS-SOSIP, WHICH WAS ALSO BOUND TO CD4-BINDING SITE ANTIBODY VRC03","10.1016/J.STR.2018.10.007 ",8.8,"1.08527e-19","6e5p_oligo16","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(6_j_)-[MAN(5_j_)]-MAN(4_j_)-BMA(3_j_)-NAG(2_j_)-NAG(1_j_)",108.014,"","",""
"6E5P","BACKBONE MODEL BASED ON CRYO-EM MAP AT 8.5 A OF DOMAIN-SWAPPED, GLYCAN-REACTIVE, NEUTRALIZING ANTIBODY 2G12 BOUND TO HIV-1 ENV BG505 DS-SOSIP, WHICH WAS ALSO BOUND TO CD4-BINDING SITE ANTIBODY VRC03","10.1016/J.STR.2018.10.007 ",8.8,"1.08527e-19","6e5p_oligo8","DManpa1-2DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","MAN(6_b_)-MAN(5_b_)-MAN(4_b_)-[MAN(7_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)",20.1653,"","",""
"6E5P","BACKBONE MODEL BASED ON CRYO-EM MAP AT 8.5 A OF DOMAIN-SWAPPED, GLYCAN-REACTIVE, NEUTRALIZING ANTIBODY 2G12 BOUND TO HIV-1 ENV BG505 DS-SOSIP, WHICH WAS ALSO BOUND TO CD4-BINDING SITE ANTIBODY VRC03","10.1016/J.STR.2018.10.007 ",8.8,"1.08527e-19","6e5p_oligo1","DManpa1-2DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","MAN(6_X_)-MAN(5_X_)-MAN(4_X_)-[MAN(7_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)",20.1653,"","",""
"6E5P","BACKBONE MODEL BASED ON CRYO-EM MAP AT 8.5 A OF DOMAIN-SWAPPED, GLYCAN-REACTIVE, NEUTRALIZING ANTIBODY 2G12 BOUND TO HIV-1 ENV BG505 DS-SOSIP, WHICH WAS ALSO BOUND TO CD4-BINDING SITE ANTIBODY VRC03","10.1016/J.STR.2018.10.007 ",8.8,"1.08527e-19","6e5p_oligo2","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(6_U_)-[MAN(5_U_)]-MAN(4_U_)-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)",108.014,"","",""
"6E5P","BACKBONE MODEL BASED ON CRYO-EM MAP AT 8.5 A OF DOMAIN-SWAPPED, GLYCAN-REACTIVE, NEUTRALIZING ANTIBODY 2G12 BOUND TO HIV-1 ENV BG505 DS-SOSIP, WHICH WAS ALSO BOUND TO CD4-BINDING SITE ANTIBODY VRC03","10.1016/J.STR.2018.10.007 ",8.8,"1.08527e-19","6e5p_oligo19","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(6_m_)-[MAN(5_m_)]-MAN(4_m_)-BMA(3_m_)-NAG(2_m_)-NAG(1_m_)",108.014,"","",""
"6E5P","BACKBONE MODEL BASED ON CRYO-EM MAP AT 8.5 A OF DOMAIN-SWAPPED, GLYCAN-REACTIVE, NEUTRALIZING ANTIBODY 2G12 BOUND TO HIV-1 ENV BG505 DS-SOSIP, WHICH WAS ALSO BOUND TO CD4-BINDING SITE ANTIBODY VRC03","10.1016/J.STR.2018.10.007 ",8.8,"1.08527e-19","6e5p_oligo10","DManpa1-2DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","MAN(6_d_)-MAN(5_d_)-MAN(4_d_)-[MAN(7_d_)]-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)",20.1653,"","",""
"6E5P","BACKBONE MODEL BASED ON CRYO-EM MAP AT 8.5 A OF DOMAIN-SWAPPED, GLYCAN-REACTIVE, NEUTRALIZING ANTIBODY 2G12 BOUND TO HIV-1 ENV BG505 DS-SOSIP, WHICH WAS ALSO BOUND TO CD4-BINDING SITE ANTIBODY VRC03","10.1016/J.STR.2018.10.007 ",8.8,"1.08527e-19","6e5p_oligo20","DManpa1-2DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","MAN(6_n_)-MAN(5_n_)-MAN(4_n_)-[MAN(7_n_)]-BMA(3_n_)-NAG(2_n_)-NAG(1_n_)",20.1653,"","",""
"6E5P","BACKBONE MODEL BASED ON CRYO-EM MAP AT 8.5 A OF DOMAIN-SWAPPED, GLYCAN-REACTIVE, NEUTRALIZING ANTIBODY 2G12 BOUND TO HIV-1 ENV BG505 DS-SOSIP, WHICH WAS ALSO BOUND TO CD4-BINDING SITE ANTIBODY VRC03","10.1016/J.STR.2018.10.007 ",8.8,"1.08527e-19","6e5p_oligo12","DManpa1-2DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","MAN(6_f_)-MAN(5_f_)-MAN(4_f_)-[MAN(7_f_)]-BMA(3_f_)-NAG(2_f_)-NAG(1_f_)",20.1653,"","",""
"6E5P","BACKBONE MODEL BASED ON CRYO-EM MAP AT 8.5 A OF DOMAIN-SWAPPED, GLYCAN-REACTIVE, NEUTRALIZING ANTIBODY 2G12 BOUND TO HIV-1 ENV BG505 DS-SOSIP, WHICH WAS ALSO BOUND TO CD4-BINDING SITE ANTIBODY VRC03","10.1016/J.STR.2018.10.007 ",8.8,"1.08527e-19","6e5p_oligo6","DManpa1-2DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","MAN(6_Z_)-MAN(5_Z_)-MAN(4_Z_)-[MAN(7_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)",20.1653,"","",""
"6E5P","BACKBONE MODEL BASED ON CRYO-EM MAP AT 8.5 A OF DOMAIN-SWAPPED, GLYCAN-REACTIVE, NEUTRALIZING ANTIBODY 2G12 BOUND TO HIV-1 ENV BG505 DS-SOSIP, WHICH WAS ALSO BOUND TO CD4-BINDING SITE ANTIBODY VRC03","10.1016/J.STR.2018.10.007 ",8.8,"1.08527e-19","6e5p_oligo11","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(4_e_)-BMA(3_e_)-NAG(2_e_)-NAG(1_e_)",20.5383,"","",""
"6E6B","CRYSTAL STRUCTURE OF THE PROTOCADHERIN GAMMAB4 EXTRACELLULAR DOMAIN","10.1038/S41586-019-1089-3 ",4.52,138.7,"6e6b_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_D_)-[MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(193_B_)",177.028,"","",""
"6E7R","HETERODIMER OF THE GLUN1B-GLUN2B NMDA RECEPTOR AMINO-TERMINAL DOMAINS BOUND TO ALLOSTERIC INHIBITOR 93-4","",2.1,38.17,"6e7r_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(389_A_)",65.4782,"","",""
"6E7S","HETERODIMER OF THE GLUN1B-GLUN2B NMDA RECEPTOR AMINO-TERMINAL DOMAINS BOUND TO ALLOSTERIC INHIBITOR 93-5","",2.72,73.42,"6e7s_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(389_A_)",92.2711,"","",""
"6E7T","HETERODIMER OF THE GLUN1B-GLUN2B NMDA RECEPTOR AMINO-TERMINAL DOMAINS BOUND TO ALLOSTERIC INHIBITOR 93-6","",2.31,42.34,"6e7t_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(389_A_)",75.8065,"","",""
"6E7U","HETERODIMER OF THE GLUN1B-GLUN2B NMDA RECEPTOR AMINO-TERMINAL DOMAINS BOUND TO ALLOSTERIC INHIBITOR 93-31","",2.27,39.6,"6e7u_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(389_A_)",67.1518,"","",""
"6E7V","HETERODIMER OF THE GLUN1B-GLUN2B NMDA RECEPTOR AMINO-TERMINAL DOMAINS BOUND TO ALLOSTERIC INHIBITOR 93-88","",2.6,51.59,"6e7v_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(389_A_)",74.7249,"","",""
"6E7W","HETERODIMER OF THE GLUN1B-GLUN2B NMDA RECEPTOR AMINO-TERMINAL DOMAINS BOUND TO ALLOSTERIC INHIBITOR 93-115","",2.67,49.17,"6e7w_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(389_A_)",75.2662,"","",""
"6E7X","HETERODIMER OF THE GLUN1B-GLUN2B NMDA RECEPTOR AMINO-TERMINAL DOMAINS BOUND TO ALLOSTERIC INHIBITOR 93-97","",2.58,48.46,"6e7x_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(389_A_)",78.5495,"","",""
"6EA4","ERAP2 BOUND TO ARYL SULFONAMIDE UNCOMPETITIVE INHIBITOR","",2.45,82.35,"6ea4_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(219_A_)",102.249,"","",""
"6EA4","ERAP2 BOUND TO ARYL SULFONAMIDE UNCOMPETITIVE INHIBITOR","",2.45,82.35,"6ea4_oligo11","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(85_B_)",97.8773,"","",""
"6EA4","ERAP2 BOUND TO ARYL SULFONAMIDE UNCOMPETITIVE INHIBITOR","",2.45,82.35,"6ea4_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(85_A_)",102.991,"","",""
"6EA5","STRUCTURE OF BDBV GPCL IN COMPLEX WITH THE PAN-EBOLAVIRUS MAB ADI- 15878","10.1128/MBIO.01674-18 ",4.75,0,"6ea5_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)",203.352,"","",""
"6EA5","STRUCTURE OF BDBV GPCL IN COMPLEX WITH THE PAN-EBOLAVIRUS MAB ADI- 15878","10.1128/MBIO.01674-18 ",4.75,0,"6ea5_oligo1","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(6_G_)-[NAG(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)",204.991,"","",""
"6EA7","STRUCTURE OF EBOV GPCL IN COMPLEX WITH THE PAN-EBOLAVIRUS MAB ADI- 15878","10.1128/MBIO.01674-18 ",4.25,0,"6ea7_oligo3","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_J_)-NAG(5_J_)-MAN(4_J_)-[NAG(8_J_)-MAN(7_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(563_D_)",178.133,"","",""
"6EA7","STRUCTURE OF EBOV GPCL IN COMPLEX WITH THE PAN-EBOLAVIRUS MAB ADI- 15878","10.1128/MBIO.01674-18 ",4.25,0,"6ea7_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_I_)-NAG(5_I_)-MAN(4_I_)-[NAG(8_I_)-MAN(7_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(563_B_)",208.453,"","",""
"6EA7","STRUCTURE OF EBOV GPCL IN COMPLEX WITH THE PAN-EBOLAVIRUS MAB ADI- 15878","10.1128/MBIO.01674-18 ",4.25,0,"6ea7_oligo4","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_K_)-MAN(6_K_)-[NAG(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(563_F_)",205.134,"","",""
"6EAQ","GLYCOSYLATED FCGR3B / CD16B IN COMPLEX WITH AFUCOSYLATED IGG1 FC","10.1074/JBC.RA118.005273 ",2.22,0,"6eaq_oligo1","LArapa1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(297_A_)",42.5249,"","",""
"6EAQ","GLYCOSYLATED FCGR3B / CD16B IN COMPLEX WITH AFUCOSYLATED IGG1 FC","10.1074/JBC.RA118.005273 ",2.22,0,"6eaq_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[NAG(8_E_)-MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(297_B_)",56.5409,"","",""
"6EAY","STRUCTURAL BASIS FOR BROAD NEUTRALIZATION OF EBOLAVIRUSES BY AN ANTIBODY TARGETING THE GLYCOPROTEIN FUSION LOOP","10.1038/S41467-018-06113-4 ",3.72,0,"6eay_oligo1","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_C_)-[MAN(7_C_)]-MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(563_A_)",102.138,"","",""
"6EDU","B41 SOSIP.664 IN COMPLEX WITH SOLUBLE CD4 (D1-D2), THE CO-RECEPTOR MIMICKING ANTIBODY 21C AND THE BROADLY NEUTRALIZING ANTIBODY 8ANC195","10.1016/J.CHOM.2018.09.003 ",4.06,"1.47221e+19","6edu_oligo1","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Z_)-MAN(4_Z_)-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(262_D_)",121.035,"","",""
"6EDU","B41 SOSIP.664 IN COMPLEX WITH SOLUBLE CD4 (D1-D2), THE CO-RECEPTOR MIMICKING ANTIBODY 21C AND THE BROADLY NEUTRALIZING ANTIBODY 8ANC195","10.1016/J.CHOM.2018.09.003 ",4.06,"1.47221e+19","6edu_oligo4","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_g_)-MAN(4_g_)-BMA(3_g_)-NAG(2_g_)-NAG(1_g_)-ASN(262_E_)",117.664,"","",""
"6EDU","B41 SOSIP.664 IN COMPLEX WITH SOLUBLE CD4 (D1-D2), THE CO-RECEPTOR MIMICKING ANTIBODY 21C AND THE BROADLY NEUTRALIZING ANTIBODY 8ANC195","10.1016/J.CHOM.2018.09.003 ",4.06,"1.47221e+19","6edu_oligo18","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_n_)-MAN(4_n_)-BMA(3_n_)-NAG(2_n_)-NAG(1_n_)-ASN(262_F_)",112.468,"","",""
"6EDU","B41 SOSIP.664 IN COMPLEX WITH SOLUBLE CD4 (D1-D2), THE CO-RECEPTOR MIMICKING ANTIBODY 21C AND THE BROADLY NEUTRALIZING ANTIBODY 8ANC195","10.1016/J.CHOM.2018.09.003 ",4.06,"1.47221e+19","6edu_oligo19","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_o_)-[MAN(4_o_)]-BMA(3_o_)-NAG(2_o_)-NAG(1_o_)-ASN(276_F_)",71.4769,"","",""
"6EDU","B41 SOSIP.664 IN COMPLEX WITH SOLUBLE CD4 (D1-D2), THE CO-RECEPTOR MIMICKING ANTIBODY 21C AND THE BROADLY NEUTRALIZING ANTIBODY 8ANC195","10.1016/J.CHOM.2018.09.003 ",4.06,"1.47221e+19","6edu_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_a_)-[MAN(4_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(276_D_)",71.4287,"","",""
"6EDU","B41 SOSIP.664 IN COMPLEX WITH SOLUBLE CD4 (D1-D2), THE CO-RECEPTOR MIMICKING ANTIBODY 21C AND THE BROADLY NEUTRALIZING ANTIBODY 8ANC195","10.1016/J.CHOM.2018.09.003 ",4.06,"1.47221e+19","6edu_oligo24","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_t_)-[MAN(8_t_)]-MAN(7_t_)-[MAN(6_t_)-MAN(5_t_)-MAN(4_t_)]-BMA(3_t_)-NAG(2_t_)-NAG(1_t_)-ASN(234_F_)",70.6465,"","",""
"6EDU","B41 SOSIP.664 IN COMPLEX WITH SOLUBLE CD4 (D1-D2), THE CO-RECEPTOR MIMICKING ANTIBODY 21C AND THE BROADLY NEUTRALIZING ANTIBODY 8ANC195","10.1016/J.CHOM.2018.09.003 ",4.06,"1.47221e+19","6edu_oligo27","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_v_)-[MAN(8_v_)]-MAN(7_v_)-[MAN(6_v_)-MAN(5_v_)-MAN(4_v_)]-BMA(3_v_)-NAG(2_v_)-NAG(1_v_)-ASN(234_E_)",71.2083,"","",""
"6EDU","B41 SOSIP.664 IN COMPLEX WITH SOLUBLE CD4 (D1-D2), THE CO-RECEPTOR MIMICKING ANTIBODY 21C AND THE BROADLY NEUTRALIZING ANTIBODY 8ANC195","10.1016/J.CHOM.2018.09.003 ",4.06,"1.47221e+19","6edu_oligo26","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_u_)-[MAN(8_u_)]-MAN(7_u_)-[MAN(6_u_)-MAN(5_u_)-MAN(4_u_)]-BMA(3_u_)-NAG(2_u_)-NAG(1_u_)-ASN(234_D_)",67.4766,"","",""
"6EDU","B41 SOSIP.664 IN COMPLEX WITH SOLUBLE CD4 (D1-D2), THE CO-RECEPTOR MIMICKING ANTIBODY 21C AND THE BROADLY NEUTRALIZING ANTIBODY 8ANC195","10.1016/J.CHOM.2018.09.003 ",4.06,"1.47221e+19","6edu_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_h_)-[MAN(4_h_)]-BMA(3_h_)-NAG(2_h_)-NAG(1_h_)-ASN(276_E_)",71.4638,"","",""
"6EFD","HSA SIGLEC AND UNIQUE DOMAINS IN COMPLEX WITH THE SIALYL T ANTIGEN TRISACCHARIDE","10.1038/S41467-022-30509-Y ",1.85,0,"6efd_oligo1","DNeup5Aca2-3DGalpb1-3DGalpNAca1-ROH","SIA(3_B_)-GAL(2_B_)-A2G(1_B_)",35.5472,"","",""
"6EFZ","CRYSTAL STRUCTURE OF DIP-THETA IG1-3","10.1016/J.NEURON.2018.10.046 ",3.5,0,"6efz_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_B_)-[MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(138_A_)",185.055,"","",""
"6EG0","CRYSTAL STRUCTURE OF DPR4 IG1-IG2 IN COMPLEX WITH DIP-ETA IG1-IG3","10.1016/J.NEURON.2018.10.046 ",2.9,0,"6eg0_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_E_)-[MAN(4_E_)-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(51_B_)",113.846,"","",""
"6EG0","CRYSTAL STRUCTURE OF DPR4 IG1-IG2 IN COMPLEX WITH DIP-ETA IG1-IG3","10.1016/J.NEURON.2018.10.046 ",2.9,0,"6eg0_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_F_)-[NAG(7_F_)-MAN(6_F_)-[NAG(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(291_B_)",98.2293,"","",""
"6EG1","CRYSTAL STRUCTURE OF DPR2 IG1-IG2 IN COMPLEX WITH DIP-THETA IG1-IG3","10.1016/J.NEURON.2018.10.046 ",2.95,0,"6eg1_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_F_)-[MAN(4_F_)-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(302_A_)",64.5105,"","",""
"6EG1","CRYSTAL STRUCTURE OF DPR2 IG1-IG2 IN COMPLEX WITH DIP-THETA IG1-IG3","10.1016/J.NEURON.2018.10.046 ",2.95,0,"6eg1_oligo8","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_L_)-[MAN(4_L_)-BMA(3_L_)-NAG(2_L_)]-NAG(1_L_)-ASN(302_C_)",71.1331,"","",""
"6EHO","DIMER OF THE SORTILIN VPS10P DOMAIN AT LOW PH","10.1016/J.STR.2017.09.015 ",3.5,0,"6eho_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(373_A_)",182.888,"","",""
"6EJJ","STRUCTURE OF A GLYCOSYLTRANSFERASE / STATE 2","10.1038/S41467-018-02880-2 ",2.7,0,"6ejj_oligo3","DGalpNAca1-4DGalpNAca1-3DGlcpNAca1-C2O7P2","A2G(3_C_)-A2G(2_C_)-NDG(1_C_)-BUE(408_A_)",59.2839,"","",""
"6EJJ","STRUCTURE OF A GLYCOSYLTRANSFERASE / STATE 2","10.1038/S41467-018-02880-2 ",2.7,0,"6ejj_oligo4","DGalpNAca1-4DGalpNAca1-3DGlcpNAca1-C2O7P2","A2G(3_D_)-A2G(2_D_)-NDG(1_D_)-BUE(407_B_)",62.4852,"","",""
"6EJK","STRUCTURE OF A GLYCOSYLTRANSFERASE","10.1038/S41467-018-02880-2 ",3.3,0,"6ejk_oligo6","DGalpNAca1-4DGalpNAca1-3DGlcpNAca1-C2O7P2","A2G(3_D_)-A2G(2_D_)-NDG(1_D_)-BUE(405_B_)",129.439,"","",""
"6EJK","STRUCTURE OF A GLYCOSYLTRANSFERASE","10.1038/S41467-018-02880-2 ",3.3,0,"6ejk_oligo5","DGalpNAca1-4DGalpNAca1-3DGlcpNAca1-C2O7P2","A2G(3_C_)-A2G(2_C_)-NDG(1_C_)-BUE(405_A_)",126.06,"","",""
"6EN3","CRYSTAL STRUCTURE OF FULL LENGTH ENDOS FROM STREPTOCOCCUS PYOGENES IN COMPLEX WITH G2 OLIGOSACCHARIDE.","10.1038/S41467-018-04300-X ",2.9,0,"6en3_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-ROH","GAL(8_B_)-NAG(7_B_)-MAN(6_B_)-[GAL(5_B_)-NAG(4_B_)-MAN(3_B_)]-BMA(2_B_)-NAG(1_B_)",87.1648,"","",""
"6EN5","CRYSTAL STRUCTURE A OF THE ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH A DIPROLYL INHIBITOR.","10.1021/ACS.JMEDCHEM.7B01478 ",1.75,0,"6en5_oligo11","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_O_)-[MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)]-NAG(1_O_)-ASN(416_D_)",60.1856,"","",""
"6EPK","CRYSTAL STRUCTURE OF THE PRECURSOR MEMBRANE PROTEIN-ENVELOPE PROTEIN HETERODIMER FROM THE YELLOW FEVER VIRUS","10.1128/MBIO.00706-23 ",2.7,0,"6epk_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(6_H_)-[MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)]-NAG(1_H_)-ASN(529_E_)",103.334,"","",""
"6EPK","CRYSTAL STRUCTURE OF THE PRECURSOR MEMBRANE PROTEIN-ENVELOPE PROTEIN HETERODIMER FROM THE YELLOW FEVER VIRUS","10.1128/MBIO.00706-23 ",2.7,0,"6epk_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(6_F_)-[MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(529_B_)",96.4894,"","",""
"6ETY","X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH A INHIBITOR JHU3371","10.1016/J.BMC.2018.11.022 ",1.68,32.92,"6ety_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(638_A_)",42.86,"","",""
"6EU6","SENSOR AMT PROTEIN","10.1038/S41467-017-02637-3 ",1.98,38.02,"6eu6_oligo3","DGlcpa1-3DGalpa6-C7O1","ZDM(503_A_)-ZDM(503_A_)",78.8505,"","",""
"6EUF","THE GH43, BETA 1,3 GALACTOSIDASE, BT0265","10.1038/S41564-018-0258-8 ",2.2,36.98,"6euf_oligo2","[LArafa1-3][LArafa1-4]DGalpb1-6DGalpb1-ROH","RAM(4_F_)-BDP(3_F_)-[AHR(6_F_)]-[AHR(5_F_)]-GAL(2_F_)-GAL(1_F_)",54.6592,"","",""
"6EUF","THE GH43, BETA 1,3 GALACTOSIDASE, BT0265","10.1038/S41564-018-0258-8 ",2.2,36.98,"6euf_oligo3","[LArafa1-3][LArafa1-4]DGalpb1-6DGalpb1-ROH","RAM(4_G_)-BDP(3_G_)-[AHR(6_G_)]-[AHR(5_G_)]-GAL(2_G_)-GAL(1_G_)",61.368,"","",""
"6EUF","THE GH43, BETA 1,3 GALACTOSIDASE, BT0265","10.1038/S41564-018-0258-8 ",2.2,36.98,"6euf_oligo4","LArafa1-3[LArafa1-4][DGlcpAb1-6]DGalpb1-6DGalpb1-ROH","BDP(5_H_)-[AHR(4_H_)]-[AHR(3_H_)]-GAL(2_H_)-GAL(1_H_)",56.3538,"","",""
"6EUF","THE GH43, BETA 1,3 GALACTOSIDASE, BT0265","10.1038/S41564-018-0258-8 ",2.2,36.98,"6euf_oligo1","LArafa1-3[LArafa1-4][DGlcpAb1-6]DGalpb1-6DGalpb1-ROH","BDP(5_E_)-[AHR(4_E_)]-[AHR(3_E_)]-GAL(2_E_)-GAL(1_E_)",53.2694,"","",""
"6EVV","X-RAY STRUCTURE OF THE COMPLEX BETWEEN HUMAN ALPHA THROMBIN AND NU172, A DUPLEX/QUADRUPLEX 26-MER DNA APTAMER, IN THE PRESENCE OF POTASSIUM IONS.","10.1093/NAR/GKY990 ",2.5,48.2,"6evv_oligo12","DNeup5Aca2-6DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","SIA(7_A_)-GAL(6_A_)-NAG(5_A_)-MAN(4_A_)-[MAN(8_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(60_H_)",71.1303,"","",""
"6EYO","STRUCTURE OF EXTENDED IGE-FC IN COMPLEX WITH TWO ANTI-IGE FABS","10.1038/S41598-018-29664-4 ",3.7,0,"6eyo_oligo2","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-[MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(394_B_)",88.1155,"","",""
"6EYO","STRUCTURE OF EXTENDED IGE-FC IN COMPLEX WITH TWO ANTI-IGE FABS","10.1038/S41598-018-29664-4 ",3.7,0,"6eyo_oligo1","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_C_)-MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(394_A_)",90.5087,"","",""
"6EZ9","X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) - THE E424M INACTIVE MUTANT, IN COMPLEX WITH A INHIBITOR JHU3372","10.1016/J.BMC.2018.11.022 ",1.61,29.42,"6ez9_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(638_A_)",41.9151,"","",""
"6EZN","CRYO-EM STRUCTURE OF THE YEAST OLIGOSACCHARYLTRANSFERASE (OST) COMPLEX","10.1038/S41467-022-35067-X ",3.3,"1.35632e-19","6ezn_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_K_)-MAN(7_K_)-[MAN(6_K_)-MAN(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(539_F_)",38.7006,"","",""
"6F1C","C1RC1S COMPLEX","10.1073/PNAS.1718709115 ",4.2,226.7,"6f1c_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(204_C_)",278.362,"","",""
"6F1C","C1RC1S COMPLEX","10.1073/PNAS.1718709115 ",4.2,226.7,"6f1c_oligo1","DGalpb1-4DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-[GAL(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(204_A_)",294.022,"","",""
"6F1H","C1RC1S COMPLEX","10.1073/PNAS.1718709115 ",4.5,255.4,"6f1h_oligo1","DGlcpNAcb1-4DGalpb1-4DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_E_)-[NAG(6_E_)-GAL(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(204_A_)",262.001,"","",""
"6F1H","C1RC1S COMPLEX","10.1073/PNAS.1718709115 ",4.5,255.4,"6f1h_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(7_F_)-[GAL(6_F_)-NAG(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)",295.58,"","",""
"6F2Z","STRUCTURE OF A FC MUTANT","",2.3,53.42,"6f2z_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_A_)",60.2502,"","",""
"6F2Z","STRUCTURE OF A FC MUTANT","",2.3,53.42,"6f2z_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(297_B_)",76.6274,"","",""
"6F39","C1R HOMODIMER CUB1-EGF-CUB2","10.1073/PNAS.1718709115 ",5.8,351.4,"6f39_oligo2","DGalpb1-4DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-[GAL(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(204_A_)",410.056,"","",""
"6F39","C1R HOMODIMER CUB1-EGF-CUB2","10.1073/PNAS.1718709115 ",5.8,351.4,"6f39_oligo1","DGalpb1-4DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-[GAL(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(204_B_)",390.7,"","",""
"6F5K","CRYSTAL STRUCTURE OF LACCASE FROM MYCELIOPHTHORA THERMOPHILA","10.1371/JOURNAL.PONE.0206589 ",1.62,25.44,"6f5k_oligo3","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_B_)-MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)",53.1978,"","",""
"6F5K","CRYSTAL STRUCTURE OF LACCASE FROM MYCELIOPHTHORA THERMOPHILA","10.1371/JOURNAL.PONE.0206589 ",1.62,25.44,"6f5k_oligo1","DManpa1-2DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-MAN(5_D_)-MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(201_A_)",39.4283,"","",""
"6F5L","X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH A INHIBITOR JHU2379","10.1016/J.BMC.2018.11.022 ",1.63,33.72,"6f5l_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(638_A_)",49.336,"","",""
"6F5M","CRYSTAL STRUCTURE OF HIGHLY GLYCOSYLATED HUMAN LEUKOCYTE ELASTASE IN COMPLEX WITH A THIAZOLIDINEDIONE INHIBITOR","10.1107/S2053230X1800537X ",2.7,0,"6f5m_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_E_)-[MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(159_B_)",124.43,"","",""
"6F6N","CRYSTAL STRUCTURE OF EBOLAVIRUS GLYCOPROTEIN IN COMPLEX WITH SERTRALINE","10.1021/ACS.JMEDCHEM.7B01249 ",2.15,0,"6f6n_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(563_B_)",105.809,"","",""
"6F7K","CRYSTAL STRUCTURE OF DETTILON TAILSPIKE PROTEIN (GP208)","10.1074/JBC.RA119.008133 ",2.1,47.44,"6f7k_oligo5","DGalpa1-6DManpb1-4LRhapa1-3DGalpa1-6DManpb1-4LRhapa1-ROH","GLA(6_L_)-BMA(5_L_)-RAM(4_L_)-GLA(3_L_)-BMA(2_L_)-RAM(1_L_)",58.0221,"","",""
"6F7K","CRYSTAL STRUCTURE OF DETTILON TAILSPIKE PROTEIN (GP208)","10.1074/JBC.RA119.008133 ",2.1,47.44,"6f7k_oligo4","DGalpa1-6DManpb1-4LRhapa1-3DGalpa1-6DManpb1-4LRhapa1-ROH","GLA(6_K_)-BMA(5_K_)-RAM(4_K_)-GLA(3_K_)-BMA(2_K_)-RAM(1_K_)",69.8502,"","",""
"6F7K","CRYSTAL STRUCTURE OF DETTILON TAILSPIKE PROTEIN (GP208)","10.1074/JBC.RA119.008133 ",2.1,47.44,"6f7k_oligo6","DGalpa1-6DManpb1-4LRhapa1-3DGalpa1-6DManpb1-4LRhapa1-ROH","GLA(6_M_)-BMA(5_M_)-RAM(4_M_)-GLA(3_M_)-BMA(2_M_)-RAM(1_M_)",53.8615,"","",""
"6F7K","CRYSTAL STRUCTURE OF DETTILON TAILSPIKE PROTEIN (GP208)","10.1074/JBC.RA119.008133 ",2.1,47.44,"6f7k_oligo3","DGalpa1-6DManpb1-4LRhapa1-3DGalpa1-6DManpb1-4LRhapa1-ROH","GLA(6_H_)-BMA(5_H_)-RAM(4_H_)-GLA(3_H_)-BMA(2_H_)-RAM(1_H_)",58.9408,"","",""
"6F7K","CRYSTAL STRUCTURE OF DETTILON TAILSPIKE PROTEIN (GP208)","10.1074/JBC.RA119.008133 ",2.1,47.44,"6f7k_oligo1","DGalpa1-6DManpb1-4LRhapa1-3DGalpa1-6DManpb1-4LRhapa1-ROH","GLA(4_I_)-BMA(3_I_)-RAM(2_I_)-GLA(1_I_)-BMA(2_J_)-RAM(1_J_)",49.3677,"","",""
"6F7K","CRYSTAL STRUCTURE OF DETTILON TAILSPIKE PROTEIN (GP208)","10.1074/JBC.RA119.008133 ",2.1,47.44,"6f7k_oligo2","DGalpa1-6DManpb1-4LRhapa1-3DGalpa1-6DManpb1-4LRhapa1-ROH","GLA(6_E_)-BMA(5_E_)-RAM(4_E_)-GLA(3_E_)-BMA(2_E_)-RAM(1_E_)",68.8091,"","",""
"6F9T","CRYSTAL STRUCTURE OF HUMAN TESTIS ANGIOTENSIN-1 CONVERTING ENZYME IN COMPLEX WITH SAMPATRILAT.","10.1111/FEBS.14421 ",1.6,0,"6f9t_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)",51.383,"","",""
"6FAT","THE CRYSTAL STRUCTURE OF A FERULOYL ESTERASE C FROM FUSARIUM OXYSPORUM.","10.1002/1873-3468.13776 ",2.3,34.96,"6fat_oligo1","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(362_A_)",58.0965,"","",""
"6FAT","THE CRYSTAL STRUCTURE OF A FERULOYL ESTERASE C FROM FUSARIUM OXYSPORUM.","10.1002/1873-3468.13776 ",2.3,34.96,"6fat_oligo5","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_G_)-[MAN(6_G_)-MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(151_B_)",41.289,"","",""
"6FAT","THE CRYSTAL STRUCTURE OF A FERULOYL ESTERASE C FROM FUSARIUM OXYSPORUM.","10.1002/1873-3468.13776 ",2.3,34.96,"6fat_oligo6","DManpa1-2DManpa1-2[DManpa1-6]DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(10_H_)-MAN(9_H_)-[MAN(11_H_)]-MAN(8_H_)-[MAN(7_H_)-[MAN(6_H_)-MAN(5_H_)]-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(362_B_)",39.1007,"","",""
"6FB3","TENEURIN 2 PARTIAL EXTRACELLULAR DOMAIN","10.1038/S41467-018-03460-0 ",2.38,76.85,"6fb3_oligo19","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_W_)-MAN(7_W_)-[MAN(6_W_)-MAN(5_W_)-MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(2365_D_)",106.033,"","",""
"6FB3","TENEURIN 2 PARTIAL EXTRACELLULAR DOMAIN","10.1038/S41467-018-03460-0 ",2.38,76.85,"6fb3_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_E_)-MAN(7_E_)-[MAN(6_E_)-MAN(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(2365_A_)",161.549,"","",""
"6FB3","TENEURIN 2 PARTIAL EXTRACELLULAR DOMAIN","10.1038/S41467-018-03460-0 ",2.38,76.85,"6fb3_oligo7","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_K_)-MAN(7_K_)-[MAN(6_K_)-MAN(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(2365_B_)",103.711,"","",""
"6FB3","TENEURIN 2 PARTIAL EXTRACELLULAR DOMAIN","10.1038/S41467-018-03460-0 ",2.38,76.85,"6fb3_oligo13","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_Q_)-MAN(7_Q_)-[MAN(6_Q_)-MAN(5_Q_)-MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(2365_C_)",84.2272,"","",""
"6FE5","X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) - THE E424M INACTIVE MUTANT, IN COMPLEX WITH A INHIBITOR JHU 2249","10.1016/J.BMC.2018.11.022 ",1.52,32.44,"6fe5_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(476_A_)",45.0091,"","",""
"6FE5","X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) - THE E424M INACTIVE MUTANT, IN COMPLEX WITH A INHIBITOR JHU 2249","10.1016/J.BMC.2018.11.022 ",1.52,32.44,"6fe5_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(638_A_)",44.9005,"","",""
"6FG8","CRYSTAL STRUCTURE OF THE BIR3 - SERK1 COMPLEX FROM ARABIDOPSIS THALIANA.","10.1038/S41477-018-0150-9 ",1.25,24.39,"6fg8_oligo6","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_H_)-[FUC(2_H_)]-NAG(1_H_)-ASN(52_B_)",111.19,"","",""
"6FGO","FC IN COMPLEX WITH ENGINEERED CALCIUM BINDING DOMAIN Z","10.1016/J.JMB.2018.06.004 ",2.5,65.2,"6fgo_oligo3","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_J_)-[NAG(5_J_)-MAN(4_J_)-[MAN(6_J_)]-BMA(3_J_)-NAG(2_J_)]-NAG(1_J_)-ASN(297_B_)",86.9288,"","",""
"6FGO","FC IN COMPLEX WITH ENGINEERED CALCIUM BINDING DOMAIN Z","10.1016/J.JMB.2018.06.004 ",2.5,65.2,"6fgo_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_I_)-[NAG(7_I_)-MAN(6_I_)-[NAG(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(297_A_)",47.6119,"","",""
"6FGO","FC IN COMPLEX WITH ENGINEERED CALCIUM BINDING DOMAIN Z","10.1016/J.JMB.2018.06.004 ",2.5,65.2,"6fgo_oligo2","DGlcpNAcb1-2DManpa1-6[DManp[2<R1>]a1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_K_)-MAN(6_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(297_C_)",63.1947,"","",""
"6FGO","FC IN COMPLEX WITH ENGINEERED CALCIUM BINDING DOMAIN Z","10.1016/J.JMB.2018.06.004 ",2.5,65.2,"6fgo_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_L_)-[MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(297_D_)",91.1002,"","",""
"6FHW","STRUCTURE OF HORMOCONIS RESINAE GLUCOAMYLASE","10.1107/S2059798318004989 ",3.6,54.06,"6fhw_oligo2","DManpa1-6DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(200_A_)",77.226,"","",""
"6FJ3","HIGH RESOLUTION CRYSTAL STRUCTURE OF PARATHYROID HORMONE 1 RECEPTOR IN COMPLEX WITH A PEPTIDE AGONIST.","10.1038/S41594-018-0151-4 ",2.5,0,"6fj3_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcx1-","FUC(6_C_)-[MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)",77.5261,"","",""
"6FJE","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH FRUCTOSE AND GLUCOSE","10.1038/S41598-019-53948-Y ",1.85,30.79,"6fje_oligo42","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-MAN(4_F_)-[MAN(6_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(58_B_)",52.9495,"","",""
"6FJE","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH FRUCTOSE AND GLUCOSE","10.1038/S41598-019-53948-Y ",1.85,30.79,"6fje_oligo43","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_G_)-MAN(8_G_)-[MAN(10_G_)]-MAN(7_G_)-[MAN(6_G_)-MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(107_B_)",42.3558,"","",""
"6FJE","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH FRUCTOSE AND GLUCOSE","10.1038/S41598-019-53948-Y ",1.85,30.79,"6fje_oligo37","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_C_)-MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(58_A_)",49.23,"","",""
"6FJE","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH FRUCTOSE AND GLUCOSE","10.1038/S41598-019-53948-Y ",1.85,30.79,"6fje_oligo40","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_D_)-MAN(8_D_)-[MAN(10_D_)]-MAN(7_D_)-[MAN(6_D_)-MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(107_A_)",39.6393,"","",""
"6FJG","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH FRUCTOSE AND 4-NITROPHENOL","10.1038/S41598-019-53948-Y ",1.73,25.41,"6fjg_oligo28","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(58_A_)",35.2355,"","",""
"6FJG","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH FRUCTOSE AND 4-NITROPHENOL","10.1038/S41598-019-53948-Y ",1.73,25.41,"6fjg_oligo34","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_G_)-MAN(5_G_)-[MAN(7_G_)]-MAN(4_G_)-[MAN(9_G_)-MAN(8_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(107_B_)",31.4304,"","",""
"6FJG","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH FRUCTOSE AND 4-NITROPHENOL","10.1038/S41598-019-53948-Y ",1.73,25.41,"6fjg_oligo29","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_D_)-MAN(8_D_)-[MAN(10_D_)]-MAN(7_D_)-[MAN(6_D_)-MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(107_A_)",34.69,"","",""
"6FJG","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH FRUCTOSE AND 4-NITROPHENOL","10.1038/S41598-019-53948-Y ",1.73,25.41,"6fjg_oligo33","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-MAN(4_F_)-[MAN(6_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(58_B_)",45.1942,"","",""
"6FK6","CRYSTAL STRUCTURE OF N2C/D282C STABILIZED OPSIN BOUND TO RS01","10.1073/PNAS.1718084115 ",2.36,86.27,"6fk6_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(15_A_)",107.065,"","",""
"6FK7","CRYSTAL STRUCTURE OF N2C/D282C STABILIZED OPSIN BOUND TO RS06","10.1073/PNAS.1718084115 ",2.62,0,"6fk7_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(15_A_)",95.286,"","",""
"6FK8","CRYSTAL STRUCTURE OF N2C/D282C STABILIZED OPSIN BOUND TO RS08","10.1073/PNAS.1718084115 ",2.87,0,"6fk8_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(15_A_)",115.814,"","",""
"6FK9","CRYSTAL STRUCTURE OF N2C/D282C STABILIZED OPSIN BOUND TO RS09","10.1073/PNAS.1718084115 ",2.63,0,"6fk9_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(15_A_)",113.036,"","",""
"6FKA","CRYSTAL STRUCTURE OF N2C/D282C STABILIZED OPSIN BOUND TO RS11","10.1073/PNAS.1718084115 ",2.7,0,"6fka_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(15_A_)",97.8678,"","",""
"6FKC","CRYSTAL STRUCTURE OF N2C/D282C STABILIZED OPSIN BOUND TO RS15","10.1073/PNAS.1718084115 ",2.46,0,"6fkc_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(15_A_)",91.3793,"","",""
"6FKD","CRYSTAL STRUCTURE OF N2C/D282C STABILIZED OPSIN BOUND TO RS16","10.1073/PNAS.1718084115 ",2.49,0,"6fkd_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(15_A_)",94.9826,"","",""
"6FKK","DROSOPHILA SEMAPHORIN 1B, EXTRACELLULAR DOMAINS 1-2","10.1038/S41467-019-11683-Y ",2.78,0,"6fkk_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(81_A_)",172.298,"","",""
"6FKK","DROSOPHILA SEMAPHORIN 1B, EXTRACELLULAR DOMAINS 1-2","10.1038/S41467-019-11683-Y ",2.78,0,"6fkk_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_B_)-[MAN(8_B_)]-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(289_A_)",151.985,"","",""
"6FKM","DROSOPHILA PLEXIN A IN COMPLEX WITH SEMAPHORIN 1B","10.15252/EMBJ.2019102926 ",2.96,0,"6fkm_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(289_B_)",117.348,"","",""
"6FKM","DROSOPHILA PLEXIN A IN COMPLEX WITH SEMAPHORIN 1B","10.15252/EMBJ.2019102926 ",2.96,0,"6fkm_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(81_B_)",152.145,"","",""
"6FKN","DROSOPHILA PLEXIN A IN COMPLEX WITH SEMAPHORIN 1B","10.15252/EMBJ.2019102926 ",4.8,0,"6fkn_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(81_D_)",388.334,"","",""
"6FKN","DROSOPHILA PLEXIN A IN COMPLEX WITH SEMAPHORIN 1B","10.15252/EMBJ.2019102926 ",4.8,0,"6fkn_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(289_B_)",272.601,"","",""
"6FKN","DROSOPHILA PLEXIN A IN COMPLEX WITH SEMAPHORIN 1B","10.15252/EMBJ.2019102926 ",4.8,0,"6fkn_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(289_D_)",328.191,"","",""
"6FWG","STRUCTURE OF AN E333Q VARIANT OF THE GH99 ENDO-ALPHA-MANNANASE FROM BACTEROIDES XYLANISOLVENS IN COMPLEX WITH TETRAMANNOSIDE YEAST MANNAN FRAGMENT","10.1021/ACSCENTSCI.0C00111 ",1.07,16.74,"6fwg_oligo1","DManpa1-3DManpa1-2DManpa1-2DManpa1-OME","MAN(4_B_)-MAN(3_B_)-MAN(2_B_)-MMA(1_B_)",14.7018,"","",""
"6FWP","STRUCTURE OF THE GH99 ENDO-ALPHA-MANNANASE FROM BACTEROIDES XYLANISOLVENS IN COMPLEX WITH ALPHA-1,3-MANNOBIOSE AND ALPHA-1,2- MANNOBIOSE","10.1021/ACSCENTSCI.0C00111 ",1.08,16.43,"6fwp_oligo1","DManpa1-3DManpa1-ROH","MAN(2_B_)-MAN(1_B_)",12.4668,"","",""
"6FWQ","STRUCTURE OF AN E333Q VARIANT OF THE GH99 ENDO-ALPHA-MANNANASE FROM BACTEROIDES XYLANISOLVENS IN COMPLEX WITH ALPHA-1,3-MANNOBIOSE AND ALPHA-1,2-MANNOBIOSE","10.1021/ACSCENTSCI.0C00111 ",1.65,26.86,"6fwq_oligo2","DManpa1-3DManpa1-ROH","MAN(2_B_)-MAN(1_B_)",20.6627,"","",""
"6FX1","CRYSTAL STRUCTURE OF PHOLIOTA SQUARROSA LECTIN IN COMPLEX WITH AN OCTASACCHARIDE","10.1002/ANIE.201805165 ",2.1,40.71,"6fx1_oligo6","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-N3","FUC(7_S_)-[NAG(5_S_)-MAN(4_S_)-[MAN(6_S_)]-BMA(3_S_)-NAG(2_S_)]-C4W(1_S_)",48.3782,"","",""
"6FX1","CRYSTAL STRUCTURE OF PHOLIOTA SQUARROSA LECTIN IN COMPLEX WITH AN OCTASACCHARIDE","10.1002/ANIE.201805165 ",2.1,40.71,"6fx1_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ROH","FUC(5_P_)-[MAN(4_P_)-BMA(3_P_)-NAG(2_P_)]-C4W(1_P_)",51.0396,"","",""
"6FX1","CRYSTAL STRUCTURE OF PHOLIOTA SQUARROSA LECTIN IN COMPLEX WITH AN OCTASACCHARIDE","10.1002/ANIE.201805165 ",2.1,40.71,"6fx1_oligo8","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ROH","FUC(8_U_)-[NAG(7_U_)-MAN(6_U_)-[NAG(5_U_)-MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)]-C4W(1_U_)",45.1991,"","",""
"6FX1","CRYSTAL STRUCTURE OF PHOLIOTA SQUARROSA LECTIN IN COMPLEX WITH AN OCTASACCHARIDE","10.1002/ANIE.201805165 ",2.1,40.71,"6fx1_oligo5","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ROH","FUC(7_Q_)-[NAG(5_Q_)-MAN(4_Q_)-[MAN(6_Q_)]-BMA(3_Q_)-NAG(2_Q_)]-C4W(1_Q_)",44.8705,"","",""
"6FX1","CRYSTAL STRUCTURE OF PHOLIOTA SQUARROSA LECTIN IN COMPLEX WITH AN OCTASACCHARIDE","10.1002/ANIE.201805165 ",2.1,40.71,"6fx1_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ROH","FUC(8_N_)-[NAG(7_N_)-MAN(6_N_)-[NAG(5_N_)-MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)]-C4W(1_N_)",49.9314,"","",""
"6FX2","CRYSTAL STRUCTURE OF PHOLIOTA SQUARROSA LECTIN IN COMPLEX WITH A DECASACCHARIDE","10.1002/ANIE.201805165 ",1.7,28.56,"6fx2_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-N3","FUC(9_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)]-C4W(1_C_)",39.6573,"","",""
"6FX3","CRYSTAL STRUCTURE OF PHOLIOTA SQUARROSA LECTIN IN COMPLEX WITH A DODECASACCHARIDE","10.1002/ANIE.201805165 ",1.7,26.6,"6fx3_oligo1","DNeup5Aca2-6DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-N3","FUC(10_C_)-[SIA(7_C_)-GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(9_C_)-MAN(8_C_)]-BMA(3_C_)-NAG(2_C_)]-C4W(1_C_)",36.0636,"","",""
"6FYT","STRUCTURE OF H1 (A/SOLOMON ISLANDS/3/06) INFLUENZA HEMAGGLUTININ IN COMPLEX WITH SD38","10.1126/SCIENCE.AAQ0620 ",2.8,0,"6fyt_oligo4","LFucpa1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_C_)-[NAG(3_C_)]-[FUC(2_C_)]-NAG(1_C_)-ASN(33_A_)",139.273,"","",""
"6FYT","STRUCTURE OF H1 (A/SOLOMON ISLANDS/3/06) INFLUENZA HEMAGGLUTININ IN COMPLEX WITH SD38","10.1126/SCIENCE.AAQ0620 ",2.8,0,"6fyt_oligo5","LFucpa1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_G_)-[NAG(3_G_)]-[FUC(2_G_)]-NAG(1_G_)-ASN(154_B_)",145.145,"","",""
"6FYW","STRUCTURE OF B/BRISBANE/60/2008 INFLUENZA HEMAGGLUTININ IN COMPLEX WITH SD83","10.1126/SCIENCE.AAQ0620 ",2.2,0,"6fyw_oligo5","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-MAN(4_H_)-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(330_A_)",76.1633,"","",""
"6FYW","STRUCTURE OF B/BRISBANE/60/2008 INFLUENZA HEMAGGLUTININ IN COMPLEX WITH SD83","10.1126/SCIENCE.AAQ0620 ",2.2,0,"6fyw_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(230_A_)",85.6995,"","",""
"6FYW","STRUCTURE OF B/BRISBANE/60/2008 INFLUENZA HEMAGGLUTININ IN COMPLEX WITH SD83","10.1126/SCIENCE.AAQ0620 ",2.2,0,"6fyw_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-[MAN(5_E_)]-MAN(4_E_)-[MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(301_A_)",71.263,"","",""
"6G01","COMPLEX OF NEURAMINIDASE FROM H1N1 INFLUENZA VIRUS WITH TAMIPHOSPHOR MONOMETHYL ESTER","10.1042/BCJ20180764 ",1.61,17.72,"6g01_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(146_B_)",28.2259,"","",""
"6G0X","TAILSPIKE PROTEIN OF E. COLI BACTERIOPHAGE HK620 IN COMPLEX WITH PENTASACCHARIDE","10.1021/JACS.8B03719 ",1.41,13.87,"6g0x_oligo1","LRhapa1-6DGlcpa1-4[DGlcpNAcb1-3]DGalpa1-3DGlcpNAcb1-ROH","RAM(4_B_)-GLC(3_B_)-[NAG(5_B_)]-GLA(2_B_)-NAG(1_B_)",13.3591,"","",""
"6G1E","BEAT FC WITH IMPROVED HETERODIMERIZATION (Q3A-D84.4Q)","10.1074/JBC.RA119.012335 ",1.88,56.12,"6g1e_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",71.6165,"","",""
"6G1E","BEAT FC WITH IMPROVED HETERODIMERIZATION (Q3A-D84.4Q)","10.1074/JBC.RA119.012335 ",1.88,56.12,"6g1e_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",95.0465,"","",""
"6G46","RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH 2-(NAPHTHALEN- 1-YL)THIAZOLE-4-CARBOXYLIC ACID","10.1016/J.EJMECH.2018.08.004 ",2.4,0,"6g46_oligo7","LFucpa1-3DGlcpNAcb1-ASN","FUC(2_K_)-NAG(1_K_)-ASN(109_D_)",59.3473,"","",""
"6G46","RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH 2-(NAPHTHALEN- 1-YL)THIAZOLE-4-CARBOXYLIC ACID","10.1016/J.EJMECH.2018.08.004 ",2.4,0,"6g46_oligo2","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_F_)-[FUC(2_F_)]-NAG(1_F_)-ASN(109_A_)",68.0461,"","",""
"6G46","RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH 2-(NAPHTHALEN- 1-YL)THIAZOLE-4-CARBOXYLIC ACID","10.1016/J.EJMECH.2018.08.004 ",2.4,0,"6g46_oligo9","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_M_)-[FUC(2_M_)]-NAG(1_M_)-ASN(396_C_)",49.5515,"","",""
"6G46","RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH 2-(NAPHTHALEN- 1-YL)THIAZOLE-4-CARBOXYLIC ACID","10.1016/J.EJMECH.2018.08.004 ",2.4,0,"6g46_oligo1","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_E_)-[FUC(2_E_)]-NAG(1_E_)-ASN(81_A_)",57.2709,"","",""
"6G46","RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH 2-(NAPHTHALEN- 1-YL)THIAZOLE-4-CARBOXYLIC ACID","10.1016/J.EJMECH.2018.08.004 ",2.4,0,"6g46_oligo3","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_G_)-[FUC(2_G_)]-NAG(1_G_)-ASN(396_A_)",37.8248,"","",""
"6G46","RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH 2-(NAPHTHALEN- 1-YL)THIAZOLE-4-CARBOXYLIC ACID","10.1016/J.EJMECH.2018.08.004 ",2.4,0,"6g46_oligo5","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_I_)-[FUC(2_I_)]-NAG(1_I_)-ASN(396_B_)",39.8167,"","",""
"6G46","RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH 2-(NAPHTHALEN- 1-YL)THIAZOLE-4-CARBOXYLIC ACID","10.1016/J.EJMECH.2018.08.004 ",2.4,0,"6g46_oligo8","LFucpa1-3DGlcpNAcb1-ASN","FUC(2_L_)-NAG(1_L_)-ASN(109_C_)",56.6382,"","",""
"6G46","RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH 2-(NAPHTHALEN- 1-YL)THIAZOLE-4-CARBOXYLIC ACID","10.1016/J.EJMECH.2018.08.004 ",2.4,0,"6g46_oligo6","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_J_)-[FUC(2_J_)]-NAG(1_J_)-ASN(396_D_)",50.5433,"","",""
"6G46","RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH 2-(NAPHTHALEN- 1-YL)THIAZOLE-4-CARBOXYLIC ACID","10.1016/J.EJMECH.2018.08.004 ",2.4,0,"6g46_oligo4","LFucpa1-3DGlcpNAcb1-ASN","FUC(2_H_)-NAG(1_H_)-ASN(109_B_)",62.545,"","",""
"6GFE","HIGH-RESOLUTION STRUCTURE OF A THERAPEUTIC FULL-LENGTH ANTI-NPRA ANTIBODY WITH EXCEPTIONAL CONFORMATIONAL DIVERSITY","10.1016/J.BPJ.2019.03.036 ",1.8,35.64,"6gfe_oligo1","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_B_)-[NAG(5_B_)-MAN(4_B_)-[MAN(6_B_)]-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(297_K_)",42.4825,"","",""
"6GFE","HIGH-RESOLUTION STRUCTURE OF A THERAPEUTIC FULL-LENGTH ANTI-NPRA ANTIBODY WITH EXCEPTIONAL CONFORMATIONAL DIVERSITY","10.1016/J.BPJ.2019.03.036 ",1.8,35.64,"6gfe_oligo2","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_A_)-[NAG(5_A_)-MAN(4_A_)-[MAN(6_A_)]-BMA(3_A_)-NAG(2_A_)]-NAG(1_A_)-ASN(297_H_)",33.1592,"","",""
"6GRT","PAIRED IMMUNOGLOBULIN-LIKE RECEPTOR B (PIRB) OR LEUKOCYTE IMMUNOGLOBULIN-LIKE RECEPTOR SUBFAMILY B MEMBER 3 (LILRB3) FULL EXTRACELLULAR DOMAIN","10.1074/JBC.RA118.004396 ",4.5,0,"6grt_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(479_B_)",273.173,"","",""
"6GSG","CRYSTAL STRUCTURE OF ASPERGILLUS ORYZAE CATECHOL OXIDASE COMPLEXED WITH RESORCINOL","10.1002/CBIC.201800387 ",2.19,0,"6gsg_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[MAN(5_B_)]-MAN(4_B_)-[MAN(7_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(104_A_)",91.3962,"","",""
"6GSZ","CRYSTAL STRUCTURE OF NATIVE ALFA-L-RHAMNOSIDASE FROM ASPERGILLUS TERREUS","10.1107/S2059798318013049 ",1.38,19.39,"6gsz_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(629_A_)",33.2035,"","",""
"6GSZ","CRYSTAL STRUCTURE OF NATIVE ALFA-L-RHAMNOSIDASE FROM ASPERGILLUS TERREUS","10.1107/S2059798318013049 ",1.38,19.39,"6gsz_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(505_A_)",31.3616,"","",""
"6GSZ","CRYSTAL STRUCTURE OF NATIVE ALFA-L-RHAMNOSIDASE FROM ASPERGILLUS TERREUS","10.1107/S2059798318013049 ",1.38,19.39,"6gsz_oligo4","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)]-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(616_A_)",35.6462,"","",""
"6GSZ","CRYSTAL STRUCTURE OF NATIVE ALFA-L-RHAMNOSIDASE FROM ASPERGILLUS TERREUS","10.1107/S2059798318013049 ",1.38,19.39,"6gsz_oligo7","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)]-MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(749_A_)",33.2839,"","",""
"6GTV","CRYSTAL STRUCTURE OF A FIMH*DSG COMPLEX FROM E.COLI F18 WITH BOUND TRIMANNOSE","10.1021/JACS.8B10736 ",2.1,0,"6gtv_oligo1","DManpa1-3[DManpa1-6]DManpa1-ROH","MAN(3_E_)-[MAN(2_E_)]-MAN(1_E_)",42.2633,"","",""
"6GTW","CRYSTAL STRUCTURE OF THE FIMH LECTIN DOMAIN FROM E.COLI F18 IN COMPLEX WITH TRIMANNOSE","10.1021/JACS.8B10736 ",2.5,0,"6gtw_oligo2","DManpa1-3[DManpa1-6]DManpa1-ROH","MAN(3_F_)-[MAN(2_F_)]-MAN(1_F_)",46.9876,"","",""
"6GTW","CRYSTAL STRUCTURE OF THE FIMH LECTIN DOMAIN FROM E.COLI F18 IN COMPLEX WITH TRIMANNOSE","10.1021/JACS.8B10736 ",2.5,0,"6gtw_oligo1","DManpa1-3[DManpa1-6]DManpa1-ROH","MAN(3_E_)-[MAN(2_E_)]-MAN(1_E_)",45.3942,"","",""
"6GTZ","CRYSTAL STRUCTURE OF A FIMH*DSG COMPLEX FROM E.COLI F18 WITH BOUND DIMANNOSIDE MAN(ALPHA1-3)MAN IN SPACE GROUP P21","10.1021/JACS.8B10736 ",1.72,0,"6gtz_oligo1","DManpa1-3DManpa1-OME","MAN(2_E_)-MMA(1_E_)",22.4982,"","",""
"6GTZ","CRYSTAL STRUCTURE OF A FIMH*DSG COMPLEX FROM E.COLI F18 WITH BOUND DIMANNOSIDE MAN(ALPHA1-3)MAN IN SPACE GROUP P21","10.1021/JACS.8B10736 ",1.72,0,"6gtz_oligo2","DManpa1-3DManpa1-OME","MAN(2_F_)-MMA(1_F_)",21.7559,"","",""
"6GU0","CRYSTAL STRUCTURE OF A FIMH*DSG COMPLEX FROM E.COLI F18 WITH BOUND DIMANNOSIDE MAN(ALPHA1-3)MAN IN SPACE GROUP P213","10.1021/JACS.8B10736 ",2.5,0,"6gu0_oligo1","DManpa1-3DManpa1-OME","MAN(2_C_)-MMA(1_C_)",44.6591,"","",""
"6GVP","TAILSPIKE PROTEIN MUTANT E372Q (DELTA N471/S472) OF E. COLI BACTERIOPHAGE HK620 IN COMPLEX WITH HEXASACCHARIDE","10.1021/JACS.8B03719 ",1.71,17.14,"6gvp_oligo1","LRhapa1-6DGlcpa1-4[DGlcpNAcb1-3]DGalpa1-3[DGlcpa1-6]DGlcpNAca1-ROH","GLC(6_B_)-[RAM(4_B_)-GLC(3_B_)-[NAG(5_B_)]-GLA(2_B_)]-NDG(1_B_)",17.9209,"","",""
"6GVR","TAILSPIKE PROTEIN MUTANT E372Q (DELTA N471/S472) OF E. COLI BACTERIOPHAGE HK620 IN COMPLEX WITH PENTASACCHARIDE","10.1021/JACS.8B03719 ",1.85,19.9,"6gvr_oligo1","LRhapa1-6DGlcpa1-4[DGlcpNAcb1-3]DGalpa1-3DGlcpNAca1-ROH","RAM(4_B_)-GLC(3_B_)-[NAG(5_B_)]-GLA(2_B_)-NDG(1_B_)",20.7371,"","",""
"6H16","STRUCTURE OF LRP6 P3E3P4E4 IN COMPLEX WITH VHH L-P2-D07","10.1038/S41467-018-08172-Z ",2.9,116,"6h16_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(1039_A_)",174.814,"","",""
"6H3T","SCHMALLENBERG VIRUS GLYCOPROTEIN GC HEAD DOMAIN IN COMPLEX WITH SCFV 1C11","10.1038/S41467-019-08832-8 ",2.84,88.28,"6h3t_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)]-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(493_A_)",104.915,"","",""
"6H3T","SCHMALLENBERG VIRUS GLYCOPROTEIN GC HEAD DOMAIN IN COMPLEX WITH SCFV 1C11","10.1038/S41467-019-08832-8 ",2.84,88.28,"6h3t_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-[MAN(5_E_)]-MAN(4_E_)-[MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(493_B_)",126.218,"","",""
"6H3U","SCHMALLENBERG VIRUS GLYCOPROTEIN GC HEAD DOMAIN IN COMPLEX WITH SCFV 4B6","10.1038/S41467-019-08832-8 ",3.17,113.1,"6h3u_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)]-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(493_A_)",139.41,"","",""
"6H3U","SCHMALLENBERG VIRUS GLYCOPROTEIN GC HEAD DOMAIN IN COMPLEX WITH SCFV 4B6","10.1038/S41467-019-08832-8 ",3.17,113.1,"6h3u_oligo3","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-[MAN(5_E_)]-MAN(4_E_)-[MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(493_B_)",151.299,"","",""
"6H3W","LA CROSSE VIRUS GLYCOPROTEIN GC HEAD DOMAIN","10.1038/S41467-019-08832-8 ",2.1,31.72,"6h3w_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(490_A_)",48.5913,"","",""
"6H7Y","X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH A INHIBITOR RNA 1-79-1","10.1021/ACSMEDCHEMLETT.8B00318 ",1.81,43.92,"6h7y_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(476_A_)",71.6234,"","",""
"6H7Y","X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH A INHIBITOR RNA 1-79-1","10.1021/ACSMEDCHEMLETT.8B00318 ",1.81,43.92,"6h7y_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(638_A_)",55.506,"","",""
"6H7Z","X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH A INHIBITOR RNA 2-65-1","10.1021/ACSMEDCHEMLETT.8B00318 ",2,23.25,"6h7z_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(638_A_)",39.5818,"","",""
"6H9Y","UNRAVELING THE ROLE OF THE SECRETOR ANTIGEN IN HUMAN ROTAVIRUS ATTACHMENT TO HISTO-BLOOD GROUP ANTIGENS","10.1371/JOURNAL.PPAT.1007865 ",1.31,12.39,"6h9y_oligo1","DGalpb1-3DGlcpNAcb1-ROH","GAL(2_C_)-NAG(1_C_)",16.3391,"","",""
"6HA0","UNRAVELING THE ROLE OF THE SECRETOR ANTIGEN IN HUMAN ROTAVIRUS ATTACHMENT TO HISTO-BLOOD GROUP ANTIGENS","10.1371/JOURNAL.PPAT.1007865 ",1.85,25.36,"6ha0_oligo1","LFucpa1-2DGalpb1-3DGlcpNAcb1-ROH","FUC(3_C_)-GAL(2_C_)-NAG(1_C_)",34.1579,"","",""
"6HCX","INFLUENZA VIRUS N9 NEURAMINIDASE A COMPLEX WITH ZANAMIVIR MOLECULE (TERN).","",1.3,15.04,"6hcx_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_B_)-[MAN(8_B_)]-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(202_A_)",22.1121,"","",""
"6HEB","INFLUENZA A VIRUS N9 NEURAMINIDASE COMPLEX WITH OSELTAMIVIR (TERN).","",1.75,14.39,"6heb_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_D_)-[MAN(8_D_)]-MAN(7_D_)-[MAN(6_D_)-MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(202_A_)",21.7317,"","",""
"6HFC","INFLUENZA A VIRUS N9 NEURAMINIDASE NATIVE (TERN).","",1.29,20.27,"6hfc_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_B_)-MAN(8_B_)-[MAN(10_B_)]-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(202_A_)",32.7769,"","",""
"6HFX","CRYSTAL STRUCTURE OF EXTRACELLULAR DOMAIN 1 (ECD1) OF FTSX FROM S. PNEUMONIE IN COMPLEX WITH N-DECYL-B-D-MALTOSIDE","10.1128/MBIO.02622-18 ",2.16,0,"6hfx_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(201_A_)-DMU(201_A_)",89.7191,"","",""
"6HFY","INFLUENZA A VIRUS N6 NEURAMINIDASE COMPLEX WITH DANA (DUCK/ENGLAND/56).","",1.65,15.84,"6hfy_oligo4","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-[MAN(5_H_)]-MAN(4_H_)-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(201_B_)",33.7579,"","",""
"6HFY","INFLUENZA A VIRUS N6 NEURAMINIDASE COMPLEX WITH DANA (DUCK/ENGLAND/56).","",1.65,15.84,"6hfy_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)]-MAN(4_F_)-[MAN(7_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(201_A_)",30.2549,"","",""
"6HFY","INFLUENZA A VIRUS N6 NEURAMINIDASE COMPLEX WITH DANA (DUCK/ENGLAND/56).","",1.65,15.84,"6hfy_oligo5","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_I_)-[MAN(5_I_)]-MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(201_C_)",39.6877,"","",""
"6HFY","INFLUENZA A VIRUS N6 NEURAMINIDASE COMPLEX WITH DANA (DUCK/ENGLAND/56).","",1.65,15.84,"6hfy_oligo6","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_J_)-[MAN(5_J_)]-MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(201_D_)",36.3067,"","",""
"6HG0","INFLUENZA A VIRUS N9 NEURAMINIDASE COMPLEX WITH NANA (TERN/AUSTRALIA).","",1.3,13.5,"6hg0_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_B_)-MAN(8_B_)-[MAN(10_B_)]-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(202_A_)",25.1245,"","",""
"6HG5","INFLUENZA A VIRUS N6 NEURAMINIDASE COMPLEX WITH OSELTAMIVIR (DUCK/ENGLAND/56).","",1.6,11.16,"6hg5_oligo8","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_L_)-[MAN(5_L_)]-MAN(4_L_)-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(201_D_)",29.3961,"","",""
"6HG5","INFLUENZA A VIRUS N6 NEURAMINIDASE COMPLEX WITH OSELTAMIVIR (DUCK/ENGLAND/56).","",1.6,11.16,"6hg5_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)]-MAN(4_F_)-[MAN(7_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(201_A_)",23.21,"","",""
"6HG5","INFLUENZA A VIRUS N6 NEURAMINIDASE COMPLEX WITH OSELTAMIVIR (DUCK/ENGLAND/56).","",1.6,11.16,"6hg5_oligo6","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_J_)-[MAN(5_J_)]-MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(201_C_)",30.4664,"","",""
"6HG5","INFLUENZA A VIRUS N6 NEURAMINIDASE COMPLEX WITH OSELTAMIVIR (DUCK/ENGLAND/56).","",1.6,11.16,"6hg5_oligo4","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-[MAN(5_H_)]-MAN(4_H_)-[MAN(7_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(201_B_)",27.2747,"","",""
"6HGB","INFLUENZA A VIRUS N6 NEURAMINIDASE NATIVE STRUCTURE (DUCK/ENGLAND/56).","",1.5,13.97,"6hgb_oligo8","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_L_)-[MAN(5_L_)]-MAN(4_L_)-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(201_C_)",28.4158,"","",""
"6HGB","INFLUENZA A VIRUS N6 NEURAMINIDASE NATIVE STRUCTURE (DUCK/ENGLAND/56).","",1.5,13.97,"6hgb_oligo9","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_M_)-[MAN(5_M_)]-MAN(4_M_)-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(201_D_)",28.7035,"","",""
"6HGB","INFLUENZA A VIRUS N6 NEURAMINIDASE NATIVE STRUCTURE (DUCK/ENGLAND/56).","",1.5,13.97,"6hgb_oligo1","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_G_)-[MAN(7_G_)]-MAN(6_G_)-[MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(201_A_)",21.962,"","",""
"6HGB","INFLUENZA A VIRUS N6 NEURAMINIDASE NATIVE STRUCTURE (DUCK/ENGLAND/56).","",1.5,13.97,"6hgb_oligo5","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_I_)-[MAN(5_I_)]-MAN(4_I_)-[MAN(7_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(201_B_)",24.5471,"","",""
"6HJD","CHOLERA TOXIN CLASSICAL B-PENTAMER IN COMPLEX WITH LEWIS-X","10.1038/S41598-019-48579-2 ",1.54,18.47,"6hjd_oligo8","LFucpa1-3[DGalpb1-4]DGlcpNAca1-ROH","GAL(3_R_)-[FUC(2_R_)]-NDG(1_R_)",29.8315,"","",""
"6HJD","CHOLERA TOXIN CLASSICAL B-PENTAMER IN COMPLEX WITH LEWIS-X","10.1038/S41598-019-48579-2 ",1.54,18.47,"6hjd_oligo7","LFucpa1-3[DGalpb1-4]DGlcpNAca1-ROH","GAL(3_Q_)-[FUC(2_Q_)]-NDG(1_Q_)",33.4318,"","",""
"6HJD","CHOLERA TOXIN CLASSICAL B-PENTAMER IN COMPLEX WITH LEWIS-X","10.1038/S41598-019-48579-2 ",1.54,18.47,"6hjd_oligo5","LFucpa1-3[DGalpb1-4]DGlcpNAcb1-ROH","GAL(3_O_)-[FUC(2_O_)]-NAG(1_O_)",16.4361,"","",""
"6HJD","CHOLERA TOXIN CLASSICAL B-PENTAMER IN COMPLEX WITH LEWIS-X","10.1038/S41598-019-48579-2 ",1.54,18.47,"6hjd_oligo3","LFucpa1-3[DGalpb1-4]DGlcpNAcb1-ROH","GAL(3_M_)-[FUC(2_M_)]-NAG(1_M_)",24.0882,"","",""
"6HJD","CHOLERA TOXIN CLASSICAL B-PENTAMER IN COMPLEX WITH LEWIS-X","10.1038/S41598-019-48579-2 ",1.54,18.47,"6hjd_oligo6","LFucpa1-3[DGalpb1-4]DGlcpNAca1-ROH","GAL(3_P_)-[FUC(2_P_)]-NDG(1_P_)",28.0227,"","",""
"6HJD","CHOLERA TOXIN CLASSICAL B-PENTAMER IN COMPLEX WITH LEWIS-X","10.1038/S41598-019-48579-2 ",1.54,18.47,"6hjd_oligo4","LFucpa1-3[DGalpb1-4]DGlcpNAca1-ROH","GAL(3_N_)-[FUC(2_N_)]-NDG(1_N_)",28.0888,"","",""
"6HJD","CHOLERA TOXIN CLASSICAL B-PENTAMER IN COMPLEX WITH LEWIS-X","10.1038/S41598-019-48579-2 ",1.54,18.47,"6hjd_oligo2","LFucpa1-3[DGalpb1-4]DGlcpNAca1-ROH","GAL(3_L_)-[FUC(2_L_)]-NDG(1_L_)",13.5958,"","",""
"6HJD","CHOLERA TOXIN CLASSICAL B-PENTAMER IN COMPLEX WITH LEWIS-X","10.1038/S41598-019-48579-2 ",1.54,18.47,"6hjd_oligo1","LFucpa1-3[DGalpb1-4]DGlcpNAca1-ROH","GAL(3_K_)-[FUC(2_K_)]-NDG(1_K_)",24.3103,"","",""
"6HJN","STRUCTURE OF INFLUENZA HEMAGGLUTININ ECTODOMAIN (A/DUCK/ALBERTA/35/76)","10.1073/PNAS.1810927115 ",3.3,0,"6hjn_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_P_)-[MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(91_C_)",189.098,"","",""
"6HJN","STRUCTURE OF INFLUENZA HEMAGGLUTININ ECTODOMAIN (A/DUCK/ALBERTA/35/76)","10.1073/PNAS.1810927115 ",3.3,0,"6hjn_oligo14","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_T_)-[MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(91_E_)",189.098,"","",""
"6HJN","STRUCTURE OF INFLUENZA HEMAGGLUTININ ECTODOMAIN (A/DUCK/ALBERTA/35/76)","10.1073/PNAS.1810927115 ",3.3,0,"6hjn_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(91_A_)",189.098,"","",""
"6HJP","STRUCTURE OF INFLUENZA HEMAGGLUTININ ECTODOMAIN (A/DUCK/ALBERTA/35/76) IN COMPLEX WITH FISW84 FAB FRAGMENT","10.1073/PNAS.1810927115 ",3.3,0,"6hjp_oligo13","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Y_)-[MAN(4_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(91_E_)",217.871,"","",""
"6HJP","STRUCTURE OF INFLUENZA HEMAGGLUTININ ECTODOMAIN (A/DUCK/ALBERTA/35/76) IN COMPLEX WITH FISW84 FAB FRAGMENT","10.1073/PNAS.1810927115 ",3.3,0,"6hjp_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(91_A_)",217.802,"","",""
"6HJP","STRUCTURE OF INFLUENZA HEMAGGLUTININ ECTODOMAIN (A/DUCK/ALBERTA/35/76) IN COMPLEX WITH FISW84 FAB FRAGMENT","10.1073/PNAS.1810927115 ",3.3,0,"6hjp_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_T_)-[MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(91_C_)",217.803,"","",""
"6HJQ","STRUCTURE OF FULL-LENGTH INFLUENZA HEMAGGLUTININ (A/DUCK/ALBERTA/35/76) IN COMPLEX WITH FISW84 FAB FRAGMENT","10.1073/PNAS.1810927115 ",4.1,0,"6hjq_oligo8","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_T_)-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(91_C_)",183.035,"","",""
"6HJQ","STRUCTURE OF FULL-LENGTH INFLUENZA HEMAGGLUTININ (A/DUCK/ALBERTA/35/76) IN COMPLEX WITH FISW84 FAB FRAGMENT","10.1073/PNAS.1810927115 ",4.1,0,"6hjq_oligo12","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_X_)-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(91_E_)",183.035,"","",""
"6HJQ","STRUCTURE OF FULL-LENGTH INFLUENZA HEMAGGLUTININ (A/DUCK/ALBERTA/35/76) IN COMPLEX WITH FISW84 FAB FRAGMENT","10.1073/PNAS.1810927115 ",4.1,0,"6hjq_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_O_)-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(91_A_)",183.035,"","",""
"6HKJ","X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH A INHIBITOR RNA 2-19-1","10.1021/ACSMEDCHEMLETT.8B00318 ",2.09,55.51,"6hkj_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(638_A_)",72.8459,"","",""
"6HKZ","X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH A INHIBITOR RNA 2-49-1","10.1021/ACSMEDCHEMLETT.8B00318 ",2.09,57.6,"6hkz_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(638_A_)",78.3264,"","",""
"6HMY","CHOLERA TOXIN CLASSICAL B-PENTAMER IN COMPLEX WITH FUCOSYL-GM1","10.1038/S41598-019-48579-2 ",1.6,13.37,"6hmy_oligo4","LFucpa1-2DGalpb1-3DGalpNAcb1-4[DNeup5Aca2-3]DGalpb1-4DGlcpa1-ROH","FUC(5_M_)-GAL(4_M_)-NGA(3_M_)-[SIA(6_M_)]-GAL(2_M_)-GLC(1_M_)",22.153,"","",""
"6HMY","CHOLERA TOXIN CLASSICAL B-PENTAMER IN COMPLEX WITH FUCOSYL-GM1","10.1038/S41598-019-48579-2 ",1.6,13.37,"6hmy_oligo10","LFucpa1-2DGalpb1-3DGalpNAcb1-4[DNeup5Aca2-3]DGalpb1-4DGlcpa1-ROH","FUC(5_Q_)-GAL(4_Q_)-NGA(3_Q_)-[SIA(6_Q_)]-GAL(2_Q_)-GLC(1_Q_)",13.6809,"","",""
"6HMY","CHOLERA TOXIN CLASSICAL B-PENTAMER IN COMPLEX WITH FUCOSYL-GM1","10.1038/S41598-019-48579-2 ",1.6,13.37,"6hmy_oligo8","LFucpa1-2DGalpb1-3DGalpNAcb1-4[DNeup5Aca2-3]DGalpb1-4DGlcpb1-ROH","FUC(5_T_)-GAL(4_T_)-NGA(3_T_)-[SIA(6_T_)]-GAL(2_T_)-BGC(1_T_)",15.7841,"","",""
"6HMY","CHOLERA TOXIN CLASSICAL B-PENTAMER IN COMPLEX WITH FUCOSYL-GM1","10.1038/S41598-019-48579-2 ",1.6,13.37,"6hmy_oligo6","LFucpa1-2DGalpb1-3DGalpNAcb1-4[DNeup5Aca2-3]DGalpb1-4DGlcpb1-ROH","FUC(5_O_)-GAL(4_O_)-NGA(3_O_)-[SIA(6_O_)]-GAL(2_O_)-BGC(1_O_)",24.3517,"","",""
"6HMY","CHOLERA TOXIN CLASSICAL B-PENTAMER IN COMPLEX WITH FUCOSYL-GM1","10.1038/S41598-019-48579-2 ",1.6,13.37,"6hmy_oligo1","LFucpa1-2DGalpb1-3DGalpNAcb1-4[DNeup5Aca2-3]DGalpb1-4DGlcpb1-ROH","FUC(5_P_)-GAL(4_P_)-NGA(3_P_)-[SIA(6_P_)]-GAL(2_P_)-BGC(1_P_)",14.3517,"","",""
"6HMY","CHOLERA TOXIN CLASSICAL B-PENTAMER IN COMPLEX WITH FUCOSYL-GM1","10.1038/S41598-019-48579-2 ",1.6,13.37,"6hmy_oligo7","LFucpa1-2DGalpb1-3DGalpNAcb1-4[DNeup5Aca2-3]DGalpb1-4DGlcpb1-ROH","FUC(5_S_)-GAL(4_S_)-NGA(3_S_)-[SIA(6_S_)]-GAL(2_S_)-BGC(1_S_)",26.5962,"","",""
"6HMY","CHOLERA TOXIN CLASSICAL B-PENTAMER IN COMPLEX WITH FUCOSYL-GM1","10.1038/S41598-019-48579-2 ",1.6,13.37,"6hmy_oligo9","LFucpa1-2DGalpb1-3DGalpNAcb1-4[DNeup5Aca2-3]DGalpb1-4DGlcpb1-ROH","FUC(5_L_)-GAL(4_L_)-NGA(3_L_)-[SIA(6_L_)]-GAL(2_L_)-BGC(1_L_)",19.1083,"","",""
"6HMY","CHOLERA TOXIN CLASSICAL B-PENTAMER IN COMPLEX WITH FUCOSYL-GM1","10.1038/S41598-019-48579-2 ",1.6,13.37,"6hmy_oligo2","LFucpa1-2DGalpb1-3DGalpNAcb1-4[DNeup5Aca2-3]DGalpb1-4DGlcpb1-ROH","FUC(5_K_)-GAL(4_K_)-NGA(3_K_)-[SIA(6_K_)]-GAL(2_K_)-BGC(1_K_)",24.3918,"","",""
"6HMY","CHOLERA TOXIN CLASSICAL B-PENTAMER IN COMPLEX WITH FUCOSYL-GM1","10.1038/S41598-019-48579-2 ",1.6,13.37,"6hmy_oligo5","LFucpa1-2DGalpb1-3DGalpNAcb1-4[DNeup5Aca2-3]DGalpb1-4DGlcpb1-ROH","FUC(5_N_)-GAL(4_N_)-NGA(3_N_)-[SIA(6_N_)]-GAL(2_N_)-BGC(1_N_)",17.1407,"","",""
"6HMY","CHOLERA TOXIN CLASSICAL B-PENTAMER IN COMPLEX WITH FUCOSYL-GM1","10.1038/S41598-019-48579-2 ",1.6,13.37,"6hmy_oligo3","LFucpa1-2DGalpb1-3DGalpNAcb1-4[DNeup5Aca2-3]DGalpb1-4DGlcpb1-ROH","FUC(5_R_)-GAL(4_R_)-NGA(3_R_)-[SIA(6_R_)]-GAL(2_R_)-BGC(1_R_)",19.3528,"","",""
"6HP0","COMPLEX OF NEURAMINIDASE FROM H1N1 INFLUENZA VIRUS IN COMPLEX WITH OSELTAMIVIR TRIAZOL DERIVATIVE","10.1016/J.BMC.2019.05.024 ",1.88,21.87,"6hp0_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_I_)-[MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(146_C_)",37.4679,"","",""
"6HRO","CRYSTAL STRUCTURE OF EBOLAVIRUS GLYCOPROTEIN IN COMPLEX WITH INHIBITOR 118A","10.1021/ACS.JMEDCHEM.8B01328 ",2.3,0,"6hro_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(563_B_)",136.312,"","",""
"6HS4","CRYSTAL STRUCTURE OF EBOLAVIRUS GLYCOPROTEIN IN COMPLEX WITH INHIBITOR 118","10.1021/ACS.JMEDCHEM.8B01328 ",2.05,0,"6hs4_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(563_B_)",105.534,"","",""
"6HUG","CRYOEM STRUCTURE OF HUMAN FULL-LENGTH ALPHA1BETA3GAMMA2L GABA(A)R IN COMPLEX WITH PICROTOXIN AND MEGABODY MB38.","10.1038/S41586-018-0832-5 ",3.1,0,"6hug_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_F_)-[MAN(8_F_)]-MAN(7_F_)-[MAN(6_F_)-MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(111_A_)",45.2824,"","",""
"6HUG","CRYOEM STRUCTURE OF HUMAN FULL-LENGTH ALPHA1BETA3GAMMA2L GABA(A)R IN COMPLEX WITH PICROTOXIN AND MEGABODY MB38.","10.1038/S41586-018-0832-5 ",3.1,0,"6hug_oligo3","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-MAN(4_I_)-[MAN(6_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(149_B_)",48.7914,"","",""
"6HUG","CRYOEM STRUCTURE OF HUMAN FULL-LENGTH ALPHA1BETA3GAMMA2L GABA(A)R IN COMPLEX WITH PICROTOXIN AND MEGABODY MB38.","10.1038/S41586-018-0832-5 ",3.1,0,"6hug_oligo7","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-MAN(4_M_)-[MAN(6_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(149_E_)",56.0283,"","",""
"6HUG","CRYOEM STRUCTURE OF HUMAN FULL-LENGTH ALPHA1BETA3GAMMA2L GABA(A)R IN COMPLEX WITH PICROTOXIN AND MEGABODY MB38.","10.1038/S41586-018-0832-5 ",3.1,0,"6hug_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(111_D_)",68.8436,"","",""
"6HUJ","CRYOEM STRUCTURE OF HUMAN FULL-LENGTH HETEROMERIC ALPHA1BETA3GAMMA2L GABA(A)R IN COMPLEX WITH PICROTOXIN, GABA AND MEGABODY MB38.","10.1038/S41586-018-0832-5 ",3.04,0,"6huj_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(111_D_)",73.4616,"","",""
"6HUJ","CRYOEM STRUCTURE OF HUMAN FULL-LENGTH HETEROMERIC ALPHA1BETA3GAMMA2L GABA(A)R IN COMPLEX WITH PICROTOXIN, GABA AND MEGABODY MB38.","10.1038/S41586-018-0832-5 ",3.04,0,"6huj_oligo7","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-MAN(4_M_)-[MAN(6_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(149_E_)",59.4049,"","",""
"6HUJ","CRYOEM STRUCTURE OF HUMAN FULL-LENGTH HETEROMERIC ALPHA1BETA3GAMMA2L GABA(A)R IN COMPLEX WITH PICROTOXIN, GABA AND MEGABODY MB38.","10.1038/S41586-018-0832-5 ",3.04,0,"6huj_oligo2","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-MAN(4_H_)-[MAN(6_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(149_B_)",62.0142,"","",""
"6HUJ","CRYOEM STRUCTURE OF HUMAN FULL-LENGTH HETEROMERIC ALPHA1BETA3GAMMA2L GABA(A)R IN COMPLEX WITH PICROTOXIN, GABA AND MEGABODY MB38.","10.1038/S41586-018-0832-5 ",3.04,0,"6huj_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)]-MAN(4_F_)-[MAN(7_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(111_A_)",58.0084,"","",""
"6HUK","CRYOEM STRUCTURE OF HUMAN FULL-LENGTH ALPHA1BETA3GAMMA2L GABA(A)R IN COMPLEX WITH BICUCULLINE AND MEGABODY MB38.","10.1038/S41586-018-0832-5 ",3.69,0,"6huk_oligo5","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)]-MAN(4_F_)-[MAN(7_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(111_A_)",82.4418,"","",""
"6HUK","CRYOEM STRUCTURE OF HUMAN FULL-LENGTH ALPHA1BETA3GAMMA2L GABA(A)R IN COMPLEX WITH BICUCULLINE AND MEGABODY MB38.","10.1038/S41586-018-0832-5 ",3.69,0,"6huk_oligo7","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-MAN(4_M_)-[MAN(6_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(149_E_)",98.6412,"","",""
"6HUK","CRYOEM STRUCTURE OF HUMAN FULL-LENGTH ALPHA1BETA3GAMMA2L GABA(A)R IN COMPLEX WITH BICUCULLINE AND MEGABODY MB38.","10.1038/S41586-018-0832-5 ",3.69,0,"6huk_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(111_D_)",108.811,"","",""
"6HUK","CRYOEM STRUCTURE OF HUMAN FULL-LENGTH ALPHA1BETA3GAMMA2L GABA(A)R IN COMPLEX WITH BICUCULLINE AND MEGABODY MB38.","10.1038/S41586-018-0832-5 ",3.69,0,"6huk_oligo1","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-MAN(4_I_)-[MAN(6_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(149_B_)",90.9571,"","",""
"6HUO","CRYOEM STRUCTURE OF HUMAN FULL-LENGTH HETEROMERIC ALPHA1BETA3GAMMA2L GABA(A)R IN COMPLEX WITH ALPRAZOLAM (XANAX), GABA AND MEGABODY MB38.","10.1038/S41586-018-0832-5 ",3.26,"1.35632e-19","6huo_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(111_D_)",76.1327,"","",""
"6HUO","CRYOEM STRUCTURE OF HUMAN FULL-LENGTH HETEROMERIC ALPHA1BETA3GAMMA2L GABA(A)R IN COMPLEX WITH ALPRAZOLAM (XANAX), GABA AND MEGABODY MB38.","10.1038/S41586-018-0832-5 ",3.26,"1.35632e-19","6huo_oligo7","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-MAN(4_M_)-[MAN(6_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(149_E_)",63.6379,"","",""
"6HUO","CRYOEM STRUCTURE OF HUMAN FULL-LENGTH HETEROMERIC ALPHA1BETA3GAMMA2L GABA(A)R IN COMPLEX WITH ALPRAZOLAM (XANAX), GABA AND MEGABODY MB38.","10.1038/S41586-018-0832-5 ",3.26,"1.35632e-19","6huo_oligo2","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-MAN(4_I_)-[MAN(6_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(149_B_)",60.0994,"","",""
"6HUO","CRYOEM STRUCTURE OF HUMAN FULL-LENGTH HETEROMERIC ALPHA1BETA3GAMMA2L GABA(A)R IN COMPLEX WITH ALPRAZOLAM (XANAX), GABA AND MEGABODY MB38.","10.1038/S41586-018-0832-5 ",3.26,"1.35632e-19","6huo_oligo5","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)]-MAN(4_F_)-[MAN(7_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(111_A_)",59.5375,"","",""
"6HUP","CRYOEM STRUCTURE OF HUMAN FULL-LENGTH ALPHA1BETA3GAMMA2L GABA(A)R IN COMPLEX WITH DIAZEPAM (VALIUM), GABA AND MEGABODY MB38.","10.1038/S41586-018-0832-5 ",3.58,"1.35632e-19","6hup_oligo7","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-MAN(4_M_)-[MAN(6_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(149_E_)",103.476,"","",""
"6HUP","CRYOEM STRUCTURE OF HUMAN FULL-LENGTH ALPHA1BETA3GAMMA2L GABA(A)R IN COMPLEX WITH DIAZEPAM (VALIUM), GABA AND MEGABODY MB38.","10.1038/S41586-018-0832-5 ",3.58,"1.35632e-19","6hup_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(111_D_)",116.475,"","",""
"6HUP","CRYOEM STRUCTURE OF HUMAN FULL-LENGTH ALPHA1BETA3GAMMA2L GABA(A)R IN COMPLEX WITH DIAZEPAM (VALIUM), GABA AND MEGABODY MB38.","10.1038/S41586-018-0832-5 ",3.58,"1.35632e-19","6hup_oligo1","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-MAN(4_I_)-[MAN(6_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(149_B_)",112.294,"","",""
"6HUP","CRYOEM STRUCTURE OF HUMAN FULL-LENGTH ALPHA1BETA3GAMMA2L GABA(A)R IN COMPLEX WITH DIAZEPAM (VALIUM), GABA AND MEGABODY MB38.","10.1038/S41586-018-0832-5 ",3.58,"1.35632e-19","6hup_oligo6","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)]-MAN(4_F_)-[MAN(7_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(111_A_)",102.414,"","",""
"6HUS","2'-FUCOSYLLACTOSE AND 3-FUCOSYLLACTOSE BINDING PROTEIN FROM BIFIDOBACTERIUM LONGUM INFANTIS, BOUND WITH 3-FUCOSYLLACTOSE","10.1126/SCIADV.AAW7696 ",1.41,18.23,"6hus_oligo2","LFucpa1-3[DGalpb1-4]DGlcpa1-ROH","GAL(4_B_)-[FUC(2_B_)]-GLC(1_B_)",12.653,"","",""
"6HWR","RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH ADENOSINE DIVANADATE","10.1002/CBIC.201900077 ",1.95,0,"6hwr_oligo2","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_E_)-[FUC(2_E_)]-NAG(1_E_)-ASN(396_C_)",25.7918,"","",""
"6HWR","RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH ADENOSINE DIVANADATE","10.1002/CBIC.201900077 ",1.95,0,"6hwr_oligo3","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_F_)-[FUC(2_F_)]-NAG(1_F_)-ASN(396_B_)",25.0842,"","",""
"6HWR","RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH ADENOSINE DIVANADATE","10.1002/CBIC.201900077 ",1.95,0,"6hwr_oligo5","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_H_)-[FUC(2_H_)]-NAG(1_H_)-ASN(396_D_)",34.8024,"","",""
"6HZN","CRYSTAL STRUCTURE OF HUMAN DERMATAN SULFATE EPIMERASE 1","10.1039/D0SC05971D ",2.41,0,"6hzn_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(336_A_)",106.805,"","",""
"6HZZ","STRUCTURE OF HUMAN D-GLUCURONYL C5 EPIMERASE","10.1073/PNAS.1818333116 ",2.52,54.66,"6hzz_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(393_B_)",111.502,"","",""
"6HZZ","STRUCTURE OF HUMAN D-GLUCURONYL C5 EPIMERASE","10.1073/PNAS.1818333116 ",2.52,54.66,"6hzz_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(393_A_)",105.622,"","",""
"6I01","STRUCTURE OF HUMAN D-GLUCURONYL C5 EPIMERASE IN COMPLEX WITH SUBSTRATE","10.1073/PNAS.1818333116 ",2.1,50.72,"6i01_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(393_B_)",103.91,"","",""
"6I01","STRUCTURE OF HUMAN D-GLUCURONYL C5 EPIMERASE IN COMPLEX WITH SUBSTRATE","10.1073/PNAS.1818333116 ",2.1,50.72,"6i01_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(393_A_)",93.7493,"","",""
"6I01","STRUCTURE OF HUMAN D-GLUCURONYL C5 EPIMERASE IN COMPLEX WITH SUBSTRATE","10.1073/PNAS.1818333116 ",2.1,50.72,"6i01_oligo1","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(225_A_)",85.052,"","",""
"6I02","STRUCTURE OF HUMAN D-GLUCURONYL C5 EPIMERASE IN COMPLEX WITH PRODUCT","10.1073/PNAS.1818333116 ",2.45,54.73,"6i02_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(225_B_)",112.671,"","",""
"6I02","STRUCTURE OF HUMAN D-GLUCURONYL C5 EPIMERASE IN COMPLEX WITH PRODUCT","10.1073/PNAS.1818333116 ",2.45,54.73,"6i02_oligo7","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_H_)-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(393_B_)",98.1241,"","",""
"6I02","STRUCTURE OF HUMAN D-GLUCURONYL C5 EPIMERASE IN COMPLEX WITH PRODUCT","10.1073/PNAS.1818333116 ",2.45,54.73,"6i02_oligo4","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(225_A_)",98.1355,"","",""
"6I2K","STRUCTURE OF EV71 COMPLEXED WITH ITS RECEPTOR SCARB2","10.1038/S41564-018-0319-Z ",3.4,0,"6i2k_oligo7","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(68_E_)",297.483,"","",""
"6I2K","STRUCTURE OF EV71 COMPLEXED WITH ITS RECEPTOR SCARB2","10.1038/S41564-018-0319-Z ",3.4,0,"6i2k_oligo8","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_J_)-MAN(10_J_)-[MAN(9_J_)-MAN(8_J_)]-MAN(7_J_)-[MAN(6_J_)-MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(325_E_)",241.234,"","",""
"6I2K","STRUCTURE OF EV71 COMPLEXED WITH ITS RECEPTOR SCARB2","10.1038/S41564-018-0319-Z ",3.4,0,"6i2k_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(412_E_)",324.282,"","",""
"6I3F","CRYSTAL STRUCTURE OF THE COMPLEX OF HUMAN ANGIOTENSINOGEN AND RENIN AT 2.55 ANGSTROM","10.1074/JBC.RA118.006608 ",2.55,40.39,"6i3f_oligo1","DGlcpNAcb1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(14_A_)",87.7704,"","",""
"6I3J","BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA IN COMPLEX WITH FERRICYANIDE","10.1038/S41598-019-50105-3 ",2.59,36.14,"6i3j_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(472_A_)",74.0665,"","",""
"6I3J","BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA IN COMPLEX WITH FERRICYANIDE","10.1038/S41598-019-50105-3 ",2.59,36.14,"6i3j_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(472_B_)",90.248,"","",""
"6I53","CRYO-EM STRUCTURE OF THE HUMAN SYNAPTIC ALPHA1-BETA3-GAMMA2 GABAA RECEPTOR IN COMPLEX WITH MEGABODY38 IN A LIPID NANODISC","10.1038/S41586-018-0833-4 ",3.2,0,"6i53_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(111_D_)",171.022,"","",""
"6I53","CRYO-EM STRUCTURE OF THE HUMAN SYNAPTIC ALPHA1-BETA3-GAMMA2 GABAA RECEPTOR IN COMPLEX WITH MEGABODY38 IN A LIPID NANODISC","10.1038/S41586-018-0833-4 ",3.2,0,"6i53_oligo3","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_I_)-[MAN(5_I_)]-MAN(4_I_)-[MAN(7_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(111_A_)",156.4,"","",""
"6I53","CRYO-EM STRUCTURE OF THE HUMAN SYNAPTIC ALPHA1-BETA3-GAMMA2 GABAA RECEPTOR IN COMPLEX WITH MEGABODY38 IN A LIPID NANODISC","10.1038/S41586-018-0833-4 ",3.2,0,"6i53_oligo2","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-MAN(4_J_)-[MAN(6_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(149_B_)",159.316,"","",""
"6I53","CRYO-EM STRUCTURE OF THE HUMAN SYNAPTIC ALPHA1-BETA3-GAMMA2 GABAA RECEPTOR IN COMPLEX WITH MEGABODY38 IN A LIPID NANODISC","10.1038/S41586-018-0833-4 ",3.2,0,"6i53_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(149_E_)",153.453,"","",""
"6I6X","NEW IRREVERSIBLE A-L-IDURONIDASE INHIBITORS AND ACTIVITY-BASED PROBES","10.1002/CHEM.201804662 ",2.39,41.98,"6i6x_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(372_A_)",42.6251,"","",""
"6I6X","NEW IRREVERSIBLE A-L-IDURONIDASE INHIBITORS AND ACTIVITY-BASED PROBES","10.1002/CHEM.201804662 ",2.39,41.98,"6i6x_oligo4","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-MAN(4_F_)-[MAN(6_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(372_B_)",65.1871,"","",""
"6IAA","HROBO2 ECTODOMAIN","10.1016/J.CELL.2019.02.004 ",3.6,0,"6iaa_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)",147.934,"","",""
"6IAA","HROBO2 ECTODOMAIN","10.1016/J.CELL.2019.02.004 ",3.6,0,"6iaa_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)",166.729,"","",""
"6IAA","HROBO2 ECTODOMAIN","10.1016/J.CELL.2019.02.004 ",3.6,0,"6iaa_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)",152.02,"","",""
"6IBK","CRYSTAL STRUCTURE OF HUMAN ALPHA-GALACTOSIDASE A IN COMPLEX WITH ALPHA-GALACTOSE CONFIGURED CYCLOSULFAMIDATE ME763","10.1039/C9SC03342D ",1.99,56.99,"6ibk_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(192_A_)",99.2616,"","",""
"6IBK","CRYSTAL STRUCTURE OF HUMAN ALPHA-GALACTOSIDASE A IN COMPLEX WITH ALPHA-GALACTOSE CONFIGURED CYCLOSULFAMIDATE ME763","10.1039/C9SC03342D ",1.99,56.99,"6ibk_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(192_B_)",95.8302,"","",""
"6IBM","CRYSTAL STRUCTURE OF HUMAN ALPHA-GALACTOSIDASE A IN COMPLEX WITH ALPHA-GALACTOSE CONFIGURED CYCLOSULFATE ME776","10.1039/C9SC03342D ",2.07,55.24,"6ibm_oligo4","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(192_B_)",100.193,"","",""
"6IBR","CRYSTAL STRUCTURE OF HUMAN ALPHA-GALACTOSIDASE A IN COMPLEX WITH ALPHA-GALACTOSE CONFIGURED CYCLOPHELLITOL EPOXIDE LWA481","10.1039/C9SC03342D ",2.02,51.35,"6ibr_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(192_B_)",84.3127,"","",""
"6IBT","CRYSTAL STRUCTURE OF HUMAN ALPHA-GALACTOSIDASE A IN COMPLEX WITH ALPHA-GALACTOSE CONFIGURED CYCLOPHELLITOL AZIRIDINE ME737","10.1039/C9SC03342D ",2.04,54.27,"6ibt_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(192_B_)",89.3305,"","",""
"6IBT","CRYSTAL STRUCTURE OF HUMAN ALPHA-GALACTOSIDASE A IN COMPLEX WITH ALPHA-GALACTOSE CONFIGURED CYCLOPHELLITOL AZIRIDINE ME737","10.1039/C9SC03342D ",2.04,54.27,"6ibt_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(192_A_)",94.825,"","",""
"6IC5","HUMAN CATHEPSIN-C IN COMPLEX WITH DIPEPTIDYL CYCLOPROPYL NITRILE INHIBITOR 2","10.1016/J.BCP.2019.04.006 ",2,17.94,"6ic5_oligo3","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(95_A_)",43.1535,"","",""
"6IC6","HUMAN CATHEPSIN-C IN COMPLEX WITH CYCLOPROPYL PEPTIDYL NITRILE INHIBITOR 1","10.1016/J.BCP.2019.04.006 ",1.9,27.47,"6ic6_oligo2","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(95_A_)",53.9093,"","",""
"6IC7","HUMAN CATHEPSIN-C IN COMPLEX WITH DIPEPTIDYL CYCLOPROPYL NITRILE INHIBITOR 3","10.1016/J.BCP.2019.04.006 ",2,20.02,"6ic7_oligo2","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(95_A_)",47.7365,"","",""
"6IDF","CRYO-EM STRUCTURE OF GAMMA SECRETASE IN COMPLEX WITH A NOTCH FRAGMENT","10.1038/S41586-018-0813-8 ",2.7,"1.35632e-19","6idf_oligo4","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_G_)-[BMA(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(55_A_)",70.3275,"","",""
"6IDN","CRYSTAL STRUCTURE OF ICCHI CHITINASE FROM IPOMOEA CARNEA","10.1016/J.PHYTOCHEM.2019.112221 ",1.5,26.03,"6idn_oligo2","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_B_)-[FUC(2_B_)]-NAG(1_B_)-ASN(45_A_)",38.803,"","",""
"6IDN","CRYSTAL STRUCTURE OF ICCHI CHITINASE FROM IPOMOEA CARNEA","10.1016/J.PHYTOCHEM.2019.112221 ",1.5,26.03,"6idn_oligo1","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_C_)-[FUC(2_C_)]-NAG(1_C_)-ASN(172_A_)",28.7027,"","",""
"6IDN","CRYSTAL STRUCTURE OF ICCHI CHITINASE FROM IPOMOEA CARNEA","10.1016/J.PHYTOCHEM.2019.112221 ",1.5,26.03,"6idn_oligo3","DXylpb1-2[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(5_D_)-[XYP(4_D_)]-BMA(3_D_)-NAG(2_D_)-[FUC(6_D_)]-NAG(1_D_)-ASN(194_A_)",33.2274,"","",""
"6IEQ","CRYSTAL STRUCTURE OF HIV-1 ENV CONM SOSIP.V7 IN COMPLEX WITH BNAB PGT124 AND 35O22","10.1038/S41467-019-10262-5 ",3.9,247.5,"6ieq_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)",319.482,"","",""
"6IEQ","CRYSTAL STRUCTURE OF HIV-1 ENV CONM SOSIP.V7 IN COMPLEX WITH BNAB PGT124 AND 35O22","10.1038/S41467-019-10262-5 ",3.9,247.5,"6ieq_oligo8","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_A_)-MAN(4_A_)-[MAN(6_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(88_G_)",232.727,"","",""
"6IEQ","CRYSTAL STRUCTURE OF HIV-1 ENV CONM SOSIP.V7 IN COMPLEX WITH BNAB PGT124 AND 35O22","10.1038/S41467-019-10262-5 ",3.9,247.5,"6ieq_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(234_G_)",323.809,"","",""
"6IEQ","CRYSTAL STRUCTURE OF HIV-1 ENV CONM SOSIP.V7 IN COMPLEX WITH BNAB PGT124 AND 35O22","10.1038/S41467-019-10262-5 ",3.9,247.5,"6ieq_oligo11","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(8_P_)-MAN(7_P_)-[MAN(6_P_)-MAN(5_P_)-MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)",225.144,"","",""
"6IEQ","CRYSTAL STRUCTURE OF HIV-1 ENV CONM SOSIP.V7 IN COMPLEX WITH BNAB PGT124 AND 35O22","10.1038/S41467-019-10262-5 ",3.9,247.5,"6ieq_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)",297.082,"","",""
"6IEQ","CRYSTAL STRUCTURE OF HIV-1 ENV CONM SOSIP.V7 IN COMPLEX WITH BNAB PGT124 AND 35O22","10.1038/S41467-019-10262-5 ",3.9,247.5,"6ieq_oligo3","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_I_)-MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)",280.174,"","",""
"6IF7","CRYSTAL STRUCTURE OF AA10 LYTIC POLYSACCHARIDE MONOOXYGENASE FROM TECTARIA MACRODONTA","10.1007/S00425-019-03135-0 ",2.2,29.96,"6if7_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","BMA(3_B_)-NAG(2_B_)-[FUC(4_B_)]-NAG(1_B_)-ASN(158_A_)",41.4957,"","",""
"6IFJ","STRUCTURE OF BISPECIFIC FC","",2.4,43.53,"6ifj_oligo1","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_E_)-[NAG(5_E_)-MAN(4_E_)-[MAN(6_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_A_)",54.7644,"","",""
"6IFJ","STRUCTURE OF BISPECIFIC FC","",2.4,43.53,"6ifj_oligo2","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_F_)-[NAG(5_F_)-MAN(4_F_)-[MAN(6_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(297_B_)",58.2293,"","",""
"6IK7","CRYSTAL STRUCTURE OF TOMATO BETA-GALACTOSIDASE (TBG) 4 IN COMPLEX WITH BETA-1,3-GALACTOBIOSE","10.1007/S00425-020-03481-4 ",3.1,41.31,"6ik7_oligo4","DGalpb1-3DGalpb1-ROH","GAL(2_F_)-GAL(1_F_)",80.3345,"","",""
"6IK7","CRYSTAL STRUCTURE OF TOMATO BETA-GALACTOSIDASE (TBG) 4 IN COMPLEX WITH BETA-1,3-GALACTOBIOSE","10.1007/S00425-020-03481-4 ",3.1,41.31,"6ik7_oligo2","DGalpb1-3DGalpb1-ROH","GAL(2_D_)-GAL(1_D_)",69.0382,"","",""
"6IQG","X-RAY CRYSTAL STRUCTURE OF FC AND PEPTIDE COMPLEX","10.1021/ACS.BIOCONJCHEM.8B00865 ",3,0,"6iqg_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_E_)-[NAG(7_E_)-MAN(6_E_)-[NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_A_)",57.5967,"","",""
"6IQG","X-RAY CRYSTAL STRUCTURE OF FC AND PEPTIDE COMPLEX","10.1021/ACS.BIOCONJCHEM.8B00865 ",3,0,"6iqg_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_F_)-[NAG(7_F_)-MAN(6_F_)-[NAG(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(297_B_)",60.6374,"","",""
"6IQH","X-RAY CRYSTAL STRUCTURE OF COVALENT-BONDED COMPLEX OF FC AND PEPTIDE","10.1021/ACS.BIOCONJCHEM.8B00865 ",3,0,"6iqh_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_F_)-[NAG(7_F_)-MAN(6_F_)-[NAG(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(297_B_)",65.2675,"","",""
"6IQH","X-RAY CRYSTAL STRUCTURE OF COVALENT-BONDED COMPLEX OF FC AND PEPTIDE","10.1021/ACS.BIOCONJCHEM.8B00865 ",3,0,"6iqh_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_E_)-[NAG(7_E_)-MAN(6_E_)-[NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_A_)",53.7805,"","",""
"6IS5","P DOMAIN OF GII.3-TV24 WITH A-TETRASACCHARIDE COMPLEX","10.1080/22221751.2019.1686335 ",2.5,0,"6is5_oligo3","LFucpa1-2[DGalpNAca1-3]DGalpb1-4DGlcpa1-ROH","A2G(4_G_)-[FUC(3_G_)]-GAL(2_G_)-GLC(1_G_)",33.7695,"","",""
"6IS5","P DOMAIN OF GII.3-TV24 WITH A-TETRASACCHARIDE COMPLEX","10.1080/22221751.2019.1686335 ",2.5,0,"6is5_oligo1","LFucpa1-2[DGalpNAca1-3]DGalpb1-4DGlcpa1-ROH","A2G(4_E_)-[FUC(3_E_)]-GAL(2_E_)-GLC(1_E_)",30.2748,"","",""
"6IS5","P DOMAIN OF GII.3-TV24 WITH A-TETRASACCHARIDE COMPLEX","10.1080/22221751.2019.1686335 ",2.5,0,"6is5_oligo2","LFucpa1-2[DGalpNAca1-3]DGalpb1-4DGlcpa1-ROH","A2G(4_F_)-[FUC(3_F_)]-GAL(2_F_)-GLC(1_F_)",34.6339,"","",""
"6IS5","P DOMAIN OF GII.3-TV24 WITH A-TETRASACCHARIDE COMPLEX","10.1080/22221751.2019.1686335 ",2.5,0,"6is5_oligo4","LFucpa1-2[DGalpNAca1-3]DGalpb1-4DGlcpa1-ROH","A2G(4_H_)-[FUC(3_H_)]-GAL(2_H_)-GLC(1_H_)",31.9514,"","",""
"6IUJ","CRYSTAL STRUCTURE OF GH30 XYLANASE B FROM TALAROMYCES CELLULOLYTICUS","10.1074/JBC.RA118.007207 ",2.25,29.48,"6iuj_oligo8","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-MAN(4_J_)-[MAN(6_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(88_B_)",56.8585,"","",""
"6IUJ","CRYSTAL STRUCTURE OF GH30 XYLANASE B FROM TALAROMYCES CELLULOLYTICUS","10.1074/JBC.RA118.007207 ",2.25,29.48,"6iuj_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(88_A_)",47.7498,"","",""
"6IYC","RECOGNITION OF THE AMYLOID PRECURSOR PROTEIN BY HUMAN GAMMA-SECRETASE","10.1126/SCIENCE.AAW0930 ",2.6,"1.57771e-19","6iyc_oligo3","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_G_)-[BMA(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(55_A_)",64.7514,"","",""
"6J0I","STRUCTURE OF [CO2+-(CHROMOMYCIN A3)2]-D(TTGGCGAA)2 COMPLEX","10.1093/NAR/GKZ653 ",2.5,39.42,"6j0i_oligo63","LOlip[3<R1>,4Ac]a1-3DOlipb1-3DOlipb1-C21O9","ERI(3_M_)-CDR(2_M_)-CDR(1_M_)",41.41,"","",""
"6J0I","STRUCTURE OF [CO2+-(CHROMOMYCIN A3)2]-D(TTGGCGAA)2 COMPLEX","10.1093/NAR/GKZ653 ",2.5,39.42,"6j0i_oligo62","LOlip[3<R1>,4Ac]a1-3DOlipb1-3DOlipb1-","ERI(3_L_)-CDR(2_L_)-CDR(1_L_)",38.0277,"","",""
"6J0I","STRUCTURE OF [CO2+-(CHROMOMYCIN A3)2]-D(TTGGCGAA)2 COMPLEX","10.1093/NAR/GKZ653 ",2.5,39.42,"6j0i_oligo37","LOlip[3<R1>,4Ac]a1-3DOlipb1-3DAltp[6H,2H]b1-","ERI(3_P_)-CDR(2_P_)-CDR(1_P_)",41.4083,"","",""
"6J0I","STRUCTURE OF [CO2+-(CHROMOMYCIN A3)2]-D(TTGGCGAA)2 COMPLEX","10.1093/NAR/GKZ653 ",2.5,39.42,"6j0i_oligo38","LOlip[3<R1>,4Ac]a1-3DOlipb1-3DOlipb1-C21O9","ERI(3_Q_)-CDR(2_Q_)-CDR(1_Q_)",43.507,"","",""
"6J0I","STRUCTURE OF [CO2+-(CHROMOMYCIN A3)2]-D(TTGGCGAA)2 COMPLEX","10.1093/NAR/GKZ653 ",2.5,39.42,"6j0i_oligo32","LOlip[3<R1>,4Ac]a1-3DOlipb1-3DOlipb1-","ERI(3_H_)-CDR(2_H_)-CDR(1_H_)",39.7037,"","",""
"6J0I","STRUCTURE OF [CO2+-(CHROMOMYCIN A3)2]-D(TTGGCGAA)2 COMPLEX","10.1093/NAR/GKZ653 ",2.5,39.42,"6j0i_oligo59","LOlip[3<R1>,4Ac]a1-3DOlipb1-3DOlipb1-C21O9","ERI(3_I_)-CDR(2_I_)-CDR(1_I_)",39.6503,"","",""
"6J11","MERS-COV SPIKE N-TERMINAL DOMAIN AND 7D10 SCFV COMPLEX","10.1038/S41467-019-10897-4 ",3,0,"6j11_oligo5","DManpa1-3DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_O_)-MAN(6_O_)-[MAN(5_O_)-MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(222_B_)",79.7082,"","",""
"6J11","MERS-COV SPIKE N-TERMINAL DOMAIN AND 7D10 SCFV COMPLEX","10.1038/S41467-019-10897-4 ",3,0,"6j11_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(104_A_)",81.9432,"","",""
"6J11","MERS-COV SPIKE N-TERMINAL DOMAIN AND 7D10 SCFV COMPLEX","10.1038/S41467-019-10897-4 ",3,0,"6j11_oligo11","DManpa1-3DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_I_)-MAN(6_I_)-[MAN(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(222_A_)",62.1653,"","",""
"6J11","MERS-COV SPIKE N-TERMINAL DOMAIN AND 7D10 SCFV COMPLEX","10.1038/S41467-019-10897-4 ",3,0,"6j11_oligo15","DManpa1-3DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcp[2<R1>]b1-ASN","MAN(7_X_)-MAN(6_X_)-[MAN(5_X_)-MAN(4_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(222_C_)",94.8035,"","",""
"6J11","MERS-COV SPIKE N-TERMINAL DOMAIN AND 7D10 SCFV COMPLEX","10.1038/S41467-019-10897-4 ",3,0,"6j11_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Q_)-[MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(125_B_)",96.1898,"","",""
"6J8M","LOW-DOSE STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE DETERMINED USING 30 KEV X-RAY","10.1107/S1600577519006805 ",1.9,42.87,"6j8m_oligo4","DGlcpa1-3DGlcpb6-C10O1","DMU(101_Z_)-DMU(101_Z_)",60.4618,"","",""
"6J8M","LOW-DOSE STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE DETERMINED USING 30 KEV X-RAY","10.1107/S1600577519006805 ",1.9,42.87,"6j8m_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(307_P_)-DMU(307_P_)",112.933,"","",""
"6J8M","LOW-DOSE STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE DETERMINED USING 30 KEV X-RAY","10.1107/S1600577519006805 ",1.9,42.87,"6j8m_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(101_M_)-DMU(101_M_)",50.6855,"","",""
"6J8M","LOW-DOSE STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE DETERMINED USING 30 KEV X-RAY","10.1107/S1600577519006805 ",1.9,42.87,"6j8m_oligo3","DGlcpa1-3DGlcpb6-C10O1","DMU(309_C_)-DMU(309_C_)",113.918,"","",""
"6JBS","BIFUNCTIONAL XYLOSIDASE/GLUCOSIDASE LXYL","10.1038/S42003-019-0744-4 ",2.4,34.18,"6jbs_oligo8","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_L_)-MAN(6_L_)-[MAN(5_L_)-MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(272_C_)",46.3161,"","",""
"6JBS","BIFUNCTIONAL XYLOSIDASE/GLUCOSIDASE LXYL","10.1038/S42003-019-0744-4 ",2.4,34.18,"6jbs_oligo1","DManpa1-2DManpb1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_F_)-MAN(6_F_)-[MAN(5_F_)-BMA(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(272_A_)",49.6883,"","",""
"6JBS","BIFUNCTIONAL XYLOSIDASE/GLUCOSIDASE LXYL","10.1038/S42003-019-0744-4 ",2.4,34.18,"6jbs_oligo5","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_I_)-MAN(6_I_)-[MAN(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(272_B_)",58.7441,"","",""
"6JBS","BIFUNCTIONAL XYLOSIDASE/GLUCOSIDASE LXYL","10.1038/S42003-019-0744-4 ",2.4,34.18,"6jbs_oligo11","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_O_)-MAN(6_O_)-[MAN(5_O_)-MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(272_D_)",49.6532,"","",""
"6JBS","BIFUNCTIONAL XYLOSIDASE/GLUCOSIDASE LXYL","10.1038/S42003-019-0744-4 ",2.4,34.18,"6jbs_oligo9","DManpb1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[BMA(4_M_)]-MAN(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(457_C_)",46.8125,"","",""
"6JBS","BIFUNCTIONAL XYLOSIDASE/GLUCOSIDASE LXYL","10.1038/S42003-019-0744-4 ",2.4,34.18,"6jbs_oligo3","DManpa1-2DManpa1-2DManpa1-3DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_G_)-MAN(5_G_)-MAN(4_G_)-MAN(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(457_A_)",70.425,"","",""
"6JBS","BIFUNCTIONAL XYLOSIDASE/GLUCOSIDASE LXYL","10.1038/S42003-019-0744-4 ",2.4,34.18,"6jbs_oligo12","DManpa1-2DManpa1-2DManpa1-3DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_P_)-MAN(5_P_)-MAN(4_P_)-MAN(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(457_D_)",43.3171,"","",""
"6JJN","CRYSTAL STRUCTURE OF MUMPS VIRUS HEMAGGLUTININ-NEURAMINIDASE BOUND TO SIALYL LEWISX","10.1128/JVI.00344-19 ",2.5,0,"6jjn_oligo6","DNeup5Aca2-3DGalpb1-4[LFucpa1-3]DGlcpNAcb1-3DGalpb1-ROH","SIA(4_H_)-GAL(3_H_)-[FUC(5_H_)]-NAG(2_H_)-GAL(1_H_)",60.6787,"","",""
"6JJN","CRYSTAL STRUCTURE OF MUMPS VIRUS HEMAGGLUTININ-NEURAMINIDASE BOUND TO SIALYL LEWISX","10.1128/JVI.00344-19 ",2.5,0,"6jjn_oligo1","DNeup5Aca2-3DGalpb1-4[LFucpa1-3]DGlcpNAcb1-3DGalpb1-ROH","SIA(4_E_)-GAL(3_E_)-[FUC(5_E_)]-NAG(2_E_)-GAL(1_E_)",64.3362,"","",""
"6JJP","CRYSTAL STRUCTURE OF FAB OF A PD-1 MONOCLONAL ANTIBODY MW11-H317 IN COMPLEX WITH PD-1","10.1038/S42003-019-0642-9 ",2.9,55.25,"6jjp_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_H_)-[MAN(4_H_)-BMA(3_H_)-NAG(2_H_)]-NAG(1_H_)-ASN(58_F_)",53.6247,"","",""
"6JJP","CRYSTAL STRUCTURE OF FAB OF A PD-1 MONOCLONAL ANTIBODY MW11-H317 IN COMPLEX WITH PD-1","10.1038/S42003-019-0642-9 ",2.9,55.25,"6jjp_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_G_)-[MAN(4_G_)-BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(58_C_)",57.462,"","",""
"6JUW","BOVINE HEART CYTOCHROME C OXIDASE IN CATALITIC INTERMEDIATES AT 1.80 ANGSTROM RESOLUTION","10.1074/JBC.RA119.009596 ",1.8,0,"6juw_oligo8","DGlcpa1-3DGlcpb6-C10O1","DMU(302_C_)-DMU(302_C_)",119.531,"","",""
"6JUW","BOVINE HEART CYTOCHROME C OXIDASE IN CATALITIC INTERMEDIATES AT 1.80 ANGSTROM RESOLUTION","10.1074/JBC.RA119.009596 ",1.8,0,"6juw_oligo12","DGlcpa1-3DGlcpb6-C12O3","DMU(101_L_)-DMU(101_L_)",110.48,"","",""
"6JUW","BOVINE HEART CYTOCHROME C OXIDASE IN CATALITIC INTERMEDIATES AT 1.80 ANGSTROM RESOLUTION","10.1074/JBC.RA119.009596 ",1.8,0,"6juw_oligo6","DGlcpa1-3DGlcpb6-C10O1","DMU(101_Y_)-DMU(101_Y_)",118.785,"","",""
"6JUW","BOVINE HEART CYTOCHROME C OXIDASE IN CATALITIC INTERMEDIATES AT 1.80 ANGSTROM RESOLUTION","10.1074/JBC.RA119.009596 ",1.8,0,"6juw_oligo7","DGlcpa1-3DGlcpb6-C10O1","DMU(101_Z_)-DMU(101_Z_)",65.0236,"","",""
"6JUW","BOVINE HEART CYTOCHROME C OXIDASE IN CATALITIC INTERMEDIATES AT 1.80 ANGSTROM RESOLUTION","10.1074/JBC.RA119.009596 ",1.8,0,"6juw_oligo9","DGlcpa1-3DGlcpb6-C10O1","DMU(303_P_)-DMU(303_P_)",119.677,"","",""
"6JUW","BOVINE HEART CYTOCHROME C OXIDASE IN CATALITIC INTERMEDIATES AT 1.80 ANGSTROM RESOLUTION","10.1074/JBC.RA119.009596 ",1.8,0,"6juw_oligo13","DGlcpa1-3DGlcpb6-C10O1","DMU(101_M_)-DMU(101_M_)",50.905,"","",""
"6JX7","CRYO-EM STRUCTURE OF SPIKE PROTEIN OF FELINE INFECTIOUS PERITONITIS VIRUS STRAIN UU4","10.1073/PNAS.1908898117 ",3.31,0,"6jx7_oligo9","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_T_)-MAN(6_T_)-[MAN(5_T_)-MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(1218_A_)",128.639,"","",""
"6JX7","CRYO-EM STRUCTURE OF SPIKE PROTEIN OF FELINE INFECTIOUS PERITONITIS VIRUS STRAIN UU4","10.1073/PNAS.1908898117 ",3.31,0,"6jx7_oligo16","DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_a_)-MAN(6_a_)-[MAN(5_a_)-MAN(4_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(357_B_)",96.2194,"","",""
"6JX7","CRYO-EM STRUCTURE OF SPIKE PROTEIN OF FELINE INFECTIOUS PERITONITIS VIRUS STRAIN UU4","10.1073/PNAS.1908898117 ",3.31,0,"6jx7_oligo53","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_3_)-MAN(6_3_)-[MAN(5_3_)-MAN(4_3_)]-BMA(3_3_)-NAG(2_3_)-NAG(1_3_)-ASN(1218_C_)",128.639,"","",""
"6JX7","CRYO-EM STRUCTURE OF SPIKE PROTEIN OF FELINE INFECTIOUS PERITONITIS VIRUS STRAIN UU4","10.1073/PNAS.1908898117 ",3.31,0,"6jx7_oligo26","DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_I_)-MAN(6_I_)-[MAN(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(357_A_)",96.2194,"","",""
"6JX7","CRYO-EM STRUCTURE OF SPIKE PROTEIN OF FELINE INFECTIOUS PERITONITIS VIRUS STRAIN UU4","10.1073/PNAS.1908898117 ",3.31,0,"6jx7_oligo34","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_k_)-[MAN(4_k_)]-BMA(3_k_)-NAG(2_k_)-NAG(1_k_)-ASN(1092_B_)",94.2756,"","",""
"6JX7","CRYO-EM STRUCTURE OF SPIKE PROTEIN OF FELINE INFECTIOUS PERITONITIS VIRUS STRAIN UU4","10.1073/PNAS.1908898117 ",3.31,0,"6jx7_oligo35","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_l_)-MAN(6_l_)-[MAN(5_l_)-MAN(4_l_)]-BMA(3_l_)-NAG(2_l_)-NAG(1_l_)-ASN(1218_B_)",128.639,"","",""
"6JX7","CRYO-EM STRUCTURE OF SPIKE PROTEIN OF FELINE INFECTIOUS PERITONITIS VIRUS STRAIN UU4","10.1073/PNAS.1908898117 ",3.31,0,"6jx7_oligo42","DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_s_)-MAN(6_s_)-[MAN(5_s_)-MAN(4_s_)]-BMA(3_s_)-NAG(2_s_)-NAG(1_s_)-ASN(357_C_)",96.2194,"","",""
"6JX7","CRYO-EM STRUCTURE OF SPIKE PROTEIN OF FELINE INFECTIOUS PERITONITIS VIRUS STRAIN UU4","10.1073/PNAS.1908898117 ",3.31,0,"6jx7_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(1092_A_)",94.2756,"","",""
"6JX7","CRYO-EM STRUCTURE OF SPIKE PROTEIN OF FELINE INFECTIOUS PERITONITIS VIRUS STRAIN UU4","10.1073/PNAS.1908898117 ",3.31,0,"6jx7_oligo52","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_2_)-[MAN(4_2_)]-BMA(3_2_)-NAG(2_2_)-NAG(1_2_)-ASN(1092_C_)",94.2756,"","",""
"6JYN","GII.13/21 NOROVIRUSES RECOGNIZE GLYCANS WITH A TERMINAL BETA-GALACTOSE VIA AN UNCONVENTIONAL GLYCAN BINDING SITE","10.1128/JVI.00723-19 ",1.6,16.19,"6jyn_oligo4","DGalpb1-3DGlcpNAcb1-ROH","GAL(2_H_)-NAG(1_H_)",32.6345,"","",""
"6JYN","GII.13/21 NOROVIRUSES RECOGNIZE GLYCANS WITH A TERMINAL BETA-GALACTOSE VIA AN UNCONVENTIONAL GLYCAN BINDING SITE","10.1128/JVI.00723-19 ",1.6,16.19,"6jyn_oligo2","DGalpb1-3DGlcpNAcb1-ROH","GAL(2_F_)-NAG(1_F_)",34.6718,"","",""
"6JYN","GII.13/21 NOROVIRUSES RECOGNIZE GLYCANS WITH A TERMINAL BETA-GALACTOSE VIA AN UNCONVENTIONAL GLYCAN BINDING SITE","10.1128/JVI.00723-19 ",1.6,16.19,"6jyn_oligo1","DGalpb1-3DGlcpNAcb1-ROH","GAL(2_E_)-NAG(1_E_)",28.6568,"","",""
"6JYN","GII.13/21 NOROVIRUSES RECOGNIZE GLYCANS WITH A TERMINAL BETA-GALACTOSE VIA AN UNCONVENTIONAL GLYCAN BINDING SITE","10.1128/JVI.00723-19 ",1.6,16.19,"6jyn_oligo3","DGalpb1-3DGlcpNAcb1-ROH","GAL(2_G_)-NAG(1_G_)",36.3705,"","",""
"6JYS","GII.13/21 NOROVIRUSES RECOGNIZE GLYCANS WITH A TERMINAL BETA-GALACTOSE VIA AN UNCONVENTIONAL GLYCAN BINDING SITE","10.1128/JVI.00723-19 ",1.7,18.97,"6jys_oligo2","DGalpb1-3DGalpNAcx1-","GAL(2_G_)-A2G(1_G_)",28.7805,"","",""
"6JYS","GII.13/21 NOROVIRUSES RECOGNIZE GLYCANS WITH A TERMINAL BETA-GALACTOSE VIA AN UNCONVENTIONAL GLYCAN BINDING SITE","10.1128/JVI.00723-19 ",1.7,18.97,"6jys_oligo1","DGalpb1-3[DGlcpNAcb1-6]DGalpNAca1-THR","NAG(3_F_)-[GAL(2_F_)]-A2G(1_F_)-THR(404_B_)",18.5264,"","",""
"6JYS","GII.13/21 NOROVIRUSES RECOGNIZE GLYCANS WITH A TERMINAL BETA-GALACTOSE VIA AN UNCONVENTIONAL GLYCAN BINDING SITE","10.1128/JVI.00723-19 ",1.7,18.97,"6jys_oligo3","DGalpb1-3DGalpNAcx1-","GAL(2_E_)-A2G(1_E_)",21.4867,"","",""
"6JYS","GII.13/21 NOROVIRUSES RECOGNIZE GLYCANS WITH A TERMINAL BETA-GALACTOSE VIA AN UNCONVENTIONAL GLYCAN BINDING SITE","10.1128/JVI.00723-19 ",1.7,18.97,"6jys_oligo4","DGalpb1-3DGalpNAcx1-","GAL(2_H_)-A2G(1_H_)",32.1621,"","",""
"6K0N","CATALYTIC DOMAIN OF GH87 ALPHA-1,3-GLUCANASE IN COMPLEX WITH NIGEROSE","10.1111/FEBS.15161 ",1.6,16.26,"6k0n_oligo2","DGlcpa1-3DGlcpa1-ROH","GLC(2_C_)-GLC(1_C_)",23.3923,"","",""
"6K0N","CATALYTIC DOMAIN OF GH87 ALPHA-1,3-GLUCANASE IN COMPLEX WITH NIGEROSE","10.1111/FEBS.15161 ",1.6,16.26,"6k0n_oligo3","DGlcpa1-3DGlcpa1-ROH","GLC(2_D_)-GLC(1_D_)",28.11,"","",""
"6K0N","CATALYTIC DOMAIN OF GH87 ALPHA-1,3-GLUCANASE IN COMPLEX WITH NIGEROSE","10.1111/FEBS.15161 ",1.6,16.26,"6k0n_oligo1","DGlcpa1-3DGlcpa1-ROH","GLC(2_B_)-GLC(1_B_)",24.3473,"","",""
"6K0P","CATALYTIC DOMAIN OF GH87 ALPHA-1,3-GLUCANASE D1045A IN COMPLEX WITH NIGEROSE","10.1111/FEBS.15161 ",1.42,16.78,"6k0p_oligo2","DGlcpa1-3DGlcpa1-ROH","GLC(2_C_)-GLC(1_C_)",21.8727,"","",""
"6K0P","CATALYTIC DOMAIN OF GH87 ALPHA-1,3-GLUCANASE D1045A IN COMPLEX WITH NIGEROSE","10.1111/FEBS.15161 ",1.42,16.78,"6k0p_oligo3","DGlcpa1-3DGlcpa1-ROH","GLC(2_D_)-GLC(1_D_)",22.0486,"","",""
"6K0P","CATALYTIC DOMAIN OF GH87 ALPHA-1,3-GLUCANASE D1045A IN COMPLEX WITH NIGEROSE","10.1111/FEBS.15161 ",1.42,16.78,"6k0p_oligo1","DGlcpa1-3DGlcpa1-ROH","GLC(2_B_)-GLC(1_B_)",21.86,"","",""
"6K0Q","CATALYTIC DOMAIN OF GH87 ALPHA-1,3-GLUCANASE D1068A IN COMPLEX WITH NIGEROSE","10.1111/FEBS.15161 ",1.56,22.1,"6k0q_oligo2","DGlcpa1-3DGlcpa1-ROH","GLC(2_B_)-GLC(1_B_)",27.2668,"","",""
"6K0Q","CATALYTIC DOMAIN OF GH87 ALPHA-1,3-GLUCANASE D1068A IN COMPLEX WITH NIGEROSE","10.1111/FEBS.15161 ",1.56,22.1,"6k0q_oligo1","DGlcpa1-3DGlcpb1-ROH","GLC(2_D_)-BGC(1_D_)",30.8109,"","",""
"6K0Q","CATALYTIC DOMAIN OF GH87 ALPHA-1,3-GLUCANASE D1068A IN COMPLEX WITH NIGEROSE","10.1111/FEBS.15161 ",1.56,22.1,"6k0q_oligo3","DGlcpa1-3DGlcpa1-ROH","GLC(2_C_)-GLC(1_C_)",28.07,"","",""
"6K0S","CATALYTIC DOMAIN OF GH87 ALPHA-1,3-GLUCANASE D1069A IN COMPLEX WITH NIGEROSE","10.1111/FEBS.15161 ",1.53,17.78,"6k0s_oligo3","DGlcpa1-3DGlcpa1-ROH","GLC(2_C_)-GLC(1_C_)",23.8364,"","",""
"6K0S","CATALYTIC DOMAIN OF GH87 ALPHA-1,3-GLUCANASE D1069A IN COMPLEX WITH NIGEROSE","10.1111/FEBS.15161 ",1.53,17.78,"6k0s_oligo2","DGlcpa1-3DGlcpa1-ROH","GLC(2_B_)-GLC(1_B_)",27.615,"","",""
"6K0S","CATALYTIC DOMAIN OF GH87 ALPHA-1,3-GLUCANASE D1069A IN COMPLEX WITH NIGEROSE","10.1111/FEBS.15161 ",1.53,17.78,"6k0s_oligo1","DGlcpa1-3DGlcpb1-ROH","GLC(2_D_)-BGC(1_D_)",26.6491,"","",""
"6K0U","CATALYTIC DOMAIN OF GH87 ALPHA-1,3-GLUCANASE D1068A IN COMPLEX WITH TETRASACCHARIDES","10.1111/FEBS.15161 ",1.95,30.36,"6k0u_oligo2","DGlcpa1-3DGlcpa1-3DGlcpa1-3DGlcpa1-ROH","GLC(4_C_)-GLC(3_C_)-GLC(2_C_)-GLC(1_C_)",47.6055,"","",""
"6K0U","CATALYTIC DOMAIN OF GH87 ALPHA-1,3-GLUCANASE D1068A IN COMPLEX WITH TETRASACCHARIDES","10.1111/FEBS.15161 ",1.95,30.36,"6k0u_oligo1","DGlcpa1-3DGlcpa1-3DGlcpa1-ROH","GLC(3_B_)-GLC(2_B_)-GLC(1_B_)",57.9615,"","",""
"6K0V","CATALYTIC DOMAIN OF GH87 ALPHA-1,3-GLUCANASE D1069A IN COMPLEX WITH TETRASACCHARIDES","10.1111/FEBS.15161 ",2.5,35.91,"6k0v_oligo6","DGlcpa1-3DGlcpa1-ROH","GLC(2_J_)-GLC(1_J_)",61.7877,"","",""
"6K0V","CATALYTIC DOMAIN OF GH87 ALPHA-1,3-GLUCANASE D1069A IN COMPLEX WITH TETRASACCHARIDES","10.1111/FEBS.15161 ",2.5,35.91,"6k0v_oligo2","DGlcpa1-3DGlcpa1-3DGlcpa1-ROH","GLC(3_E_)-GLC(2_E_)-GLC(1_E_)",38.5248,"","",""
"6K0V","CATALYTIC DOMAIN OF GH87 ALPHA-1,3-GLUCANASE D1069A IN COMPLEX WITH TETRASACCHARIDES","10.1111/FEBS.15161 ",2.5,35.91,"6k0v_oligo7","DGlcpa1-3DGlcpa1-3DGlcpa1-ROH","GLC(3_K_)-GLC(2_K_)-GLC(1_K_)",51.1052,"","",""
"6K0V","CATALYTIC DOMAIN OF GH87 ALPHA-1,3-GLUCANASE D1069A IN COMPLEX WITH TETRASACCHARIDES","10.1111/FEBS.15161 ",2.5,35.91,"6k0v_oligo3","DGlcpa1-3DGlcpa1-3DGlcpa1-ROH","GLC(3_F_)-GLC(2_F_)-GLC(1_F_)",44.3609,"","",""
"6K0V","CATALYTIC DOMAIN OF GH87 ALPHA-1,3-GLUCANASE D1069A IN COMPLEX WITH TETRASACCHARIDES","10.1111/FEBS.15161 ",2.5,35.91,"6k0v_oligo5","DGlcpa1-3DGlcpa1-3DGlcpa1-ROH","GLC(3_I_)-GLC(2_I_)-GLC(1_I_)",56.42,"","",""
"6K0V","CATALYTIC DOMAIN OF GH87 ALPHA-1,3-GLUCANASE D1069A IN COMPLEX WITH TETRASACCHARIDES","10.1111/FEBS.15161 ",2.5,35.91,"6k0v_oligo1","DGlcpa1-3DGlcpa1-3DGlcpb1-ROH","GLC(3_G_)-GLC(2_G_)-BGC(1_G_)",46.2352,"","",""
"6K0V","CATALYTIC DOMAIN OF GH87 ALPHA-1,3-GLUCANASE D1069A IN COMPLEX WITH TETRASACCHARIDES","10.1111/FEBS.15161 ",2.5,35.91,"6k0v_oligo4","DGlcpa1-3DGlcpa1-3DGlcpa1-ROH","GLC(3_H_)-GLC(2_H_)-GLC(1_H_)",61.3512,"","",""
"6K2N","STRUCTURAL BASIS OF GLYCAN RECOGNITION IN GLOBALLY PREDOMINANT HUMAN P[8] ROTAVIRUS","10.1007/S12250-019-00164-7 ",1.8,24.85,"6k2n_oligo1","DGalpb1-3[DGlcpNAcb1-6]DGalpNAca1-ROH","NAG(3_H_)-[GAL(2_H_)]-A2G(1_H_)",57.2206,"","",""
"6K2N","STRUCTURAL BASIS OF GLYCAN RECOGNITION IN GLOBALLY PREDOMINANT HUMAN P[8] ROTAVIRUS","10.1007/S12250-019-00164-7 ",1.8,24.85,"6k2n_oligo2","DGalpb1-3[DGlcpNAcb1-6]DGalpNAca1-ROH","NAG(3_G_)-[GAL(2_G_)]-A2G(1_G_)",62.9949,"","",""
"6K2O","STRUCTURAL BASIS OF GLYCAN RECOGNITION IN GLOBALLY PREDOMINANT HUMAN P[8] ROTAVIRUS","10.1007/S12250-019-00164-7 ",2.3,0,"6k2o_oligo1","LFucpa1-2DGalpb1-3DGlcpNAcb1-3DGalpx1-","FUC(4_B_)-GAL(3_B_)-NAG(2_B_)-GAL(1_B_)",73.3333,"","",""
"6KA7","THE COMPLEX STRUCTURE OF HUMAN IGG FC AND ITS BINDING REPEBODY","",3,57.46,"6ka7_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_F_)-[NAG(7_F_)-MAN(6_F_)-[NAG(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(297_D_)",68.6768,"","",""
"6KA7","THE COMPLEX STRUCTURE OF HUMAN IGG FC AND ITS BINDING REPEBODY","",3,57.46,"6ka7_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_E_)-[NAG(7_E_)-MAN(6_E_)-[NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_C_)",85.4357,"","",""
"6KAM","CRYSTAL STRUCTURE OF FKRP IN COMPLEX WITH BA ION, CDP-RIBTOL, AND SUGAR ACCEPTOR","10.1038/S41467-019-14220-Z ",2.46,75.35,"6kam_oligo9","DGalpNAc[3P]b1-3DGlcpNAcb1-4DManp[6P]a1-ROH","NGA(3_E_)-NAG(2_E_)-MAN(1_E_)",154.672,"","",""
"6KJ0","BIFUNCTIONAL XYLOSIDASE/GLUCOSIDASE LXYL MUTANT E529Q C2221","10.1038/S42003-019-0744-4 ",2.27,33.8,"6kj0_oligo1","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_D_)-MAN(6_D_)-[MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(272_A_)",37.9095,"","",""
"6KJ0","BIFUNCTIONAL XYLOSIDASE/GLUCOSIDASE LXYL MUTANT E529Q C2221","10.1038/S42003-019-0744-4 ",2.27,33.8,"6kj0_oligo5","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_G_)-MAN(6_G_)-[MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(272_B_)",47.8731,"","",""
"6KQS","CRYSTAL STRUCTURE OF GH136 LACTO-N-BIOSIDASE FROM EUBACTERIUM RAMULUS - SELENOMETHIONINE DERIVATIVE","10.1038/S41467-020-17075-X ",1.4,19.61,"6kqs_oligo1","DGalpb1-3DGlcpNAcb1-ROH","GAL(2_B_)-NAG(1_B_)",18.7064,"","",""
"6KQT","CRYSTAL STRUCTURE OF GH136 LACTO-N-BIOSIDASE FROM EUBACTERIUM RAMULUS - NATIVE PROTEIN","10.1038/S41467-020-17075-X ",2,20.59,"6kqt_oligo1","DGalpb1-3DGlcpNAcb1-ROH","GAL(2_B_)-NAG(1_B_)",21.9127,"","",""
"6KRL","CRYSTAL STRUCTURE OF GH30 XYLANASE B FROM TALAROMYCES CELLULOLYTICUS EXPRESSED BY PICHIA PASTORIS","10.1002/2211-5463.12873 ",1.6,22.06,"6krl_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(412_A_)",27.8016,"","",""
"6KRN","CRYSTAL STRUCTURE OF GH30 XYLANASE B FROM TALAROMYCES CELLULOLYTICUS EXPRESSED BY PICHIA PASTORIS IN COMPLEX WITH ALDOTRIURONIC ACID","10.1002/2211-5463.12873 ",1.65,23.32,"6krn_oligo3","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(60_A_)",38.6476,"","",""
"6KRN","CRYSTAL STRUCTURE OF GH30 XYLANASE B FROM TALAROMYCES CELLULOLYTICUS EXPRESSED BY PICHIA PASTORIS IN COMPLEX WITH ALDOTRIURONIC ACID","10.1002/2211-5463.12873 ",1.65,23.32,"6krn_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(412_A_)",28.91,"","",""
"6KRU","CRYSTAL STRUCTURE OF MOUSE IGG2B FC","10.3390/IJMS21010147 ",2.3,59.68,"6kru_oligo4","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_G_)-[GAL(6_G_)-NAG(5_G_)-MAN(4_G_)-[NAG(8_G_)-MAN(7_G_)]-MAN(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(297_A_)",76.5933,"","",""
"6KRU","CRYSTAL STRUCTURE OF MOUSE IGG2B FC","10.3390/IJMS21010147 ",2.3,59.68,"6kru_oligo6","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_I_)-[GAL(6_I_)-NAG(5_I_)-MAN(4_I_)-[NAG(8_I_)-MAN(7_I_)]-MAN(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(297_C_)",72.5033,"","",""
"6KRU","CRYSTAL STRUCTURE OF MOUSE IGG2B FC","10.3390/IJMS21010147 ",2.3,59.68,"6kru_oligo3","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_L_)-[GAL(6_L_)-NAG(5_L_)-MAN(4_L_)-[NAG(8_L_)-MAN(7_L_)]-MAN(3_L_)-NAG(2_L_)]-NAG(1_L_)-ASN(297_F_)",65.093,"","",""
"6KRU","CRYSTAL STRUCTURE OF MOUSE IGG2B FC","10.3390/IJMS21010147 ",2.3,59.68,"6kru_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_J_)-[GAL(6_J_)-NAG(5_J_)-MAN(4_J_)-[NAG(8_J_)-MAN(7_J_)]-MAN(3_J_)-NAG(2_J_)]-NAG(1_J_)-ASN(297_D_)",66.0174,"","",""
"6KRU","CRYSTAL STRUCTURE OF MOUSE IGG2B FC","10.3390/IJMS21010147 ",2.3,59.68,"6kru_oligo5","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_H_)-[GAL(6_H_)-NAG(5_H_)-MAN(4_H_)-[NAG(8_H_)-MAN(7_H_)]-MAN(3_H_)-NAG(2_H_)]-NAG(1_H_)-ASN(297_B_)",63.1105,"","",""
"6KRU","CRYSTAL STRUCTURE OF MOUSE IGG2B FC","10.3390/IJMS21010147 ",2.3,59.68,"6kru_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_K_)-NAG(5_K_)-MAN(4_K_)-[NAG(8_K_)-MAN(7_K_)]-MAN(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(297_E_)",109.683,"","",""
"6KRV","CRYSTAL STRUCTURE OF MOUSE IGG2B FC COMPLEXED WITH B DOMAIN OF PROTEIN A","10.3390/IJMS21010147 ",3.3,150.8,"6krv_oligo3","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_G_)-[NAG(7_G_)-MAN(6_G_)-[NAG(5_G_)-MAN(4_G_)]-MAN(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(297_C_)",190.445,"","",""
"6KRV","CRYSTAL STRUCTURE OF MOUSE IGG2B FC COMPLEXED WITH B DOMAIN OF PROTEIN A","10.3390/IJMS21010147 ",3.3,150.8,"6krv_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpa1-4DGlcpNAcx1-","NAG(6_F_)-MAN(5_F_)-[NAG(4_F_)-MAN(3_F_)]-MAN(2_F_)-NAG(1_F_)",227.744,"","",""
"6KRV","CRYSTAL STRUCTURE OF MOUSE IGG2B FC COMPLEXED WITH B DOMAIN OF PROTEIN A","10.3390/IJMS21010147 ",3.3,150.8,"6krv_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_E_)-[NAG(7_E_)-MAN(6_E_)-[NAG(5_E_)-MAN(4_E_)]-MAN(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_A_)",144.018,"","",""
"6KYA","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX TH1027","10.1021/ACS.JMEDCHEM.9B02128 ",2.89,100.1,"6kya_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(590_B_)",98.8778,"","",""
"6KYA","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX TH1027","10.1021/ACS.JMEDCHEM.9B02128 ",2.89,100.1,"6kya_oligo6","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(293_B_)",105.866,"","",""
"6KYA","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX TH1027","10.1021/ACS.JMEDCHEM.9B02128 ",2.89,100.1,"6kya_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(293_A_)",93.5175,"","",""
"6KYA","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX TH1027","10.1021/ACS.JMEDCHEM.9B02128 ",2.89,100.1,"6kya_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(590_A_)",89.3013,"","",""
"6L2J","CRYSTAL STRUCTURE OF YAK LACTOPEROXIDASE AT 1.93 A RESOLUTION.","",1.93,19.7,"6l2j_oligo2","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-MAN(4_B_)-[MAN(6_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(205_A_)",30.9282,"","",""
"6L76","CRYSTAL STRUCTURE OF THE NI(II)(CHRO)2-D(TTGGGCCGAA/TTCGGCCCAA) COMPLEX AT 2.94 ANGSTROM RESOLUTION","10.1093/NAR/GKAB227 ",2.94,93.87,"6l76_oligo49","LOlip[3<R1>,4Ac]a1-3DOlipb1-3DOlipb1-","ERI(3_G_)-CDR(2_G_)-CDR(1_G_)",76.327,"","",""
"6L76","CRYSTAL STRUCTURE OF THE NI(II)(CHRO)2-D(TTGGGCCGAA/TTCGGCCCAA) COMPLEX AT 2.94 ANGSTROM RESOLUTION","10.1093/NAR/GKAB227 ",2.94,93.87,"6l76_oligo44","LOlip[3<R1>,4Ac]a1-3DOlipb1-3DOlipb1-","ERI(3_L_)-CDR(2_L_)-CDR(1_L_)",83.7077,"","",""
"6L76","CRYSTAL STRUCTURE OF THE NI(II)(CHRO)2-D(TTGGGCCGAA/TTCGGCCCAA) COMPLEX AT 2.94 ANGSTROM RESOLUTION","10.1093/NAR/GKAB227 ",2.94,93.87,"6l76_oligo41","LOlip[3<R1>,4Ac]a1-3DOlipb1-3DOlipb1-C21O9","ERI(3_F_)-CDR(2_F_)-CDR(1_F_)",94.9893,"","",""
"6L76","CRYSTAL STRUCTURE OF THE NI(II)(CHRO)2-D(TTGGGCCGAA/TTCGGCCCAA) COMPLEX AT 2.94 ANGSTROM RESOLUTION","10.1093/NAR/GKAB227 ",2.94,93.87,"6l76_oligo42","LOlip[3<R1>,4Ac]a1-3DOlipb1-3DOlipb1-","ERI(3_J_)-CDR(2_J_)-CDR(1_J_)",76.8697,"","",""
"6LCP","CRYO-EM STRUCTURE OF DNF1 FROM CHAETOMIUM THERMOPHILUM IN THE E2P STATE","10.1007/S13238-020-00712-Y ",3.48,0,"6lcp_oligo1","DManpa1-3DManpx1-","MAN(2_C_)-MAN(1_C_)",50.4027,"","",""
"6LCP","CRYO-EM STRUCTURE OF DNF1 FROM CHAETOMIUM THERMOPHILUM IN THE E2P STATE","10.1007/S13238-020-00712-Y ",3.48,0,"6lcp_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(219_B_)",55.5775,"","",""
"6LEH","CRYSTAL STRUCTURE OF AUTOTAXIN IN COMPLEX WITH AN INHIBITOR","10.1021/ACS.JMEDCHEM.9B01967 ",2,41.02,"6leh_oligo1","DManpa1-2DManpa1-3DManpa1-6DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-MAN(5_B_)-MAN(4_B_)-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(524_A_)",48.1927,"","",""
"6LF2","SEVIL BOUND TO ASIALO-GM1 SACCHARIDE","10.1038/S41598-020-78926-7 ",1.6,15.22,"6lf2_oligo1","DGalpb1-3DGalpNAcb1-4DGalpb1-4DGlcpb1-ROH","GAL(4_C_)-NGA(3_C_)-GAL(2_C_)-BGC(1_C_)",17.8139,"","",""
"6LF2","SEVIL BOUND TO ASIALO-GM1 SACCHARIDE","10.1038/S41598-020-78926-7 ",1.6,15.22,"6lf2_oligo2","DGalpb1-3DGalpNAcb1-4DGalpb1-4DGlcpb1-ROH","GAL(4_D_)-NGA(3_D_)-GAL(2_D_)-BGC(1_D_)",20.053,"","",""
"6LKS","EFFECTS OF ZINC ION ON OLIGOMERIZATION AND PH STABILITY OF INFLUENZA VIRUS HEMAGGLUTININ","10.1038/S41598-020-72368-X ",3.24,74.73,"6lks_oligo4","DGlcpNAcb1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_N_)-MAN(4_N_)-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(87_K_)",81.4722,"","",""
"6LKS","EFFECTS OF ZINC ION ON OLIGOMERIZATION AND PH STABILITY OF INFLUENZA VIRUS HEMAGGLUTININ","10.1038/S41598-020-72368-X ",3.24,74.73,"6lks_oligo7","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_S_)-[NAG(5_S_)-MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(54_E_)",78.3845,"","",""
"6LKS","EFFECTS OF ZINC ION ON OLIGOMERIZATION AND PH STABILITY OF INFLUENZA VIRUS HEMAGGLUTININ","10.1038/S41598-020-72368-X ",3.24,74.73,"6lks_oligo2","DGlcpNAcb1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_P_)-MAN(4_P_)-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(87_A_)",69.9073,"","",""
"6LKS","EFFECTS OF ZINC ION ON OLIGOMERIZATION AND PH STABILITY OF INFLUENZA VIRUS HEMAGGLUTININ","10.1038/S41598-020-72368-X ",3.24,74.73,"6lks_oligo10","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_V_)-[NAG(5_V_)-MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(87_G_)",82.4494,"","",""
"6LKS","EFFECTS OF ZINC ION ON OLIGOMERIZATION AND PH STABILITY OF INFLUENZA VIRUS HEMAGGLUTININ","10.1038/S41598-020-72368-X ",3.24,74.73,"6lks_oligo9","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_U_)-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(54_G_)",74.8802,"","",""
"6LKS","EFFECTS OF ZINC ION ON OLIGOMERIZATION AND PH STABILITY OF INFLUENZA VIRUS HEMAGGLUTININ","10.1038/S41598-020-72368-X ",3.24,74.73,"6lks_oligo12","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_X_)-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(87_I_)",75.5345,"","",""
"6LKS","EFFECTS OF ZINC ION ON OLIGOMERIZATION AND PH STABILITY OF INFLUENZA VIRUS HEMAGGLUTININ","10.1038/S41598-020-72368-X ",3.24,74.73,"6lks_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_O_)-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(54_A_)",88.87,"","",""
"6LKS","EFFECTS OF ZINC ION ON OLIGOMERIZATION AND PH STABILITY OF INFLUENZA VIRUS HEMAGGLUTININ","10.1038/S41598-020-72368-X ",3.24,74.73,"6lks_oligo8","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_T_)-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(87_E_)",77.0227,"","",""
"6LKS","EFFECTS OF ZINC ION ON OLIGOMERIZATION AND PH STABILITY OF INFLUENZA VIRUS HEMAGGLUTININ","10.1038/S41598-020-72368-X ",3.24,74.73,"6lks_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_Q_)-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(54_C_)",81.0632,"","",""
"6LKS","EFFECTS OF ZINC ION ON OLIGOMERIZATION AND PH STABILITY OF INFLUENZA VIRUS HEMAGGLUTININ","10.1038/S41598-020-72368-X ",3.24,74.73,"6lks_oligo6","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_R_)-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(87_C_)",71.1566,"","",""
"6LKS","EFFECTS OF ZINC ION ON OLIGOMERIZATION AND PH STABILITY OF INFLUENZA VIRUS HEMAGGLUTININ","10.1038/S41598-020-72368-X ",3.24,74.73,"6lks_oligo5","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_M_)-[NAG(5_M_)-MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(54_K_)",87.8047,"","",""
"6LQG","HUMAN GAMMA-SECRETASE IN COMPLEX WITH SMALL MOLECULE AVAGACESTAT","10.1016/J.CELL.2020.11.049 ",3.1,"1.08527e-19","6lqg_oligo5","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_F_)-[BMA(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(55_A_)",73.1962,"","",""
"6LR4","MOLECULAR BASIS FOR INHIBITION OF HUMAN GAMMA-SECRETASE BY SMALL MOLECULE","10.1016/J.CELL.2020.11.049 ",3,"1.08527e-19","6lr4_oligo4","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_F_)-[BMA(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(55_A_)",84.3891,"","",""
"6LXJ","CRYSTAL STRUCTURE OF HUMAN Z2B3 FAB IN COMPLEX WITH INFLUENZA VIRUS NEURAMINIDASE FROM A/ANHUI/1/2013 (H7N9)","10.1128/MBIO.02315-20 ",2.9,39.88,"6lxj_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_I_)-[MAN(8_I_)]-MAN(7_I_)-[MAN(6_I_)-MAN(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(201_A_)",43.2936,"","",""
"6LXJ","CRYSTAL STRUCTURE OF HUMAN Z2B3 FAB IN COMPLEX WITH INFLUENZA VIRUS NEURAMINIDASE FROM A/ANHUI/1/2013 (H7N9)","10.1128/MBIO.02315-20 ",2.9,39.88,"6lxj_oligo6","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_R_)-[MAN(8_R_)]-MAN(7_R_)-[MAN(6_R_)-MAN(5_R_)-MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(201_C_)",43.2447,"","",""
"6LXJ","CRYSTAL STRUCTURE OF HUMAN Z2B3 FAB IN COMPLEX WITH INFLUENZA VIRUS NEURAMINIDASE FROM A/ANHUI/1/2013 (H7N9)","10.1128/MBIO.02315-20 ",2.9,39.88,"6lxj_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(146_A_)",70.578,"","",""
"6LXJ","CRYSTAL STRUCTURE OF HUMAN Z2B3 FAB IN COMPLEX WITH INFLUENZA VIRUS NEURAMINIDASE FROM A/ANHUI/1/2013 (H7N9)","10.1128/MBIO.02315-20 ",2.9,39.88,"6lxj_oligo8","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_T_)-[MAN(8_T_)]-MAN(7_T_)-[MAN(6_T_)-MAN(5_T_)-MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(201_D_)",39.8487,"","",""
"6LXJ","CRYSTAL STRUCTURE OF HUMAN Z2B3 FAB IN COMPLEX WITH INFLUENZA VIRUS NEURAMINIDASE FROM A/ANHUI/1/2013 (H7N9)","10.1128/MBIO.02315-20 ",2.9,39.88,"6lxj_oligo4","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_P_)-[MAN(8_P_)]-MAN(7_P_)-[MAN(6_P_)-MAN(5_P_)-MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(201_B_)",43.283,"","",""
"6M0R","2.7A YEAST VO STATE3","10.1126/SCIADV.ABB9605 ",2.7,"2.98315e-08","6m0r_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-C40O7P2","MAN(5_P_)-[MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)",64.3815,"","",""
"6M0Z","X-RAY STRUCTURE OF DROSOPHILA DOPAMINE TRANSPORTER WITH NET-LIKE MUTATIONS (D121G/S426M/F471L) IN L-NOREPINEPHRINE BOUND FORM","10.1038/S41467-021-22385-9 ",2.88,89.65,"6m0z_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(703_A_)-DMU(703_A_)",125.012,"","",""
"6M2R","X-RAY STRUCTURE OF A FUNCTIONAL DROSOPHILA DOPAMINE TRANSPORTER IN L- NOREPINEPHRINE BOUND FORM","10.1038/S41467-021-22385-9 ",2.8,64.3,"6m2r_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(701_A_)-DMU(701_A_)",81.9059,"","",""
"6M38","X-RAY STRUCTURE OF A DROSOPHILA DOPAMINE TRANSPORTER WITH SUBSITEB MUTATIONS (D121G/S426M) IN S-DULOXETINE BOUND FORM","10.1038/S41467-021-22385-9 ",3,78.25,"6m38_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(606_A_)-DMU(606_A_)",90.7,"","",""
"6MAM","CLEAVED EBOLA GP IN COMPLEX WITH A BROADLY NEUTRALIZING HUMAN ANTIBODY, ADI-15946","10.1038/S41594-019-0191-4 ",4.1,0,"6mam_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(563_L_)",114.129,"","",""
"6MAM","CLEAVED EBOLA GP IN COMPLEX WITH A BROADLY NEUTRALIZING HUMAN ANTIBODY, ADI-15946","10.1038/S41594-019-0191-4 ",4.1,0,"6mam_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(563_H_)",99.7146,"","",""
"6MAM","CLEAVED EBOLA GP IN COMPLEX WITH A BROADLY NEUTRALIZING HUMAN ANTIBODY, ADI-15946","10.1038/S41594-019-0191-4 ",4.1,0,"6mam_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_N_)-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(563_J_)",108.203,"","",""
"6MAR","HIV-1 ENVELOPE GLYCOPROTEIN CLONE BG505 DELCT N332T IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODY FAB PGT151","10.1038/S41467-018-06121-4 ",4.5,"1.08527e-19","6mar_oligo30","DGalpb1-4DGlcpNAcb1-2[DGalpb1-4DGlcpNAcb1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(10_n_)-[GAL(8_n_)-NAG(7_n_)-[GAL(6_n_)-NAG(5_n_)]-MAN(4_n_)-[MAN(9_n_)]-BMA(3_n_)-NAG(2_n_)]-NAG(1_n_)-ASN(611_F_)",146.443,"","",""
"6MAR","HIV-1 ENVELOPE GLYCOPROTEIN CLONE BG505 DELCT N332T IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODY FAB PGT151","10.1038/S41467-018-06121-4 ",4.5,"1.08527e-19","6mar_oligo2","DGalpb1-4DGlcpNAcb1-2[DGlcpNAcb1-4]DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(10_U_)-[NAG(9_U_)-MAN(8_U_)-[NAG(7_U_)-[GAL(6_U_)-NAG(5_U_)]-MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)]-NAG(1_U_)-ASN(637_B_)",190.606,"","",""
"6MAR","HIV-1 ENVELOPE GLYCOPROTEIN CLONE BG505 DELCT N332T IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODY FAB PGT151","10.1038/S41467-018-06121-4 ",4.5,"1.08527e-19","6mar_oligo12","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_e_)-BMA(3_e_)-NAG(2_e_)-NAG(1_e_)-ASN(262_C_)",237.673,"","",""
"6MAR","HIV-1 ENVELOPE GLYCOPROTEIN CLONE BG505 DELCT N332T IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODY FAB PGT151","10.1038/S41467-018-06121-4 ",4.5,"1.08527e-19","6mar_oligo31","DGalpb1-4DGlcpNAcb1-2[DGlcpNAcb1-4]DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(10_o_)-[NAG(9_o_)-MAN(8_o_)-[NAG(7_o_)-[GAL(6_o_)-NAG(5_o_)]-MAN(4_o_)]-BMA(3_o_)-NAG(2_o_)]-NAG(1_o_)-ASN(637_F_)",172.364,"","",""
"6MAR","HIV-1 ENVELOPE GLYCOPROTEIN CLONE BG505 DELCT N332T IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODY FAB PGT151","10.1038/S41467-018-06121-4 ",4.5,"1.08527e-19","6mar_oligo17","DGalpb1-4DGlcpNAcb1-2[DGalpb1-4DGlcpNAcb1-6]DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(11_T_)-[GAL(8_T_)-NAG(7_T_)-[GAL(6_T_)-NAG(5_T_)]-MAN(4_T_)-[NAG(10_T_)-MAN(9_T_)]-BMA(3_T_)-NAG(2_T_)]-NAG(1_T_)-ASN(611_B_)",188.354,"","",""
"6MAR","HIV-1 ENVELOPE GLYCOPROTEIN CLONE BG505 DELCT N332T IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODY FAB PGT151","10.1038/S41467-018-06121-4 ",4.5,"1.08527e-19","6mar_oligo18","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_K_)-[MAN(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(262_A_)",173.997,"","",""
"6MAR","HIV-1 ENVELOPE GLYCOPROTEIN CLONE BG505 DELCT N332T IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODY FAB PGT151","10.1038/S41467-018-06121-4 ",4.5,"1.08527e-19","6mar_oligo24","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_h_)-MAN(6_h_)-[MAN(5_h_)-MAN(4_h_)]-BMA(3_h_)-NAG(2_h_)-NAG(1_h_)-ASN(262_E_)",214.803,"","",""
"6MCO","CRYSTAL STRUCTURE OF THE B41 SOSIP.664 ENV TRIMER WITH PGT124 AND 35O22 FABS, IN P23 SPACE GROUP","10.1038/S41467-019-08738-5 ",3.53,0,"6mco_oligo7","DManpa1-2[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-3DGlcp[2<R1>]b1-4DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)]-MAN(4_F_)-[MAN(7_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(88_G_)",178.016,"","",""
"6MCO","CRYSTAL STRUCTURE OF THE B41 SOSIP.664 ENV TRIMER WITH PGT124 AND 35O22 FABS, IN P23 SPACE GROUP","10.1038/S41467-019-08738-5 ",3.53,0,"6mco_oligo13","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(392_G_)",178.329,"","",""
"6MCO","CRYSTAL STRUCTURE OF THE B41 SOSIP.664 ENV TRIMER WITH PGT124 AND 35O22 FABS, IN P23 SPACE GROUP","10.1038/S41467-019-08738-5 ",3.53,0,"6mco_oligo4","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_P_)-[MAN(7_P_)]-MAN(6_P_)-[MAN(5_P_)-MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(332_G_)",148.121,"","",""
"6MCO","CRYSTAL STRUCTURE OF THE B41 SOSIP.664 ENV TRIMER WITH PGT124 AND 35O22 FABS, IN P23 SPACE GROUP","10.1038/S41467-019-08738-5 ",3.53,0,"6mco_oligo5","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_A_)-[MAN(5_A_)-MAN(4_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(625_B_)",151.202,"","",""
"6MCO","CRYSTAL STRUCTURE OF THE B41 SOSIP.664 ENV TRIMER WITH PGT124 AND 35O22 FABS, IN P23 SPACE GROUP","10.1038/S41467-019-08738-5 ",3.53,0,"6mco_oligo14","DManpb1-3DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(413_G_)",177.684,"","",""
"6MCO","CRYSTAL STRUCTURE OF THE B41 SOSIP.664 ENV TRIMER WITH PGT124 AND 35O22 FABS, IN P23 SPACE GROUP","10.1038/S41467-019-08738-5 ",3.53,0,"6mco_oligo12","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_R_)-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(386_G_)",158.548,"","",""
"6MCX","INFLUENZA VIRUS NEURAMINIDASE SUBTYPE N9 (TERN) RECOMBINANT HEAD DOMAIN","10.1107/S2053230X18017892 ",2.3,51.41,"6mcx_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",58.5584,"","",""
"6MDS","CRYSTAL STRUCTURE OF STREPTOCOCCUS PYOGENES ENDO-BETA-N- ACETYLGLUCOSAMINIDASE (ENDOS2) WITH COMPLEX BIANTENNARY GLYCAN","10.1021/ACSCENTSCI.8B00917 ",2.5,48.7,"6mds_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-ROH","GAL(8_C_)-NAG(7_C_)-MAN(6_C_)-[GAL(5_C_)-NAG(4_C_)-MAN(3_C_)]-BMA(2_C_)-NAG(1_C_)",64.8303,"","",""
"6MDS","CRYSTAL STRUCTURE OF STREPTOCOCCUS PYOGENES ENDO-BETA-N- ACETYLGLUCOSAMINIDASE (ENDOS2) WITH COMPLEX BIANTENNARY GLYCAN","10.1021/ACSCENTSCI.8B00917 ",2.5,48.7,"6mds_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-ROH","GAL(8_D_)-NAG(7_D_)-MAN(6_D_)-[GAL(5_D_)-NAG(4_D_)-MAN(3_D_)]-BMA(2_D_)-NAG(1_D_)",69.5976,"","",""
"6MDT","CRYSTAL STRUCTURE OF THE B41 SOSIP.664 ENV TRIMER WITH PGT124 AND 35O22 FABS, IN P63 SPACE GROUP","10.1038/S41467-019-08738-5 ",3.82,0,"6mdt_oligo11","DManpa1-3[DManpa1-6]DManpb1-4DGlcp[2<R1>]b1-4DGlcpNAcb1-ASN","MAN(5_Q_)-[MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(392_G_)",118.374,"","",""
"6MDT","CRYSTAL STRUCTURE OF THE B41 SOSIP.664 ENV TRIMER WITH PGT124 AND 35O22 FABS, IN P63 SPACE GROUP","10.1038/S41467-019-08738-5 ",3.82,0,"6mdt_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(234_G_)",78.7298,"","",""
"6MDT","CRYSTAL STRUCTURE OF THE B41 SOSIP.664 ENV TRIMER WITH PGT124 AND 35O22 FABS, IN P63 SPACE GROUP","10.1038/S41467-019-08738-5 ",3.82,0,"6mdt_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_N_)-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(301_G_)",80.1841,"","",""
"6MDT","CRYSTAL STRUCTURE OF THE B41 SOSIP.664 ENV TRIMER WITH PGT124 AND 35O22 FABS, IN P63 SPACE GROUP","10.1038/S41467-019-08738-5 ",3.82,0,"6mdt_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_P_)-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(386_G_)",99.3111,"","",""
"6MDT","CRYSTAL STRUCTURE OF THE B41 SOSIP.664 ENV TRIMER WITH PGT124 AND 35O22 FABS, IN P63 SPACE GROUP","10.1038/S41467-019-08738-5 ",3.82,0,"6mdt_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)",97.06,"","",""
"6MDT","CRYSTAL STRUCTURE OF THE B41 SOSIP.664 ENV TRIMER WITH PGT124 AND 35O22 FABS, IN P63 SPACE GROUP","10.1038/S41467-019-08738-5 ",3.82,0,"6mdt_oligo10","DManpa1-2[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)]-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(88_G_)",117.766,"","",""
"6MDT","CRYSTAL STRUCTURE OF THE B41 SOSIP.664 ENV TRIMER WITH PGT124 AND 35O22 FABS, IN P63 SPACE GROUP","10.1038/S41467-019-08738-5 ",3.82,0,"6mdt_oligo14","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(9_T_)-[MAN(8_T_)]-MAN(7_T_)-[MAN(6_T_)-MAN(5_T_)-MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)",86.5705,"","",""
"6MDT","CRYSTAL STRUCTURE OF THE B41 SOSIP.664 ENV TRIMER WITH PGT124 AND 35O22 FABS, IN P63 SPACE GROUP","10.1038/S41467-019-08738-5 ",3.82,0,"6mdt_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcp[2<R1>]b1-4DGlcp[2<R2>]x1-","MAN(5_A_)-[MAN(4_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)",97.06,"","",""
"6MDV","CRYSTAL STRUCTURE OF STREPTOCOCCUS PYOGENES ENDO-BETA-N- ACETYLGLUCOSAMINIDASE (ENDOS2) WITH HIGH-MANNOSE GLYCAN","10.1021/ACSCENTSCI.8B00917 ",2.5,52.74,"6mdv_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-ROH","MAN(8_C_)-[MAN(7_C_)]-MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)-MAN(3_C_)]-BMA(2_C_)-NAG(1_C_)",68.6975,"","",""
"6MDV","CRYSTAL STRUCTURE OF STREPTOCOCCUS PYOGENES ENDO-BETA-N- ACETYLGLUCOSAMINIDASE (ENDOS2) WITH HIGH-MANNOSE GLYCAN","10.1021/ACSCENTSCI.8B00917 ",2.5,52.74,"6mdv_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-ROH","MAN(7_D_)-MAN(6_D_)-[MAN(5_D_)-MAN(4_D_)-MAN(3_D_)]-BMA(2_D_)-NAG(1_D_)",71.0774,"","",""
"6MEJ","CRYSTAL STRUCTURE OF HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ECTODOMAIN IN COMPLEX WITH HUMAN ANTIBODIES HEPC3 AND HEPC46","10.1016/J.CHOM.2018.10.009 ",2.8,75.1,"6mej_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(448_C_)",104.327,"","",""
"6MEJ","CRYSTAL STRUCTURE OF HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ECTODOMAIN IN COMPLEX WITH HUMAN ANTIBODIES HEPC3 AND HEPC46","10.1016/J.CHOM.2018.10.009 ",2.8,75.1,"6mej_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-3DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(556_C_)",111.702,"","",""
"6MEK","CRYSTAL STRUCTURE OF HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 CORE IN COMPLEX WITH HUMAN ANTIBODIES HEPC3 AND HEPC46","10.1016/J.CHOM.2018.10.009 ",3.1,76.85,"6mek_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-3DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(556_C_)",109.733,"","",""
"6MEK","CRYSTAL STRUCTURE OF HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 CORE IN COMPLEX WITH HUMAN ANTIBODIES HEPC3 AND HEPC46","10.1016/J.CHOM.2018.10.009 ",3.1,76.85,"6mek_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(623_A_)",131.463,"","",""
"6MEO","STRUCTURAL BASIS OF CORECEPTOR RECOGNITION BY HIV-1 ENVELOPE SPIKE","10.1038/S41586-018-0804-9 ",3.9,0,"6meo_oligo7","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(262_G_)",28.9891,"","",""
"6MET","STRUCTURAL BASIS OF CORECEPTOR RECOGNITION BY HIV-1 ENVELOPE SPIKE","10.1038/S41586-018-0804-9 ",4.5,0,"6met_oligo4","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-[MAN(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(262_G_)",30.0309,"","",""
"6MF0","CRYSTAL STRUCTURE DETERMINATION OF HUMAN/PORCINE CHIMERA COAGULATION FACTOR VIII","10.1111/JTH.14621 ",3.2,61.42,"6mf0_oligo5","DGlcpNAcb1-4DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_G_)-[NAG(5_G_)-MAN(4_G_)-[MAN(6_G_)]-BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(1810_B_)",123.211,"","",""
"6MF0","CRYSTAL STRUCTURE DETERMINATION OF HUMAN/PORCINE CHIMERA COAGULATION FACTOR VIII","10.1111/JTH.14621 ",3.2,61.42,"6mf0_oligo6","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-[MAN(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(2118_B_)",111.791,"","",""
"6MF0","CRYSTAL STRUCTURE DETERMINATION OF HUMAN/PORCINE CHIMERA COAGULATION FACTOR VIII","10.1111/JTH.14621 ",3.2,61.42,"6mf0_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(2118_A_)",110.503,"","",""
"6MF0","CRYSTAL STRUCTURE DETERMINATION OF HUMAN/PORCINE CHIMERA COAGULATION FACTOR VIII","10.1111/JTH.14621 ",3.2,61.42,"6mf0_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(240_A_)",140.995,"","",""
"6MF0","CRYSTAL STRUCTURE DETERMINATION OF HUMAN/PORCINE CHIMERA COAGULATION FACTOR VIII","10.1111/JTH.14621 ",3.2,61.42,"6mf0_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(240_B_)",134.112,"","",""
"6MFT","CRYSTAL STRUCTURE OF GLYCOSYLATED 426C HIV-1 GP120 CORE G459C IN COMPLEX WITH GLVRC01 A60C HEAVY CHAIN","10.7554/ELIFE.37688 ",2.32,0,"6mft_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(262_C_)",110.031,"","",""
"6MFT","CRYSTAL STRUCTURE OF GLYCOSYLATED 426C HIV-1 GP120 CORE G459C IN COMPLEX WITH GLVRC01 A60C HEAVY CHAIN","10.7554/ELIFE.37688 ",2.32,0,"6mft_oligo5","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(262_G_)",90.1629,"","",""
"6MGP","STRUCTURE OF HUMAN 4-1BB / 4-1BBL COMPLEX","",2.13,70.98,"6mgp_oligo1","LFucpa1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_D_)-[NAG(3_D_)]-[FUC(2_D_)]-NAG(1_D_)-ASN(149_X_)",125.9,"","",""
"6MGP","STRUCTURE OF HUMAN 4-1BB / 4-1BBL COMPLEX","",2.13,70.98,"6mgp_oligo3","LFucpa1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_F_)-[NAG(3_F_)]-[FUC(2_F_)]-NAG(1_F_)-ASN(149_Z_)",116.215,"","",""
"6MGP","STRUCTURE OF HUMAN 4-1BB / 4-1BBL COMPLEX","",2.13,70.98,"6mgp_oligo2","LFucpa1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_E_)-[NAG(3_E_)]-[FUC(2_E_)]-NAG(1_E_)-ASN(149_Y_)",119.288,"","",""
"6MGQ","ERAP1 IN THE OPEN CONFORMATION BOUND TO 10MER PHOSPHINIC INHIBITOR DG014","10.1038/S41467-021-25564-W ",2.92,70.7,"6mgq_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(70_A_)",67.6489,"","",""
"6MHR","STRUCTURE OF THE HUMAN 4-1BB / URELUMAB FAB COMPLEX","10.1038/S41467-018-07136-7 ",2.8,79.16,"6mhr_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcx1-","FUC(5_G_)-[BMA(3_G_)-NAG(2_G_)]-[FUC(4_G_)]-NAG(1_G_)",105.063,"","",""
"6MHR","STRUCTURE OF THE HUMAN 4-1BB / URELUMAB FAB COMPLEX","10.1038/S41467-018-07136-7 ",2.8,79.16,"6mhr_oligo2","LFucpa1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_H_)-[NAG(3_H_)]-[FUC(2_H_)]-NAG(1_H_)-ASN(149_C_)",123.22,"","",""
"6MJ3","CRYSTAL STRUCTURE OF RHESUS MACAQUE (MACACA MULATTA) IGG1 FC FRAGMENT- FC-GAMMA RECEPTOR III COMPLEX","10.3389/FIMMU.2022.960411 ",3.8,0,"6mj3_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_G_)-[NAG(7_G_)-MAN(6_G_)-[NAG(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(297_A_)",128.198,"","",""
"6MJ3","CRYSTAL STRUCTURE OF RHESUS MACAQUE (MACACA MULATTA) IGG1 FC FRAGMENT- FC-GAMMA RECEPTOR III COMPLEX","10.3389/FIMMU.2022.960411 ",3.8,0,"6mj3_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_H_)-[NAG(7_H_)-MAN(6_H_)-[NAG(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)]-NAG(1_H_)-ASN(297_B_)",109.917,"","",""
"6MJ3","CRYSTAL STRUCTURE OF RHESUS MACAQUE (MACACA MULATTA) IGG1 FC FRAGMENT- FC-GAMMA RECEPTOR III COMPLEX","10.3389/FIMMU.2022.960411 ",3.8,0,"6mj3_oligo4","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_J_)-[NAG(7_J_)-MAN(6_J_)-[NAG(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)]-NAG(1_J_)-ASN(297_E_)",118.352,"","",""
"6MJ3","CRYSTAL STRUCTURE OF RHESUS MACAQUE (MACACA MULATTA) IGG1 FC FRAGMENT- FC-GAMMA RECEPTOR III COMPLEX","10.3389/FIMMU.2022.960411 ",3.8,0,"6mj3_oligo3","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_I_)-[NAG(7_I_)-MAN(6_I_)-[NAG(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(297_D_)",107.428,"","",""
"6MJI","CRYSTAL STRUCTURE OF THE MCD1D/XXS (JJ304) /INKTCR TERNARY COMPLEX","10.1002/CMDC.201800649 ",2.3,43.91,"6mji_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_F_)-[MAN(4_F_)-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(165_A_)",78.9771,"","",""
"6MJO","CRYSTAL STRUCTURE OF RHESUS MACAQUE (MACACA MULATTA) FC-GAMMA RECEPTOR III","10.3389/FIMMU.2022.960411 ",1.9,0,"6mjo_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_A_)-[MAN(5_A_)]-MAN(4_A_)-[MAN(7_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(45_C_)",54.1484,"","",""
"6MJQ","CRYSTAL STRUCTURE OF THE MCD1D/XXP (JJ295) /INKTCR TERNARY COMPLEX","10.1002/CMDC.201800649 ",3,52.39,"6mjq_oligo7","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_M_)-[MAN(4_M_)-BMA(3_M_)-NAG(2_M_)]-NAG(1_M_)-ASN(165_E_)",80.5658,"","",""
"6MK0","INTEGRIN ALPHAVBETA3 ECTODOMAIN BOUND TO ANTAGONIST TDI-4161","10.1021/ACSPTSCI.9B00041 ",3.01,56.99,"6mk0_oligo2","DManpa1-4DManpb1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-BMA(4_D_)-[MAN(6_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(266_A_)",56.2542,"","",""
"6MKB","CRYSTAL STRUCTURE OF MURINE 4-1BB LIGAND","10.1074/JBC.RA118.006297 ",2.5,66.18,"6mkb_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(161_A_)",96.8689,"","",""
"6MKB","CRYSTAL STRUCTURE OF MURINE 4-1BB LIGAND","10.1074/JBC.RA118.006297 ",2.5,66.18,"6mkb_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(161_D_)",99.5225,"","",""
"6ML8","CRYSTAL STRUCTURE OF HEMAGGLUTININ FROM H1N1 INFLUENZA A VIRUS A/DENVER/57 BOUND TO THE C05 ANTIBODY","10.1038/S41598-023-33529-W ",2.92,87.07,"6ml8_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(104_A_)",102.026,"","",""
"6MN7","CRYO-EM STRUCTURE OF BG505.SOSIP.664 IN COMPLEX WITH BF520.1 ANTIGEN BINDING FRAGMENT","10.1038/S41467-019-09481-7 ",4.8,"1.08527e-19","6mn7_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_i_)-[MAN(4_i_)]-BMA(3_i_)-NAG(2_i_)-NAG(1_i_)-ASN(295_C_)",0,"","",""
"6MN7","CRYO-EM STRUCTURE OF BG505.SOSIP.664 IN COMPLEX WITH BF520.1 ANTIGEN BINDING FRAGMENT","10.1038/S41467-019-09481-7 ",4.8,"1.08527e-19","6mn7_oligo8","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_j_)-[MAN(5_j_)]-MAN(4_j_)-[MAN(7_j_)]-BMA(3_j_)-NAG(2_j_)-NAG(1_j_)-ASN(301_C_)",0,"","",""
"6MN7","CRYO-EM STRUCTURE OF BG505.SOSIP.664 IN COMPLEX WITH BF520.1 ANTIGEN BINDING FRAGMENT","10.1038/S41467-019-09481-7 ",4.8,"1.08527e-19","6mn7_oligo42","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_y_)-[MAN(4_y_)]-BMA(3_y_)-NAG(2_y_)-NAG(1_y_)-ASN(295_D_)",0,"","",""
"6MN7","CRYO-EM STRUCTURE OF BG505.SOSIP.664 IN COMPLEX WITH BF520.1 ANTIGEN BINDING FRAGMENT","10.1038/S41467-019-09481-7 ",4.8,"1.08527e-19","6mn7_oligo35","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(7_P_)-MAN(6_P_)-[MAN(5_P_)-MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)",0,"","",""
"6MN7","CRYO-EM STRUCTURE OF BG505.SOSIP.664 IN COMPLEX WITH BF520.1 ANTIGEN BINDING FRAGMENT","10.1038/S41467-019-09481-7 ",4.8,"1.08527e-19","6mn7_oligo38","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(6_S_)-[MAN(5_S_)]-MAN(4_S_)-[MAN(7_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)",0,"","",""
"6MN7","CRYO-EM STRUCTURE OF BG505.SOSIP.664 IN COMPLEX WITH BF520.1 ANTIGEN BINDING FRAGMENT","10.1038/S41467-019-09481-7 ",4.8,"1.08527e-19","6mn7_oligo40","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(7_w_)-MAN(6_w_)-[MAN(5_w_)-MAN(4_w_)]-BMA(3_w_)-NAG(2_w_)-NAG(1_w_)",0,"","",""
"6MN7","CRYO-EM STRUCTURE OF BG505.SOSIP.664 IN COMPLEX WITH BF520.1 ANTIGEN BINDING FRAGMENT","10.1038/S41467-019-09481-7 ",4.8,"1.08527e-19","6mn7_oligo39","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(9_T_)-MAN(8_T_)-[MAN(10_T_)]-MAN(7_T_)-[MAN(6_T_)-MAN(5_T_)-MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)",0,"","",""
"6MN7","CRYO-EM STRUCTURE OF BG505.SOSIP.664 IN COMPLEX WITH BF520.1 ANTIGEN BINDING FRAGMENT","10.1038/S41467-019-09481-7 ",4.8,"1.08527e-19","6mn7_oligo44","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(9_0_)-MAN(8_0_)-[MAN(10_0_)]-MAN(7_0_)-[MAN(6_0_)-MAN(5_0_)-MAN(4_0_)]-BMA(3_0_)-NAG(2_0_)-NAG(1_0_)",0,"","",""
"6MN7","CRYO-EM STRUCTURE OF BG505.SOSIP.664 IN COMPLEX WITH BF520.1 ANTIGEN BINDING FRAGMENT","10.1038/S41467-019-09481-7 ",4.8,"1.08527e-19","6mn7_oligo43","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(6_z_)-[MAN(5_z_)]-MAN(4_z_)-[MAN(7_z_)]-BMA(3_z_)-NAG(2_z_)-NAG(1_z_)",0,"","",""
"6MN7","CRYO-EM STRUCTURE OF BG505.SOSIP.664 IN COMPLEX WITH BF520.1 ANTIGEN BINDING FRAGMENT","10.1038/S41467-019-09481-7 ",4.8,"1.08527e-19","6mn7_oligo9","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(9_k_)-MAN(8_k_)-[MAN(10_k_)]-MAN(7_k_)-[MAN(6_k_)-MAN(5_k_)-MAN(4_k_)]-BMA(3_k_)-NAG(2_k_)-NAG(1_k_)",0,"","",""
"6MN7","CRYO-EM STRUCTURE OF BG505.SOSIP.664 IN COMPLEX WITH BF520.1 ANTIGEN BINDING FRAGMENT","10.1038/S41467-019-09481-7 ",4.8,"1.08527e-19","6mn7_oligo34","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(7_g_)-MAN(6_g_)-[MAN(5_g_)-MAN(4_g_)]-BMA(3_g_)-NAG(2_g_)-NAG(1_g_)",0,"","",""
"6MN7","CRYO-EM STRUCTURE OF BG505.SOSIP.664 IN COMPLEX WITH BF520.1 ANTIGEN BINDING FRAGMENT","10.1038/S41467-019-09481-7 ",4.8,"1.08527e-19","6mn7_oligo37","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_R_)-[MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(295_A_)",0,"","",""
"6MNF","ANTI-HIV-1 FAB 2G12 + MAN8 RE-REFINEMENT","10.1073/PNAS.0505763102 ",2.76,0,"6mnf_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpx1-","MAN(7_A_)-MAN(6_A_)-[MAN(8_A_)]-MAN(5_A_)-[MAN(4_A_)-MAN(3_A_)-MAN(2_A_)]-BMA(1_A_)",44.8795,"","",""
"6MSL","INTEGRIN ALPHAVBETA3 ECTODOMAIN BOUND TO EETI-II 2.5D","10.1016/J.STR.2019.06.011 ",3.1,62.24,"6msl_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(44_A_)",81.2645,"","",""
"6MSL","INTEGRIN ALPHAVBETA3 ECTODOMAIN BOUND TO EETI-II 2.5D","10.1016/J.STR.2019.06.011 ",3.1,62.24,"6msl_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(458_A_)",98.073,"","",""
"6MSL","INTEGRIN ALPHAVBETA3 ECTODOMAIN BOUND TO EETI-II 2.5D","10.1016/J.STR.2019.06.011 ",3.1,62.24,"6msl_oligo3","DManpa1-4DManpb1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-BMA(4_F_)-[MAN(6_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(266_A_)",71.875,"","",""
"6MSU","INTEGRIN ALPHAVBETA3 IN COMPLEX WITH EETI-II 2.5F","10.1016/J.STR.2019.06.011 ",3.11,0,"6msu_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(458_A_)",96.8268,"","",""
"6MSU","INTEGRIN ALPHAVBETA3 IN COMPLEX WITH EETI-II 2.5F","10.1016/J.STR.2019.06.011 ",3.11,0,"6msu_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(44_A_)",79.2473,"","",""
"6MSU","INTEGRIN ALPHAVBETA3 IN COMPLEX WITH EETI-II 2.5F","10.1016/J.STR.2019.06.011 ",3.11,0,"6msu_oligo2","DManpa1-4DManpb1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-BMA(4_F_)-[MAN(6_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(266_A_)",68.6494,"","",""
"6MSY","ANTI-HIV-1 FAB FAB 2G12 + MAN4 RE-REFINEMENT","10.1073/PNAS.0505763102 ",2,0,"6msy_oligo1","DManpa1-2DManpa1-2DManpa1-3DManpa1-ROH","MAN(4_A_)-MAN(3_A_)-MAN(2_A_)-MAN(1_A_)",35.4386,"","",""
"6MTJ","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-378806 IN COMPLEX WITH HUMAN ANTIBODIES 3H109L AND 35O22 AT 2.9 ANGSTROM","10.1038/S41467-018-07851-1 ",2.34,39.84,"6mtj_oligo9","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_A_)-MAN(4_A_)-[MAN(6_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(88_G_)",46.2439,"","",""
"6MTJ","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-378806 IN COMPLEX WITH HUMAN ANTIBODIES 3H109L AND 35O22 AT 2.9 ANGSTROM","10.1038/S41467-018-07851-1 ",2.34,39.84,"6mtj_oligo19","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_K_)-MAN(8_K_)-[MAN(10_K_)]-MAN(7_K_)-[MAN(6_K_)-MAN(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(332_G_)",45.5059,"","",""
"6MTN","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR COMPOUND 484 IN COMPLEX WITH HUMAN ANTIBODIES 3H109L AND 35O22 AT 3.0 ANGSTROM","10.1038/S41467-018-07851-1 ",2.5,49.33,"6mtn_oligo19","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_M_)-MAN(8_M_)-[MAN(10_M_)]-MAN(7_M_)-[MAN(6_M_)-MAN(5_M_)-MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(332_G_)",54.3368,"","",""
"6MTN","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR COMPOUND 484 IN COMPLEX WITH HUMAN ANTIBODIES 3H109L AND 35O22 AT 3.0 ANGSTROM","10.1038/S41467-018-07851-1 ",2.5,49.33,"6mtn_oligo5","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(88_G_)",58.9171,"","",""
"6MU3","ANTI-HIV-1 FAB 2G12 + MAN7 RE-REFINEMENT","10.1073/PNAS.0505763102 ",2.33,0,"6mu3_oligo1","DManpa1-2DManpa1-2DManpa1-3DManpb1-ROH","MAN(4_A_)-MAN(3_A_)-MAN(2_A_)-BMA(1_A_)",64.4089,"","",""
"6MU3","ANTI-HIV-1 FAB 2G12 + MAN7 RE-REFINEMENT","10.1073/PNAS.0505763102 ",2.33,0,"6mu3_oligo2","DManpa1-2DManpa1-2DManpa1-3DManpb1-ROH","MAN(4_B_)-MAN(3_B_)-MAN(2_B_)-BMA(1_B_)",61.0452,"","",""
"6MU6","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-814508 IN COMPLEX WITH HUMAN ANTIBODIES 3H109L AND 35O22 AT 3.2 ANGSTROM","10.1038/S41467-018-07851-1 ",2.55,47.31,"6mu6_oligo18","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_M_)-MAN(8_M_)-[MAN(10_M_)]-MAN(7_M_)-[MAN(6_M_)-MAN(5_M_)-MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(332_G_)",49.6742,"","",""
"6MU6","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-814508 IN COMPLEX WITH HUMAN ANTIBODIES 3H109L AND 35O22 AT 3.2 ANGSTROM","10.1038/S41467-018-07851-1 ",2.55,47.31,"6mu6_oligo10","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_A_)-MAN(4_A_)-[MAN(6_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(88_G_)",58.003,"","",""
"6MU7","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-818251 IN COMPLEX WITH HUMAN ANTIBODIES 3H109L AND 35O22 AT 3.1 ANGSTROM","10.1038/S41467-018-07851-1 ",2.5,39.32,"6mu7_oligo19","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_K_)-MAN(8_K_)-[MAN(10_K_)]-MAN(7_K_)-[MAN(6_K_)-MAN(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(332_G_)",43.4599,"","",""
"6MU7","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-818251 IN COMPLEX WITH HUMAN ANTIBODIES 3H109L AND 35O22 AT 3.1 ANGSTROM","10.1038/S41467-018-07851-1 ",2.5,39.32,"6mu7_oligo9","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_A_)-MAN(4_A_)-[MAN(6_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(88_G_)",45.1736,"","",""
"6MU8","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-386150 IN COMPLEX WITH HUMAN ANTIBODIES 3H109L AND 35O22 AT 3.5 ANGSTROM","10.1038/S41467-018-07851-1 ",2.99,55.65,"6mu8_oligo17","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_K_)-MAN(8_K_)-[MAN(10_K_)]-MAN(7_K_)-[MAN(6_K_)-MAN(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(332_G_)",56.1078,"","",""
"6MU8","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-386150 IN COMPLEX WITH HUMAN ANTIBODIES 3H109L AND 35O22 AT 3.5 ANGSTROM","10.1038/S41467-018-07851-1 ",2.99,55.65,"6mu8_oligo7","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_A_)-MAN(4_A_)-[MAN(6_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(88_G_)",66.193,"","",""
"6MUB","ANTI-HIV-1 FAB 2G12 + MAN5 RE-REFINEMENT","10.1073/PNAS.0505763102 ",2.5,0,"6mub_oligo1","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpb1-ROH","MAN(5_A_)-MAN(4_A_)-[MAN(3_A_)-MAN(2_A_)]-BMA(1_A_)",89.7853,"","",""
"6MUB","ANTI-HIV-1 FAB 2G12 + MAN5 RE-REFINEMENT","10.1073/PNAS.0505763102 ",2.5,0,"6mub_oligo2","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpb1-ROH","MAN(5_B_)-MAN(4_B_)-[MAN(3_B_)-MAN(2_B_)]-BMA(1_B_)",90.4504,"","",""
"6MUF","CRYSTAL STRUCTURE OF HIV-1 B41 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH HUMAN ANTIBODIES 3H109L AND 35O22 AT 3.4 ANGSTROM","10.1038/S41467-018-07851-1 ",2.91,51.2,"6muf_oligo4","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_A_)-MAN(4_A_)-[MAN(6_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(88_G_)",59.9621,"","",""
"6MUF","CRYSTAL STRUCTURE OF HIV-1 B41 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH HUMAN ANTIBODIES 3H109L AND 35O22 AT 3.4 ANGSTROM","10.1038/S41467-018-07851-1 ",2.91,51.2,"6muf_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_I_)-MAN(8_I_)-[MAN(10_I_)]-MAN(7_I_)-[MAN(6_I_)-MAN(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(332_G_)",69.205,"","",""
"6MUG","CRYSTAL STRUCTURE OF HIV-1 B41 SOSIP.664 PREFUSION ENV TRIMER BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-386150 IN COMPLEX WITH HUMAN ANTIBODIES 3H109L AND 35O22 AT 3.8 ANGSTROM","10.1038/S41467-018-07851-1 ",2.95,50.04,"6mug_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_I_)-MAN(8_I_)-[MAN(10_I_)]-MAN(7_I_)-[MAN(6_I_)-MAN(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(332_G_)",70.4369,"","",""
"6MUG","CRYSTAL STRUCTURE OF HIV-1 B41 SOSIP.664 PREFUSION ENV TRIMER BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-386150 IN COMPLEX WITH HUMAN ANTIBODIES 3H109L AND 35O22 AT 3.8 ANGSTROM","10.1038/S41467-018-07851-1 ",2.95,50.04,"6mug_oligo5","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_A_)-MAN(4_A_)-[MAN(6_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(88_G_)",59.7148,"","",""
"6MYY","GERMLINE VRC01 ANTIBODY RECOGNITION OF A MODIFIED CLADE C HIV-1 ENVELOPE TRIMER, 3 FABS BOUND, SHARPENED MAP","10.7554/ELIFE.37688 ",3.8,0,"6myy_oligo28","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_h_)-MAN(4_h_)-BMA(3_h_)-NAG(2_h_)-NAG(1_h_)-ASN(386_B_)",115.315,"","",""
"6MYY","GERMLINE VRC01 ANTIBODY RECOGNITION OF A MODIFIED CLADE C HIV-1 ENVELOPE TRIMER, 3 FABS BOUND, SHARPENED MAP","10.7554/ELIFE.37688 ",3.8,0,"6myy_oligo2","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-MAN(4_M_)-[MAN(6_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(197_A_)",105.712,"","",""
"6MYY","GERMLINE VRC01 ANTIBODY RECOGNITION OF A MODIFIED CLADE C HIV-1 ENVELOPE TRIMER, 3 FABS BOUND, SHARPENED MAP","10.7554/ELIFE.37688 ",3.8,0,"6myy_oligo35","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_o_)-MAN(4_o_)-[MAN(6_o_)]-BMA(3_o_)-NAG(2_o_)-NAG(1_o_)-ASN(197_E_)",105.712,"","",""
"6MYY","GERMLINE VRC01 ANTIBODY RECOGNITION OF A MODIFIED CLADE C HIV-1 ENVELOPE TRIMER, 3 FABS BOUND, SHARPENED MAP","10.7554/ELIFE.37688 ",3.8,0,"6myy_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(156_A_)",116.689,"","",""
"6MYY","GERMLINE VRC01 ANTIBODY RECOGNITION OF A MODIFIED CLADE C HIV-1 ENVELOPE TRIMER, 3 FABS BOUND, SHARPENED MAP","10.7554/ELIFE.37688 ",3.8,0,"6myy_oligo19","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_a_)-MAN(4_a_)-[MAN(6_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(197_B_)",105.712,"","",""
"6MYY","GERMLINE VRC01 ANTIBODY RECOGNITION OF A MODIFIED CLADE C HIV-1 ENVELOPE TRIMER, 3 FABS BOUND, SHARPENED MAP","10.7554/ELIFE.37688 ",3.8,0,"6myy_oligo21","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_c_)-MAN(6_c_)-[MAN(5_c_)-MAN(4_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(262_B_)",111.412,"","",""
"6MYY","GERMLINE VRC01 ANTIBODY RECOGNITION OF A MODIFIED CLADE C HIV-1 ENVELOPE TRIMER, 3 FABS BOUND, SHARPENED MAP","10.7554/ELIFE.37688 ",3.8,0,"6myy_oligo42","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_v_)-MAN(4_v_)-BMA(3_v_)-NAG(2_v_)-NAG(1_v_)-ASN(386_E_)",115.315,"","",""
"6MYY","GERMLINE VRC01 ANTIBODY RECOGNITION OF A MODIFIED CLADE C HIV-1 ENVELOPE TRIMER, 3 FABS BOUND, SHARPENED MAP","10.7554/ELIFE.37688 ",3.8,0,"6myy_oligo26","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_f_)-BMA(3_f_)-NAG(2_f_)-NAG(1_f_)-ASN(332_B_)",118.978,"","",""
"6MYY","GERMLINE VRC01 ANTIBODY RECOGNITION OF A MODIFIED CLADE C HIV-1 ENVELOPE TRIMER, 3 FABS BOUND, SHARPENED MAP","10.7554/ELIFE.37688 ",3.8,0,"6myy_oligo40","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_t_)-BMA(3_t_)-NAG(2_t_)-NAG(1_t_)-ASN(332_E_)",118.978,"","",""
"6MYY","GERMLINE VRC01 ANTIBODY RECOGNITION OF A MODIFIED CLADE C HIV-1 ENVELOPE TRIMER, 3 FABS BOUND, SHARPENED MAP","10.7554/ELIFE.37688 ",3.8,0,"6myy_oligo37","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_q_)-MAN(6_q_)-[MAN(5_q_)-MAN(4_q_)]-BMA(3_q_)-NAG(2_q_)-NAG(1_q_)-ASN(262_E_)",111.412,"","",""
"6MYY","GERMLINE VRC01 ANTIBODY RECOGNITION OF A MODIFIED CLADE C HIV-1 ENVELOPE TRIMER, 3 FABS BOUND, SHARPENED MAP","10.7554/ELIFE.37688 ",3.8,0,"6myy_oligo34","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_n_)-[MAN(4_n_)]-BMA(3_n_)-NAG(2_n_)-NAG(1_n_)-ASN(156_E_)",116.689,"","",""
"6MYY","GERMLINE VRC01 ANTIBODY RECOGNITION OF A MODIFIED CLADE C HIV-1 ENVELOPE TRIMER, 3 FABS BOUND, SHARPENED MAP","10.7554/ELIFE.37688 ",3.8,0,"6myy_oligo18","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Z_)-[MAN(4_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(156_B_)",116.689,"","",""
"6MYY","GERMLINE VRC01 ANTIBODY RECOGNITION OF A MODIFIED CLADE C HIV-1 ENVELOPE TRIMER, 3 FABS BOUND, SHARPENED MAP","10.7554/ELIFE.37688 ",3.8,0,"6myy_oligo10","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_R_)-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(332_A_)",118.978,"","",""
"6MYY","GERMLINE VRC01 ANTIBODY RECOGNITION OF A MODIFIED CLADE C HIV-1 ENVELOPE TRIMER, 3 FABS BOUND, SHARPENED MAP","10.7554/ELIFE.37688 ",3.8,0,"6myy_oligo12","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_T_)-MAN(4_T_)-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(386_A_)",115.315,"","",""
"6MYY","GERMLINE VRC01 ANTIBODY RECOGNITION OF A MODIFIED CLADE C HIV-1 ENVELOPE TRIMER, 3 FABS BOUND, SHARPENED MAP","10.7554/ELIFE.37688 ",3.8,0,"6myy_oligo23","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_O_)-MAN(6_O_)-[MAN(5_O_)-MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(262_A_)",111.412,"","",""
"6MZJ","GERMLINE VRC01 ANTIBODY RECOGNITION OF A MODIFIED CLADE C HIV-1 ENVELOPE TRIMER, 2 FABS BOUND, SHARPENED MAP","10.7554/ELIFE.37688 ",4.8,0,"6mzj_oligo6","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_a_)-MAN(6_a_)-[MAN(5_a_)-MAN(4_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(262_B_)",111.412,"","",""
"6MZJ","GERMLINE VRC01 ANTIBODY RECOGNITION OF A MODIFIED CLADE C HIV-1 ENVELOPE TRIMER, 2 FABS BOUND, SHARPENED MAP","10.7554/ELIFE.37688 ",4.8,0,"6mzj_oligo17","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_l_)-[MAN(4_l_)]-BMA(3_l_)-NAG(2_l_)-NAG(1_l_)-ASN(156_E_)",116.689,"","",""
"6MZJ","GERMLINE VRC01 ANTIBODY RECOGNITION OF A MODIFIED CLADE C HIV-1 ENVELOPE TRIMER, 2 FABS BOUND, SHARPENED MAP","10.7554/ELIFE.37688 ",4.8,0,"6mzj_oligo21","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_M_)-MAN(6_M_)-[MAN(5_M_)-MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(262_A_)",111.412,"","",""
"6MZJ","GERMLINE VRC01 ANTIBODY RECOGNITION OF A MODIFIED CLADE C HIV-1 ENVELOPE TRIMER, 2 FABS BOUND, SHARPENED MAP","10.7554/ELIFE.37688 ",4.8,0,"6mzj_oligo24","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_P_)-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(332_A_)",118.978,"","",""
"6MZJ","GERMLINE VRC01 ANTIBODY RECOGNITION OF A MODIFIED CLADE C HIV-1 ENVELOPE TRIMER, 2 FABS BOUND, SHARPENED MAP","10.7554/ELIFE.37688 ",4.8,0,"6mzj_oligo36","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_o_)-MAN(6_o_)-[MAN(5_o_)-MAN(4_o_)]-BMA(3_o_)-NAG(2_o_)-NAG(1_o_)-ASN(262_E_)",111.412,"","",""
"6MZJ","GERMLINE VRC01 ANTIBODY RECOGNITION OF A MODIFIED CLADE C HIV-1 ENVELOPE TRIMER, 2 FABS BOUND, SHARPENED MAP","10.7554/ELIFE.37688 ",4.8,0,"6mzj_oligo33","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Y_)-MAN(4_Y_)-[MAN(6_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(197_B_)",105.712,"","",""
"6MZJ","GERMLINE VRC01 ANTIBODY RECOGNITION OF A MODIFIED CLADE C HIV-1 ENVELOPE TRIMER, 2 FABS BOUND, SHARPENED MAP","10.7554/ELIFE.37688 ",4.8,0,"6mzj_oligo11","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_f_)-MAN(4_f_)-BMA(3_f_)-NAG(2_f_)-NAG(1_f_)-ASN(386_B_)",115.315,"","",""
"6MZJ","GERMLINE VRC01 ANTIBODY RECOGNITION OF A MODIFIED CLADE C HIV-1 ENVELOPE TRIMER, 2 FABS BOUND, SHARPENED MAP","10.7554/ELIFE.37688 ",4.8,0,"6mzj_oligo41","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_t_)-BMA(3_t_)-NAG(2_t_)-NAG(1_t_)-ASN(386_E_)",105.786,"","",""
"6MZJ","GERMLINE VRC01 ANTIBODY RECOGNITION OF A MODIFIED CLADE C HIV-1 ENVELOPE TRIMER, 2 FABS BOUND, SHARPENED MAP","10.7554/ELIFE.37688 ",4.8,0,"6mzj_oligo39","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_r_)-BMA(3_r_)-NAG(2_r_)-NAG(1_r_)-ASN(332_E_)",118.978,"","",""
"6MZJ","GERMLINE VRC01 ANTIBODY RECOGNITION OF A MODIFIED CLADE C HIV-1 ENVELOPE TRIMER, 2 FABS BOUND, SHARPENED MAP","10.7554/ELIFE.37688 ",4.8,0,"6mzj_oligo1","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-MAN(4_J_)-[MAN(6_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(197_A_)",105.712,"","",""
"6MZJ","GERMLINE VRC01 ANTIBODY RECOGNITION OF A MODIFIED CLADE C HIV-1 ENVELOPE TRIMER, 2 FABS BOUND, SHARPENED MAP","10.7554/ELIFE.37688 ",4.8,0,"6mzj_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(156_A_)",116.689,"","",""
"6MZJ","GERMLINE VRC01 ANTIBODY RECOGNITION OF A MODIFIED CLADE C HIV-1 ENVELOPE TRIMER, 2 FABS BOUND, SHARPENED MAP","10.7554/ELIFE.37688 ",4.8,0,"6mzj_oligo9","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_d_)-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(332_B_)",118.978,"","",""
"6MZJ","GERMLINE VRC01 ANTIBODY RECOGNITION OF A MODIFIED CLADE C HIV-1 ENVELOPE TRIMER, 2 FABS BOUND, SHARPENED MAP","10.7554/ELIFE.37688 ",4.8,0,"6mzj_oligo26","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_R_)-MAN(4_R_)-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(386_A_)",115.315,"","",""
"6MZJ","GERMLINE VRC01 ANTIBODY RECOGNITION OF A MODIFIED CLADE C HIV-1 ENVELOPE TRIMER, 2 FABS BOUND, SHARPENED MAP","10.7554/ELIFE.37688 ",4.8,0,"6mzj_oligo32","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_X_)-[MAN(4_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(156_B_)",116.689,"","",""
"6N1B","CRYSTAL STRUCTURE OF AN N-ACETYLGALACTOSAMINE DEACETYLASE FROM F. PLAUTII IN COMPLEX WITH BLOOD GROUP B TRISACCHARIDE","10.1038/S41564-019-0469-7 ",1.3,13.37,"6n1b_oligo1","LFucpa1-2[DGalpa1-3]DGalpb1-ROH","GLA(3_B_)-[FUC(2_B_)]-GAL(1_B_)",20.2618,"","",""
"6N2X","ANTI-HIV-1 FAB 2G12 + MAN9 RE-REFINEMENT","10.1126/SCIENCE.1083182 ",3,0,"6n2x_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(11_A_)-MAN(10_A_)-[MAN(9_A_)-MAN(8_A_)]-MAN(7_A_)-[MAN(6_A_)-MAN(5_A_)-MAN(4_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)",104.288,"","",""
"6N2X","ANTI-HIV-1 FAB 2G12 + MAN9 RE-REFINEMENT","10.1126/SCIENCE.1083182 ",3,0,"6n2x_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(11_B_)-MAN(10_B_)-[MAN(9_B_)-MAN(8_B_)]-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)",121.327,"","",""
"6N41","CRYSTAL STRUCTURE OF INVBM.18715.A.KN11: INFLUENZA HEMAGGLUTININ FROM STRAIN A/NETHERLANDS/002P1/1951","10.1038/S41598-023-33529-W ",2.5,61.39,"6n41_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(162_A_)",97.5487,"","",""
"6N41","CRYSTAL STRUCTURE OF INVBM.18715.A.KN11: INFLUENZA HEMAGGLUTININ FROM STRAIN A/NETHERLANDS/002P1/1951","10.1038/S41598-023-33529-W ",2.5,61.39,"6n41_oligo6","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-MAN(4_J_)-[MAN(6_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(162_C_)",103.603,"","",""
"6N4D","THE CRYSTAL STRUCTURE OF NEURAMINDASE FROM A/CANINE/IL/11613/2015 (H3N2) INFLUENZA VIRUS.","10.1093/INFDIS/JIW620 ",1.8,28.46,"6n4d_oligo6","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_J_)-[MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(200_C_)",38.3556,"","",""
"6N4D","THE CRYSTAL STRUCTURE OF NEURAMINDASE FROM A/CANINE/IL/11613/2015 (H3N2) INFLUENZA VIRUS.","10.1093/INFDIS/JIW620 ",1.8,28.46,"6n4d_oligo2","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-[MAN(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(200_B_)",39.4536,"","",""
"6N4D","THE CRYSTAL STRUCTURE OF NEURAMINDASE FROM A/CANINE/IL/11613/2015 (H3N2) INFLUENZA VIRUS.","10.1093/INFDIS/JIW620 ",1.8,28.46,"6n4d_oligo8","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_L_)-[MAN(5_L_)-MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(200_D_)",32.7112,"","",""
"6N4D","THE CRYSTAL STRUCTURE OF NEURAMINDASE FROM A/CANINE/IL/11613/2015 (H3N2) INFLUENZA VIRUS.","10.1093/INFDIS/JIW620 ",1.8,28.46,"6n4d_oligo4","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(200_A_)",32.0236,"","",""
"6N4Y","METABOTROPIC GLUTAMATE RECEPTOR 5 EXTRACELLULAR DOMAIN WITH NB43","10.1038/S41586-019-0881-4 ",3.26,79.14,"6n4y_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(7_J_)-[MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)]-[FUC(6_J_)]-NAG(1_J_)-ASN(445_B_)",125.693,"","",""
"6N4Y","METABOTROPIC GLUTAMATE RECEPTOR 5 EXTRACELLULAR DOMAIN WITH NB43","10.1038/S41586-019-0881-4 ",3.26,79.14,"6n4y_oligo3","DManpa1-3DManpb1-3DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_K_)-[MAN(4_K_)-BMA(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(445_C_)",139.039,"","",""
"6N4Y","METABOTROPIC GLUTAMATE RECEPTOR 5 EXTRACELLULAR DOMAIN WITH NB43","10.1038/S41586-019-0881-4 ",3.26,79.14,"6n4y_oligo4","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(6_L_)-[MAN(4_L_)-BMA(3_L_)-NAG(2_L_)]-[FUC(5_L_)]-NAG(1_L_)-ASN(378_D_)",103.711,"","",""
"6N6B","THE COMPLEX CRYSTAL STRUCTURE OF NEURAMINIDASE FROM A/MINNESOTA/11/2010 WITH B10 ANTIBODY.","10.1038/S41564-019-0522-6 ",2.3,35.45,"6n6b_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",33.1545,"","",""
"6N9T","STRUCTURE OF A PEPTIDE-BASED PHOTO-AFFINITY CROSS-LINKER WITH HERCEPTIN FC","10.1021/ACS.BIOCONJCHEM.8B00809 ",2.58,0,"6n9t_oligo1","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_D_)-[NAG(5_D_)-MAN(4_D_)-[MAN(6_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",56.9825,"","",""
"6N9T","STRUCTURE OF A PEPTIDE-BASED PHOTO-AFFINITY CROSS-LINKER WITH HERCEPTIN FC","10.1021/ACS.BIOCONJCHEM.8B00809 ",2.58,0,"6n9t_oligo2","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(7_C_)-[NAG(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",55.6258,"","",""
"6NAE","CRYSTAL STRUCTURE OF EBOLA ZAIRE GP PROTEIN WITH BOUND ARN0074898","10.1021/ACSMEDCHEMLETT.0C00025 ",2.75,65.3,"6nae_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(563_B_)",100.694,"","",""
"6NAJ","INTEGRIN ALPHAVBETA3 ECTODOMAIN BOUND TO HR10 VARIANT OF THE 10TH DOMAIN OF FIBRONECTIN.","10.1038/S41467-019-13928-2 ",3.1,0,"6naj_oligo4","DManpa1-4DManpb1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-BMA(4_E_)-[MAN(6_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(266_A_)",68.6142,"","",""
"6NB3","MERS-COV COMPLEX WITH HUMAN NEUTRALIZING LCA60 ANTIBODY FAB FRAGMENT (STATE 1)","10.1016/J.CELL.2018.12.028 ",3.5,0,"6nb3_oligo36","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_q_)-MAN(4_q_)-BMA(3_q_)-NAG(2_q_)-NAG(1_q_)-ASN(222_C_)",137.57,"","",""
"6NB3","MERS-COV COMPLEX WITH HUMAN NEUTRALIZING LCA60 ANTIBODY FAB FRAGMENT (STATE 1)","10.1016/J.CELL.2018.12.028 ",3.5,0,"6nb3_oligo19","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Z_)-[MAN(5_Z_)-MAN(4_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(125_B_)",56.8712,"","",""
"6NB3","MERS-COV COMPLEX WITH HUMAN NEUTRALIZING LCA60 ANTIBODY FAB FRAGMENT (STATE 1)","10.1016/J.CELL.2018.12.028 ",3.5,0,"6nb3_oligo5","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_P_)-[MAN(5_P_)-MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(410_A_)",66.1199,"","",""
"6NB3","MERS-COV COMPLEX WITH HUMAN NEUTRALIZING LCA60 ANTIBODY FAB FRAGMENT (STATE 1)","10.1016/J.CELL.2018.12.028 ",3.5,0,"6nb3_oligo12","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_W_)-[MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(1213_A_)",61.0153,"","",""
"6NB3","MERS-COV COMPLEX WITH HUMAN NEUTRALIZING LCA60 ANTIBODY FAB FRAGMENT (STATE 1)","10.1016/J.CELL.2018.12.028 ",3.5,0,"6nb3_oligo6","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_Q_)-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(487_A_)",95.5121,"","",""
"6NB3","MERS-COV COMPLEX WITH HUMAN NEUTRALIZING LCA60 ANTIBODY FAB FRAGMENT (STATE 1)","10.1016/J.CELL.2018.12.028 ",3.5,0,"6nb3_oligo33","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_n_)-[MAN(5_n_)-MAN(4_n_)]-BMA(3_n_)-NAG(2_n_)-NAG(1_n_)-ASN(125_C_)",114.318,"","",""
"6NB3","MERS-COV COMPLEX WITH HUMAN NEUTRALIZING LCA60 ANTIBODY FAB FRAGMENT (STATE 1)","10.1016/J.CELL.2018.12.028 ",3.5,0,"6nb3_oligo22","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_c_)-[MAN(5_c_)-MAN(4_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(222_B_)",62.1936,"","",""
"6NB3","MERS-COV COMPLEX WITH HUMAN NEUTRALIZING LCA60 ANTIBODY FAB FRAGMENT (STATE 1)","10.1016/J.CELL.2018.12.028 ",3.5,0,"6nb3_oligo44","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_y_)-[MAN(4_y_)]-BMA(3_y_)-NAG(2_y_)-NAG(1_y_)-ASN(1213_C_)",64.9509,"","",""
"6NB3","MERS-COV COMPLEX WITH HUMAN NEUTRALIZING LCA60 ANTIBODY FAB FRAGMENT (STATE 1)","10.1016/J.CELL.2018.12.028 ",3.5,0,"6nb3_oligo3","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_I_)-[MAN(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(125_A_)",51.1909,"","",""
"6NB3","MERS-COV COMPLEX WITH HUMAN NEUTRALIZING LCA60 ANTIBODY FAB FRAGMENT (STATE 1)","10.1016/J.CELL.2018.12.028 ",3.5,0,"6nb3_oligo2","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_K_)-[MAN(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(166_A_)",65.7191,"","",""
"6NB3","MERS-COV COMPLEX WITH HUMAN NEUTRALIZING LCA60 ANTIBODY FAB FRAGMENT (STATE 1)","10.1016/J.CELL.2018.12.028 ",3.5,0,"6nb3_oligo23","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_d_)-[MAN(4_d_)]-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(236_B_)",84.0842,"","",""
"6NB3","MERS-COV COMPLEX WITH HUMAN NEUTRALIZING LCA60 ANTIBODY FAB FRAGMENT (STATE 1)","10.1016/J.CELL.2018.12.028 ",3.5,0,"6nb3_oligo16","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(236_A_)",79.2451,"","",""
"6NB3","MERS-COV COMPLEX WITH HUMAN NEUTRALIZING LCA60 ANTIBODY FAB FRAGMENT (STATE 1)","10.1016/J.CELL.2018.12.028 ",3.5,0,"6nb3_oligo15","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_M_)-[MAN(5_M_)-MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(222_A_)",58.4609,"","",""
"6NB3","MERS-COV COMPLEX WITH HUMAN NEUTRALIZING LCA60 ANTIBODY FAB FRAGMENT (STATE 1)","10.1016/J.CELL.2018.12.028 ",3.5,0,"6nb3_oligo30","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_k_)-[MAN(4_k_)]-BMA(3_k_)-NAG(2_k_)-NAG(1_k_)-ASN(1213_B_)",61.632,"","",""
"6NB3","MERS-COV COMPLEX WITH HUMAN NEUTRALIZING LCA60 ANTIBODY FAB FRAGMENT (STATE 1)","10.1016/J.CELL.2018.12.028 ",3.5,0,"6nb3_oligo21","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_b_)-[MAN(5_b_)-MAN(4_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(166_B_)",74.7952,"","",""
"6NB4","MERS-COV S COMPLEX WITH HUMAN NEUTRALIZING LCA60 ANTIBODY FAB FRAGMENT (STATE 2)","10.1016/J.CELL.2018.12.028 ",3.6,0,"6nb4_oligo30","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_i_)-[MAN(4_i_)]-BMA(3_i_)-NAG(2_i_)-NAG(1_i_)-ASN(125_C_)",73.4373,"","",""
"6NB4","MERS-COV S COMPLEX WITH HUMAN NEUTRALIZING LCA60 ANTIBODY FAB FRAGMENT (STATE 2)","10.1016/J.CELL.2018.12.028 ",3.6,0,"6nb4_oligo38","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_q_)-[MAN(4_q_)]-BMA(3_q_)-NAG(2_q_)-NAG(1_q_)-ASN(1213_C_)",41.0904,"","",""
"6NB4","MERS-COV S COMPLEX WITH HUMAN NEUTRALIZING LCA60 ANTIBODY FAB FRAGMENT (STATE 2)","10.1016/J.CELL.2018.12.028 ",3.6,0,"6nb4_oligo27","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_f_)-BMA(3_f_)-NAG(2_f_)-NAG(1_f_)-ASN(1213_B_)",35.548,"","",""
"6NB4","MERS-COV S COMPLEX WITH HUMAN NEUTRALIZING LCA60 ANTIBODY FAB FRAGMENT (STATE 2)","10.1016/J.CELL.2018.12.028 ",3.6,0,"6nb4_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_R_)-[MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(1213_A_)",44.9311,"","",""
"6NB4","MERS-COV S COMPLEX WITH HUMAN NEUTRALIZING LCA60 ANTIBODY FAB FRAGMENT (STATE 2)","10.1016/J.CELL.2018.12.028 ",3.6,0,"6nb4_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(222_A_)",98.2247,"","",""
"6NB4","MERS-COV S COMPLEX WITH HUMAN NEUTRALIZING LCA60 ANTIBODY FAB FRAGMENT (STATE 2)","10.1016/J.CELL.2018.12.028 ",3.6,0,"6nb4_oligo18","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_W_)-[MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(166_B_)",109.145,"","",""
"6NB4","MERS-COV S COMPLEX WITH HUMAN NEUTRALIZING LCA60 ANTIBODY FAB FRAGMENT (STATE 2)","10.1016/J.CELL.2018.12.028 ",3.6,0,"6nb4_oligo9","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_U_)-[MAN(5_U_)-MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(125_B_)",49.4495,"","",""
"6NB4","MERS-COV S COMPLEX WITH HUMAN NEUTRALIZING LCA60 ANTIBODY FAB FRAGMENT (STATE 2)","10.1016/J.CELL.2018.12.028 ",3.6,0,"6nb4_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(125_A_)",75.154,"","",""
"6NB4","MERS-COV S COMPLEX WITH HUMAN NEUTRALIZING LCA60 ANTIBODY FAB FRAGMENT (STATE 2)","10.1016/J.CELL.2018.12.028 ",3.6,0,"6nb4_oligo19","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_X_)-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(222_B_)",58.0273,"","",""
"6NB6","SARS-COV COMPLEX WITH HUMAN NEUTRALIZING S230 ANTIBODY FAB FRAGMENT (STATE 1)","10.1016/J.CELL.2018.12.028 ",4.2,0,"6nb6_oligo21","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_b_)-[MAN(4_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(783_B_)",80.1244,"","",""
"6NB6","SARS-COV COMPLEX WITH HUMAN NEUTRALIZING S230 ANTIBODY FAB FRAGMENT (STATE 1)","10.1016/J.CELL.2018.12.028 ",4.2,0,"6nb6_oligo19","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_R_)-[MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(1116_A_)",110.488,"","",""
"6NB6","SARS-COV COMPLEX WITH HUMAN NEUTRALIZING S230 ANTIBODY FAB FRAGMENT (STATE 1)","10.1016/J.CELL.2018.12.028 ",4.2,0,"6nb6_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(691_A_)",98.4933,"","",""
"6NB6","SARS-COV COMPLEX WITH HUMAN NEUTRALIZING S230 ANTIBODY FAB FRAGMENT (STATE 1)","10.1016/J.CELL.2018.12.028 ",4.2,0,"6nb6_oligo35","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_p_)-[MAN(4_p_)]-BMA(3_p_)-NAG(2_p_)-NAG(1_p_)-ASN(783_C_)",81.8096,"","",""
"6NB6","SARS-COV COMPLEX WITH HUMAN NEUTRALIZING S230 ANTIBODY FAB FRAGMENT (STATE 1)","10.1016/J.CELL.2018.12.028 ",4.2,0,"6nb6_oligo17","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_P_)-[MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(1056_A_)",100.473,"","",""
"6NB6","SARS-COV COMPLEX WITH HUMAN NEUTRALIZING S230 ANTIBODY FAB FRAGMENT (STATE 1)","10.1016/J.CELL.2018.12.028 ",4.2,0,"6nb6_oligo37","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_r_)-[MAN(4_r_)]-BMA(3_r_)-NAG(2_r_)-NAG(1_r_)-ASN(1080_C_)",95.2198,"","",""
"6NB6","SARS-COV COMPLEX WITH HUMAN NEUTRALIZING S230 ANTIBODY FAB FRAGMENT (STATE 1)","10.1016/J.CELL.2018.12.028 ",4.2,0,"6nb6_oligo16","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(783_A_)",85.9025,"","",""
"6NB6","SARS-COV COMPLEX WITH HUMAN NEUTRALIZING S230 ANTIBODY FAB FRAGMENT (STATE 1)","10.1016/J.CELL.2018.12.028 ",4.2,0,"6nb6_oligo18","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Q_)-[MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(1080_A_)",103.094,"","",""
"6NB6","SARS-COV COMPLEX WITH HUMAN NEUTRALIZING S230 ANTIBODY FAB FRAGMENT (STATE 1)","10.1016/J.CELL.2018.12.028 ",4.2,0,"6nb6_oligo24","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_e_)-[MAN(4_e_)]-BMA(3_e_)-NAG(2_e_)-NAG(1_e_)-ASN(1116_B_)",108.226,"","",""
"6NB7","SARS-COV COMPLEX WITH HUMAN NEUTRALIZING S230 ANTIBODY FAB FRAGMENT (STATE 2)","10.1016/J.CELL.2018.12.028 ",4.5,0,"6nb7_oligo36","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_s_)-BMA(3_s_)-NAG(2_s_)-NAG(1_s_)-ASN(1080_C_)",103.027,"","",""
"6NB7","SARS-COV COMPLEX WITH HUMAN NEUTRALIZING S230 ANTIBODY FAB FRAGMENT (STATE 2)","10.1016/J.CELL.2018.12.028 ",4.5,0,"6nb7_oligo17","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_T_)-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(1080_A_)",117.533,"","",""
"6NB7","SARS-COV COMPLEX WITH HUMAN NEUTRALIZING S230 ANTIBODY FAB FRAGMENT (STATE 2)","10.1016/J.CELL.2018.12.028 ",4.5,0,"6nb7_oligo21","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_d_)-[MAN(4_d_)]-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(783_B_)",90.9585,"","",""
"6NB7","SARS-COV COMPLEX WITH HUMAN NEUTRALIZING S230 ANTIBODY FAB FRAGMENT (STATE 2)","10.1016/J.CELL.2018.12.028 ",4.5,0,"6nb7_oligo13","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_P_)-[MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(691_A_)",111.26,"","",""
"6NB7","SARS-COV COMPLEX WITH HUMAN NEUTRALIZING S230 ANTIBODY FAB FRAGMENT (STATE 2)","10.1016/J.CELL.2018.12.028 ",4.5,0,"6nb7_oligo15","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_R_)-[MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(783_A_)",90.3866,"","",""
"6NB7","SARS-COV COMPLEX WITH HUMAN NEUTRALIZING S230 ANTIBODY FAB FRAGMENT (STATE 2)","10.1016/J.CELL.2018.12.028 ",4.5,0,"6nb7_oligo34","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_q_)-[MAN(4_q_)]-BMA(3_q_)-NAG(2_q_)-NAG(1_q_)-ASN(783_C_)",92.852,"","",""
"6NB7","SARS-COV COMPLEX WITH HUMAN NEUTRALIZING S230 ANTIBODY FAB FRAGMENT (STATE 2)","10.1016/J.CELL.2018.12.028 ",4.5,0,"6nb7_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_U_)-[MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(1116_A_)",131.183,"","",""
"6NB7","SARS-COV COMPLEX WITH HUMAN NEUTRALIZING S230 ANTIBODY FAB FRAGMENT (STATE 2)","10.1016/J.CELL.2018.12.028 ",4.5,0,"6nb7_oligo16","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(1056_A_)",118.356,"","",""
"6NC2","AMC011 V4.2 SOSIP ENV TRIMER IN COMPLEX WITH FUSION PEPTIDE TARGETING ANTIBODY ACS202 FRAGMENT ANTIGEN BINDING","10.1016/J.CHOM.2019.04.011 ",5.2,0.000748774,"6nc2_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_j_)-[MAN(4_j_)]-BMA(3_j_)-NAG(2_j_)-NAG(1_j_)-ASN(262_D_)",191.072,"","",""
"6NC2","AMC011 V4.2 SOSIP ENV TRIMER IN COMPLEX WITH FUSION PEPTIDE TARGETING ANTIBODY ACS202 FRAGMENT ANTIGEN BINDING","10.1016/J.CHOM.2019.04.011 ",5.2,0.000748774,"6nc2_oligo16","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_a_)-[MAN(5_a_)-MAN(4_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(241_A_)",185.717,"","",""
"6NC2","AMC011 V4.2 SOSIP ENV TRIMER IN COMPLEX WITH FUSION PEPTIDE TARGETING ANTIBODY ACS202 FRAGMENT ANTIGEN BINDING","10.1016/J.CHOM.2019.04.011 ",5.2,0.000748774,"6nc2_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_b_)-[MAN(4_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(262_A_)",191.072,"","",""
"6NC2","AMC011 V4.2 SOSIP ENV TRIMER IN COMPLEX WITH FUSION PEPTIDE TARGETING ANTIBODY ACS202 FRAGMENT ANTIGEN BINDING","10.1016/J.CHOM.2019.04.011 ",5.2,0.000748774,"6nc2_oligo6","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_m_)-[MAN(5_m_)-MAN(4_m_)]-BMA(3_m_)-NAG(2_m_)-NAG(1_m_)-ASN(241_E_)",185.717,"","",""
"6NC2","AMC011 V4.2 SOSIP ENV TRIMER IN COMPLEX WITH FUSION PEPTIDE TARGETING ANTIBODY ACS202 FRAGMENT ANTIGEN BINDING","10.1016/J.CHOM.2019.04.011 ",5.2,0.000748774,"6nc2_oligo21","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_s_)-[MAN(4_s_)]-BMA(3_s_)-NAG(2_s_)-NAG(1_s_)-ASN(88_G_)",143.782,"","",""
"6NC2","AMC011 V4.2 SOSIP ENV TRIMER IN COMPLEX WITH FUSION PEPTIDE TARGETING ANTIBODY ACS202 FRAGMENT ANTIGEN BINDING","10.1016/J.CHOM.2019.04.011 ",5.2,0.000748774,"6nc2_oligo19","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_q_)-[MAN(5_q_)-MAN(4_q_)]-BMA(3_q_)-NAG(2_q_)-NAG(1_q_)-ASN(241_F_)",185.717,"","",""
"6NC2","AMC011 V4.2 SOSIP ENV TRIMER IN COMPLEX WITH FUSION PEPTIDE TARGETING ANTIBODY ACS202 FRAGMENT ANTIGEN BINDING","10.1016/J.CHOM.2019.04.011 ",5.2,0.000748774,"6nc2_oligo23","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_u_)-[MAN(5_u_)-MAN(4_u_)]-BMA(3_u_)-NAG(2_u_)-NAG(1_u_)-ASN(241_G_)",185.717,"","",""
"6NC2","AMC011 V4.2 SOSIP ENV TRIMER IN COMPLEX WITH FUSION PEPTIDE TARGETING ANTIBODY ACS202 FRAGMENT ANTIGEN BINDING","10.1016/J.CHOM.2019.04.011 ",5.2,0.000748774,"6nc2_oligo13","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_g_)-[MAN(4_g_)]-BMA(3_g_)-NAG(2_g_)-NAG(1_g_)-ASN(88_D_)",143.782,"","",""
"6NC2","AMC011 V4.2 SOSIP ENV TRIMER IN COMPLEX WITH FUSION PEPTIDE TARGETING ANTIBODY ACS202 FRAGMENT ANTIGEN BINDING","10.1016/J.CHOM.2019.04.011 ",5.2,0.000748774,"6nc2_oligo17","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Y_)-[MAN(4_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(88_A_)",143.782,"","",""
"6NC2","AMC011 V4.2 SOSIP ENV TRIMER IN COMPLEX WITH FUSION PEPTIDE TARGETING ANTIBODY ACS202 FRAGMENT ANTIGEN BINDING","10.1016/J.CHOM.2019.04.011 ",5.2,0.000748774,"6nc2_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_c_)-[MAN(4_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(88_C_)",143.782,"","",""
"6NC2","AMC011 V4.2 SOSIP ENV TRIMER IN COMPLEX WITH FUSION PEPTIDE TARGETING ANTIBODY ACS202 FRAGMENT ANTIGEN BINDING","10.1016/J.CHOM.2019.04.011 ",5.2,0.000748774,"6nc2_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_o_)-[MAN(4_o_)]-BMA(3_o_)-NAG(2_o_)-NAG(1_o_)-ASN(88_F_)",143.782,"","",""
"6NC2","AMC011 V4.2 SOSIP ENV TRIMER IN COMPLEX WITH FUSION PEPTIDE TARGETING ANTIBODY ACS202 FRAGMENT ANTIGEN BINDING","10.1016/J.CHOM.2019.04.011 ",5.2,0.000748774,"6nc2_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_n_)-[MAN(4_n_)]-BMA(3_n_)-NAG(2_n_)-NAG(1_n_)-ASN(262_E_)",191.072,"","",""
"6NC2","AMC011 V4.2 SOSIP ENV TRIMER IN COMPLEX WITH FUSION PEPTIDE TARGETING ANTIBODY ACS202 FRAGMENT ANTIGEN BINDING","10.1016/J.CHOM.2019.04.011 ",5.2,0.000748774,"6nc2_oligo12","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_f_)-[MAN(4_f_)]-BMA(3_f_)-NAG(2_f_)-NAG(1_f_)-ASN(262_C_)",191.072,"","",""
"6NC2","AMC011 V4.2 SOSIP ENV TRIMER IN COMPLEX WITH FUSION PEPTIDE TARGETING ANTIBODY ACS202 FRAGMENT ANTIGEN BINDING","10.1016/J.CHOM.2019.04.011 ",5.2,0.000748774,"6nc2_oligo24","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_v_)-[MAN(4_v_)]-BMA(3_v_)-NAG(2_v_)-NAG(1_v_)-ASN(262_G_)",191.072,"","",""
"6NC2","AMC011 V4.2 SOSIP ENV TRIMER IN COMPLEX WITH FUSION PEPTIDE TARGETING ANTIBODY ACS202 FRAGMENT ANTIGEN BINDING","10.1016/J.CHOM.2019.04.011 ",5.2,0.000748774,"6nc2_oligo20","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_r_)-[MAN(4_r_)]-BMA(3_r_)-NAG(2_r_)-NAG(1_r_)-ASN(262_F_)",191.072,"","",""
"6NC2","AMC011 V4.2 SOSIP ENV TRIMER IN COMPLEX WITH FUSION PEPTIDE TARGETING ANTIBODY ACS202 FRAGMENT ANTIGEN BINDING","10.1016/J.CHOM.2019.04.011 ",5.2,0.000748774,"6nc2_oligo15","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_i_)-[MAN(5_i_)-MAN(4_i_)]-BMA(3_i_)-NAG(2_i_)-NAG(1_i_)-ASN(241_D_)",185.717,"","",""
"6NC2","AMC011 V4.2 SOSIP ENV TRIMER IN COMPLEX WITH FUSION PEPTIDE TARGETING ANTIBODY ACS202 FRAGMENT ANTIGEN BINDING","10.1016/J.CHOM.2019.04.011 ",5.2,0.000748774,"6nc2_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_k_)-[MAN(4_k_)]-BMA(3_k_)-NAG(2_k_)-NAG(1_k_)-ASN(88_E_)",143.782,"","",""
"6NC2","AMC011 V4.2 SOSIP ENV TRIMER IN COMPLEX WITH FUSION PEPTIDE TARGETING ANTIBODY ACS202 FRAGMENT ANTIGEN BINDING","10.1016/J.CHOM.2019.04.011 ",5.2,0.000748774,"6nc2_oligo11","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_e_)-[MAN(5_e_)-MAN(4_e_)]-BMA(3_e_)-NAG(2_e_)-NAG(1_e_)-ASN(241_C_)",185.717,"","",""
"6NF5","BG505 MD64 N332-GT5 SOSIP TRIMER IN COMPLEX WITH BG18-LIKE PRECURSOR HMP1 FRAGMENTANTIGEN BINDING AND BASE-BINDING RM20A3 FRAGMENT ANTIGEN BINDING","10.1126/SCIENCE.AAX4380 ",3.71,"1.08595e-05","6nf5_oligo16","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_h_)-MAN(4_h_)-BMA(3_h_)-NAG(2_h_)-NAG(1_h_)-ASN(262_J_)",80.9129,"","",""
"6NF5","BG505 MD64 N332-GT5 SOSIP TRIMER IN COMPLEX WITH BG18-LIKE PRECURSOR HMP1 FRAGMENTANTIGEN BINDING AND BASE-BINDING RM20A3 FRAGMENT ANTIGEN BINDING","10.1126/SCIENCE.AAX4380 ",3.71,"1.08595e-05","6nf5_oligo6","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_a_)-MAN(4_a_)-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(262_C_)",80.9129,"","",""
"6NF5","BG505 MD64 N332-GT5 SOSIP TRIMER IN COMPLEX WITH BG18-LIKE PRECURSOR HMP1 FRAGMENTANTIGEN BINDING AND BASE-BINDING RM20A3 FRAGMENT ANTIGEN BINDING","10.1126/SCIENCE.AAX4380 ",3.71,"1.08595e-05","6nf5_oligo18","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_j_)-[MAN(5_j_)-MAN(4_j_)]-BMA(3_j_)-NAG(2_j_)-NAG(1_j_)-ASN(332_J_)",76.6965,"","",""
"6NF5","BG505 MD64 N332-GT5 SOSIP TRIMER IN COMPLEX WITH BG18-LIKE PRECURSOR HMP1 FRAGMENTANTIGEN BINDING AND BASE-BINDING RM20A3 FRAGMENT ANTIGEN BINDING","10.1126/SCIENCE.AAX4380 ",3.71,"1.08595e-05","6nf5_oligo8","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_c_)-[MAN(5_c_)-MAN(4_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(332_C_)",76.6965,"","",""
"6NF5","BG505 MD64 N332-GT5 SOSIP TRIMER IN COMPLEX WITH BG18-LIKE PRECURSOR HMP1 FRAGMENTANTIGEN BINDING AND BASE-BINDING RM20A3 FRAGMENT ANTIGEN BINDING","10.1126/SCIENCE.AAX4380 ",3.71,"1.08595e-05","6nf5_oligo3","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_T_)-MAN(4_T_)-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(262_A_)",80.9129,"","",""
"6NF5","BG505 MD64 N332-GT5 SOSIP TRIMER IN COMPLEX WITH BG18-LIKE PRECURSOR HMP1 FRAGMENTANTIGEN BINDING AND BASE-BINDING RM20A3 FRAGMENT ANTIGEN BINDING","10.1126/SCIENCE.AAX4380 ",3.71,"1.08595e-05","6nf5_oligo1","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_V_)-[MAN(5_V_)-MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(332_A_)",76.6965,"","",""
"6NFC","BG505 MD64 N332-GT5 SOSIP TRIMER IN COMPLEX WITH BG18-LIKE PRECURSOR HMP42 FRAGMENTANTIGEN BINDING AND BASE-BINDING RM20A3 FRAGMENT ANTIGEN BINDING","10.1126/SCIENCE.AAX4380 ",3.43,"1.67832e-07","6nfc_oligo15","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_c_)-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(262_F_)",84.8473,"","",""
"6NFC","BG505 MD64 N332-GT5 SOSIP TRIMER IN COMPLEX WITH BG18-LIKE PRECURSOR HMP42 FRAGMENTANTIGEN BINDING AND BASE-BINDING RM20A3 FRAGMENT ANTIGEN BINDING","10.1126/SCIENCE.AAX4380 ",3.43,"1.67832e-07","6nfc_oligo12","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_Q_)-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(262_A_)",92.8145,"","",""
"6NFC","BG505 MD64 N332-GT5 SOSIP TRIMER IN COMPLEX WITH BG18-LIKE PRECURSOR HMP42 FRAGMENTANTIGEN BINDING AND BASE-BINDING RM20A3 FRAGMENT ANTIGEN BINDING","10.1126/SCIENCE.AAX4380 ",3.43,"1.67832e-07","6nfc_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_W_)-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(262_E_)",87.6589,"","",""
"6NG3","CRYSTAL STRUCTURE OF HUMAN CD160 AND HVEM COMPLEX","10.1016/J.STR.2019.05.010 ",2.88,71.96,"6ng3_oligo1","DManpb1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(28_A_)",69.3475,"","",""
"6NHP","CRYSTAL STRUCTURE OF THE A/HONG KONG/1/1968 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ HA2 I45T MUTANT","10.1126/SCIENCE.AAZ5143 ",2.25,50.92,"6nhp_oligo6","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_L_)-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(165_E_)",76.7661,"","",""
"6NHQ","CRYSTAL STRUCTURE OF THE A/HONG KONG/1/1968 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ HA2 I45M MUTANT","10.1126/SCIENCE.AAZ5143 ",2.5,57.02,"6nhq_oligo6","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_L_)-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(165_E_)",91.675,"","",""
"6NHR","CRYSTAL STRUCTURE OF THE A/HONG KONG/1/1968 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ HA2 I45F MUTANT","10.1126/SCIENCE.AAZ5143 ",2.1,48.81,"6nhr_oligo6","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_L_)-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(165_E_)",75.0036,"","",""
"6NKN","TIME-RESOLVED SFX STRUCTURE OF THE PR INTERMEDIATE OF CYTOCHROME C OXIDASE AT ROOM TEMPERATURE","10.1073/PNAS.1814526116 ",2.5,63.44,"6nkn_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(101_G_)-DMU(101_G_)",159.414,"","",""
"6NKN","TIME-RESOLVED SFX STRUCTURE OF THE PR INTERMEDIATE OF CYTOCHROME C OXIDASE AT ROOM TEMPERATURE","10.1073/PNAS.1814526116 ",2.5,63.44,"6nkn_oligo3","DGlcpa1-3DGlcpb6-C10O1","DMU(201_Q_)-DMU(201_Q_)",117.493,"","",""
"6NKN","TIME-RESOLVED SFX STRUCTURE OF THE PR INTERMEDIATE OF CYTOCHROME C OXIDASE AT ROOM TEMPERATURE","10.1073/PNAS.1814526116 ",2.5,63.44,"6nkn_oligo4","DGlcpa1-3DGlcpb6-C10O1","DMU(101_M_)-DMU(101_M_)",69.2714,"","",""
"6NKN","TIME-RESOLVED SFX STRUCTURE OF THE PR INTERMEDIATE OF CYTOCHROME C OXIDASE AT ROOM TEMPERATURE","10.1073/PNAS.1814526116 ",2.5,63.44,"6nkn_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(101_T_)-DMU(101_T_)",175.136,"","",""
"6NM6","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO N6 FR3-03 SCFV IN COMPLEX WITH CRYSTALLIZATION CHAPERONES 3H109L FAB AND 35O22 SCFV AT 3.2 ANGSTROM","10.1038/S41467-019-08658-4 ",2.74,57.15,"6nm6_oligo9","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_O_)-MAN(8_O_)-[MAN(10_O_)]-MAN(7_O_)-[MAN(6_O_)-MAN(5_O_)-MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(332_G_)",52.7055,"","",""
"6NM6","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO N6 FR3-03 SCFV IN COMPLEX WITH CRYSTALLIZATION CHAPERONES 3H109L FAB AND 35O22 SCFV AT 3.2 ANGSTROM","10.1038/S41467-019-08658-4 ",2.74,57.15,"6nm6_oligo3","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_A_)-MAN(4_A_)-[MAN(6_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(88_G_)",54.7092,"","",""
"6NM6","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO N6 FR3-03 SCFV IN COMPLEX WITH CRYSTALLIZATION CHAPERONES 3H109L FAB AND 35O22 SCFV AT 3.2 ANGSTROM","10.1038/S41467-019-08658-4 ",2.74,57.15,"6nm6_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(156_G_)",102.146,"","",""
"6NMF","SFX STRUCTURE OF REDUCED CYTOCHROME C OXIDASE AT ROOM TEMPERATURE","10.1073/PNAS.1814526116 ",2.8,72.92,"6nmf_oligo3","DGlcpa1-3DGlcpb6-C10O1","DMU(303_P_)-DMU(303_P_)",179.793,"","",""
"6NMF","SFX STRUCTURE OF REDUCED CYTOCHROME C OXIDASE AT ROOM TEMPERATURE","10.1073/PNAS.1814526116 ",2.8,72.92,"6nmf_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(101_M_)-DMU(101_M_)",75.4377,"","",""
"6NMF","SFX STRUCTURE OF REDUCED CYTOCHROME C OXIDASE AT ROOM TEMPERATURE","10.1073/PNAS.1814526116 ",2.8,72.92,"6nmf_oligo4","DGlcpa1-3DGlcpb6-C10O1","DMU(201_Q_)-DMU(201_Q_)",116.962,"","",""
"6NMF","SFX STRUCTURE OF REDUCED CYTOCHROME C OXIDASE AT ROOM TEMPERATURE","10.1073/PNAS.1814526116 ",2.8,72.92,"6nmf_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(301_C_)-DMU(301_C_)",198.407,"","",""
"6NMP","SFX STRUCTURE OF OXIDIZED CYTOCHROME C OXIDASE AT ROOM TEMPERATURE","10.1073/PNAS.1814526116 ",2.9,63.84,"6nmp_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(101_M_)-DMU(101_M_)",63.5582,"","",""
"6NMP","SFX STRUCTURE OF OXIDIZED CYTOCHROME C OXIDASE AT ROOM TEMPERATURE","10.1073/PNAS.1814526116 ",2.9,63.84,"6nmp_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(101_T_)-DMU(101_T_)",179.24,"","",""
"6NMP","SFX STRUCTURE OF OXIDIZED CYTOCHROME C OXIDASE AT ROOM TEMPERATURE","10.1073/PNAS.1814526116 ",2.9,63.84,"6nmp_oligo4","DGlcpa1-3DGlcpb6-C10O1","DMU(302_C_)-DMU(302_C_)",152.539,"","",""
"6NMP","SFX STRUCTURE OF OXIDIZED CYTOCHROME C OXIDASE AT ROOM TEMPERATURE","10.1073/PNAS.1814526116 ",2.9,63.84,"6nmp_oligo3","DGlcpa1-3DGlcpb6-C10O1","DMU(201_Q_)-DMU(201_Q_)",110.229,"","",""
"6NN9","REFINED ATOMIC STRUCTURES OF N9 SUBTYPE INFLUENZA VIRUS NEURAMINIDASE AND ESCAPE MUTANTS","10.1016/0022-2836(91)80069-7 ",2.3,0,"6nn9_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",24.0761,"","",""
"6NNF","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO VRC01 FR3-03 SCFV IN COMPLEX WITH CRYSTALLIZATION CHAPERONES 3H109L FAB AND 35O22 SCFV AT 3.5 ANGSTROM","10.1038/S41467-019-08658-4 ",2.76,69.41,"6nnf_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(156_G_)",117.383,"","",""
"6NNF","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO VRC01 FR3-03 SCFV IN COMPLEX WITH CRYSTALLIZATION CHAPERONES 3H109L FAB AND 35O22 SCFV AT 3.5 ANGSTROM","10.1038/S41467-019-08658-4 ",2.76,69.41,"6nnf_oligo8","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_O_)-MAN(8_O_)-[MAN(10_O_)]-MAN(7_O_)-[MAN(6_O_)-MAN(5_O_)-MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(332_G_)",64.3647,"","",""
"6NNF","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO VRC01 FR3-03 SCFV IN COMPLEX WITH CRYSTALLIZATION CHAPERONES 3H109L FAB AND 35O22 SCFV AT 3.5 ANGSTROM","10.1038/S41467-019-08658-4 ",2.76,69.41,"6nnf_oligo9","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_A_)-MAN(4_A_)-[MAN(6_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(88_G_)",65.9924,"","",""
"6NNJ","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO CH31 SCFV IN COMPLEX WITH CRYSTALLIZATION CHAPERONES 3H109L FAB AND 35O22 SCFV AT 3.1 ANGSTROM","10.1038/S41467-019-08658-4 ",2.6,55.94,"6nnj_oligo8","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_A_)-MAN(4_A_)-[MAN(6_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(88_G_)",58.0939,"","",""
"6NNJ","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO CH31 SCFV IN COMPLEX WITH CRYSTALLIZATION CHAPERONES 3H109L FAB AND 35O22 SCFV AT 3.1 ANGSTROM","10.1038/S41467-019-08658-4 ",2.6,55.94,"6nnj_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(156_G_)",88.0104,"","",""
"6NNJ","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO CH31 SCFV IN COMPLEX WITH CRYSTALLIZATION CHAPERONES 3H109L FAB AND 35O22 SCFV AT 3.1 ANGSTROM","10.1038/S41467-019-08658-4 ",2.6,55.94,"6nnj_oligo7","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_N_)-MAN(8_N_)-[MAN(10_N_)]-MAN(7_N_)-[MAN(6_N_)-MAN(5_N_)-MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(332_G_)",55.063,"","",""
"6NQD","CRYO-EM STRUCTURE OF T/F100 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH 8ANC195 FAB","10.1038/S41467-019-08825-7 ",3.9,512.502,"6nqd_oligo22","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_W_)-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(637_B_)",76.3566,"","",""
"6NQD","CRYO-EM STRUCTURE OF T/F100 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH 8ANC195 FAB","10.1038/S41467-019-08825-7 ",3.9,512.502,"6nqd_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_h_)-BMA(3_h_)-NAG(2_h_)-NAG(1_h_)-ASN(637_F_)",81.1679,"","",""
"6NQD","CRYO-EM STRUCTURE OF T/F100 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH 8ANC195 FAB","10.1038/S41467-019-08825-7 ",3.9,512.502,"6nqd_oligo1","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_N_)-[MAN(5_N_)-MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(276_A_)",94.3636,"","",""
"6NQD","CRYO-EM STRUCTURE OF T/F100 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH 8ANC195 FAB","10.1038/S41467-019-08825-7 ",3.9,512.502,"6nqd_oligo5","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_j_)-[MAN(5_j_)-MAN(4_j_)]-BMA(3_j_)-NAG(2_j_)-NAG(1_j_)-ASN(276_I_)",87.9841,"","",""
"6NQD","CRYO-EM STRUCTURE OF T/F100 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH 8ANC195 FAB","10.1038/S41467-019-08825-7 ",3.9,512.502,"6nqd_oligo4","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_i_)-MAN(8_i_)-[MAN(10_i_)]-MAN(7_i_)-[MAN(6_i_)-MAN(5_i_)-MAN(4_i_)]-BMA(3_i_)-NAG(2_i_)-NAG(1_i_)-ASN(234_I_)",72.208,"","",""
"6NQD","CRYO-EM STRUCTURE OF T/F100 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH 8ANC195 FAB","10.1038/S41467-019-08825-7 ",3.9,512.502,"6nqd_oligo13","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_M_)-MAN(8_M_)-[MAN(10_M_)]-MAN(7_M_)-[MAN(6_M_)-MAN(5_M_)-MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(234_A_)",73.6707,"","",""
"6NQD","CRYO-EM STRUCTURE OF T/F100 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH 8ANC195 FAB","10.1038/S41467-019-08825-7 ",3.9,512.502,"6nqd_oligo33","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_s_)-BMA(3_s_)-NAG(2_s_)-NAG(1_s_)-ASN(637_J_)",72.5109,"","",""
"6NQD","CRYO-EM STRUCTURE OF T/F100 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH 8ANC195 FAB","10.1038/S41467-019-08825-7 ",3.9,512.502,"6nqd_oligo24","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Y_)-[MAN(5_Y_)-MAN(4_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(276_E_)",96.7367,"","",""
"6NQD","CRYO-EM STRUCTURE OF T/F100 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH 8ANC195 FAB","10.1038/S41467-019-08825-7 ",3.9,512.502,"6nqd_oligo23","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_X_)-MAN(8_X_)-[MAN(10_X_)]-MAN(7_X_)-[MAN(6_X_)-MAN(5_X_)-MAN(4_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(234_E_)",75.9651,"","",""
"6NRQ","CRYSTAL STRUCTURE OF DPR10 IG1 BOUND TO DIP-ALPHA IG1","10.7554/ELIFE.41028 ",1.8,0,"6nrq_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(6_F_)-[MAN(4_F_)-BMA(3_F_)-NAG(2_F_)]-[FUC(5_F_)]-NAG(1_F_)-ASN(82_A_)",52.0291,"","",""
"6NRQ","CRYSTAL STRUCTURE OF DPR10 IG1 BOUND TO DIP-ALPHA IG1","10.7554/ELIFE.41028 ",1.8,0,"6nrq_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(6_G_)-[MAN(4_G_)-BMA(3_G_)-NAG(2_G_)]-[FUC(5_G_)]-NAG(1_G_)-ASN(50_B_)",63.8829,"","",""
"6NRQ","CRYSTAL STRUCTURE OF DPR10 IG1 BOUND TO DIP-ALPHA IG1","10.7554/ELIFE.41028 ",1.8,0,"6nrq_oligo2","LFucpa1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_E_)-[NAG(3_E_)]-[FUC(2_E_)]-NAG(1_E_)-ASN(62_A_)",57.247,"","",""
"6NRQ","CRYSTAL STRUCTURE OF DPR10 IG1 BOUND TO DIP-ALPHA IG1","10.7554/ELIFE.41028 ",1.8,0,"6nrq_oligo4","LFucpa1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_H_)-[NAG(3_H_)]-[FUC(2_H_)]-NAG(1_H_)-ASN(62_C_)",57.8716,"","",""
"6NRW","CRYSTAL STRUCTURE OF DPR1 IG1 BOUND TO DIP-ETA IG1","10.7554/ELIFE.41028 ",2.4,0,"6nrw_oligo1","LFucpa1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_G_)-[NAG(3_G_)]-[FUC(2_G_)]-NAG(1_G_)-ASN(62_C_)",85.8334,"","",""
"6NS9","CRYSTAL STRUCTURE OF THE IVR-165 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ APO FORM","10.1016/J.CHOM.2019.04.013 ",1.95,44.23,"6ns9_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(38_A_)",61.5595,"","",""
"6NSA","CRYSTAL STRUCTURE OF THE IVR-165 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ IN COMPLEX WITH 3'-SLNLN","10.1016/J.CHOM.2019.04.013 ",1.95,42.32,"6nsa_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(38_A_)",70.0327,"","",""
"6NSA","CRYSTAL STRUCTURE OF THE IVR-165 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ IN COMPLEX WITH 3'-SLNLN","10.1016/J.CHOM.2019.04.013 ",1.95,42.32,"6nsa_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(246_A_)",94.5818,"","",""
"6NSA","CRYSTAL STRUCTURE OF THE IVR-165 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ IN COMPLEX WITH 3'-SLNLN","10.1016/J.CHOM.2019.04.013 ",1.95,42.32,"6nsa_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(165_A_)",81.8215,"","",""
"6NSC","CRYSTAL STRUCTURE OF THE A/BRISBANE/10/2007 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ G186V/L194P MUTANT APO FORM","10.1016/J.CHOM.2019.04.013 ",2.25,64.91,"6nsc_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(38_A_)",97.8246,"","",""
"6NSF","CRYSTAL STRUCTURE OF THE A/BRISBANE/10/2007 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ G186V/L194P MUTANT IN COMPLEX WITH 3'-SLNLN","10.1016/J.CHOM.2019.04.013 ",2.1,51.46,"6nsf_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(38_A_)",85.9365,"","",""
"6NSG","CRYSTAL STRUCTURE OF THE A/BRISBANE/10/2007 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ G186V/L194P MUTANT IN COMPLEX WITH 6'-SLNLN","10.1016/J.CHOM.2019.04.013 ",2.4,71.07,"6nsg_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(38_A_)",115.601,"","",""
"6NT3","CRYO-EM STRUCTURE OF A HUMAN-COCKROACH HYBRID NAV CHANNEL.","",3.4,"1.15243e-41","6nt3_oligo8","DManpb1-3[DManpb1-6]DManpb1-3DGlcpNAcb1-3DGlcpNAcb1-ASN","BMA(5_B_)-[BMA(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(330_A_)",113.85,"","",""
"6NT4","CRYO-EM STRUCTURE OF A HUMAN-COCKROACH HYBRID NAV CHANNEL BOUND TO ALPHA-SCORPION TOXIN AAH2.","10.1126/SCIENCE.AAV8573 ",3.5,"1.15243e-41","6nt4_oligo1","DManpb1-3[DManpb1-6]DManpb1-3DGlcpNAcb1-3DGlcpNAcb1-ASN","BMA(5_D_)-[BMA(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(330_A_)",95.5116,"","",""
"6NWE","CRYSTAL STRUCTURE OF BOVINE OPSIN WITH BETA OCTYL GLUCOSIDE BOUND","",2.71,0,"6nwe_oligo5","DManpb1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(15_A_)",88.5214,"","",""
"6NZK","STRUCTURAL BASIS FOR HUMAN CORONAVIRUS ATTACHMENT TO SIALIC ACID RECEPTORS","10.1038/S41594-019-0233-Y ",2.8,0,"6nzk_oligo16","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_P_)-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(1224_B_)",70.9273,"","",""
"6NZK","STRUCTURAL BASIS FOR HUMAN CORONAVIRUS ATTACHMENT TO SIALIC ACID RECEPTORS","10.1038/S41594-019-0233-Y ",2.8,0,"6nzk_oligo20","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_T_)-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(739_B_)",86.9459,"","",""
"6NZK","STRUCTURAL BASIS FOR HUMAN CORONAVIRUS ATTACHMENT TO SIALIC ACID RECEPTORS","10.1038/S41594-019-0233-Y ",2.8,0,"6nzk_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(1224_A_)",70.9273,"","",""
"6NZK","STRUCTURAL BASIS FOR HUMAN CORONAVIRUS ATTACHMENT TO SIALIC ACID RECEPTORS","10.1038/S41594-019-0233-Y ",2.8,0,"6nzk_oligo6","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(739_A_)",86.9459,"","",""
"6NZK","STRUCTURAL BASIS FOR HUMAN CORONAVIRUS ATTACHMENT TO SIALIC ACID RECEPTORS","10.1038/S41594-019-0233-Y ",2.8,0,"6nzk_oligo26","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_Z_)-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(1224_C_)",70.9273,"","",""
"6NZK","STRUCTURAL BASIS FOR HUMAN CORONAVIRUS ATTACHMENT TO SIALIC ACID RECEPTORS","10.1038/S41594-019-0233-Y ",2.8,0,"6nzk_oligo30","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_d_)-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(739_C_)",86.9459,"","",""
"6O3O","STRUCTURE OF HUMAN DNAM-1 (CD226) BOUND TO NECTIN-LIKE PROTEIN-5 (NECL-5)","10.1074/JBC.RA119.009261 ",2.8,63.74,"6o3o_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_F_)-[MAN(4_F_)-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(120_D_)",110.721,"","",""
"6O4P","THE CRYSTAL STRUCTURE OF THE INTERLEUKIN 11 ALPHA RECEPTOR","10.1074/JBC.RA119.012351 ",3.43,65.9,"6o4p_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(172_A_)",79.8041,"","",""
"6OAI","CRYSTAL STRUCTURE OF P[6] ROTAVIRUS VP8* COMPLEXED WITH LNFPI","10.1371/JOURNAL.PPAT.1008386 ",1.9,19.79,"6oai_oligo1","LFucpa1-2DGalpb1-3DGlcpNAcb1-3DGalpb1-4DGlcpb1-ROH","FUC(5_E_)-GAL(4_E_)-NAG(3_E_)-GAL(2_E_)-BGC(1_E_)",34.7631,"","",""
"6OF5","THE CRYSTAL STRUCTURE OF DODECYLOXY(NAPHTHALEN-1-YL)METHYLPHOSPHONIC ACID IN COMPLEX WITH RED KIDNEY BEAN PURPLE ACID PHOSPHATASE","10.1016/J.EJMECH.2019.111611 ",2.3,0,"6of5_oligo10","DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","BMA(3_N_)-NAG(2_N_)-[FUC(4_N_)]-NAG(1_N_)-ASN(109_C_)",69.7543,"","",""
"6OF5","THE CRYSTAL STRUCTURE OF DODECYLOXY(NAPHTHALEN-1-YL)METHYLPHOSPHONIC ACID IN COMPLEX WITH RED KIDNEY BEAN PURPLE ACID PHOSPHATASE","10.1016/J.EJMECH.2019.111611 ",2.3,0,"6of5_oligo3","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_H_)-[FUC(2_H_)]-NAG(1_H_)-ASN(109_B_)",78.507,"","",""
"6OF5","THE CRYSTAL STRUCTURE OF DODECYLOXY(NAPHTHALEN-1-YL)METHYLPHOSPHONIC ACID IN COMPLEX WITH RED KIDNEY BEAN PURPLE ACID PHOSPHATASE","10.1016/J.EJMECH.2019.111611 ",2.3,0,"6of5_oligo7","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_K_)-[FUC(2_K_)]-NAG(1_K_)-ASN(396_D_)",48.2588,"","",""
"6OF5","THE CRYSTAL STRUCTURE OF DODECYLOXY(NAPHTHALEN-1-YL)METHYLPHOSPHONIC ACID IN COMPLEX WITH RED KIDNEY BEAN PURPLE ACID PHOSPHATASE","10.1016/J.EJMECH.2019.111611 ",2.3,0,"6of5_oligo5","DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","BMA(3_F_)-NAG(2_F_)-[FUC(4_F_)]-NAG(1_F_)-ASN(81_A_)",66.722,"","",""
"6OF5","THE CRYSTAL STRUCTURE OF DODECYLOXY(NAPHTHALEN-1-YL)METHYLPHOSPHONIC ACID IN COMPLEX WITH RED KIDNEY BEAN PURPLE ACID PHOSPHATASE","10.1016/J.EJMECH.2019.111611 ",2.3,0,"6of5_oligo1","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_E_)-[FUC(2_E_)]-NAG(1_E_)-ASN(109_A_)",74.7551,"","",""
"6OF5","THE CRYSTAL STRUCTURE OF DODECYLOXY(NAPHTHALEN-1-YL)METHYLPHOSPHONIC ACID IN COMPLEX WITH RED KIDNEY BEAN PURPLE ACID PHOSPHATASE","10.1016/J.EJMECH.2019.111611 ",2.3,0,"6of5_oligo8","LFucpa1-3DGlcpNAcb1-ASN","FUC(2_L_)-NAG(1_L_)-ASN(109_D_)",58.2055,"","",""
"6OF5","THE CRYSTAL STRUCTURE OF DODECYLOXY(NAPHTHALEN-1-YL)METHYLPHOSPHONIC ACID IN COMPLEX WITH RED KIDNEY BEAN PURPLE ACID PHOSPHATASE","10.1016/J.EJMECH.2019.111611 ",2.3,0,"6of5_oligo4","DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","BMA(3_I_)-NAG(2_I_)-[FUC(4_I_)]-NAG(1_I_)-ASN(81_B_)",61.157,"","",""
"6OF5","THE CRYSTAL STRUCTURE OF DODECYLOXY(NAPHTHALEN-1-YL)METHYLPHOSPHONIC ACID IN COMPLEX WITH RED KIDNEY BEAN PURPLE ACID PHOSPHATASE","10.1016/J.EJMECH.2019.111611 ",2.3,0,"6of5_oligo6","DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","BMA(3_J_)-NAG(2_J_)-[FUC(4_J_)]-NAG(1_J_)-ASN(396_B_)",52.4982,"","",""
"6OF5","THE CRYSTAL STRUCTURE OF DODECYLOXY(NAPHTHALEN-1-YL)METHYLPHOSPHONIC ACID IN COMPLEX WITH RED KIDNEY BEAN PURPLE ACID PHOSPHATASE","10.1016/J.EJMECH.2019.111611 ",2.3,0,"6of5_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-[FUC(6_G_)]-NAG(1_G_)-ASN(396_A_)",58.3303,"","",""
"6OF5","THE CRYSTAL STRUCTURE OF DODECYLOXY(NAPHTHALEN-1-YL)METHYLPHOSPHONIC ACID IN COMPLEX WITH RED KIDNEY BEAN PURPLE ACID PHOSPHATASE","10.1016/J.EJMECH.2019.111611 ",2.3,0,"6of5_oligo9","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_M_)-[FUC(2_M_)]-NAG(1_M_)-ASN(396_C_)",50.0548,"","",""
"6OFD","THE CRYSTAL STRUCTURE OF OCTADECYLOXY(NAPHTHALEN-1-YL)METHYLPHOSPHONIC ACID IN COMPLEX WITH RED KIDNEY BEAN PURPLE ACID PHOSPHATASE","10.1016/J.EJMECH.2019.111611 ",2.2,0,"6ofd_oligo10","DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","BMA(3_N_)-NAG(2_N_)-[FUC(4_N_)]-NAG(1_N_)-ASN(109_C_)",66.5739,"","",""
"6OFD","THE CRYSTAL STRUCTURE OF OCTADECYLOXY(NAPHTHALEN-1-YL)METHYLPHOSPHONIC ACID IN COMPLEX WITH RED KIDNEY BEAN PURPLE ACID PHOSPHATASE","10.1016/J.EJMECH.2019.111611 ",2.2,0,"6ofd_oligo1","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_E_)-[FUC(2_E_)]-NAG(1_E_)-ASN(109_A_)",67.1773,"","",""
"6OFD","THE CRYSTAL STRUCTURE OF OCTADECYLOXY(NAPHTHALEN-1-YL)METHYLPHOSPHONIC ACID IN COMPLEX WITH RED KIDNEY BEAN PURPLE ACID PHOSPHATASE","10.1016/J.EJMECH.2019.111611 ",2.2,0,"6ofd_oligo4","DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","BMA(3_H_)-NAG(2_H_)-[FUC(4_H_)]-NAG(1_H_)-ASN(109_B_)",78.1509,"","",""
"6OFD","THE CRYSTAL STRUCTURE OF OCTADECYLOXY(NAPHTHALEN-1-YL)METHYLPHOSPHONIC ACID IN COMPLEX WITH RED KIDNEY BEAN PURPLE ACID PHOSPHATASE","10.1016/J.EJMECH.2019.111611 ",2.2,0,"6ofd_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","BMA(3_F_)-NAG(2_F_)-[FUC(4_F_)]-NAG(1_F_)-ASN(81_A_)",57.5973,"","",""
"6OFD","THE CRYSTAL STRUCTURE OF OCTADECYLOXY(NAPHTHALEN-1-YL)METHYLPHOSPHONIC ACID IN COMPLEX WITH RED KIDNEY BEAN PURPLE ACID PHOSPHATASE","10.1016/J.EJMECH.2019.111611 ",2.2,0,"6ofd_oligo8","LFucpa1-3DGlcpNAcb1-ASN","FUC(2_L_)-NAG(1_L_)-ASN(109_D_)",55.8232,"","",""
"6OFD","THE CRYSTAL STRUCTURE OF OCTADECYLOXY(NAPHTHALEN-1-YL)METHYLPHOSPHONIC ACID IN COMPLEX WITH RED KIDNEY BEAN PURPLE ACID PHOSPHATASE","10.1016/J.EJMECH.2019.111611 ",2.2,0,"6ofd_oligo6","DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","BMA(3_J_)-NAG(2_J_)-[FUC(4_J_)]-NAG(1_J_)-ASN(396_B_)",38.0745,"","",""
"6OFD","THE CRYSTAL STRUCTURE OF OCTADECYLOXY(NAPHTHALEN-1-YL)METHYLPHOSPHONIC ACID IN COMPLEX WITH RED KIDNEY BEAN PURPLE ACID PHOSPHATASE","10.1016/J.EJMECH.2019.111611 ",2.2,0,"6ofd_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-[FUC(6_G_)]-NAG(1_G_)-ASN(396_A_)",44.4332,"","",""
"6OFD","THE CRYSTAL STRUCTURE OF OCTADECYLOXY(NAPHTHALEN-1-YL)METHYLPHOSPHONIC ACID IN COMPLEX WITH RED KIDNEY BEAN PURPLE ACID PHOSPHATASE","10.1016/J.EJMECH.2019.111611 ",2.2,0,"6ofd_oligo9","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_M_)-[FUC(2_M_)]-NAG(1_M_)-ASN(396_C_)",46.2139,"","",""
"6OFD","THE CRYSTAL STRUCTURE OF OCTADECYLOXY(NAPHTHALEN-1-YL)METHYLPHOSPHONIC ACID IN COMPLEX WITH RED KIDNEY BEAN PURPLE ACID PHOSPHATASE","10.1016/J.EJMECH.2019.111611 ",2.2,0,"6ofd_oligo7","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_K_)-[FUC(2_K_)]-NAG(1_K_)-ASN(396_D_)",50.9415,"","",""
"6OGE","CRYO-EM STRUCTURE OF HER2 EXTRACELLULAR DOMAIN-TRASTUZUMAB FAB- PERTUZUMAB FAB COMPLEX","10.1371/JOURNAL.PONE.0216095 ",4.36,"8.66969e+14","6oge_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(259_A_)",169.483,"","",""
"6OHW","STRUCTURAL BASIS FOR HUMAN CORONAVIRUS ATTACHMENT TO SIALIC ACID RECEPTORS. APO-HCOV-OC43 S","10.1038/S41594-019-0233-Y ",2.9,0,"6ohw_oligo9","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(739_A_)",93.8823,"","",""
"6OHW","STRUCTURAL BASIS FOR HUMAN CORONAVIRUS ATTACHMENT TO SIALIC ACID RECEPTORS. APO-HCOV-OC43 S","10.1038/S41594-019-0233-Y ",2.9,0,"6ohw_oligo27","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_d_)-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(739_C_)",93.8823,"","",""
"6OHW","STRUCTURAL BASIS FOR HUMAN CORONAVIRUS ATTACHMENT TO SIALIC ACID RECEPTORS. APO-HCOV-OC43 S","10.1038/S41594-019-0233-Y ",2.9,0,"6ohw_oligo17","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_T_)-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(739_B_)",93.8823,"","",""
"6OHY","CHIMPANZEE SIV ENV TRIMERIC ECTODOMAIN.","10.1016/J.CELREP.2019.04.082 ",4.1,"1.08527e-19","6ohy_oligo14","DManpa1-3[DManpa1-6]DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_b_)-[MAN(6_b_)-[MAN(5_b_)]-MAN(4_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(262_C_)",147.794,"","",""
"6OHY","CHIMPANZEE SIV ENV TRIMERIC ECTODOMAIN.","10.1016/J.CELREP.2019.04.082 ",4.1,"1.08527e-19","6ohy_oligo36","DManpa1-3[DManpa1-6]DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_p_)-[MAN(6_p_)-[MAN(5_p_)]-MAN(4_p_)]-BMA(3_p_)-NAG(2_p_)-NAG(1_p_)-ASN(262_D_)",147.726,"","",""
"6OHY","CHIMPANZEE SIV ENV TRIMERIC ECTODOMAIN.","10.1016/J.CELREP.2019.04.082 ",4.1,"1.08527e-19","6ohy_oligo25","DManpa1-3[DManpa1-6]DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_N_)-[MAN(6_N_)-[MAN(5_N_)]-MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(262_A_)",148.601,"","",""
"6OJ1","CRYSTAL STRUCTURE OF ASPERGILLUS FUMIGATUS EGA3","10.1074/JBC.RA119.009910 ",1.76,31.35,"6oj1_oligo3","DManpa1-2[DManpa1-6]DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_B_)-MAN(7_B_)-[MAN(6_B_)-[MAN(5_B_)]-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(92_A_)",52.9317,"","",""
"6OJB","CRYSTAL STRUCTURE OF ASPERGILLUS FUMIGATUS EGA3 COMPLEX WITH GALACTOSAMINE","10.1074/JBC.RA119.009910 ",2.09,36.13,"6ojb_oligo1","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-MAN(5_C_)-[MAN(7_C_)]-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(69_A_)",74.097,"","",""
"6OJB","CRYSTAL STRUCTURE OF ASPERGILLUS FUMIGATUS EGA3 COMPLEX WITH GALACTOSAMINE","10.1074/JBC.RA119.009910 ",2.09,36.13,"6ojb_oligo3","DManpa1-2[DManpa1-6]DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_B_)-MAN(7_B_)-[MAN(6_B_)-[MAN(5_B_)]-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(92_A_)",59.1192,"","",""
"6OJP","STRUCTURE OF GLYCOLIPID ALPHA-GSA[8,6P] IN COMPLEX WITH MOUSE CD1D","10.1074/JBC.RA119.009963 ",2.17,35.5,"6ojp_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_C_)-[MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(165_A_)",52.1115,"","",""
"6OJP","STRUCTURE OF GLYCOLIPID ALPHA-GSA[8,6P] IN COMPLEX WITH MOUSE CD1D","10.1074/JBC.RA119.009963 ",2.17,35.5,"6ojp_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(7_A_)",49.0795,"","",""
"6OKP","B41 SOSIP.664 IN COMPLEX WITH THE SILENT-FACE ANTIBODY SF12 AND V3- TARGETING ANTIBODY 10-1074","10.1016/J.IMMUNI.2019.04.014 ",3.28,"5.35483e+07","6okp_oligo1","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-MAN(5_H_)-[MAN(7_H_)]-MAN(4_H_)-[MAN(9_H_)-MAN(8_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(262_D_)",43.5343,"","",""
"6OKP","B41 SOSIP.664 IN COMPLEX WITH THE SILENT-FACE ANTIBODY SF12 AND V3- TARGETING ANTIBODY 10-1074","10.1016/J.IMMUNI.2019.04.014 ",3.28,"5.35483e+07","6okp_oligo16","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_I_)-[MAN(5_I_)]-MAN(4_I_)-[MAN(7_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(448_D_)",53.6832,"","",""
"6OKP","B41 SOSIP.664 IN COMPLEX WITH THE SILENT-FACE ANTIBODY SF12 AND V3- TARGETING ANTIBODY 10-1074","10.1016/J.IMMUNI.2019.04.014 ",3.28,"5.35483e+07","6okp_oligo29","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3DManpa1-3]DManpb1-4DGlcp[2<R1>]b1-4DGlcpNAcb1-ASN","MAN(6_r_)-MAN(5_r_)-[MAN(7_r_)]-MAN(4_r_)-[MAN(9_r_)-MAN(8_r_)]-BMA(3_r_)-NAG(2_r_)-NAG(1_r_)-ASN(262_E_)",75.7427,"","",""
"6OKP","B41 SOSIP.664 IN COMPLEX WITH THE SILENT-FACE ANTIBODY SF12 AND V3- TARGETING ANTIBODY 10-1074","10.1016/J.IMMUNI.2019.04.014 ",3.28,"5.35483e+07","6okp_oligo19","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_h_)-[MAN(5_h_)-MAN(4_h_)]-BMA(3_h_)-NAG(2_h_)-NAG(1_h_)-ASN(137_E_)",139.732,"","",""
"6OKP","B41 SOSIP.664 IN COMPLEX WITH THE SILENT-FACE ANTIBODY SF12 AND V3- TARGETING ANTIBODY 10-1074","10.1016/J.IMMUNI.2019.04.014 ",3.28,"5.35483e+07","6okp_oligo30","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_G_)-[MAN(7_G_)]-MAN(6_G_)-[MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(295_D_)",98.5416,"","",""
"6OKP","B41 SOSIP.664 IN COMPLEX WITH THE SILENT-FACE ANTIBODY SF12 AND V3- TARGETING ANTIBODY 10-1074","10.1016/J.IMMUNI.2019.04.014 ",3.28,"5.35483e+07","6okp_oligo31","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3DManpa1-3]DManpb1-4DGlcp[2<R1>]b1-4DGlcpNAcb1-ASN","MAN(6_s_)-MAN(5_s_)-[MAN(7_s_)]-MAN(4_s_)-[MAN(9_s_)-MAN(8_s_)]-BMA(3_s_)-NAG(2_s_)-NAG(1_s_)-ASN(262_F_)",62.378,"","",""
"6OKP","B41 SOSIP.664 IN COMPLEX WITH THE SILENT-FACE ANTIBODY SF12 AND V3- TARGETING ANTIBODY 10-1074","10.1016/J.IMMUNI.2019.04.014 ",3.28,"5.35483e+07","6okp_oligo18","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_g_)-MAN(6_g_)-[MAN(5_g_)-MAN(4_g_)]-BMA(3_g_)-NAG(2_g_)-NAG(1_g_)-ASN(332_E_)",70.9753,"","",""
"6OKP","B41 SOSIP.664 IN COMPLEX WITH THE SILENT-FACE ANTIBODY SF12 AND V3- TARGETING ANTIBODY 10-1074","10.1016/J.IMMUNI.2019.04.014 ",3.28,"5.35483e+07","6okp_oligo21","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_j_)-[MAN(5_j_)]-MAN(4_j_)-[MAN(7_j_)]-BMA(3_j_)-NAG(2_j_)-NAG(1_j_)-ASN(448_F_)",70.9438,"","",""
"6OKP","B41 SOSIP.664 IN COMPLEX WITH THE SILENT-FACE ANTIBODY SF12 AND V3- TARGETING ANTIBODY 10-1074","10.1016/J.IMMUNI.2019.04.014 ",3.28,"5.35483e+07","6okp_oligo20","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_i_)-[MAN(5_i_)]-MAN(4_i_)-[MAN(7_i_)]-BMA(3_i_)-NAG(2_i_)-NAG(1_i_)-ASN(295_F_)",113.323,"","",""
"6OKP","B41 SOSIP.664 IN COMPLEX WITH THE SILENT-FACE ANTIBODY SF12 AND V3- TARGETING ANTIBODY 10-1074","10.1016/J.IMMUNI.2019.04.014 ",3.28,"5.35483e+07","6okp_oligo10","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Z_)-[MAN(5_Z_)]-MAN(4_Z_)-[MAN(7_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(448_E_)",60.4517,"","",""
"6OLP","FULL LENGTH HIV-1 ENV AMC011 IN COMPLEX WITH PGT151 FAB","10.1371/JOURNAL.PPAT.1007920 ",4.2,0,"6olp_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_P_)-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(262_A_)",225.372,"","",""
"6OLP","FULL LENGTH HIV-1 ENV AMC011 IN COMPLEX WITH PGT151 FAB","10.1371/JOURNAL.PPAT.1007920 ",4.2,0,"6olp_oligo20","DGalpb1-4DGlcpNAcb1-2[DGlcpNAcb1-4]DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_V_)-[MAN(8_V_)-[NAG(7_V_)-[GAL(6_V_)-NAG(5_V_)]-MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)]-NAG(1_V_)-ASN(637_B_)",122.313,"","",""
"6OLP","FULL LENGTH HIV-1 ENV AMC011 IN COMPLEX WITH PGT151 FAB","10.1371/JOURNAL.PPAT.1007920 ",4.2,0,"6olp_oligo12","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_b_)-[MAN(4_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(262_C_)",193.751,"","",""
"6OLP","FULL LENGTH HIV-1 ENV AMC011 IN COMPLEX WITH PGT151 FAB","10.1371/JOURNAL.PPAT.1007920 ",4.2,0,"6olp_oligo22","DGalpb1-4DGlcpNAcb1-2[DGalpb1-4DGlcpNAcb1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(10_f_)-[GAL(8_f_)-NAG(7_f_)-[GAL(6_f_)-NAG(5_f_)]-MAN(4_f_)-[MAN(9_f_)]-BMA(3_f_)-NAG(2_f_)]-NAG(1_f_)-ASN(611_D_)",142.411,"","",""
"6OLP","FULL LENGTH HIV-1 ENV AMC011 IN COMPLEX WITH PGT151 FAB","10.1371/JOURNAL.PPAT.1007920 ",4.2,0,"6olp_oligo7","DGalpb1-4DGlcpNAcb1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_W_)-[GAL(6_W_)-NAG(5_W_)-MAN(4_W_)-[MAN(7_W_)]-BMA(3_W_)-NAG(2_W_)]-NAG(1_W_)-ASN(611_B_)",97.6494,"","",""
"6OLP","FULL LENGTH HIV-1 ENV AMC011 IN COMPLEX WITH PGT151 FAB","10.1371/JOURNAL.PPAT.1007920 ",4.2,0,"6olp_oligo21","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_e_)-[NAG(8_e_)-MAN(7_e_)-[GAL(6_e_)-NAG(5_e_)-MAN(4_e_)]-BMA(3_e_)-NAG(2_e_)]-NAG(1_e_)-ASN(637_D_)",126.382,"","",""
"6OM1","CRYSTAL STRUCTURE OF AN ATYPICAL INTEGRIN","10.1038/S41467-019-13248-5 ",2.66,0,"6om1_oligo17","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_U_)-[MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(44_E_)",113.86,"","",""
"6OM1","CRYSTAL STRUCTURE OF AN ATYPICAL INTEGRIN","10.1038/S41467-019-13248-5 ",2.66,0,"6om1_oligo14","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_R_)-MAN(4_R_)-[MAN(6_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(266_C_)",101.519,"","",""
"6OM1","CRYSTAL STRUCTURE OF AN ATYPICAL INTEGRIN","10.1038/S41467-019-13248-5 ",2.66,0,"6om1_oligo6","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_O_)-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(414_B_)",140.274,"","",""
"6OM1","CRYSTAL STRUCTURE OF AN ATYPICAL INTEGRIN","10.1038/S41467-019-13248-5 ",2.66,0,"6om1_oligo13","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_Q_)-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(260_C_)",123.305,"","",""
"6OM1","CRYSTAL STRUCTURE OF AN ATYPICAL INTEGRIN","10.1038/S41467-019-13248-5 ",2.66,0,"6om1_oligo10","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_L_)-MAN(4_L_)-[MAN(6_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(266_A_)",104.582,"","",""
"6OM1","CRYSTAL STRUCTURE OF AN ATYPICAL INTEGRIN","10.1038/S41467-019-13248-5 ",2.66,0,"6om1_oligo19","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_W_)-MAN(4_W_)-[MAN(6_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(266_E_)",106.8,"","",""
"6OM1","CRYSTAL STRUCTURE OF AN ATYPICAL INTEGRIN","10.1038/S41467-019-13248-5 ",2.66,0,"6om1_oligo24","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_b_)-[MAN(5_b_)]-MAN(4_b_)-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(260_G_)",148.146,"","",""
"6OM1","CRYSTAL STRUCTURE OF AN ATYPICAL INTEGRIN","10.1038/S41467-019-13248-5 ",2.66,0,"6om1_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_K_)-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(260_A_)",110.182,"","",""
"6OM1","CRYSTAL STRUCTURE OF AN ATYPICAL INTEGRIN","10.1038/S41467-019-13248-5 ",2.66,0,"6om1_oligo20","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_X_)-[MAN(4_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(459_E_)",118.827,"","",""
"6OM1","CRYSTAL STRUCTURE OF AN ATYPICAL INTEGRIN","10.1038/S41467-019-13248-5 ",2.66,0,"6om1_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(44_A_)",111.477,"","",""
"6OM1","CRYSTAL STRUCTURE OF AN ATYPICAL INTEGRIN","10.1038/S41467-019-13248-5 ",2.66,0,"6om1_oligo12","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_P_)-MAN(4_P_)-[MAN(6_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(44_C_)",114.916,"","",""
"6OM1","CRYSTAL STRUCTURE OF AN ATYPICAL INTEGRIN","10.1038/S41467-019-13248-5 ",2.66,0,"6om1_oligo7","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(459_A_)",172.781,"","",""
"6OM1","CRYSTAL STRUCTURE OF AN ATYPICAL INTEGRIN","10.1038/S41467-019-13248-5 ",2.66,0,"6om1_oligo26","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_d_)-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(459_G_)",130.561,"","",""
"6OM1","CRYSTAL STRUCTURE OF AN ATYPICAL INTEGRIN","10.1038/S41467-019-13248-5 ",2.66,0,"6om1_oligo23","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_a_)-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(44_G_)",118.23,"","",""
"6OM1","CRYSTAL STRUCTURE OF AN ATYPICAL INTEGRIN","10.1038/S41467-019-13248-5 ",2.66,0,"6om1_oligo15","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_S_)-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(459_C_)",113.06,"","",""
"6OM2","CRYSTAL STRUCTURE OF ATYPICAL INTEGRIN ALPHAV BETA8 WITH PROTGF-BETA1 LIGAND PEPTIDE","10.1038/S41467-019-13248-5 ",2.77,0,"6om2_oligo9","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_O_)-[MAN(5_O_)]-MAN(4_O_)-[MAN(7_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(459_C_)",118.754,"","",""
"6OM2","CRYSTAL STRUCTURE OF ATYPICAL INTEGRIN ALPHAV BETA8 WITH PROTGF-BETA1 LIGAND PEPTIDE","10.1038/S41467-019-13248-5 ",2.77,0,"6om2_oligo8","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-MAN(4_N_)-[MAN(6_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(266_C_)",103.442,"","",""
"6OM2","CRYSTAL STRUCTURE OF ATYPICAL INTEGRIN ALPHAV BETA8 WITH PROTGF-BETA1 LIGAND PEPTIDE","10.1038/S41467-019-13248-5 ",2.77,0,"6om2_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(459_A_)",114.23,"","",""
"6OM2","CRYSTAL STRUCTURE OF ATYPICAL INTEGRIN ALPHAV BETA8 WITH PROTGF-BETA1 LIGAND PEPTIDE","10.1038/S41467-019-13248-5 ",2.77,0,"6om2_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-[MAN(5_H_)]-MAN(4_H_)-[MAN(7_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(260_A_)",90.1001,"","",""
"6OM2","CRYSTAL STRUCTURE OF ATYPICAL INTEGRIN ALPHAV BETA8 WITH PROTGF-BETA1 LIGAND PEPTIDE","10.1038/S41467-019-13248-5 ",2.77,0,"6om2_oligo6","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_L_)-[MAN(5_L_)]-MAN(4_L_)-[MAN(7_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(44_C_)",143.031,"","",""
"6OM2","CRYSTAL STRUCTURE OF ATYPICAL INTEGRIN ALPHAV BETA8 WITH PROTGF-BETA1 LIGAND PEPTIDE","10.1038/S41467-019-13248-5 ",2.77,0,"6om2_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(266_A_)",99.6089,"","",""
"6OML","HUMAN BMP CHIMERA BV261","10.1126/SCITRANSLMED.AAR4953 ",2.7,48.01,"6oml_oligo2","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_A_)-[MAN(5_A_)-MAN(4_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(56_Y_)",88.5579,"","",""
"6OMN","GLYCOSYLATED BMP2 HOMODIMER","10.1126/SCITRANSLMED.AAR4953 ",2.68,70.78,"6omn_oligo4","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(56_H_)",86.7433,"","",""
"6OMN","GLYCOSYLATED BMP2 HOMODIMER","10.1126/SCITRANSLMED.AAR4953 ",2.68,70.78,"6omn_oligo1","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(56_G_)",86.9155,"","",""
"6OMN","GLYCOSYLATED BMP2 HOMODIMER","10.1126/SCITRANSLMED.AAR4953 ",2.68,70.78,"6omn_oligo2","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_A_)-MAN(4_A_)-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(56_E_)",84.0611,"","",""
"6OMN","GLYCOSYLATED BMP2 HOMODIMER","10.1126/SCITRANSLMED.AAR4953 ",2.68,70.78,"6omn_oligo3","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(56_F_)",96.1673,"","",""
"6OPA","CRYSTAL STRUCTURE OF BOVINE FAB NC-COW1 IN COMPLEX WITH HIV-1 BG505 SOSIP.664, AND HUMAN FABS 35022 AND PGT128","10.1126/SCIADV.ABA0468 ",4.08,0,"6opa_oligo12","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_T_)-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(448_G_)",251.038,"","",""
"6OPA","CRYSTAL STRUCTURE OF BOVINE FAB NC-COW1 IN COMPLEX WITH HIV-1 BG505 SOSIP.664, AND HUMAN FABS 35022 AND PGT128","10.1126/SCIADV.ABA0468 ",4.08,0,"6opa_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(301_G_)",241.954,"","",""
"6OPA","CRYSTAL STRUCTURE OF BOVINE FAB NC-COW1 IN COMPLEX WITH HIV-1 BG505 SOSIP.664, AND HUMAN FABS 35022 AND PGT128","10.1126/SCIADV.ABA0468 ",4.08,0,"6opa_oligo13","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_U_)-[MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(276_G_)",253.2,"","",""
"6OPA","CRYSTAL STRUCTURE OF BOVINE FAB NC-COW1 IN COMPLEX WITH HIV-1 BG505 SOSIP.664, AND HUMAN FABS 35022 AND PGT128","10.1126/SCIADV.ABA0468 ",4.08,0,"6opa_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(262_G_)",215.479,"","",""
"6OPA","CRYSTAL STRUCTURE OF BOVINE FAB NC-COW1 IN COMPLEX WITH HIV-1 BG505 SOSIP.664, AND HUMAN FABS 35022 AND PGT128","10.1126/SCIADV.ABA0468 ",4.08,0,"6opa_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_A_)-[MAN(5_A_)]-MAN(4_A_)-[MAN(7_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(88_G_)",205.155,"","",""
"6OPA","CRYSTAL STRUCTURE OF BOVINE FAB NC-COW1 IN COMPLEX WITH HIV-1 BG505 SOSIP.664, AND HUMAN FABS 35022 AND PGT128","10.1126/SCIADV.ABA0468 ",4.08,0,"6opa_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_P_)-[MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(332_G_)",224.385,"","",""
"6OPN","CD4- AND 17-BOUND HIV-1 ENV B41 SOSIP IN COMPLEX WITH SMALL MOLECULE GO35","10.1016/J.CELREP.2020.108428 ",3.5,"5.37397e+08","6opn_oligo6","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-MAN(4_M_)-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(262_D_)",97.6831,"","",""
"6OPN","CD4- AND 17-BOUND HIV-1 ENV B41 SOSIP IN COMPLEX WITH SMALL MOLECULE GO35","10.1016/J.CELREP.2020.108428 ",3.5,"5.37397e+08","6opn_oligo1","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-MAN(4_K_)-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(262_A_)",97.6831,"","",""
"6OPN","CD4- AND 17-BOUND HIV-1 ENV B41 SOSIP IN COMPLEX WITH SMALL MOLECULE GO35","10.1016/J.CELREP.2020.108428 ",3.5,"5.37397e+08","6opn_oligo12","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-MAN(4_O_)-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(262_G_)",97.6831,"","",""
"6OPO","SYMMETRIC MODEL OF CD4- AND 17-BOUND B41 HIV-1 ENV SOSIP IN COMPLEX WITH DDM","10.1016/J.CELREP.2020.108428 ",3.5,"5.37397e+08","6opo_oligo10","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_b_)-MAN(4_b_)-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(262_D_)",57.2687,"","",""
"6OPO","SYMMETRIC MODEL OF CD4- AND 17-BOUND B41 HIV-1 ENV SOSIP IN COMPLEX WITH DDM","10.1016/J.CELREP.2020.108428 ",3.5,"5.37397e+08","6opo_oligo1","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_R_)-MAN(4_R_)-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(262_A_)",57.2687,"","",""
"6OPO","SYMMETRIC MODEL OF CD4- AND 17-BOUND B41 HIV-1 ENV SOSIP IN COMPLEX WITH DDM","10.1016/J.CELREP.2020.108428 ",3.5,"5.37397e+08","6opo_oligo26","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_l_)-MAN(4_l_)-BMA(3_l_)-NAG(2_l_)-NAG(1_l_)-ASN(262_J_)",57.2687,"","",""
"6OPP","ASYMMETRIC MODEL OF CD4- AND 17-BOUND B41 HIV-1 ENV SOSIP IN COMPLEX WITH DDM","10.1016/J.CELREP.2020.108428 ",3.7,"5.37397e+08","6opp_oligo21","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_g_)-BMA(3_g_)-NAG(2_g_)-NAG(1_g_)-ASN(362_D_)",152.964,"","",""
"6OPP","ASYMMETRIC MODEL OF CD4- AND 17-BOUND B41 HIV-1 ENV SOSIP IN COMPLEX WITH DDM","10.1016/J.CELREP.2020.108428 ",3.7,"5.37397e+08","6opp_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_R_)-[MAN(6_R_)-MAN(5_R_)-MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(262_A_)",107.39,"","",""
"6OPP","ASYMMETRIC MODEL OF CD4- AND 17-BOUND B41 HIV-1 ENV SOSIP IN COMPLEX WITH DDM","10.1016/J.CELREP.2020.108428 ",3.7,"5.37397e+08","6opp_oligo28","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_n_)-[MAN(5_n_)-MAN(4_n_)]-BMA(3_n_)-NAG(2_n_)-NAG(1_n_)-ASN(262_J_)",111.118,"","",""
"6OPP","ASYMMETRIC MODEL OF CD4- AND 17-BOUND B41 HIV-1 ENV SOSIP IN COMPLEX WITH DDM","10.1016/J.CELREP.2020.108428 ",3.7,"5.37397e+08","6opp_oligo6","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_V_)-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(362_A_)",160.32,"","",""
"6OPP","ASYMMETRIC MODEL OF CD4- AND 17-BOUND B41 HIV-1 ENV SOSIP IN COMPLEX WITH DDM","10.1016/J.CELREP.2020.108428 ",3.7,"5.37397e+08","6opp_oligo32","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_r_)-BMA(3_r_)-NAG(2_r_)-NAG(1_r_)-ASN(362_J_)",157.539,"","",""
"6OPP","ASYMMETRIC MODEL OF CD4- AND 17-BOUND B41 HIV-1 ENV SOSIP IN COMPLEX WITH DDM","10.1016/J.CELREP.2020.108428 ",3.7,"5.37397e+08","6opp_oligo13","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_c_)-[MAN(6_c_)-MAN(5_c_)-MAN(4_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(262_D_)",107.896,"","",""
"6OPQ","CD4- AND 17-BOUND HIV-1 ENV B41 SOSIP FROZEN WITH LMNG","10.1016/J.CELREP.2020.108428 ",3.8,"1.08527e-19","6opq_oligo20","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_i_)-MAN(4_i_)-BMA(3_i_)-NAG(2_i_)-NAG(1_i_)-ASN(262_E_)",71.3624,"","",""
"6OPQ","CD4- AND 17-BOUND HIV-1 ENV B41 SOSIP FROZEN WITH LMNG","10.1016/J.CELREP.2020.108428 ",3.8,"1.08527e-19","6opq_oligo2","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Q_)-MAN(4_Q_)-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(262_A_)",71.3624,"","",""
"6OPQ","CD4- AND 17-BOUND HIV-1 ENV B41 SOSIP FROZEN WITH LMNG","10.1016/J.CELREP.2020.108428 ",3.8,"1.08527e-19","6opq_oligo7","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Z_)-MAN(4_Z_)-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(262_D_)",71.3624,"","",""
"6OR4","CRYSTAL STRUCTURE OF SPGH29","10.1074/JBC.RA119.009368 ",2.1,22.78,"6or4_oligo2","DGalpb1-3[LFucpa1-4]DGlcpNAcb1-ROH","FUC(3_D_)-[GAL(2_D_)]-NAG(1_D_)",28.2806,"","",""
"6OR4","CRYSTAL STRUCTURE OF SPGH29","10.1074/JBC.RA119.009368 ",2.1,22.78,"6or4_oligo1","DGalpb1-3[LFucpa1-4]DGlcpNAcb1-ROH","FUC(3_C_)-[GAL(2_C_)]-NAG(1_C_)",33.5664,"","",""
"6ORF","CRYSTAL STRUCTURE OF SPGH29","10.1074/JBC.RA119.009368 ",1.7,18.51,"6orf_oligo2","LFucpa1-3[DGalpb1-4]DGlcpNAca1-ROH","GAL(3_D_)-[FUC(2_D_)]-NDG(1_D_)",13.4261,"","",""
"6ORF","CRYSTAL STRUCTURE OF SPGH29","10.1074/JBC.RA119.009368 ",1.7,18.51,"6orf_oligo1","LFucpa1-3[DGalpb1-4]DGlcpNAca1-ROH","GAL(3_C_)-[FUC(2_C_)]-NDG(1_C_)",12.2518,"","",""
"6ORH","CRYSTAL STRUCTURE OF SPGH29","10.1074/JBC.RA119.009368 ",1.62,21.9,"6orh_oligo2","LFucpa1-2DGalpb1-4[LFucpa1-3]DGlcpNAca1-ROH","FUC(3_D_)-GAL(2_D_)-[FUC(4_D_)]-NDG(1_D_)",19.5614,"","",""
"6ORH","CRYSTAL STRUCTURE OF SPGH29","10.1074/JBC.RA119.009368 ",1.62,21.9,"6orh_oligo1","LFucpa1-2DGalpb1-4[LFucpa1-3]DGlcpNAca1-ROH","FUC(3_C_)-GAL(2_C_)-[FUC(4_C_)]-NDG(1_C_)",16.3791,"","",""
"6ORM","CRYSTAL STRUCTURE OF PERUVIANIN-I (CYSTEINE PEPTIDASE FROM THEVETIA PERUVIANA LATEX)","10.1016/J.PLANTSCI.2020.110590 ",2.15,56.6,"6orm_oligo4","DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","BMA(3_G_)-NAG(2_G_)-[FUC(4_G_)]-NAG(1_G_)-ASN(144_B_)",78.885,"","",""
"6ORM","CRYSTAL STRUCTURE OF PERUVIANIN-I (CYSTEINE PEPTIDASE FROM THEVETIA PERUVIANA LATEX)","10.1016/J.PLANTSCI.2020.110590 ",2.15,56.6,"6orm_oligo3","DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","BMA(3_E_)-NAG(2_E_)-[FUC(4_E_)]-NAG(1_E_)-ASN(144_A_)",72.3066,"","",""
"6ORN","MODIFIED BG505 SOSIP-BASED IMMUNOGEN RC1 IN COMPLEX WITH THE ELICITED V3-GLYCAN PATCH BNAB 10-1074","10.1038/S41586-019-1250-Z ",4.05,"1.45136e+10","6orn_oligo8","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_H_)-MAN(6_H_)-[MAN(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(332_G_)",159.252,"","",""
"6ORN","MODIFIED BG505 SOSIP-BASED IMMUNOGEN RC1 IN COMPLEX WITH THE ELICITED V3-GLYCAN PATCH BNAB 10-1074","10.1038/S41586-019-1250-Z ",4.05,"1.45136e+10","6orn_oligo19","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_e_)-MAN(4_e_)-[MAN(6_e_)]-BMA(3_e_)-NAG(2_e_)-NAG(1_e_)-ASN(332_R_)",147.131,"","",""
"6ORN","MODIFIED BG505 SOSIP-BASED IMMUNOGEN RC1 IN COMPLEX WITH THE ELICITED V3-GLYCAN PATCH BNAB 10-1074","10.1038/S41586-019-1250-Z ",4.05,"1.45136e+10","6orn_oligo10","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_W_)-[MAN(5_W_)-MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(332_K_)",142.888,"","",""
"6ORN","MODIFIED BG505 SOSIP-BASED IMMUNOGEN RC1 IN COMPLEX WITH THE ELICITED V3-GLYCAN PATCH BNAB 10-1074","10.1038/S41586-019-1250-Z ",4.05,"1.45136e+10","6orn_oligo6","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_U_)-MAN(6_U_)-[MAN(5_U_)-MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(262_K_)",208.053,"","",""
"6ORN","MODIFIED BG505 SOSIP-BASED IMMUNOGEN RC1 IN COMPLEX WITH THE ELICITED V3-GLYCAN PATCH BNAB 10-1074","10.1038/S41586-019-1250-Z ",4.05,"1.45136e+10","6orn_oligo9","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-[MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(262_G_)",194.573,"","",""
"6ORN","MODIFIED BG505 SOSIP-BASED IMMUNOGEN RC1 IN COMPLEX WITH THE ELICITED V3-GLYCAN PATCH BNAB 10-1074","10.1038/S41586-019-1250-Z ",4.05,"1.45136e+10","6orn_oligo15","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_b_)-[MAN(5_b_)-MAN(4_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(262_R_)",193.564,"","",""
"6ORO","MODIFIED BG505 SOSIP-BASED IMMUNOGEN RC1 IN COMPLEX WITH THE ELICITED V3-GLYCAN PATCH ANTIBODY AB874NHP","10.1038/S41586-019-1250-Z ",3.9,"1.45136e+10","6oro_oligo20","DManpa1-2DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_f_)-MAN(5_f_)-MAN(4_f_)-BMA(3_f_)-NAG(2_f_)-NAG(1_f_)-ASN(332_I_)",119.446,"","",""
"6ORO","MODIFIED BG505 SOSIP-BASED IMMUNOGEN RC1 IN COMPLEX WITH THE ELICITED V3-GLYCAN PATCH ANTIBODY AB874NHP","10.1038/S41586-019-1250-Z ",3.9,"1.45136e+10","6oro_oligo7","DManpa1-2DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_N_)-MAN(5_N_)-MAN(4_N_)-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(332_B_)",116.197,"","",""
"6ORO","MODIFIED BG505 SOSIP-BASED IMMUNOGEN RC1 IN COMPLEX WITH THE ELICITED V3-GLYCAN PATCH ANTIBODY AB874NHP","10.1038/S41586-019-1250-Z ",3.9,"1.45136e+10","6oro_oligo2","DManpa1-2DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_W_)-MAN(5_W_)-MAN(4_W_)-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(332_G_)",112.493,"","",""
"6ORP","MODIFIED BG505 SOSIP-BASED IMMUNOGEN RC1 IN COMPLEX WITH THE ELICITED V3-GLYCAN PATCH ANTIBODY AB897NHP","10.1038/S41586-019-1250-Z ",4.4,"1.45136e+10","6orp_oligo24","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_j_)-[MAN(4_j_)]-BMA(3_j_)-NAG(2_j_)-NAG(1_j_)-ASN(262_I_)",378.461,"","",""
"6ORP","MODIFIED BG505 SOSIP-BASED IMMUNOGEN RC1 IN COMPLEX WITH THE ELICITED V3-GLYCAN PATCH ANTIBODY AB897NHP","10.1038/S41586-019-1250-Z ",4.4,"1.45136e+10","6orp_oligo12","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_b_)-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(262_G_)",364.064,"","",""
"6ORP","MODIFIED BG505 SOSIP-BASED IMMUNOGEN RC1 IN COMPLEX WITH THE ELICITED V3-GLYCAN PATCH ANTIBODY AB897NHP","10.1038/S41586-019-1250-Z ",4.4,"1.45136e+10","6orp_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_P_)-[MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(262_B_)",356.073,"","",""
"6ORQ","MODIFIED BG505 SOSIP-BASED IMMUNOGEN RC1 IN COMPLEX WITH THE ELICITED V3-GLYCAN PATCH ANTIBODY AB275MUR","10.1038/S41586-019-1250-Z ",4.4,12.4576,"6orq_oligo18","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_d_)-[MAN(4_d_)]-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(262_I_)",188.509,"","",""
"6ORQ","MODIFIED BG505 SOSIP-BASED IMMUNOGEN RC1 IN COMPLEX WITH THE ELICITED V3-GLYCAN PATCH ANTIBODY AB275MUR","10.1038/S41586-019-1250-Z ",4.4,12.4576,"6orq_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(262_B_)",184.31,"","",""
"6OSR","CRYSTAL STRUCTURE OF INFLUENZA HEMAGGLUTININ FROM STRAIN A/MELBOURNE/1/1946(H1N1)","10.1038/S41598-023-33529-W ",2.55,55.76,"6osr_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(271_B_)",85.6293,"","",""
"6OUS","STRUCTURE OF FUSION GLYCOPROTEIN FROM HUMAN RESPIRATORY SYNCYTIAL VIRUS","10.1038/S41467-019-12137-1 ",3.4,0,"6ous_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_b_)-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(27_G_)",79.6666,"","",""
"6OUS","STRUCTURE OF FUSION GLYCOPROTEIN FROM HUMAN RESPIRATORY SYNCYTIAL VIRUS","10.1038/S41467-019-12137-1 ",3.4,0,"6ous_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_Y_)-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(27_A_)",85.8477,"","",""
"6OUS","STRUCTURE OF FUSION GLYCOPROTEIN FROM HUMAN RESPIRATORY SYNCYTIAL VIRUS","10.1038/S41467-019-12137-1 ",3.4,0,"6ous_oligo6","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_d_)-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(27_K_)",90.6566,"","",""
"6OUS","STRUCTURE OF FUSION GLYCOPROTEIN FROM HUMAN RESPIRATORY SYNCYTIAL VIRUS","10.1038/S41467-019-12137-1 ",3.4,0,"6ous_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_a_)-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(27_E_)",86.4782,"","",""
"6OUS","STRUCTURE OF FUSION GLYCOPROTEIN FROM HUMAN RESPIRATORY SYNCYTIAL VIRUS","10.1038/S41467-019-12137-1 ",3.4,0,"6ous_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_c_)-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(27_I_)",114.644,"","",""
"6OUS","STRUCTURE OF FUSION GLYCOPROTEIN FROM HUMAN RESPIRATORY SYNCYTIAL VIRUS","10.1038/S41467-019-12137-1 ",3.4,0,"6ous_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_Z_)-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(27_C_)",91.3223,"","",""
"6OZ4","CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY N49P6 FAB IN COMPLEX WITH HIV-1 BG505 SOSIP.664 ENV TRIMER ECTODOMAIN.","10.1128/MBIO.01274-21 ",4.05,0,"6oz4_oligo3","DManpa1-2DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_K_)-MAN(5_K_)-MAN(4_K_)-[MAN(7_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(332_G_)",372.288,"","",""
"6OZC","BG505 SOSIP.664 WITH 2G12 FAB2","10.1016/J.STR.2020.04.022 ",3.79,53839.1,"6ozc_oligo22","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_n_)-[MAN(4_n_)]-BMA(3_n_)-NAG(2_n_)-NAG(1_n_)-ASN(363_F_)",143.178,"","",""
"6OZC","BG505 SOSIP.664 WITH 2G12 FAB2","10.1016/J.STR.2020.04.022 ",3.79,53839.1,"6ozc_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_f_)-[MAN(4_f_)]-BMA(3_f_)-NAG(2_f_)-NAG(1_f_)-ASN(386_E_)",128.351,"","",""
"6OZC","BG505 SOSIP.664 WITH 2G12 FAB2","10.1016/J.STR.2020.04.022 ",3.79,53839.1,"6ozc_oligo27","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_s_)-[MAN(6_s_)-MAN(5_s_)]-MAN(4_s_)-[MAN(9_s_)-MAN(8_s_)]-BMA(3_s_)-NAG(2_s_)-NAG(1_s_)-ASN(339_F_)",108.026,"","",""
"6OZC","BG505 SOSIP.664 WITH 2G12 FAB2","10.1016/J.STR.2020.04.022 ",3.79,53839.1,"6ozc_oligo11","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_X_)-[MAN(6_X_)-MAN(5_X_)-MAN(4_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(295_A_)",99.7662,"","",""
"6OZC","BG505 SOSIP.664 WITH 2G12 FAB2","10.1016/J.STR.2020.04.022 ",3.79,53839.1,"6ozc_oligo25","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_q_)-[MAN(6_q_)-MAN(5_q_)]-MAN(4_q_)-[MAN(8_q_)]-BMA(3_q_)-NAG(2_q_)-NAG(1_q_)-ASN(332_F_)",86.0985,"","",""
"6OZC","BG505 SOSIP.664 WITH 2G12 FAB2","10.1016/J.STR.2020.04.022 ",3.79,53839.1,"6ozc_oligo5","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_g_)-[MAN(6_g_)-MAN(5_g_)]-MAN(4_g_)-[MAN(8_g_)]-BMA(3_g_)-NAG(2_g_)-NAG(1_g_)-ASN(332_E_)",86.0985,"","",""
"6OZC","BG505 SOSIP.664 WITH 2G12 FAB2","10.1016/J.STR.2020.04.022 ",3.79,53839.1,"6ozc_oligo6","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_h_)-[MAN(6_h_)-MAN(5_h_)-MAN(4_h_)]-BMA(3_h_)-NAG(2_h_)-NAG(1_h_)-ASN(295_E_)",99.7662,"","",""
"6OZC","BG505 SOSIP.664 WITH 2G12 FAB2","10.1016/J.STR.2020.04.022 ",3.79,53839.1,"6ozc_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_d_)-[MAN(4_d_)]-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(363_E_)",143.178,"","",""
"6OZC","BG505 SOSIP.664 WITH 2G12 FAB2","10.1016/J.STR.2020.04.022 ",3.79,53839.1,"6ozc_oligo23","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_o_)-[MAN(8_o_)]-MAN(7_o_)-[MAN(6_o_)-MAN(5_o_)-MAN(4_o_)]-BMA(3_o_)-NAG(2_o_)-NAG(1_o_)-ASN(392_F_)",89.0711,"","",""
"6OZC","BG505 SOSIP.664 WITH 2G12 FAB2","10.1016/J.STR.2020.04.022 ",3.79,53839.1,"6ozc_oligo17","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_T_)-[MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(363_A_)",143.178,"","",""
"6OZC","BG505 SOSIP.664 WITH 2G12 FAB2","10.1016/J.STR.2020.04.022 ",3.79,53839.1,"6ozc_oligo16","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_c_)-[MAN(5_c_)-MAN(4_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(262_E_)",110.999,"","",""
"6OZC","BG505 SOSIP.664 WITH 2G12 FAB2","10.1016/J.STR.2020.04.022 ",3.79,53839.1,"6ozc_oligo26","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_r_)-[MAN(6_r_)-MAN(5_r_)-MAN(4_r_)]-BMA(3_r_)-NAG(2_r_)-NAG(1_r_)-ASN(295_F_)",99.7662,"","",""
"6OZC","BG505 SOSIP.664 WITH 2G12 FAB2","10.1016/J.STR.2020.04.022 ",3.79,53839.1,"6ozc_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_e_)-[MAN(8_e_)]-MAN(7_e_)-[MAN(6_e_)-MAN(5_e_)-MAN(4_e_)]-BMA(3_e_)-NAG(2_e_)-NAG(1_e_)-ASN(392_E_)",89.0711,"","",""
"6OZC","BG505 SOSIP.664 WITH 2G12 FAB2","10.1016/J.STR.2020.04.022 ",3.79,53839.1,"6ozc_oligo10","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_W_)-[MAN(6_W_)-MAN(5_W_)]-MAN(4_W_)-[MAN(8_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(332_A_)",86.0985,"","",""
"6OZC","BG505 SOSIP.664 WITH 2G12 FAB2","10.1016/J.STR.2020.04.022 ",3.79,53839.1,"6ozc_oligo24","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_p_)-[MAN(4_p_)]-BMA(3_p_)-NAG(2_p_)-NAG(1_p_)-ASN(386_F_)",128.351,"","",""
"6OZC","BG505 SOSIP.664 WITH 2G12 FAB2","10.1016/J.STR.2020.04.022 ",3.79,53839.1,"6ozc_oligo7","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_i_)-[MAN(6_i_)-MAN(5_i_)]-MAN(4_i_)-[MAN(9_i_)-MAN(8_i_)]-BMA(3_i_)-NAG(2_i_)-NAG(1_i_)-ASN(339_E_)",108.026,"","",""
"6OZC","BG505 SOSIP.664 WITH 2G12 FAB2","10.1016/J.STR.2020.04.022 ",3.79,53839.1,"6ozc_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_V_)-[MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(386_A_)",128.351,"","",""
"6OZC","BG505 SOSIP.664 WITH 2G12 FAB2","10.1016/J.STR.2020.04.022 ",3.79,53839.1,"6ozc_oligo8","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_U_)-[MAN(8_U_)]-MAN(7_U_)-[MAN(6_U_)-MAN(5_U_)-MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(392_A_)",89.0711,"","",""
"6OZC","BG505 SOSIP.664 WITH 2G12 FAB2","10.1016/J.STR.2020.04.022 ",3.79,53839.1,"6ozc_oligo9","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_S_)-[MAN(5_S_)-MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(262_A_)",110.999,"","",""
"6OZC","BG505 SOSIP.664 WITH 2G12 FAB2","10.1016/J.STR.2020.04.022 ",3.79,53839.1,"6ozc_oligo12","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_Y_)-[MAN(6_Y_)-MAN(5_Y_)]-MAN(4_Y_)-[MAN(9_Y_)-MAN(8_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(339_A_)",108.026,"","",""
"6OZC","BG505 SOSIP.664 WITH 2G12 FAB2","10.1016/J.STR.2020.04.022 ",3.79,53839.1,"6ozc_oligo21","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_m_)-[MAN(5_m_)-MAN(4_m_)]-BMA(3_m_)-NAG(2_m_)-NAG(1_m_)-ASN(262_F_)",110.999,"","",""
"6P3R","CRYSTAL STRUCTURE OF HUMAN FAB H5.31 IN COMPLEX WITH INFLUENZA A H5N1 VIETNAM HEMAGGLUTININ HEAD DOMAIN","",3,0,"6p3r_oligo4","DNeup5Aca2-6DGalpa1-4DGlcpNAca1-2DManpa1-6[DManpa1-3]DManpa1-4DGlcpNAca1-4DGlcpNAcx1-","SIA(7_G_)-GLA(6_G_)-NDG(5_G_)-MAN(4_G_)-[MAN(8_G_)]-MAN(3_G_)-NDG(2_G_)-NAG(1_G_)",150.739,"","",""
"6P62","HIV ENV BG505 NFL TD+ IN COMPLEX WITH ANTIBODY E70 FRAGMENT ANTIGEN BINDING","10.1016/J.IMMUNI.2019.10.008 ",3.57,0.000748774,"6p62_oligo6","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_R_)-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(262_B_)",47.7875,"","",""
"6P62","HIV ENV BG505 NFL TD+ IN COMPLEX WITH ANTIBODY E70 FRAGMENT ANTIGEN BINDING","10.1016/J.IMMUNI.2019.10.008 ",3.57,0.000748774,"6p62_oligo5","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_Q_)-[MAN(6_Q_)-MAN(5_Q_)-MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(234_B_)",49.2008,"","",""
"6P62","HIV ENV BG505 NFL TD+ IN COMPLEX WITH ANTIBODY E70 FRAGMENT ANTIGEN BINDING","10.1016/J.IMMUNI.2019.10.008 ",3.57,0.000748774,"6p62_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_J_)-[MAN(6_J_)-MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(234_A_)",49.2008,"","",""
"6P62","HIV ENV BG505 NFL TD+ IN COMPLEX WITH ANTIBODY E70 FRAGMENT ANTIGEN BINDING","10.1016/J.IMMUNI.2019.10.008 ",3.57,0.000748774,"6p62_oligo14","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_W_)-[MAN(6_W_)-MAN(5_W_)-MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(234_E_)",49.2008,"","",""
"6P62","HIV ENV BG505 NFL TD+ IN COMPLEX WITH ANTIBODY E70 FRAGMENT ANTIGEN BINDING","10.1016/J.IMMUNI.2019.10.008 ",3.57,0.000748774,"6p62_oligo15","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_X_)-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(262_E_)",47.7875,"","",""
"6P62","HIV ENV BG505 NFL TD+ IN COMPLEX WITH ANTIBODY E70 FRAGMENT ANTIGEN BINDING","10.1016/J.IMMUNI.2019.10.008 ",3.57,0.000748774,"6p62_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_K_)-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(262_A_)",47.7875,"","",""
"6P65","HIV ENV 16055 NFL TD 2CC+ IN COMPLEX WITH ANTIBODY 1C2 FRAGMENT ANTIGEN BINDING","10.1016/J.IMMUNI.2019.10.008 ",3.94,0.000748774,"6p65_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(88_A_)",97.3982,"","",""
"6P65","HIV ENV 16055 NFL TD 2CC+ IN COMPLEX WITH ANTIBODY 1C2 FRAGMENT ANTIGEN BINDING","10.1016/J.IMMUNI.2019.10.008 ",3.94,0.000748774,"6p65_oligo38","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_u_)-[MAN(4_u_)]-BMA(3_u_)-NAG(2_u_)-NAG(1_u_)-ASN(262_E_)",73.1551,"","",""
"6P65","HIV ENV 16055 NFL TD 2CC+ IN COMPLEX WITH ANTIBODY 1C2 FRAGMENT ANTIGEN BINDING","10.1016/J.IMMUNI.2019.10.008 ",3.94,0.000748774,"6p65_oligo17","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_n_)-[MAN(4_n_)]-BMA(3_n_)-NAG(2_n_)-NAG(1_n_)-ASN(88_E_)",97.3982,"","",""
"6P65","HIV ENV 16055 NFL TD 2CC+ IN COMPLEX WITH ANTIBODY 1C2 FRAGMENT ANTIGEN BINDING","10.1016/J.IMMUNI.2019.10.008 ",3.94,0.000748774,"6p65_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_f_)-[MAN(4_f_)]-BMA(3_f_)-NAG(2_f_)-NAG(1_f_)-ASN(262_B_)",73.1551,"","",""
"6P65","HIV ENV 16055 NFL TD 2CC+ IN COMPLEX WITH ANTIBODY 1C2 FRAGMENT ANTIGEN BINDING","10.1016/J.IMMUNI.2019.10.008 ",3.94,0.000748774,"6p65_oligo31","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Y_)-[MAN(4_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(88_B_)",97.3982,"","",""
"6P65","HIV ENV 16055 NFL TD 2CC+ IN COMPLEX WITH ANTIBODY 1C2 FRAGMENT ANTIGEN BINDING","10.1016/J.IMMUNI.2019.10.008 ",3.94,0.000748774,"6p65_oligo23","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Q_)-[MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(262_A_)",73.1551,"","",""
"6P6D","HUMAN IGG1 FC FRAGMENT, C239 INSERTION MUTANT","10.3390/PHARMACEUTICS11100546 ",2.31,53.83,"6p6d_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",114.865,"","",""
"6P6D","HUMAN IGG1 FC FRAGMENT, C239 INSERTION MUTANT","10.3390/PHARMACEUTICS11100546 ",2.31,53.83,"6p6d_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",74.0993,"","",""
"6P72","CRYSTAL STRUCTURE OF THE CEDAR HENIPAVIRUS ATTACHMENT G GLYCOPROTEIN GLOBAL DOMAIN","10.1073/PNAS.1911773116 ",3.28,62.17,"6p72_oligo8","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(502_C_)",104.219,"","",""
"6P72","CRYSTAL STRUCTURE OF THE CEDAR HENIPAVIRUS ATTACHMENT G GLYCOPROTEIN GLOBAL DOMAIN","10.1073/PNAS.1911773116 ",3.28,62.17,"6p72_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAca1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(562_C_)",89.2824,"","",""
"6P7Y","CRYSTAL STRUCTURE OF THE CEDAR HENIPAVIRUS ATTACHMENT G GLYCOPROTEIN GLOBULAR DOMAIN IN COMPLEX WITH THE RECEPTOR EPHRIN-B2","10.1073/PNAS.1911773116 ",2.84,65.29,"6p7y_oligo11","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(562_C_)",105.377,"","",""
"6P7Y","CRYSTAL STRUCTURE OF THE CEDAR HENIPAVIRUS ATTACHMENT G GLYCOPROTEIN GLOBULAR DOMAIN IN COMPLEX WITH THE RECEPTOR EPHRIN-B2","10.1073/PNAS.1911773116 ",2.84,65.29,"6p7y_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6][LFucpb1-3]DGlcpNAcb1-ASN","FUC(7_G_)-[MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)]-[FUC(6_G_)]-NAG(1_G_)-ASN(403_A_)",104.784,"","",""
"6P7Y","CRYSTAL STRUCTURE OF THE CEDAR HENIPAVIRUS ATTACHMENT G GLYCOPROTEIN GLOBULAR DOMAIN IN COMPLEX WITH THE RECEPTOR EPHRIN-B2","10.1073/PNAS.1911773116 ",2.84,65.29,"6p7y_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(502_A_)",81.6887,"","",""
"6P7Y","CRYSTAL STRUCTURE OF THE CEDAR HENIPAVIRUS ATTACHMENT G GLYCOPROTEIN GLOBULAR DOMAIN IN COMPLEX WITH THE RECEPTOR EPHRIN-B2","10.1073/PNAS.1911773116 ",2.84,65.29,"6p7y_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(311_C_)",128.904,"","",""
"6P7Y","CRYSTAL STRUCTURE OF THE CEDAR HENIPAVIRUS ATTACHMENT G GLYCOPROTEIN GLOBULAR DOMAIN IN COMPLEX WITH THE RECEPTOR EPHRIN-B2","10.1073/PNAS.1911773116 ",2.84,65.29,"6p7y_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(562_A_)",104.05,"","",""
"6P7Y","CRYSTAL STRUCTURE OF THE CEDAR HENIPAVIRUS ATTACHMENT G GLYCOPROTEIN GLOBULAR DOMAIN IN COMPLEX WITH THE RECEPTOR EPHRIN-B2","10.1073/PNAS.1911773116 ",2.84,65.29,"6p7y_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(425_A_)",97.1351,"","",""
"6P8I","N-TERMINAL 5 DOMAINS OF IGFIIR","10.1038/S42003-020-01211-W ",2.54,65.86,"6p8i_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(591_A_)",157.113,"","",""
"6P8M","CRYSTAL STRUCTURE OF ANTIBODY P-P3B3 A60C HEAVY CHAIN IN COMPLEX WITH 426C HIV-1 GP120 CORE G459C","10.1016/J.CELREP.2019.10.071 ",3.59,0,"6p8m_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_A_)-[MAN(4_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(262_C_)",140.773,"","",""
"6P91","STRUCTURE OF LASSA VIRUS GLYCOPROTEIN BOUND TO FAB 18.5C","10.1016/J.CELL.2019.07.020 ",4,209,"6p91_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(365_a_)",296.615,"","",""
"6P91","STRUCTURE OF LASSA VIRUS GLYCOPROTEIN BOUND TO FAB 18.5C","10.1016/J.CELL.2019.07.020 ",4,209,"6p91_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(79_A_)",259.185,"","",""
"6P95","STRUCTURE OF LASSA VIRUS GLYCOPROTEIN IN COMPLEX WITH FAB 25.6A","10.1016/J.CELL.2019.07.020 ",3.5,123.5,"6p95_oligo12","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_U_)-[MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(373_a_)",161.811,"","",""
"6P95","STRUCTURE OF LASSA VIRUS GLYCOPROTEIN IN COMPLEX WITH FAB 25.6A","10.1016/J.CELL.2019.07.020 ",3.5,123.5,"6p95_oligo14","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_W_)-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(365_b_)",165.114,"","",""
"6P95","STRUCTURE OF LASSA VIRUS GLYCOPROTEIN IN COMPLEX WITH FAB 25.6A","10.1016/J.CELL.2019.07.020 ",3.5,123.5,"6p95_oligo11","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_T_)-MAN(4_T_)-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(365_a_)",160.388,"","",""
"6P95","STRUCTURE OF LASSA VIRUS GLYCOPROTEIN IN COMPLEX WITH FAB 25.6A","10.1016/J.CELL.2019.07.020 ",3.5,123.5,"6p95_oligo17","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_Z_)-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(365_c_)",156.488,"","",""
"6P95","STRUCTURE OF LASSA VIRUS GLYCOPROTEIN IN COMPLEX WITH FAB 25.6A","10.1016/J.CELL.2019.07.020 ",3.5,123.5,"6p95_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_O_)-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(109_B_)",227.098,"","",""
"6PCI","EBOV GPDMUC (MAKONA) IN COMPLEX WITH REBOV-520 AND REBOV-548 FABS","10.1016/J.IMMUNI.2020.01.001 ",4.12,"1.08527e-19","6pci_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_U_)-[MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(563_F_)",124.551,"","",""
"6PCI","EBOV GPDMUC (MAKONA) IN COMPLEX WITH REBOV-520 AND REBOV-548 FABS","10.1016/J.IMMUNI.2020.01.001 ",4.12,"1.08527e-19","6pci_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_T_)-[MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(563_E_)",118.981,"","",""
"6PCI","EBOV GPDMUC (MAKONA) IN COMPLEX WITH REBOV-520 AND REBOV-548 FABS","10.1016/J.IMMUNI.2020.01.001 ",4.12,"1.08527e-19","6pci_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(563_D_)",120.192,"","",""
"6PD4","CRYSTAL STRUCTURE OF HENDRA VIRUS ATTACHMENT G GLYCOPROTEIN","10.1371/JOURNAL.PONE.0048742 ",2.2,32.52,"6pd4_oligo6","DManpb1-6DManpa1-4DGlcpNAcb1-4[LFucpb1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(6_H_)-[BMA(4_H_)-BMA(3_H_)-NAG(2_H_)]-[FUC(5_H_)]-NAG(1_H_)-ASN(529_B_)",57.8429,"","",""
"6PD4","CRYSTAL STRUCTURE OF HENDRA VIRUS ATTACHMENT G GLYCOPROTEIN","10.1371/JOURNAL.PONE.0048742 ",2.2,32.52,"6pd4_oligo2","LFucpa1-3[DGlcpNAcb1-4][LFucpb1-6]DGlcpNAcb1-ASN","FUC(4_E_)-[NAG(3_E_)]-[FUC(2_E_)]-NAG(1_E_)-ASN(529_A_)",51.6116,"","",""
"6PDL","CRYSTAL STRUCTURE OF HENDRA VIRUS ATTACHMENT G GLYCOPROTEIN IN COMPLEX WITH RECEPTOR EPHRIN-B2","10.1371/JOURNAL.PONE.0048742 ",2.7,35.6,"6pdl_oligo12","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(7_T_)-[MAN(5_T_)-[MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)]-[FUC(6_T_)]-NAG(1_T_)-ASN(529_G_)",35.3121,"","",""
"6PDL","CRYSTAL STRUCTURE OF HENDRA VIRUS ATTACHMENT G GLYCOPROTEIN IN COMPLEX WITH RECEPTOR EPHRIN-B2","10.1371/JOURNAL.PONE.0048742 ",2.7,35.6,"6pdl_oligo5","DManpb1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4[LFucpa1-6][LFucpb1-3]DGlcpNAcb1-ASN","FUC(7_K_)-[MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)]-[FUC(6_K_)]-NAG(1_K_)-ASN(529_A_)",70.2836,"","",""
"6PDL","CRYSTAL STRUCTURE OF HENDRA VIRUS ATTACHMENT G GLYCOPROTEIN IN COMPLEX WITH RECEPTOR EPHRIN-B2","10.1371/JOURNAL.PONE.0048742 ",2.7,35.6,"6pdl_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(7_N_)-[MAN(5_N_)-[BMA(4_N_)]-MAN(3_N_)-NAG(2_N_)]-[FUC(6_N_)]-NAG(1_N_)-ASN(529_C_)",29.4042,"","",""
"6PDL","CRYSTAL STRUCTURE OF HENDRA VIRUS ATTACHMENT G GLYCOPROTEIN IN COMPLEX WITH RECEPTOR EPHRIN-B2","10.1371/JOURNAL.PONE.0048742 ",2.7,35.6,"6pdl_oligo9","DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(5_Q_)-[BMA(3_Q_)-NAG(2_Q_)]-[FUC(4_Q_)]-NAG(1_Q_)-ASN(529_E_)",51.0882,"","",""
"6PEL","CRYSTAL STRUCTURE OF BOVINE OPSIN WITH CITRONELLOL BOUND","",3.19,0,"6pel_oligo1","DManpb1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(15_A_)",111.745,"","",""
"6PGS","CRYSTAL STRUCTURE OF BOVINE OPSIN WITH GERANIOL BOUND","",2.91,0,"6pgs_oligo2","DManpb1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(15_A_)",96.9034,"","",""
"6PH7","CRYSTAL STRUCTURE OF BOVINE OPSIN WITH NEROL BOUND","",2.9,0,"6ph7_oligo1","DManpb1-3DManpb1-4DGlcpNAcb1-4DGlcpNAca1-ASN","BMA(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(15_A_)",101.198,"","",""
"6PHY","SPAGA D472N STRUCTURE IN COMPLEX ALPHA 1,3 GALACTOBIOSE","10.1074/JBC.RA119.010280 ",2,27.47,"6phy_oligo1","DGalpa1-3DGalpb1-ROH","GLA(2_B_)-GAL(1_B_)",30.7827,"","",""
"6PHY","SPAGA D472N STRUCTURE IN COMPLEX ALPHA 1,3 GALACTOBIOSE","10.1074/JBC.RA119.010280 ",2,27.47,"6phy_oligo2","DGalpa1-3DGalpa1-ROH","GLA(2_C_)-GLA(1_C_)",47.4723,"","",""
"6PI0","AGAD472N-LINEAR BLOOD GROUP B TYPE 2 TRISACCHARIDE COMPLEX STRUCTURE","10.1074/JBC.RA119.010280 ",2.09,26.4,"6pi0_oligo1","DGalpa1-3DGalpb1-ROH","GLA(2_B_)-GAL(1_B_)",41.5782,"","",""
"6PKG","ZEBRAFISH N-ACETYLGLUCOSAMINE-1-PHOSPHODIESTER ALPHA-N- ACETYLGLUCOSAMINIDASE (NAGPA) CATALYTIC DOMAIN AUTO-INHIBITED BY PRO- PEPTIDE","10.1016/J.STR.2020.02.001 ",2.8,0,"6pkg_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_C_)-[MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(223_A_)",76.1277,"","",""
"6PKH","ZEBRAFISH N-ACETYLGLUCOSAMINE-1-PHOSPHODIESTER ALPHA-N- ACETYLGLUCOSAMINIDASE (NAGPA) CATALYTIC DOMAIN AUTO-INHIBITED BY PRO- PEPTIDE","10.1016/J.STR.2020.02.001 ",1.6,0,"6pkh_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_B_)-[MAN(4_B_)-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(223_A_)",77.0922,"","",""
"6PV7","HUMAN ALPHA3BETA4 NICOTINIC ACETYLCHOLINE RECEPTOR IN COMPLEX WITH NICOTINE","10.1016/J.NEURON.2019.07.030 ",3.34,"1.49247e-19","6pv7_oligo13","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(145_E_)",56.5693,"","",""
"6PV7","HUMAN ALPHA3BETA4 NICOTINIC ACETYLCHOLINE RECEPTOR IN COMPLEX WITH NICOTINE","10.1016/J.NEURON.2019.07.030 ",3.34,"1.49247e-19","6pv7_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(141_A_)",53.5422,"","",""
"6PV7","HUMAN ALPHA3BETA4 NICOTINIC ACETYLCHOLINE RECEPTOR IN COMPLEX WITH NICOTINE","10.1016/J.NEURON.2019.07.030 ",3.34,"1.49247e-19","6pv7_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(145_B_)",67.9196,"","",""
"6PV7","HUMAN ALPHA3BETA4 NICOTINIC ACETYLCHOLINE RECEPTOR IN COMPLEX WITH NICOTINE","10.1016/J.NEURON.2019.07.030 ",3.34,"1.49247e-19","6pv7_oligo11","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Q_)-[MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(141_D_)",43.2825,"","",""
"6PV7","HUMAN ALPHA3BETA4 NICOTINIC ACETYLCHOLINE RECEPTOR IN COMPLEX WITH NICOTINE","10.1016/J.NEURON.2019.07.030 ",3.34,"1.49247e-19","6pv7_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(145_C_)",72.0353,"","",""
"6PV8","HUMAN ALPHA3BETA4 NICOTINIC ACETYLCHOLINE RECEPTOR IN COMPLEX WITH AT- 1001","10.1016/J.NEURON.2019.07.030 ",3.87,"1.49247e-19","6pv8_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(145_E_)",49.0451,"","",""
"6PV8","HUMAN ALPHA3BETA4 NICOTINIC ACETYLCHOLINE RECEPTOR IN COMPLEX WITH AT- 1001","10.1016/J.NEURON.2019.07.030 ",3.87,"1.49247e-19","6pv8_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Q_)-[MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(141_D_)",39.86,"","",""
"6PV8","HUMAN ALPHA3BETA4 NICOTINIC ACETYLCHOLINE RECEPTOR IN COMPLEX WITH AT- 1001","10.1016/J.NEURON.2019.07.030 ",3.87,"1.49247e-19","6pv8_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(141_A_)",37.5302,"","",""
"6PV8","HUMAN ALPHA3BETA4 NICOTINIC ACETYLCHOLINE RECEPTOR IN COMPLEX WITH AT- 1001","10.1016/J.NEURON.2019.07.030 ",3.87,"1.49247e-19","6pv8_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(145_C_)",56.7971,"","",""
"6PV8","HUMAN ALPHA3BETA4 NICOTINIC ACETYLCHOLINE RECEPTOR IN COMPLEX WITH AT- 1001","10.1016/J.NEURON.2019.07.030 ",3.87,"1.49247e-19","6pv8_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(145_B_)",61.3084,"","",""
"6PW0","CYTOCHROME C OXIDASE DELTA 6 MUTANT","10.1016/J.BBABIO.2019.148116 ",2.5,51.19,"6pw0_oligo8","DGlcpa1-3DGlcpb6-ROH","DMU(301_D_)-DMU(301_D_)",79.6809,"","",""
"6PW0","CYTOCHROME C OXIDASE DELTA 6 MUTANT","10.1016/J.BBABIO.2019.148116 ",2.5,51.19,"6pw0_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(607_A_)-DMU(607_A_)",68.7973,"","",""
"6PW0","CYTOCHROME C OXIDASE DELTA 6 MUTANT","10.1016/J.BBABIO.2019.148116 ",2.5,51.19,"6pw0_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(608_A_)-DMU(608_A_)",43.9032,"","",""
"6PW0","CYTOCHROME C OXIDASE DELTA 6 MUTANT","10.1016/J.BBABIO.2019.148116 ",2.5,51.19,"6pw0_oligo5","DGlcpa1-3DGlcpb6-C10O1","DMU(605_A_)-DMU(605_A_)",66.3814,"","",""
"6PW0","CYTOCHROME C OXIDASE DELTA 6 MUTANT","10.1016/J.BBABIO.2019.148116 ",2.5,51.19,"6pw0_oligo4","DGlcpa1-3DGlcpb6-C10O1","DMU(606_A_)-DMU(606_A_)",64.4118,"","",""
"6PW0","CYTOCHROME C OXIDASE DELTA 6 MUTANT","10.1016/J.BBABIO.2019.148116 ",2.5,51.19,"6pw0_oligo10","DGlcpa1-3DGlcpb6-C10O1","DMU(604_A_)-DMU(604_A_)",98.2027,"","",""
"6PW0","CYTOCHROME C OXIDASE DELTA 6 MUTANT","10.1016/J.BBABIO.2019.148116 ",2.5,51.19,"6pw0_oligo3","DGlcpa1-3DGlcpb6-C7O1","DMU(301_B_)-DMU(301_B_)",82.9936,"","",""
"6PW0","CYTOCHROME C OXIDASE DELTA 6 MUTANT","10.1016/J.BBABIO.2019.148116 ",2.5,51.19,"6pw0_oligo6","DGlcpa1-3DGlcpb6-ROH","DMU(604_C_)-DMU(604_C_)",90.9395,"","",""
"6PW0","CYTOCHROME C OXIDASE DELTA 6 MUTANT","10.1016/J.BBABIO.2019.148116 ",2.5,51.19,"6pw0_oligo7","DGlcpa1-3DGlcpb6-C10O1","DMU(605_C_)-DMU(605_C_)",83.9873,"","",""
"6PW1","CYTOCHROME C OXIDASE DELTA 16","10.1016/J.BBABIO.2019.148116 ",2.1,40.06,"6pw1_oligo6","DGlcpa1-3DGlcpb6-C10O1","DMU(613_A_)-DMU(613_A_)",63.8023,"","",""
"6PW1","CYTOCHROME C OXIDASE DELTA 16","10.1016/J.BBABIO.2019.148116 ",2.1,40.06,"6pw1_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(614_A_)-DMU(614_A_)",62.7145,"","",""
"6PW1","CYTOCHROME C OXIDASE DELTA 16","10.1016/J.BBABIO.2019.148116 ",2.1,40.06,"6pw1_oligo4","DGlcpa1-3DGlcpb6-C10O1","DMU(611_A_)-DMU(611_A_)",86.4532,"","",""
"6PW1","CYTOCHROME C OXIDASE DELTA 16","10.1016/J.BBABIO.2019.148116 ",2.1,40.06,"6pw1_oligo3","DGlcpa1-3DGlcpb6-C10O1","DMU(612_A_)-DMU(612_A_)",33.0782,"","",""
"6PW1","CYTOCHROME C OXIDASE DELTA 16","10.1016/J.BBABIO.2019.148116 ",2.1,40.06,"6pw1_oligo2","DGlcpa1-3DGlcpb6-C7O1","DMU(302_B_)-DMU(302_B_)",58.1955,"","",""
"6PW6","THE HIV-1 ENVELOPE GLYCOPROTEIN CLONE BG505 SOSIP.664 IN COMPLEX WITH THREE COPIES OF THE BOVINE BROADLY NEUTRALIZING ANTIBODY, NC-COW1, FRAGMENT ANTIGEN BINDING DOMAIN","10.1126/SCIADV.ABA0468 ",4.5,"1.42472e+13","6pw6_oligo20","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_R_)-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(197_A_)",112.041,"","",""
"6PW6","THE HIV-1 ENVELOPE GLYCOPROTEIN CLONE BG505 SOSIP.664 IN COMPLEX WITH THREE COPIES OF THE BOVINE BROADLY NEUTRALIZING ANTIBODY, NC-COW1, FRAGMENT ANTIGEN BINDING DOMAIN","10.1126/SCIADV.ABA0468 ",4.5,"1.42472e+13","6pw6_oligo29","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_l_)-BMA(3_l_)-NAG(2_l_)-NAG(1_l_)-ASN(197_E_)",112.041,"","",""
"6PW6","THE HIV-1 ENVELOPE GLYCOPROTEIN CLONE BG505 SOSIP.664 IN COMPLEX WITH THREE COPIES OF THE BOVINE BROADLY NEUTRALIZING ANTIBODY, NC-COW1, FRAGMENT ANTIGEN BINDING DOMAIN","10.1126/SCIADV.ABA0468 ",4.5,"1.42472e+13","6pw6_oligo12","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_b_)-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(197_C_)",112.041,"","",""
"6PWT","CRYSTAL STRUCTURE OF THE COW C-TYPE CARBOHYDRATE-RECOGNITION DOMAIN OF CD23 IN THE PRESENCE OF GLCNAC2MAN3 OLIGOSACCHARIDE","10.1074/JBC.RA119.010572 ",2.7,85.3,"6pwt_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpa1-ROH","NAG(5_B_)-MAN(4_B_)-[NAG(3_B_)-MAN(2_B_)]-MAN(1_B_)",78.1735,"","",""
"6PWU","STRUCTURE OF FULL-LENGTH, FULLY GLYCOSYLATED, NON-MODIFIED HIV-1 GP160 BOUND TO PG16 FAB","10.1016/J.JMB.2019.11.028 ",6.2,844820,"6pwu_oligo16","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(160_A_)",300.024,"","",""
"6PWU","STRUCTURE OF FULL-LENGTH, FULLY GLYCOSYLATED, NON-MODIFIED HIV-1 GP160 BOUND TO PG16 FAB","10.1016/J.JMB.2019.11.028 ",6.2,844820,"6pwu_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_X_)-[MAN(5_X_)]-MAN(4_X_)-[MAN(7_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(160_E_)",302.096,"","",""
"6PWU","STRUCTURE OF FULL-LENGTH, FULLY GLYCOSYLATED, NON-MODIFIED HIV-1 GP160 BOUND TO PG16 FAB","10.1016/J.JMB.2019.11.028 ",6.2,844820,"6pwu_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(200_A_)",441.867,"","",""
"6PXH","CRYSTAL STRUCTURE OF MERS-COV S1-NTD BOUND WITH G2 FAB","10.1016/J.CELREP.2019.08.052 ",2.3,44.06,"6pxh_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(222_B_)",64.4831,"","",""
"6PXH","CRYSTAL STRUCTURE OF MERS-COV S1-NTD BOUND WITH G2 FAB","10.1016/J.CELREP.2019.08.052 ",2.3,44.06,"6pxh_oligo3","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_J_)-[MAN(7_J_)]-MAN(6_J_)-[MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(222_A_)",70.752,"","",""
"6PZ8","MERS S0 TRIMER IN COMPLEX WITH VARIABLE DOMAIN OF ANTIBODY G2","10.1016/J.CELREP.2019.08.052 ",4.19,512.502,"6pz8_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(222_B_)",372.533,"","",""
"6PZ8","MERS S0 TRIMER IN COMPLEX WITH VARIABLE DOMAIN OF ANTIBODY G2","10.1016/J.CELREP.2019.08.052 ",4.19,512.502,"6pz8_oligo23","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_i_)-[MAN(4_i_)]-BMA(3_i_)-NAG(2_i_)-NAG(1_i_)-ASN(222_F_)",372.533,"","",""
"6PZ8","MERS S0 TRIMER IN COMPLEX WITH VARIABLE DOMAIN OF ANTIBODY G2","10.1016/J.CELREP.2019.08.052 ",4.19,512.502,"6pz8_oligo15","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_a_)-[MAN(4_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(222_J_)",372.533,"","",""
"6PZD","CRYSTAL STRUCTURE OF THE NEURAMINIDASE STABILIZATION MUTANT Y169AH FROM A/SHANGHAI/2/2013 (H7N9)","10.1016/J.CHOM.2019.10.002 ",1.12,0,"6pzd_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(10_B_)-[MAN(9_B_)-MAN(8_B_)]-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",19.0801,"","",""
"6PZE","CRYSTAL STRUCTURE OF HUMAN NA-45 FAB IN COMPLEX WITH NEURAMINIDASE Y169AH MUTANT FROM A/SHANGHAI/2/2013 (H7N9)","10.1016/J.CHOM.2019.10.002 ",2.3,0,"6pze_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(10_B_)-[MAN(9_B_)-MAN(8_B_)]-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",37.029,"","",""
"6PZF","CRYSTAL STRUCTURE OF HUMAN NA-63 FAB IN COMPLEX WITH NEURAMINIDASE FROM A/HUNAN/02650/2016(H7N9)","10.1016/J.CHOM.2019.10.002 ",2.8,0,"6pzf_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_C_)-MAN(10_C_)-[MAN(9_C_)-MAN(8_C_)]-MAN(7_C_)-[MAN(6_C_)-MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(200_B_)",71.8412,"","",""
"6PZF","CRYSTAL STRUCTURE OF HUMAN NA-63 FAB IN COMPLEX WITH NEURAMINIDASE FROM A/HUNAN/02650/2016(H7N9)","10.1016/J.CHOM.2019.10.002 ",2.8,0,"6pzf_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_D_)-MAN(10_D_)-[MAN(9_D_)-MAN(8_D_)]-MAN(7_D_)-[MAN(6_D_)-MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(200_A_)",84.8722,"","",""
"6PZW","CRYOEM DERIVED MODEL OF NA-22 FAB IN COMPLEX WITH N9 SHANGHAI2","10.1016/J.CHOM.2019.10.002 ",3,0,"6pzw_oligo5","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_R_)-[MAN(8_R_)]-MAN(7_R_)-[MAN(6_R_)-MAN(5_R_)-MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(200_C_)",28.5102,"","",""
"6PZW","CRYOEM DERIVED MODEL OF NA-22 FAB IN COMPLEX WITH N9 SHANGHAI2","10.1016/J.CHOM.2019.10.002 ",3,0,"6pzw_oligo7","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_S_)-[MAN(8_S_)]-MAN(7_S_)-[MAN(6_S_)-MAN(5_S_)-MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(200_B_)",28.5102,"","",""
"6PZW","CRYOEM DERIVED MODEL OF NA-22 FAB IN COMPLEX WITH N9 SHANGHAI2","10.1016/J.CHOM.2019.10.002 ",3,0,"6pzw_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_N_)-[MAN(8_N_)]-MAN(7_N_)-[MAN(6_N_)-MAN(5_N_)-MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(200_A_)",28.5102,"","",""
"6PZW","CRYOEM DERIVED MODEL OF NA-22 FAB IN COMPLEX WITH N9 SHANGHAI2","10.1016/J.CHOM.2019.10.002 ",3,0,"6pzw_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_P_)-[MAN(8_P_)]-MAN(7_P_)-[MAN(6_P_)-MAN(5_P_)-MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(200_D_)",28.5102,"","",""
"6PZY","CRYOEM DERIVED MODEL OF NA-73 FAB IN COMPLEX WITH N9 SHANGHAI2","10.1016/J.CHOM.2019.10.002 ",3.17,0,"6pzy_oligo5","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_Q_)-[MAN(8_Q_)]-MAN(7_Q_)-[MAN(6_Q_)-MAN(5_Q_)-MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(200_E_)",63.3779,"","",""
"6PZY","CRYOEM DERIVED MODEL OF NA-73 FAB IN COMPLEX WITH N9 SHANGHAI2","10.1016/J.CHOM.2019.10.002 ",3.17,0,"6pzy_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_M_)-[MAN(8_M_)]-MAN(7_M_)-[MAN(6_M_)-MAN(5_M_)-MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(200_A_)",63.3779,"","",""
"6PZY","CRYOEM DERIVED MODEL OF NA-73 FAB IN COMPLEX WITH N9 SHANGHAI2","10.1016/J.CHOM.2019.10.002 ",3.17,0,"6pzy_oligo4","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_O_)-[MAN(8_O_)]-MAN(7_O_)-[MAN(6_O_)-MAN(5_O_)-MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(200_B_)",63.3779,"","",""
"6PZY","CRYOEM DERIVED MODEL OF NA-73 FAB IN COMPLEX WITH N9 SHANGHAI2","10.1016/J.CHOM.2019.10.002 ",3.17,0,"6pzy_oligo7","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_S_)-[MAN(8_S_)]-MAN(7_S_)-[MAN(6_S_)-MAN(5_S_)-MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(200_F_)",63.3779,"","",""
"6PZZ","CRYOEM DERIVED MODEL OF NA-80 FAB IN COMPLEX WITH N9 SHANGHAI2","10.1016/J.CHOM.2019.10.002 ",3.6,0,"6pzz_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_N_)-[MAN(8_N_)]-MAN(7_N_)-[MAN(6_N_)-MAN(5_N_)-MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(200_A_)",75.848,"","",""
"6PZZ","CRYOEM DERIVED MODEL OF NA-80 FAB IN COMPLEX WITH N9 SHANGHAI2","10.1016/J.CHOM.2019.10.002 ",3.6,0,"6pzz_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_P_)-[MAN(8_P_)]-MAN(7_P_)-[MAN(6_P_)-MAN(5_P_)-MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(200_B_)",75.848,"","",""
"6PZZ","CRYOEM DERIVED MODEL OF NA-80 FAB IN COMPLEX WITH N9 SHANGHAI2","10.1016/J.CHOM.2019.10.002 ",3.6,0,"6pzz_oligo6","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_R_)-[MAN(8_R_)]-MAN(7_R_)-[MAN(6_R_)-MAN(5_R_)-MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(200_C_)",75.848,"","",""
"6PZZ","CRYOEM DERIVED MODEL OF NA-80 FAB IN COMPLEX WITH N9 SHANGHAI2","10.1016/J.CHOM.2019.10.002 ",3.6,0,"6pzz_oligo8","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_T_)-[MAN(8_T_)]-MAN(7_T_)-[MAN(6_T_)-MAN(5_T_)-MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(200_D_)",75.848,"","",""
"6Q04","MERS-COV S STRUCTURE IN COMPLEX WITH 5-N-ACETYL NEURAMINIC ACID","10.1038/S41594-019-0334-7 ",2.5,0,"6q04_oligo21","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_X_)-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(222_C_)",16.5405,"","",""
"6Q04","MERS-COV S STRUCTURE IN COMPLEX WITH 5-N-ACETYL NEURAMINIC ACID","10.1038/S41594-019-0334-7 ",2.5,0,"6q04_oligo13","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_L_)-[MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)",25.6223,"","",""
"6Q04","MERS-COV S STRUCTURE IN COMPLEX WITH 5-N-ACETYL NEURAMINIC ACID","10.1038/S41594-019-0334-7 ",2.5,0,"6q04_oligo9","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_F_)-MAN(6_F_)-[MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(410_A_)",18.997,"","",""
"6Q04","MERS-COV S STRUCTURE IN COMPLEX WITH 5-N-ACETYL NEURAMINIC ACID","10.1038/S41594-019-0334-7 ",2.5,0,"6q04_oligo17","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_P_)-MAN(6_P_)-[MAN(5_P_)-MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(410_B_)",18.997,"","",""
"6Q04","MERS-COV S STRUCTURE IN COMPLEX WITH 5-N-ACETYL NEURAMINIC ACID","10.1038/S41594-019-0334-7 ",2.5,0,"6q04_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_U_)-[MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(125_B_)",13.2213,"","",""
"6Q04","MERS-COV S STRUCTURE IN COMPLEX WITH 5-N-ACETYL NEURAMINIC ACID","10.1038/S41594-019-0334-7 ",2.5,0,"6q04_oligo23","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_Z_)-MAN(6_Z_)-[MAN(5_Z_)-MAN(4_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(410_C_)",18.997,"","",""
"6Q04","MERS-COV S STRUCTURE IN COMPLEX WITH 5-N-ACETYL NEURAMINIC ACID","10.1038/S41594-019-0334-7 ",2.5,0,"6q04_oligo19","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_H_)-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(1213_A_)",20.5093,"","",""
"6Q04","MERS-COV S STRUCTURE IN COMPLEX WITH 5-N-ACETYL NEURAMINIC ACID","10.1038/S41594-019-0334-7 ",2.5,0,"6q04_oligo8","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(222_A_)",16.5405,"","",""
"6Q04","MERS-COV S STRUCTURE IN COMPLEX WITH 5-N-ACETYL NEURAMINIC ACID","10.1038/S41594-019-0334-7 ",2.5,0,"6q04_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_R_)-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(1213_B_)",20.5093,"","",""
"6Q04","MERS-COV S STRUCTURE IN COMPLEX WITH 5-N-ACETYL NEURAMINIC ACID","10.1038/S41594-019-0334-7 ",2.5,0,"6q04_oligo15","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_N_)-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(222_B_)",16.5405,"","",""
"6Q04","MERS-COV S STRUCTURE IN COMPLEX WITH 5-N-ACETYL NEURAMINIC ACID","10.1038/S41594-019-0334-7 ",2.5,0,"6q04_oligo29","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_f_)-[MAN(4_f_)]-BMA(3_f_)-NAG(2_f_)-NAG(1_f_)",25.6223,"","",""
"6Q04","MERS-COV S STRUCTURE IN COMPLEX WITH 5-N-ACETYL NEURAMINIC ACID","10.1038/S41594-019-0334-7 ",2.5,0,"6q04_oligo25","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_b_)-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(1213_C_)",20.5093,"","",""
"6Q04","MERS-COV S STRUCTURE IN COMPLEX WITH 5-N-ACETYL NEURAMINIC ACID","10.1038/S41594-019-0334-7 ",2.5,0,"6q04_oligo12","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(125_A_)",13.2213,"","",""
"6Q04","MERS-COV S STRUCTURE IN COMPLEX WITH 5-N-ACETYL NEURAMINIC ACID","10.1038/S41594-019-0334-7 ",2.5,0,"6q04_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_V_)-[MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)",25.6223,"","",""
"6Q04","MERS-COV S STRUCTURE IN COMPLEX WITH 5-N-ACETYL NEURAMINIC ACID","10.1038/S41594-019-0334-7 ",2.5,0,"6q04_oligo28","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_e_)-[MAN(4_e_)]-BMA(3_e_)-NAG(2_e_)-NAG(1_e_)-ASN(125_C_)",13.2213,"","",""
"6Q05","MERS-COV S STRUCTURE IN COMPLEX WITH SIALYL-LEWISX","10.1038/S41594-019-0334-7 ",2.8,0,"6q05_oligo14","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(125_A_)",12.2331,"","",""
"6Q05","MERS-COV S STRUCTURE IN COMPLEX WITH SIALYL-LEWISX","10.1038/S41594-019-0334-7 ",2.8,0,"6q05_oligo3","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_Q_)-MAN(6_Q_)-[MAN(5_Q_)-MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(410_B_)",14.7781,"","",""
"6Q05","MERS-COV S STRUCTURE IN COMPLEX WITH SIALYL-LEWISX","10.1038/S41594-019-0334-7 ",2.8,0,"6q05_oligo31","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_h_)-[MAN(4_h_)]-BMA(3_h_)-NAG(2_h_)-NAG(1_h_)",23.5246,"","",""
"6Q05","MERS-COV S STRUCTURE IN COMPLEX WITH SIALYL-LEWISX","10.1038/S41594-019-0334-7 ",2.8,0,"6q05_oligo30","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_g_)-[MAN(4_g_)]-BMA(3_g_)-NAG(2_g_)-NAG(1_g_)-ASN(125_C_)",12.2331,"","",""
"6Q05","MERS-COV S STRUCTURE IN COMPLEX WITH SIALYL-LEWISX","10.1038/S41594-019-0334-7 ",2.8,0,"6q05_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_W_)-[MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)",23.5246,"","",""
"6Q05","MERS-COV S STRUCTURE IN COMPLEX WITH SIALYL-LEWISX","10.1038/S41594-019-0334-7 ",2.8,0,"6q05_oligo20","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_F_)-MAN(6_F_)-[MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(410_A_)",14.7781,"","",""
"6Q05","MERS-COV S STRUCTURE IN COMPLEX WITH SIALYL-LEWISX","10.1038/S41594-019-0334-7 ",2.8,0,"6q05_oligo17","DNeup5Aca2-3DGalpb1-4[LFucpa1-3]DGlcpNAcb1-ROH","SIA(3_N_)-GAL(2_N_)-[FUC(4_N_)]-NAG(1_N_)",20.4855,"","",""
"6Q05","MERS-COV S STRUCTURE IN COMPLEX WITH SIALYL-LEWISX","10.1038/S41594-019-0334-7 ",2.8,0,"6q05_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_V_)-[MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(125_B_)",12.2331,"","",""
"6Q05","MERS-COV S STRUCTURE IN COMPLEX WITH SIALYL-LEWISX","10.1038/S41594-019-0334-7 ",2.8,0,"6q05_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_H_)-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(1213_A_)",18.2655,"","",""
"6Q05","MERS-COV S STRUCTURE IN COMPLEX WITH SIALYL-LEWISX","10.1038/S41594-019-0334-7 ",2.8,0,"6q05_oligo33","DNeup5Aca2-3DGalpb1-4[LFucpa1-3]DGlcpNAcb1-ROH","SIA(3_j_)-GAL(2_j_)-[FUC(4_j_)]-NAG(1_j_)",20.4855,"","",""
"6Q05","MERS-COV S STRUCTURE IN COMPLEX WITH SIALYL-LEWISX","10.1038/S41594-019-0334-7 ",2.8,0,"6q05_oligo11","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(222_A_)",13.6755,"","",""
"6Q05","MERS-COV S STRUCTURE IN COMPLEX WITH SIALYL-LEWISX","10.1038/S41594-019-0334-7 ",2.8,0,"6q05_oligo15","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_L_)-[MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)",23.5246,"","",""
"6Q05","MERS-COV S STRUCTURE IN COMPLEX WITH SIALYL-LEWISX","10.1038/S41594-019-0334-7 ",2.8,0,"6q05_oligo18","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_O_)-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(222_B_)",13.6755,"","",""
"6Q05","MERS-COV S STRUCTURE IN COMPLEX WITH SIALYL-LEWISX","10.1038/S41594-019-0334-7 ",2.8,0,"6q05_oligo22","DNeup5Aca2-3DGalpb1-4[LFucpa1-3]DGlcpNAcb1-ROH","SIA(3_Y_)-GAL(2_Y_)-[FUC(4_Y_)]-NAG(1_Y_)",20.4855,"","",""
"6Q05","MERS-COV S STRUCTURE IN COMPLEX WITH SIALYL-LEWISX","10.1038/S41594-019-0334-7 ",2.8,0,"6q05_oligo27","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_d_)-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(1213_C_)",18.2655,"","",""
"6Q05","MERS-COV S STRUCTURE IN COMPLEX WITH SIALYL-LEWISX","10.1038/S41594-019-0334-7 ",2.8,0,"6q05_oligo23","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_Z_)-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(222_C_)",13.6755,"","",""
"6Q05","MERS-COV S STRUCTURE IN COMPLEX WITH SIALYL-LEWISX","10.1038/S41594-019-0334-7 ",2.8,0,"6q05_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_S_)-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(1213_B_)",18.2655,"","",""
"6Q05","MERS-COV S STRUCTURE IN COMPLEX WITH SIALYL-LEWISX","10.1038/S41594-019-0334-7 ",2.8,0,"6q05_oligo25","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_b_)-MAN(6_b_)-[MAN(5_b_)-MAN(4_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(410_C_)",14.7781,"","",""
"6Q06","MERS-COV S STRUCTURE IN COMPLEX WITH 2,3-SIALYL-N-ACETYL-LACTOSAMINE","10.1038/S41594-019-0334-7 ",2.7,0,"6q06_oligo31","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_h_)-[MAN(4_h_)]-BMA(3_h_)-NAG(2_h_)-NAG(1_h_)",26.5844,"","",""
"6Q06","MERS-COV S STRUCTURE IN COMPLEX WITH 2,3-SIALYL-N-ACETYL-LACTOSAMINE","10.1038/S41594-019-0334-7 ",2.7,0,"6q06_oligo27","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_d_)-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(1213_C_)",19.31,"","",""
"6Q06","MERS-COV S STRUCTURE IN COMPLEX WITH 2,3-SIALYL-N-ACETYL-LACTOSAMINE","10.1038/S41594-019-0334-7 ",2.7,0,"6q06_oligo18","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_O_)-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(222_B_)",15.842,"","",""
"6Q06","MERS-COV S STRUCTURE IN COMPLEX WITH 2,3-SIALYL-N-ACETYL-LACTOSAMINE","10.1038/S41594-019-0334-7 ",2.7,0,"6q06_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_S_)-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(1213_B_)",19.31,"","",""
"6Q06","MERS-COV S STRUCTURE IN COMPLEX WITH 2,3-SIALYL-N-ACETYL-LACTOSAMINE","10.1038/S41594-019-0334-7 ",2.7,0,"6q06_oligo10","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(222_A_)",15.842,"","",""
"6Q06","MERS-COV S STRUCTURE IN COMPLEX WITH 2,3-SIALYL-N-ACETYL-LACTOSAMINE","10.1038/S41594-019-0334-7 ",2.7,0,"6q06_oligo15","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_L_)-[MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)",26.5844,"","",""
"6Q06","MERS-COV S STRUCTURE IN COMPLEX WITH 2,3-SIALYL-N-ACETYL-LACTOSAMINE","10.1038/S41594-019-0334-7 ",2.7,0,"6q06_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_W_)-[MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)",26.5844,"","",""
"6Q06","MERS-COV S STRUCTURE IN COMPLEX WITH 2,3-SIALYL-N-ACETYL-LACTOSAMINE","10.1038/S41594-019-0334-7 ",2.7,0,"6q06_oligo30","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_g_)-[MAN(4_g_)]-BMA(3_g_)-NAG(2_g_)-NAG(1_g_)-ASN(125_C_)",14.5058,"","",""
"6Q06","MERS-COV S STRUCTURE IN COMPLEX WITH 2,3-SIALYL-N-ACETYL-LACTOSAMINE","10.1038/S41594-019-0334-7 ",2.7,0,"6q06_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_H_)-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(1213_A_)",19.31,"","",""
"6Q06","MERS-COV S STRUCTURE IN COMPLEX WITH 2,3-SIALYL-N-ACETYL-LACTOSAMINE","10.1038/S41594-019-0334-7 ",2.7,0,"6q06_oligo23","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_Z_)-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(222_C_)",15.842,"","",""
"6Q06","MERS-COV S STRUCTURE IN COMPLEX WITH 2,3-SIALYL-N-ACETYL-LACTOSAMINE","10.1038/S41594-019-0334-7 ",2.7,0,"6q06_oligo14","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(125_A_)",14.5058,"","",""
"6Q06","MERS-COV S STRUCTURE IN COMPLEX WITH 2,3-SIALYL-N-ACETYL-LACTOSAMINE","10.1038/S41594-019-0334-7 ",2.7,0,"6q06_oligo3","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_Q_)-MAN(6_Q_)-[MAN(5_Q_)-MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(410_B_)",18.6408,"","",""
"6Q06","MERS-COV S STRUCTURE IN COMPLEX WITH 2,3-SIALYL-N-ACETYL-LACTOSAMINE","10.1038/S41594-019-0334-7 ",2.7,0,"6q06_oligo25","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_b_)-MAN(6_b_)-[MAN(5_b_)-MAN(4_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(410_C_)",18.6408,"","",""
"6Q06","MERS-COV S STRUCTURE IN COMPLEX WITH 2,3-SIALYL-N-ACETYL-LACTOSAMINE","10.1038/S41594-019-0334-7 ",2.7,0,"6q06_oligo20","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_F_)-MAN(6_F_)-[MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(410_A_)",18.6408,"","",""
"6Q06","MERS-COV S STRUCTURE IN COMPLEX WITH 2,3-SIALYL-N-ACETYL-LACTOSAMINE","10.1038/S41594-019-0334-7 ",2.7,0,"6q06_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_V_)-[MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(125_B_)",14.5058,"","",""
"6Q07","MERS-COV S STRUCTURE IN COMPLEX WITH 2,6-SIALYL-N-ACETYL-LACTOSAMINE","10.1038/S41594-019-0334-7 ",2.9,0,"6q07_oligo20","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_P_)-MAN(6_P_)-[MAN(5_P_)-MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(410_B_)",23.306,"","",""
"6Q07","MERS-COV S STRUCTURE IN COMPLEX WITH 2,6-SIALYL-N-ACETYL-LACTOSAMINE","10.1038/S41594-019-0334-7 ",2.9,0,"6q07_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(222_A_)",21.892,"","",""
"6Q07","MERS-COV S STRUCTURE IN COMPLEX WITH 2,6-SIALYL-N-ACETYL-LACTOSAMINE","10.1038/S41594-019-0334-7 ",2.9,0,"6q07_oligo6","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_R_)-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(1213_B_)",25.6532,"","",""
"6Q07","MERS-COV S STRUCTURE IN COMPLEX WITH 2,6-SIALYL-N-ACETYL-LACTOSAMINE","10.1038/S41594-019-0334-7 ",2.9,0,"6q07_oligo3","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_F_)-MAN(6_F_)-[MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(410_A_)",23.306,"","",""
"6Q07","MERS-COV S STRUCTURE IN COMPLEX WITH 2,6-SIALYL-N-ACETYL-LACTOSAMINE","10.1038/S41594-019-0334-7 ",2.9,0,"6q07_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_H_)-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(1213_A_)",25.6532,"","",""
"6Q07","MERS-COV S STRUCTURE IN COMPLEX WITH 2,6-SIALYL-N-ACETYL-LACTOSAMINE","10.1038/S41594-019-0334-7 ",2.9,0,"6q07_oligo23","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_Z_)-MAN(6_Z_)-[MAN(5_Z_)-MAN(4_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(410_C_)",23.306,"","",""
"6Q07","MERS-COV S STRUCTURE IN COMPLEX WITH 2,6-SIALYL-N-ACETYL-LACTOSAMINE","10.1038/S41594-019-0334-7 ",2.9,0,"6q07_oligo13","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(125_A_)",19.6578,"","",""
"6Q07","MERS-COV S STRUCTURE IN COMPLEX WITH 2,6-SIALYL-N-ACETYL-LACTOSAMINE","10.1038/S41594-019-0334-7 ",2.9,0,"6q07_oligo25","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_b_)-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(1213_C_)",25.6532,"","",""
"6Q07","MERS-COV S STRUCTURE IN COMPLEX WITH 2,6-SIALYL-N-ACETYL-LACTOSAMINE","10.1038/S41594-019-0334-7 ",2.9,0,"6q07_oligo27","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_d_)-[MAN(4_d_)]-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(125_C_)",19.6578,"","",""
"6Q07","MERS-COV S STRUCTURE IN COMPLEX WITH 2,6-SIALYL-N-ACETYL-LACTOSAMINE","10.1038/S41594-019-0334-7 ",2.9,0,"6q07_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_T_)-[MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(125_B_)",19.6578,"","",""
"6Q07","MERS-COV S STRUCTURE IN COMPLEX WITH 2,6-SIALYL-N-ACETYL-LACTOSAMINE","10.1038/S41594-019-0334-7 ",2.9,0,"6q07_oligo9","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(4_U_)-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)",29.9623,"","",""
"6Q07","MERS-COV S STRUCTURE IN COMPLEX WITH 2,6-SIALYL-N-ACETYL-LACTOSAMINE","10.1038/S41594-019-0334-7 ",2.9,0,"6q07_oligo21","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_X_)-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(222_C_)",21.892,"","",""
"6Q07","MERS-COV S STRUCTURE IN COMPLEX WITH 2,6-SIALYL-N-ACETYL-LACTOSAMINE","10.1038/S41594-019-0334-7 ",2.9,0,"6q07_oligo15","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(4_K_)-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)",29.9623,"","",""
"6Q07","MERS-COV S STRUCTURE IN COMPLEX WITH 2,6-SIALYL-N-ACETYL-LACTOSAMINE","10.1038/S41594-019-0334-7 ",2.9,0,"6q07_oligo28","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(4_e_)-BMA(3_e_)-NAG(2_e_)-NAG(1_e_)",29.9623,"","",""
"6Q07","MERS-COV S STRUCTURE IN COMPLEX WITH 2,6-SIALYL-N-ACETYL-LACTOSAMINE","10.1038/S41594-019-0334-7 ",2.9,0,"6q07_oligo18","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_N_)-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(222_B_)",21.892,"","",""
"6Q1Z","CRYSTAL STRUCTURE OF HUMAN 1G04 FAB IN COMPLEX WITH INFLUENZA VIRUS NEURAMINIDASE FROM A/HUNAN/02650/2016 (H7N9)","10.1126/SCIENCE.AAY0678 ",3.45,0,"6q1z_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_G_)-MAN(10_G_)-[MAN(9_G_)-MAN(8_G_)]-MAN(7_G_)-[MAN(6_G_)-MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(200_B_)",145.956,"","",""
"6Q1Z","CRYSTAL STRUCTURE OF HUMAN 1G04 FAB IN COMPLEX WITH INFLUENZA VIRUS NEURAMINIDASE FROM A/HUNAN/02650/2016 (H7N9)","10.1126/SCIENCE.AAY0678 ",3.45,0,"6q1z_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_E_)-MAN(10_E_)-[MAN(9_E_)-MAN(8_E_)]-MAN(7_E_)-[MAN(6_E_)-MAN(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(200_A_)",127.785,"","",""
"6Q20","CRYSTAL STRUCTURE OF HUMAN 1E01 FAB IN COMPLEX WITH INFLUENZA VIRUS NEURAMINIDASE FROM A/JAPAN/305/1957 (H2N2)","10.1126/SCIENCE.AAY0678 ",2.45,0,"6q20_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",85.2922,"","",""
"6Q7I","GH3 EXO-BETA-XYLOSIDASE (XLND)","10.1021/ACSCENTSCI.9B00221 ",1.48,21.02,"6q7i_oligo5","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_E_)-MAN(7_E_)-[MAN(6_E_)-MAN(5_E_)]-MAN(4_E_)-[MAN(10_E_)-MAN(9_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(140_A_)",35.4125,"","",""
"6Q7I","GH3 EXO-BETA-XYLOSIDASE (XLND)","10.1021/ACSCENTSCI.9B00221 ",1.48,21.02,"6q7i_oligo3","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_C_)-MAN(7_C_)-[MAN(6_C_)-MAN(5_C_)]-MAN(4_C_)-[MAN(9_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(140_B_)",31.6495,"","",""
"6Q7J","GH3 EXO-BETA-XYLOSIDASE (XLND) IN COMPLEX WITH XYLOBIOSE AZIRIDINE ACTIVITY BASED PROBE","10.1021/ACSCENTSCI.9B00221 ",2.14,46.1,"6q7j_oligo5","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-2DRhapa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_C_)-MAN(7_C_)-[MAN(6_C_)-MAN(5_C_)]-MAN(4_C_)-[MAN(10_C_)-MAN(9_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(140_B_)",67.0677,"","",""
"6Q7J","GH3 EXO-BETA-XYLOSIDASE (XLND) IN COMPLEX WITH XYLOBIOSE AZIRIDINE ACTIVITY BASED PROBE","10.1021/ACSCENTSCI.9B00221 ",2.14,46.1,"6q7j_oligo2","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-MAN(5_E_)-[MAN(7_E_)]-MAN(4_E_)-[MAN(9_E_)-MAN(8_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(140_A_)",73.5362,"","",""
"6QFA","CRYOEM STRUCTURE OF A BETA3K279T GABA(A)R HOMOMER IN COMPLEX WITH HISTAMINE AND MEGABODY MB25","10.1038/S41592-020-01001-6 ",2.49,"1.08527e-19","6qfa_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(149_B_)",40.4742,"","",""
"6QFA","CRYOEM STRUCTURE OF A BETA3K279T GABA(A)R HOMOMER IN COMPLEX WITH HISTAMINE AND MEGABODY MB25","10.1038/S41592-020-01001-6 ",2.49,"1.08527e-19","6qfa_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(149_C_)",39.4287,"","",""
"6QFA","CRYOEM STRUCTURE OF A BETA3K279T GABA(A)R HOMOMER IN COMPLEX WITH HISTAMINE AND MEGABODY MB25","10.1038/S41592-020-01001-6 ",2.49,"1.08527e-19","6qfa_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(149_A_)",39.9275,"","",""
"6QFA","CRYOEM STRUCTURE OF A BETA3K279T GABA(A)R HOMOMER IN COMPLEX WITH HISTAMINE AND MEGABODY MB25","10.1038/S41592-020-01001-6 ",2.49,"1.08527e-19","6qfa_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(149_D_)",40.5464,"","",""
"6QFA","CRYOEM STRUCTURE OF A BETA3K279T GABA(A)R HOMOMER IN COMPLEX WITH HISTAMINE AND MEGABODY MB25","10.1038/S41592-020-01001-6 ",2.49,"1.08527e-19","6qfa_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(149_E_)",41.1502,"","",""
"6QNS","CRYSTAL STRUCTURE OF THE BINDING DOMAIN OF BOTULINUM NEUROTOXIN TYPE B MUTANT I1248W/V1249W IN COMPLEX WITH HUMAN SYNAPTOTAGMIN 1 AND GD1A RECEPTORS","10.1371/JOURNAL.PBIO.3000618 ",2.4,65.14,"6qns_oligo1","DNeup5Aca2-3DGalpb1-3DGalpNAcb1-4[DNeup5Aca2-3]DGalpb1-4DGlcpb1-ROH","SIA(5_B_)-GAL(4_B_)-NGA(3_B_)-[SIA(6_B_)]-GAL(2_B_)-BGC(1_B_)",100.826,"","",""
"6QP7","DROSOPHILA SEMAPHORIN 2A","10.1038/S41467-019-11683-Y ",1.96,0,"6qp7_oligo1","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-MAN(4_E_)-[MAN(6_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(190_A_)",77.2607,"","",""
"6QP7","DROSOPHILA SEMAPHORIN 2A","10.1038/S41467-019-11683-Y ",1.96,0,"6qp7_oligo2","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-MAN(4_F_)-[MAN(6_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(314_A_)",64.9617,"","",""
"6QP7","DROSOPHILA SEMAPHORIN 2A","10.1038/S41467-019-11683-Y ",1.96,0,"6qp7_oligo4","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-MAN(5_H_)-[MAN(7_H_)]-MAN(4_H_)-[MAN(8_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(163_B_)",77.5403,"","",""
"6QP7","DROSOPHILA SEMAPHORIN 2A","10.1038/S41467-019-11683-Y ",1.96,0,"6qp7_oligo8","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_J_)-[MAN(5_J_)]-MAN(4_J_)-[MAN(7_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(314_B_)",74.9674,"","",""
"6QP8","DROSOPHILA SEMAPHORIN 2B","10.1038/S41467-019-11683-Y ",2.33,0,"6qp8_oligo1","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_G_)-[MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(236_A_)",97.5653,"","",""
"6QP8","DROSOPHILA SEMAPHORIN 2B","10.1038/S41467-019-11683-Y ",2.33,0,"6qp8_oligo2","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(197_A_)",101.67,"","",""
"6QP8","DROSOPHILA SEMAPHORIN 2B","10.1038/S41467-019-11683-Y ",2.33,0,"6qp8_oligo8","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_L_)-MAN(5_L_)-[MAN(7_L_)]-MAN(4_L_)-[MAN(8_L_)]-MAN(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(321_B_)",63.4973,"","",""
"6QP8","DROSOPHILA SEMAPHORIN 2B","10.1038/S41467-019-11683-Y ",2.33,0,"6qp8_oligo3","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-MAN(5_F_)-[MAN(7_F_)]-MAN(4_F_)-[MAN(9_F_)-MAN(8_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(321_A_)",68.5622,"","",""
"6QVM","UNDECAHEME CYTOCHROME FROM S-LAYER OF CARBOXYDOTHERMUS FERRIREDUCENS","10.1016/J.STR.2022.12.010 ",2.5,0,"6qvm_oligo2","DGalpNAcb1-3DGalpNAcb1-3DGalpNAcb1-TYR","NGA(3_D_)-NGA(2_D_)-NGA(1_D_)-TYR(388_A_)",80.2097,"","",""
"6QVM","UNDECAHEME CYTOCHROME FROM S-LAYER OF CARBOXYDOTHERMUS FERRIREDUCENS","10.1016/J.STR.2022.12.010 ",2.5,0,"6qvm_oligo3","DGalpNAcb1-3DGalpNAcb1-TYR","NGA(2_B_)-NGA(1_B_)-TYR(317_A_)",109.561,"","",""
"6QVM","UNDECAHEME CYTOCHROME FROM S-LAYER OF CARBOXYDOTHERMUS FERRIREDUCENS","10.1016/J.STR.2022.12.010 ",2.5,0,"6qvm_oligo1","DGalpNAcb1-3DGalpNAcb1-TYR","NGA(2_C_)-NGA(1_C_)-TYR(518_A_)",135.809,"","",""
"6QWN","PROTEIN PEPTIDE COMPLEX","10.1073/PNAS.2000100117 ",3.89,0,"6qwn_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_K_)-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(338_A_)",147.744,"","",""
"6QXP","PROTEIN PEPTIDE COMPLEX","10.1073/PNAS.2000100117 ",3.2,0,"6qxp_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_S_)-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(73_B_)",118.436,"","",""
"6R0X","THE EXTRACELLULAR DOMAIN OF G6B-B IN COMPLEX WITH FAB FRAGMENT AND DP12 HEPARIN OLIGOSACCHARIDE.","10.7554/ELIFE.46840 ",3.13,115.9,"6r0x_oligo1","DGalpb1-3[DNeup5Aca2-6]DGalpNAcb1-THR","SIA(3_I_)-[GAL(2_I_)]-A2G(1_I_)-THR(73_F_)",189.954,"","",""
"6R0X","THE EXTRACELLULAR DOMAIN OF G6B-B IN COMPLEX WITH FAB FRAGMENT AND DP12 HEPARIN OLIGOSACCHARIDE.","10.7554/ELIFE.46840 ",3.13,115.9,"6r0x_oligo2","DGalpb1-3[DNeup5Aca2-6]DGalpNAcb1-THR","SIA(3_G_)-[GAL(2_G_)]-A2G(1_G_)-THR(73_E_)",138.957,"","",""
"6R2W","CRYSTAL STRUCTURE OF THE SUPER-ACTIVE FVIIA VARIANT VYT IN COMPLEX WITH TISSUE FACTOR","10.1074/JBC.RA119.009183 ",1.25,27.09,"6r2w_oligo1","DXylpa1-3DXylpa1-3DGlcpb1-SER","XYS(3_A_)-XYS(2_A_)-BGC(1_A_)-SER(52_L_)",35.6458,"","",""
"6R35","STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PAO1 IN COMPLEX WITH LEWIS X TETRASACCHARIDE","10.1016/J.EJMECH.2019.05.049 ",1.8,18.2,"6r35_oligo4","LFucpa1-3[DGalpb1-4]DGlcpNAcb1-ROH","GAL(3_H_)-[FUC(2_H_)]-NAG(1_H_)",31.8136,"","",""
"6R35","STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PAO1 IN COMPLEX WITH LEWIS X TETRASACCHARIDE","10.1016/J.EJMECH.2019.05.049 ",1.8,18.2,"6r35_oligo3","LFucpa1-3[DGalpb1-4]DGlcpNAcb1-ROH","GAL(3_G_)-[FUC(2_G_)]-NAG(1_G_)",33.2118,"","",""
"6R35","STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PAO1 IN COMPLEX WITH LEWIS X TETRASACCHARIDE","10.1016/J.EJMECH.2019.05.049 ",1.8,18.2,"6r35_oligo1","LFucpa1-3[DGalpb1-4]DGlcpNAcb1-ROH","GAL(3_E_)-[FUC(2_E_)]-NAG(1_E_)",42.3246,"","",""
"6R35","STRUCTURE OF THE LECB LECTIN FROM PSEUDOMONAS AERUGINOSA STRAIN PAO1 IN COMPLEX WITH LEWIS X TETRASACCHARIDE","10.1016/J.EJMECH.2019.05.049 ",1.8,18.2,"6r35_oligo2","LFucpa1-3[DGalpb1-4]DGlcpNAcb1-ROH","GAL(3_F_)-[FUC(2_F_)]-NAG(1_F_)",30.5909,"","",""
"6R7R","CRYSTAL STRUCTURE OF THE GLUTAMATE TRANSPORTER HOMOLOGUE GLTTK IN COMPLEX WITH D-ASPARTATE","10.7554/ELIFE.45286 ",2.8,0,"6r7r_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(509_A_)-DMU(509_A_)",183.814,"","",""
"6RBC","X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH A INHIBITOR KB1157","10.1021/ACS.JMEDCHEM.9B02022 ",1.77,35.65,"6rbc_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(638_A_)",43.6411,"","",""
"6ROH","CRYO-EM STRUCTURE OF THE AUTOINHIBITED DRS2P-CDC50P","10.1038/S41586-019-1344-7 ",2.8,0,"6roh_oligo2","DManpb1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(199_C_)",72.9416,"","",""
"6ROI","CRYO-EM STRUCTURE OF THE PARTIALLY ACTIVATED DRS2P-CDC50P","10.1038/S41586-019-1344-7 ",3.7,0,"6roi_oligo2","DManpb1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(199_C_)",90.1136,"","",""
"6ROJ","CRYO-EM STRUCTURE OF THE ACTIVATED DRS2P-CDC50P","10.1038/S41586-019-1344-7 ",2.9,0,"6roj_oligo3","DManpb1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(199_C_)",68.6705,"","",""
"6ROJ","CRYO-EM STRUCTURE OF THE ACTIVATED DRS2P-CDC50P","10.1038/S41586-019-1344-7 ",2.9,0,"6roj_oligo2","DManpb1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(288_C_)",96.3473,"","",""
"6RQX","HIGH-RESOLUTION CRYSTAL STRUCTURE OF ERAP1 IN COMPLEX WITH 10MER PHOSPHINIC PEPTIDE","10.1073/PNAS.1912070116 ",1.68,0,"6rqx_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(70_A_)",68.7841,"","",""
"6RQX","HIGH-RESOLUTION CRYSTAL STRUCTURE OF ERAP1 IN COMPLEX WITH 10MER PHOSPHINIC PEPTIDE","10.1073/PNAS.1912070116 ",1.68,0,"6rqx_oligo1","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_C_)-[FUC(2_C_)]-NAG(1_C_)-ASN(760_A_)",76.8361,"","",""
"6RTI","X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH APTAMER A9G","10.1093/NAR/GKAA494 ",2.2,44,"6rti_oligo14","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(476_A_)",92.9961,"","",""
"6RU5","HUMAN COMPLEMENT C3 IN COMPLEX WITH THE HC3NB1 NANOBODY","10.3389/FIMMU.2019.02007 ",3.9,0,"6ru5_oligo1","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(939_B_)",189.934,"","",""
"6RUQ","STRUCTURE OF GLUA2CRYST IN COMPLEX THE ANTAGONIST ZK200775 AND THE NEGATIVE ALLOSTERIC MODULATOR GYKI53655 AT 4.65 A RESOLUTION","10.1111/FEBS.15455 ",4.65,210.8,"6ruq_oligo6","DManpb1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(355_B_)",282.357,"","",""
"6S1X","X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII)-E424M INACTIVE MUTANT, IN COMPLEX WITH A INHIBITOR KB1160","10.1021/ACS.JMEDCHEM.9B02022 ",1.76,37.29,"6s1x_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(638_A_)",56.8047,"","",""
"6S2G","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH FRUCTOSE AND EPIGALLOCATECHIN GALLATE (EGCG)","10.1038/S41598-019-53948-Y ",2.03,33.73,"6s2g_oligo30","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_F_)-MAN(8_F_)-[MAN(10_F_)]-MAN(7_F_)-[MAN(6_F_)-MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(107_B_)",50.8245,"","",""
"6S2G","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH FRUCTOSE AND EPIGALLOCATECHIN GALLATE (EGCG)","10.1038/S41598-019-53948-Y ",2.03,33.73,"6s2g_oligo13","DManpa1-2DManpa1-2DRhapa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_D_)-[MAN(8_D_)]-MAN(7_D_)-[MAN(6_D_)-MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(107_A_)",43.6479,"","",""
"6S2H","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH FRUCTOSE AND CATECHOL","10.1038/S41598-019-53948-Y ",1.8,25.14,"6s2h_oligo33","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_G_)-MAN(8_G_)-[MAN(10_G_)]-MAN(7_G_)-[MAN(6_G_)-MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(107_B_)",39.6481,"","",""
"6S2H","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH FRUCTOSE AND CATECHOL","10.1038/S41598-019-53948-Y ",1.8,25.14,"6s2h_oligo32","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-MAN(4_F_)-[MAN(6_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(58_B_)",45.8798,"","",""
"6S2H","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH FRUCTOSE AND CATECHOL","10.1038/S41598-019-53948-Y ",1.8,25.14,"6s2h_oligo26","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_C_)-MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(58_A_)",47.3217,"","",""
"6S2H","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH FRUCTOSE AND CATECHOL","10.1038/S41598-019-53948-Y ",1.8,25.14,"6s2h_oligo30","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_D_)-MAN(8_D_)-[MAN(10_D_)]-MAN(7_D_)-[MAN(6_D_)-MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(107_A_)",37.2593,"","",""
"6S3Z","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH FRUCTOSE AND HYDROQUINONE","10.1038/S41598-019-53948-Y ",1.85,26.76,"6s3z_oligo28","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_D_)-MAN(8_D_)-[MAN(10_D_)]-MAN(7_D_)-[MAN(6_D_)-MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(107_A_)",41.3839,"","",""
"6S3Z","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH FRUCTOSE AND HYDROQUINONE","10.1038/S41598-019-53948-Y ",1.85,26.76,"6s3z_oligo33","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-MAN(4_F_)-[MAN(6_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(58_B_)",55.5642,"","",""
"6S3Z","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH FRUCTOSE AND HYDROQUINONE","10.1038/S41598-019-53948-Y ",1.85,26.76,"6s3z_oligo27","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(58_A_)",46.4876,"","",""
"6S3Z","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH FRUCTOSE AND HYDROQUINONE","10.1038/S41598-019-53948-Y ",1.85,26.76,"6s3z_oligo34","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_G_)-MAN(8_G_)-[MAN(10_G_)]-MAN(7_G_)-[MAN(6_G_)-MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(107_B_)",42.7631,"","",""
"6S5A","CRYSTAL STRUCTURE OF FC P329G LALA WITH ANTI FC P329G FAB","10.1093/PROTEIN/GZZ027 ",1.72,48.94,"6s5a_oligo2","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_C_)-[NAG(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_D_)",43.4699,"","",""
"6S7O","CRYO-EM STRUCTURE OF HUMAN OLIGOSACCHARYLTRANSFERASE COMPLEX OST-A","10.1126/SCIENCE.AAZ3505 ",3.5,"1.08527e-19","6s7o_oligo7","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_J_)-MAN(7_J_)-[MAN(6_J_)-MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(548_A_)",48.9795,"","",""
"6S7O","CRYO-EM STRUCTURE OF HUMAN OLIGOSACCHARYLTRANSFERASE COMPLEX OST-A","10.1126/SCIENCE.AAZ3505 ",3.5,"1.08527e-19","6s7o_oligo14","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_K_)-[MAN(7_K_)]-MAN(6_K_)-[MAN(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(299_E_)",37.9019,"","",""
"6S7T","CRYO-EM STRUCTURE OF HUMAN OLIGOSACCHARYLTRANSFERASE COMPLEX OST-B","10.1126/SCIENCE.AAZ3505 ",3.5,"1.08527e-19","6s7t_oligo7","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_L_)-MAN(7_L_)-[MAN(6_L_)-MAN(5_L_)-MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(627_A_)",61.7127,"","",""
"6S7T","CRYO-EM STRUCTURE OF HUMAN OLIGOSACCHARYLTRANSFERASE COMPLEX OST-B","10.1126/SCIENCE.AAZ3505 ",3.5,"1.08527e-19","6s7t_oligo10","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_N_)-[MAN(7_N_)]-MAN(6_N_)-[MAN(5_N_)-MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(299_E_)",49.0967,"","",""
"6S82","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH TRIS-BUFFER MOLECULE AND HYDROQUINONE","10.1038/S41598-019-53948-Y ",1.85,26.47,"6s82_oligo25","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_C_)-MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(58_A_)",56.3562,"","",""
"6S82","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH TRIS-BUFFER MOLECULE AND HYDROQUINONE","10.1038/S41598-019-53948-Y ",1.85,26.47,"6s82_oligo30","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-MAN(4_F_)-[MAN(6_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(58_B_)",58.7464,"","",""
"6S82","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH TRIS-BUFFER MOLECULE AND HYDROQUINONE","10.1038/S41598-019-53948-Y ",1.85,26.47,"6s82_oligo31","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_G_)-MAN(8_G_)-[MAN(10_G_)]-MAN(7_G_)-[MAN(6_G_)-MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(107_B_)",42.2179,"","",""
"6S82","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH TRIS-BUFFER MOLECULE AND HYDROQUINONE","10.1038/S41598-019-53948-Y ",1.85,26.47,"6s82_oligo26","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_D_)-MAN(8_D_)-[MAN(10_D_)]-MAN(7_D_)-[MAN(6_D_)-MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(107_A_)",42.2915,"","",""
"6S9J","CRYSTAL STRUCTURE OF TFR1 MIMICRY IN COMPLEX WITH GP1 FROM MACV","10.1038/S41467-019-13924-6 ",2.7,0,"6s9j_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(178_B_)",89.6887,"","",""
"6SFF","MOUSE INTERLEUKIN-12 SUBUNIT BETA - P80 HOMODIMER IN SPACE GROUP I41","10.1107/S2059798320013753 ",2.4,66.83,"6sff_oligo1","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-MAN(4_B_)-[MAN(6_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(220_A_)",88.3745,"","",""
"6SGP","X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) - THE E424M INACTIVE MUTANT, IN COMPLEX WITH A SULFAMIDE INHIBITOR GLUGLU","",1.58,30.56,"6sgp_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(476_A_)",44.7611,"","",""
"6SGP","X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) - THE E424M INACTIVE MUTANT, IN COMPLEX WITH A SULFAMIDE INHIBITOR GLUGLU","",1.58,30.56,"6sgp_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(638_A_)",43.3135,"","",""
"6SKA","TENEURIN 2 IN COMPLEX WITH LATROPHILIN 1 LEC-OLF DOMAINS","10.1016/J.CELL.2019.12.014 ",3.86,0,"6ska_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_B_)-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(2365_A_)",198.766,"","",""
"6SKE","TENEURIN 2 IN COMPLEX WITH LATROPHILIN 2 LEC DOMAIN","10.1016/J.CELL.2019.12.014 ",3.62,99.36,"6ske_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_E_)-MAN(7_E_)-[MAN(6_E_)-MAN(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(2365_A_)",152.739,"","",""
"6SKE","TENEURIN 2 IN COMPLEX WITH LATROPHILIN 2 LEC DOMAIN","10.1016/J.CELL.2019.12.014 ",3.62,99.36,"6ske_oligo7","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_K_)-MAN(7_K_)-[MAN(6_K_)-MAN(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(2365_C_)",157.151,"","",""
"6SKH","X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) - THE E424M INACTIVE MUTANT, IN COMPLEX WITH A INHIBITOR SULFAMIDE INHIBITOR GLUASP","",1.58,29.21,"6skh_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(476_A_)",41.2843,"","",""
"6SKH","X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) - THE E424M INACTIVE MUTANT, IN COMPLEX WITH A INHIBITOR SULFAMIDE INHIBITOR GLUASP","",1.58,29.21,"6skh_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(638_A_)",41.954,"","",""
"6SMC","MOUSE INTERLEUKIN-12 SUBUNIT BETA - P80 HOMODIMER IN SPACE GROUP P1","",3.5,153.3,"6smc_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(220_C_)",234.708,"","",""
"6SMC","MOUSE INTERLEUKIN-12 SUBUNIT BETA - P80 HOMODIMER IN SPACE GROUP P1","",3.5,153.3,"6smc_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(220_A_)",216.003,"","",""
"6SMC","MOUSE INTERLEUKIN-12 SUBUNIT BETA - P80 HOMODIMER IN SPACE GROUP P1","",3.5,153.3,"6smc_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_H_)-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(220_D_)",217.891,"","",""
"6SMC","MOUSE INTERLEUKIN-12 SUBUNIT BETA - P80 HOMODIMER IN SPACE GROUP P1","",3.5,153.3,"6smc_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(220_B_)",198.04,"","",""
"6SP3","MOUSE INTERLEUKIN-12 SUBUNIT BETA - P80 HOMODIMER IN SPACE GROUP P21 CRYSTAL FORM 1","",3,120.5,"6sp3_oligo1","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-MAN(4_D_)-[MAN(6_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(220_B_)",139.326,"","",""
"6SP3","MOUSE INTERLEUKIN-12 SUBUNIT BETA - P80 HOMODIMER IN SPACE GROUP P21 CRYSTAL FORM 1","",3,120.5,"6sp3_oligo2","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(220_A_)",156.601,"","",""
"6SZ6","CHAETOMIUM THERMOPHILUM BETA-GLUCOSIDASE","10.3390/IJMS20235962 ",2.99,51.57,"6sz6_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(329_A_)",59.4514,"","",""
"6T18","ASR ALTERNANSUCRASE IN COMPLEX WITH OLIGOALTERNAN","10.1074/JBC.RA120.013028 ",3.15,90.65,"6t18_oligo1","DGlcpa1-6DGlcpa1-3DGlcpa1-6DGlcpa1-3DGlcpa1-6DGlcpa1-ROH","GLC(6_C_)-GLC(5_C_)-GLC(4_C_)-GLC(3_C_)-GLC(2_C_)-GLC(1_C_)",111.302,"","",""
"6T18","ASR ALTERNANSUCRASE IN COMPLEX WITH OLIGOALTERNAN","10.1074/JBC.RA120.013028 ",3.15,90.65,"6t18_oligo2","DGlcpa1-3DGlcpa1-6DGlcpa1-ROH","GLC(3_D_)-GLC(2_D_)-GLC(1_D_)",147.912,"","",""
"6T18","ASR ALTERNANSUCRASE IN COMPLEX WITH OLIGOALTERNAN","10.1074/JBC.RA120.013028 ",3.15,90.65,"6t18_oligo3","DGlcpa1-3DGlcpa1-6DGlcpa1-3DGlcpa1-ROH","GLC(4_E_)-GLC(3_E_)-GLC(2_E_)-GLC(1_E_)",117.718,"","",""
"6T72","STRUCTURE OF THE RSAA N-TERMINAL DOMAIN BOUND TO LPS","10.1016/J.CELL.2019.12.006 ",3.7,0,"6t72_oligo1","DRhap[4NAc]a1-3DRhap[4NAc]a1-3DManpb1-3DRhap[4NAc]a1-3DRhap[4NAc]a1-3DManpb1-3DRhap[4NAc]a1-3DRhap[4NAc]a1-3DManpb1-3DRhap[4NAc]a1-3DRhap[4NAc]a1-3DManpx1-","MRH(12_B_)-MRH(11_B_)-BMA(10_B_)-MRH(9_B_)-MRH(8_B_)-BMA(7_B_)-MRH(6_B_)-MRH(5_B_)-BMA(4_B_)-MRH(3_B_)-MRH(2_B_)-BMA(1_B_)",98.3129,"","",""
"6T8K","CRYSTAL STRUCTURE OF BACTEROIDES THETAIOTAMICRON ENDOBT-3987 IN COMPLEX WITH MAN9GLCNAC PRODUCT IN P1","10.1038/S41467-020-14754-7 ",2,21.34,"6t8k_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-ROH","MAN(10_C_)-MAN(9_C_)-[MAN(8_C_)-MAN(7_C_)]-MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)-MAN(3_C_)]-BMA(2_C_)-NAG(1_C_)",23.4679,"","",""
"6T8K","CRYSTAL STRUCTURE OF BACTEROIDES THETAIOTAMICRON ENDOBT-3987 IN COMPLEX WITH MAN9GLCNAC PRODUCT IN P1","10.1038/S41467-020-14754-7 ",2,21.34,"6t8k_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-ROH","MAN(10_D_)-MAN(9_D_)-[MAN(8_D_)-MAN(7_D_)]-MAN(6_D_)-[MAN(5_D_)-MAN(4_D_)-MAN(3_D_)]-BMA(2_D_)-NAG(1_D_)",23.9043,"","",""
"6T8L","CRYSTAL STRUCTURE OF BACTEROIDES THETAIOTAMICRON ENDOBT-3987 WITH MAN9GLCNAC PRODUCT IN P212121","10.1038/S41467-020-14754-7 ",1.7,18.41,"6t8l_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-ROH","MAN(10_B_)-MAN(9_B_)-[MAN(8_B_)-MAN(7_B_)]-MAN(6_B_)-[MAN(5_B_)-MAN(4_B_)-MAN(3_B_)]-BMA(2_B_)-NAG(1_B_)",25.2459,"","",""
"6TCV","CRYSTAL STRUCTURE OF BACTEROIDES THETAIOTAMICRON ENDOBT-3987 IN COMPLEX WITH MAN9GLCNAC2ASN SUBSTRATE","10.1038/S41467-020-14754-7 ",1.31,22.45,"6tcv_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_A_)-MAN(10_A_)-[MAN(9_A_)-MAN(8_A_)]-MAN(7_A_)-[MAN(6_A_)-MAN(5_A_)-MAN(4_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(501_B_)",20.6623,"","",""
"6TCW","CRYSTAL STRUCTURE OF BACTEROIDES THETAIOTAMICRON ENDOBT-3987 WITH MAN5GLCNAC PRODUCT","10.1038/S41467-020-14754-7 ",1.6,23.13,"6tcw_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-ROH","MAN(5_B_)-[MAN(4_B_)]-MAN(3_B_)-[MAN(6_B_)]-BMA(2_B_)-NAG(1_B_)",22.4539,"","",""
"6TEJ","STRUCTURE OF APO IRTAB DEVOID SID IN COMPLEX WITH SYBODY SYB_NL5","10.1038/S41586-020-2136-9 ",2.7,92.13,"6tej_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(601_B_)-DMU(601_B_)",145.458,"","",""
"6TKV","CRYSTAL STRUCTURE OF THE HUMAN FUT8 IN COMPLEX WITH GDP AND A BIANTENNARY COMPLEX N-GLYCAN","10.1038/S41467-020-14794-Z ",1.95,36.11,"6tkv_oligo3","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)",48.896,"","",""
"6TKV","CRYSTAL STRUCTURE OF THE HUMAN FUT8 IN COMPLEX WITH GDP AND A BIANTENNARY COMPLEX N-GLYCAN","10.1038/S41467-020-14794-Z ",1.95,36.11,"6tkv_oligo4","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)",39.4397,"","",""
"6TP5","CRYSTAL STRUCTURE OF HUMAN TRANSMEMBRANE PROLYL 4-HYDROXYLASE","10.1074/JBC.RA120.016542 ",2.25,87.78,"6tp5_oligo4","DManpb1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_F_)-MAN(8_F_)-[MAN(10_F_)]-MAN(7_F_)-[BMA(6_F_)-MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(382_B_)",119.763,"","",""
"6TP5","CRYSTAL STRUCTURE OF HUMAN TRANSMEMBRANE PROLYL 4-HYDROXYLASE","10.1074/JBC.RA120.016542 ",2.25,87.78,"6tp5_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_D_)-MAN(8_D_)-[MAN(10_D_)]-MAN(7_D_)-[MAN(6_D_)-MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(382_A_)",124.942,"","",""
"6TQK","CRYO-EM OF NATIVE HUMAN UROMODULIN (UMOD)/TAMM-HORSFALL PROTEIN (THP) FILAMENT.","10.15252/EMBJ.2020106807 ",3.35,0,"6tqk_oligo2","DGalpb1-4DGlcpNAcb1-2[DGlcpNAcb1-4]DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_G_)-[NAG(7_G_)-[GAL(6_G_)-NAG(5_G_)]-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(396_C_)",161.743,"","",""
"6TQK","CRYO-EM OF NATIVE HUMAN UROMODULIN (UMOD)/TAMM-HORSFALL PROTEIN (THP) FILAMENT.","10.15252/EMBJ.2020106807 ",3.35,0,"6tqk_oligo4","DGalpb1-4DGlcpNAcb1-2[DGlcpNAcb1-4]DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_E_)-[NAG(7_E_)-[GAL(6_E_)-NAG(5_E_)]-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(396_A_)",174.455,"","",""
"6TQL","CRYO-EM OF ELASTASE-TREATED HUMAN UROMODULIN (UMOD)/TAMM-HORSFALL PROTEIN (THP) FILAMENT","10.15252/EMBJ.2020106807 ",3.96,"1.15243e-41","6tql_oligo3","DGalpb1-4DGlcpNAcb1-2[DGlcpNAcb1-4]DManpa1-6[DGlcpNAcb1-2[DGlcpNAcb1-4]DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_E_)-[GAL(6_E_)-NAG(5_E_)]-MAN(4_E_)-[NAG(10_E_)-[NAG(9_E_)]-MAN(8_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(396_A_)",233.983,"","",""
"6TQL","CRYO-EM OF ELASTASE-TREATED HUMAN UROMODULIN (UMOD)/TAMM-HORSFALL PROTEIN (THP) FILAMENT","10.15252/EMBJ.2020106807 ",3.96,"1.15243e-41","6tql_oligo4","DGlcpNAcb1-2[DGlcpNAcb1-4]DManpa1-3[DGlcpNAcb1-4DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(8_G_)-MAN(7_G_)-[NAG(6_G_)-[NAG(5_G_)]-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(396_C_)",177.91,"","",""
"6TRF","CHAETOMIUM THERMOPHILUM UDP-GLUCOSE GLUCOSYL TRANSFERASE (UGGT) PURIFIED FROM CELLS TREATED WITH KIFUNENSINE.","10.1016/J.STR.2020.11.017 ",4.11,270.2,"6trf_oligo1","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-MAN(4_B_)-[MAN(6_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(56_A_)",296.427,"","",""
"6TRH","STRUCTURE OF E70A MUTANT OF REX8A FROM PAENIBACILLUS BARCINONENSIS COMPLEXED WITH 3(3)-ALPHA-L-ARABINOFURANOSYL-XYLOTETRAOSE.","10.1111/FEBS.15332 ",1.86,33.22,"6trh_oligo4","LArafa1-3[DXylpb1-4]DXylpb1-4DXylpb1-4DXylpb1-ROH","XYP(5_H_)-[AHR(4_H_)]-XYP(3_H_)-XYP(2_H_)-XYP(1_H_)",21.6324,"","",""
"6TRH","STRUCTURE OF E70A MUTANT OF REX8A FROM PAENIBACILLUS BARCINONENSIS COMPLEXED WITH 3(3)-ALPHA-L-ARABINOFURANOSYL-XYLOTETRAOSE.","10.1111/FEBS.15332 ",1.86,33.22,"6trh_oligo2","LArafa1-3[DXylpb1-4]DXylpb1-4DXylpb1-4DXylpb1-ROH","XYP(5_F_)-[AHR(4_F_)]-XYP(3_F_)-XYP(2_F_)-XYP(1_F_)",21.5943,"","",""
"6TRH","STRUCTURE OF E70A MUTANT OF REX8A FROM PAENIBACILLUS BARCINONENSIS COMPLEXED WITH 3(3)-ALPHA-L-ARABINOFURANOSYL-XYLOTETRAOSE.","10.1111/FEBS.15332 ",1.86,33.22,"6trh_oligo3","LArafa1-3[DXylpb1-4]DXylpb1-4DXylpb1-4DXylpb1-ROH","XYP(5_G_)-[AHR(4_G_)]-XYP(3_G_)-XYP(2_G_)-XYP(1_G_)",21.5945,"","",""
"6TRH","STRUCTURE OF E70A MUTANT OF REX8A FROM PAENIBACILLUS BARCINONENSIS COMPLEXED WITH 3(3)-ALPHA-L-ARABINOFURANOSYL-XYLOTETRAOSE.","10.1111/FEBS.15332 ",1.86,33.22,"6trh_oligo1","LArafa1-3[DXylpb1-4]DXylpb1-4DXylpb1-4DXylpb1-ROH","XYP(5_E_)-[AHR(4_E_)]-XYP(3_E_)-XYP(2_E_)-XYP(1_E_)",21.3911,"","",""
"6TRT","CHAETOMIUM THERMOPHILUM UDP-GLUCOSE GLUCOSYL TRANSFERASE (UGGT) DOUBLE CYSTEINE MUTANT S180C/T742C.","10.1016/J.STR.2020.11.017 ",4.58,142.9,"6trt_oligo2","DManpa1-2DManpa1-2DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-MAN(5_C_)-MAN(4_C_)-[MAN(8_C_)-MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(56_A_)",273.278,"","",""
"6TS2","TRUNCATED VERSION OF CHAETOMIUM THERMOPHILUM UDP-GLUCOSE GLUCOSYL TRANSFERASE (UGGT) LACKING DOMAIN TRXL2 (417-650).","10.1016/J.STR.2020.11.017 ",5.74,133.7,"6ts2_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(56_A_)",163.813,"","",""
"6TT4","CRYSTAL STRUCTURE OF 'RES_S2 MUTANT HUMAN ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH OMAPATRILAT.","10.1042/BCJ20200060 ",1.8,40.4,"6tt4_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_F_)-[MAN(4_F_)-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(416_B_)",65.6716,"","",""
"6TVA","CRYSTAL STRUCTURE OF THE HAEMAGGLUTININ FROM A TRANSMISSIBLE H10N7 SEAL INFLUENZA VIRUS ISOLATED IN NETHERLAND IN COMPLEX WITH AVIAN RECEPTOR ANALOGUE, 3'-SLN","10.1016/J.CHOM.2020.08.011 ",1.74,32.81,"6tva_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(154_D_)",34.9431,"","",""
"6TY5","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH COMPOUND 11","10.1021/ACS.JMEDCHEM.0C00130 ",2.79,79.47,"6ty5_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(293_A_)",90.1858,"","",""
"6TY5","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH COMPOUND 11","10.1021/ACS.JMEDCHEM.0C00130 ",2.79,79.47,"6ty5_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(293_B_)",89.4071,"","",""
"6TY5","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH COMPOUND 11","10.1021/ACS.JMEDCHEM.0C00130 ",2.79,79.47,"6ty5_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(590_B_)",81.1384,"","",""
"6TY5","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH COMPOUND 11","10.1021/ACS.JMEDCHEM.0C00130 ",2.79,79.47,"6ty5_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(590_A_)",78.2778,"","",""
"6TYB","ISOLATION AND STRUCTURE OF AN ANTIBODY THAT FULLY NEUTRALIZES ISOLATE SIVMAC239 REVEALS FUNCTIONAL SIMILARITY OF SIV AND HIV GLYCAN SHIELDS","10.1016/J.IMMUNI.2019.09.007 ",2.3,51.36,"6tyb_oligo6","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_I_)-[MAN(5_I_)]-MAN(4_I_)-[MAN(7_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(356_G_)",116.689,"","",""
"6TYB","ISOLATION AND STRUCTURE OF AN ANTIBODY THAT FULLY NEUTRALIZES ISOLATE SIVMAC239 REVEALS FUNCTIONAL SIMILARITY OF SIV AND HIV GLYCAN SHIELDS","10.1016/J.IMMUNI.2019.09.007 ",2.3,51.36,"6tyb_oligo8","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_K_)-[MAN(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(359_G_)",82.5555,"","",""
"6TYB","ISOLATION AND STRUCTURE OF AN ANTIBODY THAT FULLY NEUTRALIZES ISOLATE SIVMAC239 REVEALS FUNCTIONAL SIMILARITY OF SIV AND HIV GLYCAN SHIELDS","10.1016/J.IMMUNI.2019.09.007 ",2.3,51.36,"6tyb_oligo4","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_E_)-MAN(6_E_)-[MAN(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(262_G_)",86.0508,"","",""
"6TYB","ISOLATION AND STRUCTURE OF AN ANTIBODY THAT FULLY NEUTRALIZES ISOLATE SIVMAC239 REVEALS FUNCTIONAL SIMILARITY OF SIV AND HIV GLYCAN SHIELDS","10.1016/J.IMMUNI.2019.09.007 ",2.3,51.36,"6tyb_oligo7","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_J_)-[MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(268_G_)",98.7998,"","",""
"6TYB","ISOLATION AND STRUCTURE OF AN ANTIBODY THAT FULLY NEUTRALIZES ISOLATE SIVMAC239 REVEALS FUNCTIONAL SIMILARITY OF SIV AND HIV GLYCAN SHIELDS","10.1016/J.IMMUNI.2019.09.007 ",2.3,51.36,"6tyb_oligo5","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)]-MAN(4_F_)-[MAN(7_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(280_G_)",88.5601,"","",""
"6TYB","ISOLATION AND STRUCTURE OF AN ANTIBODY THAT FULLY NEUTRALIZES ISOLATE SIVMAC239 REVEALS FUNCTIONAL SIMILARITY OF SIV AND HIV GLYCAN SHIELDS","10.1016/J.IMMUNI.2019.09.007 ",2.3,51.36,"6tyb_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(467_G_)",98.4087,"","",""
"6TYB","ISOLATION AND STRUCTURE OF AN ANTIBODY THAT FULLY NEUTRALIZES ISOLATE SIVMAC239 REVEALS FUNCTIONAL SIMILARITY OF SIV AND HIV GLYCAN SHIELDS","10.1016/J.IMMUNI.2019.09.007 ",2.3,51.36,"6tyb_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_A_)-[MAN(5_A_)]-MAN(4_A_)-[MAN(7_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(88_G_)",95.2927,"","",""
"6TZB","CRYSTAL STRUCTURE OF THE A/HONG KONG/1/1968 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ IN COMPLEX WITH 6'-SLNLN","10.1038/S41467-020-15102-5 ",2.24,49.07,"6tzb_oligo9","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_O_)-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(165_E_)",95.942,"","",""
"6U02","CRYOEM-DERIVED MODEL OF NA-63 FAB IN COMPLEX WITH N9 SHANGHAI2","10.1016/J.CHOM.2019.10.002 ",3.05,0,"6u02_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_M_)-[MAN(8_M_)]-MAN(7_M_)-[MAN(6_M_)-MAN(5_M_)-MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(200_A_)",29.4068,"","",""
"6U02","CRYOEM-DERIVED MODEL OF NA-63 FAB IN COMPLEX WITH N9 SHANGHAI2","10.1016/J.CHOM.2019.10.002 ",3.05,0,"6u02_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_O_)-[MAN(8_O_)]-MAN(7_O_)-[MAN(6_O_)-MAN(5_O_)-MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(200_E_)",29.4068,"","",""
"6U02","CRYOEM-DERIVED MODEL OF NA-63 FAB IN COMPLEX WITH N9 SHANGHAI2","10.1016/J.CHOM.2019.10.002 ",3.05,0,"6u02_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_N_)-[MAN(8_N_)]-MAN(7_N_)-[MAN(6_N_)-MAN(5_N_)-MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(200_B_)",29.4068,"","",""
"6U02","CRYOEM-DERIVED MODEL OF NA-63 FAB IN COMPLEX WITH N9 SHANGHAI2","10.1016/J.CHOM.2019.10.002 ",3.05,0,"6u02_oligo4","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_P_)-[MAN(8_P_)]-MAN(7_P_)-[MAN(6_P_)-MAN(5_P_)-MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(200_J_)",29.4068,"","",""
"6U0L","ASYMMETRICALLY OPEN CONFORMATIONAL STATE (CLASS I) OF HIV-1 ENV TRIMER BG505 SOSIP.664 IN COMPLEX WITH SCD4 AND E51 FAB","10.1038/S41594-019-0344-5 ",3.3,"2.23709e+11","6u0l_oligo2","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-MAN(4_K_)-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(262_A_)",41.1082,"","",""
"6U0L","ASYMMETRICALLY OPEN CONFORMATIONAL STATE (CLASS I) OF HIV-1 ENV TRIMER BG505 SOSIP.664 IN COMPLEX WITH SCD4 AND E51 FAB","10.1038/S41594-019-0344-5 ",3.3,"2.23709e+11","6u0l_oligo7","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-MAN(4_S_)-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(262_C_)",33.3631,"","",""
"6U0L","ASYMMETRICALLY OPEN CONFORMATIONAL STATE (CLASS I) OF HIV-1 ENV TRIMER BG505 SOSIP.664 IN COMPLEX WITH SCD4 AND E51 FAB","10.1038/S41594-019-0344-5 ",3.3,"2.23709e+11","6u0l_oligo5","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_O_)-MAN(6_O_)-[MAN(5_O_)-MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(262_B_)",78.0496,"","",""
"6U0N","ASYMMETRICALLY OPEN CONFORMATIONAL STATE (CLASS II) OF HIV-1 ENV TRIMER BG505 SOSIP.664 IN COMPLEX WITH SCD4 AND E51 FAB","10.1038/S41594-019-0344-5 ",3.5,"5.37397e+08","6u0n_oligo2","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-MAN(4_M_)-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(262_A_)",51.0247,"","",""
"6U0N","ASYMMETRICALLY OPEN CONFORMATIONAL STATE (CLASS II) OF HIV-1 ENV TRIMER BG505 SOSIP.664 IN COMPLEX WITH SCD4 AND E51 FAB","10.1038/S41594-019-0344-5 ",3.5,"5.37397e+08","6u0n_oligo5","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-MAN(4_O_)-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(262_C_)",73.9738,"","",""
"6U0N","ASYMMETRICALLY OPEN CONFORMATIONAL STATE (CLASS II) OF HIV-1 ENV TRIMER BG505 SOSIP.664 IN COMPLEX WITH SCD4 AND E51 FAB","10.1038/S41594-019-0344-5 ",3.5,"5.37397e+08","6u0n_oligo4","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-MAN(4_N_)-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(262_B_)",70.248,"","",""
"6U59","HIV-1 B41 SOSIP.664 IN COMPLEX WITH RABBIT ANTIBODY 13B","10.1128/JVI.01861-19 ",3.86,"2.14959e+09","6u59_oligo20","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_W_)-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(262_A_)",76.783,"","",""
"6U59","HIV-1 B41 SOSIP.664 IN COMPLEX WITH RABBIT ANTIBODY 13B","10.1128/JVI.01861-19 ",3.86,"2.14959e+09","6u59_oligo37","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_w_)-BMA(3_w_)-NAG(2_w_)-NAG(1_w_)-ASN(262_G_)",76.783,"","",""
"6U59","HIV-1 B41 SOSIP.664 IN COMPLEX WITH RABBIT ANTIBODY 13B","10.1128/JVI.01861-19 ",3.86,"2.14959e+09","6u59_oligo16","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_j_)-BMA(3_j_)-NAG(2_j_)-NAG(1_j_)-ASN(262_C_)",76.783,"","",""
"6U7H","CRYO-EM STRUCTURE OF THE HCOV-229E SPIKE GLYCOPROTEIN","10.7554/ELIFE.51230 ",3.1,0,"6u7h_oligo10","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_N_)-MAN(6_N_)-[MAN(5_N_)-MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(62_C_)",126.427,"","",""
"6U7H","CRYO-EM STRUCTURE OF THE HCOV-229E SPIKE GLYCOPROTEIN","10.7554/ELIFE.51230 ",3.1,0,"6u7h_oligo5","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_I_)-MAN(6_I_)-[MAN(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(62_B_)",127.312,"","",""
"6U7H","CRYO-EM STRUCTURE OF THE HCOV-229E SPIKE GLYCOPROTEIN","10.7554/ELIFE.51230 ",3.1,0,"6u7h_oligo3","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_D_)-MAN(6_D_)-[MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(62_A_)",126.313,"","",""
"6U7K","PREFUSION STRUCTURE OF PEDV SPIKE","10.1128/JVI.00923-19 ",3.14,0,"6u7k_oligo2","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(6_I_)-[MAN(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)",30,"","",""
"6U7K","PREFUSION STRUCTURE OF PEDV SPIKE","10.1128/JVI.00923-19 ",3.14,0,"6u7k_oligo11","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAca1-ASN","MAN(6_N_)-[MAN(5_N_)-MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(261_C_)",30.5556,"","",""
"6U7K","PREFUSION STRUCTURE OF PEDV SPIKE","10.1128/JVI.00923-19 ",3.14,0,"6u7k_oligo3","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNx1-","MAN(6_D_)-[MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)",30,"","",""
"6UDA","CRYO-EM STRUCTURE OF CH235UCA BOUND TO MAN5-ENRICHED CH505.N279K.G458Y.SOSIP.664","10.1371/JOURNAL.PPAT.1008026 ",4.2,"5.37397e+08","6uda_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(4_N_)-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)",30,"","",""
"6UDA","CRYO-EM STRUCTURE OF CH235UCA BOUND TO MAN5-ENRICHED CH505.N279K.G458Y.SOSIP.664","10.1371/JOURNAL.PPAT.1008026 ",4.2,"5.37397e+08","6uda_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(4_M_)-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)",30,"","",""
"6UDA","CRYO-EM STRUCTURE OF CH235UCA BOUND TO MAN5-ENRICHED CH505.N279K.G458Y.SOSIP.664","10.1371/JOURNAL.PPAT.1008026 ",4.2,"5.37397e+08","6uda_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)",30,"","",""
"6UDK","HIV-1 BNAB 1-55 IN COMPLEX WITH MODIFIED BG505 SOSIP-BASED IMMUNOGEN RC1 AND 10-1074","10.1016/J.CELL.2020.01.010 ",3.9,"5.35483e+07","6udk_oligo9","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_a_)-[MAN(7_a_)]-MAN(6_a_)-[MAN(5_a_)-MAN(4_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(332_K_)",56.8225,"","",""
"6UDK","HIV-1 BNAB 1-55 IN COMPLEX WITH MODIFIED BG505 SOSIP-BASED IMMUNOGEN RC1 AND 10-1074","10.1016/J.CELL.2020.01.010 ",3.9,"5.35483e+07","6udk_oligo12","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_d_)-[MAN(5_d_)-MAN(4_d_)]-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(262_R_)",53.4418,"","",""
"6UDK","HIV-1 BNAB 1-55 IN COMPLEX WITH MODIFIED BG505 SOSIP-BASED IMMUNOGEN RC1 AND 10-1074","10.1016/J.CELL.2020.01.010 ",3.9,"5.35483e+07","6udk_oligo2","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_V_)-[MAN(7_V_)]-MAN(6_V_)-[MAN(5_V_)-MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(332_G_)",46.2403,"","",""
"6UDK","HIV-1 BNAB 1-55 IN COMPLEX WITH MODIFIED BG505 SOSIP-BASED IMMUNOGEN RC1 AND 10-1074","10.1016/J.CELL.2020.01.010 ",3.9,"5.35483e+07","6udk_oligo4","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_T_)-[MAN(5_T_)-MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(262_G_)",55.8962,"","",""
"6UDK","HIV-1 BNAB 1-55 IN COMPLEX WITH MODIFIED BG505 SOSIP-BASED IMMUNOGEN RC1 AND 10-1074","10.1016/J.CELL.2020.01.010 ",3.9,"5.35483e+07","6udk_oligo13","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_e_)-MAN(4_e_)-[MAN(6_e_)]-BMA(3_e_)-NAG(2_e_)-NAG(1_e_)-ASN(332_R_)",43.7697,"","",""
"6UDK","HIV-1 BNAB 1-55 IN COMPLEX WITH MODIFIED BG505 SOSIP-BASED IMMUNOGEN RC1 AND 10-1074","10.1016/J.CELL.2020.01.010 ",3.9,"5.35483e+07","6udk_oligo7","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_Y_)-MAN(6_Y_)-[MAN(5_Y_)-MAN(4_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(262_K_)",64.4775,"","",""
"6UG7","COMPLEX OF CH28/11 FAB AND SSEA-4 (TETRAGONAL FORM)","10.1074/JBC.RA119.011518 ",1.52,25.45,"6ug7_oligo1","DNeup5Aca2-3DGalpb1-3DGalpNAcb1-3DGalpa1-4DGalpb1-4DGlcpb1-ROH","SIA(6_A_)-GAL(5_A_)-NGA(4_A_)-GLA(3_A_)-GAL(2_A_)-BGC(1_A_)",18.8689,"","",""
"6UG8","COMPLEX OF CH28/11 FAB AND SSEA-4 (MONOCLINIC FORM)","10.1074/JBC.RA119.011518 ",1.89,42,"6ug8_oligo1","DNeup5Aca2-3DGalpb1-3DGalpNAcb1-3DGalpa1-4DGalpb1-4DGlcpb1-ROH","SIA(6_A_)-GAL(5_A_)-NGA(4_A_)-GLA(3_A_)-GAL(2_A_)-BGC(1_A_)",38.0814,"","",""
"6UG9","COMPLEX OF CH28/11 FAB AND SSEA-4 (HEXAGONAL FORM)","10.1074/JBC.RA119.011518 ",2.74,54.81,"6ug9_oligo1","DNeup5Aca2-3DGalpb1-3DGalpNAcb1-3DGalpa1-4DGalpb1-4DGlcpb1-ROH","SIA(6_C_)-GAL(5_C_)-NGA(4_C_)-GLA(3_C_)-GAL(2_C_)-BGC(1_C_)",53.328,"","",""
"6UG9","COMPLEX OF CH28/11 FAB AND SSEA-4 (HEXAGONAL FORM)","10.1074/JBC.RA119.011518 ",2.74,54.81,"6ug9_oligo3","DNeup5Aca2-3DGalpb1-3DGalpNAcb1-3DGalpa1-4DGalpb1-4DGlcpb1-ROH","SIA(6_E_)-GAL(5_E_)-NGA(4_E_)-GLA(3_E_)-GAL(2_E_)-BGC(1_E_)",72.5355,"","",""
"6UG9","COMPLEX OF CH28/11 FAB AND SSEA-4 (HEXAGONAL FORM)","10.1074/JBC.RA119.011518 ",2.74,54.81,"6ug9_oligo2","DNeup5Aca2-3DGalpb1-3DGalpNAcb1-3DGalpa1-4DGalpb1-4DGlcpb1-ROH","SIA(6_D_)-GAL(5_D_)-NGA(4_D_)-GLA(3_D_)-GAL(2_D_)-BGC(1_D_)",56.9185,"","",""
"6UGX","CRYSTAL STRUCTURE OF THE FC FRAGMENT OF PF06438179/GP1111 AN INFLIXIMAB BIOSIMILAR IN A PRIMATIVE ORTHORHOMBIC CRYSTAL FORM, LOT A","10.1007/S40259-019-00390-1 ",2.1,39.91,"6ugx_oligo2","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_D_)-[NAG(5_D_)-MAN(4_D_)-[MAN(6_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(300_B_)",51.9827,"","",""
"6UGX","CRYSTAL STRUCTURE OF THE FC FRAGMENT OF PF06438179/GP1111 AN INFLIXIMAB BIOSIMILAR IN A PRIMATIVE ORTHORHOMBIC CRYSTAL FORM, LOT A","10.1007/S40259-019-00390-1 ",2.1,39.91,"6ugx_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(300_A_)",48.6664,"","",""
"6UGY","CRYSTAL STRUCTURE OF THE FC FRAGMENT OF ANTI-TNFA ANTIBODY INFLIXIMAB (REMICADE) IN A PRIMATIVE ORTHORHOMBIC CRYSTAL FORM, LOT C","10.1007/S40259-019-00390-1 ",2.1,44.15,"6ugy_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_B_)-[GAL(6_B_)-NAG(5_B_)-MAN(4_B_)-[MAN(7_B_)]-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(300_A_)",68.9984,"","",""
"6UJA","INTEGRIN ALPHA-V BETA-8 IN COMPLEX WITH PRO-TGF-BETA1","10.1016/J.CELL.2019.12.030 ",3.3,"5.17114e+07","6uja_oligo1","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(266_A_)",30.7015,"","",""
"6UJB","INTEGRIN ALPHA-V BETA-8 IN COMPLEX WITH THE FABS C6D4 AND 11D12V2","10.1016/J.CELL.2019.12.030 ",3.51,869877,"6ujb_oligo1","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(266_A_)",50.378,"","",""
"6UJC","INTEGRIN ALPHA-V BETA-8 IN COMPLEX WITH THE FABS C6-RGD3 AND 11D12V2","10.1016/J.CELL.2019.12.030 ",3.56,869877,"6ujc_oligo1","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(266_A_)",76.7564,"","",""
"6ULC","STRUCTURE OF FULL-LENGTH, FULLY GLYCOSYLATED, NON-MODIFIED HIV-1 GP160 BOUND TO PG16 FAB AT A NOMINAL RESOLUTION OF 4.6 ANGSTROM","10.1016/J.JMB.2019.11.028 ",4.6,"2.14959e+09","6ulc_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_a_)-[MAN(5_a_)]-MAN(4_a_)-[MAN(7_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(160_E_)",132.807,"","",""
"6ULC","STRUCTURE OF FULL-LENGTH, FULLY GLYCOSYLATED, NON-MODIFIED HIV-1 GP160 BOUND TO PG16 FAB AT A NOMINAL RESOLUTION OF 4.6 ANGSTROM","10.1016/J.JMB.2019.11.028 ",4.6,"2.14959e+09","6ulc_oligo15","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(197_A_)",195.821,"","",""
"6ULC","STRUCTURE OF FULL-LENGTH, FULLY GLYCOSYLATED, NON-MODIFIED HIV-1 GP160 BOUND TO PG16 FAB AT A NOMINAL RESOLUTION OF 4.6 ANGSTROM","10.1016/J.JMB.2019.11.028 ",4.6,"2.14959e+09","6ulc_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(160_A_)",124.793,"","",""
"6UM5","CRYO-EM STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY DH270 UCA3 IN COMPLEX WITH CH848 10.17DT ENV","10.1126/SCIENCE.AAY7199 ",4.2,"5.37397e+08","6um5_oligo9","DManpa1-2DManpa1-3[DManpa1-6DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_N_)-BMA(6_N_)-[MAN(5_N_)-MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(332_A_)",29.6255,"","",""
"6UM5","CRYO-EM STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY DH270 UCA3 IN COMPLEX WITH CH848 10.17DT ENV","10.1126/SCIENCE.AAY7199 ",4.2,"5.37397e+08","6um5_oligo5","DManpa1-2DManpa1-3[DManpa1-6DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_U_)-BMA(6_U_)-[MAN(5_U_)-MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(332_E_)",29.6255,"","",""
"6UM5","CRYO-EM STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY DH270 UCA3 IN COMPLEX WITH CH848 10.17DT ENV","10.1126/SCIENCE.AAY7199 ",4.2,"5.37397e+08","6um5_oligo16","DManpa1-2DManpa1-3[DManpa1-6DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_b_)-BMA(6_b_)-[MAN(5_b_)-MAN(4_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(332_I_)",29.6255,"","",""
"6UM6","CRYO-EM STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY DH270.6 IN COMPLEX WITH CH848 10.17DT ENV","10.1126/SCIENCE.AAY7199 ",4.3,"5.37397e+08","6um6_oligo10","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNx1-","MAN(4_V_)-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)",30,"","",""
"6UM6","CRYO-EM STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY DH270.6 IN COMPLEX WITH CH848 10.17DT ENV","10.1126/SCIENCE.AAY7199 ",4.3,"5.37397e+08","6um6_oligo15","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(4_a_)-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)",30,"","",""
"6UM6","CRYO-EM STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY DH270.6 IN COMPLEX WITH CH848 10.17DT ENV","10.1126/SCIENCE.AAY7199 ",4.3,"5.37397e+08","6um6_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(4_Q_)-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)",30,"","",""
"6UM7","CRYO-EM STRUCTURE OF VACCINE-ELICITED HIV-1 NEUTRALIZING ANTIBODY DH270.MU1 IN COMPLEX WITH CH848 10.17DT ENV","10.1126/SCIENCE.AAY7199 ",3.5,"5.37397e+08","6um7_oligo13","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_X_)-[MAN(5_X_)-MAN(4_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(332_I_)",72.3844,"","",""
"6UM7","CRYO-EM STRUCTURE OF VACCINE-ELICITED HIV-1 NEUTRALIZING ANTIBODY DH270.MU1 IN COMPLEX WITH CH848 10.17DT ENV","10.1126/SCIENCE.AAY7199 ",3.5,"5.37397e+08","6um7_oligo8","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_S_)-[MAN(5_S_)-MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(332_E_)",71.68,"","",""
"6UM7","CRYO-EM STRUCTURE OF VACCINE-ELICITED HIV-1 NEUTRALIZING ANTIBODY DH270.MU1 IN COMPLEX WITH CH848 10.17DT ENV","10.1126/SCIENCE.AAY7199 ",3.5,"5.37397e+08","6um7_oligo7","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_N_)-[MAN(5_N_)-MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(332_A_)",79.9017,"","",""
"6UOX","STRUCTURE OF ITRACONAZOLE-BOUND NPC1","10.1038/S41467-019-13917-5 ",4.13,0,"6uox_oligo3","DManpa1-3DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(557_A_)",166.133,"","",""
"6UQC","MOUSE IGG2A BISPECIFIC FC","10.1080/19420862.2019.1685350 ",1.87,40.9,"6uqc_oligo4","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_H_)-MAN(6_H_)-[NAG(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(297_F_)",46.501,"","",""
"6UQC","MOUSE IGG2A BISPECIFIC FC","10.1080/19420862.2019.1685350 ",1.87,40.9,"6uqc_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(507_C_)-MAN(6_A_)-[NAG(5_A_)-MAN(4_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(297_C_)",71.2319,"","",""
"6UQC","MOUSE IGG2A BISPECIFIC FC","10.1080/19420862.2019.1685350 ",1.87,40.9,"6uqc_oligo3","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_G_)-MAN(6_G_)-[NAG(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(297_E_)",46.0612,"","",""
"6UQC","MOUSE IGG2A BISPECIFIC FC","10.1080/19420862.2019.1685350 ",1.87,40.9,"6uqc_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(507_D_)-MAN(6_B_)-[NAG(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(297_D_)",75.8019,"","",""
"6UQR","COMPLEX OF IGE AND LIGELIZUMAB","10.1038/S41467-019-13815-W ",3.65,113.1,"6uqr_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(394_D_)",123.3,"","",""
"6UQR","COMPLEX OF IGE AND LIGELIZUMAB","10.1038/S41467-019-13815-W ",3.65,113.1,"6uqr_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(394_B_)",123.397,"","",""
"6UR5","RESURFACED INFLUENZA HEMAGGLUTININ IN COMPLEX WITH A BROADLY NEUTRALIZING ANTIBODY","10.1021/ACSINFECDIS.0C00008 ",4,97.3,"6ur5_oligo2","DManpa1-3DManpb1-4[LFucpa1-6]DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_F_)-[FUC(5_F_)-[MAN(4_F_)-BMA(3_F_)]-NAG(2_F_)]-NAG(1_F_)-ASN(165_D_)",130.714,"","",""
"6URH","CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY AR3X IN COMPLEX WITH HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ECTODOMAIN","10.7554/ELIFE.53169 ",2.2,58.47,"6urh_oligo4","DManpa1-6DManpb1-3DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(556_C_)",116.15,"","",""
"6URH","CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY AR3X IN COMPLEX WITH HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ECTODOMAIN","10.7554/ELIFE.53169 ",2.2,58.47,"6urh_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-[MAN(5_E_)]-MAN(4_E_)-[MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(532_C_)",78.6156,"","",""
"6UTK","CRYSTAL STRUCTURE OF 438-B11 FAB IN COMPLEX WITH AN UNCLEAVED PREFUSION OPTIMIZED (UFO) SOLUBLE BG505 TRIMER AND FAB 35O22 AT 3.80 ANGSTROM","10.1126/SCIADV.ABB1328 ",3.8,166.3,"6utk_oligo13","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_R_)-[MAN(5_R_)]-MAN(4_R_)-[MAN(7_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(88_G_)",200.201,"","",""
"6UTK","CRYSTAL STRUCTURE OF 438-B11 FAB IN COMPLEX WITH AN UNCLEAVED PREFUSION OPTIMIZED (UFO) SOLUBLE BG505 TRIMER AND FAB 35O22 AT 3.80 ANGSTROM","10.1126/SCIADV.ABB1328 ",3.8,166.3,"6utk_oligo6","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-3DGlcpNAcb1-ASN","MAN(8_B_)-MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)]-MAN(4_B_)-[MAN(10_B_)-MAN(9_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(301_G_)",161.204,"","",""
"6UTK","CRYSTAL STRUCTURE OF 438-B11 FAB IN COMPLEX WITH AN UNCLEAVED PREFUSION OPTIMIZED (UFO) SOLUBLE BG505 TRIMER AND FAB 35O22 AT 3.80 ANGSTROM","10.1126/SCIADV.ABB1328 ",3.8,166.3,"6utk_oligo5","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-MAN(4_N_)-[MAN(6_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(392_G_)",188.34,"","",""
"6UTK","CRYSTAL STRUCTURE OF 438-B11 FAB IN COMPLEX WITH AN UNCLEAVED PREFUSION OPTIMIZED (UFO) SOLUBLE BG505 TRIMER AND FAB 35O22 AT 3.80 ANGSTROM","10.1126/SCIADV.ABB1328 ",3.8,166.3,"6utk_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_K_)-MAN(10_K_)-[MAN(9_K_)-MAN(8_K_)]-MAN(7_K_)-[MAN(6_K_)-MAN(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(332_G_)",146.548,"","",""
"6UTK","CRYSTAL STRUCTURE OF 438-B11 FAB IN COMPLEX WITH AN UNCLEAVED PREFUSION OPTIMIZED (UFO) SOLUBLE BG505 TRIMER AND FAB 35O22 AT 3.80 ANGSTROM","10.1126/SCIADV.ABB1328 ",3.8,166.3,"6utk_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_M_)-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(363_G_)",177.361,"","",""
"6UTK","CRYSTAL STRUCTURE OF 438-B11 FAB IN COMPLEX WITH AN UNCLEAVED PREFUSION OPTIMIZED (UFO) SOLUBLE BG505 TRIMER AND FAB 35O22 AT 3.80 ANGSTROM","10.1126/SCIADV.ABB1328 ",3.8,166.3,"6utk_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(156_G_)",148.946,"","",""
"6UTK","CRYSTAL STRUCTURE OF 438-B11 FAB IN COMPLEX WITH AN UNCLEAVED PREFUSION OPTIMIZED (UFO) SOLUBLE BG505 TRIMER AND FAB 35O22 AT 3.80 ANGSTROM","10.1126/SCIADV.ABB1328 ",3.8,166.3,"6utk_oligo14","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(262_G_)",146.964,"","",""
"6UUH","CRYSTAL STRUCTURE OF BROAD AND POTENT HIV-1 NEUTRALIZING ANTIBODY 438- B11","10.1126/SCIADV.ABB1328 ",2.7,60.13,"6uuh_oligo1","DManpa1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_G_)-[NAG(7_G_)-MAN(6_G_)-[MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(27_B_)",109.495,"","",""
"6UWZ","CRYO-EM STRUCTURE OF TORPEDO ACETYLCHOLINE RECEPTOR IN COMPLEX WITH ALPHA-BUNGAROTOXIN","10.1016/J.NEURON.2020.03.012 ",2.69,0,"6uwz_oligo4","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_K_)-MAN(8_K_)-[MAN(10_K_)]-MAN(7_K_)-[MAN(6_K_)-MAN(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(141_D_)",65.2135,"","",""
"6UWZ","CRYO-EM STRUCTURE OF TORPEDO ACETYLCHOLINE RECEPTOR IN COMPLEX WITH ALPHA-BUNGAROTOXIN","10.1016/J.NEURON.2020.03.012 ",2.69,0,"6uwz_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_H_)-MAN(8_H_)-[MAN(10_H_)]-MAN(7_H_)-[MAN(6_H_)-MAN(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(141_A_)",54.6852,"","",""
"6UYE","EBOV GPDMUC MAKONA BOUND TO REBOV-548 FAB","10.1016/J.IMMUNI.2020.01.001 ",3.96,524802,"6uye_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(257_C_)",133.96,"","",""
"6UYE","EBOV GPDMUC MAKONA BOUND TO REBOV-548 FAB","10.1016/J.IMMUNI.2020.01.001 ",3.96,524802,"6uye_oligo6","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_R_)-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(563_E_)",96.8773,"","",""
"6UYE","EBOV GPDMUC MAKONA BOUND TO REBOV-548 FAB","10.1016/J.IMMUNI.2020.01.001 ",3.96,524802,"6uye_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_O_)-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(563_D_)",94.9,"","",""
"6UYE","EBOV GPDMUC MAKONA BOUND TO REBOV-548 FAB","10.1016/J.IMMUNI.2020.01.001 ",3.96,524802,"6uye_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(257_A_)",131.936,"","",""
"6UYE","EBOV GPDMUC MAKONA BOUND TO REBOV-548 FAB","10.1016/J.IMMUNI.2020.01.001 ",3.96,524802,"6uye_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_P_)-[MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(257_B_)",139.192,"","",""
"6UYE","EBOV GPDMUC MAKONA BOUND TO REBOV-548 FAB","10.1016/J.IMMUNI.2020.01.001 ",3.96,524802,"6uye_oligo9","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_U_)-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(563_F_)",95.9016,"","",""
"6UYF","STRUCTURE OF HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2MC3-V1 REDESIGNED CORE FROM GENOTYPE 6A BOUND TO BROADLY NEUTRALIZING ANTIBODY AR3B","10.1126/SCIADV.AAZ6225 ",2.06,35.94,"6uyf_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(532_E_)",75.9302,"","",""
"6V06","CRYSTAL STRUCTURE OF BETA-2 GLYCOPROTEIN I PURIFIED FROM PLASMA (PB2GPI)","10.1074/JBC.RA120.013939 ",2.4,65.47,"6v06_oligo2","DManpa1-4DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(8_B_)-MAN(7_B_)-[MAN(6_B_)-NAG(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(143_A_)",207.568,"","",""
"6V06","CRYSTAL STRUCTURE OF BETA-2 GLYCOPROTEIN I PURIFIED FROM PLASMA (PB2GPI)","10.1074/JBC.RA120.013939 ",2.4,65.47,"6v06_oligo1","DManpb1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[BMA(4_D_)]-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(234_A_)",172.33,"","",""
"6V06","CRYSTAL STRUCTURE OF BETA-2 GLYCOPROTEIN I PURIFIED FROM PLASMA (PB2GPI)","10.1074/JBC.RA120.013939 ",2.4,65.47,"6v06_oligo3","DManpb1-4DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","NAG(8_C_)-MAN(7_C_)-[BMA(6_C_)-NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)",170.736,"","",""
"6V08","CRYSTAL STRUCTURE OF HUMAN RECOMBINANT BETA-2 GLYCOPROTEIN I (HRB2GPI)","10.1074/JBC.RA120.013939 ",2.58,68.76,"6v08_oligo4","DManpb1-4DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(8_C_)-MAN(7_C_)-[BMA(6_C_)-NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(174_A_)",172.124,"","",""
"6V08","CRYSTAL STRUCTURE OF HUMAN RECOMBINANT BETA-2 GLYCOPROTEIN I (HRB2GPI)","10.1074/JBC.RA120.013939 ",2.58,68.76,"6v08_oligo3","DManpa1-4DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(8_B_)-MAN(7_B_)-[MAN(6_B_)-NAG(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(143_A_)",204.617,"","",""
"6V08","CRYSTAL STRUCTURE OF HUMAN RECOMBINANT BETA-2 GLYCOPROTEIN I (HRB2GPI)","10.1074/JBC.RA120.013939 ",2.58,68.76,"6v08_oligo2","DManpb1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[BMA(4_E_)]-MAN(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(234_A_)",171.996,"","",""
"6V0R","BG505 SOSIP.664 TRIMER","10.1016/J.CELREP.2020.02.061 ",3.87,0,"6v0r_oligo18","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_J_)-[MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(262_A_)",76.0659,"","",""
"6V0R","BG505 SOSIP.664 TRIMER","10.1016/J.CELREP.2020.02.061 ",3.87,0,"6v0r_oligo22","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_b_)-[MAN(5_b_)-MAN(4_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(262_D_)",76.0659,"","",""
"6V0R","BG505 SOSIP.664 TRIMER","10.1016/J.CELREP.2020.02.061 ",3.87,0,"6v0r_oligo8","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_S_)-[MAN(5_S_)-MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(262_C_)",76.0659,"","",""
"6V44","THE CRYSTAL STRUCTURE OF HEMAGGLUTININ FROM SWINE INFLUENZA VIRUS A/SWINE/MISSOURI/A01727926/2015","10.1016/J.HELIYON.2020.E04068 ",2.2,50.79,"6v44_oligo1","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_G_)-[MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(162_A_)",66.2038,"","",""
"6V44","THE CRYSTAL STRUCTURE OF HEMAGGLUTININ FROM SWINE INFLUENZA VIRUS A/SWINE/MISSOURI/A01727926/2015","10.1016/J.HELIYON.2020.E04068 ",2.2,50.79,"6v44_oligo2","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-[MAN(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(162_C_)",65.9658,"","",""
"6V44","THE CRYSTAL STRUCTURE OF HEMAGGLUTININ FROM SWINE INFLUENZA VIRUS A/SWINE/MISSOURI/A01727926/2015","10.1016/J.HELIYON.2020.E04068 ",2.2,50.79,"6v44_oligo3","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_I_)-[MAN(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(162_E_)",67.8699,"","",""
"6V6W","CRYSTAL STRUCTURE OF ANTIBODY 438-B11 DSS MUTANT (CYS98A-100AA) IN COMPLEX WITH AN UNCLEAVED PREFUSION OPTIMIZED (UFO) SOLUBLE BG505 TRIMER AND FAB 35O22","10.1126/SCIADV.ABB1328 ",6.5,279.1,"6v6w_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Q_)-[MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(88_C_)",292.76,"","",""
"6V6W","CRYSTAL STRUCTURE OF ANTIBODY 438-B11 DSS MUTANT (CYS98A-100AA) IN COMPLEX WITH AN UNCLEAVED PREFUSION OPTIMIZED (UFO) SOLUBLE BG505 TRIMER AND FAB 35O22","10.1126/SCIADV.ABB1328 ",6.5,279.1,"6v6w_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(88_G_)",289.727,"","",""
"6V8X","VRC01 BOUND BG505 F14 HIV-1 SOSIP ENVELOPE TRIMER STRUCTURE","10.1038/S41467-019-14196-W ",3,524802,"6v8x_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_M_)-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(363_A_)",117.414,"","",""
"6V8X","VRC01 BOUND BG505 F14 HIV-1 SOSIP ENVELOPE TRIMER STRUCTURE","10.1038/S41467-019-14196-W ",3,524802,"6v8x_oligo25","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_k_)-BMA(3_k_)-NAG(2_k_)-NAG(1_k_)-ASN(363_I_)",117.414,"","",""
"6V8X","VRC01 BOUND BG505 F14 HIV-1 SOSIP ENVELOPE TRIMER STRUCTURE","10.1038/S41467-019-14196-W ",3,524802,"6v8x_oligo12","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_Y_)-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(363_E_)",117.414,"","",""
"6V8Z","VRC03 AND 10-1074 BOUND BG505 F14 HIV-1 SOSIP ENVELOPE TRIMER STRUCTURE","10.1038/S41467-019-14196-W ",2.9,"1.08527e-19","6v8z_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_Z_)-MAN(7_Z_)-[MAN(6_Z_)-MAN(5_Z_)-MAN(4_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(332_A_)",35.7523,"","",""
"6V8Z","VRC03 AND 10-1074 BOUND BG505 F14 HIV-1 SOSIP ENVELOPE TRIMER STRUCTURE","10.1038/S41467-019-14196-W ",2.9,"1.08527e-19","6v8z_oligo6","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_a_)-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(262_A_)",45.6355,"","",""
"6V8Z","VRC03 AND 10-1074 BOUND BG505 F14 HIV-1 SOSIP ENVELOPE TRIMER STRUCTURE","10.1038/S41467-019-14196-W ",2.9,"1.08527e-19","6v8z_oligo20","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_l_)-MAN(7_l_)-[MAN(6_l_)-MAN(5_l_)-MAN(4_l_)]-BMA(3_l_)-NAG(2_l_)-NAG(1_l_)-ASN(332_G_)",35.7523,"","",""
"6V8Z","VRC03 AND 10-1074 BOUND BG505 F14 HIV-1 SOSIP ENVELOPE TRIMER STRUCTURE","10.1038/S41467-019-14196-W ",2.9,"1.08527e-19","6v8z_oligo21","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_m_)-BMA(3_m_)-NAG(2_m_)-NAG(1_m_)-ASN(262_G_)",45.6355,"","",""
"6V8Z","VRC03 AND 10-1074 BOUND BG505 F14 HIV-1 SOSIP ENVELOPE TRIMER STRUCTURE","10.1038/S41467-019-14196-W ",2.9,"1.08527e-19","6v8z_oligo33","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_y_)-BMA(3_y_)-NAG(2_y_)-NAG(1_y_)-ASN(262_M_)",45.6355,"","",""
"6V8Z","VRC03 AND 10-1074 BOUND BG505 F14 HIV-1 SOSIP ENVELOPE TRIMER STRUCTURE","10.1038/S41467-019-14196-W ",2.9,"1.08527e-19","6v8z_oligo32","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_x_)-MAN(7_x_)-[MAN(6_x_)-MAN(5_x_)-MAN(4_x_)]-BMA(3_x_)-NAG(2_x_)-NAG(1_x_)-ASN(332_M_)",35.7523,"","",""
"6V9U","CRYSTAL STRUCTURE OF HUMAN TLR8 ECTODOMAIN BOUND TO SMALL MOLECULE ANTAGONIST 14C","10.1021/ACSMEDCHEMLETT.0C00264 ",2.65,101.3,"6v9u_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(293_A_)",88.7104,"","",""
"6V9U","CRYSTAL STRUCTURE OF HUMAN TLR8 ECTODOMAIN BOUND TO SMALL MOLECULE ANTAGONIST 14C","10.1021/ACSMEDCHEMLETT.0C00264 ",2.65,101.3,"6v9u_oligo6","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-MAN(4_H_)-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(590_B_)",67.9209,"","",""
"6V9U","CRYSTAL STRUCTURE OF HUMAN TLR8 ECTODOMAIN BOUND TO SMALL MOLECULE ANTAGONIST 14C","10.1021/ACSMEDCHEMLETT.0C00264 ",2.65,101.3,"6v9u_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(293_B_)",77.9424,"","",""
"6V9U","CRYSTAL STRUCTURE OF HUMAN TLR8 ECTODOMAIN BOUND TO SMALL MOLECULE ANTAGONIST 14C","10.1021/ACSMEDCHEMLETT.0C00264 ",2.65,101.3,"6v9u_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(590_A_)",72.0745,"","",""
"6VC9","TB19 COMPLEX","10.1074/JBC.RA120.012395 ",2.25,60.83,"6vc9_oligo1","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(311_A_)",106.128,"","",""
"6VEP","HUMAN INSULIN IN COMPLEX WITH THE HUMAN INSULIN MICRORECEPTOR IN TURN IN COMPLEX WITH FV 83-7","10.1038/S41594-020-0430-8 ",2.9,101.6,"6vep_oligo11","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_i_)-[MAN(4_i_)-BMA(3_i_)-NAG(2_i_)]-NAG(1_i_)-ASN(255_W_)",141.117,"","",""
"6VEQ","CON-INS G1 IN COMPLEX WITH THE HUMAN INSULIN MICRORECEPTOR IN TURN IN COMPLEX WITH FV 83-7","10.1038/S41594-020-0430-8 ",3.25,0,"6veq_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_M_)-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(111_E_)",167.704,"","",""
"6VEQ","CON-INS G1 IN COMPLEX WITH THE HUMAN INSULIN MICRORECEPTOR IN TURN IN COMPLEX WITH FV 83-7","10.1038/S41594-020-0430-8 ",3.25,0,"6veq_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_O_)-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(111_K_)",172.551,"","",""
"6VFL","BG505-SOSIP MODEL RECONSTRUCTED BY SUBPARTICLE EXTRACTION AND REFINEMENT FROM A TETRAHEDRAL NANOPARTICLE T33_DN10","10.1371/JOURNAL.PPAT.1008665 ",4.14,"1.08527e-19","6vfl_oligo24","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Q_)-[MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(262_C_)",76.786,"","",""
"6VFL","BG505-SOSIP MODEL RECONSTRUCTED BY SUBPARTICLE EXTRACTION AND REFINEMENT FROM A TETRAHEDRAL NANOPARTICLE T33_DN10","10.1371/JOURNAL.PPAT.1008665 ",4.14,"1.08527e-19","6vfl_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(262_A_)",76.786,"","",""
"6VFL","BG505-SOSIP MODEL RECONSTRUCTED BY SUBPARTICLE EXTRACTION AND REFINEMENT FROM A TETRAHEDRAL NANOPARTICLE T33_DN10","10.1371/JOURNAL.PPAT.1008665 ",4.14,"1.08527e-19","6vfl_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_a_)-[MAN(4_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(262_E_)",76.786,"","",""
"6VFR","CRYSTAL STRUCTURE OF HUMAN PROTOCADHERIN 18 EC1-EC4","10.1016/J.CELREP.2020.02.003 ",2.79,121.2,"6vfr_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_F_)-[MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(242_B_)",163.227,"","",""
"6VFR","CRYSTAL STRUCTURE OF HUMAN PROTOCADHERIN 18 EC1-EC4","10.1016/J.CELREP.2020.02.003 ",2.79,121.2,"6vfr_oligo2","LFucpa1-3DGlcpNAcb1-ASN","FUC(2_D_)-NAG(1_D_)-ASN(393_A_)",200.88,"","",""
"6VFW","CRYSTAL STRUCTURE OF HUMAN DELTA PROTOCADHERIN 10 EC1-EC4","10.1016/J.CELREP.2020.02.003 ",3.6,270.8,"6vfw_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_G_)-[MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(256_B_)",341.328,"","",""
"6VFW","CRYSTAL STRUCTURE OF HUMAN DELTA PROTOCADHERIN 10 EC1-EC4","10.1016/J.CELREP.2020.02.003 ",3.6,270.8,"6vfw_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_J_)-[MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)]-NAG(1_J_)-ASN(256_E_)",345.257,"","",""
"6VFW","CRYSTAL STRUCTURE OF HUMAN DELTA PROTOCADHERIN 10 EC1-EC4","10.1016/J.CELREP.2020.02.003 ",3.6,270.8,"6vfw_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_H_)-[MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)]-NAG(1_H_)-ASN(256_C_)",406.916,"","",""
"6VFW","CRYSTAL STRUCTURE OF HUMAN DELTA PROTOCADHERIN 10 EC1-EC4","10.1016/J.CELREP.2020.02.003 ",3.6,270.8,"6vfw_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_F_)-[MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(256_A_)",343.284,"","",""
"6VFW","CRYSTAL STRUCTURE OF HUMAN DELTA PROTOCADHERIN 10 EC1-EC4","10.1016/J.CELREP.2020.02.003 ",3.6,270.8,"6vfw_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_I_)-[MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(256_D_)",373.745,"","",""
"6VI0","CRYO-EM STRUCTURE OF VRC01.23 IN COMPLEX WITH HIV-1 ENV BG505 DS.SOSIP","10.1080/19420862.2021.1946918 ",3.43,"9.23241e+18","6vi0_oligo20","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_f_)-[MAN(7_f_)]-MAN(6_f_)-[MAN(5_f_)-MAN(4_f_)]-BMA(3_f_)-NAG(2_f_)-NAG(1_f_)-ASN(276_I_)",126.832,"","",""
"6VI0","CRYO-EM STRUCTURE OF VRC01.23 IN COMPLEX WITH HIV-1 ENV BG505 DS.SOSIP","10.1080/19420862.2021.1946918 ",3.43,"9.23241e+18","6vi0_oligo11","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_O_)-[MAN(5_O_)-MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(262_G_)",127.378,"","",""
"6VI0","CRYO-EM STRUCTURE OF VRC01.23 IN COMPLEX WITH HIV-1 ENV BG505 DS.SOSIP","10.1080/19420862.2021.1946918 ",3.43,"9.23241e+18","6vi0_oligo2","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_P_)-[MAN(7_P_)]-MAN(6_P_)-[MAN(5_P_)-MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(276_G_)",129.137,"","",""
"6VI0","CRYO-EM STRUCTURE OF VRC01.23 IN COMPLEX WITH HIV-1 ENV BG505 DS.SOSIP","10.1080/19420862.2021.1946918 ",3.43,"9.23241e+18","6vi0_oligo7","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_W_)-[MAN(5_W_)-MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(262_C_)",127.327,"","",""
"6VI0","CRYO-EM STRUCTURE OF VRC01.23 IN COMPLEX WITH HIV-1 ENV BG505 DS.SOSIP","10.1080/19420862.2021.1946918 ",3.43,"9.23241e+18","6vi0_oligo8","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_X_)-[MAN(7_X_)]-MAN(6_X_)-[MAN(5_X_)-MAN(4_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(276_C_)",129.032,"","",""
"6VI0","CRYO-EM STRUCTURE OF VRC01.23 IN COMPLEX WITH HIV-1 ENV BG505 DS.SOSIP","10.1080/19420862.2021.1946918 ",3.43,"9.23241e+18","6vi0_oligo19","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_e_)-[MAN(5_e_)-MAN(4_e_)]-BMA(3_e_)-NAG(2_e_)-NAG(1_e_)-ASN(262_I_)",123.697,"","",""
"6VI0","CRYO-EM STRUCTURE OF VRC01.23 IN COMPLEX WITH HIV-1 ENV BG505 DS.SOSIP","10.1080/19420862.2021.1946918 ",3.43,"9.23241e+18","6vi0_oligo22","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_h_)-MAN(4_h_)-[MAN(6_h_)]-BMA(3_h_)-NAG(2_h_)-NAG(1_h_)-ASN(363_I_)",121.831,"","",""
"6VI0","CRYO-EM STRUCTURE OF VRC01.23 IN COMPLEX WITH HIV-1 ENV BG505 DS.SOSIP","10.1080/19420862.2021.1946918 ",3.43,"9.23241e+18","6vi0_oligo10","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Z_)-MAN(4_Z_)-[MAN(6_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(363_C_)",121.845,"","",""
"6VI0","CRYO-EM STRUCTURE OF VRC01.23 IN COMPLEX WITH HIV-1 ENV BG505 DS.SOSIP","10.1080/19420862.2021.1946918 ",3.43,"9.23241e+18","6vi0_oligo14","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_R_)-MAN(4_R_)-[MAN(6_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(363_G_)",116.208,"","",""
"6VJ7","CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH ADENOSINE 5'-(BETA,GAMMA IMIDO)TRIPHOSPHATE","10.1016/J.PLANTSCI.2020.110445 ",2.6,36.75,"6vj7_oligo4","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_J_)-[FUC(2_J_)]-NAG(1_J_)-ASN(396_C_)",55.8573,"","",""
"6VJ7","CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH ADENOSINE 5'-(BETA,GAMMA IMIDO)TRIPHOSPHATE","10.1016/J.PLANTSCI.2020.110445 ",2.6,36.75,"6vj7_oligo11","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_I_)-[FUC(2_I_)]-NAG(1_I_)-ASN(109_B_)",61.1755,"","",""
"6VJ7","CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH ADENOSINE 5'-(BETA,GAMMA IMIDO)TRIPHOSPHATE","10.1016/J.PLANTSCI.2020.110445 ",2.6,36.75,"6vj7_oligo2","DManpb1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(396_A_)",51.5084,"","",""
"6VKN","BG505 SOSIP.V5.2.N241.N289 IN COMPLEX WITH RHESUS MACAQUE FAB RM19R","10.1038/S41541-020-00223-1 ",3.7,512.502,"6vkn_oligo1","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Q_)-[MAN(5_Q_)-MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(262_A_)",78.3368,"","",""
"6VKN","BG505 SOSIP.V5.2.N241.N289 IN COMPLEX WITH RHESUS MACAQUE FAB RM19R","10.1038/S41541-020-00223-1 ",3.7,512.502,"6vkn_oligo21","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_g_)-[MAN(5_g_)-MAN(4_g_)]-BMA(3_g_)-NAG(2_g_)-NAG(1_g_)-ASN(262_D_)",78.3368,"","",""
"6VKN","BG505 SOSIP.V5.2.N241.N289 IN COMPLEX WITH RHESUS MACAQUE FAB RM19R","10.1038/S41541-020-00223-1 ",3.7,512.502,"6vkn_oligo8","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Y_)-[MAN(5_Y_)-MAN(4_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(262_C_)",78.3368,"","",""
"6VL5","BG505 SOSIP RECONSTRUCTED FROM A DESIGNED TETRAHEDRAL NANOPARTICLE, BG505 SOSIP-T33_DN2","10.1038/S41541-020-00223-1 ",4.5,8.00784,"6vl5_oligo27","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Q_)-[MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(262_A_)",125.554,"","",""
"6VL5","BG505 SOSIP RECONSTRUCTED FROM A DESIGNED TETRAHEDRAL NANOPARTICLE, BG505 SOSIP-T33_DN2","10.1038/S41541-020-00223-1 ",4.5,8.00784,"6vl5_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_a_)-[MAN(4_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(262_E_)",125.554,"","",""
"6VL5","BG505 SOSIP RECONSTRUCTED FROM A DESIGNED TETRAHEDRAL NANOPARTICLE, BG505 SOSIP-T33_DN2","10.1038/S41541-020-00223-1 ",4.5,8.00784,"6vl5_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(262_C_)",125.554,"","",""
"6VLD","CRYSTAL STRUCTURE OF HUMAN ALPHA 1,6-FUCOSYLTRANSFERASE, FUT8 BOUND TO GDP AND A2SGP","10.1074/JBC.RA120.013291 ",2.28,64.03,"6vld_oligo5","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_E_)-MAN(6_E_)-[NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(601_G_)",74.1023,"","",""
"6VLD","CRYSTAL STRUCTURE OF HUMAN ALPHA 1,6-FUCOSYLTRANSFERASE, FUT8 BOUND TO GDP AND A2SGP","10.1074/JBC.RA120.013291 ",2.28,64.03,"6vld_oligo4","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(601_B_)",70.2448,"","",""
"6VLD","CRYSTAL STRUCTURE OF HUMAN ALPHA 1,6-FUCOSYLTRANSFERASE, FUT8 BOUND TO GDP AND A2SGP","10.1074/JBC.RA120.013291 ",2.28,64.03,"6vld_oligo6","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_F_)-MAN(6_F_)-[NAG(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(601_H_)",48.2195,"","",""
"6VLD","CRYSTAL STRUCTURE OF HUMAN ALPHA 1,6-FUCOSYLTRANSFERASE, FUT8 BOUND TO GDP AND A2SGP","10.1074/JBC.RA120.013291 ",2.28,64.03,"6vld_oligo3","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(601_A_)",56.7987,"","",""
"6VLK","A VARICELLA-ZOSTER VIRUS GLYCOPROTEIN","10.1038/S41467-020-17911-0 ",2.45,0,"6vlk_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(686_A_)",123.938,"","",""
"6VLK","A VARICELLA-ZOSTER VIRUS GLYCOPROTEIN","10.1038/S41467-020-17911-0 ",2.45,0,"6vlk_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)]-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(257_A_)",75.2051,"","",""
"6VLR","BG505 SOSIP.V5.2 IN COMPLEX WITH RHESUS MACAQUE FAB RM20E1 AND PGT122 FAB","10.1371/JOURNAL.PPAT.1008753 ",4.42,0.00048876,"6vlr_oligo9","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_T_)-[MAN(5_T_)-MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(332_A_)",120.672,"","",""
"6VLR","BG505 SOSIP.V5.2 IN COMPLEX WITH RHESUS MACAQUE FAB RM20E1 AND PGT122 FAB","10.1371/JOURNAL.PPAT.1008753 ",4.42,0.00048876,"6vlr_oligo14","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_b_)-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(137_H_)",150.482,"","",""
"6VLR","BG505 SOSIP.V5.2 IN COMPLEX WITH RHESUS MACAQUE FAB RM20E1 AND PGT122 FAB","10.1371/JOURNAL.PPAT.1008753 ",4.42,0.00048876,"6vlr_oligo17","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","MAN(5_e_)-[MAN(4_e_)]-BMA(3_e_)-NAG(2_e_)-NAG(1_e_)",134.999,"","",""
"6VLR","BG505 SOSIP.V5.2 IN COMPLEX WITH RHESUS MACAQUE FAB RM20E1 AND PGT122 FAB","10.1371/JOURNAL.PPAT.1008753 ",4.42,0.00048876,"6vlr_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Q_)-[MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(262_A_)",134.74,"","",""
"6VLR","BG505 SOSIP.V5.2 IN COMPLEX WITH RHESUS MACAQUE FAB RM20E1 AND PGT122 FAB","10.1371/JOURNAL.PPAT.1008753 ",4.42,0.00048876,"6vlr_oligo4","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_U_)-MAN(4_U_)-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(137_A_)",159.555,"","",""
"6VLR","BG505 SOSIP.V5.2 IN COMPLEX WITH RHESUS MACAQUE FAB RM20E1 AND PGT122 FAB","10.1371/JOURNAL.PPAT.1008753 ",4.42,0.00048876,"6vlr_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Y_)-[MAN(4_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(262_H_)",140.801,"","",""
"6VLR","BG505 SOSIP.V5.2 IN COMPLEX WITH RHESUS MACAQUE FAB RM20E1 AND PGT122 FAB","10.1371/JOURNAL.PPAT.1008753 ",4.42,0.00048876,"6vlr_oligo19","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_g_)-BMA(3_g_)-NAG(2_g_)-NAG(1_g_)-ASN(137_G_)",156.71,"","",""
"6VLR","BG505 SOSIP.V5.2 IN COMPLEX WITH RHESUS MACAQUE FAB RM20E1 AND PGT122 FAB","10.1371/JOURNAL.PPAT.1008753 ",4.42,0.00048876,"6vlr_oligo18","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_f_)-[MAN(5_f_)-MAN(4_f_)]-BMA(3_f_)-NAG(2_f_)-NAG(1_f_)-ASN(332_G_)",117.813,"","",""
"6VLR","BG505 SOSIP.V5.2 IN COMPLEX WITH RHESUS MACAQUE FAB RM20E1 AND PGT122 FAB","10.1371/JOURNAL.PPAT.1008753 ",4.42,0.00048876,"6vlr_oligo13","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_a_)-[MAN(5_a_)-MAN(4_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(332_H_)",125.332,"","",""
"6VN0","BG505 SOSIP.V4.1 IN COMPLEX WITH RHESUS MACAQUE FAB RM20F","10.1371/JOURNAL.PPAT.1008753 ",4.25,"9.23241e+18","6vn0_oligo27","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_m_)-MAN(4_m_)-BMA(3_m_)-NAG(2_m_)-NAG(1_m_)-ASN(262_D_)",115.112,"","",""
"6VN0","BG505 SOSIP.V4.1 IN COMPLEX WITH RHESUS MACAQUE FAB RM20F","10.1371/JOURNAL.PPAT.1008753 ",4.25,"9.23241e+18","6vn0_oligo14","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_b_)-MAN(4_b_)-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(262_C_)",115.112,"","",""
"6VN0","BG505 SOSIP.V4.1 IN COMPLEX WITH RHESUS MACAQUE FAB RM20F","10.1371/JOURNAL.PPAT.1008753 ",4.25,"9.23241e+18","6vn0_oligo2","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Q_)-MAN(4_Q_)-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(262_A_)",115.112,"","",""
"6VN0","BG505 SOSIP.V4.1 IN COMPLEX WITH RHESUS MACAQUE FAB RM20F","10.1371/JOURNAL.PPAT.1008753 ",4.25,"9.23241e+18","6vn0_oligo23","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(88_A_)",100.416,"","",""
"6VN0","BG505 SOSIP.V4.1 IN COMPLEX WITH RHESUS MACAQUE FAB RM20F","10.1371/JOURNAL.PPAT.1008753 ",4.25,"9.23241e+18","6vn0_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_X_)-[MAN(4_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(88_C_)",100.416,"","",""
"6VN0","BG505 SOSIP.V4.1 IN COMPLEX WITH RHESUS MACAQUE FAB RM20F","10.1371/JOURNAL.PPAT.1008753 ",4.25,"9.23241e+18","6vn0_oligo21","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_i_)-[MAN(4_i_)]-BMA(3_i_)-NAG(2_i_)-NAG(1_i_)-ASN(88_D_)",100.416,"","",""
"6VO1","BG505 SOSIP.V5.2 IN COMPLEX WITH RHESUS MACAQUE FAB RM20J","10.1371/JOURNAL.PPAT.1008753 ",3.88,"2.14959e+09","6vo1_oligo10","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Z_)-[MAN(5_Z_)-MAN(4_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(262_C_)",129.182,"","",""
"6VO1","BG505 SOSIP.V5.2 IN COMPLEX WITH RHESUS MACAQUE FAB RM20J","10.1371/JOURNAL.PPAT.1008753 ",3.88,"2.14959e+09","6vo1_oligo2","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Q_)-[MAN(5_Q_)-MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(262_A_)",129.182,"","",""
"6VO1","BG505 SOSIP.V5.2 IN COMPLEX WITH RHESUS MACAQUE FAB RM20J","10.1371/JOURNAL.PPAT.1008753 ",3.88,"2.14959e+09","6vo1_oligo23","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_i_)-[MAN(5_i_)-MAN(4_i_)]-BMA(3_i_)-NAG(2_i_)-NAG(1_i_)-ASN(262_D_)",129.182,"","",""
"6VO3","AMC009 SOSIP.V4.2 IN COMPLEX WITH PGV04 FAB","10.1128/JVI.01214-20 ",4.25,512.502,"6vo3_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(276_A_)",121.751,"","",""
"6VO3","AMC009 SOSIP.V4.2 IN COMPLEX WITH PGV04 FAB","10.1128/JVI.01214-20 ",4.25,512.502,"6vo3_oligo16","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_b_)-[MAN(4_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(276_D_)",121.751,"","",""
"6VO3","AMC009 SOSIP.V4.2 IN COMPLEX WITH PGV04 FAB","10.1128/JVI.01214-20 ",4.25,512.502,"6vo3_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_U_)-[MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(276_C_)",121.751,"","",""
"6VPX","NANODISC OF FULL-LENGTH HIV-1 ENVELOPE GLYCOPROTEIN CLONE AMC011 IN COMPLEX WITH ONE PGT151 FAB AND THREE 10E8 FABS","10.1016/J.CELREP.2020.107583 ",5,0.00048876,"6vpx_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_g_)-[MAN(4_g_)]-BMA(3_g_)-NAG(2_g_)-NAG(1_g_)-ASN(262_C_)",193.751,"","",""
"6VPX","NANODISC OF FULL-LENGTH HIV-1 ENVELOPE GLYCOPROTEIN CLONE AMC011 IN COMPLEX WITH ONE PGT151 FAB AND THREE 10E8 FABS","10.1016/J.CELREP.2020.107583 ",5,0.00048876,"6vpx_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_W_)-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(262_A_)",225.372,"","",""
"6VPX","NANODISC OF FULL-LENGTH HIV-1 ENVELOPE GLYCOPROTEIN CLONE AMC011 IN COMPLEX WITH ONE PGT151 FAB AND THREE 10E8 FABS","10.1016/J.CELREP.2020.107583 ",5,0.00048876,"6vpx_oligo21","DGalpb1-4DGlcpNAcb1-2[DGlcpNAcb1-4]DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_l_)-[MAN(8_l_)-[NAG(7_l_)-[GAL(6_l_)-NAG(5_l_)]-MAN(4_l_)]-BMA(3_l_)-NAG(2_l_)]-NAG(1_l_)-ASN(637_B_)",122.313,"","",""
"6VPX","NANODISC OF FULL-LENGTH HIV-1 ENVELOPE GLYCOPROTEIN CLONE AMC011 IN COMPLEX WITH ONE PGT151 FAB AND THREE 10E8 FABS","10.1016/J.CELREP.2020.107583 ",5,0.00048876,"6vpx_oligo22","DGalpb1-4DGlcpNAcb1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_m_)-[GAL(6_m_)-NAG(5_m_)-MAN(4_m_)-[MAN(7_m_)]-BMA(3_m_)-NAG(2_m_)]-NAG(1_m_)-ASN(611_B_)",97.6494,"","",""
"6VRW","CRYO-EM STRUCTURE OF STABILIZED HIV-1 ENV TRIMER CAP256.WK34.C80 SOSIP.RNS2","10.1016/J.CELREP.2020.03.052 ",3.71,0,"6vrw_oligo23","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_c_)-[MAN(4_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(262_D_)",158.5,"","",""
"6VRW","CRYO-EM STRUCTURE OF STABILIZED HIV-1 ENV TRIMER CAP256.WK34.C80 SOSIP.RNS2","10.1016/J.CELREP.2020.03.052 ",3.71,0,"6vrw_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_U_)-[MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(262_A_)",145.556,"","",""
"6VRW","CRYO-EM STRUCTURE OF STABILIZED HIV-1 ENV TRIMER CAP256.WK34.C80 SOSIP.RNS2","10.1016/J.CELREP.2020.03.052 ",3.71,0,"6vrw_oligo17","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(262_G_)",145.69,"","",""
"6VSL","CRYSTAL STRUCTURE OF A HUMAN FUCOSYLATED IGG1 FC EXPRESSED IN TOBACCO PLANTS (NICOTIANA BENTHAMIANA)","10.1128/JVI.00796-21 ",2.1,0,"6vsl_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",94.7328,"","",""
"6VSL","CRYSTAL STRUCTURE OF A HUMAN FUCOSYLATED IGG1 FC EXPRESSED IN TOBACCO PLANTS (NICOTIANA BENTHAMIANA)","10.1128/JVI.00796-21 ",2.1,0,"6vsl_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",64.7808,"","",""
"6VSZ","CRYSTAL STRUCTURE OF A HUMAN AFUCOSYLATED IGG1 FC EXPRESSED IN TOBACCO PLANTS (NICOTIANA BENTHAMIANA)","10.1128/JVI.00796-21 ",2.6,0,"6vsz_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(297_B_)",111.767,"","",""
"6VSZ","CRYSTAL STRUCTURE OF A HUMAN AFUCOSYLATED IGG1 FC EXPRESSED IN TOBACCO PLANTS (NICOTIANA BENTHAMIANA)","10.1128/JVI.00796-21 ",2.6,0,"6vsz_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(297_A_)",94.3261,"","",""
"6VT2","SIALIC ACID BINDING REGION OF STREPTOCOCCUS SANGUINIS SK1 ADHESIN BOUND TO STA","10.1074/JBC.RA120.014177 ",1.52,18.83,"6vt2_oligo3","DNeup5Aca2-3DGalpb1-3DGalpNAca1-ROH","SIA(3_D_)-GAL(2_D_)-A2G(1_D_)",14.6225,"","",""
"6VT2","SIALIC ACID BINDING REGION OF STREPTOCOCCUS SANGUINIS SK1 ADHESIN BOUND TO STA","10.1074/JBC.RA120.014177 ",1.52,18.83,"6vt2_oligo2","DNeup5Aca2-3DGalpb1-3DGalpNAca1-ROH","SIA(3_C_)-GAL(2_C_)-A2G(1_C_)",14.901,"","",""
"6VT2","SIALIC ACID BINDING REGION OF STREPTOCOCCUS SANGUINIS SK1 ADHESIN BOUND TO STA","10.1074/JBC.RA120.014177 ",1.52,18.83,"6vt2_oligo4","DNeup5Aca2-3DGalpb1-3DGalpNAca1-ROH","SIA(3_F_)-GAL(2_F_)-A2G(1_F_)",27.277,"","",""
"6VT2","SIALIC ACID BINDING REGION OF STREPTOCOCCUS SANGUINIS SK1 ADHESIN BOUND TO STA","10.1074/JBC.RA120.014177 ",1.52,18.83,"6vt2_oligo1","DNeup5Aca2-3DGalpb1-3DGalpNAca1-ROH","SIA(3_K_)-GAL(2_K_)-A2G(1_K_)",25.9843,"","",""
"6VTT","CRYO-EM STRUCTURE OF CAP256-VRC26.25 FAB BOUND TO HIV-1 ENV TRIMER CAP256.WK34.C80 SOSIP.RNS2","10.1016/J.CELREP.2020.03.052 ",3.7,"5.50295e+11","6vtt_oligo11","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_W_)-[MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(156_G_)",151.641,"","",""
"6VTT","CRYO-EM STRUCTURE OF CAP256-VRC26.25 FAB BOUND TO HIV-1 ENV TRIMER CAP256.WK34.C80 SOSIP.RNS2","10.1016/J.CELREP.2020.03.052 ",3.7,"5.50295e+11","6vtt_oligo20","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_b_)-[MAN(5_b_)-MAN(4_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(262_G_)",99.7773,"","",""
"6VTT","CRYO-EM STRUCTURE OF CAP256-VRC26.25 FAB BOUND TO HIV-1 ENV TRIMER CAP256.WK34.C80 SOSIP.RNS2","10.1016/J.CELREP.2020.03.052 ",3.7,"5.50295e+11","6vtt_oligo8","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_T_)-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(262_E_)",80.5893,"","",""
"6VTT","CRYO-EM STRUCTURE OF CAP256-VRC26.25 FAB BOUND TO HIV-1 ENV TRIMER CAP256.WK34.C80 SOSIP.RNS2","10.1016/J.CELREP.2020.03.052 ",3.7,"5.50295e+11","6vtt_oligo15","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(262_F_)",96.8107,"","",""
"6VTT","CRYO-EM STRUCTURE OF CAP256-VRC26.25 FAB BOUND TO HIV-1 ENV TRIMER CAP256.WK34.C80 SOSIP.RNS2","10.1016/J.CELREP.2020.03.052 ",3.7,"5.50295e+11","6vtt_oligo10","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_V_)-MAN(4_V_)-[MAN(6_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(130_G_)",164.664,"","",""
"6VV5","CRYO-EM STRUCTURE OF PORCINE EPIDEMIC DIARRHEA VIRUS (PEDV) SPIKE PROTEIN","10.1016/J.STR.2020.12.003 ",3.5,0,"6vv5_oligo18","DManpa1-2DManpa1-3[DGlcpNAcb1-2[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_X_)-[NAG(7_X_)]-MAN(6_X_)-[MAN(5_X_)-MAN(4_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(264_C_)",46.2131,"","",""
"6VV5","CRYO-EM STRUCTURE OF PORCINE EPIDEMIC DIARRHEA VIRUS (PEDV) SPIKE PROTEIN","10.1016/J.STR.2020.12.003 ",3.5,0,"6vv5_oligo8","DManpa1-2DManpa1-3[DGlcpNAcb1-2[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_D_)-[NAG(7_D_)]-MAN(6_D_)-[MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(264_A_)",46.2131,"","",""
"6VV5","CRYO-EM STRUCTURE OF PORCINE EPIDEMIC DIARRHEA VIRUS (PEDV) SPIKE PROTEIN","10.1016/J.STR.2020.12.003 ",3.5,0,"6vv5_oligo7","DManpa1-2DManpa1-3[DGlcpNAcb1-2[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_N_)-[NAG(7_N_)]-MAN(6_N_)-[MAN(5_N_)-MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(264_B_)",46.2131,"","",""
"6VY2","CRYO-EM STRUCTURE OF M1214_N1 FAB IN COMPLEX WITH CH505 TF CHIMERIC SOSIP.664 ENV TRIMER","10.1016/J.CHOM.2020.03.024 ",4.86,"5.37397e+08","6vy2_oligo9","DManpa1-3DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_Y_)-MAN(6_Y_)-[MAN(5_Y_)-MAN(4_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(386_A_)",196.204,"","",""
"6VY2","CRYO-EM STRUCTURE OF M1214_N1 FAB IN COMPLEX WITH CH505 TF CHIMERIC SOSIP.664 ENV TRIMER","10.1016/J.CHOM.2020.03.024 ",4.86,"5.37397e+08","6vy2_oligo45","DManpa1-3DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_4_)-MAN(6_4_)-[MAN(5_4_)-MAN(4_4_)]-BMA(3_4_)-NAG(2_4_)-NAG(1_4_)-ASN(386_E_)",199.47,"","",""
"6VY2","CRYO-EM STRUCTURE OF M1214_N1 FAB IN COMPLEX WITH CH505 TF CHIMERIC SOSIP.664 ENV TRIMER","10.1016/J.CHOM.2020.03.024 ",4.86,"5.37397e+08","6vy2_oligo40","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_z_)-[MAN(4_z_)]-BMA(3_z_)-NAG(2_z_)-NAG(1_z_)-ASN(262_E_)",218.989,"","",""
"6VY2","CRYO-EM STRUCTURE OF M1214_N1 FAB IN COMPLEX WITH CH505 TF CHIMERIC SOSIP.664 ENV TRIMER","10.1016/J.CHOM.2020.03.024 ",4.86,"5.37397e+08","6vy2_oligo23","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_T_)-[MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(262_A_)",228.155,"","",""
"6VY2","CRYO-EM STRUCTURE OF M1214_N1 FAB IN COMPLEX WITH CH505 TF CHIMERIC SOSIP.664 ENV TRIMER","10.1016/J.CHOM.2020.03.024 ",4.86,"5.37397e+08","6vy2_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_S_)-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(241_A_)",246.866,"","",""
"6VY2","CRYO-EM STRUCTURE OF M1214_N1 FAB IN COMPLEX WITH CH505 TF CHIMERIC SOSIP.664 ENV TRIMER","10.1016/J.CHOM.2020.03.024 ",4.86,"5.37397e+08","6vy2_oligo29","DManpa1-3DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_o_)-MAN(6_o_)-[MAN(5_o_)-MAN(4_o_)]-BMA(3_o_)-NAG(2_o_)-NAG(1_o_)-ASN(386_C_)",191.833,"","",""
"6VY2","CRYO-EM STRUCTURE OF M1214_N1 FAB IN COMPLEX WITH CH505 TF CHIMERIC SOSIP.664 ENV TRIMER","10.1016/J.CHOM.2020.03.024 ",4.86,"5.37397e+08","6vy2_oligo19","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_i_)-BMA(3_i_)-NAG(2_i_)-NAG(1_i_)-ASN(241_C_)",252.423,"","",""
"6VY2","CRYO-EM STRUCTURE OF M1214_N1 FAB IN COMPLEX WITH CH505 TF CHIMERIC SOSIP.664 ENV TRIMER","10.1016/J.CHOM.2020.03.024 ",4.86,"5.37397e+08","6vy2_oligo39","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_y_)-BMA(3_y_)-NAG(2_y_)-NAG(1_y_)-ASN(241_E_)",238.645,"","",""
"6VY2","CRYO-EM STRUCTURE OF M1214_N1 FAB IN COMPLEX WITH CH505 TF CHIMERIC SOSIP.664 ENV TRIMER","10.1016/J.CHOM.2020.03.024 ",4.86,"5.37397e+08","6vy2_oligo20","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_j_)-[MAN(4_j_)]-BMA(3_j_)-NAG(2_j_)-NAG(1_j_)-ASN(262_C_)",217.516,"","",""
"6VZI","CRYSTAL STRUCTURE OF HIV-1 CAP256 RNS-3MUT-2G-SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH HUMAN ANTIBODIES 3H109L AND 35O22 AT 3.5 ANGSTROM","10.1128/JVI.00074-20 ",2.72,49.32,"6vzi_oligo4","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_J_)-MAN(8_J_)-[MAN(10_J_)]-MAN(7_J_)-[MAN(6_J_)-MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(332_G_)",54.6252,"","",""
"6VZI","CRYSTAL STRUCTURE OF HIV-1 CAP256 RNS-3MUT-2G-SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH HUMAN ANTIBODIES 3H109L AND 35O22 AT 3.5 ANGSTROM","10.1128/JVI.00074-20 ",2.72,49.32,"6vzi_oligo5","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_A_)-MAN(4_A_)-[MAN(6_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(88_G_)",72.6259,"","",""
"6W03","CRYSTAL STRUCTURE OF HIV-1 BG505 DS-SOSIP.3MUT PREFUSION ENV TRIMER IN COMPLEX WITH HUMAN ANTIBODIES 3H109L AND 35O22 AT 3.3 ANGSTROM","10.1128/JVI.00074-20 ",2.4,47.76,"6w03_oligo14","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_N_)-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(301_G_)",112.097,"","",""
"6W03","CRYSTAL STRUCTURE OF HIV-1 BG505 DS-SOSIP.3MUT PREFUSION ENV TRIMER IN COMPLEX WITH HUMAN ANTIBODIES 3H109L AND 35O22 AT 3.3 ANGSTROM","10.1128/JVI.00074-20 ",2.4,47.76,"6w03_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(156_G_)",111.643,"","",""
"6W03","CRYSTAL STRUCTURE OF HIV-1 BG505 DS-SOSIP.3MUT PREFUSION ENV TRIMER IN COMPLEX WITH HUMAN ANTIBODIES 3H109L AND 35O22 AT 3.3 ANGSTROM","10.1128/JVI.00074-20 ",2.4,47.76,"6w03_oligo15","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-MAN(4_O_)-[MAN(6_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(88_G_)",51.3689,"","",""
"6W03","CRYSTAL STRUCTURE OF HIV-1 BG505 DS-SOSIP.3MUT PREFUSION ENV TRIMER IN COMPLEX WITH HUMAN ANTIBODIES 3H109L AND 35O22 AT 3.3 ANGSTROM","10.1128/JVI.00074-20 ",2.4,47.76,"6w03_oligo16","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_P_)-MAN(8_P_)-[MAN(10_P_)]-MAN(7_P_)-[MAN(6_P_)-MAN(5_P_)-MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(332_G_)",50.1545,"","",""
"6W16","CRYSTAL STRUCTURE OF A HUMAN METAPNEUMOVIRUS MONOMERIC FUSION PROTEIN COMPLEXED WITH 458 FAB","10.1371/JOURNAL.PPAT.1008942 ",3.1,0,"6w16_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_A_)-[MAN(4_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(57_F_)",143.755,"","",""
"6W35","A NEW AUTOTAXIN INHIBITOR FOR THE TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS: A CLINICAL CANDIDATE DISCOVERED USING DNA-ENCODED CHEMISTRY","10.1021/ACS.JMEDCHEM.0C00688 ",1.98,39.14,"6w35_oligo3","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)]-MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(525_A_)",36.2714,"","",""
"6W3H","BRAIN DELIVERY OF THERAPEUTIC PROTEINS USING AN FC FRAGMENT BLOOD- BRAIN BARRIER TRANSPORT VEHICLE IN MICE AND MONKEYS","10.1126/SCITRANSLMED.AAY1359 ",3.38,72.05,"6w3h_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_E_)-MAN(6_E_)-[NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(297_A_)",86.4807,"","",""
"6W5R","NPC1 STRUCTURE IN NANODISC","10.1016/J.CELL.2020.05.020 ",3.6,0,"6w5r_oligo1","DManpb1-3DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(557_A_)",105.137,"","",""
"6W5S","NPC1 STRUCTURE IN GDN MICELLES AT PH 8.0","10.1016/J.CELL.2020.05.020 ",3,0,"6w5s_oligo4","DManpa1-3DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(557_A_)",53.2036,"","",""
"6W5T","NPC1 STRUCTURE IN GDN MICELLES AT PH 5.5, CONFORMATION A","10.1016/J.CELL.2020.05.020 ",3.7,0,"6w5t_oligo1","DManpa1-3DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(557_A_)",95.5903,"","",""
"6W5U","NPC1 STRUCTURE IN GDN MICELLES AT PH 5.5, CONFORMATION B","10.1016/J.CELL.2020.05.020 ",3.9,0,"6w5u_oligo1","DManpb1-3DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(557_A_)",100.715,"","",""
"6W5V","NPC1-NPC2 COMPLEX STRUCTURE AT PH 5.5","10.1016/J.CELL.2020.05.020 ",4,0,"6w5v_oligo1","DManpb1-3DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(557_A_)",102.043,"","",""
"6WEO","IL-22 SIGNALING COMPLEX WITH IL-22R1 AND IL-10RBETA","10.1016/J.IMMUNI.2021.03.008 ",2.6,101.1,"6weo_oligo8","DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(5_h_)-[BMA(3_h_)-NAG(2_h_)]-[FUC(4_h_)]-NAG(1_h_)-ASN(54_D_)",118.733,"","",""
"6WEO","IL-22 SIGNALING COMPLEX WITH IL-22R1 AND IL-10RBETA","10.1016/J.IMMUNI.2021.03.008 ",2.6,101.1,"6weo_oligo6","LFucpa1-3DGlcpNAcb1-ASN","FUC(2_f_)-NAG(1_f_)-ASN(54_8_)",125.818,"","",""
"6WEO","IL-22 SIGNALING COMPLEX WITH IL-22R1 AND IL-10RBETA","10.1016/J.IMMUNI.2021.03.008 ",2.6,101.1,"6weo_oligo23","LFucpa1-3[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_w_)-[FUC(2_w_)]-NAG(1_w_)-ASN(54_Z_)",112.174,"","",""
"6WEO","IL-22 SIGNALING COMPLEX WITH IL-22R1 AND IL-10RBETA","10.1016/J.IMMUNI.2021.03.008 ",2.6,101.1,"6weo_oligo11","DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(5_k_)-[BMA(3_k_)-NAG(2_k_)]-[FUC(4_k_)]-NAG(1_k_)-ASN(172_I_)",101.319,"","",""
"6WIB","NEXT GENERATION MONOMERIC IGG4 FC","10.1038/S42003-021-02565-5 ",2.55,35.64,"6wib_oligo1","NAG1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_B_)-[NAG(7_B_)-MAN(6_B_)-[NAG(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(297_A_)",56.8193,"","",""
"6WIX","CRYSTAL STRUCTURE OF HIV-1 MI369 RNS-DS.SOSIP PREFUSION ENV TRIMER IN COMPLEX WITH HUMAN ANTIBODIES 3H109L AND 35O22 AT 3.5 ANGSTROM","10.1016/J.CELREP.2020.108432 ",2.67,47.5,"6wix_oligo6","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_A_)-MAN(4_A_)-[MAN(6_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(88_G_)",55.8452,"","",""
"6WIX","CRYSTAL STRUCTURE OF HIV-1 MI369 RNS-DS.SOSIP PREFUSION ENV TRIMER IN COMPLEX WITH HUMAN ANTIBODIES 3H109L AND 35O22 AT 3.5 ANGSTROM","10.1016/J.CELREP.2020.108432 ",2.67,47.5,"6wix_oligo4","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_K_)-MAN(8_K_)-[MAN(10_K_)]-MAN(7_K_)-[MAN(6_K_)-MAN(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(332_G_)",59.4076,"","",""
"6WJ1","CRYSTAL STRUCTURE OF FAB 54-4H03 BOUND TO H1 INFLUENZA HEMAGGLUTININ","10.1016/J.CHOM.2020.06.003 ",3.5,124.6,"6wj1_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(94_A_)",184.437,"","",""
"6WJ1","CRYSTAL STRUCTURE OF FAB 54-4H03 BOUND TO H1 INFLUENZA HEMAGGLUTININ","10.1016/J.CHOM.2020.06.003 ",3.5,124.6,"6wj1_oligo6","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_R_)-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(94_E_)",173.749,"","",""
"6WK8","CRYSTAL STRUCTURE OF GDX-CLO FROM SMALL MULTIDRUG RESISTANCE FAMILY OF TRANSPORTERS IN COMPLEX WITH PHENYLGUANIDINIUM","10.1038/S41467-020-19820-8 ",2.53,52.45,"6wk8_oligo1","DGlcpa1-3DGlcpb6-C2O1","DMU(201_A_)-DMU(201_A_)",109.402,"","",""
"6WK9","CRYSTAL STRUCTURE OF GDX-CLO FROM SMALL MULTIDRUG RESISTANCE FAMILY OF TRANSPORTERS IN COMPLEX WITH OCTYLGUANIDINIUM","10.1038/S41467-020-19820-8 ",2.32,34.92,"6wk9_oligo3","DGlcpa1-3DGlcpb6-C10O1","DMU(501_G_)-DMU(501_G_)",84.8691,"","",""
"6WK9","CRYSTAL STRUCTURE OF GDX-CLO FROM SMALL MULTIDRUG RESISTANCE FAMILY OF TRANSPORTERS IN COMPLEX WITH OCTYLGUANIDINIUM","10.1038/S41467-020-19820-8 ",2.32,34.92,"6wk9_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(103_C_)-DMU(103_C_)",68.1909,"","",""
"6WK9","CRYSTAL STRUCTURE OF GDX-CLO FROM SMALL MULTIDRUG RESISTANCE FAMILY OF TRANSPORTERS IN COMPLEX WITH OCTYLGUANIDINIUM","10.1038/S41467-020-19820-8 ",2.32,34.92,"6wk9_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(201_F_)-DMU(201_F_)",69.6182,"","",""
"6WK9","CRYSTAL STRUCTURE OF GDX-CLO FROM SMALL MULTIDRUG RESISTANCE FAMILY OF TRANSPORTERS IN COMPLEX WITH OCTYLGUANIDINIUM","10.1038/S41467-020-19820-8 ",2.32,34.92,"6wk9_oligo4","DGlcpa1-3DGlcpb6-C10O1","DMU(201_B_)-DMU(201_B_)",59.3795,"","",""
"6WLW","THE VO REGION OF HUMAN V-ATPASE IN STATE 1 (FOCUSED REFINEMENT)","10.1016/J.MOLCEL.2020.09.029 ",3,"1.08527e-19","6wlw_oligo1","DGlcpa1-2DGlcpa1-3DGlcpa1-3DManpa1-2DManpa1-2DManpa1-3[DManpb1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAca1-C25O7P2","MAN(11_r_)-MAN(10_r_)-[GLC(9_r_)-GLC(8_r_)-GLC(7_r_)-MAN(6_r_)-MAN(5_r_)-MAN(4_r_)]-BMA(3_r_)-NAG(2_r_)-NAG(1_r_)-WJP(905_R_)",65.1511,"","",""
"6WLW","THE VO REGION OF HUMAN V-ATPASE IN STATE 1 (FOCUSED REFINEMENT)","10.1016/J.MOLCEL.2020.09.029 ",3,"1.08527e-19","6wlw_oligo2","DGalpb1-3DGalpNAca1-4[DNeup5Aca2-3]DGalpx1-","GAL(3_A_)-NGA(2_A_)-[SIA(4_A_)]-GAL(1_A_)",28.3303,"","",""
"6WLW","THE VO REGION OF HUMAN V-ATPASE IN STATE 1 (FOCUSED REFINEMENT)","10.1016/J.MOLCEL.2020.09.029 ",3,"1.08527e-19","6wlw_oligo4","DGalpb1-3DGalpNAcb1-4[DNeup5Aca2-3]DGalpb1-4DGlcpb1-ROH","GAL(4_W_)-NGA(3_W_)-[SIA(5_W_)]-GAL(2_W_)-BGC(1_W_)",27.5521,"","",""
"6WM2","HUMAN V-ATPASE IN STATE 1 WITH SIDK AND ADP","10.1016/J.MOLCEL.2020.09.029 ",3.1,"1.08527e-19","6wm2_oligo3","DGalpb1-3DGalpNAca1-4[DNeup5Aca2-3]DGalpx1-","GAL(3_a_)-NGA(2_a_)-[SIA(4_a_)]-GAL(1_a_)",28.3303,"","",""
"6WM2","HUMAN V-ATPASE IN STATE 1 WITH SIDK AND ADP","10.1016/J.MOLCEL.2020.09.029 ",3.1,"1.08527e-19","6wm2_oligo9","DGlcpa1-2DGlcpa1-3DGlcpa1-3DManpa1-2DManpa1-2DManpa1-3[DManpb1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAca1-C25O7P2","MAN(11_r_)-MAN(10_r_)-[GLC(9_r_)-GLC(8_r_)-GLC(7_r_)-MAN(6_r_)-MAN(5_r_)-MAN(4_r_)]-BMA(3_r_)-NAG(2_r_)-NAG(1_r_)-WJP(907_R_)",83.4146,"","",""
"6WM2","HUMAN V-ATPASE IN STATE 1 WITH SIDK AND ADP","10.1016/J.MOLCEL.2020.09.029 ",3.1,"1.08527e-19","6wm2_oligo1","DGalpb1-3DGalpNAcb1-4[DNeup5Aca2-3]DGalpb1-4DGlcpb1-ROH","GAL(4_W_)-NGA(3_W_)-[SIA(5_W_)]-GAL(2_W_)-BGC(1_W_)",27.5521,"","",""
"6WML","HUMAN TLR8 BOUND TO THE POTENT AGONIST, GS-9688 (SELGANTOLIMOD)","10.1021/ACS.JMEDCHEM.0C00100 ",2.5,57.09,"6wml_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(913_C_)-[MAN(914_C_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)",80.8812,"","",""
"6WML","HUMAN TLR8 BOUND TO THE POTENT AGONIST, GS-9688 (SELGANTOLIMOD)","10.1021/ACS.JMEDCHEM.0C00100 ",2.5,57.09,"6wml_oligo12","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(914_D_)-[MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(590_D_)",67.5638,"","",""
"6WML","HUMAN TLR8 BOUND TO THE POTENT AGONIST, GS-9688 (SELGANTOLIMOD)","10.1021/ACS.JMEDCHEM.0C00100 ",2.5,57.09,"6wml_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(1005_B_)-[MAN(1004_B_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)",62.661,"","",""
"6WML","HUMAN TLR8 BOUND TO THE POTENT AGONIST, GS-9688 (SELGANTOLIMOD)","10.1021/ACS.JMEDCHEM.0C00100 ",2.5,57.09,"6wml_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(4_E_)-[MAN(1005_A_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)",54.9311,"","",""
"6WML","HUMAN TLR8 BOUND TO THE POTENT AGONIST, GS-9688 (SELGANTOLIMOD)","10.1021/ACS.JMEDCHEM.0C00100 ",2.5,57.09,"6wml_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(1013_B_)-[MAN(1014_B_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)",65.741,"","",""
"6WML","HUMAN TLR8 BOUND TO THE POTENT AGONIST, GS-9688 (SELGANTOLIMOD)","10.1021/ACS.JMEDCHEM.0C00100 ",2.5,57.09,"6wml_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(905_C_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)",63.3341,"","",""
"6WML","HUMAN TLR8 BOUND TO THE POTENT AGONIST, GS-9688 (SELGANTOLIMOD)","10.1021/ACS.JMEDCHEM.0C00100 ",2.5,57.09,"6wml_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(293_D_)",70.8689,"","",""
"6WMO","HUMAN POLY-N-ACETYL-LACTOSAMINE SYNTHASE STRUCTURE DEMONSTRATES A MODULAR ASSEMBLY OF CATALYTIC SUBSITES FOR GT-A GLYCOSYLTRANSFERASES","10.1074/JBC.RA120.015305 ",1.85,50.32,"6wmo_oligo6","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(219_B_)",62.8748,"","",""
"6WMO","HUMAN POLY-N-ACETYL-LACTOSAMINE SYNTHASE STRUCTURE DEMONSTRATES A MODULAR ASSEMBLY OF CATALYTIC SUBSITES FOR GT-A GLYCOSYLTRANSFERASES","10.1074/JBC.RA120.015305 ",1.85,50.32,"6wmo_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(219_A_)",63.4341,"","",""
"6WNA","NEXT GENERATION MONOMERIC IGG4 FC","10.1038/S42003-021-02565-5 ",2.4,45.39,"6wna_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4NAG1-ASN","GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(297_H_)",83.6889,"","",""
"6WO5","STRUCTURE OF HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 CORE FROM GENOTYPE 1A BOUND TO NEUTRALIZING ANTIBODY 212.1.1 AND NON NEUTRALIZING ANTIBODY E1","10.1126/SCIADV.ABB5642 ",2.62,0,"6wo5_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(430_F_)",75.8195,"","",""
"6WOL","NEXT GENERATION MONOMERIC IGG4 FC BOUND TO NEONATAL FC RECEPTOR","10.1038/S42003-021-02565-5 ",2.49,45.35,"6wol_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_H_)",79.3048,"","",""
"6WPS","STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH THE S309 NEUTRALIZING ANTIBODY FAB FRAGMENT","10.1038/S41586-020-2349-Y ",3.1,0,"6wps_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_N_)-[MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)]-NAG(1_N_)-ASN(343_A_)",69.3132,"","",""
"6WPS","STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH THE S309 NEUTRALIZING ANTIBODY FAB FRAGMENT","10.1038/S41586-020-2349-Y ",3.1,0,"6wps_oligo15","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_X_)-[MAN(5_X_)-[MAN(4_X_)]-BMA(3_X_)-NAG(2_X_)]-NAG(1_X_)-ASN(343_E_)",69.3132,"","",""
"6WPS","STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH THE S309 NEUTRALIZING ANTIBODY FAB FRAGMENT","10.1038/S41586-020-2349-Y ",3.1,0,"6wps_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_S_)-[MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)]-NAG(1_S_)-ASN(343_B_)",69.3132,"","",""
"6WPT","STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH THE S309 NEUTRALIZING ANTIBODY FAB FRAGMENT (OPEN STATE)","10.1038/S41586-020-2349-Y ",3.7,0,"6wpt_oligo12","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_S_)-[MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)]-NAG(1_S_)-ASN(343_C_)",117.21,"","",""
"6WRW","CRYSTAL STRUCTURE OF COMPUTATIONALLY DESIGNED PROTEIN 2DS25.5 IN COMPLEX WITH THE HUMAN TRANSFERRIN RECEPTOR ECTODOMAIN","10.1073/PNAS.2021569118 ",2.84,88.92,"6wrw_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(317_B_)",129.277,"","",""
"6WRX","CRYSTAL STRUCTURE OF COMPUTATIONALLY DESIGNED PROTEIN 2DS25.1 IN COMPLEX WITH THE HUMAN TRANSFERRIN RECEPTOR ECTODOMAIN","10.1073/PNAS.2021569118 ",3.07,104.3,"6wrx_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_H_)-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(317_B_)",137.249,"","",""
"6WXR","CRYOEM STRUCTURE OF MOUSE DUOX1-DUOXA1 COMPLEX IN THE ABSENCE OF NADPH","10.1038/S41594-020-0501-X ",3.2,"1.08527e-19","6wxr_oligo2","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(109_B_)",33.6549,"","",""
"6WXU","CRYOEM STRUCTURE OF MOUSE DUOX1-DUOXA1 COMPLEX IN THE DIMER-OF-DIMER STATE","10.1038/S41594-020-0501-X ",2.7,"1.08527e-19","6wxu_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_F_)-MAN(10_F_)-[MAN(9_F_)-MAN(8_F_)]-MAN(7_F_)-[MAN(6_F_)-MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(109_D_)",51.6896,"","",""
"6WXU","CRYOEM STRUCTURE OF MOUSE DUOX1-DUOXA1 COMPLEX IN THE DIMER-OF-DIMER STATE","10.1038/S41594-020-0501-X ",2.7,"1.08527e-19","6wxu_oligo12","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_E_)-MAN(10_E_)-[MAN(9_E_)-MAN(8_E_)]-MAN(7_E_)-[MAN(6_E_)-MAN(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(109_B_)",51.6896,"","",""
"6WXV","CRYOEM STRUCTURE OF MOUSE DUOX1-DUOXA1 COMPLEX IN THE PRESENCE OF NADPH","10.1038/S41594-020-0501-X ",3.3,"1.08527e-19","6wxv_oligo2","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(109_B_)",0,"","",""
"6WY0","CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) COMPLEX WITH COMPOUND-40 A.K.A 7-[(1R)-1-PHENYL-3-{[(1R,4R)-4- PHENYLCYCLOHEXYL]AMINO}PROPYL]-3H-[1,2,3]TRIAZOLO[4,5-B]PYRIDIN-5- AMINE","10.1016/J.BMC.2020.115723 ",2.8,55.74,"6wy0_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_N_)-[MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)]-NAG(1_N_)-ASN(317_I_)",51.8645,"","",""
"6WY0","CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) COMPLEX WITH COMPOUND-40 A.K.A 7-[(1R)-1-PHENYL-3-{[(1R,4R)-4- PHENYLCYCLOHEXYL]AMINO}PROPYL]-3H-[1,2,3]TRIAZOLO[4,5-B]PYRIDIN-5- AMINE","10.1016/J.BMC.2020.115723 ",2.8,55.74,"6wy0_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_M_)-[MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)]-NAG(1_M_)-ASN(317_G_)",50.1985,"","",""
"6WY0","CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) COMPLEX WITH COMPOUND-40 A.K.A 7-[(1R)-1-PHENYL-3-{[(1R,4R)-4- PHENYLCYCLOHEXYL]AMINO}PROPYL]-3H-[1,2,3]TRIAZOLO[4,5-B]PYRIDIN-5- AMINE","10.1016/J.BMC.2020.115723 ",2.8,55.74,"6wy0_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_C_)-[MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(317_B_)",52.4202,"","",""
"6WY0","CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) COMPLEX WITH COMPOUND-40 A.K.A 7-[(1R)-1-PHENYL-3-{[(1R,4R)-4- PHENYLCYCLOHEXYL]AMINO}PROPYL]-3H-[1,2,3]TRIAZOLO[4,5-B]PYRIDIN-5- AMINE","10.1016/J.BMC.2020.115723 ",2.8,55.74,"6wy0_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_K_)-[MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(317_E_)",49.8829,"","",""
"6WY5","CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) COMPLEX WITH COMPOUND-37 A.K.A 7-(1-PHENYL-3-(((1S,3S)-3-PHENYL-2,3-DIHYDRO-1H- INDEN-1-YL)AMINO)PROPYL)-1H-[1,2,3]TRIAZOLO[4,5-B]PYRIDIN-5-AMINE","10.1016/J.BMC.2020.115723 ",2.9,97.75,"6wy5_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_F_)-[MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(317_B_)",87.4176,"","",""
"6WY5","CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) COMPLEX WITH COMPOUND-37 A.K.A 7-(1-PHENYL-3-(((1S,3S)-3-PHENYL-2,3-DIHYDRO-1H- INDEN-1-YL)AMINO)PROPYL)-1H-[1,2,3]TRIAZOLO[4,5-B]PYRIDIN-5-AMINE","10.1016/J.BMC.2020.115723 ",2.9,97.75,"6wy5_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_H_)-[MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)]-NAG(1_H_)-ASN(317_E_)",77.4373,"","",""
"6WY7","CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) COMPLEX WITH COMPOUND-41 A.K.A 7-[1-PHENYL-3-({4-PHENYLBICYCLO[2.2.2]OCTAN-1- YL}AMINO)PROPYL]-3H-[1,2,3]TRIAZOLO[4,5-B]PYRIDIN-5-AMINE","10.1016/J.BMC.2020.115723 ",2.09,24.38,"6wy7_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_C_)-[MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(317_B_)",25.79,"","",""
"6WY7","CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) COMPLEX WITH COMPOUND-41 A.K.A 7-[1-PHENYL-3-({4-PHENYLBICYCLO[2.2.2]OCTAN-1- YL}AMINO)PROPYL]-3H-[1,2,3]TRIAZOLO[4,5-B]PYRIDIN-5-AMINE","10.1016/J.BMC.2020.115723 ",2.09,24.38,"6wy7_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_F_)-[MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(317_E_)",26.7079,"","",""
"6X3K","HSA SIGLEC AND UNIQUE DOMAINS IN COMPLEX WITH 6S-SIALY-LEWISX","10.1038/S41467-022-30509-Y ",2.5,55.06,"6x3k_oligo1","LFucpa1-3[DGalpb1-4]DGlcpNAcb1-ROH","GAL(3_B_)-[FUC(2_B_)]-NGS(1_B_)",57.6752,"","",""
"6X3S","HUMAN GABAA RECEPTOR ALPHA1-BETA2-GAMMA2 SUBTYPE IN COMPLEX WITH BICUCULLINE METHBROMIDE","10.1038/S41586-020-2654-5 ",3.12,"1.42472e+13","6x3s_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_G_)-MAN(8_G_)-MAN(7_G_)-[MAN(6_G_)-MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(111_B_)",50.4167,"","",""
"6X3T","HUMAN GABAA RECEPTOR ALPHA1-BETA2-GAMMA2 SUBTYPE IN COMPLEX WITH GABA PLUS PROPOFOL","10.1038/S41586-020-2654-5 ",2.55,"1.42472e+13","6x3t_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_G_)-MAN(8_G_)-[MAN(10_G_)]-MAN(7_G_)-[MAN(6_G_)-MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(111_B_)",37.1476,"","",""
"6X3U","HUMAN GABAA RECEPTOR ALPHA1-BETA2-GAMMA2 SUBTYPE IN COMPLEX WITH GABA PLUS FLUMAZENIL","10.1038/S41586-020-2654-5 ",3.49,"1.42472e+13","6x3u_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_G_)-MAN(8_G_)-[MAN(10_G_)]-MAN(7_G_)-[MAN(6_G_)-MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(111_B_)",31.0121,"","",""
"6X3V","HUMAN GABAA RECEPTOR ALPHA1-BETA2-GAMMA2 SUBTYPE IN COMPLEX WITH GABA PLUS ETOMIDATE","10.1038/S41586-020-2654-5 ",3.5,"1.42472e+13","6x3v_oligo4","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_G_)-MAN(8_G_)-[MAN(10_G_)]-MAN(7_G_)-[MAN(6_G_)-MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(111_B_)",39.123,"","",""
"6X3W","HUMAN GABAA RECEPTOR ALPHA1-BETA2-GAMMA2 SUBTYPE IN COMPLEX WITH GABA PLUS PHENOBARBITAL","10.1038/S41586-020-2654-5 ",3.3,"1.42472e+13","6x3w_oligo4","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(9_G_)-MAN(8_G_)-[MAN(10_G_)]-MAN(7_G_)-[MAN(6_G_)-MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)",41.7306,"","",""
"6X3X","HUMAN GABAA RECEPTOR ALPHA1-BETA2-GAMMA2 SUBTYPE IN COMPLEX WITH GABA PLUS DIAZEPAM","10.1038/S41586-020-2654-5 ",2.92,"1.42472e+13","6x3x_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_G_)-MAN(8_G_)-[MAN(10_G_)]-MAN(7_G_)-[MAN(6_G_)-MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(111_B_)",43.7112,"","",""
"6X3Z","HUMAN GABAA RECEPTOR ALPHA1-BETA2-GAMMA2 SUBTYPE IN COMPLEX WITH GABA","10.1038/S41586-020-2654-5 ",3.23,"5.93244e+11","6x3z_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_G_)-MAN(8_G_)-[MAN(10_G_)]-MAN(7_G_)-[MAN(6_G_)-MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(111_B_)",61.4891,"","",""
"6X40","HUMAN GABAA RECEPTOR ALPHA1-BETA2-GAMMA2 SUBTYPE IN COMPLEX WITH GABA PLUS PICROTOXIN","10.1038/S41586-020-2654-5 ",2.86,"1.42472e+13","6x40_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_G_)-MAN(8_G_)-[MAN(10_G_)]-MAN(7_G_)-[MAN(6_G_)-MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(111_B_)",54.1976,"","",""
"6X4G","CRYSTAL STRUCTURE OF ICOS IN COMPLEX WITH ICOS-L AND AN ANTI ICOS-L VNAR DOMAIN","10.1038/S41467-020-18828-4 ",3.5,85.77,"6x4g_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(173_C_)",124.116,"","",""
"6X4G","CRYSTAL STRUCTURE OF ICOS IN COMPLEX WITH ICOS-L AND AN ANTI ICOS-L VNAR DOMAIN","10.1038/S41467-020-18828-4 ",3.5,85.77,"6x4g_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(110_A_)",113.192,"","",""
"6X5R","HUMAN ALPHA-1,6-FUCOSYLTRANSFERASE (FUT8) BOUND TO GDP AND A2-ASN","10.1074/JBC.RA120.014625 ",2.4,0,"6x5r_oligo3","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_E_)-MAN(6_E_)-[NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(700_C_)",47.8686,"","",""
"6X5R","HUMAN ALPHA-1,6-FUCOSYLTRANSFERASE (FUT8) BOUND TO GDP AND A2-ASN","10.1074/JBC.RA120.014625 ",2.4,0,"6x5r_oligo4","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_F_)-MAN(6_F_)-[NAG(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(700_D_)",45.2336,"","",""
"6X5S","HUMAN ALPHA-1,6-FUCOSYLTRANSFERASE (FUT8) BOUND TO GDP AND A3'-ASN","10.1074/JBC.RA120.014625 ",3.3,0,"6x5s_oligo4","DGlcpNAcb1-2[DGlcpNAcb1-4]DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(8_F_)-MAN(7_F_)-[NAG(6_F_)-[NAG(5_F_)]-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(700_D_)",67.5676,"","",""
"6X5S","HUMAN ALPHA-1,6-FUCOSYLTRANSFERASE (FUT8) BOUND TO GDP AND A3'-ASN","10.1074/JBC.RA120.014625 ",3.3,0,"6x5s_oligo3","DGlcpNAcb1-2[DGlcpNAcb1-4]DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(8_E_)-MAN(7_E_)-[NAG(6_E_)-[NAG(5_E_)]-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(700_C_)",67.874,"","",""
"6X5T","HUMAN ALPHA-1,6-FUCOSYLTRANSFERASE (FUT8) BOUND TO GDP AND A3-ASN","10.1074/JBC.RA120.014625 ",2.47,0,"6x5t_oligo11","DGlcpNAcb1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","NAG(5_K_)-MAN(4_K_)-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)",74.5669,"","",""
"6X5T","HUMAN ALPHA-1,6-FUCOSYLTRANSFERASE (FUT8) BOUND TO GDP AND A3-ASN","10.1074/JBC.RA120.014625 ",2.47,0,"6x5t_oligo9","DGlcpNAcb1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","NAG(5_I_)-MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)",60.8722,"","",""
"6X5T","HUMAN ALPHA-1,6-FUCOSYLTRANSFERASE (FUT8) BOUND TO GDP AND A3-ASN","10.1074/JBC.RA120.014625 ",2.47,0,"6x5t_oligo10","DGlcpNAcb1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","NAG(5_J_)-MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)",58.0269,"","",""
"6X5T","HUMAN ALPHA-1,6-FUCOSYLTRANSFERASE (FUT8) BOUND TO GDP AND A3-ASN","10.1074/JBC.RA120.014625 ",2.47,0,"6x5t_oligo12","DGlcpNAcb1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","NAG(5_L_)-MAN(4_L_)-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)",64.3784,"","",""
"6X5U","HUMAN ALPHA-1,6-FUCOSYLTRANSFERASE (FUT8) BOUND TO GDP AND NM5M2-ASN","10.1074/JBC.RA120.014625 ",3.2,0,"6x5u_oligo14","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-ROH","MAN(5_N_)-[NAG(4_N_)-MAN(3_N_)]-BMA(2_N_)-NAG(1_N_)",72.5517,"","",""
"6X5U","HUMAN ALPHA-1,6-FUCOSYLTRANSFERASE (FUT8) BOUND TO GDP AND NM5M2-ASN","10.1074/JBC.RA120.014625 ",3.2,0,"6x5u_oligo9","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_I_)-[NAG(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(700_A_)",67.9324,"","",""
"6X5U","HUMAN ALPHA-1,6-FUCOSYLTRANSFERASE (FUT8) BOUND TO GDP AND NM5M2-ASN","10.1074/JBC.RA120.014625 ",3.2,0,"6x5u_oligo11","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_K_)-[NAG(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(700_C_)",62.2491,"","",""
"6X5U","HUMAN ALPHA-1,6-FUCOSYLTRANSFERASE (FUT8) BOUND TO GDP AND NM5M2-ASN","10.1074/JBC.RA120.014625 ",3.2,0,"6x5u_oligo12","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-ROH","MAN(5_L_)-[NAG(4_L_)-MAN(3_L_)]-BMA(2_L_)-NAG(1_L_)",72.644,"","",""
"6X5U","HUMAN ALPHA-1,6-FUCOSYLTRANSFERASE (FUT8) BOUND TO GDP AND NM5M2-ASN","10.1074/JBC.RA120.014625 ",3.2,0,"6x5u_oligo10","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-ROH","MAN(5_J_)-[NAG(4_J_)-MAN(3_J_)]-BMA(2_J_)-NAG(1_J_)",71.7953,"","",""
"6X5U","HUMAN ALPHA-1,6-FUCOSYLTRANSFERASE (FUT8) BOUND TO GDP AND NM5M2-ASN","10.1074/JBC.RA120.014625 ",3.2,0,"6x5u_oligo13","DGlcpNAcb1-2DManpa1-3DManpb1-4DGlcpNAcb1-ROH","NAG(4_M_)-MAN(3_M_)-BMA(2_M_)-NAG(1_M_)",71.8882,"","",""
"6X5U","HUMAN ALPHA-1,6-FUCOSYLTRANSFERASE (FUT8) BOUND TO GDP AND NM5M2-ASN","10.1074/JBC.RA120.014625 ",3.2,0,"6x5u_oligo16","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","MAN(6_P_)-[NAG(5_P_)-MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)",73.6539,"","",""
"6X5U","HUMAN ALPHA-1,6-FUCOSYLTRANSFERASE (FUT8) BOUND TO GDP AND NM5M2-ASN","10.1074/JBC.RA120.014625 ",3.2,0,"6x5u_oligo15","DGlcpNAcb1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","NAG(5_O_)-MAN(4_O_)-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)",79.2142,"","",""
"6X96","CRYO-EM MODEL OF HIV-1 ENV BG505 SOSIP.664 IN COMPLEX WITH RABBIT MONOCLONAL ANTIBODY 10A FRAGMENT ANTIGEN BINDING VARIABLE DOMAIN","",3.4,"1.08527e-19","6x96_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_M_)-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(262_A_)",46.9393,"","",""
"6X96","CRYO-EM MODEL OF HIV-1 ENV BG505 SOSIP.664 IN COMPLEX WITH RABBIT MONOCLONAL ANTIBODY 10A FRAGMENT ANTIGEN BINDING VARIABLE DOMAIN","",3.4,"1.08527e-19","6x96_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_Q_)-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(262_C_)",46.9393,"","",""
"6X96","CRYO-EM MODEL OF HIV-1 ENV BG505 SOSIP.664 IN COMPLEX WITH RABBIT MONOCLONAL ANTIBODY 10A FRAGMENT ANTIGEN BINDING VARIABLE DOMAIN","",3.4,"1.08527e-19","6x96_oligo9","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_U_)-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(262_G_)",46.9393,"","",""
"6X98","CRYO-EM MODEL OF HIV-1 ENV BG505 SOSIP.664 IN COMPLEX WITH RABBIT MONOCLONAL ANTIBODY 11B FRAGMENT ANTIGEN BINDING VARIABLE DOMAIN","",3.38,"1.08527e-19","6x98_oligo10","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_V_)-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(262_G_)",63.0741,"","",""
"6X98","CRYO-EM MODEL OF HIV-1 ENV BG505 SOSIP.664 IN COMPLEX WITH RABBIT MONOCLONAL ANTIBODY 11B FRAGMENT ANTIGEN BINDING VARIABLE DOMAIN","",3.38,"1.08527e-19","6x98_oligo7","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_R_)-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(262_C_)",63.0741,"","",""
"6X98","CRYO-EM MODEL OF HIV-1 ENV BG505 SOSIP.664 IN COMPLEX WITH RABBIT MONOCLONAL ANTIBODY 11B FRAGMENT ANTIGEN BINDING VARIABLE DOMAIN","",3.38,"1.08527e-19","6x98_oligo9","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_N_)-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(262_A_)",63.0741,"","",""
"6X9R","HIV-1 ENVELOPE GLYCOPROTEIN BG505 SOSIP.664 EXPRESSED IN HEK293F CELLS IN COMPLEX WITH RM20A3 FAB","10.1073/PNAS.2000260117 ",3.1,"1.35632e-19","6x9r_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(262_A_)",46.5984,"","",""
"6X9S","HIV-1 ENVELOPE GLYCOPROTEIN BG505 SOSIP.664 EXPRESSED IN STABLE CHO CELLS IN COMPLEX WITH RM20A3 FAB","10.1073/PNAS.2000260117 ",3.1,"1.35632e-19","6x9s_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(262_A_)",38.757,"","",""
"6X9T","HIV-1 ENVELOPE GLYCOPROTEIN BG505 SOSIP.664 EXPRESSED IN HEK293S CELLS IN COMPLEX WITH RM20A3 FAB","10.1073/PNAS.2000260117 ",3.2,"1.35632e-19","6x9t_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(262_A_)",43.1423,"","",""
"6X9U","HIV-1 ENVELOPE GLYCOPROTEIN BG505 SOSIP.664, EXPRESSED IN HEK293S CELLS AND PARTIALLY DEGLYCOSYLATED BY ENDOGLYCOSIDASE H, IN COMPLEX WITH RM20A3 FAB","10.1073/PNAS.2000260117 ",3.2,"1.35632e-19","6x9u_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(262_A_)",57.2045,"","",""
"6X9V","HIV-1 ENVELOPE GLYCOPROTEIN BG505 SOSIP.664, EXPRESSED IN HEK293S CELLS AND DEGLYCOSYLATED BY ENDOGLYCOSIDASE H, IN COMPLEX WITH RM20A3 FAB","10.1073/PNAS.2000260117 ",3.5,"1.35632e-19","6x9v_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(262_A_)",66.857,"","",""
"6XKD","STRUCTURE OF LIGAND-BOUND MOUSE CGAMP HYDROLASE ENPP1","10.1016/J.CHEMBIOL.2020.07.007 ",3.2,64,"6xkd_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(567_A_)",80.3695,"","",""
"6XKD","STRUCTURE OF LIGAND-BOUND MOUSE CGAMP HYDROLASE ENPP1","10.1016/J.CHEMBIOL.2020.07.007 ",3.2,64,"6xkd_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(567_B_)",91.6902,"","",""
"6XP6","3C11-DQ2-GLIA-A2 COMPLEX","10.1126/SCIIMMUNOL.ABG4925 ",2.4,0,"6xp6_oligo2","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(7_L_)-[BMA(5_L_)-[BMA(4_L_)]-BMA(3_L_)-NAG(2_L_)]-[FUC(6_L_)]-NAG(1_L_)-ASN(19_B_)",85.7192,"","",""
"6XQ0","HUMAN ANTIBODY S8V2-18 IN COMPLEX WITH THE INFLUENZA HEMAGGLUTININ HEAD DOMAIN OF A/CALIFORNIA/7/2009(NYMC-X181)(H1N1)","10.1128/MBIO.01144-21 ",2.3,43.35,"6xq0_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(5_G_)-[BMA(3_G_)-NAG(2_G_)]-[FUC(4_G_)]-NAG(1_G_)-ASN(94_D_)",51.0662,"","",""
"6XQ0","HUMAN ANTIBODY S8V2-18 IN COMPLEX WITH THE INFLUENZA HEMAGGLUTININ HEAD DOMAIN OF A/CALIFORNIA/7/2009(NYMC-X181)(H1N1)","10.1128/MBIO.01144-21 ",2.3,43.35,"6xq0_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(5_H_)-[BMA(3_H_)-NAG(2_H_)]-[FUC(4_H_)]-NAG(1_H_)-ASN(94_A_)",51.8884,"","",""
"6XRA","DISTINCT CONFORMATIONAL STATES OF SARS-COV-2 SPIKE PROTEIN","10.1126/SCIENCE.ABD4251 ",3,0,"6xra_oligo5","DManpa1-3DManpa1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(4_J_)-MAN(3_J_)-NAG(2_J_)-NAG(1_J_)",89.5815,"","",""
"6XRA","DISTINCT CONFORMATIONAL STATES OF SARS-COV-2 SPIKE PROTEIN","10.1126/SCIENCE.ABD4251 ",3,0,"6xra_oligo1","DManpa1-3DManpa1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(4_E_)-MAN(3_E_)-NAG(2_E_)-NAG(1_E_)",89.2459,"","",""
"6XRA","DISTINCT CONFORMATIONAL STATES OF SARS-COV-2 SPIKE PROTEIN","10.1126/SCIENCE.ABD4251 ",3,0,"6xra_oligo13","DManpa1-3DManpa1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(4_P_)-MAN(3_P_)-NAG(2_P_)-NAG(1_P_)",103.627,"","",""
"6XRA","DISTINCT CONFORMATIONAL STATES OF SARS-COV-2 SPIKE PROTEIN","10.1126/SCIENCE.ABD4251 ",3,0,"6xra_oligo6","DManpa1-3DManpa1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(4_K_)-MAN(3_K_)-NAG(2_K_)-NAG(1_K_)",101.405,"","",""
"6XRA","DISTINCT CONFORMATIONAL STATES OF SARS-COV-2 SPIKE PROTEIN","10.1126/SCIENCE.ABD4251 ",3,0,"6xra_oligo8","DManpa1-3DManpa1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(4_F_)-MAN(3_F_)-NAG(2_F_)-NAG(1_F_)",102.128,"","",""
"6XRA","DISTINCT CONFORMATIONAL STATES OF SARS-COV-2 SPIKE PROTEIN","10.1126/SCIENCE.ABD4251 ",3,0,"6xra_oligo12","DManpa1-3DManpa1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(4_O_)-MAN(3_O_)-NAG(2_O_)-NAG(1_O_)",88.8143,"","",""
"6XRT","CRYO-EM STRUCTURE OF SHIV-ELICITED RHA1.V2.01 IN COMPLEX WITH HIV-1 ENV BG505 DS-SOSIP.664","10.1126/SCIENCE.ABD2638 ",3.9,0.00048876,"6xrt_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_U_)-[MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(156_F_)",253.703,"","",""
"6XRT","CRYO-EM STRUCTURE OF SHIV-ELICITED RHA1.V2.01 IN COMPLEX WITH HIV-1 ENV BG505 DS-SOSIP.664","10.1126/SCIENCE.ABD2638 ",3.9,0.00048876,"6xrt_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_T_)-[MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(262_E_)",212.176,"","",""
"6XRT","CRYO-EM STRUCTURE OF SHIV-ELICITED RHA1.V2.01 IN COMPLEX WITH HIV-1 ENV BG505 DS-SOSIP.664","10.1126/SCIENCE.ABD2638 ",3.9,0.00048876,"6xrt_oligo9","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_V_)-[MAN(7_V_)]-MAN(6_V_)-[MAN(5_V_)-MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(160_F_)",220.016,"","",""
"6XRT","CRYO-EM STRUCTURE OF SHIV-ELICITED RHA1.V2.01 IN COMPLEX WITH HIV-1 ENV BG505 DS-SOSIP.664","10.1126/SCIENCE.ABD2638 ",3.9,0.00048876,"6xrt_oligo1","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-MAN(4_J_)-[MAN(6_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(160_G_)",244.744,"","",""
"6XRT","CRYO-EM STRUCTURE OF SHIV-ELICITED RHA1.V2.01 IN COMPLEX WITH HIV-1 ENV BG505 DS-SOSIP.664","10.1126/SCIENCE.ABD2638 ",3.9,0.00048876,"6xrt_oligo12","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(262_G_)",210.363,"","",""
"6XRT","CRYO-EM STRUCTURE OF SHIV-ELICITED RHA1.V2.01 IN COMPLEX WITH HIV-1 ENV BG505 DS-SOSIP.664","10.1126/SCIENCE.ABD2638 ",3.9,0.00048876,"6xrt_oligo14","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(156_G_)",253.157,"","",""
"6XSJ","X-RAY STRUCTURE OF A MONOCLINIC FORM OF ALPHA AMYLASE FROM ASPERGILLUS AT 1.4 A RESOLUTION","10.1016/J.JBIOSC.2021.02.008 ",1.4,19.98,"6xsj_oligo1","DManpa1-3DGlcpNAcb1-ASN","MAN(2_C_)-NAG(1_C_)-ASN(197_B_)",52.7327,"","",""
"6XT1","THE STRUCTURE OF THE M60 CATALYTIC DOMAIN FROM CLOSTRIDIUM PERFRINGENS ZMPC IN COMPLEX THE SIALYL T ANTIGEN","",2.49,41.62,"6xt1_oligo2","DGalpb1-3[DNeup5Aca2-6]DGalpNAca1-SER","SIA(3_M_)-[GAL(2_M_)]-A2G(1_M_)-SER(1006_B_)",63.707,"","",""
"6XT1","THE STRUCTURE OF THE M60 CATALYTIC DOMAIN FROM CLOSTRIDIUM PERFRINGENS ZMPC IN COMPLEX THE SIALYL T ANTIGEN","",2.49,41.62,"6xt1_oligo1","DGalpb1-3[DNeup5Aca2-6]DGalpNAca1-SER","SIA(3_F_)-[GAL(2_F_)]-A2G(1_F_)-SER(1004_A_)",78.781,"","",""
"6XTG","AB 1116NS19.9 BOUND TO CA19-9","10.1016/J.JMB.2021.167099 ",1.55,43.68,"6xtg_oligo1","DNeup5Aca2-3DGalpb1-3[LFucpa1-4]DGlcpNAcb1-ROH","FUC(4_A_)-[SIA(3_A_)-GAL(2_A_)]-NAG(1_A_)",32.553,"","",""
"6XUK","ABLIFT DESIGN 15 OF AB 1116NS19.9","10.1016/J.JMB.2021.167099 ",1.42,23.71,"6xuk_oligo1","DNeup5Aca2-3DGalpb1-3[LFucpa1-4]DGlcpNAcb1-ROH","FUC(4_A_)-[SIA(3_A_)-GAL(2_A_)]-NAG(1_A_)",22.0346,"","",""
"6XUN","AB 5B1 BOUND TO CA19-9","10.1016/J.JMB.2021.167099 ",2.41,45.3,"6xun_oligo2","DNeup5Aca2-3DGalpb1-3[LFucpa1-4]DGlcpNAcb1-ROH","FUC(4_G_)-[SIA(3_G_)-GAL(2_G_)]-NAG(1_G_)",40.6423,"","",""
"6XUN","AB 5B1 BOUND TO CA19-9","10.1016/J.JMB.2021.167099 ",2.41,45.3,"6xun_oligo3","DNeup5Aca2-3DGalpb1-3[LFucpa1-4]DGlcpNAcb1-ROH","FUC(4_E_)-[SIA(3_E_)-GAL(2_E_)]-NAG(1_E_)",46.8008,"","",""
"6XUN","AB 5B1 BOUND TO CA19-9","10.1016/J.JMB.2021.167099 ",2.41,45.3,"6xun_oligo1","DNeup5Aca2-3DGalpb1-3[LFucpa1-4]DGlcpNAcb1-ROH","FUC(4_F_)-[SIA(3_F_)-GAL(2_F_)]-NAG(1_F_)",39.3358,"","",""
"6XUT","CRYSTALLOGRAPHIC STRUCTURE OF OLIGOSACCHARIDE DEHYDROGENASE FROM PYCNOPORUS CINNABARINUS, LIGAND-FREE FORM","10.1186/S13068-021-02003-Y ",1.6,39.76,"6xut_oligo3","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_B_)-[BMA(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(439_A_)",100.282,"","",""
"6XYS","UPDATE OF NATIVE ACETYLCHOLINESTERASE FROM DROSOPHILA MELANOGASTER","10.3390/MOLECULES25051198 ",2.46,79.57,"6xys_oligo1","DManpa1-3DManpa1-3DManpa1-4DGlcpNAca1-4DGlcpNAcb1-ASN","MAN(5_B_)-BMA(4_B_)-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(493_A_)",106.08,"","",""
"6XYY","UPDATE OF ACHE FROM DROSOPHILA MELANOGASTER COMPLEX WITH TACRINE DERIVATIVE 9-(3-PHENYLMETHYLAMINO)-1,2,3,4-TETRAHYDROACRIDINE","10.3390/MOLECULES25051198 ",2.7,56.87,"6xyy_oligo1","DManpa1-3DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_B_)-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(493_A_)",93.1243,"","",""
"6Y3C","HUMAN COX-1 CRYSTAL STRUCTURE","10.1038/S41598-021-83438-Z ",3.36,90.9,"6y3c_oligo2","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcp[2<R1>]b1-ASN","BMA(5_B_)-[BMA(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(144_A_)",121.356,"","",""
"6Y3Y","HUMAN CORONAVIRUS HKU1 HAEMAGGLUTININ-ESTERASE","10.1038/S41467-020-18440-6 ",3.39,0,"6y3y_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(286_A_)",129.34,"","",""
"6Y3Y","HUMAN CORONAVIRUS HKU1 HAEMAGGLUTININ-ESTERASE","10.1038/S41467-020-18440-6 ",3.39,0,"6y3y_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(83_A_)",101.968,"","",""
"6Y3Y","HUMAN CORONAVIRUS HKU1 HAEMAGGLUTININ-ESTERASE","10.1038/S41467-020-18440-6 ",3.39,0,"6y3y_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(83_B_)",102.738,"","",""
"6Y3Y","HUMAN CORONAVIRUS HKU1 HAEMAGGLUTININ-ESTERASE","10.1038/S41467-020-18440-6 ",3.39,0,"6y3y_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(286_B_)",128.683,"","",""
"6Y5F","CRYSTAL STRUCTURE OF THE ENVELOPE GLYCOPROTEIN PREFUSION COMPLEX OF ANDES VIRUS - MUTANT H953F","10.1016/J.CELL.2020.08.023 ",3.2,104.4,"6y5f_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(138_A_)",117.516,"","",""
"6Y5F","CRYSTAL STRUCTURE OF THE ENVELOPE GLYCOPROTEIN PREFUSION COMPLEX OF ANDES VIRUS - MUTANT H953F","10.1016/J.CELL.2020.08.023 ",3.2,104.4,"6y5f_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(350_A_)",113.733,"","",""
"6Y5G","ECTODOMAIN OF X-31 HAEMAGGLUTININ AT PH 8","10.1038/S41586-020-2333-6 ",3,"1.15243e-41","6y5g_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_L_)-[MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(165_E_)",60.102,"","",""
"6Y5G","ECTODOMAIN OF X-31 HAEMAGGLUTININ AT PH 8","10.1038/S41586-020-2333-6 ",3,"1.15243e-41","6y5g_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(165_A_)",60.102,"","",""
"6Y5G","ECTODOMAIN OF X-31 HAEMAGGLUTININ AT PH 8","10.1038/S41586-020-2333-6 ",3,"1.15243e-41","6y5g_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(165_C_)",60.102,"","",""
"6Y5H","ECTODOMAIN OF X-31 HAEMAGGLUTININ AT PH 5 (STATE I)","10.1038/S41586-020-2333-6 ",3,"1.15243e-41","6y5h_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_L_)-[MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(165_E_)",51.8598,"","",""
"6Y5H","ECTODOMAIN OF X-31 HAEMAGGLUTININ AT PH 5 (STATE I)","10.1038/S41586-020-2333-6 ",3,"1.15243e-41","6y5h_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(165_A_)",51.8598,"","",""
"6Y5H","ECTODOMAIN OF X-31 HAEMAGGLUTININ AT PH 5 (STATE I)","10.1038/S41586-020-2333-6 ",3,"1.15243e-41","6y5h_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(165_C_)",51.8598,"","",""
"6Y5M","CRYSTAL STRUCTURE OF MOUSE AUTOTAXIN IN COMPLEX WITH COMPOUND 1A","10.1016/J.BMCL.2020.127663 ",2.01,35.27,"6y5m_oligo3","DManpa1-2DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-MAN(5_B_)-MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(524_A_)",42.6865,"","",""
"6Y5W","CRYSTAL STRUCTURE OF THE ENVELOPE GLYCOPROTEIN COMPLEX OF ANDES VIRUS IN A NEAR POSTFUSION CONFORMATION","10.1016/J.CELL.2020.08.023 ",2.55,70.26,"6y5w_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(138_A_)",78.3686,"","",""
"6Y62","CRYSTAL STRUCTURE OF THE ENVELOPE GLYCOPROTEIN COMPLEX OF MAPORAL VIRUS IN A PREFUSION CONFORMATION","10.1016/J.CELL.2020.08.023 ",2.2,58.13,"6y62_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(138_A_)",102.123,"","",""
"6Y62","CRYSTAL STRUCTURE OF THE ENVELOPE GLYCOPROTEIN COMPLEX OF MAPORAL VIRUS IN A PREFUSION CONFORMATION","10.1016/J.CELL.2020.08.023 ",2.2,58.13,"6y62_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(350_A_)",65.5555,"","",""
"6Y68","STRUCTURE OF MAPORAL VIRUS ENVELOPE GLYCOPROTEIN GC IN POSTFUSION CONFORMATION","10.1016/J.CELL.2020.08.023 ",2.4,69.97,"6y68_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(930_A_)",86.1075,"","",""
"6YCG","STRUCTURE THE BROMELAIN PROTEASE FROM ANANAS COMOSUS IN COMPLEX WITH THE TLCK INHIBITOR","10.1038/S41598-020-76172-5 ",1.45,17.38,"6ycg_oligo1","DXylpb1-2[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(5_C_)-[XYS(4_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(6_C_)]-NAG(1_C_)-ASN(117_A_)",24.7054,"","",""
"6YCG","STRUCTURE THE BROMELAIN PROTEASE FROM ANANAS COMOSUS IN COMPLEX WITH THE TLCK INHIBITOR","10.1038/S41598-020-76172-5 ",1.45,17.38,"6ycg_oligo2","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_D_)-[FUC(2_D_)]-NAG(1_D_)-ASN(117_B_)",28.5685,"","",""
"6YGE","NADASE FROM ASPERGILLUS FUMIGATUS","10.1038/S41467-021-21307-Z ",1.6,39.81,"6yge_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_C_)-[MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(118_B_)",58.6821,"","",""
"6YGF","NADASE FROM ASPERGILLUS FUMIGATUS WITH TRAPPED REACTION PRODUCTS","10.1038/S41467-021-21307-Z ",1.7,35.24,"6ygf_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_D_)-[MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(118_B_)",57.558,"","",""
"6YSC","GLYCOSYLATED KNOB-HOLE/DUMMY FC FRAGMENT","10.1038/S41467-020-18477-7 ",2.05,47.89,"6ysc_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",79.578,"","",""
"6YSC","GLYCOSYLATED KNOB-HOLE/DUMMY FC FRAGMENT","10.1038/S41467-020-18477-7 ",2.05,47.89,"6ysc_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",47.605,"","",""
"6YT7","GLYCOSYLATED KNOB/DUMMY-HOLE FC FRAGMENT","10.1038/S41467-020-18477-7 ",1.55,36.54,"6yt7_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",54.2184,"","",""
"6YT7","GLYCOSYLATED KNOB/DUMMY-HOLE FC FRAGMENT","10.1038/S41467-020-18477-7 ",1.55,36.54,"6yt7_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",43.4009,"","",""
"6YTB","GLYCOSYLATED KNOB/DUMMY-HOLE/DUMMY FC FRAGMENT","10.1038/S41467-020-18477-7 ",1.65,38.23,"6ytb_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",61.2668,"","",""
"6YTB","GLYCOSYLATED KNOB/DUMMY-HOLE/DUMMY FC FRAGMENT","10.1038/S41467-020-18477-7 ",1.65,38.23,"6ytb_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",42.0985,"","",""
"6Z2P","CRYSTAL STRUCTURE OF CATALYTIC INACTIVE OGPA FROM AKKERMANSIA MUCINIPHILA IN COMPLEX WITH AN O-GLYCOPEPTIDE (GLYCODROSOCIN) SUBSTRATE","10.1038/S41467-020-18696-Y ",2.16,54.13,"6z2p_oligo1","DGalpb1-3DGalpNAca1-THR","GAL(2_B_)-A2G(1_B_)-THR(8_C_)",52.1636,"","",""
"6Z2Q","CRYSTAL STRUCTURE OF WILD TYPE OGPA FROM AKKERMANSIA MUCINIPHILA IN COMPLEX WITH AN O-GLYCOPEPTIDE (GALGALNAC-TS) PRODUCT","10.1038/S41467-020-18696-Y ",2.35,37.11,"6z2q_oligo1","DGalpb1-3DGalpNAca1-THR","GAL(2_B_)-A2G(1_B_)-THR(2_D_)",42.0618,"","",""
"6Z30","HUMAN CATION-INDEPENDENT MANNOSE 6-PHOSPHATE/ IGF2 RECEPTOR DOMAINS 9- 10","10.1016/J.STR.2020.08.002 ",1.5,0,"6z30_oligo1","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-MAN(4_B_)-[MAN(6_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(1312_A_)",21.9442,"","",""
"6Z32","HUMAN CATION-INDEPENDENT MANNOSE 6-PHOSPHATE/IGF2 RECEPTOR DOMAINS 7- 11","10.1016/J.STR.2020.08.002 ",3.47,197.4,"6z32_oligo1","DManpa1-2DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-MAN(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(1312_A_)",193.112,"","",""
"6Z32","HUMAN CATION-INDEPENDENT MANNOSE 6-PHOSPHATE/IGF2 RECEPTOR DOMAINS 7- 11","10.1016/J.STR.2020.08.002 ",3.47,197.4,"6z32_oligo2","DManpa1-2DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-MAN(5_D_)-MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(1312_B_)",143.565,"","",""
"6Z79","VARIANT SURFACE GLYCOPROTEIN VSGSUR, I3C (""MAGIC TRIANGLE"") DERIVATIVE USED FOR PHASING OF THE STRUCTURE AND SUBSEQUENTLY AS A MODEL FOR MOLECULAR REPLACEMENT OF NATIVE, MUTANTS, AND DRUG SOAKS.","10.1038/S41564-020-00844-1 ",1.92,46.05,"6z79_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(130_A_)",36.84,"","",""
"6Z7A","VARIANT SURFACE GLYCOPROTEIN VSGSUR","10.1038/S41564-020-00844-1 ",1.21,29.66,"6z7a_oligo1","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(130_A_)",26.0968,"","",""
"6Z7B","VARIANT SURFACE GLYCOPROTEIN VSGSUR BOUND TO SURAMIN","10.1038/S41564-020-00844-1 ",1.86,21.54,"6z7b_oligo1","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-MAN(5_C_)-[MAN(7_C_)]-MAN(4_C_)-[MAN(9_C_)-MAN(8_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(130_A_)",32.0158,"","",""
"6Z7B","VARIANT SURFACE GLYCOPROTEIN VSGSUR BOUND TO SURAMIN","10.1038/S41564-020-00844-1 ",1.86,21.54,"6z7b_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_D_)-MAN(8_D_)-MAN(7_D_)-[MAN(6_D_)-MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(130_B_)",27.0412,"","",""
"6Z7C","VARIANT SURFACE GLYCOPROTEIN VSGSUR MUTANT H122A","10.1038/S41564-020-00844-1 ",1.64,37.76,"6z7c_oligo1","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_B_)-MAN(6_B_)-[MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(130_A_)",39.3804,"","",""
"6Z7D","VARIANT SURFACE GLYCOPROTEIN VSGSUR MUTANT H122A SOAKED IN 0.77 MM SURAMIN.","10.1038/S41564-020-00844-1 ",1.75,39.37,"6z7d_oligo1","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-MAN(4_B_)-[MAN(6_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(130_A_)",37.2715,"","",""
"6Z7E","VARIANT SURFACE GLYCOPROTEIN VSGSUR MUTANT H122A SOAKED IN 7.7 MM SURAMIN","10.1038/S41564-020-00844-1 ",1.66,39.02,"6z7e_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(130_A_)",29.786,"","",""
"6Z7P","COMPOSITE MODEL OF THE CAULOBACTER CRESCENTUS S-LAYER BOUND TO THE O- ANTIGEN OF LIPOPOLYSACCHARIDE","10.1016/J.CELL.2019.12.006 ",4.8,0,"6z7p_oligo1","DRhap[4NAc]a1-3DRhap[4NAc]a1-3DManpb1-3DRhap[4NAc]a1-3DRhap[4NAc]a1-3DManpb1-3DRhap[4NAc]a1-3DRhap[4NAc]a1-3DManpx1-","MRH(9_B_)-MRH(8_B_)-BMA(7_B_)-MRH(6_B_)-MRH(5_B_)-BMA(4_B_)-MRH(3_B_)-MRH(2_B_)-BMA(1_B_)",0,"","",""
"6ZEP","FLAVOURZYME LEUCINE AMINOPEPTIDASE A PROENZYME","10.1016/J.JSB.2021.107741 ",1.61,0,"6zep_oligo1","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_B_)-[MAN(7_B_)]-MAN(6_B_)-[MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(87_A_)",58.0933,"","",""
"6ZJM","ATOMIC MODEL OF ANDES VIRUS GLYCOPROTEIN SPIKE TETRAMER GENERATED BY FITTING INTO A TULA VIRUS RECONSTRUCTION","10.1016/J.CELL.2020.08.023 ",11.4,"1.15243e-41","6zjm_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_R_)-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(350_G_)",113.733,"","",""
"6ZJM","ATOMIC MODEL OF ANDES VIRUS GLYCOPROTEIN SPIKE TETRAMER GENERATED BY FITTING INTO A TULA VIRUS RECONSTRUCTION","10.1016/J.CELL.2020.08.023 ",11.4,"1.15243e-41","6zjm_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(138_C_)",117.516,"","",""
"6ZJM","ATOMIC MODEL OF ANDES VIRUS GLYCOPROTEIN SPIKE TETRAMER GENERATED BY FITTING INTO A TULA VIRUS RECONSTRUCTION","10.1016/J.CELL.2020.08.023 ",11.4,"1.15243e-41","6zjm_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_V_)-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(350_E_)",113.733,"","",""
"6ZJM","ATOMIC MODEL OF ANDES VIRUS GLYCOPROTEIN SPIKE TETRAMER GENERATED BY FITTING INTO A TULA VIRUS RECONSTRUCTION","10.1016/J.CELL.2020.08.023 ",11.4,"1.15243e-41","6zjm_oligo8","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(138_A_)",117.516,"","",""
"6ZJM","ATOMIC MODEL OF ANDES VIRUS GLYCOPROTEIN SPIKE TETRAMER GENERATED BY FITTING INTO A TULA VIRUS RECONSTRUCTION","10.1016/J.CELL.2020.08.023 ",11.4,"1.15243e-41","6zjm_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_N_)-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(138_E_)",117.516,"","",""
"6ZJM","ATOMIC MODEL OF ANDES VIRUS GLYCOPROTEIN SPIKE TETRAMER GENERATED BY FITTING INTO A TULA VIRUS RECONSTRUCTION","10.1016/J.CELL.2020.08.023 ",11.4,"1.15243e-41","6zjm_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_K_)-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(138_G_)",117.516,"","",""
"6ZJM","ATOMIC MODEL OF ANDES VIRUS GLYCOPROTEIN SPIKE TETRAMER GENERATED BY FITTING INTO A TULA VIRUS RECONSTRUCTION","10.1016/J.CELL.2020.08.023 ",11.4,"1.15243e-41","6zjm_oligo6","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_O_)-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(350_C_)",113.733,"","",""
"6ZJM","ATOMIC MODEL OF ANDES VIRUS GLYCOPROTEIN SPIKE TETRAMER GENERATED BY FITTING INTO A TULA VIRUS RECONSTRUCTION","10.1016/J.CELL.2020.08.023 ",11.4,"1.15243e-41","6zjm_oligo9","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_M_)-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(350_A_)",113.733,"","",""
"6ZJZ","DISCOVERY OF M5049: A NOVEL SELECTIVE TLR7/8 INHIBITOR FOR TREATMENT OF AUTOIMMUNITY","10.1124/JPET.120.000275 ",2.49,93.66,"6zjz_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(590_B_)",91.2233,"","",""
"6ZJZ","DISCOVERY OF M5049: A NOVEL SELECTIVE TLR7/8 INHIBITOR FOR TREATMENT OF AUTOIMMUNITY","10.1124/JPET.120.000275 ",2.49,93.66,"6zjz_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(293_B_)",104.921,"","",""
"6ZJZ","DISCOVERY OF M5049: A NOVEL SELECTIVE TLR7/8 INHIBITOR FOR TREATMENT OF AUTOIMMUNITY","10.1124/JPET.120.000275 ",2.49,93.66,"6zjz_oligo4","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-[MAN(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(590_A_)",96.6548,"","",""
"6ZJZ","DISCOVERY OF M5049: A NOVEL SELECTIVE TLR7/8 INHIBITOR FOR TREATMENT OF AUTOIMMUNITY","10.1124/JPET.120.000275 ",2.49,93.66,"6zjz_oligo6","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(293_A_)",98.5729,"","",""
"6ZL4","THE STRUCTURE OF GLUTAMATE TRANSPORTER HOMOLOGUE GLTTK IN COMPLEX WITH THE PHOTO SWITCHABLE COMPOUND (CIS)","10.1021/JACS.0C11336 ",3,172.7,"6zl4_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(502_A_)-DMU(502_A_)",210.216,"","",""
"6ZL4","THE STRUCTURE OF GLUTAMATE TRANSPORTER HOMOLOGUE GLTTK IN COMPLEX WITH THE PHOTO SWITCHABLE COMPOUND (CIS)","10.1021/JACS.0C11336 ",3,172.7,"6zl4_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(505_B_)-DMU(505_B_)",206.327,"","",""
"6ZL4","THE STRUCTURE OF GLUTAMATE TRANSPORTER HOMOLOGUE GLTTK IN COMPLEX WITH THE PHOTO SWITCHABLE COMPOUND (CIS)","10.1021/JACS.0C11336 ",3,172.7,"6zl4_oligo3","DGlcpa1-3DGlcpb6-C10O1","DMU(502_C_)-DMU(502_C_)",222.092,"","",""
"6ZLH","THE STRUCTURE OF GLUTAMATE TRANSPORTER HOMOLOGUE GLTTK IN COMPLEX WITH THE PHOTO SWITCHABLE COMPOUND (TRANS)","10.1021/JACS.0C11336 ",2.8,114.2,"6zlh_oligo3","DGlcpa1-3DGlcpb6-C10O1","DMU(502_C_)-DMU(502_C_)",166.906,"","",""
"6ZLH","THE STRUCTURE OF GLUTAMATE TRANSPORTER HOMOLOGUE GLTTK IN COMPLEX WITH THE PHOTO SWITCHABLE COMPOUND (TRANS)","10.1021/JACS.0C11336 ",2.8,114.2,"6zlh_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(505_B_)-DMU(505_B_)",205.886,"","",""
"6ZLH","THE STRUCTURE OF GLUTAMATE TRANSPORTER HOMOLOGUE GLTTK IN COMPLEX WITH THE PHOTO SWITCHABLE COMPOUND (TRANS)","10.1021/JACS.0C11336 ",2.8,114.2,"6zlh_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(502_A_)-DMU(502_A_)",197.815,"","",""
"6ZOW","SARS-COV-2 SPIKE IN PREFUSION STATE","10.1107/S2052252520012725 ",3,0,"6zow_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(801_A_)",69.7198,"","",""
"6ZOW","SARS-COV-2 SPIKE IN PREFUSION STATE","10.1107/S2052252520012725 ",3,0,"6zow_oligo18","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_U_)-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(1134_B_)",75.4327,"","",""
"6ZOW","SARS-COV-2 SPIKE IN PREFUSION STATE","10.1107/S2052252520012725 ",3,0,"6zow_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(717_A_)",49.7282,"","",""
"6ZOW","SARS-COV-2 SPIKE IN PREFUSION STATE","10.1107/S2052252520012725 ",3,0,"6zow_oligo15","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_R_)-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(717_C_)",45.4016,"","",""
"6ZP5","SARS-COV-2 SPIKE IN PREFUSION STATE (FLEXIBILITY ANALYSIS, 1-UP CLOSED CONFORMATION)","10.1107/S2052252520012725 ",3.1,0,"6zp5_oligo2","DManpx1-3DManp[3<R1>]x1-4DGlcpNAcx1-4DGlcpNAcx1-ASN","BMA(3_E_)-MAN(4_E_)-[NAG(2_E_)--[NAG(1_E_)]-NAG(2_E_)-NAG(1_E_)-ASN(690_A_)",6.84091,"","",""
"6ZP5","SARS-COV-2 SPIKE IN PREFUSION STATE (FLEXIBILITY ANALYSIS, 1-UP CLOSED CONFORMATION)","10.1107/S2052252520012725 ",3.1,0,"6zp5_oligo18","DManpx1-3DManp[3<R1>]x1-4DGlcpNAcx1-4DGlcpNAcb1-","BMA(3_U_)-MAN(4_U_)-[NAG(2_U_)--[NAG(1_U_)]-NAG(2_U_)-NAG(1_U_)",6.86364,"","",""
"6ZP5","SARS-COV-2 SPIKE IN PREFUSION STATE (FLEXIBILITY ANALYSIS, 1-UP CLOSED CONFORMATION)","10.1107/S2052252520012725 ",3.1,0,"6zp5_oligo3","DManpx1-3DManp[3<R1>]x1-4DGlcpNAcx1-4DGlcpNAcx1-N1O1","BMA(3_F_)-MAN(4_F_)-[NAG(2_F_)--[NAG(1_F_)]-NAG(2_F_)-NAG(1_F_)",6.86364,"","",""
"6ZP5","SARS-COV-2 SPIKE IN PREFUSION STATE (FLEXIBILITY ANALYSIS, 1-UP CLOSED CONFORMATION)","10.1107/S2052252520012725 ",3.1,0,"6zp5_oligo15","DManpx1-3DManp[3<R1>]x1-4DGlcpNAcx1-4DGlcpNAcb1-","BMA(3_R_)-MAN(4_R_)-[NAG(2_R_)--[NAG(1_R_)]-NAG(2_R_)-NAG(1_R_)",6.86364,"","",""
"6ZPU","CRYSTAL STRUCTURE OF ANGIOTENSIN-1 CONVERTING ENZYME C-DOMAIN WITH INSERTED SYMMETRY MOLECULE C-TERMINUS.","10.1111/FEBS.15601 ",2,39.6,"6zpu_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(109_A_)",57.8309,"","",""
"6ZQR","CRYSTAL STRUCTURE OF TETRAMERIC FIBRINOGEN-LIKE RECOGNITION DOMAIN OF FIBCD1 WITH GLCNAC LIGAND BOUND","",1.93,18.31,"6zqr_oligo1","LFucpa1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_C_)-[NAG(3_C_)]-[FUC(2_C_)]-NAG(1_C_)-ASN(340_A_)",47.6102,"","",""
"6ZQX","CRYSTAL STRUCTURE OF TETRAMERIC FIBRINOGEN-LIKE RECOGNITION DOMAIN OF FIBCD1 WITH N,N'-DIACETYL CHITOBIOSE LIGAND BOUND","",1.84,20.68,"6zqx_oligo1","LFucpa1-3DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(340_A_)",47.2295,"","",""
"6ZQY","CRYSTAL STRUCTURE OF TETRAMERIC FIBRINOGEN-LIKE RECOGNITION DOMAIN OF FIBCD1 WITH NEU5AC LIGAND BOUND","",1.85,16.79,"6zqy_oligo1","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_C_)-[FUC(2_C_)]-NAG(1_C_)-ASN(340_A_)",41.3567,"","",""
"6ZR0","CRYSTAL STRUCTURE OF TETRAMERIC FIBRINOGEN-LIKE RECOGNITION DOMAIN OF FIBCD1 WITH N-ACETYLALANINE LIGAND BOUND","",1.94,21.69,"6zr0_oligo1","LFucpa1-3DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(340_A_)",48.1786,"","",""
"6ZR3","CRYSTAL STRUCTURE OF TETRAMERIC FIBRINOGEN-LIKE RECOGNITION DOMAIN OF FIBCD1 WITH N-ACETYL-GALACTOSAMINE-4-SULFATE LIGAND BOUND","",1.97,23.46,"6zr3_oligo2","LFucpa1-3DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(340_A_)",64.1059,"","",""
"6ZRK","CRYSTAL STRUCTURE OF H8 HAEMAGGLUTININ","10.1101/CSHPERSPECT.A038638 ",2,44.24,"6zrk_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_A_)-[MAN(5_A_)-[MAN(4_A_)]-BMA(3_A_)-NAG(2_A_)]-NAG(1_A_)-ASN(134_C_)",52.8888,"","",""
"6ZS5","3.5 A CRYO-EM STRUCTURE OF HUMAN UROMODULIN FILAMENT CORE","10.7554/ELIFE.60265 ",3.5,0,"6zs5_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(396_A_)",132.979,"","",""
"6ZWI","HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH ((6-((2E,4E)-5- (BENZO[D][1,3]DIOXOL-5-YL)PENTA-2,4-DIENAMIDO)HEXYL) TRIPHENYLPHOSPHONIUM BROMIDE)","10.3390/ANTIOX10020329 ",1.85,56.31,"6zwi_oligo1","DManpa1-3DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_B_)-[MAN(4_B_)-MAN(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(57_A_)",122.694,"","",""
"6ZYA","EXTENDED HUMAN UROMODULIN FILAMENT CORE AT 3.5 A RESOLUTION","10.7554/ELIFE.60265 ",3.5,0,"6zya_oligo2","DManpa1-6DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_C_)-MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(396_A_)",159.163,"","",""
"6ZZW","STRUCTURE OF THE N TERMINAL DOMAIN OF BC2L-C LECTIN (1-131) IN COMPLEX WITH GLOBO H (H-TYPE 3) AND CAS NO 912569-62-1","10.1002/CHEM.202100252 ",1.9,20.85,"6zzw_oligo3","LFucpa1-2DGalpb1-3DGalpNAcb1-3DGalpa1-ROH","FUC(4_F_)-GAL(3_F_)-NGA(2_F_)-GLA(1_F_)",30.4434,"","",""
"6ZZW","STRUCTURE OF THE N TERMINAL DOMAIN OF BC2L-C LECTIN (1-131) IN COMPLEX WITH GLOBO H (H-TYPE 3) AND CAS NO 912569-62-1","10.1002/CHEM.202100252 ",1.9,20.85,"6zzw_oligo6","LFucpa1-2DGalpb1-3DGalpNAcb1-3DGalpa1-4DGalpb1-ROH","FUC(5_E_)-GAL(4_E_)-NGA(3_E_)-GLA(2_E_)-GAL(1_E_)",32.5613,"","",""
"6ZZW","STRUCTURE OF THE N TERMINAL DOMAIN OF BC2L-C LECTIN (1-131) IN COMPLEX WITH GLOBO H (H-TYPE 3) AND CAS NO 912569-62-1","10.1002/CHEM.202100252 ",1.9,20.85,"6zzw_oligo2","LFucpa1-2DGalpb1-3DGalpNAcb1-3DGalpa1-4DGalpb1-ROH","FUC(5_D_)-GAL(4_D_)-NGA(3_D_)-GLA(2_D_)-GAL(1_D_)",35.9071,"","",""
"7A0Q","CRYSTAL STRUCTURE OF KIEVITONE HYDRATASE FROM NECTRIA HAEMATOCOCCA (C2 SG)","",1.5,23.91,"7a0q_oligo3","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-MAN(5_C_)-[MAN(7_C_)]-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(218_A_)",27.2045,"","",""
"7A0T","CRYSTAL STRUCTURE OF KIEVITONE HYDRATASE FROM NECTRIA HAEMATOCOCCA (P21 SG)","",2,34.95,"7a0t_oligo4","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_D_)-MAN(8_D_)-[MAN(10_D_)]-MAN(7_D_)-[MAN(6_D_)-MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(218_B_)",37.3676,"","",""
"7A0T","CRYSTAL STRUCTURE OF KIEVITONE HYDRATASE FROM NECTRIA HAEMATOCOCCA (P21 SG)","",2,34.95,"7a0t_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_C_)-MAN(8_C_)-[MAN(10_C_)]-MAN(7_C_)-[MAN(6_C_)-MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(218_A_)",44.1531,"","",""
"7A5V","CRYOEM STRUCTURE OF A HUMAN GAMMA-AMINOBUTYRIC ACID RECEPTOR, THE GABA(A)R-BETA3 HOMOPENTAMER, IN COMPLEX WITH HISTAMINE AND MEGABODY MB25 IN LIPID NANODISC","10.1038/S41586-020-2829-0 ",1.7,0,"7a5v_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(149_A_)",58.1069,"","",""
"7ABW","CRYSTAL STRUCTURE OF SIDEROPHORE REDUCTASE FOXB","10.1073/PNAS.2101952118 ",3.35,40.87,"7abw_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(405_A_)-DMU(405_A_)",58.1786,"","",""
"7AKD","STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH THE 47D11 NEUTRALIZING ANTIBODY FAB FRAGMENT","10.1126/SCIADV.ABF5632 ",4,"1.35632e-19","7akd_oligo13","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_T_)-[MAN(5_T_)-MAN(4_T_)-BMA(3_T_)-NAG(2_T_)]-NAG(1_T_)-ASN(343_C_)",90.1902,"","",""
"7AKD","STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH THE 47D11 NEUTRALIZING ANTIBODY FAB FRAGMENT","10.1126/SCIADV.ABF5632 ",4,"1.35632e-19","7akd_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_O_)-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(343_B_)",108.763,"","",""
"7AKJ","STRUCTURE OF THE SARS-COV SPIKE GLYCOPROTEIN IN COMPLEX WITH THE 47D11 NEUTRALIZING ANTIBODY FAB FRAGMENT","10.1126/SCIADV.ABF5632 ",3.8,"1.35632e-19","7akj_oligo6","DManpa1-3DManpa1-3[DManpa1-2[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_N_)-[MAN(8_N_)-[MAN(7_N_)]-MAN(6_N_)-[MAN(5_N_)-MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)]-NAG(1_N_)-ASN(330_C_)",114.126,"","",""
"7AKJ","STRUCTURE OF THE SARS-COV SPIKE GLYCOPROTEIN IN COMPLEX WITH THE 47D11 NEUTRALIZING ANTIBODY FAB FRAGMENT","10.1126/SCIADV.ABF5632 ",3.8,"1.35632e-19","7akj_oligo11","DManpa1-3DManpa1-3[DManpa1-2[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_T_)-[MAN(8_T_)-[MAN(7_T_)]-MAN(6_T_)-[MAN(5_T_)-MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)]-NAG(1_T_)-ASN(330_B_)",116.815,"","",""
"7AKJ","STRUCTURE OF THE SARS-COV SPIKE GLYCOPROTEIN IN COMPLEX WITH THE 47D11 NEUTRALIZING ANTIBODY FAB FRAGMENT","10.1126/SCIADV.ABF5632 ",3.8,"1.35632e-19","7akj_oligo17","DManpa1-3DManpa1-3[DManpa1-2[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_Z_)-[MAN(8_Z_)-[MAN(7_Z_)]-MAN(6_Z_)-[MAN(5_Z_)-MAN(4_Z_)]-BMA(3_Z_)-NAG(2_Z_)]-NAG(1_Z_)-ASN(330_A_)",111.712,"","",""
"7ALK","STRUCTURE OF DROSOPHILA C2-DSL-EGF1","10.15252/EMBR.202152729 ",3,35.61,"7alk_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_B_)-[MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(137_A_)",41.3356,"","",""
"7AMK","ZEBRAFISH RET CADHERIN LIKE DOMAINS 1 TO 4.","10.1016/J.STR.2020.12.012 ",2.2,39.39,"7amk_oligo5","DManpa1-6DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_C_)-[MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(137_A_)",85.8083,"","",""
"7AMK","ZEBRAFISH RET CADHERIN LIKE DOMAINS 1 TO 4.","10.1016/J.STR.2020.12.012 ",2.2,39.39,"7amk_oligo10","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_K_)-[MAN(4_K_)-BMA(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(461_B_)",51.9495,"","",""
"7API","THE S VARIANT OF HUMAN ALPHA1-ANTITRYPSIN, STRUCTURE AND IMPLICATIONS FOR FUNCTION AND METABOLISM","10.1093/PROTEIN/2.6.407 ",3,0,"7api_oligo1","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_C_)-MAN(4_C_)-[MAN(6_C_)]-MAN(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(46_A_)",53.2947,"","",""
"7AQ1","CRYSTAL STRUCTURE OF HUMAN MATURE MEPRIN BETA IN COMPLEX WITH THE SPECIFIC INHIBITOR MWT-S-270","10.3390/IJMS22115651 ",2.41,55.52,"7aq1_oligo1","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_I_)-MAN(5_I_)-[MAN(7_I_)]-MAN(4_I_)-[MAN(9_I_)-MAN(8_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(547_A_)",66.9821,"","",""
"7AQ1","CRYSTAL STRUCTURE OF HUMAN MATURE MEPRIN BETA IN COMPLEX WITH THE SPECIFIC INHIBITOR MWT-S-270","10.3390/IJMS22115651 ",2.41,55.52,"7aq1_oligo4","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_L_)-MAN(5_L_)-[MAN(7_L_)]-MAN(4_L_)-[MAN(8_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(547_B_)",76.3333,"","",""
"7AQX","CO-CRYSTAL STRUCTURE OF VARIANT SURFACE GLYCOPROTEIN VSG2 IN COMPLEX WITH NANOBODY VSG2(NB9)","10.1016/J.CELREP.2021.109923 ",1.5,33.52,"7aqx_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(289_B_)",36.49,"","",""
"7AQZ","CO-CRYSTAL STRUCTURE OF VARIANT SURFACE GLYCOPROTEIN VSG2 IN COMPLEX WITH NANOBODY VSG2(NB14)","10.1016/J.CELREP.2021.109923 ",1.3,25.79,"7aqz_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(289_A_)",29.9864,"","",""
"7AQZ","CO-CRYSTAL STRUCTURE OF VARIANT SURFACE GLYCOPROTEIN VSG2 IN COMPLEX WITH NANOBODY VSG2(NB14)","10.1016/J.CELREP.2021.109923 ",1.3,25.79,"7aqz_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(289_B_)",33.2384,"","",""
"7AU2","CRYO-EM STRUCTURE OF HUMAN EXOSTOSIN-LIKE 3 (EXTL3)","10.1038/S41467-022-31048-2 ",2.43,"1.15243e-41","7au2_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(790_A_)",51.4634,"","",""
"7AU2","CRYO-EM STRUCTURE OF HUMAN EXOSTOSIN-LIKE 3 (EXTL3)","10.1038/S41467-022-31048-2 ",2.43,"1.15243e-41","7au2_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(790_B_)",51.4634,"","",""
"7AU7","CRYSTAL STRUCTURE OF NOD FACTOR PERCEPTION ECTODOMAIN","10.1073/PNAS.2111031118 ",2.55,53.89,"7au7_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(133_A_)",88.4934,"","",""
"7AUA","CRYO-EM STRUCTURE OF HUMAN EXOSTOSIN-LIKE 3 (EXTL3) IN COMPLEX WITH UDP","10.1038/S41467-022-31048-2 ",2.93,"1.15243e-41","7aua_oligo6","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(790_B_)",75.1393,"","",""
"7AUA","CRYO-EM STRUCTURE OF HUMAN EXOSTOSIN-LIKE 3 (EXTL3) IN COMPLEX WITH UDP","10.1038/S41467-022-31048-2 ",2.93,"1.15243e-41","7aua_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(790_A_)",75.1393,"","",""
"7AUW","INHIBITORY COMPLEX OF HUMAN MEPRIN BETA WITH MOUSE FETUIN-B.","10.1073/PNAS.2023839118 ",2.8,122,"7auw_oligo7","LFucpa1-3[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_K_)-[FUC(2_K_)]-NAG(1_K_)-ASN(592_A_)",161.788,"","",""
"7AUW","INHIBITORY COMPLEX OF HUMAN MEPRIN BETA WITH MOUSE FETUIN-B.","10.1073/PNAS.2023839118 ",2.8,122,"7auw_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(7_E_)-[MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-[FUC(6_E_)]-NAG(1_E_)-ASN(218_A_)",141.635,"","",""
"7AUW","INHIBITORY COMPLEX OF HUMAN MEPRIN BETA WITH MOUSE FETUIN-B.","10.1073/PNAS.2023839118 ",2.8,122,"7auw_oligo14","DGlcpa1-3DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(12_R_)-MAN(11_R_)-[MAN(10_R_)-MAN(9_R_)]-MAN(8_R_)-[GLC(7_R_)-MAN(6_R_)-MAN(5_R_)-MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(547_C_)",124.457,"","",""
"7AUW","INHIBITORY COMPLEX OF HUMAN MEPRIN BETA WITH MOUSE FETUIN-B.","10.1073/PNAS.2023839118 ",2.8,122,"7auw_oligo15","LFucpa1-3[LFucpa1-6]DGlcpNAcb1-ASN","FUC(3_S_)-[FUC(2_S_)]-NAG(1_S_)-ASN(592_C_)",155.036,"","",""
"7AUW","INHIBITORY COMPLEX OF HUMAN MEPRIN BETA WITH MOUSE FETUIN-B.","10.1073/PNAS.2023839118 ",2.8,122,"7auw_oligo6","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(6_H_)-[MAN(4_H_)-BMA(3_H_)-NAG(2_H_)]-[FUC(5_H_)]-NAG(1_H_)-ASN(436_A_)",147.234,"","",""
"7AUW","INHIBITORY COMPLEX OF HUMAN MEPRIN BETA WITH MOUSE FETUIN-B.","10.1073/PNAS.2023839118 ",2.8,122,"7auw_oligo17","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_U_)-[FUC(2_U_)]-NAG(1_U_)-ASN(139_D_)",194.913,"","",""
"7AUW","INHIBITORY COMPLEX OF HUMAN MEPRIN BETA WITH MOUSE FETUIN-B.","10.1073/PNAS.2023839118 ",2.8,122,"7auw_oligo12","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(6_P_)-[MAN(4_P_)-BMA(3_P_)-NAG(2_P_)]-[FUC(5_P_)]-NAG(1_P_)-ASN(436_C_)",151.712,"","",""
"7AUW","INHIBITORY COMPLEX OF HUMAN MEPRIN BETA WITH MOUSE FETUIN-B.","10.1073/PNAS.2023839118 ",2.8,122,"7auw_oligo11","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(7_O_)-[MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)]-[FUC(6_O_)]-NAG(1_O_)-ASN(370_C_)",156.815,"","",""
"7AUW","INHIBITORY COMPLEX OF HUMAN MEPRIN BETA WITH MOUSE FETUIN-B.","10.1073/PNAS.2023839118 ",2.8,122,"7auw_oligo5","DGlcpa1-3DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(12_J_)-MAN(11_J_)-[MAN(10_J_)-MAN(9_J_)]-MAN(8_J_)-[GLC(7_J_)-MAN(6_J_)-MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(547_A_)",121.215,"","",""
"7AUW","INHIBITORY COMPLEX OF HUMAN MEPRIN BETA WITH MOUSE FETUIN-B.","10.1073/PNAS.2023839118 ",2.8,122,"7auw_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(7_G_)-[MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)]-[FUC(6_G_)]-NAG(1_G_)-ASN(370_A_)",156.512,"","",""
"7AUW","INHIBITORY COMPLEX OF HUMAN MEPRIN BETA WITH MOUSE FETUIN-B.","10.1073/PNAS.2023839118 ",2.8,122,"7auw_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(7_M_)-[MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)]-[FUC(6_M_)]-NAG(1_M_)-ASN(218_C_)",137.172,"","",""
"7AUW","INHIBITORY COMPLEX OF HUMAN MEPRIN BETA WITH MOUSE FETUIN-B.","10.1073/PNAS.2023839118 ",2.8,122,"7auw_oligo8","DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","BMA(3_L_)-NAG(2_L_)-[FUC(4_L_)]-NAG(1_L_)-ASN(139_B_)",189.18,"","",""
"7B09","PUUMALA VIRUS GLYCOPROTEIN (GC) IN COMPLEX WITH FAB FRAGMENT P-4G2.","10.7554/ELIFE.58242 ",13.4,"4.77305e-07","7b09_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(142_B_)",78.538,"","",""
"7B0A","PUUMALA VIRUS-LIKE PARTICLE GLYCOPROTEIN SPIKE AND LATTICE CONTACTS MODEL.","10.7554/ELIFE.58242 ",13.9,"5.37397e+08","7b0a_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_H_)-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(142_B_)",78.538,"","",""
"7B0A","PUUMALA VIRUS-LIKE PARTICLE GLYCOPROTEIN SPIKE AND LATTICE CONTACTS MODEL.","10.7554/ELIFE.58242 ",13.9,"5.37397e+08","7b0a_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_M_)-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(142_G_)",78.538,"","",""
"7B75","CRYO-EM STRUCTURE OF HUMAN THYROGLOBULIN","10.1038/S41467-021-27693-8 ",3.2,0,"7b75_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(2295_A_)",136.96,"","",""
"7B75","CRYO-EM STRUCTURE OF HUMAN THYROGLOBULIN","10.1038/S41467-021-27693-8 ",3.2,0,"7b75_oligo11","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_M_)-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(2295_B_)",139.959,"","",""
"7B75","CRYO-EM STRUCTURE OF HUMAN THYROGLOBULIN","10.1038/S41467-021-27693-8 ",3.2,0,"7b75_oligo6","DManpa1-3DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-[MAN(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(2582_A_)",147.695,"","",""
"7B75","CRYO-EM STRUCTURE OF HUMAN THYROGLOBULIN","10.1038/S41467-021-27693-8 ",3.2,0,"7b75_oligo12","DManpa1-3DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_N_)-[MAN(5_N_)-MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(2582_B_)",150.89,"","",""
"7B7A","ENDO-POLYGALACTURONASE FROM ARABIDOPSIS THALIANA","10.1093/PLCELL/KOAD134 ",1.3,29.31,"7b7a_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(6_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)",47.0135,"","",""
"7B7A","ENDO-POLYGALACTURONASE FROM ARABIDOPSIS THALIANA","10.1093/PLCELL/KOAD134 ",1.3,29.31,"7b7a_oligo3","DManpa1-3DManpx1-","MAN(5_B_)-MAN(4_B_)",57.7888,"","",""
"7BEL","CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-88 AND COVOX-45 FABS","10.1016/J.CELL.2021.02.032 ",2.53,69.91,"7bel_oligo2","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-MAN(4_I_)-[MAN(6_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(35_E_)",91.1424,"","",""
"7BEL","CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-88 AND COVOX-45 FABS","10.1016/J.CELL.2021.02.032 ",2.53,69.91,"7bel_oligo1","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-MAN(4_G_)-[MAN(6_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(35_H_)",88.1701,"","",""
"7BEP","CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-384 AND S309 FABS","10.1016/J.CELL.2021.02.032 ",2.61,99.07,"7bep_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_J_)-[MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)]-NAG(1_J_)-ASN(343_E_)",144.507,"","",""
"7BEP","CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-384 AND S309 FABS","10.1016/J.CELL.2021.02.032 ",2.61,99.07,"7bep_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_K_)-[MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(343_C_)",135.208,"","",""
"7BFZ","X-RAY STRUCTURE OF HUMAN PROSTATE-SPECIFIC MEMBRANE ANTIGEN(PSMA) IN COMPLEX WITH A INHIBITOR GLU-490","10.1038/S41467-021-25746-6 ",1.73,36.47,"7bfz_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(638_A_)",51.5416,"","",""
"7BGC","HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH A TACRINE-METHYLANACARDATE HYBRID INHIBITOR","10.1021/ACS.JMEDCHEM.1C00048 ",2.4,89.48,"7bgc_oligo2","DManpa1-3DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_B_)-[MAN(4_B_)-MAN(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(57_A_)",155.328,"","",""
"7BHD","FIMH IN COMPLEX WITH ALPHA1,6 CORE-FUCOSYLATED OLIGOMANNOSE-3, CRYSTALLIZED IN THE TRIGONAL SPACE GROUP","10.1016/J.JBC.2023.104627 ",1.4,35.25,"7bhd_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ROH","FUC(6_D_)-[MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)",47.56,"","",""
"7BHD","FIMH IN COMPLEX WITH ALPHA1,6 CORE-FUCOSYLATED OLIGOMANNOSE-3, CRYSTALLIZED IN THE TRIGONAL SPACE GROUP","10.1016/J.JBC.2023.104627 ",1.4,35.25,"7bhd_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ROH","FUC(6_C_)-[MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)",58.9397,"","",""
"7BLJ","STRUCTURE OF CBM BT3015C FROM BACTEROIDES THETAIOTAOMICRON IN COMPLEX WITH O-GALNAC CORE 2-THR","",1.76,14.1,"7blj_oligo1","DGalpb1-3[DGlcpNAcb1-6]DGalpNAca1-THR","NAG(3_B_)-[GAL(2_B_)]-A2G(1_B_)-THR(202_A_)",16.047,"","",""
"7BRG","ATRIAL NATRIURETIC PEPTIDE RECEPTOR COMPLEXED WITH RAT ATRIAL NATRIURETIC PEPTIDE","",2.45,0,"7brg_oligo2","DManpa1-3DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(395_A_)",151.659,"","",""
"7BRG","ATRIAL NATRIURETIC PEPTIDE RECEPTOR COMPLEXED WITH RAT ATRIAL NATRIURETIC PEPTIDE","",2.45,0,"7brg_oligo4","DManpa1-3DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-MAN(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(395_B_)",148.617,"","",""
"7BRH","ATRIAL NATRIURETIC PEPTIDE RECEPTOR COMPLEXED WITH HUMAN ATRIAL NATRIURETIC PEPTIDE","",2.45,0,"7brh_oligo2","DManpa1-3DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(395_A_)",138.502,"","",""
"7BRH","ATRIAL NATRIURETIC PEPTIDE RECEPTOR COMPLEXED WITH HUMAN ATRIAL NATRIURETIC PEPTIDE","",2.45,0,"7brh_oligo4","DManpa1-3DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-MAN(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(395_B_)",137.832,"","",""
"7BRI","ATRIAL NATRIURETIC PEPTIDE RECEPTOR COMPLEXED WITH DENDROASPIS NATRIURETIC PEPTIDE","",2.45,0,"7bri_oligo4","DManpa1-3DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-MAN(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(395_B_)",98.4148,"","",""
"7BRI","ATRIAL NATRIURETIC PEPTIDE RECEPTOR COMPLEXED WITH DENDROASPIS NATRIURETIC PEPTIDE","",2.45,0,"7bri_oligo2","DManpa1-3DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(395_A_)",98.2975,"","",""
"7BRJ","ATRIAL NATRIURETIC PEPTIDE RECEPTOR COMPLEXED WITH DELETION MUTANT OF HUMAN ATRIAL NATRIURETIC PEPTIDE[7-28]","",2.7,0,"7brj_oligo4","DManpa1-3DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-MAN(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(395_B_)",133.564,"","",""
"7BRJ","ATRIAL NATRIURETIC PEPTIDE RECEPTOR COMPLEXED WITH DELETION MUTANT OF HUMAN ATRIAL NATRIURETIC PEPTIDE[7-28]","",2.7,0,"7brj_oligo2","DManpa1-3DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(395_A_)",132.7,"","",""
"7BRK","ATRIAL NATRIURETIC PEPTIDE RECEPTOR COMPLEXED WITH DELETION MUTANT OF HUMAN ATRIAL NATRIURETIC PEPTIDE[5-27]","",2.85,0,"7brk_oligo4","DManpa1-3DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-MAN(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(395_B_)",137.97,"","",""
"7BRK","ATRIAL NATRIURETIC PEPTIDE RECEPTOR COMPLEXED WITH DELETION MUTANT OF HUMAN ATRIAL NATRIURETIC PEPTIDE[5-27]","",2.85,0,"7brk_oligo3","DManpa1-3DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(395_A_)",137.816,"","",""
"7BRL","ATRIAL NATRIURETIC PEPTIDE RECEPTOR COMPLEXED WITH DELETION MUTANT OF RAT ATRIAL NATRIURETIC PEPTIDE[4-17,23]","",3.2,0,"7brl_oligo4","DManpa1-3DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-MAN(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(395_B_)",176.332,"","",""
"7BRL","ATRIAL NATRIURETIC PEPTIDE RECEPTOR COMPLEXED WITH DELETION MUTANT OF RAT ATRIAL NATRIURETIC PEPTIDE[4-17,23]","",3.2,0,"7brl_oligo3","DManpa1-3DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(395_A_)",189.186,"","",""
"7BSN","MEVO LECTIN COMPLEX WITH 3ALPHA-MANNOBIOSE","10.1093/GLYCOB/CWAA063 ",2.6,35.12,"7bsn_oligo5","DManpa1-3DManpa1-ROH","MAN(2_S_)-MAN(1_S_)",78.0359,"","",""
"7BSN","MEVO LECTIN COMPLEX WITH 3ALPHA-MANNOBIOSE","10.1093/GLYCOB/CWAA063 ",2.6,35.12,"7bsn_oligo4","DManpa1-3DManpa1-ROH","MAN(2_R_)-MAN(1_R_)",58.695,"","",""
"7BSN","MEVO LECTIN COMPLEX WITH 3ALPHA-MANNOBIOSE","10.1093/GLYCOB/CWAA063 ",2.6,35.12,"7bsn_oligo6","DManpa1-3DManpa1-ROH","MAN(2_T_)-MAN(1_T_)",53.1077,"","",""
"7BSN","MEVO LECTIN COMPLEX WITH 3ALPHA-MANNOBIOSE","10.1093/GLYCOB/CWAA063 ",2.6,35.12,"7bsn_oligo9","DManpa1-3DManpa1-ROH","MAN(2_W_)-MAN(1_W_)",64.3809,"","",""
"7BSN","MEVO LECTIN COMPLEX WITH 3ALPHA-MANNOBIOSE","10.1093/GLYCOB/CWAA063 ",2.6,35.12,"7bsn_oligo1","DManpa1-3DManpa1-ROH","MAN(2_O_)-MAN(1_O_)",64.6686,"","",""
"7BSN","MEVO LECTIN COMPLEX WITH 3ALPHA-MANNOBIOSE","10.1093/GLYCOB/CWAA063 ",2.6,35.12,"7bsn_oligo3","DManpa1-3DManpa1-ROH","MAN(2_Q_)-MAN(1_Q_)",75.1132,"","",""
"7BSN","MEVO LECTIN COMPLEX WITH 3ALPHA-MANNOBIOSE","10.1093/GLYCOB/CWAA063 ",2.6,35.12,"7bsn_oligo8","DManpa1-3DManpa1-ROH","MAN(2_V_)-MAN(1_V_)",76.1468,"","",""
"7BSN","MEVO LECTIN COMPLEX WITH 3ALPHA-MANNOBIOSE","10.1093/GLYCOB/CWAA063 ",2.6,35.12,"7bsn_oligo2","DManpa1-3DManpa1-ROH","MAN(2_P_)-MAN(1_P_)",52.7695,"","",""
"7BSN","MEVO LECTIN COMPLEX WITH 3ALPHA-MANNOBIOSE","10.1093/GLYCOB/CWAA063 ",2.6,35.12,"7bsn_oligo10","DManpa1-3DManpa1-ROH","MAN(2_X_)-MAN(1_X_)",54.1482,"","",""
"7BSN","MEVO LECTIN COMPLEX WITH 3ALPHA-MANNOBIOSE","10.1093/GLYCOB/CWAA063 ",2.6,35.12,"7bsn_oligo7","DManpa1-3DManpa1-ROH","MAN(2_U_)-MAN(1_U_)",57.94,"","",""
"7BSQ","CRYO-EM STRUCTURE OF A HUMAN ATP11C-CDC50A FLIPPASE IN E1ALF-ADP STATE","10.1016/J.CELREP.2020.108208 ",3.2,0,"7bsq_oligo1","DManpa1-3DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(180_C_)",34.6158,"","",""
"7BT8","MEVO LECTIN COMPLEX WITH MANNOTRIOSE","10.1093/GLYCOB/CWAA063 ",2.7,37.97,"7bt8_oligo2","DManpa1-3[DManpa1-6]DManpb1-ROH","MAN(3_I_)-[MAN(2_I_)]-BMA(1_I_)",38.3333,"","",""
"7BT8","MEVO LECTIN COMPLEX WITH MANNOTRIOSE","10.1093/GLYCOB/CWAA063 ",2.7,37.97,"7bt8_oligo1","DManpa1-3[DManpa1-6]DManpb1-ROH","MAN(3_H_)-[MAN(2_H_)]-BMA(1_H_)",52.9936,"","",""
"7BT8","MEVO LECTIN COMPLEX WITH MANNOTRIOSE","10.1093/GLYCOB/CWAA063 ",2.7,37.97,"7bt8_oligo3","DManpa1-3[DManpa1-6]DManpb1-ROH","MAN(3_J_)-[MAN(2_J_)]-BMA(1_J_)",56.0206,"","",""
"7BTL","MEVO LECTIN COMPLEX WITH MANNOPENTOSE","10.1093/GLYCOB/CWAA063 ",2.25,32.85,"7btl_oligo4","DManpa1-6DManpa1-6[DManpa1-3]DManpa1-ROH","MAN(305_D_)-MAN(3_J_)-[MAN(2_J_)]-MAN(1_J_)",58.4286,"","",""
"7BTL","MEVO LECTIN COMPLEX WITH MANNOPENTOSE","10.1093/GLYCOB/CWAA063 ",2.25,32.85,"7btl_oligo1","DManpa1-6DManpa1-6[DManpa1-3]DManpa1-ROH","MAN(3_H_)-MAN(2_H_)-[MAN(4_H_)]-MAN(1_H_)",55.1868,"","",""
"7BTL","MEVO LECTIN COMPLEX WITH MANNOPENTOSE","10.1093/GLYCOB/CWAA063 ",2.25,32.85,"7btl_oligo7","DManpa1-6DManpa1-6[DManpa1-3]DManpa1-ROH","MAN(3_M_)-MAN(2_M_)-[MAN(4_M_)]-MAN(1_M_)",53.8757,"","",""
"7BYV","CRYSTAL STRUCTURE OF EXO-BETA-1,3-GALACTANASE FROM PHANEROCHAETE CHRYSOSPORIUM PC1,3GAL43A E208Q WITH BETA-1,3-GALACTOTRIOSE","10.1074/JBC.RA120.016149 ",2.5,30.48,"7byv_oligo1","DGalpb1-3DGalpb1-3DGalpb1-ROH","GAL(3_C_)-GAL(2_C_)-GAL(1_C_)",48.8336,"","",""
"7BYX","CRYSTAL STRUCTURE OF EXO-BETA-1,3-GALACTANASE FROM PHANEROCHAETE CHRYSOSPORIUM PC1,3GAL43A E208A WITH BETA-1,3-GALACTOTRIOSE","10.1074/JBC.RA120.016149 ",2.3,32.98,"7byx_oligo8","DGalpb1-3DGalpb1-3DGalpb1-ROH","GAL(3_L_)-GAL(2_L_)-GAL(1_L_)",29.943,"","",""
"7BYX","CRYSTAL STRUCTURE OF EXO-BETA-1,3-GALACTANASE FROM PHANEROCHAETE CHRYSOSPORIUM PC1,3GAL43A E208A WITH BETA-1,3-GALACTOTRIOSE","10.1074/JBC.RA120.016149 ",2.3,32.98,"7byx_oligo15","DGalpb1-3DGalpb1-3DGalpb1-ROH","GAL(3_S_)-GAL(2_S_)-GAL(1_S_)",61.1848,"","",""
"7BYX","CRYSTAL STRUCTURE OF EXO-BETA-1,3-GALACTANASE FROM PHANEROCHAETE CHRYSOSPORIUM PC1,3GAL43A E208A WITH BETA-1,3-GALACTOTRIOSE","10.1074/JBC.RA120.016149 ",2.3,32.98,"7byx_oligo4","DGalpb1-3DGalpb1-3DGalpb1-ROH","GAL(3_H_)-GAL(2_H_)-GAL(1_H_)",30.9433,"","",""
"7BYX","CRYSTAL STRUCTURE OF EXO-BETA-1,3-GALACTANASE FROM PHANEROCHAETE CHRYSOSPORIUM PC1,3GAL43A E208A WITH BETA-1,3-GALACTOTRIOSE","10.1074/JBC.RA120.016149 ",2.3,32.98,"7byx_oligo12","DGalpb1-3DGalpb1-3DGalpb1-ROH","GAL(3_P_)-GAL(2_P_)-GAL(1_P_)",54.3436,"","",""
"7C8W","STRUCTURE OF SYBODY MR17 IN COMPLEX WITH THE SARS-COV-2 S RECEPTOR- BINDING DOMAIN (RBD)","10.1038/S41467-021-24905-Z ",2.77,73.5,"7c8w_oligo1","LFucpa1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_C_)-[NAG(3_C_)]-[FUC(2_C_)]-NAG(1_C_)-ASN(343_B_)",126.875,"","",""
"7C94","CRYSTAL STRUCTURE OF THE ANTI-HUMAN PODOPLANIN ANTIBODY FAB FRAGMENT COMPLEX WITH GLYCOPEPTIDE","10.1016/J.BBRC.2020.08.103 ",2.84,46.24,"7c94_oligo1","DNeup5Aca2-3DGalpb1-3[DNeup5Aca2-6]DGalpNAca1-THR","SIA(4_H_)-[SIA(3_H_)-GAL(2_H_)]-A2G(1_H_)-THR(76_F_)",66.1149,"","",""
"7C94","CRYSTAL STRUCTURE OF THE ANTI-HUMAN PODOPLANIN ANTIBODY FAB FRAGMENT COMPLEX WITH GLYCOPEPTIDE","10.1016/J.BBRC.2020.08.103 ",2.84,46.24,"7c94_oligo2","DNeup5Aca2-3DGalpb1-3[DNeup5Aca2-6]DGalpNAca1-THR","SIA(4_G_)-[SIA(3_G_)-GAL(2_G_)]-A2G(1_G_)-THR(76_C_)",63.6828,"","",""
"7C9I","HUMAN GAMMA-SECRETASE IN COMPLEX WITH SMALL MOLECULE L-685,458","10.1016/J.CELL.2020.11.049 ",3.1,"1.08527e-19","7c9i_oligo6","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_F_)-[BMA(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(55_A_)",66.3371,"","",""
"7CN9","CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE ECTODOMAIN","10.1016/J.CELREP.2020.108016 ",4.7,0,"7cn9_oligo12","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_Q_)-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(801_A_)",207.125,"","",""
"7COH","DIMERIC FORM OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE","10.1016/J.BBADVA.2021.100009 ",1.3,30.5,"7coh_oligo11","DGlcpa1-3DGlcpb6-C10O1","DMU(714_C_)-DMU(714_C_)",41.0659,"","",""
"7COH","DIMERIC FORM OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE","10.1016/J.BBADVA.2021.100009 ",1.3,30.5,"7coh_oligo14","DGlcpa1-3DGlcpb6-C10O1","DMU(744_A_)-DMU(744_A_)",30.7673,"","",""
"7COH","DIMERIC FORM OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE","10.1016/J.BBADVA.2021.100009 ",1.3,30.5,"7coh_oligo15","DGlcpa1-3DGlcpb6-C10O1","DMU(715_C_)-DMU(715_C_)",37.21,"","",""
"7COH","DIMERIC FORM OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE","10.1016/J.BBADVA.2021.100009 ",1.3,30.5,"7coh_oligo16","DGlcpa1-3DGlcpb6-C10O1","DMU(733_C_)-DMU(733_C_)",51.2591,"","",""
"7COH","DIMERIC FORM OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE","10.1016/J.BBADVA.2021.100009 ",1.3,30.5,"7coh_oligo20","DGlcpa1-3DGlcpb6-C10O1","DMU(734_C_)-DMU(734_C_)",52.8727,"","",""
"7COH","DIMERIC FORM OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE","10.1016/J.BBADVA.2021.100009 ",1.3,30.5,"7coh_oligo6","DGlcpa1-3DGlcpb6-C10O1","DMU(744_N_)-DMU(744_N_)",46.0141,"","",""
"7COH","DIMERIC FORM OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE","10.1016/J.BBADVA.2021.100009 ",1.3,30.5,"7coh_oligo3","DGlcpa1-3DGlcpb6-C10O1","DMU(61_W_)-DMU(61_W_)",59.5086,"","",""
"7COH","DIMERIC FORM OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE","10.1016/J.BBADVA.2021.100009 ",1.3,30.5,"7coh_oligo22","DGlcpa1-3DGlcpb6-C10O1","DMU(714_P_)-DMU(714_P_)",42.6877,"","",""
"7COH","DIMERIC FORM OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE","10.1016/J.BBADVA.2021.100009 ",1.3,30.5,"7coh_oligo25","DGlcpa1-3DGlcpb6-C10O1","DMU(733_P_)-DMU(733_P_)",51.5414,"","",""
"7COH","DIMERIC FORM OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE","10.1016/J.BBADVA.2021.100009 ",1.3,30.5,"7coh_oligo5","DGlcpa1-3DGlcpb6-C10O1","DMU(526_N_)-DMU(526_N_)",52.5259,"","",""
"7COH","DIMERIC FORM OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE","10.1016/J.BBADVA.2021.100009 ",1.3,30.5,"7coh_oligo7","DGlcpa1-3DGlcpb6-C10O1","DMU(745_N_)-DMU(745_N_)",55.155,"","",""
"7COH","DIMERIC FORM OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE","10.1016/J.BBADVA.2021.100009 ",1.3,30.5,"7coh_oligo9","DGlcpa1-3DGlcpb6-C10O1","DMU(61_J_)-DMU(61_J_)",49.71,"","",""
"7COH","DIMERIC FORM OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE","10.1016/J.BBADVA.2021.100009 ",1.3,30.5,"7coh_oligo13","DGlcpa1-3DGlcpb6-C10O1","DMU(745_A_)-DMU(745_A_)",35.2359,"","",""
"7COH","DIMERIC FORM OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE","10.1016/J.BBADVA.2021.100009 ",1.3,30.5,"7coh_oligo26","DGlcpa1-3DGlcpb6-C10O1","DMU(734_P_)-DMU(734_P_)",59.5345,"","",""
"7COH","DIMERIC FORM OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE","10.1016/J.BBADVA.2021.100009 ",1.3,30.5,"7coh_oligo18","DGlcpa1-3DGlcpb6-C10O1","DMU(526_A_)-DMU(526_A_)",41.69,"","",""
"7COH","DIMERIC FORM OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE","10.1016/J.BBADVA.2021.100009 ",1.3,30.5,"7coh_oligo23","DGlcpa1-3DGlcpb6-C10O1","DMU(715_P_)-DMU(715_P_)",39.6391,"","",""
"7CP5","BOVINE HEART CYTOCHROME C OXIDASE IN A CATALYTIC INTERMEDIATE OF E AT 1.76 ANGSTROM RESOLUTION","10.1016/J.JBC.2021.100967 ",1.76,0,"7cp5_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(101_Z_)-DMU(101_Z_)",52.2759,"","",""
"7CP5","BOVINE HEART CYTOCHROME C OXIDASE IN A CATALYTIC INTERMEDIATE OF E AT 1.76 ANGSTROM RESOLUTION","10.1016/J.JBC.2021.100967 ",1.76,0,"7cp5_oligo4","DGlcpa1-3DGlcpb6-C10O1","DMU(101_M_)-DMU(101_M_)",42.7245,"","",""
"7CRF","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH CU-CPD107","10.1038/S41467-021-24536-4 ",2.89,73.45,"7crf_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(590_A_)",79.6069,"","",""
"7CRF","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH CU-CPD107","10.1038/S41467-021-24536-4 ",2.89,73.45,"7crf_oligo7","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_F_)-MAN(6_F_)-[MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(293_B_)",99.0707,"","",""
"7CRF","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH CU-CPD107","10.1038/S41467-021-24536-4 ",2.89,73.45,"7crf_oligo8","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(293_A_)",93.1876,"","",""
"7CRF","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH CU-CPD107","10.1038/S41467-021-24536-4 ",2.89,73.45,"7crf_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(511_B_)",105.909,"","",""
"7CRF","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH CU-CPD107","10.1038/S41467-021-24536-4 ",2.89,73.45,"7crf_oligo5","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-[MAN(5_H_)]-MAN(4_H_)-[MAN(7_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(590_B_)",93.1497,"","",""
"7CU5","N-GLYCOSYLATION OF PD-1 AND GLYCOSYLATION DEPENDENT BINDING OF PD-1 SPECIFIC MONOCLONAL ANTIBODY CAMRELIZUMAB","10.15252/EMBR.202051444 ",2.81,50.7,"7cu5_oligo2","DManpa1-3DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_C_)-[MAN(4_C_)-MAN(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(58_E_)",64.1893,"","",""
"7CYC","CRYO-EM STRUCTURES OF ALPHACORONAVIRUS SPIKE GLYCOPROTEIN","10.1038/S41467-020-20401-Y ",3.21,0,"7cyc_oligo9","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_L_)-MAN(6_L_)-[MAN(5_L_)-MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(62_C_)",294.269,"","",""
"7CYC","CRYO-EM STRUCTURES OF ALPHACORONAVIRUS SPIKE GLYCOPROTEIN","10.1038/S41467-020-20401-Y ",3.21,0,"7cyc_oligo2","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_H_)-MAN(6_H_)-[MAN(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(62_B_)",294.269,"","",""
"7CYC","CRYO-EM STRUCTURES OF ALPHACORONAVIRUS SPIKE GLYCOPROTEIN","10.1038/S41467-020-20401-Y ",3.21,0,"7cyc_oligo8","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_D_)-MAN(6_D_)-[MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(62_A_)",294.269,"","",""
"7CYD","CRYO-EM STRUCTURES OF ALPHACORONAVIRUS SPIKE GLYCOPROTEIN","10.1038/S41467-020-20401-Y ",3.55,0,"7cyd_oligo9","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_D_)-MAN(6_D_)-[MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(62_A_)",318.988,"","",""
"7CYD","CRYO-EM STRUCTURES OF ALPHACORONAVIRUS SPIKE GLYCOPROTEIN","10.1038/S41467-020-20401-Y ",3.55,0,"7cyd_oligo3","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_H_)-MAN(6_H_)-[MAN(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(62_C_)",318.988,"","",""
"7CYD","CRYO-EM STRUCTURES OF ALPHACORONAVIRUS SPIKE GLYCOPROTEIN","10.1038/S41467-020-20401-Y ",3.55,0,"7cyd_oligo1","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_F_)-MAN(6_F_)-[MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(62_B_)",318.988,"","",""
"7CYV","CRYSTAL STRUCTURE OF FD20, A NEUTRALIZING SINGLE-CHAIN VARIABLE FRAGMENT (SCFV) IN COMPLEX WITH SARS-COV-2 SPIKE RECEPTOR-BINDING DOMAIN (RBD)","10.15252/EMMM.202114544 ",3.13,61.91,"7cyv_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcx1-","FUC(5_A_)-[BMA(3_A_)-NAG(2_A_)]-[FUC(4_A_)]-NAG(1_A_)",84.2282,"","",""
"7CZF","CRYSTAL STRUCTURE OF KAPOSI SARCOMA ASSOCIATED HERPESVIRUS (KSHV ) GHGL IN COMPLEX WITH THE LIGAND BINDING DOMIAN (LBD) OF EPHA2","10.1038/S41467-020-19617-9 ",3.2,64.67,"7czf_oligo2","DManpa1-4DManpa1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(6_S_)-[MAN(4_S_)-MAN(3_S_)-NAG(2_S_)]-[FUC(5_S_)]-NAG(1_S_)-ASN(54_E_)",131.373,"","",""
"7D2Z","STRUCTURE OF SYBODY SR31 IN COMPLEX WITH THE SARS-COV-2 S RECEPTOR BINDING DOMAIN (RBD)","10.1371/JOURNAL.PPAT.1009328 ",1.97,49.49,"7d2z_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(7_C_)-[MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-[FUC(6_C_)]-NAG(1_C_)-ASN(343_B_)",85.1643,"","",""
"7D30","STRUCTURE OF SYBODY MR17-SR31 FUSION IN COMPLEX WITH THE SARS-COV-2 S RECEPTOR BINDING DOMAIN (RBD)","10.1371/JOURNAL.PPAT.1009328 ",2.1,50.52,"7d30_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(6_C_)-[MAN(4_C_)-BMA(3_C_)-NAG(2_C_)]-[FUC(5_C_)]-NAG(1_C_)-ASN(343_B_)",80.7715,"","",""
"7D3E","CRYO-EM STRUCTURE OF HUMAN DUOX1-DUOXA1 IN LOW-CALCIUM STATE","10.1038/S41467-020-20466-9 ",2.8,"1.08527e-19","7d3e_oligo9","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_F_)-MAN(8_F_)-[MAN(10_F_)]-MAN(7_F_)-[MAN(6_F_)-MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(109_D_)",92.4529,"","",""
"7D3E","CRYO-EM STRUCTURE OF HUMAN DUOX1-DUOXA1 IN LOW-CALCIUM STATE","10.1038/S41467-020-20466-9 ",2.8,"1.08527e-19","7d3e_oligo8","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_E_)-MAN(8_E_)-[MAN(10_E_)]-MAN(7_E_)-[MAN(6_E_)-MAN(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(109_B_)",92.0688,"","",""
"7D3F","CRYO-EM STRUCTURE OF HUMAN DUOX1-DUOXA1 IN HIGH-CALCIUM STATE","10.1038/S41467-020-20466-9 ",2.3,"1.08527e-19","7d3f_oligo7","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_E_)-MAN(8_E_)-[MAN(10_E_)]-MAN(7_E_)-[MAN(6_E_)-MAN(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(109_B_)",53.1484,"","",""
"7D3F","CRYO-EM STRUCTURE OF HUMAN DUOX1-DUOXA1 IN HIGH-CALCIUM STATE","10.1038/S41467-020-20466-9 ",2.3,"1.08527e-19","7d3f_oligo8","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_F_)-MAN(8_F_)-[MAN(10_F_)]-MAN(7_F_)-[MAN(6_F_)-MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(109_D_)",54.0505,"","",""
"7D4B","CRYSTAL STRUCTURE OF 4-1BB IN COMPLEX WITH A VHH","10.1136/JITC-2020-002131 ",3.14,90.05,"7d4b_oligo1","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_C_)-[MAN(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(138_A_)",159.745,"","",""
"7D5W","BOVINE HEART CYTOCHROME C OXIDASE IN A CATALYTIC INTERMEDIATE OF O AT 1.84 ANGSTROM RESOLUTION","10.1016/J.JBC.2021.100967 ",1.84,0,"7d5w_oligo7","DGlcpa1-3DGlcpb6-C9O1","DMU(317_P_)-DMU(317_P_)",113.35,"","",""
"7D5W","BOVINE HEART CYTOCHROME C OXIDASE IN A CATALYTIC INTERMEDIATE OF O AT 1.84 ANGSTROM RESOLUTION","10.1016/J.JBC.2021.100967 ",1.84,0,"7d5w_oligo8","DGlcpa1-3DGlcpb6-C10O1","DMU(101_M_)-DMU(101_M_)",43.5614,"","",""
"7D5W","BOVINE HEART CYTOCHROME C OXIDASE IN A CATALYTIC INTERMEDIATE OF O AT 1.84 ANGSTROM RESOLUTION","10.1016/J.JBC.2021.100967 ",1.84,0,"7d5w_oligo9","DGlcpa1-3DGlcpb6-C10O1","DMU(308_P_)-DMU(308_P_)",111.212,"","",""
"7D5W","BOVINE HEART CYTOCHROME C OXIDASE IN A CATALYTIC INTERMEDIATE OF O AT 1.84 ANGSTROM RESOLUTION","10.1016/J.JBC.2021.100967 ",1.84,0,"7d5w_oligo3","DGlcpa1-3DGlcpb6-C10O1","DMU(206_D_)-DMU(206_D_)",120.032,"","",""
"7D5W","BOVINE HEART CYTOCHROME C OXIDASE IN A CATALYTIC INTERMEDIATE OF O AT 1.84 ANGSTROM RESOLUTION","10.1016/J.JBC.2021.100967 ",1.84,0,"7d5w_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(101_Z_)-DMU(101_Z_)",51.085,"","",""
"7D5W","BOVINE HEART CYTOCHROME C OXIDASE IN A CATALYTIC INTERMEDIATE OF O AT 1.84 ANGSTROM RESOLUTION","10.1016/J.JBC.2021.100967 ",1.84,0,"7d5w_oligo5","DGlcpa1-3DGlcpb6-C10O1","DMU(310_C_)-DMU(310_C_)",107.862,"","",""
"7D5X","BOVINE HEART CYTOCHROME C OXIDASE IN A CATALYTIC INTERMEDIATE, IO10, AT 1.74 ANGSTROM RESOLUTION","10.1016/J.JBC.2021.100967 ",1.74,0,"7d5x_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(101_Z_)-DMU(101_Z_)",54.115,"","",""
"7D5X","BOVINE HEART CYTOCHROME C OXIDASE IN A CATALYTIC INTERMEDIATE, IO10, AT 1.74 ANGSTROM RESOLUTION","10.1016/J.JBC.2021.100967 ",1.74,0,"7d5x_oligo5","DGlcpa1-3DGlcpb6-C10O1","DMU(101_M_)-DMU(101_M_)",47.0568,"","",""
"7D8X","CRYOEM STRUCTURE OF HUMAN GAMMA-SECRETASE IN COMPLEX WITH E2012 AND L685458","10.1016/J.CELL.2020.11.049 ",2.6,"1.08527e-19","7d8x_oligo4","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_F_)-[BMA(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(55_A_)",51.2158,"","",""
"7DC4","CRYSTAL STRUCTURE OF GLYCAN-BOUND PSEUDOMONAS TAIWANENSIS LECTIN","10.1016/J.JBC.2021.100698 ",0.95,13.42,"7dc4_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-ROH","MAN(4_E_)-[MAN(3_E_)]-MAN(2_E_)-[MAN(5_E_)]-BMA(1_E_)",10.3211,"","",""
"7DC4","CRYSTAL STRUCTURE OF GLYCAN-BOUND PSEUDOMONAS TAIWANENSIS LECTIN","10.1016/J.JBC.2021.100698 ",0.95,13.42,"7dc4_oligo4","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-ROH","MAN(4_F_)-[MAN(3_F_)]-MAN(2_F_)-[MAN(5_F_)]-BMA(1_F_)",20.0651,"","",""
"7DC4","CRYSTAL STRUCTURE OF GLYCAN-BOUND PSEUDOMONAS TAIWANENSIS LECTIN","10.1016/J.JBC.2021.100698 ",0.95,13.42,"7dc4_oligo3","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-ROH","MAN(4_C_)-[MAN(3_C_)]-MAN(2_C_)-[MAN(5_C_)]-BMA(1_C_)",12.1253,"","",""
"7DC4","CRYSTAL STRUCTURE OF GLYCAN-BOUND PSEUDOMONAS TAIWANENSIS LECTIN","10.1016/J.JBC.2021.100698 ",0.95,13.42,"7dc4_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-ROH","MAN(4_D_)-[MAN(3_D_)]-MAN(2_D_)-[MAN(5_D_)]-BMA(1_D_)",11.9224,"","",""
"7DE5","CRYSTAL STRUCTURE OF YAK LACTOPEROXIDASE AT 1.55 A RESOLUTION.","10.1007/S10930-020-09957-2 ",1.55,19.58,"7de5_oligo1","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-MAN(4_B_)-[MAN(6_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(205_A_)",26.693,"","",""
"7DED","MEVO LECTIN COMPLEX WITH MANNOHEPTOSE (MAN7)","10.1093/GLYCOB/CWAB022 ",2.23,19.84,"7ded_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpa1-ROH","MAN(6_I_)-MAN(5_I_)-[MAN(4_I_)-MAN(3_I_)-MAN(2_I_)]-MAN(1_I_)",37.3214,"","",""
"7DED","MEVO LECTIN COMPLEX WITH MANNOHEPTOSE (MAN7)","10.1093/GLYCOB/CWAB022 ",2.23,19.84,"7ded_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpa1-ROH","MAN(6_J_)-MAN(5_J_)-[MAN(4_J_)-MAN(3_J_)-MAN(2_J_)]-MAN(1_J_)",34.8562,"","",""
"7DED","MEVO LECTIN COMPLEX WITH MANNOHEPTOSE (MAN7)","10.1093/GLYCOB/CWAB022 ",2.23,19.84,"7ded_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpa1-ROH","MAN(6_H_)-MAN(5_H_)-[MAN(4_H_)-MAN(3_H_)-MAN(2_H_)]-MAN(1_H_)",31.0248,"","",""
"7DFN","CRYSTAL STRUCTURE OF GLYCOSIDE HYDROLASE FAMILY 11 BETA-XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86 IN COMPLEX WITH ALPHA-L- ARABINOFURANOSYL XYLOTETRAOSE","10.1007/S00253-021-11098-0 ",2,21.72,"7dfn_oligo2","LArafa1-3[DXylpb1-4]DXylpb1-4DXylpb1-4DXylpb1-ROH","XYP(5_F_)-[AHR(4_F_)]-XYP(3_F_)-XYP(2_F_)-XYP(1_F_)",48.3545,"","",""
"7DFN","CRYSTAL STRUCTURE OF GLYCOSIDE HYDROLASE FAMILY 11 BETA-XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86 IN COMPLEX WITH ALPHA-L- ARABINOFURANOSYL XYLOTETRAOSE","10.1007/S00253-021-11098-0 ",2,21.72,"7dfn_oligo1","LArafa1-3[DXylpb1-4]DXylpb1-4DXylpb1-4DXylpb1-ROH","XYP(5_E_)-[AHR(4_E_)]-XYP(3_E_)-XYP(2_E_)-XYP(1_E_)",33.8598,"","",""
"7DFN","CRYSTAL STRUCTURE OF GLYCOSIDE HYDROLASE FAMILY 11 BETA-XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86 IN COMPLEX WITH ALPHA-L- ARABINOFURANOSYL XYLOTETRAOSE","10.1007/S00253-021-11098-0 ",2,21.72,"7dfn_oligo3","LArafa1-3[DXylpb1-4]DXylpb1-4DXylpb1-4DXylpb1-ROH","XYP(5_G_)-[AHR(4_G_)]-XYP(3_G_)-XYP(2_G_)-XYP(1_G_)",44.1633,"","",""
"7DMU","STRUCTURE OF SARS-COV-2 SPIKE RECEPTOR-BINDING DOMAIN COMPLEXED WITH HIGH AFFINITY ACE2 MUTANT 3N39","10.1038/S41467-021-24013-Y ",3.2,135.4,"7dmu_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(546_A_)",230.447,"","",""
"7DMU","STRUCTURE OF SARS-COV-2 SPIKE RECEPTOR-BINDING DOMAIN COMPLEXED WITH HIGH AFFINITY ACE2 MUTANT 3N39","10.1038/S41467-021-24013-Y ",3.2,135.4,"7dmu_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_L_)-[MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(546_C_)",221.167,"","",""
"7DMU","STRUCTURE OF SARS-COV-2 SPIKE RECEPTOR-BINDING DOMAIN COMPLEXED WITH HIGH AFFINITY ACE2 MUTANT 3N39","10.1038/S41467-021-24013-Y ",3.2,135.4,"7dmu_oligo5","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(53_A_)",227.541,"","",""
"7DMU","STRUCTURE OF SARS-COV-2 SPIKE RECEPTOR-BINDING DOMAIN COMPLEXED WITH HIGH AFFINITY ACE2 MUTANT 3N39","10.1038/S41467-021-24013-Y ",3.2,135.4,"7dmu_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(53_C_)",225.217,"","",""
"7DQV","CRYSTAL STRUCTURE OF A CMABCB1 MUTANT","10.1002/PRO.4058 ",2.15,74.32,"7dqv_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(802_A_)-DMU(802_A_)",55.2041,"","",""
"7DQV","CRYSTAL STRUCTURE OF A CMABCB1 MUTANT","10.1002/PRO.4058 ",2.15,74.32,"7dqv_oligo3","DGlcpa1-3DGlcpb6-C10O1","DMU(803_A_)-DMU(803_A_)",96.1318,"","",""
"7DRC","CRYO-EM STRUCTURE OF PLANT RECEPTOR LIKE PROTEIN RXEG1 IN COMPLEX WITH XYLOGLUCANASE XEG1 AND BAK1","10.1038/S41586-022-05214-X ",2.92,865621,"7drc_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(562_C_)",85.8325,"","",""
"7DRC","CRYO-EM STRUCTURE OF PLANT RECEPTOR LIKE PROTEIN RXEG1 IN COMPLEX WITH XYLOGLUCANASE XEG1 AND BAK1","10.1038/S41586-022-05214-X ",2.92,865621,"7drc_oligo1","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-MAN(5_F_)-[MAN(7_F_)]-MAN(4_F_)-[MAN(8_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(143_C_)",75.0117,"","",""
"7E7I","CRYO-EM STRUCTURE OF HUMAN ABCA4 IN THE APO STATE","10.1038/S41467-021-24194-6 ",3.3,"1.15243e-41","7e7i_oligo2","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_M_)-[BMA(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(1529_A_)",51.898,"","",""
"7E7I","CRYO-EM STRUCTURE OF HUMAN ABCA4 IN THE APO STATE","10.1038/S41467-021-24194-6 ",3.3,"1.15243e-41","7e7i_oligo1","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_D_)-[BMA(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(415_A_)",78.2338,"","",""
"7E7O","CRYO-EM STRUCTURE OF HUMAN ABCA4 IN NRPE-BOUND STATE","10.1038/S41467-021-24194-6 ",3.4,"1.15243e-41","7e7o_oligo1","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_E_)-[BMA(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(415_A_)",86.0476,"","",""
"7E7O","CRYO-EM STRUCTURE OF HUMAN ABCA4 IN NRPE-BOUND STATE","10.1038/S41467-021-24194-6 ",3.4,"1.15243e-41","7e7o_oligo2","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_N_)-[BMA(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(1529_A_)",66.4942,"","",""
"7E7Q","CRYO-EM STRUCTURE OF HUMAN ABCA4 IN ATP-BOUND STATE","10.1038/S41467-021-24194-6 ",3.3,"1.15243e-41","7e7q_oligo4","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_M_)-[BMA(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(1529_A_)",83.9967,"","",""
"7E7Q","CRYO-EM STRUCTURE OF HUMAN ABCA4 IN ATP-BOUND STATE","10.1038/S41467-021-24194-6 ",3.3,"1.15243e-41","7e7q_oligo3","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_D_)-[BMA(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(415_A_)",100.188,"","",""
"7EEB","STRUCTURE OF THE CATSPERMASOME","10.1038/S41586-021-03742-6 ",2.9,"1.35632e-19","7eeb_oligo15","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","BMA(5_c_)-[BMA(4_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)",123.991,"","",""
"7EEB","STRUCTURE OF THE CATSPERMASOME","10.1038/S41586-021-03742-6 ",2.9,"1.35632e-19","7eeb_oligo11","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_Y_)-[BMA(4_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(502_H_)",101.864,"","",""
"7EEB","STRUCTURE OF THE CATSPERMASOME","10.1038/S41586-021-03742-6 ",2.9,"1.35632e-19","7eeb_oligo12","DManpb1-3[DManpb1-6]DManpb1-6[DManpb1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","BMA(6_Z_)-[BMA(5_Z_)]-BMA(4_Z_)-[BMA(7_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)",71.1831,"","",""
"7EEB","STRUCTURE OF THE CATSPERMASOME","10.1038/S41586-021-03742-6 ",2.9,"1.35632e-19","7eeb_oligo1","DManpb1-2DManpb1-3[DManpb1-3DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(7_O_)-BMA(6_O_)-[BMA(5_O_)-BMA(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(90_E_)",79.3492,"","",""
"7EEJ","COMPLEX STRUCTURE OF GLYCOSIDE HYDROLASE FAMILY 12 BETA-1,3-1,4- GLUCANASE WITH CELLOBIOSE","10.1016/J.JSB.2021.107774 ",1.48,23.71,"7eej_oligo1","DManpb1-4DManpb1-3DManpb1-4DManpb1-ROH","BMA(4_B_)-BMA(3_B_)-BMA(2_B_)-BMA(1_B_)",28.52,"","",""
"7ENU","CRYSTAL STRUCTURE OF IRON-SATURATED C-TERMINAL HALF OF LACTOFERRIN PRODUCED PROTEOLYTICALLY USING PEPSIN AT 2.32A RESOLUTION","",2.32,70,"7enu_oligo5","DManpa1-3DManpa1-4DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(545_A_)",138.72,"","",""
"7EOX","PROTEASE STRUCTURE FROM EUPHORBIA RESINIFERA","10.1002/BAB.2307 ",1.7,26.67,"7eox_oligo1","DXylpb1-2[DManpa1-3][DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)]-[XYP(4_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(7_C_)]-NAG(1_C_)-ASN(121_B_)",34.8843,"","",""
"7EQT","CRYSTAL STRUCTURE OF CAPSID P DOMAIN OF NOROVIRUS GI.3 DSV COMPLEXED WITH GALA1-3GALB1-4GLC","10.1128/JVI.00420-22 ",2.05,24.66,"7eqt_oligo1","DGalpa1-3DGalpb1-4DGlcpb1-ROH","GLA(3_C_)-GAL(2_C_)-BGC(1_C_)",36.3503,"","",""
"7EQU","CRYSTAL STRUCTURE OF THE C-LOBE OF LACTOFERRIN PRODUCED BY LIMITED PROTEOLYSIS USING PEPSIN AT 2.74A RESOLUTION","",2.74,70,"7equ_oligo6","DManpb1-3DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(476_A_)",155.408,"","",""
"7ER1","CRYSTAL STRUCTURE OF CAPSID P DOMAIN OF NOROVIRUS GI.3 VA115 COMPLEXED WITH GALA1-3GALB1-4GLC","10.1128/JVI.00420-22 ",2.2,24.35,"7er1_oligo1","DGalpa1-3DGalpb1-ROH","GLA(2_E_)-GAL(1_E_)",59.8941,"","",""
"7ESK","CRYSTAL STRUCTURE OF A L-RHAMNOSE-ALPHA-1,4-D-GLUCURONATE LYASE FROM FUSARIUM OXYSPORUM 12S, LIGAND FREE FORM","10.1016/J.JBC.2021.101001 ",1.05,16.02,"7esk_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(247_A_)",27.7291,"","",""
"7ESM","CRYSTAL STRUCTURE OF A L-RHAMNOSE-ALPHA-1,4-D-GLUCURONATE LYASE FROM FUSARIUM OXYSPORUM 12S, L-RHA COMPLEX","10.1016/J.JBC.2021.101001 ",1.4,15.21,"7esm_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(247_A_)",37.3705,"","",""
"7EV7","BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND FULLY REDUCED STATE AT A 50 K","",1.7,40.93,"7ev7_oligo3","DGlcpa1-3DMU6-C10O1","DMU(324_P_)-DMU(324_P_)",133.026,"","",""
"7EV7","BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND FULLY REDUCED STATE AT A 50 K","",1.7,40.93,"7ev7_oligo9","DGlcpa1-3DGlcpb6-C10O1","DMU(319_C_)-DMU(319_C_)",106.989,"","",""
"7EV7","BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND FULLY REDUCED STATE AT A 50 K","",1.7,40.93,"7ev7_oligo10","DGlcpa1-3DGlcpb6-C10O1","DMU(101_Z_)-DMU(101_Z_)",53.7891,"","",""
"7EV7","BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND FULLY REDUCED STATE AT A 50 K","",1.7,40.93,"7ev7_oligo7","DGlcpa1-3DGlcpb6-C10O1","DMU(106_M_)-DMU(106_M_)",111.238,"","",""
"7EV7","BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND FULLY REDUCED STATE AT A 50 K","",1.7,40.93,"7ev7_oligo5","DGlcpa1-3DGlcpb6-C10O1","DMU(101_M_)-DMU(101_M_)",45.3232,"","",""
"7EV7","BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND FULLY REDUCED STATE AT A 50 K","",1.7,40.93,"7ev7_oligo8","DGlcpa1-3DGlcpb6-C10O1","DMU(108_G_)-DMU(108_G_)",139.757,"","",""
"7EV7","BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND FULLY REDUCED STATE AT A 50 K","",1.7,40.93,"7ev7_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(323_P_)-DMU(323_P_)",92.7064,"","",""
"7EV7","BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND FULLY REDUCED STATE AT A 50 K","",1.7,40.93,"7ev7_oligo6","DGlcpa1-3DGlcpb6-C10O1","DMU(310_C_)-DMU(310_C_)",106.468,"","",""
"7EV7","BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND FULLY REDUCED STATE AT A 50 K","",1.7,40.93,"7ev7_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(309_P_)-DMU(309_P_)",118.464,"","",""
"7EV7","BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND FULLY REDUCED STATE AT A 50 K","",1.7,40.93,"7ev7_oligo11","DGlcpa1-3DGlcpb6-C10O1","DMU(102_Z_)-DMU(102_Z_)",107.59,"","",""
"7EV7","BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND FULLY REDUCED STATE AT A 50 K","",1.7,40.93,"7ev7_oligo4","DGlcpa1-3DGlcpb6-C10O1","DMU(102_V_)-DMU(102_V_)",162.076,"","",""
"7EY1","BIFUNCTIONAL XYLOSIDASE/GLUCOSIDASE LXYL WITH INTERMEDIATE SUBSTRATE XYLOSE","",2.46,0,"7ey1_oligo4","DManpa1-2DManpb1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-ROH","MAN(5_G_)-BMA(4_G_)-[MAN(6_G_)]-MAN(3_G_)-[MAN(8_G_)-MAN(7_G_)]-BMA(2_G_)-NAG(1_G_)",43.8794,"","",""
"7EY1","BIFUNCTIONAL XYLOSIDASE/GLUCOSIDASE LXYL WITH INTERMEDIATE SUBSTRATE XYLOSE","",2.46,0,"7ey1_oligo1","DManpa1-2DManpb1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-ROH","MAN(5_E_)-BMA(4_E_)-[MAN(6_E_)]-MAN(3_E_)-[MAN(8_E_)-MAN(7_E_)]-BMA(2_E_)-NAG(1_E_)",50.9472,"","",""
"7EY1","BIFUNCTIONAL XYLOSIDASE/GLUCOSIDASE LXYL WITH INTERMEDIATE SUBSTRATE XYLOSE","",2.46,0,"7ey1_oligo8","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_L_)-MAN(4_L_)-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(272_D_)",51.1962,"","",""
"7EY1","BIFUNCTIONAL XYLOSIDASE/GLUCOSIDASE LXYL WITH INTERMEDIATE SUBSTRATE XYLOSE","",2.46,0,"7ey1_oligo6","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-ROH","MAN(4_J_)-MAN(3_J_)-BMA(2_J_)-NAG(1_J_)",57.9889,"","",""
"7EY2","BIFUNCTIONAL XYLOSIDASE/GLUCOSIDASE LXYL D300N MUTANT WITH INTERMEDIATE SUBSTRATE XYLOSE","",2.43,30.32,"7ey2_oligo31","DManpa1-2DManpb1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-ROH","MAN(7_W_)-MAN(6_W_)-[MAN(5_W_)-BMA(4_W_)]-BMA(3_W_)-NAG(2_W_)",41.5661,"","",""
"7EY2","BIFUNCTIONAL XYLOSIDASE/GLUCOSIDASE LXYL D300N MUTANT WITH INTERMEDIATE SUBSTRATE XYLOSE","",2.43,30.32,"7ey2_oligo17","DManpa1-2DManpb1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-ROH","MAN(7_N_)-MAN(6_N_)-[MAN(5_N_)-BMA(4_N_)]-BMA(3_N_)-NAG(2_N_)",46.8612,"","",""
"7EY2","BIFUNCTIONAL XYLOSIDASE/GLUCOSIDASE LXYL D300N MUTANT WITH INTERMEDIATE SUBSTRATE XYLOSE","",2.43,30.32,"7ey2_oligo32","DManpa1-2DManpa1-2DManpa1-3DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_X_)-MAN(5_X_)-MAN(4_X_)-MAN(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(457_F_)",46.6273,"","",""
"7EY2","BIFUNCTIONAL XYLOSIDASE/GLUCOSIDASE LXYL D300N MUTANT WITH INTERMEDIATE SUBSTRATE XYLOSE","",2.43,30.32,"7ey2_oligo26","DManpa1-2DManpb1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-ROH","MAN(7_T_)-MAN(6_T_)-[MAN(5_T_)-BMA(4_T_)]-BMA(3_T_)-NAG(2_T_)",42.4547,"","",""
"7EY2","BIFUNCTIONAL XYLOSIDASE/GLUCOSIDASE LXYL D300N MUTANT WITH INTERMEDIATE SUBSTRATE XYLOSE","",2.43,30.32,"7ey2_oligo21","DManpa1-2DManpb1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-ROH","MAN(6_Q_)-MAN(5_Q_)-[MAN(4_Q_)-BMA(3_Q_)]-BMA(2_Q_)-NAG(1_Q_)",46.1589,"","",""
"7EY2","BIFUNCTIONAL XYLOSIDASE/GLUCOSIDASE LXYL D300N MUTANT WITH INTERMEDIATE SUBSTRATE XYLOSE","",2.43,30.32,"7ey2_oligo18","DManpa1-2DManpa1-2DManpa1-3DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_O_)-MAN(5_O_)-MAN(4_O_)-MAN(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(457_C_)",59.5877,"","",""
"7EY2","BIFUNCTIONAL XYLOSIDASE/GLUCOSIDASE LXYL D300N MUTANT WITH INTERMEDIATE SUBSTRATE XYLOSE","",2.43,30.32,"7ey2_oligo7","DManpa1-2DManpa1-3DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-MAN(4_I_)-MAN(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(457_A_)",52.5547,"","",""
"7EY2","BIFUNCTIONAL XYLOSIDASE/GLUCOSIDASE LXYL D300N MUTANT WITH INTERMEDIATE SUBSTRATE XYLOSE","",2.43,30.32,"7ey2_oligo22","DManpa1-2DManpa1-3DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_R_)-MAN(4_R_)-MAN(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(457_D_)",48.7438,"","",""
"7EY2","BIFUNCTIONAL XYLOSIDASE/GLUCOSIDASE LXYL D300N MUTANT WITH INTERMEDIATE SUBSTRATE XYLOSE","",2.43,30.32,"7ey2_oligo27","DManpa1-2DManpa1-2DManpa1-3DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_U_)-MAN(5_U_)-MAN(4_U_)-MAN(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(457_E_)",45.2715,"","",""
"7EY2","BIFUNCTIONAL XYLOSIDASE/GLUCOSIDASE LXYL D300N MUTANT WITH INTERMEDIATE SUBSTRATE XYLOSE","",2.43,30.32,"7ey2_oligo13","DManpa1-2DManpa1-2DManpa1-3DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_L_)-MAN(5_L_)-MAN(4_L_)-MAN(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(457_B_)",47.7817,"","",""
"7EY2","BIFUNCTIONAL XYLOSIDASE/GLUCOSIDASE LXYL D300N MUTANT WITH INTERMEDIATE SUBSTRATE XYLOSE","",2.43,30.32,"7ey2_oligo11","DManpa1-2DManpb1-3DManpb1-4DGlcpNAcb1-ROH","MAN(5_K_)-BMA(4_K_)-BMA(3_K_)-NAG(2_K_)",41.9543,"","",""
"7EY2","BIFUNCTIONAL XYLOSIDASE/GLUCOSIDASE LXYL D300N MUTANT WITH INTERMEDIATE SUBSTRATE XYLOSE","",2.43,30.32,"7ey2_oligo5","DManpa1-2DManpb1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-ROH","MAN(7_H_)-MAN(6_H_)-[MAN(5_H_)-BMA(4_H_)]-BMA(3_H_)-NAG(2_H_)",46.2948,"","",""
"7F29","CRYO-EM STRUCTURE OF THE FIBRIL FORMED BY DISACCHARIDE-MODIFIED AMYLOID-BETA(1-42)","10.1021/JACS.1C08607 ",3.1,0,"7f29_oligo5","DGalpb1-3DGalpNAca1-","GAL(2_I_)-X6X(1_I_)",130.9,"","",""
"7F29","CRYO-EM STRUCTURE OF THE FIBRIL FORMED BY DISACCHARIDE-MODIFIED AMYLOID-BETA(1-42)","10.1021/JACS.1C08607 ",3.1,0,"7f29_oligo4","DGalpb1-3DGalpNAca1-","GAL(2_H_)-X6X(1_H_)",132.07,"","",""
"7F29","CRYO-EM STRUCTURE OF THE FIBRIL FORMED BY DISACCHARIDE-MODIFIED AMYLOID-BETA(1-42)","10.1021/JACS.1C08607 ",3.1,0,"7f29_oligo3","DGalpb1-3DGalpNAca1-","GAL(2_L_)-X6X(1_L_)",127.98,"","",""
"7F29","CRYO-EM STRUCTURE OF THE FIBRIL FORMED BY DISACCHARIDE-MODIFIED AMYLOID-BETA(1-42)","10.1021/JACS.1C08607 ",3.1,0,"7f29_oligo2","DGalpb1-3DGalpNAca1-","GAL(2_K_)-X6X(1_K_)",132.28,"","",""
"7F29","CRYO-EM STRUCTURE OF THE FIBRIL FORMED BY DISACCHARIDE-MODIFIED AMYLOID-BETA(1-42)","10.1021/JACS.1C08607 ",3.1,0,"7f29_oligo6","DGalpb1-3DGalpNAca1-","GAL(2_J_)-X6X(1_J_)",130.09,"","",""
"7F29","CRYO-EM STRUCTURE OF THE FIBRIL FORMED BY DISACCHARIDE-MODIFIED AMYLOID-BETA(1-42)","10.1021/JACS.1C08607 ",3.1,0,"7f29_oligo1","DGalpb1-3DGalpNAca1-","GAL(2_G_)-X6X(1_G_)",130.72,"","",""
"7F5G","THE CRYSTAL STRUCTURE OF RBD-NANOBODY COMPLEX, DL4 (SA4)","10.1016/J.IJBIOMAC.2022.04.096 ",1.75,29.19,"7f5g_oligo2","LFucpa1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_F_)-[NAG(3_F_)]-[FUC(2_F_)]-NAG(1_F_)-ASN(343_C_)",69.0868,"","",""
"7F5G","THE CRYSTAL STRUCTURE OF RBD-NANOBODY COMPLEX, DL4 (SA4)","10.1016/J.IJBIOMAC.2022.04.096 ",1.75,29.19,"7f5g_oligo1","LFucpa1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_E_)-[NAG(3_E_)]-[FUC(2_E_)]-NAG(1_E_)-ASN(343_A_)",74.7264,"","",""
"7F5P","A MUTANT OF AN ENZYME FROM VIOLA YEDOENSIS","10.1093/PLCELL/KOAC281 ",1.9,72.89,"7f5p_oligo5","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_F_)-[MAN(4_F_)]-MAN(3_F_)-NAG(2_F_)-NAG(1_F_)",163.025,"","",""
"7F95","BIFUNCTIONAL XYLOSIDASE/GLUCOSIDASE LXYL WITH INTERMEDIATE SUBSTRATE XYLOSE FOR 2 MIN","",2.43,41.66,"7f95_oligo4","DManpa1-2DManpa1-3[DManpa1-3[DManpb1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(8_I_)-[MAN(7_I_)]-MAN(6_I_)-[MAN(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(272_C_)",67.6513,"","",""
"7F95","BIFUNCTIONAL XYLOSIDASE/GLUCOSIDASE LXYL WITH INTERMEDIATE SUBSTRATE XYLOSE FOR 2 MIN","",2.43,41.66,"7f95_oligo6","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-MAN(4_K_)-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(272_D_)",51.5129,"","",""
"7F95","BIFUNCTIONAL XYLOSIDASE/GLUCOSIDASE LXYL WITH INTERMEDIATE SUBSTRATE XYLOSE FOR 2 MIN","",2.43,41.66,"7f95_oligo9","DManpa1-2DManpb1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-ROH","MAN(5_E_)-BMA(4_E_)-[MAN(6_E_)]-MAN(3_E_)-[MAN(8_E_)-MAN(7_E_)]-BMA(2_E_)-NAG(1_E_)",55.8041,"","",""
"7F95","BIFUNCTIONAL XYLOSIDASE/GLUCOSIDASE LXYL WITH INTERMEDIATE SUBSTRATE XYLOSE FOR 2 MIN","",2.43,41.66,"7f95_oligo12","DManpa1-2DManpb1-6[DManpa1-3]DManpa1-6DManp[3<R1>]b1-4DGlcpNAcb1-ROH","MAN(6_G_)-BMA(5_G_)-[MAN(7_G_)]-MAN(4_G_)-BMA(3_G_)-NAG(2_G_)",52.6286,"","",""
"7FAP","STRUCTURE OF VAR2CSA-CSA 3D7","10.1038/S41421-021-00324-8 ",3.4,0,"7fap_oligo1","DGalpNAc[4S]b1-3BDP1-3DGalpNAc[4S]b1-4DGlcpAb1-3DGalpNAc[4S]b1-4DGlcpAb1-3DGalpNAc[4S]b1-4DGlcpAb1-3DGalpNAc[4S]b1-4DGlcpAb1-3DGalpNAc[4S]b1-4DGlcpAb1-ROH","ASG(12_B_)-BDP(11_B_)-ASG(10_B_)-BDP(9_B_)-ASG(8_B_)-BDP(7_B_)-ASG(6_B_)-BDP(5_B_)-ASG(4_B_)-BDP(3_B_)-ASG(2_B_)-BDP(1_B_)",39.2903,"","",""
"7FBP","FXIIA-CMCOFX1 COMPLEX","10.1021/JACS.1C07574 ",1.99,34.81,"7fbp_oligo1","DGlcpNb1-4DGlcpNAcb1-3DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(6_C_)-NAG(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(433_A_)",53.6023,"","",""
"7FH1","STRUCTURE OF THE HUMAN MECKELIN","10.1126/SCIADV.ABJ9748 ",3.34,0,"7fh1_oligo4","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","BMA(5_F_)-[BMA(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)",56.7076,"","",""
"7FH1","STRUCTURE OF THE HUMAN MECKELIN","10.1126/SCIADV.ABJ9748 ",3.34,0,"7fh1_oligo8","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","BMA(5_J_)-[BMA(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)",56.7076,"","",""
"7JG2","SECRETORY IMMUNOGLOBIN A (SIGA)","10.7554/ELIFE.56098 ",3.3,"1.35632e-19","7jg2_oligo1","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(72_E_)",75.5529,"","",""
"7JGZ","PROTOCADHERIN GAMMAC4 EC1-4 CRYSTAL STRUCTURE","10.7554/ELIFE.72416 ",3.51,101.2,"7jgz_oligo1","DManpb1-3DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_B_)-[BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(236_A_)",118.444,"","",""
"7JHK","STRUCTURE OF HUMAN BETA 1,3-N-ACETYLGLUCOSAMINYLTRANSFERASE 2 IN UNLIGANDED FORM","10.1074/JBC.RA120.015306 ",2.34,37.64,"7jhk_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(219_D_)",60.5251,"","",""
"7JHK","STRUCTURE OF HUMAN BETA 1,3-N-ACETYLGLUCOSAMINYLTRANSFERASE 2 IN UNLIGANDED FORM","10.1074/JBC.RA120.015306 ",2.34,37.64,"7jhk_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_H_)-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(219_C_)",67.5182,"","",""
"7JHL","STRUCTURE OF HUMAN BETA 1,3-N-ACETYLGLUCOSAMINYLTRANSFERASE 2 WITH UDP-N-ACETYLGLUCOSAMINE","10.1074/JBC.RA120.015306 ",2.26,39.08,"7jhl_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(219_B_)",63.2807,"","",""
"7JHL","STRUCTURE OF HUMAN BETA 1,3-N-ACETYLGLUCOSAMINYLTRANSFERASE 2 WITH UDP-N-ACETYLGLUCOSAMINE","10.1074/JBC.RA120.015306 ",2.26,39.08,"7jhl_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(219_A_)",56.3267,"","",""
"7JHM","STRUCTURE OF HUMAN BETA 1,3-N-ACETYLGLUCOSAMINYLTRANSFERASE 2 WITH N- ACETYL-LACTOSAMINE","10.1074/JBC.RA120.015306 ",2.19,42.35,"7jhm_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(219_A_)",58.2536,"","",""
"7JHM","STRUCTURE OF HUMAN BETA 1,3-N-ACETYLGLUCOSAMINYLTRANSFERASE 2 WITH N- ACETYL-LACTOSAMINE","10.1074/JBC.RA120.015306 ",2.19,42.35,"7jhm_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(219_B_)",68.9073,"","",""
"7JHN","STRUCTURE OF HUMAN BETA 1,3-N-ACETYLGLUCOSAMINYLTRANSFERASE 2 WITH UDP AND TRISACCHARIDE GLCNAC-BETA1-3GAL-BETA1-4GLCNAC","10.1074/JBC.RA120.015306 ",2.2,38.95,"7jhn_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(219_A_)",66.5064,"","",""
"7JHO","STRUCTURE OF HUMAN BETA 1,3-N-ACETYLGLUCOSAMINYLTRANSFERASE 2 WITH UDP","10.1074/JBC.RA120.015306 ",1.85,25.48,"7jho_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(219_A_)",40.2611,"","",""
"7JHO","STRUCTURE OF HUMAN BETA 1,3-N-ACETYLGLUCOSAMINYLTRANSFERASE 2 WITH UDP","10.1074/JBC.RA120.015306 ",1.85,25.48,"7jho_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(219_B_)",41.1384,"","",""
"7JHO","STRUCTURE OF HUMAN BETA 1,3-N-ACETYLGLUCOSAMINYLTRANSFERASE 2 WITH UDP","10.1074/JBC.RA120.015306 ",1.85,25.48,"7jho_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_E_)-[MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(173_A_)",53.9314,"","",""
"7JHZ","CRYSTAL STRUCTURE OF THE CARBOHYDRATE-BINDING DOMAIN VP8* OF HUMAN P[8] ROTAVIRUS STRAIN BM13851 IN COMPLEX WITH LNDFH I","10.1073/PNAS.2107963118 ",2.68,23.56,"7jhz_oligo1","LFucpa1-2DGalpb1-3[LFucpa1-4]DGlcpNAcb1-3DGalpb1-C6O6","FUC(6_F_)-[FUC(5_F_)-GAL(4_F_)]-NAG(3_F_)-GAL(2_F_)-BGC(1_F_)",37.2251,"","",""
"7JHZ","CRYSTAL STRUCTURE OF THE CARBOHYDRATE-BINDING DOMAIN VP8* OF HUMAN P[8] ROTAVIRUS STRAIN BM13851 IN COMPLEX WITH LNDFH I","10.1073/PNAS.2107963118 ",2.68,23.56,"7jhz_oligo2","LFucpa1-2DGalpb1-3[LFucpa1-4]DGlcpNAcb1-3DGalpb1-ROH","FUC(5_E_)-[FUC(4_E_)-GAL(3_E_)]-NAG(2_E_)-GAL(1_E_)",33.0584,"","",""
"7JIX","MURINE ANTIBODY THAT ENGAGES THE INFLUENZA HEMAGGLUTININ RECEPTOR BINDING SITE","",3.9,91.99,"7jix_oligo1","DManpa1-3DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(91_A_)",136.47,"","",""
"7JPD","CRYSTAL STRUCTURE OF THE TRIMERIC FULL LENGTH MATURE HEMAGGLUTININ FROM INFLUENZA A VIRUS A/FORT MONMOUTH/1/1947","10.1038/S41598-023-33529-W ",2.95,53.38,"7jpd_oligo4","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(89_C_)",60.4015,"","",""
"7JPD","CRYSTAL STRUCTURE OF THE TRIMERIC FULL LENGTH MATURE HEMAGGLUTININ FROM INFLUENZA A VIRUS A/FORT MONMOUTH/1/1947","10.1038/S41598-023-33529-W ",2.95,53.38,"7jpd_oligo8","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-MAN(4_N_)-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(89_E_)",73.3575,"","",""
"7JPD","CRYSTAL STRUCTURE OF THE TRIMERIC FULL LENGTH MATURE HEMAGGLUTININ FROM INFLUENZA A VIRUS A/FORT MONMOUTH/1/1947","10.1038/S41598-023-33529-W ",2.95,53.38,"7jpd_oligo3","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_L_)-MAN(4_L_)-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(89_D_)",55.2749,"","",""
"7JPD","CRYSTAL STRUCTURE OF THE TRIMERIC FULL LENGTH MATURE HEMAGGLUTININ FROM INFLUENZA A VIRUS A/FORT MONMOUTH/1/1947","10.1038/S41598-023-33529-W ",2.95,53.38,"7jpd_oligo10","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_P_)-MAN(4_P_)-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(89_F_)",69.9153,"","",""
"7JPH","CRYSTAL STRUCTURE OF EBOV GLYCOPROTEIN WITH MODIFIED HR1C AND HR2 STALK AT 3.2 A RESOLUTION","10.1038/S41467-021-22867-W ",3.2,93.62,"7jph_oligo1","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(563_B_)",103.019,"","",""
"7JPI","CRYSTAL STRUCTURE OF EBOV GLYCOPROTEIN WITH MODIFIED HR2 STALK AT 2.3A RESOLUTION","10.1038/S41467-021-22867-W ",2.28,58.37,"7jpi_oligo4","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(563_B_)",86.335,"","",""
"7JTV","STRUCTURE OF IMPA FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH AN O- GLYCOPEPTIDE","10.1093/GLYCOB/CWAA095 ",2.45,38.38,"7jtv_oligo1","DGalpb1-3DGalpNAca1-SER","GAL(2_D_)-A2G(1_D_)-SER(8_E_)",77.8032,"","",""
"7JTV","STRUCTURE OF IMPA FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH AN O- GLYCOPEPTIDE","10.1093/GLYCOB/CWAA095 ",2.45,38.38,"7jtv_oligo2","DGalpb1-3DGalpNAca1-SER","GAL(2_G_)-A2G(1_G_)-SER(8_H_)",86.8827,"","",""
"7JWF","CRYSTAL STRUCTURE OF PDGH110B D344N IN COMPLEX WITH ALPHA-(1,3)- GALACTOBIOSE","10.1074/JBC.RA120.015776 ",2.19,34.9,"7jwf_oligo4","DGalpa1-3DGalpb1-ROH","GLA(2_G_)-GAL(1_G_)",30.3495,"","",""
"7JWF","CRYSTAL STRUCTURE OF PDGH110B D344N IN COMPLEX WITH ALPHA-(1,3)- GALACTOBIOSE","10.1074/JBC.RA120.015776 ",2.19,34.9,"7jwf_oligo5","DGalpa1-3DGalpb1-ROH","GLA(2_H_)-GAL(1_H_)",28.7291,"","",""
"7JWF","CRYSTAL STRUCTURE OF PDGH110B D344N IN COMPLEX WITH ALPHA-(1,3)- GALACTOBIOSE","10.1074/JBC.RA120.015776 ",2.19,34.9,"7jwf_oligo2","DGalpa1-3DGalpb1-ROH","GLA(2_F_)-GAL(1_F_)",29.1073,"","",""
"7JWF","CRYSTAL STRUCTURE OF PDGH110B D344N IN COMPLEX WITH ALPHA-(1,3)- GALACTOBIOSE","10.1074/JBC.RA120.015776 ",2.19,34.9,"7jwf_oligo3","DGalpa1-3DGalpb1-ROH","GLA(2_E_)-GAL(1_E_)",31.3836,"","",""
"7K1S","THE N-TERMINUS OF VARICELLA-ZOSTER VIRUS GLYCOPROTEIN B HAS A FUNCTIONAL ROLE IN FUSION.","10.1371/JOURNAL.PPAT.1008961 ",3.9,0,"7k1s_oligo3","DManpa1-3DManpa1-6[DManpa1-3]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-MAN(4_F_)-[MAN(6_F_)]-MAN(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(257_C_)",78.0009,"","",""
"7K1S","THE N-TERMINUS OF VARICELLA-ZOSTER VIRUS GLYCOPROTEIN B HAS A FUNCTIONAL ROLE IN FUSION.","10.1371/JOURNAL.PPAT.1008961 ",3.9,0,"7k1s_oligo1","DManpa1-3DManpa1-6[DManpa1-3]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-MAN(4_D_)-[MAN(6_D_)]-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(257_A_)",71.7453,"","",""
"7K1S","THE N-TERMINUS OF VARICELLA-ZOSTER VIRUS GLYCOPROTEIN B HAS A FUNCTIONAL ROLE IN FUSION.","10.1371/JOURNAL.PPAT.1008961 ",3.9,0,"7k1s_oligo2","DManpa1-3DManpa1-6[DManpa1-3]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-MAN(4_E_)-[MAN(6_E_)]-MAN(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(257_B_)",77.6248,"","",""
"7K37","STRUCTURE OF FULL-LENGTH INFLUENZA HA WITH A HEAD-BINDING ANTIBODY AT PH 7.8","10.1371/JOURNAL.PPAT.1009062 ",2.8,"2.14959e+09","7k37_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Q_)-[MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(165_C_)",71.6964,"","",""
"7K37","STRUCTURE OF FULL-LENGTH INFLUENZA HA WITH A HEAD-BINDING ANTIBODY AT PH 7.8","10.1371/JOURNAL.PPAT.1009062 ",2.8,"2.14959e+09","7k37_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_T_)-[MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(165_E_)",74.3116,"","",""
"7K37","STRUCTURE OF FULL-LENGTH INFLUENZA HA WITH A HEAD-BINDING ANTIBODY AT PH 7.8","10.1371/JOURNAL.PPAT.1009062 ",2.8,"2.14959e+09","7k37_oligo6","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_R_)-MAN(5_R_)-[MAN(7_R_)]-MAN(4_R_)-[MAN(8_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(285_C_)",68.9558,"","",""
"7K37","STRUCTURE OF FULL-LENGTH INFLUENZA HA WITH A HEAD-BINDING ANTIBODY AT PH 7.8","10.1371/JOURNAL.PPAT.1009062 ",2.8,"2.14959e+09","7k37_oligo3","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_O_)-MAN(5_O_)-[MAN(7_O_)]-MAN(4_O_)-[MAN(8_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(285_A_)",71.8993,"","",""
"7K37","STRUCTURE OF FULL-LENGTH INFLUENZA HA WITH A HEAD-BINDING ANTIBODY AT PH 7.8","10.1371/JOURNAL.PPAT.1009062 ",2.8,"2.14959e+09","7k37_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(165_A_)",72.6102,"","",""
"7K37","STRUCTURE OF FULL-LENGTH INFLUENZA HA WITH A HEAD-BINDING ANTIBODY AT PH 7.8","10.1371/JOURNAL.PPAT.1009062 ",2.8,"2.14959e+09","7k37_oligo9","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_U_)-MAN(5_U_)-[MAN(7_U_)]-MAN(4_U_)-[MAN(8_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(285_E_)",70.747,"","",""
"7K39","STRUCTURE OF FULL-LENGTH INFLUENZA HA WITH A HEAD-BINDING ANTIBODY AT PH 5.2, CONFORMATION A, NEUTRAL PH-LIKE","10.1371/JOURNAL.PPAT.1009062 ",3,"2.14959e+09","7k39_oligo9","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_U_)-MAN(5_U_)-[MAN(7_U_)]-MAN(4_U_)-[MAN(8_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(285_E_)",70.747,"","",""
"7K39","STRUCTURE OF FULL-LENGTH INFLUENZA HA WITH A HEAD-BINDING ANTIBODY AT PH 5.2, CONFORMATION A, NEUTRAL PH-LIKE","10.1371/JOURNAL.PPAT.1009062 ",3,"2.14959e+09","7k39_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(165_A_)",72.6102,"","",""
"7K39","STRUCTURE OF FULL-LENGTH INFLUENZA HA WITH A HEAD-BINDING ANTIBODY AT PH 5.2, CONFORMATION A, NEUTRAL PH-LIKE","10.1371/JOURNAL.PPAT.1009062 ",3,"2.14959e+09","7k39_oligo6","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_R_)-MAN(5_R_)-[MAN(7_R_)]-MAN(4_R_)-[MAN(8_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(285_C_)",68.9558,"","",""
"7K39","STRUCTURE OF FULL-LENGTH INFLUENZA HA WITH A HEAD-BINDING ANTIBODY AT PH 5.2, CONFORMATION A, NEUTRAL PH-LIKE","10.1371/JOURNAL.PPAT.1009062 ",3,"2.14959e+09","7k39_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_T_)-[MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(165_E_)",74.3116,"","",""
"7K39","STRUCTURE OF FULL-LENGTH INFLUENZA HA WITH A HEAD-BINDING ANTIBODY AT PH 5.2, CONFORMATION A, NEUTRAL PH-LIKE","10.1371/JOURNAL.PPAT.1009062 ",3,"2.14959e+09","7k39_oligo3","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_O_)-MAN(5_O_)-[MAN(7_O_)]-MAN(4_O_)-[MAN(8_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(285_A_)",71.8993,"","",""
"7K39","STRUCTURE OF FULL-LENGTH INFLUENZA HA WITH A HEAD-BINDING ANTIBODY AT PH 5.2, CONFORMATION A, NEUTRAL PH-LIKE","10.1371/JOURNAL.PPAT.1009062 ",3,"2.14959e+09","7k39_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Q_)-[MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(165_C_)",71.6964,"","",""
"7K3A","STRUCTURE OF FULL-LENGTH INFLUENZA HA WITH A HEAD-BINDING ANTIBODY AT PH 5.2, CONFORMATION B, FUSION PEPTIDE RELEASE","10.1371/JOURNAL.PPAT.1009062 ",4.2,"2.14959e+09","7k3a_oligo3","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_O_)-MAN(5_O_)-[MAN(7_O_)]-MAN(4_O_)-[MAN(8_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(285_A_)",71.8993,"","",""
"7K3A","STRUCTURE OF FULL-LENGTH INFLUENZA HA WITH A HEAD-BINDING ANTIBODY AT PH 5.2, CONFORMATION B, FUSION PEPTIDE RELEASE","10.1371/JOURNAL.PPAT.1009062 ",4.2,"2.14959e+09","7k3a_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(165_A_)",72.6102,"","",""
"7K3A","STRUCTURE OF FULL-LENGTH INFLUENZA HA WITH A HEAD-BINDING ANTIBODY AT PH 5.2, CONFORMATION B, FUSION PEPTIDE RELEASE","10.1371/JOURNAL.PPAT.1009062 ",4.2,"2.14959e+09","7k3a_oligo6","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_R_)-MAN(5_R_)-[MAN(7_R_)]-MAN(4_R_)-[MAN(8_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(285_C_)",68.9558,"","",""
"7K3A","STRUCTURE OF FULL-LENGTH INFLUENZA HA WITH A HEAD-BINDING ANTIBODY AT PH 5.2, CONFORMATION B, FUSION PEPTIDE RELEASE","10.1371/JOURNAL.PPAT.1009062 ",4.2,"2.14959e+09","7k3a_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Q_)-[MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(165_C_)",71.6964,"","",""
"7K3A","STRUCTURE OF FULL-LENGTH INFLUENZA HA WITH A HEAD-BINDING ANTIBODY AT PH 5.2, CONFORMATION B, FUSION PEPTIDE RELEASE","10.1371/JOURNAL.PPAT.1009062 ",4.2,"2.14959e+09","7k3a_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_T_)-[MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(165_E_)",74.3116,"","",""
"7K3A","STRUCTURE OF FULL-LENGTH INFLUENZA HA WITH A HEAD-BINDING ANTIBODY AT PH 5.2, CONFORMATION B, FUSION PEPTIDE RELEASE","10.1371/JOURNAL.PPAT.1009062 ",4.2,"2.14959e+09","7k3a_oligo9","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_U_)-MAN(5_U_)-[MAN(7_U_)]-MAN(4_U_)-[MAN(8_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(285_E_)",70.747,"","",""
"7K3B","STRUCTURE OF FULL-LENGTH INFLUENZA HA WITH A HEAD-BINDING ANTIBODY AT PH 5.2, CONFORMATION C, CENTRAL HELICES SPLAY","10.1371/JOURNAL.PPAT.1009062 ",3.4,"2.14959e+09","7k3b_oligo6","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_R_)-MAN(5_R_)-[MAN(7_R_)]-MAN(4_R_)-[MAN(8_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(285_C_)",68.9558,"","",""
"7K3B","STRUCTURE OF FULL-LENGTH INFLUENZA HA WITH A HEAD-BINDING ANTIBODY AT PH 5.2, CONFORMATION C, CENTRAL HELICES SPLAY","10.1371/JOURNAL.PPAT.1009062 ",3.4,"2.14959e+09","7k3b_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Q_)-[MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(165_C_)",71.6964,"","",""
"7K3B","STRUCTURE OF FULL-LENGTH INFLUENZA HA WITH A HEAD-BINDING ANTIBODY AT PH 5.2, CONFORMATION C, CENTRAL HELICES SPLAY","10.1371/JOURNAL.PPAT.1009062 ",3.4,"2.14959e+09","7k3b_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(165_A_)",72.6102,"","",""
"7K3B","STRUCTURE OF FULL-LENGTH INFLUENZA HA WITH A HEAD-BINDING ANTIBODY AT PH 5.2, CONFORMATION C, CENTRAL HELICES SPLAY","10.1371/JOURNAL.PPAT.1009062 ",3.4,"2.14959e+09","7k3b_oligo9","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_U_)-MAN(5_U_)-[MAN(7_U_)]-MAN(4_U_)-[MAN(8_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(285_E_)",70.747,"","",""
"7K3B","STRUCTURE OF FULL-LENGTH INFLUENZA HA WITH A HEAD-BINDING ANTIBODY AT PH 5.2, CONFORMATION C, CENTRAL HELICES SPLAY","10.1371/JOURNAL.PPAT.1009062 ",3.4,"2.14959e+09","7k3b_oligo2","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_O_)-MAN(5_O_)-[MAN(7_O_)]-MAN(4_O_)-[MAN(8_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(285_A_)",71.8993,"","",""
"7K3B","STRUCTURE OF FULL-LENGTH INFLUENZA HA WITH A HEAD-BINDING ANTIBODY AT PH 5.2, CONFORMATION C, CENTRAL HELICES SPLAY","10.1371/JOURNAL.PPAT.1009062 ",3.4,"2.14959e+09","7k3b_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_T_)-[MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(165_E_)",74.3116,"","",""
"7K4O","TANNIN ACYL HYDROLASE FROM ASPERGILLUS NIGER","10.1107/S2059798320016484 ",1.65,30.72,"7k4o_oligo2","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(79_A_)",58.5002,"","",""
"7K4O","TANNIN ACYL HYDROLASE FROM ASPERGILLUS NIGER","10.1107/S2059798320016484 ",1.65,30.72,"7k4o_oligo1","DManpa1-2DManpa1-6[DRhapa1-3]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-MAN(5_B_)-[MAN(7_B_)]-MAN(4_B_)-[MAN(8_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(519_A_)",55.4916,"","",""
"7K66","STRUCTURE OF BLOOD COAGULATION FACTOR VIII IN COMPLEX WITH AN ANTI-C1 DOMAIN PATHOGENIC ANTIBODY INHIBITOR","10.1182/BLOOD.2020008940 ",3.92,148.5,"7k66_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcp[2<R1>]b1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(2118_A_)",178.032,"","",""
"7K8Z","STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C135","10.1038/S41586-020-2852-1 ",3.5,2050.01,"7k8z_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_K_)-[MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(343_A_)",174.233,"","",""
"7KBK","RICIN BOUND TO VHH ANTIBODY V6E11","10.1016/J.JMB.2021.167086 ",2.09,35.53,"7kbk_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","BMA(3_D_)-NAG(2_D_)-[FUC(4_D_)]-NAG(1_D_)-ASN(10_A_)",70.5564,"","",""
"7KC1","CRYO-EM STRUCTURE OF SRR2899884.46167H+MEDI8852L FAB IN COMPLEX WITH VICTORIA HA","10.3389/FIMMU.2021.662909 ",3.41,"5.37397e+08","7kc1_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_V_)-[MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(165_G_)",102.047,"","",""
"7KC1","CRYO-EM STRUCTURE OF SRR2899884.46167H+MEDI8852L FAB IN COMPLEX WITH VICTORIA HA","10.3389/FIMMU.2021.662909 ",3.41,"5.37397e+08","7kc1_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Q_)-[MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(38_C_)",123.048,"","",""
"7KC1","CRYO-EM STRUCTURE OF SRR2899884.46167H+MEDI8852L FAB IN COMPLEX WITH VICTORIA HA","10.3389/FIMMU.2021.662909 ",3.41,"5.37397e+08","7kc1_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(246_A_)",114.094,"","",""
"7KC1","CRYO-EM STRUCTURE OF SRR2899884.46167H+MEDI8852L FAB IN COMPLEX WITH VICTORIA HA","10.3389/FIMMU.2021.662909 ",3.41,"5.37397e+08","7kc1_oligo11","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_W_)-[MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(246_G_)",114.99,"","",""
"7KC1","CRYO-EM STRUCTURE OF SRR2899884.46167H+MEDI8852L FAB IN COMPLEX WITH VICTORIA HA","10.3389/FIMMU.2021.662909 ",3.41,"5.37397e+08","7kc1_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_U_)-[MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(38_G_)",125.914,"","",""
"7KC1","CRYO-EM STRUCTURE OF SRR2899884.46167H+MEDI8852L FAB IN COMPLEX WITH VICTORIA HA","10.3389/FIMMU.2021.662909 ",3.41,"5.37397e+08","7kc1_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_R_)-[MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(165_C_)",99.792,"","",""
"7KC1","CRYO-EM STRUCTURE OF SRR2899884.46167H+MEDI8852L FAB IN COMPLEX WITH VICTORIA HA","10.3389/FIMMU.2021.662909 ",3.41,"5.37397e+08","7kc1_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(38_A_)",121.149,"","",""
"7KC1","CRYO-EM STRUCTURE OF SRR2899884.46167H+MEDI8852L FAB IN COMPLEX WITH VICTORIA HA","10.3389/FIMMU.2021.662909 ",3.41,"5.37397e+08","7kc1_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(246_C_)",116.46,"","",""
"7KC1","CRYO-EM STRUCTURE OF SRR2899884.46167H+MEDI8852L FAB IN COMPLEX WITH VICTORIA HA","10.3389/FIMMU.2021.662909 ",3.41,"5.37397e+08","7kc1_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(165_A_)",102.764,"","",""
"7KC4","HUMAN WLS IN COMPLEX WITH WNT8A","10.1016/J.CELL.2020.11.038 ",3.19,"1.35632e-19","7kc4_oligo1","DManpa1-3DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(103_D_)",62.9036,"","",""
"7KC9","RICIN BOUND TO VHH ANTIBODY V5G1","10.1016/J.JMB.2021.167086 ",2.3,40.92,"7kc9_oligo4","LFucpa1-3DGlcpNAcb1-ASN","FUC(2_J_)-NAG(1_J_)-ASN(10_D_)",64.4464,"","",""
"7KC9","RICIN BOUND TO VHH ANTIBODY V5G1","10.1016/J.JMB.2021.167086 ",2.3,40.92,"7kc9_oligo1","LFucpa1-3DGlcpNAcb1-ASN","FUC(2_G_)-NAG(1_G_)-ASN(10_A_)",66.5573,"","",""
"7KCZ","CRYSTAL STRUCTURE OF RHESUS MACAQUE (MACACA MULATTA) IGG1 FC FRAGMENT- FC-GAMMA RECEPTOR III COMPLEX V158 MUTANT","10.3389/FIMMU.2022.960411 ",3.15,0,"7kcz_oligo5","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_K_)-[NAG(7_K_)-MAN(6_K_)-[NAG(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(297_E_)",82.9721,"","",""
"7KCZ","CRYSTAL STRUCTURE OF RHESUS MACAQUE (MACACA MULATTA) IGG1 FC FRAGMENT- FC-GAMMA RECEPTOR III COMPLEX V158 MUTANT","10.3389/FIMMU.2022.960411 ",3.15,0,"7kcz_oligo4","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_G_)-[NAG(7_G_)-MAN(6_G_)-[NAG(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(297_A_)",78.367,"","",""
"7KCZ","CRYSTAL STRUCTURE OF RHESUS MACAQUE (MACACA MULATTA) IGG1 FC FRAGMENT- FC-GAMMA RECEPTOR III COMPLEX V158 MUTANT","10.3389/FIMMU.2022.960411 ",3.15,0,"7kcz_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_J_)-[NAG(7_J_)-MAN(6_J_)-[NAG(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)]-NAG(1_J_)-ASN(297_D_)",80.854,"","",""
"7KCZ","CRYSTAL STRUCTURE OF RHESUS MACAQUE (MACACA MULATTA) IGG1 FC FRAGMENT- FC-GAMMA RECEPTOR III COMPLEX V158 MUTANT","10.3389/FIMMU.2022.960411 ",3.15,0,"7kcz_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(45_C_)",71.6702,"","",""
"7KCZ","CRYSTAL STRUCTURE OF RHESUS MACAQUE (MACACA MULATTA) IGG1 FC FRAGMENT- FC-GAMMA RECEPTOR III COMPLEX V158 MUTANT","10.3389/FIMMU.2022.960411 ",3.15,0,"7kcz_oligo3","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_H_)-[NAG(7_H_)-MAN(6_H_)-[NAG(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)]-NAG(1_H_)-ASN(297_B_)",66.2085,"","",""
"7KD0","RICIN BOUND TO VHH ANTIBODY V2C11","10.1016/J.JMB.2021.167086 ",2.77,43.39,"7kd0_oligo1","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_D_)-[FUC(2_D_)]-NAG(1_D_)-ASN(10_A_)",83.6176,"","",""
"7KD2","RICIN BOUND TO VHH ANTIBODY V11B2","10.1016/J.JMB.2021.167086 ",2.55,52.59,"7kd2_oligo1","LFucpa1-3DGlcpNAcb1-ASN","FUC(2_D_)-NAG(1_D_)-ASN(10_A_)",86.5095,"","",""
"7KDE","BG505 SOSIP.664 IN COMPLEX WITH THE V3-TARGETING RHESUS MACAQUE ANTIBODY 1485 AND HUMAN GP120-GP41 INTERFACE ANTIBODY 8ANC195","10.7554/ELIFE.61991 ",3.55,"1.08527e-19","7kde_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_W_)-[MAN(8_W_)]-MAN(7_W_)-[MAN(6_W_)-MAN(5_W_)-MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(234_E_)",62.951,"","",""
"7KDE","BG505 SOSIP.664 IN COMPLEX WITH THE V3-TARGETING RHESUS MACAQUE ANTIBODY 1485 AND HUMAN GP120-GP41 INTERFACE ANTIBODY 8ANC195","10.7554/ELIFE.61991 ",3.55,"1.08527e-19","7kde_oligo20","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_l_)-[MAN(4_l_)]-BMA(3_l_)-NAG(2_l_)-NAG(1_l_)-ASN(276_G_)",77.2333,"","",""
"7KDE","BG505 SOSIP.664 IN COMPLEX WITH THE V3-TARGETING RHESUS MACAQUE ANTIBODY 1485 AND HUMAN GP120-GP41 INTERFACE ANTIBODY 8ANC195","10.7554/ELIFE.61991 ",3.55,"1.08527e-19","7kde_oligo7","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_b_)-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(156_F_)",80.068,"","",""
"7KDE","BG505 SOSIP.664 IN COMPLEX WITH THE V3-TARGETING RHESUS MACAQUE ANTIBODY 1485 AND HUMAN GP120-GP41 INTERFACE ANTIBODY 8ANC195","10.7554/ELIFE.61991 ",3.55,"1.08527e-19","7kde_oligo18","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_j_)-[MAN(7_j_)]-MAN(6_j_)-[MAN(5_j_)-MAN(4_j_)]-BMA(3_j_)-NAG(2_j_)-NAG(1_j_)-ASN(234_G_)",53.2753,"","",""
"7KDE","BG505 SOSIP.664 IN COMPLEX WITH THE V3-TARGETING RHESUS MACAQUE ANTIBODY 1485 AND HUMAN GP120-GP41 INTERFACE ANTIBODY 8ANC195","10.7554/ELIFE.61991 ",3.55,"1.08527e-19","7kde_oligo13","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_e_)-[MAN(4_e_)]-BMA(3_e_)-NAG(2_e_)-NAG(1_e_)-ASN(276_F_)",83.0309,"","",""
"7KDE","BG505 SOSIP.664 IN COMPLEX WITH THE V3-TARGETING RHESUS MACAQUE ANTIBODY 1485 AND HUMAN GP120-GP41 INTERFACE ANTIBODY 8ANC195","10.7554/ELIFE.61991 ",3.55,"1.08527e-19","7kde_oligo11","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_V_)-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(156_E_)",89.2984,"","",""
"7KDE","BG505 SOSIP.664 IN COMPLEX WITH THE V3-TARGETING RHESUS MACAQUE ANTIBODY 1485 AND HUMAN GP120-GP41 INTERFACE ANTIBODY 8ANC195","10.7554/ELIFE.61991 ",3.55,"1.08527e-19","7kde_oligo22","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_n_)-[MAN(5_n_)-MAN(4_n_)]-BMA(3_n_)-NAG(2_n_)-NAG(1_n_)-ASN(332_G_)",60.4424,"","",""
"7KDE","BG505 SOSIP.664 IN COMPLEX WITH THE V3-TARGETING RHESUS MACAQUE ANTIBODY 1485 AND HUMAN GP120-GP41 INTERFACE ANTIBODY 8ANC195","10.7554/ELIFE.61991 ",3.55,"1.08527e-19","7kde_oligo17","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_i_)-[MAN(4_i_)]-BMA(3_i_)-NAG(2_i_)-NAG(1_i_)-ASN(156_G_)",88.7475,"","",""
"7KDE","BG505 SOSIP.664 IN COMPLEX WITH THE V3-TARGETING RHESUS MACAQUE ANTIBODY 1485 AND HUMAN GP120-GP41 INTERFACE ANTIBODY 8ANC195","10.7554/ELIFE.61991 ",3.55,"1.08527e-19","7kde_oligo5","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_Z_)-[MAN(6_Z_)-MAN(5_Z_)-MAN(4_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(332_E_)",71.531,"","",""
"7KDE","BG505 SOSIP.664 IN COMPLEX WITH THE V3-TARGETING RHESUS MACAQUE ANTIBODY 1485 AND HUMAN GP120-GP41 INTERFACE ANTIBODY 8ANC195","10.7554/ELIFE.61991 ",3.55,"1.08527e-19","7kde_oligo14","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_f_)-[MAN(6_f_)-MAN(5_f_)-MAN(4_f_)]-BMA(3_f_)-NAG(2_f_)-NAG(1_f_)-ASN(332_F_)",70.2755,"","",""
"7KDE","BG505 SOSIP.664 IN COMPLEX WITH THE V3-TARGETING RHESUS MACAQUE ANTIBODY 1485 AND HUMAN GP120-GP41 INTERFACE ANTIBODY 8ANC195","10.7554/ELIFE.61991 ",3.55,"1.08527e-19","7kde_oligo8","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_c_)-[MAN(7_c_)]-MAN(6_c_)-[MAN(5_c_)-MAN(4_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(234_F_)",62.1509,"","",""
"7KDM","RICIN BOUND TO VHH ANTIBODY V5G6","10.1016/J.JMB.2021.167086 ",2.3,40.92,"7kdm_oligo4","LFucpa1-3DGlcpNAcb1-ASN","FUC(2_J_)-NAG(1_J_)-ASN(10_D_)",64.4464,"","",""
"7KDM","RICIN BOUND TO VHH ANTIBODY V5G6","10.1016/J.JMB.2021.167086 ",2.3,40.92,"7kdm_oligo1","LFucpa1-3DGlcpNAcb1-ASN","FUC(2_G_)-NAG(1_G_)-ASN(10_A_)",66.5573,"","",""
"7KDU","RICIN BOUND TO VHH ANTIBODY V5E4","10.1016/J.JMB.2021.167086 ",2.81,79.98,"7kdu_oligo1","LFucpa1-3DGlcpNAcb1-ASN","FUC(2_D_)-NAG(1_D_)-ASN(10_A_)",90.5364,"","",""
"7KEJ","BDBV-289 BOUND TO EBOV GPDMUC MAKONA","10.1016/J.CELREP.2021.108984 ",3.8,"1.08527e-19","7kej_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(563_E_)",72.2302,"","",""
"7KEJ","BDBV-289 BOUND TO EBOV GPDMUC MAKONA","10.1016/J.CELREP.2021.108984 ",3.8,"1.08527e-19","7kej_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(563_F_)",72.2302,"","",""
"7KEJ","BDBV-289 BOUND TO EBOV GPDMUC MAKONA","10.1016/J.CELREP.2021.108984 ",3.8,"1.08527e-19","7kej_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(563_D_)",72.2302,"","",""
"7KEW","BUNDIBUGYO VIRUS GP (MUCIN DELETED) BOUND TO ANTIBODY FAB BDBV-43","10.1016/J.CELREP.2021.108984 ",4.16,"3.35873e+07","7kew_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_R_)-[MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(563_F_)",122.909,"","",""
"7KEW","BUNDIBUGYO VIRUS GP (MUCIN DELETED) BOUND TO ANTIBODY FAB BDBV-43","10.1016/J.CELREP.2021.108984 ",4.16,"3.35873e+07","7kew_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_P_)-[MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(563_E_)",122.909,"","",""
"7KEW","BUNDIBUGYO VIRUS GP (MUCIN DELETED) BOUND TO ANTIBODY FAB BDBV-43","10.1016/J.CELREP.2021.108984 ",4.16,"3.35873e+07","7kew_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(563_D_)",122.909,"","",""
"7KF9","EBOLA VIRUS GP (MUCIN DELETED, MAKONA STRAIN) BOUND TO ANTIBODY FAB EBOV-296 AND EBOV-515","10.1016/J.CELREP.2021.108984 ",4.4,"5.37397e+08","7kf9_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(563_E_)",246.137,"","",""
"7KF9","EBOLA VIRUS GP (MUCIN DELETED, MAKONA STRAIN) BOUND TO ANTIBODY FAB EBOV-296 AND EBOV-515","10.1016/J.CELREP.2021.108984 ",4.4,"5.37397e+08","7kf9_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(563_D_)",246.137,"","",""
"7KF9","EBOLA VIRUS GP (MUCIN DELETED, MAKONA STRAIN) BOUND TO ANTIBODY FAB EBOV-296 AND EBOV-515","10.1016/J.CELREP.2021.108984 ",4.4,"5.37397e+08","7kf9_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(563_F_)",246.137,"","",""
"7KFB","EBOLA VIRUS GP (MUCIN DELETED, MAKONA STRAIN) BOUND TO ANTIBODY FAB EBOV-442","10.1016/J.CELREP.2021.108984 ",3.9,"5.37397e+08","7kfb_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(257_C_)",179.001,"","",""
"7KFB","EBOLA VIRUS GP (MUCIN DELETED, MAKONA STRAIN) BOUND TO ANTIBODY FAB EBOV-442","10.1016/J.CELREP.2021.108984 ",3.9,"5.37397e+08","7kfb_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_P_)-[MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(257_B_)",179.001,"","",""
"7KFB","EBOLA VIRUS GP (MUCIN DELETED, MAKONA STRAIN) BOUND TO ANTIBODY FAB EBOV-442","10.1016/J.CELREP.2021.108984 ",3.9,"5.37397e+08","7kfb_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_R_)-[MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(563_E_)",90.586,"","",""
"7KFB","EBOLA VIRUS GP (MUCIN DELETED, MAKONA STRAIN) BOUND TO ANTIBODY FAB EBOV-442","10.1016/J.CELREP.2021.108984 ",3.9,"5.37397e+08","7kfb_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(563_D_)",90.586,"","",""
"7KFB","EBOLA VIRUS GP (MUCIN DELETED, MAKONA STRAIN) BOUND TO ANTIBODY FAB EBOV-442","10.1016/J.CELREP.2021.108984 ",3.9,"5.37397e+08","7kfb_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(257_A_)",179.001,"","",""
"7KFB","EBOLA VIRUS GP (MUCIN DELETED, MAKONA STRAIN) BOUND TO ANTIBODY FAB EBOV-442","10.1016/J.CELREP.2021.108984 ",3.9,"5.37397e+08","7kfb_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_U_)-[MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(563_F_)",90.586,"","",""
"7KFE","BUNDIBUGYO VIRUS GP (MUCIN DELETED) BOUND TO ANTIBODY FAB BDBV-329","10.1016/J.CELREP.2021.108984 ",6.6,"3.35873e+07","7kfe_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(563_D_)",208.957,"","",""
"7KFE","BUNDIBUGYO VIRUS GP (MUCIN DELETED) BOUND TO ANTIBODY FAB BDBV-329","10.1016/J.CELREP.2021.108984 ",6.6,"3.35873e+07","7kfe_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(563_F_)",173.646,"","",""
"7KFE","BUNDIBUGYO VIRUS GP (MUCIN DELETED) BOUND TO ANTIBODY FAB BDBV-329","10.1016/J.CELREP.2021.108984 ",6.6,"3.35873e+07","7kfe_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(563_E_)",187.963,"","",""
"7KFH","EBOLA VIRUS GP (MUCIN DELETED, MAKONA STRAIN) BOUND TO ANTIBODY FAB EBOV-437","10.1016/J.CELREP.2021.108984 ",3.8,"5.37397e+08","7kfh_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_R_)-[MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(563_F_)",98.392,"","",""
"7KFH","EBOLA VIRUS GP (MUCIN DELETED, MAKONA STRAIN) BOUND TO ANTIBODY FAB EBOV-437","10.1016/J.CELREP.2021.108984 ",3.8,"5.37397e+08","7kfh_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(563_D_)",98.392,"","",""
"7KFH","EBOLA VIRUS GP (MUCIN DELETED, MAKONA STRAIN) BOUND TO ANTIBODY FAB EBOV-437","10.1016/J.CELREP.2021.108984 ",3.8,"5.37397e+08","7kfh_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_P_)-[MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(563_E_)",98.392,"","",""
"7KHR","CRYO-EM STRUCTURE OF BAFILOMYCIN A1-BOUND INTACT V-ATPASE FROM BOVINE BRAIN","10.1038/S41467-021-22111-5 ",3.62,"1.35632e-19","7khr_oligo14","DGlcpa1-2DGlcpa1-3DGlcpa1-3DManpa1-2DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(2_Q_)-MAN(1_Q_)-[GLC(9_t_)-GLC(8_t_)-GLC(7_t_)-MAN(6_t_)-MAN(5_t_)-MAN(4_t_)]-BMA(3_t_)-NAG(2_t_)-NAG(1_t_)",99.5183,"","",""
"7KHU","CRYSTAL STRUCTURE OF THE CARBOHYDRATE-BINDING DOMAIN VP8* OF HUMAN P[4] ROTAVIRUS STRAIN BM5265 IN COMPLEX WITH LNDFH I","10.1073/PNAS.2107963118 ",2.54,25.95,"7khu_oligo2","LFucpa1-2DGalpb1-3[LFucpa1-4]DGlcpNAcb1-3DGalpb1-4DGlcpb1-ROH","FUC(6_E_)-[FUC(5_E_)-GAL(4_E_)]-NAG(3_E_)-GAL(2_E_)-BGC(1_E_)",25.5474,"","",""
"7KHU","CRYSTAL STRUCTURE OF THE CARBOHYDRATE-BINDING DOMAIN VP8* OF HUMAN P[4] ROTAVIRUS STRAIN BM5265 IN COMPLEX WITH LNDFH I","10.1073/PNAS.2107963118 ",2.54,25.95,"7khu_oligo1","LFucpa1-2DGalpb1-3[LFucpa1-4]DGlcpNAcb1-3DGalpb1-4DGlcpb1-ROH","FUC(6_C_)-[FUC(5_C_)-GAL(4_C_)]-NAG(3_C_)-GAL(2_C_)-BGC(1_C_)",25.8461,"","",""
"7KI4","STRUCTURE OF THE NIV F GLYCOPROTEIN IN COMPLEX WITH THE 12B2 NEUTRALIZING ANTIBODY","10.1038/S41594-021-00584-8 ",2.9,524802,"7ki4_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_M_)-[MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)]-NAG(1_M_)-ASN(67_A_)",23.4574,"","",""
"7KI4","STRUCTURE OF THE NIV F GLYCOPROTEIN IN COMPLEX WITH THE 12B2 NEUTRALIZING ANTIBODY","10.1038/S41594-021-00584-8 ",2.9,524802,"7ki4_oligo12","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_U_)-[MAN(5_U_)-[MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)]-NAG(1_U_)-ASN(67_E_)",23.4574,"","",""
"7KI4","STRUCTURE OF THE NIV F GLYCOPROTEIN IN COMPLEX WITH THE 12B2 NEUTRALIZING ANTIBODY","10.1038/S41594-021-00584-8 ",2.9,524802,"7ki4_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_Q_)-[MAN(5_Q_)-[MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)]-NAG(1_Q_)-ASN(67_B_)",23.4574,"","",""
"7KI5","CRYSTAL STRUCTURE OF P[6] ROTAVIRUS VP8* IN COMPLEX WITH LNT","10.1073/PNAS.2107963118 ",1.52,19.94,"7ki5_oligo1","DGalpb1-3DGlcpNAcb1-3DGalpb1-4DGlcpb1-ROH","GAL(4_E_)-NAG(3_E_)-GAL(2_E_)-BGC(1_E_)",61.6893,"","",""
"7KK8","FLUORIDE CHANNEL FLUC-EC2 MUTANT S81T WITH BROMIDE","10.7554/ELIFE.69482 ",2.7,64.6,"7kk8_oligo3","DGlcpa1-3DGlcpb6-C10O1","DMU(203_B_)-DMU(203_B_)",71.5827,"","",""
"7KK8","FLUORIDE CHANNEL FLUC-EC2 MUTANT S81T WITH BROMIDE","10.7554/ELIFE.69482 ",2.7,64.6,"7kk8_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(501_C_)-DMU(501_C_)",91.5473,"","",""
"7KK8","FLUORIDE CHANNEL FLUC-EC2 MUTANT S81T WITH BROMIDE","10.7554/ELIFE.69482 ",2.7,64.6,"7kk8_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(203_A_)-DMU(203_A_)",87.2714,"","",""
"7KK9","FLUORIDE CHANNEL FLUC-EC2 MUTANT S81A/T82A WITH BROMIDE","10.7554/ELIFE.69482 ",3.1,78.79,"7kk9_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(501_C_)-DMU(501_C_)",142.576,"","",""
"7KK9","FLUORIDE CHANNEL FLUC-EC2 MUTANT S81A/T82A WITH BROMIDE","10.7554/ELIFE.69482 ",3.1,78.79,"7kk9_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(202_B_)-DMU(202_B_)",93.5168,"","",""
"7KK9","FLUORIDE CHANNEL FLUC-EC2 MUTANT S81A/T82A WITH BROMIDE","10.7554/ELIFE.69482 ",3.1,78.79,"7kk9_oligo3","DGlcpa1-3DGlcpb6-C10O1","DMU(203_A_)-DMU(203_A_)",106.14,"","",""
"7KKA","FLUORIDE CHANNEL FLUC-EC2 MUTANT S81A WITH BROMIDE","10.7554/ELIFE.69482 ",2.5,66.73,"7kka_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(204_A_)-DMU(204_A_)",86.1445,"","",""
"7KKA","FLUORIDE CHANNEL FLUC-EC2 MUTANT S81A WITH BROMIDE","10.7554/ELIFE.69482 ",2.5,66.73,"7kka_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(501_C_)-DMU(501_C_)",107.235,"","",""
"7KKA","FLUORIDE CHANNEL FLUC-EC2 MUTANT S81A WITH BROMIDE","10.7554/ELIFE.69482 ",2.5,66.73,"7kka_oligo3","DGlcpa1-3DGlcpb6-C10O1","DMU(203_B_)-DMU(203_B_)",77.1414,"","",""
"7KKB","FLUORIDE CHANNEL FLUC-EC2 MUTANT S81C WITH BROMIDE","10.7554/ELIFE.69482 ",2.9,68.63,"7kkb_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(501_C_)-DMU(501_C_)",106.509,"","",""
"7KKB","FLUORIDE CHANNEL FLUC-EC2 MUTANT S81C WITH BROMIDE","10.7554/ELIFE.69482 ",2.9,68.63,"7kkb_oligo3","DGlcpa1-3DGlcpb6-C10O1","DMU(203_B_)-DMU(203_B_)",71.5614,"","",""
"7KKB","FLUORIDE CHANNEL FLUC-EC2 MUTANT S81C WITH BROMIDE","10.7554/ELIFE.69482 ",2.9,68.63,"7kkb_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(204_A_)-DMU(204_A_)",107.089,"","",""
"7KKR","FLUORIDE CHANNEL FLUC-EC2 WILD-TYPE WITH BROMIDE","10.7554/ELIFE.69482 ",3.11,46.35,"7kkr_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(501_C_)-DMU(501_C_)",70.5036,"","",""
"7KKR","FLUORIDE CHANNEL FLUC-EC2 WILD-TYPE WITH BROMIDE","10.7554/ELIFE.69482 ",3.11,46.35,"7kkr_oligo3","DGlcpa1-3DGlcpb6-C10O1","DMU(401_B_)-DMU(401_B_)",52.8373,"","",""
"7KKR","FLUORIDE CHANNEL FLUC-EC2 WILD-TYPE WITH BROMIDE","10.7554/ELIFE.69482 ",3.11,46.35,"7kkr_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(201_A_)-DMU(201_A_)",60.7414,"","",""
"7KLC","CRYSTAL STRUCTURE OF M4H2K1 FAB BOUND TO HIV-1 BG505 GP120 CORE AND TO 17B FAB","10.1128/MBIO.00429-21 ",4.3,169,"7klc_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(262_A_)",134.133,"","",""
"7KMD","CRYSTAL STRUCTURE OF A HIV-1 CLADE C ISOLATE DU172.17 HR1.R4.664 ENV TRIMER IN COMPLEX WITH HUMAN FABS PGT124 AND 35O22","10.1128/MBIO.00429-21 ",3.39,113.1,"7kmd_oligo8","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-BMA(4_K_)-NAG(3_K_)-NAG(2_K_)-ASN(262_G_)",122.177,"","",""
"7KMD","CRYSTAL STRUCTURE OF A HIV-1 CLADE C ISOLATE DU172.17 HR1.R4.664 ENV TRIMER IN COMPLEX WITH HUMAN FABS PGT124 AND 35O22","10.1128/MBIO.00429-21 ",3.39,113.1,"7kmd_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(295_G_)",161.402,"","",""
"7KMD","CRYSTAL STRUCTURE OF A HIV-1 CLADE C ISOLATE DU172.17 HR1.R4.664 ENV TRIMER IN COMPLEX WITH HUMAN FABS PGT124 AND 35O22","10.1128/MBIO.00429-21 ",3.39,113.1,"7kmd_oligo1","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-MAN(5_B_)-[MAN(7_B_)]-MAN(4_B_)-[MAN(9_B_)-MAN(8_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(88_G_)",87.3944,"","",""
"7KMD","CRYSTAL STRUCTURE OF A HIV-1 CLADE C ISOLATE DU172.17 HR1.R4.664 ENV TRIMER IN COMPLEX WITH HUMAN FABS PGT124 AND 35O22","10.1128/MBIO.00429-21 ",3.39,113.1,"7kmd_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcp[2<R1>]b1-4DGlcpNAcb1-ASN","MAN(9_I_)-[MAN(8_I_)]-MAN(7_I_)-[MAN(6_I_)-MAN(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(332_G_)",115.747,"","",""
"7KO8","CRYO-EM STRUCTURE OF THE MATURE AND INFECTIVE MAYARO VIRUS","10.1038/S41467-021-23400-9 ",4.4,"1.15243e-41","7ko8_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Q_)-[MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(262_F_)",17.8727,"","",""
"7KO8","CRYO-EM STRUCTURE OF THE MATURE AND INFECTIVE MAYARO VIRUS","10.1038/S41467-021-23400-9 ",4.4,"1.15243e-41","7ko8_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(262_I_)",29.4727,"","",""
"7KO8","CRYO-EM STRUCTURE OF THE MATURE AND INFECTIVE MAYARO VIRUS","10.1038/S41467-021-23400-9 ",4.4,"1.15243e-41","7ko8_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(262_C_)",1,"","",""
"7KO8","CRYO-EM STRUCTURE OF THE MATURE AND INFECTIVE MAYARO VIRUS","10.1038/S41467-021-23400-9 ",4.4,"1.15243e-41","7ko8_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_U_)-[MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(262_M_)",11.5455,"","",""
"7KOO","ALPHA-7 NICOTINIC ACETYLCHOLINE RECEPTOR BOUND TO ALPHA-BUNGAROTOXIN IN A RESTING STATE","10.1016/J.CELL.2021.02.049 ",3,0,"7koo_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_M_)-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(110_B_)",15.4418,"","",""
"7KOO","ALPHA-7 NICOTINIC ACETYLCHOLINE RECEPTOR BOUND TO ALPHA-BUNGAROTOXIN IN A RESTING STATE","10.1016/J.CELL.2021.02.049 ",3,0,"7koo_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_K_)-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(110_A_)",17.0123,"","",""
"7KOO","ALPHA-7 NICOTINIC ACETYLCHOLINE RECEPTOR BOUND TO ALPHA-BUNGAROTOXIN IN A RESTING STATE","10.1016/J.CELL.2021.02.049 ",3,0,"7koo_oligo9","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_S_)-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(110_E_)",15.5807,"","",""
"7KOO","ALPHA-7 NICOTINIC ACETYLCHOLINE RECEPTOR BOUND TO ALPHA-BUNGAROTOXIN IN A RESTING STATE","10.1016/J.CELL.2021.02.049 ",3,0,"7koo_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_O_)-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(110_C_)",17.3366,"","",""
"7KOO","ALPHA-7 NICOTINIC ACETYLCHOLINE RECEPTOR BOUND TO ALPHA-BUNGAROTOXIN IN A RESTING STATE","10.1016/J.CELL.2021.02.049 ",3,0,"7koo_oligo7","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_Q_)-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(110_D_)",15.5945,"","",""
"7KQG","ANTIBODIES THAT ENGAGE THE HEMAGGLUTININ RECEPTOR-BINDING SITE OF INFLUENZA B VIRUSES","10.1021/ACSINFECDIS.0C00726 ",2.6,35.87,"7kqg_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(145_A_)",53.407,"","",""
"7KX0","CRYSTAL STRUCTURE OF THE CD27:CD70 CO-STIMULATORY COMPLEX","10.1016/J.JBC.2021.101102 ",2.69,99.1,"7kx0_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_L_)-[MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(170_C_)",228.023,"","",""
"7KX0","CRYSTAL STRUCTURE OF THE CD27:CD70 CO-STIMULATORY COMPLEX","10.1016/J.JBC.2021.101102 ",2.69,99.1,"7kx0_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_H_)-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(170_A_)",201.635,"","",""
"7KX0","CRYSTAL STRUCTURE OF THE CD27:CD70 CO-STIMULATORY COMPLEX","10.1016/J.JBC.2021.101102 ",2.69,99.1,"7kx0_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(170_B_)",219.048,"","",""
"7L02","CRYO-EM STRUCTURE OF SARS-COV-2 2P S ECTODOMAIN BOUND TO ONE COPY OF DOMAIN-SWAPPED ANTIBODY 2G12","10.1016/J.CELL.2021.04.042 ",3.2,"1.08527e-19","7l02_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(801_A_)",122.799,"","",""
"7L02","CRYO-EM STRUCTURE OF SARS-COV-2 2P S ECTODOMAIN BOUND TO ONE COPY OF DOMAIN-SWAPPED ANTIBODY 2G12","10.1016/J.CELL.2021.04.042 ",3.2,"1.08527e-19","7l02_oligo13","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_T_)-[MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(709_C_)",138.591,"","",""
"7L02","CRYO-EM STRUCTURE OF SARS-COV-2 2P S ECTODOMAIN BOUND TO ONE COPY OF DOMAIN-SWAPPED ANTIBODY 2G12","10.1016/J.CELL.2021.04.042 ",3.2,"1.08527e-19","7l02_oligo3","DManpa1-2DManpa1-6[DManpb1-3]DManpa1-6[DManpb1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-MAN(5_F_)-[BMA(7_F_)]-MAN(4_F_)-[BMA(8_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(717_A_)",119.197,"","",""
"7L06","CRYO-EM STRUCTURE OF SARS-COV-2 2P S ECTODOMAIN BOUND TO TWO COPIES OF DOMAIN-SWAPPED ANTIBODY 2G12","10.1016/J.CELL.2021.04.042 ",3.3,"1.08527e-19","7l06_oligo12","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_W_)-[MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)",96.9767,"","",""
"7L06","CRYO-EM STRUCTURE OF SARS-COV-2 2P S ECTODOMAIN BOUND TO TWO COPIES OF DOMAIN-SWAPPED ANTIBODY 2G12","10.1016/J.CELL.2021.04.042 ",3.3,"1.08527e-19","7l06_oligo3","DManpa1-2DManpa1-6[DManpb1-3]DManpa1-6[DManpb1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(6_N_)-MAN(5_N_)-[BMA(7_N_)]-MAN(4_N_)-[BMA(8_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)",91.8477,"","",""
"7L06","CRYO-EM STRUCTURE OF SARS-COV-2 2P S ECTODOMAIN BOUND TO TWO COPIES OF DOMAIN-SWAPPED ANTIBODY 2G12","10.1016/J.CELL.2021.04.042 ",3.3,"1.08527e-19","7l06_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)",96.9767,"","",""
"7L06","CRYO-EM STRUCTURE OF SARS-COV-2 2P S ECTODOMAIN BOUND TO TWO COPIES OF DOMAIN-SWAPPED ANTIBODY 2G12","10.1016/J.CELL.2021.04.042 ",3.3,"1.08527e-19","7l06_oligo13","DManpa1-2DManpa1-6[DManpb1-3]DManpa1-6[DManpb1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(6_X_)-MAN(5_X_)-[BMA(7_X_)]-MAN(4_X_)-[BMA(8_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)",91.8477,"","",""
"7L06","CRYO-EM STRUCTURE OF SARS-COV-2 2P S ECTODOMAIN BOUND TO TWO COPIES OF DOMAIN-SWAPPED ANTIBODY 2G12","10.1016/J.CELL.2021.04.042 ",3.3,"1.08527e-19","7l06_oligo5","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","BMA(5_P_)-[MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)",37.0887,"","",""
"7L06","CRYO-EM STRUCTURE OF SARS-COV-2 2P S ECTODOMAIN BOUND TO TWO COPIES OF DOMAIN-SWAPPED ANTIBODY 2G12","10.1016/J.CELL.2021.04.042 ",3.3,"1.08527e-19","7l06_oligo10","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","BMA(5_U_)-[MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)",120.857,"","",""
"7L09","CRYO-EM STRUCTURE OF SARS-COV-2 2P S ECTODOMAIN BOUND DOMAIN-SWAPPED ANTIBODY 2G12 FROM MASKED 3D REFINEMENT","10.1016/J.CELL.2021.04.042 ",3.1,2050.01,"7l09_oligo13","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_T_)-[MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(709_C_)",120.37,"","",""
"7L09","CRYO-EM STRUCTURE OF SARS-COV-2 2P S ECTODOMAIN BOUND DOMAIN-SWAPPED ANTIBODY 2G12 FROM MASKED 3D REFINEMENT","10.1016/J.CELL.2021.04.042 ",3.1,2050.01,"7l09_oligo1","DManpa1-2DManpa1-6[DManpb1-3]DManpa1-6[DManpb1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-MAN(5_F_)-[BMA(7_F_)]-MAN(4_F_)-[BMA(8_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(717_A_)",91.7264,"","",""
"7L09","CRYO-EM STRUCTURE OF SARS-COV-2 2P S ECTODOMAIN BOUND DOMAIN-SWAPPED ANTIBODY 2G12 FROM MASKED 3D REFINEMENT","10.1016/J.CELL.2021.04.042 ",3.1,2050.01,"7l09_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(801_A_)",96.6767,"","",""
"7L56","CRYO-EM STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN BOUND TO FAB 2- 43","10.1016/J.CELREP.2021.108950 ",3.6,"1.08527e-19","7l56_oligo7","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-6DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_P_)-NAG(5_P_)-MAN(4_P_)-[MAN(8_P_)-MAN(7_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(343_C_)",89.2622,"","",""
"7L56","CRYO-EM STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN BOUND TO FAB 2- 43","10.1016/J.CELREP.2021.108950 ",3.6,"1.08527e-19","7l56_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_M_)-MAN(7_M_)-[GAL(6_M_)-NAG(5_M_)-MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(343_B_)",97.9957,"","",""
"7L56","CRYO-EM STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN BOUND TO FAB 2- 43","10.1016/J.CELREP.2021.108950 ",3.6,"1.08527e-19","7l56_oligo5","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_I_)-MAN(7_I_)-[GAL(6_I_)-NAG(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(343_A_)",98.394,"","",""
"7L57","CRYO-EM STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN BOUND TO FAB 2- 15","10.1016/J.CELREP.2021.108950 ",5.87,"1.08527e-19","7l57_oligo1","DGlcpNAcb1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_F_)-MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(343_A_)",268.189,"","",""
"7L64","C-TYPE CARBOHYDRATE-RECOGNITION DOMAIN 4 OF THE MANNOSE RECEPTOR COMPLEXED WITH LEWIS-A","10.1016/J.JBC.2021.100368 ",1.35,23.98,"7l64_oligo1","DGalpb1-3[LFucpa1-4]DGlcpNAcb1-ROH","FUC(3_B_)-[GAL(2_B_)]-NAG(1_B_)",26.0555,"","",""
"7L67","C-TYPE CARBOHYDRATE-RECOGNITION DOMAIN 4 OF THE MANNOSE RECEPTOR COMPLEXED WITH FUC-(ALPHA1-3)-GLCNAC","10.1016/J.JBC.2021.100368 ",1.2,15.82,"7l67_oligo1","LFucpa1-3DGlcpNAcb1-ROH","FUC(2_B_)-NAG(1_B_)",11.2514,"","",""
"7L6O","CRYO-EM STRUCTURE OF HIV-1 ENV CH848.3.D0949.10.17CHIM.6R.DS.SOSIP.664","10.1016/J.CELL.2021.04.042 ",3.9,"1.15243e-41","7l6o_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_R_)-[MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(262_c_)",100.401,"","",""
"7L6O","CRYO-EM STRUCTURE OF HIV-1 ENV CH848.3.D0949.10.17CHIM.6R.DS.SOSIP.664","10.1016/J.CELL.2021.04.042 ",3.9,"1.15243e-41","7l6o_oligo25","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(262_a_)",103.748,"","",""
"7L6O","CRYO-EM STRUCTURE OF HIV-1 ENV CH848.3.D0949.10.17CHIM.6R.DS.SOSIP.664","10.1016/J.CELL.2021.04.042 ",3.9,"1.15243e-41","7l6o_oligo31","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_k_)-[MAN(4_k_)]-BMA(3_k_)-NAG(2_k_)-NAG(1_k_)-ASN(262_e_)",99.2009,"","",""
"7L7T","BG505 SOSIP RECONSTRUCTED FROM A DESIGNED NANOPARTICLE, BG505 SOSIP- T33-31 (COMPONENT A)","10.1038/S41467-021-25087-4 ",3.7,"1.08527e-19","7l7t_oligo26","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_P_)-[MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(262_C_)",93.0489,"","",""
"7L7T","BG505 SOSIP RECONSTRUCTED FROM A DESIGNED NANOPARTICLE, BG505 SOSIP- T33-31 (COMPONENT A)","10.1038/S41467-021-25087-4 ",3.7,"1.08527e-19","7l7t_oligo23","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(262_A_)",93.0489,"","",""
"7L7T","BG505 SOSIP RECONSTRUCTED FROM A DESIGNED NANOPARTICLE, BG505 SOSIP- T33-31 (COMPONENT A)","10.1038/S41467-021-25087-4 ",3.7,"1.08527e-19","7l7t_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Y_)-[MAN(4_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(262_E_)",93.0489,"","",""
"7L7U","BG505 SOSIP RECONSTRUCTED FROM A DESIGNED NANOPARTICLE, BG505 SOSIP- T33-31 (COMPONENT B)","10.1038/S41467-021-25087-4 ",3.8,"1.08527e-19","7l7u_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_W_)-[MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(262_E_)",69.7782,"","",""
"7L7U","BG505 SOSIP RECONSTRUCTED FROM A DESIGNED NANOPARTICLE, BG505 SOSIP- T33-31 (COMPONENT B)","10.1038/S41467-021-25087-4 ",3.8,"1.08527e-19","7l7u_oligo19","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(262_A_)",69.7782,"","",""
"7L7U","BG505 SOSIP RECONSTRUCTED FROM A DESIGNED NANOPARTICLE, BG505 SOSIP- T33-31 (COMPONENT B)","10.1038/S41467-021-25087-4 ",3.8,"1.08527e-19","7l7u_oligo24","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(262_C_)",69.7782,"","",""
"7L86","BG505 SOSIP MD39 IN COMPLEX WITH THE POLYCLONAL FAB PABC-1 FROM ANIMAL RH.32034 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",3.4,"1.35632e-19","7l86_oligo57","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_V_)-[MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(262_C_)",65.9855,"","",""
"7L86","BG505 SOSIP MD39 IN COMPLEX WITH THE POLYCLONAL FAB PABC-1 FROM ANIMAL RH.32034 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",3.4,"1.35632e-19","7l86_oligo48","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(262_E_)",58.628,"","",""
"7L86","BG505 SOSIP MD39 IN COMPLEX WITH THE POLYCLONAL FAB PABC-1 FROM ANIMAL RH.32034 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",3.4,"1.35632e-19","7l86_oligo14","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_f_)-[MAN(4_f_)]-BMA(3_f_)-NAG(2_f_)-NAG(1_f_)-ASN(262_A_)",62.3382,"","",""
"7L87","BG505 SOSIP MD39 IN COMPLEX WITH THE POLYCLONAL FAB PABC-2 FROM ANIMAL RH.32034 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",3.6,"1.35632e-19","7l87_oligo19","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_m_)-[MAN(4_m_)]-BMA(3_m_)-NAG(2_m_)-NAG(1_m_)-ASN(262_D_)",79.3236,"","",""
"7L87","BG505 SOSIP MD39 IN COMPLEX WITH THE POLYCLONAL FAB PABC-2 FROM ANIMAL RH.32034 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",3.6,"1.35632e-19","7l87_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Z_)-[MAN(4_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(262_A_)",52.6146,"","",""
"7L87","BG505 SOSIP MD39 IN COMPLEX WITH THE POLYCLONAL FAB PABC-2 FROM ANIMAL RH.32034 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",3.6,"1.35632e-19","7l87_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_M_)-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(262_C_)",66.4405,"","",""
"7L88","BG505 SOSIP MD39 IN COMPLEX WITH THE POLYCLONAL FAB PABC-3 FROM ANIMAL RH.32034 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",3.6,"2.21517e+08","7l88_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_g_)-[MAN(4_g_)]-BMA(3_g_)-NAG(2_g_)-NAG(1_g_)-ASN(262_C_)",81.5304,"","",""
"7L88","BG505 SOSIP MD39 IN COMPLEX WITH THE POLYCLONAL FAB PABC-3 FROM ANIMAL RH.32034 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",3.6,"2.21517e+08","7l88_oligo55","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_X_)-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(262_A_)",65.8364,"","",""
"7L88","BG505 SOSIP MD39 IN COMPLEX WITH THE POLYCLONAL FAB PABC-3 FROM ANIMAL RH.32034 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",3.6,"2.21517e+08","7l88_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(262_D_)",76.7613,"","",""
"7L89","BG505 SOSIP MD39 IN COMPLEX WITH THE POLYCLONAL FAB PABC-4 FROM ANIMAL RH.32034 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",3.8,"1.35632e-19","7l89_oligo17","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_l_)-[MAN(4_l_)]-BMA(3_l_)-NAG(2_l_)-NAG(1_l_)-ASN(262_B_)",83.8931,"","",""
"7L89","BG505 SOSIP MD39 IN COMPLEX WITH THE POLYCLONAL FAB PABC-4 FROM ANIMAL RH.32034 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",3.8,"1.35632e-19","7l89_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Y_)-[MAN(4_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(262_A_)",76.7878,"","",""
"7L89","BG505 SOSIP MD39 IN COMPLEX WITH THE POLYCLONAL FAB PABC-4 FROM ANIMAL RH.32034 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",3.8,"1.35632e-19","7l89_oligo42","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(262_E_)",92.5907,"","",""
"7L8A","BG505 SOSIP MD39 IN COMPLEX WITH THE POLYCLONAL FAB PABC-1 FROM ANIMAL RH.33104 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",3.3,8.00784,"7l8a_oligo56","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_W_)-[MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(262_A_)",65.4229,"","",""
"7L8A","BG505 SOSIP MD39 IN COMPLEX WITH THE POLYCLONAL FAB PABC-1 FROM ANIMAL RH.33104 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",3.3,8.00784,"7l8a_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_K_)-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(262_E_)",64.1014,"","",""
"7L8A","BG505 SOSIP MD39 IN COMPLEX WITH THE POLYCLONAL FAB PABC-1 FROM ANIMAL RH.33104 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",3.3,8.00784,"7l8a_oligo16","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_h_)-[MAN(4_h_)]-BMA(3_h_)-NAG(2_h_)-NAG(1_h_)-ASN(262_C_)",68.4969,"","",""
"7L8B","BG505 SOSIP MD39 IN COMPLEX WITH THE POLYCLONAL FAB PABC-2 FROM ANIMAL RH.33104 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",3.7,8.00784,"7l8b_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(262_C_)",112.981,"","",""
"7L8B","BG505 SOSIP MD39 IN COMPLEX WITH THE POLYCLONAL FAB PABC-2 FROM ANIMAL RH.33104 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",3.7,8.00784,"7l8b_oligo14","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_e_)-[MAN(4_e_)]-BMA(3_e_)-NAG(2_e_)-NAG(1_e_)-ASN(262_E_)",84.6193,"","",""
"7L8B","BG505 SOSIP MD39 IN COMPLEX WITH THE POLYCLONAL FAB PABC-2 FROM ANIMAL RH.33104 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",3.7,8.00784,"7l8b_oligo56","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_U_)-[MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(262_A_)",76.3409,"","",""
"7L8C","BG505 SOSIP MD39 IN COMPLEX WITH THE POLYCLONAL FAB PABC-3 FROM ANIMAL RH.33104 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",3.4,8.00784,"7l8c_oligo20","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_n_)-[MAN(4_n_)]-BMA(3_n_)-NAG(2_n_)-NAG(1_n_)-ASN(262_D_)",59.8907,"","",""
"7L8C","BG505 SOSIP MD39 IN COMPLEX WITH THE POLYCLONAL FAB PABC-3 FROM ANIMAL RH.33104 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",3.4,8.00784,"7l8c_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(262_A_)",58.2362,"","",""
"7L8D","BG505 SOSIP MD39 IN COMPLEX WITH THE POLYCLONAL FAB PABC-4 FROM ANIMAL RH.33104 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",4.6,"1.08527e-19","7l8d_oligo17","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Y_)-[MAN(4_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(262_C_)",156.731,"","",""
"7L8D","BG505 SOSIP MD39 IN COMPLEX WITH THE POLYCLONAL FAB PABC-4 FROM ANIMAL RH.33104 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",4.6,"1.08527e-19","7l8d_oligo26","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_h_)-[MAN(4_h_)]-BMA(3_h_)-NAG(2_h_)-NAG(1_h_)-ASN(262_D_)",152.182,"","",""
"7L8D","BG505 SOSIP MD39 IN COMPLEX WITH THE POLYCLONAL FAB PABC-4 FROM ANIMAL RH.33104 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",4.6,"1.08527e-19","7l8d_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(262_A_)",154.26,"","",""
"7L8E","BG505 SOSIP.V5.2(7S) IN COMPLEX WITH THE POLYCLONAL FAB PABC-1 FROM ANIMAL RH.33172 (WK38 TIME POINT)","10.1038/S41467-021-25087-4 ",4.2,"1.08527e-19","7l8e_oligo45","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_X_)-[MAN(4_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(262_A_)",121.138,"","",""
"7L8E","BG505 SOSIP.V5.2(7S) IN COMPLEX WITH THE POLYCLONAL FAB PABC-1 FROM ANIMAL RH.33172 (WK38 TIME POINT)","10.1038/S41467-021-25087-4 ",4.2,"1.08527e-19","7l8e_oligo38","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Q_)-[MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(262_E_)",137.301,"","",""
"7L8E","BG505 SOSIP.V5.2(7S) IN COMPLEX WITH THE POLYCLONAL FAB PABC-1 FROM ANIMAL RH.33172 (WK38 TIME POINT)","10.1038/S41467-021-25087-4 ",4.2,"1.08527e-19","7l8e_oligo65","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(262_C_)",140.324,"","",""
"7L8G","BG505 SOSIP.V5.2(7S) IN COMPLEX WITH THE POLYCLONAL FAB PABC-3 FROM ANIMAL RH.33172 (WK38 TIME POINT)","10.1038/S41467-021-25087-4 ",4.3,"1.08527e-19","7l8g_oligo49","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Y_)-[MAN(4_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(262_A_)",142.502,"","",""
"7L8G","BG505 SOSIP.V5.2(7S) IN COMPLEX WITH THE POLYCLONAL FAB PABC-3 FROM ANIMAL RH.33172 (WK38 TIME POINT)","10.1038/S41467-021-25087-4 ",4.3,"1.08527e-19","7l8g_oligo42","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_R_)-[MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(262_E_)",150.407,"","",""
"7L8G","BG505 SOSIP.V5.2(7S) IN COMPLEX WITH THE POLYCLONAL FAB PABC-3 FROM ANIMAL RH.33172 (WK38 TIME POINT)","10.1038/S41467-021-25087-4 ",4.3,"1.08527e-19","7l8g_oligo37","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(262_C_)",153.263,"","",""
"7L8P","INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH SIBRAFIBAN","10.1016/J.CELL.2022.08.008 ",2.35,78.3,"7l8p_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(320_D_)",73.6434,"","",""
"7L8P","INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH SIBRAFIBAN","10.1016/J.CELL.2022.08.008 ",2.35,78.3,"7l8p_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(320_B_)",70.8667,"","",""
"7L8S","BG505 SOSIP.V5.2(7S) IN COMPLEX WITH THE POLYCLONAL FAB PABC-4 FROM ANIMAL RH.33172 (WK38 TIME POINT)","10.1038/S41467-021-25087-4 ",4.3,"5.50295e+11","7l8s_oligo54","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Z_)-[MAN(4_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(262_A_)",110.769,"","",""
"7L8S","BG505 SOSIP.V5.2(7S) IN COMPLEX WITH THE POLYCLONAL FAB PABC-4 FROM ANIMAL RH.33172 (WK38 TIME POINT)","10.1038/S41467-021-25087-4 ",4.3,"5.50295e+11","7l8s_oligo46","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_R_)-[MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(262_E_)",133.432,"","",""
"7L8S","BG505 SOSIP.V5.2(7S) IN COMPLEX WITH THE POLYCLONAL FAB PABC-4 FROM ANIMAL RH.33172 (WK38 TIME POINT)","10.1038/S41467-021-25087-4 ",4.3,"5.50295e+11","7l8s_oligo40","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(262_C_)",133.515,"","",""
"7L8T","BG505 SOSIP.V5.2 N241/N289 IN COMPLEX WITH THE POLYCLONAL FAB PABC-1 FROM ANIMAL RH.33311 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",3.7,"5.50295e+11","7l8t_oligo65","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(262_E_)",111.852,"","",""
"7L8T","BG505 SOSIP.V5.2 N241/N289 IN COMPLEX WITH THE POLYCLONAL FAB PABC-1 FROM ANIMAL RH.33311 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",3.7,"5.50295e+11","7l8t_oligo62","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_P_)-[MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(262_C_)",65.1265,"","",""
"7L8T","BG505 SOSIP.V5.2 N241/N289 IN COMPLEX WITH THE POLYCLONAL FAB PABC-1 FROM ANIMAL RH.33311 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",3.7,"5.50295e+11","7l8t_oligo3","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_I_)-[MAN(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(262_A_)",93.3292,"","",""
"7L8U","BG505 SOSIP.V5.2 N241/N289 IN COMPLEX WITH THE POLYCLONAL FAB PABC-2 FROM ANIMAL RH.33311 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",4.5,"5.50295e+11","7l8u_oligo55","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_P_)-[MAN(5_P_)]-MAN(4_P_)-[MAN(7_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(611_B_)",78.3561,"","",""
"7L8U","BG505 SOSIP.V5.2 N241/N289 IN COMPLEX WITH THE POLYCLONAL FAB PABC-2 FROM ANIMAL RH.33311 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",4.5,"5.50295e+11","7l8u_oligo58","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(262_E_)",132.204,"","",""
"7L8U","BG505 SOSIP.V5.2 N241/N289 IN COMPLEX WITH THE POLYCLONAL FAB PABC-2 FROM ANIMAL RH.33311 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",4.5,"5.50295e+11","7l8u_oligo1","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-MAN(4_M_)-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(262_A_)",157.357,"","",""
"7L8W","BG505 SOSIP.V5.2 N241/N289 IN COMPLEX WITH THE POLYCLONAL FAB PABC-3 FROM ANIMAL RH.33311 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",4.1,"5.50295e+11","7l8w_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(262_C_)",88.046,"","",""
"7L8W","BG505 SOSIP.V5.2 N241/N289 IN COMPLEX WITH THE POLYCLONAL FAB PABC-3 FROM ANIMAL RH.33311 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",4.1,"5.50295e+11","7l8w_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_G_)-[MAN(8_G_)]-MAN(7_G_)-[MAN(6_G_)-MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(262_A_)",70.2435,"","",""
"7L8W","BG505 SOSIP.V5.2 N241/N289 IN COMPLEX WITH THE POLYCLONAL FAB PABC-3 FROM ANIMAL RH.33311 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",4.1,"5.50295e+11","7l8w_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(262_E_)",106.78,"","",""
"7L8X","BG505 SOSIP.V5.2 N241/N289 IN COMPLEX WITH THE POLYCLONAL FAB PABC-4 FROM ANIMAL RH.33311 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",3,"5.50295e+11","7l8x_oligo11","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_b_)-[MAN(5_b_)-MAN(4_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(262_E_)",78.443,"","",""
"7L8X","BG505 SOSIP.V5.2 N241/N289 IN COMPLEX WITH THE POLYCLONAL FAB PABC-4 FROM ANIMAL RH.33311 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",3,"5.50295e+11","7l8x_oligo64","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_T_)-[MAN(5_T_)-MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(262_C_)",73.2394,"","",""
"7L8X","BG505 SOSIP.V5.2 N241/N289 IN COMPLEX WITH THE POLYCLONAL FAB PABC-4 FROM ANIMAL RH.33311 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",3,"5.50295e+11","7l8x_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpb1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_K_)-[BMA(8_K_)]-MAN(7_K_)-[MAN(6_K_)-MAN(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(262_A_)",83.734,"","",""
"7L8Y","BG505 SOSIP.V5.2 N241/N289 IN COMPLEX WITH THE POLYCLONAL FAB PABC-5 FROM ANIMAL RH.33311 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",4.2,"1.08527e-19","7l8y_oligo49","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(262_C_)",116.843,"","",""
"7L8Y","BG505 SOSIP.V5.2 N241/N289 IN COMPLEX WITH THE POLYCLONAL FAB PABC-5 FROM ANIMAL RH.33311 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",4.2,"1.08527e-19","7l8y_oligo53","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_P_)-[MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(262_A_)",90.3104,"","",""
"7L8Y","BG505 SOSIP.V5.2 N241/N289 IN COMPLEX WITH THE POLYCLONAL FAB PABC-5 FROM ANIMAL RH.33311 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",4.2,"1.08527e-19","7l8y_oligo57","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_T_)-[MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(262_E_)",101.778,"","",""
"7L8Z","BG505 SOSIP.V5.2 N241/N289 IN COMPLEX WITH THE POLYCLONAL FAB PABC-7 FROM ANIMAL RH.33311 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",3.8,"1.08527e-19","7l8z_oligo1","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_K_)-[MAN(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(262_A_)",95.9453,"","",""
"7L8Z","BG505 SOSIP.V5.2 N241/N289 IN COMPLEX WITH THE POLYCLONAL FAB PABC-7 FROM ANIMAL RH.33311 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",3.8,"1.08527e-19","7l8z_oligo57","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_T_)-[MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(262_C_)",78.9891,"","",""
"7L8Z","BG505 SOSIP.V5.2 N241/N289 IN COMPLEX WITH THE POLYCLONAL FAB PABC-7 FROM ANIMAL RH.33311 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",3.8,"1.08527e-19","7l8z_oligo7","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Z_)-[MAN(5_Z_)-MAN(4_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(262_D_)",89.1802,"","",""
"7L90","BG505 SOSIP.V5.2 N241/N289 IN COMPLEX WITH THE POLYCLONAL FAB PABC-8 FROM ANIMAL RH.33311 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",4.5,"1.08527e-19","7l90_oligo54","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_N_)-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(262_C_)",149.134,"","",""
"7L90","BG505 SOSIP.V5.2 N241/N289 IN COMPLEX WITH THE POLYCLONAL FAB PABC-8 FROM ANIMAL RH.33311 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",4.5,"1.08527e-19","7l90_oligo57","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_Q_)-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(262_E_)",137.237,"","",""
"7L90","BG505 SOSIP.V5.2 N241/N289 IN COMPLEX WITH THE POLYCLONAL FAB PABC-8 FROM ANIMAL RH.33311 (WK26 TIME POINT)","10.1038/S41467-021-25087-4 ",4.5,"1.08527e-19","7l90_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(262_A_)",157.605,"","",""
"7LA4","INTEGRIN ALPHAIIBBETA3-PT25-2 COMPLEX","10.1182/BLOODADVANCES.2020004166 ",3.3,"1.35632e-19","7la4_oligo2","DManpa1-3DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(320_B_)",56.157,"","",""
"7LAG","CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) COMPLEX WITH COMPOUND-14 AKA 7-({1-[(3-PHENOXYPHENYL)METHYL]-1H-PYRAZOL-4- YL}METHYL)-3H-[1,2,3]TRIAZOLO[4,5-B]PYRIDIN-5-AMINE","10.1016/J.BMCL.2021.128010 ",2.85,43.9,"7lag_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(6_J_)-[MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)]-NAG(1_J_)",41.135,"","",""
"7LAG","CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) COMPLEX WITH COMPOUND-14 AKA 7-({1-[(3-PHENOXYPHENYL)METHYL]-1H-PYRAZOL-4- YL}METHYL)-3H-[1,2,3]TRIAZOLO[4,5-B]PYRIDIN-5-AMINE","10.1016/J.BMCL.2021.128010 ",2.85,43.9,"7lag_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_K_)-[MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(317_E_)",43.6035,"","",""
"7LAG","CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) COMPLEX WITH COMPOUND-14 AKA 7-({1-[(3-PHENOXYPHENYL)METHYL]-1H-PYRAZOL-4- YL}METHYL)-3H-[1,2,3]TRIAZOLO[4,5-B]PYRIDIN-5-AMINE","10.1016/J.BMCL.2021.128010 ",2.85,43.9,"7lag_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(6_N_)-[MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)]-NAG(1_N_)",41.9037,"","",""
"7LAG","CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) COMPLEX WITH COMPOUND-14 AKA 7-({1-[(3-PHENOXYPHENYL)METHYL]-1H-PYRAZOL-4- YL}METHYL)-3H-[1,2,3]TRIAZOLO[4,5-B]PYRIDIN-5-AMINE","10.1016/J.BMCL.2021.128010 ",2.85,43.9,"7lag_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(6_M_)-[MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)]-NAG(1_M_)",40.7027,"","",""
"7LAL","CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) COMPLEX WITH COMPOUND-18 AKA 7-(3-(2,3-DIHYDRO-1H-INDEN-1-YLAMINO)-1- PHENYLPROPYL)-1H-[1,2,3]TRIAZOLO[4,5-B]PYRIDIN-5-AMINE","10.1016/J.BMCL.2021.128010 ",2.75,70,"7lal_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(4_G_)-[MAN(602_B_)-BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)",81.4618,"","",""
"7LAN","CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) COMPLEX WITH COMPOUND-30 AKA 7-[(3~{S},4~{R},6~{R})-4-BENZYL-2-OXA-7,13,14- TRIAZATETRACYCLO[14.3.1.1^{3,6}.1^{11,14}]DOCOSA-1(19),11(21),12, 16(20),17-PENTAEN-10-YL]-3~{H}-TRIAZOLO[4,5-B]PYRIDIN-5-AMINE","10.1016/J.BMCL.2021.128010 ",2.28,44.53,"7lan_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_J_)-[MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)]-NAG(1_J_)-ASN(317_B_)",41.1064,"","",""
"7LAN","CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) COMPLEX WITH COMPOUND-30 AKA 7-[(3~{S},4~{R},6~{R})-4-BENZYL-2-OXA-7,13,14- TRIAZATETRACYCLO[14.3.1.1^{3,6}.1^{11,14}]DOCOSA-1(19),11(21),12, 16(20),17-PENTAEN-10-YL]-3~{H}-TRIAZOLO[4,5-B]PYRIDIN-5-AMINE","10.1016/J.BMCL.2021.128010 ",2.28,44.53,"7lan_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_N_)-[MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)]-NAG(1_N_)-ASN(317_G_)",40.6742,"","",""
"7LAN","CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) COMPLEX WITH COMPOUND-30 AKA 7-[(3~{S},4~{R},6~{R})-4-BENZYL-2-OXA-7,13,14- TRIAZATETRACYCLO[14.3.1.1^{3,6}.1^{11,14}]DOCOSA-1(19),11(21),12, 16(20),17-PENTAEN-10-YL]-3~{H}-TRIAZOLO[4,5-B]PYRIDIN-5-AMINE","10.1016/J.BMCL.2021.128010 ",2.28,44.53,"7lan_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_L_)-[MAN(5_L_)-[MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)]-NAG(1_L_)-ASN(317_E_)",43.5361,"","",""
"7LAN","CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) COMPLEX WITH COMPOUND-30 AKA 7-[(3~{S},4~{R},6~{R})-4-BENZYL-2-OXA-7,13,14- TRIAZATETRACYCLO[14.3.1.1^{3,6}.1^{11,14}]DOCOSA-1(19),11(21),12, 16(20),17-PENTAEN-10-YL]-3~{H}-TRIAZOLO[4,5-B]PYRIDIN-5-AMINE","10.1016/J.BMCL.2021.128010 ",2.28,44.53,"7lan_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_O_)-[MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)]-NAG(1_O_)-ASN(317_I_)",41.9139,"","",""
"7LBE","CRYOEM STRUCTURE OF THE HCMV TRIMER GHGLGO IN COMPLEX WITH NEUTRALIZING FABS 13H11 AND MSL-109","10.1016/J.CELL.2021.01.036 ",2.9,"1.08527e-19","7lbe_oligo1","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-[MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(160_C_)",78.105,"","",""
"7LBF","CRYOEM STRUCTURE OF THE HCMV TRIMER GHGLGO IN COMPLEX WITH HUMAN PLATELET-DERIVED GROWTH FACTOR RECEPTOR ALPHA AND NEUTRALIZING FABS 13H11 AND MSL-109","10.1016/J.CELL.2021.01.036 ",2.8,524802,"7lbf_oligo3","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_K_)-MAN(6_K_)-[MAN(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(160_C_)",63.401,"","",""
"7LBG","CRYOEM STRUCTURE OF THE HCMV TRIMER GHGLGO IN COMPLEX WITH HUMAN TRANSFORMING GROWTH FACTOR BETA RECEPTOR TYPE 3 AND NEUTRALIZING FABS 13H11 AND MSL-109","10.1016/J.CELL.2021.01.036 ",2.6,524802,"7lbg_oligo2","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_J_)-MAN(6_J_)-[MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(160_C_)",42.8138,"","",""
"7LBL","STRUCTURE OF HUMAN IGG1 FC","",2.13,59.11,"7lbl_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_B_)",89.7303,"","",""
"7LBL","STRUCTURE OF HUMAN IGG1 FC","",2.13,59.11,"7lbl_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_A_)",63.4261,"","",""
"7LEN","CRYSTAL STRUCTURE OF THE EPIDERMAL GROWTH FACTOR RECEPTOR EXTRACELLULAR REGION WITH R84K MUTATION IN COMPLEX WITH EPIREGULIN CRYSTALLIZED WITH TREHALOSE","10.1038/S41586-021-04393-3 ",2.9,86.62,"7len_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(328_A_)",95.4411,"","",""
"7LEN","CRYSTAL STRUCTURE OF THE EPIDERMAL GROWTH FACTOR RECEPTOR EXTRACELLULAR REGION WITH R84K MUTATION IN COMPLEX WITH EPIREGULIN CRYSTALLIZED WITH TREHALOSE","10.1038/S41586-021-04393-3 ",2.9,86.62,"7len_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(328_B_)",117.079,"","",""
"7LER","NETRIN-1 FILAMENT ASSEMBLY","",5.99,304.5,"7ler_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(97_A_)",297.151,"","",""
"7LER","NETRIN-1 FILAMENT ASSEMBLY","",5.99,304.5,"7ler_oligo13","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_U_)-[MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(97_G_)",280.543,"","",""
"7LER","NETRIN-1 FILAMENT ASSEMBLY","",5.99,304.5,"7ler_oligo15","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_W_)-[MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(97_H_)",333.261,"","",""
"7LER","NETRIN-1 FILAMENT ASSEMBLY","",5.99,304.5,"7ler_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(97_E_)",282.177,"","",""
"7LER","NETRIN-1 FILAMENT ASSEMBLY","",5.99,304.5,"7ler_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(97_C_)",314.354,"","",""
"7LER","NETRIN-1 FILAMENT ASSEMBLY","",5.99,304.5,"7ler_oligo11","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(97_F_)",267.484,"","",""
"7LER","NETRIN-1 FILAMENT ASSEMBLY","",5.99,304.5,"7ler_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Q_)-[MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(97_D_)",306.152,"","",""
"7LER","NETRIN-1 FILAMENT ASSEMBLY","",5.99,304.5,"7ler_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(97_B_)",277.751,"","",""
"7LF5","STRUCTURE OF HYPERGLYCOSYLATED HUMAN IGG1 FC (FC267)","",2.6,92.97,"7lf5_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(297_A_)",114.462,"","",""
"7LF9","STRUCTURE OF HYPERGLYCOSYLATED HUMAN IGG1 FC (FC329)","",2.2,64.68,"7lf9_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(297_B_)",117.126,"","",""
"7LF9","STRUCTURE OF HYPERGLYCOSYLATED HUMAN IGG1 FC (FC329)","",2.2,64.68,"7lf9_oligo1","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(297_A_)",70.1762,"","",""
"7LFN","STRUCTURE OF HYPERGLYCOSYLATED HUMAN IGG1 FC (FC267_329)","",2.6,64,"7lfn_oligo3","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(297_A_)",68.1181,"","",""
"7LFN","STRUCTURE OF HYPERGLYCOSYLATED HUMAN IGG1 FC (FC267_329)","",2.6,64,"7lfn_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(297_B_)",113.798,"","",""
"7LFN","STRUCTURE OF HYPERGLYCOSYLATED HUMAN IGG1 FC (FC267_329)","",2.6,64,"7lfn_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_C_)-[MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(267_A_)",95.1127,"","",""
"7LFS","CRYSTAL STRUCTURE OF THE EPIDERMAL GROWTH FACTOR RECEPTOR EXTRACELLULAR REGION WITH A265V MUTATION IN COMPLEX WITH EPIREGULIN","10.1038/S41586-021-04393-3 ",3.5,99,"7lfs_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(328_B_)",141.21,"","",""
"7LFS","CRYSTAL STRUCTURE OF THE EPIDERMAL GROWTH FACTOR RECEPTOR EXTRACELLULAR REGION WITH A265V MUTATION IN COMPLEX WITH EPIREGULIN","10.1038/S41586-021-04393-3 ",3.5,99,"7lfs_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_M_)-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(328_D_)",173.622,"","",""
"7LFS","CRYSTAL STRUCTURE OF THE EPIDERMAL GROWTH FACTOR RECEPTOR EXTRACELLULAR REGION WITH A265V MUTATION IN COMPLEX WITH EPIREGULIN","10.1038/S41586-021-04393-3 ",3.5,99,"7lfs_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_K_)-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(328_C_)",184.771,"","",""
"7LFS","CRYSTAL STRUCTURE OF THE EPIDERMAL GROWTH FACTOR RECEPTOR EXTRACELLULAR REGION WITH A265V MUTATION IN COMPLEX WITH EPIREGULIN","10.1038/S41586-021-04393-3 ",3.5,99,"7lfs_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(328_A_)",141.958,"","",""
"7LG6","BG505 SOSIP.V5.2 IN COMPLEX WITH VRC40.01 AND RM19R FABS","10.1016/J.CELREP.2021.109922 ",3.28,"1.08527e-19","7lg6_oligo34","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_z_)-[MAN(7_z_)]-MAN(6_z_)-[MAN(5_z_)-MAN(4_z_)]-BMA(3_z_)-NAG(2_z_)-NAG(1_z_)-ASN(276_F_)",55.5635,"","",""
"7LG6","BG505 SOSIP.V5.2 IN COMPLEX WITH VRC40.01 AND RM19R FABS","10.1016/J.CELREP.2021.109922 ",3.28,"1.08527e-19","7lg6_oligo33","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_y_)-[MAN(5_y_)-MAN(4_y_)]-BMA(3_y_)-NAG(2_y_)-NAG(1_y_)-ASN(262_F_)",66.8188,"","",""
"7LG6","BG505 SOSIP.V5.2 IN COMPLEX WITH VRC40.01 AND RM19R FABS","10.1016/J.CELREP.2021.109922 ",3.28,"1.08527e-19","7lg6_oligo14","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_k_)-[MAN(5_k_)-MAN(4_k_)]-BMA(3_k_)-NAG(2_k_)-NAG(1_k_)-ASN(262_E_)",66.8188,"","",""
"7LG6","BG505 SOSIP.V5.2 IN COMPLEX WITH VRC40.01 AND RM19R FABS","10.1016/J.CELREP.2021.109922 ",3.28,"1.08527e-19","7lg6_oligo20","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_l_)-[MAN(7_l_)]-MAN(6_l_)-[MAN(5_l_)-MAN(4_l_)]-BMA(3_l_)-NAG(2_l_)-NAG(1_l_)-ASN(276_E_)",55.5635,"","",""
"7LG6","BG505 SOSIP.V5.2 IN COMPLEX WITH VRC40.01 AND RM19R FABS","10.1016/J.CELREP.2021.109922 ",3.28,"1.08527e-19","7lg6_oligo15","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_X_)-[MAN(7_X_)]-MAN(6_X_)-[MAN(5_X_)-MAN(4_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(276_A_)",55.5635,"","",""
"7LG6","BG505 SOSIP.V5.2 IN COMPLEX WITH VRC40.01 AND RM19R FABS","10.1016/J.CELREP.2021.109922 ",3.28,"1.08527e-19","7lg6_oligo18","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_W_)-[MAN(5_W_)-MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(262_A_)",66.8188,"","",""
"7LIR","STRUCTURE OF THE INVERTEBRATE ALK GRD","10.1038/S41586-021-04141-7 ",2.6,82.1,"7lir_oligo5","DManpa1-3DManpa1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcx1-","FUC(6_C_)-[MAN(4_C_)-MAN(3_C_)-NAG(2_C_)]-[FUC(5_C_)]-NAG(1_C_)",108.659,"","",""
"7LIR","STRUCTURE OF THE INVERTEBRATE ALK GRD","10.1038/S41586-021-04141-7 ",2.6,82.1,"7lir_oligo4","DManpa1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcx1-","FUC(5_G_)-[MAN(3_G_)-NAG(2_G_)]-[FUC(4_G_)]-NAG(1_G_)",102.404,"","",""
"7LJ2","STRUCTURE OF EXO-L-GALACTOSE-6-SULFATASE BUS1_11 FROM BACTEROIDES UNIFORMIS IN COMPLEX WITH NEOPORPHYRABIOSE","10.1038/S41589-022-00983-Y ",2.4,40.12,"7lj2_oligo2","LGalp[6S]a1-3DGalpb1-ROH","L6S(2_D_)-GAL(1_D_)",34.3195,"","",""
"7LJ2","STRUCTURE OF EXO-L-GALACTOSE-6-SULFATASE BUS1_11 FROM BACTEROIDES UNIFORMIS IN COMPLEX WITH NEOPORPHYRABIOSE","10.1038/S41589-022-00983-Y ",2.4,40.12,"7lj2_oligo1","LGalp[6S]a1-3DGalpb1-ROH","L6S(2_C_)-GAL(1_C_)",40.0641,"","",""
"7LKP","STRUCTURE OF ATP-FREE HUMAN ABCA4","10.7554/ELIFE.63524 ",3.27,"1.08527e-19","7lkp_oligo3","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_C_)-[BMA(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(1529_A_)",111.255,"","",""
"7LKZ","STRUCTURE OF ATP-BOUND HUMAN ABCA4","10.7554/ELIFE.63524 ",3.27,"1.15243e-41","7lkz_oligo4","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_C_)-[BMA(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(1529_A_)",90.4164,"","",""
"7LL1","CRYO-EM STRUCTURE OF BG505 DS-SOSIP IN COMPLEX WITH GLYCAN276- DEPENDENT BROADLY NEUTRALIZING ANTIBODY VRC40.01 FAB","10.1016/J.CELREP.2021.109922 ",3.73,"5.37397e+08","7ll1_oligo25","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_k_)-[MAN(5_k_)-MAN(4_k_)]-BMA(3_k_)-NAG(2_k_)-NAG(1_k_)-ASN(276_G_)",97.9476,"","",""
"7LL1","CRYO-EM STRUCTURE OF BG505 DS-SOSIP IN COMPLEX WITH GLYCAN276- DEPENDENT BROADLY NEUTRALIZING ANTIBODY VRC40.01 FAB","10.1016/J.CELREP.2021.109922 ",3.73,"5.37397e+08","7ll1_oligo7","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_a_)-[MAN(5_a_)-MAN(4_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(276_C_)",99.9556,"","",""
"7LL1","CRYO-EM STRUCTURE OF BG505 DS-SOSIP IN COMPLEX WITH GLYCAN276- DEPENDENT BROADLY NEUTRALIZING ANTIBODY VRC40.01 FAB","10.1016/J.CELREP.2021.109922 ",3.73,"5.37397e+08","7ll1_oligo3","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Q_)-[MAN(5_Q_)-MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(276_A_)",98.8192,"","",""
"7LL2","CRYO-EM STRUCTURE OF BG505 DS-SOSIP IN COMPLEX WITH GLYCAN276- DEPENDENT BROADLY NEUTRALIZING ANTIBODY VRC33.01 FAB","10.1016/J.CELREP.2021.109922 ",3.73,"5.37397e+08","7ll2_oligo11","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_d_)-[MAN(4_d_)]-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(262_C_)",155.741,"","",""
"7LL2","CRYO-EM STRUCTURE OF BG505 DS-SOSIP IN COMPLEX WITH GLYCAN276- DEPENDENT BROADLY NEUTRALIZING ANTIBODY VRC33.01 FAB","10.1016/J.CELREP.2021.109922 ",3.73,"5.37397e+08","7ll2_oligo17","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_U_)-[MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(363_A_)",135.45,"","",""
"7LL2","CRYO-EM STRUCTURE OF BG505 DS-SOSIP IN COMPLEX WITH GLYCAN276- DEPENDENT BROADLY NEUTRALIZING ANTIBODY VRC33.01 FAB","10.1016/J.CELREP.2021.109922 ",3.73,"5.37397e+08","7ll2_oligo31","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_q_)-[MAN(4_q_)]-BMA(3_q_)-NAG(2_q_)-NAG(1_q_)-ASN(363_E_)",140.303,"","",""
"7LL2","CRYO-EM STRUCTURE OF BG505 DS-SOSIP IN COMPLEX WITH GLYCAN276- DEPENDENT BROADLY NEUTRALIZING ANTIBODY VRC33.01 FAB","10.1016/J.CELREP.2021.109922 ",3.73,"5.37397e+08","7ll2_oligo15","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(262_A_)",156.027,"","",""
"7LL2","CRYO-EM STRUCTURE OF BG505 DS-SOSIP IN COMPLEX WITH GLYCAN276- DEPENDENT BROADLY NEUTRALIZING ANTIBODY VRC33.01 FAB","10.1016/J.CELREP.2021.109922 ",3.73,"5.37397e+08","7ll2_oligo20","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_f_)-[MAN(4_f_)]-BMA(3_f_)-NAG(2_f_)-NAG(1_f_)-ASN(363_C_)",141.784,"","",""
"7LL2","CRYO-EM STRUCTURE OF BG505 DS-SOSIP IN COMPLEX WITH GLYCAN276- DEPENDENT BROADLY NEUTRALIZING ANTIBODY VRC33.01 FAB","10.1016/J.CELREP.2021.109922 ",3.73,"5.37397e+08","7ll2_oligo29","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_o_)-[MAN(4_o_)]-BMA(3_o_)-NAG(2_o_)-NAG(1_o_)-ASN(262_E_)",160.708,"","",""
"7LL2","CRYO-EM STRUCTURE OF BG505 DS-SOSIP IN COMPLEX WITH GLYCAN276- DEPENDENT BROADLY NEUTRALIZING ANTIBODY VRC33.01 FAB","10.1016/J.CELREP.2021.109922 ",3.73,"5.37397e+08","7ll2_oligo16","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_T_)-[MAN(5_T_)]-MAN(4_T_)-[MAN(7_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(276_A_)",149.355,"","",""
"7LL2","CRYO-EM STRUCTURE OF BG505 DS-SOSIP IN COMPLEX WITH GLYCAN276- DEPENDENT BROADLY NEUTRALIZING ANTIBODY VRC33.01 FAB","10.1016/J.CELREP.2021.109922 ",3.73,"5.37397e+08","7ll2_oligo19","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_e_)-[MAN(5_e_)]-MAN(4_e_)-[MAN(7_e_)]-BMA(3_e_)-NAG(2_e_)-NAG(1_e_)-ASN(276_C_)",137.558,"","",""
"7LL2","CRYO-EM STRUCTURE OF BG505 DS-SOSIP IN COMPLEX WITH GLYCAN276- DEPENDENT BROADLY NEUTRALIZING ANTIBODY VRC33.01 FAB","10.1016/J.CELREP.2021.109922 ",3.73,"5.37397e+08","7ll2_oligo30","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_p_)-[MAN(5_p_)]-MAN(4_p_)-[MAN(7_p_)]-BMA(3_p_)-NAG(2_p_)-NAG(1_p_)-ASN(276_E_)",164.192,"","",""
"7LO6","STRUCTURE OF CD4 MIMETIC BNM-III-170 IN COMPLEX WITH BG505 SOSIP.664 HIV-1 ENV TRIMER AND 17B FAB","10.1038/S41467-021-21816-X ",3.9,0.00048876,"7lo6_oligo6","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_P_)-[MAN(5_P_)-MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(262_C_)",111.598,"","",""
"7LO6","STRUCTURE OF CD4 MIMETIC BNM-III-170 IN COMPLEX WITH BG505 SOSIP.664 HIV-1 ENV TRIMER AND 17B FAB","10.1038/S41467-021-21816-X ",3.9,0.00048876,"7lo6_oligo5","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_S_)-MAN(6_S_)-[MAN(5_S_)-MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(262_E_)",96.4803,"","",""
"7LO6","STRUCTURE OF CD4 MIMETIC BNM-III-170 IN COMPLEX WITH BG505 SOSIP.664 HIV-1 ENV TRIMER AND 17B FAB","10.1038/S41467-021-21816-X ",3.9,0.00048876,"7lo6_oligo2","DManpa1-6DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-MAN(4_N_)-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(262_A_)",141.492,"","",""
"7LOK","STRUCTURE OF CD4 MIMETIC M48U1 IN COMPLEX WITH BG505 SOSIP.664 HIV-1 ENV TRIMER AND 17B FAB","10.1038/S41467-021-21816-X ",3.9,0.00048876,"7lok_oligo2","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-SER","MAN(5_O_)-MAN(4_O_)-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-SER(447_A_)",72.266,"","",""
"7LOK","STRUCTURE OF CD4 MIMETIC M48U1 IN COMPLEX WITH BG505 SOSIP.664 HIV-1 ENV TRIMER AND 17B FAB","10.1038/S41467-021-21816-X ",3.9,0.00048876,"7lok_oligo1","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-MAN(4_N_)-[MAN(6_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(262_C_)",29.922,"","",""
"7LOK","STRUCTURE OF CD4 MIMETIC M48U1 IN COMPLEX WITH BG505 SOSIP.664 HIV-1 ENV TRIMER AND 17B FAB","10.1038/S41467-021-21816-X ",3.9,0.00048876,"7lok_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_P_)-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(262_E_)",82.3607,"","",""
"7LPN","CRYO-EM STRUCTURE OF LLAMA J3 VHH ANTIBODY IN COMPLEX WITH HIV-1 ENV BG505 DS-SOSIP.664","10.1016/J.STR.2022.03.012 ",3.61,"1.08527e-19","7lpn_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_R_)-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(262_G_)",145.291,"","",""
"7LPN","CRYO-EM STRUCTURE OF LLAMA J3 VHH ANTIBODY IN COMPLEX WITH HIV-1 ENV BG505 DS-SOSIP.664","10.1016/J.STR.2022.03.012 ",3.61,"1.08527e-19","7lpn_oligo27","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_j_)-BMA(3_j_)-NAG(2_j_)-NAG(1_j_)-ASN(262_F_)",144.747,"","",""
"7LPN","CRYO-EM STRUCTURE OF LLAMA J3 VHH ANTIBODY IN COMPLEX WITH HIV-1 ENV BG505 DS-SOSIP.664","10.1016/J.STR.2022.03.012 ",3.61,"1.08527e-19","7lpn_oligo12","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_a_)-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(262_C_)",141.438,"","",""
"7LRS","CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE IN COMPLEX WITH NEUTRALIZING ANTIBODY A23-58.1 THAT TARGETS THE RECEPTOR-BINDING DOMAIN","10.1126/SCIENCE.ABH1766 ",3.89,"1.08527e-19","7lrs_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_A_)-[MAN(4_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(343_C_)",110.993,"","",""
"7LRT","CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE IN COMPLEX WITH NEUTRALIZING ANTIBODY A23-58.1 THAT TARGETS THE RECEPTOR-BINDING DOMAIN","10.1126/SCIENCE.ABH1766 ",3.54,"5.50295e+11","7lrt_oligo16","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Y_)-[MAN(4_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(343_B_)",343.695,"","",""
"7LRT","CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE IN COMPLEX WITH NEUTRALIZING ANTIBODY A23-58.1 THAT TARGETS THE RECEPTOR-BINDING DOMAIN","10.1126/SCIENCE.ABH1766 ",3.54,"5.50295e+11","7lrt_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(343_A_)",340.766,"","",""
"7LRT","CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE IN COMPLEX WITH NEUTRALIZING ANTIBODY A23-58.1 THAT TARGETS THE RECEPTOR-BINDING DOMAIN","10.1126/SCIENCE.ABH1766 ",3.54,"5.50295e+11","7lrt_oligo22","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_e_)-[MAN(4_e_)]-BMA(3_e_)-NAG(2_e_)-NAG(1_e_)-ASN(343_C_)",286.798,"","",""
"7LU9","CRYO-EM STRUCTURE OF DH851.3 BOUND TO HIV-1 CH505 ENV","10.1016/J.CELL.2021.04.042 ",5.6,"5.37397e+08","7lu9_oligo13","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(262_e_)",215.077,"","",""
"7LU9","CRYO-EM STRUCTURE OF DH851.3 BOUND TO HIV-1 CH505 ENV","10.1016/J.CELL.2021.04.042 ",5.6,"5.37397e+08","7lu9_oligo10","DManpa1-6DManpa1-3[DGlcpNAcb1-4]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(6_J_)-[MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(241_e_)",50.6023,"","",""
"7LU9","CRYO-EM STRUCTURE OF DH851.3 BOUND TO HIV-1 CH505 ENV","10.1016/J.CELL.2021.04.042 ",5.6,"5.37397e+08","7lu9_oligo20","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_T_)-[MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(262_f_)",230.489,"","",""
"7LU9","CRYO-EM STRUCTURE OF DH851.3 BOUND TO HIV-1 CH505 ENV","10.1016/J.CELL.2021.04.042 ",5.6,"5.37397e+08","7lu9_oligo16","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_P_)-[MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(289_f_)",80.2638,"","",""
"7LU9","CRYO-EM STRUCTURE OF DH851.3 BOUND TO HIV-1 CH505 ENV","10.1016/J.CELL.2021.04.042 ",5.6,"5.37397e+08","7lu9_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(289_d_)",83.2305,"","",""
"7LU9","CRYO-EM STRUCTURE OF DH851.3 BOUND TO HIV-1 CH505 ENV","10.1016/J.CELL.2021.04.042 ",5.6,"5.37397e+08","7lu9_oligo1","DManpa1-6DManpa1-3[DGlcpNAcb1-4]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(6_C_)-[MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(241_d_)",43.6847,"","",""
"7LU9","CRYO-EM STRUCTURE OF DH851.3 BOUND TO HIV-1 CH505 ENV","10.1016/J.CELL.2021.04.042 ",5.6,"5.37397e+08","7lu9_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(262_d_)",242.518,"","",""
"7LU9","CRYO-EM STRUCTURE OF DH851.3 BOUND TO HIV-1 CH505 ENV","10.1016/J.CELL.2021.04.042 ",5.6,"5.37397e+08","7lu9_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(289_e_)",71.9329,"","",""
"7LU9","CRYO-EM STRUCTURE OF DH851.3 BOUND TO HIV-1 CH505 ENV","10.1016/J.CELL.2021.04.042 ",5.6,"5.37397e+08","7lu9_oligo17","DManpa1-6DManpa1-3[DGlcpNAcb1-4]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(6_Q_)-[MAN(5_Q_)-MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(241_f_)",84.9814,"","",""
"7LUA","CRYO-EM STRUCTURE OF DH898.1 FAB-DIMER BOUND NEAR THE CD4 BINDING SITE OF HIV-1 ENV CH848 SOSIP TRIMER","10.1016/J.CELL.2021.04.042 ",4.7,524802,"7lua_oligo1","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_M_)-MAN(4_M_)-[MAN(6_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)",30,"","",""
"7LUA","CRYO-EM STRUCTURE OF DH898.1 FAB-DIMER BOUND NEAR THE CD4 BINDING SITE OF HIV-1 ENV CH848 SOSIP TRIMER","10.1016/J.CELL.2021.04.042 ",4.7,524802,"7lua_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(276_e_)",31.1251,"","",""
"7LUA","CRYO-EM STRUCTURE OF DH898.1 FAB-DIMER BOUND NEAR THE CD4 BINDING SITE OF HIV-1 ENV CH848 SOSIP TRIMER","10.1016/J.CELL.2021.04.042 ",4.7,524802,"7lua_oligo32","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_p_)-[MAN(4_p_)]-BMA(3_p_)-NAG(2_p_)-NAG(1_p_)-ASN(262_c_)",30.4791,"","",""
"7LUA","CRYO-EM STRUCTURE OF DH898.1 FAB-DIMER BOUND NEAR THE CD4 BINDING SITE OF HIV-1 ENV CH848 SOSIP TRIMER","10.1016/J.CELL.2021.04.042 ",4.7,524802,"7lua_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(262_a_)",30.4827,"","",""
"7LUA","CRYO-EM STRUCTURE OF DH898.1 FAB-DIMER BOUND NEAR THE CD4 BINDING SITE OF HIV-1 ENV CH848 SOSIP TRIMER","10.1016/J.CELL.2021.04.042 ",4.7,524802,"7lua_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(262_e_)",30.4918,"","",""
"7LUS","IGG2 FC CHARGE PAIR MUTATION VERSION 1 (CPMV1)","10.1016/J.ISCI.2021.103447 ",2.45,39,"7lus_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_B_)",37.042,"","",""
"7LUS","IGG2 FC CHARGE PAIR MUTATION VERSION 1 (CPMV1)","10.1016/J.ISCI.2021.103447 ",2.45,39,"7lus_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_A_)",38.1909,"","",""
"7LX2","CRYO-EM STRUCTURE OF CONSOSL.UFO.664 (CONS) IN COMPLEX WITH BNAB PGT122","",3.12,"1.08527e-19","7lx2_oligo25","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_h_)-[MAN(8_h_)]-MAN(7_h_)-[MAN(6_h_)-MAN(5_h_)-MAN(4_h_)]-BMA(3_h_)-NAG(2_h_)-NAG(1_h_)-ASN(332_B_)",41.5229,"","",""
"7LX2","CRYO-EM STRUCTURE OF CONSOSL.UFO.664 (CONS) IN COMPLEX WITH BNAB PGT122","",3.12,"1.08527e-19","7lx2_oligo7","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_W_)-[MAN(5_W_)-MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(138_A_)",63.5006,"","",""
"7LX2","CRYO-EM STRUCTURE OF CONSOSL.UFO.664 (CONS) IN COMPLEX WITH BNAB PGT122","",3.12,"1.08527e-19","7lx2_oligo1","DManpa1-3DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_J_)-[MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(262_A_)",59.1032,"","",""
"7LX2","CRYO-EM STRUCTURE OF CONSOSL.UFO.664 (CONS) IN COMPLEX WITH BNAB PGT122","",3.12,"1.08527e-19","7lx2_oligo39","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_v_)-[MAN(8_v_)]-MAN(7_v_)-[MAN(6_v_)-MAN(5_v_)-MAN(4_v_)]-BMA(3_v_)-NAG(2_v_)-NAG(1_v_)-ASN(332_C_)",43.113,"","",""
"7LX2","CRYO-EM STRUCTURE OF CONSOSL.UFO.664 (CONS) IN COMPLEX WITH BNAB PGT122","",3.12,"1.08527e-19","7lx2_oligo4","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_T_)-[MAN(8_T_)]-MAN(7_T_)-[MAN(6_T_)-MAN(5_T_)-MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(332_A_)",41.5036,"","",""
"7LX2","CRYO-EM STRUCTURE OF CONSOSL.UFO.664 (CONS) IN COMPLEX WITH BNAB PGT122","",3.12,"1.08527e-19","7lx2_oligo13","DManpa1-3DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_c_)-[MAN(5_c_)-MAN(4_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(262_B_)",59.6742,"","",""
"7LX2","CRYO-EM STRUCTURE OF CONSOSL.UFO.664 (CONS) IN COMPLEX WITH BNAB PGT122","",3.12,"1.08527e-19","7lx2_oligo42","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_y_)-[MAN(5_y_)-MAN(4_y_)]-BMA(3_y_)-NAG(2_y_)-NAG(1_y_)-ASN(138_C_)",63.4604,"","",""
"7LX2","CRYO-EM STRUCTURE OF CONSOSL.UFO.664 (CONS) IN COMPLEX WITH BNAB PGT122","",3.12,"1.08527e-19","7lx2_oligo34","DManpa1-3DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_q_)-[MAN(5_q_)-MAN(4_q_)]-BMA(3_q_)-NAG(2_q_)-NAG(1_q_)-ASN(262_C_)",59.6732,"","",""
"7LX2","CRYO-EM STRUCTURE OF CONSOSL.UFO.664 (CONS) IN COMPLEX WITH BNAB PGT122","",3.12,"1.08527e-19","7lx2_oligo28","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_k_)-[MAN(5_k_)-MAN(4_k_)]-BMA(3_k_)-NAG(2_k_)-NAG(1_k_)-ASN(138_B_)",62.3423,"","",""
"7LX3","CRYO-EM STRUCTURE OF EDC-CROSSLINKED CONSOSL.UFO.664 (CONS-EDC) IN COMPLEX WITH BNAB PGT122","",3.45,"1.08527e-19","7lx3_oligo25","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_h_)-[MAN(8_h_)]-MAN(7_h_)-[MAN(6_h_)-MAN(5_h_)-MAN(4_h_)]-BMA(3_h_)-NAG(2_h_)-NAG(1_h_)-ASN(332_B_)",68.1506,"","",""
"7LX3","CRYO-EM STRUCTURE OF EDC-CROSSLINKED CONSOSL.UFO.664 (CONS-EDC) IN COMPLEX WITH BNAB PGT122","",3.45,"1.08527e-19","7lx3_oligo13","DManpa1-3DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_c_)-[MAN(5_c_)-MAN(4_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(262_B_)",89.7189,"","",""
"7LX3","CRYO-EM STRUCTURE OF EDC-CROSSLINKED CONSOSL.UFO.664 (CONS-EDC) IN COMPLEX WITH BNAB PGT122","",3.45,"1.08527e-19","7lx3_oligo4","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_T_)-[MAN(8_T_)]-MAN(7_T_)-[MAN(6_T_)-MAN(5_T_)-MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(332_A_)",67.7974,"","",""
"7LX3","CRYO-EM STRUCTURE OF EDC-CROSSLINKED CONSOSL.UFO.664 (CONS-EDC) IN COMPLEX WITH BNAB PGT122","",3.45,"1.08527e-19","7lx3_oligo28","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_k_)-[MAN(5_k_)-MAN(4_k_)]-BMA(3_k_)-NAG(2_k_)-NAG(1_k_)-ASN(138_B_)",89.408,"","",""
"7LX3","CRYO-EM STRUCTURE OF EDC-CROSSLINKED CONSOSL.UFO.664 (CONS-EDC) IN COMPLEX WITH BNAB PGT122","",3.45,"1.08527e-19","7lx3_oligo7","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_W_)-[MAN(5_W_)-MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(138_A_)",89.1991,"","",""
"7LX3","CRYO-EM STRUCTURE OF EDC-CROSSLINKED CONSOSL.UFO.664 (CONS-EDC) IN COMPLEX WITH BNAB PGT122","",3.45,"1.08527e-19","7lx3_oligo1","DManpa1-3DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_J_)-[MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(262_A_)",89.8459,"","",""
"7LX3","CRYO-EM STRUCTURE OF EDC-CROSSLINKED CONSOSL.UFO.664 (CONS-EDC) IN COMPLEX WITH BNAB PGT122","",3.45,"1.08527e-19","7lx3_oligo42","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_y_)-[MAN(5_y_)-MAN(4_y_)]-BMA(3_y_)-NAG(2_y_)-NAG(1_y_)-ASN(138_C_)",89.082,"","",""
"7LX3","CRYO-EM STRUCTURE OF EDC-CROSSLINKED CONSOSL.UFO.664 (CONS-EDC) IN COMPLEX WITH BNAB PGT122","",3.45,"1.08527e-19","7lx3_oligo34","DManpa1-3DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_q_)-[MAN(5_q_)-MAN(4_q_)]-BMA(3_q_)-NAG(2_q_)-NAG(1_q_)-ASN(262_C_)",89.7277,"","",""
"7LX3","CRYO-EM STRUCTURE OF EDC-CROSSLINKED CONSOSL.UFO.664 (CONS-EDC) IN COMPLEX WITH BNAB PGT122","",3.45,"1.08527e-19","7lx3_oligo39","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_v_)-[MAN(8_v_)]-MAN(7_v_)-[MAN(6_v_)-MAN(5_v_)-MAN(4_v_)]-BMA(3_v_)-NAG(2_v_)-NAG(1_v_)-ASN(332_C_)",66.3606,"","",""
"7LXM","CRYO-EM STRUCTURE OF CONM SOSIP.V7 (CONM) IN COMPLEX WITH BNAB PGT122","",3.41,"1.08527e-19","7lxm_oligo35","DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_u_)-MAN(6_u_)-[MAN(5_u_)-MAN(4_u_)]-BMA(3_u_)-NAG(2_u_)-NAG(1_u_)-ASN(262_E_)",131.317,"","",""
"7LXM","CRYO-EM STRUCTURE OF CONM SOSIP.V7 (CONM) IN COMPLEX WITH BNAB PGT122","",3.41,"1.08527e-19","7lxm_oligo28","DManpa1-6DManpa1-3DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_G_)-MAN(5_G_)-MAN(4_G_)-[MAN(8_G_)-MAN(7_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(138_A_)",64.6208,"","",""
"7LXM","CRYO-EM STRUCTURE OF CONM SOSIP.V7 (CONM) IN COMPLEX WITH BNAB PGT122","",3.41,"1.08527e-19","7lxm_oligo38","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_x_)-[MAN(8_x_)]-MAN(7_x_)-[MAN(6_x_)-MAN(5_x_)-MAN(4_x_)]-BMA(3_x_)-NAG(2_x_)-NAG(1_x_)-ASN(332_E_)",53.0979,"","",""
"7LXM","CRYO-EM STRUCTURE OF CONM SOSIP.V7 (CONM) IN COMPLEX WITH BNAB PGT122","",3.41,"1.08527e-19","7lxm_oligo9","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_j_)-[MAN(8_j_)]-MAN(7_j_)-[MAN(6_j_)-MAN(5_j_)-MAN(4_j_)]-BMA(3_j_)-NAG(2_j_)-NAG(1_j_)-ASN(332_C_)",51.7729,"","",""
"7LXM","CRYO-EM STRUCTURE OF CONM SOSIP.V7 (CONM) IN COMPLEX WITH BNAB PGT122","",3.41,"1.08527e-19","7lxm_oligo17","DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_S_)-MAN(6_S_)-[MAN(5_S_)-MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(262_A_)",132.362,"","",""
"7LXM","CRYO-EM STRUCTURE OF CONM SOSIP.V7 (CONM) IN COMPLEX WITH BNAB PGT122","",3.41,"1.08527e-19","7lxm_oligo6","DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_g_)-MAN(6_g_)-[MAN(5_g_)-MAN(4_g_)]-BMA(3_g_)-NAG(2_g_)-NAG(1_g_)-ASN(262_C_)",132.231,"","",""
"7LXM","CRYO-EM STRUCTURE OF CONM SOSIP.V7 (CONM) IN COMPLEX WITH BNAB PGT122","",3.41,"1.08527e-19","7lxm_oligo14","DManpa1-6DManpa1-3DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_o_)-MAN(5_o_)-MAN(4_o_)-[MAN(8_o_)-MAN(7_o_)]-BMA(3_o_)-NAG(2_o_)-NAG(1_o_)-ASN(138_E_)",63.5044,"","",""
"7LXM","CRYO-EM STRUCTURE OF CONM SOSIP.V7 (CONM) IN COMPLEX WITH BNAB PGT122","",3.41,"1.08527e-19","7lxm_oligo20","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_V_)-[MAN(8_V_)]-MAN(7_V_)-[MAN(6_V_)-MAN(5_V_)-MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(332_A_)",52.3971,"","",""
"7LXM","CRYO-EM STRUCTURE OF CONM SOSIP.V7 (CONM) IN COMPLEX WITH BNAB PGT122","",3.41,"1.08527e-19","7lxm_oligo25","DManpa1-6DManpa1-3DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_a_)-MAN(5_a_)-MAN(4_a_)-[MAN(8_a_)-MAN(7_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(138_C_)",63.257,"","",""
"7LXN","CRYO-EM STRUCTURE OF EDC-CROSSLINKED CONM SOSIP.V7 (CONM-EDC) IN COMPLEX WITH BNAB PGT122","",3.85,"1.08527e-19","7lxn_oligo20","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_V_)-[MAN(8_V_)]-MAN(7_V_)-[MAN(6_V_)-MAN(5_V_)-MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(332_A_)",76.9976,"","",""
"7LXN","CRYO-EM STRUCTURE OF EDC-CROSSLINKED CONM SOSIP.V7 (CONM-EDC) IN COMPLEX WITH BNAB PGT122","",3.85,"1.08527e-19","7lxn_oligo9","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_j_)-[MAN(8_j_)]-MAN(7_j_)-[MAN(6_j_)-MAN(5_j_)-MAN(4_j_)]-BMA(3_j_)-NAG(2_j_)-NAG(1_j_)-ASN(332_C_)",77.4678,"","",""
"7LXN","CRYO-EM STRUCTURE OF EDC-CROSSLINKED CONM SOSIP.V7 (CONM-EDC) IN COMPLEX WITH BNAB PGT122","",3.85,"1.08527e-19","7lxn_oligo6","DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_g_)-MAN(6_g_)-[MAN(5_g_)-MAN(4_g_)]-BMA(3_g_)-NAG(2_g_)-NAG(1_g_)-ASN(262_C_)",191.053,"","",""
"7LXN","CRYO-EM STRUCTURE OF EDC-CROSSLINKED CONM SOSIP.V7 (CONM-EDC) IN COMPLEX WITH BNAB PGT122","",3.85,"1.08527e-19","7lxn_oligo35","DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_u_)-MAN(6_u_)-[MAN(5_u_)-MAN(4_u_)]-BMA(3_u_)-NAG(2_u_)-NAG(1_u_)-ASN(262_E_)",185.128,"","",""
"7LXN","CRYO-EM STRUCTURE OF EDC-CROSSLINKED CONM SOSIP.V7 (CONM-EDC) IN COMPLEX WITH BNAB PGT122","",3.85,"1.08527e-19","7lxn_oligo14","DManpa1-6DManpa1-3DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_o_)-MAN(5_o_)-MAN(4_o_)-[MAN(8_o_)-MAN(7_o_)]-BMA(3_o_)-NAG(2_o_)-NAG(1_o_)-ASN(138_E_)",113.48,"","",""
"7LXN","CRYO-EM STRUCTURE OF EDC-CROSSLINKED CONM SOSIP.V7 (CONM-EDC) IN COMPLEX WITH BNAB PGT122","",3.85,"1.08527e-19","7lxn_oligo28","DManpa1-6DManpa1-3DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_G_)-MAN(5_G_)-MAN(4_G_)-[MAN(8_G_)-MAN(7_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(138_A_)",111.995,"","",""
"7LXN","CRYO-EM STRUCTURE OF EDC-CROSSLINKED CONM SOSIP.V7 (CONM-EDC) IN COMPLEX WITH BNAB PGT122","",3.85,"1.08527e-19","7lxn_oligo17","DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_S_)-MAN(6_S_)-[MAN(5_S_)-MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(262_A_)",191.216,"","",""
"7LXN","CRYO-EM STRUCTURE OF EDC-CROSSLINKED CONM SOSIP.V7 (CONM-EDC) IN COMPLEX WITH BNAB PGT122","",3.85,"1.08527e-19","7lxn_oligo38","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_x_)-[MAN(8_x_)]-MAN(7_x_)-[MAN(6_x_)-MAN(5_x_)-MAN(4_x_)]-BMA(3_x_)-NAG(2_x_)-NAG(1_x_)-ASN(332_E_)",77.0157,"","",""
"7LXN","CRYO-EM STRUCTURE OF EDC-CROSSLINKED CONM SOSIP.V7 (CONM-EDC) IN COMPLEX WITH BNAB PGT122","",3.85,"1.08527e-19","7lxn_oligo25","DManpa1-6DManpa1-3DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_a_)-MAN(5_a_)-MAN(4_a_)-[MAN(8_a_)-MAN(7_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(138_C_)",111.368,"","",""
"7LY9","CRYO-EM STRUCTURE OF 2909 FAB IN COMPLEX WITH 3BNC117 FAB AND CAP256.WK34.C80 SOSIP.RNS2 N160K HIV-1 ENV TRIMER","10.1038/S41467-021-26579-Z ",3.91,"5.37397e+08","7ly9_oligo3","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_U_)-[MAN(5_U_)]-MAN(4_U_)-[MAN(7_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(276_D_)",103.916,"","",""
"7LY9","CRYO-EM STRUCTURE OF 2909 FAB IN COMPLEX WITH 3BNC117 FAB AND CAP256.WK34.C80 SOSIP.RNS2 N160K HIV-1 ENV TRIMER","10.1038/S41467-021-26579-Z ",3.91,"5.37397e+08","7ly9_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_R_)-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(262_G_)",80.3873,"","",""
"7LY9","CRYO-EM STRUCTURE OF 2909 FAB IN COMPLEX WITH 3BNC117 FAB AND CAP256.WK34.C80 SOSIP.RNS2 N160K HIV-1 ENV TRIMER","10.1038/S41467-021-26579-Z ",3.91,"5.37397e+08","7ly9_oligo8","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Z_)-[MAN(5_Z_)]-MAN(4_Z_)-[MAN(7_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(276_K_)",94.9948,"","",""
"7LY9","CRYO-EM STRUCTURE OF 2909 FAB IN COMPLEX WITH 3BNC117 FAB AND CAP256.WK34.C80 SOSIP.RNS2 N160K HIV-1 ENV TRIMER","10.1038/S41467-021-26579-Z ",3.91,"5.37397e+08","7ly9_oligo12","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Q_)-[MAN(5_Q_)]-MAN(4_Q_)-[MAN(7_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(276_G_)",97.3608,"","",""
"7LYD","CRYSTAL STRUCTURE OF EBOLA ZAIRE ENVELOPE GLYCOPROTEIN GP IN COMPLEX WITH COMPOUND ARN0075146","",2.35,65.07,"7lyd_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(563_B_)",94.7145,"","",""
"7LYU","REELIN REPEAT 8","10.1016/J.BPJ.2022.06.002 ",3,64.81,"7lyu_oligo3","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(3412_A_)",73.4618,"","",""
"7LYU","REELIN REPEAT 8","10.1016/J.BPJ.2022.06.002 ",3,64.81,"7lyu_oligo1","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(3185_B_)",76.2747,"","",""
"7M1P","HUMAN ABCA4 STRUCTURE IN THE UNBOUND STATE","10.1038/S41467-021-26161-7 ",3.6,0,"7m1p_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(1529_A_)",65.4933,"","",""
"7M1Q","HUMAN ABCA4 STRUCTURE IN COMPLEX WITH N-RET-PE","10.1038/S41467-021-26161-7 ",2.92,0,"7m1q_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(1529_A_)",90.8404,"","",""
"7M5E","MERS-COV S BOUND TO THE BROADLY NEUTRALIZING B6 FAB FRAGMENT (C3 REFINEMENT)","10.1038/S41594-021-00596-4 ",2.5,0,"7m5e_oligo25","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_b_)-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(1213_E_)",16.2902,"","",""
"7M5E","MERS-COV S BOUND TO THE BROADLY NEUTRALIZING B6 FAB FRAGMENT (C3 REFINEMENT)","10.1038/S41594-021-00596-4 ",2.5,0,"7m5e_oligo12","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(125_A_)",13.2035,"","",""
"7M5E","MERS-COV S BOUND TO THE BROADLY NEUTRALIZING B6 FAB FRAGMENT (C3 REFINEMENT)","10.1038/S41594-021-00596-4 ",2.5,0,"7m5e_oligo18","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(222_A_)",15.1486,"","",""
"7M5E","MERS-COV S BOUND TO THE BROADLY NEUTRALIZING B6 FAB FRAGMENT (C3 REFINEMENT)","10.1038/S41594-021-00596-4 ",2.5,0,"7m5e_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_U_)-[MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(125_C_)",13.2035,"","",""
"7M5E","MERS-COV S BOUND TO THE BROADLY NEUTRALIZING B6 FAB FRAGMENT (C3 REFINEMENT)","10.1038/S41594-021-00596-4 ",2.5,0,"7m5e_oligo21","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_X_)-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(222_E_)",15.1486,"","",""
"7M5E","MERS-COV S BOUND TO THE BROADLY NEUTRALIZING B6 FAB FRAGMENT (C3 REFINEMENT)","10.1038/S41594-021-00596-4 ",2.5,0,"7m5e_oligo28","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_e_)-[MAN(4_e_)]-BMA(3_e_)-NAG(2_e_)-NAG(1_e_)-ASN(125_E_)",13.2035,"","",""
"7M5E","MERS-COV S BOUND TO THE BROADLY NEUTRALIZING B6 FAB FRAGMENT (C3 REFINEMENT)","10.1038/S41594-021-00596-4 ",2.5,0,"7m5e_oligo15","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_N_)-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(222_C_)",15.1486,"","",""
"7M5E","MERS-COV S BOUND TO THE BROADLY NEUTRALIZING B6 FAB FRAGMENT (C3 REFINEMENT)","10.1038/S41594-021-00596-4 ",2.5,0,"7m5e_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_V_)-[MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(166_C_)",25.2645,"","",""
"7M5E","MERS-COV S BOUND TO THE BROADLY NEUTRALIZING B6 FAB FRAGMENT (C3 REFINEMENT)","10.1038/S41594-021-00596-4 ",2.5,0,"7m5e_oligo13","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_L_)-[MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(166_A_)",25.2645,"","",""
"7M5E","MERS-COV S BOUND TO THE BROADLY NEUTRALIZING B6 FAB FRAGMENT (C3 REFINEMENT)","10.1038/S41594-021-00596-4 ",2.5,0,"7m5e_oligo29","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_f_)-[MAN(4_f_)]-BMA(3_f_)-NAG(2_f_)-NAG(1_f_)-ASN(166_E_)",25.2645,"","",""
"7M5E","MERS-COV S BOUND TO THE BROADLY NEUTRALIZING B6 FAB FRAGMENT (C3 REFINEMENT)","10.1038/S41594-021-00596-4 ",2.5,0,"7m5e_oligo1","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_F_)-MAN(6_F_)-[MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(410_A_)",16.816,"","",""
"7M5E","MERS-COV S BOUND TO THE BROADLY NEUTRALIZING B6 FAB FRAGMENT (C3 REFINEMENT)","10.1038/S41594-021-00596-4 ",2.5,0,"7m5e_oligo17","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_P_)-MAN(6_P_)-[MAN(5_P_)-MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(410_C_)",16.816,"","",""
"7M5E","MERS-COV S BOUND TO THE BROADLY NEUTRALIZING B6 FAB FRAGMENT (C3 REFINEMENT)","10.1038/S41594-021-00596-4 ",2.5,0,"7m5e_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_R_)-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(1213_C_)",16.2902,"","",""
"7M5E","MERS-COV S BOUND TO THE BROADLY NEUTRALIZING B6 FAB FRAGMENT (C3 REFINEMENT)","10.1038/S41594-021-00596-4 ",2.5,0,"7m5e_oligo23","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_Z_)-MAN(6_Z_)-[MAN(5_Z_)-MAN(4_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(410_E_)",16.816,"","",""
"7M5E","MERS-COV S BOUND TO THE BROADLY NEUTRALIZING B6 FAB FRAGMENT (C3 REFINEMENT)","10.1038/S41594-021-00596-4 ",2.5,0,"7m5e_oligo11","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_H_)-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(1213_A_)",16.2902,"","",""
"7M6D","STRUCTURE OF THE SARS-COV-2 RBD IN COMPLEX WITH NEUTRALIZING ANTIBODIES BG4-25 AND CR3022","10.1016/J.CELL.2021.04.032 ",3.1,83.66,"7m6d_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_D_)-[MAN(4_D_)-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(343_C_)",113.952,"","",""
"7M6I","STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, BG1-24","10.1016/J.CELL.2021.04.032 ",4,2050.01,"7m6i_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(165_B_)",304.377,"","",""
"7M8L","EBOV GP BOUND TO REBOV-442 AND REBOV-515 FABS","10.1016/J.CELL.2021.09.035 ",3.9,"1.08527e-19","7m8l_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Y_)-[MAN(4_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(257_C_)",179.001,"","",""
"7M8L","EBOV GP BOUND TO REBOV-442 AND REBOV-515 FABS","10.1016/J.CELL.2021.09.035 ",3.9,"1.08527e-19","7m8l_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(257_A_)",179.001,"","",""
"7M8L","EBOV GP BOUND TO REBOV-442 AND REBOV-515 FABS","10.1016/J.CELL.2021.09.035 ",3.9,"1.08527e-19","7m8l_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_X_)-[MAN(4_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(563_E_)",90.586,"","",""
"7M8L","EBOV GP BOUND TO REBOV-442 AND REBOV-515 FABS","10.1016/J.CELL.2021.09.035 ",3.9,"1.08527e-19","7m8l_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_U_)-[MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(563_D_)",90.586,"","",""
"7M8L","EBOV GP BOUND TO REBOV-442 AND REBOV-515 FABS","10.1016/J.CELL.2021.09.035 ",3.9,"1.08527e-19","7m8l_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_a_)-[MAN(4_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(563_F_)",90.586,"","",""
"7M8L","EBOV GP BOUND TO REBOV-442 AND REBOV-515 FABS","10.1016/J.CELL.2021.09.035 ",3.9,"1.08527e-19","7m8l_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_V_)-[MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(257_B_)",179.001,"","",""
"7MDT","BG505 SOSIP.V5.2 IN COMPLEX WITH THE MONOCLONAL ANTIBODY RH4O9.8 (AS FAB FRAGMENT)","10.1126/SCIADV.ABK2039 ",3.6,"1.35632e-19","7mdt_oligo8","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_V_)-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(262_C_)",109.701,"","",""
"7MDT","BG505 SOSIP.V5.2 IN COMPLEX WITH THE MONOCLONAL ANTIBODY RH4O9.8 (AS FAB FRAGMENT)","10.1126/SCIADV.ABK2039 ",3.6,"1.35632e-19","7mdt_oligo19","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_a_)-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(262_E_)",75.385,"","",""
"7MDT","BG505 SOSIP.V5.2 IN COMPLEX WITH THE MONOCLONAL ANTIBODY RH4O9.8 (AS FAB FRAGMENT)","10.1126/SCIADV.ABK2039 ",3.6,"1.35632e-19","7mdt_oligo12","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_P_)-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(262_A_)",71.085,"","",""
"7MDU","BG505 SOSIP MD39 IN COMPLEX WITH THE MONOCLONAL ANTIBODIES RH.33104 MAB.1 AND RM20A3","10.1126/SCIADV.ABK2039 ",3.3,"1.35632e-19","7mdu_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(262_A_)",74.8515,"","",""
"7MEP","BG505 SOSIP.V5.2(7S) IN COMPLEX WITH THE MONOCLONAL ANTIBODIES RH.33172 MAB.1 AND RM19R","10.1126/SCIADV.ABK2039 ",3.5,"1.35632e-19","7mep_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Y_)-[MAN(4_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(262_D_)",73.6902,"","",""
"7MEP","BG505 SOSIP.V5.2(7S) IN COMPLEX WITH THE MONOCLONAL ANTIBODIES RH.33172 MAB.1 AND RM19R","10.1126/SCIADV.ABK2039 ",3.5,"1.35632e-19","7mep_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_U_)-[MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(262_C_)",75.8071,"","",""
"7MEP","BG505 SOSIP.V5.2(7S) IN COMPLEX WITH THE MONOCLONAL ANTIBODIES RH.33172 MAB.1 AND RM19R","10.1126/SCIADV.ABK2039 ",3.5,"1.35632e-19","7mep_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(262_A_)",70.5684,"","",""
"7MFH","CRYSTAL STRUCTURE OF BIO-32546 BOUND MOUSE AUTOTAXIN","10.1021/ACSMEDCHEMLETT.1C00211 ",2.3,60.22,"7mfh_oligo1","DManpa1-2DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-MAN(5_B_)-MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(524_A_)",67.2115,"","",""
"7MLV","CRYO-EM REVEALS PARTIALLY AND FULLY ASSEMBLED NATIVE GLYCINE RECEPTORS,HOMOMERIC TETRAMER","10.1038/S41586-021-04022-Z ",4.1,"1.08527e-19","7mlv_oligo1","DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(504_D_)-MAN(507_D_)-[MAN(502_D_)-MAN(501_D_)]-BMA(503_D_)-NAG(506_D_)-NAG(505_D_)",190.534,"","",""
"7MLV","CRYO-EM REVEALS PARTIALLY AND FULLY ASSEMBLED NATIVE GLYCINE RECEPTORS,HOMOMERIC TETRAMER","10.1038/S41586-021-04022-Z ",4.1,"1.08527e-19","7mlv_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(38_A_)",168.312,"","",""
"7MLV","CRYO-EM REVEALS PARTIALLY AND FULLY ASSEMBLED NATIVE GLYCINE RECEPTORS,HOMOMERIC TETRAMER","10.1038/S41586-021-04022-Z ",4.1,"1.08527e-19","7mlv_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_O_)-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(38_B_)",174.174,"","",""
"7MLZ","CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE IN COMPLEX WITH NEUTRALIZING ANTIBODY B1-182.1 THAT TARGETS THE RECEPTOR-BINDING DOMAIN","10.1126/SCIENCE.ABH1766 ",3.71,"1.08527e-19","7mlz_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(343_A_)",125.762,"","",""
"7MN5","STRUCTURE OF THE HER2/HER3/NRG1B HETERODIMER EXTRACELLULAR DOMAIN","10.1038/S41586-021-04084-Z ",2.93,"1.08527e-19","7mn5_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(259_B_)",67.5473,"","",""
"7MN6","STRUCTURE OF THE HER2 S310F/HER3/NRG1B HETERODIMER EXTRACELLULAR DOMAIN","10.1038/S41586-021-04084-Z ",3.09,"1.08527e-19","7mn6_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(259_B_)",127.169,"","",""
"7MN8","STRUCTURE OF THE HER2/HER3/NRG1B HETERODIMER EXTRACELLULAR DOMAIN BOUND TO TRASTUZUMAB FAB","10.1038/S41586-021-04084-Z ",3.45,"1.08527e-19","7mn8_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(259_B_)",127.633,"","",""
"7MP4","CRYSTAL STRUCTURE OF EPIPHYAS POSTVITTANA ANTENNAL CARBOXYLESTERASE 24","10.1016/J.CRIS.2023.100062 ",2.43,43.79,"7mp4_oligo6","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-MAN(4_N_)-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(348_F_)",63.1291,"","",""
"7MP4","CRYSTAL STRUCTURE OF EPIPHYAS POSTVITTANA ANTENNAL CARBOXYLESTERASE 24","10.1016/J.CRIS.2023.100062 ",2.43,43.79,"7mp4_oligo2","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(348_B_)",68.2838,"","",""
"7MP4","CRYSTAL STRUCTURE OF EPIPHYAS POSTVITTANA ANTENNAL CARBOXYLESTERASE 24","10.1016/J.CRIS.2023.100062 ",2.43,43.79,"7mp4_oligo7","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-MAN(4_O_)-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(348_G_)",57.902,"","",""
"7MP4","CRYSTAL STRUCTURE OF EPIPHYAS POSTVITTANA ANTENNAL CARBOXYLESTERASE 24","10.1016/J.CRIS.2023.100062 ",2.43,43.79,"7mp4_oligo4","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_L_)-MAN(4_L_)-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(348_D_)",62.5091,"","",""
"7MP4","CRYSTAL STRUCTURE OF EPIPHYAS POSTVITTANA ANTENNAL CARBOXYLESTERASE 24","10.1016/J.CRIS.2023.100062 ",2.43,43.79,"7mp4_oligo3","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-MAN(4_K_)-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(348_C_)",64.5198,"","",""
"7MP4","CRYSTAL STRUCTURE OF EPIPHYAS POSTVITTANA ANTENNAL CARBOXYLESTERASE 24","10.1016/J.CRIS.2023.100062 ",2.43,43.79,"7mp4_oligo1","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(348_A_)",54.0164,"","",""
"7MP4","CRYSTAL STRUCTURE OF EPIPHYAS POSTVITTANA ANTENNAL CARBOXYLESTERASE 24","10.1016/J.CRIS.2023.100062 ",2.43,43.79,"7mp4_oligo5","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-MAN(4_M_)-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(348_E_)",57.3176,"","",""
"7MP4","CRYSTAL STRUCTURE OF EPIPHYAS POSTVITTANA ANTENNAL CARBOXYLESTERASE 24","10.1016/J.CRIS.2023.100062 ",2.43,43.79,"7mp4_oligo8","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_P_)-MAN(4_P_)-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(348_H_)",60.1167,"","",""
"7MSQ","COMPLEX BETWEEN THE FAB ARM OF AB-3467 AND THE SARS-COV-2 RECEPTOR BINDING DOMAIN (RBD)","10.1016/J.IMMUNI.2021.10.019 ",2.29,50.26,"7msq_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_C_)-[MAN(4_C_)-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(343_A_)",84.4324,"","",""
"7MXD","CRYO-EM STRUCTURE OF BROADLY NEUTRALIZING V2-APEX-TARGETING ANTIBODY J038 IN COMPLEX WITH HIV-1 ENV","10.1002/ADVS.202200063 ",3.4,"1.47221e+19","7mxd_oligo14","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_e_)-[MAN(5_e_)]-MAN(4_e_)-[MAN(7_e_)]-BMA(3_e_)-NAG(2_e_)-NAG(1_e_)-ASN(276_F_)",60.9167,"","",""
"7MXD","CRYO-EM STRUCTURE OF BROADLY NEUTRALIZING V2-APEX-TARGETING ANTIBODY J038 IN COMPLEX WITH HIV-1 ENV","10.1002/ADVS.202200063 ",3.4,"1.47221e+19","7mxd_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_N_)-MAN(7_N_)-[MAN(6_N_)-MAN(5_N_)-MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(262_A_)",57.73,"","",""
"7MXD","CRYO-EM STRUCTURE OF BROADLY NEUTRALIZING V2-APEX-TARGETING ANTIBODY J038 IN COMPLEX WITH HIV-1 ENV","10.1002/ADVS.202200063 ",3.4,"1.47221e+19","7mxd_oligo25","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_m_)-[MAN(5_m_)]-MAN(4_m_)-[MAN(7_m_)]-BMA(3_m_)-NAG(2_m_)-NAG(1_m_)-ASN(160_F_)",67.1953,"","",""
"7MXD","CRYO-EM STRUCTURE OF BROADLY NEUTRALIZING V2-APEX-TARGETING ANTIBODY J038 IN COMPLEX WITH HIV-1 ENV","10.1002/ADVS.202200063 ",3.4,"1.47221e+19","7mxd_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_O_)-[MAN(5_O_)]-MAN(4_O_)-[MAN(7_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(276_A_)",64.9677,"","",""
"7MXD","CRYO-EM STRUCTURE OF BROADLY NEUTRALIZING V2-APEX-TARGETING ANTIBODY J038 IN COMPLEX WITH HIV-1 ENV","10.1002/ADVS.202200063 ",3.4,"1.47221e+19","7mxd_oligo27","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_o_)-[MAN(5_o_)-MAN(4_o_)]-BMA(3_o_)-NAG(2_o_)-NAG(1_o_)-ASN(262_G_)",61.8186,"","",""
"7MXD","CRYO-EM STRUCTURE OF BROADLY NEUTRALIZING V2-APEX-TARGETING ANTIBODY J038 IN COMPLEX WITH HIV-1 ENV","10.1002/ADVS.202200063 ",3.4,"1.47221e+19","7mxd_oligo28","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_p_)-[MAN(5_p_)]-MAN(4_p_)-[MAN(7_p_)]-BMA(3_p_)-NAG(2_p_)-NAG(1_p_)-ASN(276_G_)",70.6173,"","",""
"7MXD","CRYO-EM STRUCTURE OF BROADLY NEUTRALIZING V2-APEX-TARGETING ANTIBODY J038 IN COMPLEX WITH HIV-1 ENV","10.1002/ADVS.202200063 ",3.4,"1.47221e+19","7mxd_oligo13","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_d_)-[MAN(5_d_)-MAN(4_d_)]-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(262_F_)",56.5956,"","",""
"7MXE","AB1245 FAB IN COMPLEX WITH BG505 SOSIP.664 AND 8ANC195 FAB","10.1038/S41541-021-00387-4 ",3.7,"1.08527e-19","7mxe_oligo31","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_s_)-[MAN(4_s_)]-BMA(3_s_)-NAG(2_s_)-NAG(1_s_)-ASN(276_P_)",88.3447,"","",""
"7MXE","AB1245 FAB IN COMPLEX WITH BG505 SOSIP.664 AND 8ANC195 FAB","10.1038/S41541-021-00387-4 ",3.7,"1.08527e-19","7mxe_oligo19","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_Y_)-MAN(10_Y_)-[MAN(9_Y_)-MAN(8_Y_)]-MAN(7_Y_)-[MAN(6_Y_)-MAN(5_Y_)-MAN(4_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(234_G_)",58.8008,"","",""
"7MXE","AB1245 FAB IN COMPLEX WITH BG505 SOSIP.664 AND 8ANC195 FAB","10.1038/S41541-021-00387-4 ",3.7,"1.08527e-19","7mxe_oligo7","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_i_)-MAN(8_i_)-[MAN(10_i_)]-MAN(7_i_)-[MAN(6_i_)-MAN(5_i_)-MAN(4_i_)]-BMA(3_i_)-NAG(2_i_)-NAG(1_i_)-ASN(234_J_)",41.6534,"","",""
"7MXE","AB1245 FAB IN COMPLEX WITH BG505 SOSIP.664 AND 8ANC195 FAB","10.1038/S41541-021-00387-4 ",3.7,"1.08527e-19","7mxe_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_h_)-[MAN(4_h_)]-BMA(3_h_)-NAG(2_h_)-NAG(1_h_)-ASN(276_J_)",62.362,"","",""
"7MXE","AB1245 FAB IN COMPLEX WITH BG505 SOSIP.664 AND 8ANC195 FAB","10.1038/S41541-021-00387-4 ",3.7,"1.08527e-19","7mxe_oligo30","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_r_)-MAN(8_r_)-[MAN(10_r_)]-MAN(7_r_)-[MAN(6_r_)-MAN(5_r_)-MAN(4_r_)]-BMA(3_r_)-NAG(2_r_)-NAG(1_r_)-ASN(234_P_)",69.7401,"","",""
"7MXE","AB1245 FAB IN COMPLEX WITH BG505 SOSIP.664 AND 8ANC195 FAB","10.1038/S41541-021-00387-4 ",3.7,"1.08527e-19","7mxe_oligo18","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_X_)-[MAN(5_X_)-MAN(4_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(276_G_)",79.6289,"","",""
"7MXE","AB1245 FAB IN COMPLEX WITH BG505 SOSIP.664 AND 8ANC195 FAB","10.1038/S41541-021-00387-4 ",3.7,"1.08527e-19","7mxe_oligo17","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_V_)-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(262_G_)",73.3195,"","",""
"7MZH","SARS-COV-2 RECEPTOR BINDING DOMAIN BOUND TO FAB WCSL 119","10.1016/J.CELREP.2021.109822 ",2.1,49.46,"7mzh_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_F_)-[MAN(4_F_)-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(343_A_)",74.7404,"","",""
"7N28","CRYO-EM STRUCTURE OF BROADLY NEUTRALIZING V2-APEX-TARGETING ANTIBODY J033 IN COMPLEX WITH HIV-1 ENV","10.1002/ADVS.202200063 ",4.2,0.00048876,"7n28_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_O_)-[MAN(5_O_)]-MAN(4_O_)-[MAN(7_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(276_A_)",91.8283,"","",""
"7N28","CRYO-EM STRUCTURE OF BROADLY NEUTRALIZING V2-APEX-TARGETING ANTIBODY J033 IN COMPLEX WITH HIV-1 ENV","10.1002/ADVS.202200063 ",4.2,0.00048876,"7n28_oligo25","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_m_)-[MAN(5_m_)-MAN(4_m_)]-BMA(3_m_)-NAG(2_m_)-NAG(1_m_)-ASN(262_G_)",124.711,"","",""
"7N28","CRYO-EM STRUCTURE OF BROADLY NEUTRALIZING V2-APEX-TARGETING ANTIBODY J033 IN COMPLEX WITH HIV-1 ENV","10.1002/ADVS.202200063 ",4.2,0.00048876,"7n28_oligo23","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_k_)-MAN(4_k_)-[MAN(6_k_)]-BMA(3_k_)-NAG(2_k_)-NAG(1_k_)-ASN(160_F_)",118.432,"","",""
"7N28","CRYO-EM STRUCTURE OF BROADLY NEUTRALIZING V2-APEX-TARGETING ANTIBODY J033 IN COMPLEX WITH HIV-1 ENV","10.1002/ADVS.202200063 ",4.2,0.00048876,"7n28_oligo26","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_n_)-BMA(3_n_)-NAG(2_n_)-NAG(1_n_)-ASN(276_G_)",80.3489,"","",""
"7N28","CRYO-EM STRUCTURE OF BROADLY NEUTRALIZING V2-APEX-TARGETING ANTIBODY J033 IN COMPLEX WITH HIV-1 ENV","10.1002/ADVS.202200063 ",4.2,0.00048876,"7n28_oligo17","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_L_)-MAN(7_L_)-[MAN(6_L_)-MAN(5_L_)-MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(262_A_)",146.379,"","",""
"7N28","CRYO-EM STRUCTURE OF BROADLY NEUTRALIZING V2-APEX-TARGETING ANTIBODY J033 IN COMPLEX WITH HIV-1 ENV","10.1002/ADVS.202200063 ",4.2,0.00048876,"7n28_oligo11","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_e_)-[MAN(5_e_)]-MAN(4_e_)-[MAN(7_e_)]-BMA(3_e_)-NAG(2_e_)-NAG(1_e_)-ASN(276_F_)",85.6505,"","",""
"7N6U","STRUCTURE OF UNCLEAVED HIV-1 JR-FL ENV GLYCOPROTEIN TRIMER IN STATE U1 BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-378806","10.1128/JVI.00529-21 ",4.1,0,"7n6u_oligo12","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_T_)-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(241_B_)",4.99523,"","",""
"7N6U","STRUCTURE OF UNCLEAVED HIV-1 JR-FL ENV GLYCOPROTEIN TRIMER IN STATE U1 BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-378806","10.1128/JVI.00529-21 ",4.1,0,"7n6u_oligo13","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_U_)-MAN(6_U_)-[MAN(5_U_)-MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(262_B_)",2.57273,"","",""
"7N6U","STRUCTURE OF UNCLEAVED HIV-1 JR-FL ENV GLYCOPROTEIN TRIMER IN STATE U1 BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-378806","10.1128/JVI.00529-21 ",4.1,0,"7n6u_oligo48","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_v_)-MAN(6_v_)-[MAN(5_v_)-MAN(4_v_)]-BMA(3_v_)-NAG(2_v_)-NAG(1_v_)-ASN(448_C_)",2.49247,"","",""
"7N6U","STRUCTURE OF UNCLEAVED HIV-1 JR-FL ENV GLYCOPROTEIN TRIMER IN STATE U1 BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-378806","10.1128/JVI.00529-21 ",4.1,0,"7n6u_oligo8","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_P_)-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(448_A_)",71.6059,"","",""
"7N6U","STRUCTURE OF UNCLEAVED HIV-1 JR-FL ENV GLYCOPROTEIN TRIMER IN STATE U1 BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-378806","10.1128/JVI.00529-21 ",4.1,0,"7n6u_oligo38","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_l_)-MAN(6_l_)-[MAN(5_l_)-MAN(4_l_)]-BMA(3_l_)-NAG(2_l_)-NAG(1_l_)-ASN(262_C_)",2.63623,"","",""
"7N6U","STRUCTURE OF UNCLEAVED HIV-1 JR-FL ENV GLYCOPROTEIN TRIMER IN STATE U1 BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-378806","10.1128/JVI.00529-21 ",4.1,0,"7n6u_oligo31","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_e_)-BMA(3_e_)-NAG(2_e_)-NAG(1_e_)-ASN(448_B_)",4.62455,"","",""
"7N6U","STRUCTURE OF UNCLEAVED HIV-1 JR-FL ENV GLYCOPROTEIN TRIMER IN STATE U1 BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-378806","10.1128/JVI.00529-21 ",4.1,0,"7n6u_oligo28","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_G_)-MAN(6_G_)-[MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(262_A_)",2.26545,"","",""
"7N6W","STRUCTURE OF UNCLEAVED HIV-1 JR-FL ENV GLYCOPROTEIN TRIMER IN STATE U2 BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-378806","10.1128/JVI.00529-21 ",4.7,0,"7n6w_oligo16","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_G_)-MAN(6_G_)-[MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(262_A_)",2.51571,"","",""
"7N6W","STRUCTURE OF UNCLEAVED HIV-1 JR-FL ENV GLYCOPROTEIN TRIMER IN STATE U2 BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-378806","10.1128/JVI.00529-21 ",4.7,0,"7n6w_oligo35","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_h_)-MAN(4_h_)-BMA(3_h_)-NAG(2_h_)-NAG(1_h_)-ASN(262_C_)",3.64891,"","",""
"7N6W","STRUCTURE OF UNCLEAVED HIV-1 JR-FL ENV GLYCOPROTEIN TRIMER IN STATE U2 BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-378806","10.1128/JVI.00529-21 ",4.7,0,"7n6w_oligo13","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_U_)-MAN(6_U_)-[MAN(5_U_)-MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(262_B_)",2.61831,"","",""
"7N6W","STRUCTURE OF UNCLEAVED HIV-1 JR-FL ENV GLYCOPROTEIN TRIMER IN STATE U2 BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-378806","10.1128/JVI.00529-21 ",4.7,0,"7n6w_oligo42","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_o_)-BMA(3_o_)-NAG(2_o_)-NAG(1_o_)-ASN(448_C_)",4.915,"","",""
"7N6W","STRUCTURE OF UNCLEAVED HIV-1 JR-FL ENV GLYCOPROTEIN TRIMER IN STATE U2 BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-378806","10.1128/JVI.00529-21 ",4.7,0,"7n6w_oligo8","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_P_)-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(448_A_)",71.4595,"","",""
"7NAM","LRP6_E1 IN COMPLEX WITH LR-EET-3.5","10.1073/PNAS.2207327119 ",1.6,40.69,"7nam_oligo1","DManpa1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcx1-","FUC(5_E_)-[MAN(3_E_)-NAG(2_E_)]-[FUC(4_E_)]-NAG(1_E_)",62.6361,"","",""
"7NAM","LRP6_E1 IN COMPLEX WITH LR-EET-3.5","10.1073/PNAS.2207327119 ",1.6,40.69,"7nam_oligo2","DManpa1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcx1-","FUC(5_D_)-[MAN(3_D_)-NAG(2_D_)]-[FUC(4_D_)]-NAG(1_D_)",65.2446,"","",""
"7ND4","EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-88 FAB","10.1016/J.CELL.2021.02.032 ",3.6,0,"7nd4_oligo16","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Y_)-[MAN(4_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(35_H_)",148.033,"","",""
"7NI1","CRYSTAL STRUCTURE OF NATIVE HUMAN MYELOPEROXIDASE IN COMPLEX WITH CPD 9","10.1021/ACS.JMEDCHEM.1C02141 ",2.11,24.09,"7ni1_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_F_)-[MAN(4_F_)-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(317_D_)",42.8436,"","",""
"7NI1","CRYSTAL STRUCTURE OF NATIVE HUMAN MYELOPEROXIDASE IN COMPLEX WITH CPD 9","10.1021/ACS.JMEDCHEM.1C02141 ",2.11,24.09,"7ni1_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_E_)-[MAN(4_E_)-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(317_C_)",37.0813,"","",""
"7NKS","STRUCTURE OF THE HANTAAN VIRUS GN GLYCOPROTEIN ECTODOMAIN IN COMPLEX WITH FAB HTN-GN1","10.1128/MBIO.02531-20 ",3.5,124.9,"7nks_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_G_)-[MAN(5_G_)]-MAN(4_G_)-[MAN(7_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(134_B_)",159.594,"","",""
"7NKS","STRUCTURE OF THE HANTAAN VIRUS GN GLYCOPROTEIN ECTODOMAIN IN COMPLEX WITH FAB HTN-GN1","10.1128/MBIO.02531-20 ",3.5,124.9,"7nks_oligo2","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_F_)-MAN(6_F_)-[MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(134_A_)",157.152,"","",""
"7NN9","NATIVE INFLUENZA VIRUS NEURAMINIDASE SUBTYPE N9 (TERN)","",2,0,"7nn9_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_B_)-[MAN(6_B_)-MAN(5_B_)-MAN(4_B_)]-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",29.5796,"","",""
"7NOZ","STRUCTURE OF THE NANOBODY STABLIZED PROPERDIN BOUND ALTERNATIVE PATHWAY PROCONVERTASE C3B:FB:FP","10.1002/PRO.4432 ",3.9,288.9,"7noz_oligo8","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_M_)-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(378_F_)",296.541,"","",""
"7NOZ","STRUCTURE OF THE NANOBODY STABLIZED PROPERDIN BOUND ALTERNATIVE PATHWAY PROCONVERTASE C3B:FB:FP","10.1002/PRO.4432 ",3.9,288.9,"7noz_oligo6","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_K_)-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(428_D_)",321.973,"","",""
"7NRH","HANTAAN VIRUS GLYCOPROTEIN (GN) IN COMPLEX WITH FAB FRAGMENT HTN-GN1.","10.1128/MBIO.02531-20 ",19,"1.08527e-19","7nrh_oligo1","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_F_)-MAN(6_F_)-[MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(134_A_)",157.152,"","",""
"7NSK","ENDOPLASMIC RETICULUM AMINOPEPTIDASE 2 COMPLEXED WITH A HYDROXAMIC LIGAND","",3.1,77.33,"7nsk_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(85_A_)",89.9555,"","",""
"7NSK","ENDOPLASMIC RETICULUM AMINOPEPTIDASE 2 COMPLEXED WITH A HYDROXAMIC LIGAND","",3.1,77.33,"7nsk_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(85_B_)",71.6855,"","",""
"7NUP","ENDOPLASMIC RETICULUM AMINOPEPTIDASE 2 COMPLEXED WITH A MIXED HYDROXAMIC AND SULFONYL LIGAND","",3.1,56.51,"7nup_oligo14","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(85_C_)",65.0998,"","",""
"7NUP","ENDOPLASMIC RETICULUM AMINOPEPTIDASE 2 COMPLEXED WITH A MIXED HYDROXAMIC AND SULFONYL LIGAND","",3.1,56.51,"7nup_oligo17","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_Q_)-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(85_D_)",74.373,"","",""
"7NUP","ENDOPLASMIC RETICULUM AMINOPEPTIDASE 2 COMPLEXED WITH A MIXED HYDROXAMIC AND SULFONYL LIGAND","",3.1,56.51,"7nup_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(85_A_)",74.1766,"","",""
"7NWF","CRYSTAL STRUCTURE OF BACTEROIDES THETAIOTAMICRON ENDOBT-3987 IN COMPLEX WITH HYBRID-TYPE GLYCAN (GALGLCNACMAN5GLCNAC) PRODUCT","10.1016/J.JBC.2021.101011 ",2,25.67,"7nwf_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-ROH","MAN(8_B_)-[MAN(7_B_)]-MAN(6_B_)-[GAL(5_B_)-NAG(4_B_)-MAN(3_B_)]-BMA(2_B_)-NAG(1_B_)",32.2842,"","",""
"7NWL","CRYO-EM STRUCTURE OF HUMAN INTEGRIN ALPHA5BETA1 (OPEN FORM) IN COMPLEX WITH FIBRONECTIN AND TS2/16 FV-CLASP","10.1126/SCIADV.ABE9716 ",3.1,"1.35632e-19","7nwl_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(266_A_)",183.158,"","",""
"7NWL","CRYO-EM STRUCTURE OF HUMAN INTEGRIN ALPHA5BETA1 (OPEN FORM) IN COMPLEX WITH FIBRONECTIN AND TS2/16 FV-CLASP","10.1126/SCIADV.ABE9716 ",3.1,"1.35632e-19","7nwl_oligo5","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_J_)-MAN(4_J_)-[MAN(6_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(275_A_)",109.242,"","",""
"7NXD","CRYO-EM STRUCTURE OF HUMAN INTEGRIN ALPHA5BETA1 IN THE HALF-BENT CONFORMATION","10.1126/SCIADV.ABE9716 ",4.6,0,"7nxd_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(141_A_)",153.601,"","",""
"7NXD","CRYO-EM STRUCTURE OF HUMAN INTEGRIN ALPHA5BETA1 IN THE HALF-BENT CONFORMATION","10.1126/SCIADV.ABE9716 ",4.6,0,"7nxd_oligo2","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_G_)-MAN(4_G_)-[MAN(6_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(275_A_)",141.757,"","",""
"7O0E","CRYSTAL STRUCTURE OF GH30 (MUTANT E188A) COMPLEXED WITH ALDOTRIURONIC ACID FROM THERMOTHELOMYCES THERMOPHILA.","10.1016/J.CARBPOL.2021.118553 ",1.85,21.12,"7o0e_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(314_A_)",40.7091,"","",""
"7OCI","CRYO-EM STRUCTURE OF YEAST OST6P CONTAINING OLIGOSACCHARYLTRANSFERASE COMPLEX","10.1093/GLYCOB/CWAB084 ",3.46,0.000748774,"7oci_oligo6","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_J_)-[MAN(6_J_)-MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(539_F_)",59.5461,"","",""
"7OH4","CRYO-EM STRUCTURE OF DRS2P-CDC50P IN THE E1 STATE WITH PI4P AND MG2+ BOUND","10.1016/J.JMB.2021.167062 ",3,"8.66968e+14","7oh4_oligo3","DManpb1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(199_C_)",74.4859,"","",""
"7OH5","CRYO-EM STRUCTURE OF DRS2P-CDC50P IN THE E1-ALFX-ADP STATE","10.1016/J.JMB.2021.167062 ",2.9,"1.52628e-19","7oh5_oligo4","DManpb1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(199_C_)",62.1845,"","",""
"7OH7","CRYO-EM STRUCTURE OF DRS2P-CDC50P IN THE E1-AMPPCP STATE WITH PI4P BOUND","10.1016/J.JMB.2021.167062 ",3.8,"8.66968e+14","7oh7_oligo4","DManpb1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(199_C_)",87.6602,"","",""
"7OIH","GLYCOSYLATION IN THE CRYSTAL STRUCTURE OF NEUTROPHIL MYELOPEROXIDASE","10.1107/S2059798322007082 ",2.6,59.01,"7oih_oligo1","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_c_)-[NAG(5_c_)-MAN(4_c_)-[MAN(6_c_)]-BMA(3_c_)-NAG(2_c_)]-NAG(1_c_)-ASN(483_G_)",63.8999,"","",""
"7OIH","GLYCOSYLATION IN THE CRYSTAL STRUCTURE OF NEUTROPHIL MYELOPEROXIDASE","10.1107/S2059798322007082 ",2.6,59.01,"7oih_oligo24","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_a_)-[MAN(5_a_)-MAN(4_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(355_G_)",94.7053,"","",""
"7OIH","GLYCOSYLATION IN THE CRYSTAL STRUCTURE OF NEUTROPHIL MYELOPEROXIDASE","10.1107/S2059798322007082 ",2.6,59.01,"7oih_oligo23","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(6_Z_)-[MAN(5_Z_)-[MAN(4_Z_)]-BMA(3_Z_)-NAG(2_Z_)]-NAG(1_Z_)",61.5899,"","",""
"7OIH","GLYCOSYLATION IN THE CRYSTAL STRUCTURE OF NEUTROPHIL MYELOPEROXIDASE","10.1107/S2059798322007082 ",2.6,59.01,"7oih_oligo5","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_L_)-[NAG(5_L_)-MAN(4_L_)-[MAN(6_L_)]-BMA(3_L_)-NAG(2_L_)]-NAG(1_L_)-ASN(483_A_)",66.0927,"","",""
"7OIH","GLYCOSYLATION IN THE CRYSTAL STRUCTURE OF NEUTROPHIL MYELOPEROXIDASE","10.1107/S2059798322007082 ",2.6,59.01,"7oih_oligo16","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAca1-4DGlcpNAcb1-ASN","MAN(5_R_)-MAN(4_R_)-[MAN(6_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(355_D_)",105.852,"","",""
"7OIH","GLYCOSYLATION IN THE CRYSTAL STRUCTURE OF NEUTROPHIL MYELOPEROXIDASE","10.1107/S2059798322007082 ",2.6,59.01,"7oih_oligo4","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-MAN(4_K_)-[MAN(6_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(355_A_)",92.1143,"","",""
"7OIH","GLYCOSYLATION IN THE CRYSTAL STRUCTURE OF NEUTROPHIL MYELOPEROXIDASE","10.1107/S2059798322007082 ",2.6,59.01,"7oih_oligo15","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_Q_)-[MAN(5_Q_)-[MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)]-NAG(1_Q_)-ASN(483_C_)",62.6464,"","",""
"7OIH","GLYCOSYLATION IN THE CRYSTAL STRUCTURE OF NEUTROPHIL MYELOPEROXIDASE","10.1107/S2059798322007082 ",2.6,59.01,"7oih_oligo14","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(4_P_)-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)",129.478,"","",""
"7OIH","GLYCOSYLATION IN THE CRYSTAL STRUCTURE OF NEUTROPHIL MYELOPEROXIDASE","10.1107/S2059798322007082 ",2.6,59.01,"7oih_oligo20","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_W_)-[MAN(5_W_)-[MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)]-NAG(1_W_)-ASN(483_E_)",61.2448,"","",""
"7OIH","GLYCOSYLATION IN THE CRYSTAL STRUCTURE OF NEUTROPHIL MYELOPEROXIDASE","10.1107/S2059798322007082 ",2.6,59.01,"7oih_oligo12","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_N_)-[MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)]-NAG(1_N_)-ASN(483_B_)",58.6994,"","",""
"7OIH","GLYCOSYLATION IN THE CRYSTAL STRUCTURE OF NEUTROPHIL MYELOPEROXIDASE","10.1107/S2059798322007082 ",2.6,59.01,"7oih_oligo3","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_g_)-[NAG(5_g_)-MAN(4_g_)-[MAN(6_g_)]-BMA(3_g_)-NAG(2_g_)]-NAG(1_g_)-ASN(483_H_)",61.3553,"","",""
"7OIH","GLYCOSYLATION IN THE CRYSTAL STRUCTURE OF NEUTROPHIL MYELOPEROXIDASE","10.1107/S2059798322007082 ",2.6,59.01,"7oih_oligo17","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_T_)-[MAN(5_T_)-[MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)]-NAG(1_T_)-ASN(483_D_)",62.2005,"","",""
"7OIX","STRUCTURE OF THERMOSTABLE HUMAN MFSD2A IN COMPLEX WITH THERMOSTABLE HUMAN SYNC2","10.1038/S41594-022-00786-8 ",3.6,"1.08527e-19","7oix_oligo2","DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_D_)-MAN(6_D_)-[MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(312_A_)",109.786,"","",""
"7OIX","STRUCTURE OF THERMOSTABLE HUMAN MFSD2A IN COMPLEX WITH THERMOSTABLE HUMAN SYNC2","10.1038/S41594-022-00786-8 ",3.6,"1.08527e-19","7oix_oligo1","DManpa1-3[DManpa1-6]DManpb1-6DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(177_A_)",118.868,"","",""
"7OK5","CRYSTAL STRUCTURE OF MOUSE NEUROFASCIN 155 IMMUNOGLOBULIN DOMAINS","10.1038/S41467-022-34302-9 ",2.97,113.2,"7ok5_oligo4","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_C_)-MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(420_B_)",164.496,"","",""
"7OK5","CRYSTAL STRUCTURE OF MOUSE NEUROFASCIN 155 IMMUNOGLOBULIN DOMAINS","10.1038/S41467-022-34302-9 ",2.97,113.2,"7ok5_oligo3","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_F_)-MAN(6_F_)-[MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(420_A_)",147.934,"","",""
"7OK5","CRYSTAL STRUCTURE OF MOUSE NEUROFASCIN 155 IMMUNOGLOBULIN DOMAINS","10.1038/S41467-022-34302-9 ",2.97,113.2,"7ok5_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(457_B_)",200.686,"","",""
"7OK5","CRYSTAL STRUCTURE OF MOUSE NEUROFASCIN 155 IMMUNOGLOBULIN DOMAINS","10.1038/S41467-022-34302-9 ",2.97,113.2,"7ok5_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(457_A_)",147.837,"","",""
"7OKS","X-RAY STRUCTURE OF SOLUBLE EPCR IN P212121 SPACE GROUP","10.1038/S41598-022-18844-Y ",1.95,45.89,"7oks_oligo10","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_K_)-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(119_C_)",63.2864,"","",""
"7OL2","CRYSTAL STRUCTURE OF MOUSE CONTACTIN 1 IMMUNOGLOBULIN DOMAINS","10.1038/S41467-022-34302-9 ",3.89,105.2,"7ol2_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(208_B_)",152.327,"","",""
"7OL2","CRYSTAL STRUCTURE OF MOUSE CONTACTIN 1 IMMUNOGLOBULIN DOMAINS","10.1038/S41467-022-34302-9 ",3.89,105.2,"7ol2_oligo6","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_H_)-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(457_B_)",151.676,"","",""
"7OL2","CRYSTAL STRUCTURE OF MOUSE CONTACTIN 1 IMMUNOGLOBULIN DOMAINS","10.1038/S41467-022-34302-9 ",3.89,105.2,"7ol2_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(258_A_)",165.994,"","",""
"7OL2","CRYSTAL STRUCTURE OF MOUSE CONTACTIN 1 IMMUNOGLOBULIN DOMAINS","10.1038/S41467-022-34302-9 ",3.89,105.2,"7ol2_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(457_A_)",153.601,"","",""
"7OL4","MOUSE CONTACTIN-1 NEUROFASCIN-155 IMMUNOGLOBULIN DOMAINS ADHESION COMPLEX","10.1038/S41467-022-34302-9 ",4.8,259.2,"7ol4_oligo8","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_M_)-[MAN(5_M_)]-MAN(4_M_)-[MAN(7_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(420_C_)",308.787,"","",""
"7OL4","MOUSE CONTACTIN-1 NEUROFASCIN-155 IMMUNOGLOBULIN DOMAINS ADHESION COMPLEX","10.1038/S41467-022-34302-9 ",4.8,259.2,"7ol4_oligo9","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-MAN(4_N_)-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(316_C_)",444.739,"","",""
"7OL4","MOUSE CONTACTIN-1 NEUROFASCIN-155 IMMUNOGLOBULIN DOMAINS ADHESION COMPLEX","10.1038/S41467-022-34302-9 ",4.8,259.2,"7ol4_oligo15","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(457_D_)",370.395,"","",""
"7OL4","MOUSE CONTACTIN-1 NEUROFASCIN-155 IMMUNOGLOBULIN DOMAINS ADHESION COMPLEX","10.1038/S41467-022-34302-9 ",4.8,259.2,"7ol4_oligo11","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(457_C_)",359.789,"","",""
"7OL4","MOUSE CONTACTIN-1 NEUROFASCIN-155 IMMUNOGLOBULIN DOMAINS ADHESION COMPLEX","10.1038/S41467-022-34302-9 ",4.8,259.2,"7ol4_oligo4","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-MAN(4_K_)-[MAN(6_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(457_B_)",291.537,"","",""
"7OL4","MOUSE CONTACTIN-1 NEUROFASCIN-155 IMMUNOGLOBULIN DOMAINS ADHESION COMPLEX","10.1038/S41467-022-34302-9 ",4.8,259.2,"7ol4_oligo13","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_Q_)-[MAN(7_Q_)]-MAN(6_Q_)-[MAN(5_Q_)-MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(420_D_)",299.097,"","",""
"7OL4","MOUSE CONTACTIN-1 NEUROFASCIN-155 IMMUNOGLOBULIN DOMAINS ADHESION COMPLEX","10.1038/S41467-022-34302-9 ",4.8,259.2,"7ol4_oligo6","DManpa1-3DManpb1-4DGlcpNAcb1-3DGlcpNAcb1-ASN","MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(208_B_)",230.921,"","",""
"7OL4","MOUSE CONTACTIN-1 NEUROFASCIN-155 IMMUNOGLOBULIN DOMAINS ADHESION COMPLEX","10.1038/S41467-022-34302-9 ",4.8,259.2,"7ol4_oligo14","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_R_)-MAN(4_R_)-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(316_D_)",387.751,"","",""
"7OL4","MOUSE CONTACTIN-1 NEUROFASCIN-155 IMMUNOGLOBULIN DOMAINS ADHESION COMPLEX","10.1038/S41467-022-34302-9 ",4.8,259.2,"7ol4_oligo3","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-MAN(4_J_)-[MAN(6_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(258_B_)",257.316,"","",""
"7OLY","STRUCTURE OF ACTIVIN A IN COMPLEX WITH AN ACTRIIB-ALK4 FUSION REVEAL INSIGHT INTO ACTIVIN RECEPTOR INTERACTIONS","10.1016/J.ISCI.2021.103590 ",3.27,112.9,"7oly_oligo2","DGlcpNAcb1-6DManpa1-6[DManpa1-3]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_B_)-MAN(4_B_)-[MAN(6_B_)]-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(65_C_)",175.163,"","",""
"7ORB","CRYSTAL STRUCTURE OF THE L452R MUTANT RECEPTOR BINDING DOMAIN OF SARS- COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-75 AND COVOX-253 FABS","10.1016/J.CELL.2021.06.020 ",2.5,65.47,"7orb_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_G_)-[MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(343_R_)",128.645,"","",""
"7OV2","CRYSTAL STRUCTURE OF PIG PURPLE ACID PHOSPHATASE IN COMPLEX WITH L- GLUTAMINE, (POLY)ETHYLENE GLYCOL FRAGMENTS AND GLYCEROL","10.1002/CMDC.202100486 ",2.1,27.55,"7ov2_oligo1","DManpb1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(97_A_)",59.8189,"","",""
"7P2P","HUMAN SIGNAL PEPTIDASE COMPLEX PARALOG A (SPC-A)","10.1016/J.MOLCEL.2021.07.031 ",4.9,"1.35632e-19","7p2p_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(141_B_)",276.243,"","",""
"7P2Q","HUMAN SIGNAL PEPTIDASE COMPLEX PARALOG C (SPC-C)","10.1016/J.MOLCEL.2021.07.031 ",4.9,"1.35632e-19","7p2q_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(141_B_)",337.497,"","",""
"7P57","VSG2 MUTANT STRUCTURE LACKING THE CALCIUM BINDING POCKET","10.1016/J.CELREP.2023.112262 ",1.96,43.9,"7p57_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(289_A_)",61.1614,"","",""
"7P59","VARIANT SURFACE GLYCOPROTEIN 3 (VSG3, MITAT1.3, VSG224) WITH TWO O- LINKED POST-TRANSLATIONAL MODIFICATIONS","10.1016/J.CELREP.2023.112262 ",1.27,24.21,"7p59_oligo1","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(67_A_)",23.8674,"","",""
"7P5A","VARIANT SURFACE GLYCOPROTEIN 3 (VSG3, MITAT1.3, VSG224) MUTANT (SERINE 317 TO ALANINE), SINGLE O-LINKED GLYCOSYLATED AT SER319","10.1016/J.CELREP.2023.112262 ",1.95,24.34,"7p5a_oligo1","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(67_A_)",36.3997,"","",""
"7P5B","VARIANT SURFACE GLYCOPROTEIN 3 (VSG3, MITAT1.3, VSG224) MUTANT (SERINE 319 TO ALANINE), SINGLE O-LINKED GLYCOSYLATED AT SER317","10.1016/J.CELREP.2023.112262 ",1.13,25.63,"7p5b_oligo1","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(67_A_)",28.4682,"","",""
"7P5D","VARIANT SURFACE GLYCOPROTEIN 3 (VSG3, MITAT1.3, VSG224) MUTANT (SERINE 317 AND 319 TO ALANINE)","10.1016/J.CELREP.2023.112262 ",1.42,24.97,"7p5d_oligo1","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(67_A_)",28.7906,"","",""
"7P7P","CRYSTAL STRUCTURE OF ERAP2 AMINOPEPTIDASE IN COMPLEX WITH PHOSPHINIC PSEUDOTRIPEPTIDE((1R)-1-AMINO-3-PHENYLPROPYL){(2S)-3-[((2S)-1-AMINO- 1-OXO-3-PHENYLPROPAN-2-YL)AMINO]-2-{[3-(2-HYDROXYPHENYL)-ISOXAZOL-5- YL]METHYL}-3-OXOPROPYL}PHOSPHINIC ACID","10.1021/ACSMEDCHEMLETT.1C00582 ",3,92.48,"7p7p_oligo7","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(85_A_)",138.304,"","",""
"7P7P","CRYSTAL STRUCTURE OF ERAP2 AMINOPEPTIDASE IN COMPLEX WITH PHOSPHINIC PSEUDOTRIPEPTIDE((1R)-1-AMINO-3-PHENYLPROPYL){(2S)-3-[((2S)-1-AMINO- 1-OXO-3-PHENYLPROPAN-2-YL)AMINO]-2-{[3-(2-HYDROXYPHENYL)-ISOXAZOL-5- YL]METHYL}-3-OXOPROPYL}PHOSPHINIC ACID","10.1021/ACSMEDCHEMLETT.1C00582 ",3,92.48,"7p7p_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(85_B_)",108.302,"","",""
"7P8H","CHICKEN GRIFIN BOUND TO BLOOD GROUP TETRASACCHARIDE B (TYPE 1)","10.3390/BIOM11121854 ",1.13,14.52,"7p8h_oligo1","LFucpa1-2[DGalpa1-3]DGalpb1-3DGlcpNAcb1-ROH","GLA(4_E_)-[FUC(3_E_)]-GAL(2_E_)-NAG(1_E_)",14.4693,"","",""
"7P8H","CHICKEN GRIFIN BOUND TO BLOOD GROUP TETRASACCHARIDE B (TYPE 1)","10.3390/BIOM11121854 ",1.13,14.52,"7p8h_oligo2","LFucpa1-2[DGalpa1-3]DGalpb1-3DGlcpNAcb1-ROH","GLA(4_F_)-[FUC(3_F_)]-GAL(2_F_)-NAG(1_F_)",12.6589,"","",""
"7PC2","HIV-1 ENV (BG505 SOSIP.664) IN COMPLEX WITH THE IGA BNAB 7-269 AND THE ANTIBODY 3BNC117.","10.1084/JEM.20212045 ",2.8,"1.08527e-19","7pc2_oligo26","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_r_)-MAN(10_r_)-[MAN(9_r_)-MAN(8_r_)]-MAN(7_r_)-[MAN(6_r_)-MAN(5_r_)-MAN(4_r_)]-BMA(3_r_)-NAG(2_r_)-NAG(1_r_)-ASN(332_B_)",111.551,"","",""
"7PC2","HIV-1 ENV (BG505 SOSIP.664) IN COMPLEX WITH THE IGA BNAB 7-269 AND THE ANTIBODY 3BNC117.","10.1084/JEM.20212045 ",2.8,"1.08527e-19","7pc2_oligo41","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_6_)-MAN(10_6_)-[MAN(9_6_)-MAN(8_6_)]-MAN(7_6_)-[MAN(6_6_)-MAN(5_6_)-MAN(4_6_)]-BMA(3_6_)-NAG(2_6_)-NAG(1_6_)-ASN(332_C_)",110.422,"","",""
"7PC2","HIV-1 ENV (BG505 SOSIP.664) IN COMPLEX WITH THE IGA BNAB 7-269 AND THE ANTIBODY 3BNC117.","10.1084/JEM.20212045 ",2.8,"1.08527e-19","7pc2_oligo27","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_s_)-MAN(5_s_)-[MAN(7_s_)]-MAN(4_s_)-[MAN(9_s_)-MAN(8_s_)]-BMA(3_s_)-NAG(2_s_)-NAG(1_s_)-ASN(262_B_)",127.77,"","",""
"7PC2","HIV-1 ENV (BG505 SOSIP.664) IN COMPLEX WITH THE IGA BNAB 7-269 AND THE ANTIBODY 3BNC117.","10.1084/JEM.20212045 ",2.8,"1.08527e-19","7pc2_oligo13","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_l_)-[MAN(7_l_)]-MAN(6_l_)-[MAN(5_l_)-MAN(4_l_)]-BMA(3_l_)-NAG(2_l_)-NAG(1_l_)-ASN(276_B_)",143.989,"","",""
"7PC2","HIV-1 ENV (BG505 SOSIP.664) IN COMPLEX WITH THE IGA BNAB 7-269 AND THE ANTIBODY 3BNC117.","10.1084/JEM.20212045 ",2.8,"1.08527e-19","7pc2_oligo34","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_z_)-[MAN(7_z_)]-MAN(6_z_)-[MAN(5_z_)-MAN(4_z_)]-BMA(3_z_)-NAG(2_z_)-NAG(1_z_)-ASN(276_C_)",142.312,"","",""
"7PC2","HIV-1 ENV (BG505 SOSIP.664) IN COMPLEX WITH THE IGA BNAB 7-269 AND THE ANTIBODY 3BNC117.","10.1084/JEM.20212045 ",2.8,"1.08527e-19","7pc2_oligo25","DManpa1-2DManpa1-3DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_q_)-MAN(5_q_)-MAN(4_q_)-[MAN(8_q_)-MAN(7_q_)]-BMA(3_q_)-NAG(2_q_)-NAG(1_q_)-ASN(295_B_)",119.176,"","",""
"7PC2","HIV-1 ENV (BG505 SOSIP.664) IN COMPLEX WITH THE IGA BNAB 7-269 AND THE ANTIBODY 3BNC117.","10.1084/JEM.20212045 ",2.8,"1.08527e-19","7pc2_oligo36","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_1_)-[MAN(4_1_)]-BMA(3_1_)-NAG(2_1_)-NAG(1_1_)-ASN(363_C_)",122.525,"","",""
"7PC2","HIV-1 ENV (BG505 SOSIP.664) IN COMPLEX WITH THE IGA BNAB 7-269 AND THE ANTIBODY 3BNC117.","10.1084/JEM.20212045 ",2.8,"1.08527e-19","7pc2_oligo33","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_y_)-MAN(5_y_)-[MAN(7_y_)]-MAN(4_y_)-[MAN(9_y_)-MAN(8_y_)]-BMA(3_y_)-NAG(2_y_)-NAG(1_y_)-ASN(262_C_)",124.072,"","",""
"7PC2","HIV-1 ENV (BG505 SOSIP.664) IN COMPLEX WITH THE IGA BNAB 7-269 AND THE ANTIBODY 3BNC117.","10.1084/JEM.20212045 ",2.8,"1.08527e-19","7pc2_oligo1","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_W_)-MAN(5_W_)-[MAN(7_W_)]-MAN(4_W_)-[MAN(9_W_)-MAN(8_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(262_A_)",124.626,"","",""
"7PC2","HIV-1 ENV (BG505 SOSIP.664) IN COMPLEX WITH THE IGA BNAB 7-269 AND THE ANTIBODY 3BNC117.","10.1084/JEM.20212045 ",2.8,"1.08527e-19","7pc2_oligo40","DManpa1-2DManpa1-3DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_5_)-MAN(5_5_)-MAN(4_5_)-[MAN(8_5_)-MAN(7_5_)]-BMA(3_5_)-NAG(2_5_)-NAG(1_5_)-ASN(295_C_)",119.502,"","",""
"7PC2","HIV-1 ENV (BG505 SOSIP.664) IN COMPLEX WITH THE IGA BNAB 7-269 AND THE ANTIBODY 3BNC117.","10.1084/JEM.20212045 ",2.8,"1.08527e-19","7pc2_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_e_)-[MAN(4_e_)]-BMA(3_e_)-NAG(2_e_)-NAG(1_e_)-ASN(363_A_)",127.009,"","",""
"7PC2","HIV-1 ENV (BG505 SOSIP.664) IN COMPLEX WITH THE IGA BNAB 7-269 AND THE ANTIBODY 3BNC117.","10.1084/JEM.20212045 ",2.8,"1.08527e-19","7pc2_oligo15","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_n_)-[MAN(4_n_)]-BMA(3_n_)-NAG(2_n_)-NAG(1_n_)-ASN(363_B_)",122.351,"","",""
"7PC2","HIV-1 ENV (BG505 SOSIP.664) IN COMPLEX WITH THE IGA BNAB 7-269 AND THE ANTIBODY 3BNC117.","10.1084/JEM.20212045 ",2.8,"1.08527e-19","7pc2_oligo2","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_X_)-[MAN(7_X_)]-MAN(6_X_)-[MAN(5_X_)-MAN(4_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(276_A_)",140.173,"","",""
"7PC2","HIV-1 ENV (BG505 SOSIP.664) IN COMPLEX WITH THE IGA BNAB 7-269 AND THE ANTIBODY 3BNC117.","10.1084/JEM.20212045 ",2.8,"1.08527e-19","7pc2_oligo3","DManpa1-2DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_b_)-MAN(5_b_)-MAN(4_b_)-[MAN(7_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(295_A_)",114.857,"","",""
"7PC2","HIV-1 ENV (BG505 SOSIP.664) IN COMPLEX WITH THE IGA BNAB 7-269 AND THE ANTIBODY 3BNC117.","10.1084/JEM.20212045 ",2.8,"1.08527e-19","7pc2_oligo19","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_a_)-MAN(10_a_)-[MAN(9_a_)-MAN(8_a_)]-MAN(7_a_)-[MAN(6_a_)-MAN(5_a_)-MAN(4_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(332_A_)",112.563,"","",""
"7PEM","CRYO-EM STRUCTURE OF PHOPHORYLATED DRS2P-CDC50P IN A PS AND ATP-BOUND E2P STATE","",3.1,"1.36151e+13","7pem_oligo1","DManpb1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(199_C_)",66.1143,"","",""
"7PEO","STRUCTURE OF THE CAULOBACTER CRESCENTUS S-LAYER PROTEIN RSAA N- TERMINAL DOMAIN BOUND TO LPS AND SOAKED WITH HOLMIUM","10.1016/J.STR.2021.10.012 ",4.37,"1.15243e-41","7peo_oligo1","DRhap[4NAc]a1-3DRhap[4NAc]a1-3DManpb1-3DRhap[4NAc]a1-3DRhap[4NAc]a1-3DManpb1-3DRhap[4NAc]a1-3DRhap[4NAc]a1-3DManpb1-3DRhap[4NAc]a1-3DRhap[4NAc]a1-3DManpx1-","MRH(12_B_)-MRH(11_B_)-BMA(10_B_)-MRH(9_B_)-MRH(8_B_)-BMA(7_B_)-MRH(6_B_)-MRH(5_B_)-BMA(4_B_)-MRH(3_B_)-MRH(2_B_)-BMA(1_B_)",266.294,"","",""
"7PFP","FULL-LENGTH CRYO-EM STRUCTURE OF THE NATIVE HUMAN UROMODULIN (UMOD) /TAMM-HORSFALL PROTEIN (THP) FILAMENT","10.1038/S41594-022-00729-3 ",6.1,0,"7pfp_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(9_F_)-NAG(8_F_)-MAN(7_F_)-[GAL(6_F_)-NAG(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(232_A_)",354.721,"","",""
"7PFP","FULL-LENGTH CRYO-EM STRUCTURE OF THE NATIVE HUMAN UROMODULIN (UMOD) /TAMM-HORSFALL PROTEIN (THP) FILAMENT","10.1038/S41594-022-00729-3 ",6.1,0,"7pfp_oligo6","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_O_)-[MAN(7_O_)]-MAN(6_O_)-[MAN(5_O_)-MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(275_C_)",364.812,"","",""
"7PFP","FULL-LENGTH CRYO-EM STRUCTURE OF THE NATIVE HUMAN UROMODULIN (UMOD) /TAMM-HORSFALL PROTEIN (THP) FILAMENT","10.1038/S41594-022-00729-3 ",6.1,0,"7pfp_oligo12","DGalpb1-4DGlcpNAcb1-2[DGlcpNAcb1-4]DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(9_I_)-MAN(8_I_)-[NAG(7_I_)-[GAL(6_I_)-NAG(5_I_)]-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(396_A_)",318.28,"","",""
"7PFP","FULL-LENGTH CRYO-EM STRUCTURE OF THE NATIVE HUMAN UROMODULIN (UMOD) /TAMM-HORSFALL PROTEIN (THP) FILAMENT","10.1038/S41594-022-00729-3 ",6.1,0,"7pfp_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_K_)-[MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(513_B_)",346.408,"","",""
"7PFP","FULL-LENGTH CRYO-EM STRUCTURE OF THE NATIVE HUMAN UROMODULIN (UMOD) /TAMM-HORSFALL PROTEIN (THP) FILAMENT","10.1038/S41594-022-00729-3 ",6.1,0,"7pfp_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_J_)-[MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)]-NAG(1_J_)-ASN(513_A_)",413.492,"","",""
"7PFP","FULL-LENGTH CRYO-EM STRUCTURE OF THE NATIVE HUMAN UROMODULIN (UMOD) /TAMM-HORSFALL PROTEIN (THP) FILAMENT","10.1038/S41594-022-00729-3 ",6.1,0,"7pfp_oligo5","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(9_N_)-NAG(8_N_)-MAN(7_N_)-[GAL(6_N_)-NAG(5_N_)-MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(232_C_)",323.928,"","",""
"7PFP","FULL-LENGTH CRYO-EM STRUCTURE OF THE NATIVE HUMAN UROMODULIN (UMOD) /TAMM-HORSFALL PROTEIN (THP) FILAMENT","10.1038/S41594-022-00729-3 ",6.1,0,"7pfp_oligo11","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_G_)-[MAN(7_G_)]-MAN(6_G_)-[MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(275_A_)",497.925,"","",""
"7PFP","FULL-LENGTH CRYO-EM STRUCTURE OF THE NATIVE HUMAN UROMODULIN (UMOD) /TAMM-HORSFALL PROTEIN (THP) FILAMENT","10.1038/S41594-022-00729-3 ",6.1,0,"7pfp_oligo14","DGalpb1-4DGlcpNAcb1-2[DGlcpNAcb1-4]DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(9_Q_)-MAN(8_Q_)-[NAG(7_Q_)-[GAL(6_Q_)-NAG(5_Q_)]-MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(396_C_)",303.191,"","",""
"7PFS","CRYSTAL STRUCTURE OF ERAP2 AMINOPEPTIDASE IN COMPLEX WITH PHOSPHINIC PSEUDOTRIPEPTIDE ((1R)-1-AMINO-3-PHENYLPROPYL){2-([1,1:3,1- TERPHENYL]-5-YLMETHYL)-3-[((2S)-1-AMINO-1-OXO-3-PHENYLPROPAN-2-YL)- AMINO]-3-OXOPROPYL}PHOSPHINIC ACID","10.1021/ACSMEDCHEMLETT.1C00582 ",2.7,0,"7pfs_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(85_B_)",83.2036,"","",""
"7PGM","HHIP-C IN COMPLEX WITH HEPARIN","10.1038/S41467-021-27475-2 ",2.7,0,"7pgm_oligo1","LIdopA[2S]a1-3DGlcpN[6S]a1-4LIdopA[2S]a1-4DGlcpN[6S]a1-4LIdopA[2S]a1-4DGlcpN[6S]a1-4LIdopA[2S]a1-4DGlcpN[6S]a1-ROH","IDS(8_D_)-SGN(7_D_)-IDS(6_D_)-SGN(5_D_)-IDS(4_D_)-SGN(3_D_)-IDS(2_D_)-SGN(1_D_)",194.284,"","",""
"7PS5","CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 BETA VARIANT SPIKE GLYCOPROTEIN IN COMPLEX WITH BETA-47 FAB","10.1016/J.CHOM.2021.11.013 ",3.14,129.6,"7ps5_oligo2","DManpa1-6DManpb1-3DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_B_)-[MAN(4_B_)-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(343_E_)",205.859,"","",""
"7PS5","CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 BETA VARIANT SPIKE GLYCOPROTEIN IN COMPLEX WITH BETA-47 FAB","10.1016/J.CHOM.2021.11.013 ",3.14,129.6,"7ps5_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_A_)-[MAN(5_A_)-[MAN(4_A_)]-BMA(3_A_)-NAG(2_A_)]-NAG(1_A_)-ASN(102_H_)",191.042,"","",""
"7PUK","CRYSTAL STRUCTURE OF ENDOGLYCOSIDASE E GH18 DOMAIN FROM ENTEROCOCCUS FAECALIS IN COMPLEX WITH MAN5 PRODUCT","10.1038/S41467-022-28722-W ",2.69,0,"7puk_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-ROH","MAN(5_B_)-[MAN(4_B_)]-MAN(3_B_)-[MAN(6_B_)]-BMA(2_B_)-NAG(1_B_)",61.0827,"","",""
"7PUK","CRYSTAL STRUCTURE OF ENDOGLYCOSIDASE E GH18 DOMAIN FROM ENTEROCOCCUS FAECALIS IN COMPLEX WITH MAN5 PRODUCT","10.1038/S41467-022-28722-W ",2.69,0,"7puk_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-ROH","MAN(5_D_)-[MAN(4_D_)]-MAN(3_D_)-[MAN(6_D_)]-BMA(2_D_)-NAG(1_D_)",66.0082,"","",""
"7PUR","MOUSE INTERLEUKIN-12 SUBUNIT BETA - P80 HOMODIMER IN SPACE GROUP P21 CRYSTAL FORM 2","",3.9,137.3,"7pur_oligo1","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(220_A_)",146.876,"","",""
"7PUR","MOUSE INTERLEUKIN-12 SUBUNIT BETA - P80 HOMODIMER IN SPACE GROUP P21 CRYSTAL FORM 2","",3.9,137.3,"7pur_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-[MAN(5_D_)]-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(220_B_)",178.129,"","",""
"7PUY","STRUCTURE OF THE MEMBRANE SOLUBLE SPIKE COMPLEX FROM THE LASSA VIRUS IN A C3-SYMMETRIC MAP","10.1038/S41586-022-04429-2 ",3.3,0,"7puy_oligo3","DXylpa1-3DGlcpAb1-3DXylpa1-ROH","XYS(3_O_)-BDP(2_O_)-XYS(1_O_)",42.1709,"","",""
"7PUY","STRUCTURE OF THE MEMBRANE SOLUBLE SPIKE COMPLEX FROM THE LASSA VIRUS IN A C3-SYMMETRIC MAP","10.1038/S41586-022-04429-2 ",3.3,0,"7puy_oligo7","DXylpa1-3DGlcpAb1-3DXylpa1-ROH","XYS(3_K_)-BDP(2_K_)-XYS(1_K_)",43.8396,"","",""
"7PUY","STRUCTURE OF THE MEMBRANE SOLUBLE SPIKE COMPLEX FROM THE LASSA VIRUS IN A C3-SYMMETRIC MAP","10.1038/S41586-022-04429-2 ",3.3,0,"7puy_oligo25","DXylpa1-3DGlcpAb1-3DXylpa1-ROH","XYS(3_G_)-BDP(2_G_)-XYS(1_G_)",42.5001,"","",""
"7PVD","STRUCTURE OF THE MEMBRANE SOLUBLE SPIKE COMPLEX FROM THE LASSA VIRUS IN A C1-SYMMETRIC MAP FOCUSED ON THE ECTODOMAIN","10.1038/S41586-022-04429-2 ",3.7,0,"7pvd_oligo5","DXylpa1-3DGlcpAb1-3DXylpa1-3DGlcpAb1-3DXylpa1-3DGlcpAb1-3DXylpa1-3DGlcpAb1-3DXylpa1-3DGlcpAb1-3DXylpa1-3DGlcpAb1-3DXylpa1-ROH","XYS(13_M_)-BDP(12_M_)-XYS(11_M_)-BDP(10_M_)-XYS(9_M_)-BDP(8_M_)-XYS(7_M_)-BDP(6_M_)-XYS(5_M_)-BDP(4_M_)-XYS(3_M_)-BDP(2_M_)-XYS(1_M_)",53.7306,"","",""
"7Q0G","CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 BETA VARIANT SPIKE GLYCOPROTEIN IN COMPLEX WITH BETA-49 AND FI-3A FABS","10.1016/J.CHOM.2021.11.013 ",1.82,46.63,"7q0g_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_C_)-[MAN(4_C_)-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(343_E_)",73.6862,"","",""
"7Q15","CRYSTAL STRUCTURE OF FCRN AND BETA-2-MICROGLOBULIN IN COMPLEX WITH IGG1-FC-MST-HN (EFGARTIGIMOD)","10.1038/S41467-022-33764-1 ",3.3,63.19,"7q15_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_G_)-[GAL(6_G_)-NAG(5_G_)-MAN(4_G_)-[NAG(8_G_)-MAN(7_G_)]-BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(297_E_)",123.087,"","",""
"7Q15","CRYSTAL STRUCTURE OF FCRN AND BETA-2-MICROGLOBULIN IN COMPLEX WITH IGG1-FC-MST-HN (EFGARTIGIMOD)","10.1038/S41467-022-33764-1 ",3.3,63.19,"7q15_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_H_)-[MAN(7_H_)-[GAL(6_H_)-NAG(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)]-NAG(1_H_)-ASN(297_F_)",129.195,"","",""
"7Q28","CRYSTAL STRUCTURE OF ANGIOTENSIN-1 CONVERTING ENZYME C-DOMAIN IN COMPLEX WITH DUAL ACE/NEP INHIBITOR AD012","10.1021/ACS.JMEDCHEM.1C01924 ",1.65,28.93,"7q28_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_B_)-[MAN(4_B_)-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(109_A_)",55.8865,"","",""
"7Q29","CRYSTAL STRUCTURE OF ANGIOTENSIN-1 CONVERTING ENZYME C-DOMAIN IN COMPLEX WITH DUAL ACE/NEP INHIBITOR AD013","10.1021/ACS.JMEDCHEM.1C01924 ",1.6,21.33,"7q29_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_B_)-[MAN(4_B_)-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(109_A_)",52.7927,"","",""
"7Q3N","CRYO-EM OF THE COMPLEX BETWEEN HUMAN UROMODULIN (UMOD)/TAMM-HORSFALL PROTEIN (THP) AND THE FIMH LECTIN DOMAIN FROM UROPATHOGENIC E. COLI","10.1038/S41594-022-00729-3 ",7.4,13.2733,"7q3n_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-[MAN(5_D_)]-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(275_U_)",156.824,"","",""
"7Q3N","CRYO-EM OF THE COMPLEX BETWEEN HUMAN UROMODULIN (UMOD)/TAMM-HORSFALL PROTEIN (THP) AND THE FIMH LECTIN DOMAIN FROM UROPATHOGENIC E. COLI","10.1038/S41594-022-00729-3 ",7.4,13.2733,"7q3n_oligo3","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(8_C_)-MAN(7_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(232_U_)",237.809,"","",""
"7Q3P","CRYSTAL STRUCTURE OF IGG1-FC-MST-HN (EFGARTIGIMOD)","10.1038/S41467-022-33764-1 ",2.1,50.78,"7q3p_oligo1","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcx1-","MAN(4_H_)-MAN(3_H_)-BMA(2_H_)-NAG(1_H_)",69.9221,"","",""
"7Q3P","CRYSTAL STRUCTURE OF IGG1-FC-MST-HN (EFGARTIGIMOD)","10.1038/S41467-022-33764-1 ",2.1,50.78,"7q3p_oligo7","DGlcpNAcb1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(507_B_)-MAN(504_B_)-BMA(503_B_)-NAG(502_B_)-NAG(501_B_)-ASN(297_B_)",68.5944,"","",""
"7Q3Y","STRUCTURE OF FULL-LENGTH, MONOMERIC, SOLUBLE SOMATIC ANGIOTENSIN I- CONVERTING ENZYME SHOWING THE N- AND C-TERMINAL ELLIPSOID DOMAINS","10.15252/EMBJ.2021110550 ",4.34,"1.15243e-41","7q3y_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_J_)-[MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)]-NAG(1_J_)-ASN(289_A_)",186.202,"","",""
"7Q3Y","STRUCTURE OF FULL-LENGTH, MONOMERIC, SOLUBLE SOMATIC ANGIOTENSIN I- CONVERTING ENZYME SHOWING THE N- AND C-TERMINAL ELLIPSOID DOMAINS","10.15252/EMBJ.2021110550 ",4.34,"1.15243e-41","7q3y_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(25_A_)",190.003,"","",""
"7Q49","LOCAL REFINEMENT STRUCTURE OF THE N-DOMAIN OF FULL-LENGTH, MONOMERIC, SOLUBLE SOMATIC ANGIOTENSIN I-CONVERTING ENZYME","10.15252/EMBJ.2021110550 ",3.72,"1.15243e-41","7q49_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_C_)-[MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(289_A_)",185.567,"","",""
"7Q49","LOCAL REFINEMENT STRUCTURE OF THE N-DOMAIN OF FULL-LENGTH, MONOMERIC, SOLUBLE SOMATIC ANGIOTENSIN I-CONVERTING ENZYME","10.15252/EMBJ.2021110550 ",3.72,"1.15243e-41","7q49_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(25_A_)",193.674,"","",""
"7Q4D","LOCAL REFINEMENT STRUCTURE OF THE TWO INTERACTING N-DOMAINS OF FULL- LENGTH, DIMERIC, SOLUBLE SOMATIC ANGIOTENSIN I-CONVERTING ENZYME","10.15252/EMBJ.2021110550 ",3.78,"1.15243e-41","7q4d_oligo1","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_C_)-[NAG(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(289_A_)",120.422,"","",""
"7Q4D","LOCAL REFINEMENT STRUCTURE OF THE TWO INTERACTING N-DOMAINS OF FULL- LENGTH, DIMERIC, SOLUBLE SOMATIC ANGIOTENSIN I-CONVERTING ENZYME","10.15252/EMBJ.2021110550 ",3.78,"1.15243e-41","7q4d_oligo11","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_M_)-[NAG(5_M_)-MAN(4_M_)-[MAN(6_M_)]-BMA(3_M_)-NAG(2_M_)]-NAG(1_M_)-ASN(289_B_)",115.79,"","",""
"7Q4D","LOCAL REFINEMENT STRUCTURE OF THE TWO INTERACTING N-DOMAINS OF FULL- LENGTH, DIMERIC, SOLUBLE SOMATIC ANGIOTENSIN I-CONVERTING ENZYME","10.15252/EMBJ.2021110550 ",3.78,"1.15243e-41","7q4d_oligo7","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(45_A_)",125.78,"","",""
"7Q4D","LOCAL REFINEMENT STRUCTURE OF THE TWO INTERACTING N-DOMAINS OF FULL- LENGTH, DIMERIC, SOLUBLE SOMATIC ANGIOTENSIN I-CONVERTING ENZYME","10.15252/EMBJ.2021110550 ",3.78,"1.15243e-41","7q4d_oligo9","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_K_)-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(45_B_)",130.667,"","",""
"7Q4E","LOCAL REFINEMENT STRUCTURE OF A SINGLE N-DOMAIN OF FULL-LENGTH, DIMERIC, SOLUBLE SOMATIC ANGIOTENSIN I-CONVERTING ENZYME","10.15252/EMBJ.2021110550 ",3.63,"1.15243e-41","7q4e_oligo4","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_C_)-[NAG(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(289_A_)",124.826,"","",""
"7Q4E","LOCAL REFINEMENT STRUCTURE OF A SINGLE N-DOMAIN OF FULL-LENGTH, DIMERIC, SOLUBLE SOMATIC ANGIOTENSIN I-CONVERTING ENZYME","10.15252/EMBJ.2021110550 ",3.63,"1.15243e-41","7q4e_oligo8","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(45_A_)",146.344,"","",""
"7Q6E","BETA049 FAB IN COMPLEX WITH SARS-COV2 BETA-SPIKE GLYCOPROTEIN, THE BETA MAB RESPONSE UNDERSCORES THE ANTIGENIC DISTANCE TO OTHER SARS- COV-2 VARIANTS","10.1016/J.CHOM.2021.11.013 ",2.7,512.502,"7q6e_oligo13","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_V_)-[MAN(6_V_)-[MAN(5_V_)-MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)]-NAG(1_V_)-ASN(340_C_)",85.4979,"","",""
"7Q6E","BETA049 FAB IN COMPLEX WITH SARS-COV2 BETA-SPIKE GLYCOPROTEIN, THE BETA MAB RESPONSE UNDERSCORES THE ANTIGENIC DISTANCE TO OTHER SARS- COV-2 VARIANTS","10.1016/J.CHOM.2021.11.013 ",2.7,512.502,"7q6e_oligo1","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_D_)-[MAN(6_D_)-[MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(340_A_)",69.0604,"","",""
"7Q6E","BETA049 FAB IN COMPLEX WITH SARS-COV2 BETA-SPIKE GLYCOPROTEIN, THE BETA MAB RESPONSE UNDERSCORES THE ANTIGENIC DISTANCE TO OTHER SARS- COV-2 VARIANTS","10.1016/J.CHOM.2021.11.013 ",2.7,512.502,"7q6e_oligo7","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_P_)-[MAN(5_P_)-MAN(4_P_)-BMA(3_P_)-NAG(2_P_)]-NAG(1_P_)-ASN(340_B_)",99.2105,"","",""
"7QA4","CRYSTAL STRUCTURE OF STABILIZED H3N2 A/HONG KONG/1/1968 HEMAGGLUTININ AT 2.2 ANGSTROM","10.1073/PNAS.2115379119 ",2.19,66.57,"7qa4_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(165_A_)",108.735,"","",""
"7QCL","STRUCTURE OF THE MUCIN-2 CTERMINAL DOMAINS","",3.36,0,"7qcl_oligo3","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(9_H_)-NAG(8_H_)-MAN(7_H_)-[GAL(6_H_)-NAG(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(4578_B_)",30.101,"","",""
"7QCL","STRUCTURE OF THE MUCIN-2 CTERMINAL DOMAINS","",3.36,0,"7qcl_oligo4","DGalpb1-4DGlcpNAcb1-2[DGalpb1-4DGlcpNAcb1-4]DManpa1-3[DGalpb1-4DGlcpNAcb1-2[DGalpb1-4DGlcpNAcb1-4]DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(14_D_)-[GAL(13_D_)-NAG(12_D_)-[GAL(11_D_)-NAG(10_D_)]-MAN(9_D_)-[GAL(8_D_)-NAG(7_D_)-[GAL(6_D_)-NAG(5_D_)]-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(4567_A_)",30.0649,"","",""
"7QCL","STRUCTURE OF THE MUCIN-2 CTERMINAL DOMAINS","",3.36,0,"7qcl_oligo6","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(10_C_)-[GAL(9_C_)-NAG(8_C_)-MAN(7_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(4832_A_)",30.0909,"","",""
"7QCL","STRUCTURE OF THE MUCIN-2 CTERMINAL DOMAINS","",3.36,0,"7qcl_oligo5","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(10_G_)-[GAL(9_G_)-NAG(8_G_)-MAN(7_G_)-[GAL(6_G_)-NAG(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(4703_A_)",30.0909,"","",""
"7QCL","STRUCTURE OF THE MUCIN-2 CTERMINAL DOMAINS","",3.36,0,"7qcl_oligo8","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(10_F_)-[GAL(9_F_)-NAG(8_F_)-MAN(7_F_)-[GAL(6_F_)-NAG(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(4839_B_)",30.0909,"","",""
"7QCL","STRUCTURE OF THE MUCIN-2 CTERMINAL DOMAINS","",3.36,0,"7qcl_oligo13","DGalpb1-4DGlcpNAcb1-2[DGalpb1-4DGlcpNAcb1-4]DManpa1-3[DGalpb1-4DGlcpNAcb1-4DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(12_O_)-[GAL(11_O_)-NAG(10_O_)-MAN(9_O_)-[GAL(8_O_)-NAG(7_O_)-[GAL(6_O_)-NAG(5_O_)]-MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)]-NAG(1_O_)-ASN(4567_B_)",36.6591,"","",""
"7QCL","STRUCTURE OF THE MUCIN-2 CTERMINAL DOMAINS","",3.36,0,"7qcl_oligo1","DManpa1-3[DManpb1-4]DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_I_)-[BMA(4_I_)-[MAN(3_I_)]-NAG(2_I_)]-NAG(1_I_)-ASN(4738_A_)",30.1818,"","",""
"7QCL","STRUCTURE OF THE MUCIN-2 CTERMINAL DOMAINS","",3.36,0,"7qcl_oligo9","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(10_J_)-[GAL(9_J_)-NAG(8_J_)-MAN(7_J_)-[GAL(6_J_)-NAG(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)]-NAG(1_J_)-ASN(4839_A_)",30.0909,"","",""
"7QCL","STRUCTURE OF THE MUCIN-2 CTERMINAL DOMAINS","",3.36,0,"7qcl_oligo14","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(10_Q_)-[GAL(9_Q_)-NAG(8_Q_)-MAN(7_Q_)-[GAL(6_Q_)-NAG(5_Q_)-MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)]-NAG(1_Q_)-ASN(4832_B_)",30.0909,"","",""
"7QCL","STRUCTURE OF THE MUCIN-2 CTERMINAL DOMAINS","",3.36,0,"7qcl_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(9_K_)-NAG(8_K_)-MAN(7_K_)-[GAL(6_K_)-NAG(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(4578_A_)",30.101,"","",""
"7QCL","STRUCTURE OF THE MUCIN-2 CTERMINAL DOMAINS","",3.36,0,"7qcl_oligo10","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(10_L_)-[GAL(9_L_)-NAG(8_L_)-MAN(7_L_)-[GAL(6_L_)-NAG(5_L_)-MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)]-NAG(1_L_)-ASN(4703_B_)",30.0909,"","",""
"7QCN","STRUCTURE OF THE MUCIN-2 CTERMINAL DOMAINS: VWCN TO TIL DOMAINS WITH A C2 SYMMETRY","",3.4,0,"7qcn_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(4578_A_)",30.1818,"","",""
"7QCN","STRUCTURE OF THE MUCIN-2 CTERMINAL DOMAINS: VWCN TO TIL DOMAINS WITH A C2 SYMMETRY","",3.4,0,"7qcn_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(4578_B_)",30.1818,"","",""
"7QCU","STRUCTURE OF THE MUCIN-2 CTERMINAL DOMAINS PARTIALLY DEGLYCOSYLATED.","",3.25,0,"7qcu_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(4578_A_)",41.8182,"","",""
"7QCU","STRUCTURE OF THE MUCIN-2 CTERMINAL DOMAINS PARTIALLY DEGLYCOSYLATED.","",3.25,0,"7qcu_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(4578_B_)",38.1818,"","",""
"7QKO","TORPEDO MUSCLE-TYPE NICOTINIC ACETYLCHOLINE RECEPTOR - RESTING CONFORMATION","10.1016/J.NEURON.2022.01.013 ",2.9,"1.35632e-19","7qko_oligo3","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_I_)-[MAN(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(70_C_)",188.371,"","",""
"7QKO","TORPEDO MUSCLE-TYPE NICOTINIC ACETYLCHOLINE RECEPTOR - RESTING CONFORMATION","10.1016/J.NEURON.2022.01.013 ",2.9,"1.35632e-19","7qko_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(141_B_)",120.714,"","",""
"7QKO","TORPEDO MUSCLE-TYPE NICOTINIC ACETYLCHOLINE RECEPTOR - RESTING CONFORMATION","10.1016/J.NEURON.2022.01.013 ",2.9,"1.35632e-19","7qko_oligo7","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_L_)-[MAN(5_L_)]-MAN(4_L_)-[MAN(7_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(141_E_)",120.907,"","",""
"7QKO","TORPEDO MUSCLE-TYPE NICOTINIC ACETYLCHOLINE RECEPTOR - RESTING CONFORMATION","10.1016/J.NEURON.2022.01.013 ",2.9,"1.35632e-19","7qko_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)]-MAN(4_F_)-[MAN(7_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(141_A_)",103.199,"","",""
"7QKO","TORPEDO MUSCLE-TYPE NICOTINIC ACETYLCHOLINE RECEPTOR - RESTING CONFORMATION","10.1016/J.NEURON.2022.01.013 ",2.9,"1.35632e-19","7qko_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(143_C_)",125.936,"","",""
"7QKO","TORPEDO MUSCLE-TYPE NICOTINIC ACETYLCHOLINE RECEPTOR - RESTING CONFORMATION","10.1016/J.NEURON.2022.01.013 ",2.9,"1.35632e-19","7qko_oligo6","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_K_)-[MAN(5_K_)]-MAN(4_K_)-[MAN(7_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(141_D_)",99.4149,"","",""
"7QL5","TORPEDO MUSCLE-TYPE NICOTINIC ACETYLCHOLINE RECEPTOR - NICOTINE-BOUND CONFORMATION","10.1016/J.NEURON.2022.01.013 ",2.5,"1.35632e-19","7ql5_oligo7","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_L_)-MAN(4_L_)-[MAN(6_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(141_E_)",75.2905,"","",""
"7QL5","TORPEDO MUSCLE-TYPE NICOTINIC ACETYLCHOLINE RECEPTOR - NICOTINE-BOUND CONFORMATION","10.1016/J.NEURON.2022.01.013 ",2.5,"1.35632e-19","7ql5_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(70_C_)",122.229,"","",""
"7QL5","TORPEDO MUSCLE-TYPE NICOTINIC ACETYLCHOLINE RECEPTOR - NICOTINE-BOUND CONFORMATION","10.1016/J.NEURON.2022.01.013 ",2.5,"1.35632e-19","7ql5_oligo10","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)]-MAN(4_F_)-[MAN(7_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(141_A_)",69.9748,"","",""
"7QL5","TORPEDO MUSCLE-TYPE NICOTINIC ACETYLCHOLINE RECEPTOR - NICOTINE-BOUND CONFORMATION","10.1016/J.NEURON.2022.01.013 ",2.5,"1.35632e-19","7ql5_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(141_B_)",86.1187,"","",""
"7QL5","TORPEDO MUSCLE-TYPE NICOTINIC ACETYLCHOLINE RECEPTOR - NICOTINE-BOUND CONFORMATION","10.1016/J.NEURON.2022.01.013 ",2.5,"1.35632e-19","7ql5_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(143_C_)",82.0325,"","",""
"7QL5","TORPEDO MUSCLE-TYPE NICOTINIC ACETYLCHOLINE RECEPTOR - NICOTINE-BOUND CONFORMATION","10.1016/J.NEURON.2022.01.013 ",2.5,"1.35632e-19","7ql5_oligo6","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-MAN(4_K_)-[MAN(6_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(141_D_)",65.3742,"","",""
"7QL6","TORPEDO MUSCLE-TYPE NICOTINIC ACETYLCHOLINE RECEPTOR - CARBAMYLCHOLINE-BOUND CONFORMATION","10.1016/J.NEURON.2022.01.013 ",3.23,"1.35632e-19","7ql6_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(143_C_)",123.075,"","",""
"7QL6","TORPEDO MUSCLE-TYPE NICOTINIC ACETYLCHOLINE RECEPTOR - CARBAMYLCHOLINE-BOUND CONFORMATION","10.1016/J.NEURON.2022.01.013 ",3.23,"1.35632e-19","7ql6_oligo7","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_L_)-MAN(4_L_)-[MAN(6_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(141_E_)",105.341,"","",""
"7QL6","TORPEDO MUSCLE-TYPE NICOTINIC ACETYLCHOLINE RECEPTOR - CARBAMYLCHOLINE-BOUND CONFORMATION","10.1016/J.NEURON.2022.01.013 ",3.23,"1.35632e-19","7ql6_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(70_C_)",167.488,"","",""
"7QL6","TORPEDO MUSCLE-TYPE NICOTINIC ACETYLCHOLINE RECEPTOR - CARBAMYLCHOLINE-BOUND CONFORMATION","10.1016/J.NEURON.2022.01.013 ",3.23,"1.35632e-19","7ql6_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(141_B_)",128.369,"","",""
"7QL6","TORPEDO MUSCLE-TYPE NICOTINIC ACETYLCHOLINE RECEPTOR - CARBAMYLCHOLINE-BOUND CONFORMATION","10.1016/J.NEURON.2022.01.013 ",3.23,"1.35632e-19","7ql6_oligo2","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-MAN(4_F_)-[MAN(6_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(141_A_)",93.2959,"","",""
"7QL6","TORPEDO MUSCLE-TYPE NICOTINIC ACETYLCHOLINE RECEPTOR - CARBAMYLCHOLINE-BOUND CONFORMATION","10.1016/J.NEURON.2022.01.013 ",3.23,"1.35632e-19","7ql6_oligo6","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-MAN(4_K_)-[MAN(6_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(141_D_)",96.9753,"","",""
"7QN5","CRYO-EM STRUCTURE OF HUMAN FULL-LENGTH EXTRASYNAPTIC ALPHA4BETA3DELTA GABA(A)R IN COMPLEX WITH NANOBODY NB25","10.1038/S41586-022-04517-3 ",2.5,"1.08527e-19","7qn5_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(149_B_)",84.3865,"","",""
"7QN5","CRYO-EM STRUCTURE OF HUMAN FULL-LENGTH EXTRASYNAPTIC ALPHA4BETA3DELTA GABA(A)R IN COMPLEX WITH NANOBODY NB25","10.1038/S41586-022-04517-3 ",2.5,"1.08527e-19","7qn5_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_a_)-[MAN(4_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(144_A_)",138.598,"","",""
"7QN5","CRYO-EM STRUCTURE OF HUMAN FULL-LENGTH EXTRASYNAPTIC ALPHA4BETA3DELTA GABA(A)R IN COMPLEX WITH NANOBODY NB25","10.1038/S41586-022-04517-3 ",2.5,"1.08527e-19","7qn5_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(149_D_)",78.4831,"","",""
"7QN5","CRYO-EM STRUCTURE OF HUMAN FULL-LENGTH EXTRASYNAPTIC ALPHA4BETA3DELTA GABA(A)R IN COMPLEX WITH NANOBODY NB25","10.1038/S41586-022-04517-3 ",2.5,"1.08527e-19","7qn5_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(149_C_)",77.8322,"","",""
"7QN6","CRYO-EM STRUCTURE OF HUMAN FULL-LENGTH BETA3DELTA GABA(A)R IN COMPLEX WITH NANOBODY NB25","10.1038/S41586-022-04517-3 ",2.9,"1.08527e-19","7qn6_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(149_A_)",105.804,"","",""
"7QN6","CRYO-EM STRUCTURE OF HUMAN FULL-LENGTH BETA3DELTA GABA(A)R IN COMPLEX WITH NANOBODY NB25","10.1038/S41586-022-04517-3 ",2.9,"1.08527e-19","7qn6_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(149_C_)",77.4236,"","",""
"7QN6","CRYO-EM STRUCTURE OF HUMAN FULL-LENGTH BETA3DELTA GABA(A)R IN COMPLEX WITH NANOBODY NB25","10.1038/S41586-022-04517-3 ",2.9,"1.08527e-19","7qn6_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(149_B_)",69.9598,"","",""
"7QN6","CRYO-EM STRUCTURE OF HUMAN FULL-LENGTH BETA3DELTA GABA(A)R IN COMPLEX WITH NANOBODY NB25","10.1038/S41586-022-04517-3 ",2.9,"1.08527e-19","7qn6_oligo11","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(149_D_)",95.0315,"","",""
"7QN7","CRYO-EM STRUCTURE OF HUMAN FULL-LENGTH EXTRASYNAPTIC ALPHA4BETA3DELTA GABA(A)R IN COMPLEX WITH GABA, HISTAMINE AND NANOBODY NB25","10.1038/S41586-022-04517-3 ",3,"1.08527e-19","7qn7_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(149_B_)",106.8,"","",""
"7QN7","CRYO-EM STRUCTURE OF HUMAN FULL-LENGTH EXTRASYNAPTIC ALPHA4BETA3DELTA GABA(A)R IN COMPLEX WITH GABA, HISTAMINE AND NANOBODY NB25","10.1038/S41586-022-04517-3 ",3,"1.08527e-19","7qn7_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(149_C_)",98.9287,"","",""
"7QN7","CRYO-EM STRUCTURE OF HUMAN FULL-LENGTH EXTRASYNAPTIC ALPHA4BETA3DELTA GABA(A)R IN COMPLEX WITH GABA, HISTAMINE AND NANOBODY NB25","10.1038/S41586-022-04517-3 ",3,"1.08527e-19","7qn7_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(149_D_)",100.545,"","",""
"7QN7","CRYO-EM STRUCTURE OF HUMAN FULL-LENGTH EXTRASYNAPTIC ALPHA4BETA3DELTA GABA(A)R IN COMPLEX WITH GABA, HISTAMINE AND NANOBODY NB25","10.1038/S41586-022-04517-3 ",3,"1.08527e-19","7qn7_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_a_)-[MAN(4_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(144_A_)",159.157,"","",""
"7QN8","CRYO-EM STRUCTURE OF HUMAN FULL-LENGTH BETA3DELTA GABA(A)R IN COMPLEX WITH HISTAMINE AND NANOBODY NB25","10.1038/S41586-022-04517-3 ",3.1,"1.08527e-19","7qn8_oligo11","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(149_D_)",100.687,"","",""
"7QN8","CRYO-EM STRUCTURE OF HUMAN FULL-LENGTH BETA3DELTA GABA(A)R IN COMPLEX WITH HISTAMINE AND NANOBODY NB25","10.1038/S41586-022-04517-3 ",3.1,"1.08527e-19","7qn8_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(149_A_)",123.403,"","",""
"7QN8","CRYO-EM STRUCTURE OF HUMAN FULL-LENGTH BETA3DELTA GABA(A)R IN COMPLEX WITH HISTAMINE AND NANOBODY NB25","10.1038/S41586-022-04517-3 ",3.1,"1.08527e-19","7qn8_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(149_C_)",92.7305,"","",""
"7QN8","CRYO-EM STRUCTURE OF HUMAN FULL-LENGTH BETA3DELTA GABA(A)R IN COMPLEX WITH HISTAMINE AND NANOBODY NB25","10.1038/S41586-022-04517-3 ",3.1,"1.08527e-19","7qn8_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(149_B_)",93.398,"","",""
"7QN9","CRYO-EM STRUCTURE OF HUMAN FULL-LENGTH EXTRASYNAPTIC ALPHA4BETA3DELTA GABA(A)R IN COMPLEX WITH GABA, HISTAMINE AND NANOBODY NB25 IN A PRE- OPEN/CLOSED STATE","10.1038/S41586-022-04517-3 ",2.9,"3.35875e+07","7qn9_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(149_C_)",98.6518,"","",""
"7QN9","CRYO-EM STRUCTURE OF HUMAN FULL-LENGTH EXTRASYNAPTIC ALPHA4BETA3DELTA GABA(A)R IN COMPLEX WITH GABA, HISTAMINE AND NANOBODY NB25 IN A PRE- OPEN/CLOSED STATE","10.1038/S41586-022-04517-3 ",2.9,"3.35875e+07","7qn9_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(149_D_)",107.843,"","",""
"7QN9","CRYO-EM STRUCTURE OF HUMAN FULL-LENGTH EXTRASYNAPTIC ALPHA4BETA3DELTA GABA(A)R IN COMPLEX WITH GABA, HISTAMINE AND NANOBODY NB25 IN A PRE- OPEN/CLOSED STATE","10.1038/S41586-022-04517-3 ",2.9,"3.35875e+07","7qn9_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(149_B_)",111.025,"","",""
"7QNA","CRYO-EM STRUCTURE OF HUMAN FULL-LENGTH ALPHA4BETA3GAMMA2 GABA(A)R IN COMPLEX WITH GABA AND NANOBODY NB25","10.1038/S41586-022-04517-3 ",3,"1.08527e-19","7qna_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(149_E_)",126.206,"","",""
"7QNA","CRYO-EM STRUCTURE OF HUMAN FULL-LENGTH ALPHA4BETA3GAMMA2 GABA(A)R IN COMPLEX WITH GABA AND NANOBODY NB25","10.1038/S41586-022-04517-3 ",3,"1.08527e-19","7qna_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(149_D_)",154.745,"","",""
"7QNA","CRYO-EM STRUCTURE OF HUMAN FULL-LENGTH ALPHA4BETA3GAMMA2 GABA(A)R IN COMPLEX WITH GABA AND NANOBODY NB25","10.1038/S41586-022-04517-3 ",3,"1.08527e-19","7qna_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(149_B_)",136.393,"","",""
"7QNA","CRYO-EM STRUCTURE OF HUMAN FULL-LENGTH ALPHA4BETA3GAMMA2 GABA(A)R IN COMPLEX WITH GABA AND NANOBODY NB25","10.1038/S41586-022-04517-3 ",3,"1.08527e-19","7qna_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_a_)-[MAN(4_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(144_A_)",192.224,"","",""
"7QNB","CRYO-EM STRUCTURE OF HUMAN FULL-LENGTH BETA3GAMMA2 GABA(A)R IN COMPLEX WITH GABA AND NANOBODY NB25","10.1038/S41586-022-04517-3 ",3.1,"1.08527e-19","7qnb_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(149_E_)",113.428,"","",""
"7QNB","CRYO-EM STRUCTURE OF HUMAN FULL-LENGTH BETA3GAMMA2 GABA(A)R IN COMPLEX WITH GABA AND NANOBODY NB25","10.1038/S41586-022-04517-3 ",3.1,"1.08527e-19","7qnb_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(149_D_)",155.846,"","",""
"7QNB","CRYO-EM STRUCTURE OF HUMAN FULL-LENGTH BETA3GAMMA2 GABA(A)R IN COMPLEX WITH GABA AND NANOBODY NB25","10.1038/S41586-022-04517-3 ",3.1,"1.08527e-19","7qnb_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(149_B_)",154.516,"","",""
"7QNC","CRYO-EM STRUCTURE OF HUMAN FULL-LENGTH EXTRASYNAPTIC ALPHA4BETA3DELTA GABA(A)R IN COMPLEX WITH THIP (GABOXADOL), HISTAMINE AND NANOBODY NB25","10.1038/S41586-022-04517-3 ",2.9,"3.35875e+07","7qnc_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(149_D_)",98.0682,"","",""
"7QNC","CRYO-EM STRUCTURE OF HUMAN FULL-LENGTH EXTRASYNAPTIC ALPHA4BETA3DELTA GABA(A)R IN COMPLEX WITH THIP (GABOXADOL), HISTAMINE AND NANOBODY NB25","10.1038/S41586-022-04517-3 ",2.9,"3.35875e+07","7qnc_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(149_C_)",95.5549,"","",""
"7QNC","CRYO-EM STRUCTURE OF HUMAN FULL-LENGTH EXTRASYNAPTIC ALPHA4BETA3DELTA GABA(A)R IN COMPLEX WITH THIP (GABOXADOL), HISTAMINE AND NANOBODY NB25","10.1038/S41586-022-04517-3 ",2.9,"3.35875e+07","7qnc_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_a_)-[MAN(4_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(144_A_)",154.41,"","",""
"7QNC","CRYO-EM STRUCTURE OF HUMAN FULL-LENGTH EXTRASYNAPTIC ALPHA4BETA3DELTA GABA(A)R IN COMPLEX WITH THIP (GABOXADOL), HISTAMINE AND NANOBODY NB25","10.1038/S41586-022-04517-3 ",2.9,"3.35875e+07","7qnc_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(149_B_)",107.594,"","",""
"7QND","CRYO-EM STRUCTURE OF HUMAN FULL-LENGTH EXTRASYNAPTIC BETA3DELTA GABA(A)R IN COMPLEX WITH THIP (GABOXADOL), HISTAMINE AND NANOBODY NB25","10.1038/S41586-022-04517-3 ",3.4,"1.08527e-19","7qnd_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(149_A_)",161.598,"","",""
"7QND","CRYO-EM STRUCTURE OF HUMAN FULL-LENGTH EXTRASYNAPTIC BETA3DELTA GABA(A)R IN COMPLEX WITH THIP (GABOXADOL), HISTAMINE AND NANOBODY NB25","10.1038/S41586-022-04517-3 ",3.4,"1.08527e-19","7qnd_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(149_B_)",98.2911,"","",""
"7QND","CRYO-EM STRUCTURE OF HUMAN FULL-LENGTH EXTRASYNAPTIC BETA3DELTA GABA(A)R IN COMPLEX WITH THIP (GABOXADOL), HISTAMINE AND NANOBODY NB25","10.1038/S41586-022-04517-3 ",3.4,"1.08527e-19","7qnd_oligo11","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(149_D_)",104.781,"","",""
"7QND","CRYO-EM STRUCTURE OF HUMAN FULL-LENGTH EXTRASYNAPTIC BETA3DELTA GABA(A)R IN COMPLEX WITH THIP (GABOXADOL), HISTAMINE AND NANOBODY NB25","10.1038/S41586-022-04517-3 ",3.4,"1.08527e-19","7qnd_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(149_C_)",96.7836,"","",""
"7QNE","CRYO-EM STRUCTURE OF HUMAN FULL-LENGTH SYNAPTIC ALPHA1BETA3GAMMA2 GABA(A)R IN COMPLEX WITH RO15-4513 AND MEGABODY MB38","10.1038/S41586-022-04517-3 ",2.7,"1.08527e-19","7qne_oligo6","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-MAN(4_H_)-[MAN(6_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(149_E_)",78.2491,"","",""
"7QNE","CRYO-EM STRUCTURE OF HUMAN FULL-LENGTH SYNAPTIC ALPHA1BETA3GAMMA2 GABA(A)R IN COMPLEX WITH RO15-4513 AND MEGABODY MB38","10.1038/S41586-022-04517-3 ",2.7,"1.08527e-19","7qne_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_a_)-[MAN(8_a_)]-MAN(7_a_)-[MAN(6_a_)-MAN(5_a_)-MAN(4_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(111_A_)",65.8454,"","",""
"7QNE","CRYO-EM STRUCTURE OF HUMAN FULL-LENGTH SYNAPTIC ALPHA1BETA3GAMMA2 GABA(A)R IN COMPLEX WITH RO15-4513 AND MEGABODY MB38","10.1038/S41586-022-04517-3 ",2.7,"1.08527e-19","7qne_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_d_)-[MAN(4_d_)]-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(111_D_)",93.0927,"","",""
"7QNE","CRYO-EM STRUCTURE OF HUMAN FULL-LENGTH SYNAPTIC ALPHA1BETA3GAMMA2 GABA(A)R IN COMPLEX WITH RO15-4513 AND MEGABODY MB38","10.1038/S41586-022-04517-3 ",2.7,"1.08527e-19","7qne_oligo2","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-MAN(4_F_)-[MAN(6_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(149_B_)",75.7353,"","",""
"7QO7","SARS-COV-2 S OMICRON SPIKE B.1.1.529","10.1101/2021.12.27.474250 ",3.02,0,"7qo7_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(120_A_)",233.001,"","",""
"7QPD","STRUCTURE OF THE HUMAN MHC I PEPTIDE-LOADING COMPLEX EDITING MODULE","10.1038/S41467-022-32384-Z ",3.73,"1.35632e-19","7qpd_oligo2","DGlcpa1-3DManpa1-2DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GLC(7_D_)-MAN(6_D_)-MAN(5_D_)-MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(86_M_)",102.339,"","",""
"7QPT","BOTULINUM NEUROTOXIN A4 CELL BINDING DOMAIN IN COMPLEX WITH GD1A OLIGOSACCHARIDE","10.3390/TOXINS14020129 ",2.3,42.62,"7qpt_oligo1","DNeup5Aca2-3DGalpb1-3DGalpNAcb1-4DGalpb1-4DGlcpb1-ROH","SIA(5_C_)-GAL(4_C_)-NGA(3_C_)-GAL(2_C_)-BGC(1_C_)",80.613,"","",""
"7QPT","BOTULINUM NEUROTOXIN A4 CELL BINDING DOMAIN IN COMPLEX WITH GD1A OLIGOSACCHARIDE","10.3390/TOXINS14020129 ",2.3,42.62,"7qpt_oligo2","DNeup5Aca2-3DGalpb1-3DGalpNAcb1-4DGalpb1-4DGlcpb1-ROH","SIA(5_D_)-GAL(4_D_)-NGA(3_D_)-GAL(2_D_)-BGC(1_D_)",69.8718,"","",""
"7QQF","CRYSTAL STRUCTURE OF UNLIGANDED MYORG","10.1371/JOURNAL.PBIO.3001764 ",2.43,58.35,"7qqf_oligo6","LFucpa1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_J_)-[NAG(3_J_)]-[FUC(2_J_)]-NAG(1_J_)-ASN(372_C_)",106.247,"","",""
"7QTI","SARS-COV-2 S OMICRON SPIKE B.1.1.529 - 3-P2G3 AND 1-P5C3 FABS (GLOBAL)","10.1038/S41564-022-01198-6 ",3.04,"2.14959e+09","7qti_oligo13","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_X_)-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(340_A_)",106.493,"","",""
"7QU1","MACHUPO VIRUS GP1 GLYCOPROTEIN IN COMPLEX WITH FAB FRAGMENT OF ANTIBODY MAC1","10.1128/MBIO.02650-21 ",1.91,44.95,"7qu1_oligo1","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-MAN(5_D_)-[MAN(7_D_)]-MAN(4_D_)-[MAN(9_D_)-MAN(8_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(178_C_)",74.2584,"","",""
"7QUO","FIMH LECTIN DOMAIN IN COMPLEX WITH OLIGOMANNOSE-6","10.1016/J.JBC.2023.104627 ",3,44.82,"7quo_oligo2","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","MAN(8_E_)-[MAN(7_E_)]-MAN(6_E_)-[MAN(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)",68.9084,"","",""
"7QUO","FIMH LECTIN DOMAIN IN COMPLEX WITH OLIGOMANNOSE-6","10.1016/J.JBC.2023.104627 ",3,44.82,"7quo_oligo1","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","MAN(8_F_)-[MAN(7_F_)]-MAN(6_F_)-[MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)",63.8168,"","",""
"7QUR","SARS-COV-2 SPIKE WITH ETHYLBENZAMIDE-TRI-IODO SIALLYLLACTOSE, C3 SYMMETRY","10.1126/SCIENCE.ABM3125 ",2.27,"1.15243e-41","7qur_oligo12","LFucpa1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_O_)-[NAG(3_O_)]-[FUC(2_O_)]-NAG(1_O_)-ASN(165_C_)",73.8577,"","",""
"7QUR","SARS-COV-2 SPIKE WITH ETHYLBENZAMIDE-TRI-IODO SIALLYLLACTOSE, C3 SYMMETRY","10.1126/SCIENCE.ABM3125 ",2.27,"1.15243e-41","7qur_oligo1","LFucpa1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_G_)-[NAG(3_G_)]-[FUC(2_G_)]-NAG(1_G_)-ASN(165_A_)",73.8577,"","",""
"7QUR","SARS-COV-2 SPIKE WITH ETHYLBENZAMIDE-TRI-IODO SIALLYLLACTOSE, C3 SYMMETRY","10.1126/SCIENCE.ABM3125 ",2.27,"1.15243e-41","7qur_oligo8","LFucpa1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_K_)-[NAG(3_K_)]-[FUC(2_K_)]-NAG(1_K_)-ASN(165_B_)",73.8577,"","",""
"7QUS","SARS-COV-2 SPIKE, C3 SYMMETRY","10.1126/SCIENCE.ABM3125 ",2.39,"1.15243e-41","7qus_oligo12","LFucpa1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_O_)-[NAG(3_O_)]-[FUC(2_O_)]-NAG(1_O_)-ASN(165_C_)",58.3302,"","",""
"7QUS","SARS-COV-2 SPIKE, C3 SYMMETRY","10.1126/SCIENCE.ABM3125 ",2.39,"1.15243e-41","7qus_oligo1","LFucpa1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_G_)-[NAG(3_G_)]-[FUC(2_G_)]-NAG(1_G_)-ASN(165_A_)",58.3302,"","",""
"7QUS","SARS-COV-2 SPIKE, C3 SYMMETRY","10.1126/SCIENCE.ABM3125 ",2.39,"1.15243e-41","7qus_oligo5","LFucpa1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_K_)-[NAG(3_K_)]-[FUC(2_K_)]-NAG(1_K_)-ASN(165_B_)",58.3302,"","",""
"7QZR","STRUCTURE OF NATIVE LEUKOCYTE MYELOPEROXIDASE IN COMPLEX WITH THE STAPHYLOCCAL PEROXIDASE INHIBITOR SPIN FROM STAPHYLOCOCCUS AUREUS","10.1016/J.JBC.2022.102514 ",2.18,32.35,"7qzr_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_L_)-[MAN(5_L_)-[MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)]-NAG(1_L_)-ASN(483_D_)",35.353,"","",""
"7QZR","STRUCTURE OF NATIVE LEUKOCYTE MYELOPEROXIDASE IN COMPLEX WITH THE STAPHYLOCCAL PEROXIDASE INHIBITOR SPIN FROM STAPHYLOCOCCUS AUREUS","10.1016/J.JBC.2022.102514 ",2.18,32.35,"7qzr_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_I_)-[MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(483_B_)",35.4898,"","",""
"7R52","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH COMPOUND 2","10.1021/ACSMEDCHEMLETT.1C00696 ",2.94,91.02,"7r52_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(590_A_)",89.1007,"","",""
"7R52","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH COMPOUND 2","10.1021/ACSMEDCHEMLETT.1C00696 ",2.94,91.02,"7r52_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(590_B_)",92.6009,"","",""
"7R52","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH COMPOUND 2","10.1021/ACSMEDCHEMLETT.1C00696 ",2.94,91.02,"7r52_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(293_A_)",94.6846,"","",""
"7R52","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH COMPOUND 2","10.1021/ACSMEDCHEMLETT.1C00696 ",2.94,91.02,"7r52_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(293_B_)",92.5293,"","",""
"7R53","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH COMPOUND 15","10.1021/ACSMEDCHEMLETT.1C00696 ",3.12,101.4,"7r53_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(293_A_)",111.123,"","",""
"7R53","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH COMPOUND 15","10.1021/ACSMEDCHEMLETT.1C00696 ",3.12,101.4,"7r53_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(590_B_)",102.033,"","",""
"7R53","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH COMPOUND 15","10.1021/ACSMEDCHEMLETT.1C00696 ",3.12,101.4,"7r53_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(590_A_)",91.0413,"","",""
"7R53","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH COMPOUND 15","10.1021/ACSMEDCHEMLETT.1C00696 ",3.12,101.4,"7r53_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(293_B_)",99.7284,"","",""
"7R54","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH COMPOUND 4","10.1021/ACSMEDCHEMLETT.1C00696 ",2.84,94.36,"7r54_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(590_B_)",97.7238,"","",""
"7R54","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH COMPOUND 4","10.1021/ACSMEDCHEMLETT.1C00696 ",2.84,94.36,"7r54_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(293_A_)",100.23,"","",""
"7R54","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH COMPOUND 4","10.1021/ACSMEDCHEMLETT.1C00696 ",2.84,94.36,"7r54_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(293_B_)",111.082,"","",""
"7R54","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH COMPOUND 4","10.1021/ACSMEDCHEMLETT.1C00696 ",2.84,94.36,"7r54_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(590_A_)",79.4584,"","",""
"7RAI","CRYO-EM STRUCTURE OF M4008_N1 FAB IN COMPLEX WITH BG505 DS-SOSIP.664 ENV TRIMER","10.1038/S41467-021-26846-Z ",3.24,"1.08527e-19","7rai_oligo4","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_b_)-[MAN(6_b_)-MAN(5_b_)-MAN(4_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(262_C_)",89.9704,"","",""
"7RAI","CRYO-EM STRUCTURE OF M4008_N1 FAB IN COMPLEX WITH BG505 DS-SOSIP.664 ENV TRIMER","10.1038/S41467-021-26846-Z ",3.24,"1.08527e-19","7rai_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_P_)-[MAN(6_P_)-MAN(5_P_)-MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(262_A_)",89.9704,"","",""
"7RAI","CRYO-EM STRUCTURE OF M4008_N1 FAB IN COMPLEX WITH BG505 DS-SOSIP.664 ENV TRIMER","10.1038/S41467-021-26846-Z ",3.24,"1.08527e-19","7rai_oligo28","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_n_)-[MAN(6_n_)-MAN(5_n_)-MAN(4_n_)]-BMA(3_n_)-NAG(2_n_)-NAG(1_n_)-ASN(262_E_)",89.9704,"","",""
"7RAI","CRYO-EM STRUCTURE OF M4008_N1 FAB IN COMPLEX WITH BG505 DS-SOSIP.664 ENV TRIMER","10.1038/S41467-021-26846-Z ",3.24,"1.08527e-19","7rai_oligo25","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(156_A_)",103.891,"","",""
"7RAI","CRYO-EM STRUCTURE OF M4008_N1 FAB IN COMPLEX WITH BG505 DS-SOSIP.664 ENV TRIMER","10.1038/S41467-021-26846-Z ",3.24,"1.08527e-19","7rai_oligo13","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_k_)-[MAN(4_k_)]-BMA(3_k_)-NAG(2_k_)-NAG(1_k_)-ASN(156_E_)",103.891,"","",""
"7RAI","CRYO-EM STRUCTURE OF M4008_N1 FAB IN COMPLEX WITH BG505 DS-SOSIP.664 ENV TRIMER","10.1038/S41467-021-26846-Z ",3.24,"1.08527e-19","7rai_oligo22","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Y_)-[MAN(4_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(156_C_)",103.891,"","",""
"7RBV","SARS-COV-2 SPIKE IN COMPLEX WITH PVI.V6-14 FAB","10.1128/MBIO.03580-21 ",3.6,"8.69569e+08","7rbv_oligo23","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_b_)-MAN(4_b_)-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(137_C_)",325.86,"","",""
"7RBV","SARS-COV-2 SPIKE IN COMPLEX WITH PVI.V6-14 FAB","10.1128/MBIO.03580-21 ",3.6,"8.69569e+08","7rbv_oligo13","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_R_)-MAN(4_R_)-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(137_B_)",232.911,"","",""
"7RBV","SARS-COV-2 SPIKE IN COMPLEX WITH PVI.V6-14 FAB","10.1128/MBIO.03580-21 ",3.6,"8.69569e+08","7rbv_oligo11","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(137_A_)",242.775,"","",""
"7RC9","CRYSTAL STRUCTURE OF HUMAN TLR8 ECTODOMAIN BOUND TO SMALL MOLECULE ANTAGONIST 21","10.1021/ACSMEDCHEMLETT.2C00049 ",2.76,90.81,"7rc9_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(590_B_)",97.5545,"","",""
"7RC9","CRYSTAL STRUCTURE OF HUMAN TLR8 ECTODOMAIN BOUND TO SMALL MOLECULE ANTAGONIST 21","10.1021/ACSMEDCHEMLETT.2C00049 ",2.76,90.81,"7rc9_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(293_B_)",109.128,"","",""
"7RC9","CRYSTAL STRUCTURE OF HUMAN TLR8 ECTODOMAIN BOUND TO SMALL MOLECULE ANTAGONIST 21","10.1021/ACSMEDCHEMLETT.2C00049 ",2.76,90.81,"7rc9_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(590_A_)",81.0415,"","",""
"7RC9","CRYSTAL STRUCTURE OF HUMAN TLR8 ECTODOMAIN BOUND TO SMALL MOLECULE ANTAGONIST 21","10.1021/ACSMEDCHEMLETT.2C00049 ",2.76,90.81,"7rc9_oligo9","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(511_B_)",95.6123,"","",""
"7RFB","CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY MAB1198 IN COMPLEX WITH HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ECTODOMAIN","10.1016/J.IMMUNI.2021.12.003 ",2.7,91.76,"7rfb_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(540_D_)",133.039,"","",""
"7RFB","CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY MAB1198 IN COMPLEX WITH HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ECTODOMAIN","10.1016/J.IMMUNI.2021.12.003 ",2.7,91.76,"7rfb_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(623_D_)",127.645,"","",""
"7RFB","CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY MAB1198 IN COMPLEX WITH HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ECTODOMAIN","10.1016/J.IMMUNI.2021.12.003 ",2.7,91.76,"7rfb_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(623_C_)",119.201,"","",""
"7RFC","CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY MAB1382 IN COMPLEX WITH HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ECTODOMAIN","10.1016/J.IMMUNI.2021.12.003 ",3.24,72.59,"7rfc_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(556_D_)",111.64,"","",""
"7RGF","PROTOCADHERIN GAMMAC4 EC1-4 CRYSTAL STRUCTURE DISRUPTED TRANS INTERFACE","10.7554/ELIFE.72416 ",2.4,73.39,"7rgf_oligo2","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_D_)-[MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(236_B_)",93.0596,"","",""
"7RGF","PROTOCADHERIN GAMMAC4 EC1-4 CRYSTAL STRUCTURE DISRUPTED TRANS INTERFACE","10.7554/ELIFE.72416 ",2.4,73.39,"7rgf_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[MAN(7_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(236_A_)",88.4368,"","",""
"7ROQ","ALTERNATIVE STRUCTURE OF HUMAN ABCA1","",4.1,0,"7roq_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(1504_A_)",77.7536,"","",""
"7RSN","AMC018 SOSIP.V4.2 IN COMPLEX WITH PGV04 FAB","10.1128/JVI.01552-21 ",3.49,"5.37397e+08","7rsn_oligo12","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Z_)-[MAN(5_Z_)-MAN(4_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(197_G_)",68.1662,"","",""
"7RSN","AMC018 SOSIP.V4.2 IN COMPLEX WITH PGV04 FAB","10.1128/JVI.01552-21 ",3.49,"5.37397e+08","7rsn_oligo13","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(276_A_)",63.6827,"","",""
"7RSN","AMC018 SOSIP.V4.2 IN COMPLEX WITH PGV04 FAB","10.1128/JVI.01552-21 ",3.49,"5.37397e+08","7rsn_oligo14","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_N_)-[MAN(5_N_)-MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(197_A_)",68.1662,"","",""
"7RSN","AMC018 SOSIP.V4.2 IN COMPLEX WITH PGV04 FAB","10.1128/JVI.01552-21 ",3.49,"5.37397e+08","7rsn_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(276_C_)",63.6827,"","",""
"7RSN","AMC018 SOSIP.V4.2 IN COMPLEX WITH PGV04 FAB","10.1128/JVI.01552-21 ",3.49,"5.37397e+08","7rsn_oligo11","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Y_)-[MAN(4_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(276_G_)",63.6827,"","",""
"7RSN","AMC018 SOSIP.V4.2 IN COMPLEX WITH PGV04 FAB","10.1128/JVI.01552-21 ",3.49,"5.37397e+08","7rsn_oligo17","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_c_)-MAN(4_c_)-[MAN(6_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(262_G_)",78.4573,"","",""
"7RSN","AMC018 SOSIP.V4.2 IN COMPLEX WITH PGV04 FAB","10.1128/JVI.01552-21 ",3.49,"5.37397e+08","7rsn_oligo5","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_T_)-[MAN(5_T_)-MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(197_C_)",68.1662,"","",""
"7RSN","AMC018 SOSIP.V4.2 IN COMPLEX WITH PGV04 FAB","10.1128/JVI.01552-21 ",3.49,"5.37397e+08","7rsn_oligo9","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_W_)-MAN(4_W_)-[MAN(6_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(262_C_)",78.4573,"","",""
"7RSN","AMC018 SOSIP.V4.2 IN COMPLEX WITH PGV04 FAB","10.1128/JVI.01552-21 ",3.49,"5.37397e+08","7rsn_oligo2","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Q_)-MAN(4_Q_)-[MAN(6_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(262_A_)",78.4573,"","",""
"7RSO","AMC016 SOSIP.V4.2 IN COMPLEX WITH PGV04 FAB","10.1128/JVI.01552-21 ",4.1,"5.37397e+08","7rso_oligo12","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_c_)-[MAN(4_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(276_C_)",120.377,"","",""
"7RSO","AMC016 SOSIP.V4.2 IN COMPLEX WITH PGV04 FAB","10.1128/JVI.01552-21 ",4.1,"5.37397e+08","7rso_oligo24","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_o_)-[MAN(4_o_)]-BMA(3_o_)-NAG(2_o_)-NAG(1_o_)-ASN(276_D_)",120.377,"","",""
"7RSO","AMC016 SOSIP.V4.2 IN COMPLEX WITH PGV04 FAB","10.1128/JVI.01552-21 ",4.1,"5.37397e+08","7rso_oligo8","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_P_)-[MAN(5_P_)-MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(262_A_)",96.2758,"","",""
"7RSO","AMC016 SOSIP.V4.2 IN COMPLEX WITH PGV04 FAB","10.1128/JVI.01552-21 ",4.1,"5.37397e+08","7rso_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Q_)-[MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(276_A_)",120.377,"","",""
"7RSO","AMC016 SOSIP.V4.2 IN COMPLEX WITH PGV04 FAB","10.1128/JVI.01552-21 ",4.1,"5.37397e+08","7rso_oligo11","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_b_)-[MAN(5_b_)-MAN(4_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(262_C_)",96.2758,"","",""
"7RSO","AMC016 SOSIP.V4.2 IN COMPLEX WITH PGV04 FAB","10.1128/JVI.01552-21 ",4.1,"5.37397e+08","7rso_oligo23","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_n_)-[MAN(5_n_)-MAN(4_n_)]-BMA(3_n_)-NAG(2_n_)-NAG(1_n_)-ASN(262_D_)",96.2758,"","",""
"7S0I","CRYSTAL STRUCTURE OF N1 NEURAMINIDASE FROM A/MICHIGAN/45/2015(H1N1)","10.1128/MBIO.02241-21 ",2.89,35.35,"7s0i_oligo2","DManpa1-3DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_B_)-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(146_A_)",58.51,"","",""
"7S0K","HAP2 FROM CYANIDIOSCHYZON MEROLAE","10.1038/S41467-022-31744-Z ",2.3,90.79,"7s0k_oligo2","DManpa1-3DManpb1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-BMA(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(247_A_)",142.847,"","",""
"7S69","N-ACETYLGLUCOSAMINE-1-PHOSPHOTRANSFERASE (GNPT) GAMMA SUBUNIT (GNPTG), FROM CLAWED FROG","10.1073/PNAS.2203518119 ",3.04,56.35,"7s69_oligo2","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(87_A_)",76.8762,"","",""
"7S69","N-ACETYLGLUCOSAMINE-1-PHOSPHOTRANSFERASE (GNPT) GAMMA SUBUNIT (GNPTG), FROM CLAWED FROG","10.1073/PNAS.2203518119 ",3.04,56.35,"7s69_oligo1","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-MAN(5_D_)-[MAN(7_D_)]-MAN(4_D_)-[MAN(9_D_)-MAN(8_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(87_B_)",72.0631,"","",""
"7S6N","N-ACETYLGLUCOSAMINE-1-PHOSPHOTRANSFERASE (GNPT) ALPHA AND BETA SUBUNITS (GNPTAB) CATALYTIC DOMAIN, FROM ZEBRAFISH","10.1073/PNAS.2203518119 ",2.7,46.95,"7s6n_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(88_A_)",61.8486,"","",""
"7S8H","STRUCTURE OF LASSA VIRUS GLYCOPROTEIN BOUND TO FAB 18.5C AND FAB 36.1F","10.1016/J.CELREP.2022.110841 ",2.7,79.91,"7s8h_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_N_)-[MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)]-NAG(1_N_)-ASN(395_a_)",120.156,"","",""
"7S8H","STRUCTURE OF LASSA VIRUS GLYCOPROTEIN BOUND TO FAB 18.5C AND FAB 36.1F","10.1016/J.CELREP.2022.110841 ",2.7,79.91,"7s8h_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_I_)-[MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(119_A_)",128.201,"","",""
"7SBD","MURINE FAB/IGE IN COMPLEX WITH PROFILIN FROM HEVEA BRASIELIENSIS (HEV B 8)","10.1038/S42003-022-03718-W ",3.04,63.99,"7sbd_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_F_)-[MAN(4_F_)-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(189_H_)",81.3969,"","",""
"7SGD","LASSA VIRUS GLYCOPROTEIN CONSTRUCT(JOSIAH GPCYSR4) RECOVERED FROM GPC- I53-50 NANOPARTICLE BY LOCALIZED RECONSTRUCTION","10.1016/J.CHOM.2022.10.018 ",3.97,"1.15243e-41","7sgd_oligo25","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_e_)-[MAN(4_e_)]-BMA(3_e_)-NAG(2_e_)-NAG(1_e_)-ASN(365_c_)",100.971,"","",""
"7SGD","LASSA VIRUS GLYCOPROTEIN CONSTRUCT(JOSIAH GPCYSR4) RECOVERED FROM GPC- I53-50 NANOPARTICLE BY LOCALIZED RECONSTRUCTION","10.1016/J.CHOM.2022.10.018 ",3.97,"1.15243e-41","7sgd_oligo11","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(365_b_)",100.971,"","",""
"7SGD","LASSA VIRUS GLYCOPROTEIN CONSTRUCT(JOSIAH GPCYSR4) RECOVERED FROM GPC- I53-50 NANOPARTICLE BY LOCALIZED RECONSTRUCTION","10.1016/J.CHOM.2022.10.018 ",3.97,"1.15243e-41","7sgd_oligo15","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(365_a_)",100.971,"","",""
"7SGF","LASSA VIRUS GLYCOPROTEIN CONSTRUCT (JOSIAH GPC-I53-50A) IN COMPLEX WITH LAVA01 ANTIBODY","10.1016/J.CHOM.2022.10.018 ",4.41,8.00784,"7sgf_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(109_A_)",142.597,"","",""
"7SGF","LASSA VIRUS GLYCOPROTEIN CONSTRUCT (JOSIAH GPC-I53-50A) IN COMPLEX WITH LAVA01 ANTIBODY","10.1016/J.CHOM.2022.10.018 ",4.41,8.00784,"7sgf_oligo21","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_g_)-[MAN(4_g_)]-BMA(3_g_)-NAG(2_g_)-NAG(1_g_)-ASN(109_C_)",142.597,"","",""
"7SGF","LASSA VIRUS GLYCOPROTEIN CONSTRUCT (JOSIAH GPC-I53-50A) IN COMPLEX WITH LAVA01 ANTIBODY","10.1016/J.CHOM.2022.10.018 ",4.41,8.00784,"7sgf_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_U_)-[MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(109_B_)",142.597,"","",""
"7SHT","STRUCTURE OF A PARTIALLY DISRUPTED IGE HIGH AFFINITY RECEPTOR COMPLEX BOUND TO AN OMALIZUMAB VARIANT","10.1038/S41467-021-27397-Z ",7.29,"2.06915e+08","7sht_oligo6","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-MAN(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(394_B_)",320.077,"","",""
"7SHT","STRUCTURE OF A PARTIALLY DISRUPTED IGE HIGH AFFINITY RECEPTOR COMPLEX BOUND TO AN OMALIZUMAB VARIANT","10.1038/S41467-021-27397-Z ",7.29,"2.06915e+08","7sht_oligo7","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-MAN(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(394_D_)",343.719,"","",""
"7SHU","IGE-FC IN COMPLEX WITH OMALIZUMAB VARIANT C02","10.1038/S41467-021-27397-Z ",2.75,98.91,"7shu_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcp[2<R1>]x1-","MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)",142.25,"","",""
"7SHY","IGE-FC IN COMPLEX WITH OMALIZUMAB SCFV","10.1038/S41467-021-27397-Z ",3,99.2,"7shy_oligo2","DManpb1-4DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_N_)-MAN(4_N_)-[MAN(6_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(394_G_)",131.48,"","",""
"7SHY","IGE-FC IN COMPLEX WITH OMALIZUMAB SCFV","10.1038/S41467-021-27397-Z ",3,99.2,"7shy_oligo4","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_P_)-[MAN(5_P_)]-MAN(4_P_)-[MAN(7_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(394_B_)",142.045,"","",""
"7SHY","IGE-FC IN COMPLEX WITH OMALIZUMAB SCFV","10.1038/S41467-021-27397-Z ",3,99.2,"7shy_oligo1","DManpa1-3DGlcp[2<R1>]x[LFucpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAca1-ASN","FUC(6_M_)-[MAN(5_M_)-MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(394_A_)",138.014,"","",""
"7SHZ","IGE-FC IN COMPLEX WITH HAE","10.1038/S41467-021-27397-Z ",3,112.4,"7shz_oligo1","DManpa1-2[DManpa1-6]DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_M_)-[MAN(6_M_)-[MAN(5_M_)]-MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(394_B_)",154.672,"","",""
"7SHZ","IGE-FC IN COMPLEX WITH HAE","10.1038/S41467-021-27397-Z ",3,112.4,"7shz_oligo3","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-MAN(4_O_)-[MAN(6_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(394_H_)",171.196,"","",""
"7SI0","IGE-FC IN COMPLEX WITH 813","10.1038/S41467-021-27397-Z ",3,65.07,"7si0_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(4_P_)-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)",97.8764,"","",""
"7SI0","IGE-FC IN COMPLEX WITH 813","10.1038/S41467-021-27397-Z ",3,65.07,"7si0_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_O_)-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(394_G_)",103.653,"","",""
"7SI0","IGE-FC IN COMPLEX WITH 813","10.1038/S41467-021-27397-Z ",3,65.07,"7si0_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_R_)-[MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(394_A_)",89.0682,"","",""
"7SI0","IGE-FC IN COMPLEX WITH 813","10.1038/S41467-021-27397-Z ",3,65.07,"7si0_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_M_)-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(394_B_)",64.3448,"","",""
"7SJ2","N-ACETYLGLUCOSAMINE-1-PHOSPHOTRANSFERASE (GNPT) ALPHA AND BETA SUBUNITS (GNPTAB) CATALYTIC DOMAIN, FROM ZEBRAFISH, IN COMPLEX WITH URIDINE DIPHOSPHATE N-ACETYLGLUCOSAMINE (UDP-GLCNAC) AND MAGNESIUM","10.1073/PNAS.2203518119 ",2.3,50.76,"7sj2_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(88_A_)",67.0871,"","",""
"7SKA","SUB-TOMOGRAM AVERAGED STRUCTURE OF HIV-1 ENVELOPE PROTEIN IN NATIVE MEMBRANE","10.1016/J.CELL.2022.01.013 ",9.1,0,"7ska_oligo11","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(4_a_)-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)",185.246,"","",""
"7SKA","SUB-TOMOGRAM AVERAGED STRUCTURE OF HIV-1 ENVELOPE PROTEIN IN NATIVE MEMBRANE","10.1016/J.CELL.2022.01.013 ",9.1,0,"7ska_oligo23","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_F_)-MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)",162.588,"","",""
"7SKA","SUB-TOMOGRAM AVERAGED STRUCTURE OF HIV-1 ENVELOPE PROTEIN IN NATIVE MEMBRANE","10.1016/J.CELL.2022.01.013 ",9.1,0,"7ska_oligo44","DGalpb1-4DGlcpNAcb1-2[DGalpb1-4DGlcpNAcb1-4]DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","GAL(8_x_)-NAG(7_x_)-[GAL(6_x_)-NAG(5_x_)]-MAN(4_x_)-BMA(3_x_)-NAG(2_x_)-NAG(1_x_)",0,"","",""
"7SKA","SUB-TOMOGRAM AVERAGED STRUCTURE OF HIV-1 ENVELOPE PROTEIN IN NATIVE MEMBRANE","10.1016/J.CELL.2022.01.013 ",9.1,0,"7ska_oligo39","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_s_)-MAN(4_s_)-BMA(3_s_)-NAG(2_s_)-NAG(1_s_)",0,"","",""
"7SKA","SUB-TOMOGRAM AVERAGED STRUCTURE OF HIV-1 ENVELOPE PROTEIN IN NATIVE MEMBRANE","10.1016/J.CELL.2022.01.013 ",9.1,0,"7ska_oligo17","DGalpb1-4DGlcpNAcb1-2[DGalpb1-4DGlcpNAcb1-4]DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","GAL(8_g_)-NAG(7_g_)-[GAL(6_g_)-NAG(5_g_)]-MAN(4_g_)-BMA(3_g_)-NAG(2_g_)-NAG(1_g_)",0,"","",""
"7SKA","SUB-TOMOGRAM AVERAGED STRUCTURE OF HIV-1 ENVELOPE PROTEIN IN NATIVE MEMBRANE","10.1016/J.CELL.2022.01.013 ",9.1,0,"7ska_oligo5","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_T_)-MAN(4_T_)-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)",162.588,"","",""
"7SKA","SUB-TOMOGRAM AVERAGED STRUCTURE OF HIV-1 ENVELOPE PROTEIN IN NATIVE MEMBRANE","10.1016/J.CELL.2022.01.013 ",9.1,0,"7ska_oligo25","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_J_)-MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)",0,"","",""
"7SKA","SUB-TOMOGRAM AVERAGED STRUCTURE OF HIV-1 ENVELOPE PROTEIN IN NATIVE MEMBRANE","10.1016/J.CELL.2022.01.013 ",9.1,0,"7ska_oligo34","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_m_)-MAN(4_m_)-[MAN(6_m_)]-BMA(3_m_)-NAG(2_m_)-NAG(1_m_)",166.894,"","",""
"7SKA","SUB-TOMOGRAM AVERAGED STRUCTURE OF HIV-1 ENVELOPE PROTEIN IN NATIVE MEMBRANE","10.1016/J.CELL.2022.01.013 ",9.1,0,"7ska_oligo6","DManpa1-2DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(6_d_)-MAN(5_d_)-MAN(4_d_)-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)",130.419,"","",""
"7SKA","SUB-TOMOGRAM AVERAGED STRUCTURE OF HIV-1 ENVELOPE PROTEIN IN NATIVE MEMBRANE","10.1016/J.CELL.2022.01.013 ",9.1,0,"7ska_oligo43","DGlcpNAcb1-2DManpa1-3DManpb1-4DGlcpNAcb1-4NAG1-","NAG(5_w_)-MAN(4_w_)-BMA(3_w_)-NAG(2_w_)-NAG(1_w_)",0,"","",""
"7SKA","SUB-TOMOGRAM AVERAGED STRUCTURE OF HIV-1 ENVELOPE PROTEIN IN NATIVE MEMBRANE","10.1016/J.CELL.2022.01.013 ",9.1,0,"7ska_oligo24","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)",185.246,"","",""
"7SKA","SUB-TOMOGRAM AVERAGED STRUCTURE OF HIV-1 ENVELOPE PROTEIN IN NATIVE MEMBRANE","10.1016/J.CELL.2022.01.013 ",9.1,0,"7ska_oligo30","DGalpb1-4DGlcpNAcb1-2[DGalpb1-4DGlcpNAcb1-4]DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","GAL(8_Q_)-NAG(7_Q_)-[GAL(6_Q_)-NAG(5_Q_)]-MAN(4_Q_)-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)",0,"","",""
"7SKA","SUB-TOMOGRAM AVERAGED STRUCTURE OF HIV-1 ENVELOPE PROTEIN IN NATIVE MEMBRANE","10.1016/J.CELL.2022.01.013 ",9.1,0,"7ska_oligo20","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_j_)-MAN(4_j_)-BMA(3_j_)-NAG(2_j_)-NAG(1_j_)",162.588,"","",""
"7SKA","SUB-TOMOGRAM AVERAGED STRUCTURE OF HIV-1 ENVELOPE PROTEIN IN NATIVE MEMBRANE","10.1016/J.CELL.2022.01.013 ",9.1,0,"7ska_oligo19","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_i_)-MAN(4_i_)-[MAN(6_i_)]-BMA(3_i_)-NAG(2_i_)-NAG(1_i_)",166.894,"","",""
"7SKA","SUB-TOMOGRAM AVERAGED STRUCTURE OF HIV-1 ENVELOPE PROTEIN IN NATIVE MEMBRANE","10.1016/J.CELL.2022.01.013 ",9.1,0,"7ska_oligo29","DGlcpNAcb1-2DManpa1-3DManpb1-4DGlcpNAcb1-4NAG1-","NAG(5_P_)-MAN(4_P_)-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)",0,"","",""
"7SKA","SUB-TOMOGRAM AVERAGED STRUCTURE OF HIV-1 ENVELOPE PROTEIN IN NATIVE MEMBRANE","10.1016/J.CELL.2022.01.013 ",9.1,0,"7ska_oligo12","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_b_)-MAN(4_b_)-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)",0,"","",""
"7SKA","SUB-TOMOGRAM AVERAGED STRUCTURE OF HIV-1 ENVELOPE PROTEIN IN NATIVE MEMBRANE","10.1016/J.CELL.2022.01.013 ",9.1,0,"7ska_oligo1","DManpa1-2DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(6_H_)-MAN(5_H_)-MAN(4_H_)-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)",130.419,"","",""
"7SKA","SUB-TOMOGRAM AVERAGED STRUCTURE OF HIV-1 ENVELOPE PROTEIN IN NATIVE MEMBRANE","10.1016/J.CELL.2022.01.013 ",9.1,0,"7ska_oligo16","DGlcpNAcb1-2DManpa1-3DManpb1-4DGlcpNAcb1-4NAG1-","NAG(5_n_)-MAN(4_n_)-BMA(3_n_)-NAG(2_n_)-NAG(1_n_)",0,"","",""
"7SKA","SUB-TOMOGRAM AVERAGED STRUCTURE OF HIV-1 ENVELOPE PROTEIN IN NATIVE MEMBRANE","10.1016/J.CELL.2022.01.013 ",9.1,0,"7ska_oligo38","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(4_r_)-BMA(3_r_)-NAG(2_r_)-NAG(1_r_)",185.246,"","",""
"7SKA","SUB-TOMOGRAM AVERAGED STRUCTURE OF HIV-1 ENVELOPE PROTEIN IN NATIVE MEMBRANE","10.1016/J.CELL.2022.01.013 ",9.1,0,"7ska_oligo21","DManpa1-2DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(6_k_)-MAN(5_k_)-MAN(4_k_)-BMA(3_k_)-NAG(2_k_)-NAG(1_k_)",130.419,"","",""
"7SKA","SUB-TOMOGRAM AVERAGED STRUCTURE OF HIV-1 ENVELOPE PROTEIN IN NATIVE MEMBRANE","10.1016/J.CELL.2022.01.013 ",9.1,0,"7ska_oligo32","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_S_)-MAN(4_S_)-[MAN(6_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)",166.894,"","",""
"7SLV","VANIN-1 COMPLEXED WITH COMPOUND 3","10.1021/ACS.JMEDCHEM.1C01849 ",2.13,53.28,"7slv_oligo6","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_B_)-[BMA(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(294_A_)",92.1431,"","",""
"7SLV","VANIN-1 COMPLEXED WITH COMPOUND 3","10.1021/ACS.JMEDCHEM.1C01849 ",2.13,53.28,"7slv_oligo1","DManpb1-3DManpb1-6[DManpb1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_D_)-BMA(4_D_)-[BMA(6_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(179_A_)",53.1135,"","",""
"7SLX","VANIN-1 COMPLEXED WITH COMPOUND 11","10.1021/ACS.JMEDCHEM.1C01849 ",2.35,59.19,"7slx_oligo5","DManpb1-3DManpb1-6[DManpb1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","BMA(5_D_)-BMA(4_D_)-[BMA(6_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)",57.5398,"","",""
"7SLY","VANIN-1 COMPLEXED WITH COMPOUND 27","10.1021/ACS.JMEDCHEM.1C01849 ",2.17,65.13,"7sly_oligo6","DManpb1-3DManpb1-6[DManpb1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_D_)-BMA(4_D_)-[BMA(6_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(179_A_)",62.0695,"","",""
"7SMM","CRYO-EM STRUCTURE OF TORPEDO ACETYLCHOLINE RECEPTOR IN APO FORM","10.1038/S41594-022-00737-3 ",2.5,"1.08527e-19","7smm_oligo3","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_I_)-[MAN(5_I_)]-MAN(4_I_)-[MAN(7_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(141_D_)",71.6678,"","",""
"7SMM","CRYO-EM STRUCTURE OF TORPEDO ACETYLCHOLINE RECEPTOR IN APO FORM","10.1038/S41594-022-00737-3 ",2.5,"1.08527e-19","7smm_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)]-MAN(4_F_)-[MAN(7_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(141_A_)",75.4939,"","",""
"7SMQ","CRYO-EM STRUCTURE OF TORPEDO ACETYLCHOLINE RECEPTOR IN APO FORM WITH ADDED CHOLESTEROL","10.1038/S41594-022-00737-3 ",2.7,"1.08527e-19","7smq_oligo7","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)]-MAN(4_F_)-[MAN(7_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(141_A_)",74.6358,"","",""
"7SMQ","CRYO-EM STRUCTURE OF TORPEDO ACETYLCHOLINE RECEPTOR IN APO FORM WITH ADDED CHOLESTEROL","10.1038/S41594-022-00737-3 ",2.7,"1.08527e-19","7smq_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_I_)-[MAN(5_I_)]-MAN(4_I_)-[MAN(7_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(141_D_)",73.2971,"","",""
"7SN0","CRYSTAL STRUCTURE OF SPIKE PROTEIN RECEPTOR BINDING DOMAIN OF ESCAPE MUTANT SARS-COV-2 FROM IMMUNOCOMPROMISED PATIENT (D146*) IN COMPLEX WITH HUMAN RECEPTOR ACE2","10.1126/SCIENCE.ABL6251 ",3.08,97.77,"7sn0_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(103_A_)",137.377,"","",""
"7SN0","CRYSTAL STRUCTURE OF SPIKE PROTEIN RECEPTOR BINDING DOMAIN OF ESCAPE MUTANT SARS-COV-2 FROM IMMUNOCOMPROMISED PATIENT (D146*) IN COMPLEX WITH HUMAN RECEPTOR ACE2","10.1126/SCIENCE.ABL6251 ",3.08,97.77,"7sn0_oligo11","DGalpb1-4DGlcpNAcb1-4[DGlcpNAcb1-2]DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(9_O_)-MAN(8_O_)-[GAL(6_O_)-NAG(5_O_)-[NAG(7_O_)]-MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(90_B_)",154.758,"","",""
"7SN0","CRYSTAL STRUCTURE OF SPIKE PROTEIN RECEPTOR BINDING DOMAIN OF ESCAPE MUTANT SARS-COV-2 FROM IMMUNOCOMPROMISED PATIENT (D146*) IN COMPLEX WITH HUMAN RECEPTOR ACE2","10.1126/SCIENCE.ABL6251 ",3.08,97.77,"7sn0_oligo3","DGalpb1-4DGlcpNAcb1-2[DGalpb1-4DGlcpNAcb1-4]DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(10_I_)-MAN(9_I_)-[GAL(8_I_)-NAG(7_I_)-[GAL(6_I_)-NAG(5_I_)]-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(90_A_)",153.312,"","",""
"7SN0","CRYSTAL STRUCTURE OF SPIKE PROTEIN RECEPTOR BINDING DOMAIN OF ESCAPE MUTANT SARS-COV-2 FROM IMMUNOCOMPROMISED PATIENT (D146*) IN COMPLEX WITH HUMAN RECEPTOR ACE2","10.1126/SCIENCE.ABL6251 ",3.08,97.77,"7sn0_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(103_B_)",146.426,"","",""
"7SN0","CRYSTAL STRUCTURE OF SPIKE PROTEIN RECEPTOR BINDING DOMAIN OF ESCAPE MUTANT SARS-COV-2 FROM IMMUNOCOMPROMISED PATIENT (D146*) IN COMPLEX WITH HUMAN RECEPTOR ACE2","10.1126/SCIENCE.ABL6251 ",3.08,97.77,"7sn0_oligo9","DGlcpNAcb1-4DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_M_)-[NAG(5_M_)-MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(546_B_)",157.943,"","",""
"7SN0","CRYSTAL STRUCTURE OF SPIKE PROTEIN RECEPTOR BINDING DOMAIN OF ESCAPE MUTANT SARS-COV-2 FROM IMMUNOCOMPROMISED PATIENT (D146*) IN COMPLEX WITH HUMAN RECEPTOR ACE2","10.1126/SCIENCE.ABL6251 ",3.08,97.77,"7sn0_oligo5","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_K_)-[NAG(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(322_B_)",150.049,"","",""
"7SN0","CRYSTAL STRUCTURE OF SPIKE PROTEIN RECEPTOR BINDING DOMAIN OF ESCAPE MUTANT SARS-COV-2 FROM IMMUNOCOMPROMISED PATIENT (D146*) IN COMPLEX WITH HUMAN RECEPTOR ACE2","10.1126/SCIENCE.ABL6251 ",3.08,97.77,"7sn0_oligo2","DGalpb1-4DGlcpNAcb1-4[DGlcpNAcb1-2]DManpa1-3[DGalpb1-4DGlcpNAcb1-4DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(10_H_)-NAG(9_H_)-MAN(8_H_)-[GAL(6_H_)-NAG(5_H_)-[NAG(7_H_)]-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(53_A_)",163.886,"","",""
"7SN2","STRUCTURE OF HUMAN SARS-COV-2 NEUTRALIZING ANTIBODY C1C-A3 FAB","10.1126/SCIENCE.ABL6251 ",4.3,"1.08527e-19","7sn2_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(343_A_)",112.631,"","",""
"7SNO","STRUCTURE OF BACPLE_01701(H214N), A 6-O-GALACTOSE PORPHYRAN SULFATASE","10.1101/2023.03.30.534863 ",2.1,0,"7sno_oligo1","LGalp[6S]a1-3DGalpb1-4LGalp[6S]a1-3DGalpb1-ROH","L6S(4_B_)-GAL(3_B_)-L6S(2_B_)-GAL(1_B_)",63.8155,"","",""
"7SOC","SARS-COV-2 S RBD B.1.617.1 KAPPA VARIANT S309 LOCAL REFINEMENT","10.1126/SCIENCE.ABL8506 ",3.3,"5.50295e+11","7soc_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_B_)-[MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(343_A_)",23.2536,"","",""
"7SQ1","BG505.MD39TS ENV TRIMER IN COMPLEX WITH FAB FROM ANTIBODY C05","10.1038/S41467-022-28363-Z ",3.8,"1.08527e-19","7sq1_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(2_O_)-BMA(1_O_)-NAG(2_N_)-NAG(1_N_)-ASN(262_C_)",143.01,"","",""
"7SQ1","BG505.MD39TS ENV TRIMER IN COMPLEX WITH FAB FROM ANTIBODY C05","10.1038/S41467-022-28363-Z ",3.8,"1.08527e-19","7sq1_oligo6","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_V_)-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(262_E_)",115.346,"","",""
"7SSQ","CRYSTAL STRUCTURE OF EBOLA ZAIRE ENVELOPE GLYCOPROTEIN GP IN COMPLEX WITH COMPOUND ARN0075231","",2.25,67.34,"7ssq_oligo4","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(563_B_)",87.7576,"","",""
"7SYY","HENDRA VIRUS G PROTEIN HEAD DOMAIN IN COMPLEX WITH CROSS-NEUTRALIZING MURINE ANTIBODY HAH1.3","10.1073/PNAS.2122769119 ",2.74,73.91,"7syy_oligo1","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(481_A_)",112.409,"","",""
"7SYY","HENDRA VIRUS G PROTEIN HEAD DOMAIN IN COMPLEX WITH CROSS-NEUTRALIZING MURINE ANTIBODY HAH1.3","10.1073/PNAS.2122769119 ",2.74,73.91,"7syy_oligo2","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(6_B_)-[MAN(4_B_)-BMA(3_B_)-NAG(2_B_)]-[FUC(5_B_)]-NAG(1_B_)-ASN(529_A_)",92.6753,"","",""
"7SYZ","HENDRA VIRUS G PROTEIN HEAD DOMAIN IN COMPLEX WITH CROSS-NEUTRALIZING MURINE ANTIBODY HAH1.3","10.1073/PNAS.2122769119 ",2.86,67.92,"7syz_oligo4","DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(5_D_)-[BMA(3_D_)-NAG(2_D_)]-[FUC(4_D_)]-NAG(1_D_)-ASN(378_A_)",86.1089,"","",""
"7SYZ","HENDRA VIRUS G PROTEIN HEAD DOMAIN IN COMPLEX WITH CROSS-NEUTRALIZING MURINE ANTIBODY HAH1.3","10.1073/PNAS.2122769119 ",2.86,67.92,"7syz_oligo2","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(6_E_)-[MAN(4_E_)-BMA(3_E_)-NAG(2_E_)]-[FUC(5_E_)]-NAG(1_E_)-ASN(529_A_)",80.2823,"","",""
"7T2D","CRYSTAL STRUCTURE OF THE B1 TCR IN COMPLEX WITH HLA-DP4-PLY","10.1016/J.IMMUNI.2023.03.020 ",3.4,103.2,"7t2d_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_U_)-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(118_A_)",139.238,"","",""
"7T2P","THE ENVELOPE GLYCOPROTEIN SIVMAC239.K180S SOSIP TRIMER IN COMPLEX WITH 3 COPIES OF THE NEUTRALIZING ANTIBODY K11","10.1038/S41467-022-32783-2 ",3.47,0.00048876,"7t2p_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(284_A_)",97.2355,"","",""
"7T2P","THE ENVELOPE GLYCOPROTEIN SIVMAC239.K180S SOSIP TRIMER IN COMPLEX WITH 3 COPIES OF THE NEUTRALIZING ANTIBODY K11","10.1038/S41467-022-32783-2 ",3.47,0.00048876,"7t2p_oligo8","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_C_)-[MAN(6_C_)-MAN(5_C_)]-MAN(4_C_)-[MAN(8_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(37_A_)",59.4957,"","",""
"7T2P","THE ENVELOPE GLYCOPROTEIN SIVMAC239.K180S SOSIP TRIMER IN COMPLEX WITH 3 COPIES OF THE NEUTRALIZING ANTIBODY K11","10.1038/S41467-022-32783-2 ",3.47,0.00048876,"7t2p_oligo4","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_I_)-[MAN(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(278_A_)",66.1891,"","",""
"7T4G","THE ENVELOPE GLYCOPROTEIN SIVMAC239.K180S SOSIP TRIMER IN COMPLEX WITH 3 COPIES OF THE NEUTRALIZING ANTIBODY K11","10.1038/S41467-022-32783-2 ",3.7,"1.08527e-19","7t4g_oligo27","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_m_)-[MAN(6_m_)-MAN(5_m_)]-MAN(4_m_)-[MAN(8_m_)]-BMA(3_m_)-NAG(2_m_)-NAG(1_m_)-ASN(37_E_)",75.832,"","",""
"7T4G","THE ENVELOPE GLYCOPROTEIN SIVMAC239.K180S SOSIP TRIMER IN COMPLEX WITH 3 COPIES OF THE NEUTRALIZING ANTIBODY K11","10.1038/S41467-022-32783-2 ",3.7,"1.08527e-19","7t4g_oligo37","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_w_)-BMA(3_w_)-NAG(2_w_)-NAG(1_w_)-ASN(377_E_)",75.2286,"","",""
"7T4G","THE ENVELOPE GLYCOPROTEIN SIVMAC239.K180S SOSIP TRIMER IN COMPLEX WITH 3 COPIES OF THE NEUTRALIZING ANTIBODY K11","10.1038/S41467-022-32783-2 ",3.7,"1.08527e-19","7t4g_oligo8","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_M_)-[MAN(6_M_)-MAN(5_M_)]-MAN(4_M_)-[MAN(8_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(37_A_)",78.6119,"","",""
"7T4G","THE ENVELOPE GLYCOPROTEIN SIVMAC239.K180S SOSIP TRIMER IN COMPLEX WITH 3 COPIES OF THE NEUTRALIZING ANTIBODY K11","10.1038/S41467-022-32783-2 ",3.7,"1.08527e-19","7t4g_oligo23","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_Z_)-[MAN(6_Z_)-MAN(5_Z_)]-MAN(4_Z_)-[MAN(8_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(37_C_)",81.2136,"","",""
"7T4G","THE ENVELOPE GLYCOPROTEIN SIVMAC239.K180S SOSIP TRIMER IN COMPLEX WITH 3 COPIES OF THE NEUTRALIZING ANTIBODY K11","10.1038/S41467-022-32783-2 ",3.7,"1.08527e-19","7t4g_oligo9","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_e_)-[MAN(6_e_)-MAN(5_e_)-MAN(4_e_)]-BMA(3_e_)-NAG(2_e_)-NAG(1_e_)-ASN(278_C_)",88.9912,"","",""
"7T4G","THE ENVELOPE GLYCOPROTEIN SIVMAC239.K180S SOSIP TRIMER IN COMPLEX WITH 3 COPIES OF THE NEUTRALIZING ANTIBODY K11","10.1038/S41467-022-32783-2 ",3.7,"1.08527e-19","7t4g_oligo17","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_f_)-[MAN(4_f_)]-BMA(3_f_)-NAG(2_f_)-NAG(1_f_)-ASN(284_C_)",122.412,"","",""
"7T4G","THE ENVELOPE GLYCOPROTEIN SIVMAC239.K180S SOSIP TRIMER IN COMPLEX WITH 3 COPIES OF THE NEUTRALIZING ANTIBODY K11","10.1038/S41467-022-32783-2 ",3.7,"1.08527e-19","7t4g_oligo5","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_R_)-[MAN(6_R_)-MAN(5_R_)-MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(278_A_)",94.0865,"","",""
"7T4G","THE ENVELOPE GLYCOPROTEIN SIVMAC239.K180S SOSIP TRIMER IN COMPLEX WITH 3 COPIES OF THE NEUTRALIZING ANTIBODY K11","10.1038/S41467-022-32783-2 ",3.7,"1.08527e-19","7t4g_oligo32","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_r_)-[MAN(6_r_)-MAN(5_r_)-MAN(4_r_)]-BMA(3_r_)-NAG(2_r_)-NAG(1_r_)-ASN(278_E_)",86.6279,"","",""
"7T4G","THE ENVELOPE GLYCOPROTEIN SIVMAC239.K180S SOSIP TRIMER IN COMPLEX WITH 3 COPIES OF THE NEUTRALIZING ANTIBODY K11","10.1038/S41467-022-32783-2 ",3.7,"1.08527e-19","7t4g_oligo34","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_t_)-BMA(3_t_)-NAG(2_t_)-NAG(1_t_)-ASN(295_E_)",49.0455,"","",""
"7T6X","CRYO-EM STRUCTURE OF FULL-LENGTH HEPATITIS C VIRUS E1E2 GLYCOPROTEIN IN COMPLEX WITH AR4A, AT12009, AND IGH505 FABS","10.1126/SCIENCE.ABN9884 ",3.83,0.00048876,"7t6x_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(305_E_)",147.276,"","",""
"7T6X","CRYO-EM STRUCTURE OF FULL-LENGTH HEPATITIS C VIRUS E1E2 GLYCOPROTEIN IN COMPLEX WITH AR4A, AT12009, AND IGH505 FABS","10.1126/SCIENCE.ABN9884 ",3.83,0.00048876,"7t6x_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(196_E_)",141.618,"","",""
"7TBW","THE STRUCTURE OF ATP-BOUND ABCA1","10.1038/S44161-022-00022-Y ",3.1,"1.15243e-41","7tbw_oligo2","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_C_)-[BMA(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(1504_A_)",91.1685,"","",""
"7TBY","THE STRUCTURE OF HUMAN ABCA1 IN NANODISC","10.1038/S44161-022-00022-Y ",4,"1.15243e-41","7tby_oligo2","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_C_)-[BMA(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(1504_A_)",116.744,"","",""
"7TBZ","THE STRUCTURE OF ABCA1 Y482C","10.1038/S44161-022-00022-Y ",4.3,"1.15243e-41","7tbz_oligo2","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_C_)-[BMA(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(1504_A_)",177.528,"","",""
"7TC0","THE STRUCTURE OF HUMAN ABCA1 IN DIGITONIN","10.1038/S44161-022-00022-Y ",3.1,"1.15243e-41","7tc0_oligo2","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_C_)-[BMA(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(1504_A_)",73.1611,"","",""
"7TCN","CRYO-EM STRUCTURE OF CH235.12 IN COMPLEX WITH HIV-1 ENV TRIMER CH505TF.N279K.SOSIP.664 WITH HIGH-MANNOSE GLYCANS","",4.1,"5.37397e+08","7tcn_oligo9","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_n_)-BMA(3_n_)-NAG(2_n_)-NAG(1_n_)-ASN(197_E_)",140.432,"","",""
"7TCN","CRYO-EM STRUCTURE OF CH235.12 IN COMPLEX WITH HIV-1 ENV TRIMER CH505TF.N279K.SOSIP.664 WITH HIGH-MANNOSE GLYCANS","",4.1,"5.37397e+08","7tcn_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_4_)-BMA(3_4_)-NAG(2_4_)-NAG(1_4_)-ASN(197_I_)",136.363,"","",""
"7TCN","CRYO-EM STRUCTURE OF CH235.12 IN COMPLEX WITH HIV-1 ENV TRIMER CH505TF.N279K.SOSIP.664 WITH HIGH-MANNOSE GLYCANS","",4.1,"5.37397e+08","7tcn_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_R_)-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(197_A_)",141.107,"","",""
"7TCO","CRYO-EM STRUCTURE OF CH235.12 IN COMPLEX WITH HIV-1 ENV TRIMER CH505TF.N279K.G458Y.SOSIP.664 WITH HIGH-MANNOSE GLYCANS","",4.19,"5.37397e+08","7tco_oligo11","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_X_)-MAN(4_X_)-[MAN(6_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(197_M_)",185.422,"","",""
"7TCO","CRYO-EM STRUCTURE OF CH235.12 IN COMPLEX WITH HIV-1 ENV TRIMER CH505TF.N279K.G458Y.SOSIP.664 WITH HIGH-MANNOSE GLYCANS","",4.19,"5.37397e+08","7tco_oligo8","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_T_)-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(262_E_)",212.466,"","",""
"7TCO","CRYO-EM STRUCTURE OF CH235.12 IN COMPLEX WITH HIV-1 ENV TRIMER CH505TF.N279K.G458Y.SOSIP.664 WITH HIGH-MANNOSE GLYCANS","",4.19,"5.37397e+08","7tco_oligo12","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_Y_)-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(262_M_)",213.226,"","",""
"7TCO","CRYO-EM STRUCTURE OF CH235.12 IN COMPLEX WITH HIV-1 ENV TRIMER CH505TF.N279K.G458Y.SOSIP.664 WITH HIGH-MANNOSE GLYCANS","",4.19,"5.37397e+08","7tco_oligo3","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-MAN(4_S_)-[MAN(6_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(197_E_)",189.823,"","",""
"7TCO","CRYO-EM STRUCTURE OF CH235.12 IN COMPLEX WITH HIV-1 ENV TRIMER CH505TF.N279K.G458Y.SOSIP.664 WITH HIGH-MANNOSE GLYCANS","",4.19,"5.37397e+08","7tco_oligo6","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_L_)-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(262_A_)",204.382,"","",""
"7TCO","CRYO-EM STRUCTURE OF CH235.12 IN COMPLEX WITH HIV-1 ENV TRIMER CH505TF.N279K.G458Y.SOSIP.664 WITH HIGH-MANNOSE GLYCANS","",4.19,"5.37397e+08","7tco_oligo5","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-MAN(4_K_)-[MAN(6_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(197_A_)",190.258,"","",""
"7TCT","INTEGRIN ALAPHIIBBETA3 COMPLEX WITH UR2922","10.1016/J.CELL.2022.08.008 ",2.5,62.64,"7tct_oligo5","DManpb1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(320_D_)",89.7836,"","",""
"7TCT","INTEGRIN ALAPHIIBBETA3 COMPLEX WITH UR2922","10.1016/J.CELL.2022.08.008 ",2.5,62.64,"7tct_oligo3","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_G_)-[BMA(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(320_B_)",89.3584,"","",""
"7TD8","INTEGRIN ALAPHIIBBETA3 COMPLEX WITH TIROFIBAN","10.1016/J.CELL.2022.08.008 ",2.6,82.07,"7td8_oligo3","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_G_)-[BMA(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(320_B_)",108.479,"","",""
"7TD8","INTEGRIN ALAPHIIBBETA3 COMPLEX WITH TIROFIBAN","10.1016/J.CELL.2022.08.008 ",2.6,82.07,"7td8_oligo5","DManpb1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(320_D_)",115.845,"","",""
"7TF8","SARS-COV-2 OMICRON 3-RBD DOWN SPIKE PROTEIN TRIMER WITHOUT THE P986- P987 STABILIZING MUTATIONS (S-GSAS-OMICRON)","10.1016/J.MOLCEL.2022.03.028 ",3.36,0,"7tf8_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Z_)-[MAN(4_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(717_B_)",123.361,"","",""
"7TF8","SARS-COV-2 OMICRON 3-RBD DOWN SPIKE PROTEIN TRIMER WITHOUT THE P986- P987 STABILIZING MUTATIONS (S-GSAS-OMICRON)","10.1016/J.MOLCEL.2022.03.028 ",3.36,0,"7tf8_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(801_A_)",128.919,"","",""
"7TF8","SARS-COV-2 OMICRON 3-RBD DOWN SPIKE PROTEIN TRIMER WITHOUT THE P986- P987 STABILIZING MUTATIONS (S-GSAS-OMICRON)","10.1016/J.MOLCEL.2022.03.028 ",3.36,0,"7tf8_oligo12","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_a_)-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(801_B_)",107.825,"","",""
"7TF8","SARS-COV-2 OMICRON 3-RBD DOWN SPIKE PROTEIN TRIMER WITHOUT THE P986- P987 STABILIZING MUTATIONS (S-GSAS-OMICRON)","10.1016/J.MOLCEL.2022.03.028 ",3.36,0,"7tf8_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_U_)-[MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(234_B_)",157.146,"","",""
"7TF8","SARS-COV-2 OMICRON 3-RBD DOWN SPIKE PROTEIN TRIMER WITHOUT THE P986- P987 STABILIZING MUTATIONS (S-GSAS-OMICRON)","10.1016/J.MOLCEL.2022.03.028 ",3.36,0,"7tf8_oligo9","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_M_)-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(717_A_)",108.117,"","",""
"7TF8","SARS-COV-2 OMICRON 3-RBD DOWN SPIKE PROTEIN TRIMER WITHOUT THE P986- P987 STABILIZING MUTATIONS (S-GSAS-OMICRON)","10.1016/J.MOLCEL.2022.03.028 ",3.36,0,"7tf8_oligo15","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_o_)-[MAN(4_o_)]-BMA(3_o_)-NAG(2_o_)-NAG(1_o_)-ASN(717_C_)",119.737,"","",""
"7TFN","CRYO-EM STRUCTURE OF CD4BS ANTIBODY AB1303 IN COMPLEX WITH HIV-1 ENV TRIMER BG505 SOSIP.664","10.1038/S41467-022-28424-3 ",4,"5.37397e+08","7tfn_oligo9","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_S_)-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(363_B_)",118.926,"","",""
"7TFN","CRYO-EM STRUCTURE OF CD4BS ANTIBODY AB1303 IN COMPLEX WITH HIV-1 ENV TRIMER BG505 SOSIP.664","10.1038/S41467-022-28424-3 ",4,"5.37397e+08","7tfn_oligo13","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_W_)-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(363_C_)",122.639,"","",""
"7TFN","CRYO-EM STRUCTURE OF CD4BS ANTIBODY AB1303 IN COMPLEX WITH HIV-1 ENV TRIMER BG505 SOSIP.664","10.1038/S41467-022-28424-3 ",4,"5.37397e+08","7tfn_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(363_A_)",82.9851,"","",""
"7TFN","CRYO-EM STRUCTURE OF CD4BS ANTIBODY AB1303 IN COMPLEX WITH HIV-1 ENV TRIMER BG505 SOSIP.664","10.1038/S41467-022-28424-3 ",4,"5.37397e+08","7tfn_oligo11","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_U_)-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(262_C_)",100.341,"","",""
"7TFN","CRYO-EM STRUCTURE OF CD4BS ANTIBODY AB1303 IN COMPLEX WITH HIV-1 ENV TRIMER BG505 SOSIP.664","10.1038/S41467-022-28424-3 ",4,"5.37397e+08","7tfn_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_M_)-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(262_B_)",124.713,"","",""
"7THO","INTEGRIN ALAPHIIBBETA3 COMPLEX WITH EPTIFIBATIDE","10.1016/J.CELL.2022.08.008 ",2.75,99.21,"7tho_oligo1","DManpb1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(320_B_)",128.499,"","",""
"7THU","STRUCTURE OF REDUCED BOVINE CYTOCHROME C OXIDASE AT 1.93 ANGSTROM RESOLUTION OBTAINED BY SYNCHROTRON X-RAYS","10.1016/J.JBC.2022.101799 ",1.93,46.82,"7thu_oligo3","DGlcpa1-3DGlcpb6-C10O1","DMU(101_M_)-DMU(101_M_)",56.6423,"","",""
"7THU","STRUCTURE OF REDUCED BOVINE CYTOCHROME C OXIDASE AT 1.93 ANGSTROM RESOLUTION OBTAINED BY SYNCHROTRON X-RAYS","10.1016/J.JBC.2022.101799 ",1.93,46.82,"7thu_oligo5","DGlcpa1-3DGlcpb6-C10O1","DMU(1302_G_)-DMU(1302_G_)",111.062,"","",""
"7THU","STRUCTURE OF REDUCED BOVINE CYTOCHROME C OXIDASE AT 1.93 ANGSTROM RESOLUTION OBTAINED BY SYNCHROTRON X-RAYS","10.1016/J.JBC.2022.101799 ",1.93,46.82,"7thu_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(302_P_)-DMU(302_P_)",114.51,"","",""
"7THU","STRUCTURE OF REDUCED BOVINE CYTOCHROME C OXIDASE AT 1.93 ANGSTROM RESOLUTION OBTAINED BY SYNCHROTRON X-RAYS","10.1016/J.JBC.2022.101799 ",1.93,46.82,"7thu_oligo6","DGlcpa1-3DGlcpb6-C10O1","DMU(101_Z_)-DMU(101_Z_)",73.92,"","",""
"7THU","STRUCTURE OF REDUCED BOVINE CYTOCHROME C OXIDASE AT 1.93 ANGSTROM RESOLUTION OBTAINED BY SYNCHROTRON X-RAYS","10.1016/J.JBC.2022.101799 ",1.93,46.82,"7thu_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(313_C_)-DMU(313_C_)",93.8164,"","",""
"7THU","STRUCTURE OF REDUCED BOVINE CYTOCHROME C OXIDASE AT 1.93 ANGSTROM RESOLUTION OBTAINED BY SYNCHROTRON X-RAYS","10.1016/J.JBC.2022.101799 ",1.93,46.82,"7thu_oligo4","DGlcpa1-3DGlcpb6-C10O1","DMU(301_C_)-DMU(301_C_)",134.684,"","",""
"7TIE","STRUCTURE OF OXIDIZED BOVINE CYTOCHROME C OXIDASE AT 1.90 ANGSTROM RESOLUTION OBTAINED BY SYNCHROTRON X-RAYS","10.1016/J.JBC.2022.101799 ",1.9,43.5,"7tie_oligo3","DGlcpa1-3DGlcpb6-C10O1","DMU(104_G_)-DMU(104_G_)",108.333,"","",""
"7TIE","STRUCTURE OF OXIDIZED BOVINE CYTOCHROME C OXIDASE AT 1.90 ANGSTROM RESOLUTION OBTAINED BY SYNCHROTRON X-RAYS","10.1016/J.JBC.2022.101799 ",1.9,43.5,"7tie_oligo4","DGlcpa1-3DGlcpb6-C10O1","DMU(311_C_)-DMU(311_C_)",93.1073,"","",""
"7TIE","STRUCTURE OF OXIDIZED BOVINE CYTOCHROME C OXIDASE AT 1.90 ANGSTROM RESOLUTION OBTAINED BY SYNCHROTRON X-RAYS","10.1016/J.JBC.2022.101799 ",1.9,43.5,"7tie_oligo6","DGlcpa1-3DGlcpb6-C10O1","DMU(101_Z_)-DMU(101_Z_)",76.2932,"","",""
"7TIE","STRUCTURE OF OXIDIZED BOVINE CYTOCHROME C OXIDASE AT 1.90 ANGSTROM RESOLUTION OBTAINED BY SYNCHROTRON X-RAYS","10.1016/J.JBC.2022.101799 ",1.9,43.5,"7tie_oligo5","DGlcpa1-3DGlcpb6-C10O1","DMU(101_G_)-DMU(101_G_)",129.12,"","",""
"7TIE","STRUCTURE OF OXIDIZED BOVINE CYTOCHROME C OXIDASE AT 1.90 ANGSTROM RESOLUTION OBTAINED BY SYNCHROTRON X-RAYS","10.1016/J.JBC.2022.101799 ",1.9,43.5,"7tie_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(302_P_)-DMU(302_P_)",108.375,"","",""
"7TIE","STRUCTURE OF OXIDIZED BOVINE CYTOCHROME C OXIDASE AT 1.90 ANGSTROM RESOLUTION OBTAINED BY SYNCHROTRON X-RAYS","10.1016/J.JBC.2022.101799 ",1.9,43.5,"7tie_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(102_M_)-DMU(102_M_)",56.9505,"","",""
"7TIH","STRUCTURE OF OXIDIZED BOVINE CYTOCHROME C OXIDASE WITH REDUCED METAL CENTERS INDUCED BY SYNCHROTRON X-RAY EXPOSURE","10.1016/J.JBC.2022.101799 ",2.35,45.6,"7tih_oligo3","DGlcpa1-3DGlcpb6-C10O1","DMU(312_C_)-DMU(312_C_)",110.135,"","",""
"7TIH","STRUCTURE OF OXIDIZED BOVINE CYTOCHROME C OXIDASE WITH REDUCED METAL CENTERS INDUCED BY SYNCHROTRON X-RAY EXPOSURE","10.1016/J.JBC.2022.101799 ",2.35,45.6,"7tih_oligo4","DGlcpa1-3DGlcpb6-C10O1","DMU(311_C_)-DMU(311_C_)",116.966,"","",""
"7TIH","STRUCTURE OF OXIDIZED BOVINE CYTOCHROME C OXIDASE WITH REDUCED METAL CENTERS INDUCED BY SYNCHROTRON X-RAY EXPOSURE","10.1016/J.JBC.2022.101799 ",2.35,45.6,"7tih_oligo5","DGlcpa1-3DGlcpb6-C10O1","DMU(208_D_)-DMU(208_D_)",58.5868,"","",""
"7TIH","STRUCTURE OF OXIDIZED BOVINE CYTOCHROME C OXIDASE WITH REDUCED METAL CENTERS INDUCED BY SYNCHROTRON X-RAY EXPOSURE","10.1016/J.JBC.2022.101799 ",2.35,45.6,"7tih_oligo6","DGlcpa1-3DGlcpb6-C10O1","DMU(206_Q_)-DMU(206_Q_)",73.4236,"","",""
"7TIH","STRUCTURE OF OXIDIZED BOVINE CYTOCHROME C OXIDASE WITH REDUCED METAL CENTERS INDUCED BY SYNCHROTRON X-RAY EXPOSURE","10.1016/J.JBC.2022.101799 ",2.35,45.6,"7tih_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(303_P_)-DMU(303_P_)",111.9,"","",""
"7TIH","STRUCTURE OF OXIDIZED BOVINE CYTOCHROME C OXIDASE WITH REDUCED METAL CENTERS INDUCED BY SYNCHROTRON X-RAY EXPOSURE","10.1016/J.JBC.2022.101799 ",2.35,45.6,"7tih_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(101_G_)-DMU(101_G_)",128.053,"","",""
"7TII","ANNEALED STRUCTURE OF OXIDIZED BOVINE CYTOCHROME C OXIDASE WITH REDUCED METAL CENTERS INDUCED BY SYNCHROTRON X-RAY EXPOSURE","10.1016/J.JBC.2022.101799 ",2.45,46.83,"7tii_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(102_Z_)-DMU(102_Z_)",72.0818,"","",""
"7TII","ANNEALED STRUCTURE OF OXIDIZED BOVINE CYTOCHROME C OXIDASE WITH REDUCED METAL CENTERS INDUCED BY SYNCHROTRON X-RAY EXPOSURE","10.1016/J.JBC.2022.101799 ",2.45,46.83,"7tii_oligo4","DGlcpa1-3DGlcpb6-C10O1","DMU(301_C_)-DMU(301_C_)",121.492,"","",""
"7TII","ANNEALED STRUCTURE OF OXIDIZED BOVINE CYTOCHROME C OXIDASE WITH REDUCED METAL CENTERS INDUCED BY SYNCHROTRON X-RAY EXPOSURE","10.1016/J.JBC.2022.101799 ",2.45,46.83,"7tii_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(202_D_)-DMU(202_D_)",57.9986,"","",""
"7TII","ANNEALED STRUCTURE OF OXIDIZED BOVINE CYTOCHROME C OXIDASE WITH REDUCED METAL CENTERS INDUCED BY SYNCHROTRON X-RAY EXPOSURE","10.1016/J.JBC.2022.101799 ",2.45,46.83,"7tii_oligo3","DGlcpa1-3DGlcpb6-C10O1","DMU(101_W_)-DMU(101_W_)",113.846,"","",""
"7TL1","SARS-COV-2 OMICRON 3-RBD DOWN SPIKE PROTEIN TRIMER WITHOUT THE P986- P987 STABILIZING MUTATIONS (S-GSAS-OMICRON)","10.1016/J.MOLCEL.2022.03.028 ",3.5,0,"7tl1_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_M_)-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(717_A_)",145.805,"","",""
"7TMZ","INTEGRIN ALAPHIIBBETA3 COMPLEX WITH BMS COMPOUND 4","10.1016/J.CELL.2022.08.008 ",2.2,66.87,"7tmz_oligo7","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(320_D_)",94.817,"","",""
"7TMZ","INTEGRIN ALAPHIIBBETA3 COMPLEX WITH BMS COMPOUND 4","10.1016/J.CELL.2022.08.008 ",2.2,66.87,"7tmz_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)",84.4705,"","",""
"7TN9","STRUCTURE OF THE INMAZEB COCKTAIL AND RESISTANCE TO ESCAPE AGAINST EBOLA VIRUS","10.1016/J.CHOM.2023.01.002 ",3.1,512.502,"7tn9_oligo3","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Y_)-MAN(4_Y_)-[MAN(6_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(563_X_)",119.979,"","",""
"7TN9","STRUCTURE OF THE INMAZEB COCKTAIL AND RESISTANCE TO ESCAPE AGAINST EBOLA VIRUS","10.1016/J.CHOM.2023.01.002 ",3.1,512.502,"7tn9_oligo1","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-MAN(4_K_)-[MAN(6_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(563_W_)",119.139,"","",""
"7TN9","STRUCTURE OF THE INMAZEB COCKTAIL AND RESISTANCE TO ESCAPE AGAINST EBOLA VIRUS","10.1016/J.CHOM.2023.01.002 ",3.1,512.502,"7tn9_oligo2","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_L_)-MAN(4_L_)-[MAN(6_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(563_V_)",100.592,"","",""
"7TPD","INTEGRIN ALAPHIIBBETA3 COMPLEX WITH EF5154","10.1016/J.CELL.2022.08.008 ",2.6,63.63,"7tpd_oligo5","DManpb1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(320_D_)",96.7852,"","",""
"7TPD","INTEGRIN ALAPHIIBBETA3 COMPLEX WITH EF5154","10.1016/J.CELL.2022.08.008 ",2.6,63.63,"7tpd_oligo3","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_G_)-[BMA(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(320_B_)",88.5156,"","",""
"7TPU","CRYSTAL STRUCTURE OF A CHITINASE-MODIFYING PROTEIN FROM FUSARIUM VANETTENII (FVAN-CMP)","10.1107/S2059798323000311 ",2.19,33.29,"7tpu_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(461_A_)",70.9645,"","",""
"7TXD","CRYO-EM STRUCTURE OF BG505 SOSIP HIV-1 ENV TRIMER IN COMPLEX WITH CD4 RECEPTOR (D1D2) AND BROADLY NEUTRALIZING DARPIN BND.9","10.1038/S41594-023-01062-Z ",3.87,512.502,"7txd_oligo5","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_b_)-[MAN(6_b_)-MAN(5_b_)-MAN(4_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(262_E_)",64.9825,"","",""
"7TXD","CRYO-EM STRUCTURE OF BG505 SOSIP HIV-1 ENV TRIMER IN COMPLEX WITH CD4 RECEPTOR (D1D2) AND BROADLY NEUTRALIZING DARPIN BND.9","10.1038/S41594-023-01062-Z ",3.87,512.502,"7txd_oligo13","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_M_)-[MAN(6_M_)-MAN(5_M_)-MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(262_A_)",87.3618,"","",""
"7TXD","CRYO-EM STRUCTURE OF BG505 SOSIP HIV-1 ENV TRIMER IN COMPLEX WITH CD4 RECEPTOR (D1D2) AND BROADLY NEUTRALIZING DARPIN BND.9","10.1038/S41594-023-01062-Z ",3.87,512.502,"7txd_oligo19","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_V_)-[MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(262_C_)",131.939,"","",""
"7TYV","STRUCTURE OF LASSA VIRUS GLYCOPROTEIN (JOSIAH) BOUND TO FAB 25.10C","10.1016/J.CELREP.2022.110841 ",2.8,"5.37397e+08","7tyv_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_R_)-[MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(79_C_)",57.6689,"","",""
"7TYV","STRUCTURE OF LASSA VIRUS GLYCOPROTEIN (JOSIAH) BOUND TO FAB 25.10C","10.1016/J.CELREP.2022.110841 ",2.8,"5.37397e+08","7tyv_oligo3","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-MAN(4_M_)-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(365_a_)",60.1051,"","",""
"7TYV","STRUCTURE OF LASSA VIRUS GLYCOPROTEIN (JOSIAH) BOUND TO FAB 25.10C","10.1016/J.CELREP.2022.110841 ",2.8,"5.37397e+08","7tyv_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(79_A_)",56.5965,"","",""
"7TYV","STRUCTURE OF LASSA VIRUS GLYCOPROTEIN (JOSIAH) BOUND TO FAB 25.10C","10.1016/J.CELREP.2022.110841 ",2.8,"5.37397e+08","7tyv_oligo12","DManpa1-2DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_U_)-MAN(5_U_)-MAN(4_U_)-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(365_c_)",62.3074,"","",""
"7TYV","STRUCTURE OF LASSA VIRUS GLYCOPROTEIN (JOSIAH) BOUND TO FAB 25.10C","10.1016/J.CELREP.2022.110841 ",2.8,"5.37397e+08","7tyv_oligo7","DManpa1-2DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Q_)-MAN(5_Q_)-MAN(4_Q_)-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(365_b_)",61.5858,"","",""
"7TYV","STRUCTURE OF LASSA VIRUS GLYCOPROTEIN (JOSIAH) BOUND TO FAB 25.10C","10.1016/J.CELREP.2022.110841 ",2.8,"5.37397e+08","7tyv_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(79_B_)",58.8022,"","",""
"7TYZ","CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE IN COMPLEX WITH FSR22, AN ANTI- SARS-COV-2 DARPIN","10.1038/S41589-022-01193-2 ",3.51,"1.08527e-19","7tyz_oligo13","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_S_)-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(331_E_)",175.217,"","",""
"7TYZ","CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE IN COMPLEX WITH FSR22, AN ANTI- SARS-COV-2 DARPIN","10.1038/S41589-022-01193-2 ",3.51,"1.08527e-19","7tyz_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(331_A_)",110.159,"","",""
"7TYZ","CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE IN COMPLEX WITH FSR22, AN ANTI- SARS-COV-2 DARPIN","10.1038/S41589-022-01193-2 ",3.51,"1.08527e-19","7tyz_oligo12","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_R_)-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(331_C_)",149.231,"","",""
"7U4E","NEURAMINIDASE FROM INFLUENZA VIRUS A/BILTHOVEN/17938/1969(H3N2)","10.1038/S41467-022-34060-8 ",1.54,17.2,"7u4e_oligo7","DManpa1-2DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-MAN(5_H_)-MAN(4_H_)-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(200_C_)",24.8818,"","",""
"7U4E","NEURAMINIDASE FROM INFLUENZA VIRUS A/BILTHOVEN/17938/1969(H3N2)","10.1038/S41467-022-34060-8 ",1.54,17.2,"7u4e_oligo8","DManpa1-2DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_K_)-MAN(5_K_)-MAN(4_K_)-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(200_D_)",29.0165,"","",""
"7U4E","NEURAMINIDASE FROM INFLUENZA VIRUS A/BILTHOVEN/17938/1969(H3N2)","10.1038/S41467-022-34060-8 ",1.54,17.2,"7u4e_oligo5","DManpa1-2DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-MAN(5_F_)-MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(200_A_)",15.2882,"","",""
"7U4E","NEURAMINIDASE FROM INFLUENZA VIRUS A/BILTHOVEN/17938/1969(H3N2)","10.1038/S41467-022-34060-8 ",1.54,17.2,"7u4e_oligo6","DManpa1-2DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_G_)-MAN(5_G_)-MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(200_B_)",24.6482,"","",""
"7U4F","NEURAMINIDASE FROM INFLUENZA VIRUS A/MOSCOW/10/1999(H3N2)","10.1038/S41467-022-34060-8 ",1.4,16.75,"7u4f_oligo1","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_B_)-MAN(6_B_)-[MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",25.0175,"","",""
"7U4G","NEURAMINIDASE FROM INFLUENZA VIRUS A/SHANDONG/9/1993(H3N2)","10.1038/S41467-022-34060-8 ",1.65,19.37,"7u4g_oligo2","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(200_A_)",30.76,"","",""
"7U60","INTEGRIN ALAPHIIBBETA3 COMPLEX WITH CRGDFV","10.1016/J.CELL.2022.08.008 ",2.55,61.19,"7u60_oligo3","DManpa1-3DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_J_)-MAN(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(320_D_)",94.817,"","",""
"7U60","INTEGRIN ALAPHIIBBETA3 COMPLEX WITH CRGDFV","10.1016/J.CELL.2022.08.008 ",2.55,61.19,"7u60_oligo1","DManpa1-3DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_G_)-MAN(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(320_B_)",82.2802,"","",""
"7U9F","INTEGRIN ALAPHIIBBETA3 COMPLEX WITH BMS COMPOUND 4 IN MN2+","10.1016/J.CELL.2022.08.008 ",2.7,80.48,"7u9f_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(320_B_)",68.0471,"","",""
"7U9F","INTEGRIN ALAPHIIBBETA3 COMPLEX WITH BMS COMPOUND 4 IN MN2+","10.1016/J.CELL.2022.08.008 ",2.7,80.48,"7u9f_oligo7","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(320_D_)",87.0148,"","",""
"7U9V","INTEGRIN ALAPHIIBBETA3 COMPLEX WITH BMS4-1","10.1016/J.CELL.2022.08.008 ",2.25,77.51,"7u9v_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(320_D_)",88.902,"","",""
"7U9V","INTEGRIN ALAPHIIBBETA3 COMPLEX WITH BMS4-1","10.1016/J.CELL.2022.08.008 ",2.25,77.51,"7u9v_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(320_B_)",81.2971,"","",""
"7UBR","INTEGRIN ALAPHIIBBETA3 COMPLEX WITH GR144053","10.1016/J.CELL.2022.08.008 ",2.05,72.94,"7ubr_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(320_B_)",78.0127,"","",""
"7UBR","INTEGRIN ALAPHIIBBETA3 COMPLEX WITH GR144053","10.1016/J.CELL.2022.08.008 ",2.05,72.94,"7ubr_oligo7","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(320_D_)",84.5236,"","",""
"7UCF","STRUCTURE OF THE BG505 SOSIP.664 TRIMER IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB FRAGMENTS 10-1074 AND BG24","10.1126/SCIADV.ABP8155 ",4,264.8,"7ucf_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(160_G_)",332.543,"","",""
"7UCF","STRUCTURE OF THE BG505 SOSIP.664 TRIMER IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB FRAGMENTS 10-1074 AND BG24","10.1126/SCIADV.ABP8155 ",4,264.8,"7ucf_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_Q_)-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(197_G_)",244.77,"","",""
"7UCF","STRUCTURE OF THE BG505 SOSIP.664 TRIMER IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB FRAGMENTS 10-1074 AND BG24","10.1126/SCIADV.ABP8155 ",4,264.8,"7ucf_oligo7","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_S_)-[MAN(5_S_)]-MAN(4_S_)-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(386_G_)",286.96,"","",""
"7UCF","STRUCTURE OF THE BG505 SOSIP.664 TRIMER IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB FRAGMENTS 10-1074 AND BG24","10.1126/SCIADV.ABP8155 ",4,264.8,"7ucf_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_J_)-NAG(5_J_)-MAN(4_J_)-[MAN(7_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(276_G_)",300.557,"","",""
"7UCF","STRUCTURE OF THE BG505 SOSIP.664 TRIMER IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB FRAGMENTS 10-1074 AND BG24","10.1126/SCIADV.ABP8155 ",4,264.8,"7ucf_oligo13","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_T_)-[MAN(5_T_)]-MAN(4_T_)-[MAN(7_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(301_G_)",293.716,"","",""
"7UCF","STRUCTURE OF THE BG505 SOSIP.664 TRIMER IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB FRAGMENTS 10-1074 AND BG24","10.1126/SCIADV.ABP8155 ",4,264.8,"7ucf_oligo17","DManpb1-4DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_X_)-MAN(4_X_)-[MAN(6_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(156_G_)",311.131,"","",""
"7UCG","STRUCTURE OF THE DU422 SOSIP.664 TRIMER IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB FRAGMENTS 10-1074 AND BG24","10.1126/SCIADV.ABP8155 ",3.5,0.00048876,"7ucg_oligo6","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_b_)-MAN(6_b_)-[MAN(5_b_)-MAN(4_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(332_G_)",45.9453,"","",""
"7UCG","STRUCTURE OF THE DU422 SOSIP.664 TRIMER IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB FRAGMENTS 10-1074 AND BG24","10.1126/SCIADV.ABP8155 ",3.5,0.00048876,"7ucg_oligo22","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_n_)-[MAN(4_n_)]-BMA(3_n_)-NAG(2_n_)-NAG(1_n_)-ASN(262_P_)",43.1522,"","",""
"7UCG","STRUCTURE OF THE DU422 SOSIP.664 TRIMER IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB FRAGMENTS 10-1074 AND BG24","10.1126/SCIADV.ABP8155 ",3.5,0.00048876,"7ucg_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_X_)-[MAN(4_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(262_G_)",41.9787,"","",""
"7UCG","STRUCTURE OF THE DU422 SOSIP.664 TRIMER IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB FRAGMENTS 10-1074 AND BG24","10.1126/SCIADV.ABP8155 ",3.5,0.00048876,"7ucg_oligo18","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_j_)-MAN(6_j_)-[MAN(5_j_)-MAN(4_j_)]-BMA(3_j_)-NAG(2_j_)-NAG(1_j_)-ASN(332_I_)",40.8734,"","",""
"7UCG","STRUCTURE OF THE DU422 SOSIP.664 TRIMER IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB FRAGMENTS 10-1074 AND BG24","10.1126/SCIADV.ABP8155 ",3.5,0.00048876,"7ucg_oligo26","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_r_)-MAN(6_r_)-[MAN(5_r_)-MAN(4_r_)]-BMA(3_r_)-NAG(2_r_)-NAG(1_r_)-ASN(332_P_)",44.571,"","",""
"7UCG","STRUCTURE OF THE DU422 SOSIP.664 TRIMER IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB FRAGMENTS 10-1074 AND BG24","10.1126/SCIADV.ABP8155 ",3.5,0.00048876,"7ucg_oligo14","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_f_)-[MAN(4_f_)]-BMA(3_f_)-NAG(2_f_)-NAG(1_f_)-ASN(262_I_)",40.5847,"","",""
"7UCY","INTEGRIN ALAPHIIBBETA3 COMPLEX WITH GANTOFIBAN","10.1016/J.CELL.2022.08.008 ",2.35,74.46,"7ucy_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(320_D_)",79.0402,"","",""
"7UCY","INTEGRIN ALAPHIIBBETA3 COMPLEX WITH GANTOFIBAN","10.1016/J.CELL.2022.08.008 ",2.35,74.46,"7ucy_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(320_B_)",72.1291,"","",""
"7UDG","INTEGRIN ALAPHIIBBETA3 COMPLEX WITH LOTRAFIBAN","10.1016/J.CELL.2022.08.008 ",2.8,103.3,"7udg_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(320_B_)",102.156,"","",""
"7UDG","INTEGRIN ALAPHIIBBETA3 COMPLEX WITH LOTRAFIBAN","10.1016/J.CELL.2022.08.008 ",2.8,103.3,"7udg_oligo7","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(320_D_)",119.375,"","",""
"7UDH","INTEGRIN ALAPHIIBBETA3 COMPLEX WITH BMS4-3","10.1016/J.CELL.2022.08.008 ",2,80.57,"7udh_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)",124.361,"","",""
"7UDH","INTEGRIN ALAPHIIBBETA3 COMPLEX WITH BMS4-3","10.1016/J.CELL.2022.08.008 ",2,80.57,"7udh_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(501_C_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)",109.582,"","",""
"7UDS","STRUCTURE OF LINEAGE I (PINNEO) LASSA VIRUS GLYCOPROTEIN BOUND TO FAB 25.10C","10.1128/MBIO.01278-22 ",3.1,0,"7uds_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(78_C_)",47.3998,"","",""
"7UDS","STRUCTURE OF LINEAGE I (PINNEO) LASSA VIRUS GLYCOPROTEIN BOUND TO FAB 25.10C","10.1128/MBIO.01278-22 ",3.1,0,"7uds_oligo11","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_T_)-[MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(78_B_)",51.4784,"","",""
"7UDS","STRUCTURE OF LINEAGE I (PINNEO) LASSA VIRUS GLYCOPROTEIN BOUND TO FAB 25.10C","10.1128/MBIO.01278-22 ",3.1,0,"7uds_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(78_A_)",53.156,"","",""
"7UDS","STRUCTURE OF LINEAGE I (PINNEO) LASSA VIRUS GLYCOPROTEIN BOUND TO FAB 25.10C","10.1128/MBIO.01278-22 ",3.1,0,"7uds_oligo8","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_Q_)-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(98_C_)",55.8498,"","",""
"7UDS","STRUCTURE OF LINEAGE I (PINNEO) LASSA VIRUS GLYCOPROTEIN BOUND TO FAB 25.10C","10.1128/MBIO.01278-22 ",3.1,0,"7uds_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_K_)-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(98_A_)",57.1143,"","",""
"7UDS","STRUCTURE OF LINEAGE I (PINNEO) LASSA VIRUS GLYCOPROTEIN BOUND TO FAB 25.10C","10.1128/MBIO.01278-22 ",3.1,0,"7uds_oligo13","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_V_)-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(98_B_)",61.5382,"","",""
"7UE0","INTEGRIN ALAPHIIBBETA3 COMPLEX WITH FRADAFIBAN","10.1016/J.CELL.2022.08.008 ",2.74,93.48,"7ue0_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(320_B_)",93.4467,"","",""
"7UE0","INTEGRIN ALAPHIIBBETA3 COMPLEX WITH FRADAFIBAN","10.1016/J.CELL.2022.08.008 ",2.74,93.48,"7ue0_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(320_D_)",96.308,"","",""
"7UEM","GENOMIC AND STRUCTURAL BASIS FOR THE HUMAN ANTI-ALPHA-GALACTOSYL ANTIBODY RESPONSE","10.1073/PNAS.2123212119 ",2.31,37.01,"7uem_oligo1","DGalpa1-3DGalpb1-ROH","GLA(2_A_)-GAL(1_A_)",39.585,"","",""
"7UEM","GENOMIC AND STRUCTURAL BASIS FOR THE HUMAN ANTI-ALPHA-GALACTOSYL ANTIBODY RESPONSE","10.1073/PNAS.2123212119 ",2.31,37.01,"7uem_oligo2","DGalpa1-3DGalpb1-ROH","GLA(2_B_)-GAL(1_B_)",42.3977,"","",""
"7UEN","GENETIC AND STRUCTURAL BASIS OF THE HUMAN ANTI-ALPHA-GALACTOSYL ANTIBODY RESPONSE","10.1073/PNAS.2123212119 ",1.55,27.96,"7uen_oligo1","DGalpa1-3DGalpb1-ROH","GLA(2_A_)-GAL(1_A_)",19.9491,"","",""
"7UFH","INTEGRIN ALAPHIIBBETA3 COMPLEX WITH FRADAFIBAN (MN/CA)","10.1016/J.CELL.2022.08.008 ",3,104.2,"7ufh_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(320_D_)",117.454,"","",""
"7UFH","INTEGRIN ALAPHIIBBETA3 COMPLEX WITH FRADAFIBAN (MN/CA)","10.1016/J.CELL.2022.08.008 ",3,104.2,"7ufh_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(320_B_)",99.0776,"","",""
"7UFK","CRYSTAL STRUCTURE OF CHIMERIC OMICRON RBD (STRAIN BA.2) COMPLEXED WITH HUMAN ACE2","10.1073/PNAS.2206509119 ",2.38,77.96,"7ufk_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(546_B_)",81.2602,"","",""
"7UGN","CRYO-EM STRUCTURE OF BG24 INFERRED GERMLINE FABS WITH GERMLINE CDR3S AND 10-1074 FABS IN COMPLEX WITH HIV-1 ENV IMMUNOGEN BG505-SOSIPV4.1- GT1 - CLASS 1","10.1038/S41467-022-33860-2 ",3.4,"1.35754e-19","7ugn_oligo23","DManpa1-3DManpa1-3[DManp[3<R1>]b1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_n_)-[MAN(5_n_)-MAN(4_n_)]-BMA(3_n_)-NAG(2_n_)-NAG(1_n_)-ASN(332_C_)",71.367,"","",""
"7UGN","CRYO-EM STRUCTURE OF BG24 INFERRED GERMLINE FABS WITH GERMLINE CDR3S AND 10-1074 FABS IN COMPLEX WITH HIV-1 ENV IMMUNOGEN BG505-SOSIPV4.1- GT1 - CLASS 1","10.1038/S41467-022-33860-2 ",3.4,"1.35754e-19","7ugn_oligo12","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_c_)-[MAN(4_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(262_B_)",69.0705,"","",""
"7UGN","CRYO-EM STRUCTURE OF BG24 INFERRED GERMLINE FABS WITH GERMLINE CDR3S AND 10-1074 FABS IN COMPLEX WITH HIV-1 ENV IMMUNOGEN BG505-SOSIPV4.1- GT1 - CLASS 1","10.1038/S41467-022-33860-2 ",3.4,"1.35754e-19","7ugn_oligo15","DManpa1-3[DManp[3<R1>]a1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_f_)-[MAN(6_f_)]-BMA(3_f_)-NAG(2_f_)-NAG(1_f_)-ASN(332_B_)",65.4373,"","",""
"7UGN","CRYO-EM STRUCTURE OF BG24 INFERRED GERMLINE FABS WITH GERMLINE CDR3S AND 10-1074 FABS IN COMPLEX WITH HIV-1 ENV IMMUNOGEN BG505-SOSIPV4.1- GT1 - CLASS 1","10.1038/S41467-022-33860-2 ",3.4,"1.35754e-19","7ugn_oligo20","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_k_)-[MAN(4_k_)]-BMA(3_k_)-NAG(2_k_)-NAG(1_k_)-ASN(262_C_)",75.7151,"","",""
"7UGN","CRYO-EM STRUCTURE OF BG24 INFERRED GERMLINE FABS WITH GERMLINE CDR3S AND 10-1074 FABS IN COMPLEX WITH HIV-1 ENV IMMUNOGEN BG505-SOSIPV4.1- GT1 - CLASS 1","10.1038/S41467-022-33860-2 ",3.4,"1.35754e-19","7ugn_oligo7","DManpa1-3DManpa1-3[DManp[3<R1>]a1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_X_)-[MAN(5_X_)-MAN(4_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(332_A_)",66.9489,"","",""
"7UGN","CRYO-EM STRUCTURE OF BG24 INFERRED GERMLINE FABS WITH GERMLINE CDR3S AND 10-1074 FABS IN COMPLEX WITH HIV-1 ENV IMMUNOGEN BG505-SOSIPV4.1- GT1 - CLASS 1","10.1038/S41467-022-33860-2 ",3.4,"1.35754e-19","7ugn_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_U_)-[MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(262_A_)",69.1395,"","",""
"7UGO","CRYO-EM STRUCTURE OF BG24 INFERRED GERMLINE FABS WITH MATURE CDR3S AND 10-1074 FABS IN COMPLEX WITH HIV-1 ENV IMMUNOGEN BG505-SOSIPV4.1-GT1","10.1038/S41467-022-33860-2 ",4.1,"1.52628e-19","7ugo_oligo17","DManpa1-2DManpa1-6[DManpb1-3]DManpa1-6[DManpb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_h_)-MAN(5_h_)-[MAN(7_h_)]-MAN(4_h_)-[MAN(9_h_)-MAN(8_h_)]-BMA(3_h_)-NAG(2_h_)-NAG(1_h_)-ASN(332_C_)",98.9344,"","",""
"7UGO","CRYO-EM STRUCTURE OF BG24 INFERRED GERMLINE FABS WITH MATURE CDR3S AND 10-1074 FABS IN COMPLEX WITH HIV-1 ENV IMMUNOGEN BG505-SOSIPV4.1-GT1","10.1038/S41467-022-33860-2 ",4.1,"1.52628e-19","7ugo_oligo16","DManpb1-3[DManpb1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(606_C_)-[MAN(4_g_)]-BMA(3_g_)-NAG(2_g_)-NAG(1_g_)-ASN(262_C_)",77.2122,"","",""
"7UGO","CRYO-EM STRUCTURE OF BG24 INFERRED GERMLINE FABS WITH MATURE CDR3S AND 10-1074 FABS IN COMPLEX WITH HIV-1 ENV IMMUNOGEN BG505-SOSIPV4.1-GT1","10.1038/S41467-022-33860-2 ",4.1,"1.52628e-19","7ugo_oligo10","DManpa1-2DManpa1-6[DManpb1-3]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_a_)-MAN(5_a_)-[MAN(7_a_)]-MAN(4_a_)-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(332_B_)",100.406,"","",""
"7UGO","CRYO-EM STRUCTURE OF BG24 INFERRED GERMLINE FABS WITH MATURE CDR3S AND 10-1074 FABS IN COMPLEX WITH HIV-1 ENV IMMUNOGEN BG505-SOSIPV4.1-GT1","10.1038/S41467-022-33860-2 ",4.1,"1.52628e-19","7ugo_oligo8","DManpb1-3DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_S_)-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(262_A_)",61.0814,"","",""
"7UGQ","CRYO-EM STRUCTURE OF BG24 FABS WITH AN INFERRED GERMLINE CDRL1 AND 10- 1074 FABS IN COMPLEX WITH HIV-1 ENV 6405-SOSIP.664","10.1038/S41467-022-33860-2 ",3.4,"6.59844e-07","7ugq_oligo24","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_p_)-MAN(7_p_)-[MAN(6_p_)-MAN(5_p_)-MAN(4_p_)]-BMA(3_p_)-NAG(2_p_)-NAG(1_p_)-ASN(332_B_)",27.5606,"","",""
"7UGQ","CRYO-EM STRUCTURE OF BG24 FABS WITH AN INFERRED GERMLINE CDRL1 AND 10- 1074 FABS IN COMPLEX WITH HIV-1 ENV 6405-SOSIP.664","10.1038/S41467-022-33860-2 ",3.4,"6.59844e-07","7ugq_oligo36","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_1_)-[MAN(8_1_)]-MAN(7_1_)-[MAN(6_1_)-MAN(5_1_)-MAN(4_1_)]-BMA(3_1_)-NAG(2_1_)-NAG(1_1_)-ASN(332_C_)",28.7037,"","",""
"7UGQ","CRYO-EM STRUCTURE OF BG24 FABS WITH AN INFERRED GERMLINE CDRL1 AND 10- 1074 FABS IN COMPLEX WITH HIV-1 ENV 6405-SOSIP.664","10.1038/S41467-022-33860-2 ",3.4,"6.59844e-07","7ugq_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_W_)-[MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(262_A_)",29.5504,"","",""
"7UGQ","CRYO-EM STRUCTURE OF BG24 FABS WITH AN INFERRED GERMLINE CDRL1 AND 10- 1074 FABS IN COMPLEX WITH HIV-1 ENV 6405-SOSIP.664","10.1038/S41467-022-33860-2 ",3.4,"6.59844e-07","7ugq_oligo11","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_i_)-[MAN(4_i_)]-BMA(3_i_)-NAG(2_i_)-NAG(1_i_)-ASN(262_B_)",29.9547,"","",""
"7UGQ","CRYO-EM STRUCTURE OF BG24 FABS WITH AN INFERRED GERMLINE CDRL1 AND 10- 1074 FABS IN COMPLEX WITH HIV-1 ENV 6405-SOSIP.664","10.1038/S41467-022-33860-2 ",3.4,"6.59844e-07","7ugq_oligo6","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_d_)-[MAN(8_d_)]-MAN(7_d_)-[MAN(6_d_)-MAN(5_d_)-MAN(4_d_)]-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(332_A_)",33.6194,"","",""
"7UGQ","CRYO-EM STRUCTURE OF BG24 FABS WITH AN INFERRED GERMLINE CDRL1 AND 10- 1074 FABS IN COMPLEX WITH HIV-1 ENV 6405-SOSIP.664","10.1038/S41467-022-33860-2 ",3.4,"6.59844e-07","7ugq_oligo29","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_u_)-[MAN(4_u_)]-BMA(3_u_)-NAG(2_u_)-NAG(1_u_)-ASN(262_C_)",30.6655,"","",""
"7UH8","INTEGRIN ALAPHIIBBETA3 COMPLEX WITH ROXIFIBAN (MN/CA)","10.1016/J.CELL.2022.08.008 ",2.75,92.04,"7uh8_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(320_B_)",81.9382,"","",""
"7UH8","INTEGRIN ALAPHIIBBETA3 COMPLEX WITH ROXIFIBAN (MN/CA)","10.1016/J.CELL.2022.08.008 ",2.75,92.04,"7uh8_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(320_D_)",101.272,"","",""
"7UJE","INTEGRIN ALAPHIIBBETA3 COMPLEX WITH UR2922 IN MN2+","10.1016/J.CELL.2022.08.008 ",2.5,86.9,"7uje_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(320_B_)",106.106,"","",""
"7UJE","INTEGRIN ALAPHIIBBETA3 COMPLEX WITH UR2922 IN MN2+","10.1016/J.CELL.2022.08.008 ",2.5,86.9,"7uje_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(320_D_)",112.538,"","",""
"7UJK","INTEGRIN ALAPHIIBBETA3 COMPLEX WITH LAMIFIBAN","10.1016/J.CELL.2022.08.008 ",2.43,68.02,"7ujk_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(320_B_)",64.2862,"","",""
"7UJK","INTEGRIN ALAPHIIBBETA3 COMPLEX WITH LAMIFIBAN","10.1016/J.CELL.2022.08.008 ",2.43,68.02,"7ujk_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(320_D_)",69.3291,"","",""
"7UK9","INTEGRIN ALAPHIIBBETA3 COMPLEX WITH LAMIFIBAN (MN)","10.1016/J.CELL.2022.08.008 ",2.6,93.59,"7uk9_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(320_B_)",87.8336,"","",""
"7UK9","INTEGRIN ALAPHIIBBETA3 COMPLEX WITH LAMIFIBAN (MN)","10.1016/J.CELL.2022.08.008 ",2.6,93.59,"7uk9_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(320_D_)",98.2689,"","",""
"7UKO","INTEGRIN ALAPHIIBBETA3 COMPLEX WITH SIBRAFIBAN (MN)","10.1016/J.CELL.2022.08.008 ",2.6,67.23,"7uko_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(320_D_)",67.3989,"","",""
"7UKO","INTEGRIN ALAPHIIBBETA3 COMPLEX WITH SIBRAFIBAN (MN)","10.1016/J.CELL.2022.08.008 ",2.6,67.23,"7uko_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(320_B_)",62.084,"","",""
"7UKP","INTEGRIN ALAPHIIBBETA3 COMPLEX WITH A GANTOFIBAN ANALOG","10.1016/J.CELL.2022.08.008 ",2.8,111.4,"7ukp_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(320_B_)",100.168,"","",""
"7UKP","INTEGRIN ALAPHIIBBETA3 COMPLEX WITH A GANTOFIBAN ANALOG","10.1016/J.CELL.2022.08.008 ",2.8,111.4,"7ukp_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(320_D_)",123.033,"","",""
"7UKT","INTEGRIN ALAPHIIBBETA3 COMPLEX WITH BMS4.2","10.1016/J.CELL.2022.08.008 ",2.37,103.9,"7ukt_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(320_B_)",123.444,"","",""
"7UKT","INTEGRIN ALAPHIIBBETA3 COMPLEX WITH BMS4.2","10.1016/J.CELL.2022.08.008 ",2.37,103.9,"7ukt_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(320_D_)",136.363,"","",""
"7UNY","CRYSTAL STRUCTURE OF D2 NANOBODY IN COMPLEX WITH PFCSS","10.1038/S41564-022-01261-2 ",4.13,202.3,"7uny_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(74_A_)",306.725,"","",""
"7UNY","CRYSTAL STRUCTURE OF D2 NANOBODY IN COMPLEX WITH PFCSS","10.1038/S41564-022-01261-2 ",4.13,202.3,"7uny_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(88_D_)",229.013,"","",""
"7UNY","CRYSTAL STRUCTURE OF D2 NANOBODY IN COMPLEX WITH PFCSS","10.1038/S41564-022-01261-2 ",4.13,202.3,"7uny_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(74_D_)",307.562,"","",""
"7UNY","CRYSTAL STRUCTURE OF D2 NANOBODY IN COMPLEX WITH PFCSS","10.1038/S41564-022-01261-2 ",4.13,202.3,"7uny_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(88_A_)",225.288,"","",""
"7UOJ","THE CRYOEM STRUCTURE OF N49-P9.6-FR3 AND PGT121 FABS IN COMPLEX WITH BG505 SOSIP.664","",4.02,524802,"7uoj_oligo31","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_w_)-[MAN(8_w_)]-MAN(7_w_)-[MAN(6_w_)-MAN(5_w_)-MAN(4_w_)]-BMA(3_w_)-NAG(2_w_)-NAG(1_w_)-ASN(332_I_)",41.6446,"","",""
"7UOJ","THE CRYOEM STRUCTURE OF N49-P9.6-FR3 AND PGT121 FABS IN COMPLEX WITH BG505 SOSIP.664","",4.02,524802,"7uoj_oligo29","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_u_)-[MAN(4_u_)]-BMA(3_u_)-NAG(2_u_)-NAG(1_u_)-ASN(386_I_)",29.9762,"","",""
"7UOJ","THE CRYOEM STRUCTURE OF N49-P9.6-FR3 AND PGT121 FABS IN COMPLEX WITH BG505 SOSIP.664","",4.02,524802,"7uoj_oligo25","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_q_)-BMA(3_q_)-NAG(2_q_)-NAG(1_q_)-ASN(262_I_)",37.3377,"","",""
"7UOJ","THE CRYOEM STRUCTURE OF N49-P9.6-FR3 AND PGT121 FABS IN COMPLEX WITH BG505 SOSIP.664","",4.02,524802,"7uoj_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(386_G_)",39.4849,"","",""
"7UOJ","THE CRYOEM STRUCTURE OF N49-P9.6-FR3 AND PGT121 FABS IN COMPLEX WITH BG505 SOSIP.664","",4.02,524802,"7uoj_oligo13","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_Z_)-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(262_A_)",33.2868,"","",""
"7UOJ","THE CRYOEM STRUCTURE OF N49-P9.6-FR3 AND PGT121 FABS IN COMPLEX WITH BG505 SOSIP.664","",4.02,524802,"7uoj_oligo17","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_f_)-[MAN(4_f_)]-BMA(3_f_)-NAG(2_f_)-NAG(1_f_)-ASN(386_A_)",36.3307,"","",""
"7UOJ","THE CRYOEM STRUCTURE OF N49-P9.6-FR3 AND PGT121 FABS IN COMPLEX WITH BG505 SOSIP.664","",4.02,524802,"7uoj_oligo20","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_O_)-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(262_G_)",31.9098,"","",""
"7UOJ","THE CRYOEM STRUCTURE OF N49-P9.6-FR3 AND PGT121 FABS IN COMPLEX WITH BG505 SOSIP.664","",4.02,524802,"7uoj_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_U_)-[MAN(8_U_)]-MAN(7_U_)-[MAN(6_U_)-MAN(5_U_)-MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(332_G_)",38.2005,"","",""
"7UOJ","THE CRYOEM STRUCTURE OF N49-P9.6-FR3 AND PGT121 FABS IN COMPLEX WITH BG505 SOSIP.664","",4.02,524802,"7uoj_oligo19","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_i_)-[MAN(8_i_)]-MAN(7_i_)-[MAN(6_i_)-MAN(5_i_)-MAN(4_i_)]-BMA(3_i_)-NAG(2_i_)-NAG(1_i_)-ASN(332_A_)",26.9699,"","",""
"7UOT","NATIVE LASSA GLYCOPROTEIN IN COMPLEX WITH NEUTRALIZING ANTIBODIES 8.9F AND 37.2D","10.1126/SCITRANSLMED.ABQ0991 ",2.77,"1.08527e-19","7uot_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_I_)-[MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(119_A_)",68.5214,"","",""
"7UOT","NATIVE LASSA GLYCOPROTEIN IN COMPLEX WITH NEUTRALIZING ANTIBODIES 8.9F AND 37.2D","10.1126/SCITRANSLMED.ABQ0991 ",2.77,"1.08527e-19","7uot_oligo18","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_f_)-[FUC(2_f_)]-NAG(1_f_)-ASN(119_B_)",69.973,"","",""
"7UOT","NATIVE LASSA GLYCOPROTEIN IN COMPLEX WITH NEUTRALIZING ANTIBODIES 8.9F AND 37.2D","10.1126/SCITRANSLMED.ABQ0991 ",2.77,"1.08527e-19","7uot_oligo33","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_u_)-[MAN(5_u_)-[MAN(4_u_)]-BMA(3_u_)-NAG(2_u_)]-NAG(1_u_)-ASN(395_c_)",83.363,"","",""
"7UOT","NATIVE LASSA GLYCOPROTEIN IN COMPLEX WITH NEUTRALIZING ANTIBODIES 8.9F AND 37.2D","10.1126/SCITRANSLMED.ABQ0991 ",2.77,"1.08527e-19","7uot_oligo19","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_g_)-[MAN(5_g_)-MAN(4_g_)]-BMA(3_g_)-NAG(2_g_)-NAG(1_g_)-ASN(365_b_)",56.0532,"","",""
"7UOT","NATIVE LASSA GLYCOPROTEIN IN COMPLEX WITH NEUTRALIZING ANTIBODIES 8.9F AND 37.2D","10.1126/SCITRANSLMED.ABQ0991 ",2.77,"1.08527e-19","7uot_oligo29","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_q_)-[MAN(5_q_)-[MAN(4_q_)]-BMA(3_q_)-NAG(2_q_)]-NAG(1_q_)-ASN(119_C_)",71.1451,"","",""
"7UOT","NATIVE LASSA GLYCOPROTEIN IN COMPLEX WITH NEUTRALIZING ANTIBODIES 8.9F AND 37.2D","10.1126/SCITRANSLMED.ABQ0991 ",2.77,"1.08527e-19","7uot_oligo22","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_j_)-[MAN(5_j_)-[MAN(4_j_)]-BMA(3_j_)-NAG(2_j_)]-NAG(1_j_)-ASN(395_b_)",85.0394,"","",""
"7UOT","NATIVE LASSA GLYCOPROTEIN IN COMPLEX WITH NEUTRALIZING ANTIBODIES 8.9F AND 37.2D","10.1126/SCITRANSLMED.ABQ0991 ",2.77,"1.08527e-19","7uot_oligo14","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_M_)-[MAN(5_M_)-MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(365_a_)",55.337,"","",""
"7UOT","NATIVE LASSA GLYCOPROTEIN IN COMPLEX WITH NEUTRALIZING ANTIBODIES 8.9F AND 37.2D","10.1126/SCITRANSLMED.ABQ0991 ",2.77,"1.08527e-19","7uot_oligo30","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_r_)-[MAN(5_r_)-MAN(4_r_)]-BMA(3_r_)-NAG(2_r_)-NAG(1_r_)-ASN(365_c_)",57.1744,"","",""
"7UOT","NATIVE LASSA GLYCOPROTEIN IN COMPLEX WITH NEUTRALIZING ANTIBODIES 8.9F AND 37.2D","10.1126/SCITRANSLMED.ABQ0991 ",2.77,"1.08527e-19","7uot_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_V_)-[MAN(5_V_)-[MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)]-NAG(1_V_)-ASN(395_a_)",83.5571,"","",""
"7UOV","NATIVE LASSA GLYCOPROTEIN IN COMPLEX WITH NEUTRALIZING ANTIBODIES 12.1F AND 37.2D","10.1126/SCITRANSLMED.ABQ0991 ",2.75,"1.08527e-19","7uov_oligo21","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_m_)-[MAN(5_m_)-[MAN(4_m_)]-BMA(3_m_)-NAG(2_m_)]-NAG(1_m_)-ASN(395_b_)",90.2483,"","",""
"7UOV","NATIVE LASSA GLYCOPROTEIN IN COMPLEX WITH NEUTRALIZING ANTIBODIES 12.1F AND 37.2D","10.1126/SCITRANSLMED.ABQ0991 ",2.75,"1.08527e-19","7uov_oligo13","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_V_)-[MAN(5_V_)-MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(365_a_)",56.4217,"","",""
"7UOV","NATIVE LASSA GLYCOPROTEIN IN COMPLEX WITH NEUTRALIZING ANTIBODIES 12.1F AND 37.2D","10.1126/SCITRANSLMED.ABQ0991 ",2.75,"1.08527e-19","7uov_oligo2","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_J_)-[MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(89_A_)",64.1244,"","",""
"7UOV","NATIVE LASSA GLYCOPROTEIN IN COMPLEX WITH NEUTRALIZING ANTIBODIES 12.1F AND 37.2D","10.1126/SCITRANSLMED.ABQ0991 ",2.75,"1.08527e-19","7uov_oligo32","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_x_)-[MAN(5_x_)-[MAN(4_x_)]-BMA(3_x_)-NAG(2_x_)]-NAG(1_x_)-ASN(395_c_)",91.1989,"","",""
"7UOV","NATIVE LASSA GLYCOPROTEIN IN COMPLEX WITH NEUTRALIZING ANTIBODIES 12.1F AND 37.2D","10.1126/SCITRANSLMED.ABQ0991 ",2.75,"1.08527e-19","7uov_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_Y_)-[MAN(5_Y_)-[MAN(4_Y_)]-BMA(3_Y_)-NAG(2_Y_)]-NAG(1_Y_)-ASN(395_a_)",86.6397,"","",""
"7UOV","NATIVE LASSA GLYCOPROTEIN IN COMPLEX WITH NEUTRALIZING ANTIBODIES 12.1F AND 37.2D","10.1126/SCITRANSLMED.ABQ0991 ",2.75,"1.08527e-19","7uov_oligo18","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_j_)-[MAN(5_j_)-MAN(4_j_)]-BMA(3_j_)-NAG(2_j_)-NAG(1_j_)-ASN(365_b_)",59.795,"","",""
"7UOV","NATIVE LASSA GLYCOPROTEIN IN COMPLEX WITH NEUTRALIZING ANTIBODIES 12.1F AND 37.2D","10.1126/SCITRANSLMED.ABQ0991 ",2.75,"1.08527e-19","7uov_oligo5","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Z_)-[MAN(5_Z_)-MAN(4_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(89_B_)",58.4092,"","",""
"7UOV","NATIVE LASSA GLYCOPROTEIN IN COMPLEX WITH NEUTRALIZING ANTIBODIES 12.1F AND 37.2D","10.1126/SCITRANSLMED.ABQ0991 ",2.75,"1.08527e-19","7uov_oligo22","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_n_)-[MAN(4_n_)-BMA(3_n_)-NAG(2_n_)]-NAG(1_n_)-ASN(109_C_)",86.61,"","",""
"7UOV","NATIVE LASSA GLYCOPROTEIN IN COMPLEX WITH NEUTRALIZING ANTIBODIES 12.1F AND 37.2D","10.1126/SCITRANSLMED.ABQ0991 ",2.75,"1.08527e-19","7uov_oligo29","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_u_)-[MAN(5_u_)-MAN(4_u_)]-BMA(3_u_)-NAG(2_u_)-NAG(1_u_)-ASN(365_c_)",57.9815,"","",""
"7UOV","NATIVE LASSA GLYCOPROTEIN IN COMPLEX WITH NEUTRALIZING ANTIBODIES 12.1F AND 37.2D","10.1126/SCITRANSLMED.ABQ0991 ",2.75,"1.08527e-19","7uov_oligo10","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_K_)-[MAN(4_K_)-BMA(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(109_A_)",91.7025,"","",""
"7UOV","NATIVE LASSA GLYCOPROTEIN IN COMPLEX WITH NEUTRALIZING ANTIBODIES 12.1F AND 37.2D","10.1126/SCITRANSLMED.ABQ0991 ",2.75,"1.08527e-19","7uov_oligo24","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_p_)-[MAN(5_p_)-MAN(4_p_)]-BMA(3_p_)-NAG(2_p_)-NAG(1_p_)-ASN(89_C_)",61.8833,"","",""
"7UR6","CRYO-EM STRUCTURE OF SHIV-ELICITED, FP-DIRECTED RHESUS FAB RM6561.DH1021.14 IN COMPLEX WITH STABILIZED HIV-1 ENV CE1176 DS- SOSIP.664","",3.46,131200,"7ur6_oligo35","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_q_)-[MAN(4_q_)]-BMA(3_q_)-NAG(2_q_)-NAG(1_q_)-ASN(262_F_)",113.537,"","",""
"7UR6","CRYO-EM STRUCTURE OF SHIV-ELICITED, FP-DIRECTED RHESUS FAB RM6561.DH1021.14 IN COMPLEX WITH STABILIZED HIV-1 ENV CE1176 DS- SOSIP.664","",3.46,131200,"7ur6_oligo13","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Q_)-[MAN(5_Q_)-MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(88_G_)",116.437,"","",""
"7UR6","CRYO-EM STRUCTURE OF SHIV-ELICITED, FP-DIRECTED RHESUS FAB RM6561.DH1021.14 IN COMPLEX WITH STABILIZED HIV-1 ENV CE1176 DS- SOSIP.664","",3.46,131200,"7ur6_oligo41","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_c_)-[MAN(4_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(262_A_)",110.825,"","",""
"7UR6","CRYO-EM STRUCTURE OF SHIV-ELICITED, FP-DIRECTED RHESUS FAB RM6561.DH1021.14 IN COMPLEX WITH STABILIZED HIV-1 ENV CE1176 DS- SOSIP.664","",3.46,131200,"7ur6_oligo36","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_e_)-[MAN(5_e_)-MAN(4_e_)]-BMA(3_e_)-NAG(2_e_)-NAG(1_e_)-ASN(88_A_)",114.387,"","",""
"7UR6","CRYO-EM STRUCTURE OF SHIV-ELICITED, FP-DIRECTED RHESUS FAB RM6561.DH1021.14 IN COMPLEX WITH STABILIZED HIV-1 ENV CE1176 DS- SOSIP.664","",3.46,131200,"7ur6_oligo4","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_d_)-MAN(5_d_)-[MAN(7_d_)]-MAN(4_d_)-[MAN(9_d_)-MAN(8_d_)]-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(241_A_)",104.198,"","",""
"7UR6","CRYO-EM STRUCTURE OF SHIV-ELICITED, FP-DIRECTED RHESUS FAB RM6561.DH1021.14 IN COMPLEX WITH STABILIZED HIV-1 ENV CE1176 DS- SOSIP.664","",3.46,131200,"7ur6_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Y_)-[MAN(4_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(339_G_)",155.873,"","",""
"7UR6","CRYO-EM STRUCTURE OF SHIV-ELICITED, FP-DIRECTED RHESUS FAB RM6561.DH1021.14 IN COMPLEX WITH STABILIZED HIV-1 ENV CE1176 DS- SOSIP.664","",3.46,131200,"7ur6_oligo18","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_s_)-[MAN(5_s_)-MAN(4_s_)]-BMA(3_s_)-NAG(2_s_)-NAG(1_s_)-ASN(88_F_)",115.885,"","",""
"7UR6","CRYO-EM STRUCTURE OF SHIV-ELICITED, FP-DIRECTED RHESUS FAB RM6561.DH1021.14 IN COMPLEX WITH STABILIZED HIV-1 ENV CE1176 DS- SOSIP.664","",3.46,131200,"7ur6_oligo17","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_r_)-MAN(5_r_)-[MAN(7_r_)]-MAN(4_r_)-[MAN(9_r_)-MAN(8_r_)]-BMA(3_r_)-NAG(2_r_)-NAG(1_r_)-ASN(241_F_)",105.298,"","",""
"7UR6","CRYO-EM STRUCTURE OF SHIV-ELICITED, FP-DIRECTED RHESUS FAB RM6561.DH1021.14 IN COMPLEX WITH STABILIZED HIV-1 ENV CE1176 DS- SOSIP.664","",3.46,131200,"7ur6_oligo26","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_0_)-[MAN(4_0_)]-BMA(3_0_)-NAG(2_0_)-NAG(1_0_)-ASN(339_F_)",154.559,"","",""
"7UR6","CRYO-EM STRUCTURE OF SHIV-ELICITED, FP-DIRECTED RHESUS FAB RM6561.DH1021.14 IN COMPLEX WITH STABILIZED HIV-1 ENV CE1176 DS- SOSIP.664","",3.46,131200,"7ur6_oligo14","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(262_G_)",112.49,"","",""
"7UR6","CRYO-EM STRUCTURE OF SHIV-ELICITED, FP-DIRECTED RHESUS FAB RM6561.DH1021.14 IN COMPLEX WITH STABILIZED HIV-1 ENV CE1176 DS- SOSIP.664","",3.46,131200,"7ur6_oligo16","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_P_)-MAN(5_P_)-[MAN(7_P_)]-MAN(4_P_)-[MAN(9_P_)-MAN(8_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(241_G_)",105.298,"","",""
"7UR6","CRYO-EM STRUCTURE OF SHIV-ELICITED, FP-DIRECTED RHESUS FAB RM6561.DH1021.14 IN COMPLEX WITH STABILIZED HIV-1 ENV CE1176 DS- SOSIP.664","",3.46,131200,"7ur6_oligo31","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_m_)-[MAN(4_m_)]-BMA(3_m_)-NAG(2_m_)-NAG(1_m_)-ASN(339_A_)",157.015,"","",""
"7URU","CRYSTAL STRUCTURE OF THE LOW AFFINITY FC GAMMA RECEPTOR IIIA VARIANT IN COMPLEX WITH THE FC OF IGG1.","",2.4,0,"7uru_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_E_)-[NAG(7_E_)-MAN(6_E_)-[NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_B_)",92.0661,"","",""
"7URU","CRYSTAL STRUCTURE OF THE LOW AFFINITY FC GAMMA RECEPTOR IIIA VARIANT IN COMPLEX WITH THE FC OF IGG1.","",2.4,0,"7uru_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_A_)",89.1557,"","",""
"7US6","STRUCTURE OF THE HUMAN CORONAVIRUS CCOV-HUPN-2018 SPIKE GLYCOPROTEIN WITH DOMAIN 0 IN THE PROXIMAL CONFORMATION","10.1016/J.CELL.2022.05.019 ",3.8,"1.15243e-41","7us6_oligo19","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(3_Y_)-[MAN(2_Y_)]-BMA(1_Y_)-NAG(2_X_)-NAG(1_X_)-ASN(284_C_)",34.1865,"","",""
"7US6","STRUCTURE OF THE HUMAN CORONAVIRUS CCOV-HUPN-2018 SPIKE GLYCOPROTEIN WITH DOMAIN 0 IN THE PROXIMAL CONFORMATION","10.1016/J.CELL.2022.05.019 ",3.8,"1.15243e-41","7us6_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(3_Q_)-[MAN(2_Q_)]-BMA(1_Q_)-NAG(2_P_)-NAG(1_P_)-ASN(284_B_)",34.1865,"","",""
"7US6","STRUCTURE OF THE HUMAN CORONAVIRUS CCOV-HUPN-2018 SPIKE GLYCOPROTEIN WITH DOMAIN 0 IN THE PROXIMAL CONFORMATION","10.1016/J.CELL.2022.05.019 ",3.8,"1.15243e-41","7us6_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(1199_B_)",29.7329,"","",""
"7US6","STRUCTURE OF THE HUMAN CORONAVIRUS CCOV-HUPN-2018 SPIKE GLYCOPROTEIN WITH DOMAIN 0 IN THE PROXIMAL CONFORMATION","10.1016/J.CELL.2022.05.019 ",3.8,"1.15243e-41","7us6_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(3_H_)-[MAN(2_H_)]-BMA(1_H_)-NAG(2_G_)-NAG(1_G_)-ASN(284_A_)",34.1865,"","",""
"7US6","STRUCTURE OF THE HUMAN CORONAVIRUS CCOV-HUPN-2018 SPIKE GLYCOPROTEIN WITH DOMAIN 0 IN THE PROXIMAL CONFORMATION","10.1016/J.CELL.2022.05.019 ",3.8,"1.15243e-41","7us6_oligo17","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_V_)-[MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(1199_C_)",29.7329,"","",""
"7US6","STRUCTURE OF THE HUMAN CORONAVIRUS CCOV-HUPN-2018 SPIKE GLYCOPROTEIN WITH DOMAIN 0 IN THE PROXIMAL CONFORMATION","10.1016/J.CELL.2022.05.019 ",3.8,"1.15243e-41","7us6_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(1199_A_)",29.7329,"","",""
"7UYI","CRYSTAL STRUCTURE OF THE COMPUTATIONALLY OPTIMIZED BROADLY REACTIVE H1 INFLUENZA HEMAGGLUTININ P1","10.1038/S42003-023-04793-3 ",3,80.54,"7uyi_oligo10","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_P_)-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(87_F_)",98.2455,"","",""
"7UYI","CRYSTAL STRUCTURE OF THE COMPUTATIONALLY OPTIMIZED BROADLY REACTIVE H1 INFLUENZA HEMAGGLUTININ P1","10.1038/S42003-023-04793-3 ",3,80.54,"7uyi_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(87_A_)",104.298,"","",""
"7UYI","CRYSTAL STRUCTURE OF THE COMPUTATIONALLY OPTIMIZED BROADLY REACTIVE H1 INFLUENZA HEMAGGLUTININ P1","10.1038/S42003-023-04793-3 ",3,80.54,"7uyi_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(87_E_)",101.357,"","",""
"7UYI","CRYSTAL STRUCTURE OF THE COMPUTATIONALLY OPTIMIZED BROADLY REACTIVE H1 INFLUENZA HEMAGGLUTININ P1","10.1038/S42003-023-04793-3 ",3,80.54,"7uyi_oligo12","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_R_)-[MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(87_D_)",103.581,"","",""
"7UZ3","BAND 3-GLYCOPHORIN A COMPLEX, OUTWARD FACING","10.1038/S41594-022-00792-W ",2.35,0,"7uz3_oligo2","DManpa1-3[DManpa1-4]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_F_)-[MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(642_E_)",43.1927,"","",""
"7UZ3","BAND 3-GLYCOPHORIN A COMPLEX, OUTWARD FACING","10.1038/S41594-022-00792-W ",2.35,0,"7uz3_oligo1","DManpa1-3[DManpa1-4]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_A_)-[MAN(5_A_)-[MAN(4_A_)]-BMA(3_A_)-NAG(2_A_)]-NAG(1_A_)-ASN(642_C_)",43.1927,"","",""
"7UZC","STRUCTURE OF THE SARS-COV-2 RBD IN COMPLEX WITH THE MOUSE ANTIBODY FAB FRAGMENT, M8A-34","10.1016/J.IMMUNI.2022.10.019 ",2.2,47.02,"7uzc_oligo1","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(343_A_)",84.5227,"","",""
"7UZC","STRUCTURE OF THE SARS-COV-2 RBD IN COMPLEX WITH THE MOUSE ANTIBODY FAB FRAGMENT, M8A-34","10.1016/J.IMMUNI.2022.10.019 ",2.2,47.02,"7uzc_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(343_B_)",90.8225,"","",""
"7V07","BAND 3-I-TM LOCAL REFINEMENT FROM ERYTHROCYTE ANKYRIN-1 COMPLEX CONSENSUS RECONSTRUCTION","10.1038/S41594-022-00792-W ",2.8,0,"7v07_oligo1","DManpa1-3[DManpa1-4]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_A_)-[MAN(5_A_)-[MAN(4_A_)]-BMA(3_A_)-NAG(2_A_)]-NAG(1_A_)-ASN(642_C_)",43.0485,"","",""
"7V07","BAND 3-I-TM LOCAL REFINEMENT FROM ERYTHROCYTE ANKYRIN-1 COMPLEX CONSENSUS RECONSTRUCTION","10.1038/S41594-022-00792-W ",2.8,0,"7v07_oligo2","DManpa1-3[DManpa1-4]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_F_)-[MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(642_E_)",62.4177,"","",""
"7V6I","CRYSTAL STRUCTURE OF LACTO-N-BIOSIDASE BSAX FROM BIFIDOBACTERIUM SAGUINI, LACTO-N-BIOSE COMPLEX","10.1093/BBB/ZBAC015 ",2.51,25.6,"7v6i_oligo1","DGalpb1-3DGlcpNAcb1-ROH","GAL(2_B_)-NAG(1_B_)",58.7136,"","",""
"7V6M","CRYSTAL STRUCTURE OF LACTO-N-BIOSIDASE TNX FROM TYNZENELLA NEXILIS, LACTO-N-BIOSE COMPLEX","10.1093/BBB/ZBAC015 ",1.92,21.64,"7v6m_oligo1","DGalpb1-3DGlcpNAcb1-ROH","GAL(2_B_)-NAG(1_B_)",17.1091,"","",""
"7VFQ","WILD TYPE GLTA FROM BIFIDOBACTERIUM INFANTIS JCM 1222 COMPLEXED WITH LACTO-N-TETRAOSE","",1.55,10.99,"7vfq_oligo4","DGalpb1-3DGlcpNAcb1-3DGalpb1-4DGlcpb1-ROH","GAL(4_H_)-NAG(3_H_)-GAL(2_H_)-BGC(1_H_)",8.63432,"","",""
"7VFQ","WILD TYPE GLTA FROM BIFIDOBACTERIUM INFANTIS JCM 1222 COMPLEXED WITH LACTO-N-TETRAOSE","",1.55,10.99,"7vfq_oligo2","DGalpb1-3DGlcpNAcb1-3DGalpb1-4DGlcpb1-ROH","GAL(4_F_)-NAG(3_F_)-GAL(2_F_)-BGC(1_F_)",8.27409,"","",""
"7VFQ","WILD TYPE GLTA FROM BIFIDOBACTERIUM INFANTIS JCM 1222 COMPLEXED WITH LACTO-N-TETRAOSE","",1.55,10.99,"7vfq_oligo1","DGalpb1-3DGlcpNAcb1-3DGalpb1-4DGlcpb1-ROH","GAL(4_E_)-NAG(3_E_)-GAL(2_E_)-BGC(1_E_)",8.34227,"","",""
"7VFQ","WILD TYPE GLTA FROM BIFIDOBACTERIUM INFANTIS JCM 1222 COMPLEXED WITH LACTO-N-TETRAOSE","",1.55,10.99,"7vfq_oligo3","DGalpb1-3DGlcpNAcb1-3DGalpb1-4DGlcpb1-ROH","GAL(4_G_)-NAG(3_G_)-GAL(2_G_)-BGC(1_G_)",7.98909,"","",""
"7VFR","GLTA N83K MUTANT FROM BIFIDOBACTERIUM INFANTIS JCM 1222 COMPLEXED WITH LACTO-N-TETRAOSE","",1.56,20.89,"7vfr_oligo1","DGalpb1-3DGlcpNAcb1-3DGalpb1-4DGlcpb1-ROH","GAL(4_B_)-NAG(3_B_)-GAL(2_B_)-BGC(1_B_)",19.1357,"","",""
"7VFS","HUMAN N-TYPE VOLTAGE GATED CALCIUM CHANNEL CAV2.2-ALPHA2/DELTA1-BETA1 COMPLEX, APO STATE","10.1016/J.CELREP.2021.109931 ",2.8,"1.35632e-19","7vfs_oligo8","DManpb1-3DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(824_B_)",128.619,"","",""
"7VFU","HUMAN N-TYPE VOLTAGE GATED CALCIUM CHANNEL CAV2.2-ALPHA2/DELTA1-BETA1 COMPLEX, BOUND TO ZICONOTIDE","10.1016/J.CELREP.2021.109931 ",3,"1.35632e-19","7vfu_oligo3","DManpb1-3DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(824_B_)",150.175,"","",""
"7VFV","HUMAN N-TYPE VOLTAGE GATED CALCIUM CHANNEL CAV2.2-ALPHA2/DELTA1-BETA1 COMPLEX, BOUND TO PD173212","10.1016/J.CELREP.2021.109931 ",3,"1.35632e-19","7vfv_oligo3","DManpb1-3DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(824_B_)",150.175,"","",""
"7VFW","HUMAN N-TYPE VOLTAGE GATED CALCIUM CHANNEL CAV2.2-ALPHA2/DELTA1-BETA1 COMPLEX, BOUND TO CAV2.2-BLOCKER1","10.1016/J.CELREP.2021.109931 ",3.3,"1.35632e-19","7vfw_oligo5","DManpb1-3DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(824_B_)",150.175,"","",""
"7VGH","CRYO-EM STRUCTURE OF THE HUMAN P4-TYPE FLIPPASE ATP8B1-CDC50B IN THE AUTO-INHIBITED E2P STATE","10.1073/PNAS.2118656119 ",3.39,"1.08527e-19","7vgh_oligo2","DManpa1-6DManpa1-6[DManpa1-3]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-MAN(4_D_)-[MAN(6_D_)]-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(171_A_)",95.0941,"","",""
"7VR5","CRYSTAL STRUCTURE OF CMABCB1 W114Y/W161Y/W363Y/W364Y/M391W (4WY/M391W) MUTANT","10.1002/PRO.4331 ",3,121.4,"7vr5_oligo2","DGlcpa1-3DMU6-OME","DMU(802_A_)-DMU(802_A_)",157.308,"","",""
"7VR5","CRYSTAL STRUCTURE OF CMABCB1 W114Y/W161Y/W363Y/W364Y/M391W (4WY/M391W) MUTANT","10.1002/PRO.4331 ",3,121.4,"7vr5_oligo1","DGlcpa1-3DGlcpb6-C3O1","DMU(801_A_)-DMU(801_A_)",164.027,"","",""
"7VS7","CRYSTAL STRUCTURE OF THE ECTODOMAIN OF OSCERK1 IN COMPLEX WITH CHITIN HEXAMER","10.1111/JIPB.13279 ",2.02,42.88,"7vs7_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(5_C_)-[BMA(3_C_)-NAG(2_C_)]-[FUC(4_C_)]-NAG(1_C_)-ASN(48_A_)",56.2365,"","",""
"7VS8","CRYSTAL STRUCTURE OF P DOMAIN FROM NOROVIRUS GI.9 CAPSID PROTEIN IN COMPLEX WITH LEWIS B ANTIGEN.","10.1002/2211-5463.13370 ",2.4,0,"7vs8_oligo1","LFucpa1-2DGalpb1-3[LFucpa1-4]DGlcpNAca1-ROH","FUC(4_C_)-[FUC(3_C_)-GAL(2_C_)]-NDG(1_C_)",41.078,"","",""
"7VS8","CRYSTAL STRUCTURE OF P DOMAIN FROM NOROVIRUS GI.9 CAPSID PROTEIN IN COMPLEX WITH LEWIS B ANTIGEN.","10.1002/2211-5463.13370 ",2.4,0,"7vs8_oligo2","LFucpa1-2DGalpb1-3[LFucpa1-4]DGlcpNAca1-ROH","FUC(4_D_)-[FUC(3_D_)-GAL(2_D_)]-NDG(1_D_)",41.0332,"","",""
"7VS9","CRYSTAL STRUCTURE OF P DOMAIN FROM NOROVIRUS GI.9 CAPSID PROTEIN IN COMPLEX WITH LEWIS X ANTIGEN.","10.1002/2211-5463.13370 ",2.26,0,"7vs9_oligo2","LFucpa1-3[DGalpb1-4]DGlcpNAca1-ROH","GAL(3_D_)-[FUC(2_D_)]-NDG(1_D_)",42.6988,"","",""
"7VS9","CRYSTAL STRUCTURE OF P DOMAIN FROM NOROVIRUS GI.9 CAPSID PROTEIN IN COMPLEX WITH LEWIS X ANTIGEN.","10.1002/2211-5463.13370 ",2.26,0,"7vs9_oligo1","LFucpa1-3[DGalpb1-4]DGlcpNAca1-ROH","GAL(3_C_)-[FUC(2_C_)]-NDG(1_C_)",42.2642,"","",""
"7VSH","CRYO-EM STRUCTURE OF A HUMAN ATP11C-CDC50A FLIPPASE RECONSTITUTED IN THE NANODISC IN E1P STATE.","10.1016/J.JBC.2021.101498 ",3.4,"1.08527e-19","7vsh_oligo1","DManpa1-3DGlcpNAcb1-3DGlcpNAcb1-ASN","MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(180_C_)",34.5176,"","",""
"7VTL","CRYSTAL STRUCTURE OF GH FAMILY 64 BETA-1,3-GLUCANASE COMPLEXED WITH LAMINARITRIOSE","",2.07,63.87,"7vtl_oligo1","DManpb1-3DManpb1-ROH","BMA(2_B_)-BMA(1_B_)",117.798,"","",""
"7VTL","CRYSTAL STRUCTURE OF GH FAMILY 64 BETA-1,3-GLUCANASE COMPLEXED WITH LAMINARITRIOSE","",2.07,63.87,"7vtl_oligo2","DManpb1-3DManpb1-ROH","BMA(2_C_)-BMA(1_C_)",119.405,"","",""
"7VTM","CRYSTAL STRUCTURE OF GLUCOSIDE HYDROLASE FAMILY 64 BETA-1,3-GLUCANASE COMPLEXED WITH LAMINARITETRAOSE","",2.05,34.21,"7vtm_oligo1","DManpb1-3DManpb1-3DManpb1-ROH","BMA(3_C_)-BMA(2_C_)-BMA(1_C_)",57.7906,"","",""
"7VTM","CRYSTAL STRUCTURE OF GLUCOSIDE HYDROLASE FAMILY 64 BETA-1,3-GLUCANASE COMPLEXED WITH LAMINARITETRAOSE","",2.05,34.21,"7vtm_oligo2","DManpb1-3DManpb1-3DManpb1-ROH","BMA(3_B_)-BMA(2_B_)-BMA(1_B_)",63.9439,"","",""
"7VU0","CHITOPORIN FROM ESCHERICHIA COLI","",1.85,31.92,"7vu0_oligo3","DGlcpa1-3DGlcpb6-OME","DMU(501_B_)-DMU(501_B_)",29.1755,"","",""
"7VU0","CHITOPORIN FROM ESCHERICHIA COLI","",1.85,31.92,"7vu0_oligo4","DGlcpa1-3DGlcpb6-C6O1","DMU(502_B_)-DMU(502_B_)",22.57,"","",""
"7VU0","CHITOPORIN FROM ESCHERICHIA COLI","",1.85,31.92,"7vu0_oligo2","DGlcpa1-3DGlcpb6-OME","DMU(502_A_)-DMU(502_A_)",31.6309,"","",""
"7VU0","CHITOPORIN FROM ESCHERICHIA COLI","",1.85,31.92,"7vu0_oligo1","DGlcpa1-3DGlcpb6-C6O1","DMU(501_A_)-DMU(501_A_)",24.3082,"","",""
"7VU1","CHITOPORIN FROM ESCHERICHIA COLI COMPLEX WITH CHITOHEXAOSE","",1.9,38.02,"7vu1_oligo6","DGlcpa1-3DGlcpb6-C6O1","DMU(502_A_)-DMU(502_A_)",34.9182,"","",""
"7VU1","CHITOPORIN FROM ESCHERICHIA COLI COMPLEX WITH CHITOHEXAOSE","",1.9,38.02,"7vu1_oligo1","DGlcpa1-3DGlcpb6-ROH","DMU(501_A_)-DMU(501_A_)",47.925,"","",""
"7VU1","CHITOPORIN FROM ESCHERICHIA COLI COMPLEX WITH CHITOHEXAOSE","",1.9,38.02,"7vu1_oligo8","DGlcpa1-3DGlcpb6-C4O1","DMU(503_B_)-DMU(503_B_)",74.5082,"","",""
"7VU1","CHITOPORIN FROM ESCHERICHIA COLI COMPLEX WITH CHITOHEXAOSE","",1.9,38.02,"7vu1_oligo3","DGlcpa1-3DGlcpb6-OME","DMU(501_B_)-DMU(501_B_)",43.2627,"","",""
"7VU1","CHITOPORIN FROM ESCHERICHIA COLI COMPLEX WITH CHITOHEXAOSE","",1.9,38.02,"7vu1_oligo7","DGlcpa1-3DGlcpb6-C6O1","DMU(502_B_)-DMU(502_B_)",31.6332,"","",""
"7VU1","CHITOPORIN FROM ESCHERICHIA COLI COMPLEX WITH CHITOHEXAOSE","",1.9,38.02,"7vu1_oligo2","DGlcpa1-3DGlcpb6-C5O1","DMU(503_A_)-DMU(503_A_)",83.9118,"","",""
"7VUW","BOVINE HEART CYTOCHROME C OXIDASE IN THE CYANIDE-BOUND FULLY OXIDIZED STATE AT 50 K","",1.6,0,"7vuw_oligo8","DGlcpa1-3DGlcpb6-C10O1","DMU(310_P_)-DMU(310_P_)",79.5173,"","",""
"7VUW","BOVINE HEART CYTOCHROME C OXIDASE IN THE CYANIDE-BOUND FULLY OXIDIZED STATE AT 50 K","",1.6,0,"7vuw_oligo4","DGlcpa1-3DGlcpb6-C10O1","DMU(103_X_)-DMU(103_X_)",83.9805,"","",""
"7VUW","BOVINE HEART CYTOCHROME C OXIDASE IN THE CYANIDE-BOUND FULLY OXIDIZED STATE AT 50 K","",1.6,0,"7vuw_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(303_O_)-DMU(303_O_)",86.305,"","",""
"7VUW","BOVINE HEART CYTOCHROME C OXIDASE IN THE CYANIDE-BOUND FULLY OXIDIZED STATE AT 50 K","",1.6,0,"7vuw_oligo5","DGlcpa1-3DGlcpb6-C10O1","DMU(101_Z_)-DMU(101_Z_)",52.6082,"","",""
"7VUW","BOVINE HEART CYTOCHROME C OXIDASE IN THE CYANIDE-BOUND FULLY OXIDIZED STATE AT 50 K","",1.6,0,"7vuw_oligo10","DGlcpa1-3DGlcpb6-C10O1","DMU(310_C_)-DMU(310_C_)",83.0509,"","",""
"7VUW","BOVINE HEART CYTOCHROME C OXIDASE IN THE CYANIDE-BOUND FULLY OXIDIZED STATE AT 50 K","",1.6,0,"7vuw_oligo3","DGlcpa1-3DGlcpb6-ROH","DMU(101_J_)-DMU(101_J_)",78.5995,"","",""
"7VUW","BOVINE HEART CYTOCHROME C OXIDASE IN THE CYANIDE-BOUND FULLY OXIDIZED STATE AT 50 K","",1.6,0,"7vuw_oligo12","DGlcpa1-3DGlcpb6-C10O1","DMU(101_M_)-DMU(101_M_)",42.1564,"","",""
"7VUW","BOVINE HEART CYTOCHROME C OXIDASE IN THE CYANIDE-BOUND FULLY OXIDIZED STATE AT 50 K","",1.6,0,"7vuw_oligo7","DGlcpa1-3DGlcpb6-C10O1","DMU(309_P_)-DMU(309_P_)",82.9823,"","",""
"7VVR","BOVINE CYTOCHROME C OXIDESE IN CN-BOUND MIXED VALENCE STATE AT 50 K","",1.65,0,"7vvr_oligo5","DGlcpa1-3DGlcpb6-C10O1","DMU(103_K_)-DMU(103_K_)",79.4468,"","",""
"7VVR","BOVINE CYTOCHROME C OXIDESE IN CN-BOUND MIXED VALENCE STATE AT 50 K","",1.65,0,"7vvr_oligo11","DGlcpa1-3DGlcpb6-C10O1","DMU(105_G_)-DMU(105_G_)",84.7723,"","",""
"7VVR","BOVINE CYTOCHROME C OXIDESE IN CN-BOUND MIXED VALENCE STATE AT 50 K","",1.65,0,"7vvr_oligo4","DGlcpa1-3DGlcpb6-C10O1","DMU(315_C_)-DMU(315_C_)",84.2414,"","",""
"7VVR","BOVINE CYTOCHROME C OXIDESE IN CN-BOUND MIXED VALENCE STATE AT 50 K","",1.65,0,"7vvr_oligo7","DGlcpa1-3DGlcpb6-C10O1","DMU(316_P_)-DMU(316_P_)",67.2104,"","",""
"7VVR","BOVINE CYTOCHROME C OXIDESE IN CN-BOUND MIXED VALENCE STATE AT 50 K","",1.65,0,"7vvr_oligo3","DGlcpa1-3DGlcpb6-C10O1","DMU(101_M_)-DMU(101_M_)",45.6718,"","",""
"7VVR","BOVINE CYTOCHROME C OXIDESE IN CN-BOUND MIXED VALENCE STATE AT 50 K","",1.65,0,"7vvr_oligo12","DGlcpa1-3DGlcpb6-C10O1","DMU(101_J_)-DMU(101_J_)",76.2295,"","",""
"7VVR","BOVINE CYTOCHROME C OXIDESE IN CN-BOUND MIXED VALENCE STATE AT 50 K","",1.65,0,"7vvr_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(101_Z_)-DMU(101_Z_)",54.5218,"","",""
"7VVR","BOVINE CYTOCHROME C OXIDESE IN CN-BOUND MIXED VALENCE STATE AT 50 K","",1.65,0,"7vvr_oligo10","DGlcpa1-3DGlcpb6-C10O1","DMU(309_P_)-DMU(309_P_)",75.3495,"","",""
"7W3E","BOVINE CYTOCHROME C OXIDESE IN CN-BOUND FULLY REDUCED STATE AT 50 K","",1.45,0,"7w3e_oligo14","DGlcpa1-3DGlcpb6-C10O1","DMU(311_C_)-DMU(311_C_)",75.9146,"","",""
"7W3E","BOVINE CYTOCHROME C OXIDESE IN CN-BOUND FULLY REDUCED STATE AT 50 K","",1.45,0,"7w3e_oligo13","DGlcpa1-3DGlcpb6-C10O1","DMU(101_M_)-DMU(101_M_)",43.4059,"","",""
"7W3E","BOVINE CYTOCHROME C OXIDESE IN CN-BOUND FULLY REDUCED STATE AT 50 K","",1.45,0,"7w3e_oligo10","DGlcpa1-3DGlcpb6-C10O1","DMU(315_P_)-DMU(315_P_)",68.8109,"","",""
"7W3E","BOVINE CYTOCHROME C OXIDESE IN CN-BOUND FULLY REDUCED STATE AT 50 K","",1.45,0,"7w3e_oligo7","DGlcpa1-3DGlcpb6-C10O1","DMU(310_P_)-DMU(310_P_)",80.0896,"","",""
"7W3E","BOVINE CYTOCHROME C OXIDESE IN CN-BOUND FULLY REDUCED STATE AT 50 K","",1.45,0,"7w3e_oligo6","DGlcpa1-3DGlcpb6-C10O1","DMU(101_Z_)-DMU(101_Z_)",51.64,"","",""
"7W3E","BOVINE CYTOCHROME C OXIDESE IN CN-BOUND FULLY REDUCED STATE AT 50 K","",1.45,0,"7w3e_oligo9","DGlcpa1-3DGlcpb6-C10O1","DMU(312_P_)-DMU(312_P_)",80.9814,"","",""
"7W3E","BOVINE CYTOCHROME C OXIDESE IN CN-BOUND FULLY REDUCED STATE AT 50 K","",1.45,0,"7w3e_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(101_J_)-DMU(101_J_)",78.4373,"","",""
"7W3E","BOVINE CYTOCHROME C OXIDESE IN CN-BOUND FULLY REDUCED STATE AT 50 K","",1.45,0,"7w3e_oligo8","DGlcpa1-3DGlcpb6-C10O1","DMU(311_P_)-DMU(311_P_)",85.9659,"","",""
"7W3V","PLANT RECEPTOR LIKE PROTEIN RXEG1 IN COMPLEX WITH XYLOGLUCANASE XEG1","10.1038/S41586-022-05214-X ",3.11,0,"7w3v_oligo2","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-MAN(5_D_)-[MAN(7_D_)]-MAN(4_D_)-[MAN(8_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(143_C_)",67.7395,"","",""
"7W3X","CRYO-EM STRUCTURE OF PLANT RECEPTOR LIKE PROTEIN RXEG1","10.1038/S41586-022-05214-X ",3.21,0,"7w3x_oligo1","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_A_)-MAN(5_A_)-[MAN(7_A_)]-MAN(4_A_)-[MAN(8_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(143_C_)",80.743,"","",""
"7W3X","CRYO-EM STRUCTURE OF PLANT RECEPTOR LIKE PROTEIN RXEG1","10.1038/S41586-022-05214-X ",3.21,0,"7w3x_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(562_C_)",82.9325,"","",""
"7W6M","CRYO-EM MAP OF PEDV (PINTUNG 52) S PROTEIN WITH ALL THREE PROTOMERS IN THE D0-DOWN CONFORMATION DETERMINED IN SITU ON INTACT VIRAL PARTICLES.","10.1038/S41467-022-32588-3 ",4.7,"1.15243e-41","7w6m_oligo22","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(726_A_)",322.928,"","",""
"7W6M","CRYO-EM MAP OF PEDV (PINTUNG 52) S PROTEIN WITH ALL THREE PROTOMERS IN THE D0-DOWN CONFORMATION DETERMINED IN SITU ON INTACT VIRAL PARTICLES.","10.1038/S41467-022-32588-3 ",4.7,"1.15243e-41","7w6m_oligo37","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_n_)-[MAN(4_n_)]-BMA(3_n_)-NAG(2_n_)-NAG(1_n_)-ASN(514_C_)",298.627,"","",""
"7W6M","CRYO-EM MAP OF PEDV (PINTUNG 52) S PROTEIN WITH ALL THREE PROTOMERS IN THE D0-DOWN CONFORMATION DETERMINED IN SITU ON INTACT VIRAL PARTICLES.","10.1038/S41467-022-32588-3 ",4.7,"1.15243e-41","7w6m_oligo29","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_f_)-[MAN(4_f_)]-BMA(3_f_)-NAG(2_f_)-NAG(1_f_)-ASN(1232_B_)",306.36,"","",""
"7W6M","CRYO-EM MAP OF PEDV (PINTUNG 52) S PROTEIN WITH ALL THREE PROTOMERS IN THE D0-DOWN CONFORMATION DETERMINED IN SITU ON INTACT VIRAL PARTICLES.","10.1038/S41467-022-32588-3 ",4.7,"1.15243e-41","7w6m_oligo25","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_b_)-[MAN(4_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(726_B_)",300.987,"","",""
"7W6M","CRYO-EM MAP OF PEDV (PINTUNG 52) S PROTEIN WITH ALL THREE PROTOMERS IN THE D0-DOWN CONFORMATION DETERMINED IN SITU ON INTACT VIRAL PARTICLES.","10.1038/S41467-022-32588-3 ",4.7,"1.15243e-41","7w6m_oligo16","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Y_)-[MAN(4_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(514_B_)",314.099,"","",""
"7W6M","CRYO-EM MAP OF PEDV (PINTUNG 52) S PROTEIN WITH ALL THREE PROTOMERS IN THE D0-DOWN CONFORMATION DETERMINED IN SITU ON INTACT VIRAL PARTICLES.","10.1038/S41467-022-32588-3 ",4.7,"1.15243e-41","7w6m_oligo27","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_d_)-[MAN(4_d_)]-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(787_B_)",363.683,"","",""
"7W6M","CRYO-EM MAP OF PEDV (PINTUNG 52) S PROTEIN WITH ALL THREE PROTOMERS IN THE D0-DOWN CONFORMATION DETERMINED IN SITU ON INTACT VIRAL PARTICLES.","10.1038/S41467-022-32588-3 ",4.7,"1.15243e-41","7w6m_oligo24","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_a_)-[MAN(4_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(688_B_)",279.114,"","",""
"7W6M","CRYO-EM MAP OF PEDV (PINTUNG 52) S PROTEIN WITH ALL THREE PROTOMERS IN THE D0-DOWN CONFORMATION DETERMINED IN SITU ON INTACT VIRAL PARTICLES.","10.1038/S41467-022-32588-3 ",4.7,"1.15243e-41","7w6m_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(514_A_)",313.122,"","",""
"7W6M","CRYO-EM MAP OF PEDV (PINTUNG 52) S PROTEIN WITH ALL THREE PROTOMERS IN THE D0-DOWN CONFORMATION DETERMINED IN SITU ON INTACT VIRAL PARTICLES.","10.1038/S41467-022-32588-3 ",4.7,"1.15243e-41","7w6m_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(781_A_)",343.14,"","",""
"7W6M","CRYO-EM MAP OF PEDV (PINTUNG 52) S PROTEIN WITH ALL THREE PROTOMERS IN THE D0-DOWN CONFORMATION DETERMINED IN SITU ON INTACT VIRAL PARTICLES.","10.1038/S41467-022-32588-3 ",4.7,"1.15243e-41","7w6m_oligo39","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_p_)-[MAN(4_p_)]-BMA(3_p_)-NAG(2_p_)-NAG(1_p_)-ASN(688_C_)",265.089,"","",""
"7W6M","CRYO-EM MAP OF PEDV (PINTUNG 52) S PROTEIN WITH ALL THREE PROTOMERS IN THE D0-DOWN CONFORMATION DETERMINED IN SITU ON INTACT VIRAL PARTICLES.","10.1038/S41467-022-32588-3 ",4.7,"1.15243e-41","7w6m_oligo17","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(264_A_)",200.741,"","",""
"7W6M","CRYO-EM MAP OF PEDV (PINTUNG 52) S PROTEIN WITH ALL THREE PROTOMERS IN THE D0-DOWN CONFORMATION DETERMINED IN SITU ON INTACT VIRAL PARTICLES.","10.1038/S41467-022-32588-3 ",4.7,"1.15243e-41","7w6m_oligo40","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_q_)-[MAN(4_q_)]-BMA(3_q_)-NAG(2_q_)-NAG(1_q_)-ASN(726_C_)",284.692,"","",""
"7W6M","CRYO-EM MAP OF PEDV (PINTUNG 52) S PROTEIN WITH ALL THREE PROTOMERS IN THE D0-DOWN CONFORMATION DETERMINED IN SITU ON INTACT VIRAL PARTICLES.","10.1038/S41467-022-32588-3 ",4.7,"1.15243e-41","7w6m_oligo23","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_Z_)-[MAN(4_Z_)-BMA(3_Z_)-NAG(2_Z_)]-NAG(1_Z_)-ASN(556_B_)",303.125,"","",""
"7W6M","CRYO-EM MAP OF PEDV (PINTUNG 52) S PROTEIN WITH ALL THREE PROTOMERS IN THE D0-DOWN CONFORMATION DETERMINED IN SITU ON INTACT VIRAL PARTICLES.","10.1038/S41467-022-32588-3 ",4.7,"1.15243e-41","7w6m_oligo32","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_i_)-[MAN(4_i_)]-BMA(3_i_)-NAG(2_i_)-NAG(1_i_)-ASN(264_C_)",205.319,"","",""
"7W6M","CRYO-EM MAP OF PEDV (PINTUNG 52) S PROTEIN WITH ALL THREE PROTOMERS IN THE D0-DOWN CONFORMATION DETERMINED IN SITU ON INTACT VIRAL PARTICLES.","10.1038/S41467-022-32588-3 ",4.7,"1.15243e-41","7w6m_oligo11","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_T_)-[MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(264_B_)",194.815,"","",""
"7W6M","CRYO-EM MAP OF PEDV (PINTUNG 52) S PROTEIN WITH ALL THREE PROTOMERS IN THE D0-DOWN CONFORMATION DETERMINED IN SITU ON INTACT VIRAL PARTICLES.","10.1038/S41467-022-32588-3 ",4.7,"1.15243e-41","7w6m_oligo20","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_K_)-[MAN(4_K_)-BMA(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(556_A_)",307.728,"","",""
"7W6M","CRYO-EM MAP OF PEDV (PINTUNG 52) S PROTEIN WITH ALL THREE PROTOMERS IN THE D0-DOWN CONFORMATION DETERMINED IN SITU ON INTACT VIRAL PARTICLES.","10.1038/S41467-022-32588-3 ",4.7,"1.15243e-41","7w6m_oligo38","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_o_)-[MAN(4_o_)-BMA(3_o_)-NAG(2_o_)]-NAG(1_o_)-ASN(556_C_)",290.678,"","",""
"7W6M","CRYO-EM MAP OF PEDV (PINTUNG 52) S PROTEIN WITH ALL THREE PROTOMERS IN THE D0-DOWN CONFORMATION DETERMINED IN SITU ON INTACT VIRAL PARTICLES.","10.1038/S41467-022-32588-3 ",4.7,"1.15243e-41","7w6m_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(787_A_)",359.688,"","",""
"7W6M","CRYO-EM MAP OF PEDV (PINTUNG 52) S PROTEIN WITH ALL THREE PROTOMERS IN THE D0-DOWN CONFORMATION DETERMINED IN SITU ON INTACT VIRAL PARTICLES.","10.1038/S41467-022-32588-3 ",4.7,"1.15243e-41","7w6m_oligo44","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_u_)-[MAN(4_u_)]-BMA(3_u_)-NAG(2_u_)-NAG(1_u_)-ASN(1232_C_)",330.493,"","",""
"7W6M","CRYO-EM MAP OF PEDV (PINTUNG 52) S PROTEIN WITH ALL THREE PROTOMERS IN THE D0-DOWN CONFORMATION DETERMINED IN SITU ON INTACT VIRAL PARTICLES.","10.1038/S41467-022-32588-3 ",4.7,"1.15243e-41","7w6m_oligo26","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_c_)-[MAN(4_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(781_B_)",350.559,"","",""
"7W6M","CRYO-EM MAP OF PEDV (PINTUNG 52) S PROTEIN WITH ALL THREE PROTOMERS IN THE D0-DOWN CONFORMATION DETERMINED IN SITU ON INTACT VIRAL PARTICLES.","10.1038/S41467-022-32588-3 ",4.7,"1.15243e-41","7w6m_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Q_)-[MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(1232_A_)",329.966,"","",""
"7W6M","CRYO-EM MAP OF PEDV (PINTUNG 52) S PROTEIN WITH ALL THREE PROTOMERS IN THE D0-DOWN CONFORMATION DETERMINED IN SITU ON INTACT VIRAL PARTICLES.","10.1038/S41467-022-32588-3 ",4.7,"1.15243e-41","7w6m_oligo41","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_r_)-[MAN(4_r_)]-BMA(3_r_)-NAG(2_r_)-NAG(1_r_)-ASN(781_C_)",355.567,"","",""
"7W6M","CRYO-EM MAP OF PEDV (PINTUNG 52) S PROTEIN WITH ALL THREE PROTOMERS IN THE D0-DOWN CONFORMATION DETERMINED IN SITU ON INTACT VIRAL PARTICLES.","10.1038/S41467-022-32588-3 ",4.7,"1.15243e-41","7w6m_oligo21","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_L_)-[MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(688_A_)",257.872,"","",""
"7W6M","CRYO-EM MAP OF PEDV (PINTUNG 52) S PROTEIN WITH ALL THREE PROTOMERS IN THE D0-DOWN CONFORMATION DETERMINED IN SITU ON INTACT VIRAL PARTICLES.","10.1038/S41467-022-32588-3 ",4.7,"1.15243e-41","7w6m_oligo42","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_s_)-[MAN(4_s_)]-BMA(3_s_)-NAG(2_s_)-NAG(1_s_)-ASN(787_C_)",363.318,"","",""
"7W73","CRYO-EM MAP OF PEDV S PROTEIN WITH ONE PROTOMER IN THE D0-UP CONFORMATION WHILE THE OTHER TWO IN THE D0-DOWN CONFORMATION","10.1038/S41467-022-32588-3 ",6.4,"1.15243e-41","7w73_oligo39","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_p_)-[MAN(4_p_)]-BMA(3_p_)-NAG(2_p_)-NAG(1_p_)-ASN(787_C_)",399.475,"","",""
"7W73","CRYO-EM MAP OF PEDV S PROTEIN WITH ONE PROTOMER IN THE D0-UP CONFORMATION WHILE THE OTHER TWO IN THE D0-DOWN CONFORMATION","10.1038/S41467-022-32588-3 ",6.4,"1.15243e-41","7w73_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_X_)-[MAN(4_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(688_B_)",306.494,"","",""
"7W73","CRYO-EM MAP OF PEDV S PROTEIN WITH ONE PROTOMER IN THE D0-UP CONFORMATION WHILE THE OTHER TWO IN THE D0-DOWN CONFORMATION","10.1038/S41467-022-32588-3 ",6.4,"1.15243e-41","7w73_oligo25","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(787_A_)",392.784,"","",""
"7W73","CRYO-EM MAP OF PEDV S PROTEIN WITH ONE PROTOMER IN THE D0-UP CONFORMATION WHILE THE OTHER TWO IN THE D0-DOWN CONFORMATION","10.1038/S41467-022-32588-3 ",6.4,"1.15243e-41","7w73_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_W_)-[MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(556_B_)",332.096,"","",""
"7W73","CRYO-EM MAP OF PEDV S PROTEIN WITH ONE PROTOMER IN THE D0-UP CONFORMATION WHILE THE OTHER TWO IN THE D0-DOWN CONFORMATION","10.1038/S41467-022-32588-3 ",6.4,"1.15243e-41","7w73_oligo36","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_m_)-[MAN(4_m_)]-BMA(3_m_)-NAG(2_m_)-NAG(1_m_)-ASN(556_C_)",388.181,"","",""
"7W73","CRYO-EM MAP OF PEDV S PROTEIN WITH ONE PROTOMER IN THE D0-UP CONFORMATION WHILE THE OTHER TWO IN THE D0-DOWN CONFORMATION","10.1038/S41467-022-32588-3 ",6.4,"1.15243e-41","7w73_oligo31","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_h_)-[MAN(4_h_)]-BMA(3_h_)-NAG(2_h_)-NAG(1_h_)-ASN(264_C_)",267.961,"","",""
"7W73","CRYO-EM MAP OF PEDV S PROTEIN WITH ONE PROTOMER IN THE D0-UP CONFORMATION WHILE THE OTHER TWO IN THE D0-DOWN CONFORMATION","10.1038/S41467-022-32588-3 ",6.4,"1.15243e-41","7w73_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_T_)-[MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(264_B_)",190.37,"","",""
"7W73","CRYO-EM MAP OF PEDV S PROTEIN WITH ONE PROTOMER IN THE D0-UP CONFORMATION WHILE THE OTHER TWO IN THE D0-DOWN CONFORMATION","10.1038/S41467-022-32588-3 ",6.4,"1.15243e-41","7w73_oligo18","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(344_A_)",379.379,"","",""
"7W73","CRYO-EM MAP OF PEDV S PROTEIN WITH ONE PROTOMER IN THE D0-UP CONFORMATION WHILE THE OTHER TWO IN THE D0-DOWN CONFORMATION","10.1038/S41467-022-32588-3 ",6.4,"1.15243e-41","7w73_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_S_)-[MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)]-NAG(1_S_)-ASN(216_B_)",422.306,"","",""
"7W73","CRYO-EM MAP OF PEDV S PROTEIN WITH ONE PROTOMER IN THE D0-UP CONFORMATION WHILE THE OTHER TWO IN THE D0-DOWN CONFORMATION","10.1038/S41467-022-32588-3 ",6.4,"1.15243e-41","7w73_oligo32","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_i_)-[MAN(5_i_)-[MAN(4_i_)]-BMA(3_i_)-NAG(2_i_)]-NAG(1_i_)-ASN(300_C_)",414.769,"","",""
"7W73","CRYO-EM MAP OF PEDV S PROTEIN WITH ONE PROTOMER IN THE D0-UP CONFORMATION WHILE THE OTHER TWO IN THE D0-DOWN CONFORMATION","10.1038/S41467-022-32588-3 ",6.4,"1.15243e-41","7w73_oligo28","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_e_)-[MAN(5_e_)-[MAN(4_e_)]-BMA(3_e_)-NAG(2_e_)]-NAG(1_e_)-ASN(300_B_)",387.366,"","",""
"7W73","CRYO-EM MAP OF PEDV S PROTEIN WITH ONE PROTOMER IN THE D0-UP CONFORMATION WHILE THE OTHER TWO IN THE D0-DOWN CONFORMATION","10.1038/S41467-022-32588-3 ",6.4,"1.15243e-41","7w73_oligo26","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(264_A_)",199.843,"","",""
"7W73","CRYO-EM MAP OF PEDV S PROTEIN WITH ONE PROTOMER IN THE D0-UP CONFORMATION WHILE THE OTHER TWO IN THE D0-DOWN CONFORMATION","10.1038/S41467-022-32588-3 ",6.4,"1.15243e-41","7w73_oligo19","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_O_)-[MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)]-NAG(1_O_)-ASN(216_A_)",436.92,"","",""
"7W73","CRYO-EM MAP OF PEDV S PROTEIN WITH ONE PROTOMER IN THE D0-UP CONFORMATION WHILE THE OTHER TWO IN THE D0-DOWN CONFORMATION","10.1038/S41467-022-32588-3 ",6.4,"1.15243e-41","7w73_oligo22","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_R_)-[MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(781_A_)",391.52,"","",""
"7W73","CRYO-EM MAP OF PEDV S PROTEIN WITH ONE PROTOMER IN THE D0-UP CONFORMATION WHILE THE OTHER TWO IN THE D0-DOWN CONFORMATION","10.1038/S41467-022-32588-3 ",6.4,"1.15243e-41","7w73_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Y_)-[MAN(4_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(726_B_)",399.214,"","",""
"7W73","CRYO-EM MAP OF PEDV S PROTEIN WITH ONE PROTOMER IN THE D0-UP CONFORMATION WHILE THE OTHER TWO IN THE D0-DOWN CONFORMATION","10.1038/S41467-022-32588-3 ",6.4,"1.15243e-41","7w73_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(556_A_)",367.393,"","",""
"7W73","CRYO-EM MAP OF PEDV S PROTEIN WITH ONE PROTOMER IN THE D0-UP CONFORMATION WHILE THE OTHER TWO IN THE D0-DOWN CONFORMATION","10.1038/S41467-022-32588-3 ",6.4,"1.15243e-41","7w73_oligo13","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_b_)-[MAN(4_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(787_B_)",413.761,"","",""
"7W73","CRYO-EM MAP OF PEDV S PROTEIN WITH ONE PROTOMER IN THE D0-UP CONFORMATION WHILE THE OTHER TWO IN THE D0-DOWN CONFORMATION","10.1038/S41467-022-32588-3 ",6.4,"1.15243e-41","7w73_oligo12","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_a_)-[MAN(4_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(781_B_)",386.924,"","",""
"7W73","CRYO-EM MAP OF PEDV S PROTEIN WITH ONE PROTOMER IN THE D0-UP CONFORMATION WHILE THE OTHER TWO IN THE D0-DOWN CONFORMATION","10.1038/S41467-022-32588-3 ",6.4,"1.15243e-41","7w73_oligo44","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_u_)-[MAN(4_u_)]-BMA(3_u_)-NAG(2_u_)-NAG(1_u_)-ASN(688_C_)",319.281,"","",""
"7W73","CRYO-EM MAP OF PEDV S PROTEIN WITH ONE PROTOMER IN THE D0-UP CONFORMATION WHILE THE OTHER TWO IN THE D0-DOWN CONFORMATION","10.1038/S41467-022-32588-3 ",6.4,"1.15243e-41","7w73_oligo20","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_P_)-[MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(324_A_)",364.513,"","",""
"7W73","CRYO-EM MAP OF PEDV S PROTEIN WITH ONE PROTOMER IN THE D0-UP CONFORMATION WHILE THE OTHER TWO IN THE D0-DOWN CONFORMATION","10.1038/S41467-022-32588-3 ",6.4,"1.15243e-41","7w73_oligo27","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_d_)-[MAN(4_d_)]-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(344_B_)",372.977,"","",""
"7W73","CRYO-EM MAP OF PEDV S PROTEIN WITH ONE PROTOMER IN THE D0-UP CONFORMATION WHILE THE OTHER TWO IN THE D0-DOWN CONFORMATION","10.1038/S41467-022-32588-3 ",6.4,"1.15243e-41","7w73_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_U_)-[MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(324_B_)",354.213,"","",""
"7W73","CRYO-EM MAP OF PEDV S PROTEIN WITH ONE PROTOMER IN THE D0-UP CONFORMATION WHILE THE OTHER TWO IN THE D0-DOWN CONFORMATION","10.1038/S41467-022-32588-3 ",6.4,"1.15243e-41","7w73_oligo34","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_k_)-[MAN(4_k_)]-BMA(3_k_)-NAG(2_k_)-NAG(1_k_)-ASN(344_C_)",396.997,"","",""
"7W73","CRYO-EM MAP OF PEDV S PROTEIN WITH ONE PROTOMER IN THE D0-UP CONFORMATION WHILE THE OTHER TWO IN THE D0-DOWN CONFORMATION","10.1038/S41467-022-32588-3 ",6.4,"1.15243e-41","7w73_oligo38","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_o_)-[MAN(4_o_)]-BMA(3_o_)-NAG(2_o_)-NAG(1_o_)-ASN(781_C_)",389.956,"","",""
"7W73","CRYO-EM MAP OF PEDV S PROTEIN WITH ONE PROTOMER IN THE D0-UP CONFORMATION WHILE THE OTHER TWO IN THE D0-DOWN CONFORMATION","10.1038/S41467-022-32588-3 ",6.4,"1.15243e-41","7w73_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(688_A_)",273.78,"","",""
"7W73","CRYO-EM MAP OF PEDV S PROTEIN WITH ONE PROTOMER IN THE D0-UP CONFORMATION WHILE THE OTHER TWO IN THE D0-DOWN CONFORMATION","10.1038/S41467-022-32588-3 ",6.4,"1.15243e-41","7w73_oligo23","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(726_A_)",393.201,"","",""
"7W73","CRYO-EM MAP OF PEDV S PROTEIN WITH ONE PROTOMER IN THE D0-UP CONFORMATION WHILE THE OTHER TWO IN THE D0-DOWN CONFORMATION","10.1038/S41467-022-32588-3 ",6.4,"1.15243e-41","7w73_oligo37","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_n_)-[MAN(4_n_)]-BMA(3_n_)-NAG(2_n_)-NAG(1_n_)-ASN(726_C_)",393.771,"","",""
"7W73","CRYO-EM MAP OF PEDV S PROTEIN WITH ONE PROTOMER IN THE D0-UP CONFORMATION WHILE THE OTHER TWO IN THE D0-DOWN CONFORMATION","10.1038/S41467-022-32588-3 ",6.4,"1.15243e-41","7w73_oligo33","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_j_)-[MAN(4_j_)]-BMA(3_j_)-NAG(2_j_)-NAG(1_j_)-ASN(324_C_)",344.091,"","",""
"7W73","CRYO-EM MAP OF PEDV S PROTEIN WITH ONE PROTOMER IN THE D0-UP CONFORMATION WHILE THE OTHER TWO IN THE D0-DOWN CONFORMATION","10.1038/S41467-022-32588-3 ",6.4,"1.15243e-41","7w73_oligo30","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_g_)-[MAN(4_g_)]-BMA(3_g_)-NAG(2_g_)-NAG(1_g_)-ASN(216_C_)",398.031,"","",""
"7WAB","CRYSTAL STRUCTURE OF THE PROLYL ENDOPROTEASE, PEP, FROM ASPERGILLUS NIGER","10.1016/J.BBRC.2021.12.114 ",1.75,31.14,"7wab_oligo1","DManpa1-2DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-MAN(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(226_A_)",35.5405,"","",""
"7WC2","CRYO-EM STRUCTURE OF ALPHAVIRUS, GETAH VIRUS","",3.5,"1.15243e-41","7wc2_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_d_)-[MAN(4_d_)]-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(141_G_)",30.712,"","",""
"7WC2","CRYO-EM STRUCTURE OF ALPHAVIRUS, GETAH VIRUS","",3.5,"1.15243e-41","7wc2_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_b_)-[MAN(4_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(200_E_)",32.7404,"","",""
"7WC2","CRYO-EM STRUCTURE OF ALPHAVIRUS, GETAH VIRUS","",3.5,"1.15243e-41","7wc2_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_i_)-[MAN(4_i_)]-BMA(3_i_)-NAG(2_i_)-NAG(1_i_)-ASN(262_K_)",31.0485,"","",""
"7WC2","CRYO-EM STRUCTURE OF ALPHAVIRUS, GETAH VIRUS","",3.5,"1.15243e-41","7wc2_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_e_)-[MAN(4_e_)]-BMA(3_e_)-NAG(2_e_)-NAG(1_e_)-ASN(200_H_)",32.7404,"","",""
"7WC2","CRYO-EM STRUCTURE OF ALPHAVIRUS, GETAH VIRUS","",3.5,"1.15243e-41","7wc2_oligo12","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_l_)-[MAN(4_l_)]-BMA(3_l_)-NAG(2_l_)-NAG(1_l_)-ASN(262_B_)",31.0485,"","",""
"7WC2","CRYO-EM STRUCTURE OF ALPHAVIRUS, GETAH VIRUS","",3.5,"1.15243e-41","7wc2_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_g_)-[MAN(4_g_)]-BMA(3_g_)-NAG(2_g_)-NAG(1_g_)-ASN(141_J_)",30.712,"","",""
"7WC2","CRYO-EM STRUCTURE OF ALPHAVIRUS, GETAH VIRUS","",3.5,"1.15243e-41","7wc2_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_c_)-[MAN(4_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(262_E_)",31.0485,"","",""
"7WC2","CRYO-EM STRUCTURE OF ALPHAVIRUS, GETAH VIRUS","",3.5,"1.15243e-41","7wc2_oligo11","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_k_)-[MAN(4_k_)]-BMA(3_k_)-NAG(2_k_)-NAG(1_k_)-ASN(200_B_)",32.7404,"","",""
"7WC2","CRYO-EM STRUCTURE OF ALPHAVIRUS, GETAH VIRUS","",3.5,"1.15243e-41","7wc2_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_f_)-[MAN(4_f_)]-BMA(3_f_)-NAG(2_f_)-NAG(1_f_)-ASN(262_H_)",31.0485,"","",""
"7WC2","CRYO-EM STRUCTURE OF ALPHAVIRUS, GETAH VIRUS","",3.5,"1.15243e-41","7wc2_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_h_)-[MAN(4_h_)]-BMA(3_h_)-NAG(2_h_)-NAG(1_h_)-ASN(200_K_)",32.7404,"","",""
"7WC2","CRYO-EM STRUCTURE OF ALPHAVIRUS, GETAH VIRUS","",3.5,"1.15243e-41","7wc2_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_j_)-[MAN(4_j_)]-BMA(3_j_)-NAG(2_j_)-NAG(1_j_)-ASN(141_A_)",30.712,"","",""
"7WC2","CRYO-EM STRUCTURE OF ALPHAVIRUS, GETAH VIRUS","",3.5,"1.15243e-41","7wc2_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_a_)-[MAN(4_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(141_D_)",30.712,"","",""
"7WG3","STRUCTURAL BASIS OF INTERLEUKIN-17B RECEPTOR IN COMPLEX WITH A NEUTRALIZING ANTIBODY D9 FOR GUIDING HUMANIZATION AND AFFINITY MATURATION FOR CANCER THERAPY","10.1016/J.CELREP.2022.111555 ",2.19,46.47,"7wg3_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(50_J_)",88.0342,"","",""
"7WG3","STRUCTURAL BASIS OF INTERLEUKIN-17B RECEPTOR IN COMPLEX WITH A NEUTRALIZING ANTIBODY D9 FOR GUIDING HUMANIZATION AND AFFINITY MATURATION FOR CANCER THERAPY","10.1016/J.CELREP.2022.111555 ",2.19,46.47,"7wg3_oligo1","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-MAN(4_M_)-[MAN(6_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(50_I_)",84.3209,"","",""
"7WH6","THE MUTANT CRYSTAL STRUCTURE OF B-1,4-XYLANASE (XYNAF1_N179S)","",1.58,14.93,"7wh6_oligo2","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(105_B_)",21.2791,"","",""
"7WH6","THE MUTANT CRYSTAL STRUCTURE OF B-1,4-XYLANASE (XYNAF1_N179S)","",1.58,14.93,"7wh6_oligo1","DManpa1-2[DManpa1-6]DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_C_)-[MAN(6_C_)-[MAN(5_C_)]-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(105_A_)",25.0805,"","",""
"7WH7","THE MUTANT CRYSTAL STRUCTURE OF B-1,4-XYLANASE (XYNAF1_N179S) WITH XYLOTETRAOSE","",1.44,13.84,"7wh7_oligo3","DManpa1-2[DManpa1-6]DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_D_)-[MAN(6_D_)-[MAN(5_D_)]-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(105_A_)",22.5778,"","",""
"7WH7","THE MUTANT CRYSTAL STRUCTURE OF B-1,4-XYLANASE (XYNAF1_N179S) WITH XYLOTETRAOSE","",1.44,13.84,"7wh7_oligo4","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_F_)-[MAN(6_F_)-MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(105_B_)",21.726,"","",""
"7WHH","CRYSTAL STRUCTURE OF SARS-COV-2 OMICRON RBD AND HUMAN ACE2","",2.6,50.95,"7whh_oligo1","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_B_)-[FUC(2_B_)]-NAG(1_B_)-ASN(90_A_)",91.6427,"","",""
"7WHU","HUMAN NEUTROPHIL ELASTASE IN-COMPLEX WITH ECOTIN PEPTIDE","10.1002/PRO.4274 ",2.89,0,"7whu_oligo6","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_M_)-[FUC(2_M_)]-NAG(1_M_)-ASN(105_B_)",46.1733,"","",""
"7WJC","CRYSTAL STRUCTURE OF LACTOCOCCUS LACTIS SUBSP. CREMORIS GH31 ALPHA-1, 3-GLUCOSIDASE MUTANT D394A IN COMPLEX WITH NIGEROSE","10.1016/J.JBC.2022.101827 ",1.75,32.27,"7wjc_oligo1","DGlcpa1-3DGlcpa1-ROH","GLC(2_B_)-GLC(1_B_)",29.2255,"","",""
"7WJD","CRYSTAL STRUCTURE OF LACTOCOCCUS LACTIS SUBSP. CREMORIS GH31 ALPHA-1, 3-GLUCOSIDASE MUTANT D394A IN COMPLEX WITH NIGEROTRIOSE","10.1016/J.JBC.2022.101827 ",1.8,35.26,"7wjd_oligo1","DGlcpa1-3DGlcpa1-3DGlcpa1-ROH","GLC(3_B_)-GLC(2_B_)-GLC(1_B_)",36.4324,"","",""
"7WJE","CRYSTAL STRUCTURE OF LACTOCOCCUS LACTIS SUBSP. CREMORIS GH31 ALPHA-1, 3-GLUCOSIDASE MUTANT D394A IN COMPLEX WITH NIGEROTETRAOSE","10.1016/J.JBC.2022.101827 ",1.8,30.18,"7wje_oligo1","DGlcpa1-3DGlcpa1-3DGlcpa1-3DGlcpa1-ROH","GLC(4_B_)-GLC(3_B_)-GLC(2_B_)-GLC(1_B_)",38.0134,"","",""
"7WLW","X-RAY STRUCTURE OF THERMOSTABILIZED DROSOPHILA DOPAMINE TRANSPORTER WITH GABA TRANSPORTER1-LIKE SUBSTITUTIONS IN THE BINDING SITE, IN COMPLEX WITH SKF89976A","10.15252/EMBJ.2022110735 ",2.9,68.52,"7wlw_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(707_A_)-DMU(707_A_)",99.605,"","",""
"7WPO","STRUCTURE OF NEOCOV RBD BINDING TO BAT37 ACE2","10.1038/S41586-022-05513-3 ",3.5,0,"7wpo_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(54_A_)",43.3104,"","",""
"7WPZ","STRUCTURE OF PDF-2180-COV RBD BINDING TO BAT37 ACE2","10.1038/S41586-022-05513-3 ",3.8,0,"7wpz_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(54_A_)",66.8255,"","",""
"7WQV","CRYSTAL STRUCTURE OF A NEUTRALIZING MONOCLONAL ANTIBODY (AB08) IN COMPLEX WITH SARS-COV-2 RECEPTOR-BINDING DOMAIN (RBD)","10.1371/JOURNAL.PPAT.1011085 ",2.8,56.4,"7wqv_oligo5","LFucpa1-3DGlcpNAcb1-ASN","FUC(2_R_)-NAG(1_R_)-ASN(343_E_)",108.661,"","",""
"7WSK","CRYSTAL STRUCTURE OF SARS-COV-2 OMICRON SPIKE RECEPTOR-BINDING DOMAIN IN COMPLEX WITH CIVET ACE2","10.1038/S41421-022-00431-0 ",3.3,71.17,"7wsk_oligo1","DManpa1-3DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(53_A_)",109.614,"","",""
"7WUH","SARS-COV-2 SPIKE IN COMPLEX WITH FAB OF M31A7","10.1126/SCITRANSLMED.ABM0899 ",4.7,"5.50295e+11","7wuh_oligo14","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_W_)-[MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(717_C_)",193.014,"","",""
"7WUH","SARS-COV-2 SPIKE IN COMPLEX WITH FAB OF M31A7","10.1126/SCITRANSLMED.ABM0899 ",4.7,"5.50295e+11","7wuh_oligo23","DManpa1-3[DManpa1-6]DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_f_)-[MAN(5_f_)]-MAN(4_f_)-BMA(3_f_)-NAG(2_f_)-NAG(1_f_)-ASN(1074_E_)",158.84,"","",""
"7WUH","SARS-COV-2 SPIKE IN COMPLEX WITH FAB OF M31A7","10.1126/SCITRANSLMED.ABM0899 ",4.7,"5.50295e+11","7wuh_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(331_C_)",170.389,"","",""
"7WUH","SARS-COV-2 SPIKE IN COMPLEX WITH FAB OF M31A7","10.1126/SCITRANSLMED.ABM0899 ",4.7,"5.50295e+11","7wuh_oligo21","DGlcpNAcb1-2[DManpa1-6]DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_d_)-[NAG(5_d_)]-MAN(4_d_)-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(331_E_)",185.229,"","",""
"7WVG","CRYSTAL STRUCTURE OF H18 COMPLEXED WITH SIA28","10.1038/S41467-022-35236-Y ",2.6,49.66,"7wvg_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(268_A_)",74.2066,"","",""
"7WYU","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY ATP","10.1073/PNAS.2123226119 ",3.4,"1.15243e-41","7wyu_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_I_)-[MAN(4_I_)-BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(194_B_)",134.525,"","",""
"7WYU","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY ATP","10.1073/PNAS.2123226119 ",3.4,"1.15243e-41","7wyu_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_F_)-[MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(114_B_)",132.398,"","",""
"7WYU","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY ATP","10.1073/PNAS.2123226119 ",3.4,"1.15243e-41","7wyu_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_K_)-[MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(114_D_)",134.072,"","",""
"7WYU","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY ATP","10.1073/PNAS.2123226119 ",3.4,"1.15243e-41","7wyu_oligo8","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_L_)-[NAG(5_L_)-MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(159_D_)",143.179,"","",""
"7WYU","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY ATP","10.1073/PNAS.2123226119 ",3.4,"1.15243e-41","7wyu_oligo9","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_M_)-[MAN(4_M_)-BMA(3_M_)-NAG(2_M_)]-NAG(1_M_)-ASN(194_D_)",135.398,"","",""
"7WYU","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY ATP","10.1073/PNAS.2123226119 ",3.4,"1.15243e-41","7wyu_oligo5","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-[NAG(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(159_B_)",139.536,"","",""
"7WYV","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY ATP IN THE PRESENCE OF 40 MM MG2+","10.1073/PNAS.2123226119 ",3.7,"1.15243e-41","7wyv_oligo8","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_I_)-[MAN(4_I_)-BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(194_B_)",123.032,"","",""
"7WYV","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY ATP IN THE PRESENCE OF 40 MM MG2+","10.1073/PNAS.2123226119 ",3.7,"1.15243e-41","7wyv_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_K_)-[MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(114_D_)",99.815,"","",""
"7WYV","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY ATP IN THE PRESENCE OF 40 MM MG2+","10.1073/PNAS.2123226119 ",3.7,"1.15243e-41","7wyv_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_F_)-[MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(114_B_)",100.985,"","",""
"7WYV","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY ATP IN THE PRESENCE OF 40 MM MG2+","10.1073/PNAS.2123226119 ",3.7,"1.15243e-41","7wyv_oligo4","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_L_)-[NAG(5_L_)-MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(159_D_)",129.912,"","",""
"7WYV","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY ATP IN THE PRESENCE OF 40 MM MG2+","10.1073/PNAS.2123226119 ",3.7,"1.15243e-41","7wyv_oligo7","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-[NAG(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(159_B_)",130.728,"","",""
"7WYV","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY ATP IN THE PRESENCE OF 40 MM MG2+","10.1073/PNAS.2123226119 ",3.7,"1.15243e-41","7wyv_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_M_)-[MAN(4_M_)-BMA(3_M_)-NAG(2_M_)]-NAG(1_M_)-ASN(194_D_)",122.626,"","",""
"7WYW","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY INORGANIC PHOSPHATE","10.1073/PNAS.2123226119 ",3.8,"1.15243e-41","7wyw_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_F_)-[MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(114_B_)",126.666,"","",""
"7WYW","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY INORGANIC PHOSPHATE","10.1073/PNAS.2123226119 ",3.8,"1.15243e-41","7wyw_oligo7","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_L_)-[NAG(5_L_)-MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(159_D_)",151.224,"","",""
"7WYW","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY INORGANIC PHOSPHATE","10.1073/PNAS.2123226119 ",3.8,"1.15243e-41","7wyw_oligo2","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-[NAG(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(159_B_)",149.673,"","",""
"7WYW","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY INORGANIC PHOSPHATE","10.1073/PNAS.2123226119 ",3.8,"1.15243e-41","7wyw_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_K_)-[MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(114_D_)",126.569,"","",""
"7WYW","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY INORGANIC PHOSPHATE","10.1073/PNAS.2123226119 ",3.8,"1.15243e-41","7wyw_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_I_)-[MAN(4_I_)-BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(194_B_)",137.543,"","",""
"7WYW","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY INORGANIC PHOSPHATE","10.1073/PNAS.2123226119 ",3.8,"1.15243e-41","7wyw_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_M_)-[MAN(4_M_)-BMA(3_M_)-NAG(2_M_)]-NAG(1_M_)-ASN(194_D_)",138.996,"","",""
"7WYX","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY ATP WITH ISTAROXIME","10.1073/PNAS.2123226119 ",3.4,"1.15243e-41","7wyx_oligo6","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_L_)-[NAG(5_L_)-MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(159_D_)",149.642,"","",""
"7WYX","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY ATP WITH ISTAROXIME","10.1073/PNAS.2123226119 ",3.4,"1.15243e-41","7wyx_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_I_)-[MAN(4_I_)-BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(194_B_)",139.569,"","",""
"7WYX","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY ATP WITH ISTAROXIME","10.1073/PNAS.2123226119 ",3.4,"1.15243e-41","7wyx_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_K_)-[MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(114_D_)",130.65,"","",""
"7WYX","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY ATP WITH ISTAROXIME","10.1073/PNAS.2123226119 ",3.4,"1.15243e-41","7wyx_oligo7","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_M_)-[MAN(4_M_)-BMA(3_M_)-NAG(2_M_)]-NAG(1_M_)-ASN(194_D_)",139.333,"","",""
"7WYX","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY ATP WITH ISTAROXIME","10.1073/PNAS.2123226119 ",3.4,"1.15243e-41","7wyx_oligo2","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-[NAG(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(159_B_)",151.553,"","",""
"7WYX","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY ATP WITH ISTAROXIME","10.1073/PNAS.2123226119 ",3.4,"1.15243e-41","7wyx_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_F_)-[MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(114_B_)",129.71,"","",""
"7WYY","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY INORGANIC PHOSPHATE WITH ISTAROXIME","10.1073/PNAS.2123226119 ",3.9,"1.15243e-41","7wyy_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_M_)-[MAN(4_M_)-BMA(3_M_)-NAG(2_M_)]-NAG(1_M_)-ASN(194_D_)",124.978,"","",""
"7WYY","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY INORGANIC PHOSPHATE WITH ISTAROXIME","10.1073/PNAS.2123226119 ",3.9,"1.15243e-41","7wyy_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_K_)-[MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(114_D_)",116.278,"","",""
"7WYY","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY INORGANIC PHOSPHATE WITH ISTAROXIME","10.1073/PNAS.2123226119 ",3.9,"1.15243e-41","7wyy_oligo7","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_L_)-[NAG(5_L_)-MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(159_D_)",125.568,"","",""
"7WYY","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY INORGANIC PHOSPHATE WITH ISTAROXIME","10.1073/PNAS.2123226119 ",3.9,"1.15243e-41","7wyy_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_I_)-[MAN(4_I_)-BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(194_B_)",123.725,"","",""
"7WYY","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY INORGANIC PHOSPHATE WITH ISTAROXIME","10.1073/PNAS.2123226119 ",3.9,"1.15243e-41","7wyy_oligo3","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-[NAG(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(159_B_)",123.146,"","",""
"7WYY","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY INORGANIC PHOSPHATE WITH ISTAROXIME","10.1073/PNAS.2123226119 ",3.9,"1.15243e-41","7wyy_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_F_)-[MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(114_B_)",115.116,"","",""
"7WYZ","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY ATP WITH OUABAIN","10.1073/PNAS.2123226119 ",3.4,"1.15243e-41","7wyz_oligo8","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_I_)-[MAN(4_I_)-BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(194_B_)",139.962,"","",""
"7WYZ","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY ATP WITH OUABAIN","10.1073/PNAS.2123226119 ",3.4,"1.15243e-41","7wyz_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_K_)-[MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(114_D_)",120.427,"","",""
"7WYZ","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY ATP WITH OUABAIN","10.1073/PNAS.2123226119 ",3.4,"1.15243e-41","7wyz_oligo5","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-[NAG(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(159_B_)",160.914,"","",""
"7WYZ","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY ATP WITH OUABAIN","10.1073/PNAS.2123226119 ",3.4,"1.15243e-41","7wyz_oligo6","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_M_)-[MAN(4_M_)-BMA(3_M_)-NAG(2_M_)]-NAG(1_M_)-ASN(194_D_)",140.642,"","",""
"7WYZ","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY ATP WITH OUABAIN","10.1073/PNAS.2123226119 ",3.4,"1.15243e-41","7wyz_oligo9","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_L_)-[NAG(5_L_)-MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(159_D_)",161.85,"","",""
"7WYZ","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY ATP WITH OUABAIN","10.1073/PNAS.2123226119 ",3.4,"1.15243e-41","7wyz_oligo11","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_F_)-[MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(114_B_)",119.45,"","",""
"7WZ0","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY INORGANIC PHOSPHATE WITH OUABAIN","10.1073/PNAS.2123226119 ",3,"1.15243e-41","7wz0_oligo11","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_F_)-[MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(114_B_)",102.1,"","",""
"7WZ0","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY INORGANIC PHOSPHATE WITH OUABAIN","10.1073/PNAS.2123226119 ",3,"1.15243e-41","7wz0_oligo8","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_M_)-[MAN(4_M_)-BMA(3_M_)-NAG(2_M_)]-NAG(1_M_)-ASN(194_D_)",121.977,"","",""
"7WZ0","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY INORGANIC PHOSPHATE WITH OUABAIN","10.1073/PNAS.2123226119 ",3,"1.15243e-41","7wz0_oligo6","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_L_)-[NAG(5_L_)-MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(159_D_)",128.61,"","",""
"7WZ0","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY INORGANIC PHOSPHATE WITH OUABAIN","10.1073/PNAS.2123226119 ",3,"1.15243e-41","7wz0_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_K_)-[MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(114_D_)",102.692,"","",""
"7WZ0","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY INORGANIC PHOSPHATE WITH OUABAIN","10.1073/PNAS.2123226119 ",3,"1.15243e-41","7wz0_oligo5","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-[NAG(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(159_B_)",128.258,"","",""
"7WZ0","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E2P STATE FORMED BY INORGANIC PHOSPHATE WITH OUABAIN","10.1073/PNAS.2123226119 ",3,"1.15243e-41","7wz0_oligo7","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_I_)-[MAN(4_I_)-BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(194_B_)",120.917,"","",""
"7X2N","CRYSTAL STRUCTURE OF DIELS-ALDERASE PYCR1","",1.72,33.45,"7x2n_oligo1","DManpa1-2DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-MAN(5_B_)-MAN(4_B_)-[MAN(7_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(211_A_)",51.2327,"","",""
"7X2N","CRYSTAL STRUCTURE OF DIELS-ALDERASE PYCR1","",1.72,33.45,"7x2n_oligo2","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)]-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(43_A_)",75.0538,"","",""
"7X2S","CRYSTAL STRUCTURE OF HETERO-DIELS-ALDERASE PYCR1 IN COMPLEX WITH NEOSETOPHOMONE B AND TROPOLONE O-QUINONE METHIDE","",1.92,36.33,"7x2s_oligo3","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-MAN(5_B_)-[MAN(7_B_)]-MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(211_A_)",43.1609,"","",""
"7X2X","CRYSTAL STRUCTURE OF HETERO-DIELS-ALDERASE PYCR1 IN COMPLEX WITH 10- HYDROXY-8E-HUMULENE","",1.58,29.45,"7x2x_oligo2","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(43_A_)",63.5571,"","",""
"7X2X","CRYSTAL STRUCTURE OF HETERO-DIELS-ALDERASE PYCR1 IN COMPLEX WITH 10- HYDROXY-8E-HUMULENE","",1.58,29.45,"7x2x_oligo1","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpb]DManp[3<R1>]b1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-MAN(5_B_)-[MAN(7_B_)]-MAN(4_B_)-[BMA(8_B_)--NAG(2_B_)-NAG(1_B_)-ASN(211_A_)",38.07,"","",""
"7X8W","THE SARS-COV-2 RECEPTOR BINDING DOMAIN BOUND WITH THE FAB FRAGMENT OF A HUMAN NEUTRALIZING ANTIBODY AB354","10.1016/J.ISCI.2022.105596 ",3.1,"1.08527e-19","7x8w_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_C_)-[MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(59_H_)",127.288,"","",""
"7X93","THE SARS-COV-2 RECEPTOR BINDING DOMAIN BOUND WITH THE FAB FRAGMENT OF A HUMAN NEUTRALIZING ANTIBODY AB765","10.1016/J.ISCI.2023.106955 ",3.3,"1.08527e-19","7x93_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(343_D_)",177.602,"","",""
"7X96","THE SARS-COV-2 RECEPTOR BINDING DOMAIN BOUND WITH THE FAB FRAGMENT OF A HUMAN NEUTRALIZING ANTIBODY AB847","10.1016/J.ISCI.2023.106955 ",3.4,"1.08527e-19","7x96_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_A_)-[MAN(5_A_)-[MAN(4_A_)]-BMA(3_A_)-NAG(2_A_)]-NAG(1_A_)-ASN(343_G_)",173.07,"","",""
"7XLQ","STRUCTURE OF HUMAN R-TYPE VOLTAGE-GATED CAV2.3-ALPHA2/DELTA1-BETA1 CHANNEL COMPLEX IN THE LIGAND-FREE (APO) STATE","10.1038/S41467-023-36260-2 ",3.1,"1.35632e-19","7xlq_oligo2","DManpb1-3DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(824_D_)",135.945,"","",""
"7XMA","CRYSTAL STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE, APO STRUCTURE WITH DMSO","10.1038/S41467-022-34771-Y ",2.2,45.37,"7xma_oligo4","DGlcpa1-3DGlcpb6-C10O1","DMU(101_Z_)-DMU(101_Z_)",60.3591,"","",""
"7XMA","CRYSTAL STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE, APO STRUCTURE WITH DMSO","10.1038/S41467-022-34771-Y ",2.2,45.37,"7xma_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(101_J_)-DMU(101_J_)",100.575,"","",""
"7XMA","CRYSTAL STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE, APO STRUCTURE WITH DMSO","10.1038/S41467-022-34771-Y ",2.2,45.37,"7xma_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(101_M_)-DMU(101_M_)",54.1496,"","",""
"7XMA","CRYSTAL STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE, APO STRUCTURE WITH DMSO","10.1038/S41467-022-34771-Y ",2.2,45.37,"7xma_oligo3","DGlcpa1-3DGlcpb6-C10O1","DMU(101_W_)-DMU(101_W_)",102.689,"","",""
"7XMB","CRYSTAL STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE, THE STRUCTURE COMPLEXED WITH AN ALLOSTERIC INHIBITOR T113","10.1038/S41467-022-34771-Y ",2.2,42.41,"7xmb_oligo3","DGlcpa1-3DGlcpb6-C10O1","DMU(101_Z_)-DMU(101_Z_)",64.3832,"","",""
"7XMB","CRYSTAL STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE, THE STRUCTURE COMPLEXED WITH AN ALLOSTERIC INHIBITOR T113","10.1038/S41467-022-34771-Y ",2.2,42.41,"7xmb_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(308_C_)-DMU(308_C_)",97.0273,"","",""
"7XMB","CRYSTAL STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE, THE STRUCTURE COMPLEXED WITH AN ALLOSTERIC INHIBITOR T113","10.1038/S41467-022-34771-Y ",2.2,42.41,"7xmb_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(101_W_)-DMU(101_W_)",90.3427,"","",""
"7XMB","CRYSTAL STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE, THE STRUCTURE COMPLEXED WITH AN ALLOSTERIC INHIBITOR T113","10.1038/S41467-022-34771-Y ",2.2,42.41,"7xmb_oligo4","DGlcpa1-3DGlcpb6-C10O1","DMU(101_M_)-DMU(101_M_)",52.4068,"","",""
"7XNM","STRUCTURE OF PORCINE DIPEPTIDYL PEPTIDASE 4 INHIBITORY PEPTIDE COMPLEX","",3.58,77.02,"7xnm_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(685_A_)",84.9968,"","",""
"7XT6","STRUCTURE OF A MEMBRANE PROTEIN M3","10.1126/SCIENCE.ABO3828 ",3.63,"1.35632e-19","7xt6_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(415_D_)",193.522,"","",""
"7XT6","STRUCTURE OF A MEMBRANE PROTEIN M3","10.1126/SCIENCE.ABO3828 ",3.63,"1.35632e-19","7xt6_oligo2","DGlcpNAcb1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_F_)-MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(415_B_)",111.41,"","",""
"7XTJ","CRYSTAL STRUCTURE OF E88A MUTANT OF GH3 BETA-XYLOSIDASE FROM ASPERGILLUS NIGER (ANBX)","10.1007/S00253-023-12445-Z ",2.5,60.85,"7xtj_oligo3","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-[MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(121_A_)",71.1197,"","",""
"7XTJ","CRYSTAL STRUCTURE OF E88A MUTANT OF GH3 BETA-XYLOSIDASE FROM ASPERGILLUS NIGER (ANBX)","10.1007/S00253-023-12445-Z ",2.5,60.85,"7xtj_oligo4","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-[MAN(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(121_B_)",76.5102,"","",""
"7XWA","CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 OMICRON BA.4/5 VARIANT SPIKE PROTEIN IN COMPLEX WITH ITS RECEPTOR ACE2","10.1016/J.CELL.2022.09.018 ",3.36,130.2,"7xwa_oligo8","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_O_)-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(546_C_)",156.719,"","",""
"7Y1T","COMPLEX OF INTEGRIN ALPHAV/BETA8 AND L-TGF-BETA1 AT A RATIO OF 1:2","10.1038/S41467-022-32655-9 ",3.24,"1.35632e-19","7y1t_oligo4","DManpa1-6DManpa1-4[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-MAN(4_G_)-[MAN(6_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(266_A_)",96.4047,"","",""
"7Y44","RE-REFINEMENT OF DAMAGE FREE X-RAY STRUCTURE OF BOVINE CYTOCHROME C OXIDASE AT 1.9 ANGSTROM RESOLUTION","10.1038/NMETH.2962 ",1.9,0,"7y44_oligo20","DGlcpa1-3DGlcpb6-C10O1","DMU(104_G_)-DMU(104_G_)",132.619,"","",""
"7Y44","RE-REFINEMENT OF DAMAGE FREE X-RAY STRUCTURE OF BOVINE CYTOCHROME C OXIDASE AT 1.9 ANGSTROM RESOLUTION","10.1038/NMETH.2962 ",1.9,0,"7y44_oligo18","DGlcpa1-3DGlcpb6-C10O1","DMU(616_A_)-DMU(616_A_)",153.513,"","",""
"7Y44","RE-REFINEMENT OF DAMAGE FREE X-RAY STRUCTURE OF BOVINE CYTOCHROME C OXIDASE AT 1.9 ANGSTROM RESOLUTION","10.1038/NMETH.2962 ",1.9,0,"7y44_oligo11","DGlcpa1-3DGlcpb6-C10O1","DMU(101_M_)-DMU(101_M_)",43.7145,"","",""
"7Y44","RE-REFINEMENT OF DAMAGE FREE X-RAY STRUCTURE OF BOVINE CYTOCHROME C OXIDASE AT 1.9 ANGSTROM RESOLUTION","10.1038/NMETH.2962 ",1.9,0,"7y44_oligo12","DGlcpa1-3DGlcpb6-C10O1","DMU(305_O_)-DMU(305_O_)",142.241,"","",""
"7Y44","RE-REFINEMENT OF DAMAGE FREE X-RAY STRUCTURE OF BOVINE CYTOCHROME C OXIDASE AT 1.9 ANGSTROM RESOLUTION","10.1038/NMETH.2962 ",1.9,0,"7y44_oligo13","DGlcpa1-3DGlcpb6-C10O1","DMU(102_K_)-DMU(102_K_)",169.622,"","",""
"7Y44","RE-REFINEMENT OF DAMAGE FREE X-RAY STRUCTURE OF BOVINE CYTOCHROME C OXIDASE AT 1.9 ANGSTROM RESOLUTION","10.1038/NMETH.2962 ",1.9,0,"7y44_oligo21","DGlcpa1-3DGlcpb6-C10O1","DMU(101_K_)-DMU(101_K_)",126.755,"","",""
"7Y44","RE-REFINEMENT OF DAMAGE FREE X-RAY STRUCTURE OF BOVINE CYTOCHROME C OXIDASE AT 1.9 ANGSTROM RESOLUTION","10.1038/NMETH.2962 ",1.9,0,"7y44_oligo14","DGlcpa1-3DGlcpb6-C10O1","DMU(103_K_)-DMU(103_K_)",153.943,"","",""
"7Y44","RE-REFINEMENT OF DAMAGE FREE X-RAY STRUCTURE OF BOVINE CYTOCHROME C OXIDASE AT 1.9 ANGSTROM RESOLUTION","10.1038/NMETH.2962 ",1.9,0,"7y44_oligo19","DGlcpa1-3DGlcpb6-C10O1","DMU(104_K_)-DMU(104_K_)",135.57,"","",""
"7Y44","RE-REFINEMENT OF DAMAGE FREE X-RAY STRUCTURE OF BOVINE CYTOCHROME C OXIDASE AT 1.9 ANGSTROM RESOLUTION","10.1038/NMETH.2962 ",1.9,0,"7y44_oligo22","DGlcpa1-3DGlcpb6-C10O1","DMU(106_K_)-DMU(106_K_)",165.224,"","",""
"7Y44","RE-REFINEMENT OF DAMAGE FREE X-RAY STRUCTURE OF BOVINE CYTOCHROME C OXIDASE AT 1.9 ANGSTROM RESOLUTION","10.1038/NMETH.2962 ",1.9,0,"7y44_oligo10","DGlcpa1-3DGlcpb6-C10O1","DMU(306_B_)-DMU(306_B_)",80.9205,"","",""
"7Y44","RE-REFINEMENT OF DAMAGE FREE X-RAY STRUCTURE OF BOVINE CYTOCHROME C OXIDASE AT 1.9 ANGSTROM RESOLUTION","10.1038/NMETH.2962 ",1.9,0,"7y44_oligo17","DGlcpa1-3DGlcpb6-C10O1","DMU(312_C_)-DMU(312_C_)",120.309,"","",""
"7Y44","RE-REFINEMENT OF DAMAGE FREE X-RAY STRUCTURE OF BOVINE CYTOCHROME C OXIDASE AT 1.9 ANGSTROM RESOLUTION","10.1038/NMETH.2962 ",1.9,0,"7y44_oligo15","DGlcpa1-3DGlcpb6-C10O1","DMU(105_K_)-DMU(105_K_)",167.118,"","",""
"7Y44","RE-REFINEMENT OF DAMAGE FREE X-RAY STRUCTURE OF BOVINE CYTOCHROME C OXIDASE AT 1.9 ANGSTROM RESOLUTION","10.1038/NMETH.2962 ",1.9,0,"7y44_oligo3","DGlcpa1-3DGlcpb6-C10O1","DMU(101_X_)-DMU(101_X_)",174.595,"","",""
"7Y44","RE-REFINEMENT OF DAMAGE FREE X-RAY STRUCTURE OF BOVINE CYTOCHROME C OXIDASE AT 1.9 ANGSTROM RESOLUTION","10.1038/NMETH.2962 ",1.9,0,"7y44_oligo8","DGlcpa1-3DGlcpb6-C10O1","DMU(203_Q_)-DMU(203_Q_)",76.3027,"","",""
"7Y44","RE-REFINEMENT OF DAMAGE FREE X-RAY STRUCTURE OF BOVINE CYTOCHROME C OXIDASE AT 1.9 ANGSTROM RESOLUTION","10.1038/NMETH.2962 ",1.9,0,"7y44_oligo23","DGlcpa1-3DGlcpb6-C10O1","DMU(102_L_)-DMU(102_L_)",108.301,"","",""
"7Y44","RE-REFINEMENT OF DAMAGE FREE X-RAY STRUCTURE OF BOVINE CYTOCHROME C OXIDASE AT 1.9 ANGSTROM RESOLUTION","10.1038/NMETH.2962 ",1.9,0,"7y44_oligo16","DGlcpa1-3DGlcpb6-C10O1","DMU(202_D_)-DMU(202_D_)",157.284,"","",""
"7Y44","RE-REFINEMENT OF DAMAGE FREE X-RAY STRUCTURE OF BOVINE CYTOCHROME C OXIDASE AT 1.9 ANGSTROM RESOLUTION","10.1038/NMETH.2962 ",1.9,0,"7y44_oligo9","DGlcpa1-3DGlcpb6-C10O1","DMU(103_T_)-DMU(103_T_)",131.028,"","",""
"7Y44","RE-REFINEMENT OF DAMAGE FREE X-RAY STRUCTURE OF BOVINE CYTOCHROME C OXIDASE AT 1.9 ANGSTROM RESOLUTION","10.1038/NMETH.2962 ",1.9,0,"7y44_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(101_Z_)-DMU(101_Z_)",53.0155,"","",""
"7Y44","RE-REFINEMENT OF DAMAGE FREE X-RAY STRUCTURE OF BOVINE CYTOCHROME C OXIDASE AT 1.9 ANGSTROM RESOLUTION","10.1038/NMETH.2962 ",1.9,0,"7y44_oligo6","DGlcpa1-3DGlcpb6-C10O1","DMU(314_P_)-DMU(314_P_)",111.591,"","",""
"7Y44","RE-REFINEMENT OF DAMAGE FREE X-RAY STRUCTURE OF BOVINE CYTOCHROME C OXIDASE AT 1.9 ANGSTROM RESOLUTION","10.1038/NMETH.2962 ",1.9,0,"7y44_oligo7","DGlcpa1-3DGlcpb6-C10O1","DMU(316_P_)-DMU(316_P_)",76.8027,"","",""
"7Y45","CRYO-EM STRUCTURE OF THE NA+,K+-ATPASE IN THE E2.2K+ STATE","10.1002/1873-3468.14437 ",3.3,"1.15243e-41","7y45_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_M_)-[MAN(4_M_)-BMA(3_M_)-NAG(2_M_)]-NAG(1_M_)-ASN(194_B_)",148.773,"","",""
"7Y45","CRYO-EM STRUCTURE OF THE NA+,K+-ATPASE IN THE E2.2K+ STATE","10.1002/1873-3468.14437 ",3.3,"1.15243e-41","7y45_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_K_)-[MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(114_B_)",111.239,"","",""
"7Y45","CRYO-EM STRUCTURE OF THE NA+,K+-ATPASE IN THE E2.2K+ STATE","10.1002/1873-3468.14437 ",3.3,"1.15243e-41","7y45_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_F_)-[MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(114_D_)",114.903,"","",""
"7Y45","CRYO-EM STRUCTURE OF THE NA+,K+-ATPASE IN THE E2.2K+ STATE","10.1002/1873-3468.14437 ",3.3,"1.15243e-41","7y45_oligo8","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-[NAG(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(159_D_)",178.716,"","",""
"7Y45","CRYO-EM STRUCTURE OF THE NA+,K+-ATPASE IN THE E2.2K+ STATE","10.1002/1873-3468.14437 ",3.3,"1.15243e-41","7y45_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_I_)-[MAN(4_I_)-BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(194_D_)",158.421,"","",""
"7Y45","CRYO-EM STRUCTURE OF THE NA+,K+-ATPASE IN THE E2.2K+ STATE","10.1002/1873-3468.14437 ",3.3,"1.15243e-41","7y45_oligo3","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_L_)-[NAG(5_L_)-MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(159_B_)",183.215,"","",""
"7Y46","CRYO-EM STRUCTURE OF THE NA+,K+-ATPASE IN THE E2.2K+ STATE AFTER ADDITION OF ATP","10.1002/1873-3468.14437 ",7.2,"1.15243e-41","7y46_oligo1","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-[NAG(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(159_D_)",474.941,"","",""
"7Y46","CRYO-EM STRUCTURE OF THE NA+,K+-ATPASE IN THE E2.2K+ STATE AFTER ADDITION OF ATP","10.1002/1873-3468.14437 ",7.2,"1.15243e-41","7y46_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_I_)-[MAN(4_I_)-BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(194_D_)",464.855,"","",""
"7Y46","CRYO-EM STRUCTURE OF THE NA+,K+-ATPASE IN THE E2.2K+ STATE AFTER ADDITION OF ATP","10.1002/1873-3468.14437 ",7.2,"1.15243e-41","7y46_oligo8","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_L_)-[NAG(5_L_)-MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(159_B_)",478.944,"","",""
"7Y46","CRYO-EM STRUCTURE OF THE NA+,K+-ATPASE IN THE E2.2K+ STATE AFTER ADDITION OF ATP","10.1002/1873-3468.14437 ",7.2,"1.15243e-41","7y46_oligo9","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_M_)-[MAN(4_M_)-BMA(3_M_)-NAG(2_M_)]-NAG(1_M_)-ASN(194_B_)",475.308,"","",""
"7Y46","CRYO-EM STRUCTURE OF THE NA+,K+-ATPASE IN THE E2.2K+ STATE AFTER ADDITION OF ATP","10.1002/1873-3468.14437 ",7.2,"1.15243e-41","7y46_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_F_)-[MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(114_D_)",525.33,"","",""
"7Y46","CRYO-EM STRUCTURE OF THE NA+,K+-ATPASE IN THE E2.2K+ STATE AFTER ADDITION OF ATP","10.1002/1873-3468.14437 ",7.2,"1.15243e-41","7y46_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_K_)-[MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(114_B_)",500.705,"","",""
"7Y5T","CRYOEM STRUCTURE OF PS1-CONTAINING GAMMA-SECRETASE IN COMPLEX WITH MRK-560","10.1038/S41467-022-33817-5 ",2.9,"1.35632e-19","7y5t_oligo2","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_F_)-[BMA(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(55_A_)",82.5651,"","",""
"7Y5X","CRYOEM STRUCTURE OF PS2-CONTAINING GAMMA-SECRETASE TREATED WITH MRK- 560","10.1038/S41467-022-33817-5 ",3,3397.21,"7y5x_oligo4","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_F_)-[BMA(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(55_A_)",62.7262,"","",""
"7Y5Z","CRYOEM STRUCTURE OF HUMAN PS2-CONTAINING GAMMA-SECRETASE","10.1038/S41467-022-33817-5 ",3.4,"2.15283e+08","7y5z_oligo4","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_F_)-[BMA(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(55_A_)",97.0602,"","",""
"7Y6T","CRYO-EM MAP OF IPEC-J2 CELL-DERIVED PEDV PT52 S PROTEIN ONE D0-DOWN AND TWO D0-UP","10.1038/S41467-022-32588-3 ",4.2,"1.15243e-41","7y6t_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(264_C_)",725.682,"","",""
"7Y6T","CRYO-EM MAP OF IPEC-J2 CELL-DERIVED PEDV PT52 S PROTEIN ONE D0-DOWN AND TWO D0-UP","10.1038/S41467-022-32588-3 ",4.2,"1.15243e-41","7y6t_oligo20","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(264_A_)",827.514,"","",""
"7Y6T","CRYO-EM MAP OF IPEC-J2 CELL-DERIVED PEDV PT52 S PROTEIN ONE D0-DOWN AND TWO D0-UP","10.1038/S41467-022-32588-3 ",4.2,"1.15243e-41","7y6t_oligo25","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_b_)-[MAN(4_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(264_B_)",724.089,"","",""
"7Y6U","SYMMETRY-EXPANDED AND LOCALLY REFINED PROTOMER STRUCTURE OF IPEC-J2 CELL-DERIVED PEDV PT52 S WITH A CTD-CLOSE CONFORMATION","10.1038/S41467-022-32588-3 ",3.2,"1.15243e-41","7y6u_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(264_A_)",156.813,"","",""
"7Y6V","SYMMETRY-EXPANDED AND LOCALLY REFINED PROTOMER STRUCTURE OF IPEC-J2 CELL-DERIVED PEDV PT52 S WITH A CTD-OPEN CONFORMATION","10.1038/S41467-022-32588-3 ",3.3,"1.15243e-41","7y6v_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(264_A_)",159.096,"","",""
"7YBH","SARS-COV-2 LAMBDA VARIANT SPIKE","",3.5,0,"7ybh_oligo16","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(1091_A_)",149.668,"","",""
"7YMT","CRYO-EM STRUCTURE OF MERS-COV SPIKE PROTEIN, TWO RBD-UP CONFORMATION 2","",6.55,"1.15243e-41","7ymt_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(125_A_)",255.422,"","",""
"7YMV","CRYO-EM STRUCTURE OF MERS-COV SPIKE PROTEIN, TWO RBD-UP CONFORMATION 1","",6.74,"1.15243e-41","7ymv_oligo8","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(222_A_)",705.527,"","",""
"7YMV","CRYO-EM STRUCTURE OF MERS-COV SPIKE PROTEIN, TWO RBD-UP CONFORMATION 1","",6.74,"1.15243e-41","7ymv_oligo21","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_X_)-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(125_C_)",661.281,"","",""
"7YMV","CRYO-EM STRUCTURE OF MERS-COV SPIKE PROTEIN, TWO RBD-UP CONFORMATION 1","",6.74,"1.15243e-41","7ymv_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(66_A_)",651.411,"","",""
"7YMV","CRYO-EM STRUCTURE OF MERS-COV SPIKE PROTEIN, TWO RBD-UP CONFORMATION 1","",6.74,"1.15243e-41","7ymv_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_N_)-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(125_B_)",604.356,"","",""
"7YMV","CRYO-EM STRUCTURE OF MERS-COV SPIKE PROTEIN, TWO RBD-UP CONFORMATION 1","",6.74,"1.15243e-41","7ymv_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(125_A_)",622.727,"","",""
"7YMX","CRYO-EM STRUCTURE OF MERS-COV SPIKE PROTEIN, ONE RBD-UP CONFORMATION 2","",4.44,"1.15243e-41","7ymx_oligo12","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(125_C_)",232.728,"","",""
"7YMX","CRYO-EM STRUCTURE OF MERS-COV SPIKE PROTEIN, ONE RBD-UP CONFORMATION 2","",4.44,"1.15243e-41","7ymx_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(125_A_)",192.833,"","",""
"7YMX","CRYO-EM STRUCTURE OF MERS-COV SPIKE PROTEIN, ONE RBD-UP CONFORMATION 2","",4.44,"1.15243e-41","7ymx_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(125_B_)",218.301,"","",""
"7YMY","CRYO-EM STRUCTURE OF MERS-COV SPIKE PROTEIN, ONE RBD-UP CONFORMATION 1","",4.96,"1.15243e-41","7ymy_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(125_B_)",241.422,"","",""
"7YMY","CRYO-EM STRUCTURE OF MERS-COV SPIKE PROTEIN, ONE RBD-UP CONFORMATION 1","",4.96,"1.15243e-41","7ymy_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(125_A_)",270.17,"","",""
"7YMY","CRYO-EM STRUCTURE OF MERS-COV SPIKE PROTEIN, ONE RBD-UP CONFORMATION 1","",4.96,"1.15243e-41","7ymy_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_L_)-[MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(125_C_)",267.567,"","",""
"7YMZ","CRYO-EM STRUCTURE OF MERS-COV SPIKE PROTEIN, INTERMEDIATE CONFORMATION","",4.39,"1.15243e-41","7ymz_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(125_A_)",198.233,"","",""
"7YMZ","CRYO-EM STRUCTURE OF MERS-COV SPIKE PROTEIN, INTERMEDIATE CONFORMATION","",4.39,"1.15243e-41","7ymz_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(125_B_)",206.637,"","",""
"7YMZ","CRYO-EM STRUCTURE OF MERS-COV SPIKE PROTEIN, INTERMEDIATE CONFORMATION","",4.39,"1.15243e-41","7ymz_oligo15","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_R_)-[MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(125_C_)",203.405,"","",""
"7YPY","BOVINE HEART CYTOCHROME C OXIDASE IN FULLY OXIDIZED STATE AT 1.5 ANGSTROM RESOLUTION","10.1074/JBC.M115.711770 ",1.5,0,"7ypy_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(105_L_)-DMU(105_L_)",111.416,"","",""
"7YPY","BOVINE HEART CYTOCHROME C OXIDASE IN FULLY OXIDIZED STATE AT 1.5 ANGSTROM RESOLUTION","10.1074/JBC.M115.711770 ",1.5,0,"7ypy_oligo16","DGlcpa1-3DGlcpb6-C10O1","DMU(206_D_)-DMU(206_D_)",159.958,"","",""
"7YPY","BOVINE HEART CYTOCHROME C OXIDASE IN FULLY OXIDIZED STATE AT 1.5 ANGSTROM RESOLUTION","10.1074/JBC.M115.711770 ",1.5,0,"7ypy_oligo22","DGlcpa1-3DGlcpb6-C10O1","DMU(107_X_)-DMU(107_X_)",126.664,"","",""
"7YPY","BOVINE HEART CYTOCHROME C OXIDASE IN FULLY OXIDIZED STATE AT 1.5 ANGSTROM RESOLUTION","10.1074/JBC.M115.711770 ",1.5,0,"7ypy_oligo11","DGlcpa1-3DGlcpb6-C10O1","DMU(102_K_)-DMU(102_K_)",116.094,"","",""
"7YPY","BOVINE HEART CYTOCHROME C OXIDASE IN FULLY OXIDIZED STATE AT 1.5 ANGSTROM RESOLUTION","10.1074/JBC.M115.711770 ",1.5,0,"7ypy_oligo6","DGlcpa1-3DGlcpb6-C10O1","DMU(315_P_)-DMU(315_P_)",108.501,"","",""
"7YPY","BOVINE HEART CYTOCHROME C OXIDASE IN FULLY OXIDIZED STATE AT 1.5 ANGSTROM RESOLUTION","10.1074/JBC.M115.711770 ",1.5,0,"7ypy_oligo14","DGlcpa1-3DGlcpb6-C10O1","DMU(318_C_)-DMU(318_C_)",115.887,"","",""
"7YPY","BOVINE HEART CYTOCHROME C OXIDASE IN FULLY OXIDIZED STATE AT 1.5 ANGSTROM RESOLUTION","10.1074/JBC.M115.711770 ",1.5,0,"7ypy_oligo19","DGlcpa1-3DGlcpb6-C10O1","DMU(316_C_)-DMU(316_C_)",110.199,"","",""
"7YPY","BOVINE HEART CYTOCHROME C OXIDASE IN FULLY OXIDIZED STATE AT 1.5 ANGSTROM RESOLUTION","10.1074/JBC.M115.711770 ",1.5,0,"7ypy_oligo18","DGlcpa1-3DGlcpb6-C10O1","DMU(308_C_)-DMU(308_C_)",96.1573,"","",""
"7YPY","BOVINE HEART CYTOCHROME C OXIDASE IN FULLY OXIDIZED STATE AT 1.5 ANGSTROM RESOLUTION","10.1074/JBC.M115.711770 ",1.5,0,"7ypy_oligo4","DGlcpa1-3DGlcpb6-C10O1","DMU(305_P_)-DMU(305_P_)",115.398,"","",""
"7YPY","BOVINE HEART CYTOCHROME C OXIDASE IN FULLY OXIDIZED STATE AT 1.5 ANGSTROM RESOLUTION","10.1074/JBC.M115.711770 ",1.5,0,"7ypy_oligo13","DGlcpa1-3DGlcpb6-C10O1","DMU(106_K_)-DMU(106_K_)",121.963,"","",""
"7YPY","BOVINE HEART CYTOCHROME C OXIDASE IN FULLY OXIDIZED STATE AT 1.5 ANGSTROM RESOLUTION","10.1074/JBC.M115.711770 ",1.5,0,"7ypy_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(101_M_)-DMU(101_M_)",41.2514,"","",""
"7YPY","BOVINE HEART CYTOCHROME C OXIDASE IN FULLY OXIDIZED STATE AT 1.5 ANGSTROM RESOLUTION","10.1074/JBC.M115.711770 ",1.5,0,"7ypy_oligo12","DGlcpa1-3DGlcpb6-C10O1","DMU(105_K_)-DMU(105_K_)",107.747,"","",""
"7YPY","BOVINE HEART CYTOCHROME C OXIDASE IN FULLY OXIDIZED STATE AT 1.5 ANGSTROM RESOLUTION","10.1074/JBC.M115.711770 ",1.5,0,"7ypy_oligo8","DGlcpa1-3DGlcpb6-C10O1","DMU(103_X_)-DMU(103_X_)",116.422,"","",""
"7YPY","BOVINE HEART CYTOCHROME C OXIDASE IN FULLY OXIDIZED STATE AT 1.5 ANGSTROM RESOLUTION","10.1074/JBC.M115.711770 ",1.5,0,"7ypy_oligo15","DGlcpa1-3DGlcpb6-C10O1","DMU(104_K_)-DMU(104_K_)",118.883,"","",""
"7YPY","BOVINE HEART CYTOCHROME C OXIDASE IN FULLY OXIDIZED STATE AT 1.5 ANGSTROM RESOLUTION","10.1074/JBC.M115.711770 ",1.5,0,"7ypy_oligo10","DGlcpa1-3DGlcpb6-C10O1","DMU(101_K_)-DMU(101_K_)",119.785,"","",""
"7YPY","BOVINE HEART CYTOCHROME C OXIDASE IN FULLY OXIDIZED STATE AT 1.5 ANGSTROM RESOLUTION","10.1074/JBC.M115.711770 ",1.5,0,"7ypy_oligo24","DGlcpa1-3DGlcpb6-C10O1","DMU(101_I_)-DMU(101_I_)",122.197,"","",""
"7YPY","BOVINE HEART CYTOCHROME C OXIDASE IN FULLY OXIDIZED STATE AT 1.5 ANGSTROM RESOLUTION","10.1074/JBC.M115.711770 ",1.5,0,"7ypy_oligo20","DGlcpa1-3DGlcpb6-C10O1","DMU(105_X_)-DMU(105_X_)",121.485,"","",""
"7YPY","BOVINE HEART CYTOCHROME C OXIDASE IN FULLY OXIDIZED STATE AT 1.5 ANGSTROM RESOLUTION","10.1074/JBC.M115.711770 ",1.5,0,"7ypy_oligo23","DGlcpa1-3DGlcpb6-C10O1","DMU(101_Z_)-DMU(101_Z_)",56.1905,"","",""
"7YPY","BOVINE HEART CYTOCHROME C OXIDASE IN FULLY OXIDIZED STATE AT 1.5 ANGSTROM RESOLUTION","10.1074/JBC.M115.711770 ",1.5,0,"7ypy_oligo21","DGlcpa1-3DGlcpb6-C10O1","DMU(106_X_)-DMU(106_X_)",89.5668,"","",""
"7YPY","BOVINE HEART CYTOCHROME C OXIDASE IN FULLY OXIDIZED STATE AT 1.5 ANGSTROM RESOLUTION","10.1074/JBC.M115.711770 ",1.5,0,"7ypy_oligo25","DGlcpa1-3DGlcpb6-C10O1","DMU(628_A_)-DMU(628_A_)",118.737,"","",""
"7YPY","BOVINE HEART CYTOCHROME C OXIDASE IN FULLY OXIDIZED STATE AT 1.5 ANGSTROM RESOLUTION","10.1074/JBC.M115.711770 ",1.5,0,"7ypy_oligo3","DGlcpa1-3DGlcpb6-C10O1","DMU(307_O_)-DMU(307_O_)",120.765,"","",""
"7YPY","BOVINE HEART CYTOCHROME C OXIDASE IN FULLY OXIDIZED STATE AT 1.5 ANGSTROM RESOLUTION","10.1074/JBC.M115.711770 ",1.5,0,"7ypy_oligo17","DGlcpa1-3DGlcpb6-C10O1","DMU(317_C_)-DMU(317_C_)",108.465,"","",""
"7YPY","BOVINE HEART CYTOCHROME C OXIDASE IN FULLY OXIDIZED STATE AT 1.5 ANGSTROM RESOLUTION","10.1074/JBC.M115.711770 ",1.5,0,"7ypy_oligo26","DGlcpa1-3DManp[2H]b6-C10O1","DMU(103_K_)-DMU(103_K_)",110.149,"","",""
"7YPY","BOVINE HEART CYTOCHROME C OXIDASE IN FULLY OXIDIZED STATE AT 1.5 ANGSTROM RESOLUTION","10.1074/JBC.M115.711770 ",1.5,0,"7ypy_oligo5","DGlcpa1-3DGlcpb6-C10O1","DMU(314_P_)-DMU(314_P_)",104.905,"","",""
"7YPY","BOVINE HEART CYTOCHROME C OXIDASE IN FULLY OXIDIZED STATE AT 1.5 ANGSTROM RESOLUTION","10.1074/JBC.M115.711770 ",1.5,0,"7ypy_oligo9","DGlcpa1-3DGlcpb6-C10O1","DMU(104_X_)-DMU(104_X_)",106.815,"","",""
"7YPY","BOVINE HEART CYTOCHROME C OXIDASE IN FULLY OXIDIZED STATE AT 1.5 ANGSTROM RESOLUTION","10.1074/JBC.M115.711770 ",1.5,0,"7ypy_oligo7","DGlcpa1-3DGlcpb6-C10O1","DMU(102_X_)-DMU(102_X_)",121.289,"","",""
"7YQS","NEUTRON STRUCTURE OF A L-RHAMNOSE-ALPHA-1,4-D-GLUCURONATE LYASE FROM FUSARIUM OXYSPORUM 12S, L-RHA COMPLEX","",1.25,0,"7yqs_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[MAN(5_B_)]-MAN(4_B_)-[MAN(7_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(247_A_)",59.5691,"","",""
"7YX8","CRYSTAL STRUCTURE OF THE AM0627 (E326A) INACTIVE MUTANT IN COMPLEX WITH PSGL-1-LIKE BIS-T GLYCOPEPTIDE AND ZN2+","10.1038/S41467-022-32021-9 ",1.5,27.68,"7yx8_oligo2","DGalpb1-3DGalpNAca1-THR","GAL(2_C_)-A2G(1_C_)-THR(5_F_)",56.2132,"","",""
"7YX8","CRYSTAL STRUCTURE OF THE AM0627 (E326A) INACTIVE MUTANT IN COMPLEX WITH PSGL-1-LIKE BIS-T GLYCOPEPTIDE AND ZN2+","10.1038/S41467-022-32021-9 ",1.5,27.68,"7yx8_oligo3","DGalpb1-3DGalpNAca1-THR","GAL(2_G_)-A2G(1_G_)-THR(6_H_)",40.67,"","",""
"7YX8","CRYSTAL STRUCTURE OF THE AM0627 (E326A) INACTIVE MUTANT IN COMPLEX WITH PSGL-1-LIKE BIS-T GLYCOPEPTIDE AND ZN2+","10.1038/S41467-022-32021-9 ",1.5,27.68,"7yx8_oligo4","DGalpb1-3DGalpNAca1-THR","GAL(2_E_)-A2G(1_E_)-THR(5_H_)",63.8109,"","",""
"7YX8","CRYSTAL STRUCTURE OF THE AM0627 (E326A) INACTIVE MUTANT IN COMPLEX WITH PSGL-1-LIKE BIS-T GLYCOPEPTIDE AND ZN2+","10.1038/S41467-022-32021-9 ",1.5,27.68,"7yx8_oligo1","DGalpb1-3DGalpNAca1-THR","GAL(2_D_)-A2G(1_D_)-THR(6_F_)",48.6323,"","",""
"7Z14","CRYO-EM STRUCTURE OF TORPEDO NICOTINIC ACETYLCHOLINE RECEPTOR IN COMPLEX WITH A SHORT-CHAIN NEUROTOXIN.","10.1038/S41467-022-32174-7 ",3.15,"1.35632e-19","7z14_oligo1","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-MAN(5_H_)-[MAN(7_H_)]-MAN(4_H_)-[MAN(9_H_)-MAN(8_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(141_D_)",102.763,"","",""
"7Z14","CRYO-EM STRUCTURE OF TORPEDO NICOTINIC ACETYLCHOLINE RECEPTOR IN COMPLEX WITH A SHORT-CHAIN NEUROTOXIN.","10.1038/S41467-022-32174-7 ",3.15,"1.35632e-19","7z14_oligo4","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_K_)-MAN(5_K_)-[MAN(7_K_)]-MAN(4_K_)-[MAN(9_K_)-MAN(8_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(141_A_)",106.075,"","",""
"7Z53","STRUCTURE OF NATIVE LEUKOCYTE MYELOPEROXIDASE IN COMPLEX WITH A TRUNCATED VERSION (SPIN TRUNCATED) OF THE STAPHYLOCCAL PEROXIDASE INHIBITOR SPIN FROM STAPHYLOCOCCUS AUREUS","10.1016/J.JBC.2022.102514 ",2.28,40.3,"7z53_oligo19","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_q_)-[MAN(5_q_)-[MAN(4_q_)]-BMA(3_q_)-NAG(2_q_)]-NAG(1_q_)-ASN(483_T_)",37.0665,"","",""
"7Z53","STRUCTURE OF NATIVE LEUKOCYTE MYELOPEROXIDASE IN COMPLEX WITH A TRUNCATED VERSION (SPIN TRUNCATED) OF THE STAPHYLOCCAL PEROXIDASE INHIBITOR SPIN FROM STAPHYLOCOCCUS AUREUS","10.1016/J.JBC.2022.102514 ",2.28,40.3,"7z53_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_c_)-[MAN(5_c_)-[MAN(4_c_)]-BMA(3_c_)-NAG(2_c_)]-NAG(1_c_)-ASN(483_D_)",33.2317,"","",""
"7Z53","STRUCTURE OF NATIVE LEUKOCYTE MYELOPEROXIDASE IN COMPLEX WITH A TRUNCATED VERSION (SPIN TRUNCATED) OF THE STAPHYLOCCAL PEROXIDASE INHIBITOR SPIN FROM STAPHYLOCOCCUS AUREUS","10.1016/J.JBC.2022.102514 ",2.28,40.3,"7z53_oligo12","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_j_)-[MAN(4_j_)]-BMA(3_j_)-NAG(2_j_)-NAG(1_j_)-ASN(391_N_)",63.1913,"","",""
"7Z53","STRUCTURE OF NATIVE LEUKOCYTE MYELOPEROXIDASE IN COMPLEX WITH A TRUNCATED VERSION (SPIN TRUNCATED) OF THE STAPHYLOCCAL PEROXIDASE INHIBITOR SPIN FROM STAPHYLOCOCCUS AUREUS","10.1016/J.JBC.2022.102514 ",2.28,40.3,"7z53_oligo13","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_k_)-[MAN(5_k_)-[MAN(4_k_)]-BMA(3_k_)-NAG(2_k_)]-NAG(1_k_)-ASN(483_N_)",38.2741,"","",""
"7Z53","STRUCTURE OF NATIVE LEUKOCYTE MYELOPEROXIDASE IN COMPLEX WITH A TRUNCATED VERSION (SPIN TRUNCATED) OF THE STAPHYLOCCAL PEROXIDASE INHIBITOR SPIN FROM STAPHYLOCOCCUS AUREUS","10.1016/J.JBC.2022.102514 ",2.28,40.3,"7z53_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_e_)-[MAN(5_e_)-[MAN(4_e_)]-BMA(3_e_)-NAG(2_e_)]-NAG(1_e_)-ASN(483_H_)",42.6933,"","",""
"7Z53","STRUCTURE OF NATIVE LEUKOCYTE MYELOPEROXIDASE IN COMPLEX WITH A TRUNCATED VERSION (SPIN TRUNCATED) OF THE STAPHYLOCCAL PEROXIDASE INHIBITOR SPIN FROM STAPHYLOCOCCUS AUREUS","10.1016/J.JBC.2022.102514 ",2.28,40.3,"7z53_oligo11","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_i_)-BMA(3_i_)-NAG(2_i_)-NAG(1_i_)-ASN(355_N_)",61.1345,"","",""
"7Z53","STRUCTURE OF NATIVE LEUKOCYTE MYELOPEROXIDASE IN COMPLEX WITH A TRUNCATED VERSION (SPIN TRUNCATED) OF THE STAPHYLOCCAL PEROXIDASE INHIBITOR SPIN FROM STAPHYLOCOCCUS AUREUS","10.1016/J.JBC.2022.102514 ",2.28,40.3,"7z53_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_a_)-[MAN(5_a_)-[MAN(4_a_)]-BMA(3_a_)-NAG(2_a_)]-NAG(1_a_)-ASN(483_B_)",36.1155,"","",""
"7Z53","STRUCTURE OF NATIVE LEUKOCYTE MYELOPEROXIDASE IN COMPLEX WITH A TRUNCATED VERSION (SPIN TRUNCATED) OF THE STAPHYLOCCAL PEROXIDASE INHIBITOR SPIN FROM STAPHYLOCOCCUS AUREUS","10.1016/J.JBC.2022.102514 ",2.28,40.3,"7z53_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_h_)-[MAN(5_h_)-[MAN(4_h_)]-BMA(3_h_)-NAG(2_h_)]-NAG(1_h_)-ASN(483_J_)",39.5667,"","",""
"7Z53","STRUCTURE OF NATIVE LEUKOCYTE MYELOPEROXIDASE IN COMPLEX WITH A TRUNCATED VERSION (SPIN TRUNCATED) OF THE STAPHYLOCCAL PEROXIDASE INHIBITOR SPIN FROM STAPHYLOCOCCUS AUREUS","10.1016/J.JBC.2022.102514 ",2.28,40.3,"7z53_oligo16","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_n_)-[MAN(5_n_)-[MAN(4_n_)]-BMA(3_n_)-NAG(2_n_)]-NAG(1_n_)-ASN(483_P_)",35.288,"","",""
"7Z53","STRUCTURE OF NATIVE LEUKOCYTE MYELOPEROXIDASE IN COMPLEX WITH A TRUNCATED VERSION (SPIN TRUNCATED) OF THE STAPHYLOCCAL PEROXIDASE INHIBITOR SPIN FROM STAPHYLOCOCCUS AUREUS","10.1016/J.JBC.2022.102514 ",2.28,40.3,"7z53_oligo22","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_t_)-[MAN(5_t_)-[MAN(4_t_)]-BMA(3_t_)-NAG(2_t_)]-NAG(1_t_)-ASN(483_V_)",39.0839,"","",""
"7Z70","CRYSTAL STRUCTURE OF ANGIOTENSIN-1 CONVERTING ENZYME C-DOMAIN IN COMPLEX WITH FOSINOPRILAT","10.1111/FEBS.16543 ",1.85,26.35,"7z70_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcx1-","FUC(5_B_)-[MAN(4_B_)-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)",53.3118,"","",""
"7ZA1","GPC3-UNC5D OCTAMER STRUCTURE AND ROLE IN CELL MIGRATION","10.1016/J.CELL.2022.09.025 ",4.1,186.2,"7za1_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(4_N_)-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)",181.43,"","",""
"7ZA1","GPC3-UNC5D OCTAMER STRUCTURE AND ROLE IN CELL MIGRATION","10.1016/J.CELL.2022.09.025 ",4.1,186.2,"7za1_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_M_)-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(241_D_)",210.615,"","",""
"7ZA1","GPC3-UNC5D OCTAMER STRUCTURE AND ROLE IN CELL MIGRATION","10.1016/J.CELL.2022.09.025 ",4.1,186.2,"7za1_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_K_)-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(241_C_)",192.201,"","",""
"7ZA1","GPC3-UNC5D OCTAMER STRUCTURE AND ROLE IN CELL MIGRATION","10.1016/J.CELL.2022.09.025 ",4.1,186.2,"7za1_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(241_A_)",139.949,"","",""
"7ZJ6","X-31 HEMAGGLUTININ PRECURSOR HA0 AT PH 7.5","10.1073/PNAS.2208011119 ",2.6,0,"7zj6_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(165_B_)",152.449,"","",""
"7ZJ6","X-31 HEMAGGLUTININ PRECURSOR HA0 AT PH 7.5","10.1073/PNAS.2208011119 ",2.6,0,"7zj6_oligo11","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(165_C_)",151.5,"","",""
"7ZJ6","X-31 HEMAGGLUTININ PRECURSOR HA0 AT PH 7.5","10.1073/PNAS.2208011119 ",2.6,0,"7zj6_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(165_A_)",152.01,"","",""
"7ZJ8","X-31 HEMAGGLUTININ PRECURSOR HA0 AT PH 7.5 AFTER RENEUTRALIZATION","10.1073/PNAS.2208011119 ",3.1,164121,"7zj8_oligo11","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(165_C_)",230.717,"","",""
"7ZJ8","X-31 HEMAGGLUTININ PRECURSOR HA0 AT PH 7.5 AFTER RENEUTRALIZATION","10.1073/PNAS.2208011119 ",3.1,164121,"7zj8_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(165_A_)",222.121,"","",""
"7ZJ8","X-31 HEMAGGLUTININ PRECURSOR HA0 AT PH 7.5 AFTER RENEUTRALIZATION","10.1073/PNAS.2208011119 ",3.1,164121,"7zj8_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(165_B_)",223.486,"","",""
"7ZLK","AMC009 SOSIPV5.2 IN COMPLEX WITH FABS ACS101 AND ACS124","10.1371/JOURNAL.PPAT.1010945 ",3.99,"1.08527e-19","7zlk_oligo5","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_X_)-[MAN(5_X_)]-MAN(4_X_)-[MAN(7_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(295_C_)",112.964,"","",""
"7ZLK","AMC009 SOSIPV5.2 IN COMPLEX WITH FABS ACS101 AND ACS124","10.1371/JOURNAL.PPAT.1010945 ",3.99,"1.08527e-19","7zlk_oligo12","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_b_)-[MAN(4_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(262_D_)",124.973,"","",""
"7ZLK","AMC009 SOSIPV5.2 IN COMPLEX WITH FABS ACS101 AND ACS124","10.1371/JOURNAL.PPAT.1010945 ",3.99,"1.08527e-19","7zlk_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(262_A_)",131.367,"","",""
"7ZLK","AMC009 SOSIPV5.2 IN COMPLEX WITH FABS ACS101 AND ACS124","10.1371/JOURNAL.PPAT.1010945 ",3.99,"1.08527e-19","7zlk_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_J_)-[MAN(5_J_)]-MAN(4_J_)-[MAN(7_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(295_A_)",145.946,"","",""
"7ZLK","AMC009 SOSIPV5.2 IN COMPLEX WITH FABS ACS101 AND ACS124","10.1371/JOURNAL.PPAT.1010945 ",3.99,"1.08527e-19","7zlk_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Y_)-[MAN(4_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(301_C_)",125.959,"","",""
"7ZLK","AMC009 SOSIPV5.2 IN COMPLEX WITH FABS ACS101 AND ACS124","10.1371/JOURNAL.PPAT.1010945 ",3.99,"1.08527e-19","7zlk_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_W_)-[MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(262_C_)",117.527,"","",""
"7ZLK","AMC009 SOSIPV5.2 IN COMPLEX WITH FABS ACS101 AND ACS124","10.1371/JOURNAL.PPAT.1010945 ",3.99,"1.08527e-19","7zlk_oligo13","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_c_)-[MAN(5_c_)]-MAN(4_c_)-[MAN(7_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(295_D_)",147.389,"","",""
"7ZLK","AMC009 SOSIPV5.2 IN COMPLEX WITH FABS ACS101 AND ACS124","10.1371/JOURNAL.PPAT.1010945 ",3.99,"1.08527e-19","7zlk_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_U_)-[MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(332_A_)",136.065,"","",""
"7ZLK","AMC009 SOSIPV5.2 IN COMPLEX WITH FABS ACS101 AND ACS124","10.1371/JOURNAL.PPAT.1010945 ",3.99,"1.08527e-19","7zlk_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Z_)-[MAN(4_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(332_C_)",105.493,"","",""
"7ZLK","AMC009 SOSIPV5.2 IN COMPLEX WITH FABS ACS101 AND ACS124","10.1371/JOURNAL.PPAT.1010945 ",3.99,"1.08527e-19","7zlk_oligo16","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_f_)-[MAN(4_f_)]-BMA(3_f_)-NAG(2_f_)-NAG(1_f_)-ASN(301_D_)",154.196,"","",""
"7ZLK","AMC009 SOSIPV5.2 IN COMPLEX WITH FABS ACS101 AND ACS124","10.1371/JOURNAL.PPAT.1010945 ",3.99,"1.08527e-19","7zlk_oligo14","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_d_)-[MAN(7_d_)]-MAN(6_d_)-[MAN(5_d_)-MAN(4_d_)]-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(332_D_)",180.322,"","",""
"7ZVB","CRYSTAL STRUCTURE OF THE MATURE FORM OF THE GLUTAMIC-CLASS PROLYL- ENDOPEPTIDASE NEPROSIN AT 2.35 A RESOLUTION.","10.1038/S41467-022-32215-1 ",2.35,39.57,"7zvb_oligo1","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-MAN(4_B_)-[MAN(6_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(152_A_)",52.4817,"","",""
"7ZXF","PFS48/45 BOUND TO MONOCLONAL ANTIBODIES 10D8 AND 85RF45.1","10.1038/S41467-022-33379-6 ",3.72,216.2,"7zxf_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(204_A_)",250.106,"","",""
"7ZXF","PFS48/45 BOUND TO MONOCLONAL ANTIBODIES 10D8 AND 85RF45.1","10.1038/S41467-022-33379-6 ",3.72,216.2,"7zxf_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(190_A_)",260.391,"","",""
"7ZXG","PFS48/45 BOUND TO FAB FRAGMENT OF MONOCLONAL ANTIBODY 10D8","10.1038/S41467-022-33379-6 ",4.2,212.1,"7zxg_oligo4","DManpb1-3DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(204_D_)",252.594,"","",""
"7ZYF","INSULIN REGULATED AMINOPEPTIDASE (IRAP) IN COMPLEX WITH A NANOMOLAR ALPHA HYDROXY BETA AMINO ACID BASED INHIBITOR.","10.1021/ACS.JMEDCHEM.2C00904 ",2.81,39.16,"7zyf_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(760_B_)",96.8527,"","",""
"7ZYF","INSULIN REGULATED AMINOPEPTIDASE (IRAP) IN COMPLEX WITH A NANOMOLAR ALPHA HYDROXY BETA AMINO ACID BASED INHIBITOR.","10.1021/ACS.JMEDCHEM.2C00904 ",2.81,39.16,"7zyf_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(184_B_)",71.9616,"","",""
"8A1F","HUMAN PTPRK N-TERMINAL DOMAINS MAM-IG-FN1","10.1016/J.JBC.2022.102750 ",3,116.9,"8a1f_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(140_A_)",129.377,"","",""
"8A48","LESS CRYSTALLISABLE"" IGG1 FC FRAGMENT (E382S VARIANT)","10.1038/S41467-022-35340-Z ",3.04,136.2,"8a48_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",154.664,"","",""
"8A48","LESS CRYSTALLISABLE"" IGG1 FC FRAGMENT (E382S VARIANT)","10.1038/S41467-022-35340-Z ",3.04,136.2,"8a48_oligo2","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(7_C_)-[NAG(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",201.009,"","",""
"8A49","ENDOGLYCOSIDASE S IN COMPLEX WITH IGG1 FC","10.1038/S41467-022-35340-Z ",3.45,146.6,"8a49_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_E_)-[NAG(7_E_)-MAN(6_E_)-[NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_A_)",155.645,"","",""
"8AEZ","X-RAY STRUCTURE OF THE DEGLYCOSYLATED RECEPTOR BINDING DOMAIN OF ENV GLYCOPROTEIN OF SIMIAN FOAMY VIRUS","10.1038/S41467-023-36923-0 ",2.57,75.14,"8aez_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_C_)-MAN(7_C_)-[MAN(6_C_)-MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(390_A_)",85.7584,"","",""
"8AGC","STRUCTURE OF YEAST OLIGOSACCHARYLRANSFERASE COMPLEX WITH LIPID-LINKED OLIGOSACCHARIDE AND NON-ACCEPTOR PEPTIDE BOUND","10.1038/S41467-022-35067-X ",3.1,"1.35632e-19","8agc_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_I_)-[MAN(6_I_)-MAN(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(539_A_)",53.7575,"","",""
"8AGC","STRUCTURE OF YEAST OLIGOSACCHARYLRANSFERASE COMPLEX WITH LIPID-LINKED OLIGOSACCHARIDE AND NON-ACCEPTOR PEPTIDE BOUND","10.1038/S41467-022-35067-X ",3.1,"1.35632e-19","8agc_oligo3","DGlcpa1-2DGlcpa1-3DGlcpa1-3DManpa1-2DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAca1-C20O7P2","MAN(11_L_)-MAN(10_L_)-[GLC(9_L_)-GLC(8_L_)-GLC(7_L_)-MAN(6_L_)-MAN(5_L_)-MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NDG(1_L_)-ELU(1001_A_)",76.5284,"","",""
"8AGE","STRUCTURE OF YEAST OLIGOSACCHARYLRANSFERASE COMPLEX WITH ACCEPTOR PEPTIDE BOUND","10.1038/S41467-022-35067-X ",2.8,"1.35632e-19","8age_oligo19","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(303_F_)-[MAN(302_F_)-MAN(301_F_)-MAN(503_G_)]-BMA(502_G_)-NAG(501_G_)-NAG(801_A_)-ASN(539_A_)",51.0703,"","",""
"8AIC","X-RAY STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF ENV GLYCOPROTEIN OF SIMIAN FOAMY VIRUS","10.1038/S41467-023-36923-0 ",2.8,69.54,"8aic_oligo9","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_K_)-[MAN(8_K_)]-MAN(7_K_)-[MAN(6_K_)-MAN(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(390_B_)",101.843,"","",""
"8AIC","X-RAY STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF ENV GLYCOPROTEIN OF SIMIAN FOAMY VIRUS","10.1038/S41467-023-36923-0 ",2.8,69.54,"8aic_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_F_)-MAN(8_F_)-[MAN(10_F_)]-MAN(7_F_)-[MAN(6_F_)-MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(390_A_)",103.245,"","",""
"8AKP","CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF G7048 FROM PENICILLIUM SUMATRAENSE","10.1186/S13068-022-02233-8 ",1.9,0,"8akp_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[MAN(5_B_)]-MAN(4_B_)-[MAN(7_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(166_A_)",54.0327,"","",""
"8API","THE S VARIANT OF HUMAN ALPHA1-ANTITRYPSIN, STRUCTURE AND IMPLICATIONS FOR FUNCTION AND METABOLISM","10.1093/PROTEIN/2.6.407 ",3.1,0,"8api_oligo1","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_C_)-MAN(4_C_)-[MAN(6_C_)]-MAN(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(46_A_)",25.9524,"","",""
"8AS0","PD-1 EXTRACELLULAR DOMAIN IN COMPLEX WITH FAB FRAGMENT FROM D12 ANTIBODY","10.1002/PRO.4486 ",3.5,0,"8as0_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_U_)-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(116_X_)",114.885,"","",""
"8AS0","PD-1 EXTRACELLULAR DOMAIN IN COMPLEX WITH FAB FRAGMENT FROM D12 ANTIBODY","10.1002/PRO.4486 ",3.5,0,"8as0_oligo5","DManpb1-3DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_c_)-[BMA(3_c_)-NAG(2_c_)]-NAG(1_c_)-ASN(58_F_)",88.8161,"","",""
"8AS0","PD-1 EXTRACELLULAR DOMAIN IN COMPLEX WITH FAB FRAGMENT FROM D12 ANTIBODY","10.1002/PRO.4486 ",3.5,0,"8as0_oligo8","DManpa1-3[DManpa1-6]DManpb1-3DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_f_)-[MAN(5_f_)-[MAN(4_f_)]-BMA(3_f_)-NAG(2_f_)]-NAG(1_f_)-ASN(58_L_)",108.284,"","",""
"8AV5","GLYCOSYLATED PADA-I MUTANT OF UNSPECIFIC PEROXYGENASE FROM AGROCYBE AEGERITA","",1.62,30.39,"8av5_oligo3","DManpa1-2[DManpa1-6]DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_D_)-[MAN(8_D_)]-MAN(7_D_)-[MAN(6_D_)-[MAN(5_D_)]-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(286_A_)",43.5868,"","",""
"8AXI","SIALIDASES AND FUCOSIDASES OF AKKERMANSIA MUCINIPHILA ARE KEY FOR RAPID GROWTH ON COLONIC MUCIN AND NUTRIENT SHARING AMONGST MUCIN- ASSOCIATED HUMAN GUT MICROBIOTA","",1.25,22.25,"8axi_oligo1","DGalpb1-3DGulpNAcb1-ROH","GAL(2_F_)-LXB(1_F_)",36.2068,"","",""
"8AXI","SIALIDASES AND FUCOSIDASES OF AKKERMANSIA MUCINIPHILA ARE KEY FOR RAPID GROWTH ON COLONIC MUCIN AND NUTRIENT SHARING AMONGST MUCIN- ASSOCIATED HUMAN GUT MICROBIOTA","",1.25,22.25,"8axi_oligo2","DGalpb1-3DGulpNAcb1-ROH","GAL(2_G_)-LXB(1_G_)",38.0927,"","",""
"8B3B","STRUCTURE OF METACYCLIC VSG (MVSG) 531 FROM TRYPANOSOMA BRUCEI","10.1371/JOURNAL.PNTD.0011093 ",1.95,0,"8b3b_oligo8","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(506_H_)-[MAN(505_H_)-MAN(504_H_)]-BMA(503_H_)-NAG(502_H_)-NAG(501_H_)",35.9318,"","",""
"8B3B","STRUCTURE OF METACYCLIC VSG (MVSG) 531 FROM TRYPANOSOMA BRUCEI","10.1371/JOURNAL.PNTD.0011093 ",1.95,0,"8b3b_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(405_F_)-[MAN(404_F_)]-BMA(403_F_)-NAG(402_F_)-NAG(401_F_)",30,"","",""
"8B3B","STRUCTURE OF METACYCLIC VSG (MVSG) 531 FROM TRYPANOSOMA BRUCEI","10.1371/JOURNAL.PNTD.0011093 ",1.95,0,"8b3b_oligo6","DManpa1-2DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(406_E_)-[MAN(405_E_)-MAN(404_E_)]-MAN(403_E_)-NAG(402_E_)-NAG(401_E_)-ASN(295_E_)",30.6309,"","",""
"8B3B","STRUCTURE OF METACYCLIC VSG (MVSG) 531 FROM TRYPANOSOMA BRUCEI","10.1371/JOURNAL.PNTD.0011093 ",1.95,0,"8b3b_oligo1","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(6_I_)-[MAN(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)",31.0804,"","",""
"8B3B","STRUCTURE OF METACYCLIC VSG (MVSG) 531 FROM TRYPANOSOMA BRUCEI","10.1371/JOURNAL.PNTD.0011093 ",1.95,0,"8b3b_oligo2","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_J_)-[MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(295_G_)",30.5764,"","",""
"8B3B","STRUCTURE OF METACYCLIC VSG (MVSG) 531 FROM TRYPANOSOMA BRUCEI","10.1371/JOURNAL.PNTD.0011093 ",1.95,0,"8b3b_oligo4","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(506_D_)-[MAN(505_D_)-MAN(504_D_)]-BMA(503_D_)-NAG(502_D_)-NAG(501_D_)-ASN(295_D_)",30.4518,"","",""
"8B3B","STRUCTURE OF METACYCLIC VSG (MVSG) 531 FROM TRYPANOSOMA BRUCEI","10.1371/JOURNAL.PNTD.0011093 ",1.95,0,"8b3b_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(406_C_)-[MAN(405_C_)-MAN(404_C_)-MAN(403_C_)]-BMA(402_C_)-NAG(401_C_)-NAG(400_C_)-ASN(295_C_)",30.1875,"","",""
"8B3B","STRUCTURE OF METACYCLIC VSG (MVSG) 531 FROM TRYPANOSOMA BRUCEI","10.1371/JOURNAL.PNTD.0011093 ",1.95,0,"8b3b_oligo5","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(405_B_)-[MAN(406_B_)-MAN(404_B_)]-BMA(403_B_)-NAG(402_B_)-NAG(401_B_)-ASN(295_B_)",30.4167,"","",""
"8B48","STRUCTURE OF LENTITHECIUM FLUVIATILE CARBOHYDRATE ESTERASE FROM THE CE15 FAMILY (LFCE15C)","10.1107/S205979832300325X ",2.65,59.1,"8b48_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(241_D_)",117.055,"","",""
"8B48","STRUCTURE OF LENTITHECIUM FLUVIATILE CARBOHYDRATE ESTERASE FROM THE CE15 FAMILY (LFCE15C)","10.1107/S205979832300325X ",2.65,59.1,"8b48_oligo1","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-MAN(4_G_)-[MAN(6_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(241_C_)",121.98,"","",""
"8B48","STRUCTURE OF LENTITHECIUM FLUVIATILE CARBOHYDRATE ESTERASE FROM THE CE15 FAMILY (LFCE15C)","10.1107/S205979832300325X ",2.65,59.1,"8b48_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(241_B_)",134.829,"","",""
"8B48","STRUCTURE OF LENTITHECIUM FLUVIATILE CARBOHYDRATE ESTERASE FROM THE CE15 FAMILY (LFCE15C)","10.1107/S205979832300325X ",2.65,59.1,"8b48_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(241_A_)",112.225,"","",""
"8BES","STRUCTURE OF D188A-FRUCTOFURANOSIDASE FROM RHODOTORULA DAIRENENSIS IN COMPLEX WITH FRUCTOSE","10.3390/IJMS232314981 ",1.86,26.5,"8bes_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(350_A_)",58.818,"","",""
"8BES","STRUCTURE OF D188A-FRUCTOFURANOSIDASE FROM RHODOTORULA DAIRENENSIS IN COMPLEX WITH FRUCTOSE","10.3390/IJMS232314981 ",1.86,26.5,"8bes_oligo4","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-MAN(4_H_)-[MAN(6_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(350_C_)",62.4867,"","",""
"8BET","STRUCTURE OF D188A-FRUCTOFURANOSIDASE FROM RHODOTORULA DAIRENESIS IN COMPLEX WITH SUCROSE","10.3390/IJMS232314981 ",2.38,37.08,"8bet_oligo5","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_G_)-[MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(350_C_)",68.9794,"","",""
"8BEU","STRUCTURE OF D188A-FRUCTOFURANOSIDASE FROM RHODOTORULA DAIRENENSIS IN COMPLEX WITH RAFFINOSE","10.3390/IJMS232314981 ",2.27,47.7,"8beu_oligo6","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_K_)-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(350_C_)",80.3032,"","",""
"8BEU","STRUCTURE OF D188A-FRUCTOFURANOSIDASE FROM RHODOTORULA DAIRENENSIS IN COMPLEX WITH RAFFINOSE","10.3390/IJMS232314981 ",2.27,47.7,"8beu_oligo2","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-MAN(4_H_)-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(350_B_)",82.7954,"","",""
"8BEU","STRUCTURE OF D188A-FRUCTOFURANOSIDASE FROM RHODOTORULA DAIRENENSIS IN COMPLEX WITH RAFFINOSE","10.3390/IJMS232314981 ",2.27,47.7,"8beu_oligo10","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(350_A_)",68.9314,"","",""
"8BGG","CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE (OMICRON BA.1 VARIANT) IN COMPLEX WITH NANOBODY W25 (MAP 5, FOCUS REFINEMENT ON RBD, W25 AND ADJACENT NTD)","",6.04,"1.08527e-19","8bgg_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_A_)-[MAN(4_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(122_B_)",185.493,"","",""
"8BHH","THE CRYSTAL STRUCTURE OF A FERULOYL ESTERASE C FROM FUSARIUM OXYSPORUM IN COMPLEX WITH P-COUMARIC ACID","10.1107/S2059798323004175 ",1.69,28.71,"8bhh_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_G_)-MAN(8_G_)-[MAN(10_G_)]-MAN(7_G_)-[MAN(6_G_)-MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(151_B_)",30.6568,"","",""
"8BHH","THE CRYSTAL STRUCTURE OF A FERULOYL ESTERASE C FROM FUSARIUM OXYSPORUM IN COMPLEX WITH P-COUMARIC ACID","10.1107/S2059798323004175 ",1.69,28.71,"8bhh_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_I_)-MAN(8_I_)-[MAN(10_I_)]-MAN(7_I_)-[MAN(6_I_)-MAN(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(362_B_)",26.596,"","",""
"8BHH","THE CRYSTAL STRUCTURE OF A FERULOYL ESTERASE C FROM FUSARIUM OXYSPORUM IN COMPLEX WITH P-COUMARIC ACID","10.1107/S2059798323004175 ",1.69,28.71,"8bhh_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_C_)-MAN(8_C_)-[MAN(10_C_)]-MAN(7_C_)-[MAN(6_C_)-MAN(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(362_A_)",31.3338,"","",""
"8BQE","IN SITU STRUCTURE OF THE CAULOBACTER CRESCENTUS S-LAYER","10.7554/ELIFE.83724 ",3.5,0,"8bqe_oligo7","DRhap[4NAc]a1-3DManpb1-3DRhap[4NAc]a1-3DRhap[4NAc]a1-3DManpb1-3DRhap[4NAc]a1-ROH","MRH(6_K_)-BMA(5_K_)-MRH(4_K_)-MRH(3_K_)-BMA(2_K_)-MRH(1_K_)",38.3982,"","",""
"8BQE","IN SITU STRUCTURE OF THE CAULOBACTER CRESCENTUS S-LAYER","10.7554/ELIFE.83724 ",3.5,0,"8bqe_oligo11","DRhap[4NAc]a1-3DManpb1-3DRhap[4NAc]a1-3DRhap[4NAc]a1-3DManpb1-3DRhap[4NAc]a1-ROH","MRH(6_G_)-BMA(5_G_)-MRH(4_G_)-MRH(3_G_)-BMA(2_G_)-MRH(1_G_)",38.2074,"","",""
"8BQE","IN SITU STRUCTURE OF THE CAULOBACTER CRESCENTUS S-LAYER","10.7554/ELIFE.83724 ",3.5,0,"8bqe_oligo3","DRhap[4NAc]a1-3DManpb1-3DRhap[4NAc]a1-3DRhap[4NAc]a1-3DManpb1-3DRhap[4NAc]a1-ROH","MRH(6_N_)-BMA(5_N_)-MRH(4_N_)-MRH(3_N_)-BMA(2_N_)-MRH(1_N_)",45.6505,"","",""
"8BQE","IN SITU STRUCTURE OF THE CAULOBACTER CRESCENTUS S-LAYER","10.7554/ELIFE.83724 ",3.5,0,"8bqe_oligo6","DRhap[4NAc]a1-3DManpb1-3DRhap[4NAc]a1-3DRhap[4NAc]a1-3DManpb1-3DRhap[4NAc]a1-ROH","MRH(6_J_)-BMA(5_J_)-MRH(4_J_)-MRH(3_J_)-BMA(2_J_)-MRH(1_J_)",46.245,"","",""
"8BQE","IN SITU STRUCTURE OF THE CAULOBACTER CRESCENTUS S-LAYER","10.7554/ELIFE.83724 ",3.5,0,"8bqe_oligo1","DRhap[4NAc]a1-3DManpb1-3DRhap[4NAc]a1-3DRhap[4NAc]a1-3DManpb1-3DRhap[4NAc]a1-ROH","MRH(6_L_)-BMA(5_L_)-MRH(4_L_)-MRH(3_L_)-BMA(2_L_)-MRH(1_L_)",48.3127,"","",""
"8BQE","IN SITU STRUCTURE OF THE CAULOBACTER CRESCENTUS S-LAYER","10.7554/ELIFE.83724 ",3.5,0,"8bqe_oligo12","DRhap[4NAc]a1-3DManpb1-3DRhap[4NAc]a1-3DRhap[4NAc]a1-3DManpb1-3DRhap[4NAc]a1-ROH","MRH(6_H_)-BMA(5_H_)-MRH(4_H_)-MRH(3_H_)-BMA(2_H_)-MRH(1_H_)",48.0424,"","",""
"8BQE","IN SITU STRUCTURE OF THE CAULOBACTER CRESCENTUS S-LAYER","10.7554/ELIFE.83724 ",3.5,0,"8bqe_oligo2","DRhap[4NAc]a1-3DManpb1-3DRhap[4NAc]a1-3DRhap[4NAc]a1-3DManpb1-3DRhap[4NAc]a1-ROH","MRH(6_M_)-BMA(5_M_)-MRH(4_M_)-MRH(3_M_)-BMA(2_M_)-MRH(1_M_)",38.2821,"","",""
"8BQE","IN SITU STRUCTURE OF THE CAULOBACTER CRESCENTUS S-LAYER","10.7554/ELIFE.83724 ",3.5,0,"8bqe_oligo9","DRhap[4NAc]a1-3DManpb1-3DRhap[4NAc]a1-3DRhap[4NAc]a1-3DManpb1-3DRhap[4NAc]a1-ROH","MRH(6_Q_)-BMA(5_Q_)-MRH(4_Q_)-MRH(3_Q_)-BMA(2_Q_)-MRH(1_Q_)",38.5056,"","",""
"8BQE","IN SITU STRUCTURE OF THE CAULOBACTER CRESCENTUS S-LAYER","10.7554/ELIFE.83724 ",3.5,0,"8bqe_oligo5","DRhap[4NAc]a1-3DManpb1-3DRhap[4NAc]a1-3DRhap[4NAc]a1-3DManpb1-3DRhap[4NAc]a1-ROH","MRH(6_I_)-BMA(5_I_)-MRH(4_I_)-MRH(3_I_)-BMA(2_I_)-MRH(1_I_)",39.8167,"","",""
"8BQE","IN SITU STRUCTURE OF THE CAULOBACTER CRESCENTUS S-LAYER","10.7554/ELIFE.83724 ",3.5,0,"8bqe_oligo4","DRhap[4NAc]a1-3DManpb1-3DRhap[4NAc]a1-3DRhap[4NAc]a1-3DManpb1-3DRhap[4NAc]a1-ROH","MRH(6_O_)-BMA(5_O_)-MRH(4_O_)-MRH(3_O_)-BMA(2_O_)-MRH(1_O_)",39.8589,"","",""
"8BQE","IN SITU STRUCTURE OF THE CAULOBACTER CRESCENTUS S-LAYER","10.7554/ELIFE.83724 ",3.5,0,"8bqe_oligo8","DRhap[4NAc]a1-3DManpb1-3DRhap[4NAc]a1-3DRhap[4NAc]a1-3DManpb1-3DRhap[4NAc]a1-ROH","MRH(6_P_)-BMA(5_P_)-MRH(4_P_)-MRH(3_P_)-BMA(2_P_)-MRH(1_P_)",46.5389,"","",""
"8BQE","IN SITU STRUCTURE OF THE CAULOBACTER CRESCENTUS S-LAYER","10.7554/ELIFE.83724 ",3.5,0,"8bqe_oligo10","DRhap[4NAc]a1-3DManpb1-3DRhap[4NAc]a1-3DRhap[4NAc]a1-3DManpb1-3DRhap[4NAc]a1-ROH","MRH(6_R_)-BMA(5_R_)-MRH(4_R_)-MRH(3_R_)-BMA(2_R_)-MRH(1_R_)",45.9535,"","",""
"8BRN","CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH AN ALPHA-AMINONAPHTHYLMETHYLPHOSPHONIC ACID INHIBITOR","10.1016/J.EJMECH.2023.115383 ",2,26.26,"8brn_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-[FUC(6_J_)]-NAG(1_J_)-ASN(81_B_)",43.6947,"","",""
"8BRN","CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH AN ALPHA-AMINONAPHTHYLMETHYLPHOSPHONIC ACID INHIBITOR","10.1016/J.EJMECH.2023.115383 ",2,26.26,"8brn_oligo3","DManpa1-2DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(4_L_)-BMA(3_L_)-NAG(2_L_)-[FUC(5_L_)]-NAG(1_L_)-ASN(396_B_)",36.0891,"","",""
"8BRN","CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH AN ALPHA-AMINONAPHTHYLMETHYLPHOSPHONIC ACID INHIBITOR","10.1016/J.EJMECH.2023.115383 ",2,26.26,"8brn_oligo13","DManpa1-2[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-[FUC(6_F_)]-NAG(1_F_)-ASN(81_A_)",45.6718,"","",""
"8BRN","CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH AN ALPHA-AMINONAPHTHYLMETHYLPHOSPHONIC ACID INHIBITOR","10.1016/J.EJMECH.2023.115383 ",2,26.26,"8brn_oligo17","DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","BMA(3_V_)-NAG(2_V_)-[FUC(4_V_)]-NAG(1_V_)-ASN(396_C_)",41.4452,"","",""
"8BRN","CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH AN ALPHA-AMINONAPHTHYLMETHYLPHOSPHONIC ACID INHIBITOR","10.1016/J.EJMECH.2023.115383 ",2,26.26,"8brn_oligo16","LFucpa1-3DGlcpNAcb1-ASN","FUC(2_T_)-NAG(1_T_)-ASN(211_B_)",50.0205,"","",""
"8BRN","CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH AN ALPHA-AMINONAPHTHYLMETHYLPHOSPHONIC ACID INHIBITOR","10.1016/J.EJMECH.2023.115383 ",2,26.26,"8brn_oligo14","DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","BMA(3_R_)-NAG(2_R_)-[FUC(4_R_)]-NAG(1_R_)-ASN(81_C_)",53.5561,"","",""
"8BRN","CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH AN ALPHA-AMINONAPHTHYLMETHYLPHOSPHONIC ACID INHIBITOR","10.1016/J.EJMECH.2023.115383 ",2,26.26,"8brn_oligo8","DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","BMA(3_N_)-NAG(2_N_)-[FUC(4_N_)]-NAG(1_N_)-ASN(109_D_)",51.1557,"","",""
"8BRN","CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH AN ALPHA-AMINONAPHTHYLMETHYLPHOSPHONIC ACID INHIBITOR","10.1016/J.EJMECH.2023.115383 ",2,26.26,"8brn_oligo4","DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","BMA(3_I_)-NAG(2_I_)-[FUC(4_I_)]-NAG(1_I_)-ASN(109_B_)",70.3152,"","",""
"8BRN","CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH AN ALPHA-AMINONAPHTHYLMETHYLPHOSPHONIC ACID INHIBITOR","10.1016/J.EJMECH.2023.115383 ",2,26.26,"8brn_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-[FUC(6_H_)]-NAG(1_H_)-ASN(396_A_)",31.453,"","",""
"8BRN","CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH AN ALPHA-AMINONAPHTHYLMETHYLPHOSPHONIC ACID INHIBITOR","10.1016/J.EJMECH.2023.115383 ",2,26.26,"8brn_oligo15","DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","BMA(3_S_)-NAG(2_S_)-[FUC(4_S_)]-NAG(1_S_)-ASN(109_C_)",50.4443,"","",""
"8BRN","CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH AN ALPHA-AMINONAPHTHYLMETHYLPHOSPHONIC ACID INHIBITOR","10.1016/J.EJMECH.2023.115383 ",2,26.26,"8brn_oligo10","DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","BMA(3_P_)-NAG(2_P_)-[FUC(4_P_)]-NAG(1_P_)-ASN(396_D_)",48.6541,"","",""
"8BRN","CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH AN ALPHA-AMINONAPHTHYLMETHYLPHOSPHONIC ACID INHIBITOR","10.1016/J.EJMECH.2023.115383 ",2,26.26,"8brn_oligo6","DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","BMA(3_G_)-NAG(2_G_)-[FUC(4_G_)]-NAG(1_G_)-ASN(109_A_)",59.1443,"","",""
"8BW5","X-RAY STRUCTURE OF THE COMPLEX BETWEEN HUMAN ALPHA THROMBIN AND THE DUPLEX/QUADRUPLEX APTAMER M08S-1_41MER","10.1093/NAR/GKAD634 ",2.8,77.14,"8bw5_oligo19","DNeup5Aca2-6DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","SIA(7_A_)-GAL(6_A_)-NAG(5_A_)-MAN(4_A_)-[MAN(8_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(60_H_)",104.268,"","",""
"8BXY","FIMH IN COMPLEX WITH ALPHA1,6 CORE-FUCOSYLATED OLIGOMANNOSE-3, CRYSTALLIZED IN THE TRIGONAL SPACE GROUP","10.1016/J.JBC.2023.104627 ",1.45,32.69,"8bxy_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ROH","FUC(6_D_)-[MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)",61.4667,"","",""
"8BXY","FIMH IN COMPLEX WITH ALPHA1,6 CORE-FUCOSYLATED OLIGOMANNOSE-3, CRYSTALLIZED IN THE TRIGONAL SPACE GROUP","10.1016/J.JBC.2023.104627 ",1.45,32.69,"8bxy_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DManp[2H]b1-ROH","FUC(6_C_)-[MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-",73.5086,"","",""
"8BY3","FIMH LECTIN DOMAIN IN COMPLEX WITH OLIGOMANNOSE-6","10.1016/J.JBC.2023.104627 ",3.19,61.21,"8by3_oligo1","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","MAN(8_F_)-[MAN(7_F_)]-MAN(6_F_)-[MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)",90.5867,"","",""
"8BY3","FIMH LECTIN DOMAIN IN COMPLEX WITH OLIGOMANNOSE-6","10.1016/J.JBC.2023.104627 ",3.19,61.21,"8by3_oligo2","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROH","MAN(8_E_)-[MAN(7_E_)]-MAN(6_E_)-[MAN(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)",83.1976,"","",""
"8C1B","FOCUSED MAP FOR STRUCTURE OF IGE BOUND TO THE ECTODOMAIN OF FCERIA","",3.8,0,"8c1b_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_A_)-[MAN(4_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(391_H_)",134.259,"","",""
"8C1B","FOCUSED MAP FOR STRUCTURE OF IGE BOUND TO THE ECTODOMAIN OF FCERIA","",3.8,0,"8c1b_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(391_X_)",141.325,"","",""
"8C1C","STRUCTURE OF IGE BOUND TO THE ECTODOMAIN OF FCERIA","",4.1,"2.2904e+11","8c1c_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_A_)-[MAN(4_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(391_H_)",145.552,"","",""
"8C1C","STRUCTURE OF IGE BOUND TO THE ECTODOMAIN OF FCERIA","",4.1,"2.2904e+11","8c1c_oligo6","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(166_R_)",187.437,"","",""
"8C1C","STRUCTURE OF IGE BOUND TO THE ECTODOMAIN OF FCERIA","",4.1,"2.2904e+11","8c1c_oligo1","DManpa1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-MAN(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(42_R_)",157.426,"","",""
"8C1C","STRUCTURE OF IGE BOUND TO THE ECTODOMAIN OF FCERIA","",4.1,"2.2904e+11","8c1c_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(391_X_)",168.317,"","",""
"8C3V","SARS-COV-2 DELTA-RBD COMPLEXED WITH BA.2-13 FAB AND C1 NANOBODY","10.1016/J.CELREP.2023.112271 ",2.74,93.88,"8c3v_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_E_)-[MAN(4_E_)-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(343_R_)",124.911,"","",""
"8C6I","TMEM2 ECTODOMAIN","10.12688/WELLCOMEOPENRES.18937.2 ",3.5,0,"8c6i_oligo6","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(739_A_)",116.447,"","",""
"8CSE","WBBB IN COMPLEX WITH ALPHA-RHA-(1-3)-BETA-GLCNAC ACCEPTOR","10.1038/S41467-022-33988-1 ",2.3,48.67,"8cse_oligo7","LRhapa1-3DGlcpNAcb1-ROH","RAM(2_F_)-NAG(1_F_)",78.3636,"","",""
"8CSE","WBBB IN COMPLEX WITH ALPHA-RHA-(1-3)-BETA-GLCNAC ACCEPTOR","10.1038/S41467-022-33988-1 ",2.3,48.67,"8cse_oligo6","LRhapa1-3DGlcpNAcb1-ROH","RAM(2_E_)-NAG(1_E_)",41.5641,"","",""
"8CSE","WBBB IN COMPLEX WITH ALPHA-RHA-(1-3)-BETA-GLCNAC ACCEPTOR","10.1038/S41467-022-33988-1 ",2.3,48.67,"8cse_oligo5","LRhapa1-3DGlcpNAcb1-ROH","RAM(2_D_)-NAG(1_D_)",43.6445,"","",""
"8CSE","WBBB IN COMPLEX WITH ALPHA-RHA-(1-3)-BETA-GLCNAC ACCEPTOR","10.1038/S41467-022-33988-1 ",2.3,48.67,"8cse_oligo8","LRhapa1-3DGlcpNAcb1-ROH","RAM(2_G_)-NAG(1_G_)",74.3923,"","",""
"8CSE","WBBB IN COMPLEX WITH ALPHA-RHA-(1-3)-BETA-GLCNAC ACCEPTOR","10.1038/S41467-022-33988-1 ",2.3,48.67,"8cse_oligo9","LRhapa1-3DGlcpNAcb1-C16N1O3","RAM(2_H_)-NAG(1_H_)-PXV(501_A_)",54.3941,"","",""
"8CSF","WBBB D232C-KDO ADDUCT + ALPHA-RHA(1,3)GLCNAC TERNARY COMPLEX","10.1038/S41467-022-33988-1 ",2.4,51.11,"8csf_oligo5","LRhapa1-3DGlcpNAcb1-ROH","RAM(2_E_)-NAG(1_E_)",47.3368,"","",""
"8CSF","WBBB D232C-KDO ADDUCT + ALPHA-RHA(1,3)GLCNAC TERNARY COMPLEX","10.1038/S41467-022-33988-1 ",2.4,51.11,"8csf_oligo6","LRhapa1-3DGlcpNAcb1-ROH","RAM(2_F_)-NAG(1_F_)",42.0305,"","",""
"8CT6","1F8 MAB IN COMPLEX WITH THE COMPUTATIONALLY OPTIMIZED BROADLY REACTIVE H1 INFLUENZA HEMAGGLUTININ P1","10.1038/S42003-023-04793-3 ",3.1,"1.08527e-19","8ct6_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(87_A_)",93.2441,"","",""
"8CT6","1F8 MAB IN COMPLEX WITH THE COMPUTATIONALLY OPTIMIZED BROADLY REACTIVE H1 INFLUENZA HEMAGGLUTININ P1","10.1038/S42003-023-04793-3 ",3.1,"1.08527e-19","8ct6_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(87_C_)",88.6748,"","",""
"8CWI","FAB ARM OF ANTIBODY 10G4 BOUND TO COV-2 RECEPTOR BINDING DOMAIN (RBD)","",1.87,35.18,"8cwi_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_B_)-[MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(343_A_)",70.3282,"","",""
"8CYB","SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH A PAN-SARBECOVIRUS NANOBODY 1-8","10.1016/J.CELREP.2022.111004 ",2.7,0,"8cyb_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(801_A_)",144.248,"","",""
"8CYB","SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH A PAN-SARBECOVIRUS NANOBODY 1-8","10.1016/J.CELREP.2022.111004 ",2.7,0,"8cyb_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(1098_A_)",167.511,"","",""
"8CYB","SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH A PAN-SARBECOVIRUS NANOBODY 1-8","10.1016/J.CELREP.2022.111004 ",2.7,0,"8cyb_oligo11","DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","BMA(3_N_)-NAG(2_N_)-[FUC(4_N_)]-NAG(1_N_)-ASN(1074_B_)",179.636,"","",""
"8CYB","SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH A PAN-SARBECOVIRUS NANOBODY 1-8","10.1016/J.CELREP.2022.111004 ",2.7,0,"8cyb_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(717_A_)",141.855,"","",""
"8CYB","SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH A PAN-SARBECOVIRUS NANOBODY 1-8","10.1016/J.CELREP.2022.111004 ",2.7,0,"8cyb_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(709_A_)",158.823,"","",""
"8CYB","SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH A PAN-SARBECOVIRUS NANOBODY 1-8","10.1016/J.CELREP.2022.111004 ",2.7,0,"8cyb_oligo20","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_W_)-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(801_C_)",134.359,"","",""
"8CYB","SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH A PAN-SARBECOVIRUS NANOBODY 1-8","10.1016/J.CELREP.2022.111004 ",2.7,0,"8cyb_oligo21","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_X_)-[FUC(2_X_)]-NAG(1_X_)-ASN(1074_C_)",150.605,"","",""
"8CYB","SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH A PAN-SARBECOVIRUS NANOBODY 1-8","10.1016/J.CELREP.2022.111004 ",2.7,0,"8cyb_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(1098_B_)",150.921,"","",""
"8CYB","SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH A PAN-SARBECOVIRUS NANOBODY 1-8","10.1016/J.CELREP.2022.111004 ",2.7,0,"8cyb_oligo12","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(801_B_)",155.129,"","",""
"8CYB","SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH A PAN-SARBECOVIRUS NANOBODY 1-8","10.1016/J.CELREP.2022.111004 ",2.7,0,"8cyb_oligo19","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_V_)-[MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(717_C_)",142.779,"","",""
"8CZZ","CRYO-EM STRUCTURE OF T/F100 SOSIP.664 HIV-1 ENV TRIMER WITH LMHS MUTATIONS IN COMPLEX WITH TEMSAVIR, 8ANC195, AND 10-1074","",3.14,"5.37397e+08","8czz_oligo11","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_b_)-[MAN(5_b_)-MAN(4_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(276_E_)",79.6994,"","",""
"8CZZ","CRYO-EM STRUCTURE OF T/F100 SOSIP.664 HIV-1 ENV TRIMER WITH LMHS MUTATIONS IN COMPLEX WITH TEMSAVIR, 8ANC195, AND 10-1074","",3.14,"5.37397e+08","8czz_oligo9","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_T_)-[MAN(5_T_)-MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(276_A_)",78.7414,"","",""
"8CZZ","CRYO-EM STRUCTURE OF T/F100 SOSIP.664 HIV-1 ENV TRIMER WITH LMHS MUTATIONS IN COMPLEX WITH TEMSAVIR, 8ANC195, AND 10-1074","",3.14,"5.37397e+08","8czz_oligo25","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_k_)-[MAN(5_k_)-MAN(4_k_)]-BMA(3_k_)-NAG(2_k_)-NAG(1_k_)-ASN(276_I_)",84.9538,"","",""
"8CZZ","CRYO-EM STRUCTURE OF T/F100 SOSIP.664 HIV-1 ENV TRIMER WITH LMHS MUTATIONS IN COMPLEX WITH TEMSAVIR, 8ANC195, AND 10-1074","",3.14,"5.37397e+08","8czz_oligo10","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_a_)-MAN(8_a_)-[MAN(10_a_)]-MAN(7_a_)-[MAN(6_a_)-MAN(5_a_)-MAN(4_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(234_E_)",89.2785,"","",""
"8CZZ","CRYO-EM STRUCTURE OF T/F100 SOSIP.664 HIV-1 ENV TRIMER WITH LMHS MUTATIONS IN COMPLEX WITH TEMSAVIR, 8ANC195, AND 10-1074","",3.14,"5.37397e+08","8czz_oligo33","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_s_)-BMA(3_s_)-NAG(2_s_)-NAG(1_s_)-ASN(637_J_)",62.32,"","",""
"8CZZ","CRYO-EM STRUCTURE OF T/F100 SOSIP.664 HIV-1 ENV TRIMER WITH LMHS MUTATIONS IN COMPLEX WITH TEMSAVIR, 8ANC195, AND 10-1074","",3.14,"5.37397e+08","8czz_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_S_)-MAN(8_S_)-MAN(7_S_)-[MAN(6_S_)-MAN(5_S_)-MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(234_A_)",60.0807,"","",""
"8CZZ","CRYO-EM STRUCTURE OF T/F100 SOSIP.664 HIV-1 ENV TRIMER WITH LMHS MUTATIONS IN COMPLEX WITH TEMSAVIR, 8ANC195, AND 10-1074","",3.14,"5.37397e+08","8czz_oligo24","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_j_)-MAN(8_j_)-MAN(7_j_)-[MAN(6_j_)-MAN(5_j_)-MAN(4_j_)]-BMA(3_j_)-NAG(2_j_)-NAG(1_j_)-ASN(234_I_)",56.3614,"","",""
"8D0P","HUMAN FUT9, UNLIGANDED","10.1038/S41589-023-01345-Y ",1.09,17.4,"8d0p_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(153_A_)",21.6316,"","",""
"8D0S","HUMAN FUT9 BOUND TO GDP AND LNNT","10.1038/S41589-023-01345-Y ",1.37,0,"8d0s_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(153_A_)",31.14,"","",""
"8D0U","HUMAN FUT9 BOUND TO GDP","10.1038/S41589-023-01345-Y ",1.29,0,"8d0u_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(153_A_)",23.9327,"","",""
"8D0X","HUMAN FUT9 BOUND TO LNNT","10.1038/S41589-023-01345-Y ",1.33,0,"8d0x_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(153_A_)",26.4618,"","",""
"8D0Y","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIPV8 TRIMER IN COMPLEX WITH CD4BS TARGETING ANTIBODY 21N13 AND INTERFACE TARGETING ANTIBODY 35O22 AT 4.7 ANGSTROM","",4.7,351.6,"8d0y_oligo5","DManpa1-2DManpa1-3[DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_F_)-MAN(6_F_)-[MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(241_G_)",487.322,"","",""
"8D0Y","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIPV8 TRIMER IN COMPLEX WITH CD4BS TARGETING ANTIBODY 21N13 AND INTERFACE TARGETING ANTIBODY 35O22 AT 4.7 ANGSTROM","",4.7,351.6,"8d0y_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(363_G_)",479.639,"","",""
"8D0Y","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIPV8 TRIMER IN COMPLEX WITH CD4BS TARGETING ANTIBODY 21N13 AND INTERFACE TARGETING ANTIBODY 35O22 AT 4.7 ANGSTROM","",4.7,351.6,"8d0y_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_P_)-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(448_G_)",450.659,"","",""
"8D0Y","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIPV8 TRIMER IN COMPLEX WITH CD4BS TARGETING ANTIBODY 21N13 AND INTERFACE TARGETING ANTIBODY 35O22 AT 4.7 ANGSTROM","",4.7,351.6,"8d0y_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)",425.457,"","",""
"8D0Y","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIPV8 TRIMER IN COMPLEX WITH CD4BS TARGETING ANTIBODY 21N13 AND INTERFACE TARGETING ANTIBODY 35O22 AT 4.7 ANGSTROM","",4.7,351.6,"8d0y_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(301_G_)",481.207,"","",""
"8D0Y","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIPV8 TRIMER IN COMPLEX WITH CD4BS TARGETING ANTIBODY 21N13 AND INTERFACE TARGETING ANTIBODY 35O22 AT 4.7 ANGSTROM","",4.7,351.6,"8d0y_oligo16","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_A_)-[MAN(5_A_)]-MAN(4_A_)-[MAN(7_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(88_G_)",395.041,"","",""
"8D0Y","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIPV8 TRIMER IN COMPLEX WITH CD4BS TARGETING ANTIBODY 21N13 AND INTERFACE TARGETING ANTIBODY 35O22 AT 4.7 ANGSTROM","",4.7,351.6,"8d0y_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(295_G_)",489.664,"","",""
"8D0Y","CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIPV8 TRIMER IN COMPLEX WITH CD4BS TARGETING ANTIBODY 21N13 AND INTERFACE TARGETING ANTIBODY 35O22 AT 4.7 ANGSTROM","",4.7,351.6,"8d0y_oligo6","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-MAN(4_I_)-[MAN(6_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(262_G_)",404.094,"","",""
"8D3A","CRYSTAL STRUCTURE OF DH475 FAB IN COMPLEX WITH MAN9","10.3389/FIMMU.2022.962939 ",2.9,82.4,"8d3a_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(11_G_)-MAN(10_G_)-[MAN(9_G_)-MAN(8_G_)]-MAN(7_G_)-[MAN(6_G_)-MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)",81.0283,"","",""
"8D3T","CRYSTAL STRUCTURE OF GALS1 FROM POPULUS TRICHOCARPAS","10.1038/S41477-023-01358-4 ",2.37,44.7,"8d3t_oligo8","DGlcpNAcb1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_L_)-MAN(6_L_)-[NAG(5_L_)-MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(107_D_)",65.1504,"","",""
"8D3T","CRYSTAL STRUCTURE OF GALS1 FROM POPULUS TRICHOCARPAS","10.1038/S41477-023-01358-4 ",2.37,44.7,"8d3t_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_H_)-[MAN(6_H_)-MAN(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(107_B_)",53.616,"","",""
"8D3T","CRYSTAL STRUCTURE OF GALS1 FROM POPULUS TRICHOCARPAS","10.1038/S41477-023-01358-4 ",2.37,44.7,"8d3t_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_F_)-[MAN(6_F_)-MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(107_A_)",61.7229,"","",""
"8D3T","CRYSTAL STRUCTURE OF GALS1 FROM POPULUS TRICHOCARPAS","10.1038/S41477-023-01358-4 ",2.37,44.7,"8d3t_oligo5","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_J_)-[MAN(6_J_)-MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(107_C_)",66.1091,"","",""
"8D3Z","CRYSTAL STRUCTURE OF GALS1 IN COMPLEX WITH MANGANESE FROM POPULUS TRICHOCARPAS","10.1038/S41477-023-01358-4 ",2.56,107.4,"8d3z_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_D_)-[MAN(6_D_)-MAN(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(107_A_)",81.8578,"","",""
"8D3Z","CRYSTAL STRUCTURE OF GALS1 IN COMPLEX WITH MANGANESE FROM POPULUS TRICHOCARPAS","10.1038/S41477-023-01358-4 ",2.56,107.4,"8d3z_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_F_)-[MAN(6_F_)-MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(107_B_)",171.509,"","",""
"8D43","CRYO-EM STRUCTURE OF HUMAN KIDNEY GLUCOSIDASE II","",2.88,0,"8d43_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(97_A_)",93.1614,"","",""
"8D87","FITTED CRYSTAL STRUCTURE OF THE HOMOTRIMER OF FUSION GLYCOPROTEIN E1 FROM SFV INTO SUBTOMOGRAM AVERAGED CHIKV E1 GLYCOPROTEIN DENSITY","10.1038/S41467-022-32431-9 ",27.2,"1.15243e-41","8d87_oligo2","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAca1-ASN","FUC(7_E_)-[MAN(6_E_)-[NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NDG(1_E_)-ASN(141_B_)",134.96,"","",""
"8D87","FITTED CRYSTAL STRUCTURE OF THE HOMOTRIMER OF FUSION GLYCOPROTEIN E1 FROM SFV INTO SUBTOMOGRAM AVERAGED CHIKV E1 GLYCOPROTEIN DENSITY","10.1038/S41467-022-32431-9 ",27.2,"1.15243e-41","8d87_oligo1","DGlcpNAcb1-2DManpb1-3DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(6_D_)-[NAG(5_D_)-BMA(4_D_)-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(141_A_)",134.071,"","",""
"8DD2","HUMAN GABAA RECEPTOR ALPHA1-BETA2-GAMMA2 SUBTYPE IN COMPLEX WITH GABA PLUS ZOLPIDEM","10.1038/S41467-022-32212-4 ",2.9,"2.14959e+09","8dd2_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_G_)-MAN(8_G_)-[MAN(10_G_)]-MAN(7_G_)-[MAN(6_G_)-MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(111_B_)",37.1905,"","",""
"8DDK","CCHFV GP38 HOTI/KOSOVO BOUND WITH CC5_17","10.1038/S41467-022-34923-0 ",3.86,247.1,"8ddk_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(380_C_)",327.949,"","",""
"8DDK","CCHFV GP38 HOTI/KOSOVO BOUND WITH CC5_17","10.1038/S41467-022-34923-0 ",3.86,247.1,"8ddk_oligo1","DManpa1-2DManpa1-3DManpb1-4[DManpa1-3]DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-MAN(4_D_)-BMA(3_D_)-[MAN(6_D_)]-NAG(2_D_)-NAG(1_D_)-ASN(430_C_)",274.233,"","",""
"8DF1","CHI3L1 BOUND BY ANTIBODY C59","10.1093/ABT/TBAC027 ",3.3,71.17,"8df1_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(65_C_)",129.236,"","",""
"8DIN","THE COMPLEX STRUCTURE BETWEEN HUMAN IGG1 FC AND ITS HIGH AFFINITY RECEPTOR FCGRI H174R VARIANT","10.3389/FIMMU.2023.1100499 ",2.5,68.26,"8din_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[NAG(8_E_)-MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_A_)",59.0284,"","",""
"8DIN","THE COMPLEX STRUCTURE BETWEEN HUMAN IGG1 FC AND ITS HIGH AFFINITY RECEPTOR FCGRI H174R VARIANT","10.3389/FIMMU.2023.1100499 ",2.5,68.26,"8din_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",97.4553,"","",""
"8DIR","THE COMPLEX STRUCTURE BETWEEN HUMAN IGG1 FC AND ITS HIGH AFFINITY RECEPTOR FCGRI H174R VARIANT","10.3389/FIMMU.2023.1100499 ",2.3,61.7,"8dir_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[NAG(8_E_)-MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_A_)",53.7698,"","",""
"8DIR","THE COMPLEX STRUCTURE BETWEEN HUMAN IGG1 FC AND ITS HIGH AFFINITY RECEPTOR FCGRI H174R VARIANT","10.3389/FIMMU.2023.1100499 ",2.3,61.7,"8dir_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",90.7651,"","",""
"8DJ7","THE COMPLEX STRUCTURE BETWEEN HUMAN IGG1 FC AND ITS HIGH AFFINITY RECEPTOR FCGRI H174R VARIANT","10.3389/FIMMU.2023.1100499 ",2.39,69.66,"8dj7_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[NAG(8_E_)-MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_A_)",62.1081,"","",""
"8DJ7","THE COMPLEX STRUCTURE BETWEEN HUMAN IGG1 FC AND ITS HIGH AFFINITY RECEPTOR FCGRI H174R VARIANT","10.3389/FIMMU.2023.1100499 ",2.39,69.66,"8dj7_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",94.2131,"","",""
"8DKU","CRYOEM STRUCTURE OF THE A. AEOLICUS WZMWZT TRANSPORTER BOUND TO THE NATIVE O ANTIGEN","10.1038/S41467-022-32597-2 ",3.2,"1.08527e-19","8dku_oligo1","DRhap[3Me]a1-3DRhapb1-2DRhapa1-ROH","UBH(3_F_)-UBO(2_F_)-XXR(1_F_)",66.78,"","",""
"8DNC","CRYOEM STRUCTURE OF THE A. AEOLICUS WZMWZT TRANSPORTER BOUND TO THE NATIVE O ANTIGEN AND ADP","10.1038/S41467-022-32597-2 ",3.3,"1.08527e-19","8dnc_oligo2","DRhap[3Me]a1-3DRhapb1-2DRhapa1-ROH","UBH(3_E_)-UBO(2_E_)-XXR(1_E_)",56.65,"","",""
"8DOK","CRYO-EM STRUCTURE OF T/F100 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH 8ANC195 AND 10-1074","",3.2,"5.37397e+08","8dok_oligo9","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_i_)-MAN(8_i_)-MAN(7_i_)-[MAN(6_i_)-MAN(5_i_)-MAN(4_i_)]-BMA(3_i_)-NAG(2_i_)-NAG(1_i_)-ASN(234_I_)",55.284,"","",""
"8DOK","CRYO-EM STRUCTURE OF T/F100 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH 8ANC195 AND 10-1074","",3.2,"5.37397e+08","8dok_oligo5","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Z_)-[MAN(5_Z_)-MAN(4_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(276_E_)",95.7844,"","",""
"8DOK","CRYO-EM STRUCTURE OF T/F100 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH 8ANC195 AND 10-1074","",3.2,"5.37397e+08","8dok_oligo4","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_S_)-MAN(8_S_)-MAN(7_S_)-[MAN(6_S_)-MAN(5_S_)-MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(234_A_)",65.5456,"","",""
"8DOK","CRYO-EM STRUCTURE OF T/F100 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH 8ANC195 AND 10-1074","",3.2,"5.37397e+08","8dok_oligo12","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_j_)-[MAN(4_j_)]-BMA(3_j_)-NAG(2_j_)-NAG(1_j_)-ASN(276_I_)",80.9815,"","",""
"8DOK","CRYO-EM STRUCTURE OF T/F100 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH 8ANC195 AND 10-1074","",3.2,"5.37397e+08","8dok_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_Y_)-MAN(8_Y_)-[MAN(10_Y_)]-MAN(7_Y_)-[MAN(6_Y_)-MAN(5_Y_)-MAN(4_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(234_E_)",63.8452,"","",""
"8DOW","CRYO-EM STRUCTURE OF HIV-1 ENV(CH848 10.17 DS.SOSIP_DT) IN COMPLEX WITH DH1030.1 FAB","",3.69,"2.06915e+08","8dow_oligo4","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-MAN(4_S_)-[MAN(6_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(332_E_)",82.8048,"","",""
"8DOW","CRYO-EM STRUCTURE OF HIV-1 ENV(CH848 10.17 DS.SOSIP_DT) IN COMPLEX WITH DH1030.1 FAB","",3.69,"2.06915e+08","8dow_oligo11","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_W_)-MAN(4_W_)-[MAN(6_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(332_I_)",79.6404,"","",""
"8DOW","CRYO-EM STRUCTURE OF HIV-1 ENV(CH848 10.17 DS.SOSIP_DT) IN COMPLEX WITH DH1030.1 FAB","",3.69,"2.06915e+08","8dow_oligo10","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-MAN(4_N_)-[MAN(6_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(332_A_)",81.97,"","",""
"8DPL","STRUCTURE OF EBOV GP LACKING THE MUCIN-LIKE DOMAIN WITH 2.1.1D5 SCFV AND 6D6 SCFV BOUND","",2.53,"1.08527e-19","8dpl_oligo3","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_R_)-MAN(4_R_)-[MAN(6_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(563_N_)",52.3908,"","",""
"8DPL","STRUCTURE OF EBOV GP LACKING THE MUCIN-LIKE DOMAIN WITH 2.1.1D5 SCFV AND 6D6 SCFV BOUND","",2.53,"1.08527e-19","8dpl_oligo2","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Q_)-MAN(4_Q_)-[MAN(6_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(563_E_)",52.0005,"","",""
"8DPL","STRUCTURE OF EBOV GP LACKING THE MUCIN-LIKE DOMAIN WITH 2.1.1D5 SCFV AND 6D6 SCFV BOUND","",2.53,"1.08527e-19","8dpl_oligo1","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_P_)-MAN(4_P_)-[MAN(6_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(563_J_)",52.0312,"","",""
"8DPM","STRUCTURE OF EBOV GP LACKING THE MUCIN-LIKE DOMAIN WITH 9.20.1A2 FAB AND 6D6 SCFV BOUND","",3,"1.08527e-19","8dpm_oligo3","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_R_)-MAN(4_R_)-[MAN(6_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(563_L_)",17.6167,"","",""
"8DPM","STRUCTURE OF EBOV GP LACKING THE MUCIN-LIKE DOMAIN WITH 9.20.1A2 FAB AND 6D6 SCFV BOUND","",3,"1.08527e-19","8dpm_oligo2","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Q_)-MAN(4_Q_)-[MAN(6_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(563_B_)",18.3777,"","",""
"8DPM","STRUCTURE OF EBOV GP LACKING THE MUCIN-LIKE DOMAIN WITH 9.20.1A2 FAB AND 6D6 SCFV BOUND","",3,"1.08527e-19","8dpm_oligo1","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_P_)-MAN(4_P_)-[MAN(6_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(563_G_)",17.7744,"","",""
"8DTO","VACCINE ELICITED ANTIBODY MU89 BOUND TO CH848.D949.10.17_N133D_N138T.DS.SOSIP.664 HIV-1 ENV TRIMER","10.1101/2022.11.11.516143V1 ",3.57,"1.08527e-19","8dto_oligo17","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(154_E_)",132.83,"","",""
"8DTO","VACCINE ELICITED ANTIBODY MU89 BOUND TO CH848.D949.10.17_N133D_N138T.DS.SOSIP.664 HIV-1 ENV TRIMER","10.1101/2022.11.11.516143V1 ",3.57,"1.08527e-19","8dto_oligo34","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_t_)-[MAN(6_t_)-MAN(5_t_)-MAN(4_t_)]-BMA(3_t_)-NAG(2_t_)-NAG(1_t_)-ASN(332_I_)",91.3969,"","",""
"8DTO","VACCINE ELICITED ANTIBODY MU89 BOUND TO CH848.D949.10.17_N133D_N138T.DS.SOSIP.664 HIV-1 ENV TRIMER","10.1101/2022.11.11.516143V1 ",3.57,"1.08527e-19","8dto_oligo36","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_v_)-[MAN(4_v_)]-BMA(3_v_)-NAG(2_v_)-NAG(1_v_)-ASN(262_I_)",89.128,"","",""
"8DTO","VACCINE ELICITED ANTIBODY MU89 BOUND TO CH848.D949.10.17_N133D_N138T.DS.SOSIP.664 HIV-1 ENV TRIMER","10.1101/2022.11.11.516143V1 ",3.57,"1.08527e-19","8dto_oligo30","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_p_)-[MAN(4_p_)]-BMA(3_p_)-NAG(2_p_)-NAG(1_p_)-ASN(154_I_)",120.453,"","",""
"8DTO","VACCINE ELICITED ANTIBODY MU89 BOUND TO CH848.D949.10.17_N133D_N138T.DS.SOSIP.664 HIV-1 ENV TRIMER","10.1101/2022.11.11.516143V1 ",3.57,"1.08527e-19","8dto_oligo6","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_S_)-[MAN(6_S_)-MAN(5_S_)-MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(332_E_)",90.4809,"","",""
"8DTO","VACCINE ELICITED ANTIBODY MU89 BOUND TO CH848.D949.10.17_N133D_N138T.DS.SOSIP.664 HIV-1 ENV TRIMER","10.1101/2022.11.11.516143V1 ",3.57,"1.08527e-19","8dto_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_b_)-[MAN(4_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(154_A_)",129.73,"","",""
"8DTO","VACCINE ELICITED ANTIBODY MU89 BOUND TO CH848.D949.10.17_N133D_N138T.DS.SOSIP.664 HIV-1 ENV TRIMER","10.1101/2022.11.11.516143V1 ",3.57,"1.08527e-19","8dto_oligo16","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_U_)-[MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)",90.5089,"","",""
"8DTO","VACCINE ELICITED ANTIBODY MU89 BOUND TO CH848.D949.10.17_N133D_N138T.DS.SOSIP.664 HIV-1 ENV TRIMER","10.1101/2022.11.11.516143V1 ",3.57,"1.08527e-19","8dto_oligo19","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_f_)-[MAN(6_f_)-MAN(5_f_)-MAN(4_f_)]-BMA(3_f_)-NAG(2_f_)-NAG(1_f_)-ASN(332_A_)",88.2883,"","",""
"8DTO","VACCINE ELICITED ANTIBODY MU89 BOUND TO CH848.D949.10.17_N133D_N138T.DS.SOSIP.664 HIV-1 ENV TRIMER","10.1101/2022.11.11.516143V1 ",3.57,"1.08527e-19","8dto_oligo21","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_h_)-[MAN(4_h_)]-BMA(3_h_)-NAG(2_h_)-NAG(1_h_)-ASN(262_A_)",82.8638,"","",""
"8DU5","MURINE SIALIDASE-1 (NEU1)","10.1126/SCIADV.ADF8169 ",3.5,93.91,"8du5_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(180_A_)",148.595,"","",""
"8DUA","SIV E660.CR54 SOS-2P ENV TRIMER WITH ITS92.02","10.1038/S41594-022-00852-1 ",4.32,0,"8dua_oligo12","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_X_)-[MAN(4_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(612_F_)",117.614,"","",""
"8DUA","SIV E660.CR54 SOS-2P ENV TRIMER WITH ITS92.02","10.1038/S41594-022-00852-1 ",4.32,0,"8dua_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_V_)-[MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(47_C_)",86.6251,"","",""
"8DUA","SIV E660.CR54 SOS-2P ENV TRIMER WITH ITS92.02","10.1038/S41594-022-00852-1 ",4.32,0,"8dua_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_P_)-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(262_G_)",127.741,"","",""
"8DUA","SIV E660.CR54 SOS-2P ENV TRIMER WITH ITS92.02","10.1038/S41594-022-00852-1 ",4.32,0,"8dua_oligo14","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_Z_)-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(262_I_)",136.825,"","",""
"8DUA","SIV E660.CR54 SOS-2P ENV TRIMER WITH ITS92.02","10.1038/S41594-022-00852-1 ",4.32,0,"8dua_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Q_)-[MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(47_G_)",94.5591,"","",""
"8DUA","SIV E660.CR54 SOS-2P ENV TRIMER WITH ITS92.02","10.1038/S41594-022-00852-1 ",4.32,0,"8dua_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(612_B_)",107.709,"","",""
"8DUA","SIV E660.CR54 SOS-2P ENV TRIMER WITH ITS92.02","10.1038/S41594-022-00852-1 ",4.32,0,"8dua_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(612_A_)",119.03,"","",""
"8DUA","SIV E660.CR54 SOS-2P ENV TRIMER WITH ITS92.02","10.1038/S41594-022-00852-1 ",4.32,0,"8dua_oligo7","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_U_)-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(262_C_)",145.773,"","",""
"8DUA","SIV E660.CR54 SOS-2P ENV TRIMER WITH ITS92.02","10.1038/S41594-022-00852-1 ",4.32,0,"8dua_oligo15","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_a_)-[MAN(4_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(47_I_)",90.1546,"","",""
"8DV3","CRYSTAL STRUCTURE OF HUMAN CD1B PRESENTING PHOSPHATIDYLINOSITOL C34:1","10.1016/J.JBC.2022.102849 ",1.9,0,"8dv3_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(7_C_)-[MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-[FUC(6_C_)]-NAG(1_C_)-ASN(57_A_)",28.1208,"","",""
"8DV4","CRYSTAL STRUCTURE OF THE BC8B TCR-CD1B-PI COMPLEX","10.1016/J.JBC.2022.102849 ",2.4,0,"8dv4_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(57_A_)",76.3114,"","",""
"8DVL","CRYSTAL STRUCTURE OF LRP6 E3E4 IN COMPLEX WITH DISULFIDE CONSTRAINED PEPTIDE E3.18","10.1021/ACSCHEMBIO.2C00753 ",2.5,63.03,"8dvl_oligo2","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_E_)-MAN(4_E_)-[MAN(6_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)",82.5737,"","",""
"8DVL","CRYSTAL STRUCTURE OF LRP6 E3E4 IN COMPLEX WITH DISULFIDE CONSTRAINED PEPTIDE E3.18","10.1021/ACSCHEMBIO.2C00753 ",2.5,63.03,"8dvl_oligo1","LFucpa1-3[DGlcpNAcb1-4]DGlcpNAcx1-","NAG(3_C_)-[FUC(2_C_)]-NAG(1_C_)",128.282,"","",""
"8DVM","CRYSTAL STRUCTURE OF LRP6 E3E4 IN COMPLEX WITH DISULFIDE CONSTRAINED PEPTIDE E3.6","10.1021/ACSCHEMBIO.2C00753 ",2,49.36,"8dvm_oligo2","LFucpa1-3[LFucpa1-6]DGlcpNAcb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcx1-","FUC(7_F_)-[FUC(5_F_)-[FUC(4_F_)]-NAG(3_F_)-NAG(2_F_)]-[FUC(6_F_)]-NAG(1_F_)",69.9421,"","",""
"8EE6","CRYO-EM STRUCTURE OF HUMAN ABCA7 IN PE/CH NANODISCS","10.15252/EMBJ.2022111065 ",4,0,"8ee6_oligo9","DManpb1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(1386_A_)",43.2916,"","",""
"8EGW","COMPLEX OF FAT4(EC1-4) BOUND TO DCHS1(EC1-3)","10.1038/S41467-023-36435-X ",2.3,0,"8egw_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(6_E_)-[MAN(4_E_)-BMA(3_E_)-NAG(2_E_)]-[FUC(5_E_)]-NAG(1_E_)-ASN(435_B_)",112.057,"","",""
"8EJD","STRUCTURE OF LINEAGE IV LASSA VIRUS GLYCOPROTEIN COMPLEX (STRAIN JOSIAH)","10.1016/J.CELREP.2023.112524 ",3.8,"1.08527e-19","8ejd_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(365_c_)",90.0535,"","",""
"8EJD","STRUCTURE OF LINEAGE IV LASSA VIRUS GLYCOPROTEIN COMPLEX (STRAIN JOSIAH)","10.1016/J.CELREP.2023.112524 ",3.8,"1.08527e-19","8ejd_oligo14","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_T_)-[MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(365_a_)",90.0535,"","",""
"8EJD","STRUCTURE OF LINEAGE IV LASSA VIRUS GLYCOPROTEIN COMPLEX (STRAIN JOSIAH)","10.1016/J.CELREP.2023.112524 ",3.8,"1.08527e-19","8ejd_oligo26","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_f_)-[MAN(4_f_)]-BMA(3_f_)-NAG(2_f_)-NAG(1_f_)-ASN(365_b_)",90.0535,"","",""
"8EJE","STRUCTURE OF LINEAGE II LASSA VIRUS GLYCOPROTEIN COMPLEX (STRAIN NIG08-A41)","10.1016/J.CELREP.2023.112524 ",3.69,"5.50295e+11","8eje_oligo20","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_W_)-[MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(364_c_)",58.364,"","",""
"8EJE","STRUCTURE OF LINEAGE II LASSA VIRUS GLYCOPROTEIN COMPLEX (STRAIN NIG08-A41)","10.1016/J.CELREP.2023.112524 ",3.69,"5.50295e+11","8eje_oligo14","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(364_a_)",58.364,"","",""
"8EJE","STRUCTURE OF LINEAGE II LASSA VIRUS GLYCOPROTEIN COMPLEX (STRAIN NIG08-A41)","10.1016/J.CELREP.2023.112524 ",3.69,"5.50295e+11","8eje_oligo11","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_P_)-[MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(364_b_)",58.364,"","",""
"8EJF","STRUCTURE OF LINEAGE V LASSA VIRUS GLYCOPROTEIN COMPLEX (STRAIN SOROMBA-R)","10.1016/J.CELREP.2023.112524 ",3.72,"5.50295e+11","8ejf_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(365_a_)",95.5775,"","",""
"8EJF","STRUCTURE OF LINEAGE V LASSA VIRUS GLYCOPROTEIN COMPLEX (STRAIN SOROMBA-R)","10.1016/J.CELREP.2023.112524 ",3.72,"5.50295e+11","8ejf_oligo17","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_T_)-[MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(79_C_)",99.6153,"","",""
"8EJF","STRUCTURE OF LINEAGE V LASSA VIRUS GLYCOPROTEIN COMPLEX (STRAIN SOROMBA-R)","10.1016/J.CELREP.2023.112524 ",3.72,"5.50295e+11","8ejf_oligo23","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Z_)-[MAN(4_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(365_c_)",95.5775,"","",""
"8EJF","STRUCTURE OF LINEAGE V LASSA VIRUS GLYCOPROTEIN COMPLEX (STRAIN SOROMBA-R)","10.1016/J.CELREP.2023.112524 ",3.72,"5.50295e+11","8ejf_oligo11","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_R_)-[MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(365_b_)",95.5775,"","",""
"8EJF","STRUCTURE OF LINEAGE V LASSA VIRUS GLYCOPROTEIN COMPLEX (STRAIN SOROMBA-R)","10.1016/J.CELREP.2023.112524 ",3.72,"5.50295e+11","8ejf_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(79_A_)",99.6153,"","",""
"8EJF","STRUCTURE OF LINEAGE V LASSA VIRUS GLYCOPROTEIN COMPLEX (STRAIN SOROMBA-R)","10.1016/J.CELREP.2023.112524 ",3.72,"5.50295e+11","8ejf_oligo13","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_L_)-[MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(79_B_)",99.6153,"","",""
"8EJF","STRUCTURE OF LINEAGE V LASSA VIRUS GLYCOPROTEIN COMPLEX (STRAIN SOROMBA-R)","10.1016/J.CELREP.2023.112524 ",3.72,"5.50295e+11","8ejf_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(119_A_)",188.233,"","",""
"8EJF","STRUCTURE OF LINEAGE V LASSA VIRUS GLYCOPROTEIN COMPLEX (STRAIN SOROMBA-R)","10.1016/J.CELREP.2023.112524 ",3.72,"5.50295e+11","8ejf_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(119_B_)",188.233,"","",""
"8EJF","STRUCTURE OF LINEAGE V LASSA VIRUS GLYCOPROTEIN COMPLEX (STRAIN SOROMBA-R)","10.1016/J.CELREP.2023.112524 ",3.72,"5.50295e+11","8ejf_oligo20","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_W_)-[MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(119_C_)",188.233,"","",""
"8EJG","STRUCTURE OF LINEAGE VII LASSA VIRUS GLYCOPROTEIN COMPLEX (STRAIN TOGO/2016/7082)","10.1016/J.CELREP.2023.112524 ",3.13,"5.50295e+11","8ejg_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(78_A_)",74.4213,"","",""
"8EJG","STRUCTURE OF LINEAGE VII LASSA VIRUS GLYCOPROTEIN COMPLEX (STRAIN TOGO/2016/7082)","10.1016/J.CELREP.2023.112524 ",3.13,"5.50295e+11","8ejg_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(78_B_)",74.4213,"","",""
"8EJG","STRUCTURE OF LINEAGE VII LASSA VIRUS GLYCOPROTEIN COMPLEX (STRAIN TOGO/2016/7082)","10.1016/J.CELREP.2023.112524 ",3.13,"5.50295e+11","8ejg_oligo13","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_T_)-[MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(78_C_)",74.4213,"","",""
"8EJG","STRUCTURE OF LINEAGE VII LASSA VIRUS GLYCOPROTEIN COMPLEX (STRAIN TOGO/2016/7082)","10.1016/J.CELREP.2023.112524 ",3.13,"5.50295e+11","8ejg_oligo7","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_K_)-MAN(6_K_)-[MAN(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(364_a_)",51.9904,"","",""
"8EJG","STRUCTURE OF LINEAGE VII LASSA VIRUS GLYCOPROTEIN COMPLEX (STRAIN TOGO/2016/7082)","10.1016/J.CELREP.2023.112524 ",3.13,"5.50295e+11","8ejg_oligo24","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_d_)-MAN(6_d_)-[MAN(5_d_)-MAN(4_d_)]-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(364_b_)",51.9904,"","",""
"8EJG","STRUCTURE OF LINEAGE VII LASSA VIRUS GLYCOPROTEIN COMPLEX (STRAIN TOGO/2016/7082)","10.1016/J.CELREP.2023.112524 ",3.13,"5.50295e+11","8ejg_oligo26","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_f_)-MAN(6_f_)-[MAN(5_f_)-MAN(4_f_)]-BMA(3_f_)-NAG(2_f_)-NAG(1_f_)-ASN(364_c_)",51.9904,"","",""
"8EJH","LASSA VIRUS GLYCOPROTEIN COMPLEX (JOSIAH) BOUND TO 12.1F FAB","10.1016/J.CELREP.2023.112524 ",3.71,524802,"8ejh_oligo26","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_k_)-MAN(6_k_)-[MAN(5_k_)-MAN(4_k_)]-BMA(3_k_)-NAG(2_k_)-NAG(1_k_)-ASN(365_a_)",77.387,"","",""
"8EJH","LASSA VIRUS GLYCOPROTEIN COMPLEX (JOSIAH) BOUND TO 12.1F FAB","10.1016/J.CELREP.2023.112524 ",3.71,524802,"8ejh_oligo4","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-MAN(4_E_)-[MAN(201_J_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(89_C_)",67.412,"","",""
"8EJH","LASSA VIRUS GLYCOPROTEIN COMPLEX (JOSIAH) BOUND TO 12.1F FAB","10.1016/J.CELREP.2023.112524 ",3.71,524802,"8ejh_oligo15","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_V_)-MAN(6_V_)-[MAN(5_V_)-MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(365_c_)",77.387,"","",""
"8EJH","LASSA VIRUS GLYCOPROTEIN COMPLEX (JOSIAH) BOUND TO 12.1F FAB","10.1016/J.CELREP.2023.112524 ",3.71,524802,"8ejh_oligo18","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Y_)-MAN(4_Y_)-[MAN(201_H_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(89_A_)",67.412,"","",""
"8EJH","LASSA VIRUS GLYCOPROTEIN COMPLEX (JOSIAH) BOUND TO 12.1F FAB","10.1016/J.CELREP.2023.112524 ",3.71,524802,"8ejh_oligo24","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_i_)-MAN(6_i_)-[MAN(5_i_)-MAN(4_i_)]-BMA(3_i_)-NAG(2_i_)-NAG(1_i_)-ASN(365_b_)",77.387,"","",""
"8EJH","LASSA VIRUS GLYCOPROTEIN COMPLEX (JOSIAH) BOUND TO 12.1F FAB","10.1016/J.CELREP.2023.112524 ",3.71,524802,"8ejh_oligo11","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_P_)-MAN(4_P_)-[MAN(201_h_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(89_B_)",67.412,"","",""
"8EJI","LASSA VIRUS GLYCOPROTEIN COMPLEX (JOSIAH) BOUND TO 19.7E FAB","10.1016/J.CELREP.2023.112524 ",3.81,524802,"8eji_oligo5","DManpa1-3DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(167_A_)",100.892,"","",""
"8EJI","LASSA VIRUS GLYCOPROTEIN COMPLEX (JOSIAH) BOUND TO 19.7E FAB","10.1016/J.CELREP.2023.112524 ",3.81,524802,"8eji_oligo18","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_W_)-[MAN(5_W_)-MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(365_c_)",115.703,"","",""
"8EJI","LASSA VIRUS GLYCOPROTEIN COMPLEX (JOSIAH) BOUND TO 19.7E FAB","10.1016/J.CELREP.2023.112524 ",3.81,524802,"8eji_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(365_a_)",113.156,"","",""
"8EJI","LASSA VIRUS GLYCOPROTEIN COMPLEX (JOSIAH) BOUND TO 19.7E FAB","10.1016/J.CELREP.2023.112524 ",3.81,524802,"8eji_oligo11","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_R_)-[MAN(5_R_)-MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(365_b_)",115.703,"","",""
"8EJI","LASSA VIRUS GLYCOPROTEIN COMPLEX (JOSIAH) BOUND TO 19.7E FAB","10.1016/J.CELREP.2023.112524 ",3.81,524802,"8eji_oligo3","DManpa1-6DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(89_A_)",137.833,"","",""
"8EJI","LASSA VIRUS GLYCOPROTEIN COMPLEX (JOSIAH) BOUND TO 19.7E FAB","10.1016/J.CELREP.2023.112524 ",3.81,524802,"8eji_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(109_A_)",187.534,"","",""
"8EJJ","LASSA VIRUS GLYCOPROTEIN COMPLEX (JOSIAH) BOUND TO S370.7 FAB","10.1016/J.CELREP.2023.112524 ",3.22,524802,"8ejj_oligo11","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Z_)-[MAN(5_Z_)-MAN(4_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(365_a_)",47.8673,"","",""
"8EJJ","LASSA VIRUS GLYCOPROTEIN COMPLEX (JOSIAH) BOUND TO S370.7 FAB","10.1016/J.CELREP.2023.112524 ",3.22,524802,"8ejj_oligo19","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_T_)-[MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(79_C_)",60.9587,"","",""
"8EJJ","LASSA VIRUS GLYCOPROTEIN COMPLEX (JOSIAH) BOUND TO S370.7 FAB","10.1016/J.CELREP.2023.112524 ",3.22,524802,"8ejj_oligo22","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-[MAN(201_l_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(79_A_)",60.9587,"","",""
"8EJJ","LASSA VIRUS GLYCOPROTEIN COMPLEX (JOSIAH) BOUND TO S370.7 FAB","10.1016/J.CELREP.2023.112524 ",3.22,524802,"8ejj_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(79_B_)",60.9587,"","",""
"8EJJ","LASSA VIRUS GLYCOPROTEIN COMPLEX (JOSIAH) BOUND TO S370.7 FAB","10.1016/J.CELREP.2023.112524 ",3.22,524802,"8ejj_oligo14","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_f_)-[MAN(5_f_)-MAN(4_f_)]-BMA(3_f_)-NAG(2_f_)-NAG(1_f_)-ASN(365_b_)",47.8673,"","",""
"8EJJ","LASSA VIRUS GLYCOPROTEIN COMPLEX (JOSIAH) BOUND TO S370.7 FAB","10.1016/J.CELREP.2023.112524 ",3.22,524802,"8ejj_oligo25","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_j_)-[MAN(5_j_)-MAN(4_j_)]-BMA(3_j_)-NAG(2_j_)-NAG(1_j_)-ASN(365_c_)",47.8673,"","",""
"8EMR","CRYO-EM STRUCTURE OF HUMAN LIVER GLUCOSIDASE II","",2.92,0,"8emr_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(97_A_)",119.728,"","",""
"8EPN","CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE TRIMER S2D14 IN THE 3-RBD DOWN CONFORMATION","10.1126/SCIADV.ADG0330 ",2.8,"1.15243e-41","8epn_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(343_A_)",257.559,"","",""
"8EPN","CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE TRIMER S2D14 IN THE 3-RBD DOWN CONFORMATION","10.1126/SCIADV.ADG0330 ",2.8,"1.15243e-41","8epn_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(717_A_)",186.987,"","",""
"8EPN","CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE TRIMER S2D14 IN THE 3-RBD DOWN CONFORMATION","10.1126/SCIADV.ADG0330 ",2.8,"1.15243e-41","8epn_oligo19","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_L_)-[MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(1134_A_)",226.735,"","",""
"8EPN","CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE TRIMER S2D14 IN THE 3-RBD DOWN CONFORMATION","10.1126/SCIADV.ADG0330 ",2.8,"1.15243e-41","8epn_oligo31","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_h_)-[MAN(4_h_)]-BMA(3_h_)-NAG(2_h_)-NAG(1_h_)-ASN(1134_C_)",225.975,"","",""
"8EPN","CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE TRIMER S2D14 IN THE 3-RBD DOWN CONFORMATION","10.1126/SCIADV.ADG0330 ",2.8,"1.15243e-41","8epn_oligo24","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Q_)-[MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(282_B_)",229.525,"","",""
"8EPN","CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE TRIMER S2D14 IN THE 3-RBD DOWN CONFORMATION","10.1126/SCIADV.ADG0330 ",2.8,"1.15243e-41","8epn_oligo27","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_d_)-[MAN(4_d_)]-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(801_C_)",179.632,"","",""
"8EPN","CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE TRIMER S2D14 IN THE 3-RBD DOWN CONFORMATION","10.1126/SCIADV.ADG0330 ",2.8,"1.15243e-41","8epn_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(282_A_)",225.8,"","",""
"8EPN","CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE TRIMER S2D14 IN THE 3-RBD DOWN CONFORMATION","10.1126/SCIADV.ADG0330 ",2.8,"1.15243e-41","8epn_oligo25","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_R_)-[MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(343_B_)",254.683,"","",""
"8EPN","CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE TRIMER S2D14 IN THE 3-RBD DOWN CONFORMATION","10.1126/SCIADV.ADG0330 ",2.8,"1.15243e-41","8epn_oligo15","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(801_A_)",178.291,"","",""
"8EPN","CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE TRIMER S2D14 IN THE 3-RBD DOWN CONFORMATION","10.1126/SCIADV.ADG0330 ",2.8,"1.15243e-41","8epn_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_W_)-[MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(1134_B_)",229.907,"","",""
"8EPN","CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE TRIMER S2D14 IN THE 3-RBD DOWN CONFORMATION","10.1126/SCIADV.ADG0330 ",2.8,"1.15243e-41","8epn_oligo13","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_a_)-[MAN(4_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(717_C_)",181.629,"","",""
"8EPN","CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE TRIMER S2D14 IN THE 3-RBD DOWN CONFORMATION","10.1126/SCIADV.ADG0330 ",2.8,"1.15243e-41","8epn_oligo23","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_P_)-[MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(717_B_)",190.597,"","",""
"8EPN","CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE TRIMER S2D14 IN THE 3-RBD DOWN CONFORMATION","10.1126/SCIADV.ADG0330 ",2.8,"1.15243e-41","8epn_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(801_B_)",183.011,"","",""
"8EPN","CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE TRIMER S2D14 IN THE 3-RBD DOWN CONFORMATION","10.1126/SCIADV.ADG0330 ",2.8,"1.15243e-41","8epn_oligo14","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_b_)-[MAN(4_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(282_C_)",229.337,"","",""
"8EPN","CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE TRIMER S2D14 IN THE 3-RBD DOWN CONFORMATION","10.1126/SCIADV.ADG0330 ",2.8,"1.15243e-41","8epn_oligo26","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_c_)-[MAN(4_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(343_C_)",250.81,"","",""
"8EPP","CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE TRIMER S2D14 WITH TWO RBDS IN THE OPEN CONFORMATION","10.1126/SCIADV.ADG0330 ",3.1,"1.15243e-41","8epp_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(282_A_)",325.633,"","",""
"8EPP","CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE TRIMER S2D14 WITH TWO RBDS IN THE OPEN CONFORMATION","10.1126/SCIADV.ADG0330 ",3.1,"1.15243e-41","8epp_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(801_B_)",187.069,"","",""
"8EPP","CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE TRIMER S2D14 WITH TWO RBDS IN THE OPEN CONFORMATION","10.1126/SCIADV.ADG0330 ",3.1,"1.15243e-41","8epp_oligo12","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(801_C_)",190.59,"","",""
"8ESK","CRYO-EM STRUCTURE OF TORPEDO NICOTINIC ACETYLCHOLINE RECEPTOR IN COMPLEX WITH ROCURONIUM, RESTING-LIKE STATE","10.1038/S41467-023-38827-5 ",2.9,"1.08527e-19","8esk_oligo3","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_I_)-[MAN(5_I_)]-MAN(4_I_)-[MAN(7_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(141_D_)",85.5935,"","",""
"8ESK","CRYO-EM STRUCTURE OF TORPEDO NICOTINIC ACETYLCHOLINE RECEPTOR IN COMPLEX WITH ROCURONIUM, RESTING-LIKE STATE","10.1038/S41467-023-38827-5 ",2.9,"1.08527e-19","8esk_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_F_)-[MAN(5_F_)]-MAN(4_F_)-[MAN(7_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(141_A_)",88.0286,"","",""
"8ESV","STRUCTURE OF HUMAN ADAM10-TSPAN15 COMPLEX BOUND TO 11G2 VFAB","10.1016/J.CELL.2023.06.026 ",3.3,524802,"8esv_oligo1","DManpa1-3DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_C_)-MAN(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(278_A_)",95.2,"","",""
"8EW1","STRUCTURE OF BACPLE_01703-E145L","10.1101/2023.03.30.534863 ",1.8,0,"8ew1_oligo2","DGalp[3H]b1-4LGalp[6S]a1-3DGalpb1-ROH","GAL(3_E_)-L6S(2_E_)-GAL(1_E_)",38.9014,"","",""
"8EW1","STRUCTURE OF BACPLE_01703-E145L","10.1101/2023.03.30.534863 ",1.8,0,"8ew1_oligo1","DGalp[3H]b1-4LGalp[6S]a1-3DGalpb1-ROH","GAL(3_D_)-L6S(2_D_)-GAL(1_D_)",37.1531,"","",""
"8EW1","STRUCTURE OF BACPLE_01703-E145L","10.1101/2023.03.30.534863 ",1.8,0,"8ew1_oligo3","DGalp[3H]b1-4LGalp[6S]a1-3DGalpb1-ROH","GAL(3_F_)-L6S(2_F_)-GAL(1_F_)",51.4719,"","",""
"8F0P","STRUCTURE OF VSD4-NAV1.7-NAVPAS CHANNEL CHIMERA BOUND TO THE HYBRID INHIBITOR GNE-1305","10.7554/ELIFE.84151 ",2.2,"1.15243e-41","8f0p_oligo1","DManpb1-3[DManpb1-6]DManpb1-3DGlcpNAcb1-3DGlcpNAcb1-ASN","BMA(5_B_)-[BMA(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(330_A_)",15.7485,"","",""
"8F0Q","STRUCTURE OF VSD4-NAV1.7-NAVPAS CHANNEL CHIMERA BOUND TO THE ACYLSULFONAMIDE INHIBITOR GDC-0310","10.7554/ELIFE.84151 ",2.5,"1.15243e-41","8f0q_oligo5","DManpb1-3DManpb1-3DGlcpNAcb1-3DGlcpNAcx1-","BMA(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)",21.1805,"","",""
"8F0R","STRUCTURE OF VSD4-NAV1.7-NAVPAS CHANNEL CHIMERA BOUND TO THE ARYLSULFONAMIDE INHIBITOR GNE-3565","10.7554/ELIFE.84151 ",2.9,"1.15243e-41","8f0r_oligo2","DManpb1-3[DManpb1-6]DManpb1-3DGlcpNAcb1-3DGlcpNAcx1-","BMA(5_B_)-[BMA(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)",38.1534,"","",""
"8F0S","STRUCTURE OF VSD4-NAV1.7-NAVPAS CHANNEL CHIMERA BOUND TO THE HYBRID INHIBITOR GNE-9296","10.7554/ELIFE.84151 ",3.1,"1.15243e-41","8f0s_oligo1","DManpb1-3[DManpb1-6]DManpb1-3DGlcpNAcb1-3DGlcpNAcx1-","BMA(5_C_)-[BMA(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)",35.3938,"","",""
"8F2S","CRYO-EM STRUCTURE OF TORPEDO NICOTINIC ACETYLCHOLINE RECEPTOR IN COMPLEX WITH ROCURONIUM, PORE-BLOCKED STATE","10.1038/S41467-023-38827-5 ",2.9,"1.08527e-19","8f2s_oligo2","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(6_F_)-[MAN(5_F_)]-MAN(4_F_)-[MAN(7_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)",104.401,"","",""
"8F8W","CRYSTAL STRUCTURE OF NB.X0 BOUND TO THE AFUCOSYLATED HUMAN IGG1 FRAGMENT CRYSTAL FORM I","",2.71,93.28,"8f8w_oligo4","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_L_)-MAN(6_L_)-[NAG(5_L_)-MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(297_F_)",82.2497,"","",""
"8F8W","CRYSTAL STRUCTURE OF NB.X0 BOUND TO THE AFUCOSYLATED HUMAN IGG1 FRAGMENT CRYSTAL FORM I","",2.71,93.28,"8f8w_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_I_)-MAN(6_I_)-[NAG(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(297_A_)",77.1554,"","",""
"8F8W","CRYSTAL STRUCTURE OF NB.X0 BOUND TO THE AFUCOSYLATED HUMAN IGG1 FRAGMENT CRYSTAL FORM I","",2.71,93.28,"8f8w_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_K_)-MAN(6_K_)-[NAG(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(297_E_)",73.2138,"","",""
"8F8W","CRYSTAL STRUCTURE OF NB.X0 BOUND TO THE AFUCOSYLATED HUMAN IGG1 FRAGMENT CRYSTAL FORM I","",2.71,93.28,"8f8w_oligo3","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_J_)-MAN(6_J_)-[NAG(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(297_B_)",89.7328,"","",""
"8F8X","CRYSTAL STRUCTURE OF NB.X0 BOUND TO THE AFUCOSYLATED HUMAN IGG1 FRAGMENT CRYSTAL FORM II","",2.6,79.15,"8f8x_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_F_)-MAN(6_F_)-[NAG(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(297_B_)",85.9644,"","",""
"8F8X","CRYSTAL STRUCTURE OF NB.X0 BOUND TO THE AFUCOSYLATED HUMAN IGG1 FRAGMENT CRYSTAL FORM II","",2.6,79.15,"8f8x_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(7_E_)-MAN(6_E_)-[NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(297_A_)",84.3382,"","",""
"8FAD","ASYMMETRIC STRUCTURE OF CLEAVED HIV-1 AD8 ENVELOPE GLYCOPROTEIN TRIMER IN STYRENE-MALEIC ACID LIPID NANOPARTICLES","10.1038/S42003-023-04916-W ",4,"1.35632e-19","8fad_oligo41","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_r_)-MAN(4_r_)-[MAN(6_r_)]-BMA(3_r_)-NAG(2_r_)-NAG(1_r_)-ASN(262_A_)",84.1124,"","",""
"8FAD","ASYMMETRIC STRUCTURE OF CLEAVED HIV-1 AD8 ENVELOPE GLYCOPROTEIN TRIMER IN STYRENE-MALEIC ACID LIPID NANOPARTICLES","10.1038/S42003-023-04916-W ",4,"1.35632e-19","8fad_oligo26","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_h_)-MAN(4_h_)-BMA(3_h_)-NAG(2_h_)-NAG(1_h_)-ASN(339_E_)",206.185,"","",""
"8FAD","ASYMMETRIC STRUCTURE OF CLEAVED HIV-1 AD8 ENVELOPE GLYCOPROTEIN TRIMER IN STYRENE-MALEIC ACID LIPID NANOPARTICLES","10.1038/S42003-023-04916-W ",4,"1.35632e-19","8fad_oligo21","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_c_)-[MAN(4_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(262_E_)",127.66,"","",""
"8FAD","ASYMMETRIC STRUCTURE OF CLEAVED HIV-1 AD8 ENVELOPE GLYCOPROTEIN TRIMER IN STYRENE-MALEIC ACID LIPID NANOPARTICLES","10.1038/S42003-023-04916-W ",4,"1.35632e-19","8fad_oligo16","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_M_)-[MAN(5_M_)-MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(262_C_)",83.9999,"","",""
"8FCZ","CRYSTAL STRUCTURE OF GROUND-STATE RHODOPSIN IN COMPLEX WITH A NANOBODY","",3.7,211.1,"8fcz_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(15_B_)",222.166,"","",""
"8FCZ","CRYSTAL STRUCTURE OF GROUND-STATE RHODOPSIN IN COMPLEX WITH A NANOBODY","",3.7,211.1,"8fcz_oligo1","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-[NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(15_A_)",228.688,"","",""
"8FD0","CRYSTAL STRUCTURE OF BOVINE ROD OPSIN IN COMPLEX WITH A NANOBODY","",3.71,230.9,"8fd0_oligo1","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-[NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(15_A_)",248.428,"","",""
"8FD0","CRYSTAL STRUCTURE OF BOVINE ROD OPSIN IN COMPLEX WITH A NANOBODY","",3.71,230.9,"8fd0_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(15_B_)",234.581,"","",""
"8FD1","CRYSTAL STRUCTURE OF PHOTOACTIVATED RHODOPSIN IN COMPLEX WITH A NANOBODY","",4.25,291.8,"8fd1_oligo1","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-[NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(15_A_)",319.058,"","",""
"8FD1","CRYSTAL STRUCTURE OF PHOTOACTIVATED RHODOPSIN IN COMPLEX WITH A NANOBODY","",4.25,291.8,"8fd1_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(15_B_)",304.517,"","",""
"8FDW","CRYO-EM STRUCTURE OF SARS-COV-2 POSTFUSION SPIKE IN MEMBRANE","10.1038/S41586-023-06273-4 ",2.9,0,"8fdw_oligo2","DManpa1-3DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(1098_B_)",102.739,"","",""
"8FDW","CRYO-EM STRUCTURE OF SARS-COV-2 POSTFUSION SPIKE IN MEMBRANE","10.1038/S41586-023-06273-4 ",2.9,0,"8fdw_oligo9","DManpa1-3DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_O_)-MAN(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(1134_C_)",90.6373,"","",""
"8FDW","CRYO-EM STRUCTURE OF SARS-COV-2 POSTFUSION SPIKE IN MEMBRANE","10.1038/S41586-023-06273-4 ",2.9,0,"8fdw_oligo8","DManpa1-3DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_N_)-MAN(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(1098_C_)",102.739,"","",""
"8FDW","CRYO-EM STRUCTURE OF SARS-COV-2 POSTFUSION SPIKE IN MEMBRANE","10.1038/S41586-023-06273-4 ",2.9,0,"8fdw_oligo4","DManpa1-3DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_J_)-MAN(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(1134_A_)",90.6373,"","",""
"8FDW","CRYO-EM STRUCTURE OF SARS-COV-2 POSTFUSION SPIKE IN MEMBRANE","10.1038/S41586-023-06273-4 ",2.9,0,"8fdw_oligo1","DManpa1-3DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-MAN(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(1134_B_)",90.6373,"","",""
"8FDW","CRYO-EM STRUCTURE OF SARS-COV-2 POSTFUSION SPIKE IN MEMBRANE","10.1038/S41586-023-06273-4 ",2.9,0,"8fdw_oligo3","DManpa1-3DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_I_)-MAN(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(1098_A_)",102.739,"","",""
"8FFE","CRYSTAL STRUCTURE OF LRP6 E1E2 DOMAINS BOUND TO YW210.09 FAB AND ENGINEERED XWNT8 PEPTIDE","10.1073/PNAS.2218238120 ",1.72,38.7,"8ffe_oligo3","DManpa1-3[DGlcpNAcb1-4]DGlcpNAcb1-ASN","NAG(3_D_)-[MAN(2_D_)]-NAG(1_D_)-ASN(281_A_)",88.0948,"","",""
"8FFE","CRYSTAL STRUCTURE OF LRP6 E1E2 DOMAINS BOUND TO YW210.09 FAB AND ENGINEERED XWNT8 PEPTIDE","10.1073/PNAS.2218238120 ",1.72,38.7,"8ffe_oligo1","LFucpa1-3[DGlcpNAcb1-4][LFucpa1-6]DGlcpNAcb1-ASN","FUC(4_B_)-[NAG(3_B_)]-[FUC(2_B_)]-NAG(1_B_)-ASN(486_A_)",87.4034,"","",""
"8FFE","CRYSTAL STRUCTURE OF LRP6 E1E2 DOMAINS BOUND TO YW210.09 FAB AND ENGINEERED XWNT8 PEPTIDE","10.1073/PNAS.2218238120 ",1.72,38.7,"8ffe_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(5_C_)-[BMA(3_C_)-NAG(2_C_)]-[FUC(4_C_)]-NAG(1_C_)-ASN(433_A_)",55.5996,"","",""
"8FHD","CRYO-EM STRUCTURE OF HUMAN VOLTAGE-GATED SODIUM CHANNEL NAV1.6","10.1073/PNAS.2220578120 ",3.1,"1.08527e-19","8fhd_oligo2","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_D_)-MAN(5_D_)-[MAN(7_D_)]-MAN(4_D_)-[MAN(9_D_)-MAN(8_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(326_A_)",174.537,"","",""
"8FIA","THE STRUCTURE OF FLY TENEURIN SELF ASSEMBLY","10.15252/EMBR.202256728 ",2.4,68.53,"8fia_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_D_)-[MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(2091_A_)",94.9194,"","",""
"8FIA","THE STRUCTURE OF FLY TENEURIN SELF ASSEMBLY","10.15252/EMBR.202256728 ",2.4,68.53,"8fia_oligo1","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(857_A_)",77.322,"","",""
"8FIS","STRUCTURE OF BISPECIFIC CAP256V2LS-J3 FAB IN COMPLEX WITH BG505 DS- SOSIP.664","10.1080/19420862.2023.2165390 ",3.18,0.00048876,"8fis_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_T_)-[MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(363_C_)",90.0496,"","",""
"8FIS","STRUCTURE OF BISPECIFIC CAP256V2LS-J3 FAB IN COMPLEX WITH BG505 DS- SOSIP.664","10.1080/19420862.2023.2165390 ",3.18,0.00048876,"8fis_oligo29","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_X_)-[MAN(4_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(156_C_)",100.376,"","",""
"8FIS","STRUCTURE OF BISPECIFIC CAP256V2LS-J3 FAB IN COMPLEX WITH BG505 DS- SOSIP.664","10.1080/19420862.2023.2165390 ",3.18,0.00048876,"8fis_oligo39","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_w_)-[MAN(4_w_)]-BMA(3_w_)-NAG(2_w_)-NAG(1_w_)-ASN(160_G_)",72.2878,"","",""
"8FIS","STRUCTURE OF BISPECIFIC CAP256V2LS-J3 FAB IN COMPLEX WITH BG505 DS- SOSIP.664","10.1080/19420862.2023.2165390 ",3.18,0.00048876,"8fis_oligo9","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_M_)-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(262_C_)",58.5386,"","",""
"8FIS","STRUCTURE OF BISPECIFIC CAP256V2LS-J3 FAB IN COMPLEX WITH BG505 DS- SOSIP.664","10.1080/19420862.2023.2165390 ",3.18,0.00048876,"8fis_oligo14","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_c_)-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(262_F_)",45.7666,"","",""
"8FIS","STRUCTURE OF BISPECIFIC CAP256V2LS-J3 FAB IN COMPLEX WITH BG505 DS- SOSIP.664","10.1080/19420862.2023.2165390 ",3.18,0.00048876,"8fis_oligo41","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_y_)-[MAN(4_y_)]-BMA(3_y_)-NAG(2_y_)-NAG(1_y_)-ASN(156_G_)",98.3051,"","",""
"8FIS","STRUCTURE OF BISPECIFIC CAP256V2LS-J3 FAB IN COMPLEX WITH BG505 DS- SOSIP.664","10.1080/19420862.2023.2165390 ",3.18,0.00048876,"8fis_oligo30","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Y_)-[MAN(4_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(448_C_)",113.123,"","",""
"8FIS","STRUCTURE OF BISPECIFIC CAP256V2LS-J3 FAB IN COMPLEX WITH BG505 DS- SOSIP.664","10.1080/19420862.2023.2165390 ",3.18,0.00048876,"8fis_oligo27","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_p_)-BMA(3_p_)-NAG(2_p_)-NAG(1_p_)-ASN(262_G_)",57.4927,"","",""
"8FLW","CRYO-EM STRUCTURE OF PGT145 DU303 FAB IN COMPLEX WITH BG505 DS- SOSIP.664","10.1016/J.CELREP.2023.112711 ",3.58,"1.08527e-19","8flw_oligo16","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_X_)-[MAN(5_X_)-MAN(4_X_)]-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(262_I_)",60.0806,"","",""
"8FLW","CRYO-EM STRUCTURE OF PGT145 DU303 FAB IN COMPLEX WITH BG505 DS- SOSIP.664","10.1016/J.CELREP.2023.112711 ",3.58,"1.08527e-19","8flw_oligo1","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_N_)-[MAN(5_N_)-MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(160_C_)",60.7071,"","",""
"8FLW","CRYO-EM STRUCTURE OF PGT145 DU303 FAB IN COMPLEX WITH BG505 DS- SOSIP.664","10.1016/J.CELREP.2023.112711 ",3.58,"1.08527e-19","8flw_oligo9","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Q_)-[MAN(5_Q_)-MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(262_G_)",60.7438,"","",""
"8FLW","CRYO-EM STRUCTURE OF PGT145 DU303 FAB IN COMPLEX WITH BG505 DS- SOSIP.664","10.1016/J.CELREP.2023.112711 ",3.58,"1.08527e-19","8flw_oligo7","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-SER","MAN(6_E_)-[MAN(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-SER(447_C_)",52.9086,"","",""
"8FR6","ANTIBODY VFP53.02 IN COMPLEX WITH HIV-1 ENVELOPE TRIMER BG505 DS-SOSIP","10.1128/JVI.01604-22 ",2.5,"1.08527e-19","8fr6_oligo13","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_b_)-[MAN(4_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(156_G_)",146.459,"","",""
"8FR6","ANTIBODY VFP53.02 IN COMPLEX WITH HIV-1 ENVELOPE TRIMER BG505 DS-SOSIP","10.1128/JVI.01604-22 ",2.5,"1.08527e-19","8fr6_oligo25","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_k_)-[MAN(4_k_)]-BMA(3_k_)-NAG(2_k_)-NAG(1_k_)-ASN(386_G_)",153.773,"","",""
"8FR6","ANTIBODY VFP53.02 IN COMPLEX WITH HIV-1 ENVELOPE TRIMER BG505 DS-SOSIP","10.1128/JVI.01604-22 ",2.5,"1.08527e-19","8fr6_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(156_C_)",146.459,"","",""
"8FR6","ANTIBODY VFP53.02 IN COMPLEX WITH HIV-1 ENVELOPE TRIMER BG505 DS-SOSIP","10.1128/JVI.01604-22 ",2.5,"1.08527e-19","8fr6_oligo33","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_s_)-[MAN(5_s_)-MAN(4_s_)]-BMA(3_s_)-NAG(2_s_)-NAG(1_s_)-ASN(262_I_)",119.866,"","",""
"8FR6","ANTIBODY VFP53.02 IN COMPLEX WITH HIV-1 ENVELOPE TRIMER BG505 DS-SOSIP","10.1128/JVI.01604-22 ",2.5,"1.08527e-19","8fr6_oligo19","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_e_)-[MAN(5_e_)-MAN(4_e_)]-BMA(3_e_)-NAG(2_e_)-NAG(1_e_)-ASN(262_G_)",119.866,"","",""
"8FR6","ANTIBODY VFP53.02 IN COMPLEX WITH HIV-1 ENVELOPE TRIMER BG505 DS-SOSIP","10.1128/JVI.01604-22 ",2.5,"1.08527e-19","8fr6_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_W_)-[MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(386_C_)",153.773,"","",""
"8FR6","ANTIBODY VFP53.02 IN COMPLEX WITH HIV-1 ENVELOPE TRIMER BG505 DS-SOSIP","10.1128/JVI.01604-22 ",2.5,"1.08527e-19","8fr6_oligo30","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_p_)-[MAN(4_p_)]-BMA(3_p_)-NAG(2_p_)-NAG(1_p_)-ASN(156_I_)",146.459,"","",""
"8FR6","ANTIBODY VFP53.02 IN COMPLEX WITH HIV-1 ENVELOPE TRIMER BG505 DS-SOSIP","10.1128/JVI.01604-22 ",2.5,"1.08527e-19","8fr6_oligo9","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Q_)-[MAN(5_Q_)-MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(262_C_)",119.866,"","",""
"8FR6","ANTIBODY VFP53.02 IN COMPLEX WITH HIV-1 ENVELOPE TRIMER BG505 DS-SOSIP","10.1128/JVI.01604-22 ",2.5,"1.08527e-19","8fr6_oligo39","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_y_)-[MAN(4_y_)]-BMA(3_y_)-NAG(2_y_)-NAG(1_y_)-ASN(386_I_)",153.773,"","",""
"8FWQ","STRUCTURE OF KAINATE RECEPTOR GLUK2 IN COMPLEX WITH THE POSITIVE ALLOSTERIC MODULATOR BPAM344","10.1016/J.CELREP.2023.112124 ",3.96,"1.15243e-41","8fwq_oligo2","DManpb1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(546_B_)",142.147,"","",""
"8FWQ","STRUCTURE OF KAINATE RECEPTOR GLUK2 IN COMPLEX WITH THE POSITIVE ALLOSTERIC MODULATOR BPAM344","10.1016/J.CELREP.2023.112124 ",3.96,"1.15243e-41","8fwq_oligo11","DManpb1-3DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(378_C_)",75.8521,"","",""
"8FWQ","STRUCTURE OF KAINATE RECEPTOR GLUK2 IN COMPLEX WITH THE POSITIVE ALLOSTERIC MODULATOR BPAM344","10.1016/J.CELREP.2023.112124 ",3.96,"1.15243e-41","8fwq_oligo14","DManpb1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_R_)-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(546_D_)",133.493,"","",""
"8FWQ","STRUCTURE OF KAINATE RECEPTOR GLUK2 IN COMPLEX WITH THE POSITIVE ALLOSTERIC MODULATOR BPAM344","10.1016/J.CELREP.2023.112124 ",3.96,"1.15243e-41","8fwq_oligo3","DManpb1-3DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(378_A_)",81.4876,"","",""
"8FWS","STRUCTURE OF THE LIGAND-BINDING AND TRANSMEMBRANE DOMAINS OF KAINATE RECEPTOR GLUK2 IN COMPLEX WITH THE POSITIVE ALLOSTERIC MODULATOR BPAM344","10.1016/J.CELREP.2023.112124 ",3.23,"1.15243e-41","8fws_oligo1","DManpb1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(546_B_)",36.8109,"","",""
"8FWS","STRUCTURE OF THE LIGAND-BINDING AND TRANSMEMBRANE DOMAINS OF KAINATE RECEPTOR GLUK2 IN COMPLEX WITH THE POSITIVE ALLOSTERIC MODULATOR BPAM344","10.1016/J.CELREP.2023.112124 ",3.23,"1.15243e-41","8fws_oligo6","DManpb1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(546_D_)",35.095,"","",""
"8FWU","STRUCTURE OF THE LIGAND-BINDING AND TRANSMEMBRANE DOMAINS OF KAINATE RECEPTOR GLUK2 IN COMPLEX WITH THE POSITIVE ALLOSTERIC MODULATOR BPAM344 AND COMPETITIVE ANTAGONIST DNQX","10.1016/J.CELREP.2023.112124 ",3.18,"1.15243e-41","8fwu_oligo4","DManpb1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(546_B_)",33.9941,"","",""
"8FWU","STRUCTURE OF THE LIGAND-BINDING AND TRANSMEMBRANE DOMAINS OF KAINATE RECEPTOR GLUK2 IN COMPLEX WITH THE POSITIVE ALLOSTERIC MODULATOR BPAM344 AND COMPETITIVE ANTAGONIST DNQX","10.1016/J.CELREP.2023.112124 ",3.18,"1.15243e-41","8fwu_oligo3","DManpb1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(546_D_)",27.2591,"","",""
"8FWW","STRUCTURE OF THE LIGAND-BINDING AND TRANSMEMBRANE DOMAINS OF KAINATE RECEPTOR GLUK2 IN COMPLEX WITH THE POSITIVE ALLOSTERIC MODULATOR BPAM344 AND NONCOMPETITIVE INHIBITOR PERAMPANEL","10.1016/J.CELREP.2023.112124 ",3.1,"1.15243e-41","8fww_oligo9","DManpb1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_I_)-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(546_D_)",22.6259,"","",""
"8FWW","STRUCTURE OF THE LIGAND-BINDING AND TRANSMEMBRANE DOMAINS OF KAINATE RECEPTOR GLUK2 IN COMPLEX WITH THE POSITIVE ALLOSTERIC MODULATOR BPAM344 AND NONCOMPETITIVE INHIBITOR PERAMPANEL","10.1016/J.CELREP.2023.112124 ",3.1,"1.15243e-41","8fww_oligo3","DManpb1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(546_B_)",21.5075,"","",""
"8G18","HETERODIMER OF THE GLUN1B-GLUN2B NMDA RECEPTOR AMINO-TERMINAL DOMAINS BOUND TO ALLOSTERIC INHIBITOR 93-108","10.1021/ACSCHEMNEURO.2C00779 ",2.85,51.91,"8g18_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)",20,"","",""
"8G30","N2 NEURAMINIDASE OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH 4 FNI19 FAB MOLECULES","10.1038/S41586-023-06136-Y ",3.1,"1.08527e-19","8g30_oligo15","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_s_)-[MAN(7_s_)]-MAN(6_s_)-[MAN(5_s_)-MAN(4_s_)]-BMA(3_s_)-NAG(2_s_)-NAG(1_s_)-ASN(200_O_)",151.008,"","",""
"8G30","N2 NEURAMINIDASE OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH 4 FNI19 FAB MOLECULES","10.1038/S41586-023-06136-Y ",3.1,"1.08527e-19","8g30_oligo5","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_k_)-[MAN(7_k_)]-MAN(6_k_)-[MAN(5_k_)-MAN(4_k_)]-BMA(3_k_)-NAG(2_k_)-NAG(1_k_)-ASN(200_N_)",150.754,"","",""
"8G30","N2 NEURAMINIDASE OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH 4 FNI19 FAB MOLECULES","10.1038/S41586-023-06136-Y ",3.1,"1.08527e-19","8g30_oligo11","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_c_)-[MAN(7_c_)]-MAN(6_c_)-[MAN(5_c_)-MAN(4_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(200_M_)",149.749,"","",""
"8G30","N2 NEURAMINIDASE OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH 4 FNI19 FAB MOLECULES","10.1038/S41586-023-06136-Y ",3.1,"1.08527e-19","8g30_oligo21","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_3_)-[MAN(7_3_)]-MAN(6_3_)-[MAN(5_3_)-MAN(4_3_)]-BMA(3_3_)-NAG(2_3_)-NAG(1_3_)-ASN(200_P_)",150.737,"","",""
"8G3M","N2 NEURAMINIDASE OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH 3 FNI9 FAB MOLECULES","10.1038/S41586-023-06136-Y ",3,"1.08527e-19","8g3m_oligo21","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_U_)-[MAN(7_U_)]-MAN(6_U_)-[MAN(5_U_)-MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(200_L_)",109.522,"","",""
"8G3M","N2 NEURAMINIDASE OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH 3 FNI9 FAB MOLECULES","10.1038/S41586-023-06136-Y ",3,"1.08527e-19","8g3m_oligo15","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_T_)-[MAN(7_T_)]-MAN(6_T_)-[MAN(5_T_)-MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(200_K_)",112.937,"","",""
"8G3M","N2 NEURAMINIDASE OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH 3 FNI9 FAB MOLECULES","10.1038/S41586-023-06136-Y ",3,"1.08527e-19","8g3m_oligo4","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_s_)-[MAN(7_s_)]-MAN(6_s_)-[MAN(5_s_)-MAN(4_s_)]-BMA(3_s_)-NAG(2_s_)-NAG(1_s_)-ASN(200_G_)",116.749,"","",""
"8G3M","N2 NEURAMINIDASE OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH 3 FNI9 FAB MOLECULES","10.1038/S41586-023-06136-Y ",3,"1.08527e-19","8g3m_oligo6","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_S_)-[MAN(7_S_)]-MAN(6_S_)-[MAN(5_S_)-MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(200_J_)",103.872,"","",""
"8G3N","N2 NEURAMINIDASE OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH 4 FNI9 FAB MOLECULES","10.1038/S41586-023-06136-Y ",2.9,"1.08527e-19","8g3n_oligo6","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_s_)-[MAN(7_s_)]-MAN(6_s_)-[MAN(5_s_)-MAN(4_s_)]-BMA(3_s_)-NAG(2_s_)-NAG(1_s_)-ASN(200_G_)",97.4353,"","",""
"8G3N","N2 NEURAMINIDASE OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH 4 FNI9 FAB MOLECULES","10.1038/S41586-023-06136-Y ",2.9,"1.08527e-19","8g3n_oligo20","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_U_)-[MAN(7_U_)]-MAN(6_U_)-[MAN(5_U_)-MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(200_L_)",97.4265,"","",""
"8G3N","N2 NEURAMINIDASE OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH 4 FNI9 FAB MOLECULES","10.1038/S41586-023-06136-Y ",2.9,"1.08527e-19","8g3n_oligo4","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_S_)-[MAN(7_S_)]-MAN(6_S_)-[MAN(5_S_)-MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(200_J_)",97.4011,"","",""
"8G3N","N2 NEURAMINIDASE OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH 4 FNI9 FAB MOLECULES","10.1038/S41586-023-06136-Y ",2.9,"1.08527e-19","8g3n_oligo14","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_T_)-[MAN(7_T_)]-MAN(6_T_)-[MAN(5_T_)-MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(200_K_)",97.4069,"","",""
"8G3O","N2 NEURAMINIDASE OF A/HONG_KONG/2671/2019 IN COMPLEX WITH 3 FNI9 FAB MOLECULES","10.1038/S41586-023-06136-Y ",3.1,"1.08527e-19","8g3o_oligo1","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_k_)-[MAN(7_k_)]-MAN(6_k_)-[MAN(5_k_)-MAN(4_k_)]-BMA(3_k_)-NAG(2_k_)-NAG(1_k_)-ASN(200_H_)",128.259,"","",""
"8G3O","N2 NEURAMINIDASE OF A/HONG_KONG/2671/2019 IN COMPLEX WITH 3 FNI9 FAB MOLECULES","10.1038/S41586-023-06136-Y ",3.1,"1.08527e-19","8g3o_oligo2","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_3_)-[MAN(7_3_)]-MAN(6_3_)-[MAN(5_3_)-MAN(4_3_)]-BMA(3_3_)-NAG(2_3_)-NAG(1_3_)-ASN(200_J_)",146.598,"","",""
"8G3O","N2 NEURAMINIDASE OF A/HONG_KONG/2671/2019 IN COMPLEX WITH 3 FNI9 FAB MOLECULES","10.1038/S41586-023-06136-Y ",3.1,"1.08527e-19","8g3o_oligo7","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_s_)-[MAN(7_s_)]-MAN(6_s_)-[MAN(5_s_)-MAN(4_s_)]-BMA(3_s_)-NAG(2_s_)-NAG(1_s_)-ASN(200_B_)",127.726,"","",""
"8G3O","N2 NEURAMINIDASE OF A/HONG_KONG/2671/2019 IN COMPLEX WITH 3 FNI9 FAB MOLECULES","10.1038/S41586-023-06136-Y ",3.1,"1.08527e-19","8g3o_oligo5","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_c_)-[MAN(7_c_)]-MAN(6_c_)-[MAN(5_c_)-MAN(4_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(200_G_)",129.074,"","",""
"8G3P","N2 NEURAMINIDASE OF A/HONG_KONG/2671/2019 IN COMPLEX WITH 4 FNI9 FAB MOLECULES","10.1038/S41586-023-06136-Y ",2.5,"1.08527e-19","8g3p_oligo7","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_s_)-[MAN(7_s_)]-MAN(6_s_)-[MAN(5_s_)-MAN(4_s_)]-BMA(3_s_)-NAG(2_s_)-NAG(1_s_)-ASN(200_B_)",88.3875,"","",""
"8G3P","N2 NEURAMINIDASE OF A/HONG_KONG/2671/2019 IN COMPLEX WITH 4 FNI9 FAB MOLECULES","10.1038/S41586-023-06136-Y ",2.5,"1.08527e-19","8g3p_oligo19","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_U_)-[MAN(7_U_)]-MAN(6_U_)-[MAN(5_U_)-MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(200_E_)",88.3216,"","",""
"8G3P","N2 NEURAMINIDASE OF A/HONG_KONG/2671/2019 IN COMPLEX WITH 4 FNI9 FAB MOLECULES","10.1038/S41586-023-06136-Y ",2.5,"1.08527e-19","8g3p_oligo2","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_S_)-[MAN(7_S_)]-MAN(6_S_)-[MAN(5_S_)-MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(200_A_)",88.3861,"","",""
"8G3P","N2 NEURAMINIDASE OF A/HONG_KONG/2671/2019 IN COMPLEX WITH 4 FNI9 FAB MOLECULES","10.1038/S41586-023-06136-Y ",2.5,"1.08527e-19","8g3p_oligo13","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_T_)-[MAN(7_T_)]-MAN(6_T_)-[MAN(5_T_)-MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(200_D_)",88.3419,"","",""
"8G3Q","N2 NEURAMINIDASE OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH 3 FNI17 FAB MOLECULES","10.1038/S41586-023-06136-Y ",2.3,"1.08527e-19","8g3q_oligo11","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_c_)-[MAN(7_c_)]-MAN(6_c_)-[MAN(5_c_)-MAN(4_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(200_E_)",69.6674,"","",""
"8G3Q","N2 NEURAMINIDASE OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH 3 FNI17 FAB MOLECULES","10.1038/S41586-023-06136-Y ",2.3,"1.08527e-19","8g3q_oligo21","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_3_)-[MAN(7_3_)]-MAN(6_3_)-[MAN(5_3_)-MAN(4_3_)]-BMA(3_3_)-NAG(2_3_)-NAG(1_3_)-ASN(200_H_)",73.4307,"","",""
"8G3Q","N2 NEURAMINIDASE OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH 3 FNI17 FAB MOLECULES","10.1038/S41586-023-06136-Y ",2.3,"1.08527e-19","8g3q_oligo15","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_s_)-[MAN(7_s_)]-MAN(6_s_)-[MAN(5_s_)-MAN(4_s_)]-BMA(3_s_)-NAG(2_s_)-NAG(1_s_)-ASN(200_G_)",72.3917,"","",""
"8G3Q","N2 NEURAMINIDASE OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH 3 FNI17 FAB MOLECULES","10.1038/S41586-023-06136-Y ",2.3,"1.08527e-19","8g3q_oligo14","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_k_)-[MAN(7_k_)]-MAN(6_k_)-[MAN(5_k_)-MAN(4_k_)]-BMA(3_k_)-NAG(2_k_)-NAG(1_k_)-ASN(200_F_)",71.9847,"","",""
"8G3R","N2 NEURAMINIDASE OF A/TANZANIA/205/2010 H3N2 WITH S245N S247T MUTATIONS IN COMPLEX WITH ONE FNI17 FAB MOLECULE","10.1038/S41586-023-06136-Y ",2.3,"1.08527e-19","8g3r_oligo22","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_s_)-[MAN(7_s_)]-MAN(6_s_)-[MAN(5_s_)-MAN(4_s_)]-BMA(3_s_)-NAG(2_s_)-NAG(1_s_)-ASN(200_G_)",78.1568,"","",""
"8G3R","N2 NEURAMINIDASE OF A/TANZANIA/205/2010 H3N2 WITH S245N S247T MUTATIONS IN COMPLEX WITH ONE FNI17 FAB MOLECULE","10.1038/S41586-023-06136-Y ",2.3,"1.08527e-19","8g3r_oligo16","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_k_)-[MAN(7_k_)]-MAN(6_k_)-[MAN(5_k_)-MAN(4_k_)]-BMA(3_k_)-NAG(2_k_)-NAG(1_k_)-ASN(200_F_)",77.9231,"","",""
"8G3R","N2 NEURAMINIDASE OF A/TANZANIA/205/2010 H3N2 WITH S245N S247T MUTATIONS IN COMPLEX WITH ONE FNI17 FAB MOLECULE","10.1038/S41586-023-06136-Y ",2.3,"1.08527e-19","8g3r_oligo2","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_c_)-[MAN(7_c_)]-MAN(6_c_)-[MAN(5_c_)-MAN(4_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(200_E_)",75.3932,"","",""
"8G3R","N2 NEURAMINIDASE OF A/TANZANIA/205/2010 H3N2 WITH S245N S247T MUTATIONS IN COMPLEX WITH ONE FNI17 FAB MOLECULE","10.1038/S41586-023-06136-Y ",2.3,"1.08527e-19","8g3r_oligo10","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_3_)-[MAN(7_3_)]-MAN(6_3_)-[MAN(5_3_)-MAN(4_3_)]-BMA(3_3_)-NAG(2_3_)-NAG(1_3_)-ASN(200_H_)",77.7738,"","",""
"8G3V","N2 NEURAMINIDASE OF A/HONG_KONG/2671/2019 IN COMPLEX WITH 4 FNI19 FAB MOLECULES","10.1038/S41586-023-06136-Y ",2.21,"5.50295e+11","8g3v_oligo1","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_F_)-[MAN(7_F_)]-MAN(6_F_)-[MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(200_G_)",72.0359,"","",""
"8G3V","N2 NEURAMINIDASE OF A/HONG_KONG/2671/2019 IN COMPLEX WITH 4 FNI19 FAB MOLECULES","10.1038/S41586-023-06136-Y ",2.21,"5.50295e+11","8g3v_oligo11","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_W_)-[MAN(7_W_)]-MAN(6_W_)-[MAN(5_W_)-MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(200_J_)",72.01,"","",""
"8G3V","N2 NEURAMINIDASE OF A/HONG_KONG/2671/2019 IN COMPLEX WITH 4 FNI19 FAB MOLECULES","10.1038/S41586-023-06136-Y ",2.21,"5.50295e+11","8g3v_oligo3","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_T_)-[MAN(7_T_)]-MAN(6_T_)-[MAN(5_T_)-MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(200_I_)",72.0668,"","",""
"8G3V","N2 NEURAMINIDASE OF A/HONG_KONG/2671/2019 IN COMPLEX WITH 4 FNI19 FAB MOLECULES","10.1038/S41586-023-06136-Y ",2.21,"5.50295e+11","8g3v_oligo7","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_Q_)-[MAN(7_Q_)]-MAN(6_Q_)-[MAN(5_Q_)-MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(200_H_)",71.993,"","",""
"8G40","N2 NEURAMINIDASE OF A/HONG_KONG/2671/2019 IN COMPLEX WITH 3 FNI19 FAB MOLECULES","10.1038/S41586-023-06136-Y ",2.8,"5.50295e+11","8g40_oligo11","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_3_)-[MAN(7_3_)]-MAN(6_3_)-[MAN(5_3_)-MAN(4_3_)]-BMA(3_3_)-NAG(2_3_)-NAG(1_3_)-ASN(200_J_)",102.554,"","",""
"8G40","N2 NEURAMINIDASE OF A/HONG_KONG/2671/2019 IN COMPLEX WITH 3 FNI19 FAB MOLECULES","10.1038/S41586-023-06136-Y ",2.8,"5.50295e+11","8g40_oligo9","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_c_)-[MAN(7_c_)]-MAN(6_c_)-[MAN(5_c_)-MAN(4_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(200_G_)",77.8418,"","",""
"8G40","N2 NEURAMINIDASE OF A/HONG_KONG/2671/2019 IN COMPLEX WITH 3 FNI19 FAB MOLECULES","10.1038/S41586-023-06136-Y ",2.8,"5.50295e+11","8g40_oligo10","DManpa1-2DManpa1-3[DManpa1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_s_)-MAN(6_s_)-[MAN(5_s_)-MAN(4_s_)]-BMA(3_s_)-NAG(2_s_)-NAG(1_s_)-ASN(200_I_)",72.1523,"","",""
"8G40","N2 NEURAMINIDASE OF A/HONG_KONG/2671/2019 IN COMPLEX WITH 3 FNI19 FAB MOLECULES","10.1038/S41586-023-06136-Y ",2.8,"5.50295e+11","8g40_oligo1","DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_k_)-[MAN(7_k_)]-MAN(6_k_)-[MAN(5_k_)-MAN(4_k_)]-BMA(3_k_)-NAG(2_k_)-NAG(1_k_)-ASN(200_H_)",87.4539,"","",""
"8G4M","VACCINE-ELICITED HUMAN ANTIBODY 2C06 IN COMPLEX WITH HIV-1 ENVELOPE TRIMER BG505 DS-SOSIP","10.1016/J.CELREP.2023.112755 ",2.95,0.00048876,"8g4m_oligo29","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_a_)-[MAN(4_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(88_G_)",138.542,"","",""
"8G4M","VACCINE-ELICITED HUMAN ANTIBODY 2C06 IN COMPLEX WITH HIV-1 ENVELOPE TRIMER BG505 DS-SOSIP","10.1016/J.CELREP.2023.112755 ",2.95,0.00048876,"8g4m_oligo33","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_e_)-MAN(4_e_)-BMA(3_e_)-NAG(2_e_)-NAG(1_e_)-ASN(262_G_)",151.516,"","",""
"8G4M","VACCINE-ELICITED HUMAN ANTIBODY 2C06 IN COMPLEX WITH HIV-1 ENVELOPE TRIMER BG505 DS-SOSIP","10.1016/J.CELREP.2023.112755 ",2.95,0.00048876,"8g4m_oligo15","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_o_)-[MAN(4_o_)]-BMA(3_o_)-NAG(2_o_)-NAG(1_o_)-ASN(88_I_)",145.314,"","",""
"8G4M","VACCINE-ELICITED HUMAN ANTIBODY 2C06 IN COMPLEX WITH HIV-1 ENVELOPE TRIMER BG505 DS-SOSIP","10.1016/J.CELREP.2023.112755 ",2.95,0.00048876,"8g4m_oligo20","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_t_)-[MAN(5_t_)-MAN(4_t_)]-BMA(3_t_)-NAG(2_t_)-NAG(1_t_)-ASN(262_I_)",160.55,"","",""
"8G4M","VACCINE-ELICITED HUMAN ANTIBODY 2C06 IN COMPLEX WITH HIV-1 ENVELOPE TRIMER BG505 DS-SOSIP","10.1016/J.CELREP.2023.112755 ",2.95,0.00048876,"8g4m_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(88_C_)",146.259,"","",""
"8G4M","VACCINE-ELICITED HUMAN ANTIBODY 2C06 IN COMPLEX WITH HIV-1 ENVELOPE TRIMER BG505 DS-SOSIP","10.1016/J.CELREP.2023.112755 ",2.95,0.00048876,"8g4m_oligo3","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Q_)-[MAN(5_Q_)-MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(262_C_)",148.856,"","",""
"8G4T","VACCINE-ELICITED HUMAN ANTIBODY 2C09 IN COMPLEX WITH HIV-1 ENVELOPE TRIMER BG505 DS-SOSIP","10.1016/J.CELREP.2023.112755 ",2.81,"5.37397e+08","8g4t_oligo25","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_b_)-[MAN(4_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(88_G_)",136.735,"","",""
"8G4T","VACCINE-ELICITED HUMAN ANTIBODY 2C09 IN COMPLEX WITH HIV-1 ENVELOPE TRIMER BG505 DS-SOSIP","10.1016/J.CELREP.2023.112755 ",2.81,"5.37397e+08","8g4t_oligo17","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_q_)-[MAN(4_q_)]-BMA(3_q_)-NAG(2_q_)-NAG(1_q_)-ASN(88_I_)",137.029,"","",""
"8G4T","VACCINE-ELICITED HUMAN ANTIBODY 2C09 IN COMPLEX WITH HIV-1 ENVELOPE TRIMER BG505 DS-SOSIP","10.1016/J.CELREP.2023.112755 ",2.81,"5.37397e+08","8g4t_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(88_C_)",136.883,"","",""
"8G4T","VACCINE-ELICITED HUMAN ANTIBODY 2C09 IN COMPLEX WITH HIV-1 ENVELOPE TRIMER BG505 DS-SOSIP","10.1016/J.CELREP.2023.112755 ",2.81,"5.37397e+08","8g4t_oligo30","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_g_)-[MAN(5_g_)-MAN(4_g_)]-BMA(3_g_)-NAG(2_g_)-NAG(1_g_)-ASN(262_G_)",148.411,"","",""
"8G4T","VACCINE-ELICITED HUMAN ANTIBODY 2C09 IN COMPLEX WITH HIV-1 ENVELOPE TRIMER BG505 DS-SOSIP","10.1016/J.CELREP.2023.112755 ",2.81,"5.37397e+08","8g4t_oligo22","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_v_)-[MAN(5_v_)-MAN(4_v_)]-BMA(3_v_)-NAG(2_v_)-NAG(1_v_)-ASN(262_I_)",149.143,"","",""
"8G4T","VACCINE-ELICITED HUMAN ANTIBODY 2C09 IN COMPLEX WITH HIV-1 ENVELOPE TRIMER BG505 DS-SOSIP","10.1016/J.CELREP.2023.112755 ",2.81,"5.37397e+08","8g4t_oligo5","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_R_)-[MAN(5_R_)-MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(262_C_)",149.552,"","",""
"8G85","VFP52.02 FAB IN COMPLEX WITH BG505 DS-SOSIP ENV TRIMER","10.1128/JVI.01604-22 ",3.99,"1.08527e-19","8g85_oligo21","DManpa1-3DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-MAN(4_M_)-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(262_G_)",137.729,"","",""
"8G85","VFP52.02 FAB IN COMPLEX WITH BG505 DS-SOSIP ENV TRIMER","10.1128/JVI.01604-22 ",3.99,"1.08527e-19","8g85_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_d_)-[MAN(4_d_)]-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(262_J_)",82.2551,"","",""
"8G85","VFP52.02 FAB IN COMPLEX WITH BG505 DS-SOSIP ENV TRIMER","10.1128/JVI.01604-22 ",3.99,"1.08527e-19","8g85_oligo33","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_S_)-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(448_G_)",162.024,"","",""
"8G85","VFP52.02 FAB IN COMPLEX WITH BG505 DS-SOSIP ENV TRIMER","10.1128/JVI.01604-22 ",3.99,"1.08527e-19","8g85_oligo22","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_T_)-[MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(88_G_)",193.126,"","",""
"8G9W","CRYO-EM STRUCTURE OF VFP49.02 FAB IN COMPLEX WITH HIV-1 ENV BG505 DS- SOSIP.664 (CONFORMATION 1)","10.1128/JVI.01604-22 ",4.66,"1.08527e-19","8g9w_oligo32","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_n_)-BMA(3_n_)-NAG(2_n_)-NAG(1_n_)-ASN(262_P_)",412.418,"","",""
"8G9W","CRYO-EM STRUCTURE OF VFP49.02 FAB IN COMPLEX WITH HIV-1 ENV BG505 DS- SOSIP.664 (CONFORMATION 1)","10.1128/JVI.01604-22 ",4.66,"1.08527e-19","8g9w_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(386_E_)",530.275,"","",""
"8G9W","CRYO-EM STRUCTURE OF VFP49.02 FAB IN COMPLEX WITH HIV-1 ENV BG505 DS- SOSIP.664 (CONFORMATION 1)","10.1128/JVI.01604-22 ",4.66,"1.08527e-19","8g9w_oligo16","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_a_)-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(262_G_)",407.668,"","",""
"8G9W","CRYO-EM STRUCTURE OF VFP49.02 FAB IN COMPLEX WITH HIV-1 ENV BG505 DS- SOSIP.664 (CONFORMATION 1)","10.1128/JVI.01604-22 ",4.66,"1.08527e-19","8g9w_oligo7","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_K_)-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(262_E_)",372.501,"","",""
"8G9W","CRYO-EM STRUCTURE OF VFP49.02 FAB IN COMPLEX WITH HIV-1 ENV BG505 DS- SOSIP.664 (CONFORMATION 1)","10.1128/JVI.01604-22 ",4.66,"1.08527e-19","8g9w_oligo37","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_s_)-[MAN(4_s_)]-BMA(3_s_)-NAG(2_s_)-NAG(1_s_)-ASN(386_P_)",508.357,"","",""
"8G9W","CRYO-EM STRUCTURE OF VFP49.02 FAB IN COMPLEX WITH HIV-1 ENV BG505 DS- SOSIP.664 (CONFORMATION 1)","10.1128/JVI.01604-22 ",4.66,"1.08527e-19","8g9w_oligo21","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_f_)-[MAN(4_f_)]-BMA(3_f_)-NAG(2_f_)-NAG(1_f_)-ASN(386_G_)",494.234,"","",""
"8G9X","CRYO-EM STRUCTURE OF VFP49.02 FAB IN COMPLEX WITH HIV-1 ENV BG505 DS- SOSIP.664 (CONFORMATION 2)","10.1128/JVI.01604-22 ",4.46,"1.08527e-19","8g9x_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_K_)-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(262_E_)",364.306,"","",""
"8G9X","CRYO-EM STRUCTURE OF VFP49.02 FAB IN COMPLEX WITH HIV-1 ENV BG505 DS- SOSIP.664 (CONFORMATION 2)","10.1128/JVI.01604-22 ",4.46,"1.08527e-19","8g9x_oligo32","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_n_)-BMA(3_n_)-NAG(2_n_)-NAG(1_n_)-ASN(262_P_)",330.388,"","",""
"8G9X","CRYO-EM STRUCTURE OF VFP49.02 FAB IN COMPLEX WITH HIV-1 ENV BG505 DS- SOSIP.664 (CONFORMATION 2)","10.1128/JVI.01604-22 ",4.46,"1.08527e-19","8g9x_oligo13","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_a_)-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(262_G_)",328.489,"","",""
"8G9Y","CRYO-EM STRUCTURE OF VFP49.02 FAB IN COMPLEX WITH HIV-1 ENV BG505 DS- SOSIP.664 (CONFORMATION 3)","10.1128/JVI.01604-22 ",4.28,"1.08527e-19","8g9y_oligo37","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_s_)-[MAN(4_s_)]-BMA(3_s_)-NAG(2_s_)-NAG(1_s_)-ASN(386_P_)",375.861,"","",""
"8G9Y","CRYO-EM STRUCTURE OF VFP49.02 FAB IN COMPLEX WITH HIV-1 ENV BG505 DS- SOSIP.664 (CONFORMATION 3)","10.1128/JVI.01604-22 ",4.28,"1.08527e-19","8g9y_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_K_)-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(262_E_)",269.901,"","",""
"8G9Y","CRYO-EM STRUCTURE OF VFP49.02 FAB IN COMPLEX WITH HIV-1 ENV BG505 DS- SOSIP.664 (CONFORMATION 3)","10.1128/JVI.01604-22 ",4.28,"1.08527e-19","8g9y_oligo20","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_f_)-[MAN(4_f_)]-BMA(3_f_)-NAG(2_f_)-NAG(1_f_)-ASN(386_G_)",445.952,"","",""
"8G9Y","CRYO-EM STRUCTURE OF VFP49.02 FAB IN COMPLEX WITH HIV-1 ENV BG505 DS- SOSIP.664 (CONFORMATION 3)","10.1128/JVI.01604-22 ",4.28,"1.08527e-19","8g9y_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(386_E_)",365.397,"","",""
"8G9Y","CRYO-EM STRUCTURE OF VFP49.02 FAB IN COMPLEX WITH HIV-1 ENV BG505 DS- SOSIP.664 (CONFORMATION 3)","10.1128/JVI.01604-22 ",4.28,"1.08527e-19","8g9y_oligo15","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_a_)-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(262_G_)",259.761,"","",""
"8G9Y","CRYO-EM STRUCTURE OF VFP49.02 FAB IN COMPLEX WITH HIV-1 ENV BG505 DS- SOSIP.664 (CONFORMATION 3)","10.1128/JVI.01604-22 ",4.28,"1.08527e-19","8g9y_oligo32","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_n_)-BMA(3_n_)-NAG(2_n_)-NAG(1_n_)-ASN(262_P_)",248.972,"","",""
"8GAS","VFP48.02 FAB IN COMPLEX WITH BG505 DS-SOSIP ENV TRIMER","10.1128/JVI.01604-22 ",4.04,"1.08527e-19","8gas_oligo21","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_g_)-BMA(3_g_)-NAG(2_g_)-NAG(1_g_)-ASN(262_J_)",70.12,"","",""
"8GAS","VFP48.02 FAB IN COMPLEX WITH BG505 DS-SOSIP ENV TRIMER","10.1128/JVI.01604-22 ",4.04,"1.08527e-19","8gas_oligo16","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_S_)-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(262_G_)",71.2889,"","",""
"8GAS","VFP48.02 FAB IN COMPLEX WITH BG505 DS-SOSIP ENV TRIMER","10.1128/JVI.01604-22 ",4.04,"1.08527e-19","8gas_oligo10","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_Z_)-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(262_D_)",70.4868,"","",""
"8GB5","CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY 25F9","10.1126/SCITRANSLMED.ADG7404 ",3.35,0,"8gb5_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(343_D_)",87.8078,"","",""
"8GP5","STRUCTURE OF X18 UFO PROTOMER IN COMPLEX WITH F6 FAB VHVL DOMAIN","10.1038/S41467-023-40321-X ",4.05,0,"8gp5_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(262_X_)",131.432,"","",""
"8GP5","STRUCTURE OF X18 UFO PROTOMER IN COMPLEX WITH F6 FAB VHVL DOMAIN","10.1038/S41467-023-40321-X ",4.05,0,"8gp5_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(88_X_)",111.288,"","",""
"8GPG","HIV-1 ENV X18 UFO IN COMPLEX WITH F6 FAB","10.1038/S41467-023-40321-X ",4.1,0,"8gpg_oligo16","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_M_)-[MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(88_Z_)",100.193,"","",""
"8GPG","HIV-1 ENV X18 UFO IN COMPLEX WITH F6 FAB","10.1038/S41467-023-40321-X ",4.1,0,"8gpg_oligo13","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(88_Y_)",101.563,"","",""
"8GPG","HIV-1 ENV X18 UFO IN COMPLEX WITH F6 FAB","10.1038/S41467-023-40321-X ",4.1,0,"8gpg_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(88_X_)",98.4871,"","",""
"8GPJ","HIV-1 ENV X16 UFO IN COMPLEX WITH 8ANC195 FAB","10.1038/S41467-023-40321-X ",3.5,"1.35632e-19","8gpj_oligo27","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_m_)-BMA(3_m_)-NAG(2_m_)-NAG(1_m_)-ASN(276_Z_)",88.9609,"","",""
"8GPJ","HIV-1 ENV X16 UFO IN COMPLEX WITH 8ANC195 FAB","10.1038/S41467-023-40321-X ",3.5,"1.35632e-19","8gpj_oligo26","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_l_)-[MAN(4_l_)]-BMA(3_l_)-NAG(2_l_)-NAG(1_l_)-ASN(262_Z_)",83.28,"","",""
"8GPJ","HIV-1 ENV X16 UFO IN COMPLEX WITH 8ANC195 FAB","10.1038/S41467-023-40321-X ",3.5,"1.35632e-19","8gpj_oligo16","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_d_)-BMA(3_d_)-NAG(2_d_)-NAG(1_d_)-ASN(276_Y_)",86.0582,"","",""
"8GPJ","HIV-1 ENV X16 UFO IN COMPLEX WITH 8ANC195 FAB","10.1038/S41467-023-40321-X ",3.5,"1.35632e-19","8gpj_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_O_)-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(276_X_)",87.5632,"","",""
"8GPJ","HIV-1 ENV X16 UFO IN COMPLEX WITH 8ANC195 FAB","10.1038/S41467-023-40321-X ",3.5,"1.35632e-19","8gpj_oligo13","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_a_)-MAN(8_a_)-[MAN(10_a_)]-MAN(7_a_)-[MAN(6_a_)-MAN(5_a_)-MAN(4_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(234_Y_)",82.2711,"","",""
"8GPJ","HIV-1 ENV X16 UFO IN COMPLEX WITH 8ANC195 FAB","10.1038/S41467-023-40321-X ",3.5,"1.35632e-19","8gpj_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(262_X_)",79.1638,"","",""
"8GPJ","HIV-1 ENV X16 UFO IN COMPLEX WITH 8ANC195 FAB","10.1038/S41467-023-40321-X ",3.5,"1.35632e-19","8gpj_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_K_)-MAN(8_K_)-[MAN(10_K_)]-MAN(7_K_)-[MAN(6_K_)-MAN(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(234_X_)",83.1753,"","",""
"8GPJ","HIV-1 ENV X16 UFO IN COMPLEX WITH 8ANC195 FAB","10.1038/S41467-023-40321-X ",3.5,"1.35632e-19","8gpj_oligo24","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_j_)-MAN(10_j_)-[MAN(9_j_)-MAN(8_j_)]-MAN(7_j_)-[MAN(6_j_)-MAN(5_j_)-MAN(4_j_)]-BMA(3_j_)-NAG(2_j_)-NAG(1_j_)-ASN(234_Z_)",84.668,"","",""
"8GPJ","HIV-1 ENV X16 UFO IN COMPLEX WITH 8ANC195 FAB","10.1038/S41467-023-40321-X ",3.5,"1.35632e-19","8gpj_oligo15","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_c_)-[MAN(4_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(262_Y_)",87.0662,"","",""
"8GV7","CRYSTAL STRUCTURE OF PN-SIA28 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ H18 A/FLAT-FACED BAT/PERU/033/2010","10.1038/S41467-022-35236-Y ",2.6,49.41,"8gv7_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(268_A_)",74.552,"","",""
"8GVM","THE STRUCTURE OF AZIDE-BOUND CYTOCHROME C OXIDASE DETERMINED USING THE CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 4 DAYS","10.1074/JBC.RA118.003123 ",1.85,0,"8gvm_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(101_Z_)-DMU(101_Z_)",67.4573,"","",""
"8GVM","THE STRUCTURE OF AZIDE-BOUND CYTOCHROME C OXIDASE DETERMINED USING THE CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 4 DAYS","10.1074/JBC.RA118.003123 ",1.85,0,"8gvm_oligo7","DGlcpa1-3DGlcpb6-C10O1","DMU(302_C_)-DMU(302_C_)",95.5582,"","",""
"8GVM","THE STRUCTURE OF AZIDE-BOUND CYTOCHROME C OXIDASE DETERMINED USING THE CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 4 DAYS","10.1074/JBC.RA118.003123 ",1.85,0,"8gvm_oligo3","DGlcpa1-3DGlcpb6-C10O1","DMU(309_C_)-DMU(309_C_)",90.5995,"","",""
"8GVM","THE STRUCTURE OF AZIDE-BOUND CYTOCHROME C OXIDASE DETERMINED USING THE CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 4 DAYS","10.1074/JBC.RA118.003123 ",1.85,0,"8gvm_oligo8","DGlcpa1-3DGlcpb6-C10O1","DMU(101_M_)-DMU(101_M_)",51.7786,"","",""
"8GVM","THE STRUCTURE OF AZIDE-BOUND CYTOCHROME C OXIDASE DETERMINED USING THE CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 4 DAYS","10.1074/JBC.RA118.003123 ",1.85,0,"8gvm_oligo9","DGlcpa1-3DGlcpb6-C10O1","DMU(306_P_)-DMU(306_P_)",100.109,"","",""
"8GVM","THE STRUCTURE OF AZIDE-BOUND CYTOCHROME C OXIDASE DETERMINED USING THE CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 4 DAYS","10.1074/JBC.RA118.003123 ",1.85,0,"8gvm_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(307_P_)-DMU(307_P_)",80.5859,"","",""
"8GVM","THE STRUCTURE OF AZIDE-BOUND CYTOCHROME C OXIDASE DETERMINED USING THE CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 4 DAYS","10.1074/JBC.RA118.003123 ",1.85,0,"8gvm_oligo5","DGlcpa1-3DGlcpb6-C7O1","DMU(102_L_)-DMU(102_L_)",115.529,"","",""
"8GVM","THE STRUCTURE OF AZIDE-BOUND CYTOCHROME C OXIDASE DETERMINED USING THE CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 4 DAYS","10.1074/JBC.RA118.003123 ",1.85,0,"8gvm_oligo4","DGlcpa1-3DGlcpb6-C10O1","DMU(308_P_)-DMU(308_P_)",94.1632,"","",""
"8H8R","BOVINE HEART CYTOCHROME C OXIDASE IN THE CALCIUM-BOUND FULLY OXIDIZED STATE","10.1016/J.BBABIO.2023.148956 ",1.7,42.42,"8h8r_oligo3","DGlcpa1-3DGlcpb6-C10O1","DMU(101_Z_)-DMU(101_Z_)",71.0868,"","",""
"8H8R","BOVINE HEART CYTOCHROME C OXIDASE IN THE CALCIUM-BOUND FULLY OXIDIZED STATE","10.1016/J.BBABIO.2023.148956 ",1.7,42.42,"8h8r_oligo13","DGlcpa1-3DGlcpb6-C10O1","DMU(324_P_)-DMU(324_P_)",74.1864,"","",""
"8H8R","BOVINE HEART CYTOCHROME C OXIDASE IN THE CALCIUM-BOUND FULLY OXIDIZED STATE","10.1016/J.BBABIO.2023.148956 ",1.7,42.42,"8h8r_oligo19","DGlcpa1-3DGlcpb6-C28O1","DMU(101_H_)-DMU(101_H_)",47.6123,"","",""
"8H8R","BOVINE HEART CYTOCHROME C OXIDASE IN THE CALCIUM-BOUND FULLY OXIDIZED STATE","10.1016/J.BBABIO.2023.148956 ",1.7,42.42,"8h8r_oligo27","DGlcpa1-3DGlcpb6-C10O1","DMU(318_P_)-DMU(318_P_)",69.8427,"","",""
"8H8R","BOVINE HEART CYTOCHROME C OXIDASE IN THE CALCIUM-BOUND FULLY OXIDIZED STATE","10.1016/J.BBABIO.2023.148956 ",1.7,42.42,"8h8r_oligo20","DGlcpa1-3DGlcpb6-C10O1","DMU(202_D_)-DMU(202_D_)",43.4145,"","",""
"8H8R","BOVINE HEART CYTOCHROME C OXIDASE IN THE CALCIUM-BOUND FULLY OXIDIZED STATE","10.1016/J.BBABIO.2023.148956 ",1.7,42.42,"8h8r_oligo4","DGlcpa1-3DGlcpb6-C10O1","DMU(324_C_)-DMU(324_C_)",62.8086,"","",""
"8H8R","BOVINE HEART CYTOCHROME C OXIDASE IN THE CALCIUM-BOUND FULLY OXIDIZED STATE","10.1016/J.BBABIO.2023.148956 ",1.7,42.42,"8h8r_oligo15","DGlcpa1-3DGlcpb6-C10O1","DMU(611_N_)-DMU(611_N_)",62.4018,"","",""
"8H8R","BOVINE HEART CYTOCHROME C OXIDASE IN THE CALCIUM-BOUND FULLY OXIDIZED STATE","10.1016/J.BBABIO.2023.148956 ",1.7,42.42,"8h8r_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(202_Q_)-DMU(202_Q_)",57.1473,"","",""
"8H8R","BOVINE HEART CYTOCHROME C OXIDASE IN THE CALCIUM-BOUND FULLY OXIDIZED STATE","10.1016/J.BBABIO.2023.148956 ",1.7,42.42,"8h8r_oligo7","DGlcpa1-3DGlcpb6-C10O1","DMU(318_C_)-DMU(318_C_)",59.8586,"","",""
"8H8R","BOVINE HEART CYTOCHROME C OXIDASE IN THE CALCIUM-BOUND FULLY OXIDIZED STATE","10.1016/J.BBABIO.2023.148956 ",1.7,42.42,"8h8r_oligo8","DGlcpa1-3DGlcpb6-C10O1","DMU(101_M_)-DMU(101_M_)",55.3668,"","",""
"8H8R","BOVINE HEART CYTOCHROME C OXIDASE IN THE CALCIUM-BOUND FULLY OXIDIZED STATE","10.1016/J.BBABIO.2023.148956 ",1.7,42.42,"8h8r_oligo11","DGlcpa1-3DGlcpb6-C10O1","DMU(319_P_)-DMU(319_P_)",74.0623,"","",""
"8H8R","BOVINE HEART CYTOCHROME C OXIDASE IN THE CALCIUM-BOUND FULLY OXIDIZED STATE","10.1016/J.BBABIO.2023.148956 ",1.7,42.42,"8h8r_oligo22","DGlcpa1-3DGlcpb6-C10O1","DMU(319_C_)-DMU(319_C_)",66.3695,"","",""
"8H8R","BOVINE HEART CYTOCHROME C OXIDASE IN THE CALCIUM-BOUND FULLY OXIDIZED STATE","10.1016/J.BBABIO.2023.148956 ",1.7,42.42,"8h8r_oligo25","DGlcpa1-3DGlcpb6-C10O1","DMU(315_P_)-DMU(315_P_)",53.5245,"","",""
"8H8R","BOVINE HEART CYTOCHROME C OXIDASE IN THE CALCIUM-BOUND FULLY OXIDIZED STATE","10.1016/J.BBABIO.2023.148956 ",1.7,42.42,"8h8r_oligo28","DGlcpAa1-3DGlcpb6-C10O1","DMU(610_A_)-DMU(610_A_)",45.705,"","",""
"8H8R","BOVINE HEART CYTOCHROME C OXIDASE IN THE CALCIUM-BOUND FULLY OXIDIZED STATE","10.1016/J.BBABIO.2023.148956 ",1.7,42.42,"8h8r_oligo23","DGlcpa1-3DGlcpb6-C10O1","DMU(315_C_)-DMU(315_C_)",55.8714,"","",""
"8H8S","BOVINE HEART CYTOCHROME C OXIDASE IN THE CALCIUM-BOUND FULLY REDUCED STATE","10.1016/J.BBABIO.2023.148956 ",1.7,42.65,"8h8s_oligo1","DGlcpa1-3DGlcpb6-C28O1","DMU(616_N_)-DMU(616_N_)",55.7955,"","",""
"8H8S","BOVINE HEART CYTOCHROME C OXIDASE IN THE CALCIUM-BOUND FULLY REDUCED STATE","10.1016/J.BBABIO.2023.148956 ",1.7,42.65,"8h8s_oligo28","DGlcpa1-3DGlcpb6-C10O1","DMU(322_P_)-DMU(322_P_)",76.7209,"","",""
"8H8S","BOVINE HEART CYTOCHROME C OXIDASE IN THE CALCIUM-BOUND FULLY REDUCED STATE","10.1016/J.BBABIO.2023.148956 ",1.7,42.65,"8h8s_oligo17","DGlcpa1-3DGlcpb6-C10O1","DMU(202_Q_)-DMU(202_Q_)",62.1118,"","",""
"8H8S","BOVINE HEART CYTOCHROME C OXIDASE IN THE CALCIUM-BOUND FULLY REDUCED STATE","10.1016/J.BBABIO.2023.148956 ",1.7,42.65,"8h8s_oligo27","DGlcpa1-3DGlcpb6-C10O1","DMU(202_D_)-DMU(202_D_)",48.8264,"","",""
"8H8S","BOVINE HEART CYTOCHROME C OXIDASE IN THE CALCIUM-BOUND FULLY REDUCED STATE","10.1016/J.BBABIO.2023.148956 ",1.7,42.65,"8h8s_oligo23","DGlcpa1-3DGlcpb6-C10O1","DMU(314_P_)-DMU(314_P_)",56.1377,"","",""
"8H8S","BOVINE HEART CYTOCHROME C OXIDASE IN THE CALCIUM-BOUND FULLY REDUCED STATE","10.1016/J.BBABIO.2023.148956 ",1.7,42.65,"8h8s_oligo15","DGlcpa1-3DGlcpb6-C10O1","DMU(318_P_)-DMU(318_P_)",77.1932,"","",""
"8H8S","BOVINE HEART CYTOCHROME C OXIDASE IN THE CALCIUM-BOUND FULLY REDUCED STATE","10.1016/J.BBABIO.2023.148956 ",1.7,42.65,"8h8s_oligo19","DGlcpa1-3DGlcpb6-C10O1","DMU(101_Z_)-DMU(101_Z_)",66.5632,"","",""
"8H8S","BOVINE HEART CYTOCHROME C OXIDASE IN THE CALCIUM-BOUND FULLY REDUCED STATE","10.1016/J.BBABIO.2023.148956 ",1.7,42.65,"8h8s_oligo14","DGlcpa1-3DGlcpb6-C10O1","DMU(317_P_)-DMU(317_P_)",67.0555,"","",""
"8H8S","BOVINE HEART CYTOCHROME C OXIDASE IN THE CALCIUM-BOUND FULLY REDUCED STATE","10.1016/J.BBABIO.2023.148956 ",1.7,42.65,"8h8s_oligo12","DGlcpa1-3DGlcpb6-C10O1","DMU(316_C_)-DMU(316_C_)",54.3836,"","",""
"8H8S","BOVINE HEART CYTOCHROME C OXIDASE IN THE CALCIUM-BOUND FULLY REDUCED STATE","10.1016/J.BBABIO.2023.148956 ",1.7,42.65,"8h8s_oligo11","DGlcpa1-3DGlcpb6-C10O1","DMU(320_C_)-DMU(320_C_)",71.4959,"","",""
"8H8S","BOVINE HEART CYTOCHROME C OXIDASE IN THE CALCIUM-BOUND FULLY REDUCED STATE","10.1016/J.BBABIO.2023.148956 ",1.7,42.65,"8h8s_oligo4","DGlcpa1-3DGlcpb6-C10O1","DMU(319_C_)-DMU(319_C_)",64.7618,"","",""
"8H8S","BOVINE HEART CYTOCHROME C OXIDASE IN THE CALCIUM-BOUND FULLY REDUCED STATE","10.1016/J.BBABIO.2023.148956 ",1.7,42.65,"8h8s_oligo6","DGlcpa1-3DGlcpb6-C10O1","DMU(609_N_)-DMU(609_N_)",64.5945,"","",""
"8H8S","BOVINE HEART CYTOCHROME C OXIDASE IN THE CALCIUM-BOUND FULLY REDUCED STATE","10.1016/J.BBABIO.2023.148956 ",1.7,42.65,"8h8s_oligo10","DGlcpAa1-3DGlcpb6-C10O1","DMU(609_A_)-DMU(609_A_)",52.3409,"","",""
"8H8S","BOVINE HEART CYTOCHROME C OXIDASE IN THE CALCIUM-BOUND FULLY REDUCED STATE","10.1016/J.BBABIO.2023.148956 ",1.7,42.65,"8h8s_oligo7","DGlcpa1-3DGlcpb6-C10O1","DMU(324_C_)-DMU(324_C_)",66.4068,"","",""
"8H8S","BOVINE HEART CYTOCHROME C OXIDASE IN THE CALCIUM-BOUND FULLY REDUCED STATE","10.1016/J.BBABIO.2023.148956 ",1.7,42.65,"8h8s_oligo5","DGlcpa1-3DGlcpb6-C10O1","DMU(101_M_)-DMU(101_M_)",55.3618,"","",""
"8HC0","CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAINS OF GPR110","10.1016/J.JMB.2023.167979 ",2.9,0,"8hc0_oligo1","DManpa1-3DManpa1-6[DManpa1-3]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-MAN(4_D_)-[MAN(6_D_)]-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(389_A_)",74.6032,"","",""
"8HGO","THE EGF-BOUND EGFR/HER2 ECTODOMAIN COMPLEX","10.1038/S41421-023-00523-5 ",3.31,0,"8hgo_oligo1","DManpa1-3DManpb1-3DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(352_A_)",90.7891,"","",""
"8HGP","THE EREG-BOUND EGFR/HER2 ECTODOMAIN COMPLEX","10.1038/S41421-023-00523-5 ",4.53,0,"8hgp_oligo1","DManpa1-3DManpb1-3DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(352_A_)",185.726,"","",""
"8HGS","THE EGF-BOUND EGFR ECTODOMAIN HOMODIMER","10.1038/S41421-023-00523-5 ",3.81,0,"8hgs_oligo6","DManpa1-3DManpb1-3DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(352_B_)",107.48,"","",""
"8HGS","THE EGF-BOUND EGFR ECTODOMAIN HOMODIMER","10.1038/S41421-023-00523-5 ",3.81,0,"8hgs_oligo2","DManpa1-3DManpb1-3DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(352_A_)",111.543,"","",""
"8HRH","SN-131/1B2 ANTI-MUC1 ANTIBODY WITH A GLYCOPEPTIDE","10.1039/D3CB00036B ",2.07,37.88,"8hrh_oligo2","DNeup5Aca2-3DGalpb1-3DGalpNAca1-THR","SIA(3_D_)-GAL(2_D_)-A2G(1_D_)-THR(503_A_)",50.3936,"","",""
"8IBT","CRYSTAL STRUCTURE OF GH42 BETA-GALACTOSIDASE BIBGA42A FROM BIFIDOBACTERIUM LONGUM SUBSPECIES INFANTIS E318S MUTANT IN COMPLEX WITH LACTO-N-TETRAOSE","10.20517/MRR.2023.14 ",2.2,28.36,"8ibt_oligo2","DGalpb1-3DGlcpNAcb1-3DGalpb1-4DGlcpb1-ROH","GAL(4_D_)-NAG(3_D_)-GAL(2_D_)-BGC(1_D_)",46.3998,"","",""
"8IBT","CRYSTAL STRUCTURE OF GH42 BETA-GALACTOSIDASE BIBGA42A FROM BIFIDOBACTERIUM LONGUM SUBSPECIES INFANTIS E318S MUTANT IN COMPLEX WITH LACTO-N-TETRAOSE","10.20517/MRR.2023.14 ",2.2,28.36,"8ibt_oligo1","DGalpb1-3DGlcpNAcb1-3DGalpb1-4DGlcpb1-ROH","GAL(4_C_)-NAG(3_C_)-GAL(2_C_)-BGC(1_C_)",43.5148,"","",""
"8IDN","CRYO-EM STRUCTURE OF RBD/E77-FAB COMPLEX","10.1107/S2059798323005041 ",3.35,"2.14959e+09","8idn_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(79_H_)",93.4934,"","",""
"8IDP","CRYSTAL STRUCTURE OF REDUCING-END XYLOSE-RELEASING EXOXYLANASE IN GH30 FROM TALAROMYCES CELLULOLYTICUS","10.1002/PROT.26505 ",1.8,0,"8idp_oligo5","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_L_)-MAN(4_L_)-[MAN(6_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(433_B_)",36.6682,"","",""
"8IDP","CRYSTAL STRUCTURE OF REDUCING-END XYLOSE-RELEASING EXOXYLANASE IN GH30 FROM TALAROMYCES CELLULOLYTICUS","10.1002/PROT.26505 ",1.8,0,"8idp_oligo7","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-MAN(5_H_)-[MAN(7_H_)]-MAN(4_H_)-[MAN(9_H_)-MAN(8_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(393_C_)",33.0036,"","",""
"8IDP","CRYSTAL STRUCTURE OF REDUCING-END XYLOSE-RELEASING EXOXYLANASE IN GH30 FROM TALAROMYCES CELLULOLYTICUS","10.1002/PROT.26505 ",1.8,0,"8idp_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(433_C_)",39.5875,"","",""
"8IDP","CRYSTAL STRUCTURE OF REDUCING-END XYLOSE-RELEASING EXOXYLANASE IN GH30 FROM TALAROMYCES CELLULOLYTICUS","10.1002/PROT.26505 ",1.8,0,"8idp_oligo12","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_P_)-[MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(433_D_)",35.7476,"","",""
"8IDP","CRYSTAL STRUCTURE OF REDUCING-END XYLOSE-RELEASING EXOXYLANASE IN GH30 FROM TALAROMYCES CELLULOLYTICUS","10.1002/PROT.26505 ",1.8,0,"8idp_oligo8","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_E_)-MAN(10_E_)-[MAN(9_E_)-MAN(8_E_)]-MAN(7_E_)-[MAN(6_E_)-MAN(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(393_A_)",32.7889,"","",""
"8IDP","CRYSTAL STRUCTURE OF REDUCING-END XYLOSE-RELEASING EXOXYLANASE IN GH30 FROM TALAROMYCES CELLULOLYTICUS","10.1002/PROT.26505 ",1.8,0,"8idp_oligo1","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-MAN(4_F_)-[MAN(6_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(433_A_)",37.0061,"","",""
"8IDP","CRYSTAL STRUCTURE OF REDUCING-END XYLOSE-RELEASING EXOXYLANASE IN GH30 FROM TALAROMYCES CELLULOLYTICUS","10.1002/PROT.26505 ",1.8,0,"8idp_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_K_)-MAN(10_K_)-[MAN(9_K_)-MAN(8_K_)]-MAN(7_K_)-[MAN(6_K_)-MAN(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(393_B_)",31.9383,"","",""
"8IDP","CRYSTAL STRUCTURE OF REDUCING-END XYLOSE-RELEASING EXOXYLANASE IN GH30 FROM TALAROMYCES CELLULOLYTICUS","10.1002/PROT.26505 ",1.8,0,"8idp_oligo10","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_N_)-MAN(7_N_)-[MAN(6_N_)-MAN(5_N_)]-MAN(4_N_)-[MAN(9_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(393_D_)",28.2597,"","",""
"8IDQ","CRYSTAL STRUCTURE OF REDUCING-END XYLOSE-RELEASING EXOXYLANASE IN GH30 FROM TALAROMYCES CELLULOLYTICUS WITH XYLOSE","10.1002/PROT.26505 ",1.7,0,"8idq_oligo3","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-MAN(4_G_)-[MAN(6_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(433_A_)",30.7447,"","",""
"8IDQ","CRYSTAL STRUCTURE OF REDUCING-END XYLOSE-RELEASING EXOXYLANASE IN GH30 FROM TALAROMYCES CELLULOLYTICUS WITH XYLOSE","10.1002/PROT.26505 ",1.7,0,"8idq_oligo10","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_N_)-MAN(10_N_)-[MAN(9_N_)-MAN(8_N_)]-MAN(7_N_)-[MAN(6_N_)-MAN(5_N_)-MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(393_D_)",26.9676,"","",""
"8IDQ","CRYSTAL STRUCTURE OF REDUCING-END XYLOSE-RELEASING EXOXYLANASE IN GH30 FROM TALAROMYCES CELLULOLYTICUS WITH XYLOSE","10.1002/PROT.26505 ",1.7,0,"8idq_oligo12","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_P_)-MAN(4_P_)-[MAN(6_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(433_D_)",29.9224,"","",""
"8IDQ","CRYSTAL STRUCTURE OF REDUCING-END XYLOSE-RELEASING EXOXYLANASE IN GH30 FROM TALAROMYCES CELLULOLYTICUS WITH XYLOSE","10.1002/PROT.26505 ",1.7,0,"8idq_oligo4","DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_H_)-MAN(7_H_)-[MAN(6_H_)-MAN(5_H_)]-MAN(4_H_)-[MAN(10_H_)-MAN(9_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(393_B_)",25.3125,"","",""
"8IDQ","CRYSTAL STRUCTURE OF REDUCING-END XYLOSE-RELEASING EXOXYLANASE IN GH30 FROM TALAROMYCES CELLULOLYTICUS WITH XYLOSE","10.1002/PROT.26505 ",1.7,0,"8idq_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_E_)-MAN(10_E_)-[MAN(9_E_)-MAN(8_E_)]-MAN(7_E_)-[MAN(6_E_)-MAN(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(393_A_)",23.915,"","",""
"8IDQ","CRYSTAL STRUCTURE OF REDUCING-END XYLOSE-RELEASING EXOXYLANASE IN GH30 FROM TALAROMYCES CELLULOLYTICUS WITH XYLOSE","10.1002/PROT.26505 ",1.7,0,"8idq_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_L_)-[MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(433_C_)",30.9458,"","",""
"8IDQ","CRYSTAL STRUCTURE OF REDUCING-END XYLOSE-RELEASING EXOXYLANASE IN GH30 FROM TALAROMYCES CELLULOLYTICUS WITH XYLOSE","10.1002/PROT.26505 ",1.7,0,"8idq_oligo5","DManpa1-3DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_I_)-MAN(4_I_)-[MAN(6_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(433_B_)",31.6368,"","",""
"8IDQ","CRYSTAL STRUCTURE OF REDUCING-END XYLOSE-RELEASING EXOXYLANASE IN GH30 FROM TALAROMYCES CELLULOLYTICUS WITH XYLOSE","10.1002/PROT.26505 ",1.7,0,"8idq_oligo7","DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_K_)-MAN(5_K_)-[MAN(7_K_)]-MAN(4_K_)-[MAN(9_K_)-MAN(8_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(393_C_)",27.2081,"","",""
"8IF2","CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 OMICRON BQ.1.1 VARIANT SPIKE PROTEIN IN COMPLEX WITH ITS RECEPTOR ACE2","10.1038/S41467-023-38188-Z ",2.78,83.2,"8if2_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_K_)-[MAN(5_K_)]-MAN(4_K_)-[MAN(7_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(90_A_)",137.253,"","",""
"8IJN","BOVINE HEART CYTOCHROME C OXIDASE IN THE NITRIC OXIDE-BOUND FULLY REDUCED STATE AT 100 K","10.1073/PNAS.0910410107 ",1.8,0,"8ijn_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(101_M_)-DMU(101_M_)",54.0991,"","",""
"8IJN","BOVINE HEART CYTOCHROME C OXIDASE IN THE NITRIC OXIDE-BOUND FULLY REDUCED STATE AT 100 K","10.1073/PNAS.0910410107 ",1.8,0,"8ijn_oligo3","DGlcpa1-3DGlcpb6-C9O1","DMU(102_W_)-DMU(102_W_)",87.8641,"","",""
"8IJN","BOVINE HEART CYTOCHROME C OXIDASE IN THE NITRIC OXIDE-BOUND FULLY REDUCED STATE AT 100 K","10.1073/PNAS.0910410107 ",1.8,0,"8ijn_oligo5","DGlcpa1-3DGlcpb6-C10O1","DMU(307_P_)-DMU(307_P_)",115.401,"","",""
"8IJN","BOVINE HEART CYTOCHROME C OXIDASE IN THE NITRIC OXIDE-BOUND FULLY REDUCED STATE AT 100 K","10.1073/PNAS.0910410107 ",1.8,0,"8ijn_oligo4","DGlcpa1-3DGlcpb6-C10O1","DMU(101_Z_)-DMU(101_Z_)",66.4005,"","",""
"8IJN","BOVINE HEART CYTOCHROME C OXIDASE IN THE NITRIC OXIDE-BOUND FULLY REDUCED STATE AT 100 K","10.1073/PNAS.0910410107 ",1.8,0,"8ijn_oligo6","DGlcpa1-3DGlcpb6-C10O1","DMU(307_C_)-DMU(307_C_)",108.948,"","",""
"8IOU","STRUCTURE OF SARS-COV-2 XBB.1 SPIKE GLYCOPROTEIN IN COMPLEX WITH ACE2 (1-UP STATE)","10.1038/S41467-023-38435-3 ",3.18,"1.08527e-19","8iou_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(103_D_)",155.583,"","",""
"8IOV","STRUCTURE OF SARS-COV-2 XBB.1 SPIKE RBD IN COMPLEX WITH ACE2","10.1038/S41467-023-38435-3 ",3.29,"1.08527e-19","8iov_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(103_A_)",194.021,"","",""
"8ISN","HLA-A24 IN COMPLEX WITH MODIFIED 9MER WT1 PEPTIDE","10.1002/PRO.4775 ",2.48,62.23,"8isn_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(86_A_)",109.839,"","",""
"8JBK","CRYSTAL STRUCTURE OF NA+,K+-ATPASE IN THE E1.3NA+ STATE","10.1002/1873-3468.14689 ",2.8,83.89,"8jbk_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(265_B_)",147.973,"","",""
"8JBK","CRYSTAL STRUCTURE OF NA+,K+-ATPASE IN THE E1.3NA+ STATE","10.1002/1873-3468.14689 ",2.8,83.89,"8jbk_oligo1","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-MAN(4_F_)-[MAN(6_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(158_B_)",126.566,"","",""
"8JBK","CRYSTAL STRUCTURE OF NA+,K+-ATPASE IN THE E1.3NA+ STATE","10.1002/1873-3468.14689 ",2.8,83.89,"8jbk_oligo5","DGlcpa1-3DGlcpb6-C10O1","DMU(102_E_)-DMU(102_E_)",56.0409,"","",""
"8JBL","CRYSTAL STRUCTURE OF NA+,K+-ATPASE IN THE E1.MG2+ STATE","10.1002/1873-3468.14689 ",3,90.02,"8jbl_oligo5","DGlcpa1-3DGlcpb6-C10O1","DMU(102_E_)-DMU(102_E_)",68.5005,"","",""
"8JBL","CRYSTAL STRUCTURE OF NA+,K+-ATPASE IN THE E1.MG2+ STATE","10.1002/1873-3468.14689 ",3,90.02,"8jbl_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(265_B_)",173.5,"","",""
"8JBL","CRYSTAL STRUCTURE OF NA+,K+-ATPASE IN THE E1.MG2+ STATE","10.1002/1873-3468.14689 ",3,90.02,"8jbl_oligo1","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-MAN(4_F_)-[MAN(6_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(158_B_)",145.961,"","",""
"8JBM","CRYSTAL STRUCTURE OF NA+,K+-ATPASE IN THE E1.MN2+ STATE","10.1002/1873-3468.14689 ",2.9,88.06,"8jbm_oligo1","DManpa1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-MAN(4_F_)-[MAN(6_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(158_B_)",137.849,"","",""
"8JBM","CRYSTAL STRUCTURE OF NA+,K+-ATPASE IN THE E1.MN2+ STATE","10.1002/1873-3468.14689 ",2.9,88.06,"8jbm_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(265_B_)",189.62,"","",""
"8JBM","CRYSTAL STRUCTURE OF NA+,K+-ATPASE IN THE E1.MN2+ STATE","10.1002/1873-3468.14689 ",2.9,88.06,"8jbm_oligo2","DGlcpa1-3DGlcpb6-C10O1","DMU(102_E_)-DMU(102_E_)",71.65,"","",""
"8JFZ","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E1.MG2+ STATE.","10.1002/1873-3468.14689 ",3.5,"1.15243e-41","8jfz_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_K_)-[MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(114_B_)",125.396,"","",""
"8JFZ","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E1.MG2+ STATE.","10.1002/1873-3468.14689 ",3.5,"1.15243e-41","8jfz_oligo2","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-[NAG(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(159_D_)",153.56,"","",""
"8JFZ","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E1.MG2+ STATE.","10.1002/1873-3468.14689 ",3.5,"1.15243e-41","8jfz_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_F_)-[MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(114_D_)",128.621,"","",""
"8JFZ","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E1.MG2+ STATE.","10.1002/1873-3468.14689 ",3.5,"1.15243e-41","8jfz_oligo5","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_L_)-[NAG(5_L_)-MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(159_B_)",151.463,"","",""
"8JFZ","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E1.MG2+ STATE.","10.1002/1873-3468.14689 ",3.5,"1.15243e-41","8jfz_oligo6","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_M_)-[MAN(4_M_)-BMA(3_M_)-NAG(2_M_)]-NAG(1_M_)-ASN(194_B_)",132.833,"","",""
"8JFZ","CRYO-EM STRUCTURE OF NA+,K+-ATPASE IN THE E1.MG2+ STATE.","10.1002/1873-3468.14689 ",3.5,"1.15243e-41","8jfz_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(5_I_)-[MAN(4_I_)-BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(194_D_)",124.943,"","",""
"8JJ5","PORCINE UROPLAKIN COMPLEX","",3.5,"1.08527e-19","8jj5_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(139_C_)",31.068,"","",""
"8OG1","EXOSTOSIN-LIKE 3 APO ENZYME","",1.58,36.17,"8og1_oligo1","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(790_A_)",64.0968,"","",""
"8OG4","EXOSTOSIN-LIKE 3 UDP COMPLEX","",2.1,65.78,"8og4_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(790_B_)",76.0851,"","",""
"8OG4","EXOSTOSIN-LIKE 3 UDP COMPLEX","",2.1,65.78,"8og4_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(790_A_)",90.2511,"","",""
"8OK4","VARIANT SURFACE GLYCOPROTEIN VSG11WT-OIL","10.1371/JOURNAL.PNTD.0011621 ",1.23,22.25,"8ok4_oligo2","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(68_A_)",24.9371,"","",""
"8OK5","VARIANT SURFACE GLYCOPROTEIN VSG11 MONOMER WITH IODINE","10.1371/JOURNAL.PNTD.0011621 ",1.27,20.7,"8ok5_oligo1","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(68_A_)",18.6879,"","",""
"8OK6","VARIANT SURFACE GLYCOPROTEIN VSG11 TWO MONOMERS","10.1371/JOURNAL.PNTD.0011621 ",1.75,42.68,"8ok6_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(68_C_)",43.5873,"","",""
"8OK6","VARIANT SURFACE GLYCOPROTEIN VSG11 TWO MONOMERS","10.1371/JOURNAL.PNTD.0011621 ",1.75,42.68,"8ok6_oligo3","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[MAN(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(68_A_)",49.7111,"","",""
"8OK7","VARIANT SURFACE GLYCOPROTEIN VSG558 NTD","10.1371/JOURNAL.PNTD.0011621 ",1.74,44.06,"8ok7_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(198_A_)",57.1453,"","",""
"8OK7","VARIANT SURFACE GLYCOPROTEIN VSG558 NTD","10.1371/JOURNAL.PNTD.0011621 ",1.74,44.06,"8ok7_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_G_)-[MAN(6_G_)-MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(145_B_)",45.6173,"","",""
"8OK7","VARIANT SURFACE GLYCOPROTEIN VSG558 NTD","10.1371/JOURNAL.PNTD.0011621 ",1.74,44.06,"8ok7_oligo3","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_H_)-[MAN(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(198_B_)",51.5929,"","",""
"8OK7","VARIANT SURFACE GLYCOPROTEIN VSG558 NTD","10.1371/JOURNAL.PNTD.0011621 ",1.74,44.06,"8ok7_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(198_C_)",53.7345,"","",""
"8OK7","VARIANT SURFACE GLYCOPROTEIN VSG558 NTD","10.1371/JOURNAL.PNTD.0011621 ",1.74,44.06,"8ok7_oligo7","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_K_)-[MAN(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(145_D_)",48.4826,"","",""
"8OK7","VARIANT SURFACE GLYCOPROTEIN VSG558 NTD","10.1371/JOURNAL.PNTD.0011621 ",1.74,44.06,"8ok7_oligo4","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_I_)-[MAN(6_I_)-MAN(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(145_C_)",44.833,"","",""
"8OK7","VARIANT SURFACE GLYCOPROTEIN VSG558 NTD","10.1371/JOURNAL.PNTD.0011621 ",1.74,44.06,"8ok7_oligo5","DManpa1-2DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-MAN(5_E_)-MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(145_A_)",43.067,"","",""
"8OK7","VARIANT SURFACE GLYCOPROTEIN VSG558 NTD","10.1371/JOURNAL.PNTD.0011621 ",1.74,44.06,"8ok7_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_L_)-[MAN(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(198_D_)",59.8656,"","",""
"8ONH","VARIANT SURFACE GLYCOPROTEIN VSG11WT-OIL","10.1371/JOURNAL.PNTD.0011621 ",2.59,66.92,"8onh_oligo1","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_S_)-[MAN(5_S_)-MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(68_A_)",88.8741,"","",""
"8ONH","VARIANT SURFACE GLYCOPROTEIN VSG11WT-OIL","10.1371/JOURNAL.PNTD.0011621 ",2.59,66.92,"8onh_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-3DGlcpNAcb1-ASN","MAN(5_T_)-[MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(68_B_)",115.42,"","",""
"8ONH","VARIANT SURFACE GLYCOPROTEIN VSG11WT-OIL","10.1371/JOURNAL.PNTD.0011621 ",2.59,66.92,"8onh_oligo11","DManpa1-3[DManpa1-6]DManpb1-3DGlcpNAcb1-3DGlcpNAcb1-ASN","MAN(5_c_)-[MAN(4_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)-ASN(68_N_)",142.533,"","",""
"8ONH","VARIANT SURFACE GLYCOPROTEIN VSG11WT-OIL","10.1371/JOURNAL.PNTD.0011621 ",2.59,66.92,"8onh_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_a_)-[MAN(4_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(68_K_)",123.651,"","",""
"8ONH","VARIANT SURFACE GLYCOPROTEIN VSG11WT-OIL","10.1371/JOURNAL.PNTD.0011621 ",2.59,66.92,"8onh_oligo5","DManpa1-3[DManpa1-6]DManpb1-3DGlcpNAcb1-3DGlcpNAcb1-ASN","MAN(5_W_)-[MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(68_G_)",97.3885,"","",""
"8ONH","VARIANT SURFACE GLYCOPROTEIN VSG11WT-OIL","10.1371/JOURNAL.PNTD.0011621 ",2.59,66.92,"8onh_oligo8","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Z_)-[MAN(5_Z_)-MAN(4_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(68_J_)",88.2132,"","",""
"8ONH","VARIANT SURFACE GLYCOPROTEIN VSG11WT-OIL","10.1371/JOURNAL.PNTD.0011621 ",2.59,66.92,"8onh_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_b_)-[MAN(4_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(68_L_)",132.101,"","",""
"8PFI","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH COMPOUND 34","10.1021/ACSMEDCHEMLETT.3C00136 ",2.79,76.7,"8pfi_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(293_B_)",81.4487,"","",""
"8PFI","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH COMPOUND 34","10.1021/ACSMEDCHEMLETT.3C00136 ",2.79,76.7,"8pfi_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(590_A_)",68.9822,"","",""
"8PFI","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH COMPOUND 34","10.1021/ACSMEDCHEMLETT.3C00136 ",2.79,76.7,"8pfi_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(293_A_)",81.6622,"","",""
"8PFI","CRYSTAL STRUCTURE OF HUMAN TLR8 IN COMPLEX WITH COMPOUND 34","10.1021/ACSMEDCHEMLETT.3C00136 ",2.79,76.7,"8pfi_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(590_B_)",78.2827,"","",""
"8SAN","CRYOEM STRUCTURE OF VRC01-CH848.0836.10","10.1038/S41467-023-38108-1 ",4.6,"1.08527e-19","8san_oligo4","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_O_)-[MAN(5_O_)]-MAN(4_O_)-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(276_A_)",144.203,"","",""
"8SAN","CRYOEM STRUCTURE OF VRC01-CH848.0836.10","10.1038/S41467-023-38108-1 ",4.6,"1.08527e-19","8san_oligo6","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_R_)-[MAN(5_R_)]-MAN(4_R_)-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(276_E_)",140.317,"","",""
"8SAN","CRYOEM STRUCTURE OF VRC01-CH848.0836.10","10.1038/S41467-023-38108-1 ",4.6,"1.08527e-19","8san_oligo5","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Q_)-[MAN(5_Q_)]-MAN(4_Q_)-[MAN(7_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(262_E_)",134.785,"","",""
"8SAN","CRYOEM STRUCTURE OF VRC01-CH848.0836.10","10.1038/S41467-023-38108-1 ",4.6,"1.08527e-19","8san_oligo1","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_N_)-[MAN(5_N_)]-MAN(4_N_)-[MAN(7_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(262_A_)",134.943,"","",""
"8SAN","CRYOEM STRUCTURE OF VRC01-CH848.0836.10","10.1038/S41467-023-38108-1 ",4.6,"1.08527e-19","8san_oligo9","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_U_)-[MAN(5_U_)]-MAN(4_U_)-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(276_I_)",149.743,"","",""
"8SAN","CRYOEM STRUCTURE OF VRC01-CH848.0836.10","10.1038/S41467-023-38108-1 ",4.6,"1.08527e-19","8san_oligo8","DManpa1-3[DManpa1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_T_)-[MAN(5_T_)]-MAN(4_T_)-[MAN(7_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(262_I_)",136.549,"","",""
"8SAQ","CRYOEM STRUCTURE OF DH270.6-CH848.0526.25","10.1038/S41467-023-38108-1 ",3.9,"1.08527e-19","8saq_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_R_)-[MAN(6_R_)-MAN(5_R_)-MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(332_E_)",47.7093,"","",""
"8SAQ","CRYOEM STRUCTURE OF DH270.6-CH848.0526.25","10.1038/S41467-023-38108-1 ",3.9,"1.08527e-19","8saq_oligo4","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_J_)-[MAN(6_J_)-MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(332_A_)",40.0284,"","",""
"8SAQ","CRYOEM STRUCTURE OF DH270.6-CH848.0526.25","10.1038/S41467-023-38108-1 ",3.9,"1.08527e-19","8saq_oligo6","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_V_)-[MAN(6_V_)-MAN(5_V_)-MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(334_K_)",41.9823,"","",""
"8SAR","CRYOEM STRUCTURE OF DH270.6-CH848.10.17","10.1038/S41467-023-38108-1 ",3.82,"1.08527e-19","8sar_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_T_)-MAN(8_T_)-[MAN(10_T_)]-MAN(7_T_)-[MAN(6_T_)-MAN(5_T_)-MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(332_F_)",81.0319,"","",""
"8SAR","CRYOEM STRUCTURE OF DH270.6-CH848.10.17","10.1038/S41467-023-38108-1 ",3.82,"1.08527e-19","8sar_oligo6","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_X_)-MAN(4_X_)-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(301_K_)",129.013,"","",""
"8SAR","CRYOEM STRUCTURE OF DH270.6-CH848.10.17","10.1038/S41467-023-38108-1 ",3.82,"1.08527e-19","8sar_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_O_)-MAN(10_O_)-[MAN(9_O_)-MAN(8_O_)]-MAN(7_O_)-[MAN(6_O_)-MAN(5_O_)-MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(332_A_)",91.0326,"","",""
"8SAR","CRYOEM STRUCTURE OF DH270.6-CH848.10.17","10.1038/S41467-023-38108-1 ",3.82,"1.08527e-19","8sar_oligo10","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_Y_)-MAN(10_Y_)-[MAN(9_Y_)-MAN(8_Y_)]-MAN(7_Y_)-[MAN(6_Y_)-MAN(5_Y_)-MAN(4_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(332_K_)",89.1712,"","",""
"8SAR","CRYOEM STRUCTURE OF DH270.6-CH848.10.17","10.1038/S41467-023-38108-1 ",3.82,"1.08527e-19","8sar_oligo9","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_S_)-MAN(4_S_)-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(301_F_)",91.0205,"","",""
"8SAR","CRYOEM STRUCTURE OF DH270.6-CH848.10.17","10.1038/S41467-023-38108-1 ",3.82,"1.08527e-19","8sar_oligo2","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(301_A_)",98.0071,"","",""
"8SAS","CRYOEM STRUCTURE OF DH270.5-CH848.10.17","10.1038/S41467-023-38108-1 ",4,"1.08527e-19","8sas_oligo12","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_X_)-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(442_K_)",136.985,"","",""
"8SAS","CRYOEM STRUCTURE OF DH270.5-CH848.10.17","10.1038/S41467-023-38108-1 ",4,"1.08527e-19","8sas_oligo9","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_U_)-[MAN(5_U_)-MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(301_K_)",144.62,"","",""
"8SAS","CRYOEM STRUCTURE OF DH270.5-CH848.10.17","10.1038/S41467-023-38108-1 ",4,"1.08527e-19","8sas_oligo10","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_V_)-[MAN(8_V_)]-MAN(7_V_)-[MAN(6_V_)-MAN(5_V_)-MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(332_K_)",93.5735,"","",""
"8SAS","CRYOEM STRUCTURE OF DH270.5-CH848.10.17","10.1038/S41467-023-38108-1 ",4,"1.08527e-19","8sas_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_J_)-MAN(8_J_)-MAN(7_J_)-[MAN(6_J_)-MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(332_A_)",104.093,"","",""
"8SAS","CRYOEM STRUCTURE OF DH270.5-CH848.10.17","10.1038/S41467-023-38108-1 ",4,"1.08527e-19","8sas_oligo1","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Q_)-[MAN(5_Q_)-MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(301_F_)",120.787,"","",""
"8SAS","CRYOEM STRUCTURE OF DH270.5-CH848.10.17","10.1038/S41467-023-38108-1 ",4,"1.08527e-19","8sas_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_R_)-MAN(10_R_)-[MAN(9_R_)-MAN(8_R_)]-MAN(7_R_)-[MAN(6_R_)-MAN(5_R_)-MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(332_F_)",115.657,"","",""
"8SAS","CRYOEM STRUCTURE OF DH270.5-CH848.10.17","10.1038/S41467-023-38108-1 ",4,"1.08527e-19","8sas_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(301_A_)",108.144,"","",""
"8SAV","CRYOEM STRUCTURE OF VRC01-CH848.0526.25","10.1038/S41467-023-38108-1 ",4,"1.08527e-19","8sav_oligo7","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_U_)-[MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(262_E_)",125.879,"","",""
"8SAV","CRYOEM STRUCTURE OF VRC01-CH848.0526.25","10.1038/S41467-023-38108-1 ",4,"1.08527e-19","8sav_oligo15","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Z_)-[MAN(4_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(262_I_)",121.531,"","",""
"8SAV","CRYOEM STRUCTURE OF VRC01-CH848.0526.25","10.1038/S41467-023-38108-1 ",4,"1.08527e-19","8sav_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_P_)-[MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(262_A_)",119.121,"","",""
"8SAW","CRYOEM STRUCTURE OF DH270.UCA.G57R-CH848.10.17DT","10.1038/S41467-023-38108-1 ",3.3,"1.08527e-19","8saw_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_J_)-[MAN(8_J_)]-MAN(7_J_)-[MAN(6_J_)-MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(332_A_)",44.5952,"","",""
"8SAW","CRYOEM STRUCTURE OF DH270.UCA.G57R-CH848.10.17DT","10.1038/S41467-023-38108-1 ",3.3,"1.08527e-19","8saw_oligo10","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_V_)-[MAN(8_V_)]-MAN(7_V_)-[MAN(6_V_)-MAN(5_V_)-MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(292_K_)",45.9862,"","",""
"8SAW","CRYOEM STRUCTURE OF DH270.UCA.G57R-CH848.10.17DT","10.1038/S41467-023-38108-1 ",3.3,"1.08527e-19","8saw_oligo6","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_R_)-[MAN(8_R_)]-MAN(7_R_)-[MAN(6_R_)-MAN(5_R_)-MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(332_E_)",45.408,"","",""
"8SAX","CRYOEM STRUCTURE OF DH270.UCA-CH848.10.17DT","10.1038/S41467-023-38108-1 ",4,"1.08527e-19","8sax_oligo5","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(9_N_)-[MAN(8_N_)]-MAN(7_N_)-[MAN(6_N_)-MAN(5_N_)-MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)",117.623,"","",""
"8SAX","CRYOEM STRUCTURE OF DH270.UCA-CH848.10.17DT","10.1038/S41467-023-38108-1 ",4,"1.08527e-19","8sax_oligo10","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(9_V_)-[MAN(8_V_)]-MAN(7_V_)-[MAN(6_V_)-MAN(5_V_)-MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)",120.791,"","",""
"8SAX","CRYOEM STRUCTURE OF DH270.UCA-CH848.10.17DT","10.1038/S41467-023-38108-1 ",4,"1.08527e-19","8sax_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_M_)-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(301_A_)",145.458,"","",""
"8SAX","CRYOEM STRUCTURE OF DH270.UCA-CH848.10.17DT","10.1038/S41467-023-38108-1 ",4,"1.08527e-19","8sax_oligo9","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_U_)-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(301_I_)",144.027,"","",""
"8SAX","CRYOEM STRUCTURE OF DH270.UCA-CH848.10.17DT","10.1038/S41467-023-38108-1 ",4,"1.08527e-19","8sax_oligo4","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_Q_)-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(301_E_)",145.69,"","",""
"8SAX","CRYOEM STRUCTURE OF DH270.UCA-CH848.10.17DT","10.1038/S41467-023-38108-1 ",4,"1.08527e-19","8sax_oligo6","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(9_R_)-[MAN(8_R_)]-MAN(7_R_)-[MAN(6_R_)-MAN(5_R_)-MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)",119.892,"","",""
"8SAY","CRYOEM STRUCTURE OF DH270.3-CH848.10.17","10.1038/S41467-023-38108-1 ",3.4,"1.08527e-19","8say_oligo11","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_W_)-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(156_K_)",73.0452,"","",""
"8SAY","CRYOEM STRUCTURE OF DH270.3-CH848.10.17","10.1038/S41467-023-38108-1 ",3.4,"1.08527e-19","8say_oligo10","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_V_)-MAN(10_V_)-[MAN(9_V_)-MAN(8_V_)]-MAN(7_V_)-[MAN(6_V_)-MAN(5_V_)-MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(332_K_)",32.9092,"","",""
"8SAY","CRYOEM STRUCTURE OF DH270.3-CH848.10.17","10.1038/S41467-023-38108-1 ",3.4,"1.08527e-19","8say_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_T_)-[MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(442_F_)",91.5831,"","",""
"8SAY","CRYOEM STRUCTURE OF DH270.3-CH848.10.17","10.1038/S41467-023-38108-1 ",3.4,"1.08527e-19","8say_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_J_)-MAN(10_J_)-[MAN(9_J_)-MAN(8_J_)]-MAN(7_J_)-[MAN(6_J_)-MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(332_A_)",32.843,"","",""
"8SAY","CRYOEM STRUCTURE OF DH270.3-CH848.10.17","10.1038/S41467-023-38108-1 ",3.4,"1.08527e-19","8say_oligo5","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_R_)-MAN(10_R_)-[MAN(9_R_)-MAN(8_R_)]-MAN(7_R_)-[MAN(6_R_)-MAN(5_R_)-MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(332_F_)",26.1882,"","",""
"8SAY","CRYOEM STRUCTURE OF DH270.3-CH848.10.17","10.1038/S41467-023-38108-1 ",3.4,"1.08527e-19","8say_oligo3","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-MAN(4_O_)-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(156_A_)",91.2315,"","",""
"8SAY","CRYOEM STRUCTURE OF DH270.3-CH848.10.17","10.1038/S41467-023-38108-1 ",3.4,"1.08527e-19","8say_oligo7","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_S_)-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(156_F_)",81.6132,"","",""
"8SB0","CRYOEM STRUCTURE OF DH270.I4.6-CH848.10.17","10.1038/S41467-023-38108-1 ",4.2,"1.08527e-19","8sb0_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_J_)-MAN(8_J_)-[MAN(10_J_)]-MAN(7_J_)-[MAN(6_J_)-MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(332_A_)",23.711,"","",""
"8SB0","CRYOEM STRUCTURE OF DH270.I4.6-CH848.10.17","10.1038/S41467-023-38108-1 ",4.2,"1.08527e-19","8sb0_oligo4","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Q_)-[MAN(5_Q_)-MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(301_F_)",39.2394,"","",""
"8SB0","CRYOEM STRUCTURE OF DH270.I4.6-CH848.10.17","10.1038/S41467-023-38108-1 ",4.2,"1.08527e-19","8sb0_oligo6","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_R_)-MAN(8_R_)-[MAN(10_R_)]-MAN(7_R_)-[MAN(6_R_)-MAN(5_R_)-MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(332_F_)",25.9853,"","",""
"8SB0","CRYOEM STRUCTURE OF DH270.I4.6-CH848.10.17","10.1038/S41467-023-38108-1 ",4.2,"1.08527e-19","8sb0_oligo2","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(301_A_)",35.4047,"","",""
"8SB0","CRYOEM STRUCTURE OF DH270.I4.6-CH848.10.17","10.1038/S41467-023-38108-1 ",4.2,"1.08527e-19","8sb0_oligo10","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_V_)-MAN(8_V_)-[MAN(10_V_)]-MAN(7_V_)-[MAN(6_V_)-MAN(5_V_)-MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(332_K_)",25.1853,"","",""
"8SB0","CRYOEM STRUCTURE OF DH270.I4.6-CH848.10.17","10.1038/S41467-023-38108-1 ",4.2,"1.08527e-19","8sb0_oligo9","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_U_)-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(301_K_)",31.1532,"","",""
"8SB1","CRYOEM STRUCTURE OF DH270.I3-CH848.10.17","10.1038/S41467-023-38108-1 ",4.3,"1.08527e-19","8sb1_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_O_)-[MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(156_A_)",40.0345,"","",""
"8SB1","CRYOEM STRUCTURE OF DH270.I3-CH848.10.17","10.1038/S41467-023-38108-1 ",4.3,"1.08527e-19","8sb1_oligo7","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_S_)-[MAN(5_S_)-MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(156_F_)",46.1342,"","",""
"8SB1","CRYOEM STRUCTURE OF DH270.I3-CH848.10.17","10.1038/S41467-023-38108-1 ",4.3,"1.08527e-19","8sb1_oligo11","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_W_)-[MAN(5_W_)-MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(156_K_)",49.9155,"","",""
"8SB1","CRYOEM STRUCTURE OF DH270.I3-CH848.10.17","10.1038/S41467-023-38108-1 ",4.3,"1.08527e-19","8sb1_oligo5","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(301_A_)",48.6778,"","",""
"8SB1","CRYOEM STRUCTURE OF DH270.I3-CH848.10.17","10.1038/S41467-023-38108-1 ",4.3,"1.08527e-19","8sb1_oligo4","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(10_J_)-[MAN(9_J_)-MAN(8_J_)]-MAN(7_J_)-[MAN(6_J_)-MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(332_A_)",41.6835,"","",""
"8SB1","CRYOEM STRUCTURE OF DH270.I3-CH848.10.17","10.1038/S41467-023-38108-1 ",4.3,"1.08527e-19","8sb1_oligo10","DManpa1-2DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_V_)-[MAN(8_V_)]-MAN(7_V_)-[MAN(6_V_)-MAN(5_V_)-MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(332_K_)",34.1154,"","",""
"8SB1","CRYOEM STRUCTURE OF DH270.I3-CH848.10.17","10.1038/S41467-023-38108-1 ",4.3,"1.08527e-19","8sb1_oligo6","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(10_R_)-[MAN(9_R_)-MAN(8_R_)]-MAN(7_R_)-[MAN(6_R_)-MAN(5_R_)-MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(332_F_)",41.5063,"","",""
"8SB1","CRYOEM STRUCTURE OF DH270.I3-CH848.10.17","10.1038/S41467-023-38108-1 ",4.3,"1.08527e-19","8sb1_oligo2","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Q_)-MAN(4_Q_)-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(301_F_)",46.5311,"","",""
"8SB1","CRYOEM STRUCTURE OF DH270.I3-CH848.10.17","10.1038/S41467-023-38108-1 ",4.3,"1.08527e-19","8sb1_oligo9","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_U_)-MAN(4_U_)-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(301_K_)",41.4847,"","",""
"8SB2","CRYOEM STRUCTURE OF DH270.I2-CH848.10.17","10.1038/S41467-023-38108-1 ",3.5,"1.08527e-19","8sb2_oligo12","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_X_)-MAN(4_X_)-BMA(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(301_K_)",38.1665,"","",""
"8SB2","CRYOEM STRUCTURE OF DH270.I2-CH848.10.17","10.1038/S41467-023-38108-1 ",3.5,"1.08527e-19","8sb2_oligo7","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_P_)-[MAN(5_P_)]-MAN(4_P_)-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(156_A_)",57.8124,"","",""
"8SB2","CRYOEM STRUCTURE OF DH270.I2-CH848.10.17","10.1038/S41467-023-38108-1 ",3.5,"1.08527e-19","8sb2_oligo13","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_Y_)-MAN(10_Y_)-[MAN(9_Y_)-MAN(8_Y_)]-MAN(7_Y_)-[MAN(6_Y_)-MAN(5_Y_)-MAN(4_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(332_K_)",27.3535,"","",""
"8SB2","CRYOEM STRUCTURE OF DH270.I2-CH848.10.17","10.1038/S41467-023-38108-1 ",3.5,"1.08527e-19","8sb2_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_Q_)-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(442_A_)",56.5652,"","",""
"8SB2","CRYOEM STRUCTURE OF DH270.I2-CH848.10.17","10.1038/S41467-023-38108-1 ",3.5,"1.08527e-19","8sb2_oligo6","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_O_)-MAN(10_O_)-[MAN(9_O_)-MAN(8_O_)]-MAN(7_O_)-[MAN(6_O_)-MAN(5_O_)-MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(332_A_)",31.4939,"","",""
"8SB2","CRYOEM STRUCTURE OF DH270.I2-CH848.10.17","10.1038/S41467-023-38108-1 ",3.5,"1.08527e-19","8sb2_oligo1","DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-MAN(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(301_A_)",38.7213,"","",""
"8SB2","CRYOEM STRUCTURE OF DH270.I2-CH848.10.17","10.1038/S41467-023-38108-1 ",3.5,"1.08527e-19","8sb2_oligo8","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_T_)-MAN(10_T_)-[MAN(9_T_)-MAN(8_T_)]-MAN(7_T_)-[MAN(6_T_)-MAN(5_T_)-MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(332_F_)",33.9937,"","",""
"8SB2","CRYOEM STRUCTURE OF DH270.I2-CH848.10.17","10.1038/S41467-023-38108-1 ",3.5,"1.08527e-19","8sb2_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_S_)-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(301_F_)",28.2377,"","",""
"8SB2","CRYOEM STRUCTURE OF DH270.I2-CH848.10.17","10.1038/S41467-023-38108-1 ",3.5,"1.08527e-19","8sb2_oligo14","DManpa1-3[DManpa1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Z_)-[MAN(5_Z_)]-MAN(4_Z_)-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(156_K_)",52.0526,"","",""
"8SB3","CRYOEM STRUCTURE OF DH270.2-CH848.10.17","10.1038/S41467-023-38108-1 ",4.1,"1.08527e-19","8sb3_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_Q_)-[MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(301_F_)",89.3938,"","",""
"8SB3","CRYOEM STRUCTURE OF DH270.2-CH848.10.17","10.1038/S41467-023-38108-1 ",4.1,"1.08527e-19","8sb3_oligo9","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_U_)-[MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(301_K_)",88.5625,"","",""
"8SB3","CRYOEM STRUCTURE OF DH270.2-CH848.10.17","10.1038/S41467-023-38108-1 ",4.1,"1.08527e-19","8sb3_oligo4","DManpa1-2DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_O_)-[MAN(6_O_)-MAN(5_O_)-MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(156_A_)",106.819,"","",""
"8SB3","CRYOEM STRUCTURE OF DH270.2-CH848.10.17","10.1038/S41467-023-38108-1 ",4.1,"1.08527e-19","8sb3_oligo10","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_V_)-MAN(10_V_)-[MAN(9_V_)-MAN(8_V_)]-MAN(7_V_)-[MAN(6_V_)-MAN(5_V_)-MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(332_K_)",71.0108,"","",""
"8SB3","CRYOEM STRUCTURE OF DH270.2-CH848.10.17","10.1038/S41467-023-38108-1 ",4.1,"1.08527e-19","8sb3_oligo7","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_S_)-[MAN(5_S_)-MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(156_F_)",99.2912,"","",""
"8SB3","CRYOEM STRUCTURE OF DH270.2-CH848.10.17","10.1038/S41467-023-38108-1 ",4.1,"1.08527e-19","8sb3_oligo5","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_R_)-MAN(10_R_)-[MAN(9_R_)-MAN(8_R_)]-MAN(7_R_)-[MAN(6_R_)-MAN(5_R_)-MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(332_F_)",62.7731,"","",""
"8SB3","CRYOEM STRUCTURE OF DH270.2-CH848.10.17","10.1038/S41467-023-38108-1 ",4.1,"1.08527e-19","8sb3_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(301_A_)",87.9335,"","",""
"8SB3","CRYOEM STRUCTURE OF DH270.2-CH848.10.17","10.1038/S41467-023-38108-1 ",4.1,"1.08527e-19","8sb3_oligo6","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_J_)-MAN(10_J_)-[MAN(9_J_)-MAN(8_J_)]-MAN(7_J_)-[MAN(6_J_)-MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(332_A_)",64.7202,"","",""
"8SB3","CRYOEM STRUCTURE OF DH270.2-CH848.10.17","10.1038/S41467-023-38108-1 ",4.1,"1.08527e-19","8sb3_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_P_)-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)-ASN(442_A_)",98.9734,"","",""
"8SB3","CRYOEM STRUCTURE OF DH270.2-CH848.10.17","10.1038/S41467-023-38108-1 ",4.1,"1.08527e-19","8sb3_oligo8","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_T_)-[MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(442_F_)",99.5085,"","",""
"8SB3","CRYOEM STRUCTURE OF DH270.2-CH848.10.17","10.1038/S41467-023-38108-1 ",4.1,"1.08527e-19","8sb3_oligo11","DManpa1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_W_)-[MAN(5_W_)-MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(156_K_)",101.45,"","",""
"8SB5","CRYOEM STRUCTURE OF DH270.I1.6-CH848.10.17","10.1038/S41467-023-38108-1 ",3.9,"1.08527e-19","8sb5_oligo7","DManpa1-2DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_S_)-MAN(5_S_)-MAN(4_S_)-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(156_F_)",52.7433,"","",""
"8SB5","CRYOEM STRUCTURE OF DH270.I1.6-CH848.10.17","10.1038/S41467-023-38108-1 ",3.9,"1.08527e-19","8sb5_oligo5","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_R_)-MAN(10_R_)-[MAN(9_R_)-MAN(8_R_)]-MAN(7_R_)-[MAN(6_R_)-MAN(5_R_)-MAN(4_R_)]-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(332_F_)",24.0663,"","",""
"8SB5","CRYOEM STRUCTURE OF DH270.I1.6-CH848.10.17","10.1038/S41467-023-38108-1 ",3.9,"1.08527e-19","8sb5_oligo9","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_U_)-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(301_K_)",35.3948,"","",""
"8SB5","CRYOEM STRUCTURE OF DH270.I1.6-CH848.10.17","10.1038/S41467-023-38108-1 ",3.9,"1.08527e-19","8sb5_oligo4","DManpa1-2DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_O_)-MAN(5_O_)-MAN(4_O_)-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(156_A_)",50.32,"","",""
"8SB5","CRYOEM STRUCTURE OF DH270.I1.6-CH848.10.17","10.1038/S41467-023-38108-1 ",3.9,"1.08527e-19","8sb5_oligo3","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_J_)-MAN(10_J_)-[MAN(9_J_)-MAN(8_J_)]-MAN(7_J_)-[MAN(6_J_)-MAN(5_J_)-MAN(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(332_A_)",24.8931,"","",""
"8SB5","CRYOEM STRUCTURE OF DH270.I1.6-CH848.10.17","10.1038/S41467-023-38108-1 ",3.9,"1.08527e-19","8sb5_oligo11","DManpa1-2DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_W_)-MAN(5_W_)-MAN(4_W_)-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(156_K_)",59.9618,"","",""
"8SB5","CRYOEM STRUCTURE OF DH270.I1.6-CH848.10.17","10.1038/S41467-023-38108-1 ",3.9,"1.08527e-19","8sb5_oligo10","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-3[DManpa1-2DManpa1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(11_V_)-MAN(10_V_)-[MAN(9_V_)-MAN(8_V_)]-MAN(7_V_)-[MAN(6_V_)-MAN(5_V_)-MAN(4_V_)]-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(332_K_)",14.7497,"","",""
"8SB5","CRYOEM STRUCTURE OF DH270.I1.6-CH848.10.17","10.1038/S41467-023-38108-1 ",3.9,"1.08527e-19","8sb5_oligo2","DManpa1-2DManpa1-2DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_Q_)-MAN(5_Q_)-MAN(4_Q_)-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(301_F_)",42.6306,"","",""
"8SB5","CRYOEM STRUCTURE OF DH270.I1.6-CH848.10.17","10.1038/S41467-023-38108-1 ",3.9,"1.08527e-19","8sb5_oligo6","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(301_A_)",32.5932,"","",""
"8SGO","HUMAN GABAA RECEPTOR ALPHA1-BETA2-GAMMA2 SUBTYPE IN COMPLEX WITH GABA PLUS PREGNENOLONE SULFATE","10.1038/S41467-023-40800-1 ",2.65,"1.35632e-19","8sgo_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_G_)-MAN(8_G_)-[MAN(10_G_)]-MAN(7_G_)-[MAN(6_G_)-MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(111_B_)",52.2102,"","",""
"8SI9","HUMAN GABAA RECEPTOR ALPHA1-BETA2-GAMMA2 SUBTYPE IN COMPLEX WITH GABA PLUS ALLOPREGNANOLONE","10.1038/S41467-023-40800-1 ",2.98,"1.35632e-19","8si9_oligo1","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_G_)-MAN(8_G_)-[MAN(10_G_)]-MAN(7_G_)-[MAN(6_G_)-MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(111_B_)",75.5249,"","",""
"8SID","HUMAN GABAA RECEPTOR ALPHA1-BETA2-GAMMA2 SUBTYPE IN COMPLEX WITH GABA PLUS DEHYDROEPIANDROSTERONE SULFATE","10.1038/S41467-023-40800-1 ",2.71,"1.35632e-19","8sid_oligo2","DManpa1-2DManpa1-2DManpa1-3[DManpa1-2DManpa1-6[DManpa1-3]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(9_G_)-MAN(8_G_)-[MAN(10_G_)]-MAN(7_G_)-[MAN(6_G_)-MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(111_B_)",81.0507,"","",""
"8T2V","CRYO-EM STRUCTURES OF FULL-LENGTH INTEGRIN ALPHAIIBBETA3 IN NATIVE LIPIDS","10.1038/S41467-023-39763-0 ",3.4,"1.15243e-41","8t2v_oligo2","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_F_)-[BMA(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(371_B_)",293.528,"","",""
"8TGY","CRYSTAL STRUCTURE OF GDX-CLO FROM SMALL MULTIDRUG RESISTANCE FAMILY OF TRANSPORTERS IN COMPLEX WITH GUANYLUREA","",2.18,0,"8tgy_oligo2","DGlcpa1-3DGlcpb6-C2O1","DMU(101_D_)-DMU(101_D_)",72.0777,"","",""
"8TGY","CRYSTAL STRUCTURE OF GDX-CLO FROM SMALL MULTIDRUG RESISTANCE FAMILY OF TRANSPORTERS IN COMPLEX WITH GUANYLUREA","",2.18,0,"8tgy_oligo1","DGlcpa1-3DGlcpb6-C10O1","DMU(501_C_)-DMU(501_C_)",79.2164,"","",""
"8TY1","CRYO-EM STRUCTURE OF COAGULATION FACTOR VIII BOUND TO NB2E9","",3.46,"1.35632e-19","8ty1_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(28_C_)",234.931,"","",""
"8TY1","CRYO-EM STRUCTURE OF COAGULATION FACTOR VIII BOUND TO NB2E9","",3.46,"1.35632e-19","8ty1_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(240_A_)",215.2,"","",""
"8TY1","CRYO-EM STRUCTURE OF COAGULATION FACTOR VIII BOUND TO NB2E9","",3.46,"1.35632e-19","8ty1_oligo2","DManpa1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(1810_A_)",222.185,"","",""
"9API","THE S VARIANT OF HUMAN ALPHA1-ANTITRYPSIN, STRUCTURE AND IMPLICATIONS FOR FUNCTION AND METABOLISM","10.1093/PROTEIN/2.6.407 ",3,0,"9api_oligo1","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_C_)-MAN(4_C_)-[MAN(6_C_)]-MAN(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(46_A_)",57.3958,"","",""
